PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Boudreau, LH; Bertin, J; Robichaud, PP; Laflamme, M; Ouellette, RJ; Flamand, N; Surette, ME				Boudreau, Luc H.; Bertin, Jonathan; Robichaud, Philippe P.; Laflamme, Mark; Ouellette, Rodney J.; Flamand, Nicolas; Surette, Marc E.			Novel 5-lipoxygenase isoforms affect the biosynthesis of 5-lipoxygenase products	FASEB JOURNAL			English	Article						inflammation; lipid mediators; leukocytes; leukotrienes; eicosanoids	COACTOSIN-LIKE PROTEIN; ARACHIDONIC-ACID; ACTIVATING PROTEIN; HUMAN NEUTROPHILS; ENZYME-ACTIVITY; LEUKOTRIENE BIOSYNTHESIS; GENE PROMOTER; BINDING-SITE; STEM-CELLS; EXPRESSION	5-Lipoxygenase (5-LO) is the essential enzyme for the biosynthesis of leukotrienes, important mediators of inflammation. This study investigated whether variants of 5-LO exist in human leukocytes. 5-LO mRNA isoforms that are consistent with alternative splicing were identified by RT-PCR in a cell line or cell type-specific pattern. All evaluated cells expressed mRNA containing all 14 exons of 5-LO with the expected splicing sites. Individual isoforms that retained intron 10 (alpha-10), lacked exon 13 (Delta-13), and lacked exons 10 and 13 (Delta-10,13) or that lacked the first 96 base pairs of exon 10 (Delta-p10) were identified. Immunoreactive bands coeluting with the cloned alpha-10 and Delta-13 isoforms were measured in primary neutrophils and in Raji cells. When expressed in HEK293 cells, alternative proteins were without catalytic activity. However, when coexpressed with the active full-length 5-LO, alternative isoforms significantly decreased the biosynthesis of 5-LO products by up to 44%, as assessed by reverse-phase HPLC analysis. Additionally, in stimulated neutrophils the full-length active 5-LO was detected by immunoblot in both nuclear and nonnuclear compartments, while the Delta-13 isoform was only detected in the nuclear fraction. These alternative 5-LO isoforms may represent a new mechanism for the regulation of the 5-LO pathway and lipid mediator biosynthesis.-Boudreau, L. H., Bertin, J., Robichaud, P. P., Laflamme, M., Ouellette, R. J., Flamand, N., Surette, M. E. Novel 5-lipoxygenase isoforms affect the biosynthesis of 5-lipoxygenase products. FASEB J. 25, 1097-1105 (2011). www.fasebj.org	[Boudreau, Luc H.; Bertin, Jonathan; Robichaud, Philippe P.; Surette, Marc E.] Univ Moncton, Dept Chim & Biochim, Moncton, NB E1A 3E9, Canada; [Boudreau, Luc H.; Flamand, Nicolas] Univ Laval, Dept Med, Ctr Rech, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ G1K 7P4, Canada; [Boudreau, Luc H.; Flamand, Nicolas] Univ Laval, Fac Med, Quebec City, PQ G1K 7P4, Canada; [Laflamme, Mark; Ouellette, Rodney J.] Atlantic Canc Res Inst, Moncton, NB, Canada; [Laflamme, Mark] Dept Fisheries & Oceans Canada, Moncton, NB, Canada	University of Moncton; Laval University; Laval University; Fisheries & Oceans Canada	Surette, ME (corresponding author), Univ Moncton, Dept Chim & Biochim, Moncton, NB E1A 3E9, Canada.	marc.surette@umoncton.ca	Flamand, Nicolas/H-5823-2019; Surette, Marc/AAW-1078-2021; Laflamme, MarK/B-5077-2010	Flamand, Nicolas/0000-0001-5944-7200; Laflamme, MarK/0000-0001-5955-7098; Boudreau, Luc H/0000-0002-3674-5026	Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada; Canada Research Chairs Program; Canadian Arthritis Network; Fonds de la Recherche en Sante du Quebec; Fonds de Recherche sur l'Arthrite et Les Maladies Rhumatismales de l'Universite Laval	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canada Research Chairs Program(Canada Research Chairs); Canadian Arthritis Network; Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Fonds de Recherche sur l'Arthrite et Les Maladies Rhumatismales de l'Universite Laval	This work was supported by grants from the Canadian Institutes of Health Research (to M. E. S.) and the Heart and Stroke Foundation of Canada (to M. E. S.). M. E. S. is supported by the Canada Research Chairs Program. N.F. is the recipient of scholarship awards from the Canadian Arthritis Network and the Fonds de la Recherche en Sante du Quebec. L. H. B is the recipient of a scholarship from the Fonds de Recherche sur l'Arthrite et Les Maladies Rhumatismales de l'Universite Laval and a graduate student award from the Canadian Arthritis Network.	ABRAMOVITZ M, 1993, EUR J BIOCHEM, V215, P105, DOI 10.1111/j.1432-1033.1993.tb18012.x; Allard JB, 2005, CURR PROTEIN PEPT SC, V6, P125, DOI 10.2174/1389203053545417; Arseneau JR, 2009, BRIT J HAEMATOL, V147, P328, DOI 10.1111/j.1365-2141.2009.07859.x; Ben-Dov C, 2008, J BIOL CHEM, V283, P1229, DOI 10.1074/jbc.R700033200; BORGEAT P, 1990, METHOD ENZYMOL, V187, P98; BORGEAT P, 1976, J BIOL CHEM, V251, P7816; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; BROCK TG, 1995, J BIOL CHEM, V270, P21652, DOI 10.1074/jbc.270.37.21652; Chen XS, 2001, J BIOL CHEM, V276, P811, DOI 10.1074/jbc.M008203200; Chen YY, 2009, CELL CYCLE, V8, P3488, DOI 10.4161/cc.8.21.9852; Dishart D, 2005, BBA-MOL CELL BIOL L, V1738, P37, DOI 10.1016/j.bbalip.2005.11.008; Dwyer JH, 2004, NEW ENGL J MED, V350, P29, DOI 10.1056/NEJMoa025079; Ferguson AD, 2007, SCIENCE, V317, P510, DOI 10.1126/science.1144346; Finkensieper A, 2010, CARDIOVASC RES, V86, P37, DOI 10.1093/cvr/cvp385; Flamand N, 2007, CELL MOL LIFE SCI, V64, P2657, DOI 10.1007/s00018-007-7228-2; Flamand N, 2006, J BIOL CHEM, V281, P129, DOI 10.1074/jbc.M506513200; Flamand N, 2002, MOL PHARMACOL, V62, P250, DOI 10.1124/mol.62.2.250; Flamand N, 2009, J BIOL CHEM, V284, P306, DOI 10.1074/jbc.M805593200; FUNK CD, 1989, P NATL ACAD SCI USA, V86, P2587, DOI 10.1073/pnas.86.8.2587; Gao KP, 2008, NUCLEIC ACIDS RES, V36, P2257, DOI 10.1093/nar/gkn073; Hammarberg T, 2000, J BIOL CHEM, V275, P38787, DOI 10.1074/jbc.M006136200; Hegg EL, 1997, EUR J BIOCHEM, V250, P625, DOI 10.1111/j.1432-1033.1997.t01-1-00625.x; Helgadottir A, 2004, NAT GENET, V36, P233, DOI 10.1038/ng1311; Hemak J, 2002, J MOL MODEL, V8, P102, DOI 10.1007/s00894-002-0076-y; HOSHIKO S, 1990, P NATL ACAD SCI USA, V87, P9073, DOI 10.1073/pnas.87.23.9073; Jendraschak E, 1996, BIOCHEM J, V314, P733, DOI 10.1042/bj3140733; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Kilty I, 1999, EUR J BIOCHEM, V266, P83, DOI 10.1046/j.1432-1327.1999.00818.x; Leff JA, 1998, NEW ENGL J MED, V339, P147, DOI 10.1056/NEJM199807163390302; Markwell M A, 1981, Methods Enzymol, V72, P296; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Michel AAY, 2008, PROTEIN EXPRES PURIF, V59, P110, DOI 10.1016/j.pep.2008.01.010; Newcomer ME, 2010, J BIOL CHEM, V285, P25109, DOI 10.1074/jbc.R110.125880; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Plante H, 2006, BIOCHEM J, V393, P211, DOI 10.1042/BJ20060669; Provost P, 2001, J BIOL CHEM, V276, P16520, DOI 10.1074/jbc.M011205200; Radmark O, 2007, TRENDS BIOCHEM SCI, V32, P332, DOI 10.1016/j.tibs.2007.06.002; Rakonjac M, 2006, P NATL ACAD SCI USA, V103, P13150, DOI 10.1073/pnas.0605150103; Ring WL, 1997, AM J PHYSIOL-CELL PH, V273, pC2057, DOI 10.1152/ajpcell.1997.273.6.C2057; Roos KLT, 2005, BIOCHEM BIOPH RES CO, V338, P62, DOI 10.1016/j.bbrc.2005.08.031; ROUZER CA, 1987, P NATL ACAD SCI USA, V84, P7393, DOI 10.1073/pnas.84.21.7393; Serhan CN, 2010, AM J PATHOL, V177, P1576, DOI 10.2353/ajpath.2010.100322; Seuter S, 2007, BBA-MOL CELL BIOL L, V1771, P864, DOI 10.1016/j.bbalip.2007.04.007; Seuter S, 2006, BIOCHEM BIOPH RES CO, V348, P1403, DOI 10.1016/j.bbrc.2006.08.011; Sorg BL, 2006, BBA-MOL CELL BIOL L, V1761, P686, DOI 10.1016/j.bbalip.2006.04.005; Tardif JC, 2010, CIRC-CARDIOVASC IMAG, V3, P298, DOI 10.1161/CIRCIMAGING.110.937169; Uhl J, 2002, J BIOL CHEM, V277, P4374, DOI 10.1074/jbc.M107665200; Werz O, 2005, P NATL ACAD SCI USA, V102, P13164, DOI 10.1073/pnas.0505991102; Werz O, 2000, EUR J BIOCHEM, V267, P1263, DOI 10.1046/j.1432-1327.2000.01000.x; WOODS JW, 1993, J EXP MED, V178, P1935, DOI 10.1084/jem.178.6.1935	51	20	21	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2011	25	3					1097	1105		10.1096/fj.10-173856	http://dx.doi.org/10.1096/fj.10-173856			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	727MZ	21098726				2022-12-25	WOS:000287806200029
J	Suter, M; Bocock, P; Showalter, L; Hu, M; Shope, C; McKnight, R; Grove, K; Lane, R; Aagaard-Tillery, K				Suter, Melissa; Bocock, Philip; Showalter, Lori; Hu, Min; Shope, Cynthia; McKnight, Robert; Grove, Kevin; Lane, Robert; Aagaard-Tillery, Kjersti			Epigenomics: maternal high-fat diet exposure in utero disrupts peripheral circadian gene expression in nonhuman primates	FASEB JOURNAL			English	Article						Npas2; epigenetics; fetal origins of adult disease	REV-ERB-ALPHA; BODY-MASS INDEX; SUPRACHIASMATIC NUCLEUS; HISTONE ACETYLATION; CHROMATIN-STRUCTURE; METABOLIC SYNDROME; GLUCOSE-TOLERANCE; CLOCK; FETAL; DNA	The effect of in utero exposure to a maternal high-fat diet on the peripheral circadian system of the fetus is unknown. Using mRNA copy number analysis, we report that the components of the peripheral circadian machinery are transcribed in the nonhuman primate fetal liver in an intact phase-antiphase fashion and that Npas2, a paralog of the Clock transcription factor, serves as the rate-limiting transcript by virtue of its relative low abundance (10- to 1000-fold lower). We show that exposure to a maternal high-fat diet in utero significantly alters the expression of fetal hepatic Npas2 (up to 7.1-fold, P<0.001) compared with that in control diet-exposed animals and is reversible in fetal offspring from obese dams reversed to a control diet (1.3-fold, P>0.05). Although the Npas2 promoter remains largely unmethylated, differential Npas2 promoter occupancy of acetylation of fetal histone H3 at lysine 14 (H3K14ac) occurs in response to maternal high-fat diet exposure compared with control diet-exposed animals. Furthermore, we find that disruption of Npas2 is consistent with high-fat diet exposure in juvenile animals, regardless of in utero diet exposure. In summary, the data suggest that peripheral Npas2 expression is uniquely vulnerable to diet exposure.-Suter, M., Bocock, P., Showalter, L., Hu, M., Shope, C., McKnight, R., Grove, K., Lane, R., Aagaard-Tillery, K. Epigenomics: maternal high-fat diet exposure in utero disrupts peripheral circadian gene expression in nonhuman primates. FASEB J. 25, 714-726 (2011). www.fasebj.org	[Aagaard-Tillery, Kjersti] Baylor Coll Med, Div Maternal Fetal Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; [McKnight, Robert; Lane, Robert] Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT USA; [Grove, Kevin] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Div Neurosci, Beaverton, OR USA	Baylor College of Medicine; Utah System of Higher Education; University of Utah; Oregon Health & Science University; Oregon National Primate Research Center	Aagaard-Tillery, K (corresponding author), Baylor Coll Med, Div Maternal Fetal Med, Dept Obstet & Gynecol, 1 Baylor Plaza,Jones 314, Houston, TX 77030 USA.	aagaardt@bcm.edu			U.S. National Institutes of Health (NIH) [DP2120OD001500-01]; National Institute of Child Health and Human Development/National Institute of Diabetes and Digestive and Kidney Diseases [R01-DK080558-01, DK79194]; NIH [K12-GM084897]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080558, R01DK079194, R24DK090964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM084897] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001500] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Child Health and Human Development/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors acknowledge the helpful comments of members of the Ignatia B. Van Den Veyver and Shannon M. Hawkins laboratories at Baylor College of Medicine. This work was supported by the U.S. National Institutes of Health (NIH) Director New Innovator Award (DP2120OD001500-01 to K. A. T.), National Institute of Child Health and Human Development/National Institute of Diabetes and Digestive and Kidney Diseases (grants R01-DK080558-01 to R. H. L and K. A. T and DK79194 to K. L. G.), and the NIH Research Education and Career Horizon Institutional Research and Academic Career Development Award (grant K12-GM084897 to M. S.). The authors report no conflicts of interest or financial disclosures.	Aagaard-Tillery KM, 2008, J MOL ENDOCRINOL, V41, P91, DOI 10.1677/JME-08-0025; Anttila S, 2003, CANCER RES, V63, P8623; Bae K, 2000, J NEUROSCI, V20, P1746; Barnea M, 2009, ENDOCRINOLOGY, V150, P161, DOI 10.1210/en.2008-0944; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; Chen RM, 2009, MOL CELL, V36, P417, DOI 10.1016/j.molcel.2009.10.012; Cheng XD, 2010, BIOCHEMISTRY-US, V49, P2999, DOI 10.1021/bi100213t; Cox J, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.041; Curtis AM, 2004, J BIOL CHEM, V279, P7091, DOI 10.1074/jbc.M311973200; Datta J, 2003, J CELL BIOCHEM, V88, P855, DOI 10.1002/jcb.10457; Debruyne J, 2008, J GENET, V87, P437, DOI 10.1007/s12041-008-0066-7; Dudley CA, 2003, SCIENCE, V301, P379, DOI 10.1126/science.1082795; Duez H, 2008, FEBS LETT, V582, P19, DOI 10.1016/j.febslet.2007.08.032; Duez H, 2009, J APPL PHYSIOL, V107, P1972, DOI 10.1152/japplphysiol.00570.2009; El-Hennamy R, 2008, J BIOL RHYTHM, V23, P435, DOI 10.1177/0748730408322635; Englund Ani, 2009, J Circadian Rhythms, V7, P5, DOI 10.1186/1740-3391-7-5; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130; Fu Q, 2004, PHYSIOL GENOMICS, V20, P108, DOI 10.1152/physiolgenomics.00175.2004; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; Gangwisch JE, 2009, OBES REV, V10, P37, DOI 10.1111/j.1467-789X.2009.00663.x; Grove KL, 2005, PHYSIOL BEHAV, V86, P646, DOI 10.1016/j.physbeh.2005.08.063; Hartil K, 2009, PEDIATR RES, V66, P368, DOI 10.1203/PDR.0b013e3181b33375; Herzog ED, 1998, NAT NEUROSCI, V1, P708, DOI 10.1038/3708; Hiragami-Hamada K, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-14; Horikawa K, 2005, NEUROSCIENCE, V134, P335, DOI 10.1016/j.neuroscience.2005.03.057; Ibuka N, 1980, Waking Sleeping, V4, P167; Kennaway DJ, 2002, TRENDS ENDOCRIN MET, V13, P398, DOI 10.1016/S1043-2760(02)00692-6; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Kovacikova Z, 2006, J BIOL RHYTHM, V21, P140, DOI 10.1177/0748730405285876; la Fleur SE, 2001, DIABETES, V50, P1237, DOI 10.2337/diabetes.50.6.1237; Lane RH, 1996, PEDIATR RES, V39, P390, DOI 10.1203/00006450-199603000-00003; Lane RH, 2000, PEDIATR RES, V47, P792, DOI 10.1203/00006450-200006000-00019; LeGates TA, 2009, PHYSIOL BEHAV, V98, P427, DOI 10.1016/j.physbeh.2009.07.007; Lemos DR, 2006, MOL ENDOCRINOL, V20, P1164, DOI 10.1210/me.2005-0361; Leroy G, 2008, MOL CELL, V30, P51, DOI 10.1016/j.molcel.2008.01.018; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loyola A, 2009, EMBO REP, V10, P769, DOI 10.1038/embor.2009.90; MacLennan NK, 2004, PHYSIOL GENOMICS, V18, P43, DOI 10.1152/physiolgenomics.00042.2004; Martinato F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003650; McCurdy CE, 2009, J CLIN INVEST, V119, P323, DOI 10.1172/JCI32661; Mendoza J, 2008, J PHYSIOL-LONDON, V586, P5901, DOI 10.1113/jphysiol.2008.159566; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Ohta H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002601; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Patton HM, 2006, J PEDIATR GASTR NUTR, V43, P413, DOI 10.1097/01.mpg.0000239995.58388.56; Plata MP, 2009, CHROMOSOMA, V118, P303, DOI 10.1007/s00412-008-0198-9; Popkin BM, 2004, INT J OBESITY, V28, pS2, DOI [10.1038/sj.ijo.0802804, 10.1038/sj.ijo.0802557]; Porterfield VM, 2009, NEUROSCI LETT, V463, P70, DOI 10.1016/j.neulet.2009.07.066; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rich-Edwards JW, 2005, BMJ-BRIT MED J, V330, P1115, DOI 10.1136/bmj.38434.629630.E0; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Ruger M, 2009, REV ENDOCR METAB DIS, V10, P245, DOI 10.1007/s11154-009-9122-8; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Schwimmer JB, 2005, HEPATOLOGY, V42, p610A; Seron-Ferre M, 2002, MOL CELL ENDOCRINOL, V186, P169, DOI 10.1016/S0303-7207(01)00682-7; Seron-Ferre Maria, 2007, Birth Defects Research, V81, P204, DOI 10.1002/bdrc.20101; SERONFERRE M, 1983, J CLIN ENDOCR METAB, V57, P1173, DOI 10.1210/jcem-57-6-1173; Siepka SM, 2007, COLD SPRING HARB SYM, V72, P251, DOI 10.1101/sqb.2007.72.052; Slyper AH, 2004, J CLIN ENDOCR METAB, V89, P2540, DOI 10.1210/jc.2003-031449; SOCOL ML, 1981, AM J OBSTET GYNECOL, V139, P712, DOI 10.1016/0002-9378(81)90493-2; Sosniyenko S, 2009, EUR J NEUROSCI, V30, P1802, DOI 10.1111/j.1460-9568.2009.06945.x; Speiser PW, 2005, J CLIN ENDOCR METAB, V90, P1871, DOI 10.1210/jc.2004-1389; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Strauss RS, 2001, JAMA-J AM MED ASSOC, V286, P2845, DOI 10.1001/jama.286.22.2845; Suter M, 2010, METABOLISM, V59, P1481, DOI 10.1016/j.metabol.2010.01.013; Suter MA, 2009, SEMIN REPROD MED, V27, P380, DOI 10.1055/s-0029-1237426; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Vaquero A, 2007, NATURE, V450, P440, DOI 10.1038/nature06268; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; WALSH SW, 1984, AM J OBSTET GYNECOL, V150, P745, DOI 10.1016/0002-9378(84)90679-3; Yamamoto T, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-18; Zvonic S, 2006, DIABETES, V55, P962, DOI 10.2337/diabetes.55.04.06.db05-0873	76	88	92	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2011	25	2					714	726		10.1096/fj.10-172080	http://dx.doi.org/10.1096/fj.10-172080			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	713GZ	21097519	Green Published			2022-12-25	WOS:000286724800029
J	Jeffery, E; Peters, LR; Raghavan, M				Jeffery, Elise; Peters, Larry Robert; Raghavan, Malini			The Polypeptide Binding Conformation of Calreticulin Facilitates Its Cell-surface Expression under Conditions of Endoplasmic Reticulum Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I HISTOCOMPATIBILITY MOLECULES; QUALITY-CONTROL; CHAPERONE; CALCIUM; DEATH; IMMUNOGENICITY; CALNEXIN; ERP57; PROTEINS; IDENTIFICATION	We define two classes of calreticulin mutants that retain glycan binding activity; those that display enhanced or reduced polypeptide-specific chaperone activity, due to conformational effects. Under normal conditions, neither set of mutants significantly impacts the ability of calreticulin to mediate assembly and trafficking of major histocompatibility complex class I molecules, which are calreticulin substrates. However, in cells treated with thapsigargin, which depletes endoplasmic reticulum calcium, major histocompatibility complex class I trafficking rates are accelerated coincident with calreticulin secretion, and detection of cell-surface calreticulin is dependent on its polypeptide binding conformations. Together, these findings identify a site on calreticulin that is an important determinant of the induction of its polypeptide binding conformation and demonstrate the relevance of the polypeptide binding conformations of calreticulin to endoplasmic reticulum stress-induced interactions.	[Jeffery, Elise; Raghavan, Malini] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Peters, Larry Robert] Univ Michigan, Sch Med, Grad Program Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Raghavan, M (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, 5641 Med Sci Bldg 2, Ann Arbor, MI 48109 USA.	malinir@umich.edu			National Institutes of Health [AI066131]; University of Michigan Rheumatic Diseases Core Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044115, R01AI066131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Rheumatic Diseases Core Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AI066131 (to M.R.). This work was also supported by the University of Michigan Rheumatic Diseases Core Center.	BOOTH C, 1989, CELL, V59, P729, DOI 10.1016/0092-8674(89)90019-6; Chiu J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh172; Del Cid N, 2010, J BIOL CHEM, V285, P4520, DOI 10.1074/jbc.M109.085407; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fu HM, 2009, MOL IMMUNOL, V46, P3198, DOI 10.1016/j.molimm.2009.08.012; Gao B, 2002, IMMUNITY, V16, P99, DOI 10.1016/S1074-7613(01)00260-6; Gold LI, 2010, FASEB J, V24, P665, DOI 10.1096/fj.09-145482; Guo L, 2003, J BIOL CHEM, V278, P50645, DOI 10.1074/jbc.M309497200; Howe C, 2009, EMBO J, V28, P3730, DOI 10.1038/emboj.2009.296; Ireland BS, 2008, MOL BIOL CELL, V19, P2413, DOI 10.1091/mbc.E07-10-1055; Kepp O, 2009, CURR OPIN ONCOL, V21, P71, DOI 10.1097/CCO.0b013e32831bc375; Kozlov G, 2010, J BIOL CHEM, V285, P38612, DOI 10.1074/jbc.M110.168294; Leach MR, 2002, J BIOL CHEM, V277, P29686, DOI 10.1074/jbc.M202405200; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; LODISH HF, 1990, J BIOL CHEM, V265, P10893; LODISH HF, 1992, J BIOL CHEM, V267, P12753; Malawski GA, 2006, PROTEIN SCI, V15, P2718, DOI 10.1110/ps.062491906; Mandal M, 2003, METHOD ENZYMOL, V372, P319; Nakamura K, 2001, J CELL BIOL, V154, P961, DOI 10.1083/jcb.200102073; Obeid M, 2008, J IMMUNOL, V181, P2533, DOI 10.4049/jimmunol.181.4.2533; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Panaretakis T, 2008, CELL DEATH DIFFER, V15, P1499, DOI 10.1038/cdd.2008.67; Peaper DR, 2008, ANNU REV CELL DEV BI, V24, P343, DOI 10.1146/annurev.cellbio.24.110707.175347; Pieper U, 2004, NUCLEIC ACIDS RES, V32, pD217, DOI 10.1093/nar/gkh095; Raghavan M, 2008, TRENDS IMMUNOL, V29, P436, DOI 10.1016/j.it.2008.06.004; Rizvi SM, 2004, MOL CELL, V15, P913, DOI 10.1016/j.molcel.2004.09.001; Saito Y, 1999, EMBO J, V18, P6718, DOI 10.1093/emboj/18.23.6718; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; Schwarze SR, 2008, PROSTATE, V68, P1615, DOI 10.1002/pros.20828; SONNICHSEN B, 1994, J CELL SCI, V107, P2705; Subramanian K, 1997, CELL, V89, P963, DOI 10.1016/S0092-8674(00)80281-0; Tarr JM, 2010, J MOL BIOL, V401, P799, DOI 10.1016/j.jmb.2010.06.064; Tufi R, 2008, CELL DEATH DIFFER, V15, P274, DOI 10.1038/sj.cdd.4402275; WIEST DL, 1995, EMBO J, V14, P3425, DOI 10.1002/j.1460-2075.1995.tb07348.x; Zhang Y, 2009, J BIOL CHEM, V284, P10160, DOI 10.1074/jbc.M808356200	35	34	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2402	2415		10.1074/jbc.M110.180877	http://dx.doi.org/10.1074/jbc.M110.180877			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21075854	Green Published, hybrid			2022-12-25	WOS:000286464300004
J	Wakamatsu, T; Kim, K; Uemura, Y; Nakagawa, N; Kuramitsu, S; Masui, R				Wakamatsu, Taisuke; Kim, Kwang; Uemura, Yuri; Nakagawa, Noriko; Kuramitsu, Seiki; Masui, Ryoji			Role of RecJ-like Protein with 5 '-3 ' Exonuclease Activity in Oligo(deoxy)nucleotide Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; DIRECTED MISMATCH REPAIR; THERMUS-THERMOPHILUS HB8; EXORIBONUCLEASE RNASE-R; ESCHERICHIA-COLI; MYCOPLASMA-PNEUMONIAE; SUBSTRATE-SPECIFICITY; PHOSPHATASE-ACTIVITY; RESTRICTION ENZYMES; BACILLUS-SUBTILIS	RecJ-like proteins belonging to the DHH family have been proposed to function as oligoribonucleases and 3 '-phosphoadenosine 5 '-phosphate (pAp) phosphatases in bacteria and archaea, which do not have Orn (oligoribonuclease) and CysQ (pAp phosphatase) homologs. In this study, we analyzed the biochemical and physiological characterization of the RecJ-like protein TTHA0118 from Thermus thermophilus HB8. TTHA0118 had high enzymatic activity as an oligodeoxyribo-nucleotide- and oligoribonucleotide-specific exonuclease and as pAp phosphatase. The polarity of degradation was 5 ' to 3 ', in contrast to previous reports about Bacillus subtilis NrnA, a RecJ-like protein. TTHA0118 preferentially hydrolyzed short oligodeoxyribonucleotides and oligoribonucleotides, whereas the RecJ exonuclease from T. thermophilus HB8 showed no such length dependence on oligodeoxyribonucleotide substrates. An insertion mutation of the ttha0118 gene led to growth reduction in minimum essential medium. Added 5 ' mononucleotides, nucleosides, and cysteine increased growth of the ttha0118 mutant in minimum essential medium. The RecJ-like protein Mpn140 from Mycoplasma pneumoniae M129, which cannot synthesize nucleic acid precursors de novo, showed similar biochemical features to TTHA0118. Furthermore, B. subtilis NrnA also hydrolyzed oligo(deoxy) ribonucleotides in a 5 '-3 ' direction. These results suggested that these RecJ-like proteins act in recycling short oligonucleotides to mononucleotides and in controlling pAp concentrations in vivo.	[Kim, Kwang; Uemura, Yuri; Nakagawa, Noriko; Kuramitsu, Seiki; Masui, Ryoji] Osaka Univ, Dept Biol Sci, Grad Sch Sci, Osaka 5600043, Japan; Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Nakagawa, Noriko; Kuramitsu, Seiki; Masui, Ryoji] Harima Inst, RIKEN, SPring Ctr 8, Sayo, Hyogo 6795148, Japan	Osaka University; Osaka University; RIKEN	Masui, R (corresponding author), Osaka Univ, Dept Biol Sci, Grad Sch Sci, 1-1 Machikaneyama Cho, Osaka 5600043, Japan.	rmasui@bio.sci.osaka-u.ac.jp	Wakamatsu, Taisuke/AAD-8007-2022		Ministry of Education, Science, Sports and Culture of Japan [20570131, 19770083]	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant-in-Aid for Scientific Research 20570131 (to R. M.) and 19770083 (to N. N.) from the Ministry of Education, Science, Sports and Culture of Japan.	Amblar M, 2007, RNA, V13, P317, DOI 10.1261/rna.220407; Amblar M, 2006, J MOL BIOL, V360, P921, DOI 10.1016/j.jmb.2006.05.043; Aravind L, 2000, NUCLEIC ACIDS RES, V28, P3417, DOI 10.1093/nar/28.18.3417; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P17, DOI 10.1016/S0968-0004(97)01162-6; Bujnicki JM, 2001, TRENDS BIOCHEM SCI, V26, P9, DOI 10.1016/S0968-0004(00)01690-X; Burdett V, 2001, P NATL ACAD SCI USA, V98, P6765, DOI 10.1073/pnas.121183298; Cheng ZF, 2002, J BIOL CHEM, V277, P21624, DOI 10.1074/jbc.M202942200; Condon C, 2007, CURR OPIN MICROBIOL, V10, P271, DOI 10.1016/j.mib.2007.05.008; COOPER DL, 1993, J BIOL CHEM, V268, P11823; D'Angelo A, 2004, CANCER CELL, V5, P137, DOI 10.1016/S1535-6108(04)00021-2; DATTA AK, 1975, J BIOL CHEM, V250, P7313; DIANOV G, 1994, NUCLEIC ACIDS RES, V22, P993, DOI 10.1093/nar/22.6.993; Dichtl B, 1997, EMBO J, V16, P7184, DOI 10.1093/emboj/16.23.7184; Fang M, 2009, NUCLEIC ACIDS RES, V37, P5114, DOI 10.1093/nar/gkp527; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Ghosh S, 1999, P NATL ACAD SCI USA, V96, P4372, DOI 10.1073/pnas.96.8.4372; Han ES, 2006, NUCLEIC ACIDS RES, V34, P1084, DOI 10.1093/nar/gkj503; Hashimoto Y, 2001, FEBS LETT, V506, P231, DOI 10.1016/S0014-5793(01)02926-X; Hatzios SK, 2008, BIOCHEMISTRY-US, V47, P5823, DOI 10.1021/bi702453s; Himmelreich R, 1996, NUCLEIC ACIDS RES, V24, P4420, DOI 10.1093/nar/24.22.4420; Klaassen CD, 1997, FASEB J, V11, P404, DOI 10.1096/fasebj.11.6.9194521; Krause A, 1999, BIOINFORMATICS, V15, P262, DOI 10.1093/bioinformatics/15.3.262; KURAMITSU S, 1990, BIOCHEMISTRY-US, V29, P5469, DOI 10.1021/bi00475a010; LOVETT ST, 1989, P NATL ACAD SCI USA, V86, P2627, DOI 10.1073/pnas.86.8.2627; Marti TM, 2004, CELL MOL LIFE SCI, V61, P336, DOI 10.1007/s00018-003-3223-4; MCLUCKEY SA, 1992, J AM SOC MASS SPECTR, V3, P60, DOI 10.1016/1044-0305(92)85019-G; Mechold U, 2007, NUCLEIC ACIDS RES, V35, P4552, DOI 10.1093/nar/gkm462; Mechold U, 2006, NUCLEIC ACIDS RES, V34, P2364, DOI 10.1093/nar/gkl247; MURGUIA JR, 1995, SCIENCE, V267, P232; NEUWALD AF, 1992, J BACTERIOL, V174, P415, DOI 10.1128/jb.174.2.415-425.1992; Nguyen LH, 2000, J BIOL CHEM, V275, P25900, DOI 10.1074/jbc.M002672200; Nishino T, 2002, ONCOGENE, V21, P9022, DOI 10.1038/sj.onc.1206135; PENG ZH, 1995, J BIOL CHEM, V270, P29105, DOI 10.1074/jbc.270.49.29105; Pollack JD, 1997, CRIT REV MICROBIOL, V23, P269, DOI 10.3109/10408419709115140; RAZIN S, 1978, MICROBIOL REV, V42, P414, DOI 10.1128/MMBR.42.2.414-470.1978; Sapranauskas R, 2000, J BIOL CHEM, V275, P30878, DOI 10.1074/jbc.M003350200; Schneider B, 1998, J BIOL CHEM, V273, P28773, DOI 10.1074/jbc.273.44.28773; Sharma R, 2009, J MOL BIOL, V385, P1375, DOI 10.1016/j.jmb.2008.11.041; Tammenkoski M, 2008, BIOCHEMISTRY-US, V47, P9707, DOI 10.1021/bi8010847; Theobald DL, 2003, ANNU REV BIOPH BIOM, V32, P115, DOI 10.1146/annurev.biophys.32.110601.142506; Vincent HA, 2006, J BIOL CHEM, V281, P29769, DOI 10.1074/jbc.M606744200; Waites KB, 2004, CLIN MICROBIOL REV, V17, P697, DOI 10.1128/CMR.17.4.697-728.2004; Wakamatsu T, 2008, J BACTERIOL, V190, P1108, DOI 10.1128/JB.01522-07; Wakamatsu T, 2010, J BIOL CHEM, V285, P9762, DOI 10.1074/jbc.M109.096487; Waldo RH, 2006, J BACTERIOL, V188, P569, DOI 10.1128/JB.188.2.569-575.2006; Wang LY, 2001, MOL MICROBIOL, V42, P1065, DOI 10.1046/j.1365-2958.2001.02700.x; Westberg J, 2004, GENOME RES, V14, P221, DOI 10.1101/gr.1673304; WURST H, 1994, J BIOL CHEM, V269, P10996; Yamagata A, 2002, P NATL ACAD SCI USA, V99, P5908, DOI 10.1073/pnas.092547099; Yamagata A, 2001, NUCLEIC ACIDS RES, V29, P4617, DOI 10.1093/nar/29.22.4617; Yokoyama S, 2000, NAT STRUCT BIOL, V7, P943, DOI 10.1038/80712; Zhang JQ, 2009, J BACTERIOL, V191, P4330, DOI 10.1128/JB.00184-09; Zhang XL, 1998, J BACTERIOL, V180, P2779, DOI 10.1128/JB.180.10.2779-2781.1998; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017	54	29	33	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2807	2816		10.1074/jbc.M110.161596	http://dx.doi.org/10.1074/jbc.M110.161596			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21087930	Green Published, hybrid			2022-12-25	WOS:000286464300046
J	Wei, XC; Schneider, JG; Shenouda, SM; Lee, A; Towler, DA; Chakravarthy, MV; Vita, JA; Semenkovich, CF				Wei, Xiaochao; Schneider, Jochen G.; Shenouda, Sherene M.; Lee, Ada; Towler, Dwight A.; Chakravarthy, Manu V.; Vita, Joseph A.; Semenkovich, Clay F.			De Novo Lipogenesis Maintains Vascular Homeostasis through Endothelial Nitric-oxide Synthase (eNOS) Palmitoylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHASE; PPAR-ALPHA; GENE; INHIBITION; GLUCOSE; OVEREXPRESSION; ANGIOGENESIS; HYPERTENSION; DYSFUNCTION; ELEVATION	Endothelial dysfunction leads to lethal vascular complications in diabetes and related metabolic disorders. Here, we demonstrate that de novo lipogenesis, an insulin-dependent process driven by the multifunctional enzyme fatty-acid synthase (FAS), maintains endothelial function by targeting endothelial nitric-oxide synthase (eNOS) to the plasma membrane. In mice with endothelial inactivation of FAS (FASTie mice), eNOS membrane content and activity were decreased. eNOS and FAS were physically associated; eNOS palmitoylation was decreased in FAS-deficient cells, and incorporation of labeled carbon into eNOS-associated palmitate was FAS-dependent. FASTie mice manifested a proinflammatory state reflected as increases in vascular permeability, endothelial inflammatory markers, leukocyte migration, and susceptibility to LPS-induced death that was reversed with an NO donor. FAS-deficient endothelial cells showed deficient migratory capacity, and angiogenesis was decreased in FASTie mice subjected to hindlimb ischemia. Insulin induced FAS in endothelial cells freshly isolated from humans, and eNOS palmitoylation was decreased in mice with insulin-deficient or insulin-resistant diabetes. Thus, disrupting eNOS bioavailability through impaired lipogenesis identifies a novel mechanism coordinating nutritional status and tissue repair that may contribute to diabetic vascular disease.	[Wei, Xiaochao; Schneider, Jochen G.; Lee, Ada; Towler, Dwight A.; Chakravarthy, Manu V.; Semenkovich, Clay F.] Washington Univ, Sch Med, Div Endocrinol Metab & Lipid Res, Dept Med, St Louis, MO 63110 USA; [Semenkovich, Clay F.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Towler, Dwight A.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Shenouda, Sherene M.; Vita, Joseph A.] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Shenouda, Sherene M.; Vita, Joseph A.] Boston Univ, Sch Med, Evans Dept Med, Boston, MA 02118 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Boston University; Boston University	Semenkovich, CF (corresponding author), Washington Univ, Sch Med, Div Endocrinol Metab & Lipid Res, Dept Med, Campus Box 8127,660 S Euclid Ave, St Louis, MO 63110 USA.	csemenko@wustl.edu	Chakravarthy, Manu/AAD-7553-2021	Chakravarthy, Manu/0000-0002-3699-150X; Vita, Joseph/0000-0001-5607-1797; Semenkovich, Clay/0000-0003-1163-1871; Towler, Dwight/0000-0003-2107-7923	National Institutes of Health [DK076729, P50 HL083762, DK20579, DK56341]; American Heart Association; American Diabetes Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL083762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020579, R01DK076729, R01DK088083, P30DK056341, P30DK020579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Diabetes Association(American Diabetes Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK076729, P50 HL083762, and DK20579 (to Diabetes Research and Training Center) and DK56341 (to Nutrition Obesity Research Center). This work was also supported by an American Heart Association postdoctoral fellowship award and by the American Diabetes Association (mentor-based postdoctoral fellowship award).	Berka V, 2004, J BIOL CHEM, V279, P32243, DOI 10.1074/jbc.M404044200; Bernal-Mizrachi C, 2003, NAT MED, V9, P1069, DOI 10.1038/nm898; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Browne CD, 2006, FASEB J, V20, P2027, DOI 10.1096/fj.05-5404com; Calles-Escandon J, 2001, ENDOCR REV, V22, P36, DOI 10.1210/er.22.1.36; Chakravarthy MV, 2005, CELL METAB, V1, P309, DOI 10.1016/j.cmet.2005.04.002; Chen JH, 2005, NAT MED, V11, P1188, DOI 10.1038/nm1307; Chirala SS, 2003, P NATL ACAD SCI USA, V100, P6358, DOI 10.1073/pnas.0931394100; Colombo PC, 2002, J APPL PHYSIOL, V92, P1331, DOI 10.1152/japplphysiol.00680.2001; Du XL, 2006, J CLIN INVEST, V116, P1071, DOI 10.1172/JCI23354; Dudzinski DM, 2007, CARDIOVASC RES, V75, P247, DOI 10.1016/j.cardiores.2007.03.023; Emanueli C, 2004, DIABETES, V53, P1096, DOI 10.2337/diabetes.53.4.1096; Fernandez-Hernando C, 2006, J CELL BIOL, V174, P369, DOI 10.1083/jcb.200601051; Fiorentino M, 2008, LAB INVEST, V88, P1340, DOI 10.1038/labinvest.2008.97; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; GarciaCardena G, 1996, P NATL ACAD SCI USA, V93, P6448, DOI 10.1073/pnas.93.13.6448; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; GOODRIDGE AG, 1986, FASEB J, V45, P2399; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Komers R, 2006, DIABETES, V55, P1651, DOI 10.2337/db05-1595; Koni PA, 2001, J EXP MED, V193, P741, DOI 10.1084/jem.193.6.741; Kurokawa J, 2010, CELL METAB, V11, P479, DOI 10.1016/j.cmet.2010.04.013; Liu JW, 1996, BIOCHEMISTRY-US, V35, P13277, DOI 10.1021/bi961720e; Maier T, 2008, SCIENCE, V321, P1315, DOI 10.1126/science.1161269; Martinez-Villaluenga C, 2010, FEBS J, V277, P1481, DOI 10.1111/j.1742-4658.2010.07577.x; Mashima T, 2009, BRIT J CANCER, V100, P1369, DOI 10.1038/sj.bjc.6605007; Menendez JA, 2004, P NATL ACAD SCI USA, V101, P10715, DOI 10.1073/pnas.0403390101; Michel T, 1999, BRAZ J MED BIOL RES, V32, P1361, DOI 10.1590/S0100-879X1999001100006; Najjar SM, 2005, CELL METAB, V2, P43, DOI 10.1016/j.cmet.2005.06.001; Niiyama Hiroshi, 2009, J Vis Exp, DOI 10.3791/1035; Razani B, 2009, NAT MED, V15, P372, DOI 10.1038/nm0409-372; Schiekofer S, 2005, ARTERIOSCL THROM VAS, V25, P1603, DOI 10.1161/01.ATV.0000171994.89106.ca; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shaul PW, 2002, ANNU REV PHYSIOL, V64, P749, DOI 10.1146/annurev.physiol.64.081501.155952; Sowa G, 1999, J BIOL CHEM, V274, P22524, DOI 10.1074/jbc.274.32.22524; Steffes MW, 2003, JAMA-J AM MED ASSOC, V290, P2159, DOI 10.1001/jama.290.16.2159; Steinberg HO, 2000, DIABETES, V49, P1231, DOI 10.2337/diabetes.49.7.1231; Toda N, 2007, REV PHYSIOL BIOCH P, V157, P31, DOI 10.1007/s112_0601; Tripathy D, 2003, DIABETES, V52, P2882, DOI 10.2337/diabetes.52.12.2882; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Ueno K, 1997, J BIOL CHEM, V272, P13519, DOI 10.1074/jbc.272.21.13519; Versari D, 2009, DIABETES CARE, V32, pS314, DOI 10.2337/dc09-S330; WAKIL SJ, 1989, BIOCHEMISTRY-US, V28, P4523, DOI 10.1021/bi00437a001; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Wang CY, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000143; Wong RHF, 2009, CELL, V136, P1056, DOI 10.1016/j.cell.2008.12.040; Zeng GY, 2000, CIRCULATION, V101, P1539, DOI 10.1161/01.CIR.101.13.1539	48	90	94	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2933	2945		10.1074/jbc.M110.193037	http://dx.doi.org/10.1074/jbc.M110.193037			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21098489	Green Published, hybrid			2022-12-25	WOS:000286464300057
J	Mao, XM; Sano, Y; Park, JM; Payne, AS				Mao, Xuming; Sano, Yasuyo; Park, Jin Mo; Payne, Aimee S.			p38 MAPK Activation Is Downstream of the Loss of Intercellular Adhesion in Pemphigus Vulgaris	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCALDED-SKIN SYNDROME; BULLOUS IMPETIGO; SUBSTRATE-SPECIFICITY; PROTEIN-KINASES; DESMOGLEIN 1; AUTOANTIBODIES; IGG; P38MAPK; DISEASE; PHOSPHORYLATION	Pemphigus vulgaris (PV) is a potentially fatal blistering disease characterized by autoantibodies against the desmosomal adhesion protein desmoglein (Dsg) 3. Whether autoantibody steric hindrance or signaling through pathways such as p38 MAPK is primary in disease pathogenesis is controversial. PV mAbs that cause endocytosis of Dsg3 but do not dissociate keratinocytes because of compensatory adhesion by Dsg1 do not activate p38. The same mAbs plus exfoliative toxin to inactivate Dsg1 but not exfoliative toxin alone activate p38, suggesting that p38 activation is secondary to loss of adhesion. Mice with epidermal p38 alpha deficiency blister after passive transfer of PV mAbs; however, acantholytic cells retain cell surface Dsg3 compared with wild-type mice. In cultured keratinocytes, p38 knockdown prevents loss of desmosomal Dsg3 by PV mAbs, and exogenous p38 activation causes internalization of Dsg3, desmocollin 3, and desmoplakin. p38 alpha MAPK is therefore not required for the loss of intercellular adhesion in PV, but may function downstream to augment blistering via Dsg3 endocytosis. Treatments aimed at increasing keratinocyte adhesion could be used in conjunction with immunosuppressive agents, potentially leading to safer and more effective combination therapy regimens.	Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA; [Sano, Yasuyo; Park, Jin Mo] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; [Sano, Yasuyo; Park, Jin Mo] Harvard Univ, Sch Med, Charlestown, MA 02129 USA	University of Pennsylvania; Harvard University; Massachusetts General Hospital; Harvard University	Payne, AS (corresponding author), 217A Clin Res Bldg,415 Curie Blvd, Philadelphia, PA 19104 USA.	paynea@mail.med.upenn.edu			National Institutes of Health [AR053505]; NIAMS [AR057001]; NIAID [AI074957]; Penn Skin Disease Research [AR057217]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR053505, R01AR057001, P30AR057217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Penn Skin Disease Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR053505 and AR057001 from NIAMS (to A. S. P.) and Grant AI074957 from NIAID (to J. M. P.). This work was also supported by Penn Skin Disease Research Core Grant AR057217.	Al-Amoudi A, 2007, NATURE, V450, P832, DOI 10.1038/nature05994; Amagai M, 2000, NAT MED, V6, P1275, DOI 10.1038/81385; AMAGAI M, 1991, CELL, V67, P869, DOI 10.1016/0092-8674(91)90360-B; Amagai M, 1999, J AM ACAD DERMATOL, V40, P167, DOI 10.1016/S0190-9622(99)70183-0; AMAGAI M, 1992, J CLIN INVEST, V90, P919, DOI 10.1172/JCI115968; AMAGAI M, 1994, J CLIN INVEST, V94, P59, DOI 10.1172/JCI117349; Aoyama Y, 1999, J INVEST DERMATOL, V112, P67, DOI 10.1046/j.1523-1747.1999.00463.x; Berkowitz P, 2005, J BIOL CHEM, V280, P23778, DOI 10.1074/jbc.M501365200; Berkowitz P, 2008, J INVEST DERMATOL, V128, P738, DOI 10.1038/sj.jid.5701080; Berkowitz P, 2006, P NATL ACAD SCI USA, V103, P12855, DOI 10.1073/pnas.0602973103; Calkins CC, 2006, J BIOL CHEM, V281, P7623, DOI 10.1074/jbc.M512447200; Dashti SR, 2001, J BIOL CHEM, V276, P8059, DOI 10.1074/jbc.C000862200; Delva E, 2008, J BIOL CHEM, V283, P18303, DOI 10.1074/jbc.M710046200; Ding X, 1997, J INVEST DERMATOL, V109, P592, DOI 10.1111/1523-1747.ep12337524; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; FRESHNEY NW, 1994, CELL, V78, P1039, DOI 10.1016/0092-8674(94)90278-X; Futei Y, 2000, J INVEST DERMATOL, V115, P829, DOI 10.1046/j.1523-1747.2000.00137.x; Goedert M, 1997, EMBO J, V16, P3563, DOI 10.1093/emboj/16.12.3563; Grando SA, 2003, J AM ACAD DERMATOL, V48, P86, DOI 10.1067/mjd.2003.39; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Hanakawa Y, 2002, J CLIN INVEST, V110, P53, DOI 10.1172/JCI200215766; Heupel WM, 2008, J IMMUNOL, V181, P1825, DOI 10.4049/jimmunol.181.3.1825; Ishii K, 2005, J INVEST DERMATOL, V124, P939, DOI 10.1111/j.0022-202X.2005.23714.x; Jiang Y, 1996, J BIOL CHEM, V271, P17920, DOI 10.1074/jbc.271.30.17920; Jiang Y, 1997, J BIOL CHEM, V272, P30122, DOI 10.1074/jbc.272.48.30122; Jolly PS, 2010, J BIOL CHEM, V285, P8936, DOI 10.1074/jbc.M109.087999; Kim C, 2008, NAT IMMUNOL, V9, P1019, DOI 10.1038/ni.1640; Kumar S, 1997, BIOCHEM BIOPH RES CO, V235, P533, DOI 10.1006/bbrc.1997.6849; Lechner C, 1996, P NATL ACAD SCI USA, V93, P4355, DOI 10.1073/pnas.93.9.4355; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Mahoney MG, 1999, J CLIN INVEST, V103, P461, DOI 10.1172/JCI5252; Mao XM, 2009, J INVEST DERMATOL, V129, P908, DOI 10.1038/jid.2008.339; Mertens S, 1996, FEBS LETT, V383, P273, DOI 10.1016/0014-5793(96)00255-4; Miyagawa S, 1999, BRIT J DERMATOL, V141, P1084, DOI 10.1046/j.1365-2133.1999.03209.x; Nguyen VT, 2004, J BIOL CHEM, V279, P2135, DOI 10.1074/jbc.M309000200; Payne AS, 2005, J CLIN INVEST, V115, P888, DOI 10.1172/JCI200524185; Payne AS, 2004, CURR OPIN CELL BIOL, V16, P536, DOI 10.1016/j.ceb.2004.07.006; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; Sekiguchi M, 2001, J IMMUNOL, V167, P5439, DOI 10.4049/jimmunol.167.9.5439; Sharma P, 2007, J DERMATOL SCI, V48, P1, DOI 10.1016/j.jdermsci.2007.05.005; Shirakata Y, 1998, J INVEST DERMATOL, V110, P76, DOI 10.1046/j.1523-1747.1998.00085.x; Tsunoda K, 2003, J IMMUNOL, V170, P2170, DOI 10.4049/jimmunol.170.4.2170	42	60	60	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1283	1291		10.1074/jbc.M110.172874	http://dx.doi.org/10.1074/jbc.M110.172874			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21078676	Green Published, hybrid			2022-12-25	WOS:000286005000040
J	Holder, B; Miles, DJC; Kaye, S; Crozier, S; Mohammed, NI; Duah, NO; Roberts, E; Ojuola, O; Palmero, MS; Touray, ES; Waight, P; Cotten, M; Rowland-Jones, S; van der Sande, M; Whittle, H				Holder, Beth; Miles, David J. C.; Kaye, Steve; Crozier, Sarah; Mohammed, Nuredin Ibrahim; Duah, Nancy O.; Roberts, Elishia; Ojuola, Olubukola; Palmero, Melba S.; Touray, Ebrima S.; Waight, Pauline; Cotten, Matthew; Rowland-Jones, Sarah; van der Sande, Marianne; Whittle, Hilton			Epstein-Barr Virus but Not Cytomegalovirus Is Associated with Reduced Vaccine Antibody Responses in Gambian Infants	PLOS ONE			English	Article							T-CELL DIFFERENTIATION; PLASMODIUM-FALCIPARUM; NEISSERIA-MENINGITIDIS; DEVELOPING-COUNTRIES; MATERNAL ANTIBODIES; MEASLES; INFECTION; MORTALITY; MALARIA; IMMUNIZATION	Background: Epstein-Barr virus (EBV) and cytomegalovirus (CMV) are persistent herpesviruses that have various immunomodulatory effects on their hosts. Both viruses are usually acquired in infancy in Sub-Saharan Africa, a region where childhood vaccines are less effective than in high income settings. To establish whether there is an association between these two observations, we tested the hypothesis that infection with one or both viruses modulate antibody responses to the T-cell independent meningococcal polysaccharide vaccine and the T-cell dependent measles vaccines. Methodology/Principal Findings: Infection with EBV and CMV was diagnosed by the presence of virus-specific IgM in the peripheral blood or by the presence of IgG at higher levels than that found in umbilical cord blood. Anti-meningococcus IgG and IgM were quantified by ELISA. Anti-measles antibody responses were quantified by haemagglutinin antibody inhibition assay. Infants infected with EBV had reduced IgG and IgM antibody responses to meningococcal polysaccharides and to measles vaccine. Infection with CMV alone predicted no changes in the response to meningococcal polysaccharide. While CMV alone had no discernable effect on the antibody response to measles, the response of infants infected with both CMV and EBV was similar to that of infants infected with neither, suggesting that the effects of CMV infection countered the effects of EBV on measles antibody responses. Conclusions: The results of this exploratory study indicate that infection with EBV is associated with reduced antibody responses to polysaccharides and to measles vaccine, but suggest that the response to T-cell dependent antigens such as measles haemagglutinin may be restored by infection with CMV.	[Holder, Beth; Miles, David J. C.; Crozier, Sarah; Mohammed, Nuredin Ibrahim; Duah, Nancy O.; Roberts, Elishia; Ojuola, Olubukola; Palmero, Melba S.; Touray, Ebrima S.; Cotten, Matthew; Rowland-Jones, Sarah; Whittle, Hilton] MRC Labs Gambia, Banjul, Gambia; [Miles, David J. C.] Univ Cape Town, S African TB Vaccine Initiat, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Kaye, Steve] Univ London Imperial Coll Sci Technol & Med, Jefferiss Trust Lab, London, England; [Crozier, Sarah] Univ Southampton, Southampton Gen Hosp, MRC Epidemiol Resource Ctr, Southampton, Hants, England; [Mohammed, Nuredin Ibrahim; Duah, Nancy O.] London Sch Hyg & Trop Med, London WC1, England; [Waight, Pauline] Hlth Protect Agcy Ctr Infect, Immunisat Dept, London, England; [van der Sande, Marianne] Ctr Infect Dis Control CIb, Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [van der Sande, Marianne] Univ Med Ctr Utrecht, Julius Ctr, Utrecht, Netherlands	University of Cape Town; Imperial College London; University of Southampton; University of London; London School of Hygiene & Tropical Medicine; Health Protection Agency; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center	Holder, B (corresponding author), MRC Labs Gambia, Banjul, Gambia.	hcwhittle@yahoo.co.uk	Holder, Beth/AAD-8341-2020	Holder, Beth/0000-0003-2157-9819; Duah-Quashie, Nancy/0000-0001-8819-1793; Cotten, Matthew/0000-0002-3361-3351; Mohammed, Nuredin/0000-0002-4067-1103; van der Sande, Marianne AB/0000-0002-4778-6739; Crozier, Sarah/0000-0002-9524-1127	MRC; Sukuta Health Centre; Western Division Health Team; MRC [MC_U190081978] Funding Source: UKRI; Medical Research Council [MC_U190081978] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Sukuta Health Centre; Western Division Health Team; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by the MRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the staff of the Sukuta birth cohort, Omar Badjie, Fatou Bah, Saihou Bobb, Sarah Burl, Janko Camara, Sulayman Colley, Momodou Cox, Isatou Drammeh, Mam Maram Drammeh, Momodou Lamin Fatty, Tisbeh Faye-Joof, Samboujang Makalo, John S Mendy, Ngui Ndow, Bala Musa Sambou, Sarjo Sanneh and Lady Chilel Sanyang. We are extremely grateful for the support of Sally Savage of Sukuta Health Centre and the Western Division Health Team, and to Professor Brian Greenwood of the London School of Hygiene and Tropical Medicine for advice and help. Some reagents for the meningococcus ELISA were a gift from Dr. Musa King of Chiron. The method for quantification of EBV DNA was adapted from methods developed by Prof A. Rickinson of the Division of Cancer Studies, University of Birmingham. Dr David Jefferies and Dr. John Townend of the MRC Unit, The Gambia provided statistical advice.	AABY P, 1990, J INFECT DIS, V162, P1043, DOI 10.1093/infdis/162.5.1043; AABY P, 1995, BRIT MED J, V311, P481, DOI 10.1136/bmj.311.7003.481; AABY P, 1984, AM J EPIDEMIOL, V120, P49, DOI 10.1093/oxfordjournals.aje.a113874; Aaby P, 2007, PEDIATR INFECT DIS J, V26, P247, DOI 10.1097/01.inf.0000256735.05098.01; Ben-Smith A, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-139; BIGGAR RJ, 1978, INT J CANCER, V22, P239, DOI 10.1002/ijc.2910220304; BLAKEBROUGH IS, 1982, J INFECT DIS, V146, P626, DOI 10.1093/infdis/146.5.626; Cavanagh DR, 1998, J IMMUNOL, V161, P347; Cisse B, 1999, AM J EPIDEMIOL, V149, P295, DOI 10.1093/oxfordjournals.aje.a009811; Clute SC, 2005, J CLIN INVEST, V115, P3602, DOI 10.1172/JCI25078; Cohen JI, 2000, NEW ENGL J MED, V343, P481, DOI 10.1056/NEJM200008173430707; DETHE G, 1978, NATURE, V274, P756, DOI 10.1038/274756a0; Duah NO, 2010, PARASITE IMMUNOL, V32, P125, DOI 10.1111/j.1365-3024.2009.01165.x; Dutta S, 2002, INFECT IMMUN, V70, P3101, DOI 10.1128/IAI.70.6.3101-3110.2002; GHEESLING LL, 1994, J CLIN MICROBIOL, V32, P1475, DOI 10.1128/JCM.32.6.1475-1482.1994; GRATAMA JW, 1987, BLOOD, V70, P516; Grivel JC, 2005, J INFECT DIS, V192, P71, DOI 10.1086/430743; Grivel JC, 2001, NAT MED, V7, P1232, DOI 10.1038/nm1101-1232; Hochberg D, 2004, J VIROL, V78, P5194, DOI 10.1128/JVI.78.10.5194-5204.2004; Janaszek W, 2003, VACCINE, V21, P473, DOI 10.1016/S0264-410X(02)00482-6; Jaye A, 1998, J INFECT DIS, V177, P1282, DOI 10.1086/515271; KAYE S, 2008, J INFECT DIS, V197; KLEIN G, 1972, INT J CANCER, V10, P44, DOI 10.1002/ijc.2910100108; Looney RJ, 1999, CLIN IMMUNOL, V90, P213, DOI 10.1006/clim.1998.4638; Lynn TV, 2004, J INFECT DIS, V189, pS86, DOI 10.1086/377699; MALFAIT P, 1994, PEDIATR INFECT DIS J, V13, P38, DOI 10.1097/00006454-199401000-00009; Martro E, 2004, J MED VIROL, V72, P126, DOI 10.1002/jmv.10548; Miles DJC, 2008, IMMUNOLOGY, V124, P388, DOI 10.1111/j.1365-2567.2007.02787.x; Miles DJC, 2007, J VIROL, V81, P5766, DOI 10.1128/JVI.00052-07; MILLER G, 1972, P NATL ACAD SCI USA, V69, P383, DOI 10.1073/pnas.69.2.383; *MIN HLTH N POL CO, 1966, B WORLD HEALTH ORGAN, V34, P865; NORRBY E, 1972, INFECT IMMUN, V6, P240, DOI 10.1128/IAI.6.3.240-247.1972; ODempsey TJD, 1996, ARCH DIS CHILD-FETAL, V74, pF43, DOI 10.1136/fn.74.1.F43; Olsson J, 2000, MECH AGEING DEV, V121, P187; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Polley SD, 2006, VACCINE, V24, P4233, DOI 10.1016/j.vaccine.2005.06.030; REINGOLD AL, 1985, LANCET, V2, P114; Saurwein-Teissl M, 2002, J IMMUNOL, V168, P5893, DOI 10.4049/jimmunol.168.11.5893; Siegrist CA, 2003, VACCINE, V21, P3406, DOI 10.1016/S0264-410X(03)00342-6; Sinclair J, 2006, J GEN VIROL, V87, P1763, DOI 10.1099/vir.0.81891-0; SODERBERG C, 1993, J VIROL, V67, P3166; Souza TA, 2007, J IMMUNOL, V179, P3153, DOI 10.4049/jimmunol.179.5.3153; Sze DMY, 2000, J EXP MED, V192, P813, DOI 10.1084/jem.192.6.813; Trzonkowski P, 2003, VACCINE, V21, P3826, DOI 10.1016/S0264-410X(03)00309-8; Usen S, 2000, PEDIATR INFECT DIS J, V19, P444, DOI 10.1097/00006454-200005000-00010; van der Loeff MFS, 2003, AIDS, V17, P1841, DOI [10.1097/00002030-200308150-00014, 10.1097/01.aids.0000076303.76477.49]; Vitek CR, 1999, PEDIATR INFECT DIS J, V18, P620, DOI 10.1097/00006454-199907000-00010; WHITTLE H, 1988, LANCET, V331, P963; WHITTLE HC, 1984, NATURE, V312, P449, DOI 10.1038/312449a0; WHO, 2005, WKLY EPIDEMIOL REC, V80, P313; *WHO, 2002, WKLY EPIDEMIOL REC, V77, P331; WILLIAMSON WA, 1978, LANCET, V1, P1328; Xiao LH, 1998, J INFECT DIS, V177, P437, DOI 10.1086/514212	53	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2010	5	11							e14013	10.1371/journal.pone.0014013	http://dx.doi.org/10.1371/journal.pone.0014013			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681OY	21103338	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000284327800005
J	Kim, Y; Rajagopalan, P				Kim, Yeonhee; Rajagopalan, Padmavathy			3D Hepatic Cultures Simultaneously Maintain Primary Hepatocyte and Liver Sinusoidal Endothelial Cell Phenotypes	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; IN-VITRO; EXTRACELLULAR-MATRIX; RAT-LIVER; MICROPATTERNED SURFACES; SANDWICH CONFIGURATION; NONPARENCHYMAL CELLS; MONOCLONAL-ANTIBODY; HYALURONIC-ACID; KUPFFER CELLS	Developing in vitro engineered hepatic tissues that exhibit stable phenotype is a major challenge in the field of hepatic tissue engineering. However, the rapid dedifferentiation of hepatic parenchymal (hepatocytes) and non-parenchymal (liver sinusoidal endothelial, LSEC) cell types when removed from their natural environment in vivo remains a major obstacle. The primary goal of this study was to demonstrate that hepatic cells cultured in layered architectures could preserve or potentially enhance liver-specific behavior of both cell types. Primary rat hepatocytes and rat LSECs (rLSECs) were cultured in a layered three-dimensional (3D) configuration. The cell layers were separated by a chitosan-hyaluronic acid polyelectrolyte multilayer (PEM), which served to mimic the Space of Disse. Hepatocytes and rLSECs exhibited several key phenotypic characteristics over a twelve day culture period. Immunostaining for the sinusoidal endothelial 1 antibody (SE-1) demonstrated that rLSECs cultured in the 3D hepatic model maintained this unique feature over twelve days. In contrast, rLSECs cultured in monolayers lost their phenotype within three days. The unique stratified structure of the 3D culture resulted in enhanced heterotypic cell-cell interactions, which led to improvements in hepatocyte functions. Albumin production increased three to six fold in the rLSEC-PEM-Hepatocyte cultures. Only rLSEC-PEM-Hepatocyte cultures exhibited increasing CYP1A1/2 and CYP3A activity. Well-defined bile canaliculi were observed only in the rLSEC-PEM-Hepatocyte cultures. Together, these data suggest that rLSEC-PEM-Hepatocyte cultures are highly suitable models to monitor the transformation of toxins in the liver and their transport out of this organ. In summary, these results indicate that the layered rLSEC-PEM-hepatocyte model, which recapitulates key features of hepatic sinusoids, is a potentially powerful medium for obtaining comprehensive knowledge on liver metabolism, detoxification and signaling pathways in vitro.	[Kim, Yeonhee; Rajagopalan, Padmavathy] Virginia Polytech Inst & State Univ, Dept Chem Engn, Blacksburg, VA 24061 USA; [Rajagopalan, Padmavathy] Virginia Polytech Inst & State Univ, ICTAS Ctr Syst Biol Engn Tissues, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Kim, Y (corresponding author), Virginia Polytech Inst & State Univ, Dept Chem Engn, Blacksburg, VA 24061 USA.	padmar@vt.edu			National Institutes of Health [NIDDK-1R21DK077802]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK077802] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors gratefully acknowledge financial support from the National Institutes of Health (NIDDK-1R21DK077802, P. R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias I. M., 2001, LIVER BIOL PATHOLOGY; Behnia K, 2000, TISSUE ENG, V6, P467, DOI 10.1089/107632700750022125; Bhatia SN, 1999, FASEB J, V13, P1883, DOI 10.1096/fasebj.13.14.1883; Bhatia SN, 1997, J BIOMED MATER RES, V34, P189, DOI 10.1002/(SICI)1097-4636(199702)34:2<189::AID-JBM8>3.0.CO;2-M; Chung TW, 2002, BIOMATERIALS, V23, P2827, DOI 10.1016/S0142-9612(01)00399-4; Corlu A, 1997, CELL BIOL TOXICOL, V13, P235, DOI 10.1023/A:1007475122321; DeLeve LD, 2004, AM J PHYSIOL-GASTR L, V287, pG757, DOI 10.1152/ajpgi.00017.2004; Deo AK, 2008, DRUG METAB DISPOS, V36, P1983, DOI 10.1124/dmd.108.022194; DUNN JCY, 1989, FASEB J, V3, P174, DOI 10.1096/fasebj.3.2.2914628; DUNN JCY, 1991, BIOTECHNOL PROGR, V7, P237, DOI 10.1021/bp00009a007; Elvevold Kjetil H, 2004, Comp Hepatol, V3, P4, DOI 10.1186/1476-5926-3-4; FRASER R, 1995, HEPATOLOGY, V21, P863, DOI 10.1016/0270-9139(95)90542-1; Gao WS, 1998, HEPATOLOGY, V27, P1652, DOI 10.1002/hep.510270626; Hofmann AF, 2008, CELL MOL LIFE SCI, V65, P2461, DOI 10.1007/s00018-008-7568-6; Hwa AJ, 2007, FASEB J, V21, P2564, DOI 10.1096/fj.06-7473com; Joddar B, 2006, BIOMATERIALS, V27, P5698, DOI 10.1016/j.biomaterials.2006.07.020; Khetani SR, 2008, NAT BIOTECHNOL, V26, P120, DOI 10.1038/nbt1361; Khetani SR, 2004, HEPATOLOGY, V40, P545, DOI 10.1002/hep.20351; Kim Y, 2010, TISSUE ENG PT A, V16, P2731, DOI 10.1089/ten.tea.2009.0695; KURIHARCUCH W, 1989, DIFFERENTIATION, V41, P148, DOI 10.1111/j.1432-0436.1989.tb00742.x; LeCouter J, 2003, SCIENCE, V299, P890, DOI 10.1126/science.1079562; March S, 2009, HEPATOLOGY, V50, P920, DOI 10.1002/hep.23085; McCuskey RS, 2006, CLIN HEMORHEOL MICRO, V34, P5; MCGUIRE RF, 1992, HEPATOLOGY, V15, P989, DOI 10.1002/hep.1840150603; Moghe PV, 1996, BIOMATERIALS, V17, P373, DOI 10.1016/0142-9612(96)85576-1; Nahmias Y, 2006, TISSUE ENG, V12, P1627, DOI 10.1089/ten.2006.12.1627; OHMURA T, 1993, J HISTOCHEM CYTOCHEM, V41, P1253, DOI 10.1177/41.8.8331290; Omiecinski CJ, 1999, TOXICOL SCI, V48, P151, DOI 10.1093/toxsci/48.2.151; Park IK, 2003, BIOMATERIALS, V24, P2331, DOI 10.1016/S0142-9612(03)00108-X; Park IK, 2001, J CONTROL RELEASE, V76, P349, DOI 10.1016/S0168-3659(01)00448-5; Rajagopalan P, 2005, TISSUE ENG, V11, P1527, DOI 10.1089/ten.2005.11.1527; Rajagopalan P, 2006, TISSUE ENG, V12, P1553, DOI 10.1089/ten.2006.12.1553; Remuzzi A, 2004, TISSUE ENG, V10, P699, DOI 10.1089/1076327041348347; RIEDER H, 1992, J HEPATOL, V15, P237, DOI 10.1016/0168-8278(92)90042-N; Sellaro TL, 2007, TISSUE ENG, V13, P2301, DOI 10.1089/ten.2006.0437; Sellaro TL, 2010, TISSUE ENG PT A, V16, P1075, DOI [10.1089/ten.tea.2008.0587, 10.1089/ten.TEA.2008.0587]; Smedsrod B, 1997, BIOCHEM J, V322, P567, DOI 10.1042/bj3220567; Smedsrod Bard, 2004, Comp Hepatol, V3 Suppl 1, pS22, DOI 10.1186/1476-5926-2-S1-S22; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; Thummel KE, 1998, ANNU REV PHARMACOL, V38, P389, DOI 10.1146/annurev.pharmtox.38.1.389; Tokairin T, 2002, J HEPATOL, V36, P725, DOI 10.1016/S0168-8278(02)00048-X; Ueno, 1999, LIVER DIS HEPATIC SI, P17, DOI DOI 10.1007/978-4-431-67935-6_2; Wang S, 2008, TISSUE ENG PT A, V14, P227, DOI 10.1089/tea.2007.0143; Wang XJ, 1997, BIOCHEM J, V328, P937, DOI 10.1042/bj3280937; ZIMNIAK P, 1991, BIOCHEM J, V275, P105, DOI 10.1042/bj2750105; Zinchenko YS, 2006, TISSUE ENG, V12, P751, DOI 10.1089/ten.2006.12.751; Zinchenko YS, 2005, J BIOMED MATER RES A, V75A, P242, DOI 10.1002/jbm.a.30399	47	79	80	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e15456	10.1371/journal.pone.0015456	http://dx.doi.org/10.1371/journal.pone.0015456			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103392	Green Published, gold, Green Submitted			2022-12-25	WOS:000284147700029
J	Tamura, EK; Fernandes, PA; Marcola, M; Cruz-Machado, SD; Markus, RP				Tamura, Eduardo Koji; Fernandes, Pedro Augusto; Marcola, Marina; Cruz-Machado, Sanseray da Silveira; Markus, Regina Pekelmann			Long-Lasting Priming of Endothelial Cells by Plasma Melatonin Levels	PLOS ONE			English	Article							RAT PINEAL-GLAND; NITRIC-OXIDE PRODUCTION; NECROSIS-FACTOR-ALPHA; FACTOR-KAPPA-B; NEUTROPHIL MOBILIZATION; IN-VITRO; LIPOPOLYSACCHARIDE; INHIBITION; MECHANISMS; PATHWAY	Background: Endothelial cells are of great interest for cell therapy and tissue engineering. Understanding the heterogeneity among cell lines originating from different sources and culture protocols may allow more standardized material to be obtained. In a recent paper, we showed that adrenalectomy interferes with the expression of membrane adhesion molecules on endothelial cells maintained in culture for 16 to 18 days. In addition, the pineal hormone, melatonin, reduces the adhesion of neutrophils to post-capillary veins in rats. Here, we evaluated whether the reactivity of cultured endothelial cells maintained for more than two weeks in culture is inversely correlated to plasma melatonin concentration. Methodology/Principal Findings: The nocturnal levels of melatonin were manipulated by treating rats with LPS. Nocturnal plasma melatonin, significantly reduced two hours after LPS treatment, returned to control levels after six hours. Endothelial cells obtained from animals that had lower nocturnal melatonin levels significantly express enhanced adhesion molecules and iNOS, and have more leukocytes adhered than cells from animals that had normal nocturnal levels of melatonin (naive or injected with vehicle). Endothelial cells from animals sacrificed two hours after a simultaneous injection of LPS and melatonin present similar phenotype and function than those obtained fromcontrol animals. Analyzing together all the data, taking into account the plasma melatonin concentration versus the expression of adhesion molecules or iNOS we detected a significant inverse correlation. Conclusions/Significance: Our data strongly suggest that the plasma melatonin level primes endothelial cells "in vivo," indicating that the state of the donor animal is translated to cells in culture and therefore, should be considered for establishing cell banks in ideal conditions.	[Tamura, Eduardo Koji; Fernandes, Pedro Augusto; Marcola, Marina; Cruz-Machado, Sanseray da Silveira; Markus, Regina Pekelmann] Univ Sao Paulo, Lab Chronopharmacol, Dept Physiol, Inst Biosci, Sao Paulo, Brazil	Universidade de Sao Paulo	Tamura, EK (corresponding author), Univ Sao Paulo, Lab Chronopharmacol, Dept Physiol, Inst Biosci, Sao Paulo, Brazil.	rpmarkus@usp.br	Markus, Regina P/K-2954-2012; Marçola, Marina/D-4097-2015; Tamura, Eduardo Koji/L-4360-2019; Markus, Regina P./AAC-1505-2021; Tamura, Eduardo Koji/F-7068-2012; Fernandes, Pedro/L-1869-2013	Markus, Regina P/0000-0003-4606-6120; Tamura, Eduardo Koji/0000-0002-6105-7452; Markus, Regina P./0000-0003-4606-6120; Tamura, Eduardo Koji/0000-0002-6105-7452; Carlos Magno Fernandes, Pedro Augusto/0000-0002-4871-8201; da Silveira Cruz-Machado, Sanseray/0000-0002-6937-7207	FAPESP [07/07871-6]; CNPq [472881/2009-4]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	EKT and PACMF are post-doctoral fellows. MM and SSCM are graduate fellows of the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). RPM is a senior fellow of the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). This article was supported by grants from FAPESP (07/07871-6) and CNPq (472881/2009-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; BERGHE WV, 2006, BIOCHEM PHARMACOL, V72, P1114; Cavalcanti DMH, 2007, BRIT J PHARMACOL, V152, P1291, DOI 10.1038/sj.bjp.0707512; Cavalcanti DMH, 2006, MOL CELL ENDOCRINOL, V249, P32, DOI 10.1016/j.mce.2006.01.007; Cecon E, 2010, CHRONOBIOL INT, V27, P52, DOI 10.3109/07420521003661615; Cruz-Machado SD, 2010, J PINEAL RES, V49, P183, DOI 10.1111/j.1600-079X.2010.00785.x; Fernandes PACM, 2009, J NEUROENDOCRINOL, V21, P90, DOI 10.1111/j.1365-2826.2008.01817.x; Fernandes PACM, 2006, J PINEAL RES, V41, P344, DOI 10.1111/j.1600-079X.2006.00373.x; Ferreira ZS, 2005, J PINEAL RES, V38, P182, DOI 10.1111/j.1600-079X.2004.00191.x; Gilad E, 1998, FASEB J, V12, P685, DOI 10.1096/fasebj.12.9.685; Kakizaki Y, 1999, ENDOCR J, V46, P487, DOI 10.1507/endocrj.46.487; Laude K, 2002, CARDIOVASC RES, V55, P466, DOI 10.1016/S0008-6363(02)00277-8; Lotufo CMC, 2006, EUR J PHARMACOL, V534, P258, DOI 10.1016/j.ejphar.2006.01.050; Lotufo CMC, 2001, EUR J PHARMACOL, V430, P351, DOI 10.1016/S0014-2999(01)01369-3; Markus RP, 2007, NEUROIMMUNOMODULAT, V14, P126, DOI 10.1159/000110635; POHLMAN TH, 1986, J IMMUNOL, V136, P4548; Silva CLM, 2007, BRIT J PHARMACOL, V151, P195, DOI 10.1038/sj.bjp.0707225; Tamura EK, 2006, J PINEAL RES, V41, P267, DOI 10.1111/j.1600-079X.2006.00366.x; Tamura EK, 2009, J PINEAL RES, V46, P268, DOI 10.1111/j.1600-079X.2008.00657.x; Wada Y, 2005, FASEB J, V19, P1914, DOI 10.1096/fj.05-4037fje	20	40	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e13958	10.1371/journal.pone.0013958	http://dx.doi.org/10.1371/journal.pone.0013958			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103056	Green Published, gold, Green Submitted			2022-12-25	WOS:000284147700009
J	Shao, H; Wang, JHC; Pollak, MR; Wells, A				Shao, Hanshuang; Wang, James H. -C.; Pollak, Martin R.; Wells, Alan			alpha-Actinin-4 Is Essential for Maintaining the Spreading, Motility and Contractility of Fibroblasts	PLOS ONE			English	Article							ALPHA-ACTININ; GENE AMPLIFICATION; CELL MOTILITY; CANCER; CYTOKINESIS; ADHESIONS; KINASE	Background: alpha-Actinins cross-link actin filaments, with this cross-linking activity regulating the formation of focal adhesions, intracellular tension, and cell migration. Most non-muscle cells such as fibroblasts express two isoforms, alpha-actinin-1 (ACTN1) and alpha-actinin-4 (ACTN4). The high homology between these two isoforms would suggest redundancy of their function, but recent studies have suggested different regulatory roles. Interestingly, ACTN4 is phosphorylated upon growth factor stimulation, and this loosens its interaction with actin. Methodology/Principal Findings: Using molecular, biochemical and cellular techniques, we probed the cellular functions of ACTN4 in fibroblasts. Knockdown of ACTN4 expression in murine lung fibroblasts significantly impaired cell migration, spreading, adhesion, and proliferation. Surprisingly, knockdown of ACTN4 enhanced cellular compaction and contraction force, and increased cellular and nuclear cross-sectional area. These results, except the increased contractility, are consistent with a putative role of ACTN4 in cytokinesis. For the transcellular tension, knockdown of ACTN4 significantly increased the expression of myosin light chain 2, a element of the contractility machinery. Re-expression of wild type human ACTN4 in ACTN4 knockdown murine lung fibroblasts reverted cell spreading, cellular and nuclear cross-sectional area, and contractility back towards baseline, demonstrating that the defect was due to absence of ACTN4. Significance: These results suggest that ACTN4 is essential for maintaining normal spreading, motility, cellular and nuclear cross-sectional area, and contractility of murine lung fibroblasts by maintaining the balance between transcellular contractility and cell-substratum adhesion.	[Shao, Hanshuang; Wells, Alan] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA; [Wang, James H. -C.] Univ Pittsburgh, Dept Orthopaed Surg, Pittsburgh, PA USA; [Pollak, Martin R.] Beth Israel Deaconess Med Ctr, Dept Med, Div Nephrol, Boston, MA 02215 USA; [Pollak, Martin R.] Harvard Univ, Sch Med, Boston, MA USA; [Wells, Alan] Pittsburgh VA Hlth Syst, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Shao, H (corresponding author), Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA.	wellsa@upmc.edu		Wells, Alan/0000-0002-1637-8150	National Institute of General Medical Science [R01GM069668]; National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (NIH) (USA) [R01DK054931]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069668] Funding Source: NIH RePORTER	National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (NIH) (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the National Institute of General Medical Science (R01GM069668) and the National Institute of Diabetes and Digestive and Kidney Diseases (R01DK054931) of the National Institutes of Health (NIH) (USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen FD, 2002, WOUND REPAIR REGEN, V10, P67, DOI 10.1046/j.1524-475X.2002.10701.x; Assoian RK, 2008, TRENDS CELL BIOL, V18, P347, DOI 10.1016/j.tcb.2008.05.002; Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001; CHEN P, 1994, J CELL BIOL, V124, P547, DOI 10.1083/jcb.124.4.547; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Dandapani SV, 2007, J BIOL CHEM, V282, P467, DOI 10.1074/jbc.M605024200; Ghosh K, 2007, ADV DRUG DELIVER REV, V59, P1306, DOI 10.1016/j.addr.2007.08.014; Hauge H, 2009, CELL SIGNAL, V21, P1866, DOI 10.1016/j.cellsig.2009.08.001; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Honda K, 2005, GASTROENTEROLOGY, V128, P51, DOI 10.1053/j.gastro.2004.10.004; Iwabu A, 2004, J BIOL CHEM, V279, P14551, DOI 10.1074/jbc.M311981200; Kikuchi S, 2008, CLIN CANCER RES, V14, P5348, DOI 10.1158/1078-0432.CCR-08-0075; Kos CH, 2003, J CLIN INVEST, V111, P1683, DOI 10.1172/JCI200317988; Kumeta M, 2010, J CELL SCI, V123, P1020, DOI 10.1242/jcs.059568; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Li B, 2008, J BIOMECH, V41, P3349, DOI 10.1016/j.jbiomech.2008.09.025; Low SH, 2010, EXP CELL RES, V316, P1925, DOI 10.1016/j.yexcr.2010.03.004; Michaud JLR, 2009, CELL MOTIL CYTOSKEL, V66, P166, DOI 10.1002/cm.20339; Mukhina S, 2007, DEV CELL, V13, P554, DOI 10.1016/j.devcel.2007.08.003; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; Quick Q, 2010, EXP CELL RES, V316, P1137, DOI 10.1016/j.yexcr.2010.02.011; Sen S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008427; Shao HS, 2010, J BIOL CHEM, V285, P2591, DOI 10.1074/jbc.M109.035790; Smith KD, 2006, EXP CELL RES, V312, P1970, DOI 10.1016/j.yexcr.2006.02.022; Tager AM, 2004, AM J RESP CELL MOL, V31, P395, DOI 10.1165/rcmb.2004-0175OC; Yamamoto S, 2009, MODERN PATHOL, V22, P499, DOI 10.1038/modpathol.2008.234	27	66	66	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e13921	10.1371/journal.pone.0013921	http://dx.doi.org/10.1371/journal.pone.0013921			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21085685	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000284087800004
J	Tasaki, S; Nagasaki, M; Kozuka-Hata, H; Semba, K; Gotoh, N; Hattori, S; Inoue, J; Yamamoto, T; Miyano, S; Sugano, S; Oyama, M				Tasaki, Shinya; Nagasaki, Masao; Kozuka-Hata, Hiroko; Semba, Kentaro; Gotoh, Noriko; Hattori, Seisuke; Inoue, Jun-ichiro; Yamamoto, Tadashi; Miyano, Satoru; Sugano, Sumio; Oyama, Masaaki			Phosphoproteomics-Based Modeling Defines the Regulatory Mechanism Underlying Aberrant EGFR Signaling	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; TYROSINE PHOSPHORYLATION; MASS-SPECTROMETRY; BINDING-SITE; MAPK CASCADE; PROTEIN; DYNAMICS; NETWORK; PATHWAYS; REVEALS	Background: Mutation of the epidermal growth factor receptor (EGFR) results in a discordant cell signaling, leading to the development of various diseases. However, the mechanism underlying the alteration of downstream signaling due to such mutation has not yet been completely understood at the system level. Here, we report a phosphoproteomics-based methodology for characterizing the regulatory mechanism underlying aberrant EGFR signaling using computational network modeling. Methodology/Principal Findings: Our phosphoproteomic analysis of the mutation at tyrosine 992 (Y992), one of the multifunctional docking sites of EGFR, revealed network-wide effects of the mutation on EGF signaling in a time-resolved manner. Computational modeling based on the temporal activation profiles enabled us to not only rediscover already-known protein interactions with Y992 and internalization property of mutated EGFR but also further gain model-driven insights into the effect of cellular content and the regulation of EGFR degradation. Our kinetic model also suggested critical reactions facilitating the reconstruction of the diverse effects of the mutation on phosphoproteome dynamics. Conclusions/Significance: Our integrative approach provided a mechanistic description of the disorders of mutated EGFR signaling networks, which could facilitate the development of a systematic strategy toward controlling disease-related cell signaling.	[Tasaki, Shinya; Kozuka-Hata, Hiroko; Inoue, Jun-ichiro; Oyama, Masaaki] Univ Tokyo, Inst Med Sci, Med Prote Lab, Tokyo, Japan; [Tasaki, Shinya; Sugano, Sumio] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Tokyo, Japan; [Nagasaki, Masao; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Tokyo, Japan; [Semba, Kentaro] Waseda Univ, Dept Life Sci & Med Biosci, Tokyo, Japan; [Gotoh, Noriko] Univ Tokyo, Inst Med Sci, Div Syst Biomed Technol, Tokyo, Japan; [Hattori, Seisuke] Univ Tokyo, Inst Med Sci, Div Cellular Prote BML, Tokyo, Japan; [Hattori, Seisuke] Kitasato Univ, Sch Pharmaceut Sci, Dept Biochem, Tokyo 108, Japan; [Inoue, Jun-ichiro; Yamamoto, Tadashi] Univ Tokyo, Inst Med Sci, Dept Canc Biol, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Waseda University; University of Tokyo; University of Tokyo; Kitasato University; University of Tokyo	Tasaki, S (corresponding author), Univ Tokyo, Inst Med Sci, Med Prote Lab, Tokyo, Japan.	moyama@ims.u-tokyo.ac.jp	GOTOH, Noriko/D-8430-2015	Gotoh, Noriko/0000-0003-3733-260X; Miyano, Satoru/0000-0002-1753-6616; Oyama, Masaaki/0000-0001-6478-3735; Kozuka-Hata, Hiroko/0000-0002-9286-6594; Nagasaki, Masao/0000-0002-4292-8785	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research on Priority Areas and Japan Society for the Promotion of Science (JSPS) Fellows from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agazie YM, 2003, MOL CELL BIOL, V23, P7875, DOI 10.1128/MCB.23.21.7875-7886.2003; Anastasi S, 2007, ONCOGENE, V26, P7833, DOI 10.1038/sj.onc.1210590; Beebe JA, 2003, J BIOL CHEM, V278, P26810, DOI 10.1074/jbc.M301397200; Bhalla US, 2004, BIOPHYS J, V87, P745, DOI 10.1529/biophysj.104.040501; Birtwistle MR, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100188; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Blinov ML, 2006, BIOSYSTEMS, V83, P136, DOI 10.1016/j.biosystems.2005.06.014; Bose R, 2006, P NATL ACAD SCI USA, V103, P9773, DOI 10.1073/pnas.0603948103; Brightman FA, 2000, FEBS LETT, V482, P169, DOI 10.1016/S0014-5793(00)02037-8; Bublil EM, 2007, CURR OPIN CELL BIOL, V19, P124, DOI 10.1016/j.ceb.2007.02.008; CHEN D, 1995, SCIENCE, V269, P1699, DOI 10.1126/science.269.5231.1699; Chen WW, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.74; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; Dengjel J, 2009, MOL BIOSYST, V5, P1112, DOI 10.1039/b909534a; Doi Atsushi, 2004, In Silico Biol, V4, P271; Emlet DR, 1997, J BIOL CHEM, V272, P4079, DOI 10.1074/jbc.272.7.4079; Fujioka A, 2006, J BIOL CHEM, V281, P8917, DOI 10.1074/jbc.M509344200; GOTOH N, 1994, P NATL ACAD SCI USA, V91, P167, DOI 10.1073/pnas.91.1.167; Guha U, 2008, P NATL ACAD SCI USA, V105, P14112, DOI 10.1073/pnas.0806158105; Hatakeyama M, 2003, BIOCHEM J, V373, P451, DOI 10.1042/BJ20021824; Hendriks BS, 2003, J BIOL CHEM, V278, P23343, DOI 10.1074/jbc.M300477200; Holbrook MR, 1999, BIOCHEMISTRY-US, V38, P9348, DOI 10.1021/bi990195r; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Joughin BA, 2009, MOL BIOSYST, V5, P59, DOI 10.1039/b815075c; Kaushansky A, 2008, MOL BIOSYST, V4, P643, DOI 10.1039/b801018h; Kholodenko BN, 1999, J BIOL CHEM, V274, P30169, DOI 10.1074/jbc.274.42.30169; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Koh G, 2006, BIOINFORMATICS, V22, pE271, DOI 10.1093/bioinformatics/btl264; MATSUNO H, 2000, PAC S BIOC, V5, P341; MILARSKI KL, 1993, J BIOL CHEM, V268, P23634; Nagasaki Masao, 2006, Genome Inform, V17, P46; Nagasaki Masao, 2004, Genome Inform, V15, P180; Nakamura K, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P227; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Oyama M, 2004, GENOME RES, V14, P2048, DOI 10.1101/gr.2384604; Oyama M, 2007, MOL CELL PROTEOMICS, V6, P1000, DOI 10.1074/mcp.M600297-MCP200; Oyama M, 2009, MOL CELL PROTEOMICS, V8, P226, DOI 10.1074/mcp.M800186-MCP200; Resat H, 2003, BIOPHYS J, V85, P730, DOI 10.1016/S0006-3495(03)74516-0; ROTIN D, 1992, EMBO J, V11, P559, DOI 10.1002/j.1460-2075.1992.tb05087.x; Saito A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-15; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Schulze WX, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100012; Schulze WX, 2004, J BIOL CHEM, V279, P10756, DOI 10.1074/jbc.M309909200; Selvarajoo K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003430; Shankaran H, 2006, BIOPHYS J, V90, P3993, DOI 10.1529/biophysj.105.080580; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; SOLER C, 1993, J BIOL CHEM, V268, P22010; Tamas P, 2003, J BIOL CHEM, V278, P5163, DOI 10.1074/jbc.M207555200; Tasaki Shinya, 2006, Genome Inform, V17, P226; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Tong JF, 2009, MOL CELL PROTEOMICS, V8, P2131, DOI 10.1074/mcp.M900148-MCP200; TRONCALE S, 2006, PAC S BIOC, V11, P427; Wolf-Yadlin A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100094; Yoshida R, 2008, BIOINFORMATICS, V24, P2592, DOI 10.1093/bioinformatics/btn483; Zhang XW, 2007, NATURE, V450, P741, DOI 10.1038/nature05998; Zhang Y, 2005, MOL CELL PROTEOMICS, V4, P1240, DOI 10.1074/mcp.M500089-MCP200	57	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e13926	10.1371/journal.pone.0013926	http://dx.doi.org/10.1371/journal.pone.0013926			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085658	gold, Green Submitted, Green Published			2022-12-25	WOS:000284036800017
J	Wiley, MR; Roberts, LO; Adelman, ZN; Myles, KM				Wiley, Michael R.; Roberts, Lisa O.; Adelman, Zach N.; Myles, Kevin M.			Double Subgenomic Alphaviruses Expressing Multiple Fluorescent Proteins Using a Rhopalosiphum padi Virus Internal Ribosome Entry Site Element	PLOS ONE			English	Article							ONYONG-NYONG VIRUS; RNA INTERFERENCE; 5'-UNTRANSLATED REGION; GENE-EXPRESSION; MOSQUITO; VECTORS; REPLICATION; INFECTION; PLANT	Double subgenomic Sindbis virus (dsSINV) vectors are widely used for the expression of proteins, peptides, and RNA sequences. These recombinant RNA viruses permit high level expression of a heterologous sequence in a wide range of animals, tissues, and cells. However, the alphavirus genome structure and replication strategy is not readily amenable to the expression of more than one heterologous sequence. The Rhopalosiphum padi virus (RhPV) genome contains two internal ribosome entry site (IRES) elements that mediate cap-independent translation of the virus nonstructural and structural proteins. Most IRES elements that have been characterized function only in mammalian cells but previous work has shown that the IRES element present in the 5' untranslated region (UTR) of the RhPV genome functions efficiently in mammalian, insect, and plant systems. To determine if the 5' RhPV IRES element could be used to express more than one heterologous sequence from a dsSINV vector, RhPV 5' IRES sequences were placed between genes for two different fluorescent marker proteins in the dsSINV, TE/3'2J/mcs. While mammalian and insect cells infected with recombinant viruses containing the RhPV sequences expressed both fluorescent marker proteins, only single marker proteins were routinely observed in cells infected with dsSINV vectors in which the RhPV IRES had been replaced by a luciferase fragment, an antisense RhPV IRES, or no intergenic sequence. Thus, we report development of a versatile tool for the expression of multiple sequences in diverse cell types.	[Wiley, Michael R.; Adelman, Zach N.; Myles, Kevin M.] Virginia Tech, Dept Entomol, Fralin Life Sci Inst, Blacksburg, VA 24061 USA; [Roberts, Lisa O.] Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 5XH, Surrey, England	Virginia Polytechnic Institute & State University; University of Surrey	Wiley, MR (corresponding author), Virginia Tech, Dept Entomol, Fralin Life Sci Inst, Blacksburg, VA 24061 USA.	mylesk@vt.edu		Adelman, Zach/0000-0001-5901-7171; Wiley, Michael/0000-0001-6688-007X	National Institute of Allergy and Infectious Diseases [AI077726]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077726] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project described was supported by Grant Number AI077726 from National Institute of Allergy and Infectious Diseases. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman ZN, 2008, INSECT BIOCHEM MOLEC, V38, P705, DOI 10.1016/j.ibmb.2008.04.002; Attardo GM, 2003, P NATL ACAD SCI USA, V100, P13374, DOI 10.1073/pnas.2235649100; Avadhanula V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000582; Brault AC, 2004, INSECT MOL BIOL, V13, P625, DOI 10.1111/j.0962-1075.2004.00521.x; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Frolov I, 1996, P NATL ACAD SCI USA, V93, P11371, DOI 10.1073/pnas.93.21.11371; Garoff H, 1998, CURR OPIN BIOTECH, V9, P464, DOI 10.1016/S0958-1669(98)80030-X; Groppelli E, 2007, J GEN VIROL, V88, P1583, DOI 10.1099/vir.0.82682-0; HAHN CS, 1992, P NATL ACAD SCI USA, V89, P2679, DOI 10.1073/pnas.89.7.2679; Horn C, 2000, DEV GENES EVOL, V210, P630, DOI 10.1007/s004270000110; Jan E, 2006, VIRUS RES, V119, P16, DOI 10.1016/j.virusres.2005.10.011; Kamrud KI, 2007, VIROLOGY, V360, P376, DOI 10.1016/j.virol.2006.10.049; Keene KM, 2004, P NATL ACAD SCI USA, V101, P17240, DOI 10.1073/pnas.0406983101; Kohl A, 2004, J VIROL, V78, P5679, DOI 10.1128/JVI.78.11.5679-5685.2004; Lundstrom K, 2005, GENE THER, V12, pS92, DOI 10.1038/sj.gt.3302620; Myles KM, 2006, J VIROL, V80, P4992, DOI 10.1128/JVI.80.10.4992-4997.2006; Olson KE, 1996, SCIENCE, V272, P884, DOI 10.1126/science.272.5263.884; Pijlman GP, 2006, J BIOTECHNOL, V123, P13, DOI 10.1016/j.jbiotec.2005.10.022; Pugachev KV, 2000, J VIROL, V74, P10811, DOI 10.1128/JVI.74.22.10811-10815.2000; Rayner JO, 2002, REV MED VIROL, V12, P279, DOI 10.1002/rmv.360; Roberts LO, 2009, PROG MOL BIOL TRANSL, V90, P313, DOI 10.1016/S1877-1173(09)90009-6; Royall E, 2004, J GEN VIROL, V85, P1565, DOI 10.1099/vir.0.79992-0; Schlesinger S, 2001, EXPERT OPIN BIOL TH, V1, P177, DOI 10.1517/14712598.1.2.177; Shiao SH, 2001, INSECT MOL BIOL, V10, P315, DOI 10.1046/j.0962-1075.2001.00268.x; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Strauss JH, 1990, SEMIN VIROL, V1, P347; Thomas JM, 2003, J VIROL, V77, P5598, DOI 10.1128/JVI.77.10.5598-5606.2003; Uhlirova M, 2003, P NATL ACAD SCI USA, V100, P15607, DOI 10.1073/pnas.2136837100; Volkova E, 2008, VIROLOGY, V377, P160, DOI 10.1016/j.virol.2008.04.020; Woolaway KE, 2001, J VIROL, V75, P10244, DOI 10.1128/JVI.75.21.10244-10249.2001	30	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e13924	10.1371/journal.pone.0013924	http://dx.doi.org/10.1371/journal.pone.0013924			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085714	Green Published, gold, Green Submitted			2022-12-25	WOS:000284036800015
J	Pugacheva, EM; Suzuki, T; Pack, SD; Kosaka-Suzuki, N; Yoon, J; Vostrov, AA; Barsov, E; Strunnikov, AV; Morse, HC; Loukinov, D; Lobanenkov, V				Pugacheva, Elena M.; Suzuki, Teruhiko; Pack, Svetlana D.; Kosaka-Suzuki, Natsuki; Yoon, Jeongheon; Vostrov, Alexander A.; Barsov, Eugene; Strunnikov, Alexander V.; Morse, Herbert C., III; Loukinov, Dmitri; Lobanenkov, Victor			The Structural Complexity of the Human BORIS Gene in Gametogenesis and Cancer	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; ENHANCER-BLOCKING; IMPRINTED SITES; TESTIS ANTIGEN; CTCF-BINDING; H19 GENE; EXPRESSION; PROMOTER; METHYLATION; CELLS	Background: BORIS/CTCFL is a paralogue of CTCF, the major epigenetic regulator of vertebrate genomes. BORIS is normally expressed only in germ cells but is aberrantly activated in numerous cancers. While recent studies demonstrated that BORIS is a transcriptional activator of testis-specific genes, little is generally known about its biological and molecular functions. Methodology/Principal Findings: Here we show that BORIS is expressed as 23 isoforms in germline and cancer cells. The isoforms are comprised of alternative N- and C-termini combined with varying numbers of zinc fingers (ZF) in the DNA binding domain. The patterns of BORIS isoform expression are distinct in germ and cancer cells. Isoform expression is activated by downregulation of CTCF, upregulated by reduction in CpG methylation caused by inactivation of DNMT1 or DNMT3b, and repressed by activation of p53. Studies of ectopically expressed isoforms showed that all are translated and localized to the nucleus. Using the testis-specific cerebroside sulfotransferase (CST) promoter and the IGF2/H19 imprinting control region (ICR), it was shown that binding of BORIS isoforms to DNA targets in vitro is methylation-sensitive and depends on the number and specific composition of ZF. The ability to bind target DNA and the presence of a specific long amino terminus (N258) in different isoforms are necessary and sufficient to activate CST transcription. Comparative sequence analyses revealed an evolutionary burst in mammals with strong conservation of BORIS isoproteins among primates. Conclusions: The extensive repertoire of spliced BORIS variants in humans that confer distinct DNA binding and transcriptional activation properties, and their differential patterns of expression among germ cells and neoplastic cells suggest that the gene is involved in a range of functionally important aspects of both normal gametogenesis and cancer development. In addition, a burst in isoform diversification may be evolutionarily tied to unique aspects of primate speciation.	[Pugacheva, Elena M.; Suzuki, Teruhiko; Kosaka-Suzuki, Natsuki; Yoon, Jeongheon; Strunnikov, Alexander V.; Morse, Herbert C., III; Loukinov, Dmitri; Lobanenkov, Victor] NIAID, Immunopathol Lab, NIH, Rockville, MD USA; [Pack, Svetlana D.] NCI, Chromosome Pathol Unit, Pathol Lab, CCR,NIH, Bethesda, MD 20892 USA; [Vostrov, Alexander A.] SUNY Stony Brook, Dept Psychiat & Behav Sci, Stony Brook, NY 11794 USA; [Barsov, Eugene] SAIC Frederick NCI Frederick, AIDS & Canc Viruses Program, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Pugacheva, EM (corresponding author), NIAID, Immunopathol Lab, NIH, Rockville, MD USA.	epugacheva@niaid.nih.gov	Pack, Svetlana D./C-2020-2014; Pugacheva, Elena M/GNH-1756-2022; Lobanenkov, Victor/ABD-5710-2021; Lobanenkov, Victor V./AGQ-8903-2022	Pack, Svetlana D./0000-0003-3256-6626; Pugacheva, Elena M/0000-0001-9693-9853; Strunnikov, Alexander/0000-0002-9058-2256; Lobanenkov, Victor/0000-0001-6665-3635; Morse, Herbert/0000-0002-9331-3705	NIAID; NIH Office of AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000858] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH Office of AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the intramural research program of NIAID and by the intramural grant from NIH Office of AIDS Research to A. V. S. and D. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Chao W, 2002, SCIENCE, V295, P345, DOI 10.1126/science.1065982; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; D'Arcy V, 2008, BRIT J CANCER, V98, P571, DOI 10.1038/sj.bjc.6604181; Darcy V, 2006, CLIN CANCER RES, V12, P5978, DOI 10.1158/1078-0432.CCR-05-2731; De Cesare D, 2000, J ENDOCRINOL INVEST, V23, P592, DOI 10.1007/BF03343781; De la Rosa-Velazquez IA, 2007, CANCER RES, V67, P2577, DOI 10.1158/0008-5472.CAN-06-2024; Fedoriw AM, 2004, SCIENCE, V303, P238, DOI 10.1126/science.1090934; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Gazin C, 2007, NATURE, V449, P1073, DOI 10.1038/nature06251; Gedye C, 2009, CANCER IMMUNOL IMMUN, V58, P1635, DOI 10.1007/s00262-009-0672-0; Ghochikyan A, 2007, J IMMUNOL, V178, P566, DOI 10.4049/jimmunol.178.1.566; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hirahara Y, 2000, EUR J BIOCHEM, V267, P1909, DOI 10.1046/j.1432-1327.2000.01139.x; Hoffmann MJ, 2006, BIOCHEM PHARMACOL, V72, P1577, DOI 10.1016/j.bcp.2006.06.020; Hong JA, 2005, CANCER RES, V65, P7763, DOI 10.1158/0008-5472.CAN-05-0823; Hore TA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000169; Jelinic P, 2006, PLOS BIOL, V4, P1910, DOI 10.1371/journal.pbio.0040355; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Kawashima I, 1992, DNA Seq, V2, P313, DOI 10.3109/10425179209030964; Klenova EA, 2002, SEMIN CANCER BIOL, V12, P399, DOI 10.1016/S1044-579X(02)00060-3; Libby RT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000257; Loukinov DI, 2002, P NATL ACAD SCI USA, V99, P6806, DOI 10.1073/pnas.092123699; Loukinov D, 2006, J CELL BIOCHEM, V98, P1037, DOI 10.1002/jcb.20953; Monk M, 2008, MOL HUM REPROD, V14, P347, DOI 10.1093/molehr/gan025; Moon H, 2005, EMBO REP, V6, P165, DOI 10.1038/sj.embor.7400334; Nguyen P, 2008, CANCER RES, V68, P5546, DOI 10.1158/0008-5472.CAN-08-1005; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Pack SD, 1999, CANCER RES, V59, P5560; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Pugacheva EM, 2006, GENE, V375, P26, DOI 10.1016/j.gene.2006.01.036; Pugacheva EM, 2005, HUM MOL GENET, V14, P953, DOI 10.1093/hmg/ddi089; Quitschke WW, 2000, NUCLEIC ACIDS RES, V28, P3370, DOI 10.1093/nar/28.17.3370; RENAUD S, 2010, NUCL ACIDS RES; Renaud S, 2007, NUCLEIC ACIDS RES, V35, P7372, DOI 10.1093/nar/gkm896; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Risinger JI, 2007, CLIN CANCER RES, V13, P1713, DOI 10.1158/1078-0432.CCR-05-2569; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Smith IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004961; SUZUKI T, 2010, MOL CELL BIOL; Szabo PE, 2000, CURR BIOL, V10, P607, DOI 10.1016/S0960-9822(00)00489-9; Takai D, 2001, HUM MOL GENET, V10, P2619, DOI 10.1093/hmg/10.23.2619; Vatolin S, 2005, CANCER RES, V65, P7751, DOI 10.1158/0008-5472.CAN-05-0858; Vostrov AA, 1997, J BIOL CHEM, V272, P33353, DOI 10.1074/jbc.272.52.33353; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Yawata T, 2010, MOL CARCINOGEN, V49, P532, DOI 10.1002/mc.20614	48	43	45	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e13872	10.1371/journal.pone.0013872	http://dx.doi.org/10.1371/journal.pone.0013872			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	676NU	21079786	Green Submitted, Green Published, gold			2022-12-25	WOS:000283920000006
J	Han, YY; Wang, QL; Song, P; Zhu, Y; Zou, MH				Han, Yingying; Wang, Qilong; Song, Ping; Zhu, Yi; Zou, Ming-Hui			Redox Regulation of the AMP-Activated Protein Kinase	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ENDOTHELIAL-CELLS; CARCINOMA-CELLS; MUSCLE-CELLS; IN-VIVO; BERBERINE; MECHANISM; APOPTOSIS; PHOSPHORYLATION; INDUCTION	Redox state is a critical determinant of cell function, and any major imbalances can cause severe damage or death. Objectives: The aim of this study is to determine if AMP-activated protein kinase (AMPK), a cellular energy sensor, is activated by oxidants generated by Berberine in endothelial cells (EC). Methods: Bovine aortic endothelial cells (BAEC) were exposed to Berberine. AMPK activity and reactive oxygen species were monitored after the incubation. Results: In BAEC, Berberine caused a dose- and time-dependent increase in the phosphorylation of AMPK at Thr172 and acetyl CoA carboxylase (ACC) at Ser79, a well characterized downstream target of AMPK. Concomitantly, Berberine increased peroxynitrite, a potent oxidant formed by simultaneous generation of superoxide and nitric oxide. Pre-incubation of BAEC with anti-oxidants markedly attenuated Berberine-enhanced phosphorylation of both AMPK and ACC. Consistently, adenoviral expression of superoxide dismutase and pretreatment of L-N-G-Nitroarginine methyl ester (L-NAME; a non-selective NOS inhibitor) blunted Berberine-induced phosphorylation of AMPK. Furthermore, mitochondria-targeted tempol (mito-tempol) pretreatment or expression of uncoupling protein attenuated AMPK activation caused by Berberine. Depletion of mitochondria abolished the effects of Berberine on AMPK in EC. Finally, Berberine significantly increased the phosphorylation of LKB1 at Ser307 and gene silencing of LKB1 attenuated Berberine-enhanced AMPK Thr172 phosphorylation in BAEC. Conclusion: Our results suggest that mitochondria-derived superoxide anions and peroxynitrite are required for Berberine-induced AMPK activation in endothelial cells.	[Han, Yingying; Wang, Qilong; Song, Ping; Zou, Ming-Hui] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem, Oklahoma City, OK 73190 USA; [Han, Yingying; Wang, Qilong; Song, Ping; Zou, Ming-Hui] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK USA; [Han, Yingying; Zhu, Yi] Peking Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, Beijing 100871, Peoples R China	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Peking University	Han, YY (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem, Oklahoma City, OK 73190 USA.	ming-hui-zou@ouhsc.edu	Song, Ping/N-8456-2018; Song, Ping/D-6972-2011; wang, qilong/O-1962-2013	Song, Ping/0000-0002-6143-4270; Song, Ping/0000-0002-2654-6162; 	National Institutes of Health (NIH) [HL079584, HL080499, HL074399, HL089920, HL096032, HL105157]; American Diabetes Association; Travis Endowed Chair of the University of Oklahoma Health Science Center; American Heart Association; Chinese National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089920, R01HL110488, R01HL074399, R01HL079584, R01HL096032, R01HL105157, R01HL080499] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Travis Endowed Chair of the University of Oklahoma Health Science Center; American Heart Association(American Heart Association); Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding: This study was supported by National Institutes of Health (NIH) grants (HL079584, HL080499, HL074399, HL089920, HL096032, and HL105157), and a Research Award from the American Diabetes Association, and funds from the Travis Endowed Chair of the University of Oklahoma Health Science Center (all to Dr. Zou). Dr. M. H. Zou is a recipient of Established Investigator Award of American Heart Association. Part of this work was also supported by an international cooperation grant from the Chinese National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker T, 2006, CARDIOVASC RES, V71, P195, DOI 10.1016/j.cardiores.2006.04.008; An ZB, 2007, J BIOL CHEM, V282, P26793, DOI 10.1074/jbc.M703701200; BOVA S, 1992, J PHARMACOL EXP THER, V261, P318; Brusq JM, 2006, J LIPID RES, V47, P1281, DOI 10.1194/jlr.M600020-JLR200; Ceolotto G, 2007, ARTERIOSCL THROM VAS, V27, P2627, DOI 10.1161/ATVBAHA.107.155762; Choi HC, 2008, J BIOL CHEM, V283, P20186, DOI 10.1074/jbc.M803020200; Choi MS, 2008, ANTICANCER RES, V28, P3777; Coven DL, 2003, AM J PHYSIOL-ENDOC M, V285, pE629, DOI 10.1152/ajpendo.00171.2003; CUI G, 2009, J BIOL CHEM; Fernandes DC, 2007, AM J PHYSIOL-CELL PH, V292, pC413, DOI 10.1152/ajpcell.00188.2006; Foretz M, 2006, M S-MED SCI, V22, P381, DOI 10.1051/medsci/2006224381; Fukuyama Y, 2007, J DENT RES, V86, P903, DOI 10.1177/154405910708600919; Hardie DG, 2006, PHYSIOLOGY, V21, P48, DOI 10.1152/physiol.00044.2005; Jeong HW, 2009, AM J PHYSIOL-ENDOC M, V296, pE955, DOI 10.1152/ajpendo.90599.2008; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Kim WS, 2009, AM J PHYSIOL-ENDOC M, V296, pE812, DOI 10.1152/ajpendo.90710.2008; Kou R, 2009, J BIOL CHEM, V284, P14734, DOI 10.1074/jbc.M808664200; Kukidome D, 2006, DIABETES, V55, P120, DOI 10.2337/diabetes.55.01.06.db05-0943; Lee YS, 2006, DIABETES, V55, P2256, DOI 10.2337/db06-0006; Letasiova S, 2006, J PHARM PHARMACOL, V58, P263, DOI 10.1211/jpp.58.2.0015; Li XX, 2008, ARTERIOSCL THROM VAS, V28, P1789, DOI 10.1161/ATVBAHA.108.172452; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Mantena SK, 2006, MOL CANCER THER, V5, P296, DOI 10.1158/1535-7163.MCT-05-0448; McCrimmon RJ, 2004, DIABETES, V53, P1953, DOI 10.2337/diabetes.53.8.1953; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Mueller CFH, 2005, ARTERIOSCL THROM VAS, V25, P274, DOI 10.1161/01.ATV.0000149143.04821.eb; Nagata D, 2003, J BIOL CHEM, V278, P31000, DOI 10.1074/jbc.M300643200; Pereira CV, 2008, TOXICOL SCI, V105, P408, DOI 10.1093/toxsci/kfn131; Pereira GC, 2007, J PHARMACOL EXP THER, V323, P636, DOI 10.1124/jpet.107.128017; Song P, 2008, J BIOL CHEM, V283, P12446, DOI 10.1074/jbc.M708208200; Song P, 2009, J BIOL CHEM, V284, P17120, DOI 10.1074/jbc.M109.012583; Turner N, 2008, DIABETES, V57, P1414, DOI 10.2337/db07-1552; Wang YQ, 2009, CARDIOVASC RES, V82, P484, DOI 10.1093/cvr/cvp078; Wu Y, 2007, J BIOL CHEM, V282, P9777, DOI 10.1074/jbc.M608310200; XIAO X, 2009, J NUTR BIOCH; Xie ZL, 2009, MOL CELL BIOL, V29, P3582, DOI 10.1128/MCB.01417-08; Yin J, 2008, AM J PHYSIOL-ENDOC M, V294, pE148, DOI 10.1152/ajpendo.00211.2007; Zang MW, 2006, DIABETES, V55, P2180, DOI 10.2337/db05-1188; Zhang JH, 2008, J BIOL CHEM, V283, P27452, DOI 10.1074/jbc.M802578200; Zhang M, 2008, CIRC RES, V102, P328, DOI 10.1161/CIRCRESAHA.107.163253; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zhou LJ, 2009, J BIOL CHEM, V284, P22426, DOI 10.1074/jbc.M109.028357; Zou MH, 2004, J BIOL CHEM, V279, P43940, DOI 10.1074/jbc.M404421200; Zou MH, 2002, J BIOL CHEM, V277, P32552, DOI 10.1074/jbc.M204512200	45	55	57	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2010	5	11							e15420	10.1371/journal.pone.0015420	http://dx.doi.org/10.1371/journal.pone.0015420			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675OD	21079763	gold, Green Submitted, Green Published			2022-12-25	WOS:000283839100022
J	Wersinger, E; McLean, WJ; Fuchs, PA; Pyott, SJ				Wersinger, Eric; McLean, Will J.; Fuchs, Paul A.; Pyott, Sonja J.			BK Channels Mediate Cholinergic Inhibition of High Frequency Cochlear Hair Cells	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; ACTIVATED POTASSIUM CHANNELS; CA2+-ACTIVATED K+ CHANNELS; SMALL-CONDUCTANCE; MESSENGER-RNA; ALPHA-SUBUNIT; DEVELOPMENTAL EXPRESSION; DIFFERENTIAL EXPRESSION; INNER; CURRENTS	Background: Outer hair cells are the specialized sensory cells that empower the mammalian hearing organ, the cochlea, with its remarkable sensitivity and frequency selectivity. Sound-evoked receptor potentials in outer hair cells are shaped by both voltage-gated K+ channels that control the membrane potential and also ligand-gated K+ channels involved in the cholinergic efferent modulation of the membrane potential. The objectives of this study were to investigate the tonotopic contribution of BK channels to voltage-and ligand-gated currents in mature outer hair cells from the rat cochlea. Methodology/Principal: Findings In this work we used patch clamp electrophysiology and immunofluorescence in tonotopically defined segments of the rat cochlea to determine the contribution of BK channels to voltage-and ligand-gated currents in outer hair cells. Although voltage and ligand-gated currents have been investigated previously in hair cells from the rat cochlea, little is known about their tonotopic distribution or potential contribution to efferent inhibition. We found that apical (low frequency) outer hair cells had no BK channel immunoreactivity and little or no BK current. In marked contrast, basal (high frequency) outer hair cells had abundant BK channel immunoreactivity and BK currents contributed significantly to both voltage-gated and ACh-evoked K+ currents. Conclusions/Significance: Our findings suggest that basal (high frequency) outer hair cells may employ an alternative mechanism of efferent inhibition mediated by BK channels instead of SK2 channels. Thus, efferent synapses may use different mechanisms of action both developmentally and tonotopically to support high frequency audition. High frequency audition has required various functional specializations of the mammalian cochlea, and as shown in our work, may include the utilization of BK channels at efferent synapses. This mechanism of efferent inhibition may be related to the unique acetylcholine receptors that have evolved in mammalian hair cells compared to those of other vertebrates.	[Wersinger, Eric; Fuchs, Paul A.] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Ctr Hearing & Balance, Baltimore, MD 21205 USA; [Wersinger, Eric; Fuchs, Paul A.] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Baltimore, MD 21205 USA; [McLean, Will J.; Pyott, Sonja J.] Univ N Carolina, Dept Biol & Marine Biol, Wilmington, NC 28401 USA	Johns Hopkins University; Johns Hopkins University; University of North Carolina; University of North Carolina Wilmington	Wersinger, E (corresponding author), Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Ctr Hearing & Balance, Baltimore, MD 21205 USA.	pyotts@uncw.edu	Pyott, Sonja/AAW-8789-2020	Pyott, Sonja/0000-0001-7750-2437; McLean, Will/0000-0003-1335-4556	Deafness Research Foundation [R01 DC001508, P30 DC005211]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC005211, R01DC001508] Funding Source: NIH RePORTER	Deafness Research Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by a research grant from the Deafness Research Foundation to SJP, R01 DC001508 to PAF, and P30 DC005211 to the Center for Hearing and Balance at Johns Hopkins. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHMORE JF, 1986, NATURE, V322, P368, DOI 10.1038/322368a0; Belyantseva IA, 2000, J NEUROSCI, V20, part. no.; Cui J, 2009, CELL MOL LIFE SCI, V66, P852, DOI 10.1007/s00018-008-8609-x; DALLOS P, 1992, SOC GEN PHY, V47, P371; DALLOS P, 1978, J NEUROPHYSIOL, V41, P365, DOI 10.1152/jn.1978.41.2.365; Martin JZD, 2010, J NEUROSCI, V30, P12157, DOI 10.1523/JNEUROSCI.2541-10.2010; Dulon D, 1998, EUR J NEUROSCI, V10, P907, DOI 10.1046/j.1460-9568.1998.00098.x; ELGOYHEN AB, 1994, CELL, V79, P705, DOI 10.1016/0092-8674(94)90555-X; Elgoyhen AB, 2001, P NATL ACAD SCI USA, V98, P3501, DOI 10.1073/pnas.051622798; Engel J, 2006, NEUROSCIENCE, V143, P837, DOI 10.1016/j.neuroscience.2006.08.060; Franchini LF, 2006, MOL PHYLOGENET EVOL, V41, P622, DOI 10.1016/j.ympev.2006.05.042; GITTER AH, 1992, HEARING RES, V60, P13, DOI 10.1016/0378-5955(92)90053-P; Glowatzki E, 2000, SCIENCE, V288, P2366, DOI 10.1126/science.288.5475.2366; Hafidi A, 2005, NEUROSCIENCE, V130, P475, DOI 10.1016/j.neuroscience.2004.09.038; Hiel H, 1996, BRAIN RES, V738, P347, DOI 10.1016/S0006-8993(96)01046-3; HOUSLEY GD, 1992, J PHYSIOL-LONDON, V448, P73, DOI 10.1113/jphysiol.1992.sp019030; Katz E, 2004, J NEUROSCI, V24, P7814, DOI 10.1523/JNEUROSCI.2102-04.2004; Kharkovets T, 2006, EMBO J, V25, P642, DOI 10.1038/sj.emboj.7600951; Kharkovets T, 2000, P NATL ACAD SCI USA, V97, P4333, DOI 10.1073/pnas.97.8.4333; Knirsch M, 2007, J NEUROSCI, V27, P6442, DOI 10.1523/JNEUROSCI.5364-06.2007; Kong JH, 2008, J PHYSIOL-LONDON, V586, P5471, DOI 10.1113/jphysiol.2008.160077; Kong WJ, 2005, HEARING RES, V209, P1, DOI 10.1016/j.heares.2005.06.001; KROS CJ, 1990, J PHYSIOL-LONDON, V421, P263, DOI 10.1113/jphysiol.1990.sp017944; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Langer P, 2003, J COMP NEUROL, V455, P198, DOI 10.1002/cne.10471; Latorre R, 2006, BIOL RES, V39, P385, DOI 10.4067/S0716-97602006000300003; Lin MT, 2008, NAT NEUROSCI, V11, P170, DOI 10.1038/nn2041; Lioudyno M, 2004, J NEUROSCI, V24, P11160, DOI 10.1523/JNEUROSCI.3674-04.2004; Mammano F, 1996, J PHYSIOL-LONDON, V496, P639, DOI 10.1113/jphysiol.1996.sp021715; Marcotti W, 2004, J PHYSIOL-LONDON, V560, P691, DOI 10.1113/jphysiol.2004.072868; Marcotti W, 2004, J PHYSIOL-LONDON, V557, P613, DOI 10.1113/jphysiol.2003.060137; Marcotti W, 1999, J PHYSIOL-LONDON, V520, P653, DOI 10.1111/j.1469-7793.1999.00653.x; MARTY A, 1981, NATURE, V291, P497, DOI 10.1038/291497a0; McLean WJ, 2009, JARO-J ASSOC RES OTO, V10, P37, DOI 10.1007/s10162-008-0152-9; Meera P, 2000, P NATL ACAD SCI USA, V97, P5562, DOI 10.1073/pnas.100118597; Morley BJ, 2002, DEV BRAIN RES, V139, P87, DOI 10.1016/S0165-3806(02)00514-X; MULLER M, 1991, HEARING RES, V51, P247, DOI 10.1016/0378-5955(91)90041-7; Murthy V, 2009, MOL CELL NEUROSCI, V40, P39, DOI 10.1016/j.mcn.2008.08.011; NAKAGAWA T, 1994, EUR ARCH OTO-RHINO-L, V251, pS57, DOI 10.1007/BF02565221; Nenov AP, 1997, HEARING RES, V105, P146, DOI 10.1016/S0378-5955(96)00207-9; Nenov AP, 1996, HEARING RES, V101, P149, DOI 10.1016/S0378-5955(96)00143-8; Oliver D, 2006, J NEUROSCI, V26, P6181, DOI 10.1523/JNEUROSCI.1047-06.2006; Oliver D, 2000, NEURON, V26, P595, DOI 10.1016/S0896-6273(00)81197-6; PALLOTTA BS, 1981, NATURE, V293, P471, DOI 10.1038/293471a0; Pyott SJ, 2004, J NEUROSCI, V24, P9469, DOI 10.1523/JNEUROSCI.3162-04.2004; Pyott SJ, 2007, J BIOL CHEM, V282, P3312, DOI 10.1074/jbc.M608726200; Ruttiger L, 2004, P NATL ACAD SCI USA, V101, P12922, DOI 10.1073/pnas.0402660101; RYAN A, 1975, NATURE, V253, P44, DOI 10.1038/253044a0; Sanchez M, 1996, NEUROPHARMACOLOGY, V35, P963, DOI 10.1016/0028-3908(96)00137-2; Simmons DD, 1998, MOL BRAIN RES, V56, P287, DOI 10.1016/S0169-328X(98)00056-4; Simmons DD, 1996, DEV BRAIN RES, V95, P213; Soh H, 2002, BIOPHYS J, V83, P2528, DOI 10.1016/S0006-3495(02)75264-8; Spreadbury IC, 2004, HEARING RES, V190, P115, DOI 10.1016/S0378-5955(03)00376-9; Thurm H, 2005, J PHYSIOL-LONDON, V569, P137, DOI 10.1113/jphysiol.2005.094680; Van den Abbeele T, 1999, AM J PHYSIOL-CELL PH, V277, pC913, DOI 10.1152/ajpcell.1999.277.5.C913; WANGEMANN P, 1993, HEARING RES, V66, P123, DOI 10.1016/0378-5955(93)90133-L; Weisstaub N, 2002, HEARING RES, V167, P122, DOI 10.1016/S0378-5955(02)00380-5; Winter H, 2007, HISTOCHEM CELL BIOL, V128, P65, DOI 10.1007/s00418-007-0294-6; Yoshida N, 2001, J NEUROPHYSIOL, V85, P84, DOI 10.1152/jn.2001.85.1.84; Yuhas WA, 1999, J COMP PHYSIOL A, V185, P455, DOI 10.1007/s003590050406	60	51	51	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e13836	10.1371/journal.pone.0013836	http://dx.doi.org/10.1371/journal.pone.0013836			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079807	Green Published, Green Submitted, gold			2022-12-25	WOS:000283838600011
J	Hobor, F; Pergoli, R; Kubicek, K; Hrossova, D; Bacikova, V; Zimmermann, M; Pasulka, J; Hofr, C; Vanacova, S; Stefl, R				Hobor, Fruzsina; Pergoli, Roberto; Kubicek, Karel; Hrossova, Dominika; Bacikova, Veronika; Zimmermann, Michal; Pasulka, Josef; Hofr, Ctirad; Vanacova, Stepanka; Stefl, Richard			Recognition of Transcription Termination Signal by the Nuclear Polyadenylated RNA-binding (NAB) 3 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYPTIC UNSTABLE TRANSCRIPTS; TORSION ANGLE DYNAMICS; MESSENGER-RNA; 3'-END FORMATION; NRD1; SEQUENCE; COMPLEX; QUALITY; EXOSOME; PATHWAY	Non-coding RNA polymerase II transcripts are processed by the poly(A)-independent termination pathway that requires the Nrd1 complex. The Nrd1 complex includes two RNA-binding proteins, the nuclear polyadenylated RNA-binding (Nab) 3 and the nuclear pre-mRNA down-regulation (Nrd) 1 that bind their specific termination elements. Here we report the solution structure of the RNA-recognition motif (RRM) of Nab3 in complex with a UCUU oligonucleotide, representing the Nab3 termination element. The structure shows that the first three nucleotides of UCUU are accommodated on the beta-sheet surface of Nab3 RRM, but reveals a sequence-specific recognition only for the central cytidine and uridine. The specific contacts we identified are important for binding affinity in vitro as well as for yeast viability. Furthermore, we show that both RNA-binding motifs of Nab3 and Nrd1 alone bind their termination elements with a weak affinity. Interestingly, when Nab3 and Nrd1 form a heterodimer, the affinity to RNA is significantly increased due to the cooperative binding. These findings are in accordance with the model of their function in the poly(A) independent termination, in which binding to the combined and/or repetitive termination elements elicits efficient termination.	[Pasulka, Josef; Vanacova, Stepanka; Stefl, Richard] Masaryk Univ, Natl Ctr Biomol Res, Fac Sci, CZ-62500 Brno, Czech Republic; [Zimmermann, Michal; Hofr, Ctirad] Masaryk Univ, Dept Funct Genom & Prote, Fac Sci, Cent European Inst Technol, CZ-62500 Brno, Czech Republic	Masaryk University Brno; Masaryk University Brno	Stefl, R (corresponding author), Univ Campus Bohunice, Kamenice 5-A4, CZ-62500 Brno, Czech Republic.	stefl@chemi.muni.cz	Kubicek, Karel/D-8495-2012; Vanacova, Stepanka/D-6858-2012; Hrossova, Dominika/D-7256-2012; Vanacova, Stepanka/AGO-9953-2022; Stefl, Richard/D-7010-2012; Hofr, Ctirad/E-3322-2012; Pasulka, Josef/D-8830-2012	Vanacova, Stepanka/0000-0001-8807-0684; Vanacova, Stepanka/0000-0001-8807-0684; Kubicek, Karel/0000-0002-8990-4481; Stefl, Richard/0000-0003-0558-5952; Pasulka, Josef/0000-0001-6190-0465	Howard Hughes Medical Institute/European Molecular Biology Organization; Human Frontier Science Program Career Development; Ministry of Education of the Czech Republic [MSM0021622413, MSM0021622415, Ingo LA08008]; Czech Science Foundation [204/08/1212, 305/10/1490]; Grant Agency of the Academy of Sciences of the Czech Republic [IAA401630903]; Wellcome Trust [084316/Z/07/Z]; EMBO [1642]; Brno City Municipality; European Community [205872]; GACR [204/08/H054]; European Union [RII3-026145]	Howard Hughes Medical Institute/European Molecular Biology Organization(Howard Hughes Medical InstituteEuropean Molecular Biology Organization (EMBO)); Human Frontier Science Program Career Development(Human Frontier Science Program); Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic); Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic); Wellcome Trust(Wellcome TrustEuropean Commission); EMBO(European Molecular Biology Organization (EMBO)); Brno City Municipality; European Community(European Commission); GACR(Grant Agency of the Czech Republic); European Union(European Commission)	This work was supported in part by a Howard Hughes Medical Institute/European Molecular Biology Organization start-up grant, a Human Frontier Science Program Career Development Award, Ministry of Education of the Czech Republic Grants MSM0021622413, MSM0021622415, and Ingo LA08008, Czech Science Foundation Grants 204/08/1212 and 305/10/1490, Grant Agency of the Academy of Sciences of the Czech Republic IAA401630903, Wellcome Trust Grant 084316/Z/07/Z, and EMBO Installation Grant 1642.; Supported by Brno City Municipality Scholarships for Talented Ph.D. Students.; Supported by the European Community FP-7 Grant 205872.; Supported by the GACR Grant 204/08/H054.; We thank to Dr. D. Libri for the GAL1::Nab3 strain and Dr. J. L. Corden for the generous gift of the Nab3 2F12 antibodies and the pST39 plasmid, containing Nab3-(191-565) and Nrd1-(1-548). We are grateful to Massimo Lucci for assistance with NMR measurements at CERM Florence, Italy. The NOESY spectra including the intermolecular filter experiments were obtained at the CERM NMR facility supported by European Union-NMR program Grant RII3-026145.	ADAM SA, 1986, MOL CELL BIOL, V6, P2932, DOI 10.1128/MCB.6.8.2932; [Anonymous], 2008, AMBER 10; Arigo JT, 2006, MOL CELL, V23, P841, DOI 10.1016/j.molcel.2006.07.024; Auweter SD, 2007, J MOL BIOL, V367, P174, DOI 10.1016/j.jmb.2006.12.053; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Bentley D, 2002, CURR OPIN CELL BIOL, V14, P336, DOI 10.1016/S0955-0674(02)00333-2; Carroll KL, 2004, MOL CELL BIOL, V24, P6241, DOI 10.1128/MCB.24.14.6241-6252.2004; Carroll KL, 2007, RNA, V13, P361, DOI 10.1261/rna.338407; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002; Conrad NK, 2000, GENETICS, V154, P557; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DREYFUSS G, 1988, TRENDS BIOCHEM SCI, V13, P86, DOI 10.1016/0968-0004(88)90046-1; Gudipati RK, 2008, NAT STRUCT MOL BIOL, V15, P786, DOI 10.1038/nsmb.1460; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hargous Y, 2006, EMBO J, V25, P5126, DOI 10.1038/sj.emboj.7601385; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; HEYDUK T, 1990, P NATL ACAD SCI USA, V87, P1744, DOI 10.1073/pnas.87.5.1744; Hooft RWW, 1997, COMPUT APPL BIOSCI, V13, P425; Kielkopf CL, 2001, CELL, V106, P595, DOI 10.1016/S0092-8674(01)00480-9; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Morlando M, 2002, MOL CELL BIOL, V22, P1379, DOI 10.1128/MCB.22.5.1379-1389.2002; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Oberstrass FC, 2005, SCIENCE, V309, P2054, DOI 10.1126/science.1114066; Padrta P, 2002, J BIOMOL NMR, V24, P1, DOI 10.1023/A:1020632900961; Paolo SS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000555; Pergoli R, 2010, BIOMOL NMR ASSIGN, V4, P119, DOI 10.1007/s12104-010-9221-1; Peterson RD, 2004, J BIOMOL NMR, V28, P59, DOI 10.1023/B:JNMR.0000012861.95939.05; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Richard P, 2009, GENE DEV, V23, P1247, DOI 10.1101/gad.1792809; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; SIKORSKI RS, 1989, GENETICS, V122, P19; SINGH R, 1995, SCIENCE, V268, P1173, DOI 10.1126/science.7761834; Spronk CAEM, 2004, PROG NUCL MAG RES SP, V45, P315, DOI 10.1016/j.pnmrs.2004.08.003; Stefl R, 2005, EMBO REP, V6, P33, DOI 10.1038/sj.embor.7400325; Steinmetz EJ, 1998, P NATL ACAD SCI USA, V95, P6699, DOI 10.1073/pnas.95.12.6699; Steinmetz EJ, 1996, MOL CELL BIOL, V16, P6993, DOI 10.1128/mcb.16.12.6993; Steinmetz EJ, 2001, NATURE, V413, P327, DOI 10.1038/35095090; SWANSON MS, 1987, MOL CELL BIOL, V7, P1731, DOI 10.1128/MCB.7.5.1731; Thiebaut M, 2006, MOL CELL, V23, P853, DOI 10.1016/j.molcel.2006.07.029; Trantirek L, 2002, J BIOMOL NMR, V23, P1, DOI 10.1023/A:1015389118506; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Varani G, 1996, PROG NUCL MAG RES SP, V29, P51, DOI 10.1016/0079-6565(96)01028-X; Vasiljeva L, 2006, MOL CELL, V21, P239, DOI 10.1016/j.molcel.2005.11.028; Vasiljeva L, 2008, NAT STRUCT MOL BIOL, V15, P795, DOI 10.1038/nsmb.1468; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; WILSON SM, 1994, J CELL BIOL, V127, P1173, DOI 10.1083/jcb.127.5.1173; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	57	35	35	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3645	3657		10.1074/jbc.M110.158774	http://dx.doi.org/10.1074/jbc.M110.158774			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21084293	hybrid, Green Published			2022-12-25	WOS:000286653200048
J	Zanotti, S; Smerdel-Ramoya, A; Canalis, E				Zanotti, Stefano; Smerdel-Ramoya, Anna; Canalis, Ernesto			HES1 (Hairy and Enhancer of Split 1) Is a Determinant of Bone Mass	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NOTCH SIGNALING PATHWAY; OSTEOBLAST DIFFERENTIATION; OSTEOCLAST PRECURSORS; CAUSES OSTEOPENIA; NERVOUS-SYSTEM; IN-VITRO; CELLS; GENES; TRANSCRIPTION; RECEPTOR	HES1 (hairy and enhancer of split) is a transcription factor that regulates osteoblastogenesis in vitro. The skeletal effects of HES1 misexpression were studied. Transgenic mice where a 3.6-kilobase fragment of the collagen type 1 alpha 1 promoter directs HES1 overexpression were created. Transgenics were osteopenic due to decreased osteoblast function in female and increased bone resorption in male mice. HES1 impaired osteoblastogenesis in vitro, and transgenic osteoblasts enhanced the resorptive activity of co-cultured osteoclast precursors. Mice homozygous for a Hes1 loxP-targeted allele were bred to transgenics, where the paired-related homeobox gene enhancer or the osteocalcin promoter direct Cre recombinase expression to inactivate Hes1 in the limb bud or in osteoblasts. To avoid genetic compensation, Hes1 was inactivated in the context of the global deletion of Hes3 and Hes5. Hes3 and Hes5 null mice had no skeletal phenotype. Hes1 inactivation in the limb bud increased femoral length and trabecular number. Hes1 inactivation in osteoblasts increased trabecular bone volume, number, and connectivity due to increased mineral apposition rate and suppressed bone resorption. Hes1 inactivation in vitro increased alkaline phosphatase expression and suppressed the resorptive activity of co-cultured osteoclast precursors. In conclusion, by inhibiting osteoblast function and inducing bone resorption, HES1 is an intracellular determinant of bone mass and structure.	[Zanotti, Stefano] St Francis Hosp & Med Ctr, Dept Res, Hartford, CT 06105 USA; [Zanotti, Stefano; Canalis, Ernesto] Univ Connecticut, Sch Med, Farmington, CT 06030 USA	Saint Francis Hospital & Medical Center; University of Connecticut	Zanotti, S (corresponding author), St Francis Hosp & Med Ctr, Dept Res, 114 Woodland St, Hartford, CT 06105 USA.	szanotti@stfranciscare.org			National Institutes of Health, NIDDK [DK045227]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045227] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK045227 from the NIDDK.	AKAZAWA C, 1992, J BIOL CHEM, V267, P21879; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Bai S, 2008, J BIOL CHEM, V283, P6509, DOI 10.1074/jbc.M707000200; Bianco P, 2000, J CLIN INVEST, V105, P1663, DOI 10.1172/JCI10413; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023; Canalis E, 2005, NEW ENGL J MED, V352, P2014, DOI 10.1056/NEJMe058080; Canalis E, 2007, NEW ENGL J MED, V357, P905, DOI 10.1056/NEJMra067395; Canalis E, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.117pe17; Cau E, 2000, DEVELOPMENT, V127, P2323; Cornell RA, 2005, SEMIN CELL DEV BIOL, V16, P663, DOI 10.1016/j.semcdb.2005.06.009; DeMambro VE, 2008, ENDOCRINOLOGY, V149, P2051, DOI 10.1210/en.2007-1068; Engin FZ, 2008, NAT MED, V14, P299, DOI 10.1038/nm1712; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Gazzerro E, 2005, ENDOCRINOLOGY, V146, P655, DOI 10.1210/en.2004-0766; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Grogan SP, 2008, ARTHRITIS RHEUM-US, V58, P2754, DOI 10.1002/art.23730; Hatakeyama J, 2004, DEVELOPMENT, V131, P5539, DOI 10.1242/dev.01436; Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716; Hirata H, 2001, EMBO J, V20, P4454, DOI 10.1093/emboj/20.16.4454; Imayoshi I, 2008, DEVELOPMENT, V135, P2531, DOI 10.1242/dev.021535; IRWIN N, 1989, SAMBROOK; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Kalajzic I, 2002, J BONE MINER RES, V17, P15, DOI 10.1359/jbmr.2002.17.1.15; Karlsson C, 2010, CELLS TISSUES ORGANS, V192, P17, DOI 10.1159/000280416; Katoh M, 2004, INT J ONCOL, V25, P529; Kodama Y, 2004, GASTROENTEROLOGY, V127, P1775, DOI 10.1053/j.gastro.2004.09.004; Kouadjo KE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-127; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lee JS, 2006, J BONE MINER RES, V21, P921, DOI 10.1359/JBMR.060303; Lee J, 2007, DEVELOPMENT, V134, P2795, DOI 10.1242/dev.02868; Lee SK, 2002, J IMMUNOL, V169, P2374, DOI 10.4049/jimmunol.169.5.2374; LIAN J, 1989, P NATL ACAD SCI USA, V86, P1143, DOI 10.1073/pnas.86.4.1143; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Looker AC, 1997, J BONE MINER RES, V12, P1761, DOI 10.1359/jbmr.1997.12.11.1761; MCCARTHY TL, 1990, J BIOL CHEM, V265, P15353; McLarren KW, 2000, J BIOL CHEM, V275, P530, DOI 10.1074/jbc.275.1.530; Mead TJ, 2009, P NATL ACAD SCI USA, V106, P14420, DOI 10.1073/pnas.0902306106; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Nagy TR, 2001, J BONE MINER RES, V16, P1682, DOI 10.1359/jbmr.2001.16.9.1682; Nazarenko I, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e37; Nazarenko I, 2002, NUCLEIC ACIDS RES, V30, P2089, DOI 10.1093/nar/30.9.2089; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Ross DA, 2006, MOL ENDOCRINOL, V20, P698, DOI 10.1210/me.2005-0325; Ross DA, 2004, MOL CELL BIOL, V24, P3505, DOI 10.1128/MCB.24.8.3505-3513.2004; Shen Q, 2005, J BIOL CHEM, V280, P40589, DOI 10.1074/jbc.M504166200; Smerdel-Ramoya A, 2008, J BIOL CHEM, V283, P22690, DOI 10.1074/jbc.M710140200; Suh JH, 2008, BIOCHEM BIOPH RES CO, V367, P97, DOI 10.1016/j.bbrc.2007.12.100; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Wyzga N, 2004, BONE, V35, P614, DOI 10.1016/j.bone.2004.04.022; Yamada T, 2003, BLOOD, V101, P2227, DOI 10.1182/blood-2002-06-1740; Zanotti S, 2008, ENDOCRINOLOGY, V149, P3890, DOI 10.1210/en.2008-0140; Zanotti S, 2010, MOL CELL BIOL, V30, P886, DOI 10.1128/MCB.01285-09; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200; Zhang Y, 2009, J CELL BIOCHEM, V108, P651, DOI 10.1002/jcb.22299	62	38	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2648	2657		10.1074/jbc.M110.183038	http://dx.doi.org/10.1074/jbc.M110.183038			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21084301	hybrid, Green Published			2022-12-25	WOS:000286464300030
J	Hernandez, D; Miquel-Serra, L; Docampo, MJ; Marco-Ramell, A; Cabrera, J; Fabra, A; Bassols, A				Hernandez, Daniel; Miquel-Serra, Laia; Docampo, Maria-Jose; Marco-Ramell, Anna; Cabrera, Jennifer; Fabra, Angels; Bassols, Anna			V3 Versican Isoform Alters the Behavior of Human Melanoma Cells by Interfering with CD44/ErbB-dependent Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; CHONDROITIN SULFATE PROTEOGLYCAN; BREAST-CANCER; CLINICOPATHOLOGICAL FACTORS; CD44 EXPRESSION; CARCINOMA-CELLS; FACTOR RECEPTOR; OVARIAN-CANCER; COLON-CANCER; IN-VIVO	Versican is a hyaluronan-binding, extracellular chondroitin sulfate proteoglycan produced by several tumor types, including malignant melanoma, which exists as four different splice variants. The short V3 isoform contains the G1 and G3 terminal domains of versican that may potentially interact directly or indirectly with the hyaluronan receptor CD44 and the EGFR, respectively. We have previously described that overexpression of V3 in MeWo human melanoma cells markedly reduces tumor cell growth in vitro and in vivo. In this study we have investigated the signaling mechanism of V3 by silencing the expression of CD44 in control and V3-expressing melanoma cells. Suppression of CD44 had the same effects on cell proliferation and cell migration than those provoked by V3 expression, suggesting that V3 acts through a CD44-mediated mechanism. Furthermore, CD44-dependent hyaluronan internalization was blocked by V3 expression and CD44 silencing, leading to an accumulation of this glycosaminoglycan in the pericellular matrix and to changes in cell migration on hyaluronan. Furthermore, ERK1/2 and p38 activation after EGF treatment were decreased in V3-expressing cells suggesting that V3 may also interact with the EGFR through its G3 domain. The existence of a EGFR/ErbB2 receptor complex able to interact with CD44 was identified in MeWo melanoma cells. V3 overexpression resulted in a reduced interaction between EGFR/ErbB2 and CD44 in response to EGF treatment. Our results indicate that the V3 isoform of versican interferes with CD44 and the CD44-EGFR/ErbB2 interaction, altering the signaling pathways, such as ERK1/2 and p38 MAPK, that regulate cell proliferation and migration.	[Bassols, Anna] Univ Autonoma Barcelona, Fac Vet, Dept Bioquim & Biol Mol, Cerdanyola Del Valles 08193, Spain; [Fabra, Angels] IDIBELL, Inst Recerca Oncol, Lhospitalet De Llobregat 08907, Spain	Autonomous University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)	Bassols, A (corresponding author), Edifici 5, Cerdanyola Del Valles 08193, Spain.	anna.bassols@uab.cat	Docampo, María José/A-4957-2009; Bassols, Anna/K-7961-2014; Marco-Ramell, Anna/C-7799-2011	Bassols, Anna/0000-0003-4213-2274; Miquel Serra, Laia/0000-0001-8382-3341; Docampo, Maria Jose/0000-0003-1242-222X	Ministerio de Ciencia y Tecnologia [AGL2006-02365]; Generalitat de Catalunya [2009 SGR-1091]; European Union; Spanish Ministerio de Educacion	Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); European Union(European Commission); Spanish Ministerio de Educacion(Spanish Government)	This work was supported in part by Grant AGL2006-02365 from the Ministerio de Ciencia y Tecnologia, Grant 2009 SGR-1091 from the Generalitat de Catalunya (to A.B.), and the FEDER program from the European Union.; Supported by a fellowship from the Spanish Ministerio de Educacion	Bourguignon LYW, 2007, J BIOL CHEM, V282, P19426, DOI 10.1074/jbc.M610054200; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Bourguignon LYW, 2001, J BIOL CHEM, V276, P48679, DOI 10.1074/jbc.M106759200; Bourguignon LYW, 1997, J BIOL CHEM, V272, P27913, DOI 10.1074/jbc.272.44.27913; Burgess AW, 2008, GROWTH FACTORS, V26, P263, DOI 10.1080/08977190802312844; DOURSZIMMERMANN MT, 1994, J BIOL CHEM, V269, P32992; Estrada Y, 2009, PIGM CELL MELANOMA R, V22, P66, DOI 10.1111/j.1755-148X.2008.00520.x; Ghatak S, 2005, J BIOL CHEM, V280, P8875, DOI 10.1074/jbc.M410882200; Gordon-Thomson C, 2005, MELANOMA RES, V15, P21, DOI 10.1097/00008390-200502000-00005; Harada H, 2007, J BIOL CHEM, V282, P5597, DOI 10.1074/jbc.M608358200; Harris VK, 2000, J BIOL CHEM, V275, P10802, DOI 10.1074/jbc.275.15.10802; HUA Q, 1993, J CELL SCI, V106, P365; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; Isogai Z, 1996, CANCER RES, V56, P3902; ITO K, 1995, J BIOL CHEM, V270, P958, DOI 10.1074/jbc.270.2.958; Knudson W, 2002, MATRIX BIOL, V21, P15, DOI 10.1016/S0945-053X(01)00186-X; Lemire JM, 2002, J CELL PHYSIOL, V190, P38, DOI 10.1002/jcp.10043; Li CZ, 2008, FOLIA BIOL-PRAGUE, V54, P180; Marhaba R, 2004, J MOL HISTOL, V35, P211; Matsumoto K, 2003, J BIOL CHEM, V278, P41205, DOI 10.1074/jbc.M305060200; McDermott EP, 2002, J BIOL CHEM, V277, P7808, DOI 10.1074/jbc.M108133200; Miquel-Serra L, 2006, LAB INVEST, V86, P889, DOI 10.1038/labinvest.3700449; Misra S, 2008, CONNECT TISSUE RES, V49, P219, DOI 10.1080/03008200802143356; New LG, 2001, J CELL BIOCHEM, V83, P585, DOI 10.1002/jcb.1253; Nikitovic D, 2006, IUBMB LIFE, V58, P47, DOI 10.1080/15216540500531713; Ostrander JH, 2007, CANCER RES, V67, P4199, DOI 10.1158/0008-5472.CAN-06-3409; Palsson EM, 2000, J BIOL CHEM, V275, P7818, DOI 10.1074/jbc.275.11.7818; Pirinen R, 2005, HUM PATHOL, V36, P44, DOI 10.1016/j.humpath.2004.10.010; Pukkila M, 2007, J CLIN PATHOL, V60, P267, DOI 10.1136/jcp.2005.034181; Ricciardelli C, 2002, CLIN CANCER RES, V8, P1054; Ricciardelli C, 1998, CLIN CANCER RES, V4, P963; Ricciardelli C, 2009, CANCER METAST REV, V28, P233, DOI 10.1007/s10555-009-9182-y; Serra M, 2005, INT J CANCER, V114, P879, DOI 10.1002/ijc.20813; Shi Y, 2007, ONCOL REP, V18, P397; STERN M, 1992, MATRIX, V12, P397, DOI 10.1016/S0934-8832(11)80036-3; Stove C, 2003, J INVEST DERMATOL, V121, P802, DOI 10.1046/j.1523-1747.2003.12522.x; Subramaniam V, 2007, EXP MOL PATHOL, V83, P332, DOI 10.1016/j.yexmp.2007.08.013; Suwiwat S, 2004, CLIN CANCER RES, V10, P2491, DOI 10.1158/1078-0432.CCR-03-0146; Tao RH, 2008, J CELL SCI, V121, P3207, DOI 10.1242/jcs.033399; Touab M, 2003, AM J CLIN PATHOL, V119, P587, DOI 10.1309/ME25J1G5E57LM3; Touab M, 2002, AM J PATHOL, V160, P549, DOI 10.1016/S0002-9440(10)64874-2; Tzircotis G, 2005, J CELL SCI, V118, P5119, DOI 10.1242/jcs.02629; Voutilainen K, 2003, INT J CANCER, V107, P359, DOI 10.1002/ijc.11423; Wang SJ, 2006, ARCH OTOLARYNGOL, V132, P771, DOI 10.1001/archotol.132.7.771; Wight TN, 2002, CURR OPIN CELL BIOL, V14, P617, DOI 10.1016/S0955-0674(02)00375-7; Wu YJ, 2005, CELL RES, V15, P483, DOI 10.1038/sj.cr.7290318; Zhang Y, 1999, J CELL BIOCHEM, V73, P445, DOI 10.1002/(SICI)1097-4644(19990615)73:4<445::AID-JCB3>3.0.CO;2-D; Zhang Y, 1998, J BIOL CHEM, V273, P21342, DOI 10.1074/jbc.273.33.21342	48	29	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1475	1485		10.1074/jbc.M110.127522	http://dx.doi.org/10.1074/jbc.M110.127522			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21078678	hybrid, Green Published			2022-12-25	WOS:000286005000060
J	Kim, HM; Wangemann, P				Kim, Hyoung-Mi; Wangemann, Philine			Failure of Fluid Absorption in the Endolymphatic Sac Initiates Cochlear Enlargement that Leads to Deafness in Mice Lacking Pendrin Expression	PLOS ONE			English	Article							NONSYNDROMIC HEARING IMPAIRMENT; GENOTYPE-PHENOTYPE CORRELATION; KCNJ10 PROTEIN EXPRESSION; NA+-H+ EXCHANGER; INNER-EAR; SENSORY TRANSDUCTION; GUINEA-PIG; DEVELOPMENTAL ACQUISITION; CONGENITAL DEAFNESS; VESTIBULAR AQUEDUCT	Mutations of SLC26A4 are among the most prevalent causes of hereditary deafness. Deafness in the corresponding mouse model, Slc26a4(-/-), results from an abnormally enlarged cochlear lumen. The goal of this study was to determine whether the cochlear enlargement originates with defective cochlear fluid transport or with a malfunction of fluid transport in the connected compartments, which are the vestibular labyrinth and the endolymphatic sac. Embryonic inner ears from Slc26a4(+/-) and Slc26a4(-/-) mice were examined by confocal microscopy ex vivo or after 2 days of organ culture. Culture allowed observations of intact, ligated or partially resected inner ears. Cochlear lumen formation was found to begin at the base of the cochlea between embryonic day (E) 13.5 and 14.5. Enlargement was immediately evident in Slc26a4(-/-) compared to Slc26a4(+/-) mice. In Slc26a4(+/-) and Slc26a4(-/-) mice, separation of the cochlea from the vestibular labyrinth by ligation at E14.5 resulted in a reduced cochlear lumen. Resection of the endolymphatic sacs at E14.5 led to an enlarged cochlear lumen in Slc26a4(+/-) mice but caused no further enlargement of the already enlarged cochlear lumen in Slc26a4(-/-) mice. Ligation or resection performed later, at E17.5, did not alter the cochlea lumen. In conclusion, the data suggest that cochlear lumen formation is initiated by fluid secretion in the vestibular labyrinth and temporarily controlled by fluid absorption in the endolymphatic sac. Failure of fluid absorption in the endolymphatic sac due to lack of Slc26a4 expression appears to initiate cochlear enlargement in mice, and possibly humans, lacking functional Slc26a4 expression.	[Kim, Hyoung-Mi; Wangemann, Philine] Kansas State Univ, Dept Anat & Physiol, Manhattan, KS 66506 USA	Kansas State University	Kim, HM (corresponding author), Kansas State Univ, Dept Anat & Physiol, Manhattan, KS 66506 USA.	wange@vet.ksu.edu	Wangemann, Philine/N-2826-2013		NIH [R01 DC01098, R01 DC00212, P20 RR017686]; SMILE-Kansas State University; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001098, R01DC000212] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SMILE-Kansas State University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	NIH R01 DC01098; NIH R01 DC00212; NIH P20 RR017686; SMILE-Kansas State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert S, 2006, EUR J HUM GENET, V14, P773, DOI 10.1038/sj.ejhg.5201611; AMANO H, 1983, ARCH OTO-RHINO-LARYN, V237, P273, DOI 10.1007/BF00453732; Campos-Barros A, 2000, P NATL ACAD SCI USA, V97, P1287, DOI 10.1073/pnas.97.3.1287; Choi BY, 2009, HUM MUTAT, V30, P599, DOI 10.1002/humu.20884; Colvin IB, 2006, LARYNGOSCOPE, V116, P2027, DOI 10.1097/01.mlg.0000240908.88759.fe; Couloigner V, 1998, LARYNGOSCOPE, V108, P592, DOI 10.1097/00005537-199804000-00024; del Castillo I, 2003, AM J HUM GENET, V73, P1452, DOI 10.1086/380205; DEOL MS, 1973, J MED GENET, V10, P235, DOI 10.1136/jmg.10.3.235; Dou HW, 2004, J HISTOCHEM CYTOCHEM, V52, P1377, DOI 10.1369/jhc.3A6228.2004; Everett LA, 2001, HUM MOL GENET, V10, P153, DOI 10.1093/hmg/10.2.153; Everett LA, 1999, P NATL ACAD SCI USA, V96, P9727, DOI 10.1073/pnas.96.17.9727; FRASER GR, 1965, ANN HUM GENET, V28, P201; Geleoc GSG, 2003, NAT NEUROSCI, V6, P1019, DOI 10.1038/nn1120; Grunder S, 2001, EUR J NEUROSCI, V13, P641, DOI 10.1046/j.1460-9568.2001.01426.x; HARVEY BJ, 1992, J EXP BIOL, V172, P289; Karet FE, 1999, NAT GENET, V21, P84, DOI 10.1038/5022; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; KIMURA RS, 1967, ANN OTO RHINOL LARYN, V76, P664, DOI 10.1177/000348946707600311; Lelli A, 2009, J NEUROPHYSIOL, V101, P2961, DOI 10.1152/jn.00136.2009; LUNDQUIST P G, 1964, Acta Otolaryngol, V57, P65, DOI 10.3109/00016486409136947; Luxon LM, 2003, INT J AUDIOL, V42, P82, DOI 10.3109/14992020309078339; MANSOUR SL, 2005, SPRINGER HDB AUDITOR, P43; MORI N, 1987, ARCH OTO-RHINO-LARYN, V244, P61, DOI 10.1007/BF00453493; Mori N, 1996, PFLUG ARCH EUR J PHY, V433, P58, DOI 10.1007/s004240050248; Nakaya K, 2007, AM J PHYSIOL-RENAL, V292, pF1314, DOI 10.1152/ajprenal.00432.2006; Ng L, 2009, ENDOCRINOLOGY, V150, P1952, DOI 10.1210/en.2008-1419; Park HJ, 2003, J MED GENET, V40, P242, DOI 10.1136/jmg.40.4.242; Reardon W, 1997, QJM-MON J ASSOC PHYS, V90, P443, DOI 10.1093/qjmed/90.7.443; Royaux IE, 2003, JARO-J ASSOC RES OTO, V4, P394, DOI 10.1007/s10162-002-3052-4; Rueda J, 2003, NEUROSCI RES, V45, P401, DOI 10.1016/S0168-0102(03)00009-9; RUGH R, 1968, MOUSE ITS REPROD DEV; Shcheynikov N, 2008, J PHYSIOL-LONDON, V586, P3813, DOI 10.1113/jphysiol.2008.154468; Singh R, 2008, AM J PHYSIOL-RENAL, V294, pF139, DOI 10.1152/ajprenal.00433.2007; Son EJ, 2009, J CELL BIOCHEM, V107, P965, DOI 10.1002/jcb.22201; Stankovic KM, 1997, HEARING RES, V114, P21, DOI 10.1016/S0378-5955(97)00072-5; Suzuki H, 2007, ACTA OTO-LARYNGOL, V127, P1292, DOI 10.1080/00016480701258739; TENCATE WJF, 1994, ORL J OTO-RHINO-LARY, V56, P257; Theiler K., 1972, HOUSE MOUSE; VANDEWATER TR, 1973, ANN OTOLRHINOLLARY S, V82, P21; Wangemann P, 2007, AM J PHYSIOL-RENAL, V292, pF1345, DOI 10.1152/ajprenal.00487.2006; Wangemann P, 2006, J PHYSIOL-LONDON, V576, P11, DOI 10.1113/jphysiol.2006.112888; Wangemann P, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-30; Wangemann P, 2009, AM J PHYSIOL-RENAL, V297, pF1435, DOI 10.1152/ajprenal.00011.2009; Wu DZ, 1998, PFLUG ARCH EUR J PHY, V436, P182, DOI 10.1007/s004240050621; Yamasaki M, 2000, ORL J OTO-RHINO-LARY, V62, P241, DOI 10.1159/000027753; Yuan Y, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-79	46	81	83	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2010	5	11							e14041	10.1371/journal.pone.0014041	http://dx.doi.org/10.1371/journal.pone.0014041			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681OY	21103348	Green Submitted, Green Published, gold			2022-12-25	WOS:000284327800019
J	Gusev, O; Nakahara, Y; Vanyagina, V; Malutina, L; Cornette, R; Sakashita, T; Hamada, N; Kikawada, T; Kobayashi, Y; Okuda, T				Gusev, Oleg; Nakahara, Yuichi; Vanyagina, Veronica; Malutina, Ludmila; Cornette, Richard; Sakashita, Tetsuya; Hamada, Nobuyuki; Kikawada, Takahiro; Kobayashi, Yasuhiko; Okuda, Takashi			Anhydrobiosis-Associated Nuclear DNA Damage and Repair in the Sleeping Chironomid: Linkage with Radioresistance	PLOS ONE			English	Article							RADIATION TOLERANCE; POLYPEDILUM-VANDERPLANKI; CHROMATIN-STRUCTURE; BDELLOID ROTIFERS; OXIDATIVE STRESS; ANTARCTIC MIDGE; HEAT-SHOCK; DEHYDRATION; TREHALOSE; APOPTOSIS	Anhydrobiotic chironomid larvae can withstand prolonged complete desiccation as well as other external stresses including ionizing radiation. To understand the cross-tolerance mechanism, we have analyzed the structural changes in the nuclear DNA using transmission electron microscopy and DNA comet assays in relation to anhydrobiosis and radiation. We found that dehydration causes alterations in chromatin structure and a severe fragmentation of nuclear DNA in the cells of the larvae despite successful anhydrobiosis. Furthermore, while the larvae had restored physiological activity within an hour following rehydration, nuclear DNA restoration typically took 72 to 96 h. The DNA fragmentation level and the recovery of DNA integrity in the rehydrated larvae after anhydrobiosis were similar to those of hydrated larvae irradiated with 70 Gy of high-linear energy transfer (LET) ions (He-4). In contrast, low-LET radiation (gamma-rays) of the same dose caused less initial damage to the larvae, and DNA was completely repaired within within 24 h. The expression of genes encoding the DNA repair enzymes occurred upon entering anhydrobiosis and exposure to high-and low-LET radiations, indicative of DNA damage that includes double-strand breaks and their subsequent repair. The expression of antioxidant enzymes-coding genes was also elevated in the anhydrobiotic and the gamma-ray-irradiated larvae that probably functions to reduce the negative effect of reactive oxygen species upon exposure to these stresses. Indeed the mature antioxidant proteins accumulated in the dry larvae and the total activity of antioxidants increased by a 3-4 fold in association with anhydrobiosis. We conclude that one of the factors explaining the relationship between radioresistance and the ability to undergo anhydrobiosis in the sleeping chironomid could be an adaptation to desiccation-inflicted nuclear DNA damage. There were also similarities in the molecular response of the larvae to damage caused by desiccation and ionizing radiation.	[Gusev, Oleg; Nakahara, Yuichi; Cornette, Richard; Kikawada, Takahiro; Okuda, Takashi] Natl Inst Agrobiol Sci, Anhydrobiosis Res Unit, Tsukuba, Ibaraki, Japan; [Gusev, Oleg; Vanyagina, Veronica; Malutina, Ludmila] Kazan VI Lenin State Univ, Dept Invertebrate Zool, Kazan 420008, Russia; [Sakashita, Tetsuya; Kobayashi, Yasuhiko] Japan Atom Energy Agcy, Microbeam Radiat Biol Grp, Takasaki, Gunma, Japan; [Hamada, Nobuyuki] Cent Res Inst Elect Power Ind, Radiat Safety Res Ctr, Nucl Technol Res Lab, Tokyo 201, Japan	National Institute of Agrobiological Sciences - Japan; Kazan Federal University; Japan Atomic Energy Agency; Central Research Institute of Electric Power Industry - Japan	Gusev, O (corresponding author), Natl Inst Agrobiol Sci, Anhydrobiosis Res Unit, Tsukuba, Ibaraki, Japan.	oku@affrc.go.jp	Gusev, Oleg/D-9383-2011; Kikawada, Takahiro/A-1289-2010	Gusev, Oleg/0000-0002-6203-9758; Kikawada, Takahiro/0000-0002-2329-9282; Hamada, Nobuyuki/0000-0003-2518-6131; CORNETTE, Richard/0000-0002-0185-1443	Ministry of Education, Culture, Sport and Technology of Japan;  [21688004]	Ministry of Education, Culture, Sport and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This study is the result of the "Elucidation of mechanisms underlying radiation-tolerance linked to anhydrobiosis" project carried under the Strategic Promotion program for basic Nuclear Research by the Ministry of Education, Culture, Sport and Technology of Japan. Funding was provided by the Grant-in-Aid for Young Scientists (A) Kakenhi (21688004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert P, 2006, J EXP BIOL, V209, P1575, DOI 10.1242/jeb.02179; BARRETT J, 1985, ANN APPL BIOL, V106, P121, DOI 10.1111/j.1744-7348.1985.tb03101.x; Benoit JB, 2007, AM J TROP MED HYG, V76, P987, DOI 10.4269/ajtmh.2007.76.987; Benoit JB, 2007, EUR J ENTOMOL, V104, P9, DOI 10.14411/eje.2007.002; Benoit JB, 2009, COMP BIOCHEM PHYS A, V152, P518, DOI 10.1016/j.cbpa.2008.12.009; Billi D, 2009, EXTREMOPHILES, V13, P49, DOI 10.1007/s00792-008-0196-0; Blokhina O, 2003, ANN BOT-LONDON, V91, P179, DOI 10.1093/aob/mcf118; Boubriak II, 2008, ANN BOT-LONDON, V101, P267, DOI 10.1093/aob/mcm276; Cashio P, 2005, SEMIN CELL DEV BIOL, V16, P225, DOI 10.1016/j.semcdb.2005.01.002; CLEAVER JE, 1982, AM J HUM GENET, V34, P566; Clegg JS, 2007, BIOL BULL-US, V212, P74, DOI 10.2307/25066582; CORNETTE R, 2010, J BIOL CHEM; Cox MM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000815; Cox MM, 2005, NAT REV MICROBIOL, V3, P882, DOI 10.1038/nrmicro1264; Cromie GA, 2001, MOL CELL, V8, P1163, DOI 10.1016/S1097-2765(01)00419-1; Crowe JH, 2002, INTEGR COMP BIOL, V42, P497, DOI 10.1093/icb/42.3.497; Crowe LM, 2002, COMP BIOCHEM PHYS A, V131, P505, DOI 10.1016/S1095-6433(01)00503-7; CROWE LM, 1992, ADV SPACE RES-SERIES, V12, P239, DOI 10.1016/0273-1177(92)90178-Z; Cuiffo B P, 1985, J Free Radic Biol Med, V1, P139, DOI 10.1016/0748-5514(85)90018-2; Daly MJ, 2007, PLOS BIOL, V5, P769, DOI 10.1371/journal.pbio.0050092; Dinant C, 2008, EPIGENET CHROMATIN, V1, DOI 10.1186/1756-8935-1-9; Franca MB, 2007, COMP BIOCHEM PHYS A, V146, P621, DOI 10.1016/j.cbpa.2006.02.030; Gladyshev E, 2008, P NATL ACAD SCI USA, V105, P5139, DOI 10.1073/pnas.0800966105; Gladyshev EA, 2008, SCIENCE, V320, P1210, DOI 10.1126/science.1156407; Gladyshev EA, 2010, J HERED, V101, pS85, DOI 10.1093/jhered/esq008; GUSEV O, 2010, CELL STRESS CHAPERON; Hashimoto H, 1998, Biol Sci Space, V12, P106, DOI 10.2187/bss.12.106; Hengherr S, 2009, PHYSIOL BIOCHEM ZOOL, V82, P749, DOI 10.1086/605954; Hengherr S, 2008, FEBS J, V275, P281, DOI 10.1111/j.1742-4658.2007.06198.x; Horikawa DD, 2006, INT J RADIAT BIOL, V82, P843, DOI 10.1080/09553000600972956; Horneck G, 1992, Adv Space Biol Med, V2, P229, DOI 10.1016/S1569-2574(08)60023-4; Huang ZY, 2008, ANN BOT-LONDON, V101, P277, DOI 10.1093/aob/mcm089; Jenks M.A., 2007, PLANT DESICCATION TO; Jia J, 2001, STRUCTURE, V9, P267, DOI 10.1016/S0969-2126(01)00585-8; Jonsson KI, 2008, CURR BIOL, V18, pR729, DOI 10.1016/j.cub.2008.06.048; Jonsson KI, 2005, INT J RADIAT BIOL, V81, P649, DOI 10.1080/09553000500368453; Kikawada T, 2008, BBA-BIOMEMBRANES, V1778, P514, DOI 10.1016/j.bbamem.2007.11.009; Kikawada T, 2007, P NATL ACAD SCI USA, V104, P11585, DOI 10.1073/pnas.0702538104; Kikawada T, 2006, BIOCHEM BIOPH RES CO, V348, P56, DOI 10.1016/j.bbrc.2006.07.003; KING RC, 1982, INSECT ULTRASTRUCTUR; Kornbluth S, 2005, J CELL SCI, V118, P1779, DOI 10.1242/jcs.02377; Kranner I, 2005, INTEGR COMP BIOL, V45, P734, DOI 10.1093/icb/45.5.734; Lapinski J, 2003, FEBS LETT, V553, P387, DOI 10.1016/S0014-5793(03)01062-7; Lushchak VI, 2001, BIOCHEMISTRY-MOSCOW+, V66, P476, DOI 10.1023/A:1010294415625; McLennan AG, 2009, J EXP BIOL, V212, P785, DOI 10.1242/jeb.023663; Menze MA, 2007, AM J PHYSIOL-REG I, V292, pR2039, DOI 10.1152/ajpregu.00659.2006; Michaud MR, 2008, J INSECT PHYSIOL, V54, P645, DOI 10.1016/j.jinsphys.2008.01.003; MORASON RT, 1994, J INSECT PHYSIOL, V40, P155, DOI 10.1016/0022-1910(94)90087-6; Nakahara Y, 2008, J INSECT PHYSIOL, V54, P1220, DOI 10.1016/j.jinsphys.2008.05.007; Nakahara Y, 2010, CRYOBIOLOGY, V60, P138, DOI 10.1016/j.cryobiol.2009.10.004; Neumann S, 2009, COMP BIOCHEM PHYS A, V153, P425, DOI 10.1016/j.cbpa.2009.04.611; NICKOLOFF JA, 1998, DNA DAMAGE REPAIR; OSBORNE DJ, 1984, FOLIA BIOL-PRAGUE, V30, P155; Pitcher RS, 2005, CELL CYCLE, V4, P675, DOI 10.4161/cc.4.5.1676; Reardon W, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-6; Rebecchi L, 2009, J EXP BIOL, V212, P4033, DOI 10.1242/jeb.033266; Sakurai M, 2008, P NATL ACAD SCI USA, V105, P5093, DOI 10.1073/pnas.0706197105; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; Schill RO, 2009, BIOTECHNOL ADV, V27, P348, DOI 10.1016/j.biotechadv.2009.01.011; Simonin H, 2007, BBA-BIOMEMBRANES, V1768, P1600, DOI 10.1016/j.bbamem.2007.03.017; Slade D, 2009, CELL, V136, P1044, DOI 10.1016/j.cell.2009.01.018; Villenueve TS, 2006, CELL STRESS CHAPERON, V11, P71, DOI 10.1379/CSC-154R.1; Watanabe M, 2006, APPL ENTOMOL ZOOL, V41, P15, DOI 10.1303/aez.2006.15; Watanabe M, 2005, J INSECT PHYSIOL, V51, P727, DOI 10.1016/j.jinsphys.2005.02.008; Watanabe M, 2003, J EXP BIOL, V206, P2281, DOI 10.1242/jeb.00418; Watanabe M, 2002, J EXP BIOL, V205, P2799; Watanabe M, 2007, J INSECT PHYSIOL, V53, P573, DOI 10.1016/j.jinsphys.2007.02.008; Watanabe M, 2006, INT J RADIAT BIOL, V82, P835, DOI 10.1080/09553000600979100; Watanabe M, 2006, INT J RADIAT BIOL, V82, P587, DOI 10.1080/09553000600876652; Yoshinaga K, 1997, BIOSCI BIOTECH BIOCH, V61, P160, DOI 10.1271/bbb.61.160; Zhou L, 2003, DEV CELL, V4, P599, DOI 10.1016/S1534-5807(03)00085-6	71	48	49	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e14008	10.1371/journal.pone.0014008	http://dx.doi.org/10.1371/journal.pone.0014008			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103355	gold, Green Published, Green Submitted			2022-12-25	WOS:000284257400012
J	Mao, G; Brody, JP				Mao, Grace; Brody, James P.			Reverse Engineering the Yeast RNR1 Transcriptional Control System	PLOS ONE			English	Article							PROTEIN-DNA INTERACTIONS; PLASMON RESONANCE SPECTROSCOPY; CHROMATIN IMMUNOPRECIPITATION; BINDING; DATABASE; APTAMER; SENSORS; JASPAR	Transcription is controlled by multi-protein complexes binding to short non-coding regions of genomic DNA. These complexes interact combinatorially. A major goal of modern biology is to provide simple models that predict this complex behavior. The yeast gene RNR1 is transcribed periodically during the cell cycle. Here, we present a pilot study to demonstrate a new method of deciphering the logic behind transcriptional regulation. We took regular samples from cell cycle synchronized cultures of Saccharomyces cerevisiae and extracted nuclear protein. We tested these samples to measure the amount of protein that bound to seven different 16 base pair sequences of DNA that have been previously identified as protein binding locations in the promoter of the RNR1 gene. These tests were performed using surface plasmon resonance. We found that the surface plasmon resonance signals showed significant variation throughout the cell cycle. We correlated the protein binding data with previously published mRNA expression data and interpreted this to show that transcription requires protein bound to a particular site and either five different sites or one additional sites. We conclude that this demonstrates the feasibility of this approach to decipher the combinatorial logic of transcription.	[Mao, Grace; Brody, James P.] Univ Calif Irvine, Henry Samueli Sch Engn, Dept Biomed Engn, Irvine, CA 92717 USA	University of California System; University of California Irvine	Mao, G (corresponding author), Univ Calif Irvine, Henry Samueli Sch Engn, Dept Biomed Engn, Irvine, CA 92717 USA.	jpbrody@uci.edu		Brody, James/0000-0002-7995-5197	Defense Advanced Research Projects Agency (DARPA) Micro/Nano Fluidics Fundamentals Focus (MF3) Center	Defense Advanced Research Projects Agency (DARPA) Micro/Nano Fluidics Fundamentals Focus (MF3) Center(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This work was supported by the Defense Advanced Research Projects Agency (DARPA) Micro/Nano Fluidics Fundamentals Focus (MF3) Center, http://www.inrf.uci.edu/mf3/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; BONDESON K, 1993, ANAL BIOCHEM, V214, P245, DOI 10.1006/abio.1993.1484; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brenowitz M, 2001, Curr Protoc Mol Biol, VChapter 12, DOI 10.1002/0471142727.mb1204s07; Brockman JM, 2000, ANNU REV PHYS CHEM, V51, P41, DOI 10.1146/annurev.physchem.51.1.41; Buck MJ, 2004, GENOMICS, V83, P349, DOI 10.1016/j.ygeno.2003.11.004; Bulyk ML, 2006, CURR OPIN BIOTECH, V17, P422, DOI 10.1016/j.copbio.2006.06.015; Bulyk ML, 1999, NAT BIOTECHNOL, V17, P573, DOI 10.1038/9878; Chinowsky TM, 2007, BIOSENS BIOELECTRON, V22, P2208, DOI 10.1016/j.bios.2006.10.030; Davidson E. H., 2001, DEV EVOLUTION; GALAS DJ, 1978, NUCLEIC ACIDS RES, V5, P3157, DOI 10.1093/nar/5.9.3157; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Homola J, 1999, SENSOR ACTUAT B-CHEM, V54, P3, DOI 10.1016/S0925-4005(98)00321-9; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kaiser P, 1998, GENE DEV, V12, P2587, DOI 10.1101/gad.12.16.2587; Kim DK, 2008, ANAL BIOCHEM, V379, P1, DOI 10.1016/j.ab.2008.04.029; Kim HD, 2009, SCIENCE, V325, P429, DOI 10.1126/science.1171347; Kyo M, 2004, GENES CELLS, V9, P153, DOI 10.1111/j.1356-9597.2004.00711.x; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; LIN L, 2005, THESIS U CALIFORNIA; Lin LM, 2004, ANAL CHEM, V76, P6555, DOI 10.1021/ac049371e; Majka J, 2007, ADV BIOCHEM ENG BIOT, V104, P13, DOI 10.1007/10_026; Mao G, 2007, BIOCHEM BIOPH RES CO, V363, P153, DOI 10.1016/j.bbrc.2007.08.130; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; Moyroud E, 2009, PLANT J, V59, P851, DOI 10.1111/j.1365-313X.2009.03903.x; NEO SJ, 2009, ANAL CHEM; Prud'homme B, 2007, P NATL ACAD SCI USA, V104, P8605, DOI 10.1073/pnas.0700488104; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Smith EA, 2003, APPL SPECTROSC, V57, p320A, DOI 10.1366/000370203322554446; SOLOMON MJ, 1988, CELL, V53, P937, DOI 10.1016/S0092-8674(88)90469-2; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Su XD, 2008, ANAL BIOCHEM, V376, P137, DOI 10.1016/j.ab.2008.02.002; Teh HF, 2007, BIOCHEMISTRY-US, V46, P2127, DOI 10.1021/bi061903t; Tirosh I, 2009, SCIENCE, V324, P659, DOI 10.1126/science.1169766; Vlieghe D, 2006, NUCLEIC ACIDS RES, V34, pD95, DOI 10.1093/nar/gkj115; Wang ZZ, 2007, ANAL BIOANAL CHEM, V389, P819, DOI 10.1007/s00216-007-1510-x; Weinstock GM, 2007, GENOME RES, V17, P667, DOI 10.1101/gr.6534207	40	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e13895	10.1371/journal.pone.0013895	http://dx.doi.org/10.1371/journal.pone.0013895			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103376	Green Published, gold			2022-12-25	WOS:000284257400002
J	Karkey, A; Arjyal, A; Anders, KL; Boni, MF; Dongol, S; Koirala, S; Phan, VTM; Tran, VTN; Clements, ACA; Holt, KE; Pham, TD; Day, JN; Campbell, JI; Dougan, G; Dolecek, C; Farrar, J; Basnyat, B; Baker, S				Karkey, Abhilasha; Arjyal, Amit; Anders, Katherine L.; Boni, Maciej F.; Dongol, Sabina; Koirala, Samir; Phan Vu Tra My; Tran Vu Thieu Nga; Clements, Archie C. A.; Holt, Kathryn E.; Pham Thanh Duy; Day, Jeremy N.; Campbell, James I.; Dougan, Gordon; Dolecek, Christiane; Farrar, Jeremy; Basnyat, Buddha; Baker, Stephen			The Burden and Characteristics of Enteric Fever at a Healthcare Facility in a Densely Populated Area of Kathmandu	PLOS ONE			English	Article							TYPHOID-FEVER; PARATYPHOID FEVER; EFFECTIVENESS TRIAL; RISK-FACTORS; INDIA; NEPAL; VACCINE; INDONESIA; PAKISTAN; KOLKATA	Enteric fever, caused by Salmonella enterica serovars Typhi and Paratyphi A (S. Typhi and S. Paratyphi A) remains a major public health problem in many settings. The disease is limited to locations with poor sanitation which facilitates the transmission of the infecting organisms. Efficacious and inexpensive vaccines are available for S. Typhi, yet are not commonly deployed to control the disease. Lack of vaccination is due partly to uncertainty of the disease burden arising from a paucity of epidemiological information in key locations. We have collected and analyzed data from 3,898 cases of blood culture-confirmed enteric fever from Patan Hospital in Lalitpur Sub-Metropolitan City (LSMC), between June 2005 and May 2009. Demographic data was available for a subset of these patients (n = 527) that were resident in LSMC and who were enrolled in trials. We show a considerable burden of enteric fever caused by S. Typhi (2,672; 68.5%) and S. Paratyphi A (1,226; 31.5%) at this Hospital over a four year period, which correlate with seasonal fluctuations in rainfall. We found that local population density was not related to incidence and we identified a focus of infections in the east of LSMC. With data from patients resident in LSMC we found that the median age of those with S. Typhi (16 years) was significantly less than S. Paratyphi A (20 years) and that males aged 15 to 25 were disproportionately infected. Our findings provide a snapshot into the epidemiological patterns of enteric fever in Kathmandu. The uneven distribution of enteric fever patients within the population suggests local variation in risk factors, such as contaminated drinking water. These findings are important for initiating a vaccination scheme and improvements in sanitation. We suggest any such intervention should be implemented throughout the LSMC area.	[Karkey, Abhilasha; Arjyal, Amit; Dongol, Sabina; Koirala, Samir; Basnyat, Buddha] Univ Oxford, Patan Acad Hlth Sci, Clin Res Unit, Kathmandu, Nepal; [Anders, Katherine L.; Boni, Maciej F.; Phan Vu Tra My; Tran Vu Thieu Nga; Pham Thanh Duy; Day, Jeremy N.; Campbell, James I.; Dolecek, Christiane; Farrar, Jeremy; Baker, Stephen] Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Boni, Maciej F.] MRC Ctr Genom & Global Hlth, Oxford, England; [Clements, Archie C. A.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Holt, Kathryn E.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Dougan, Gordon] Wellcome Trust Sanger Inst, Cambridge, England	University of Oxford; University of Oxford; University of Queensland; University of Melbourne; Wellcome Trust Sanger Institute	Karkey, A (corresponding author), Univ Oxford, Patan Acad Hlth Sci, Clin Res Unit, Kathmandu, Nepal.	sbaker@oucru.org	Holt, Kathryn E/A-8108-2012; Pham, Thanh Duy/AAX-3845-2020; Farrar, Jeremy J./HGA-7610-2022; Clements, Archie/D-9619-2013	Holt, Kathryn E/0000-0003-3949-2471; Pham, Thanh Duy/0000-0001-7029-9210; Farrar, Jeremy/0000-0002-2700-623X; Baker, Stephen/0000-0003-1308-5755; Phan, My VT/0000-0002-6905-8513	Wellcome Trust, Euston Road, London, United Kingdom; Medical Research Council [G0600718]; OAK foundation through Oxford University; MRC [G0600718] Funding Source: UKRI	Wellcome Trust, Euston Road, London, United Kingdom(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); OAK foundation through Oxford University; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by The Wellcome Trust, Euston Road, London, United Kingdom. MFB is supported by the Medical Research Council (grant G0600718). SB is supported by an OAK foundation fellowship through Oxford University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, Wkly Epidemiol Rec, V83, P49; Baker S, 2008, J CLIN MICROBIOL, V46, P1741, DOI 10.1128/JCM.02249-07; Basnyat B, 2005, CLIN INFECT DIS, V41, P1467, DOI 10.1086/497136; Bhan MK, 2005, LANCET, V366, P749, DOI 10.1016/S0140-6736(05)67181-4; Chanh NQ, 2004, CLIN INFECT DIS, V39, P61, DOI 10.1086/421555; Cook J, 2009, J HEALTH POPUL NUTR, V27, P711; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Crump JA, 2010, CLIN INFECT DIS, V50, P241, DOI 10.1086/649541; DeRoeck D, 2007, NEW ENGL J MED, V357, P1069, DOI 10.1056/NEJMp078144; Holt KE, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-144; Karkey A, 2008, J INFECT DEV COUNTR, V2, P461; *KATHM HIS MAJ GOV, 2002, POP NEP POP CENS 200; Kelly-Hope LA, 2007, AM J TROP MED HYG, V76, P706, DOI 10.4269/ajtmh.2007.76.706; Khan MI, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-17; Kothari A, 2008, J INFECT DEV COUNTR, V2, P253; Lin FYC, 2000, AM J TROP MED HYG, V62, P644, DOI 10.4269/ajtmh.2000.62.644; Lynch MF, 2009, JAMA-J AM MED ASSOC, V302, P859, DOI 10.1001/jama.2009.1229; Maskey AP, 2006, CLIN INFECT DIS, V42, P1247, DOI 10.1086/503033; Maskey AP, 2008, T ROY SOC TROP MED H, V102, P91, DOI 10.1016/j.trstmh.2007.10.003; Mermin JH, 1999, J INFECT DIS, V179, P1416, DOI 10.1086/314766; *MOHP NEP NE, 2007, NEP DEM HLTH SURV 20; Ochiai RL, 2008, B WORLD HEALTH ORGAN, V86, P260, DOI 10.2471/BLT.06.039818; Ochiai RL, 2005, EMERG INFECT DIS, V11, P1764, DOI 10.3201/eid1111.050168; PANDIT A, 2007, PLOS CLIN TRIALS, V2, pNIL12; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Pulickal AS, 2009, CLIN VACCINE IMMUNOL, V16, P1413, DOI 10.1128/CVI.00245-09; Siddiqui FJ, 2006, INT J INFECT DIS, V10, P215, DOI 10.1016/j.ijid.2005.03.010; Sood S, 1999, EMERG INFECT DIS, V5, P483, DOI 10.3201/eid0503.990329; Steele D, 2008, J INFECT DEV COUNTR, V2, P250, DOI 10.3855/jidc.217; Sur D, 2009, HUM VACCINES, V5, P614, DOI 10.4161/hv.9313; Sur D, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-289; Sur D, 2009, NEW ENGL J MED, V361, P335, DOI 10.1056/NEJMoa0807521; Vollaard AM, 2004, JAMA-J AM MED ASSOC, V291, P2607, DOI 10.1001/jama.291.21.2607; WHO, 2008, WEEKLY EPIDEMIOLOGY, V83, P1; Woods CW, 2006, T ROY SOC TROP MED H, V100, P1063, DOI 10.1016/j.trstmh.2005.12.011; *WORLD BANK, 2007, NEP DAT STAT WORLD D	36	52	54	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e13988	10.1371/journal.pone.0013988	http://dx.doi.org/10.1371/journal.pone.0013988			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085575	Green Published, Green Submitted, gold			2022-12-25	WOS:000284231800018
J	Templeton, DJ; Aye, MS; Rady, J; Xu, F; Cross, JV				Templeton, Dennis J.; Aye, Myo-Sabai; Rady, Joshua; Xu, Fang; Cross, Janet V.			Purification of Reversibly Oxidized Proteins (PROP) Reveals a Redox Switch Controlling p38 MAP Kinase Activity	PLOS ONE			English	Article							OXIDATIVE STRESS; THIOREDOXIN REDUCTASE; CYSTEINE RESIDUES; IN-VIVO; GLUTATHIONYLATION; P53; PROSTAGLANDINS; IDENTIFICATION; INACTIVATION; ACTIVATION	Oxidation of cysteine residues of proteins is emerging as an important means of regulation of signal transduction, particularly of protein kinase function. Tools to detect and quantify cysteine oxidation of proteins have been a limiting factor in understanding the role of cysteine oxidation in signal transduction. As an example, the p38 MAP kinase is activated by several stress-related stimuli that are often accompanied by in vitro generation of hydrogen peroxide. We noted that hydrogen peroxide inhibited p38 activity despite paradoxically increasing the activating phosphorylation of p38. To address the possibility that cysteine oxidation may provide a negative regulatory effect on p38 activity, we developed a biochemical assay to detect reversible cysteine oxidation in intact cells. This procedure, PROP, demonstrated in vivo oxidation of p38 in response to hydrogen peroxide and also to the natural inflammatory lipid prostaglandin J2. Mutagenesis of the potential target cysteines showed that oxidation occurred preferentially on residues near the surface of the p38 molecule. Cysteine oxidation thus controls a functional redox switch regulating the intensity or duration of p38 activity that would not be revealed by immunodetection of phosphoprotein commonly interpreted as reflective of p38 activity.	[Templeton, Dennis J.; Aye, Myo-Sabai; Rady, Joshua; Xu, Fang; Cross, Janet V.] Univ Virginia, Sch Med, Dept Pathol, Charlottesville, VA 22908 USA	University of Virginia	Templeton, DJ (corresponding author), Univ Virginia, Sch Med, Dept Pathol, Charlottesville, VA 22908 USA.	dtempleton@virginia.edu; jvc5b@virginia.edu	Cross, Janet V/F-8276-2011; Templeton, Dennis J/F-7695-2011	Rady, Joshua/0000-0002-7806-136X	NIH [R01CA113899, R01AT004323]; NATIONAL CANCER INSTITUTE [R01CA113899] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT004323] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported by NIH grants R01CA113899 to DJT and R01AT004323 to JVC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aracena-Parks P, 2006, J BIOL CHEM, V281, P40354, DOI 10.1074/jbc.M600876200; Boivin B, 2008, P NATL ACAD SCI USA, V105, P9959, DOI 10.1073/pnas.0804336105; Burgoyne JR, 2007, SCIENCE, V317, P1393, DOI 10.1126/science.1144318; Cassidy PB, 2006, CARCINOGENESIS, V27, P2538, DOI 10.1093/carcin/bgl111; Chu F, 2003, CARCINOGENESIS, V24, P317, DOI 10.1093/carcin/24.2.317; Chu F, 2001, CARCINOGENESIS, V22, P1221, DOI 10.1093/carcin/22.8.1221; Cross JV, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-183; Cross JV, 2006, ANTIOXID REDOX SIGN, V8, P1819, DOI 10.1089/ars.2006.8.1819; Cross JV, 2004, J CELL BIOCHEM, V93, P104, DOI 10.1002/jcb.20202; Cross JV, 2004, BIOCHEM J, V381, P675, DOI 10.1042/BJ20040591; Ghezzi P, 2002, MOL IMMUNOL, V38, P773, DOI 10.1016/S0161-5890(01)00114-6; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; HELD JM, MOL CELL PROTEOMICS, V9, P1400; Humphries KM, 2005, J BIOL CHEM, V280, P2750, DOI 10.1074/jbc.M410242200; Humphries KM, 2002, J BIOL CHEM, V277, P43505, DOI 10.1074/jbc.M207088200; Jaffrey SR, 2005, METHOD ENZYMOL, V396, P105, DOI 10.1016/S0076-6879(05)96011-4; Le Moan Natacha, 2008, V476, P181, DOI 10.1007/978-1-59745-129-1_13; Leichert LI, 2008, P NATL ACAD SCI USA, V105, P8197, DOI 10.1073/pnas.0707723105; Leonberg AK, 2007, MOL CELL BIOCHEM, V304, P207, DOI 10.1007/s11010-007-9501-y; Mamoon NM, 2007, BIOCHEMISTRY-US, V46, P14810, DOI 10.1021/bi701118u; Moos PJ, 2003, J BIOL CHEM, V278, P745, DOI 10.1074/jbc.M211134200; Murata H, 2003, J BIOL CHEM, V278, P50226, DOI 10.1074/jbc.M310171200; Natoli G, 1997, SCIENCE, V275, P200, DOI 10.1126/science.275.5297.200; Piotukh K, 2007, FREE RADICAL BIO MED, V43, P1263, DOI 10.1016/j.freeradbiomed.2007.06.010; Saurin AT, 2004, P NATL ACAD SCI USA, V101, P17982, DOI 10.1073/pnas.0404762101; Seanor KL, 2003, ANTIOXID REDOX SIGN, V5, P103, DOI 10.1089/152308603321223595; Sun GQ, 2009, CELL CYCLE, V8, P2353, DOI 10.4161/cc.8.15.9225; Wagner TM, 2006, J BIOL CHEM, V281, P2598, DOI 10.1074/jbc.M509723200; Wilson KP, 1996, J BIOL CHEM, V271, P27696, DOI 10.1074/jbc.271.44.27696; Wu HH, 2000, BIOCHEM J, V351, P87, DOI 10.1042/0264-6021:3510087; Zhang XS, 1997, FREE RADICAL BIO MED, V23, P980, DOI 10.1016/S0891-5849(97)00126-3	31	33	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e15012	10.1371/journal.pone.0015012	http://dx.doi.org/10.1371/journal.pone.0015012			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085594	gold, Green Published, Green Submitted			2022-12-25	WOS:000284231800028
J	Siervo, M; Horta, BL; Stephan, BCM; Victora, CG; Wells, JCK				Siervo, Mario; Horta, Bernardo L.; Stephan, Blossom C. M.; Victora, Cesar G.; Wells, Jonathan C. K.			First-Borns Carry a Higher Metabolic Risk in Early Adulthood: Evidence from a Prospective Cohort Study	PLOS ONE			English	Article							BIRTH-WEIGHT; PSYCHOLOGICAL STRESS; CHILDHOOD GROWTH; BODY-COMPOSITION; FETAL; PREGNANCY; OBESITY; ASSOCIATION; PREMATURITY; DISTRESS	Background: Birth order has been associated with early growth variability and subsequent increased adiposity, but the consequent effects of increased fat mass on metabolic risk during adulthood have not been assessed. We aimed to quantify the metabolic risk in young adulthood of being first-born relative to those born second or subsequently. Methodology and Principal Findings: Body composition and metabolic risk were assessed in 2,249 men, aged 17-19 years, from a birth cohort in southern Brazil. Metabolic risk was assessed using a composite z-score integrating standardized measurements of blood pressure, total cholesterol, high density lipoprotein, triglycerides and fat mass. First-borns had lower birth weight z-score (Delta = -0.25, 95%CI -0.35, -0.15, p<0.001) but showed greater weight gain during infancy (change in weight z-score from birth to 20 months: Delta = 0.39, 95%CI 0.28-0.50, P<0.0001) and had greater mean height (Delta = 1.2 cm, 95%CI: 0.7-1.6, p<0.0001) and weight (Delta = 0.34 kg, 95%CI: 0.13-0.55, p<0.002) at 43 months. This greater weight and height tracked into early adulthood, with first-borns being significantly taller, heavier and with significantly higher fat mass than later-borns. The metabolic risk z-score was significantly higher in first-borns. Conclusions/Significance: First-born status is associated with significantly elevated adiposity and metabolic risk in young adult men in Brazil. Our results, linking cardiovascular risk with life history variables, suggest that metabolic risk may be associated with the worldwide trend to smaller family size and it may interact with changes in behavioural or environmental risk factors.	[Siervo, Mario] Univ Naples Federico II, Dept Neurosci, Naples, Italy; [Horta, Bernardo L.; Victora, Cesar G.] Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, Brazil; [Stephan, Blossom C. M.] Univ Cambridge, Inst Publ Hlth, Cambridge, England; [Wells, Jonathan C. K.] UCL Inst Child Hlth, Childhood Nutr Res Ctr, London, England	University of Naples Federico II; Universidade Federal de Pelotas; University of Cambridge; University of London; University College London	Siervo, M (corresponding author), Univ Naples Federico II, Dept Neurosci, Naples, Italy.	masiervo@yahoo.com	Victora, Cesar G/D-4476-2013; Horta, Bernardo/A-7604-2008; Victora, Cesar Gomes/Y-2455-2019; Siervo, Mario/AAB-9302-2019; Wells, Jonathan/A-4604-2009	Victora, Cesar G/0000-0002-2465-2180; Horta, Bernardo/0000-0001-9843-412X; Victora, Cesar Gomes/0000-0002-2465-2180; Wells, Jonathan/0000-0003-0411-8025; Stephan, Blossom/0000-0002-1235-360X; Siervo, Mario/0000-0001-5515-0944	International Development research Center (Canada); World Health Organization (Department of Child and Adolescent Health and Development); Overseas Development Administration (United Kingdom); United Nations Development Fund for Women; National Program for Centers of Excellence (Brazil); National Research Council (Brazil); Ministry of Health (Brazil); Medical Research Council [G0701539] Funding Source: researchfish; MRC [G0701539] Funding Source: UKRI	International Development research Center (Canada)(CGIAR); World Health Organization (Department of Child and Adolescent Health and Development)(World Health Organization); Overseas Development Administration (United Kingdom); United Nations Development Fund for Women; National Program for Centers of Excellence (Brazil); National Research Council (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministry of Health (Brazil); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Earlier phases of the 1982 cohort study were funded by the International Development research Center (Canada), the World Health Organization (Department of Child and Adolescent Health and Development, and Human Reproduction Programme), the Overseas Development Administration (United Kingdom), the United Nations Development Fund for Women, the National Program for Centers of Excellence (Brazil), the National Research Council (Brazil) and the Ministry of Health (Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandelow B, 2006, EUR PSYCHIAT, V21, P495, DOI 10.1016/j.eurpsy.2005.11.005; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Barker DJP, 2007, HYPERTENSION, V50, P565, DOI 10.1161/HYPERTENSIONAHA.107.091512; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; Barros FC, 2008, REV SAUDE PUBL, V42, P7, DOI 10.1590/S0034-89102008000900003; Brage S, 2004, DIABETES CARE, V27, P2141, DOI 10.2337/diacare.27.9.2141; Copper RL, 1996, AM J OBSTET GYNECOL, V175, P1286, DOI 10.1016/S0002-9378(96)70042-X; Diego MA, 2006, PSYCHOSOM MED, V68, P747, DOI 10.1097/01.psy.0000238212.21598.7b; Dunger DB, 2007, P NUTR SOC, V66, P451, DOI 10.1017/S0029665107005721; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Ekelund U, 2007, J CLIN ENDOCR METAB, V92, P98, DOI 10.1210/jc.2006-1071; Fewtrell MS, 2004, AM J CLIN NUTR, V80, P436, DOI 10.1093/ajcn/80.2.436; Flaherty JH, 2007, J AM GERIATR SOC, V55, P1295, DOI 10.1111/j.1532-5415.2007.01273.x; Forsen T, 2000, ANN INTERN MED, V133, P176, DOI 10.7326/0003-4819-133-3-200008010-00008; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gitau R, 1998, LANCET, V352, P707, DOI 10.1016/S0140-6736(05)60824-0; GRIMM ER, 1961, PSYCHOSOM MED, V23, P520, DOI 10.1097/00006842-196111000-00006; HAIG D, 1993, Q REV BIOL, V68, P495, DOI 10.1086/418300; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; HALES CN, 2002, J PHYSL, P5; HAMILL PVV, 1979, AM J CLIN NUTR, V32, P607, DOI 10.1093/ajcn/32.3.607; Hoa HT, 1996, BRIT MED J, V313, P1113, DOI 10.1136/bmj.313.7065.1113; Horta BL, 2003, J EPIDEMIOL COMMUN H, V57, P226, DOI 10.1136/jech.57.3.226; Khong TY, 2003, PLACENTA, V24, P348, DOI 10.1053/plac.2002.0922; Kivlighan KT, 2008, PSYCHONEUROENDOCRINO, V33, P1225, DOI 10.1016/j.psyneuen.2008.06.008; Leunissen RWJ, 2009, CLIN ENDOCRINOL, V70, P245, DOI 10.1111/j.1365-2265.2008.03320.x; Leunissen RWJ, 2009, JAMA-J AM MED ASSOC, V301, P2234, DOI 10.1001/jama.2009.761; Macbeth AH, 2010, NEUROSCI BIOBEHAV R, V34, P452, DOI 10.1016/j.neubiorev.2009.08.011; O'Rahilly S, 2008, INT J OBESITY, V32, pS55, DOI 10.1038/ijo.2008.239; Ong KK, 2007, PLOS MED, V4, P737, DOI 10.1371/journal.pmed.0040132; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Ong KKL, 2002, PEDIATR RES, V52, P863, DOI 10.1203/00006450-200212000-00009; Petry CJ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-22; RASHEED FN, 1993, LANCET, V341, P828, DOI 10.1016/0140-6736(93)90602-D; Ritchie SA, 2007, NUTR METAB CARDIOVAS, V17, P319, DOI 10.1016/j.numecd.2006.07.005; Rondo PHC, 2003, EUR J CLIN NUTR, V57, P266, DOI 10.1038/sj.ejcn.1601526; Stettler N, 2000, AM J CLIN NUTR, V72, P378; STUBBS RJ, 1995, AM J CLIN NUTR, V62, P330, DOI 10.1093/ajcn/62.2.330; Teixeira JMA, 1999, BRIT MED J, V318, P153, DOI 10.1136/bmj.318.7177.153; United Nations, 2007, WORLD POP AG; VANITALLIE TB, 1990, AM J CLIN NUTR, V52, P953, DOI 10.1093/ajcn/52.6.953; Wells JCK, 2007, P NUTR SOC, V66, P423, DOI 10.1017/S0029665107005691; Wisborg K, 2008, BJOG-INT J OBSTET GY, V115, P882, DOI 10.1111/j.1471-0528.2008.01734.x; Wolf AM, 2009, AM J MED, V122, pS19, DOI 10.1016/j.amjmed.2009.01.004	44	41	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e13907	10.1371/journal.pone.0013907	http://dx.doi.org/10.1371/journal.pone.0013907			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085691	gold, Green Published, Green Submitted			2022-12-25	WOS:000284035900014
J	Bowden, SD; Ramachandran, VK; Knudsen, GM; Hinton, JCD; Thompson, A				Bowden, Steven D.; Ramachandran, Vinoy K.; Knudsen, Gitte M.; Hinton, Jay C. D.; Thompson, Arthur			An Incomplete TCA Cycle Increases Survival of Salmonella Typhimurium during Infection of Resting and Activated Murine Macrophages	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; ESCHERICHIA-COLI; HOST-CELLS; MYCOBACTERIUM-TUBERCULOSIS; INTRACELLULAR SALMONELLA; PHAGOCYTE OXIDASE; EPITHELIAL-CELLS; TYPHOID-FEVER; BALB/C MICE; GENE	Background: In comparison to the comprehensive analyses performed on virulence gene expression, regulation and action, the intracellular metabolism of Salmonella during infection is a relatively under-studied area. We investigated the role of the tricarboxylic acid (TCA) cycle in the intracellular replication of Salmonella Typhimurium in resting and activated macrophages, epithelial cells, and during infection of mice. Methodology/Principal Findings: We constructed deletion mutations of 5 TCA cycle genes in S. Typhimurium including gltA, mdh, sdhCDAB, sucAB, and sucCD. We found that the mutants exhibited increased net intracellular replication in resting and activated murine macrophages compared to the wild-type. In contrast, an epithelial cell infection model showed that the S. Typhimurium Delta sucCD and Delta gftA strains had reduced net intracellular replication compared to the wild-type. The glyoxylate shunt was not responsible for the net increased replication of the TCA cycle mutants within resting macrophages. We also confirmed that, in a murine infection model, the S. Typhimurium Delta sucAB and Delta sucCD strains are attenuated for virulence. Conclusions/Significance: Our results suggest that disruption of the TCA cycle increases the ability of S. Typhimurium to survive within resting and activated murine macrophages. In contrast, epithelial cells are non-phagocytic cells and unlike macrophages cannot mount an oxidative and nitrosative defence response against pathogens; our results show that in HeLa cells the S. Typhimurium TCA cycle mutant strains show reduced or no change in intracellular levels compared to the wild-type [1]. The attenuation of the S. Typhimurium Delta sucAB and Delta sucCD mutants in mice, compared to their increased net intracellular replication in resting and activated macrophages suggest that Salmonella may encounter environments within the host where a complete TCA cycle is advantageous.	[Bowden, Steven D.; Ramachandran, Vinoy K.; Knudsen, Gitte M.; Thompson, Arthur] Inst Food Res, Norwich NR4 7UA, Norfolk, England; [Hinton, Jay C. D.] Trinity Coll Dublin, Moyne Inst Prevent Med, Sch Genet & Microbiol, Dublin, Ireland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; Trinity College Dublin	Bowden, SD (corresponding author), Inst Food Res, Colney Lane, Norwich NR4 7UA, Norfolk, England.	arthur.thompson@bbsrc.ac.uk	Hinton, Jay C. D./B-2142-2008; Knudsen, Gitte/J-1858-2015; Ramachandran, Vinoy/H-6790-2013; Knudsen, Gitte Moos/C-1368-2013	Hinton, Jay C. D./0000-0003-2671-6026; Knudsen, Gitte Moos/0000-0003-1508-6866; Knudsen, Gitte Maegaard/0000-0002-3983-0541	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/D004810/1]; BBSRC [BB/D004810/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D004810/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors are grateful to the Biotechnology and Biological Sciences Research Council (BBSRC) for funding this work (Grant BB/D004810/1 to AT, and the Core Strategic Grant to JCDH). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams GL, 2006, CELL MICROBIOL, V8, P728, DOI 10.1111/j.1462-5822.2006.00706.x; Alteri CJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000448; Baumler AJ, 1997, INFECT IMMUN, V65, P2254; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Bowden SD, 2009, INFECT IMMUN, V77, P3117, DOI 10.1128/IAI.00093-09; Bumann D, 2009, CURR OPIN MICROBIOL, V12, P559, DOI 10.1016/j.mib.2009.08.004; CARRILLO.G, 1970, J BACTERIOL, V102, P524; Chakravortty D, 2002, J EXP MED, V195, P1155, DOI 10.1084/jem.20011547; CRONAN JEJ, 1996, TRICARBOXYLIC ACID C, P206; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Cvitkovitch DG, 1997, J BACTERIOL, V179, P650, DOI 10.1128/jb.179.3.650-655.1997; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Ehrt S, 2001, J EXP MED, V194, P1123, DOI 10.1084/jem.194.8.1123; Eriksson S, 2000, CELL MICROBIOL, V2, P239, DOI 10.1046/j.1462-5822.2000.00051.x; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Grant AJ, 2008, PLOS BIOL, V6, P757, DOI 10.1371/journal.pbio.0060074; GREENE RC, 1996, ESCHERICHIA COLI SAL, P542; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hautefort I, 2008, CELL MICROBIOL, V10, P958, DOI 10.1111/j.1462-5822.2007.01099.x; Humphreys S, 1999, INFECT IMMUN, V67, P1560; Husain M, 2008, J BIOL CHEM, V283, P7682, DOI 10.1074/jbc.M708845200; Klose KE, 1997, INFECT IMMUN, V65, P587, DOI 10.1128/IAI.65.2.587-596.1997; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333; Mastroeni P, 1998, INFECT IMMUN, V66, P4767, DOI 10.1128/IAI.66.10.4767-4776.1998; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Mota LJ, 2009, CELL MICROBIOL, V11, P1236, DOI 10.1111/j.1462-5822.2009.01329.x; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; OSWALD IP, 1992, CLIN EXP IMMUNOL, V87, P373, DOI 10.1111/j.1365-2249.1992.tb03005.x; Paterson GK, 2009, MICROB PATHOGENESIS, V46, P261, DOI 10.1016/j.micpath.2009.01.008; Paterson GK, 2009, FEMS MICROBIOL LETT, V294, P45, DOI 10.1111/j.1574-6968.2009.01553.x; Portillo FGD, 2001, MICROBES INFECT, V3, P1305, DOI 10.1016/S1286-4579(01)01491-5; RichterDahlfors A, 1997, J EXP MED, V186, P569, DOI 10.1084/jem.186.4.569; Rosenberger CM, 2002, J BIOL CHEM, V277, P18753, DOI 10.1074/jbc.M110649200; Santos RL, 2001, MICROBES INFECT, V3, P1335, DOI 10.1016/S1286-4579(01)01495-2; Schilling CH, 2000, J THEOR BIOL, V203, P249, DOI 10.1006/jtbi.2000.1088; Schilling CH, 2002, J BACTERIOL, V184, P4582, DOI 10.1128/JB.184.16.4582-4593.2002; Shiloh MU, 2000, CURR OPIN MICROBIOL, V3, P35, DOI 10.1016/S1369-5274(99)00048-X; SMITH HO, 1967, VIROLOGY, V31, P207, DOI 10.1016/0042-6822(67)90164-X; Steele-Mortimer O, 1999, CELL MICROBIOL, V1, P33, DOI 10.1046/j.1462-5822.1999.00003.x; Vazquez-Torres A, 2001, P NATL ACAD SCI USA, V98, P2561, DOI 10.1073/pnas.041618998; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; WILSON RB, 1987, J BACTERIOL, V169, P3029, DOI 10.1128/jb.169.7.3029-3034.1987; WOODCOCK DM, 1989, NUCLEIC ACIDS RES, V17, P3469, DOI 10.1093/nar/17.9.3469; WRAY C, 1978, RES VET SCI, V25, P139, DOI 10.1016/S0034-5288(18)32968-0; Yimga MT, 2006, INFECT IMMUN, V74, P1130, DOI 10.1128/IAI.74.2.1130-1140.2006	46	39	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e13871	10.1371/journal.pone.0013871	http://dx.doi.org/10.1371/journal.pone.0013871			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	676NU	21079785	gold, Green Submitted, Green Published			2022-12-25	WOS:000283920000005
J	Elgaaen, BV; Haug, KBF; Wang, JB; Olstad, OK; Fortunati, D; Onsrud, M; Staff, AC; Sauer, T; Gautvik, KM				Elgaaen, Bente Vilming; Haug, Kari Bente Foss; Wang, Junbai; Olstad, Ole Kristoffer; Fortunati, Dario; Onsrud, Mathias; Staff, Anne Cathrine; Sauer, Torill; Gautvik, Kaare M.			POLD2 and KSP37 (FGFBP2) Correlate Strongly with Histology, Stage and Outcome in Ovarian Carcinomas	PLOS ONE			English	Article							SURFACE EPITHELIAL-CELLS; GENE-EXPRESSION; CLEAR-CELL; CANCER; PROTEIN; MODEL; GROWTH; PCR	Background: Epithelial ovarian cancer (EOC) constitutes more than 90% of ovarian cancers and is associated with high mortality. EOC comprises a heterogeneous group of tumours, and the causes and molecular pathology are essentially unknown. Improved insight into the molecular characteristics of the different subgroups of EOC is urgently needed, and should eventually lead to earlier diagnosis as well as more individualized and effective treatments. Previously, we reported a limited number of mRNAs strongly upregulated in human osteosarcomas and other malignancies, and six were selected to be tested for a possible association with three subgroups of ovarian carcinomas and clinical parameters. Methodology/Principal Findings: The six selected mRNAs were quantified by RT-qPCR in biopsies from eleven poorly differentiated serous carcinomas (PDSC, stage III-IV), twelve moderately differentiated serous carcinomas (MDSC, stage III-IV) and eight clear cell carcinomas (CCC, stage I-IV) of the ovary. Superficial scrapings from six normal ovaries (SNO), as well as biopsies from three normal ovaries (BNO) and three benign ovarian cysts (BBOC) were analyzed for comparison. The gene expression level was related to the histological and clinical parameters of human ovarian carcinoma samples. One of the mRNAs, DNA polymerase delta 2 small subunit (POLD2), was increased in average 2.5- to almost 20-fold in MDSC and PDSC, respectively, paralleling the degree of dedifferentiation and concordant with a poor prognosis. Except for POLD2, the serous carcinomas showed a similar transcription profile, being clearly different from CCC. Another mRNA, Killer-specific secretory protein of 37 kDa (KSP37) showed six-to eight-fold higher levels in CCC stage I compared with the more advanced staged carcinomas, and correlated positively with an improved clinical outcome. Conclusions/Significance: We have identified two biomarkers which are markedly upregulated in two subgroups of ovarian carcinomas and are also associated with stage and outcome. The results suggest that POLD2 and KSP37 might be potential prognostic biomarkers.	[Elgaaen, Bente Vilming; Onsrud, Mathias; Staff, Anne Cathrine] Oslo Univ Hosp, Dept Gynaecol, Oslo, Norway; [Haug, Kari Bente Foss; Olstad, Ole Kristoffer; Fortunati, Dario; Gautvik, Kaare M.] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway; [Wang, Junbai; Sauer, Torill] Oslo Univ Hosp, Dept Pathol, Oslo, Norway; [Onsrud, Mathias; Staff, Anne Cathrine; Sauer, Torill; Gautvik, Kaare M.] Univ Oslo, Fac Med, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo	Elgaaen, BV (corresponding author), Oslo Univ Hosp, Dept Gynaecol Oncol, Oslo, Norway.	bente.vilming.elgaaen@medisin.uio.no	Sauer, Torill/H-7041-2019; wang, junbai/B-2093-2008; wang, junbai/AFQ-5325-2022	wang, junbai/0000-0001-5505-5613	Former Eastern Norway Regional Health Authority; Organon; Merck; Sharp; Dohme	Former Eastern Norway Regional Health Authority; Organon; Merck(Merck & Company); Sharp; Dohme	The authors acknowledge former Eastern Norway Regional Health Authority for economical support as well as Organon (currently part of Merck, Sharp and Dohme) for providing a research grant through the Norwegian Society for Gynecology and Obstetrics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; BATTINI R, 1987, J BIOL CHEM, V262, P4355; Bell DA, 2005, MODERN PATHOL, V18, pS19, DOI 10.1038/modpathol.3800306; Bray F, 2009, CANC NORWAY 2008 CAN; Bredel M, 2009, JAMA-J AM MED ASSOC, V302, P261, DOI 10.1001/jama.2009.997; Chan WY, 2000, AM J PATHOL, V156, P409, DOI 10.1016/S0002-9440(10)64744-X; Farley J, 2008, CELL RES, V18, P538, DOI 10.1038/cr.2008.52; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Landen CN, 2008, J CLIN ONCOL, V26, P995, DOI 10.1200/JCO.2006.07.9970; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsushima-Nishiu M, 2001, CANCER RES, V61, P3741; Meinhold-Heerlein I, 2005, ONCOGENE, V24, P1053, DOI 10.1038/sj.onc.1208298; Naora Honami, 2007, Expert Reviews in Molecular Medicine, V9, DOI 10.1017/S1462399407000324; Ogawa K, 2001, J IMMUNOL, V166, P6404, DOI 10.4049/jimmunol.166.10.6404; Okamura H, 2005, INT REV CYTOL, V242, P1; Olstad OK, 2003, ANTICANCER RES, V23, P2201; Orsulic S, 2002, CANCER CELL, V1, P53, DOI 10.1016/S1535-6108(01)00002-2; Perez A, 2000, BBA-GENE STRUCT EXPR, V1493, P231, DOI 10.1016/S0167-4781(00)00153-6; Pogacic V, 2000, MOL CELL BIOL, V20, P9028, DOI 10.1128/MCB.20.23.9028-9040.2000; PRAT J, 2009, ROBBOYS PATHOLOGY FE; Sasaki R, 2009, CARCINOGENESIS, V30, P423, DOI 10.1093/carcin/bgp007; Schwartz DR, 2002, CANCER RES, V62, P4722; Shih IM, 2004, AM J PATHOL, V164, P1511, DOI 10.1016/S0002-9440(10)63708-X; Shimizu M, 1999, CANCER, V85, P669, DOI 10.1002/(SICI)1097-0142(19990201)85:3<669::AID-CNCR17>3.0.CO;2-F; Wakabayashi Y, 2006, J IMMUNOL, V177, P1772, DOI 10.4049/jimmunol.177.3.1772; Wang JB, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-36; Wang JB, 2007, J BIOMED INFORM, V40, P707, DOI 10.1016/j.jbi.2007.02.003; Woo HN, 2004, FEBS LETT, V578, P239, DOI 10.1016/j.febslet.2004.10.094; Yamanaka R, 2006, ONCOGENE, V25, P5994, DOI 10.1038/sj.onc.1209585; Zorn KK, 2003, CLIN CANCER RES, V9, P4811	30	24	27	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e13837	10.1371/journal.pone.0013837	http://dx.doi.org/10.1371/journal.pone.0013837			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079801	gold, Green Submitted, Green Published			2022-12-25	WOS:000283838600012
J	Aslam, N; Zaheer, I				Aslam, Naveed; Zaheer, Irum			The Biosynthesis Characteristics of TTP and TNF Can Be Regulated through a Posttranscriptional Molecular Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; INFLAMMATORY-BOWEL-DISEASE; 3' UNTRANSLATED REGION; AU-RICH ELEMENTS; MESSENGER-RNA; RHEUMATOID-ARTHRITIS; SIGNALING PATHWAY; FOS PROTEIN; GM-CSF; GENE	The abundant expression of tumor necrosis factor (TNF) is a hallmark of chronic inflammation of the gastrointestinal tract. Prolonged inflammation can lead to inflammatory bowel disease. TNF biosynthesis is regulated both at transcription and posttranscriptional levels. However, the stimulation-induced increase in translation rate is much larger. This might indicate the possibility of a posttranscriptional regulatory mechanism. How, during basal conditions, is the free concentration of TNF tightly regulated at low levels? The stability and translational efficiency of TNF transcript are regulated by an AU-rich element (ARE) in the 3'-UTR of messenger RNA. A transacting protein, TTP, binds to ARE and enhances the mRNA turnover. Here, we examine a proposal that TNF homeostasis is regulated by a TTP-TNF interaction loop at the posttranscriptional level. We propose a computational framework of this regulatory loop by modeling the role of AREs in mediating the messenger RNA stability and translation. This posttranscriptional regulatory loop between TTP and TNF is composed of two feedback loops (i.e. positive and negative). The mutual interaction of these feedback loops regulates the biosynthesis response of TNF during basal and inflammatory conditions. Here, we also propose an explanation for why the p38 inhibitors become insensitive for TTP knock-out mice.	[Aslam, Naveed] Univ Texas Med Sch Houston, Dept Neurobiol & Anat, Houston, TX 77030 USA; [Zaheer, Irum] Methodist Hosp, Dept Internal Med, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; The Methodist Hospital System; The Methodist Hospital - Houston	Aslam, N (corresponding author), Univ Texas Med Sch Houston, Dept Neurobiol & Anat, 6431 Fannin St, Houston, TX 77030 USA.	naslam621@yahoo.com	Aslam, Naveed/AAX-1323-2020		National Institutes of Health [2 P01-NS038310]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS038310] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 2 P01-NS038310.	Audic Y, 2004, BIOL CELL, V96, P479, DOI 10.1016/j.biolcel.2004.05.002; Bakheet T, 2001, NUCLEIC ACIDS RES, V29, P246, DOI 10.1093/nar/29.1.246; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Brook M, 2006, MOL CELL BIOL, V26, P2408, DOI 10.1128/MCB.26.6.2408-2418.2006; Cao HP, 2004, J BIOL CHEM, V279, P21489, DOI 10.1074/jbc.M400900200; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Carballo E, 2001, J BIOL CHEM, V276, P42580, DOI 10.1074/jbc.M104953200; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Conne B, 2000, NAT MED, V6, P637, DOI 10.1038/76211; Feldmann M, 1996, ANNU REV IMMUNOL, V14, P397, DOI 10.1146/annurev.immunol.14.1.397; Franks TM, 2007, GENE DEV, V21, P719, DOI 10.1101/gad.1494707; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; Jacob CO, 1996, J IMMUNOL, V156, P3043; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; KEYOMARSI K, 1993, P NATL ACAD SCI USA, V90, P1112, DOI 10.1073/pnas.90.3.1112; Kollias G, 2005, SEMIN ARTHRITIS RHEU, V34, P3, DOI 10.1016/j.semarthrit.2005.01.002; Kollias G, 1999, IMMUNOL REV, V169, P175, DOI 10.1111/j.1600-065X.1999.tb01315.x; KRUYS V, 1993, J EXP MED, V177, P1383, DOI 10.1084/jem.177.5.1383; Laroia G, 1999, SCIENCE, V284, P499, DOI 10.1126/science.284.5413.499; LEBWOHL DE, 1994, ONCOGENE, V9, P1925; LEE WMF, 1988, MOL CELL BIOL, V8, P5521, DOI 10.1128/MCB.8.12.5521; MEIJLINK F, 1985, P NATL ACAD SCI USA, V82, P4987, DOI 10.1073/pnas.82.15.4987; MILLER AD, 1984, CELL, V36, P51; NAIR APK, 1994, NATURE, V369, P239, DOI 10.1038/369239a0; PEREZ C, 1990, CELL, V63, P251, DOI 10.1016/0092-8674(90)90158-B; Pullmann R, 2005, J BIOL CHEM, V280, P22819, DOI 10.1074/jbc.M501106200; Sandborn WJ, 1999, INFLAMM BOWEL DIS, V5, P119, DOI 10.1097/00054725-199905000-00008; SCHULER GD, 1988, CELL, V55, P1115, DOI 10.1016/0092-8674(88)90256-5; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SPRIGGS DR, 1990, CANCER RES, V50, P7101; VANDENABEELE P, 1995, TRENDS CELL BIOL, V5, P392, DOI 10.1016/S0962-8924(00)89088-1; VASSALLI P, 1992, ANNU REV IMMUNOL, V10, P411, DOI 10.1146/annurev.iy.10.040192.002211; Wilson GM, 2003, J BIOL CHEM, V278, P33039, DOI 10.1074/jbc.M305775200	35	4	4	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3767	3776		10.1074/jbc.M110.168757	http://dx.doi.org/10.1074/jbc.M110.168757			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21088298	Green Published, hybrid			2022-12-25	WOS:000286653200058
J	Bermek, O; Grindley, NDF; Joyce, CM				Bermek, Oya; Grindley, Nigel D. F.; Joyce, Catherine M.			Distinct Roles of the Active-site Mg2+ Ligands, Asp(882) and Asp(705), of DNA Polymerase I (Klenow Fragment) during the Prechemistry Conformational Transitions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURES; ESCHERICHIA-COLI; DEOXYNUCLEOSIDE TRIPHOSPHATE; NUCLEOTIDE INCORPORATION; STRUCTURAL BASIS; TERNARY COMPLEX; BETA; MECHANISM; CATALYSIS; REPLICATION	DNA polymerases catalyze the incorporation of deoxynucleoside triphosphates into a growing DNA chain using a pair of Mg2+ ions, coordinated at the active site by two invariant aspartates, whose removal by mutation typically reduces the polymerase activity to barely detectable levels. Using two stopped-flow fluorescence assays that we developed previously, we have investigated the role of the carboxylate ligands, Asp(705) and Asp(882), of DNA polymerase I (Klenow fragment) in the early prechemistry steps that prepare the active site for catalysis. We find that neither carboxylate is required for an early conformational transition, reported by a 2-aminopurine probe, that takes place in the open ternary complex after binding of the complementary dNTP. However, the subsequent fingers-closing step requires Asp(882); this step converts the open ternary complex into the closed conformation, creating the active-site geometry required for catalysis. Crystal structures indicate that the Asp(882) position changes very little during fingers-closing; this side chain may therefore serve as an anchor point to receive the dNTP-associated metal ion as the nucleotide is delivered into the active site. The Asp(705) carboxylate is not required until after the fingers-closing step, and we suggest that its role is to facilitate the entry of the second Mg2+ into the active site. The two early prechemistry steps that we have studied take place normally at very low Mg2+ concentrations, although higher concentrations are needed for covalent nucleotide addition, consistent with the second metal ion entering the ternary complex after fingers-closing.	[Joyce, Catherine M.] Yale Univ, Bass Ctr Mol & Struct Biol, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Joyce, CM (corresponding author), Yale Univ, Bass Ctr Mol & Struct Biol, Dept Mol Biophys & Biochem, 266 Whitney Ave,POB 208114, New Haven, CT 06520 USA.	catherine.joyce@yale.edu			National Institutes of Health [GM-28550]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028550] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-28550.	Arndt JW, 2001, BIOCHEMISTRY-US, V40, P5368, DOI 10.1021/bi002176j; ASTATKE M, 1995, J BIOL CHEM, V270, P1945, DOI 10.1074/jbc.270.4.1945; Bakhtina M, 2005, BIOCHEMISTRY-US, V44, P5177, DOI 10.1021/bi047664w; Batra VK, 2006, STRUCTURE, V14, P757, DOI 10.1016/j.str.2006.01.011; BEESE LS, 1993, BIOCHEMISTRY-US, V32, P14095, DOI 10.1021/bi00214a004; Brautigam CA, 1998, CURR OPIN STRUC BIOL, V8, P54, DOI 10.1016/S0959-440X(98)80010-9; DAHLBERG ME, 1991, BIOCHEMISTRY-US, V30, P4835, DOI 10.1021/bi00234a002; DELARUE M, 1990, PROTEIN ENG, V3, P461, DOI 10.1093/protein/3.6.461; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Doublie S, 1999, STRUCTURE, V7, pR31, DOI 10.1016/S0969-2126(99)80017-3; ELDEIRY WS, 1984, P NATL ACAD SCI-BIOL, V81, P7378, DOI 10.1073/pnas.81.23.7378; Florian J, 2003, J AM CHEM SOC, V125, P8163, DOI 10.1021/ja028997o; GOODMAN MF, 1983, J BIOL CHEM, V258, P3469; Johnson SJ, 2003, P NATL ACAD SCI USA, V100, P3895, DOI 10.1073/pnas.0630532100; Joyce CM, 2008, BIOCHEMISTRY-US, V47, P6103, DOI 10.1021/bi7021848; Joyce CM, 1995, METHOD ENZYMOL, V262, P3; Joyce CM, 2004, BIOCHEMISTRY-US, V43, P14317, DOI 10.1021/bi048422z; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; KUNKEL TA, 1979, J BIOL CHEM, V254, P5718; Lee HR, 2009, BIOCHEMISTRY-US, V48, P2087, DOI 10.1021/bi8016284; Li Y, 1998, PROTEIN SCI, V7, P1116, DOI 10.1002/pro.5560070505; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; MULLEN GP, 1990, J BIOL CHEM, V265, P14327; Pelletier H, 1996, BIOCHEMISTRY-US, V35, P12762, DOI 10.1021/bi9529566; POLESKY AH, 1992, J BIOL CHEM, V267, P8417; POLESKY AH, 1990, J BIOL CHEM, V265, P14579; Purohit V, 2003, BIOCHEMISTRY-US, V42, P10200, DOI 10.1021/bi0341206; Radhakrishnan R, 2006, BIOCHEMISTRY-US, V45, P15142, DOI 10.1021/bi061353z; Santoso Y, 2010, P NATL ACAD SCI USA, V107, P715, DOI 10.1073/pnas.0910909107; Sarafianos SG, 2002, EMBO J, V21, P6614, DOI 10.1093/emboj/cdf637; STEITZ TA, 1994, SCIENCE, V266, P2022, DOI 10.1126/science.7528445; Wang M, 2009, BIOCHEMISTRY-US, V48, P2075, DOI 10.1021/bi801627h; Yang LJ, 2004, J AM CHEM SOC, V126, P8441, DOI 10.1021/ja049412o; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; Zakharova E, 2004, BIOCHEMISTRY-US, V43, P6587, DOI 10.1021/bi049615p; Zhong XJ, 1998, J AM CHEM SOC, V120, P235, DOI 10.1021/ja973507r	36	30	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3755	3766		10.1074/jbc.M110.167593	http://dx.doi.org/10.1074/jbc.M110.167593			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21084297	Green Published, hybrid			2022-12-25	WOS:000286653200057
J	Palomo, M; Pijning, T; Booiman, T; Dobruchowska, JM; van der Vlist, J; Kralj, S; Planas, A; Loos, K; Kamerling, JP; Dijkstra, BW; van der Maarel, MJEC; Dijkhuizen, L; Leemhuis, H				Palomo, Marta; Pijning, Tjaard; Booiman, Thijs; Dobruchowska, Justyna M.; van der Vlist, Jeroen; Kralj, Slavko; Planas, Antoni; Loos, Katja; Kamerling, Johannis P.; Dijkstra, Bauke W.; van der Maarel, Marc J. E. C.; Dijkhuizen, Lubbert; Leemhuis, Hans			Thermus thermophilus Glycoside Hydrolase Family 57 Branching Enzyme CRYSTAL STRUCTURE, MECHANISM OF ACTION, AND PRODUCTS FORMED	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERMOCOCCUS-LITORALIS; BACTERIAL GLYCOGEN; 4-ALPHA-GLUCANOTRANSFERASE; IDENTIFICATION; PHOSPHORYLASE; EVOLUTION; PROTEINS; MARKER	Branching enzyme (EC 2.4.1.18; glycogen branching enzyme; GBE) catalyzes the formation of alpha 1,6-branching points in glycogen. Until recently it was believed that all GBEs belong to glycoside hydrolase family 13 (GH13). Here we describe the cloning and expression of the Thermus thermophilus family GH57-type GBE and report its biochemical properties and crystal structure at 1.35-angstrom resolution. The enzyme has a central (beta/alpha)(7)-fold catalytic domain A with an inserted domain B between beta 2 and alpha 5 and an alpha-helix-rich C-terminal domain, which is shown to be essential for substrate binding and catalysis. A maltotriose was modeled in the active site of the enzyme which suggests that there is insufficient space for simultaneously binding of donor and acceptor substrates, and that the donor substrate must be cleaved before acceptor substrate can bind. The biochemical assessment showed that the GH57 GBE possesses about 4% hydrolytic activity with amylose and in vitro forms a glucan product with a novel fine structure, demonstrating that the GH57 GBE is clearly different from the GH13 GBEs characterized to date.	[Palomo, Marta; Booiman, Thijs; Dobruchowska, Justyna M.; Kralj, Slavko; Kamerling, Johannis P.; van der Maarel, Marc J. E. C.; Dijkhuizen, Lubbert; Leemhuis, Hans] Groningen Biomol Sci & Biotechnol Inst GBB, Dept Microbiol, NL-9751 NN Haren, Netherlands; [Pijning, Tjaard; Dijkstra, Bauke W.] Univ Groningen, Zernike Inst Adv Mat, Biophys Chem Lab, NL-9747 AG Groningen, Netherlands; [van der Vlist, Jeroen; Loos, Katja] Univ Groningen, Zernike Inst Adv Mat, Dept Polymer Chem, NL-9747 AG Groningen, Netherlands; [Planas, Antoni] Univ Ramon Llull, Inst Quim Sarria, Biochem Lab, Barcelona 08017, Spain	University of Groningen; University of Groningen; University of Groningen; Universitat Ramon Llull; Institut Quimic de Sarria	Dijkhuizen, L (corresponding author), Groningen Biomol Sci & Biotechnol Inst GBB, Dept Microbiol, Kerklaan 30, NL-9751 NN Haren, Netherlands.	L.Dijkhuizen@rug.nl	Institute, Zernike/W-7033-2019; Pijning, Tjaard/HDO-3704-2022; Pijning, Tjaard/ABA-2929-2021; Dijkhuizen, Lubbert/E-9454-2014; DOBRUCHOWSKA, JUSTYNA/AAY-1409-2021; Dijkhuizen, Lubbert/K-3539-2019; PLANAS, ANTONI/I-4803-2015; Loos, Katja/ABH-1104-2021; Dijkstra, Bauke W./H-4308-2019; Loos, Katja/B-9792-2008	Pijning, Tjaard/0000-0003-4107-3663; Dijkhuizen, Lubbert/0000-0003-2312-7162; PLANAS, ANTONI/0000-0001-7073-3320; Loos, Katja/0000-0002-4613-1159; Dijkstra, Bauke W./0000-0001-9731-6586; Loos, Katja/0000-0002-4613-1159; Kralj, Slavko/0000-0001-7855-4888	The Netherlands Organization of Applied Scientific Research Quality of Life	The Netherlands Organization of Applied Scientific Research Quality of Life	This work was supported by The Netherlands Organization of Applied Scientific Research Quality of Life.	BAILEY AE, 1994, PHYS REV E, V50, P4853, DOI 10.1103/PhysRevE.50.4853; Barends TRM, 2007, J BIOL CHEM, V282, P17242, DOI 10.1074/jbc.M701444200; Boeck B, 1998, RES MICROBIOL, V149, P171, DOI 10.1016/S0923-2508(98)80077-6; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Delano WL., 2002, PYMOL MOL GRAPHICS S; Dickmanns A, 2006, ACTA CRYSTALLOGR D, V62, P262, DOI [10.1107/S0907444905041363, 10.1107/S0904777905041363]; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Fiske CH, 1925, J BIOL CHEM, V66, P375; Francois J, 2001, FEMS MICROBIOL REV, V25, P125, DOI 10.1111/j.1574-6976.2001.tb00574.x; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GUAN HP, 1993, PLANT PHYSIOL, V102, P1269, DOI 10.1104/pp.102.4.1269; Hashimoto Y, 2001, FEBS LETT, V506, P231, DOI 10.1016/S0014-5793(01)02926-X; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; Hoseki J, 1999, J BIOCHEM-TOKYO, V126, P951, DOI 10.1093/oxfordjournals.jbchem.a022539; IDAKA M, 2003, CRYSTAL STRUCTURE TT, DOI DOI 10.2210/PDB1UFA/PDB; Imamura H, 2003, J BIOL CHEM, V278, P19378, DOI 10.1074/jbc.M213134200; Imamura H, 2001, BIOCHEMISTRY-US, V40, P12400, DOI 10.1021/bi011017c; JANECEK S, 2010, GLYCOSIDE HYDROLASE, V57; Kajiura H, 2008, BIOCATAL BIOTRANSFOR, V26, P133, DOI 10.1080/10242420701789411; Kelly RM, 2009, APPL MICROBIOL BIOT, V84, P119, DOI 10.1007/s00253-009-1988-6; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Murakami T, 2006, J BACTERIOL, V188, P5915, DOI 10.1128/JB.00390-06; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Palomo M, 2009, APPL ENVIRON MICROB, V75, P1355, DOI 10.1128/AEM.02141-08; PREISS J, 1984, ANNU REV MICROBIOL, V38, P419, DOI 10.1146/annurev.mi.38.100184.002223; Sambrook J., 2002, MOL CLONING LAB MANU; Stam MR, 2006, PROTEIN ENG DES SEL, V19, P555, DOI 10.1093/protein/gzl044; TAKEDA Y, 1993, CARBOHYD RES, V240, P253, DOI 10.1016/0008-6215(93)84188-C; Tang SY, 2006, BBA-PROTEINS PROTEOM, V1764, P1633, DOI 10.1016/j.bbapap.2006.08.013; Ugalde JE, 2003, P NATL ACAD SCI USA, V100, P10659, DOI 10.1073/pnas.1534787100; Uitdehaag JCM, 2001, PROTEINS, V43, P327, DOI 10.1002/prot.1044; VAGIN AA, 1997, J APPL CRYSTALLOGR, P1022; van der Vlist J, 2008, MACROMOL RAPID COMM, V29, P1293, DOI 10.1002/marc.200800248; VANDERMAAREL MJE, 2010, Patent No. 2010030185; Yokoyama S, 2000, NAT STRUCT BIOL, V7, P943, DOI 10.1038/80712; Zona R, 2004, EUR J BIOCHEM, V271, P2863, DOI 10.1111/j.1432-1033.2004.04144.x	37	70	75	3	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3520	3530		10.1074/jbc.M110.179515	http://dx.doi.org/10.1074/jbc.M110.179515			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21097495	Green Published, hybrid			2022-12-25	WOS:000286653200037
J	Swiecki, M; Scheaffer, SM; Allaire, M; Fremont, DH; Colonna, M; Brett, TJ				Swiecki, Melissa; Scheaffer, Suzanne M.; Allaire, Marc; Fremont, Daved H.; Colonna, Marco; Brett, Tom J.			Structural and Biophysical Analysis of BST-2/Tetherin Ectodomains Reveals an Evolutionary Conserved Design to Inhibit Virus Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAY SOLUTION SCATTERING; COILED-COIL; MOLECULAR-GRAPHICS; HIV-1 RELEASE; CELL-SURFACE; PROTEIN; DOMAIN; VPU; RESTRICTION; GLYCOPROTEIN	BST-2/tetherin is a host antiviral molecule that functions to potently inhibit the release of enveloped viruses from infected cells. In return, viruses have evolved antagonists to this activity. BST-2 traps budding virions by using two separate membrane-anchoring regions that simultaneously incorporate into the host and viral membranes. Here, we detailed the structural and biophysical properties of the full-length BST-2 ectodomain, which spans the two membrane anchors. The 1.6-angstrom crystal structure of the complete mouse BST-2 ectodomain reveals an similar to 145-angstrom parallel dimer in an extended alpha-helix conformation that predominantly forms a coiled coil bridged by three intermolecular disulfides that are required for stability. Sequence analysis in the context of the structure revealed an evolutionarily conserved design that destabilizes the coiled coil, resulting in a labile superstructure, as evidenced by solution x-ray scattering displaying bent conformations spanning 150 and 180 angstrom for the mouse and human BST-2 ectodomains, respectively. Additionally, crystal packing analysis revealed possible curvature-sensing tetrameric structures that may aid in proper placement of BST-2 during the genesis of viral progeny. Overall, this extended coiled-coil structure with inherent plasticity is undoubtedly necessary to accommodate the dynamics of viral budding while ensuring separation of the anchors.	[Scheaffer, Suzanne M.; Brett, Tom J.] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Swiecki, Melissa; Fremont, Daved H.; Colonna, Marco] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Fremont, Daved H.; Brett, Tom J.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Brett, Tom J.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Allaire, Marc] Brookhaven Natl Lab, Upton, NY 11973 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); United States Department of Energy (DOE); Brookhaven National Laboratory	Brett, TJ (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Campus Box 8052,660 S Euclid, St Louis, MO 63110 USA.	tbrett@wustl.edu	Brett, Thomas/AAC-9147-2019	Brett, Thomas/0000-0002-6871-6676; Fremont, Daved/0000-0002-8544-2689; Colonna, Marco/0000-0001-5222-4987				Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Andrew AJ, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-80; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Blankenfeldt W, 2006, P NATL ACAD SCI USA, V103, P17713, DOI 10.1073/pnas.0606741103; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Brown JH, 2001, P NATL ACAD SCI USA, V98, P8496, DOI 10.1073/pnas.131219198; Burkhard P, 2000, STRUCTURE, V8, P223, DOI 10.1016/S0969-2126(00)00100-3; Cao W, 2009, J EXP MED, V206, P1603, DOI 10.1084/jem.20090547; Douglas JL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000913; Dube M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000856; Eisenhaber B, 2001, PROTEIN ENG, V14, P17, DOI 10.1093/protein/14.1.17; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans DT, 2010, TRENDS MICROBIOL, V18, P388, DOI 10.1016/j.tim.2010.06.010; Fitzpatrick K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000701; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; GOFFINET C, 2010, J VIROL IN PRESS; Goffinet C, 2009, CELL HOST MICROBE, V5, P285, DOI 10.1016/j.chom.2009.01.009; Habermann A, 2010, J VIROL, V84, P4646, DOI 10.1128/JVI.02421-09; Hammonds J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000749; Hauser H, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-51; Hinz A, 2010, CELL HOST MICROBE, V7, P314, DOI 10.1016/j.chom.2010.03.005; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; Iwabu Yukie, 2010, Commun Integr Biol, V3, P366; Iwabu Y, 2009, J BIOL CHEM, V284, P35060, DOI 10.1074/jbc.M109.058305; Jia B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000429; Jouvenet N, 2009, J VIROL, V83, P1837, DOI 10.1128/JVI.02211-08; Kaletsky RL, 2009, P NATL ACAD SCI USA, V106, P2886, DOI 10.1073/pnas.0811014106; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Le Tortorec A, 2009, J VIROL, V83, P11966, DOI 10.1128/JVI.01515-09; Li Y, 2003, NATURE, V424, P341, DOI 10.1038/nature01801; Lim ES, 2009, J VIROL, V83, P11673, DOI 10.1128/JVI.00569-09; Lopez LA, 2010, J VIROL, V84, P7243, DOI 10.1128/JVI.02636-09; Mansouri M, 2009, J VIROL, V83, P9672, DOI 10.1128/JVI.00597-09; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNamara C, 2008, SCIENCE, V319, P1405, DOI 10.1126/science.1154470; McNatt MW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000300; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Mitchell RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000450; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Ohtomo T, 1999, BIOCHEM BIOPH RES CO, V258, P583, DOI 10.1006/bbrc.1999.0683; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pardieu C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000843; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; RADOSHITZKY SR, 2010, J VIROL IN PRESS; Rollason R, 2009, J CELL BIOL, V184, P721, DOI 10.1083/jcb.200804154; Rong LW, 2009, J VIROL, V83, P7536, DOI 10.1128/JVI.00620-09; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sakuma T, 2009, J VIROL, V83, P2382, DOI 10.1128/JVI.01607-08; Sauter D, 2010, CELL, V141, P392, DOI 10.1016/j.cell.2010.04.022; Strelkov SV, 2002, J STRUCT BIOL, V137, P54, DOI 10.1006/jsbi.2002.4454; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Walshaw J, 2001, J MOL BIOL, V307, P1427, DOI 10.1006/jmbi.2001.4545; Wolf D, 2008, ANNU REV GENET, V42, P143, DOI 10.1146/annurev.genet.42.110807.091704; Zhu P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000203	58	59	64	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2987	2997		10.1074/jbc.M110.190538	http://dx.doi.org/10.1074/jbc.M110.190538			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21084286	hybrid, Green Published			2022-12-25	WOS:000286464300062
J	Chavaroche, AAE; van den Broek, LAM; Springer, J; Boeriu, C; Eggink, G				Chavaroche, Anais A. E.; van den Broek, Lambertus A. M.; Springer, Jan; Boeriu, Carmen; Eggink, Gerrit			Analysis of the Polymerization Initiation and Activity of Pasteurella multocida Heparosan Synthase PmHS2, an Enzyme with Glycosyltransferase and UDP-sugar Hydrolase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOENZYMATIC SYNTHESIS; HYALURONAN SYNTHASE; IDENTIFICATION; BIOSYNTHESIS; GLYCOSIDASES; TRANSFERASE; MECHANISM; DISTINCT; SULFATE; HEPARIN	Heparosan synthase catalyzes the polymerization of heparosan (-4GlcUA beta 1-4GlcNAc alpha 1-)(n) by transferring alternatively the monosaccharide units from UDP-GlcUA and UDP-GlcNAc to an acceptor molecule. Details on the heparosan chain initiation by Pasteurella multocida heparosan synthase PmHS2 and its influence on the polymerization process have not been reported yet. By site-directed mutagenesis of PmHS2, the single action transferases PmHS2-GlcUA(+) and PmHS2-GlcNAc(+) were obtained. When incubated together in the standard polymerization conditions, the PmHS2-GlcUA(+)/PmHS2-GlcNAc(+) showed comparable polymerization properties as determined for PmHS2. We investigated the first step occurring in heparosan chain initiation by the use of the single action transferases and by studying the PmHS2 polymerization process in the presence of heparosan templates and various UDP-sugar concentrations. We observed that PmHS2 favored the initiation of the heparosan chains when incubated in the presence of an excess of UDP-GlcNAc. It resulted in a higher number of heparosan chains with a lower average molecular weight or in the synthesis of two distinct groups of heparosan chain length, in the absence or in the presence of heparosan templates, respectively. These data suggest that PmHS2 transfers GlcUA from UDP-GlcUA moiety to a UDP-GlcNAc acceptor molecule to initiate the heparosan polymerization; as a consequence, not only the UDP-sugar concentration but also the amount of each UDP-sugar is influencing the PmHS2 polymerization process. In addition, it was shown that PmHS2 hydrolyzes the UDP-sugars, UDP-GlcUA being more degraded than UDP-GlcNAc. However, PmHS2 incubated in the presence of both UDP-sugars favors the synthesis of heparosan polymers over the hydrolysis of UDP-sugars.	[Chavaroche, Anais A. E.; Eggink, Gerrit] Univ Wageningen & Res Ctr, Bioproc Engn Grp, NL-6700 EV Wageningen, Netherlands; [Chavaroche, Anais A. E.; van den Broek, Lambertus A. M.; Springer, Jan; Boeriu, Carmen; Eggink, Gerrit] Univ Wageningen & Res Ctr, NL-6700 AA Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	Eggink, G (corresponding author), Univ Wageningen & Res Ctr, Bioproc Engn Grp, POB 8129, NL-6700 EV Wageningen, Netherlands.	gerrit.eggink@wur.nl	Boeriu, Carmen/L-1173-2016; van den Broek, Lambertus/O-1253-2019; van den Broek, Lambertus/K-4930-2012	Boeriu, Carmen/0000-0003-4903-6621; van den Broek, Lambertus/0000-0002-4374-5753; van den Broek, Lambertus/0000-0002-4374-5753	Netherlands Ministry of Economic Affairs; B-Basic partner organizations through B-Basic, a public-private NWO-ACTS	Netherlands Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); B-Basic partner organizations through B-Basic, a public-private NWO-ACTS	This work was carried out in close collaboration with Merck Sharp & Dohme (Oss, The Netherlands) and supported by the Netherlands Ministry of Economic Affairs and the B-Basic partner organizations through B-Basic, a public-private NWO-ACTS (Advanced Chemical Technologies for Sustainability) program.	Casu B, 2007, PATHOPHYSIOL HAEMO T, V36, P195, DOI 10.1159/000175157; Charnock SJ, 1999, BIOCHEMISTRY-US, V38, P6380, DOI 10.1021/bi990270y; Chavaroche AAE, 2010, APPL MICROBIOL BIOT, V85, P1881, DOI 10.1007/s00253-009-2214-2; Chen M, 2006, BIOCHEMISTRY-US, V45, P12358, DOI 10.1021/bi060844g; Ciesla WP, 1998, J BIOL CHEM, V273, P16021, DOI 10.1074/jbc.273.26.16021; DeAngelis PL, 2004, J BACTERIOL, V186, P8529, DOI 10.1128/JB.186.24.8529-8532.2004; DeAngelis PL, 2002, J BIOL CHEM, V277, P7209, DOI 10.1074/jbc.M112130200; GOSSELIN S, 1994, ANAL BIOCHEM, V220, P92, DOI 10.1006/abio.1994.1303; Griffiths G, 1998, J BIOL CHEM, V273, P11752, DOI 10.1074/jbc.273.19.11752; Hancock SM, 2006, CURR OPIN CHEM BIOL, V10, P509, DOI 10.1016/j.cbpa.2006.07.015; Hodson N, 2000, J BIOL CHEM, V275, P27311; Jing W, 2000, GLYCOBIOLOGY, V10, P883, DOI 10.1093/glycob/10.9.883; Jing W, 2004, J BIOL CHEM, V279, P42345, DOI 10.1074/jbc.M402744200; Jing W, 2003, GLYCOBIOLOGY, V13, P661, DOI 10.1093/glycob/cwg085; Kane TA, 2006, J BIOL CHEM, V281, P33192, DOI 10.1074/jbc.M606897200; Krupa JC, 2007, ANAL BIOCHEM, V361, P218, DOI 10.1016/j.ab.2006.11.011; Lazo-Langner A, 2007, J THROMB HAEMOST, V5, P729, DOI 10.1111/j.1538-7836.2007.02427.x; Orellana A, 1999, ANAL BIOCHEM, V272, P224, DOI 10.1006/abio.1999.4159; Pedersen LC, 2000, J BIOL CHEM, V275, P34580, DOI 10.1074/jbc.M007399200; Perugino G, 2004, TRENDS BIOTECHNOL, V22, P31, DOI 10.1016/j.tibtech.2003.10.008; Rabenstein DL, 2002, NAT PROD REP, V19, P312, DOI 10.1039/b100916h; Shaikh FA, 2008, BIOCHEM CELL BIOL, V86, P169, DOI 10.1139/O07-149; Sismey-Ragatz AE, 2007, J BIOL CHEM, V282, P28321, DOI 10.1074/jbc.M701599200; Sugiura N, 2007, ANAL BIOCHEM, V365, P62, DOI 10.1016/j.ab.2007.02.023; Tlapak-Simmons VL, 2005, J BIOL CHEM, V280, P13012, DOI 10.1074/jbc.M409788200; Vetting MW, 2008, J BIOL CHEM, V283, P15834, DOI 10.1074/jbc.M801017200; Williams KJ, 2006, J BIOL CHEM, V281, P5391, DOI 10.1074/jbc.M510439200; Zhang CS, 2006, SCIENCE, V313, P1291, DOI 10.1126/science.1130028; Zhang YN, 2001, J BIOL CHEM, V276, P11567, DOI 10.1074/jbc.M006530200	29	17	20	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1777	1785		10.1074/jbc.M110.136754	http://dx.doi.org/10.1074/jbc.M110.136754			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21084307	hybrid, Green Published			2022-12-25	WOS:000286191500017
J	Leinenweber, A; Machtens, JP; Begemann, B; Fahlke, C				Leinenweber, Ariane; Machtens, Jan-Philipp; Begemann, Birgit; Fahlke, Christoph			Regulation of Glial Glutamate Transporters by C-terminal Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID TRANSPORTER; AMYOTROPHIC-LATERAL-SCLEROSIS; CHLORIDE CHANNEL; MOLECULAR-MECHANISM; MULTIPLE-SCLEROSIS; ANION CONDUCTANCE; ION FLUXES; EAAC1; SUBSTRATE; KINETICS	Excitatory amino acid transporter 2 (EAAT2) is a high affinity glutamate transporter predominantly expressed in astroglia. Human EAAT2 encompasses eight transmembrane domains and a 74-amino acid C-terminal domain that resides in the cytoplasm. We examined the role of this region by studying various C-terminal truncations and mutations using heterologous expression in mammalian cells, whole-cell patch clamp recording and confocal imaging. Removal of the complete C terminus (K498X EAAT2) results in loss of function because of intracellular retention of truncated proteins in the cytoplasm. However, a short stretch of amino acids (E500X EAAT2) within the C terminus results in correctly processed transporters. E500X reduced glutamate transport currents by 90%. Moreover, the voltage and substrate dependence of E500X EAAT2 anion currents was significantly altered. WT and mutant EAAT2 anion channels are modified by external Na+ in the presence as well as in the absence of L-glutamate. Whereas Na+ stimulates EAAT2 anion currents in the presence of L-glutamate, increased [Na+] reduces such currents without glutamate. In cells internally dialyzed with Na+, WT, and truncated EAAT2 display comparable Na+ dependence. With K+ as main internal cation, E500X drastically increased the apparent dissociation constant for external Na+. The effects of E500X can be represented by a kinetic model that allows translocation of the empty transporter from the outward-to the inward-facing conformation and stabilization of the inward-facing conformation by internal K+. Our results demonstrate that the C terminus modifies the glutamate uptake cycle, possibly affecting the movements of the translocation domain of EAAT2 glutamate transporter.	Hannover Med Sch, Inst Neurophysiol, D-30625 Hannover, Germany; [Leinenweber, Ariane; Fahlke, Christoph] Zentrum Syst Neurowissensch Hannover ZSN, D-30559 Hannover, Germany	Hannover Medical School		fahlke.christoph@mh-hannover.de	Machtens, Jan-Philipp/M-8659-2013; Fahlke, Christoph/G-3635-2013	Machtens, Jan-Philipp/0000-0003-1673-8571; Fahlke, Christoph/0000-0001-8602-9952	Deutsche Forschungsgemeinschaft [FA301/9]; state of Lower Saxony, Germany	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); state of Lower Saxony, Germany	These studies were supported by the Deutsche Forschungsgemeinschaft (FA301/9, to C. F.) and a Georg-Christoph-Lichtenberg fellowship by the state of Lower Saxony, Germany (to A. L.).	Amara SG, 2002, NEUROCHEM INT, V41, P313, DOI 10.1016/S0197-0186(02)00018-9; Bergles DE, 2002, J NEUROSCI, V22, P10153; Boston-Howes W, 2006, J BIOL CHEM, V281, P14076, DOI 10.1074/jbc.M600653200; BOUVIER M, 1992, NATURE, V360, P471, DOI 10.1038/360471a0; BREW H, 1987, NATURE, V327, P707, DOI 10.1038/327707a0; Cheng CL, 2002, J NEUROSCI, V22, P10643; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Garcia-Olivares J, 2008, J PHYSIOL-LONDON, V586, P5325, DOI 10.1113/jphysiol.2008.158097; Gibb SL, 2007, J BIOL CHEM, V282, P32480, DOI 10.1074/jbc.M704314200; Grewer C, 2000, P NATL ACAD SCI USA, V97, P9706, DOI 10.1073/pnas.160170397; Grewer C, 2005, J MEMBRANE BIOL, V203, P1, DOI 10.1007/s00232-004-0731-6; Grewer C, 2003, J BIOL CHEM, V278, P2585, DOI 10.1074/jbc.M207956200; Grewer C, 2008, IUBMB LIFE, V60, P609, DOI 10.1002/iub.98; Hebeisen S, 2004, J BIOL CHEM, V279, P13140, DOI 10.1074/jbc.M312649200; Holley DC, 2009, PHILOS T R SOC B, V364, P155, DOI 10.1098/rstb.2008.0246; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Huang YHH, 2004, J NEUROSCI, V24, P103, DOI 10.1523/JNEUROSCI.4473-03.2004; Janssen AGH, 2009, J AM SOC NEPHROL, V20, P145, DOI 10.1681/ASN.2008010102; Kanai Y, 2004, PFLUG ARCH EUR J PHY, V447, P469, DOI 10.1007/s00424-003-1146-4; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; Kovermann P, 2010, J BIOL CHEM, V285, P23676, DOI 10.1074/jbc.M110.126557; Kreusch A, 1998, NATURE, V392, P945, DOI 10.1038/31978; Laruelle M, 2003, ANN NY ACAD SCI, V1003, P138, DOI 10.1196/annals.1300.063; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; Melzer N, 2003, J BIOL CHEM, V278, P50112, DOI 10.1074/jbc.M307990200; Melzer N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003149; Mim C, 2005, J GEN PHYSIOL, V126, P571, DOI 10.1085/jgp.200509365; Peghini P, 1997, EMBO J, V16, P3822, DOI 10.1093/emboj/16.13.3822; Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; ROTHSTEIN JD, 1992, NEW ENGL J MED, V326, P1464, DOI 10.1056/NEJM199205283262204; Scott HL, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-03-j0004.2002; Shachnai L, 2005, NEUROPHARMACOLOGY, V49, P862, DOI 10.1016/j.neuropharm.2005.07.005; Smith T, 2000, NAT MED, V6, P62, DOI 10.1038/71548; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Tao Z, 2007, J GEN PHYSIOL, V129, P331, DOI 10.1085/jgp.200609678; Torres-Salazar D, 2006, J NEUROSCI, V26, P7513, DOI 10.1523/JNEUROSCI.4545-05.2006; VANDENBERG RJ, 1995, J BIOL CHEM, V270, P17668, DOI 10.1074/jbc.270.30.17668; Wadiche JI, 1998, J NEUROSCI, V18, P7650; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Watase K, 1998, EUR J NEUROSCI, V10, P976, DOI 10.1046/j.1460-9568.1998.00108.x; Watzke N, 2001, FEBS LETT, V503, P121, DOI 10.1016/S0014-5793(01)02715-6; Watzke N, 2001, J GEN PHYSIOL, V117, P547, DOI 10.1085/jgp.117.6.547; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, J BIOL CHEM, V271, P27991, DOI 10.1074/jbc.271.45.27991; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhang YM, 1998, P NATL ACAD SCI USA, V95, P751, DOI 10.1073/pnas.95.2.751; Zhang Z, 2007, P NATL ACAD SCI USA, V104, P18025, DOI 10.1073/pnas.0704570104	50	24	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1927	1937		10.1074/jbc.M110.153486	http://dx.doi.org/10.1074/jbc.M110.153486			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21097502	Green Published, hybrid			2022-12-25	WOS:000286191500034
J	Nakamura, Y; Fujita, Y; Ueno, M; Takai, T; Yamashita, T				Nakamura, Yuka; Fujita, Yuki; Ueno, Masaki; Takai, Toshiyuki; Yamashita, Toshihide			Paired Immunoglobulin-like Receptor B Knockout Does Not Enhance Axonal Regeneration or Locomotor Recovery after Spinal Cord Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL RECOVERY; GENETIC DELETION; ANTAGONIST; MICE; NOGO; INHIBITION; PLASTICITY; GROWTH; PIRB	Myelin components that inhibit axonal regeneration are believed to contribute significantly to the lack of axonal regeneration noted in the adult central nervous system. Three proteins found in myelin, Nogo, myelin-associated glycoprotein, and oligodendrocyte-myelin glycoprotein, inhibit neurite outgrowth in vitro. All of these proteins interact with the same receptors, namely, the Nogo receptor (NgR) and paired immunoglobulin-like receptor B (PIR-B). As per previous reports, corticospinal tract (CST) regeneration is not enhanced in NgR-knock-out mice after spinal cord injury. Therefore, we assessed CST regeneration in PIR-B-knock-out mice. We found that hindlimb motor function, as assessed using the Basso mouse scale, footprint test, inclined plane test, and beam walking test, did not differ between the PIR-B-knock-out and wildtype mice after dorsal hemisection of the spinal cord. Further, tracing of the CST fibers after injury did not reveal enhanced axonal regeneration or sprouting in the CST of the PIR-B-knock-out mice. Systemic administration of NEP1-40, a NgR antagonist, to PIR-B knock-out mice did not enhance the regenerative response. These results indicate that PIR-B knockout is not sufficient to induce extensive axonal regeneration after spinal cord injury.	[Nakamura, Yuka; Fujita, Yuki; Ueno, Masaki; Yamashita, Toshihide] Osaka Univ, Dept Mol Neurosci, Grad Sch Med, Suita, Osaka 5650871, Japan; [Nakamura, Yuka; Fujita, Yuki; Ueno, Masaki; Yamashita, Toshihide] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo 1020075, Japan; [Takai, Toshiyuki] Tohoku Univ, Dept Expt Immunol, Sendai, Miyagi 9808575, Japan; [Takai, Toshiyuki] Tohoku Univ, Inst Dev Aging & Canc, CREST, JST, Sendai, Miyagi 9808575, Japan	Osaka University; Japan Science & Technology Agency (JST); Tohoku University; Japan Science & Technology Agency (JST); Tohoku University	Yamashita, T (corresponding author), Osaka Univ, Dept Mol Neurosci, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	yamashita@molneu.med.osaka-u.ac.jp	Ueno, Masaki/J-1216-2019	Ueno, Masaki/0000-0003-1484-9921; Yamashita, Toshihide/0000-0003-4559-7018	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant-in-aid for young scientists from the Japan Society for the Promotion of Science.	Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Hu FH, 2008, J NEUROSCI, V28, P1262, DOI 10.1523/JNEUROSCI.1068-07.2008; Kim JE, 2004, NEURON, V44, P439, DOI 10.1016/j.neuron.2004.10.015; Li SX, 2003, J NEUROSCI, V23, P4219; Madura T, 2004, EMBO REP, V5, P412, DOI 10.1038/sj.embor.7400117; Omoto S, 2010, J NEUROSCI, V30, P13045, DOI 10.1523/JNEUROSCI.3228-10.2010; Schnaar RL, 2009, J NEUROSCI RES, V87, P3267, DOI 10.1002/jnr.21992; Silver J, 2010, NEURON, V66, P619, DOI 10.1016/j.neuron.2010.05.028; Steward O, 2008, J NEUROSCI, V28, P6836, DOI 10.1523/JNEUROSCI.5372-07.2008; Steward O, 2008, EXP NEUROL, V209, P446, DOI 10.1016/j.expneurol.2007.12.010; Syken J, 2006, SCIENCE, V313, P1795, DOI 10.1126/science.1128232; Takai T, 2005, IMMUNOLOGY, V115, P433, DOI 10.1111/j.1365-2567.2005.02177.x; Ujike A, 2002, NAT IMMUNOL, V3, P542, DOI 10.1038/ni801; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Zheng BH, 2005, P NATL ACAD SCI USA, V102, P1205, DOI 10.1073/pnas.0409026102	16	55	60	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1876	1883		10.1074/jbc.M110.163493	http://dx.doi.org/10.1074/jbc.M110.163493			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21087927	Green Published, hybrid			2022-12-25	WOS:000286191500028
J	Alves, G; Ogurtsov, AY; Yu, YK				Alves, Gelio; Ogurtsov, Aleksey Y.; Yu, Yi-Kuo			RAId_aPS: MS/MS Analysis with Multiple Scoring Functions and Spectrum-Specific Statistics	PLOS ONE			English	Article							PEPTIDE IDENTIFICATION; PROTEIN IDENTIFICATIONS; IMPROVING SENSITIVITY; SEARCH; TANDEM; CONFIDENCE; ACCURACY; DESIGN	Statistically meaningful comparison/combination of peptide identification results from various search methods is impeded by the lack of a universal statistical standard. Providing an E-value calibration protocol, we demonstrated earlier the feasibility of translating either the score or heuristic E-value reported by any method into the textbook-defined E-value, which may serve as the universal statistical standard. This protocol, although robust, may lose spectrum-specific statistics and might require a new calibration when changes in experimental setup occur. To mitigate these issues, we developed a new MS/MS search tool, RAId_aPS, that is able to provide spectrum-specific E-values for additive scoring functions. Given a selection of scoring functions out of RAId score, K-score, Hyperscore and XCorr, RAId_aPS generates the corresponding score histograms of all possible peptides using dynamic programming. Using these score histograms to assign E-values enables a calibration-free protocol for accurate significance assignment for each scoring function. RAId_aPS features four different modes: (i) compute the total number of possible peptides for a given molecular mass range, (ii) generate the score histogram given a MS/MS spectrum and a scoring function, (iii) reassign E-values for a list of candidate peptides given a MS/MS spectrum and the scoring functions chosen, and (iv) perform database searches using selected scoring functions. In modes (iii) and (iv), RAId_aPS is also capable of combining results from different scoring functions using spectrum-specific statistics. The web link is http://www.ncbi.nlm.nih.gov/ CBBresearch/Yu/raid_aps/index.html. Relevant binaries for Linux, Windows, and Mac OS X are available from the same page.	[Alves, Gelio; Ogurtsov, Aleksey Y.; Yu, Yi-Kuo] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Alves, G (corresponding author), NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA.	yyu@ncbi.nlm.nih.gov			National Library of Medicine of the National Institutes of Health/DHHS; NATIONAL LIBRARY OF MEDICINE [ZIALM092404] Funding Source: NIH RePORTER	National Library of Medicine of the National Institutes of Health/DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the Intramural Research Program of the National Library of Medicine of the National Institutes of Health/DHHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves G, 2005, BIOINFORMATICS, V21, P3726, DOI 10.1093/bioinformatics/bti620; ALVES G, 2007, BIOL DIRECT, V2; Alves G, 2008, PHYSICA A, V387, P6538, DOI 10.1016/j.physa.2008.08.024; Alves G, 2008, J PROTEOME RES, V7, P3102, DOI 10.1021/pr700798h; Alves G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-505; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Doerr TP, 2005, PHYSICA A, V354, P558, DOI 10.1016/j.physa.2005.03.004; Edwards N., 2009, CLIN PROTEOM, V5, P23; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Eng JK, 2008, J PROTEOME RES, V7, P4598, DOI 10.1021/pr800420s; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fenyo D, 2003, ANAL CHEM, V75, P768, DOI 10.1021/ac0258709; Jones AR, 2009, PROTEOMICS, V9, P1220, DOI 10.1002/pmic.200800473; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Keller A, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100024; Keller Andrew, 2002, OMICS A Journal of Integrative Biology, V6, P207, DOI 10.1089/153623102760092805; Kim S, 2008, J PROTEOME RES, V7, P3354, DOI 10.1021/pr8001244; Klammer AA, 2009, J PROTEOME RES, V8, P2106, DOI 10.1021/pr8011107; MacLean B, 2006, BIOINFORMATICS, V22, P2830, DOI 10.1093/bioinformatics/btl379; McIntosh M, 2008, J PROTEOME RES, V7, P18, DOI 10.1021/pr083686j; Oberg AL, 2009, J PROTEOME RES, V8, P2144, DOI 10.1021/pr8010099; Park CY, 2008, J PROTEOME RES, V7, P3022, DOI 10.1021/pr800127y; Prakash A, 2007, MOL CELL PROTEOMICS, V6, P1741, DOI 10.1074/mcp.M600470-MCP200; Press W. H., 1999, NUMERICAL RECIPES C; ROBINSON AB, 1991, P NATL ACAD SCI USA, V88, P8880, DOI 10.1073/pnas.88.20.8880; Searle BC, 2008, J PROTEOME RES, V7, P245, DOI 10.1021/pr070540w; Taylor CF, 2007, NAT BIOTECHNOL, V25, P887, DOI 10.1038/nbt1329; Yu YK, 2006, NUCLEIC ACIDS RES, V34, P5966, DOI 10.1093/nar/gkl731; Zhang N, 2002, PROTEOMICS, V2, P1406, DOI 10.1002/1615-9861(200210)2:10<1406::AID-PROT1406>3.0.CO;2-9	30	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e15438	10.1371/journal.pone.0015438	http://dx.doi.org/10.1371/journal.pone.0015438			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103371	Green Published, gold, Green Submitted			2022-12-25	WOS:000284257400022
J	De Chiara, G; Marcocci, ME; Civitelli, L; Argnani, R; Piacentini, R; Ripoli, C; Manservigi, R; Grassi, C; Garaci, E; Palamara, AT				De Chiara, Giovanna; Marcocci, Maria Elena; Civitelli, Livia; Argnani, Rafaela; Piacentini, Roberto; Ripoli, Cristian; Manservigi, Roberto; Grassi, Claudio; Garaci, Enrico; Palamara, Anna Teresa			APP Processing Induced by Herpes Simplex Virus Type 1 (HSV-1) Yields Several APP Fragments in Human and Rat Neuronal Cells	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; INTRACELLULAR DOMAIN AICD; ALZHEIMERS-DISEASE; BETA-SECRETASE; OXIDATIVE STRESS; NERVOUS-SYSTEM; UP-REGULATION; CYTOSKELETAL DYNAMICS; ANTEROGRADE TRANSPORT; VIRAL-INFECTIONS	Lifelong latent infections of the trigeminal ganglion by the neurotropic herpes simplex virus type 1 (HSV-1) are characterized by periodic reactivation. During these episodes, newly produced virions may also reach the central nervous system (CNS), causing productive but generally asymptomatic infections. Epidemiological and experimental findings suggest that HSV-1 might contribute to the pathogenesis of Alzheimer's disease (AD). This multifactorial neurodegenerative disorder is related to an overproduction of amyloid beta (A beta) and other neurotoxic peptides, which occurs during amyloidogenic endoproteolytic processing of the transmembrane amyloid precursor protein (APP). The aim of our study was to identify the effects of productive HSV-1 infection on APP processing in neuronal cells. We found that infection of SH-SY5Y human neuroblastoma cells and rat cortical neurons is followed by multiple cleavages of APP, which result in the intra-and/or extra-cellular accumulation of various neurotoxic species. These include: i) APP fragments (APP-Fs) of 35 and 45 kDa (APP-F35 and APP-F45) that comprise portions of Ab; ii) N-terminal APP-Fs that are secreted; iii) intracellular C-terminal APP-Fs; and iv) A beta(1-40) and A beta(1-42). Western blot analysis of infected-cell lysates treated with formic acid suggests that APP-F35 may be an Ab oligomer. The multiple cleavages of APP that occur in infected cells are produced in part by known components of the amyloidogenic APP processing pathway, i.e., host-cell beta-secretase, gamma-secretase, and caspase-3-like enzymes. These findings demonstrate that HSV-1 infection of neuronal cells can generate multiple APP fragments with well-documented neurotoxic potentials. It is tempting to speculate that intra-and extracellular accumulation of these species in the CNS resulting from repeated HSV-1 reactivation could, in the presence of other risk factors, play a co-factorial role in the development of AD.	[De Chiara, Giovanna] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy; [Palamara, Anna Teresa] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Inst Pasteur, Cenci Bolognetti Fdn, Rome, Italy; [Argnani, Rafaela; Manservigi, Roberto] Univ Ferrara, Dept Expt Med & Diagnost, I-44100 Ferrara, Italy; [Piacentini, Roberto; Ripoli, Cristian; Grassi, Claudio] Catholic Univ, Sch Med, Inst Human Physiol, Rome, Italy; [Garaci, Enrico] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00173 Rome, Italy; [Palamara, Anna Teresa] San Raffaele Pisana Sci Inst Res Hospitalizat & H, Rome, Italy	Istituto Superiore di Sanita (ISS); Fondazione Cenci Bolognetti; Sapienza University Rome; University of Ferrara; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Rome Tor Vergata; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	De Chiara, G (corresponding author), Ist Super Sanita, Dept Cell Biol & Neurosci, Viale Regina Elena 299, I-00161 Rome, Italy.	annateresa.palamara@uniroma1.it	Piacentini, Roberto/K-7526-2016; GARACI, ENRICO/AAB-3349-2021; Ripoli, Cristian/K-8954-2016; Elena, Marcocci Maria/I-9550-2014; De Chiara, Giovanna/AAJ-7843-2021; Grassi, Claudio/C-3188-2017	Piacentini, Roberto/0000-0003-4215-1643; Elena, Marcocci Maria/0000-0003-4751-4263; De Chiara, Giovanna/0000-0002-2219-6097; Grassi, Claudio/0000-0001-7253-1685; Civitelli, Livia/0000-0003-2399-1436; PALAMARA, ANNA TERESA/0000-0001-8330-4381; RIPOLI, Cristian/0000-0002-5315-0163; MANSERVIGI, Roberto/0000-0002-2827-229X	Italian Ministry of Education University and Research; Italian Ministry of Health-Ricerca Finalizzata	Italian Ministry of Education University and Research(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Health-Ricerca Finalizzata(Ministry of Health, Italy)	This work was supported by grants from the Italian Ministry of Education University and Research (PRIN2007 and FIRB2006), and the Italian Ministry of Health-Ricerca Finalizzata 2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALL MJ, 1982, CAN J NEUROL SCI, V9, P303, DOI 10.1017/S0317167100044115; Bearer EL, 2004, AGING CELL, V3, P81, DOI 10.1111/j.1474-9728.2004.00089.x; Chang KA, 2005, J PHARMACOL SCI, V97, P461, DOI 10.1254/jphs.CR0050014; Chyung ASC, 1997, J CELL BIOL, V138, P671, DOI 10.1083/jcb.138.3.671; Cook DG, 1997, NAT MED, V3, P1021, DOI 10.1038/nm0997-1021; Cribbs DH, 2000, BIOCHEMISTRY-US, V39, P5988, DOI 10.1021/bi000029f; DEATLY AM, 1990, NEUROPATH APPL NEURO, V16, P213, DOI 10.1111/j.1365-2990.1990.tb01158.x; Dobson CB, 1999, NEUROBIOL AGING, V20, P457, DOI 10.1016/S0197-4580(99)00055-X; Fan YW, 2002, J NEUROSCI METH, V120, P17, DOI 10.1016/S0165-0270(02)00181-4; Fujii S, 1999, VIROLOGY, V256, P203, DOI 10.1006/viro.1999.9610; Gianni D, 2003, J BIOL CHEM, V278, P9290, DOI 10.1074/jbc.M211899200; Goodger ZV, 2009, J CELL SCI, V122, P3703, DOI 10.1242/jcs.048090; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; He B, 1998, J BIOL CHEM, V273, P20737, DOI 10.1074/jbc.273.33.20737; Hill JM, 2005, MED HYPOTHESES, V64, P320, DOI 10.1016/j.mehy.2003.11.045; Itabashi S, 1997, LANCET, V349, P1102, DOI 10.1016/S0140-6736(05)62325-2; Itzhaki Ruth, 2004, Herpes, V11 Suppl 2, p77A; JAMIESON GA, 1991, J MED VIROL, V33, P224, DOI 10.1002/jmv.1890330403; JAMIESON GA, 1991, BIOCHEM SOC T, V19, pS122, DOI 10.1042/bst019122s; KASTRUKOFF L, 1982, J NEUROIMMUNOL, V2, P295, DOI 10.1016/0165-5728(82)90062-5; Kavouras JH, 2007, J NEUROVIROL, V13, P416, DOI 10.1080/13550280701460573; Killington RA, 1991, VIROLOGY PRATICAL AP, P212; KOO EH, 1994, J BIOL CHEM, V269, P17386; KWONG AD, 1989, J VIROL, V63, P4834, DOI 10.1128/JVI.63.11.4834-4839.1989; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Letenneur L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003637; Lewandowski G, 2002, ARCH VIROL, V147, P167, DOI 10.1007/s705-002-8309-9; Lu DC, 2000, NAT MED, V6, P397, DOI 10.1038/74656; Matis J, 2001, ACTA VIROL, V45, P269; Mori I, 2004, J MED VIROL, V73, P605, DOI 10.1002/jmv.20133; Muller T, 2008, PROG NEUROBIOL, V85, P393, DOI 10.1016/j.pneurobio.2008.05.002; Muller T, 2007, MOL BIOL CELL, V18, P201, DOI 10.1091/mbc.E06-04-0283; Ohyagi Y, 2005, FASEB J, V19, P255, DOI 10.1096/fj.04-2637fje; PALAMARA AT, 1995, ANTIVIR RES, V27, P237, DOI 10.1016/0166-3542(95)00008-A; Park SA, 2009, BIOCHEM BIOPH RES CO, V388, P450, DOI 10.1016/j.bbrc.2009.08.042; Piacentini R, 2008, J CELL PHYSIOL, V215, P129, DOI 10.1002/jcp.21293; Piacentini R, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.06.009; Roizman B, 2001, FIELDS VIROLOGY, P2432; Satpute-Krishnan P, 2003, AGING CELL, V2, P305, DOI 10.1046/j.1474-9728.2003.00069.x; Satpute-Krishnan P, 2006, P NATL ACAD SCI USA, V103, P16532, DOI 10.1073/pnas.0607527103; Schmutzhard E, 2001, J NEUROL, V248, P469, DOI 10.1007/s004150170155; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shipley SJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-48; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Skovronsky DM, 1998, J CELL BIOL, V141, P1031, DOI 10.1083/jcb.141.4.1031; Tamagno E, 2005, J NEUROCHEM, V92, P628, DOI 10.1111/j.1471-4159.2004.02895.x; Tamagno E, 2002, NEUROBIOL DIS, V10, P279, DOI 10.1006/nbdi.2002.0515; Tamagno E, 2008, J NEUROCHEM, V104, P683, DOI 10.1111/j.1471-4159.2007.05072.x; Valyi-Nagy T, 2005, HISTOL HISTOPATHOL, V20, P957, DOI 10.14670/HH-20.957; Valyi-Nagy T, 2000, VIROLOGY, V278, P309, DOI 10.1006/viro.2000.0678; Vassar R, 2001, J MOL NEUROSCI, V17, P157, DOI 10.1385/JMN:17:2:157; Wozniak MA, 2009, J PATHOL, V217, P131, DOI 10.1002/path.2449; Wozniak MA, 2005, J MED VIROL, V75, P300, DOI 10.1002/jmv.20271; Wozniak MA, 2007, NEUROSCI LETT, V429, P95, DOI 10.1016/j.neulet.2007.09.077; Xu HX, 1997, P NATL ACAD SCI USA, V94, P3748, DOI 10.1073/pnas.94.8.3748	56	103	103	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e13989	10.1371/journal.pone.0013989	http://dx.doi.org/10.1371/journal.pone.0013989			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085580	gold, Green Published, Green Submitted			2022-12-25	WOS:000284231800019
J	Lucarelli, AP; Buroni, S; Pasca, MR; Rizzi, M; Cavagnino, A; Valentini, G; Riccardi, G; Chiarelli, LR				Lucarelli, Anna P.; Buroni, Silvia; Pasca, Maria R.; Rizzi, Menico; Cavagnino, Andrea; Valentini, Giovanna; Riccardi, Giovanna; Chiarelli, Laurent R.			+Mycobacterium tuberculosis Phosphoribosylpyrophosphate Synthetase: Biochemical Features of a Crucial Enzyme for Mycobacterial Cell Wall Biosynthesis	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; ESCHERICHIA-COLI; DIPHOSPHATE SYNTHASE; BACILLUS-SUBTILIS; PURIFICATION; BINDING; MECHANISM; CATALYSIS; ARABINAN; RIBOSE	The selection and soaring spread of Mycobacterium tuberculosis multidrug-resistant (MDR-TB) and extensively drug-resistant strains (XDR-TB) is a severe public health problem. Currently, there is an urgent need for new drugs for tuberculosis treatment, with novel mechanisms of action and, moreover, the necessity to identify new drug targets. Mycobacterial phosphoribosylpyrophosphate synthetase (MtbPRPPase) is a crucial enzyme involved in the biosynthesis of decaprenylphosphoryl-arabinose, an essential precursor for the mycobacterial cell wall biosynthesis. Moreover, phosphoribosylpyrophosphate, which is the product of the PRPPase catalyzed reaction, is the precursor for the biosynthesis of nucleotides and of some amino acids such as histidine and tryptophan. In this context, the elucidation of the molecular and functional features of MtbPRPPase is mandatory. MtbPRPPase was obtained as a recombinant form, purified to homogeneity and characterized. According to its hexameric form, substrate specificity and requirement of phosphate for activity, the enzyme proved to belong to the class I of PRPPases. Although the sulfate mimicked the phosphate, it was less effective and required higher concentrations for the enzyme activation. MtbPRPPase showed hyperbolic response to ribose 5-phosphate, but sigmoidal behaviour towards Mg-ATP. The enzyme resulted to be allosterically activated by Mg(2+) or Mn(2+) and inhibited by Ca(2+) and Cu(2+) but, differently from other characterized PRPPases, it showed a better affinity for the Mn(2+) and Cu(2+) ions, indicating a different cation binding site geometry. Moreover, the enzyme from M. tuberculosis was allosterically inhibited by ADP, but less sensitive to inhibition by GDP. The characterization of M. tuberculosis PRPPase provides the starting point for the development of inhibitors for antitubercular drug design.	[Lucarelli, Anna P.; Buroni, Silvia; Pasca, Maria R.; Riccardi, Giovanna] Univ Pavia, Dipartimento Genet & Microbiol, I-27100 Pavia, Italy; [Valentini, Giovanna; Chiarelli, Laurent R.] Univ Pavia, Dipartimento Biochim A Castellani, I-27100 Pavia, Italy; [Rizzi, Menico; Cavagnino, Andrea] Univ Piemonte Orientale, DISCAFF, Novara, Italy	University of Pavia; University of Pavia; University of Eastern Piedmont Amedeo Avogadro	Lucarelli, AP (corresponding author), Univ Pavia, Dipartimento Genet & Microbiol, Via Palestro 3, I-27100 Pavia, Italy.	laurent.chiarelli@unipv.it	Chiarelli, Laurent Roberto/J-8368-2016; Pasca, Maria Rosalia/J-8752-2016; Buroni, Silvia/AAX-5454-2020; riccardi, gabriele/A-9269-2012	Chiarelli, Laurent Roberto/0000-0003-0348-9764; Pasca, Maria Rosalia/0000-0002-8906-4937; RICCARDI, Giovanna/0000-0003-3295-0070; Buroni, Silvia/0000-0002-6979-2275	EC [LSHP-CT-2005-018923]	EC(European CommissionEuropean Commission Joint Research Centre)	This work was supported by EC-VI Framework, Contract no. LSHP-CT-2005-018923. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNVIG K, 1990, EUR J BIOCHEM, V192, P195, DOI 10.1111/j.1432-1033.1990.tb19214.x; Barry Clifton E., 2007, Infectious Disorders - Drug Targets, V7, P182; Blasi P, 2009, EXPERT OPIN DRUG DEL, V6, P977, DOI 10.1517/17425240903130577; Cho Y, 2008, J MED CHEM, V51, P5984, DOI 10.1021/jm800328v; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Eriksen TA, 2002, PROTEIN SCI, V11, P271, DOI 10.1110/ps.28502; Eriksen TA, 2000, NAT STRUCT BIOL, V7, P303; FOX IH, 1971, J BIOL CHEM, V246, P5739; GIBSON KJ, 1982, J BIOL CHEM, V257, P2391; HOVEJENSEN B, 1986, J BIOL CHEM, V261, P6765; HOVEJENSEN B, 1988, J BACTERIOL, V170, P1148, DOI 10.1128/jb.170.3.1148-1152.1988; ISHIJIMA S, 1991, J BIOL CHEM, V266, P15693; Jain A, 2008, FEMS IMMUNOL MED MIC, V53, P145, DOI 10.1111/j.1574-695X.2008.00400.x; Kadziola A, 2005, J MOL BIOL, V354, P815, DOI 10.1016/j.jmb.2005.10.001; Krath BN, 1999, BBA-PROTEIN STRUCT M, V1430, P403, DOI 10.1016/S0167-4838(99)00022-9; Krath BN, 2001, J BIOL CHEM, V276, P17851, DOI 10.1074/jbc.M010172200; Krath BN, 2001, PROTEIN SCI, V10, P2317, DOI 10.1110/ps.11801; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li S, 2007, BIOCHEM J, V401, P39, DOI 10.1042/BJ20061066; Loughran ST, 2006, ANAL BIOCHEM, V355, P148, DOI 10.1016/j.ab.2006.05.011; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Makarov V, 2009, SCIENCE, V324, P801, DOI 10.1126/science.1171583; Manina G, 2010, CURR MED CHEM, V17, P3099, DOI 10.2174/092986710791959693; Mikusova K, 2005, J BACTERIOL, V187, P8020, DOI 10.1128/JB.187.23.8020-8025.2005; MILLER GA, 1975, ARCH BIOCHEM BIOPHYS, V171, P732, DOI 10.1016/0003-9861(75)90086-7; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Nathanson E, 2006, EMERG INFECT DIS, V12, P1389, DOI 10.3201/eid1209.051618; NOSAL JM, 1993, J BIOL CHEM, V268, P10168; Palomino JC, 2009, CURR MED CHEM, V16, P1898, DOI 10.2174/092986709788186066; Pan F, 2001, J BACTERIOL, V183, P3991, DOI 10.1128/JB.183.13.3991-3998.2001; ROTH DG, 1974, J BIOL CHEM, V249, P297; Russell DG, 2010, SCIENCE, V328, P852, DOI 10.1126/science.1184784; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Sharma SK, 2006, CHEST, V130, P261, DOI [10.1378/chest.130.1.261, 10.1016/S0012-3692(15)50981-1]; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; SWITZER RL, 1973, J BIOL CHEM, V248, P1063; Willemoes M, 1997, BIOCHEMISTRY-US, V36, P5078, DOI 10.1021/bi962610a; Wolucka BA, 2008, FEBS J, V275, P2691, DOI 10.1111/j.1742-4658.2008.06395.x; World Health Organization, 2008, GLOB TUB CONTR SURV	40	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e15494	10.1371/journal.pone.0015494	http://dx.doi.org/10.1371/journal.pone.0015494			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085589	gold, Green Published, Green Submitted			2022-12-25	WOS:000284231800038
J	Schaefer, U; Kodzius, R; Kai, C; Kawai, J; Carninci, P; Hayashizaki, Y; Bajic, VB				Schaefer, Ulf; Kodzius, Rimantas; Kai, Chikatoshi; Kawai, Jun; Carninci, Piero; Hayashizaki, Yoshihide; Bajic, Vladimir B.			High Sensitivity TSS Prediction: Estimates of Locations Where TSS Cannot Occur	PLOS ONE			English	Article							TRANSCRIPTION START SITES; APPROXIMATE LOCATIONS; GENE-EXPRESSION; IDENTIFICATION; GENOME; RECOGNITION; PROMOTERS; FINDER; ARCHITECTURE	Background: Although transcription in mammalian genomes can initiate from various genomic positions (e. g., 3'UTR, coding exons, etc.), most locations on genomes are not prone to transcription initiation. It is of practical and theoretical interest to be able to estimate such collections of non-TSS locations (NTLs). The identification of large portions of NTLs can contribute to better focusing the search for TSS locations and thus contribute to promoter and gene finding. It can help in the assessment of 59 completeness of expressed sequences, contribute to more successful experimental designs, as well as more accurate gene annotation. Methodology: Using comprehensive collections of Cap Analysis of Gene Expression (CAGE) and other transcript data from mouse and human genomes, we developed a methodology that allows us, by performing computational TSS prediction with very high sensitivity, to annotate, with a high accuracy in a strand specific manner, locations of mammalian genomes that are highly unlikely to harbor transcription start sites (TSSs). The properties of the immediate genomic neighborhood of 98,682 accurately determined mouse and 113,814 human TSSs are used to determine features that distinguish genomic transcription initiation locations from those that are not likely to initiate transcription. In our algorithm we utilize various constraining properties of features identified in the upstream and downstream regions around TSSs, as well as statistical analyses of these surrounding regions. Conclusions: Our analysis of human chromosomes 4, 21 and 22 estimates,46%,,41% and,27% of these chromosomes, respectively, as being NTLs. This suggests that on average more than 40% of the human genome can be expected to be highly unlikely to initiate transcription. Our method represents the first one that utilizes high-sensitivity TSS prediction to identify, with high accuracy, large portions of mammalian genomes as NTLs. The server with our algorithm implemented is available at http://cbrc.kaust.edu.sa/ddm/.	[Schaefer, Ulf; Bajic, Vladimir B.] King Abdullah Univ Sci & Technol, CBRC, Thuwal, Saudi Arabia; [Kodzius, Rimantas] King Abdullah Univ Sci & Technol, Div Phys Sci & Engn, Thuwal, Saudi Arabia; [Kai, Chikatoshi; Kawai, Jun; Hayashizaki, Yoshihide] RIKEN Yokohama Inst, RIKEN Genom Sci Ctr, Genome Explorat Res Grp, Genome Network Project Core Grp, Kanagawa, Japan; [Carninci, Piero] RIKEN Wako Inst, Discovery Res Inst, Genome Sci Lab, Wako, Saitama, Japan	King Abdullah University of Science & Technology; King Abdullah University of Science & Technology; RIKEN; RIKEN	Schaefer, U (corresponding author), King Abdullah Univ Sci & Technol, CBRC, Thuwal, Saudi Arabia.	vladimir.bajic@kaust.edu.sa	Carninci, Piero/K-1568-2014; K, Rimantas/H-4512-2019; Hayashizaki, Yoshihide/N-6590-2015; Kawai, Jun/A-6451-2016; Bajic, Vladimir/D-2810-2009	Carninci, Piero/0000-0001-7202-7243; K, Rimantas/0000-0001-9417-8894; Bajic, Vladimir/0000-0001-5435-4750	Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government; Ministry of Education, Culture, Sports, Science and Technology, Japan; European Union	Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); European Union(European Commission)	This study was supported by the following research grants: a) Research Grant for the RIKEN (RIkagaku KENkyusho, Engl.: Institute of Physical and Chemical Research) Genome Exploration Research Project from the Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government to YH. b) A grant of the Genome Network Project from the Ministry of Education, Culture, Sports, Science and Technology, Japan to YH. c) Grant for the Strategic Programs for R&D of RIKEN to YH. d) Individual fellowship from the European Union (FP5 program INCO2 to Japan) to RK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, DISCRIMINANT ANAL ST; Bajic VB, 2004, NAT BIOTECHNOL, V22, P1467, DOI 10.1038/nbt1032; Bajic VB, 2003, GENOME RES, V13, P1923, DOI 10.1101/gr.869803; Bajic VB, 2002, BIOINFORMATICS, V18, P198, DOI 10.1093/bioinformatics/18.1.198; Bajic VB, 2003, NUCLEIC ACIDS RES, V31, P3560, DOI 10.1093/nar/gkg570; Bajic VB, 2003, J MOL GRAPH MODEL, V21, P323, DOI 10.1016/S1093-3263(02)00179-1; BAJIC VB, 2002, IEEE INTELL SYST APP, P64; Bajic VB, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s3; Bajic VB, 2006, PLOS GENET, V2, P614, DOI 10.1371/journal.pgen.0020054; Carninci P, 1999, METHOD ENZYMOL, V303, P19; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carninci P, 1997, DNA Res, V4, P61, DOI 10.1093/dnares/4.1.61; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Cohen N, 2005, MOL BIOL EVOL, V22, P1260, DOI 10.1093/molbev/msi115; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Davuluri RV, 2001, NAT GENET, V29, P412, DOI 10.1038/ng780; Down TA, 2002, GENOME RES, V12, P458, DOI 10.1101/gr.216102; Frith MC, 2008, GENOME RES, V18, P1, DOI 10.1101/gr.6831208; Hashimoto S, 2004, NAT BIOTECHNOL, V22, P1146, DOI 10.1038/nbt998; Kanhere A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-1; Kapranov P, 2005, GENOME RES, V15, P987, DOI 10.1101/gr.3455305; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Kawaji H, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r118; Knudsen S, 1999, BIOINFORMATICS, V15, P356, DOI 10.1093/bioinformatics/15.5.356; Korf I, 2001, BIOINFORMATICS, V17, pS140, DOI DOI 10.1093/BI0INF0RMATICS/17.SUPPL_; MARUYAMA K, 1994, GENE, V138, P171; Ng P, 2005, NAT METHODS, V2, P105, DOI 10.1038/NMETH733; Ohler U, 2000, Pac Symp Biocomput, P380; Ovcharenko I, 2005, GENOME RES, V15, P137, DOI 10.1101/gr.3015505; Ponger L, 2002, BIOINFORMATICS, V18, P631, DOI 10.1093/bioinformatics/18.4.631; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Rinn JL, 2003, GENE DEV, V17, P529, DOI 10.1101/gad.1055203; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Solovyev VV, 2003, NUCLEIC ACIDS RES, V31, P3540, DOI 10.1093/nar/gkg525; Sugahara Y, 2001, GENE, V263, P93, DOI 10.1016/S0378-1119(00)00557-6; Wakaguri H, 2008, NUCLEIC ACIDS RES, V36, pD97, DOI 10.1093/nar/gkm901; Wei CL, 2004, P NATL ACAD SCI USA, V101, P11701, DOI 10.1073/pnas.0403514101	37	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e13934	10.1371/journal.pone.0013934	http://dx.doi.org/10.1371/journal.pone.0013934			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085627	Green Published, Green Submitted, gold			2022-12-25	WOS:000284231800003
J	Henriques, A; Pitzer, C; Schneider, A				Henriques, Alexandre; Pitzer, Claudia; Schneider, Armin			Characterization of a Novel SOD-1(G93A) Transgenic Mouse Line with Very Decelerated Disease Development	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MODEL; MICE; ALS	Amyotrophic Lateral Sclerosis (ALS) is a fatal motoneuron disease, characterized by progressive weakness, muscle wasting and death ensuing 3-5 years after diagnosis. The etiology of ALS is complex and therapeutic approaches rely mostly on transgenic animal models with SOD-1 mutations. Most frequently employed is a mouse line transgenic for SOD-1 (SOD-1 Tg) that contains a point mutation at amino acid position 93 (G- > A), present in patients suffering from a familial form of amyotrophic lateral sclerosis. Here we report on a SOD-1 (G93A) Tg mouse line with abnormally delayed onset of disease and prolonged survival. This phenotype arose spontaneously in our colony of the classic SOD-1 (G93A) line. We found that the copy number of the SOD-1 transgene was drastically decreased. We established a new breeding colony, the SOD-1 (G93A) PS line (PS for prolonged survival) where the phenotype is stably inherited for 4 generations now. The mice develop symptoms at an age of approximately 12 months and die at 15 months of age. The delayed development of disease may more closely mimic human pathophysiology, and studying drug effects in this model may yield added confidence for potential efficacy of ALS drug candidates.	[Henriques, Alexandre; Pitzer, Claudia; Schneider, Armin] SYGNIS Biosci, Dept Mol Neurol, Heidelberg, Germany; [Henriques, Alexandre] INSERM, U692, Strasbourg, France; [Henriques, Alexandre] Univ Strasbourg, Fac Med, UMRS692, Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Henriques, A (corresponding author), SYGNIS Biosci, Dept Mol Neurol, Heidelberg, Germany.	schneider@sygnis.de		Schneider, Armin/0000-0003-0296-0059				Alexander GM, 2004, MOL BRAIN RES, V130, P7, DOI 10.1016/j.molbrainres.2004.07.002; DalCanto MC, 1997, ACTA NEUROPATHOL, V93, P537; Dupuis L, 2004, P NATL ACAD SCI USA, V101, P11159, DOI 10.1073/pnas.0402026101; Feeney SJ, 2001, MUSCLE NERVE, V24, P1510, DOI 10.1002/mus.1176; FRIDOVICH I, 1986, ADV ENZYMOL RAMB, V58, P61; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Henriques A, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00032; Mitchell JD, 2007, LANCET, V369, P2031, DOI 10.1016/S0140-6736(07)60944-1; Pambo-Pambo A, 2009, J NEUROPHYSIOL, V102, P3627, DOI 10.1152/jn.00482.2009; Pitzer C, 2008, BRAIN, V131, P3335, DOI 10.1093/brain/awn243; Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300; Stieber A, 1998, ACTA NEUROPATHOL, V95, P245, DOI 10.1007/s004010050794; Tu PH, 1996, P NATL ACAD SCI USA, V93, P3155, DOI 10.1073/pnas.93.7.3155	13	36	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e15445	10.1371/journal.pone.0015445	http://dx.doi.org/10.1371/journal.pone.0015445			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21102999	Green Published, gold, Green Submitted			2022-12-25	WOS:000284087800023
J	Cantuti-Castelvetri, I; Hernandez, LF; Keller-McGandy, CE; Kett, LR; Landy, A; Hollingsworth, ZR; Saka, E; Crittenden, JR; Nillni, EA; Young, AB; Standaert, DG; Graybiel, AM				Cantuti-Castelvetri, Ippolita; Hernandez, Ledia F.; Keller-McGandy, Christine E.; Kett, Lauren R.; Landy, Alex; Hollingsworth, Zane R.; Saka, Esen; Crittenden, Jill R.; Nillni, Eduardo A.; Young, Anne B.; Standaert, David G.; Graybiel, Ann M.			Levodopa-Induced Dyskinesia Is Associated with Increased Thyrotropin Releasing Hormone in the Dorsal Striatum of Hemi-Parkinsonian Rats	PLOS ONE			English	Article							DOPA-INDUCED DYSKINESIA; MEDIUM SPINY NEURONS; BASAL GANGLIA; NUCLEUS-ACCUMBENS; IMMUNOHISTOCHEMICAL LOCALIZATION; ANTITHYROID TREATMENT; DEPLETED STRIATUM; INDUCED BEHAVIOR; GENE-EXPRESSION; DISEASE	Background: Dyskinesias associated with involuntary movements and painful muscle contractions are a common and severe complication of standard levodopa (L-DOPA, L-3,4-dihydroxyphenylalanine) therapy for Parkinson's disease. Pathologic neuroplasticity leading to hyper-responsive dopamine receptor signaling in the sensorimotor striatum is thought to underlie this currently untreatable condition. Methodology/Principal Findings: Quantitative real-time polymerase chain reaction (PCR) was employed to evaluate the molecular changes associated with L-DOPA-induced dyskinesias in Parkinson's disease. With this technique, we determined that thyrotropin releasing hormone (TRH) was greatly increased in the dopamine-depleted striatum of hemi-parkinsonian rats that developed abnormal movements in response to L-DOPA therapy, relative to the levels measured in the contralateral non-dopamine-depleted striatum, and in the striatum of non-dyskinetic control rats. ProTRH immunostaining suggested that TRH peptide levels were almost absent in the dopamine-depleted striatum of control rats that did not develop dyskinesias, but in the dyskinetic rats, proTRH immunostaining was dramatically up-regulated in the striatum, particularly in the sensorimotor striatum. This up-regulation of TRH peptide affected striatal medium spiny neurons of both the direct and indirect pathways, as well as neurons in striosomes. Conclusions/Significance: TRH is not known to be a key striatal neuromodulator, but intrastriatal injection of TRH in experimental animals can induce abnormal movements, apparently through increasing dopamine release. Our finding of a dramatic and selective up-regulation of TRH expression in the sensorimotor striatum of dyskinetic rat models suggests a TRH-mediated regulatory mechanism that may underlie the pathologic neuroplasticity driving dopamine hyper-responsivity in Parkinson's disease.	[Cantuti-Castelvetri, Ippolita; Kett, Lauren R.; Landy, Alex; Hollingsworth, Zane R.; Young, Anne B.] Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis, Dept Neurol, Charlestown, MA USA; [Hernandez, Ledia F.; Keller-McGandy, Christine E.; Crittenden, Jill R.; Graybiel, Ann M.] MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Saka, Esen] Hacettepe Univ, Fac Med, Dept Neurol, TR-06100 Ankara, Turkey; [Standaert, David G.] Univ Alabama Birmingham, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL USA; [Nillni, Eduardo A.] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Dept Med,Div Endocrinol, Providence, RI 02903 USA	Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Hacettepe University; University of Alabama System; University of Alabama Birmingham; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Cantuti-Castelvetri, I (corresponding author), Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis, Dept Neurol, Charlestown, MA USA.	can-cas@helix.mgh.harvard.edu	Young, Anne/AAF-4283-2020; Hernandez, Ledia F./J-3077-2012; Crittenden, Jill/V-5490-2019	Hernandez, Ledia F./0000-0002-5293-3748; Crittenden, Jill/0000-0002-1981-1917; Graybiel, Ann/0000-0002-4326-7720; Standaert, David/0000-0003-2921-8348	MGH/MIT Morris Udall Center of Excellence [NIH NS38372]; American Parkinson Disease Association Advanced Centers for Parkinson Research at Massachusetts General Hospital; University of Alabama Birmingham; NIDDK/NIH [R01 DK58148, NS045231]; Stanley H. and Sheila G. Sydney Fund; Parkinson's Disease Foundation; Fulbright Fellowship; Michael J. Fox Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045231, P50NS038372] Funding Source: NIH RePORTER	MGH/MIT Morris Udall Center of Excellence; American Parkinson Disease Association Advanced Centers for Parkinson Research at Massachusetts General Hospital; University of Alabama Birmingham; NIDDK/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Stanley H. and Sheila G. Sydney Fund; Parkinson's Disease Foundation; Fulbright Fellowship; Michael J. Fox Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported in part by the MGH/MIT Morris Udall Center of Excellence in PD Research (NIH NS38372) (ICC, LRK, ZRH, ABY, LFH, AMG, CEKMcG, JRC), and the American Parkinson Disease Association Advanced Centers for Parkinson Research at Massachusetts General Hospital (ICC, ABY) and University of Alabama Birmingham (DGS); NIDDK/NIH grant R01 DK58148 and R01 NINDS/NIH grant NS045231 (EAN); Stanley H. and Sheila G. Sydney Fund (AMG); Parkinson's Disease Foundation Fellowship and Fulbright Fellowship (LFH); Michael J. Fox Foundation (AMG, JRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MR, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000664; Bezard E, 2001, NAT REV NEUROSCI, V2, P577, DOI 10.1038/35086062; Calabresi P, 2008, MOVEMENT DISORD, V23, pS570, DOI 10.1002/mds.22019; Canales JJ, 2000, NAT NEUROSCI, V3, P377, DOI 10.1038/73949; Canales JJ, 2000, ANN NEUROL, V47, pS53; Cantuti-Castelvetri I, 2005, J NEUROPATH EXP NEUR, V64, P1058, DOI 10.1097/01.jnen.0000190063.90440.69; Cantuti-Castelvetri I, 2002, BRAIN RES, V930, P170, DOI 10.1016/S0006-8993(02)02244-8; CARADOCDAVIES TH, 1986, BRIT MED J, V293, P38, DOI 10.1136/bmj.293.6538.38; Cenci MA, 2002, AMINO ACIDS, V23, P105, DOI 10.1007/s00726-001-0116-4; Cenci MA, 1999, NEUROSCIENCE, V94, P515, DOI 10.1016/S0306-4522(99)00294-8; Chase TN, 2000, ANN NEUROL, V47, pS122; Crittenden JR, 2009, P NATL ACAD SCI USA, V106, P2892, DOI 10.1073/pnas.0812822106; delaCruz IP, 1996, J BIOL CHEM, V271, P22736, DOI 10.1074/jbc.271.37.22736; Dunah AW, 1999, MOL NEUROBIOL, V19, P151, DOI 10.1007/BF02743658; Fabbrini G, 2007, MOVEMENT DISORD, V22, P1379, DOI 10.1002/mds.21475; Faiz M, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-26; Fink L, 1998, NAT MED, V4, P1329, DOI 10.1038/3327; FRIEDMAN TC, 1995, ENDOCRINOLOGY, V136, P4462, DOI 10.1210/en.136.10.4462; Gerfen CR, 2002, J NEUROSCI, V22, P5042, DOI 10.1523/JNEUROSCI.22-12-05042.2002; Grace AA, 2008, MOVEMENT DISORD, V23, pS560, DOI 10.1002/mds.22020; Graybiel AM, 2000, TRENDS NEUROSCI, V23, pS71, DOI 10.1016/S1471-1931(00)00027-6; Isaacs JD, 2005, MOVEMENT DISORD, V20, P1656, DOI 10.1002/mds.20603; JACKSON IMD, 1985, SCIENCE, V229, P1097, DOI 10.1126/science.3929378; JaworskaFeil L, 1997, NEUROPEPTIDES, V31, P253, DOI 10.1016/S0143-4179(97)90056-1; Johansson PA, 2001, NEUROBIOL DIS, V8, P220, DOI 10.1006/nbdi.2000.0372; Kim HT, 2005, PARKINSONISM RELAT D, V11, P331, DOI 10.1016/j.parkreldis.2005.01.009; KISH SJ, 1988, NEW ENGL J MED, V318, P876, DOI 10.1056/NEJM198804073181402; Konradi C, 2004, NEUROBIOL DIS, V17, P219, DOI 10.1016/j.nbd.2004.07.005; KREUTZ MR, 1990, BRAIN RES, V536, P347, DOI 10.1016/0006-8993(90)90049-H; LAVY S, 1974, EUR NEUROL, V12, P20, DOI 10.1159/000114600; LECHAN RM, 1986, SCIENCE, V231, P159, DOI 10.1126/science.3079917; LECHAN RM, 1986, ENDOCRINOLOGY, V119, P1210, DOI 10.1210/endo-119-3-1210; LECHAN RM, 1982, ENDOCRINOLOGY, V111, P55, DOI 10.1210/endo-111-1-55; Lee J, 2008, BRAIN, V131, P1574, DOI 10.1093/brain/awn085; Linazasoro G, 2006, EUR NEUROL, V55, P108, DOI 10.1159/000092786; Lindgren HS, 2007, BEHAV BRAIN RES, V177, P150, DOI 10.1016/j.bbr.2006.09.019; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MIWA Y, 1995, EUR J PHARMACOL, V277, P63, DOI 10.1016/0014-2999(95)00066-T; NILLNI EA, 1993, ENDOCRINOLOGY, V132, P1260, DOI 10.1210/en.132.3.1260; Nillni EA, 1999, ENDOCR REV, V20, P599, DOI 10.1210/er.20.5.599; NILLNI EA, 1995, J NEUROCHEM, V65, P2462; Nillni EA, 1996, ENDOCRINOLOGY, V137, P5651, DOI 10.1210/en.137.12.5651; NILLNI EA, 1991, METHODS NEUROSCIENCE, P51; Obeso JA, 2000, TRENDS NEUROSCI, V23, pS1, DOI 10.1016/S1471-1931(00)00060-4; Obeso JA, 2008, ANN NEUROL, V64, pS30, DOI 10.1002/ana.21481; Paille V, 2007, MOVEMENT DISORD, V22, P533, DOI 10.1002/mds.21308; Pierret P, 2002, NEUROSCIENCE, V111, P83, DOI 10.1016/S0306-4522(01)00597-8; POPOLI P, 1989, EUR J PHARMACOL, V173, P211, DOI 10.1016/0014-2999(89)90523-2; POPOLI P, 1993, BEHAV BRAIN RES, V57, P105, DOI 10.1016/0166-4328(93)90066-Y; POPOLI P, 1991, EUR J PHARMACOL, V201, P11, DOI 10.1016/0014-2999(91)90316-I; PRZEGALINSKI E, 1993, NEUROPEPTIDES, V25, P277, DOI 10.1016/0143-4179(93)90044-B; PRZEGALINSKI E, 1991, NEUROPEPTIDES, V19, P189, DOI 10.1016/0143-4179(91)90118-3; Richardson RM, 2005, BRAIN RES, V1032, P11, DOI 10.1016/j.brainres.2004.10.043; Ristic AJ, 2004, MOVEMENT DISORD, V19, P982, DOI 10.1002/mds.20119; Rylander D, 2010, NEUROBIOL DIS, V39, P352, DOI 10.1016/j.nbd.2010.05.001; Saka E, 1999, BRAIN RES, V825, P104, DOI 10.1016/S0006-8993(99)01231-7; Santini E, 2009, J NEUROCHEM, V108, P621, DOI 10.1111/j.1471-4159.2008.05831.x; Sato K, 2008, P NATL ACAD SCI USA, V105, P12551, DOI 10.1073/pnas.0806065105; Sato K, 2007, MOVEMENT DISORD, V22, P2365, DOI 10.1002/mds.21732; Schaner P, 1997, J BIOL CHEM, V272, P19958, DOI 10.1074/jbc.272.32.19958; Tippett LJ, 2007, BRAIN, V130, P206, DOI 10.1093/brain/awl243; VERGES B, 1988, LANCET, V2, P564; Winkler C, 2002, NEUROBIOL DIS, V10, P165, DOI 10.1006/nbdi.2002.0499; WU P, 1988, BRAIN RES, V456, P22, DOI 10.1016/0006-8993(88)90342-3; WU P, 1991, METHODS NEUROSCIENCE, P337; Yen DJ, 1998, MOVEMENT DISORD, V13, P361, DOI 10.1002/mds.870130231; Young B, 2007, MOVEMENT DISORD, V22, P434, DOI 10.1002/mds.21279	67	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e13861	10.1371/journal.pone.0013861	http://dx.doi.org/10.1371/journal.pone.0013861			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085660	Green Submitted, Green Published, gold			2022-12-25	WOS:000284036800007
J	Mondal, S; Burgute, B; Rieger, D; Muller, R; Rivero, F; Faix, J; Schleicher, M; Noegel, AA				Mondal, Subhanjan; Burgute, Bhagyashri; Rieger, Daniela; Mueller, Rolf; Rivero, Francisco; Faix, Jan; Schleicher, Michael; Noegel, Angelika A.			Regulation of the Actin Cytoskeleton by an Interaction of IQGAP Related Protein GAPA with Filamin and Cortexillin I	PLOS ONE			English	Article							GELATION FACTOR ABP120; DICTYOSTELIUM-DISCOIDEUM; BINDING PROTEINS; CLEAVAGE FURROW; CELL MOTILITY; MONOCLONAL-ANTIBODIES; BUNDLING PROTEIN; HOMOLOGY DOMAIN; TARGETS FILAMIN; CROSS-LINKING	Filamin and Cortexillin are F-actin crosslinking proteins in Dictyostelium discoideum allowing actin filaments to form three-dimensional networks. GAPA, an IQGAP related protein, is required for cytokinesis and localizes to the cleavage furrow during cytokinesis. Here we describe a novel interaction with Filamin which is required for cytokinesis and regulation of the F-actin content. The interaction occurs through the actin binding domain of Filamin and the GRD domain of GAPA. A similar interaction takes place with Cortexillin I. We further report that Filamin associates with Rac1a implying that filamin might act as a scaffold for small GTPases. Filamin and activated Rac associate with GAPA to regulate actin remodelling. Overexpression of filamin and GAPA in the various strains suggests that GAPA regulates the actin cytoskeleton through interaction with Filamin and that it controls cytokinesis through association with Filamin and Cortexillin.	[Mondal, Subhanjan; Burgute, Bhagyashri; Mueller, Rolf; Rivero, Francisco; Noegel, Angelika A.] Univ Cologne, CMMC, Inst Biochem 1, Fac Med, Cologne, Germany; [Rieger, Daniela; Schleicher, Michael] Univ Munich, Inst Anat & Cell Biol, Munich, Germany; [Rieger, Daniela; Schleicher, Michael] Univ Munich, Ctr Integrated Prot Sci CIPSM, Munich, Germany; [Rivero, Francisco] Univ Hull, Hull York Med Sch, Dept Biol Sci, Kingston Upon Hull HU6 7RX, N Humberside, England; [Faix, Jan] Hannover Med Sch, Inst Biophys Chem, D-3000 Hannover, Germany	University of Cologne; University of Munich; University of Munich; University of Hull; University of York - UK; Hannover Medical School	Mondal, S (corresponding author), Univ Cologne, CMMC, Inst Biochem 1, Fac Med, Cologne, Germany.	noegel@uni-koeln.de	Rivero, Francisco/N-2969-2013	Rivero, Francisco/0000-0001-5435-6991	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Research was supported by the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi H, 1997, J CELL BIOL, V137, P891, DOI 10.1083/jcb.137.4.891; Bandala-Sanchez E, 2006, EUR J CELL BIOL, V85, P1099, DOI 10.1016/j.ejcb.2006.04.005; Bellanger JM, 2000, NAT CELL BIOL, V2, P888, DOI 10.1038/35046533; Blau-Wasser R, 2009, MOL BIOL CELL, V20, P4348, DOI 10.1091/mbc.E09-03-0180; Brandt DT, 2007, EMBO REP, V8, P1019, DOI 10.1038/sj.embor.7401089; Briggs MW, 2003, FEBS LETT, V542, P7, DOI 10.1016/S0014-5793(03)00333-8; BRINK M, 1990, J CELL BIOL, V111, P1477, DOI 10.1083/jcb.111.4.1477; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Calderwood DA, 2001, NAT CELL BIOL, V3, P1060, DOI 10.1038/ncb1201-1060; CLAVIEZ M, 1982, EMBO J, V1, P1017, DOI 10.1002/j.1460-2075.1982.tb01287.x; CONDEELIS J, 1984, J CELL BIOL, V99, pS119, DOI 10.1083/jcb.99.1.119s; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Dumontier M, 2000, J CELL SCI, V113, P2253; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Faix J, 1996, CELL, V86, P631, DOI 10.1016/S0092-8674(00)80136-1; Faix J, 1996, FEBS LETT, V394, P251, DOI 10.1016/0014-5793(96)00963-5; Faix J, 1998, J CELL SCI, V111, P3059; Faix J, 2001, EMBO J, V20, P3705, DOI 10.1093/emboj/20.14.3705; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Fucini P, 1999, J MOL BIOL, V291, P1017, DOI 10.1006/jmbi.1999.3046; Fukata M, 1997, J BIOL CHEM, V272, P29579, DOI 10.1074/jbc.272.47.29579; Gerisch G, 2000, CURR OPIN CELL BIOL, V12, P126, DOI 10.1016/S0955-0674(99)00066-6; Girard KD, 2004, EMBO J, V23, P1536, DOI 10.1038/sj.emboj.7600167; Gloss A, 2003, MOL BIOL CELL, V14, P2716, DOI 10.1091/mbc.E02-12-0827; HARTMANN H, 1989, J BIOL CHEM, V264, P12639; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; HOFMANN A, 1992, CELL MOTIL CYTOSKEL, V23, P133, DOI 10.1002/cm.970230206; Khaire N, 2007, J BIOL CHEM, V282, P1948, DOI 10.1074/jbc.M610262200; KILMARTIN JV, 1982, J CELL BIOL, V93, P576, DOI 10.1083/jcb.93.3.576; Knecht D, 1995, Methods Mol Biol, V47, P321; Knuth M, 2004, J CELL SCI, V117, P5013, DOI 10.1242/jcs.01366; Korenbaum E, 2002, J CELL SCI, V115, P3543, DOI 10.1242/jcs.00003; Larochelle DA, 1996, J CELL BIOL, V133, P1321, DOI 10.1083/jcb.133.6.1321; Lim RWL, 1999, BIOCHEMISTRY-US, V38, P800, DOI 10.1021/bi981392d; Loo DT, 1998, J BIOL CHEM, V273, P23304, DOI 10.1074/jbc.273.36.23304; MANSTEIN DJ, 1989, EMBO J, V8, P923, DOI 10.1002/j.1460-2075.1989.tb03453.x; Mateer SC, 2004, CELL MOTIL CYTOSKEL, V58, P231, DOI 10.1002/cm.20013; McCoy AJ, 1999, NAT STRUCT BIOL, V6, P836; MCROBBIE SJ, 1983, BIOCHEM BIOPH RES CO, V115, P351, DOI 10.1016/0006-291X(83)91011-2; Nakamura F, 2005, J BIOL CHEM, V280, P32426, DOI 10.1074/jbc.M502203200; Noegel AA, 2000, J CELL SCI, V113, P759; Noegel AA, 2004, MOL BIOL CELL, V15, P934, DOI 10.1091/mbc.E03-05-0269; NUNNALLY MH, 1980, J CELL BIOL, V87, P219, DOI 10.1083/jcb.87.1.219; Ohta Y, 1999, P NATL ACAD SCI USA, V96, P2122, DOI 10.1073/pnas.96.5.2122; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Pang KM, 1998, CURR BIOL, V8, P405, DOI 10.1016/S0960-9822(98)70159-9; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; Robinson DN, 2002, J BIOL CHEM, V277, P9088, DOI 10.1074/jbc.M112144200; SHARMA CP, 1995, J IMMUNOL, V154, P3461; SIMPSON PA, 1984, J CELL BIOL, V99, P287, DOI 10.1083/jcb.99.1.287; Stock A, 1999, EMBO J, V18, P5274, DOI 10.1093/emboj/18.19.5274; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Ueda K, 2003, BIOCHEM BIOPH RES CO, V301, P886, DOI 10.1016/S0006-291X(03)00048-2; Uyeda TQP, 2004, CURR OPIN CELL BIOL, V16, P55, DOI 10.1016/j.ceb.2003.11.004; Vadlamudi RK, 2002, NAT CELL BIOL, V4, P681, DOI 10.1038/ncb838; Vlahou G, 2006, EUR J CELL BIOL, V85, P947, DOI 10.1016/j.ejcb.2006.04.011; Vorgerd M, 2005, AM J HUM GENET, V77, P297, DOI 10.1086/431959; Weber I, 1999, EMBO J, V18, P586, DOI 10.1093/emboj/18.3.586; Xiong HJ, 2008, TRAFFIC, V9, P708, DOI 10.1111/j.1600-0854.2008.00721.x; YANG F, 1990, NATURE, V347, P494, DOI 10.1038/347494a0; YASUTAKA O, 1995, BIOCHEMISTRY-US, V34, P6745, DOI 10.1021/bi00020a020	61	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e15440	10.1371/journal.pone.0015440	http://dx.doi.org/10.1371/journal.pone.0015440			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085675	Green Published, Green Submitted, gold			2022-12-25	WOS:000284036800030
J	Gustavsson, N; Wang, XR; Wang, Y; Seah, T; Xu, J; Radda, GK; Sudhof, TC; Han, WP				Gustavsson, Natalia; Wang, Xiaorui; Wang, Yue; Seah, Tingting; Xu, Jun; Radda, George K.; Suedhof, Thomas C.; Han, Weiping			Neuronal Calcium Sensor Synaptotagmin-9 Is Not Involved in the Regulation of Glucose Homeostasis or Insulin Secretion	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; CA2+ SENSOR; CAPACITANCE MEASUREMENTS; EXOCYTOSIS; RELEASE; ISLETS; MICE	Background: Insulin secretion is a complex and highly regulated process. It is well established that cytoplasmic calcium is a key regulator of insulin secretion, but how elevated intracellular calcium triggers insulin granule exocytosis remains unclear, and we have only begun to define the identities of proteins that are responsible for sensing calcium changes and for transmitting the calcium signal to release machineries. Synaptotagmins are primarily expressed in brain and endocrine cells and exhibit diverse calcium binding properties. Synaptotagmin-1, -2 and -9 are calcium sensors for fast neurotransmitter release in respective brain regions, while synaptotagmin-7 is a positive regulator of calcium-dependent insulin release. Unlike the three neuronal calcium sensors, whose deletion abolished fast neurotransmitter release, synaptotagmin-7 deletion resulted in only partial loss of calcium-dependent insulin secretion, thus suggesting that other calcium-sensors must participate in the regulation of insulin secretion. Of the other synaptotagmin isoforms that are present in pancreatic islets, the neuronal calcium sensor synaptotagmin-9 is expressed at the highest level after synaptotagmin-7. Methodology/Principal Findings: In this study we tested whether synaptotagmin-9 participates in the regulation of glucose-stimulated insulin release by using pancreas-specific synaptotagmin-9 knockout (p-S9X) mice. Deletion of synaptotagmin-9 in the pancreas resulted in no changes in glucose homeostasis or body weight. Glucose tolerance, and insulin secretion in vivo and from isolated islets were not affected in the p-S9X mice. Single-cell capacitance measurements showed no difference in insulin granule exocytosis between p-S9X and control mice. Conclusions: Thus, synaptotagmin-9, although a major calcium sensor in the brain, is not involved in the regulation of glucose-stimulated insulin release from pancreatic beta-cells.	[Gustavsson, Natalia; Wang, Xiaorui; Wang, Yue; Seah, Tingting; Radda, George K.; Han, Weiping] Agcy Sci Technol & Res, Singapore Bioimaging Consortium, Lab Metab Med, Singapore, Singapore; [Xu, Jun; Suedhof, Thomas C.] Howard Hughes Med Inst, Palo Alto, CA USA; [Xu, Jun; Suedhof, Thomas C.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Palo Alto, CA 94304 USA; [Han, Weiping] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC); Howard Hughes Medical Institute; Stanford University; National University of Singapore	Gustavsson, N (corresponding author), Agcy Sci Technol & Res, Singapore Bioimaging Consortium, Lab Metab Med, Singapore, Singapore.	natalia_gustavsson@sbic.a-star.edu.sg; weiping_han@sbic.a-star.edu.sg	Holt, Janet E/B-2415-2013; Petersen, Natalia/J-8800-2015	Petersen, Natalia/0000-0001-9344-6041; Seah, Ting Ting/0000-0002-2050-0171	A*STAR (Agency for Science, Technology and Research, Singapore) Biomedical Research Council	A*STAR (Agency for Science, Technology and Research, Singapore) Biomedical Research Council(Agency for Science Technology & Research (A*STAR))	This study was supported by intramural funding from A*STAR (Agency for Science, Technology and Research, Singapore) Biomedical Research Council (W.H.). T.C.S. is a Howard Hughes Medical Institute investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHCROFT FM, 1994, J CELL BIOCHEM, V55, P54, DOI 10.1002/jcb.240550007; Barg S, 2004, J GEN PHYSIOL, V124, P623, DOI 10.1085/jgp.200409206; Gauthier BR, 2008, AM J PHYSIOL-ENDOC M, V295, pE1279, DOI 10.1152/ajpendo.90568.2008; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Gerber SH, 2002, DIABETES, V51, pS3, DOI 10.2337/diabetes.51.2007.S3; Gopel S, 2004, J PHYSIOL-LONDON, V556, P711, DOI 10.1113/jphysiol.2003.059675; Gustavsson N, 2008, P NATL ACAD SCI USA, V105, P3992, DOI 10.1073/pnas.0711700105; Gustavsson N, 2009, BIOSCIENCE REP, V29, P245, DOI 10.1042/BSR20090031; Gustavsson N, 2009, J PHYSIOL-LONDON, V587, P1169, DOI 10.1113/jphysiol.2008.168005; Henquin JC, 2009, DIABETES OBES METAB, V11, P168, DOI 10.1111/j.1463-1326.2009.01109.x; Iezzi M, 2005, FEBS LETT, V579, P5241, DOI 10.1016/j.febslet.2005.08.047; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; LERNMARK A, 1974, DIABETOLOGIA, V10, P431, DOI 10.1007/BF01221634; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; Marshall C, 2005, MOL ENDOCRINOL, V19, P213, DOI 10.1210/me.2004-0064; Ort T, 2001, EMBO J, V20, P4013, DOI 10.1093/emboj/20.15.4013; Pang ZPP, 2006, J NEUROSCI, V26, P13493, DOI 10.1523/JNEUROSCI.3519-06.2006; Rettig J, 2002, SCIENCE, V298, P781, DOI 10.1126/science.1075375; Schonn JS, 2008, P NATL ACAD SCI USA, V105, P3998, DOI 10.1073/pnas.0712373105; Sudhof TC, 2002, J BIOL CHEM, V277, P7629, DOI 10.1074/jbc.R100052200; Svoboda P, 2007, CURR OPIN MOL THER, V9, P248; Turner MD, 2007, MOL GENET METAB, V91, P305, DOI 10.1016/j.ymgme.2007.04.019; Turner MD, 2007, BIOCHEM BIOPH RES CO, V352, P650, DOI 10.1016/j.bbrc.2006.11.077; Xu J, 2007, NEURON, V54, P567, DOI 10.1016/j.neuron.2007.05.004; Zawalich WS, 2008, METABOLISM, V57, P30, DOI 10.1016/j.metabol.2007.07.020; Zawalich WS, 1996, ENDOCRINOLOGY, V137, P1664, DOI 10.1210/en.137.5.1664	26	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e15414	10.1371/journal.pone.0015414	http://dx.doi.org/10.1371/journal.pone.0015414			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085706	Green Published, gold, Green Submitted			2022-12-25	WOS:000284035900029
J	Lise, MC; Sparsa, A; Marie, I; Lalloue, F; Ly, K; Martel, C; Bezanahary, H; Gondran, G; Loustaud-Ratti, V; Bonnetblanc, JM; Vidal, E; Jauberteau, MO; Fauchais, AL				Lise, Marie-Claude; Sparsa, Agnes; Marie, Isabelle; Lalloue, Fabrice; Ly, Kim; Martel, Clothilde; Bezanahary, Holy; Gondran, Guillaume; Loustaud-Ratti, Veronique; Bonnetblanc, Jean-Marie; Vidal, Elisabeth; Jauberteau, Marie-Odile; Fauchais, Anne-Laure			Serum Neurotrophin Profile in Systemic Sclerosis	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; LUPUS-ERYTHEMATOSUS PATIENTS; OXIDATIVE STRESS; ANTIPHOSPHOLIPID ANTIBODIES; RHEUMATOID-ARTHRITIS; ENDOTHELIAL-CELLS; SURVIVAL FACTOR; B-LYMPHOCYTES; FACTOR-BETA; IN-VITRO	Background: Neurotrophins (NTs) are able to activate lymphocytes and fibroblasts; they can modulate angiogenesis and sympathic vascular function. Thus, they can be implicated in the three pathogenic processes of systemic sclerosis (SSc). The aims of this study are to determine blood levels of Nerve Growth Factor (NGF), Brain-Derived Neurotrophic Factor (BDNF) and Neurotrophin-3 (NT-3) in SSc and to correlate them with clinical and biological data. Methods: Serum samples were obtained from 55 SSc patients and 32 control subjects to measure NTs levels by ELISA and to determine their relationships with SSc profiles. Findings: Serum NGF levels were higher in SSc patients (288.26 +/- 170.34 pg/mL) than in control subjects (170.34 +/- 50.8 pg/mL, p<0.001) and correlated with gammaglobulins levels and the presence of both anti-cardiolipin and anti-Scl-70 antibodies (p<0.05). In contrast, BDNF levels were lower in SSc patients than in controls (1121.9 +/- 158.1 vs 1372.9 +/- 190.9 pg/mL, p<0.0001), especially in pulmonary arterial hypertension and diffuse SSc as compared to limited forms (all p<0.05). NT-3 levels were similar in SSc and in the control group (2657.2 +/- 2296 vs 2959.3 +/- 2555 pg/mL, NS). BDNF levels correlated negatively with increased NGF levels in the SSc group (and not in controls). Conclusion: Low BDNF serum levels were not previously documented in SSc, particularly in the diffuse SSc subset and in patients with pulmonary hypertension or anti-Scl-70 antibodies. The negative correlation between NGF and BDNF levels observed in SSc and not in healthy controls could be implicated in sympathic vascular dysfunction in SSc.	[Lise, Marie-Claude; Sparsa, Agnes; Lalloue, Fabrice; Martel, Clothilde; Vidal, Elisabeth; Jauberteau, Marie-Odile; Fauchais, Anne-Laure] Limoges Univ Hosp, IFR 145, Homeostasie Cellulaire & Pathol EA3842, Limoges, France; [Ly, Kim; Bezanahary, Holy; Gondran, Guillaume; Loustaud-Ratti, Veronique; Vidal, Elisabeth; Fauchais, Anne-Laure] Limoges Univ Hosp, Dept Internal Med, Limoges, France; [Sparsa, Agnes; Bonnetblanc, Jean-Marie] Limoges Univ Hosp, Dept Dermatol, Limoges, France; [Jauberteau, Marie-Odile] Limoges Univ Hosp, Dept Immunol, Limoges, France; [Marie, Isabelle] Rouen Univ Hosp, Dept Internal Med, Rouen, France	CHU Limoges; CHU Limoges; CHU Limoges; CHU Limoges; CHU de Rouen	Lise, MC (corresponding author), Limoges Univ Hosp, IFR 145, Homeostasie Cellulaire & Pathol EA3842, Limoges, France.	anne-laure.fauchais@chu-limoges.fr	Loustaud-Ratti, Véronique/A-5262-2017; Ly, Kim/AAN-4092-2021	Lalloue, Fabrice/0000-0003-0382-4948; Fauchais, Anne Laure/0000-0002-0489-8570; Ly, Kim Heang/0000-0002-8511-903X; Jauberteau, Marie-Odile/0000-0002-8811-8948	AREML, Association Regionale d'Entraide a la Maladie Lupique	AREML, Association Regionale d'Entraide a la Maladie Lupique	This work was supported by AREML, Association Regionale d'Entraide a la Maladie Lupique, a local association of patients with lupus erythematosus and auto-immune disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalto K, 2002, CYTOKINE, V20, P136, DOI 10.1006/cyto.2002.1991; Abe T, 1997, CIRCULATION, V95, P213, DOI 10.1161/01.CIR.95.1.213; Aloe L, 1997, ALLERGY, V52, P883, DOI 10.1111/j.1398-9995.1997.tb01247.x; Alves JD, 2005, RHEUMATOLOGY, V44, P1238, DOI 10.1093/rheumatology/keh722; Assous N, 2005, CLIN EXP RHEUMATOL, V23, P199; Barthel C, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2716; Besser M, 1999, J IMMUNOL, V162, P6303; BRACCILAUDIERO L, 1993, NEUROREPORT, V4, P563, DOI 10.1097/00001756-199305000-00025; Chaldakov G N, 2001, Arch Physiol Biochem, V109, P357, DOI 10.1076/apab.109.3.357.9353; Chul BL, 2009, ALCOHOL, V43, P265, DOI 10.1016/j.alcohol.2009.04.003; CLEMENTS P, 1995, J RHEUMATOL, V22, P1281; Coassin M, 2006, GRAEF ARCH CLIN EXP, V244, P485, DOI 10.1007/s00417-005-0098-0; Del Porto F, 2006, ANN NY ACAD SCI, V1069, P438, DOI 10.1196/annals.1351.042; Denton CP, 2001, CURR OPIN RHEUMATOL, V13, P505, DOI 10.1097/00002281-200111000-00010; DICOU E, 1993, NEUROREPORT, V5, P321, DOI 10.1097/00001756-199312000-00036; DONOVAN MJ, 1995, AM J PATHOL, V147, P309; Donovan MJ, 2000, DEVELOPMENT, V127, P4531; Fauchais AL, 2009, SCAND J RHEUMATOL, V38, P50, DOI 10.1080/03009740802378832; Goss JR, 1997, EXP NEUROL, V146, P291, DOI 10.1006/exnr.1997.6515; Grimsholm O, 2008, CLIN RHEUMATOL, V27, P1289, DOI 10.1007/s10067-008-0910-4; Gupta SK, 2005, MOL CELL BIOCHEM, V275, P67, DOI 10.1007/s11010-005-1999-2; Hiltunen JO, 2001, J PATHOL, V194, P247, DOI 10.1002/path.878; Iwata Y, 2007, RHEUMATOLOGY, V46, P790, DOI 10.1093/rheumatology/kem010; Julio-Pieper M, 2009, J CLIN ENDOCR METAB, V94, P3065, DOI 10.1210/jc.2009-0542; Kapczinski F, 2008, REV BRAS PSIQUIATR, V30, P243, DOI 10.1590/S1516-44462008000300011; Kasselman LJ, 2006, J NEUROIMMUNOL, V175, P118, DOI 10.1016/j.jneuroim.2006.03.008; Kawaguchi-Manabe H, 2007, LIFE SCI, V81, P385, DOI 10.1016/j.lfs.2007.05.024; Kermani P, 2005, J CLIN INVEST, V115, P653, DOI 10.1172/JCI200522655; Kermani P, 2007, TRENDS CARDIOVAS MED, V17, P140, DOI 10.1016/j.tcm.2007.03.002; Kerschensteiner M, 1999, J EXP MED, V189, P865, DOI 10.1084/jem.189.5.865; LEROY EC, 1988, J RHEUMATOL, V15, P202; Lonzetti LS, 2001, ARTHRITIS RHEUM-US, V44, P735; Manni L, 2005, INT J CARDIOL, V102, P169, DOI 10.1016/j.ijcard.2004.10.041; Matucci-Cerinic M, 2009, RHEUMATOLOGY, V48, P8, DOI 10.1093/rheumatology/ken482; Matucci-Cerinic M, 2001, ANN RHEUM DIS, V60, P487, DOI 10.1136/ard.60.5.487; Medsger TA, 2003, CLIN EXP RHEUMATOL, V21, pS42; Micera A, 2005, CLIN EXP ALLERGY, V35, P650, DOI 10.1111/j.1365-2222.2005.02241.x; Micera A, 2001, P NATL ACAD SCI USA, V98, P6162, DOI 10.1073/pnas.101130898; Nakahashi T, 2000, FEBS LETT, V470, P113, DOI 10.1016/S0014-5793(00)01302-8; Noga O, 2001, CLIN EXP ALLERGY, V31, P1906, DOI 10.1046/j.1365-2222.2001.01249.x; Ogawa F, 2006, RHEUMATOLOGY, V45, P815, DOI 10.1093/rheumatology/kel012; OTTEN U, 1989, P NATL ACAD SCI USA, V86, P10059, DOI 10.1073/pnas.86.24.10059; Piga, 2000, Eur J Intern Med, V11, P156, DOI 10.1016/S0953-6205(00)00084-4; Ricci A, 2000, J VASC RES, V37, P355, DOI 10.1159/000025751; Rihl M, 2005, ANN RHEUM DIS, V64, P1542, DOI 10.1136/ard.2004.032599; SANTHANAM AV, STROKE, V41, P350; SEIDEL MF, 2009, SEMIN ARTHRITIS RHEU; Steen VD, 1996, SYSTEMIC SCLEROSIS, P51; Torcia M, 1996, CELL, V85, P345, DOI 10.1016/S0092-8674(00)81113-7; TUVERI MA, 1993, CLIN EXP RHEUMATOL, V11, P319; Wu AG, 2004, EUR J NEUROSCI, V19, P1699, DOI 10.1111/j.1460-9568.2004.03246.x; Xu M, 2008, AM J PHYSIOL-HEART C, V295, pH1529, DOI 10.1152/ajpheart.00115.2008; Yang ZF, 2006, ONCOL REP, V16, P1237	53	11	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e13918	10.1371/journal.pone.0013918	http://dx.doi.org/10.1371/journal.pone.0013918			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085492	Green Published, Green Submitted, gold			2022-12-25	WOS:000284035900023
J	Rodriguez-Bies, E; Calvo, SSC; Fontan-Lozano, A; Amaro, JP; de la Rosa, FJB; Carrion, AM; Navas, P; Lopez-Lluch, G				Rodriguez-Bies, Elizabeth; Santa-Cruz Calvo, Sara; Fontan-Lozano, Angela; Pena Amaro, Jose; Berral de la Rosa, Francisco J.; Carrion, Angel M.; Navas, Placido; Lopez-Lluch, Guillermo			Muscle Physiology Changes Induced by Every Other Day Feeding and Endurance Exercise in Mice: Effects on Physical Performance	PLOS ONE			English	Article							CALORIC RESTRICTION; SKELETAL-MUSCLE; MITOCHONDRIAL BIOGENESIS; DIETARY RESTRICTION; OXIDATIVE STRESS; FISCHER-344 RATS; BLOOD-PRESSURE; MOUSE-LIVER; COENZYME-Q; PROTEIN	Every other day feeding (EOD) and exercise induce changes in cell metabolism. The aim of the present work was to know if both EOD and exercise produce similar effects on physical capacity, studying their physiological, biochemical and metabolic effects on muscle. Male OF-1 mice were fed either ad libitum (AL) or under EOD. After 18 weeks under EOD, animals were also trained by using a treadmill for another 6 weeks and then analyzed for physical activity. Both, EOD and endurance exercise increased the resistance of animals to extenuating activity and improved motor coordination. Among the groups that showed the highest performance, AL and EOD trained animals, ALT and EODT respectively, only the EODT group was able to increase glucose and triglycerides levels in plasma after extenuating exercise. No high effects on mitochondrial respiratory chain activities or protein levels neither on coenzyme Q levels were found in gastrocnemius muscle. However, exercise and EOD did increase beta-oxidation activity in this muscle accompanied by increased CD36 levels in animals fed under EOD and by changes in shape and localization of mitochondria in muscle fibers. Furthermore, EOD and training decreased muscle damage after strenuous exercise. EOD also reduced the levels of lipid peroxidation in muscle. Our results indicate that EOD improves muscle performance and resistance by increasing lipid catabolism in muscle mitochondria at the same time that prevents lipid peroxidation and muscle damage.	[Rodriguez-Bies, Elizabeth; Santa-Cruz Calvo, Sara; Navas, Placido; Lopez-Lluch, Guillermo] Univ Pablo de Olavide, CSIC, Inst Salud Carlos III, CIBERER,CABD, Seville, Spain; [Fontan-Lozano, Angela; Carrion, Angel M.] Univ Pablo de Olavide, Dept Fisiol Anat & Biol Celular, Div Neurociencia, Seville, Spain; [Pena Amaro, Jose] Univ Cordoba, Fac Med, Dept Ciencias Morfol, Cordoba, Spain; [Berral de la Rosa, Francisco J.] Univ Pablo de Olavide, Fac Deporte, Dept Deporte & Informat, Seville, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); Instituto de Salud Carlos III; Universidad Pablo de Olavide; Universidad de Cordoba; Universidad Pablo de Olavide	Rodriguez-Bies, E (corresponding author), Univ Pablo de Olavide, CSIC, Inst Salud Carlos III, CIBERER,CABD, Seville, Spain.	glopllu@upo.es	Berral de la Rosa, Francisco José/C-6553-2013; De La Rosa, Francisco/GWU-4894-2022; Carrion, Angel Manuel/K-5875-2014; Bies, Elisabet Rodríguez/A-4459-2016; Peña-Amaro, Jose/ABG-9424-2020; Lopez-Lluch, Guillermo/N-4742-2014; FONTÁN-LOZANO, ÁNGELA/R-9081-2019; NAVAS, PLACIDO/R-5943-2019	Carrion, Angel Manuel/0000-0001-8158-9512; Bies, Elisabet Rodríguez/0000-0002-5910-2920; Peña-Amaro, Jose/0000-0002-2637-1112; Lopez-Lluch, Guillermo/0000-0001-9830-8502; FONTÁN-LOZANO, ÁNGELA/0000-0003-1646-0952; NAVAS, PLACIDO/0000-0002-4115-7966; Santa-Cruz Calvo, Sara/0000-0001-6037-8986	Spanish Ministry of Science and Innovation [DEP2005-00238-C04-04, DEP2009-12019]; Spanish Sport Council [01/UPB31/07, 15/UPB31/06]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Sport Council	This work was supported by the Spanish Ministry of Science and Innovation grants DEP2005-00238-C04-04 and DEP2009-12019. E. Rodriguez-Bies has been supported by the 01/UPB31/07 and 15/UPB31/06 grants from the Spanish Sport Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin-Perez R, 2009, CELL METAB, V9, P265, DOI 10.1016/j.cmet.2009.01.012; Anson RM, 2003, P NATL ACAD SCI USA, V100, P6216, DOI 10.1073/pnas.1035720100; Azab M, 2009, J TOXICOL ENV HEAL A, V72, P295, DOI 10.1080/15287390802526357; Baker DJ, 2006, J GERONTOL A-BIOL, V61, P675, DOI 10.1093/gerona/61.7.675; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bonkowski MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004567; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burelle Y, 2002, J APPL PHYSIOL, V92, P2429, DOI 10.1152/japplphysiol.01024.2001; Campbell SE, 2004, J BIOL CHEM, V279, P36235, DOI 10.1074/jbc.M400566200; Caro P, 2008, REJUV RES, V11, P621, DOI 10.1089/rej.2008.0704; Cerqueira FM, 2010, AGEING RES REV, V9, P424, DOI 10.1016/j.arr.2010.05.002; Chomentowski P, 2009, J GERONTOL A-BIOL, V64, P575, DOI 10.1093/gerona/glp007; Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Cooper CE, 2002, BIOCHEM SOC T, V30, P280, DOI 10.1042/BST0300280; Crescenzo R, 2006, DIABETES, V55, P2286, DOI 10.2337/db06-0312; De Cabo R, 2004, EXP GERONTOL, V39, P297, DOI 10.1016/j.exger.2003.12.003; Desai VG, 1996, ARCH BIOCHEM BIOPHYS, V333, P145, DOI 10.1006/abbi.1996.0375; FAVIER RJ, 1998, AM J PHYSIOL, V254, pR877; Fernandez-Ayala DJM, 2005, BBA-BIOENERGETICS, V1706, P174, DOI 10.1016/j.bbabio.2004.10.009; Fontana L, 2004, P NATL ACAD SCI USA, V101, P6659, DOI 10.1073/pnas.0308291101; Freyssenet D, 2007, J APPL PHYSIOL, V102, P529, DOI 10.1152/japplphysiol.01126.2005; Gerard-Monnier D, 1998, CHEM RES TOXICOL, V11, P1176, DOI 10.1021/tx9701790; Hepple RT, 2006, REJUV RES, V9, P219, DOI 10.1089/rej.2006.9.219; HOPPELER H, 1986, INT J SPORTS MED, V7, P187, DOI 10.1055/s-2008-1025758; Horska A, 1999, AM J PHYSIOL-ENDOC M, V276, pE766, DOI 10.1152/ajpendo.1999.276.4.E766; Huffman DM, 2008, AM J PHYSIOL-REG I, V294, pR1618, DOI 10.1152/ajpregu.00890.2007; Irrcher I, 2003, SPORTS MED, V33, P783, DOI 10.2165/00007256-200333110-00001; Kalain R, 2006, J GERONTOL A-BIOL, V61, P211, DOI 10.1093/gerona/61.3.211; Kim JH, 2009, CELL DEATH DIFFER, V16, P584, DOI 10.1038/cdd.2008.186; Kim JH, 2008, EXP GERONTOL, V43, P317, DOI 10.1016/j.exger.2007.12.012; King KL, 2007, ARCH BIOCHEM BIOPHYS, V467, P234, DOI 10.1016/j.abb.2007.08.020; Kirkendall DT, 1998, AM J SPORT MED, V26, P598, DOI 10.1177/03635465980260042401; KRIEGER DA, 1980, J APPL PHYSIOL, V48, P23, DOI 10.1152/jappl.1980.48.1.23; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lanza IR, 2008, DIABETES, V57, P2933, DOI 10.2337/db08-0349; Larson-Meyer DE, 2010, MED SCI SPORT EXER, V42, P152, DOI 10.1249/MSS.0b013e3181ad7f17; Lass A, 1999, BIOFACTORS, V9, P199, DOI 10.1002/biof.5520090215; Leeuwenburgh C, 1999, FREE RADICAL BIO MED, V27, P186, DOI 10.1016/S0891-5849(99)00071-4; Lopez-Lluch G, 2005, AGE, V27, P153, DOI 10.1007/s11357-005-2726-3; Lopez-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103; Lopez-Lluch G, 2008, EXP GERONTOL, V43, P813, DOI 10.1016/j.exger.2008.06.014; Lopez-Lluch G, 2010, MECH AGEING DEV, V131, P225, DOI 10.1016/j.mad.2010.02.003; Lowenthal DT, 2006, THESCIENTIFICWORLDJO, V6, P1339, DOI 10.1100/tsw.2006.183; Mager DE, 2006, FASEB J, V20, P631, DOI 10.1096/fj.05-5263com; Marzetti E, 2009, BIOFACTORS, V35, P28, DOI 10.1002/biof.5; Mattson MP, 2005, J NUTR BIOCHEM, V16, P129, DOI 10.1016/j.jnutbio.2004.12.007; Mattson MP, 2003, J NEUROCHEM, V84, P417, DOI 10.1046/j.1471-4159.2003.01586.x; MCCARTER RJM, 2000, HDB OXIDANTS ANTIOXI, P797; MCMURRAY RG, 1991, INT J SPORTS MED, V12, P167, DOI 10.1055/s-2007-1024662; MEANS LW, 1993, PHYSIOL BEHAV, V54, P503, DOI 10.1016/0031-9384(93)90243-9; Murase T, 2002, J LIPID RES, V43, P1312, DOI 10.1194/jlr.M200094-JLR200; Poehlman ET, 2001, J GERONTOL A-BIOL, V56, P45, DOI 10.1093/gerona/56.suppl_1.45; RODRIGUEZBIES E, 2009, REV ANDALUZA MED DEP, V2, P13; Senchina DS, 2007, CLIN INTERV AGING, V2, P3, DOI 10.2147/ciia.2007.2.1.3; Shimotoyodome A, 2005, MED SCI SPORT EXER, V37, P1884, DOI 10.1249/01.mss.0000178062.66981.a8; Smith PJ, 2010, HYPERTENSION, V55, P1331, DOI 10.1161/HYPERTENSIONAHA.109.146795; Sreekumar R, 2002, AM J PHYSIOL-ENDOC M, V283, pE38, DOI 10.1152/ajpendo.00387.2001; Takahashi S, 2006, PHARMACOL RES, V53, P501, DOI 10.1016/j.phrs.2006.03.019; WANG N, 1993, PFLUG ARCH EUR J PHY, V424, P494, DOI 10.1007/BF00374913; Wang Y, 2004, PLOS BIOL, V2, P610, DOI 10.1371/journal.pbio.0020128; Weiss EP, 2006, AM J CLIN NUTR, V84, P1033; Wright DC, 2007, J BIOL CHEM, V282, P194, DOI 10.1074/jbc.M606116200; Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163; YU BP, 1985, J GERONTOL, V40, P657, DOI 10.1093/geronj/40.6.657	65	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e13900	10.1371/journal.pone.0013900	http://dx.doi.org/10.1371/journal.pone.0013900			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085477	Green Published, gold			2022-12-25	WOS:000284035900011
J	Abaffy, T; Duncan, R; Riemer, DD; Tietje, O; Elgart, G; Milikowski, C; DeFazio, RA				Abaffy, Tatjana; Duncan, Robert; Riemer, Daniel D.; Tietje, Olaf; Elgart, George; Milikowski, Clara; DeFazio, R. Anthony			Differential Volatile Signatures from Skin, Naevi and Melanoma: A Novel Approach to Detect a Pathological Process	PLOS ONE			English	Article							ORGANIC-COMPOUNDS; OXIDATIVE STRESS; EXHALED BREATH; SPECTROMETRY; BIOMARKERS; IDENTIFICATION; PATHOGENESIS; EXPRESSION; PROFILES; BIOLOGY	Background: Early detection of melanoma is of great importance to reduce mortality. Discovering new melanoma biomarkers would improve early detection and diagnosis. Here, we present a novel approach to detect volatile compounds from skin. Methods and Findings: We used Head Space Solid Phase Micro-Extraction (HS-SPME) and gas chromatography/mass spectrometry (GC/MS) to identify volatile signatures from melanoma, naevi and skin samples. We hypothesized that the metabolic state of tissue alters the profile of volatile compounds. Volatiles released from fresh biopsy tissue of melanoma and benign naevus were compared based on their difference in frequency distribution and their expression level. We also analyzed volatile profiles from frozen tissue, including skin and melanoma. Conclusions: Three volatiles, 4-methyl decane, dodecane and undecane were preferentially expressed in both fresh and frozen melanoma, indicating that they are candidate biomarkers. Twelve candidate biomarkers evaluated by fuzzy logic analysis of frozen samples distinguished melanoma from skin with 89% sensitivity and 90% specificity. Our results demonstrate proof-of-principle that there is differential expression of volatiles in melanoma. Our volatile metabolomic approach will lead to a better understanding of melanoma and can enable development of new diagnostic and treatment strategies based on altered metabolism.	[Abaffy, Tatjana; Duncan, Robert] Univ Miami, Miller Sch Med, Dept Epidemiol & Publ Hlth, Div Biostat, Miami, FL 33136 USA; [Riemer, Daniel D.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; [Tietje, Olaf] Systaim GmbH, Zurich, Switzerland; [Elgart, George] Univ Miami, Dept Dermatol & Cutaneous Surg, Miami, FL USA; [Milikowski, Clara] Univ Miami, Dept Pathol, Miami, FL USA; [DeFazio, R. Anthony] Univ Miami, Dept Neurol, Miami, FL USA	University of Miami; University of Miami; University of Miami; University of Miami; University of Miami	Abaffy, T (corresponding author), Univ Miami, Miller Sch Med, Dept Epidemiol & Publ Hlth, Div Biostat, Miami, FL 33136 USA.	tabaffy@med.miami.edu	Abaffy, Tatjana/C-2071-2015; DeFazio, Richard/AFO-0041-2022	DeFazio, Richard/0000-0001-7302-7528; milikowski, clara/0000-0002-6410-2300	University of Miami; Florida Biomedical Bankhead-Coley Research Program; National Institutes of Health (NIH) National Cancer Institute (NCI) [R21CA 132046]; NATIONAL CANCER INSTITUTE [R21CA132046] Funding Source: NIH RePORTER	University of Miami; Florida Biomedical Bankhead-Coley Research Program; National Institutes of Health (NIH) National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the University of Miami (TA), Florida Biomedical Bankhead-Coley Research Program (TA) and from National Institutes of Health (NIH) National Cancer Institute (NCI) R21CA 132046 (TA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajtarevic A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-348; BALARD B, 1989, MUTAT RES, V219, P71, DOI 10.1016/0921-8734(89)90042-8; BAMSHAD J, 1964, J INVEST DERMATOL, V43, P111, DOI 10.1038/jid.1964.125; Benevenga NJ, 2007, AM J CLIN NUTR, V85, P946, DOI 10.1093/ajcn/85.4.946; BENJAMIN RC, 1980, J BIOL CHEM, V255, P493; Bernier UR, 2000, ANAL CHEM, V72, P747, DOI 10.1021/ac990963k; Bickers DR, 2006, J INVEST DERMATOL, V126, P2565, DOI 10.1038/sj.jid.5700340; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Cellarier E, 2003, CANCER TREAT REV, V29, P489, DOI 10.1016/S0305-7372(03)00118-X; Chan HP, 2009, LUNG CANCER, V63, P164, DOI 10.1016/j.lungcan.2008.05.020; D'Amico A, 2008, SKIN RES TECHNOL, V14, P226, DOI 10.1111/j.1600-0846.2007.00284.x; De Marzo AM, 1999, CANCER RES, V59, P3855; Deng CH, 2004, J CHROMATOGR B, V808, P269, DOI 10.1016/j.jchromb.2004.05.015; Dettmer K, 2004, ENVIRON HEALTH PERSP, V112, pA396; Dettmer K, 2007, MASS SPECTROM REV, V26, P51, DOI 10.1002/mas.20108; Dunn WB, 2008, INT J EPIDEMIOL, V37, P23, DOI 10.1093/ije/dym281; Gallagher M, 2008, BRIT J DERMATOL, V159, P780, DOI 10.1111/j.1365-2133.2008.08748.x; GHOLSON RK, 1966, NATURE, V212, P933, DOI 10.1038/212933a0; Griffin JL, 2004, NAT REV CANCER, V4, P551, DOI 10.1038/nrc1390; Haze S, 2001, J INVEST DERMATOL, V116, P520, DOI 10.1046/j.0022-202x.2001.01287.x; HOFFMAN RM, 1985, ANTICANCER RES, V5, P1; Horst B, 2009, AM J PATHOL, V174, P1524, DOI 10.2353/ajpath.2009.080543; Horvath I, 2009, EUR RESPIR J, V34, P261, DOI 10.1183/09031936.00142508; Howell PM, 2009, CANCER CONTROL, V16, P200, DOI 10.1177/107327480901600302; Ji J, 2006, TALANTA, V69, P894, DOI 10.1016/j.talanta.2005.11.032; Lee BWK, 2010, J AM CHEM SOC, V132, P3642, DOI 10.1021/ja908995p; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Lin WS, 1997, J BIOL CHEM, V272, P11895, DOI 10.1074/jbc.272.18.11895; Mazzone PJ, 2008, J THORAC ONCOL, V3, P774, DOI 10.1097/JTO.0b013e31817c7439; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Montgomery BD, 2009, CAN FAM PHYSICIAN, V55, P24; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; Olivares C, 2009, PIGM CELL MELANOMA R, V22, P750, DOI 10.1111/j.1755-148X.2009.00636.x; Oliver SG, 2002, PHILOS T R SOC B, V357, P17, DOI 10.1098/rstb.2001.1049; Pawliszyn J, 2000, J CHROMATOGR SCI, V38, P270, DOI 10.1093/chromsci/38.7.270; Pfahlberg A, 2004, PREV MED, V38, P382, DOI 10.1016/j.ypmed.2003.11.015; Phillips Michael, 2007, Cancer Biomarkers, V3, P95; Phillips Michael, 2003, Breast J, V9, P184, DOI 10.1046/j.1524-4741.2003.09309.x; Risticevic S, 2009, ANAL BIOANAL CHEM, V393, P781, DOI 10.1007/s00216-008-2375-3; Rivers JK, 2004, LANCET, V363, P728, DOI 10.1016/S0140-6736(04)15649-3; Robertson KD, 1999, NUCLEIC ACIDS RES, V27, P2291, DOI 10.1093/nar/27.11.2291; Saghatelian A, 2004, BIOCHEMISTRY-US, V43, P14332, DOI 10.1021/bi0480335; Sanchez-del-Campo L, 2008, INT J CANCER, V123, P2446, DOI 10.1002/ijc.23813; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Smit NPM, 1995, BIOCHEM PHARMACOL, V50, P1955, DOI 10.1016/0006-2952(95)00243-X; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Stepien K, 2009, J AM SOC MASS SPECTR, V20, P464, DOI 10.1016/j.jasms.2008.11.003; Tagore R, 2008, J AM CHEM SOC, V130, P14111, DOI 10.1021/ja806463c; Takata M, 2010, PIGM CELL MELANOMA R, V23, P64, DOI 10.1111/j.1755-148X.2009.00645.x; Urayama S, 2010, RAPID COMMUN MASS SP, V24, P613, DOI 10.1002/rcm.4420; Viros A, 2008, PLOS MED, V5, P941, DOI 10.1371/journal.pmed.0050120; ZHANG ZY, 1993, ANAL CHEM, V65, P1843, DOI 10.1021/ac00062a008	53	51	53	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e13813	10.1371/journal.pone.0013813	http://dx.doi.org/10.1371/journal.pone.0013813			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079799	gold, Green Published, Green Submitted			2022-12-25	WOS:000283838600006
J	Pinos, T; Barbosa-Desongles, A; Hurtado, A; Santamaria-Martinez, A; de Torres, I; Reventos, J; Munell, F				Pinos, Tomas; Barbosa-Desongles, Anna; Hurtado, Antoni; Santamaria-Martinez, Albert; de Torres, Ines; Reventos, Jaume; Munell, Francina			Human SHBG mRNA Translation Is Modulated by Alternative 5 '-Non-Coding Exons 1A and 1B	PLOS ONE			English	Article							HORMONE-BINDING GLOBULIN; PROTEIN; 5'-UTR; GENE; EXPRESSION; INITIATION; ISOFORM	Background: The human sex hormone-binding globulin (SHBG) gene comprises at least 6 different transcription units (TU-1, -1A,-1B,-1C,-1D and -1E), and is regulated by no less than 6 different promoters. The best characterized are TU-1 and TU-1A: TU-1 is responsible for producing plasma SHBG, while TU-1A is transcribed and translated in the testis. Transcription of the recently described TU-1B,-1C, and-1D has been demonstrated in human prostate tissue and prostate cancer cell lines, as well as in other human cell lines such as HeLa, HepG2, HeK 293, CW 9019 and imr 32. However, there are no reported data demonstrating their translation. In the present study, we aimed to determine whether TU-1A and TU-1B are indeed translated in the human prostate and whether 5' UTR exons 1A and 1B differently regulate SHBG translation. Results: Cis-regulatory elements that could potentially regulate translation were identified within the 5'UTRs of SHBG TU-1A and TU-1B. Although full-length SHBG TU-1A and TU-1B mRNAs were present in prostate cancer cell lines, the endogenous SHBG protein was not detected by western blot in any of them. LNCaP prostate cancer cells transfected with several SHBG constructs containing exons 2 to 8 but lacking the 5'UTR sequence did show SHBG translation, whereas inclusion of the 5'UTR sequences of either exon 1A or 1B caused a dramatic decrease in SHBG protein levels. The molecular weight of SHBG did not vary between cells transfected with constructs with or without the 5'UTR sequence, thus confirming that the first in-frame ATG of exon 2 is the translation start site of TU-1A and TU-1B. Conclusions: The use of alternative SHBG first exons 1A and 1B differentially inhibits translation from the ATG situated in exon 2, which codes for methionine 30 of transcripts that begin with the exon 1 sequence.	[Pinos, Tomas; Barbosa-Desongles, Anna; Hurtado, Antoni; Santamaria-Martinez, Albert; Reventos, Jaume; Munell, Francina] Inst Recerca Hosp Univ Vall Hebron, Barcelona, Spain; [Pinos, Tomas] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Valencia, Spain; [de Torres, Ines] Hosp Univ Vall Hebron, Serv Anat Patol, Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitari Vall d'Hebron	Pinos, T (corresponding author), Inst Recerca Hosp Univ Vall Hebron, Barcelona, Spain.	fmunell@ir.vhebron.net	Reventos, Jaume/I-1633-2012; Santamaria-Martínez, Albert/X-1411-2018	Santamaria-Martínez, Albert/0000-0001-5436-9207; Munell Casadesus, Francina/0000-0001-8580-2819; Hurtado, Antoni/0000-0002-0145-4763	Ministerio de Sanidad y Consumo, Fundacion para la Investigacion en Urologia [PI052684]	Ministerio de Sanidad y Consumo, Fundacion para la Investigacion en Urologia	This work was supported by grants from the Ministerio de Sanidad y Consumo (PI052684), Fundacion para la Investigacion en Urologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araud T, 2007, NUCLEIC ACIDS RES, V35, P4649, DOI 10.1093/nar/gkm482; Babendure JR, 2006, RNA, V12, P851, DOI 10.1261/rna.2309906; Baek D, 2007, GENOME RES, V17, P145, DOI 10.1101/gr.5872707; Davuluri RV, 2000, GENOME RES, V10, P1807, DOI 10.1101/gr.GR-1460R; GERSHAGEN S, 1989, NUCLEIC ACIDS RES, V17, P9245, DOI 10.1093/nar/17.22.9245; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Gupta R., BMC BIOINFORMATIC S1, V11, pS65; HAMMOND GL, 1989, MOL ENDOCRINOL, V3, P1869, DOI 10.1210/mend-3-11-1869; Iadevaia V, 2008, RNA, V14, P1730, DOI 10.1261/rna.1037108; Janne M, 1998, J BIOL CHEM, V273, P34105, DOI 10.1074/jbc.273.51.34105; JOSEPH DR, 1994, VITAM HORM, V49, P197; KOZAK M, 1986, P NATL ACAD SCI USA, V83, P2850, DOI 10.1073/pnas.83.9.2850; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; Nakhla AM, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-37; Nie L, 2006, GENETICS, V174, P2229, DOI 10.1534/genetics.106.065862; Pickering BM, 2005, SEMIN CELL DEV BIOL, V16, P39, DOI 10.1016/j.semcdb.2004.11.006; Pinos T, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-59; Raveh-Amit H, 2009, MOL CELL BIOL, V29, P6140, DOI 10.1128/MCB.01044-09; Resch AM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-162; Roberts AG, 2005, FEBS LETT, V579, P1061, DOI 10.1016/j.febslet.2004.12.080; Selva DM, 2006, HORM METAB RES, V38, P230, DOI 10.1055/s-2006-925336; Selva DM, 2005, J CLIN ENDOCR METAB, V90, P6275, DOI 10.1210/jc.2005-1192; Selva DM, 2002, J BIOL CHEM, V277, P45291, DOI 10.1074/jbc.M205903200; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Wang GD, 2005, AM J PHYSIOL-GASTR L, V289, pG614, DOI 10.1152/ajpgi.00119.2005; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	26	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e13844	10.1371/journal.pone.0013844	http://dx.doi.org/10.1371/journal.pone.0013844			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079794	Green Submitted, Green Published, gold			2022-12-25	WOS:000283838600018
J	Xiang, YW; Xu, GL; Weigel-Van Aken, KAK				Xiang, Yiwen; Xu, Guilian; Weigel-Van Aken, Kirsten A. K.			Lactic Acid Induces Aberrant Amyloid Precursor Protein Processing by Promoting Its Interaction with Endoplasmic Reticulum Chaperone Proteins	PLOS ONE			English	Article							BETA-SECRETASE SITE; ENERGY-METABOLISM; HUMAN BRAIN; NEURODEGENERATIVE DISEASES; MITOCHONDRIAL-FUNCTION; LACTATE; STRESS; EXERCISE; CELLS; ACCUMULATION	Background: Lactic acid, a natural by-product of glycolysis, is produced at excess levels in response to impaired mitochondrial function, high-energy demand, and low oxygen availability. The enzyme involved in the production of beta-amyloid peptide (A beta) of Alzheimer's disease, BACE1, functions optimally at lower pH, which led us to investigate a potential role of lactic acid in the processing of amyloid precursor protein (APP). Methodology/Principal Findings: Lactic acid increased levels of A beta 40 and 42, as measured by ELISA, in culture medium of human neuroblastoma cells (SH-SY5Y), whereas it decreased APP metabolites, such as sAPP alpha. In cell lysates, APP levels were increased and APP was found to interact with ER-chaperones in a perinuclear region, as determined by co-immunoprecipitation and fluorescence microscopy studies. Lactic acid had only a very modest effect on cellular pH, did increase the levels of ER chaperones Grp78 and Grp94 and led to APP aggregate formation reminiscent of aggresomes. Conclusions/Significance: These findings suggest that sustained elevations in lactic acid levels could be a risk factor in amyloidogenesis related to Alzheimer's disease through enhanced APP interaction with ER chaperone proteins and aberrant APP processing leading to increased generation of amyloid peptides and APP aggregates.	[Xiang, Yiwen; Weigel-Van Aken, Kirsten A. K.] Univ Florida, Coll Med, Div Cellular & Mol Therapy, Dept Pediat, Gainesville, FL 32611 USA; [Weigel-Van Aken, Kirsten A. K.] Univ Florida, Coll Med, Powell Gene Therapy Ctr, Gainesville, FL USA; [Weigel-Van Aken, Kirsten A. K.] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Xu, Guilian] Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Xiang, YW (corresponding author), Univ Florida, Coll Med, Div Cellular & Mol Therapy, Dept Pediat, Gainesville, FL 32611 USA.	weigel@ufl.edu			Santa Fe Health Care Alzheimer's Disease Research Center; National Institutes of Health [NS 044278]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044278] Funding Source: NIH RePORTER	Santa Fe Health Care Alzheimer's Disease Research Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the Santa Fe Health Care Alzheimer's Disease Research Center and the National Institutes of Health (NS 044278). The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama K, 2005, J CEREBR BLOOD F MET, V25, P358, DOI 10.1038/sj.jcbfm.9600043; Bai Y, 2008, MOL CELL PROTEOMICS, V7, P15, DOI 10.1074/mcp.M700077-MCP200; Brody DL, 2008, SCIENCE, V321, P1221, DOI 10.1126/science.1161591; Coco M, 2009, BRAIN RES, V1302, P205, DOI 10.1016/j.brainres.2009.09.032; Dalsgaard MK, 2004, J PHYSIOL-LONDON, V554, P571, DOI 10.1113/jphysiol.2003.055053; Debray FG, 2008, CURR OPIN PEDIATR, V20, P471, DOI 10.1097/MOP.0b013e328306ebb6; Evans CG, 2006, J BIOL CHEM, V281, P33182, DOI 10.1074/jbc.M606192200; FEDDERSEN K, 1986, ANN THORAC SURG, V41, P395, DOI 10.1016/S0003-4975(10)62694-X; GARDINER M, 1982, J CEREBR BLOOD F MET, V2, P429, DOI 10.1038/jcbfm.1982.49; Hoshino T, 2007, BIOCHEM J, V402, P581, DOI 10.1042/BJ20061318; Kudo T, 2006, BIOCHEM BIOPH RES CO, V344, P525, DOI 10.1016/j.bbrc.2006.03.173; Ladilov Y, 2000, CARDIOVASC RES, V47, P394, DOI 10.1016/S0008-6363(00)00108-5; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; MADUREIRA G, 1988, COMP BIOCHEM PHYS A, V89, P693, DOI 10.1016/0300-9629(88)90854-7; NORBERG K, 1975, ACTA PHYSIOL SCAND, V95, P301, DOI 10.1111/j.1748-1716.1975.tb10054.x; Olzmann JA, 2008, CURR MED CHEM, V15, P47; Peraus GC, 1997, J NEUROSCI, V17, P7714; Quistorff B, 2008, FASEB J, V22, P3443, DOI 10.1096/fj.08-106104; Redjems-Bennani N, 1998, GERONTOLOGY, V44, P300, DOI 10.1159/000022031; Schurr A, 2002, INT J MOL MED, V10, P131, DOI 10.3892/ijmm.10.2.131; Siesjo B K, 1982, Ciba Found Symp, V87, P77, DOI 10.1002/9780470720691.ch5; Steiner H, 2008, CURR ALZHEIMER RES, V5, P147, DOI 10.2174/156720508783954677; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; Um HS, 2008, INT J MOL MED, V22, P529, DOI 10.3892/ijmm_00000052; Vantelon N, 2007, EUR J NEUROSCI, V26, P689, DOI 10.1111/j.1460-9568.2007.05698.x; Wolfe MS, 2007, J CELL SCI, V120, P3157, DOI 10.1242/jcs.03481; YAMAKAWA H, J BIOL CHEM, V285, P1634; Yang YN, 1998, J BIOL CHEM, V273, P25552, DOI 10.1074/jbc.273.40.25552	30	18	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e13820	10.1371/journal.pone.0013820	http://dx.doi.org/10.1371/journal.pone.0013820			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21072203	Green Published, gold			2022-12-25	WOS:000283780800018
J	Ammosova, T; Yedavalli, VRK; Niu, XM; Jerebtsova, M; Van Eynde, A; Beullens, M; Bollen, M; Jeang, KT; Nekhai, S				Ammosova, Tatiana; Yedavalli, Venkat R. K.; Niu, Xiaomei; Jerebtsova, Marina; Van Eynde, Aleyde; Beullens, Monique; Bollen, Mathieu; Jeang, Kuan-Teh; Nekhai, Sergei			Expression of a Protein Phosphatase 1 Inhibitor, cdNIPP1, Increases CDK9 Threonine 186 Phosphorylation and Inhibits HIV-1 Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; LONG-TERMINAL REPEAT; P-TEFB; TAT TRANSACTIVATION; CYCLIN T1; 7SK SNRNA; KINASE; VIRUS; ACETYLATION; ELONGATION	CDK9/cyclin T1, a key enzyme in HIV-1 transcription, is negatively regulated by 7SK RNA and the HEXIM1 protein. Dephosphorylation of CDK9 on Thr(186) by protein phosphatase 1 (PP1) in stress-induced cells or by protein phosphatase M1A in normally growing cells activates CDK9. Our previous studies showed that HIV-1 Tat protein binds to PP1 through the Tat Q(35)VCF(38) sequence, which is similar to the PP1-binding RVXF motif and that this interaction facilitates HIV-1 transcription. In the present study, we analyzed the effect of expression of the central domain of nuclear inhibitor of PP1 (cdNIPP1) in an engineered cell line and also when cdNIPP1 was expressed as part of HIV-1 pNL4-3 in place of nef. Stable expression of cdNIPP1 increased CDK9 phosphorylation on Thr(186) and the association of CDK9 with 7SK RNA. The stable expression of cdNIPP1 disrupted the interaction of Tat and PP1 and inhibited HIV-1 transcription. Expression of cdNIPP1 as a part of the HIV-1 genome inhibited HIV-1 replication. Our study provides a proof-of-concept for the future development of PP1-targeting compounds as inhibitors of HIV-1 replication.	[Ammosova, Tatiana; Niu, Xiaomei; Nekhai, Sergei] Howard Univ, Ctr Sickle Cell Dis, Washington, DC 20001 USA; [Yedavalli, Venkat R. K.; Jeang, Kuan-Teh] NIAID, Natl Inst Hlth, Mol Virol Sect, Mol Microbiol Lab, Bethesda, MD 20817 USA; [Jerebtsova, Marina] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Van Eynde, Aleyde; Beullens, Monique; Bollen, Mathieu] Catholic Univ Louvain, Dept Mol Cell Biol, B-3000 Louvain, Belgium	Howard University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Children's National Health System; Universite Catholique Louvain	Nekhai, S (corresponding author), Howard Univ, Ctr Sickle Cell Dis, 1840 7th St NW,HURB1,Suite 202, Washington, DC 20001 USA.	snekhai@howard.edu	, nekhai/AFO-2652-2022; , nekhai/AAW-3105-2021; Jeang, Kuan-Teh/A-2424-2008; Ammosova, Tatiana/J-7564-2018; Ammosova, Tatiana/HIA-0704-2022	Ammosova, Tatiana/0000-0001-8777-1032; 	National Institutes of Health Research by NHLBI [2 R25 HL003679-12]; Office of Research on Minority by National Institute for General Medical Sciences [1SC1GM082325-03]; Howard University; Research Centers in Minority Institutions Program, Division of Research Infrastructure, National Center for Research Resources, National Institutes of Health [RCMI-NIH 2G12RR003048-22]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003048] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R25HL003679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC1GM082325] Funding Source: NIH RePORTER	National Institutes of Health Research by NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Office of Research on Minority by National Institute for General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard University; Research Centers in Minority Institutions Program, Division of Research Infrastructure, National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Research Grant 2 R25 HL003679-12 funded by the NHLBI. This work was also supported by the Office of Research on Minority, Grant 1SC1GM082325-03, funded by the National Institute for General Medical Sciences; by a Howard University Seed Grant (to S. N.); and by Grant RCMI-NIH 2G12RR003048-22 from the Research Centers in Minority Institutions Program, Division of Research Infrastructure, National Center for Research Resources, National Institutes of Health.	Ali SA, 2010, AIDS RES HUM RETROV, V26, P173, DOI 10.1089/aid.2009.0068; Ammosova T, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-47; Ammosova T, 2005, J BIOL CHEM, V280, P36364, DOI 10.1074/jbc.M503673200; Ammosova T, 2003, J BIOL CHEM, V278, P32189, DOI 10.1074/jbc.M300521200; Barboric M, 2007, NUCLEIC ACIDS RES, V35, P2003, DOI 10.1093/nar/gkm063; Beullens M, 2000, BIOCHEM J, V352, P651, DOI 10.1042/0264-6021:3520651; Bharucha DC, 2002, VIROLOGY, V296, P6, DOI 10.1006/viro.2002.1438; Bollen M, 2002, TRENDS CELL BIOL, V12, P138, DOI 10.1016/S0962-8924(01)02247-4; Bollen M, 2001, TRENDS BIOCHEM SCI, V26, P426, DOI 10.1016/S0968-0004(01)01836-9; Ceulemans H, 2002, J BIOL CHEM, V277, P47331, DOI 10.1074/jbc.M206838200; Chen RC, 2004, J BIOL CHEM, V279, P4153, DOI 10.1074/jbc.M310044200; Chen RC, 2008, GENE DEV, V22, P1356, DOI 10.1101/gad.1636008; Chirmule N, 1999, GENE THER, V6, P1574, DOI 10.1038/sj.gt.3300994; Chun RF, 1998, J VIROL, V72, P2615, DOI 10.1128/JVI.72.4.2615-2629.1998; DEGUZMAN A, 1988, METHOD ENZYMOL, V159, P356; Deng LW, 2002, J BIOL CHEM, V277, P33922, DOI 10.1074/jbc.M111349200; Deng LW, 2000, VIROLOGY, V277, P278, DOI 10.1006/viro.2000.0593; Dey A, 2009, MOL BIOL CELL, V20, P4899, DOI 10.1091/mbc.E09-05-0380; Garber ME, 1998, COLD SPRING HARB SYM, V63, P371, DOI 10.1101/sqb.1998.63.371; Hendrickx A, 2009, CHEM BIOL, V16, P365, DOI 10.1016/j.chembiol.2009.02.012; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jerebtsova M, 2011, MOL CELL BIOCHEM, V347, P79, DOI 10.1007/s11010-010-0614-3; Jochmann R, 2009, J VIROL, V83, P3704, DOI 10.1128/JVI.01384-08; Kiernan RE, 1999, EMBO J, V18, P6106, DOI 10.1093/emboj/18.21.6106; Lesage B, 2004, J BIOL CHEM, V279, P55978, DOI 10.1074/jbc.M411911200; Li QT, 2005, J BIOL CHEM, V280, P28819, DOI 10.1074/jbc.M502712200; Michels AA, 2003, MOL CELL BIOL, V23, P4859, DOI 10.1128/MCB.23.14.4859-4869.2003; Nekhai S, 2007, ONCOGENE, V26, P3899, DOI 10.1038/sj.onc.1210158; Nekhai S, 2006, FUTURE MICROBIOL, V1, P417, DOI 10.2217/17460913.1.4.417; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Ott M, 1999, CURR BIOL, V9, P1489, DOI 10.1016/S0960-9822(00)80120-7; Vanham G, 2000, AIDS, V14, P2299, DOI 10.1097/00002030-200010200-00011; Wang Y, 2008, J BIOL CHEM, V283, P33578, DOI 10.1074/jbc.M807495200; Washington K, 2002, J BIOL CHEM, V277, P40442, DOI 10.1074/jbc.M205687200; Yang XZ, 1997, P NATL ACAD SCI USA, V94, P12331, DOI 10.1073/pnas.94.23.12331; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575; Yedavalli VSRK, 2003, J BIOL CHEM, V278, P6404, DOI 10.1074/jbc.M209162200; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5; Zhang Y, 2008, J BIOL CHEM, V283, P24039, DOI 10.1074/jbc.M801878200; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	41	37	38	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3798	3804		10.1074/jbc.M110.196493	http://dx.doi.org/10.1074/jbc.M110.196493			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21098020	Green Published, hybrid			2022-12-25	WOS:000286653200061
J	Qi, YN; Chuah, MLC; Dong, XM; Xie, KL; Luo, Z; Tang, K; Liang, ZX				Qi, Yaning; Chuah, Mary Lay Cheng; Dong, Xueming; Xie, Kailing; Luo, Zhen; Tang, Kai; Liang, Zhao-Xun			Binding of Cyclic Diguanylate in the Non-catalytic EAL Domain of FimX Induces a Long-range Conformational Change	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-DI-GMP; PSEUDOMONAS-AERUGINOSA; ALCOHOL-DEHYDROGENASE; STRUCTURAL-ANALYSIS; TWITCHING MOTILITY; PROTEIN DOMAIN; PHOSPHODIESTERASE; MECHANISM; DEGRADATION; BACTERIA	FimX is a multidomain signaling protein required for type IV pilus biogenesis and twitching motility in the opportunistic pathogen Pseudomonas aeruginosa. FimX is localized to the single pole of the bacterial cell, and the unipolar localization is crucial for the correct assembly of type IV pili. FimX contains a non-catalytic EAL domain that lacks cyclic diguanylate (c-di-GMP) phosphodiesterase activity. It was shown that deletion of the EAL domain or mutation of the signature EVL motif affects the unipolar localization of FimX. However, it was not understood how the C-terminal EAL domain could influence protein localization considering that the localization sequence resides in the remote N-terminal region of the protein. Using hydrogen/deuterium exchange-coupled mass spectrometry, we found that the binding of c-di-GMP to the EAL domain triggers a long-range (similar to ca. 70 angstrom) conformational change in the N-terminal REC domain and the adjacent linker. In conjunction with the observation that mutation of the EVL motif of the EAL domain abolishes the binding of c-di-GMP, the hydrogen/deuterium exchange results provide a molecular explanation for the mediation of protein localization and type IV pilus biogenesis by c-di-GMP through a remarkable allosteric regulation mechanism.	[Qi, Yaning; Chuah, Mary Lay Cheng; Dong, Xueming; Xie, Kailing; Luo, Zhen; Tang, Kai; Liang, Zhao-Xun] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Liang, ZX (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	zxliang@ntu.edu	Liang, Zhao-Xun/A-2191-2011; Dong, Xueming/M-2137-2017; Tang, Kai/A-2194-2011	Liang, Zhao-Xun/0000-0002-3128-1330; Dong, Xueming/0000-0001-8726-7565	Biomedical Research Council [06/1/22/19/464]; University Research Council [RG62/06]	Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); University Research Council	This work was supported by Biomedical Research Council Grant 06/1/22/19/464 (to Z.-X. L.) and University Research Council Grant RG62/06 (to K. T.).	Barends TRM, 2009, NATURE, V459, P1015, DOI 10.1038/nature07966; Boehm A, 2010, CELL, V141, P107, DOI 10.1016/j.cell.2010.01.018; Christen B, 2006, J BIOL CHEM, V281, P32015, DOI 10.1074/jbc.M603589200; Djordjevic S, 1998, P NATL ACAD SCI USA, V95, P1381, DOI 10.1073/pnas.95.4.1381; Duerig A, 2009, GENE DEV, V23, P93, DOI 10.1101/gad.502409; Fang X, 2010, MOL MICROBIOL, V76, P1295, DOI 10.1111/j.1365-2958.2010.07179.x; Guhaniyogi J, 2008, J BACTERIOL, V190, P1419, DOI 10.1128/JB.01414-07; Guzzo CR, 2009, J MOL BIOL, V393, P848, DOI 10.1016/j.jmb.2009.07.065; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Hoofnagle AN, 2003, ANNU REV BIOPH BIOM, V32, P1, DOI 10.1146/annurev.biophys.32.110601.142417; Huang BX, 2003, J BACTERIOL, V185, P7068, DOI 10.1128/JB.185.24.7068-7076.2003; Kazmierczak BI, 2006, MOL MICROBIOL, V60, P1026, DOI 10.1111/j.1365-2958.2006.05156.x; Kulesekara H, 2006, P NATL ACAD SCI USA, V103, P2839, DOI 10.1073/pnas.0511090103; Liang ZX, 2004, BIOCHEMISTRY-US, V43, P14676, DOI 10.1021/bi049004x; Liang ZX, 2004, P NATL ACAD SCI USA, V101, P9556, DOI 10.1073/pnas.0403337101; Navarro MVAS, 2009, STRUCTURE, V17, P1104, DOI 10.1016/j.str.2009.06.010; Newell PD, 2009, P NATL ACAD SCI USA, V106, P3461, DOI 10.1073/pnas.0808933106; Pasunooti S, 2010, J MOL CATAL B-ENZYM, V67, P98, DOI 10.1016/j.molcatb.2010.07.012; Paul K, 2010, MOL CELL, V38, P128, DOI 10.1016/j.molcel.2010.03.001; Qi YN, 2009, BIOCHEMISTRY-US, V48, P10275, DOI 10.1021/bi901121w; Rao F, 2008, J BACTERIOL, V190, P3622, DOI 10.1128/JB.00165-08; Rao F, 2010, J BIOL CHEM, V285, P473, DOI 10.1074/jbc.M109.040238; Rao F, 2009, J BACTERIOL, V191, P4722, DOI 10.1128/JB.00327-09; Rao F, 2009, ANAL BIOCHEM, V389, P138, DOI 10.1016/j.ab.2009.03.031; Robinson VL, 2003, J BACTERIOL, V185, P4186, DOI 10.1128/JB.185.14.4186-4194.2003; Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x; Ryjenkov DA, 2005, J BACTERIOL, V187, P1792, DOI 10.1128/JB.187.5.1792-1798.2005; Ryjenkov DA, 2006, J BIOL CHEM, V281, P30310, DOI 10.1074/jbc.C600179200; Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Suzuki K, 2006, GENE DEV, V20, P2605, DOI 10.1101/gad.1461606; Tamayo R, 2005, J BIOL CHEM, V280, P33324, DOI 10.1074/jbc.M506500200; Tschowri N, 2009, GENE DEV, V23, P522, DOI 10.1101/gad.499409; Weis DD, 2006, J AM SOC MASS SPECTR, V17, P1700, DOI 10.1016/j.jasms.2006.07.025; Ye S, 2004, J BIOL CHEM, V279, P20511, DOI 10.1074/jbc.M400077200	35	56	59	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2910	2917		10.1074/jbc.M110.196220	http://dx.doi.org/10.1074/jbc.M110.196220			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21098028	hybrid, Green Published			2022-12-25	WOS:000286464300055
J	Csepeggi, C; Jiang, M; Kojima, F; Crofford, LJ; Frolov, A				Csepeggi, Chad; Jiang, Min; Kojima, Fumiaki; Crofford, Leslie J.; Frolov, Andrey			Somatic Cell Plasticity and Niemann-Pick Type C2 Protein FIBROBLAST ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR CHOLESTEROL TRAFFICKING; DENSITY-LIPOPROTEIN CHOLESTEROL; EPIDERMAL-GROWTH-FACTOR; DISEASE TYPE-C; RHEUMATOID-ARTHRITIS; STEM-CELLS; MYOFIBROBLAST DIFFERENTIATION; FUNCTIONAL-CHARACTERIZATION; SYNOVIAL FIBROBLASTS; CARDIAC FIBROBLASTS	A growing body of evidence points toward activated fibroblasts, also known as myofibroblasts, as one of the leading mediators in several major human pathologies including proliferative fibrotic disorders, invasive tumor growth, rheumatoid arthritis, and atherosclerosis. Niemann-Pick Type C2 (NPC2) protein has been recently identified as a product of the second gene in NPC disease. It encodes ubiquitous, highly conserved, secretory protein with the poorly defined function. Here we show that NPC2 deficiency in human fibroblasts confers their activation. The activation phenomenon was not limited to fibroblasts as it was also observed in aortic smooth muscle cells upon silencing NPC2 gene by siRNA. More importantly, activated synovial fibroblasts isolated from patients with rheumatoid arthritis were also identified as NPC2-deficient at both the NPC2 mRNA and protein levels. The molecular mechanism responsible for activation of NPC2-null cells was shown to be a sustained phosphorylation of ERK 1/2 mitogen-activated protein kinase ( MAPK), which fulfills both the sufficient and necessary fibroblast activation criteria. All of these findings highlight a novel mechanism where NPC2 by negatively regulating ERK 1/2 MAPK phosphorylation may efficiently suppress development of maladaptive tissue remodeling and inflammation.	[Kojima, Fumiaki; Crofford, Leslie J.; Frolov, Andrey] Univ Kentucky, Div Rheumatol, Dept Internal Med, Lexington, KY 40536 USA; [Csepeggi, Chad; Jiang, Min; Frolov, Andrey] Univ Cincinnati, Coll Med, Dept Internal Med, Div Cardiovasc Dis, Cincinnati, OH 45267 USA	University of Kentucky; University System of Ohio; University of Cincinnati	Frolov, A (corresponding author), Univ Kentucky, Div Rheumatol, Dept Internal Med, 900 S Limestone St,Wethington Hlth Sci Bldg,Rm 45, Lexington, KY 40536 USA.	andrey.frolov@uky.edu	Crofford, Leslie J/J-8010-2013	Crofford, Leslie J/0000-0002-6347-5738	National Institutes of Health [RO1AR049010]; American Heart Association [SDG 023017N]; University of Cincinnati; Department of Internal Medicine; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049010] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); University of Cincinnati; Department of Internal Medicine; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1AR049010 (to L. J. C.). This work was also supported by American Heart Association Scientist Development Grant SDG 023017N, the University of Cincinnati Millennium Fund, and the Department of Internal Medicine Start-Up Fund (to A. F.).	Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bjurulf B, 2008, MED SCI MONITOR, V14, pCS71; Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020; Chang TY, 2005, J BIOL CHEM, V280, P20917, DOI 10.1074/jbc.R400040200; Chintalgattu V, 2003, J MOL CELL CARDIOL, V35, P277, DOI 10.1016/S0022-2828(03)00006-3; Chung SW, 2008, J CLIN INVEST, V118, P239, DOI 10.1172/JCI32730; Corre J, 2006, J CELL PHYSIOL, V208, P282, DOI 10.1002/jcp.20655; Csepeggi C, 2010, J BIOL CHEM, V285, P30347, DOI 10.1074/jbc.M110.135939; Davies JP, 2000, SCIENCE, V290, P2295, DOI 10.1126/science.290.5500.2295; De Wever O, 2008, INT J CANCER, V123, P2229, DOI 10.1002/ijc.23925; Del Vecchio MA, 2001, ARTHRITIS RES, V3, P259, DOI 10.1186/ar311; Derynck R, 2007, NAT CELL BIOL, V9, P1000, DOI 10.1038/ncb434; Desmouliere A, 2005, WOUND REPAIR REGEN, V13, P7, DOI 10.1111/j.1067-1927.2005.130102.x; Dormeyer W, 2008, J PROTEOME RES, V7, P2936, DOI 10.1021/pr800056j; Dzau VJ, 2002, NAT MED, V8, P1249, DOI 10.1038/nm1102-1249; Ebihara N, 2007, INVEST OPHTH VIS SCI, V48, P3069, DOI 10.1167/iovs.06-0968; Eriksson M, 2007, J CELL PHYSIOL, V210, P538, DOI 10.1002/jcp.20907; Erwig LP, 2006, P NATL ACAD SCI USA, V103, P12825, DOI 10.1073/pnas.0605331103; Faggin E, 1999, ARTERIOSCL THROM VAS, V19, P1393, DOI 10.1161/01.ATV.19.6.1393; Friedland N, 2003, P NATL ACAD SCI USA, V100, P2512, DOI 10.1073/pnas.0437840100; Frolov A, 2003, J BIOL CHEM, V278, P25517, DOI 10.1074/jbc.M302588200; Frolov A, 2001, J BIOL CHEM, V276, P46414, DOI 10.1074/jbc.M108099200; Gabriel SE, 2008, AM J MED, V121, P9, DOI 10.1016/j.amjmed.2008.06.011; Gardai SJ, 2004, J BIOL CHEM, V279, P44695, DOI 10.1074/jbc.M405313200; Gillibert-Duplantier J, 2007, AM J PHYSIOL-GASTR L, V293, pG128, DOI 10.1152/ajpgi.00031.2007; Goldman SDB, 2010, J BIOL CHEM, V285, P4983, DOI 10.1074/jbc.M109.037622; GONG QQ, 1995, J BIOL CHEM, V270, P21672, DOI 10.1074/jbc.270.37.21672; Gressner OA, 2008, J GASTROEN HEPATOL, V23, P1024, DOI 10.1111/j.1440-1746.2008.05345.x; Grotendorst GR, 2004, FASEB J, V18, P469, DOI 10.1096/fj.03-0699com; Haniffa MA, 2009, HAEMATOL-HEMATOL J, V94, P258, DOI 10.3324/haematol.13699; Haque S, 2008, CURR OPIN LIPIDOL, V19, P338, DOI 10.1097/MOL.0b013e328304b65f; Heo K, 2006, STEM CELLS, V24, P1549, DOI 10.1634/stemcells.2005-0458; Herrmann J, 2005, ARTERIOSCL THROM VAS, V25, P447, DOI 10.1161/01.ATV.0000152606.34120.97; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hobbs RM, 2003, J BIOL CHEM, V278, P19798, DOI 10.1074/jbc.M300513200; Hu CP, 2008, J BIOL CHEM, V283, P10226, DOI 10.1074/jbc.M708820200; Huber LC, 2006, RHEUMATOLOGY, V45, P669, DOI 10.1093/rheumatology/kel065; Junker JPE, 2010, CELLS TISSUES ORGANS, V191, P105, DOI 10.1159/000232157; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Karouzakis E, 2009, NAT REV RHEUMATOL, V5, P266, DOI 10.1038/nrrheum.2009.55; Kaufmann AM, 2008, J BIOL CHEM, V283, P24584, DOI 10.1074/jbc.M803715200; Kinnman N, 2000, LAB INVEST, V80, P697, DOI 10.1038/labinvest.3780073; Klein A, 2006, HEPATOLOGY, V43, P126, DOI 10.1002/hep.20985; Ko DC, 2003, P NATL ACAD SCI USA, V100, P2518, DOI 10.1073/pnas.0530027100; LE PT, 1991, J EXP MED, V174, P1147, DOI 10.1084/jem.174.5.1147; Li XL, 2006, P NATL ACAD SCI USA, V103, P17432, DOI 10.1073/pnas.0607939103; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Lloyd-Evans E, 2010, TRAFFIC, V11, P419, DOI 10.1111/j.1600-0854.2010.01032.x; Lopez-Bergami P, 2007, CANCER CELL, V11, P447, DOI 10.1016/j.ccr.2007.03.009; Lysy PA, 2007, HEPATOLOGY, V46, P1574, DOI 10.1002/hep.21839; Manabe I, 2002, CIRC RES, V91, P1103, DOI 10.1161/01.RES.0000046452.67724.B8; McAnulty RJ, 2007, INT J BIOCHEM CELL B, V39, P666, DOI 10.1016/j.biocel.2006.11.005; Millard EE, 2005, J BIOL CHEM, V280, P28581, DOI 10.1074/jbc.M414024200; Millat G, 2001, AM J HUM GENET, V69, P1013, DOI 10.1086/324068; Mor A, 2005, CLIN IMMUNOL, V115, P118, DOI 10.1016/j.clim.2004.12.009; Na SY, 2003, J IMMUNOL, V171, P1285, DOI 10.4049/jimmunol.171.3.1285; NAGAO S, 1986, J CUTAN PATHOL, V13, P261, DOI 10.1111/j.1600-0560.1986.tb01521.x; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; Naz SM, 2007, BEST PRACT RES CL RH, V21, P871, DOI 10.1016/j.berh.2007.05.003; Okamura DM, 2009, J AM SOC NEPHROL, V20, P495, DOI 10.1681/ASN.2008010009; Okamura N, 1999, BBA-MOL CELL BIOL L, V1438, P377, DOI 10.1016/S1388-1981(99)00070-0; Ospelt C, 2004, ANN RHEUM DIS, V63, P90, DOI 10.1136/ard.2004.028324; Santucci M, 2001, VIRCHOWS ARCH, V438, P457, DOI 10.1007/s004280000335; Sartore S, 2001, CIRC RES, V89, P1111, DOI 10.1161/hh2401.100844; Schlessinger J, 2004, SCIENCE, V306, P1506, DOI 10.1126/science.1105396; Schramek H, 1997, J BIOL CHEM, V272, P11426; Schramek H, 2003, AM J PHYSIOL-CELL PH, V285, pC652, DOI 10.1152/ajpcell.00463.2002; Schramek H, 1997, AM J PHYSIOL-CELL PH, V272, pC383, DOI 10.1152/ajpcell.1997.272.2.C383; Schrantz N, 2007, J EXP MED, V204, P841, DOI 10.1084/jem.20061562; Scotton CJ, 2007, CHEST, V132, P1311, DOI 10.1378/chest.06-2568; Sen M, 2000, P NATL ACAD SCI USA, V97, P2791, DOI 10.1073/pnas.050574297; Sleat DE, 2004, P NATL ACAD SCI USA, V101, P5886, DOI 10.1073/pnas.0308456101; Srikanth K. N., 2005, Sarcoma, V9, P33, DOI 10.1080/13577140500090030; Stenmark KR, 2006, PHYSIOLOGY, V21, P134, DOI 10.1152/physiol.00053.2005; Storch J, 2009, BBA-MOL CELL BIOL L, V1791, P671, DOI 10.1016/j.bbalip.2009.02.001; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tashiro K, 2009, J BIOL CHEM, V284, P20206, DOI 10.1074/jbc.M109.021139; van den Borne SWM, 2010, NAT REV CARDIOL, V7, P30, DOI 10.1038/nrcardio.2009.199; Van Doornum S, 2002, ARTHRITIS RHEUM-US, V46, P862, DOI 10.1002/art.10089; Vanier MT, 2003, CLIN GENET, V64, P269, DOI 10.1034/j.1399-0004.2003.00147.x; Verot L, 2007, CLIN GENET, V71, P320, DOI 10.1111/j.1399-0004.2007.00782.x; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Welch CL, 2007, CIRCULATION, V116, P2444, DOI 10.1161/CIRCULATIONAHA.107.701276; Wilcox JN, 2001, ANN NY ACAD SCI, V947, P68; Wilcox JN, 1996, INT J CARDIOL, V54, pS21, DOI 10.1016/S0167-5273(96)02811-2; Wojtanik KM, 2003, J BIOL CHEM, V278, P14850, DOI 10.1074/jbc.M300488200; Yamasaki S, 2002, CLIN EXP IMMUNOL, V129, P379, DOI 10.1046/j.1365-2249.2002.01876.x; Yanagimoto C, 2009, EXP CELL RES, V315, P119, DOI 10.1016/j.yexcr.2008.10.022; Yang M, 2004, FASEB J, V18, P1920, DOI 10.1096/fj.04-2357fje	92	12	13	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2078	2087		10.1074/jbc.M110.135897	http://dx.doi.org/10.1074/jbc.M110.135897			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21084287	hybrid, Green Published			2022-12-25	WOS:000286191500050
J	Hisano, Y; Kobayashi, N; Kawahara, A; Yamaguchi, A; Nishi, T				Hisano, Yu; Kobayashi, Naoki; Kawahara, Atsuo; Yamaguchi, Akihito; Nishi, Tsuyoshi			The Sphingosine 1-Phosphate Transporter, SPNS2, Functions as a Transporter of the Phosphorylated Form of the Immunomodulating Agent FTY720	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR EXPRESSION PROFILE; PROTEIN-COUPLED RECEPTORS; CANCER CELLS; SPHINGOSINE-1-PHOSPHATE LYASE; CERAMIDE SYNTHASES; MOLECULAR-CLONING; KINASE TYPE-2; PLATELETS; MIGRATION; RELEASE	FTY720 is a novel immunomodulating drug that can be phosphorylated inside cells; its phosphorylated form, FTY720-P, binds to a sphingosine 1-phosphate (S1P) receptor, S1P(1), and inhibits lymphocyte egress into the circulating blood. Although the importance of its pharmacological action has been well recognized, little is known about how FTY720-P is released from cells after its phosphorylation inside cells. Previously, we showed that zebrafish Spns2 can act as an S1P exporter from cells and is essential for zebrafish heart formation. Here, we demonstrate that human SPNS2 can transport several S1P analogues, including FTY720-P. Moreover, FTY720-P is transported by SPNS2 through the same pathway as S1P. This is the first identification of an FTY720-P transporter in cells; this finding is important for understanding FTY720 metabolism.	[Hisano, Yu; Kobayashi, Naoki; Yamaguchi, Akihito; Nishi, Tsuyoshi] Osaka Univ, Inst Sci & Ind Res, Dept Cell Membrane Biol, Osaka 5670047, Japan; [Kobayashi, Naoki] Teikyo Heisei Univ, Fac Pharmaceut Sci, Chiba 2900193, Japan; [Kawahara, Atsuo] Natl Cardiovasc Ctr, Res Inst, Dept Struct Anal, Osaka 5658565, Japan; [Yamaguchi, Akihito; Nishi, Tsuyoshi] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan	Osaka University; National Cerebral & Cardiovascular Center - Japan; Osaka University	Nishi, T (corresponding author), 8-1 Mihogaoka, Ibaraki, Osaka 5670047, Japan.	tnishi@sanken.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Takeda Science Foundation; Management Expenses Grants	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Management Expenses Grants	This study was supported by in part by the Management Expenses Grants for National Universities Corporations; a grant-in-aid for Scientific Research (S) (to A.Y.) and grants-in-aid for Scientific Research on Innovation and Scientific Research (C) (to T.N.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; and the Takeda Science Foundation (to T.N. and A.Y.).	Anada Y, 2007, EUR J PHARMACOL, V568, P106, DOI 10.1016/j.ejphar.2007.04.053; Anliker B, 2004, J BIOL CHEM, V279, P20555, DOI 10.1074/jbc.R400013200; Balthasar S, 2006, BIOCHEM J, V398, P547, DOI 10.1042/BJ20060299; Bandhuvula P, 2005, J BIOL CHEM, V280, P33697, DOI 10.1074/jbc.C500294200; Berdyshev EV, 2009, J BIOL CHEM, V284, P5467, DOI 10.1074/jbc.M805186200; Billich A, 2003, J BIOL CHEM, V278, P47408, DOI 10.1074/jbc.M307687200; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2004, YONSEI MED J, V45, P991, DOI 10.3349/ymj.2004.45.6.991; Brinkmann V, 2007, PHARMACOL THERAPEUT, V115, P84, DOI 10.1016/j.pharmthera.2007.04.006; Budde K, 2006, CLIN TRANSPLANT, V20, P17, DOI 10.1111/j.1399-0012.2006.00596.x; Chiba K, 1998, J IMMUNOL, V160, P5037; Glickman M, 1999, MOL CELL NEUROSCI, V14, P141, DOI 10.1006/mcne.1999.0776; Graler MH, 1998, GENOMICS, V53, P164, DOI 10.1006/geno.1998.5491; Hanel P, 2007, FASEB J, V21, P1202, DOI 10.1096/fj.06-7433com; Hla T, 2008, BBA-MOL CELL BIOL L, V1781, P477, DOI 10.1016/j.bbalip.2008.07.003; Honig SM, 2003, J CLIN INVEST, V111, P627, DOI 10.1172/JCI200316200; Igarashi N, 2003, J BIOL CHEM, V278, P46832, DOI 10.1074/jbc.M306577200; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Kawahara A, 2009, SCIENCE, V323, P524, DOI 10.1126/science.1167449; Kihara A, 2003, J BIOL CHEM, V278, P14578, DOI 10.1074/jbc.M211416200; Kihara A, 2008, BBA-MOL CELL BIOL L, V1781, P496, DOI 10.1016/j.bbalip.2008.05.003; Kluk MJ, 2002, BBA-MOL CELL BIOL L, V1582, P72, DOI 10.1016/S1388-1981(02)00139-7; Kobayashi N, 2006, J LIPID RES, V47, P614, DOI 10.1194/jlr.M500468-JLR200; Kobayashi N, 2009, J BIOL CHEM, V284, P21192, DOI 10.1074/jbc.M109.006163; Kovarik JM, 2004, BRIT J CLIN PHARMACO, V57, P586, DOI 10.1111/j.1365-2125.2003.02065.x; Lee YM, 2007, PROSTAG OTH LIPID M, V84, P154, DOI 10.1016/j.prostaglandins.2007.08.001; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Maceyka M, 2005, J BIOL CHEM, V280, P37118, DOI 10.1074/jbc.M502207200; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Min JK, 2002, ANAL BIOCHEM, V303, P167, DOI 10.1006/abio.2002.5579; Mitra P, 2006, P NATL ACAD SCI USA, V103, P16394, DOI 10.1073/pnas.0603734103; Nieuwenhuis B, 2009, J MOL MED, V87, P645, DOI 10.1007/s00109-009-0468-x; Paugh SW, 2003, FEBS LETT, V554, P189, DOI 10.1016/S0014-5793(03)01168-2; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Sato K, 2007, J NEUROCHEM, V103, P2610, DOI 10.1111/j.1471-4159.2007.04958.x; Taha TA, 2004, BBA-MOL CELL BIOL L, V1682, P48, DOI 10.1016/S1388-1981(04)00023-X; Takabe K, 2010, J BIOL CHEM, V285, P10477, DOI 10.1074/jbc.M109.064162; Thangada S, 2010, J EXP MED, V207, P1475, DOI 10.1084/jem.20091343; Yamashita H, 2006, J SURG RES, V130, P80, DOI 10.1016/j.jss.2005.08.004; YATOMI Y, 1995, BLOOD, V86, P193, DOI 10.1182/blood.V86.1.193.bloodjournal861193	41	108	112	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1758	1766		10.1074/jbc.M110.171116	http://dx.doi.org/10.1074/jbc.M110.171116			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21084291	Green Published, hybrid			2022-12-25	WOS:000286191500015
J	So, HC; Yip, BHK; Sham, PC				So, Hon-Cheong; Yip, Benjamin H. K.; Sham, Pak Chung			Estimating the Total Number of Susceptibility Variants Underlying Complex Diseases from Genome-Wide Association Studies	PLOS ONE			English	Article							CROHNS-DISEASE; ODDS RATIOS; POPULATION; GENETICS; TRAITS; LOCI; BIAS	Recently genome-wide association studies (GWAS) have identified numerous susceptibility variants for complex diseases. In this study we proposed several approaches to estimate the total number of variants underlying these diseases. We assume that the variance explained by genetic markers (Vg) follow an exponential distribution, which is justified by previous studies on theories of adaptation. Our aim is to fit the observed distribution of Vg from GWAS to its theoretical distribution. The number of variants is obtained by the heritability divided by the estimated mean of the exponential distribution. In practice, due to limited sample sizes, there is insufficient power to detect variants with small effects. Therefore the power was taken into account in fitting. Besides considering the most significant variants, we also tried to relax the significance threshold, allowing more markers to be fitted. The effects of false positive variants were removed by considering the local false discovery rates. In addition, we developed an alternative approach by directly fitting the z-statistics from GWAS to its theoretical distribution. In all cases, the "winner's curse" effect was corrected analytically. Confidence intervals were also derived. Simulations were performed to compare and verify the performance of different estimators (which incorporates various means of winner's curse correction) and the coverage of the proposed analytic confidence intervals. Our methodology only requires summary statistics and is able to handle both binary and continuous traits. Finally we applied the methods to a few real disease examples (lipid traits, type 2 diabetes and Crohn's disease) and estimated that hundreds to nearly a thousand variants underlie these traits.	[So, Hon-Cheong; Yip, Benjamin H. K.; Sham, Pak Chung] Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Sham, Pak Chung] Univ Hong Kong, Genome Res Ctr, Hong Kong, Hong Kong, Peoples R China; [Sham, Pak Chung] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	So, HC (corresponding author), Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China.	pcsham@hkucc.hku.hk	YIP, Benjamin HK/I-2336-2013; So, Hon-Cheong/I-1100-2016; Yip, Benjamin/AAC-7845-2019	Yip, Benjamin/0000-0002-4749-7611; So, Hon-Cheong/0000-0002-7102-833X	Hong Kong Research Grants Council [HKU 766906M, HKU 774707M]; University of Hong Kong Strategic Research Theme of Genomics; Croucher Foundation	Hong Kong Research Grants Council(Hong Kong Research Grants Council); University of Hong Kong Strategic Research Theme of Genomics; Croucher Foundation	The work was supported by the Hong Kong Research Grants Council General Research Fund HKU 766906M and HKU 774707M and the University of Hong Kong Strategic Research Theme of Genomics. HCS was supported by a Croucher Foundation Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abney M, 2001, AM J HUM GENET, V68, P1302, DOI 10.1086/320112; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bost B, 1999, GENETICS, V153, P2001; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Efron B, 2004, J AM STAT ASSOC, V99, P96, DOI 10.1198/016214504000000089; Efron B, 2001, J AM STAT ASSOC, V96, P1151, DOI 10.1198/016214501753382129; Garner C, 2007, GENET EPIDEMIOL, V31, P288, DOI 10.1002/gepi.20209; Ghosh A, 2008, AM J HUM GENET, V82, P1064, DOI 10.1016/j.ajhg.2008.03.002; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; KAPRIO J, 1992, DIABETOLOGIA, V35, P1060, DOI 10.1007/BF02221682; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Orr HA, 1998, EVOLUTION, V52, P935, DOI [10.2307/2411226, 10.1111/j.1558-5646.1998.tb01823.x]; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Pawitan Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007969; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; So H. C., 2010, GENETICS COMPLEX HUM, P49; SO HC, 2010, EVALUATING HER UNPUB; SOFAER J, 1993, GUT, V34, P869, DOI 10.1136/gut.34.7.869; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zhong H, 2008, BIOSTATISTICS, V9, P621, DOI 10.1093/biostatistics/kxn001	22	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2010	5	11							e13898	10.1371/journal.pone.0013898	http://dx.doi.org/10.1371/journal.pone.0013898			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681OY	21103334	gold, Green Submitted, Green Published			2022-12-25	WOS:000284327800002
J	Meng, L; Sefah, K; O'Donoghue, MB; Zhu, GZ; Shangguan, D; Noorali, A; Chen, Y; Zhou, L; Tan, WH				Meng, Ling; Sefah, Kwame; O'Donoghue, Meghan B.; Zhu, Guizhi; Shangguan, Dihua; Noorali, Afshan; Chen, Yan; Zhou, Lei; Tan, Weihong			Silencing of PTK7 in Colon Cancer Cells: Caspase-10-Dependent Apoptosis via Mitochondrial Pathway	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; EXPRESSION; INTERFERENCE; P53; METASTASIS; ACTIVATION; CASPASES; POLARITY; GENES	Protein tyrosine kinase-7 (PTK7) is a catalytically inactive receptor tyrosine kinase (RTK). PTK7 is upregulated in many common human cancers, including colon cancer, lung cancer, gastric cancer and acute myeloid leukemia. The reason for this up-regulation is not yet known. To explore the functional role of PTK7, the expression of PTK7 in HCT 116 cells was examined using small interference (siRNA)-mediated gene silencing. Following transfection, the siRNA successfully suppressed PTK7 mRNA and protein expression. Knocking down of PTK7 in HCT 116 cells inhibited cell proliferation compared to control groups and induced apoptosis. Furthermore, this apoptosis was characterized by decreased mitochondrial membrane potential and activation of caspase-9 and -10. Addition of a caspase-10 inhibitor totally blocked this apoptosis, suggesting that caspase-10 may play a critical role in PTK7-knockdown-induced apoptosis, downstream of mitochondria. These observations may indicate a role for PTK7 in cell proliferation and cell apoptosis and may provide a potential therapeutic pathway for the treatment of a variety of cancers.	[Meng, Ling] Univ Florida, Dept Chem, Gainesville, FL 32611 USA; Univ Florida, Shands Canc Ctr, Dept Physiol & Funct Genom, Gainesville, FL 32611 USA; Univ Florida, UF Genet Inst, Ctr Res Bio Nano Interface, Gainesville, FL 32611 USA; Univ Florida, McKnight Brain Inst, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Meng, L (corresponding author), Univ Florida, Dept Chem, Gainesville, FL 32611 USA.	tan@chem.ufl.edu	Zhu, Guizhi/AAN-2888-2020; Tan, Weihong/A-5412-2008; Altman, Meghan O/J-2975-2015; Tan, Weihong/AAA-4536-2020; Zhu, Guizhi/C-9150-2015; Shangguan, Dihua/G-4530-2011; Meng, Ling/B-4170-2012	Tan, Weihong/0000-0002-8066-1524; Altman, Meghan O/0000-0002-8910-9074; Shangguan, Dihua/0000-0002-5746-803X; Zhu, Guizhi/0000-0002-2945-7982	National Institutes of Health (NIH) [R01GM066137]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066137] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH), Agency #R01GM066137 (http://grants.nih.gov/grants/oer.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Devi GR, 2006, CANCER GENE THER, V13, P819, DOI 10.1038/sj.cgt.7700931; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Endoh H, 2004, J CLIN ONCOL, V22, P811, DOI 10.1200/JCO.2004.04.109; FernandesAlnemri T, 1996, P NATL ACAD SCI USA, V93, P7464, DOI 10.1073/pnas.93.15.7464; Filomenko R, 2006, ONCOGENE, V25, P7635, DOI 10.1038/sj.onc.1209733; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gorringe KL, 2005, GENE CHROMOSOME CANC, V42, P247, DOI 10.1002/gcc.20136; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Harada K, 2002, CANCER RES, V62, P5897; Kaeser MD, 2004, J BIOL CHEM, V279, P7598, DOI 10.1074/jbc.M311732200; Karagiannis TC, 2005, CANCER GENE THER, V12, P787, DOI 10.1038/sj.cgt.7700857; Katoh M, 2007, INT J MOL MED, V20, P405; Kroiher M, 2001, BIOESSAYS, V23, P69, DOI 10.1002/1521-1878(200101)23:1<69::AID-BIES1009>3.3.CO;2-B; Lu XW, 2004, NATURE, V430, P93, DOI 10.1038/nature02677; MATLASHEWSKI G, 1984, EMBO J, V3, P3257, DOI 10.1002/j.1460-2075.1984.tb02287.x; McNamara JO, 2006, NAT BIOTECHNOL, V24, P1005, DOI 10.1038/nbt1223; MOSSIE K, 1995, ONCOGENE, V11, P2179; Muller-Tidow C, 2004, CLIN CANCER RES, V10, P1241, DOI 10.1158/1078-0432.CCR-0954-03; Park SJ, 2004, J BIOL CHEM, V279, P51057, DOI 10.1074/jbc.M406543200; Park SK, 1996, J BIOCHEM, V119, P235; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Shangguan D, 2008, J PROTEOME RES, V7, P2133, DOI 10.1021/pr700894d; Shin MS, 2002, ONCOGENE, V21, P4129, DOI 10.1038/sj.onc.1205527; Shin WS, 2008, BIOCHEM BIOPH RES CO, V371, P793, DOI 10.1016/j.bbrc.2008.04.168; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; 2002, BLOOD, V99	33	72	75	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e14018	10.1371/journal.pone.0014018	http://dx.doi.org/10.1371/journal.pone.0014018			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103379	Green Published, Green Submitted, gold			2022-12-25	WOS:000284257400017
J	Bishop, JR; Passos-Bueno, MR; Fong, L; Stanford, KI; Gonzales, JC; Yeh, E; Young, SG; Bensadoun, A; Witztum, JL; Esko, JD; Moulton, KS				Bishop, Joseph R.; Passos-Bueno, Maria Rita; Fong, Loren; Stanford, Kristin I.; Gonzales, Jon C.; Yeh, Erika; Young, Stephen G.; Bensadoun, Andre; Witztum, Joseph L.; Esko, Jeffrey D.; Moulton, Karen S.			Deletion of the Basement Membrane Heparan Sulfate Proteoglycan Type XVIII Collagen Causes Hypertriglyceridemia in Mice and Humans	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; KNOBLOCH-SYNDROME; NONFASTING TRIGLYCERIDES; MORPHOGEN GRADIENT; KNOCKOUT MICE; HEART-DISEASE; LDL RECEPTOR; LIPASE; BINDING; IDENTIFICATION	Background: Lipoprotein lipase (Lpl) acts on triglyceride-rich lipoproteins in the peripheral circulation, liberating free fatty acids for energy metabolism or storage. This essential enzyme is synthesized in parenchymal cells of adipose tissue, heart, and skeletal muscle and migrates to the luminal side of the vascular endothelium where it acts upon circulating lipoproteins. Prior studies suggested that Lpl is immobilized by way of heparan sulfate proteoglycans on the endothelium, but genetically altering endothelial cell heparan sulfate had no effect on Lpl localization or lipolysis. The objective of this study was to determine if extracellular matrix proteoglycans affect Lpl distribution and triglyceride metabolism. Methods and Findings: We examined mutant mice defective in collagen XVIII (Col18), a heparan sulfate proteoglycan present in vascular basement membranes. Loss of Col18 reduces plasma levels of Lpl enzyme and activity, which results in mild fasting hypertriglyceridemia and diet-induced hyperchylomicronemia. Humans with Knobloch Syndrome caused by a null mutation in the vascular form of Col18 also present lower than normal plasma Lpl mass and activity and exhibit fasting hypertriglyceridemia. Conclusions: This is the first report demonstrating that Lpl presentation on the lumenal side of the endothelium depends on a basement membrane proteoglycan and demonstrates a previously unrecognized phenotype in patients lacking Col18.	[Bishop, Joseph R.; Stanford, Kristin I.; Gonzales, Jon C.; Esko, Jeffrey D.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Passos-Bueno, Maria Rita; Yeh, Erika] Univ Sao Paulo, Inst Biosci, Dept Genet & Evolutionary Biol, Ctr Human Genome, Sao Paulo, Brazil; [Fong, Loren; Young, Stephen G.] Univ Calif Los Angeles, David Geffen Sch Med, Div Cardiol, Los Angeles, CA 90095 USA; [Bensadoun, Andre] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Witztum, Joseph L.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Moulton, Karen S.] Univ Colorado Denver, Div Cardiol, Aurora, CO USA	University of California System; University of California San Diego; Universidade de Sao Paulo; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cornell University; University of California System; University of California San Diego; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Bishop, JR (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	jesko@ucsd.edu; karen.moulton@ucdenver.edu	Passos-Bueno, Maria Rita/I-6796-2016; Cetgen, Inct/I-2412-2013	Passos-Bueno, Maria Rita/0000-0002-9248-3008; Yeh, Erika/0000-0002-2374-1528; Young, Stephen/0000-0001-7270-3176	National Institute of Health [HL087228, GM33063, HL67255]; CEPID/FAPESP; CNPq; University of Colorado Denver Department of Medicine; Leducq Foundation; American Heart Association [0735038N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087228, R01HL067255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033063, R37GM033063] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CEPID/FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); University of Colorado Denver Department of Medicine; Leducq Foundation(Leducq Foundation); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institute of Health grants HL087228 (A.B.), GM33063 (J.D.E.) and HL67255 (K.S.M.); CEPID/FAPESP and CNPq (M.R.B-P.), a University of Colorado Denver Department of Medicine Pilot Grant (K.S.M.), the Leducq Foundation. (J.L.W.). J.R.B. is funded by a Scientist Development Grant 0735038N from the American Heart Association. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arikawa-Hirasawa E, 1999, NAT GENET, V23, P354, DOI 10.1038/15537; Augustus AS, 2003, AM J PHYSIOL-ENDOC M, V284, pE331, DOI 10.1152/ajpendo.00298.2002; Baeg GH, 2004, DEV BIOL, V276, P89, DOI 10.1016/j.ydbio.2004.08.023; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Beigneux AP, 2007, CELL METAB, V5, P279, DOI 10.1016/j.cmet.2007.02.002; Beigneux AP, 2009, J BIOL CHEM, V284, P30240, DOI 10.1074/jbc.M109.046391; BEISSWENGER PJ, 1970, SCIENCE, V168, P596, DOI 10.1126/science.168.3931.596; BERRYMAN DE, 1993, J BIOL CHEM, V268, P3272; Bezakova G, 2003, NAT REV MOL CELL BIO, V4, P295, DOI 10.1038/nrm1074; Bornemann DJ, 2008, DEVELOPMENT, V135, P1039, DOI 10.1242/dev.017061; Briquet-Laugier V, 1999, METH MOL B, V109, P81; BRUNZELL JD, 2001, METABOLIC MOL BASES, P2789; Davies BSJ, 2010, CELL METAB, V12, P42, DOI 10.1016/j.cmet.2010.04.016; Echtermeyer F, 2001, J CLIN INVEST, V107, pR9, DOI 10.1172/JCI10559; Frank PG, 2008, AM J PHYSIOL-CELL PH, V295, pC242, DOI 10.1152/ajpcell.00185.2008; FRANK RN, 1983, INVEST OPHTH VIS SCI, V24, P1519; Fukai N, 2002, EMBO J, V21, P1535, DOI 10.1093/emboj/21.7.1535; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; Gin P, 2008, J BIOL CHEM, V283, P29554, DOI 10.1074/jbc.M802579200; Goldberg IJ, 2001, FRONT BIOSCI-LANDMRK, V6, pD388, DOI 10.2741/Goldberg; HATA A, 1993, J BIOL CHEM, V268, P8447; Hirano T, 2001, AM J PHYSIOL-ENDOC M, V281, pE665, DOI 10.1152/ajpendo.2001.281.4.E665; Iozzo RV, 2005, NAT REV MOL CELL BIO, V6, P646, DOI 10.1038/nrm1702; Ishibashi S, 1996, J BIOL CHEM, V271, P22422, DOI 10.1074/jbc.271.37.22422; Keren B, 2007, AM J MED GENET A, V143A, P1514, DOI 10.1002/ajmg.a.31784; Knox SM, 2006, CELL MOL LIFE SCI, V63, P2435, DOI 10.1007/s00018-006-6162-z; KOBAYASHI J, 1993, CLIN CHIM ACTA, V216, P113, DOI 10.1016/0009-8981(93)90144-S; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; Lander AD, 2002, DEV CELL, V2, P785, DOI 10.1016/S1534-5807(02)00179-X; Lander AD, 2007, CELL, V128, P245, DOI 10.1016/j.cell.2007.01.004; Lutz EP, 2001, J CLIN INVEST, V107, P1183, DOI 10.1172/JCI11774; MA YH, 1994, J LIPID RES, V35, P2049; MacArthur JM, 2007, J CLIN INVEST, V117, P153, DOI 10.1172/JCI29154; Marneros AG, 2005, FASEB J, V19, P716, DOI 10.1096/fj.04-2134rev; Marneros AG, 2004, EMBO J, V23, P89, DOI 10.1038/sj.emboj.7600014; Menzel O, 2004, HUM MUTAT, V23, P77, DOI 10.1002/humu.10284; Moulton KS, 2004, CIRCULATION, V110, P1330, DOI 10.1161/01.CIR.0000140720.79015.3C; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Nybakken K, 2002, BBA-GEN SUBJECTS, V1573, P280, DOI 10.1016/S0304-4165(02)00395-1; Orchard TJ, 2002, KIDNEY INT, V62, P963, DOI 10.1046/j.1523-1755.2002.00507.x; Page S, 2006, J BIOL CHEM, V281, P13931, DOI 10.1074/jbc.M600995200; Park PW, 2001, NATURE, V411, P98, DOI 10.1038/35075100; PASSOSBUENO MR, 1994, AM J MED GENET, V52, P170, DOI 10.1002/ajmg.1320520209; Qi D, 2006, CARDIOVASC RES, V72, P124, DOI 10.1016/j.cardiores.2006.07.022; Reizes O, 2001, CELL, V106, P105, DOI 10.1016/S0092-8674(01)00415-9; Rossi M, 2003, EMBO J, V22, P236, DOI 10.1093/emboj/cdg019; Saarela J, 1998, MATRIX BIOL, V16, P319, DOI 10.1016/S0945-053X(98)90003-8; Saarela J, 1998, AM J PATHOL, V153, P611, DOI 10.1016/S0002-9440(10)65603-9; SAXENA U, 1991, J BIOL CHEM, V266, P17516; SAXENA U, 1991, P NATL ACAD SCI USA, V88, P2254, DOI 10.1073/pnas.88.6.2254; SEAVER LH, 1993, AM J MED GENET, V46, P203, DOI 10.1002/ajmg.1320460221; Sendak RA, 2000, J LIPID RES, V41, P260; Serpinskaya AS, 1999, DEV BIOL, V205, P65, DOI 10.1006/dbio.1998.9112; Sertie AL, 1996, HUM MOL GENET, V5, P843, DOI 10.1093/hmg/5.6.843; Stanford KI, 2010, J BIOL CHEM, V285, P286, DOI 10.1074/jbc.M109.063701; Stanford KI, 2009, J CLIN INVEST, V119, P3236, DOI 10.1172/JCI38251; Tran-Lundmark K, 2008, CIRC RES, V103, P43, DOI 10.1161/CIRCRESAHA.108.172833; Utriainen A, 2004, HUM MOL GENET, V13, P2089, DOI 10.1093/hmg/ddh213; VILARO S, 1988, AM J PHYSIOL, V254, pG711, DOI 10.1152/ajpgi.1988.254.5.G711; WALLINDER L, 1979, BIOCHIM BIOPHYS ACTA, V575, P166, DOI 10.1016/0005-2760(79)90142-5; Weinstein MM, 2008, J BIOL CHEM, V283, P34511, DOI 10.1074/jbc.M806067200; Weinstock PH, 1995, J CLIN INVEST, V96, P2555, DOI 10.1172/JCI118319; Wilson C, 1998, AM J MED GENET, V78, P286, DOI 10.1002/(SICI)1096-8628(19980707)78:3<286::AID-AJMG16>3.0.CO;2-B; WINGARD DL, 1983, AM J EPIDEMIOL, V117, P19, DOI 10.1093/oxfordjournals.aje.a113510	64	33	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e13919	10.1371/journal.pone.0013919	http://dx.doi.org/10.1371/journal.pone.0013919			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085708	Green Published, Green Submitted, gold			2022-12-25	WOS:000284036800012
J	Jia, DL; Rahbar, R; Chan, RWY; Lee, SMY; Chan, MCW; Wang, BXH; Baker, DP; Sun, B; Peiris, JSM; Nicholls, JM; Fish, EN				Jia, Danlin; Rahbar, Ramtin; Chan, Renee W. Y.; Lee, Suki M. Y.; Chan, Michael C. W.; Wang, Ben Xuhao; Baker, Darren P.; Sun, Bing; Peiris, J. S. Malik; Nicholls, John M.; Fish, Eleanor N.			Influenza Virus Non-Structural Protein 1 (NS1) Disrupts Interferon Signaling	PLOS ONE			English	Article							H5N1 AVIAN INFLUENZA; CHRONIC HEPATITIS-C; A VIRUS; ANTIVIRAL RESPONSES; NEURAMINIDASE INHIBITORS; ALPHA-INTERFERON; IMMUNE-RESPONSE; BETA-INTERFERON; VIRAL DISEASE; CORE PROTEIN	Type I interferons (IFNs) function as the first line of defense against viral infections by modulating cell growth, establishing an antiviral state and influencing the activation of various immune cells. Viruses such as influenza have developed mechanisms to evade this defense mechanism and during infection with influenza A viruses, the non-structural protein 1 (NS1) encoded by the virus genome suppresses induction of IFNs-alpha/beta. Here we show that expression of avian H5N1 NS1 in HeLa cells leads to a block in IFN signaling. H5N1 NS1 reduces IFN-inducible tyrosine phosphorylation of STAT1, STAT2 and STAT3 and inhibits the nuclear translocation of phospho-STAT2 and the formation of IFN-inducible STAT1:1-, STAT1:3- and STAT3:3-DNA complexes. Inhibition of IFN-inducible STAT signaling by NS1 in HeLa cells is, in part, a consequence of NS1-mediated inhibition of expression of the IFN receptor subunit, IFNAR1. In support of this NS1-mediated inhibition, we observed a reduction in expression of ifnar1 in ex vivo human non-tumor lung tissues infected with H5N1 and H1N1 viruses. Moreover, H1N1 and H5N1 virus infection of human monocyte-derived macrophages led to inhibition of both ifnar1 and ifnar2 expression. In addition, NS1 expression induces up-regulation of the JAK/STAT inhibitors, SOCS1 and SOCS3. By contrast, treatment of ex vivo human lung tissues with IFN-alpha results in the up-regulation of a number of IFN-stimulated genes and inhibits both H5N1 and H1N1 virus replication. The data suggest that NS1 can directly interfere with IFN signaling to enhance viral replication, but that treatment with IFN can nevertheless override these inhibitory effects to block H5N1 and H1N1 virus infections.	[Jia, Danlin; Rahbar, Ramtin; Wang, Ben Xuhao; Fish, Eleanor N.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Chan, Renee W. Y.; Nicholls, John M.] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Chan, Renee W. Y.; Lee, Suki M. Y.; Chan, Michael C. W.; Peiris, J. S. Malik] Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Baker, Darren P.] Biogen Idec Inc, Cambridge, MA USA; [Sun, Bing] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Fish, Eleanor N.] Univ Hlth Network, Toronto Gen Res Inst, Div Cell & Mol Biol, Toronto, ON, Canada	University of Toronto; University of Hong Kong; University of Hong Kong; Biogen; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Jia, DL (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.	en.fish@utoronto.ca	Chan, Michael Chi Wai/C-4212-2009; Chan, Renee Wan Yi/AAA-6598-2020; Nicholls, John Malcolm/C-4375-2009	Chan, Michael Chi Wai/0000-0001-8174-8405; Chan, Renee Wan Yi/0000-0001-6485-0926; Nicholls, John Malcolm/0000-0001-7217-7444	Canadian Institutes of Health Research [MOP-15094]; Public Health Agency of Canada; Research Funds for the Control of Infectious Diseases [10090202]; University Grants Committee of the Hong Kong Special Administrative Region, China [AoE/M-12/-06]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Public Health Agency of Canada; Research Funds for the Control of Infectious Diseases; University Grants Committee of the Hong Kong Special Administrative Region, China	These studies were supported by a Canadian Institutes of Health Research grant (MOP-15094) and a Public Health Agency of Canada grant to E.N.F., Research Funds for the Control of Infectious Diseases grant to J.M.N. (10090202) and funding to R.W.Y.C., M.C.W.C. and J.S.M.P. from the Area of Excellence Scheme of the University Grants Committee (grant AoE/M-12/-06 of the Hong Kong Special Administrative Region, China). D.J. and R.R. are recipients of Canadian Institutes of Health Research scholarship awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. D.P.B. is employed by Biogen Idec, thus Biogen Idec did have a role in providing IFN-beta and in the review and editing of the manuscript.	Aragon T, 2000, MOL CELL BIOL, V20, P6259, DOI 10.1128/MCB.20.17.6259-6268.2000; Asnaghi L, 2004, PHARMACOL RES, V50, P545, DOI 10.1016/j.phrs.2004.03.007; Aucan C, 2003, GENES IMMUN, V4, P275, DOI 10.1038/sj.gene.6363962; Bode JG, 2003, FASEB J, V17, P488, DOI 10.1096/fj.02-0664fje; Bonjardim CA, 2009, IMMUNOL LETT, V122, P1, DOI 10.1016/j.imlet.2008.11.002; Bornholdt ZA, 2008, NATURE, V456, P985, DOI 10.1038/nature07444; Brierley MM, 2006, FEBS J, V273, P1569, DOI 10.1111/j.1742-4658.2006.05176.x; Bright RA, 2005, LANCET, V366, P1175, DOI 10.1016/S0140-6736(05)67338-2; Burgui I, 2003, J GEN VIROL, V84, P3263, DOI 10.1099/vir.0.19487-0; *CDC, 2009, MMWR-MORBID MORTAL W, P893; Chan MCW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-135; Chen XP, 2000, IMMUNITY, V13, P287, DOI 10.1016/S1074-7613(00)00028-5; Chen ZY, 1999, EMBO J, V18, P2273, DOI 10.1093/emboj/18.8.2273; Cheng PKC, 2009, EMERG INFECT DIS, V15, P966, DOI 10.3201/eid1506.081357; Cheung CL, 2006, J INFECT DIS, V193, P1626, DOI 10.1086/504723; Diop G, 2006, BIOMED PHARMACOTHER, V60, P569, DOI 10.1016/j.biopha.2006.08.002; Donelan NR, 2004, J VIROL, V78, P11574, DOI 10.1128/JVI.78.21.11574-11582.2004; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Ehrhardt C, 2007, J VIROL, V81, P3058, DOI 10.1128/JVI.02082-06; Fernandez-Sesma A, 2006, J VIROL, V80, P6295, DOI 10.1128/JVI.02381-05; FREY KG, 2009, J IMMUNOL; Fuke H, 2008, NUCLEIC ACIDS RES, V36, P1037, DOI 10.1093/nar/gkm1120; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Goldman LA, 1999, J INTERF CYTOK RES, V19, P15, DOI 10.1089/107999099314379; Gregorieff A, 2000, J BIOL CHEM, V275, P21596, DOI 10.1074/jbc.M910087199; Guo Z, 2007, AM J RESP CELL MOL, V36, P263, DOI 10.1165/rcmb.2006-0283RC; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hengel H, 2005, TRENDS IMMUNOL, V26, P396, DOI 10.1016/j.it.2005.05.004; Hill AW, 2009, INFECT GENET EVOL, V9, P169, DOI 10.1016/j.meegid.2008.10.006; Hui KPY, 2009, J IMMUNOL, V182, P1088, DOI 10.4049/jimmunol.182.2.1088; HWANG SY, 1995, P NATL ACAD SCI USA, V92, P11284, DOI 10.1073/pnas.92.24.11284; Jefferson T., 2004, COCHRANE DB SYST REV, V2, DOI [10.1002/14651858.CD001169.pub2, DOI 10.1002/14651858.CD001169.PUB2]; Karber G., 1931, ARCH EXP PATHOL PH, V162, P480, DOI DOI 10.1007/BF01863914; Kim CU, 1997, J AM CHEM SOC, V119, P681, DOI 10.1021/ja963036t; Krebs DL, 2000, J CELL SCI, V113, P2813; Kugel D, 2009, J VIROL, V83, P3843, DOI 10.1128/JVI.02453-08; Lee SMY, 2008, J INFECT DIS, V198, P525, DOI 10.1086/590499; Leyva L, 2005, J NEUROIMMUNOL, V163, P165, DOI 10.1016/j.jneuroim.2005.02.010; Lin WY, 2006, J VIROL, V80, P9226, DOI 10.1128/JVI.00459-06; Matsumoto A, 1999, MOL CELL BIOL, V19, P6396; Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; MOWSHOWITZ SL, 1983, J NEURAL TRANSM, V57, P121, DOI 10.1007/BF01250054; Nemeroff ME, 1998, MOL CELL, V1, P991, DOI 10.1016/S1097-2765(00)80099-4; Oshansky CM, 2009, VIRAL IMMUNOL, V22, P147, DOI 10.1089/vim.2008.0098; Park C, 2000, IMMUNITY, V13, P795, DOI 10.1016/S1074-7613(00)00077-7; Park YJ, 2007, BIOCHEM BIOPH RES CO, V363, P361, DOI 10.1016/j.bbrc.2007.08.195; Pauli EK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000196; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pothlichet J, 2008, J IMMUNOL, V180, P2034, DOI 10.4049/jimmunol.180.4.2034; Precious B, 2005, J GEN VIROL, V86, P151, DOI 10.1099/vir.0.80263-0; QIU Y, 1995, RNA, V1, P304; Rahbar R, 2006, J VIROL, V80, P7245, DOI 10.1128/JVI.00463-06; Saito T, 2007, CURR OPIN IMMUNOL, V19, P17, DOI 10.1016/j.coi.2006.11.003; Shin YK, 2007, J VIROL, V81, P12730, DOI 10.1128/JVI.01427-07; Tena-Tomas C, 2007, EUR CYTOKINE NETW, V18, P136; Van Hoeven N, 2009, J VIROL, V83, P2851, DOI 10.1128/JVI.02174-08; Vlotides G, 2004, BIOCHEM BIOPH RES CO, V320, P1007, DOI 10.1016/j.bbrc.2004.06.051; von Itzstein Mark, 2009, V189, P111, DOI 10.1007/978-3-540-79086-0_5; WANG SQ, 2009, BIOCH BIOPHYS RES CO; Wang W, 1999, RNA, V5, P195, DOI 10.1017/S1355838299981621; Wang XY, 2000, J VIROL, V74, P11566, DOI 10.1128/JVI.74.24.11566-11573.2000; Welzel TM, 2009, HEPATOLOGY, V49, P1847, DOI 10.1002/hep.22877; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Zurney J, 2007, J VIROL, V81, P13668, DOI 10.1128/JVI.01172-07	66	119	125	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e13927	10.1371/journal.pone.0013927	http://dx.doi.org/10.1371/journal.pone.0013927			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085662	Green Published, Green Submitted, gold			2022-12-25	WOS:000284036800018
J	Bojer, MS; Struve, C; Ingmer, H; Hansen, DS; Krogfelt, KA				Bojer, Martin Saxtorph; Struve, Carsten; Ingmer, Hanne; Hansen, Dennis Schroder; Krogfelt, Karen Angeliki			Heat Resistance Mediated by a New Plasmid Encoded Clp ATPase, ClpK, as a Possible Novel Mechanism for Nosocomial Persistence of Klebsiella pneumoniae	PLOS ONE			English	Article							SPECTRUM-BETA-LACTAMASE; ESCHERICHIA-COLI; SHOCK-PROTEIN; LACTOCOCCUS-LACTIS; STRESS TOLERANCE; BACTEREMIA; INFECTIONS; EPIDEMIOLOGY; PROTEOLYSIS; GENES	Klebsiella pneumoniae is an important opportunistic pathogen and a frequent cause of nosocomial infections. We have characterized a K. pneumoniae strain responsible for a series of critical infections in an intensive care unit over a two-year period. The strain was found to be remarkably thermotolerant providing a conceivable explanation of its persistence in the hospital environment. This marked phenotype is mediated by a novel type of Clp ATPase, designated ClpK. The clpK gene is encoded by a conjugative plasmid and we find that the clpK gene alone renders an otherwise sensitive E. coli strain resistant to lethal heat shock. Furthermore, one third of a collection of nosocomial K. pneumoniae isolates carry clpK and exhibit a heat resistant phenotype. The discovery of ClpK as a plasmid encoded factor and its profound impact on thermal stress survival sheds new light on the biological relevance of Clp ATPases in acquired environmental fitness and highlights the challenges of mobile genetic elements in fighting nosocomial infections.	[Bojer, Martin Saxtorph; Struve, Carsten; Krogfelt, Karen Angeliki] Statens Serum Inst, Dept Microbiol Surveillance & Res, DK-2300 Copenhagen, Denmark; [Ingmer, Hanne] Univ Copenhagen, Fac Life Sci, Dept Vet Pathobiol, Frederiksberg, Denmark; [Hansen, Dennis Schroder] Univ Copenhagen, Hvidovre Hosp, Dept Clin Microbiol, DK-2650 Hvidovre, Denmark; [Hansen, Dennis Schroder] Hillerod Hosp, Dept Clin Microbiol, Hillerod, Denmark	Statens Serum Institut; University of Copenhagen; University of Copenhagen; University of Copenhagen	Bojer, MS (corresponding author), Statens Serum Inst, Dept Microbiol Surveillance & Res, DK-2300 Copenhagen, Denmark.	cas@ssi.dk	Krogfelt, Karen Angeliki A/O-8145-2016; Krogfelt, Karen Angeliki/P-2430-2018	Krogfelt, Karen Angeliki A/0000-0001-7536-3453; Ingmer, Hanne/0000-0002-8350-5631; Bojer, Martin Saxtorph/0000-0002-8488-9593				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Banecki B, 2001, J BIOL CHEM, V276, P18843, DOI 10.1074/jbc.M007507200; BINGEN EH, 1993, J CLIN MICROBIOL, V31, P179, DOI 10.1128/JCM.31.2.179-184.1993; Branger C, 1997, J HOSP INFECT, V36, P23, DOI 10.1016/S0195-6701(97)90088-8; Brisse S, 2001, INT J SYST EVOL MICR, V51, P915, DOI 10.1099/00207713-51-3-915; Chaveroche MK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e97; Cordery RJ, 2008, J HOSP INFECT, V68, P108, DOI 10.1016/j.jhin.2007.10.011; Couto RC, 2007, AM J INFECT CONTROL, V35, P183, DOI 10.1016/j.ajic.2006.06.013; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DELATORRE MG, 1985, REV INFECT DIS, V7, P143; FELDMAN C, 1990, J INFECTION, V20, P21, DOI 10.1016/S0163-4453(90)92258-M; Frees D, 2004, MOL MICROBIOL, V54, P1445, DOI 10.1111/j.1365-2958.2004.04368.x; Gaillot O, 1998, J CLIN MICROBIOL, V36, P1357, DOI 10.1128/JCM.36.5.1357-1360.1998; Ghotaslou R, 2007, JPN J INFECT DIS, V60, P126; Guisbert E, 2008, MICROBIOL MOL BIOL R, V72, P545, DOI 10.1128/MMBR.00007-08; Hansen DS, 1998, J HOSP INFECT, V38, P119, DOI 10.1016/S0195-6701(98)90065-2; HUANG DC, 1993, MOL MICROBIOL, V7, P957, DOI 10.1111/j.1365-2958.1993.tb01187.x; Jenal U, 2003, CURR OPIN MICROBIOL, V6, P163, DOI 10.1016/S1369-5274(03)00029-8; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; Kim YI, 2001, NAT STRUCT BIOL, V8, P230, DOI 10.1038/84967; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowska E, 1996, BIOCHIMIE, V78, P117, DOI 10.1016/0300-9084(96)82643-5; Matuszewska M, 2005, J BIOL CHEM, V280, P12292, DOI 10.1074/jbc.M412706200; Mogk A, 2003, MOL MICROBIOL, V50, P585, DOI 10.1046/j.1365-2958.2003.03710.x; Mogk A, 2003, J BIOL CHEM, V278, P31033, DOI 10.1074/jbc.M303587200; MONTGOMERIE JZ, 1979, REV INFECT DIS, V1, P736; Naas T, 2010, J ANTIMICROB CHEMOTH, V65, P1305, DOI 10.1093/jac/dkq117; Oelschlaeger TA, 1997, INFECT IMMUN, V65, P2950, DOI 10.1128/IAI.65.7.2950-2958.1997; ORSKOV I, 1984, SEROTYPING KLEBSIELL, P143; Paterson DL, 2004, ANN INTERN MED, V140, P26, DOI 10.7326/0003-4819-140-1-200401060-00008; Perez-Gonzalez LF, 2007, INFECT CONT HOSP EP, V28, P418, DOI 10.1086/513025; Podschun R, 2001, APPL ENVIRON MICROB, V67, P3325, DOI 10.1128/AEM.67.7.3325-3327.2001; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Reisner A, 2002, FEMS MICROBIOL ECOL, V42, P251, DOI 10.1111/j.1574-6941.2002.tb01015.x; Rouquette C, 1996, MOL MICROBIOL, V21, P977, DOI 10.1046/j.1365-2958.1996.641432.x; Sahly H, 2000, ADV EXP MED BIOL, V479, P237; Sahly H, 1997, CLIN DIAGN LAB IMMUN, V4, P393, DOI 10.1128/CDLI.4.4.393-399.1997; Schirmer EC, 1996, TRENDS BIOCHEM SCI, V21, P289, DOI 10.1016/0968-0004(96)10038-4; Schlothauer T, 2003, P NATL ACAD SCI USA, V100, P2306, DOI 10.1073/pnas.0535717100; Schwaber MJ, 2006, ANTIMICROB AGENTS CH, V50, P1257, DOI 10.1128/AAC.50.4.1257-1262.2006; Singh SK, 2001, J BIOL CHEM, V276, P29420, DOI 10.1074/jbc.M103489200; SQUIRES C, 1992, J BACTERIOL, V174, P1081, DOI 10.1128/jb.174.4.1081-1085.1992; Struve C, 2004, ENVIRON MICROBIOL, V6, P584, DOI 10.1111/j.1462-2920.2004.00590.x; Struve C, 2008, INFECT IMMUN, V76, P4055, DOI 10.1128/IAI.00494-08; Suokko A, 2005, APPL ENVIRON MICROB, V71, P2061, DOI 10.1128/AEM.71.4.2061-2069.2005; THRELFALL EJ, 1986, J HYG-CAMBRIDGE, V97, P419, DOI 10.1017/S0022172400063609; Tomoyasu T, 2001, MOL MICROBIOL, V40, P397, DOI 10.1046/j.1365-2958.2001.02383.x; van't Veen A, 2005, J CLIN MICROBIOL, V43, P4961, DOI 10.1128/JCM.43.10.4961-4967.2005; Varmanen P, 2003, J BACTERIOL, V185, P5117, DOI 10.1128/JB.185.17.5117-5124.2003; Veinger L, 1998, J BIOL CHEM, V273, P11032, DOI 10.1074/jbc.273.18.11032; WAWRZYNOW A, 1995, EMBO J, V14, P1867, DOI 10.1002/j.1460-2075.1995.tb07179.x; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; WICKNER S, 1994, P NATL ACAD SCI USA, V91, P12218, DOI 10.1073/pnas.91.25.12218; Zolkiewski M, 2006, MOL MICROBIOL, V61, P1094, DOI 10.1111/j.1365-2958.2006.05309.x; Zuhlsdorf B, 2003, J HOSP INFECT, V55, P276, DOI 10.1016/j.jhin.2003.08.014	55	53	53	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e15467	10.1371/journal.pone.0015467	http://dx.doi.org/10.1371/journal.pone.0015467			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085699	gold, Green Submitted, Green Published			2022-12-25	WOS:000284035900031
J	Glynn, RW; Chin, JZ; Kerin, MJ; Sweeney, KJ				Glynn, Ronan W.; Chin, Ji Z.; Kerin, Michael J.; Sweeney, Karl J.			Representation of Cancer in the Medical Literature - A Bibliometric Analysis	PLOS ONE			English	Article							WEB-OF-SCIENCE; IMPACT	Background: There exists a lack of knowledge regarding the quantity and quality of scientific yield in relation to individual cancer types. We aimed to measure the proportion, quality and relevance of oncology-related articles, and to relate this output to their associated disease burden. By incorporating the impact factor(IF) and Eigenfactor (TM)(EF) into our analysis we also assessed the relationship between these indices and the output under study. Methods: All publications in 2007 were retrieved for the 26 most common cancers. The top 20 journals ranked by IF and EF in general medicine and oncology, and the presence of each malignancy within these titles was analysed. Journals publishing most prolifically on each cancer were identified and their impact assessed. Principal Findings: 63260 (PubMed) and 126845 (WoS) entries were generated, respectively. 26 neoplasms accounted for 25% of total output from the top medical publications. 5 cancers dominated the first quartile of output in the top oncology journals; breast, prostate, lung, and intestinal cancer, and leukaemia. Journals associated with these cancers were associated with much higher IFs and EFs than those journals associated with the other cancer types under study, although these measures were not equivalent across all sub-specialties. In addition, yield on each cancer was related to its disease burden as measured by its incidence and prevalence. Conclusions: Oncology enjoys disproportionate representation in the more prestigious medical journals. 5 cancers dominate yield, although this attention is justified given their associated disease burden. The commonly used IF and the recently introduced EF do not correlate in the assessment of the preeminent oncology journals, nor at the level of individual malignancies; there is a need to delineate between proxy measures of quality and the relevance of output when assessing its merit. These results raise significant questions regarding the best method of assessment of research and scientific output in the field of oncology.	[Glynn, Ronan W.; Chin, Ji Z.; Kerin, Michael J.; Sweeney, Karl J.] Natl Univ Ireland Galway, Inst Clin Sci, Dept Surg, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway	Glynn, RW (corresponding author), Natl Univ Ireland Galway, Inst Clin Sci, Dept Surg, Galway, Ireland.	ronanglynn@doctors.org.uk	Kerin, Michael J/D-6748-2013	Kerin, Michael/0000-0003-4164-5561	National Breast Cancer Research Institute (NBCRI) of Ireland	National Breast Cancer Research Institute (NBCRI) of Ireland	RWG was funded by the National Breast Cancer Research Institute (NBCRI) of Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler KB, 2009, AM J RESP CELL MOL, V41, P127, DOI 10.1165/rcmb.2009-0201ED; Al-Shahi R, 2001, BRIT MED J, V323, P1461, DOI 10.1136/bmj.323.7327.1461; [Anonymous], SURVEILLANCE EPIDEMI; Bergstrom CT, 2008, J NEUROSCI, V28, P11433, DOI 10.1523/JNEUROSCI.0003-08.2008; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Cambrosio A, 2006, EUR J CANCER, V42, P3140, DOI 10.1016/j.ejca.2006.07.020; Falagas ME, 2008, FASEB J, V22, P338, DOI 10.1096/fj.07-9492LSF; FERNANDEZ P, 2006, GOOGLES PAGERANK SCI, P1; Garfield E, 2006, JAMA-J AM MED ASSOC, V295, P90, DOI 10.1001/jama.295.1.90; Grossi F, 2003, EUR J CANCER, V39, P106, DOI 10.1016/S0959-8049(02)00239-3; Kamath PS, 2009, HEPATOLOGY, V49, P1787, DOI 10.1002/hep.23040; Lopez-Illescas C, 2008, J INFORMETR, V2, P304, DOI 10.1016/j.joi.2008.08.001; McNally N, 2003, BRIT MED J, V327, P550, DOI 10.1136/bmj.327.7414.550; Michon F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006544; O'Toole L, 2003, NAT REV CANCER, V3, P139, DOI 10.1038/nrc994; Rossner M, 2007, J CELL BIOL, V179, P1091, DOI 10.1083/jcb.200711140; Simons K, 2008, SCIENCE, V322, P165, DOI 10.1126/science.1165316; Sosa JA, 2009, ANN SURG, V250, P152, DOI 10.1097/SLA.0b013e3181ad8905; Ugolini D, 2007, CARCINOGENESIS, V28, P1774, DOI 10.1093/carcin/bgm129	19	42	43	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e13902	10.1371/journal.pone.0013902	http://dx.doi.org/10.1371/journal.pone.0013902			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085482	Green Published, Green Submitted, gold			2022-12-25	WOS:000284035900012
J	Orbach, DN; Fenton, B				Orbach, Dara N.; Fenton, Brock			Vision Impairs the Abilities of Bats to Avoid Colliding with Stationary Obstacles	PLOS ONE			English	Article							MACROTUS-CALIFORNICUS CHIROPTERA; MYOTIS-LUCIFUGUS CHIROPTERA; ECHOLOCATING BATS; BROWN BATS; DISTRESS CALLS; RESPONSES; VESPERTILIONIDAE; DISCRIMINATION; PHYLLOSTOMIDAE; BEHAVIOR	Background: Free-flying insectivorous bats occasionally collide with stationary objects they should easily detect by echolocation and avoid. Collisions often occur with lighted objects, suggesting ambient light may deleteriously affect obstacle avoidance capabilities. We tested the hypothesis that free-flying bats may orient by vision when they collide with some obstacles. We additionally tested whether acoustic distractions, such as "distress calls'' of other bats, contributed to probabilities of collision. Methodology/Principal Findings: To investigate the role of visual cues in the collisions of free-flying little brown bats (Myotis lucifugus) with stationary objects, we set up obstacles in an area of high bat traffic during swarming. We used combinations of light intensities and visually dissimilar obstacles to verify that bats orient by vision. In early August, bats collided more often in the light than the dark, and probabilities of collision varied with the visibility of obstacles. However, the probabilities of collisions altered in mid to late August, coincident with the start of behavioural, hormonal, and physiological changes occurring during swarming and mating. Distress calls did not distract bats and increase the incidence of collisions. Conclusions/Significance: Our findings indicate that visual cues are more important for free-flying bats than previously recognized, suggesting integration of multi-sensory modalities during orientation. Furthermore, our study highlights differences between responses of captive and wild bats, indicating a need for more field experiments.	[Orbach, Dara N.; Fenton, Brock] Univ Western Ontario, Dept Biol, London, ON, Canada	Western University (University of Western Ontario)	Orbach, DN (corresponding author), Univ Western Ontario, Dept Biol, London, ON, Canada.	dnorbach@gmail.com	Vazquez-Dominguez, Guillermo GVD/L-7818-2014		Natural Sciences and Engineering Research Council of Canada [3331]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This project was supported by a grant from the Natural Sciences and Engineering Research Council of Canada to M.B. Fenton (3331). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDRIDGE H, 1986, CAN J ZOOL, V64, P1878, DOI 10.1139/z86-280; Altringham JD, 2003, BAT ECOLOGY, P90; AVERY M, 1972, Prairie Naturalist, V4, P87; BELL GP, 1986, ANIM BEHAV, V34, P409, DOI 10.1016/S0003-3472(86)80110-5; BELL GP, 1985, BEHAV ECOL SOCIOBIOL, V16, P343, DOI 10.1007/BF00295547; BRADBURY JW, 1969, ANIM BEHAV, V17, P480, DOI 10.1016/0003-3472(69)90150-X; CHASE J, 1983, ANIM BEHAV, V31, P526, DOI 10.1016/S0003-3472(83)80075-X; CHASE J, 1981, ANIM BEHAV, V29, P708, DOI 10.1016/S0003-3472(81)80005-X; CHASE J, 1969, ANIM BEHAV, V17, P201, DOI 10.1016/0003-3472(69)90001-3; CHASE J, 1972, THESIS INDIANA U BLO; CONDON CJ, 1994, J NEUROPHYSIOL, V71, P768, DOI 10.1152/jn.1994.71.2.768; CRAWFORD RL, 1981, J MAMMAL, V62, P651, DOI 10.2307/1380421; Davis W. H., 1965, Journal of Mammalogy, V46, P296, DOI 10.2307/1377850; DAVIS WH, 1965, AM MIDL NAT, V74, P497, DOI 10.2307/2423278; Eklof J, 2003, ANIM BEHAV, V66, P949, DOI 10.1006/anbe.2003.2272; Eklof J, 2002, MAMM BIOL, V67, P42, DOI 10.1078/1616-5047-00004; ELLINS SR, 1974, BRAIN BEHAV EVOLUT, V9, P248, DOI 10.1159/000123669; FENTON MB, 1969, CAN J ZOOLOG, V47, P597, DOI 10.1139/z69-103; FENTON MB, 1976, CAN J ZOOL, V54, P1443, DOI 10.1139/z76-167; Galambos R, 1942, J EXP ZOOL, V89, P475, DOI 10.1002/jez.1400890308; Ganier A.F., 1962, MIGRANT, V33, P58; Gollop M. A., 1965, Blue Jay, V23, P15; Griffin D. R., 1960, Animal Behaviour, V8, P141, DOI 10.1016/0003-3472(60)90022-1; GUSTAFSON AW, 1976, BIOL REPROD, V15, P9, DOI 10.1093/biolreprod/15.1.9; HALL HS, 1968, J MAMMAL, V49, P779; HOPE GM, 1979, EXPERIENTIA, V35, P1191, DOI 10.1007/BF01963280; Jen P.H.-S., 1982, PROCEEDINGS OF THE NATIONAL SCIENCE COUNCIL REPUBLIC OF CHINA PART B BASIC SCIENCE, V6, P71; JEN PHS, 1980, P 5 INT BAT RES C, P23; Kronfeld-Schor N, 2000, AM J PHYSIOL-REG I, V279, pR1277, DOI 10.1152/ajpregu.2000.279.4.R1277; MASTERSON FA, 1974, BEHAVIOUR, V51, P88, DOI 10.1163/156853974X00156; McGuire LP, 2009, CAN J ZOOL, V87, P515, DOI 10.1139/Z09-041; McGuire LP, 2010, ACTA CHIROPTEROL, V12, P247, DOI 10.3161/150811010X504734; Neuweiler G., 2000, BIOL BATS, P210; NORBERG U M, 1987, Philosophical Transactions of the Royal Society of London B Biological Sciences, V316, P335, DOI 10.1098/rstb.1987.0030; Russ JM, 2004, ANIM BEHAV, V67, P1005, DOI 10.1016/j.anbehav.2003.09.003; Russ JM, 1998, ANIM BEHAV, V55, P705, DOI 10.1006/anbe.1997.0665; Rydell J, 2003, NATURWISSENSCHAFTEN, V90, P481, DOI 10.1007/s00114-003-0464-x; SAUNDERS W. E., 1930, AUK, V47, P507; Skowronski MD, 2008, J ACOUST SOC AM, V124, P328, DOI 10.1121/1.2924122; SUTHERS R, 1969, BIOL BULL, V137, P535, DOI 10.2307/1540174; Suthers R. A., 1970, BIOL BATS, P265; SUTHERS RA, 1970, VISION RES, V10, P1165, DOI 10.1016/0042-6989(70)90034-9; SUTHERS RA, 1966, SCIENCE, V152, P1102, DOI 10.1126/science.152.3725.1102; TEST FH, 1967, J MAMMAL, V48, P482, DOI 10.2307/1377791; THOMAS DW, 1979, BEHAV ECOL SOCIOBIOL, V6, P129, DOI 10.1007/BF00292559; Timm R.M., 1989, Bulletin of the Chicago Academy of Sciences, V14, P1; Van Gelder R. G., 1956, Transactions of the Kansas Academy of Science, V59, P220; WAIPING V, 1988, J MAMMAL, V69, P641, DOI 10.2307/1381364; ZINN TL, 1979, J MAMMAL, V60, P634, DOI 10.2307/1380110; [No title captured]	50	38	38	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e13912	10.1371/journal.pone.0013912	http://dx.doi.org/10.1371/journal.pone.0013912			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085481	Green Published, gold			2022-12-25	WOS:000284035900019
J	Aguilar-Morante, D; Morales-Garcia, JA; Sanz-SanCristobal, M; Garcia-Cabezas, MA; Santos, A; Perez-Castillo, A				Aguilar-Morante, Diana; Angel Morales-Garcia, Jose; Sanz-SanCristobal, Marina; Angel Garcia-Cabezas, Miguel; Santos, Angel; Perez-Castillo, Ana			Inhibition of Glioblastoma Growth by the Thiadiazolidinone Compound TDZD-8	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; NF-KAPPA-B; EXPERIMENTAL BRAIN-TUMORS; COLORECTAL-CANCER CELLS; NEURAL STEM-CELLS; PROGENITOR CELLS; P53-DEPENDENT APOPTOSIS; ALZHEIMERS-DISEASE; INITIATING CELLS; BINDING PROTEIN	Background: Thiadiazolidinones (TDZD) are small heterocyclic compounds first described as non-ATP competitive inhibitors of glycogen synthase kinase 3 beta (GSK-3 beta). In this study, we analyzed the effects of 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5- dione (TDZD-8), on murine GL261 cells growth in vitro and on the growth of established intracerebral murine gliomas in vivo. Methodology/Principal Findings: Our data show that TDZD-8 decreased proliferation and induced apoptosis of GL261 glioblastoma cells in vitro, delayed tumor growth in vivo, and augmented animal survival. These effects were associated with an early activation of extracellular signal-regulated kinase (ERK) pathway and increased expression of EGR-1 and p21 genes. Also, we observed a sustained activation of the ERK pathway, a concomitant phosphorylation and activation of ribosomal S6 kinase (p90RSK) and an inactivation of GSK-3 beta by phosphorylation at Ser 9. Finally, treatment of glioblastoma stem cells with TDZD-8 resulted in an inhibition of proliferation and self-renewal of these cells. Conclusions/Significance: Our results suggest that TDZD-8 uses a novel mechanism to target glioblastoma cells, and that malignant progenitor population could be a target of this compound.	[Aguilar-Morante, Diana; Angel Morales-Garcia, Jose; Sanz-SanCristobal, Marina; Perez-Castillo, Ana] Univ Autonoma Madrid, Inst Invest Biomed, Consejo Super Invest Cient, Madrid, Spain; [Aguilar-Morante, Diana; Angel Morales-Garcia, Jose; Sanz-SanCristobal, Marina; Perez-Castillo, Ana] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Santos, Angel] Univ Complutense Madrid, Fac Med, Dept Bioquim & Biol Mol, Madrid, Spain; [Angel Garcia-Cabezas, Miguel] Hosp Univ La Paz, Dept Anat Patol, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CIBERNED; Complutense University of Madrid; Hospital Universitario La Paz	Aguilar-Morante, D (corresponding author), Univ Autonoma Madrid, Inst Invest Biomed, Consejo Super Invest Cient, Madrid, Spain.	piedras3@med.ucm.es	Santos, Angel/K-3744-2014; García-Cabezas, Miguel Ángel/K-4737-2019; Perez-Castillo, Ana/A-9505-2015; Morales-Garcia, Jose A/L-4552-2014; Aguilar-Morante, Diana/AAE-8572-2019	Santos, Angel/0000-0002-7551-8483; García-Cabezas, Miguel Ángel/0000-0003-0534-5182; Morales-Garcia, Jose A/0000-0001-9008-0056; Aguilar-Morante, Diana/0000-0001-9775-0841; Perez-Castillo, Ana/0000-0002-2632-5853	Ministerio de Educacion y Ciencia [SAF2007-62811]; Instituto de Salud Carlos III	Ministerio de Educacion y Ciencia(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by the Ministerio de Educacion y Ciencia grant SAF2007-62811 (to A.P.-C.). CIBERNED is funded by the Instituto de Salud Carlos III. JA.M.-G. and M.S.-S. are fellows of CIBERNED. D.A.-M. is a fellow of the Consejo Superior de Investigaciones Cienti-ficas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Benedetti S, 2000, NAT MED, V6, P447, DOI 10.1038/74710; BOTTOMLEY PA, 1987, ANN NY ACAD SCI, V508, P333, DOI 10.1111/j.1749-6632.1987.tb32915.x; Chin PC, 2005, MOL BRAIN RES, V137, P193, DOI 10.1016/j.molbrainres.2005.03.004; Choi BH, 2008, CANCER RES, V68, P1369, DOI 10.1158/0008-5472.CAN-07-5222; Collino M, 2009, DIABETES, V58, P235, DOI 10.2337/db08-0691; Cortes-Canteli M, 2004, J BIOL CHEM, V279, P14409, DOI 10.1074/jbc.M313253200; Cuzzocrea S, 2006, CLIN IMMUNOL, V120, P57, DOI 10.1016/j.clim.2006.03.005; Cuzzocrea S, 2006, J PHARMACOL EXP THER, V318, P79, DOI 10.1124/jpet.106.102863; De Ferrari GV, 2000, BRAIN RES REV, V33, P1, DOI 10.1016/S0165-0173(00)00021-7; DeAngelis LM, 2001, NEW ENGL J MED, V344, P114, DOI 10.1056/NEJM200101113440207; Deng J, 2004, MOL CARCINOGEN, V39, P139, DOI 10.1002/mc.10169; Dugo L, 2006, SHOCK, V25, P485, DOI 10.1097/01.shk.0000209545.29671.31; Edwards E, 2002, CANCER RES, V62, P4671; El Andaloussi A, 2006, GLIA, V54, P526, DOI 10.1002/glia.20401; Eldar-Finkelman H, 2002, TRENDS MOL MED, V8, P126, DOI 10.1016/S1471-4914(01)02266-3; Fomchenko EI, 2006, CLIN CANCER RES, V12, P5288, DOI 10.1158/1078-0432.CCR-06-0438; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gao HK, 2008, J CARDIOVASC PHARM, V52, P286, DOI 10.1097/FJC.0b013e318186a84d; Ghosh JC, 2005, CLIN CANCER RES, V11, P4580, DOI 10.1158/1078-0432.CCR-04-2624; Goulet AC, 2005, CARCINOGENESIS, V26, P109, DOI 10.1093/carcin/bgh306; Guzman ML, 2007, BLOOD, V110, P4436, DOI 10.1182/blood-2007-05-088815; HENNIG J, 1986, MAGNET RESON MED, V3, P823, DOI 10.1002/mrm.1910030602; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kaidanovich Oksana, 2002, Expert Opin Ther Targets, V6, P555; Kim L, 2000, CURR OPIN GENET DEV, V10, P508, DOI 10.1016/S0959-437X(00)00120-9; Kim SD, 2007, BRAIN RES, V1186, P12, DOI 10.1016/j.brainres.2007.10.018; Kjaergaard J, 2000, CANCER RES, V60, P5514; Kong H, 2008, J CELL SCI, V121, P4029, DOI 10.1242/jcs.035758; Kotliarova S, 2008, CANCER RES, V68, P6643, DOI 10.1158/0008-5472.CAN-08-0850; Luna-Medina R, 2005, J BIOL CHEM, V280, P21453, DOI 10.1074/jbc.M414390200; Luna-Medina R, 2007, J NEUROSCI, V27, P5766, DOI 10.1523/JNEUROSCI.1004-07.2007; Ma CL, 2008, J BIOL CHEM, V283, P9248, DOI 10.1074/jbc.M707316200; Martinez A, 2002, MED RES REV, V22, P373, DOI 10.1002/med.10011; Martinez A, 2002, J MED CHEM, V45, P1292, DOI 10.1021/jm011020u; Miyatake SI, 1997, CANCER GENE THER, V4, P222; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Pignatelli M, 2005, CARCINOGENESIS, V26, P81, DOI 10.1093/carcin/bgh308; Roux PP, 2003, MOL CELL BIOL, V23, P4796, DOI 10.1128/MCB.23.14.4796-4804.2003; Sanai N, 2005, NEW ENGL J MED, V353, P811, DOI 10.1056/NEJMra043666; Singh SK, 2004, ONCOGENE, V23, P7267, DOI 10.1038/sj.onc.1207946; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sun AJ, 2007, PROSTATE, V67, P976, DOI 10.1002/pros.20586; Takada Y, 2004, J BIOL CHEM, V279, P39541, DOI 10.1074/jbc.M403449200; Tan J, 2005, CANCER RES, V65, P9012, DOI 10.1158/0008-5472.CAN-05-1226; Tang DM, 2002, J BIOL CHEM, V277, P12710, DOI 10.1074/jbc.M111598200; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; Tewari R, 2008, J NEUROCHEM, V107, P616, DOI 10.1111/j.1471-4159.2008.05625.x; Tkac I, 1999, MAGNET RESON MED, V41, P649, DOI 10.1002/(SICI)1522-2594(199904)41:4<649::AID-MRM2>3.0.CO;2-G; Wang ZQ, 2003, J BIOL CHEM, V278, P11138, DOI 10.1074/jbc.M209108200; Whittle BJR, 2006, BRIT J PHARMACOL, V147, P575, DOI 10.1038/sj.bjp.0706509; Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104; Zagzag D, 2003, BRAIN PATHOL, V13, P34; Zhou Y, 2008, LEUKEMIA LYMPHOMA, V49, P1945, DOI 10.1080/10428190802304966	58	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e13879	10.1371/journal.pone.0013879	http://dx.doi.org/10.1371/journal.pone.0013879			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	676NU	21079728	Green Published, gold			2022-12-25	WOS:000283920000012
J	Jacobs, H; Moalin, M; Bast, A; van der Vijgh, WJF; Haenen, GRMM				Jacobs, Hilde; Moalin, Mohamed; Bast, Aalt; van der Vijgh, Wim J. F.; Haenen, Guido R. M. M.			An Essential Difference between the Flavonoids MonoHER and Quercetin in Their Interplay with the Endogenous Antioxidant Network	PLOS ONE			English	Article							DOXORUBICIN-INDUCED CARDIOTOXICITY; VITAMIN-C; GLUTATHIONE; MONOHYDROXYETHYLRUTOSIDE; TOCOPHEROL; ASCORBATE; OXIDATION	Antioxidants can scavenge highly reactive radicals. As a result the antioxidants are converted into oxidation products that might cause damage to vital cellular components. To prevent this damage, the human body possesses an intricate network of antioxidants that pass over the reactivity from one antioxidant to another in a controlled way. The aim of the present study was to investigate how the semi-synthetic flavonoid 7-mono-O-(beta-hydroxyethyl)-rutoside (monoHER), a potential protective agent against doxorubicin-induced cardiotoxicity, fits into this antioxidant network. This position was compared with that of the well-known flavonoid quercetin. The present study shows that the oxidation products of both monoHER and quercetin are reactive towards thiol groups of both GSH and proteins. However, in human blood plasma, oxidized quercetin easily reacts with protein thiols, whereas oxidized monoHER does not react with plasma protein thiols. Our results indicate that this can be explained by the presence of ascorbate in plasma; ascorbate is able to reduce oxidized monoHER to the parent compound monoHER before oxidized monoHER can react with thiols. This is a major difference with oxidized quercetin that preferentially reacts with thiols rather than ascorbate. The difference in selectivity between monoHER and quercetin originates from an intrinsic difference in the chemical nature of their oxidation products, which was corroborated by molecular quantum chemical calculations. These findings point towards an essential difference between structurally closely related flavonoids in their interplay with the endogenous antioxidant network. The advantage of monoHER is that it can safely channel the reactivity of radicals into the antioxidant network where the reactivity is completely neutralized.	[Jacobs, Hilde; Moalin, Mohamed; Bast, Aalt; van der Vijgh, Wim J. F.; Haenen, Guido R. M. M.] Maastricht Univ Med Ctr MUMC, Dept Pharmacol & Toxicol, NUTRIM Sch Nutr Toxicol & Metab, Maastricht, Netherlands; [Moalin, Mohamed] Hogesch Zuyd, Fac Life Sci, Heerlen, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC)	Jacobs, H (corresponding author), Maastricht Univ Med Ctr MUMC, Dept Pharmacol & Toxicol, NUTRIM Sch Nutr Toxicol & Metab, Maastricht, Netherlands.	hilde.jacobs@maastrichtuniversity.nl	Haenen, Guido/H-9209-2013; Bast, Aalt/I-7809-2013	Haenen, Guido/0000-0001-6986-290X; Bast, Aalt/0000-0002-5383-2789				Amic D, 2007, CURR MED CHEM, V14, P827, DOI 10.2174/092986707780090954; BAST A, 1991, AM J MED, V91, pS2, DOI 10.1016/0002-9343(91)90278-6; Bast A, 2002, ENVIRON TOXICOL PHAR, V11, P251, DOI 10.1016/S1382-6689(01)00118-1; Boots AW, 2008, EUR J PHARMACOL, V585, P325, DOI 10.1016/j.ejphar.2008.03.008; Boots AW, 2007, TOXICOL APPL PHARM, V222, P89, DOI 10.1016/j.taap.2007.04.004; Boots AW, 2003, BIOCHEM BIOPH RES CO, V308, P560, DOI 10.1016/S0006-291X(03)01438-4; BOWRY VW, 1992, BIOCHEM J, V288, P341, DOI 10.1042/bj2880341; Brubacher D, 2000, INT J VITAM NUTR RES, V70, P226, DOI 10.1024/0300-9831.70.5.226; Bruynzeel AME, 2007, BRIT J CANCER, V97, P1084, DOI 10.1038/sj.bjc.6603994; Formica JV, 1995, FOOD CHEM TOXICOL, V33, P1061, DOI 10.1016/0278-6915(95)00077-1; Galati G, 2001, FREE RADICAL BIO MED, V30, P370, DOI 10.1016/S0891-5849(00)00481-0; Haenen G.R., 1993, PHLEBOLOGY S, V1, P10; Haenen GRMM, 2002, THERAPIE, V57, P119; HERTOG MGL, 1993, NUTR CANCER, V20, P21, DOI 10.1080/01635589309514267; Jacobs H, 2009, FREE RADICAL BIO MED, V46, P1567, DOI 10.1016/j.freeradbiomed.2009.02.031; KALYANARAMAN B, 1987, J BIOL CHEM, V262, P11080; Kuhnau J, 1976, World Rev Nutr Diet, V24, P117; Landis-Piwowar K R, 2008, Curr Mol Pharmacol, V1, P233; Liu HL, 2010, RECENT PAT ANTI-CANC, V5, P152, DOI 10.2174/157489210790936261; MEISTER A, 1994, J BIOL CHEM, V269, P9397; MEISTER A, 1994, CANCER RES, V54, pS1969; MOORE GA, 1988, ARCH BIOCHEM BIOPHYS, V267, P539, DOI 10.1016/0003-9861(88)90061-6; MUKAI K, 1991, J BIOL CHEM, V266, P274; NIKI E, 1987, ANN NY ACAD SCI, V498, P186, DOI 10.1111/j.1749-6632.1987.tb23761.x; OBRIEN PJ, 1991, CHEM-BIOL INTERACT, V80, P1, DOI 10.1016/0009-2797(91)90029-7; PACKER JE, 1979, NATURE, V278, P737, DOI 10.1038/278737a0; PEARSON, 1963, J AM CHEM SOC, V85, P3533; Petruzzellis V, 2002, ANGIOLOGY, V53, P257, DOI 10.1177/000331970205300302; Rathee Permender, 2009, Inflammation & Allergy Drug Targets, V8, P229; Upston JM, 1999, FASEB J, V13, P977, DOI 10.1096/fasebj.13.9.977; van Acker FAA, 2000, CLIN CANCER RES, V6, P1337; VANACKER SAB, 1993, PHLEBOLOGY S, V1, P31; VANACKER SABE, 1995, BRIT J PHARMACOL, V115, P1260; Willems AM, 2006, CANCER CHEMOTH PHARM, V57, P678, DOI 10.1007/s00280-005-0083-7; Yen GC, 2003, BIOSCI BIOTECH BIOCH, V67, P1215, DOI 10.1271/bbb.67.1215; YU BP, 1994, PHYSIOL REV, V74, P139, DOI 10.1152/physrev.1994.74.1.139	36	28	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e13880	10.1371/journal.pone.0013880	http://dx.doi.org/10.1371/journal.pone.0013880			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	676NU	21079733	Green Submitted, Green Published, gold			2022-12-25	WOS:000283920000013
J	Mann, D; Hill-Cook, M; Manire, C; Greenhow, D; Montie, E; Powell, J; Wells, R; Bauer, G; Cunningham-Smith, P; Lingenfelser, R; DiGiovanni, R; Stone, A; Brodsky, M; Stevens, R; Kieffer, G; Hoetjes, P				Mann, David; Hill-Cook, Mandy; Manire, Charles; Greenhow, Danielle; Montie, Eric; Powell, Jessica; Wells, Randall; Bauer, Gordon; Cunningham-Smith, Petra; Lingenfelser, Robert; DiGiovanni, Robert, Jr.; Stone, Abigale; Brodsky, Micah; Stevens, Robert; Kieffer, George; Hoetjes, Paul			Hearing Loss in Stranded Odontocete Dolphins and Whales	PLOS ONE			English	Article							EVOKED-POTENTIAL AUDIOMETRY; TEMPORARY THRESHOLD SHIFTS; TURSIOPS-TRUNCATUS; NOISE EXPOSURE; ORCINUS-ORCA; SENSITIVITY; AUDIOGRAMS	The causes of dolphin and whale stranding can often be difficult to determine. Because toothed whales rely on echolocation for orientation and feeding, hearing deficits could lead to stranding. We report on the results of auditory evoked potential measurements from eight species of odontocete cetaceans that were found stranded or severely entangled in fishing gear during the period 2004 through 2009. Approximately 57% of the bottlenose dolphins and 36% of the rough-toothed dolphins had significant hearing deficits with a reduction in sensitivity equivalent to severe (70-90 dB) or profound (>90 dB) hearing loss in humans. The only stranded short-finned pilot whale examined had profound hearing loss. No impairments were detected in seven Risso's dolphins from three different stranding events, two pygmy killer whales, one Atlantic spotted dolphin, one spinner dolphin, or a juvenile Gervais' beaked whale. Hearing impairment could play a significant role in some cetacean stranding events, and the hearing of all cetaceans in rehabilitation should be tested.	[Mann, David; Greenhow, Danielle; Montie, Eric; Powell, Jessica; Wells, Randall] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA; [Wells, Randall] Mote Marine Lab, Chicago Zool Soc, Sarasota, FL 34236 USA; [Hill-Cook, Mandy] Portland State Univ, Dept Biol, Portland, OR 97207 USA; [Bauer, Gordon] New Coll Florida, Div Social Sci, Sarasota, FL USA; [Lingenfelser, Robert] Marine Mammal Conservancy, Key Largo, FL USA; [DiGiovanni, Robert, Jr.] Riverhead Fdn Marine Res & Preservat, Riverhead, NY USA; [Stone, Abigale] Clearwater Marine Aquarium, Clearwater, FL USA; [Brodsky, Micah] Dolphins Plus, Key Largo, FL USA; [Kieffer, George] SCCN, Bapor Kibra, Curacao, Neth Antilles; [Hoetjes, Paul] Dept Environm & Nat, Willemstad, Curacao, Neth Antilles	State University System of Florida; University of South Florida; Mote Marine Laboratory & Aquarium; Portland State University; State University System of Florida; New College Florida	Mann, D (corresponding author), Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA.	dmann@marine.usf.edu			National Oceanographic and Atmospheric Administration (NOAA); Office of Naval Research (ONR)	National Oceanographic and Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA); Office of Naval Research (ONR)(Office of Naval Research)	Funding was provided by National Oceanographic and Atmospheric Administration (NOAA) Ocean Acoustics program for equipment and the Office of Naval Research (ONR) for pilot whale testing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au W. W., 1993, SONAR DOLPHINS; AWBREY FT, 1988, J ACOUST SOC AM, V84, P2273, DOI 10.1121/1.397022; Brill RL, 2001, J ACOUST SOC AM, V109, P1717, DOI 10.1121/1.1356704; BRODIE PF, 1969, AM MIDL NAT, V82, P312, DOI 10.2307/2423849; Clark J G, 1981, ASHA, V23, P493; Cook MLH, 2006, J COMP PHYSIOL A, V192, P489, DOI 10.1007/s00359-005-0086-1; COOK MLH, 2006, THESIS U S FLORIDA; Dobie RA, 1996, J ACOUST SOC AM, V100, P2236, DOI 10.1121/1.417933; DOLPHIN WF, 1995, J COMP PHYSIOL A, V177, P235; Finitzo T, 1998, PEDIATRICS, V102, P1452, DOI 10.1542/peds.102.6.1452; Finneran JJ, 2005, J ACOUST SOC AM, V118, P2696, DOI 10.1121/1.2032087; Finneran JJ, 2002, J ACOUST SOC AM, V111, P2929, DOI 10.1121/1.1479150; Goldey ES, 1998, TOXICOL SCI, V45, P94, DOI 10.1006/toxs.1998.2495; HALL JD, 1972, J ACOUST SOC AM, V51, P515, DOI 10.1121/1.1912871; Houser DS, 2008, MAR MAMMAL SCI, V24, P28, DOI 10.1111/j.1748-7692.2007.00148.x; Houser DS, 2006, J ACOUST SOC AM, V120, P4090, DOI 10.1121/1.2357993; Houser DS, 2006, J ACOUST SOC AM, V120, P1713, DOI 10.1121/1.2229286; JOHNSON C. SCOTT, 1967, MAR BIO ACOUSTICS, V2, P247; Kastelein RA, 2003, J ACOUST SOC AM, V113, P1130, DOI 10.1121/1.1532310; Lucke K, 2009, J ACOUST SOC AM, V125, P4060, DOI 10.1121/1.3117443; MATZ GJ, 1980, AM J OTOL, V1, P169; Nachtigall PE, 2005, J EXP BIOL, V208, P4181, DOI 10.1242/jeb.01876; Nachtigall PE, 2004, MAR MAMMAL SCI, V20, P673, DOI 10.1111/j.1748-7692.2004.tb01187.x; Nachtigall PE, 2003, J ACOUST SOC AM, V113, P3425, DOI 10.1121/1.1570438; Odell D.K., 1987, Cetus, V7, P2; POPOV VV, 1990, J COMP PHYSIOL A, V166, P385; Prahl S, 2011, MYCOSES, V54, pE260, DOI 10.1111/j.1439-0507.2010.01863.x; Ridgway SH, 1997, J ACOUST SOC AM, V101, P590, DOI 10.1121/1.418122; Ross PS, 2000, MAR POLLUT BULL, V40, P504, DOI 10.1016/S0025-326X(99)00233-7; Supin AY, 1995, HEARING RES, V92, P38, DOI 10.1016/0378-5955(95)00194-8; Szymanski MD, 1999, J ACOUST SOC AM, V106, P1134, DOI 10.1121/1.427121; TARTER SK, 1990, J OCCUP ENVIRON MED, V32, P685; Wells R.S., 2004, ECOHEALTH, V1, P246, DOI [10.1007/s10393-004-0094-6, DOI 10.1007/S10393-004-0094-6]; Wells RS, 2005, SCI TOTAL ENVIRON, V349, P106, DOI 10.1016/j.scitotenv.2005.01.010; Yuen MML, 2005, J ACOUST SOC AM, V118, P2688, DOI 10.1121/1.2010350	35	39	40	4	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e13824	10.1371/journal.pone.0013824	http://dx.doi.org/10.1371/journal.pone.0013824			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21072206	gold, Green Submitted, Green Published			2022-12-25	WOS:000283780800021
J	Tsitoura, P; Andronopoulou, E; Tsikou, D; Agalou, A; Papakonstantinou, MP; Kotzia, GA; Labropoulou, V; Swevers, L; Georgoussi, Z; Iatrou, K				Tsitoura, Panagiota; Andronopoulou, Evi; Tsikou, Daniela; Agalou, Adamantia; Papakonstantinou, Maria P.; Kotzia, Georgia A.; Labropoulou, Vassiliki; Swevers, Luc; Georgoussi, Zafiroula; Iatrou, Kostas			Expression and Membrane Topology of Anopheles gambiae Odorant Receptors in Lepidopteran Insect Cells	PLOS ONE			English	Article							THROUGHPUT SCREENING PLATFORMS; PROTEIN-COUPLED RECEPTORS; OPIOID-RECEPTORS; BOMBYX-MORI; FUNCTIONAL EXPRESSION; REGULATORY CASCADE; MOLECULAR-BASIS; CELLULAR BASIS; DROSOPHILA; MOSQUITO	A lepidopteran insect cell-based expression system has been employed to express three Anopheles gambiae odorant receptors (ORs), OR1 and OR2, which respond to components of human sweat, and OR7, the ortholog of Drosophila's OR83b, the heteromerization partner of all functional ORs in that system. With the aid of epitope tagging and specific antibodies, efficient expression of all ORs was demonstrated and intrinsic properties of the proteins were revealed. Moreover, analysis of the orientation of OR1 and OR2 on the cellular plasma membrane through the use of a novel 'topology screen' assay and FACS analysis demonstrates that, as was recently reported for the ORs in Drosophila melanogaster, mosquito ORs also have a topology different than their mammalian counterparts with their N-terminal ends located in the cytoplasm and their C-terminal ends facing outside the cell. These results set the stage for the production of mosquito ORs in quantities that should permit their detailed biochemical and structural characterization and the exploration of their functional properties.	[Tsitoura, Panagiota; Andronopoulou, Evi; Tsikou, Daniela; Kotzia, Georgia A.; Labropoulou, Vassiliki; Swevers, Luc; Iatrou, Kostas] Natl Ctr Sci Res Demokritos, Inst Biol, Insect Mol Genet & Biotechnol Grp, Athens, Greece; [Agalou, Adamantia; Papakonstantinou, Maria P.; Georgoussi, Zafiroula] Natl Ctr Sci Res Demokritos, Inst Biol, Lab Cellular Signaling & Mol Pharmacol, Athens, Greece	National Centre of Scientific Research "Demokritos"; National Centre of Scientific Research "Demokritos"	Tsitoura, P (corresponding author), Natl Ctr Sci Res Demokritos, Inst Biol, Insect Mol Genet & Biotechnol Grp, Athens, Greece.	iatrou@bio.demokritos.gr	Labropoulou, Vassiliki/E-7567-2013; Tsikou, Daniela/AAT-3646-2021	Labropoulou, Vassiliki/0000-0002-9247-6617; Tsikou, Daniela/0000-0001-6295-4860	General Secretariat for Research and Technology, Greek Ministry of Development (Greece-USA) [052]; European Union [FP7/2007-2013, FP7-222927]	General Secretariat for Research and Technology, Greek Ministry of Development (Greece-USA)(Greek Ministry of Development-GSRT); European Union(European Commission)	This research was funded by grants of the General Secretariat for Research and Technology, Greek Ministry of Development (Greece-USA grant No 052) and the European Union (FP7/2007-2013, grant agreement No FP7-222927) to KI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AR, 2009, INSECT BIOCHEM MOLEC, V39, P189, DOI 10.1016/j.ibmb.2008.11.002; Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Biessmann H, 2002, INSECT MOL BIOL, V11, P123, DOI 10.1046/j.1365-2583.2002.00316.x; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; CARRINGTON JC, 1988, P NATL ACAD SCI USA, V85, P3391, DOI 10.1073/pnas.85.10.3391; Cook BL, 2009, P NATL ACAD SCI USA, V106, P11925, DOI 10.1073/pnas.0811089106; Cook BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002920; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Douris V, 2006, ADV VIRUS RES, V68, P113, DOI 10.1016/S0065-3527(06)68004-4; Eystathioy T, 2001, MECH DEVELOP, V103, P107, DOI 10.1016/S0925-4773(01)00335-5; Farrell P.J., 2005, P475; Farrell PJ, 1998, BIOTECHNOL BIOENG, V60, P656, DOI 10.1002/(SICI)1097-0290(19981220)60:6<656::AID-BIT2>3.0.CO;2-9; Farrell PJ, 1999, BIOTECHNOL BIOENG, V64, P426, DOI 10.1002/(SICI)1097-0290(19990820)64:4&lt;426::AID-BIT5&gt;3.0.CO;2-#; Farrell PJ, 2000, PROTEINS, V41, P144, DOI 10.1002/1097-0134(20001001)41:1<144::AID-PROT160>3.3.CO;2-8; Gauczynski S, 2001, EMBO J, V20, P5863, DOI 10.1093/emboj/20.21.5863; GEORGANTA EM, 2010, NEUROPHARMACOLO 0428; GRACE TDC, 1967, NATURE, V216, P613, DOI 10.1038/216613a0; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, TRENDS GENET, V20, P453, DOI 10.1016/j.tig.2004.06.015; Hallem EA, 2004, NATURE, V427, P212, DOI 10.1038/427212a; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Iatrou K, 2008, INSECT BIOCHEM MOLEC, V38, P268, DOI 10.1016/j.ibmb.2007.11.008; JOHNSON R, 1992, VIROLOGY, V190, P815, DOI 10.1016/0042-6822(92)90919-G; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Jordan MD, 2009, CHEM SENSES, V34, P383, DOI 10.1093/chemse/bjp010; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; Keith DE, 1996, J BIOL CHEM, V271, P19021, DOI 10.1074/jbc.271.32.19021; Keith MB, 1999, BIOTECHNOL PROGR, V15, P1046, DOI 10.1021/bp990119f; Kiely A, 2007, J NEUROSCI METH, V159, P189, DOI 10.1016/j.jneumeth.2006.07.005; Kost TA, 2005, NAT BIOTECHNOL, V23, P567, DOI 10.1038/nbt1095; Krietsch T, 2006, MOL ENDOCRINOL, V20, P3146, DOI 10.1210/me.2006-0129; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lee SP, 2000, NEUROPSYCHOPHARMACOL, V23, pS32, DOI 10.1016/S0893-133X(00)00155-X; Leontiadis LJ, 2009, CELL SIGNAL, V21, P1218, DOI 10.1016/j.cellsig.2009.03.013; Lu M, 1997, J BIOL CHEM, V272, P30724, DOI 10.1074/jbc.272.49.30724; Lu ML, 1996, VIROLOGY, V218, P103, DOI 10.1006/viro.1996.0170; Lundin C, 2007, FEBS LETT, V581, P5601, DOI 10.1016/j.febslet.2007.11.007; Megaritis G, 2000, RECEPTOR CHANNEL, V7, P199; Milligan G, 2010, CURR OPIN PHARMACOL, V10, P23, DOI 10.1016/j.coph.2009.09.010; Morou E, 2005, J PHARMACOL EXP THER, V315, P1368, DOI 10.1124/jpet.105.089946; Nakagawa T, 2009, CURR OPIN NEUROBIOL, V19, P284, DOI 10.1016/j.conb.2009.07.015; Pellegrino M, 2009, J EXP BIOL, V212, P1973, DOI 10.1242/jeb.023036; Pelletier J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010090; Pitts RJ, 2004, P NATL ACAD SCI USA, V101, P5058, DOI 10.1073/pnas.0308146101; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Sagne C, 1996, BIOCHEM J, V316, P825, DOI 10.1042/bj3160825; Sahni J, 2007, BIOCHEM J, V401, P505, DOI 10.1042/BJ20060673; Sarramegna V, 2005, PROTEIN EXPRES PURIF, V43, P85, DOI 10.1016/j.pep.2005.05.007; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Seck T, 2005, MOL ENDOCRINOL, V19, P2132, DOI 10.1210/me.2004-0472; Smart R, 2008, INSECT BIOCHEM MOLEC, V38, P770, DOI 10.1016/j.ibmb.2008.05.002; Swevers L, 2002, J BIOL CHEM, V277, P41637, DOI 10.1074/jbc.M203581200; Swevers L, 2005, CELL MOL LIFE SCI, V62, P919, DOI 10.1007/s00018-005-4537-1; Swevers L, 2003, INSECT BIOCHEM MOLEC, V33, P1285, DOI 10.1016/j.ibmb.2003.06.012; Swevers L, 1999, INSECT BIOCHEM MOLEC, V29, P955, DOI 10.1016/S0965-1748(99)00059-4; Szerencsei RT, 2000, J BIOL CHEM, V275, P669, DOI 10.1074/jbc.275.1.669; Vicentic A, 2002, J PHARMACOL EXP THER, V302, P58, DOI 10.1124/jpet.302.1.58; Wang GR, 2010, P NATL ACAD SCI USA, V107, P4418, DOI 10.1073/pnas.0913392107; Wetzel CH, 2001, P NATL ACAD SCI USA, V98, P9377, DOI 10.1073/pnas.151103998; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; WICKHAM TJ, 1992, BIOTECHNOL PROGR, V8, P391, DOI 10.1021/bp00017a003; Wistrand M, 2006, PROTEIN SCI, V15, P509, DOI 10.1110/ps.051745906; Xia YF, 2008, P NATL ACAD SCI USA, V105, P6433, DOI 10.1073/pnas.0801007105	66	43	50	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e15428	10.1371/journal.pone.0015428	http://dx.doi.org/10.1371/journal.pone.0015428			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	800AR	21082026	gold, Green Submitted, Green Published			2022-12-25	WOS:000293329500004
J	Jepson, JEC; Savva, YA; Yokose, C; Sugden, AU; Sahin, A; Reenan, RA				Jepson, James E. C.; Savva, Yiannis A.; Yokose, Chio; Sugden, Arthur U.; Sahin, Asli; Reenan, Robert A.			Engineered Alterations in RNA Editing Modulate Complex Behavior in Drosophila REGULATORY DIVERSITY OF ADENOSINE DEAMINASE ACTING ON RNA (ADAR) TARGETS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALE COURTSHIP BEHAVIOR; HOMOLOGOUS RECOMBINATION; NERVOUS-SYSTEM; NEURAL CIRCUITRY; MELANOGASTER; GENE; FRUITLESS; SONG; INACTIVATION; EXPRESSION	Select proteins involved in electrical and chemical neurotransmission are re-coded at the RNA level via the deamination of particular adenosines to inosine by adenosine deaminases acting on RNA (ADARs). It has been hypothesized that this process, termed RNA editing, acts to "fine-tune" neurophysiological properties in animals and potentially downstream behavioral outputs. However, the extreme phenotypes resulting from deletions of adar loci have precluded investigations into the relationship between ADAR levels, target transcripts, and complex behaviors. Here, we engineer Drosophila hypomorphic for ADAR expression using homologous recombination. A substantial reduction in ADAR activity (> 80%) leads to altered circadian motor patterns and abnormal male courtship, although surprisingly, general locomotor coordination is spared. The altered phenotypic landscape in our adar hypomorph is paralleled by an unexpected dichotomous response of ADAR target transcripts, i.e. certain adenosines are minimally affected by dramatic ADAR reduction, whereas editing of others is severely curtailed. Furthermore, we use a novel reporter to map RNA editing activity across the nervous system, and we demonstrate that knockdown of editing in fruitless-expressing neurons is sufficient to modify the male courtship song. Our data demonstrate that network-wide temporal and spatial regulation of ADAR activity can tune the complex system of RNA-editing sites and modulate multiple ethologically relevant behavioral modalities.	[Jepson, James E. C.; Savva, Yiannis A.; Yokose, Chio; Sugden, Arthur U.; Sahin, Asli; Reenan, Robert A.] Brown Univ, Dept Biochem Mol Biol & Cell Biol, Providence, RI 02912 USA	Brown University	Reenan, RA (corresponding author), Brown Univ, Dept Biochem Mol Biol & Cell Biol, SFH Life Sci Bldg,185 Meeting St, Providence, RI 02912 USA.	Robert_Reenan@brown.edu		jepson, james/0000-0002-3357-2801; Yokose, Chio/0000-0001-7557-3303	Ellison Medical Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007601] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an Ellison Medical Foundation Senior Scholar award.	Allada R, 2010, ANNU REV PHYSIOL, V72, P605, DOI 10.1146/annurev-physiol-021909-135815; Barolo S, 2004, BIOTECHNIQUES, V36, P436, DOI 10.2144/04363ST03; BASILIO C, 1962, P NATL ACAD SCI USA, V48, P613, DOI 10.1073/pnas.48.4.613; Bhalla T, 2004, NAT STRUCT MOL BIOL, V11, P950, DOI 10.1038/nsmb825; BRAND AH, 1993, DEVELOPMENT, V118, P401; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Clyne JD, 2008, CELL, V133, P354, DOI 10.1016/j.cell.2008.01.050; Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Grauso M, 2002, GENETICS, V160, P1519; HALL JC, 1979, GENETICS, V92, P437; Hanrahan CJ, 2000, GENETICS, V155, P1149; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; Hoopengardner B, 2003, SCIENCE, V301, P832, DOI 10.1126/science.1086763; Ingleby L, 2009, J GEN PHYSIOL, V133, P17, DOI 10.1085/jgp.200810133; Jacobs MM, 2009, DEV NEUROSCI-BASEL, V31, P223, DOI 10.1159/000210185; Jepson JEC, 2009, J BIOL CHEM, V284, P31391, DOI 10.1074/jbc.M109.035048; Jin YF, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-98; Jones AK, 2009, J NEUROSCI, V29, P4287, DOI 10.1523/JNEUROSCI.5251-08.2009; Keegan LP, 2005, EMBO J, V24, P2183, DOI 10.1038/sj.emboj.7600691; Kimura K, 2008, NEURON, V59, P759, DOI 10.1016/j.neuron.2008.06.007; Kimura KI, 2005, NATURE, V438, P229, DOI 10.1038/nature04229; Maggert Keith A., 2008, V420, P155, DOI 10.1007/978-1-59745-583-1_9; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Marcucci R, 2009, NUCLEIC ACIDS RES, V37, P1663, DOI 10.1093/nar/gkn1080; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Ohlson J, 2007, RNA, V13, P698, DOI 10.1261/rna.349107; Palladino MJ, 2000, CELL, V102, P437, DOI 10.1016/S0092-8674(00)00049-0; Palladino MJ, 2000, RNA, V6, P1004, DOI 10.1017/S1355838200000248; Peixoto AA, 1998, GENETICS, V148, P827; Reenan RA, 2005, NATURE, V434, P409, DOI 10.1038/nature03364; Rong YKS, 2002, GENE DEV, V16, P1568, DOI 10.1101/gad.986602; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Rula EY, 2008, J NEUROSCI, V28, P6196, DOI 10.1523/JNEUROSCI.0443-08.2008; Semenov EP, 1999, J NEUROCHEM, V72, P66, DOI 10.1046/j.1471-4159.1999.0720066.x; Smith L A, 1998, J Neurogenet, V12, P227; Stapleton M, 2006, RNA, V12, P1922, DOI 10.1261/rna.254306; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; VONSCHILCHER F, 1979, J COMP PHYSIOL, V129, P85, DOI 10.1007/BF00679915; Wu JS, 2006, NAT PROTOC, V1, P2110, DOI 10.1038/nprot.2006.336; ZEHRING WA, 1984, CELL, V39, P369, DOI 10.1016/0092-8674(84)90015-1	43	56	56	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8325	8337		10.1074/jbc.M110.186817	http://dx.doi.org/10.1074/jbc.M110.186817			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21078670	Green Published, hybrid			2022-12-25	WOS:000288013300061
J	Kaufman, Y; Ma, L; Washington, I				Kaufman, Yardana; Ma, Li; Washington, Ilyas			Deuterium Enrichment of Vitamin A at the C20 Position Slows the Formation of Detrimental Vitamin A Dimers in Wild-type Rodents	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINAL-PIGMENT EPITHELIUM; LIPOFUSCIN FLUOROPHORE; MOUSE MODEL; MACULAR DEGENERATION; VISUAL CYCLE; A2E; ACCUMULATION; INHIBITION; RPE; COMPONENT	Degenerative eye diseases are the most common causes of untreatable blindness. Accumulation of lipofuscin (granular deposits) in the retinal pigment epithelium (RPE) is a hallmark of major degenerative eye diseases such as Stargardt disease, Best disease, and age-related macular degeneration. The intrinsic reactivity of vitamin A leads to its dimerization and to the formation of pigments such as A2E, and is believed to play a key role in the formation of ocular lipofuscin. We sought a clinically pragmatic method to slow vitamin A dimerization as a means to elucidate the pathogenesis of macular degenerations and to develop a therapeutic intervention. We prepared vitamin A enriched with the stable isotope deuterium at carbon twenty (C20-D-3-vitamin A). Results showed that dimerization of deuterium-enriched vitamin A was considerably slower than that of vitamin A at natural abundance as measured in vitro. Administration of C20-D-3-vitamin A to wild-type rodents with no obvious genetic defects in vitamin A processing, slowed A2E biosynthesis. This study elucidates the mechanism of A2E biosynthesis and suggests that administration of C20-D-3-vitamin A may be a viable, long-term approach to retard vitamin A dimerization and by extension, may slow lipofuscin deposition and the progression of common degenerative eye diseases.	[Kaufman, Yardana; Ma, Li; Washington, Ilyas] Columbia Univ, Med Ctr, Dept Ophthalmol, New York, NY 10032 USA	Columbia University	Washington, I (corresponding author), Columbia Univ, Med Ctr, Dept Ophthalmol, New York, NY 10032 USA.	iw2101@columbia.edu		W, I/0000-0002-2238-7918	International Retinal Research Foundation; NATIONAL EYE INSTITUTE [R01EY021207] Funding Source: NIH RePORTER	International Retinal Research Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the International Retinal Research Foundation.	Avalle LB, 2004, EXP EYE RES, V78, P895, DOI 10.1016/j.exer.2003.10.023; Baehr W, 2003, VISION RES, V43, P2957, DOI 10.1016/j.visres.2003.10.001; Bakall B, 2007, EXP EYE RES, V85, P34, DOI 10.1016/j.exer.2007.02.018; Ben-Shabat S, 2002, ANGEW CHEM INT EDIT, V41, P814, DOI 10.1002/1521-3773(20020301)41:5<814::AID-ANIE814>3.0.CO;2-2; Ben-Shabat S, 2001, BIOORG MED CHEM LETT, V11, P1533, DOI 10.1016/S0960-894X(01)00314-6; Bench BJ, 2006, J ORG CHEM, V71, P9458, DOI 10.1021/jo061763t; BENDICH A, 1989, AM J CLIN NUTR, V49, P358, DOI 10.1093/ajcn/49.2.358; BERGEN HR, 1988, J LABELLED COMPD RAD, V25, P11; Bergmann M, 2004, FASEB J, V18, P562, DOI 10.1096/fj.03-0289fje; BRIDGES CDB, 1982, INVEST OPHTH VIS SCI, V22, P706; ELDRED GE, 1993, NATURE, V361, P724, DOI 10.1038/361724a0; Ervin R Bethene, 2004, Adv Data, P1; Finnemann SC, 2002, P NATL ACAD SCI USA, V99, P3842, DOI 10.1073/pnas.052025899; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Golczak M, 2008, J BIOL CHEM, V283, P9543, DOI 10.1074/jbc.M708982200; Gronemeyer H, 2001, CELL MOL BIOL LETT, V6, P3; Harkness J.E., 1989, BIOL MED RABBITS ROD, V3rd ed.; Holz FG, 1999, INVEST OPHTH VIS SCI, V40, P737; ISLER O, 1949, HELV CHIM ACTA, V32, P489, DOI 10.1002/hlca.19490320218; Karan G, 2005, P NATL ACAD SCI USA, V102, P4164, DOI 10.1073/pnas.0407698102; Katz ML, 1996, MECH AGEING DEV, V92, P159, DOI 10.1016/S0047-6374(96)01817-9; Kim SR, 2004, P NATL ACAD SCI USA, V101, P11668, DOI 10.1073/pnas.0403499101; Kong J, 2008, GENE THER, V15, P1311, DOI 10.1038/gt.2008.78; Lakkaraju A, 2007, P NATL ACAD SCI USA, V104, P11026, DOI 10.1073/pnas.0702504104; Maeda A, 2006, MOL PHARMACOL, V70, P1220, DOI 10.1124/mol.106.026823; Maiti P, 2006, BIOCHEMISTRY-US, V45, P852, DOI 10.1021/bi0518545; Mata NL, 2000, P NATL ACAD SCI USA, V97, P7154, DOI 10.1073/pnas.130110497; PARDOEN JA, 1985, CAN J CHEM, V63, P1431, DOI 10.1139/v85-246; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; RADDING CM, 1956, J GEN PHYSIOL, V39, P923, DOI 10.1085/jgp.39.6.923; Radu RA, 2005, INVEST OPHTH VIS SCI, V46, P4393, DOI 10.1167/iovs.05-0820; Radu RA, 2003, P NATL ACAD SCI USA, V100, P4742, DOI 10.1073/pnas.0737855100; Radu RA, 2008, INVEST OPHTH VIS SCI, V49, P3821, DOI 10.1167/iovs.07-1470; Ribaya-Mercado JD, 2003, AM J CLIN NUTR, V77, P694, DOI 10.1093/ajcn/77.3.694; ROBERTS RD, 1980, J AM CHEM SOC, V102, P7054, DOI 10.1021/ja00543a027; Rodriguez-Otero J, 1999, J ORG CHEM, V64, P6842, DOI 10.1021/jo990881w; Rozanowski B, 2008, PHOTOCHEM PHOTOBIOL, V84, P650, DOI 10.1111/j.1751-1097.2007.00259.x; Saettel NJ, 2000, J ORG CHEM, V65, P2331, DOI 10.1021/jo991488t; Sakai N, 1996, J AM CHEM SOC, V118, P1559, DOI 10.1021/ja953480g; Schutt F, 2002, OPHTHALMOLOGE, V99, P861, DOI 10.1007/s00347-002-0672-3; Schutt F, 2001, OPHTHALMOLOGE, V98, P721, DOI 10.1007/s003470170078; Shamsi FA, 2001, INVEST OPHTH VIS SCI, V42, P3041; Sparrow JR, 1999, INVEST OPHTH VIS SCI, V40, P2988; Sparrow JR, 2000, INVEST OPHTH VIS SCI, V41, P1981; SZWEDA LI, 1994, J BIOL CHEM, V269, P8712; Um SJ, 2004, CHEM PHARM BULL, V52, P501, DOI 10.1248/cpb.52.501; UNDERWOOD BA, 1970, AM J CLIN NUTR, V23, P1037; Vogel R., 2009, ANN M ASS RES VIS OP; Washington I, 2005, ANGEW CHEM INT EDIT, V44, P7097, DOI 10.1002/anie.200501346; Washington I, 2006, PHOTOCHEM PHOTOBIOL, V82, P1394, DOI 10.1562/2006-02-28-RA-828; Wingerath T, 1997, ANAL CHEM, V69, P3855, DOI 10.1021/ac970463w	51	43	53	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7958	7965		10.1074/jbc.M110.178640	http://dx.doi.org/10.1074/jbc.M110.178640			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21075840	Green Published, hybrid			2022-12-25	WOS:000288013300026
J	Chung, CY; Bien, H; Sobie, EA; Dasari, V; McKinnon, D; Rosati, B; Entcheva, E				Chung, Chiung-yin; Bien, Harold; Sobie, Eric A.; Dasari, Vikram; McKinnon, David; Rosati, Barbara; Entcheva, Emilia			Hypertrophic phenotype in cardiac cell assemblies solely by structural cues and ensuing self-organization	FASEB JOURNAL			English	Article						cardiomyocytes; cell culture; electrophysiology; natriuretic peptides	ATRIAL-NATRIURETIC-PEPTIDE; RAT VENTRICULAR MYOCYTES; ACUTE MYOCARDIAL-INFARCTION; MESSENGER-RNA EXPRESSION; ACUTE HEART-FAILURE; GENE-EXPRESSION; DOWN-REGULATION; I-F; CARDIOMYOCYTE NETWORKS; K+ CURRENT	In vitro models of cardiac hypertrophy focus exclusively on applying "external" dynamic signals (electrical, mechanical, and chemical) to achieve a hypertrophic state. In contrast, here we set out to demonstrate the role of "self-organized" cellular architecture and activity in reprogramming cardiac cell/tissue function toward a hypertrophic phenotype. We report that in neonatal rat cardiomyocyte culture, subtle out-of-plane microtopographic cues alter cell attachment, increase biomechanical stresses, and induce not only structural remodeling, but also yield essential molecular and electrophysiological signatures of hypertrophy. Increased cell size and cell binucleation, molecular up-regulation of released atrial natriuretic peptide, altered expression of classic hypertrophy markers, ion channel remodeling, and corresponding changes in electrophysiological function indicate a state of hypertrophy on par with other in vitro and in vivo models. Clinically used antihypertrophic pharmacological treatments partially reversed hypertrophic behavior in this in vitro model. Partial least-squares regression analysis, combining gene expression and functional data, yielded clear separation of phenotypes (control: cells grown on flat surfaces; hypertrophic: cells grown on quasi-3-dimensional surfaces and treated). In summary, structural surface features can guide cardiac cell attachment, and the subsequent syncytial behavior can facilitate trophic signals, unexpectedly on par with externally applied mechanical, electrical, and chemical stimulation.-Chung, C., Bien, H., Sobie, E. A., Dasari, V., McKinnon, D., Rosati, B., Entcheva, E. Hypertrophic phenotype in cardiac cell assemblies solely by structural cues and ensuing self-organization. FASEB J. 25, 851-862 (2011). www.fasebj.org	[Chung, Chiung-yin; Bien, Harold; Dasari, Vikram; Entcheva, Emilia] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA; [McKinnon, David; Rosati, Barbara] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA; [Sobie, Eric A.] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Icahn School of Medicine at Mount Sinai	Entcheva, E (corresponding author), SUNY Stony Brook, Dept Biomed Engn, HSC T18-30, Stony Brook, NY 11794 USA.	emilia.entcheva@sunysb.edu			American Heart Association [0430307N]; National Science Foundation [BES-0503336, 0235467T, T2390172]; National Institutes of Health [GM071558]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071558, T32GM008444] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Zhiheng Jia and Jacqueline Gunther for help with some experiments. This work was supported by grants from the American Heart Association (0430307N), the National Science Foundation (BES-0503336, 0235467T, and T2390172), and the National Institutes of Health (GM071558).	ADACHI S, 1995, AM J PHYSIOL-HEART C, V268, pH162, DOI 10.1152/ajpheart.1995.268.1.H162; Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; ANVERSA P, 1980, CIRC RES, V46, P495, DOI 10.1161/01.RES.46.4.495; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; BAY BK, 1995, J ORTHOPAED RES, V13, P258, DOI 10.1002/jor.1100130214; Bien H, 2006, BIOPHYS J, V90, P2628, DOI 10.1529/biophysj.105.063321; Bien H, 2003, IEEE ENG MED BIOL, V22, P108, DOI 10.1109/MEMB.2003.1256279; Bodi I, 2003, J AM COLL CARDIOL, V41, P1611, DOI 10.1016/S0735-1097(03)00244-4; Cadre BM, 1998, J MOL CELL CARDIOL, V30, P2247, DOI 10.1006/jmcc.1998.0788; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Chung CY, 2007, J CARDIOVASC ELECTR, V18, P1323, DOI 10.1111/j.1540-8167.2007.00959.x; Domenighetti AA, 2007, J MOL CELL CARDIOL, V42, P63, DOI 10.1016/j.yjmcc.2006.09.019; Dunn AK, 1996, APPL OPTICS, V35, P3441, DOI 10.1364/AO.35.003441; Eghbali M, 2005, CIRC RES, V96, P1208, DOI 10.1161/01.RES.0000170652.71414.16; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Entcheva E, 2005, LAB CHIP, V5, P179, DOI 10.1039/b409478f; Entcheva E, 2003, BIOMED MICRODEVICES, V5, P163, DOI 10.1023/A:1024551614629; Fernandez-Velasco M, 2003, J PHYSIOL-LONDON, V553, P395, DOI 10.1113/jphysiol.2003.041954; Fernandez-Velasco M, 2006, PFLUG ARCH EUR J PHY, V452, P146, DOI 10.1007/s00424-005-0024-7; Folch A, 2000, ANNU REV BIOMED ENG, V2, P227, DOI 10.1146/annurev.bioeng.2.1.227; Gaughan JP, 1998, AM J PHYSIOL-HEART C, V275, pH577, DOI 10.1152/ajpheart.1998.275.2.H577; Geiger B, 2001, SCIENCE, V294, P1661, DOI 10.1126/science.1066919; GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9; GidhJain M, 1996, CIRC RES, V79, P669, DOI 10.1161/01.RES.79.4.669; Goltz D, 2007, CARDIOVASC RES, V74, P85, DOI 10.1016/j.cardiores.2007.01.001; Gong NL, 2006, J BIOL CHEM, V281, P38498, DOI 10.1074/jbc.M607774200; Hardt SE, 2004, CARDIOVASC RES, V63, P500, DOI 10.1016/j.cardiores.2004.03.015; Hayashi M, 2001, J AM COLL CARDIOL, V37, P1820, DOI 10.1016/S0735-1097(01)01233-5; Hesse M, 2007, CARDIOVASC RES, V75, P498, DOI 10.1016/j.cardiores.2007.04.009; Hill JA, 2003, TRENDS CARDIOVAS MED, V13, P316, DOI 10.1016/j.tcm.2003.08.002; Hiramatsu M, 2002, J CARDIOVASC PHARM, V39, P866, DOI 10.1097/00005344-200206000-00012; Horio T, 2000, HYPERTENSION, V35, P19, DOI 10.1161/01.HYP.35.1.19; Kecskemeti V, 1996, MOL CELL BIOCHEM, V161, P53, DOI 10.1007/BF00240031; KINNUNEN P, 1990, BRIT J PHARMACOL, V99, P701, DOI 10.1111/j.1476-5381.1990.tb12992.x; Kitashiro S, 1999, J CARDIOVASC PHARM, V33, P948, DOI 10.1097/00005344-199906000-00016; Koyanagi T, 2008, AM J PHYSIOL-HEART C, V295, pH220, DOI 10.1152/ajpheart.00289.2008; Kuga H, 2003, CIRC J, V67, P443; Lalevee N, 2005, CARDIOVASC RES, V67, P216, DOI 10.1016/j.cardiores.2005.05.009; Lau YH, 2001, PHYS MED BIOL, V46, P1297, DOI 10.1088/0031-9155/46/4/326; Lee JK, 1999, AM J PHYSIOL-HEART C, V277, pH1725, DOI 10.1152/ajpheart.1999.277.5.H1725; Makhlouf AA, 1998, AM J PHYSIOL-HEART C, V274, pH2133, DOI 10.1152/ajpheart.1998.274.6.H2133; MCDONOUGH PM, 1992, J BIOL CHEM, V267, P11665; McGrath MF, 2005, TRENDS ENDOCRIN MET, V16, P469, DOI 10.1016/j.tem.2005.10.007; Rosenberg SS, 2008, P NATL ACAD SCI USA, V105, P14662, DOI 10.1073/pnas.0805640105; Shi WM, 1999, CIRC RES, V85, pE1; Sobie EA, 2009, BIOPHYS J, V96, P1264, DOI 10.1016/j.bpj.2008.10.056; Strait JB, 2000, J MOL CELL CARDIOL, V32, P1553, DOI 10.1006/jmcc.2000.1191; Suwa M, 2005, CIRC J, V69, P283, DOI 10.1253/circj.69.283; Swynghedauw B, 1999, PHYSIOL REV, V79, P215, DOI 10.1152/physrev.1999.79.1.215; TOHSE N, 1995, BRIT J PHARMACOL, V114, P1076, DOI 10.1111/j.1476-5381.1995.tb13316.x; Tomaselli GF, 1999, CARDIOVASC RES, V42, P270, DOI 10.1016/S0008-6363(99)00017-6; Walsh KB, 2001, J MOL CELL CARDIOL, V33, P1233, DOI 10.1006/jmcc.2001.1386; Wang ZY, 2001, CIRCULATION, V104, P1657, DOI 10.1161/hc3901.095766; Wolk R, 2000, EUROPACE, V2, P216, DOI 10.1053/eupc.2000.0110; Yasui K, 2001, CIRC RES, V88, P536, DOI 10.1161/01.RES.88.5.536; Yin LH, 2004, AM J PHYSIOL-HEART C, V287, pH1276, DOI 10.1152/ajpheart.01120.2003; Yoshizumi M, 1997, FEBS LETT, V419, P255, DOI 10.1016/S0014-5793(97)01470-1; Zhang TT, 2004, ACTA PHARMACOL SIN, V25, P226; Zhuang JP, 2000, CIRC RES, V87, P316, DOI 10.1161/01.RES.87.4.316; Zobel C, 2007, CARDIOLOGY, V107, P281, DOI 10.1159/000099063	60	23	23	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAR	2011	25	3					851	862		10.1096/fj.10-168625	http://dx.doi.org/10.1096/fj.10-168625			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	727MZ	21084696	Green Published			2022-12-25	WOS:000287806200006
J	Duch, A; Palou, G; Jonsson, ZO; Palou, R; Calvo, E; Wohlschlegel, J; Quintana, DG				Duch, Alba; Palou, Gloria; Jonsson, Zophonias O.; Palou, Roger; Calvo, Enrique; Wohlschlegel, James; Quintana, David G.			A Dbf4 Mutant Contributes to Bypassing the Rad53-mediated Block of Origins of Replication in Response to Genotoxic Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S PHASE CHECKPOINT; DNA-REPLICATION; PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; DAMAGE; PHOSPHORYLATION; RAD53; PROGRESSION; SLD3	An intra-S phase checkpoint slows the rate of DNA replication in response to DNA damage and replication fork blocks in eukaryotic cells. In the budding yeast Saccharomyces cerevisiae, such down-regulation is achieved through the Rad53 kinase-dependent block of origins of replication. We have identified the Rad53 phosphorylation sites on Dbf4, the activator subunit of the essential S phase Dbf4-dependent kinase, and generated a non-phosphorylatable Dbf4 mutant (dbf4(7A)). We show here that dbf4(7A) is a bona fide intra-S phase checkpoint bypass allele that contributes to abrogating the Rad53 block of origin firing in response to genotoxic stress.	[Duch, Alba; Palou, Gloria; Palou, Roger; Quintana, David G.] Univ Autonoma Barcelona, Sch Med, Dept Biochem & Mol Biol, Biophys Unit, Bellaterra 08193, Catalonia, Spain; [Duch, Alba; Palou, Gloria; Palou, Roger; Quintana, David G.] Univ Autonoma Barcelona, Ctr Biophys Studies, Bellaterra 08193, Catalonia, Spain; [Jonsson, Zophonias O.; Wohlschlegel, James] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Calvo, Enrique] Ctr Nacl Invest Cardiovasc CNIC, Unidad Prote, Madrid 28029, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; University of California System; University of California Los Angeles; Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Quintana, DG (corresponding author), Univ Autonoma Barcelona, Sch Med, Dept Biochem & Mol Biol, Biophys Unit, Bellaterra 08193, Catalonia, Spain.	davidg.quintana@uab.cat	Jónsson, Zophonías/E-1960-2015; Quintana, David G/M-5628-2018; Duch, Alba/AGI-1035-2022; Jónsson, Zophonías Oddur/AAO-1354-2020	Duch, Alba/0000-0001-6041-1360; Jónsson, Zophonías Oddur/0000-0001-5798-9647; Quintana, David G./0000-0002-4909-6686	National Institutes of Health [GM089778]; Ministerio de Ciencia e Innovacion [BFU2008-03778]; UCLA Jonsson Cancer Center; Ministerio de Educacion y Ciencia; Generalitat de Catalunya; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089778] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); UCLA Jonsson Cancer Center; Ministerio de Educacion y Ciencia(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM089778 (to J.W.). This work was also supported by Grant BFU2008-03778 from the Ministerio de Ciencia e Innovacion (to D.G.Q.), the UCLA Jonsson Cancer Center (to J.W.), a Formacion de Personal Investigador fellowship from the Ministerio de Educacion y Ciencia (to A.D.), and a Formacio d'Investigadors fellowship from the Generalitat de Catalunya (to G.P.).	Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; ALLEN JB, 1994, GENE DEV, V8, P2401, DOI 10.1101/gad.8.20.2401; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bell DW, 1999, SCIENCE, V286, P2528, DOI 10.1126/science.286.5449.2528; Bousset K, 1998, GENE DEV, V12, P480, DOI 10.1101/gad.12.4.480; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Jares P, 2000, EMBO REP, V1, P319, DOI 10.1093/embo-reports/kvd076; Lee SJ, 2003, MOL CELL BIOL, V23, P6300, DOI 10.1128/MCB.23.17.6300-6314.2003; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Lopez-Mosqueda J, 2010, NATURE, V467, P479, DOI 10.1038/nature09377; Muramatsu S, 2010, GENE DEV, V24, P602, DOI 10.1101/gad.1883410; PAINTER RB, 1980, P NATL ACAD SCI-BIOL, V77, P7315, DOI 10.1073/pnas.77.12.7315; Palou G, 2010, J BIOL CHEM, V285, P26431, DOI 10.1074/jbc.M110.138669; PAULOVICH AG, 1995, CELL, V82, P841, DOI 10.1016/0092-8674(95)90481-6; Sanchez Y, 1996, SCIENCE, V271, P357, DOI 10.1126/science.271.5247.357; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Sheu YJ, 2010, NATURE, V463, P113, DOI 10.1038/nature08647; Shirahige K, 1998, NATURE, V395, P618, DOI 10.1038/27007; Sun ZX, 1996, GENE DEV, V10, P395, DOI 10.1101/gad.10.4.395; Tercero JA, 2003, MOL CELL, V11, P1323, DOI 10.1016/S1097-2765(03)00169-2; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Travesa A, 2008, J BIOL CHEM, V283, P17123, DOI 10.1074/jbc.M801402200; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; Weinreich M, 1999, EMBO J, V18, P5334, DOI 10.1093/emboj/18.19.5334; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432; Zegerman P, 2010, NATURE, V467, P474, DOI 10.1038/nature09373	30	20	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2486	2491		10.1074/jbc.M110.190843	http://dx.doi.org/10.1074/jbc.M110.190843			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21098477	hybrid, Green Published			2022-12-25	WOS:000286464300013
J	Wang, L; Payton, R; Dai, W; Lu, L				Wang, Ling; Payton, Reid; Dai, Wei; Lu, Luo			Hyperosmotic Stress-induced ATF-2 Activation through Polo-like Kinase 3 in Human Corneal Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAY; C-JUN; TRANSCRIPTIONAL ACTIVATION; SERINE/THREONINE KINASE; PROTEIN-KINASES; APOPTOSIS; PHOSPHORYLATION; POLO-LIKE-KINASE-3; PROLIFERATION; INDUCTION	Elevated extracellular solute concentration (hyperosmotic stress) perturbs cell function and stimulates cell responses by evoking MAPK cascades and activating AP-1 transcription complex resulting in alterations of gene expression, cell cycle arrest, and apoptosis. The results presented here demonstrate that hyperosmotic stress elicited increases in ATF-2 phosphorylation through a novel Polo-like kinase 3 (Plk3) pathway in human corneal epithelial (HCE) cells. We found in hyperosmotic stress-induced HCE cells that Plk3 transferred to the nuclear compartment and was colocalized with ATF-2 in nuclei. Kinase activity of Plk3 was significantly activated by hyperosmotic stimulation. Further downstream, active Plk3 phosphorylated ATF-2 at the Thr-71 site in vivo and in vitro. Overexpression of Plk3 and its mutants enhanced hyperosmotic stress-induced ATF-2 phosphorylation. In contrast, suppression of Plk3 by knocking down Plk3 mRNA effectively diminished the effect of hyperosmotic stress-induced ATF-2 phosphorylation. The effect of hyperosmotic stress-induced activation of Plk3 on ATF-2 transcription factor function was also examined in CRE reporter-overexpressed HCE cells. Our results for the first time reveal that hyperosmotic stress can activate the Plk3 signaling pathway that subsequently regulates the AP-1 complex by directly phosphorylating ATF-2 independent from the effects of JNK and p38 activation.	[Lu, Luo] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Torrance, CA 90502 USA; [Dai, Wei] NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY 10987 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; New York University	Lu, L (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, 1124 W Carson St,H-H Bldg, Torrance, CA 90502 USA.	lluou@ucla.edu		Dai, Wei/0000-0003-0169-8327	National Institutes of Health [EY 018343, CA074229]; NATIONAL CANCER INSTITUTE [R01CA074229] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY015281, R01EY018343] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY 018343 (to L. L.) and CA074229 (to W. D.).	Bin OY, 1997, J BIOL CHEM, V272, P28646, DOI 10.1074/jbc.272.45.28646; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Carrillo RJ, 2010, J MOL BIOL, V396, P431, DOI 10.1016/j.jmb.2009.11.050; Conn CW, 2000, CANCER RES, V60, P6826; Corrales RM, 2008, CORNEA, V27, P574, DOI 10.1097/ICO.0b013e318165b19e; Cortez D, 2003, J BIOL CHEM, V278, P37139, DOI 10.1074/jbc.M307088200; Dai W, 2005, ONCOGENE, V24, P214, DOI 10.1038/sj.onc.1208270; DEUTSCH C, 1982, BIOCHIM BIOPHYS ACTA, V721, P262, DOI 10.1016/0167-4889(82)90078-7; DONOHUE PJ, 1995, J BIOL CHEM, V270, P10351, DOI 10.1074/jbc.270.17.10351; GALCHEVAGARGOVA Z, 1994, SCIENCE, V265, P806, DOI 10.1126/science.8047888; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; HAMANAKA R, 1995, J BIOL CHEM, V270, P21086, DOI 10.1074/jbc.270.36.21086; Huang ZB, 2004, J PHYSIOL-LONDON, V558, P181, DOI 10.1113/jphysiol.2004.065540; HURST HC, 1995, PROTEIN PROFILE, V2, P105; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kimura K, 2008, INVEST OPHTH VIS SCI, V49, P125, DOI 10.1167/iovs.07-0725; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Lee JH, 2008, INVEST OPHTH VIS SCI, V49, P1827, DOI 10.1167/iovs.07-1142; Lee M, 2004, J BIOL CHEM, V279, P48692, DOI 10.1074/jbc.M403132200; Li B, 1996, J BIOL CHEM, V271, P19402, DOI 10.1074/jbc.271.32.19402; Liu H, 2006, EMBO J, V25, P1058, DOI 10.1038/sj.emboj.7601020; LIVINGSTONE C, 1995, EMBO J, V14, P1785, DOI 10.1002/j.1460-2075.1995.tb07167.x; Lu L, 2003, INVEST OPHTH VIS SCI, V44, P5102, DOI 10.1167/iovs.03-0591; Lunn JA, 2007, J BIOL CHEM, V282, P10370, DOI 10.1074/jbc.M607780200; Nam JS, 2002, CLIN CANCER RES, V8, P2430; Ouwens DM, 2002, EMBO J, V21, P3782, DOI 10.1093/emboj/cdf361; Rosette C, 1996, SCIENCE, V274, P1194, DOI 10.1126/science.274.5290.1194; Saika S, 2004, INVEST OPHTH VIS SCI, V45, P100, DOI 10.1167/iovs.03-0700; Sarkaria JN, 1999, CANCER RES, V59, P4375; Schumacher MA, 2000, J BIOL CHEM, V275, P35242, DOI 10.1074/jbc.M007293200; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Sheikh-Hamad D, 2004, AM J PHYSIOL-RENAL, V287, pF1102, DOI 10.1152/ajprenal.00225.2004; Uhlik MT, 2003, NAT CELL BIOL, V5, P1104, DOI 10.1038/ncb1071; VANDAM H, 1995, EMBO J, V14, P1798, DOI 10.1002/j.1460-2075.1995.tb07168.x; Wang L, 2008, J BIOL CHEM, V283, P25928, DOI 10.1074/jbc.M801326200; Wang L, 2007, J BIOL CHEM, V282, P32121, DOI 10.1074/jbc.M702791200; Wang L, 2007, INVEST OPHTH VIS SCI, V48, P652, DOI 10.1167/iovs.06-1007; Wang Q, 2002, MOL CELL BIOL, V22, P3450, DOI 10.1128/MCB.22.10.3450-3459.2002; Westfall PJ, 2008, P NATL ACAD SCI USA, V105, P12212, DOI 10.1073/pnas.0805797105; Yu SP, 2000, P NATL ACAD SCI USA, V97, P9360, DOI 10.1073/pnas.97.17.9360	41	31	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1951	1958		10.1074/jbc.M110.166009	http://dx.doi.org/10.1074/jbc.M110.166009			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21098032	Green Published, hybrid			2022-12-25	WOS:000286191500036
J	Zhang, HT; Zhou, R; Li, L; Chen, J; Chen, LL; Li, CJ; Ding, H; Yu, LA; Hu, LH; Jiang, HL; Shen, X				Zhang, Haitao; Zhou, Rong; Li, Li; Chen, Jing; Chen, Lili; Li, Chenjing; Ding, Hong; Yu, Liang; Hu, Lihong; Jiang, Hualiang; Shen, Xu			Danthron Functions as a Retinoic X Receptor Antagonist by Stabilizing Tetramers of the Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING DOMAIN; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; RXR; RAR; MODULATION; ACTIVATION; COMPLEX; CANCER; ACID	Retinoic X receptor (RXR) is a promising target for drug discovery against cancer and metabolic syndromes. Here, we identified a specific RXR alpha antagonist, danthron, from the traditional Chinese medicine rhubarb. Danthron repressed all tested RXR alpha-involved response element transcription, including the RXRE, PPRE, FXRE, and LXRE. Results from native PAGE and isothermal titration calorimetry (ITC)-based assays indicated that danthron bound to the tetrameric RXR alpha-LBD in a specific stoichimetric ratio, and such a binding could influence the corepressor SMRT affinity to the receptor. Additionally, a unique tetrameric structure of the apo-RXR alpha ligand-binding domain (LBD) was determined, which exhibited a larger tetramer interface and different ligand-binding pocket size compared with the one previously reported. Together with the biochemical and biophysical results, the determined crystal structure of danthron-soaked RXR alpha-LBD suggested a new mechanism for danthron antagonism to tetrameric RXR alpha. Moreover, the in vivo efficient improvement of insulin sensitivity by danthron was observed in diet-induced obese (DIO) mice. Thus, our findings were expected to supply new insights into the structural basis of RXR alpha antagonist for its further potential therapeutic application.	[Jiang, Hualiang; Shen, Xu] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China; [Zhou, Rong; Li, Li; Shen, Xu] E China Univ Sci & Technol, Shanghai 200237, Peoples R China; [Shen, Xu] Shanghai Jiao Tong Univ, Sch Med, E Inst Shanghai Municipal Educ Commiss, Shanghai 200025, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; East China University of Science & Technology; Shanghai Jiao Tong University		simmhulh@mail.shcnc.ac.cn; xshen@mail.shcnc.ac.cn	Zhang, Haitao/L-7612-2015	Zhang, Haitao/0000-0003-4879-2951	State Key Program of Basic Research of China [2010CB912501, 2007CB914304, 2009CB918502]; National Natural Science Foundation of China [30925040, 30890044, 10979072]; Key New Drug Creation and Manufacturing Program [2009ZX09301-001]; Science Foundation of Shanghai [08431902900]; E-Institutes of Shanghai Municipal Education Commission [E09013]; Foundation of Chinese Academy of Sciences [KSCX2-YW-R-168, SCX1-YW-02-2]	State Key Program of Basic Research of China(State Key Development Program for Basic Research of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key New Drug Creation and Manufacturing Program; Science Foundation of Shanghai(Natural Science Foundation of Shanghai); E-Institutes of Shanghai Municipal Education Commission; Foundation of Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the State Key Program of Basic Research of China (Grants 2010CB912501, 2007CB914304, and 2009CB918502), the National Natural Science Foundation of China (Grants 30925040, 30890044, and 10979072), Key New Drug Creation and Manufacturing Program (2009ZX09301-001), the Science Foundation of Shanghai (Grant 08431902900), the E-Institutes of Shanghai Municipal Education Commission (Grant E09013), and the Foundation of Chinese Academy of Sciences (Grants KSCX2-YW-R-168 and SCX1-YW-02-2).	Altucci L, 2007, NAT REV DRUG DISCOV, V6, P793, DOI 10.1038/nrd2397; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bourguet W, 2000, MOL CELL, V5, P289, DOI 10.1016/S1097-2765(00)80424-4; BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; de Lera AR, 2007, NAT REV DRUG DISCOV, V6, P811, DOI 10.1038/nrd2398; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Egea PF, 2000, EMBO J, V19, P2592, DOI 10.1093/emboj/19.11.2592; Egea PF, 2002, MOL ENDOCRINOL, V16, P987, DOI 10.1210/me.16.5.987; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gampe RT, 2000, GENE DEV, V14, P2229, DOI 10.1101/gad.802300; Gao Q, 2010, PLANTA MED, V76, P27, DOI 10.1055/s-0029-1185948; Germain P, 2006, PHARMACOL REV, V58, P760, DOI 10.1124/pr.58.4.7; GIGUERE V, 1994, ENDOCR REV, V15, P61, DOI 10.1210/er.15.1.61; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Huang Q, 2007, MED RES REV, V27, P609, DOI 10.1002/med.20094; Jackson TA, 1997, MOL ENDOCRINOL, V11, P693, DOI 10.1210/me.11.6.693; KERSTEN S, 1995, BIOCHEMISTRY-US, V34, P14263, DOI 10.1021/bi00043a034; Kersten S, 1998, J MOL BIOL, V284, P21, DOI 10.1006/jmbi.1998.2168; KERSTEN S, 1995, P NATL ACAD SCI USA, V92, P8645, DOI 10.1073/pnas.92.19.8645; Kersten S, 1997, J BIOL CHEM, V272, P29759, DOI 10.1074/jbc.272.47.29759; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu Y, 2009, EXP MOL MED, V41, P648, DOI 10.3858/emm.2009.41.9.071; MANGELSDORF DJ, 1993, RECENT PROG HORM RES, V48, P99; Nahoum V, 2007, P NATL ACAD SCI USA, V104, P17323, DOI 10.1073/pnas.0705356104; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pinaire JA, 2007, PPAR RES, V2007, DOI 10.1155/2007/94156; Sakaki J, 2007, BIOORG MED CHEM LETT, V17, P4804, DOI 10.1016/j.bmcl.2007.06.080; Schoch GA, 2010, J MOL BIOL, V395, P568, DOI 10.1016/j.jmb.2009.11.011; Tanaka T, 2009, CANCER RES, V69, P4945, DOI 10.1158/0008-5472.CAN-08-4407; Xu HE, 2002, NATURE, V415, P813, DOI 10.1038/415813a; Xue JF, 2010, FITOTERAPIA, V81, P173, DOI 10.1016/j.fitote.2009.08.020; Yotsumoto T, 2005, METABOLISM, V54, P573, DOI 10.1016/j.metabol.2004.11.013; Zhang L, 2008, J BIOL CHEM, V283, P5370, DOI 10.1074/jbc.M705566200	36	46	48	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1868	1875		10.1074/jbc.M110.166215	http://dx.doi.org/10.1074/jbc.M110.166215			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21084305	Green Published, hybrid			2022-12-25	WOS:000286191500027
J	Bhave, DP; Hong, JA; Lee, M; Jiang, W; Krebs, C; Carroll, KS				Bhave, Devayani P.; Hong, Jiyoung A.; Lee, Michael; Jiang, Wei; Krebs, Carsten; Carroll, Kate S.			Spectroscopic Studies on the [4Fe-4S] Cluster in Adenosine 5 '-Phosphosulfate Reductase from Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR CLUSTER; ELECTRON-PARAMAGNETIC-RES; LYASE ACTIVATING ENZYME; ESCHERICHIA-COLI; 3'-PHOSPHOADENOSINE-5'-PHOSPHOSULFATE REDUCTASE; PSEUDOMONAS-AERUGINOSA; SULFATE REDUCTASE; CRYSTAL-STRUCTURE; ADENOSINE-5'-PHOSPHOSULFATE REDUCTASE; REDOX POTENTIALS	Mycobacterium tuberculosis adenosine 5'-phosphosulfate reductase (MtAPR) is an iron-sulfur protein and a validated target to develop new antitubercular agents, particularly for the treatment of latent infection. The enzyme harbors a [4Fe-4S](2+) cluster that is coordinated by four cysteinyl ligands, two of which are adjacent in the amino acid sequence. The iron-sulfur cluster is essential for catalysis; however, the precise role of the [4Fe-4S] cluster in APR remains unknown. Progress in this area has been hampered by the failure to generate a paramagnetic state of the [4Fe-4S] cluster that can be studied by electron paramagnetic resonance spectroscopy. Herein, we overcome this limitation and report the EPR spectra of MtAPR in the [4Fe-4S](+) state. The EPR signal is rhombic and consists of two overlapping S = 1/2 species. Substrate binding to MtAPR led to a marked increase in the intensity and resolution of the EPR signal and to minor shifts in principle g values that were not observed among a panel of substrate analogs, including adenosine 5'-diphosphate. Using site-directed mutagenesis, in conjunction with kinetic and EPR studies, we have also identified an essential role for the active site residue Lys-144, whose side chain interacts with both the iron-sulfur cluster and the sulfate group of adenosine 5'-phosphosulfate. The implications of these findings are discussed with respect to the role of the iron-sulfur cluster in the catalytic mechanism of APR.	[Carroll, Kate S.] Scripps Res Inst, Dept Chem, Jupiter, FL 33458 USA; Univ Michigan, Chem Biol Grad Program, Ann Arbor, MI 48109 USA; [Hong, Jiyoung A.; Carroll, Kate S.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Lee, Michael; Krebs, Carsten] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Jiang, Wei; Krebs, Carsten] Penn State Univ, Dept Chem, University Pk, PA 16802 USA	Scripps Research Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Carroll, KS (corresponding author), Scripps Res Inst, Dept Chem, 130 Scripps Way 2B2, Jupiter, FL 33458 USA.	kcarroll@scripps.edu	Krebs, Carsten/D-4773-2009; Bhave, Devayani/D-1915-2017	Krebs, Carsten/0000-0002-3302-7053; Bhave, Devayani/0000-0002-0773-9962; Hong, Jiyoung/0000-0002-0430-3290; Carroll, Kate/0000-0002-7624-9617	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087638] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM087638-03S1, R01 GM087638, R01 GM087638-04] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agarwalla S, 2004, J BIOL CHEM, V279, P34123, DOI 10.1074/jbc.M405702200; ANTANAITIS BC, 1980, J BIOL CHEM, V255, P1204; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Beinert H, 1996, CHEM REV, V96, P2335, DOI 10.1021/cr950040z; Berndt C, 2004, J BIOL CHEM, V279, P7850, DOI 10.1074/jbc.M309332200; Bhave Devayani P., 2007, Infectious Disorders - Drug Targets, V7, P140; Booker SJ, 2009, CURR OPIN CHEM BIOL, V13, P58, DOI 10.1016/j.cbpa.2009.02.036; Carroll KS, 2005, PLOS BIOL, V3, P1418, DOI 10.1371/journal.pbio.0030250; Carroll KS, 2005, BIOCHEMISTRY-US, V44, P14647, DOI 10.1021/bi051344a; Catrina I, 2007, J AM CHEM SOC, V129, P5760, DOI 10.1021/ja069111+; Chapman E, 2003, P NATL ACAD SCI USA, V100, P910, DOI 10.1073/pnas.0337638100; Chartron J, 2007, BIOCHEMISTRY-US, V46, P3942, DOI 10.1021/bi700130e; Chartron J, 2006, J MOL BIOL, V364, P152, DOI 10.1016/j.jmb.2006.08.080; Cleland WW, 2006, CHEM REV, V106, P3252, DOI 10.1021/cr050287o; Cosper MM, 2004, BIOCHEMISTRY-US, V43, P2007, DOI 10.1021/bi0356653; CUNNINGHAM RP, 1989, BIOCHEMISTRY-US, V28, P4450, DOI 10.1021/bi00436a049; Davydov R, 1999, BIOCHEMISTRY-US, V38, P4188, DOI 10.1021/bi982391o; Dey KR, 2010, TETRAHEDRON LETT, V51, P1329, DOI 10.1016/j.tetlet.2010.01.004; Dos Santos PC, 2008, P NATL ACAD SCI USA, V105, P11589, DOI 10.1073/pnas.0805713105; EMPTAGE MH, 1983, P NATL ACAD SCI-BIOL, V80, P4674, DOI 10.1073/pnas.80.15.4674; Engstrom M, 2000, CHEM PHYS LETT, V328, P483, DOI 10.1016/S0009-2614(00)00961-1; Fontecave M, 2006, NAT CHEM BIOL, V2, P171, DOI 10.1038/nchembio0406-171; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; GILLUM WO, 1977, J AM CHEM SOC, V99, P584, DOI 10.1021/ja00444a044; HAGEN WR, 1992, ADV INORG CHEM, V38, P165, DOI 10.1016/S0898-8838(08)60064-1; Hernick M, 2006, BIOCHEMISTRY-US, V45, P15240, DOI 10.1021/bi061405k; Hong JA, 2009, J MED CHEM, V52, P5485, DOI 10.1021/jm900728u; JENSEN GM, 1994, BIOCHEMISTRY-US, V33, P10911, DOI 10.1021/bi00202a010; Kim SK, 2005, BBA-BIOENERGETICS, V1710, P103, DOI 10.1016/j.bbabio.2005.09.004; Kim SK, 2004, BIOCHEMISTRY-US, V43, P13478, DOI 10.1021/bi048811t; Kopriva S, 2002, J BIOL CHEM, V277, P21786, DOI 10.1074/jbc.M202152200; Kopriva S, 2001, J BIOL CHEM, V276, P42881, DOI 10.1074/jbc.M107424200; Kopriva S, 2007, J BIOL CHEM, V282, P22930, DOI 10.1074/jbc.M702522200; Krebs C, 2002, J AM CHEM SOC, V124, P912, DOI 10.1021/ja017562i; Kriek M, 2003, PROTEIN EXPRES PURIF, V28, P241, DOI 10.1016/S1046-5928(02)00680-0; LANGEN R, 1992, J BIOL CHEM, V267, P25625; Lawrence CC, 1999, P NATL ACAD SCI USA, V96, P8979, DOI 10.1073/pnas.96.16.8979; Lee KH, 2009, BIOCHEMISTRY-US, V48, P10162, DOI 10.1021/bi900939w; LEYH TS, 1988, J BIOL CHEM, V263, P2409; Mdluli K, 2006, CURR OPIN PHARMACOL, V6, P459, DOI 10.1016/j.coph.2006.06.004; Mougous JD, 2006, MOL CELL, V21, P109, DOI 10.1016/j.molcel.2005.10.034; Noodleman L, 2002, CURR OPIN CHEM BIOL, V6, P259, DOI 10.1016/S1367-5931(02)00309-5; Noodleman L., 2008, WILEY ENCY CHEM BIOL, P1; Orme-Johnson W H, 1978, Methods Enzymol, V53, P268; RAGSDALE SW, 1987, J BIOL CHEM, V262, P14289; RENOSTO F, 1984, J BIOL CHEM, V259, P2113; SATISHCHANDRAN C, 1992, BIOORG CHEM, V20, P107, DOI 10.1016/0045-2068(92)90031-W; Saunders AH, 2008, BIOCHEMISTRY-US, V47, P10999, DOI 10.1021/bi801268f; Savage H, 1997, STRUCTURE, V5, P895, DOI 10.1016/S0969-2126(97)00244-X; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Torres RA, 2003, J AM CHEM SOC, V125, P1923, DOI 10.1021/ja0211104; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; Walsby CJ, 2002, J AM CHEM SOC, V124, P3143, DOI 10.1021/ja012034s; Weiner BE, 2007, J BIOL CHEM, V282, P33444, DOI 10.1074/jbc.M705826200; Williams SJ, 2002, J BIOL CHEM, V277, P32606, DOI 10.1074/jbc.M204613200; Yu ZH, 2008, BIOCHEMISTRY-US, V47, P12777, DOI 10.1021/bi801118f	56	12	13	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1216	1226		10.1074/jbc.M110.193722	http://dx.doi.org/10.1074/jbc.M110.193722			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21075841	Green Published, hybrid			2022-12-25	WOS:000286005000033
J	Price, DL; Rockenstein, E; Ubhi, K; Van, P; MacLean-Lewis, N; Askay, D; Cartier, A; Spencer, B; Patrick, C; Desplats, P; Ellisman, MH; Masliah, E				Price, Diana L.; Rockenstein, Edward; Ubhi, Kiren; Van Phung; MacLean-Lewis, Natalie; Askay, David; Cartier, Anna; Spencer, Brian; Patrick, Christina; Desplats, Paula; Ellisman, Mark H.; Masliah, Eliezer			Alterations in mGluR5 Expression and Signaling in Lewy Body Disease and in Transgenic Models of Alpha-Synucleinopathy - Implications for Excitotoxicity	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; A-BETA COMPONENT; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; BASAL-GANGLIA; NEURODEGENERATIVE DISORDERS; UNSTRUCTURED PROTEINS; HIPPOCAMPAL-NEURONS; PRESYNAPTIC PROTEIN; STRIATAL DOPAMINE	Dementia with Lewy bodies (DLB) and Parkinson's Disease (PD) are neurodegenerative disorders of the aging population characterized by the abnormal accumulation of alpha-synuclein (alpha-syn). Previous studies have suggested that excitotoxicity may contribute to neurodegeneration in these disorders, however the underlying mechanisms and their relationship to alpha-syn remain unclear. For this study we proposed that accumulation of alpha-syn might result in alterations in metabotropic glutamate receptors (mGluR), particularly mGluR5 which has been linked to deficits in murine models of PD. In this context, levels of mGluR5 were analyzed in the brains of PD and DLB human cases and alpha-syn transgenic (tg) mice and compared to age-matched, unimpaired controls, we report a 40% increase in the levels of mGluR5 and beta-arrestin immunoreactivity in the frontal cortex, hippocampus and putamen in DLB cases and in the putamen in PD cases. In the hippocampus, mGluR5 was more abundant in the CA3 region and co-localized with alpha-syn aggregates. Similarly, in the hippocampus and basal ganglia of alpha-syn tg mice, levels of mGluR5 were increased and mGluR5 and alpha-syn were co-localized and co-immunoprecipated, suggesting that alpha-syn interferes with mGluR5 trafficking. The increased levels of mGluR5 were accompanied by a concomitant increase in the activation of downstream signaling components including ERK, Elk-1 and CREB. Consistent with the increased accumulation of alpha-syn and alterations in mGluR5 in cognitive-and motor-associated brain regions, these mice displayed impaired performance in the water maze and pole test, these behavioral alterations were reversed with the mGluR5 antagonist, MPEP. Taken together the results from study suggest that mGluR5 may directly interact with alpha-syn resulting in its over activation and that this over activation may contribute to excitotoxic cell death in select neuronal regions. These results highlight the therapeutic importance of mGluR5 antagonists in alpha-synucleinopathies.	[Price, Diana L.; Rockenstein, Edward; Ubhi, Kiren; Askay, David; Cartier, Anna; Spencer, Brian; Patrick, Christina; Desplats, Paula; Ellisman, Mark H.; Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Masliah, Eliezer] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Price, Diana L.; Van Phung; MacLean-Lewis, Natalie; Askay, David; Ellisman, Mark H.] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA; [Van Phung; MacLean-Lewis, Natalie; Ellisman, Mark H.] Univ Calif San Diego, Ctr Res Biol Syst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Price, DL (corresponding author), ACADIA Pharmaceut Inc, San Diego, CA USA.	emasliah@ucsd.edu	Askay, David/I-8080-2019; Desplats, Paula/AFW-5030-2022	Askay, David/0000-0001-5612-9944; Desplats, Paula/0000-0002-4758-4280	Branfman Family and MJ Fox Foundations; National Center for Research Resources [RR004050]; National Institute on Deafness and Other Communication Disorders [DC03192, RR043050]; National Institute on Aging [AG18840, AG022074, AG10435]; National Institutes of Health [LM07292]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG010435, P01AG022074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003192] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM007292] Funding Source: NIH RePORTER	Branfman Family and MJ Fox Foundations; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by The Branfman Family and MJ Fox Foundations, National Center for Research Resources RR004050, National Institute on Deafness and Other Communication Disorders DC03192 (CCDB), RR043050 (Mouse BIRN), National Institute on Aging AG18840, AG022074, AG10435 and National Institutes of Health LM07292. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre JA, 2005, BRAIN RES, V1033, P216, DOI 10.1016/j.brainres.2004.11.040; Aronica E, 2001, NEUROSCIENCE, V105, P509, DOI 10.1016/S0306-4522(01)00181-6; Battaglia G, 2004, J NEUROSCI, V24, P828, DOI 10.1523/JNEUROSCI.3831-03.2004; Braak H, 2000, J NEUROL, V247, P3; Breysse N, 2003, J NEUROSCI, V23, P8302; Breysse N, 2002, J NEUROSCI, V22, P5669; Bruno V, 2001, J CEREBR BLOOD F MET, V21, P1013, DOI 10.1097/00004647-200109000-00001; Chase TN, 2000, TRENDS NEUROSCI, V23, pS86, DOI 10.1016/S1471-1931(00)00018-5; Chow SK, 2006, J MICROSC-OXFORD, V222, P76, DOI 10.1111/j.1365-2818.2006.01577.x; Coccurello R, 2004, NEUROPSYCHOPHARMACOL, V29, P1451, DOI 10.1038/sj.npp.1300444; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Dale LB, 2001, MOL PHARMACOL, V60, P1243, DOI 10.1124/mol.60.6.1243; Dale LB, 2002, NEUROCHEM INT, V41, P319, DOI 10.1016/S0197-0186(02)00073-6; De Leonibus E, 2009, NEUROPSYCHOPHARMACOL, V34, P729, DOI 10.1038/npp.2008.129; DICKSON DW, 1989, ACTA NEUROPATHOL, V78, P572, DOI 10.1007/BF00691284; DICKSON DW, 1987, ACTA NEUROPATHOL, V75, P8, DOI 10.1007/BF00686786; Fan GY, 1999, BIOPHYS J, V76, P2412, DOI 10.1016/S0006-3495(99)77396-0; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Fernagut PO, 2003, NEUROSCIENCE, V116, P1123, DOI 10.1016/S0306-4522(02)00778-9; Galasko D, 1996, BRAIN COGNITION, V31, P166, DOI 10.1006/brcg.1996.0040; Gasparini F, 1999, NEUROPHARMACOLOGY, V38, P1493, DOI 10.1016/S0028-3908(99)00082-9; Greenamyre JT, 2001, CLIN NEUROPHARMACOL, V24, P65, DOI 10.1097/00002826-200103000-00001; Gregoire L, 2009, PARKINSONISM RELAT D, V15, P445, DOI 10.1016/j.parkreldis.2008.11.001; Halliday GM, 2005, BRAIN, V128, P2272, DOI 10.1093/brain/awh596; Hansen LA, 1997, NEUROLOGY, V48, P126, DOI 10.1212/WNL.48.1.126; Harding AJ, 2002, ANN NEUROL, V51, P125, DOI 10.1002/ana.10071; Harding AJ, 2001, ACTA NEUROPATHOL, V102, P355; Hilton GD, 2006, EUR J NEUROSCI, V24, P3008, DOI 10.1111/j.1460-9568.2006.05189.x; Irizarry MC, 1998, J NEUROPATH EXP NEUR, V57, P334, DOI 10.1097/00005072-199804000-00005; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Iwata A, 2001, J NEUROCHEM, V77, P239, DOI 10.1046/j.1471-4159.2001.t01-1-00232.x; Iwata A, 2001, J BIOL CHEM, V276, P45320, DOI 10.1074/jbc.M103736200; Kachroo A, 2005, J NEUROSCI, V25, P10414, DOI 10.1523/JNEUROSCI.3660-05.2005; Kearney JAF, 2003, EXP NEUROL, V184, pS30, DOI 10.1016/S0014-4886(03)00391-1; Lansbury PT, 1999, P NATL ACAD SCI USA, V96, P3342, DOI 10.1073/pnas.96.7.3342; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Lee H, 2004, ACTA NEUROBIOL EXP, V64, P89; Lee H, 2004, ACTA NEUROPATHOL, V107, P365, DOI 10.1007/s00401-004-0820-8; Lee HG, 2002, NEUROSIGNALS, V11, P282, DOI 10.1159/000067427; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; Lee VMY, 2004, TRENDS NEUROSCI, V27, P129, DOI 10.1016/j.tins.2004.01.007; Marino MJ, 2003, DRUG AGING, V20, P377, DOI 10.2165/00002512-200320050-00006; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Matsuura K, 1997, J NEUROSCI METH, V73, P45, DOI 10.1016/S0165-0270(96)02211-X; Mattila PM, 2000, ACTA NEUROPATHOL, V100, P285, DOI 10.1007/s004019900168; Mattson MP, 2007, AGING CELL, V6, P337, DOI 10.1111/j.1474-9726.2007.00275.x; Mcgeehan AJ, 2004, PSYCHOPHARMACOLOGY, V174, P266, DOI 10.1007/s00213-003-1733-2; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; Mundell SJ, 2001, J NEUROCHEM, V78, P546, DOI 10.1046/j.1471-4159.2001.00421.x; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Nafia I, 2008, J NEUROCHEM, V105, P484, DOI 10.1111/j.1471-4159.2007.05146.x; Naie K, 2004, CEREB CORTEX, V14, P189, DOI 10.1093/cercor/bhg118; Nicoletti F, 1996, TRENDS NEUROSCI, V19, P267, DOI 10.1016/S0166-2236(96)20019-0; O'Leary DM, 2000, BRIT J PHARMACOL, V131, P1429, DOI 10.1038/sj.bjp.0703715; OHNO Y, 1994, PHARMACOL BIOCHEM BE, V49, P19, DOI 10.1016/0091-3057(94)90451-0; Oka A, 1999, ACTA NEUROPATHOL, V97, P275, DOI 10.1007/s004010050985; Ossowska K, 2001, NEUROPHARMACOLOGY, V41, P413, DOI 10.1016/S0028-3908(01)00083-1; Ouattara B, 2010, J NEUROCHEM, V113, P715, DOI 10.1111/j.1471-4159.2010.06635.x; Outeiro TF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006906; Perez RG, 2002, J NEUROSCI, V22, P3090, DOI 10.1523/JNEUROSCI.22-08-03090.2002; Phillips JM, 2006, EUR J NEUROSCI, V23, P151, DOI 10.1111/j.1460-9568.2005.04550.x; Popoli P, 2001, NEUROPSYCHOPHARMACOL, V25, P505, DOI 10.1016/S0893-133X(01)00256-1; Price DL, 2006, NEUROINFORMATICS, V4, P65, DOI 10.1385/NI:4:1:65; Rascovsky K, 2002, NEUROLOGY, V58, P1801, DOI 10.1212/WNL.58.12.1801; Rochet JC, 2004, J MOL NEUROSCI, V23, P23, DOI 10.1385/JMN:23:1-2:023; Rockenstein E, 2003, J NEURAL TRANSM, V110, P1313, DOI 10.1007/s00702-003-0025-7; Rockenstein E, 2002, J NEUROSCI RES, V68, P568, DOI 10.1002/jnr.10231; ROMANO C, 1995, J COMP NEUROL, V355, P455, DOI 10.1002/cne.903550310; Rouse ST, 2000, PHARMACOL THERAPEUT, V88, P427, DOI 10.1016/S0163-7258(00)00098-X; RYLANDER D, 2010, NEUROBIOL DIS; SALMON DP, 1990, NEUROLOGY, V40, P1225, DOI 10.1212/WNL.40.8.1225; Sanchez-Pernaute R, 2008, NEUROIMAGE, V42, P248, DOI 10.1016/j.neuroimage.2008.04.170; Shastry BS, 2001, NEUROSCI RES, V41, P5, DOI 10.1016/S0168-0102(01)00254-1; Sidhu A, 2004, FASEB J, V18, P637, DOI 10.1096/fj.03-1112rev; Simonyi A, 2005, DRUG NEWS PERSPECT, V18, P353, DOI 10.1358/dnp.2005.18.6.927927; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Takeda A, 1998, LAB INVEST, V78, P1169; Takeda A, 1998, AM J PATHOL, V152, P367; Thorns V, 1997, ACTA NEUROPATHOL, V94, P539, DOI 10.1007/s004010050748; Tisch S, 2004, PSYCHIAT CLIN N AM, V27, P757, DOI 10.1016/j.psc.2004.06.004; Trojanowski JQ, 1998, CELL DEATH DIFFER, V5, P832, DOI 10.1038/sj.cdd.4400432; Tsigelny IF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003135; Tsigelny IF, 2008, NANOMED-NANOTECHNOL, V4, P350, DOI 10.1016/j.nano.2008.05.005; Turle-Lorenzo N, 2005, PSYCHOPHARMACOLOGY, V179, P117, DOI 10.1007/s00213-005-2202-x; Wakabayashi K, 1998, ACTA NEUROPATHOL, V96, P445, DOI 10.1007/s004010050918; Wakabayashi K, 1997, NEUROSCI LETT, V239, P45, DOI 10.1016/S0304-3940(97)00891-4; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Yamakawa K, 2010, BIOCHEM BIOPH RES CO, V391, P129, DOI 10.1016/j.bbrc.2009.11.015; Zhu JH, 2002, AM J PATHOL, V161, P2087, DOI 10.1016/S0002-9440(10)64487-2	90	58	60	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e14020	10.1371/journal.pone.0014020	http://dx.doi.org/10.1371/journal.pone.0014020			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103359	Green Published, gold			2022-12-25	WOS:000284257400019
J	Xie, X; Ma, YT; Yang, YN; Fu, ZY; Li, XM; Huang, D; Ma, XA; Chen, BD; Liu, F				Xie, Xiang; Ma, Yi-Tong; Yang, Yi-Ning; Fu, Zhen-Yan; Li, Xiao-Mei; Huang, Ding; Ma, Xiang; Chen, Bang-Dang; Liu, Fen			Polymorphisms in the SAA1/2 Gene Are Associated with Carotid Intima Media Thickness in Healthy Han Chinese Subjects: The Cardiovascular Risk Survey	PLOS ONE			English	Article							SERUM AMYLOID-A; HIGH-DENSITY-LIPOPROTEIN; CORONARY-ARTERY-DISEASE; ACUTE-PHASE REACTANT; PROTEIN SAA; ANKYLOSING-SPONDYLITIS; MYOCARDIAL-INFARCTION; HDL; ATHEROSCLEROSIS; INFLAMMATION	Background: Serum amyloid A protein (SAA) is not only an inflammatory factor, but also an apolipoprotein that can replace apolipoprotein A1 (apoA1) as the major apolipoprotein of high-density lipoprotein (HDL), which has been linked to atherosclerosis. However, the relationship between genetic polymorphisms of SAA and the intima-media thickness (IMT) of the common carotid artery in healthy subjects remains unclear. We investigated the role of SAA1 and SAA2 gene polymorphisms with IMT in a cohort of healthy subjects participating in the Cardiovascular Risk Survey (CRS) study. Methodology/Principal Findings: Anthropometric and B-mode ultrasound of the carotid IMT were measured in 1914 subjects (849 men; 1065 women) recruited from seven cities in Xinjiang province, (western China). Four SNPs (rs12218, rs2229338, rs1059559, and rs2468844) were genotyped by use of the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. The SNP rs12218 was associated with carotid IMT by analyses of a dominate model (P<0.001) and additive model (P=0.003), and the difference remained significant after multivariate adjustment (P=0.008, P<0.001, respectively). This relationship was also observed in rs2468844 after multivariate adjustment by recessive model analysis (P=0.011) but this was not observed in rs2229338 and rs1059559 before and after multivariate adjustment. These associations were not modified by serum HDL concentration. Furthermore, there were significant interactions between rs2468844 and rs12218 (interaction P<0.001) and rs2229338 (interaction P=0.001) on carotid IMT. Conclusion/Significance: Both rs12218 of the SAA1 gene and rs2468844 of SAA2 gene are associated with carotid IMT in healthy Han Chinese subjects.	[Xie, Xiang; Ma, Yi-Tong; Yang, Yi-Ning; Fu, Zhen-Yan; Li, Xiao-Mei; Huang, Ding; Ma, Xiang] Xinjiang Med Univ, Affiliated Hosp 1, Dept Cardiol, Urumqi, Peoples R China; [Xie, Xiang; Ma, Yi-Tong; Yang, Yi-Ning; Fu, Zhen-Yan; Li, Xiao-Mei; Ma, Xiang; Chen, Bang-Dang; Liu, Fen] Xinjiang Key Lab Cardiovasc Dis Res, Urumqi, Peoples R China	Xinjiang Medical University	Ma, YT (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Dept Cardiol, Urumqi, Peoples R China.	myt-xj@163.com	xie, xiang/AAG-2128-2021		Great Technology Special Item Foundation of Xinjiang, China [200733146-3]	Great Technology Special Item Foundation of Xinjiang, China	This work was supported financially by grants from the Great Technology Special Item Foundation of Xinjiang, China (200733146-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artl A, 2000, ARTERIOSCL THROM VAS, V20, P763, DOI 10.1161/01.ATV.20.3.763; BENDITT EP, 1971, FEBS LETT, V19, P169, DOI 10.1016/0014-5793(71)80506-9; BENDITT EP, 1979, P NATL ACAD SCI USA, V76, P4092, DOI 10.1073/pnas.76.8.4092; BENDITT EP, 1977, P NATL ACAD SCI USA, V74, P4025, DOI 10.1073/pnas.74.9.4025; BENDITT EP, 1982, ANN NY ACAD SCI, V389, P183, DOI 10.1111/j.1749-6632.1982.tb22136.x; Carty CL, 2009, J ATHEROSCLER THROMB, V16, P419, DOI 10.5551/jat.No968; CLIFTON PM, 1985, J LIPID RES, V26, P1389; COETZEE GA, 1986, J BIOL CHEM, V261, P9644; Fyfe AI, 1997, CIRCULATION, V96, P2914, DOI 10.1161/01.CIR.96.9.2914; Graversen JH, 2008, LIPIDS, V43, P467, DOI 10.1007/s11745-008-3169-2; Hayat S, 2000, SCAND J IMMUNOL, V51, P141; Johnson BD, 2004, CIRCULATION, V109, P726, DOI 10.1161/01.CIR.0000115516.54550.B1; Kimchi-Sarfaty C, 2007, SCIENCE, V318, P1382; KIRWAN J, 1993, BRIT J RHEUMATOL, V32, P729; Lee YI, 2009, CURR APPL PHYS, V9, pS79, DOI 10.1016/j.cap.2008.08.024; LEVIN M, 1972, J CLIN INVEST, V51, pA56; Liao YC, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-93; Liu GM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-66; LOWELL CA, 1986, J BIOL CHEM, V261, P8453; Malle E, 1996, EUR J CLIN INVEST, V26, P427, DOI 10.1046/j.1365-2362.1996.159291.x; Moriguchi M, 2001, ARTHRITIS RHEUM, V44, P1266, DOI 10.1002/1529-0131(200106)44:6<1266::AID-ART218>3.0.CO;2-3; Navarro MA, 2005, CYTOKINE, V31, P52, DOI 10.1016/j.cyto.2005.03.002; O'Brien KD, 2005, ARTERIOSCL THROM VAS, V25, P785, DOI 10.1161/01.ATV.0000158383.65277.2b; Patel S, 2008, EUR HEART J, V29, P386, DOI 10.1093/eurheartj/ehm526; Scalapino KJ, 2003, CLIN EXP MED, V2, P159, DOI 10.1007/s102380300000; Schillinger M, 2005, CIRCULATION, V111, P2203, DOI 10.1161/01.CIR.0000163569.97918.C0; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Xie X, 2009, CLIN APPL THROMB-HEM, V15, P574, DOI 10.1177/1076029608329581; Xie X, 2009, CLIN CHEM LAB MED, V47, P347, DOI 10.1515/CCLM.2009.078; Yamada T, 1999, AMYLOID, V6, P199, DOI 10.3109/13506129909007327	30	70	73	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e13997	10.1371/journal.pone.0013997	http://dx.doi.org/10.1371/journal.pone.0013997			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103356	gold, Green Published, Green Submitted			2022-12-25	WOS:000284257400005
J	Aspelund, T; Gudnason, V; Magnusdottir, BT; Andersen, K; Sigurdsson, G; Thorsson, B; Steingrimsdottir, L; Critchley, J; Bennett, K; O'Flaherty, M; Capewell, S				Aspelund, Thor; Gudnason, Vilmundur; Magnusdottir, Bergrun Tinna; Andersen, Karl; Sigurdsson, Gunnar; Thorsson, Bolli; Steingrimsdottir, Laufey; Critchley, Julia; Bennett, Kathleen; O'Flaherty, Martin; Capewell, Simon			Analysing the Large Decline in Coronary Heart Disease Mortality in the Icelandic Population Aged 25-74 between the Years 1981 and 2006	PLOS ONE			English	Article							RISK-FACTOR CHANGES; VASCULAR MORTALITY; INDIVIDUAL DATA; BLOOD-PRESSURE; ENGLAND; WALES; DEATHS; PREVENTION; LIFE; METAANALYSIS	Background: Coronary heart disease (CHD) mortality rates have been decreasing in Iceland since the 1980s. We examined how much of the decrease between 1981 and 2006 could be attributed to medical and surgical treatments and how much to changes in cardiovascular risk factors. Methodology: The previously validated IMPACT CHD mortality model was applied to the Icelandic population. The data sources were official statistics, national quality registers, published trials and meta-analyses, clinical audits and a series of national population surveys. Principal Findings: Between 1981 and 2006, CHD mortality rates in Iceland decreased by 80% in men and women aged 25 to 74 years, which resulted in 295 fewer deaths in 2006 than if the 1981 rates had persisted. Incidence of myocardial infarction (MI) decreased by 66% and resulted in some 500 fewer incident MI cases per year, which is a major determinant of possible deaths from MI. Based on the IMPACT model approximately 73% (lower and upper bound estimates: 54%-93%) of the mortality decrease was attributable to risk factor reductions: cholesterol 32%; smoking 22%; systolic blood pressure 22%, and physical inactivity 5% with adverse trends for diabetes (-5%), and obesity (-4%). Approximately 25% (lower and upper bound estimates: 8%-40%) of the mortality decrease was attributable to treatments in individuals: secondary prevention 8%; heart failure treatments 6%; acute coronary syndrome treatments 5%; revascularisation 3%; hypertension treatments 2%, and statins 0.5%. Conclusions: Almost three quarters of the large CHD mortality decrease in Iceland between 1981 and 2006 was attributable to reductions in major cardiovascular risk factors in the population. These findings emphasize the value of a comprehensive prevention strategy that promotes tobacco control and a healthier diet to reduce incidence of MI and highlights the potential importance of effective, evidence based medical treatments.	[Aspelund, Thor; Gudnason, Vilmundur; Magnusdottir, Bergrun Tinna; Sigurdsson, Gunnar; Thorsson, Bolli] Iceland Heart Assoc, Kopavogur, Iceland; [Aspelund, Thor; Gudnason, Vilmundur; Andersen, Karl; Steingrimsdottir, Laufey] Univ Iceland, Reykjavik, Iceland; [Andersen, Karl; Sigurdsson, Gunnar] Landspitali Univ Hosp, Reykavik, Iceland; [Critchley, Julia] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Bennett, Kathleen] St James Hosp, Dept Pharmacol & Therapeut, Trinity Ctr Hlth Sci, Dublin, Ireland; [O'Flaherty, Martin; Capewell, Simon] Univ Liverpool, Div Publ Hlth, Liverpool L69 3BX, Merseyside, England	Icelandic Heart Association; University of Iceland; Landspitali National University Hospital; Newcastle University - UK; Trinity College Dublin; University of Liverpool	Aspelund, T (corresponding author), Iceland Heart Assoc, Kopavogur, Iceland.	v.gudnason@hjarta.is	Steingrimsdottir, Laufey/L-3150-2015; Aspelund, Thor/K-7022-2019; Aspelund, Thor/F-4826-2011; Gudnason, Vilmundur/AAE-7126-2019; Aspelund, Thor/C-5983-2008; Shao, Ruitai/AAU-7642-2021; Thorsson, Bolli/V-7992-2017; Gudnason, Vilmundur/K-6885-2015	Aspelund, Thor/0000-0002-7998-5433; Gudnason, Vilmundur/0000-0001-5696-0084; Aspelund, Thor/0000-0002-7998-5433; Gudnason, Vilmundur/0000-0001-5696-0084; Bennett, Kathleen/0000-0002-2861-7665; O'Flaherty, Martin/0000-0001-8944-4131; Critchley, Julia/0000-0002-5248-4188	Icelandic Heart Association; University of Iceland	Icelandic Heart Association; University of Iceland	This work was supported by the Icelandic Heart Association and the University of Iceland Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAGLEHOLE R, 1986, BMJ-BRIT MED J, V292, P33, DOI 10.1136/bmj.292.6512.33; Bennett K, 2006, J EPIDEMIOL COMMUN H, V60, P322, DOI 10.1136/jech.2005.038638; Bjorck L, 2009, EUR HEART J, V30, P1046, DOI 10.1093/eurheartj/ehn554; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Bots M L, 1996, J Cardiovasc Risk, V3, P271, DOI 10.1097/00043798-199606000-00002; BRIGGS A, 1994, HEALTH ECON, V3, P95, DOI 10.1002/hec.4730030206; Capewell S, 1999, HEART, V81, P380, DOI 10.1136/hrt.81.4.380; Capewell S, 2006, HEART, V92, P521, DOI 10.1136/hrt.2004.053645; Capewell S, 2000, CIRCULATION, V102, P1511, DOI 10.1161/01.CIR.102.13.1511; CAPEWELL S, 2008, WHO B IN PRESS; Critchley J, 2004, CIRCULATION, V110, P1236, DOI 10.1161/01.CIR.0000140668.91896.AE; Critchley JA, 2003, J CLIN EPIDEMIOL, V56, P583, DOI 10.1016/S0895-4356(03)00059-3; Critchley JA, 2003, JAMA-J AM MED ASSOC, V290, P86, DOI 10.1001/jama.290.1.86; Critchley JA, 2003, J EPIDEMIOL COMMUN H, V57, P243, DOI 10.1136/jech.57.4.243; Fidan D, 2007, QJM-INT J MED, V100, P277, DOI 10.1093/qjmed/hcm020; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Gudnason V, 2008, CIRCULATION, V118, pS1080; Heiat A, 2002, ARCH INTERN MED, V162, P1682, DOI 10.1001/archinte.162.15.1682; Hu FB, 2002, JAMA-J AM MED ASSOC, V288, P2569, DOI 10.1001/jama.288.20.2569; Hunink MGM, 1997, JAMA-J AM MED ASSOC, V277, P535, DOI 10.1001/jama.277.7.535; Laatikainen T, 2005, AM J EPIDEMIOL, V162, P764, DOI 10.1093/aje/kwi274; Lewington S, 2008, LANCET, V372, P292; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lewington S, 2003, LANCET, V361, P1060; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; MANT J, 1995, BMJ-BRIT MED J, V311, P793, DOI 10.1136/bmj.311.7008.793; OLAFSSON O, 1969, MANUAL EPIDEMIOLOGIC; *PUBL HLTH I IC, 2009, IC FOOD SUPPL DAT; SIGFUSSON N, 1991, BRIT MED J, V302, P1371, DOI 10.1136/bmj.302.6789.1371; *STAT IC, 2008, BIRTHS DEATHS; Thorsson B, 2009, LAEKNABLADID, V95, P259; Unal B, 2005, BMJ-BRIT MED J, V331, P614, DOI 10.1136/bmj.38561.633345.8F; Unal B, 2005, J CLIN EPIDEMIOL, V58, P733, DOI 10.1016/j.jclinepi.2004.09.015; Unal B, 2005, AM J PUBLIC HEALTH, V95, P103, DOI 10.2105/AJPH.2003.029579; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; VARTIAINEN E, 1994, BMJ-BRIT MED J, V309, P23, DOI 10.1136/bmj.309.6946.23; Weintraub WS, 2008, NEW ENGL J MED, V359, P677, DOI 10.1056/NEJMoa072771	37	87	92	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e13957	10.1371/journal.pone.0013957	http://dx.doi.org/10.1371/journal.pone.0013957			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103050	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000284147700008
J	Gandille, P; Narbonne-Reveau, K; Boissonneau, E; Randsholt, N; Busson, D; Pret, AM				Gandille, Pierre; Narbonne-Reveau, Karine; Boissonneau, Elisabeth; Randsholt, Neel; Busson, Denise; Pret, Anne-Marie			Mutations in the Polycomb Group Gene polyhomeotic Lead to Epithelial Instability in both the Ovary and Wing Imaginal Disc in Drosophila	PLOS ONE			English	Article							TUMOR-SUPPRESSOR ACTIVITY; TRITHORAX GROUP PROTEINS; BORDER-CELL-MIGRATION; HOX GENES; EXPRESSION; OOGENESIS; POLARITY; MELANOGASTER; BOUNDARIES; JUNCTIONS	Background: Most human cancers originate from epithelial tissues and cell polarity and adhesion defects can lead to metastasis. The Polycomb-Group of chromatin factors were first characterized in Drosophila as repressors of homeotic genes during development, while studies in mammals indicate a conserved role in body plan organization, as well as an implication in other processes such as stem cell maintenance, cell proliferation, and tumorigenesis. We have analyzed the function of the Drosophila Polycomb-Group gene polyhomeotic in epithelial cells of two different organs, the ovary and the wing imaginal disc. Results: Clonal analysis of loss and gain of function of polyhomeotic resulted in segregation between mutant and wild-type cells in both the follicular and wing imaginal disc epithelia, without excessive cell proliferation. Both basal and apical expulsion of mutant cells was observed, the former characterized by specific reorganization of cell adhesion and polarity proteins, the latter by complete cytoplasmic diffusion of these proteins. Among several candidate target genes tested, only the homeotic gene Abdominal-B was a target of PH in both ovarian and wing disc cells. Although overexpression of Abdominal-B was sufficient to cause cell segregation in the wing disc, epistatic analysis indicated that the presence of Abdominal-B is not necessary for expulsion of polyhomeotic mutant epithelial cells suggesting that additional POLYHOMEOTIC targets are implicated in this phenomenon. Conclusion: Our results indicate that polyhomeotic mutations have a direct effect on epithelial integrity that can be uncoupled from overproliferation. We show that cells in an epithelium expressing different levels of POLYHOMEOTIC sort out indicating differential adhesive properties between the cell populations. Interestingly, we found distinct modalities between apical and basal expulsion of ph mutant cells and further studies of this phenomenon should allow parallels to be made with the modified adhesive and polarity properties of different types of epithelial tumors.	[Gandille, Pierre; Boissonneau, Elisabeth; Randsholt, Neel; Pret, Anne-Marie] CNRS, Ctr Genet Mol FRE 3144, Gif Sur Yvette, France; Univ Mediterannee Aix Marseille II, CNRS, Marseille, France; [Narbonne-Reveau, Karine] Univ Mediterannee Aix Marseille II, CNRS, Inst Biol Dev Marseille Luminy, UMR 6216, Marseille, France; [Narbonne-Reveau, Karine; Busson, Denise; Pret, Anne-Marie] Univ Paris 07, Univ Paris 06, CNRS, Inst Jacques Monod,UMR7592, Paris, France; [Busson, Denise] Univ Paris 06, Systemat Adaptat Evolut UMR7138, Paris, France; [Randsholt, Neel] Univ Paris 06, CNRS, Dev Biol Lab, UMR7622, Paris, France; [Pret, Anne-Marie] Univ Versailles St Quentin, Versailles, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay	Gandille, P (corresponding author), CNRS, Ctr Genet Mol FRE 3144, Gif Sur Yvette, France.	pret@cgm.cnrs-gif.fr		Narbonne-Reveau, Karine/0000-0002-4650-4576	Centre National de la Recherche Scientifique ATIP; Fondation pour la Recherch Medicale [INE20050303456]; Ministe de l'Enseignement Superieure et de la Recherche Technologique	Centre National de la Recherche Scientifique ATIP(Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherch Medicale; Ministe de l'Enseignement Superieure et de la Recherche Technologique	This work was supported by the Centre National de la Recherche Scientifique ATIP (http://www.cnrs.fr/); the Fondation pour la Recherch Medicale INE20050303456 (http://www.frm.org/); and the Ministe de l'Enseignement Superieure et de la Recherche Technologique (http://www.enseignementsup-recherche.gouv.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becam IE, 2005, NAT CELL BIOL, V7, P510, DOI 10.1038/ncb1253; Beuchle D, 2001, DEVELOPMENT, V128, P993; Bokel C, 2002, DEV CELL, V3, P311, DOI 10.1016/S1534-5807(02)00265-4; Breiling A, 2007, INT REV CYTOL, V258, P83, DOI 10.1016/S0074-7696(07)58002-2; Bruggeman SWM, 2009, BBA-GEN SUBJECTS, V1790, P351, DOI 10.1016/j.bbagen.2009.03.009; BUSTURIA A, 1988, DEVELOPMENT, V104, P713; Castelli-Gair J, 1998, INT J DEV BIOL, V42, P437; Classen AK, 2009, NAT GENET, V41, P1150, DOI 10.1038/ng.445; Dahmann C, 1999, TRENDS GENET, V15, P320, DOI 10.1016/S0168-9525(99)01774-6; DeFalco T, 2004, MECH DEVELOP, V121, P1323, DOI 10.1016/j.mod.2004.07.001; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; DUNCAN IM, 1982, GENETICS, V102, P49; DURA JM, 1988, DEVELOPMENT, V103, P733; DURA JM, 1987, CELL, V51, P829, DOI 10.1016/0092-8674(87)90106-1; Faucheux M, 2003, MOL CELL BIOL, V23, P1181, DOI 10.1128/MCB.23.4.1181-1195.2003; Forbes AJ, 1996, DEVELOPMENT, V122, P3283; Forbes AJ, 1996, DEVELOPMENT, V122, P1125; Gates J, 2005, CELL, V123, P769, DOI 10.1016/j.cell.2005.11.009; Gibson MC, 2005, SCIENCE, V307, P1785, DOI 10.1126/science.1104751; Gibson MC, 2003, CURR OPIN CELL BIOL, V15, P747, DOI 10.1016/j.ceb.2003.10.008; Godt D, 2009, NAT CELL BIOL, V11, P536, DOI 10.1038/ncb0509-536; Goode S, 2005, DEV DYNAM, V232, P855, DOI 10.1002/dvdy.20336; Goode S, 1997, GENE DEV, V11, P2532, DOI 10.1101/gad.11.19.2532; Grammont M, 2007, J CELL BIOL, V177, P139, DOI 10.1083/jcb.200609079; Huang L, 2010, CURR OPIN GENET DEV, V20, P41, DOI 10.1016/j.gde.2009.12.001; Jang ACC, 2009, NAT CELL BIOL, V11, P569, DOI 10.1038/ncb1863; Kerppola TK, 2009, TRENDS CELL BIOL, V19, P692, DOI 10.1016/j.tcb.2009.10.001; Kiecker C, 2005, NAT REV NEUROSCI, V6, P553, DOI 10.1038/nrn1702; Lovegrove B, 2006, CURR BIOL, V16, P2206, DOI 10.1016/j.cub.2006.09.029; Madsen CD, 2010, DEV CELL, V19, P13, DOI 10.1016/j.devcel.2010.06.013; Martinez AM, 2006, CELL CYCLE, V5, P1189, DOI 10.4161/cc.5.11.2781; Martinez AM, 2009, NAT GENET, V41, P1076, DOI 10.1038/ng.414; McClure KD, 2005, DEVELOPMENT, V132, P5033, DOI 10.1242/dev.02092; McNeill H, 2000, NAT REV GENET, V1, P100, DOI 10.1038/35038540; Muller HAJ, 2000, DEV DYNAM, V218, P52; Narbonne K, 2004, DEVELOPMENT, V131, P1389, DOI 10.1242/dev.01003; Netter S, 2001, DNA CELL BIOL, V20, P483, DOI 10.1089/104454901316976118; Oktaba K, 2008, DEV CELL, V15, P877, DOI 10.1016/j.devcel.2008.10.005; Pallavi SK, 2005, J CELL SCI, V118, P3363, DOI 10.1242/jcs.02464; Pietersen AM, 2008, CURR OPIN CELL BIOL, V20, P201, DOI 10.1016/j.ceb.2008.01.004; Pokutta S, 2007, ANNU REV CELL DEV BI, V23, P237, DOI 10.1146/annurev.cellbio.22.010305.104241; Randsholt NB, 2000, MECH DEVELOP, V95, P89, DOI 10.1016/S0925-4773(00)00342-7; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Ringrose L, 2007, CURR OPIN CELL BIOL, V19, P290, DOI 10.1016/j.ceb.2007.04.010; Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723; SANTAMARIA P, 1989, ROUX ARCH DEV BIOL, V198, P65, DOI 10.1007/BF02447741; Shen J, 2005, SCIENCE, V307, P1789, DOI 10.1126/science.1104784; SIMON J, 1992, DEVELOPMENT, V114, P493; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; STRUHL G, 1981, NATURE, V293, P36, DOI 10.1038/293036a0; Szafranski P, 2007, DEV DYNAM, V236, P364, DOI 10.1002/dvdy.21020; Tepass U, 2001, ANNU REV GENET, V35, P747, DOI 10.1146/annurev.genet.35.102401.091415; Tepass U, 1999, CURR OPIN CELL BIOL, V11, P540, DOI 10.1016/S0955-0674(99)00025-3; Tepass U, 2002, CURR OPIN GENET DEV, V12, P572, DOI 10.1016/S0959-437X(02)00342-8; Tepass U, 1996, GENE DEV, V10, P672, DOI 10.1101/gad.10.6.672; Tumpel S, 2009, CURR TOP DEV BIOL, V88, P103, DOI 10.1016/S0070-2153(09)88004-6; Wheelock MJ, 2003, ANNU REV CELL DEV BI, V19, P207, DOI 10.1146/annurev.cellbio.19.011102.111135; Widmann TJ, 2009, J CELL SCI, V122, P1362, DOI 10.1242/jcs.044271; XU T, 1993, DEVELOPMENT, V117, P1223; ZECCA M, 1995, DEVELOPMENT, V121, P2265	61	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e13946	10.1371/journal.pone.0013946	http://dx.doi.org/10.1371/journal.pone.0013946			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21085656	Green Published, gold, Green Submitted			2022-12-25	WOS:000284087800012
J	Krasemann, S; Neumann, M; Geissen, M; Bodemer, W; Kaup, FJ; Schulz-Schaeffer, W; Morel, N; Aguzzi, A; Glatzel, M				Krasemann, Susanne; Neumann, Melanie; Geissen, Markus; Bodemer, Walter; Kaup, Franz-Josef; Schulz-Schaeffer, Walter; Morel, Nathalie; Aguzzi, Adriano; Glatzel, Markus			Preclinical Deposition of Pathological Prion Protein in Muscle of Experimentally Infected Primates	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; SPONGIFORM ENCEPHALOPATHY AGENT; TISSUE DISTRIBUTION; BLOOD-TRANSFUSION; INCUBATION-TIME; VARIANT; PRPSC; TRANSMISSION; RISK; EPIDEMIOLOGY	Prion diseases are transmissible fatal neurodegenerative disorders affecting humans and animals. A central step in disease progression is the accumulation of a misfolded form (PrPSc) of the host encoded prion protein (PrPC) in neuronal and non-neuronal tissues. The involvement of peripheral tissues in preclinical states increases the risk of accidental transmission. On the other hand, detection of PrPSc in non-neuronal easy-accessible compartments such as muscle may offer a novel diagnostic tool. Primate models have proven invaluable to investigate prion diseases. We have studied the deposition of PrPSc in muscle and central nervous system of rhesus monkeys challenged with sporadic Creutzfeldt-Jakob disease (sCJD), variant CJD (vCJD) and bovine spongiform encephalopathy (BSE) in preclinical and clinical stage using biochemical and morphological methods. Here, we show the preclinical presence of PrPSc in muscle and central nervous system of rhesus monkeys experimentally infected with vCJD.	[Krasemann, Susanne; Neumann, Melanie; Geissen, Markus; Glatzel, Markus] Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, Hamburg, Germany; [Schulz-Schaeffer, Walter] Univ Hosp Gottingen, Inst Neuropathol, Gottingen, Germany; [Morel, Nathalie] CEA Saclay, Serv Pharmacol & Immunoanal, IBitec S, F-91191 Gif Sur Yvette, France; [Aguzzi, Adriano] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Gottingen; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Zurich; University Zurich Hospital	Krasemann, S (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, Hamburg, Germany.	adriano.aguzzi@usz.ch; m.glatzel@uke.de	Aguzzi, Adriano/A-3351-2008; Glatzel, Markus/V-8844-2019; Glatzel, Markus/G-3356-2011; Morel, Nathalie/O-9012-2016	Glatzel, Markus/0000-0002-7720-8817; Glatzel, Markus/0000-0002-7720-8817; Krasemann, Susanne/0000-0001-8795-818X; Aguzzi, Adriano/0000-0002-0344-6708	European Union [EU BMH4 CT 98 7026]; Deutsche Forschungs Gemeinschaft (DFG) [KA 864/2-1, FOR885, Gl 589/2-1]; Deutsches Primaten Zentrum Foerderpreis	European Union(European Commission); Deutsche Forschungs Gemeinschaft (DFG)(German Research Foundation (DFG)); Deutsches Primaten Zentrum Foerderpreis	This work was financed by the European Union grant EU BMH4 CT 98 7026, the Deutsche Forschungs Gemeinschaft (DFG) grants KA 864/2-1 and FOR885. S. K. was supported by the Deutsches Primaten Zentrum Foerderpreis, M. N. was supported by DFG grant Gl 589/2-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Aguzzi A, 2004, NAT CELL BIOL, V6, P290, DOI 10.1038/ncb0404-290; Aguzzi A, 2006, NAT CLIN PRACT NEURO, V2, P321, DOI 10.1038/ncpneuro0214; Aguzzi A, 2006, NAT REV MICROBIOL, V4, P765, DOI 10.1038/nrmicro1492; Aguzzi A, 2006, J NEUROCHEM, V97, P1726, DOI 10.1111/j.1471-4159.2006.03909.x; Andreoletti O, 2004, NAT MED, V10, P591, DOI 10.1038/nm1055; Bartz JC, 2003, J VIROL, V77, P583, DOI 10.1128/JVI.77.1.583-591.2003; Belay ED, 1999, ANNU REV MICROBIOL, V53, P283, DOI 10.1146/annurev.micro.53.1.283; Bishop MT, 2006, LANCET NEUROL, V5, P393, DOI 10.1016/S1474-4422(06)70413-6; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; BUELER H, 1994, MOL MED, V1, P19; Casalone C, 2005, J VIROL, V79, P5847, DOI 10.1128/JVI.79.9.5847-5849.2005; CAUGHEY B, 1991, J VIROL, V65, P6597, DOI 10.1128/JVI.65.12.6597-6603.1991; COHEN FE, 1994, SCIENCE, V264, P530, DOI 10.1126/science.7909169; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Comoy EE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003017; Dietz K, 2007, EMERG INFECT DIS, V13, P89, DOI 10.3201/eid1301.060396; GEISSEN M, 2007, VACCINE; Glatzel M, 2005, ARCH NEUROL-CHICAGO, V62, P545, DOI 10.1001/archneur.62.4.545; Glatzel M, 2003, LANCET NEUROL, V2, P757, DOI 10.1016/S1474-4422(03)00588-X; Glatzel M, 2002, LANCET, V360, P139, DOI 10.1016/S0140-6736(02)09384-4; Glatzel M, 2001, NEURON, V31, P25, DOI 10.1016/S0896-6273(01)00331-2; Glatzel M, 2003, NEW ENGL J MED, V349, P1812, DOI 10.1056/NEJMoa030351; Head MW, 2003, BRIT DENT J, V195, P339, DOI 10.1038/sj.bdj.4810536; Herzog C, 2005, J VIROL, V79, P14339, DOI 10.1128/JVI.79.22.14339-14345.2005; Herzog C, 2004, LANCET, V363, P422, DOI 10.1016/S0140-6736(04)15487-1; Hill AF, 2003, BRAIN, V126, P1333, DOI 10.1093/brain/awg125; Horiuchi M, 1999, EMBO J, V18, P3193, DOI 10.1093/emboj/18.12.3193; Ironside JW, 1998, J PATHOL, V186, P227, DOI 10.1002/(SICI)1096-9896(1998110)186:3&lt;227::AID-PATH174&gt;3.0.CO;2-3; Kovacs GG, 2004, ANN NEUROL, V55, P121, DOI 10.1002/ana.10813; Krasemann S, 1996, MOL MED, V2, P725, DOI 10.1007/BF03401656; Lasmezas CI, 2001, P NATL ACAD SCI USA, V98, P4142, DOI 10.1073/pnas.041490898; Lasmezas CI, 2005, LANCET, V365, P781, DOI 10.1016/S0140-6736(05)17985-9; Lefrere JJ, 2009, TRANSFUSION, V49, P797, DOI 10.1111/j.1537-2995.2008.02044.x; Notari S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008765; Peden A, 2010, HAEMOPHILIA; Peden AH, 2006, AM J PATHOL, V168, P927, DOI 10.2353/ajpath.2006.050788; Prusiner SB, 1997, ANNU REV GENET, V31, P139, DOI 10.1146/annurev.genet.31.1.139; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Schulz-Schaeffer WJ, 2000, AM J PATHOL, V156, P51, DOI 10.1016/S0002-9440(10)64705-0; Thomzig A, 2006, J GEN VIROL, V87, P251, DOI 10.1099/vir.0.81277-0; Thomzig A, 2004, J CLIN INVEST, V113, P1465, DOI 10.1172/JCI200421083; Thomzig A, 2003, EMBO REP, V4, P530, DOI 10.1038/sj.embor.embor827; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Zou S, 2008, TRANSFUS MED REV, V22, P58, DOI 10.1016/j.tmrv.2007.09.003	44	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e13906	10.1371/journal.pone.0013906	http://dx.doi.org/10.1371/journal.pone.0013906			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21085647	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000284087800003
J	Li, JA; Kuruba, R; Wilson, A; Gao, XA; Zhang, YF; Li, S				Li, Jiang; Kuruba, Ramalinga; Wilson, Annette; Gao, Xiang; Zhang, Yifei; Li, Song			Inhibition of Endothelin-1-Mediated Contraction of Hepatic Stellate Cells by FXR Ligand	PLOS ONE			English	Article							VASCULAR ENDOTHELIAL-CELLS; FARNESOID-X-RECEPTOR; TRANSCRIPTIONAL REGULATION; PORTAL-HYPERTENSION; NUCLEAR RECEPTORS; LIVER FIBROSIS; ACID; RAT; EXPRESSION; PATHOPHYSIOLOGY	Activation of hepatic stellate cells (HSCs) plays an important role in the development of cirrhosis through the increased production of collagen and the enhanced contractile response to vasoactive mediators such as endothelin-1 (ET-1). The farnesoid X receptor (FXR) is a member of the nuclear receptor superfamily that is highly expressed in liver, kidneys, adrenals, and intestine. FXR is also expressed in HSCs and activation of FXR in HSCs is associated with significant decreases in collagen production. However, little is known about the roles of FXR in the regulation of contraction of HSCs. We report in this study that treatment of quiescent HSCs with GW4064, a synthetic FXR agonist, significantly inhibited the HSC transdifferentiation, which was associated with an inhibition of the upregulation of ET-1 expression. These GW4064-treated cells also showed reduced contractile response to ET-1 in comparison to HSCs without GW4064 treatment. We have further shown that GW4064 treatment inhibited the ET-1-mediated contraction in fully activated HSCs. To elucidate the potential mechanism we showed that GW4064 inhibited ET-1-mediated activation of Rho/ROCK pathway in activated HSCs. Our studies unveiled a new mechanism that might contribute to the anti-cirrhotic effects of FXR ligands.	[Li, Jiang; Kuruba, Ramalinga; Wilson, Annette; Gao, Xiang; Zhang, Yifei; Li, Song] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Ctr Pharmacogenet, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Li, JA (corresponding author), Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Ctr Pharmacogenet, Pittsburgh, PA 15261 USA.	sol4@pitt.edu		Wilson, Annette/0000-0002-7426-1786	National Institutes of Health [HL091828]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091828] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported in part by the National Institutes of Health [Grant HL091828] (to S. L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bataller R, 2000, GASTROENTEROLOGY, V118, P1149, DOI 10.1016/S0016-5085(00)70368-4; Bertolotti M, 2008, CURR MED CHEM, V15, P2271, DOI 10.2174/092986708785747544; BLOMHOFF R, 1991, FASEB J, V5, P271, DOI 10.1096/fasebj.5.3.2001786; Casini A, 1997, HEPATOLOGY, V25, P361; Chi XD, 2003, BRIT J PHARMACOL, V139, P765, DOI 10.1038/sj.bjp.0705303; Chiang JYL, 2002, ENDOCR REV, V23, P443, DOI 10.1210/er.2000-0035; Cichoz-Lach H, 2008, J PHYSIOL PHARMACOL, V59, P231; Eloranta JJ, 2005, ARCH BIOCHEM BIOPHYS, V433, P397, DOI 10.1016/j.abb.2004.09.019; Fiorucci S, 2005, J PHARMACOL EXP THER, V314, P584, DOI 10.1124/jpet.105.084905; Fiorucci S, 2004, GASTROENTEROLOGY, V127, P1497, DOI 10.1053/j.gastro.2004.08.001; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Galli A, 2000, HEPATOLOGY, V31, P101, DOI 10.1002/hep.510310117; Haughton EL, 2006, GASTROENTEROLOGY, V131, P194, DOI 10.1053/j.gastro.2006.04.012; He FT, 2006, CIRC RES, V98, P192, DOI 10.1161/01.RES.0000200400.55539.85; Hellemams K, 2004, HEPATOLOGY, V39, P97, DOI 10.1002/hep.20015; KAWADA N, 1992, BIOCHEM J, V285, P367, DOI 10.1042/bj2850367; Kharbanda KK, 2004, J HEPATOL, V41, P60, DOI 10.1016/j.jhep.2004.03.019; Li J, 2008, CARDIOVASC RES, V77, P169, DOI 10.1093/cvr/cvm016; Li J, 2009, J PHARMACOL EXP THER, V331, P234, DOI 10.1124/jpet.109.153510; Liu CH, 2003, J BIOL CHEM, V278, P11721, DOI 10.1074/jbc.M207728200; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Pellicciari R, 2002, J MED CHEM, V45, P3569, DOI 10.1021/jm025529g; Reynaert H, 2002, GUT, V50, P571, DOI 10.1136/gut.50.4.571; Rockey DC, 1998, HEPATOLOGY, V27, P472, DOI 10.1002/hep.510270222; Rockey DC, 1996, HEPATOLOGY, V24, P233; Sancho-Bru P, 2006, AM J PHYSIOL-GASTR L, V291, pG877, DOI 10.1152/ajpgi.00537.2005; She HY, 2005, J BIOL CHEM, V280, P4959, DOI 10.1074/jbc.M410078200; Sohail MA, 2009, HEPATOLOGY, V49, P185, DOI 10.1002/hep.22589; Soon RK, 2008, CLIN LIVER DIS, V12, P791, DOI 10.1016/j.cld.2008.07.004; Willson TM, 2001, MED RES REV, V21, P513, DOI 10.1002/med.1023; Yee HF, 1998, HEPATOLOGY, V28, P843, DOI 10.1002/hep.510280336	31	46	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e13955	10.1371/journal.pone.0013955	http://dx.doi.org/10.1371/journal.pone.0013955			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21085652	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000284087800019
J	Scotti, C; Sommi, P; Pasquetto, MV; Cappelletti, D; Stivala, S; Mignosi, P; Savio, M; Chiarelli, LR; Valentini, G; Bolanos-Garcia, VM; Merrell, DS; Franchini, S; Verona, ML; Bolis, C; Solcia, E; Manca, R; Franciotta, D; Casasco, A; Filipazzi, P; Zardini, E; Vannini, V				Scotti, Claudia; Sommi, Patrizia; Pasquetto, Maria Valentina; Cappelletti, Donata; Stivala, Simona; Mignosi, Paola; Savio, Monica; Chiarelli, Laurent Roberto; Valentini, Giovanna; Bolanos-Garcia, Victor M.; Merrell, Douglas Scott; Franchini, Silvia; Verona, Maria Luisa; Bolis, Cristina; Solcia, Enrico; Manca, Rachele; Franciotta, Diego; Casasco, Andrea; Filipazzi, Paola; Zardini, Elisabetta; Vannini, Vanio			Cell-Cycle Inhibition by Helicobacter pylori L-Asparaginase	PLOS ONE			English	Article							GAMMA-GLUTAMYL-TRANSPEPTIDASE; GASTRIC EPITHELIAL-CELLS; ACUTE LYMPHOBLASTIC-LEUKEMIA; COLI L-ASPARAGINASE; PROTEOME ANALYSIS; CRYSTAL-STRUCTURE; PROLIFERATION; APOPTOSIS; INFECTION; CARCINOMA	Helicobacter pylori (H. pylori) is a major human pathogen causing chronic gastritis, peptic ulcer, gastric cancer, and mucosa-associated lymphoid tissue lymphoma. One of the mechanisms whereby it induces damage depends on its interference with proliferation of host tissues. We here describe the discovery of a novel bacterial factor able to inhibit the cell-cycle of exposed cells, both of gastric and non-gastric origin. An integrated approach was adopted to isolate and characterise the molecule from the bacterial culture filtrate produced in a protein-free medium: size-exclusion chromatography, nonreducing gel electrophoresis, mass spectrometry, mutant analysis, recombinant protein expression and enzymatic assays. L-asparaginase was identified as the factor responsible for cell-cycle inhibition of fibroblasts and gastric cell lines. Its effect on cell-cycle was confirmed by inhibitors, a knockout strain and the action of recombinant L-asparaginase on cell lines. Interference with cell-cycle in vitro depended on cell genotype and was related to the expression levels of the concurrent enzyme asparagine synthetase. Bacterial subcellular distribution of L-asparaginase was also analysed along with its immunogenicity. H. pylori L-asparaginase is a novel antigen that functions as a cell-cycle inhibitor of fibroblasts and gastric cell lines. We give evidence supporting a role in the pathogenesis of H. pylori-related diseases and discuss its potential diagnostic application.	[Scotti, Claudia; Pasquetto, Maria Valentina; Cappelletti, Donata; Stivala, Simona; Mignosi, Paola; Savio, Monica; Vannini, Vanio] Univ Pavia, Dept Expt Med, Sect Gen Pathol, I-27100 Pavia, Italy; [Sommi, Patrizia] Univ Pavia, Dept Physiol, Sect Human Physiol, I-27100 Pavia, Italy; [Chiarelli, Laurent Roberto; Valentini, Giovanna] Univ Pavia, Dept Biochem A Castellani, I-27100 Pavia, Italy; [Bolanos-Garcia, Victor M.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Merrell, Douglas Scott] Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD 20814 USA; [Franchini, Silvia] Univ Modena & Reggio Emilia, Dept Pharmaceut Sci, Modena, Italy; [Verona, Maria Luisa; Bolis, Cristina] CAM, Monza, Italy; [Solcia, Enrico; Manca, Rachele] Univ Pavia, Dept Human Pathol, I-27100 Pavia, Italy; [Solcia, Enrico; Manca, Rachele] Fdn Ist Ricovero & Cura Carattere Sci IRCCS Polic, Serv Anat Pathol, I-27100 Pavia, Italy; [Franciotta, Diego; Zardini, Elisabetta] Fdn Ist Ricovero & Cura Carattere Sci IRCCS Polic, Neurol Inst C Mondino, Lab Neuroimmunol, I-27100 Pavia, Italy; [Casasco, Andrea] Univ Pavia, Dept Expt Med, Sect Histol & Gen Embriol, I-27100 Pavia, Italy; [Filipazzi, Paola] Fdn Ist Ricovero & Cura Carattere Sci Ist Nazl Tu, Unit Immunotherapy Human Tumours, Milan, Italy	University of Pavia; University of Pavia; University of Pavia; University of Cambridge; Uniformed Services University of the Health Sciences - USA; Universita di Modena e Reggio Emilia; University of Pavia; IRCCS Fondazione Casimiro Mondino; University of Pavia	Scotti, C (corresponding author), Univ Pavia, Dept Expt Med, Sect Gen Pathol, Via Palestro 3, I-27100 Pavia, Italy.	claudia.scotti@unipv.it	Franchini, Silvia/R-2040-2019; Franciotta, Diego/ABE-0957-2022; Bolanos-Garcia, Victor M./AAN-8575-2020; Franciotta, Diego/K-8262-2016; Scotti, Claudia/A-7126-2012; Chiarelli, Laurent Roberto/J-8368-2016; Franchini, Silvia/C-5733-2015; Scotti, Claudia/AAM-3372-2021	Franchini, Silvia/0000-0002-6320-9712; Franciotta, Diego/0000-0002-3014-3913; Bolanos-Garcia, Victor M./0000-0003-2700-1479; Franciotta, Diego/0000-0002-3014-3913; Scotti, Claudia/0000-0002-5790-1833; Chiarelli, Laurent Roberto/0000-0003-0348-9764; Franchini, Silvia/0000-0002-6320-9712; Stivala, Simona/0000-0003-1549-8932	Ministry of Education, University and Research, MIUR; Ministero della Salute	Ministry of Education, University and Research, MIUR(Ministry of Education, Universities and Research (MIUR)); Ministero della Salute(Ministry of Health, Italy)	This work was supported by a grant from the Ministry of Education, University and Research, MIUR (Progetti di Ricerca di Interesse Nazionale, 2004) and by funding from the Ministero della Salute to IRCCS Fondazione Policlinico S. Matteo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alyamani EJ, 2007, MICROBIOL-SGM, V153, P1006, DOI 10.1099/mic.0.29184-0; BAHARI HMM, 1982, GUT, V23, P513, DOI 10.1136/gut.23.6.513; BARRANCO SC, 1983, CANCER RES, V43, P1703; BEERS RF, 1952, J BIOL CHEM, V195, P133; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bergmeyer HU, 1983, METHOD ENZYMAT AN, P163; Bumann D, 2002, INFECT IMMUN, V70, P3396, DOI 10.1128/IAI.70.7.3396-3403.2002; Cappelletti D, 2008, BIOCHEM BIOPH RES CO, V377, P1222, DOI 10.1016/j.bbrc.2008.10.118; Chang K, 1993, J Physiol Pharmacol, V44, P17; de Freitas D, 2004, HEPATO-GASTROENTEROL, V51, P876; Ding Y, 2005, LEUKEMIA, V19, P420, DOI 10.1038/sj.leu.2403639; EGUIGUREN JM, 1992, MED PEDIATR ONCOL, V20, P58, DOI 10.1002/mpo.2950200112; Fan XG, 1996, GUT, V38, P19, DOI 10.1136/gut.38.1.19; Ferreira AC, 2008, HELICOBACTER, V13, P28, DOI 10.1111/j.1523-5378.2008.00633.x; Fiocca R, 1999, J PATHOL, V188, P220, DOI 10.1002/(SICI)1096-9896(199906)188:2<220::AID-PATH307>3.0.CO;2-C; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Gerhard M, 2005, GASTROENTEROLOGY, V128, P1327, DOI 10.1053/j.gastro.2005.03.018; HANADA T, 1989, EUR J PEDIATR, V149, P162, DOI 10.1007/BF01958270; Havard TJ, 1996, J CLIN PATHOL, V49, P68, DOI 10.1136/jcp.49.1.68; HO PPK, 1970, BIOCHIM BIOPHYS ACTA, V206, P196, DOI 10.1016/0005-2744(70)90101-4; Hochstrasser D F, 1988, Appl Theor Electrophor, V1, P35; Honda S, 1998, CANCER RES, V58, P4255; HOWARD JB, 1972, J BIOL CHEM, V247, P1020; Jones NL, 1997, AM J PATHOL, V151, P1695; KAARTINEN V, 1991, J BIOL CHEM, V266, P5860; Keating M J, 1993, Leuk Lymphoma, V10 Suppl, P153, DOI 10.3109/10428199309149129; Kim KM, 2010, J MICROBIOL, V48, P372, DOI 10.1007/s12275-010-9293-8; Leduc D, 2010, INFECT IMMUN, V78, P2782, DOI 10.1128/IAI.00149-10; Lubkowski J, 1996, EUR J BIOCHEM, V241, P201, DOI 10.1111/j.1432-1033.1996.0201t.x; LYNCH DAF, 1995, GUT, V36, P346, DOI 10.1136/gut.36.3.346; Marcus EA, 2005, J BACTERIOL, V187, P729, DOI 10.1128/JB.187.2.729-738.2005; Merrell DS, 2003, INFECT IMMUN, V71, P3529, DOI 10.1128/IAI.71.6.3529-3539.2003; MOOLA ZB, 1994, BIOCHEM J, V302, P921, DOI 10.1042/bj3020921; Moss SF, 1996, GUT, V38, P498, DOI 10.1136/gut.38.4.498; MOTOYAMA T, 1986, ACTA PATHOL JAPON, V36, P65; Necchi V, 2007, GASTROENTEROLOGY, V132, P1009, DOI 10.1053/j.gastro.2007.01.049; NOMURA A, 1991, NEW ENGL J MED, V325, P1132, DOI 10.1056/NEJM199110173251604; Pai R, 1998, AM J PATHOL, V152, P1617; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Pitson SM, 1999, EUR J BIOCHEM, V260, P258, DOI 10.1046/j.1432-1327.1999.00153.x; Ricci V, 1996, INFECT IMMUN, V64, P2829, DOI 10.1128/IAI.64.7.2829-2833.1996; Romiti A, 2005, WORLD J GASTROENTERO, V11, P4400; Rotoli BM, 2005, CELL PHYSIOL BIOCHEM, V15, P281, DOI 10.1159/000087238; Sahoo S, 2003, SEMIN LIVER DIS, V23, P295; Schmees C, 2007, GASTROENTEROLOGY, V132, P1820, DOI 10.1053/j.gastro.2007.02.031; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shirin H, 1999, CANCER RES, V59, P2277; Smith TJ, 2005, CLIN EXP IMMUNOL, V141, P388, DOI 10.1111/j.1365-2249.2005.02824.x; Sommi P, 2002, EXP CELL RES, V281, P128, DOI 10.1006/excr.2002.5629; STORY MD, 1993, CANCER CHEMOTH PHARM, V32, P129, DOI 10.1007/BF00685615; SWAIN AL, 1993, P NATL ACAD SCI USA, V90, P1474, DOI 10.1073/pnas.90.4.1474; SZASZ G, 1974, Z KLIN CHEM KLIN BIO, V12, P228; Testerman TL, 2001, J CLIN MICROBIOL, V39, P3842, DOI 10.1128/JCM.39.11.3842-3850.2001; THORSLUND A, 1967, EUR J BIOCHEM, V3, P117, DOI 10.1111/j.1432-1033.1967.tb19504.x; Top PC, 2005, PEDIATR BLOOD CANCER, V44, P95, DOI 10.1002/pbc.20187; Ueno T, 1997, LEUKEMIA, V11, P1858, DOI 10.1038/sj.leu.2400834; Wacker P, 2007, J PEDIAT HEMATOL ONC, V29, P627, DOI 10.1097/MPH.0b013e3181483df1; Wagner S, 1997, GASTROENTEROLOGY, V113, P1836, DOI 10.1016/S0016-5085(97)70003-9; WRISTON JC, 1973, ADV ENZYMOL RAMB, V39, P185; Xia HHX, 2005, WORLD J GASTROENTERO, V11, P1946; Xia HHX, 2004, J GASTROEN HEPATOL, V19, P1257, DOI 10.1111/j.1440-1746.2004.03489.x	61	46	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e13892	10.1371/journal.pone.0013892	http://dx.doi.org/10.1371/journal.pone.0013892			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085483	Green Submitted, Green Published, gold			2022-12-25	WOS:000284035900009
J	Vaine, M; Wang, SX; Liu, Q; Arthos, J; Montefiori, D; Goepfert, P; McElrath, MJ; Lu, S				Vaine, Michael; Wang, Shixia; Liu, Qin; Arthos, James; Montefiori, David; Goepfert, Paul; McElrath, M. Juliana; Lu, Shan			Profiles of Human Serum Antibody Responses Elicited by Three Leading HIV Vaccines Focusing on the Induction of Env-Specific Antibodies	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; NEUTRALIZING ANTIBODIES; CONFORMATIONAL EPITOPES; MONOCLONAL-ANTIBODIES; PASSIVE-IMMUNIZATION; NEONATAL MACAQUES; SUBTYPE-B; PROTECTION; BROAD; INFECTION	In the current report, we compared the specificities of antibody responses in sera from volunteers enrolled in three US NIH-supported HIV vaccine trials using different immunization regimens. HIV-1 Env-specific binding antibody, neutralizing antibody, antibody-dependent cell-mediated cytotoxicity (ADCC), and profiles of antibody specificity were analyzed for human immune sera collected from vaccinees enrolled in the NIH HIV Vaccine Trial Network (HVTN) Study #041 (recombinant protein alone), HVTN Study #203 (poxviral vector prime-protein boost), and the DP6-001 study (DNA prime-protein boost). Vaccinees from HVTN Study #041 had the highest neutralizing antibody activities against the sensitive virus along with the highest binding antibody responses, particularly those directed toward the V3 loop. DP6-001 sera showed a higher frequency of positive neutralizing antibody activities against more resistant viral isolate with a significantly higher CD4 binding site (CD4bs) antibody response compared to both HVTN studies #041 and #203. No differences were found in CD4-induced (CD4i) antibody responses, ADCC activity, or complement activation by Env-specific antibody among these sera. Given recent renewed interest in realizing the importance of antibody responses for next generation HIV vaccine development, different antibody profiles shown in the current report, based on the analysis of a wide range of antibody parameters, provide critical biomarker information for the selection of HIV vaccines for more advanced human studies and, in particular, those that can elicit antibodies targeting conformational-sensitive and functionally conserved epitopes.	[Vaine, Michael; Wang, Shixia; Lu, Shan] Univ Massachusetts, Sch Med, Dept Med, Lab Nucle Acid Vaccines, Worcester, MA 01605 USA; [Liu, Qin] Univ Massachusetts, Sch Med, Dept Med, Div Prevent & Behav Med, Worcester, MA USA; [Arthos, James] NIAID, NIH, Immunoregulat Lab, Bethesda, MD 20892 USA; [Montefiori, David] Duke Univ, Med Ctr, Durham, NC USA; [Goepfert, Paul] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Goepfert, Paul] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [McElrath, M. Juliana] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [McElrath, M. Juliana] Univ Washington, Sch Med, Lab Med, Seattle, WA 98195 USA; [McElrath, M. Juliana] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Inst, Seattle, WA 98104 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Duke University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Vaine, M (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Lab Nucle Acid Vaccines, Worcester, MA 01605 USA.	shan.lu@umassmed.edu		Lu, Shan/0000-0002-8417-7588	NIH [AI065250, AI082274, AI082676, AI 27742]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000883, U19AI082676, P01AI082274, U01AI068618, R01AI065250, P30AI027742, R21AI087191] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by NIH grants AI065250, AI082274, & AI082676. Dr. Susan Zolla-Pazner provided mAb 447-52D supported under NIH grant AI 27742. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barouch DH, 2008, NATURE, V455, P613, DOI 10.1038/nature07352; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Casimiro DR, 2005, J VIROL, V79, P15547, DOI 10.1128/JVI.79.24.15547-15555.2005; Christensen ND, 2001, VIROLOGY, V291, P324, DOI 10.1006/viro.2001.1220; Clements-Mann ML, 1998, J INFECT DIS, V177, P1230, DOI 10.1086/515288; Conley AJ, 1996, J VIROL, V70, P6751, DOI 10.1128/JVI.70.10.6751-6758.1996; Conway JF, 2003, J VIROL, V77, P6466, DOI 10.1128/JVI.77.11.6466-6473.2003; Crooks ET, 2007, VIROLOGY, V366, P245, DOI 10.1016/j.virol.2007.04.033; Decker JM, 2005, J EXP MED, V201, P1407, DOI 10.1084/jem.20042510; Derby NR, 2006, J VIROL, V80, P8745, DOI 10.1128/JVI.00956-06; EMINI EA, 1992, NATURE, V355, P728, DOI 10.1038/355728a0; Fleury MJJ, 2006, ARCH VIROL, V151, P1511, DOI 10.1007/s00705-006-0734-y; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Forsell MNE, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000171; Goepfert PA, 2007, VACCINE, V25, P510, DOI 10.1016/j.vaccine.2006.07.050; Gomez-Roman VR, 2006, J IMMUNOL METHODS, V308, P53, DOI 10.1016/j.jim.2005.09.018; Haynes BF, 2006, EXPERT REV VACCINES, V5, P578; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hofmann-Lehmann R, 2002, J MED PRIMATOL, V31, P109, DOI 10.1034/j.1600-0684.2002.01014.x; Hofmann-Lehmann R, 2001, J VIROL, V75, P7470, DOI 10.1128/JVI.75.16.7470-7480.2001; Karnasuta C, 2005, VACCINE, V23, P2522, DOI 10.1016/j.vaccine.2004.10.028; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; MONTEFIORI DC, 2004, CURRENT PROTOCOLS IM, P1; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Russell ND, 2007, JAIDS-J ACQ IMM DEF, V44, P203, DOI 10.1097/01.qai.0000248356.48501.ff; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Srivastava IK, 2005, HUM VACCINES, V1, P45, DOI 10.4161/hv.1.2.1764; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang S, 2008, VACCINE, V26, P3946, DOI 10.1016/j.vaccine.2008.04.025; Wu XL, 2008, VIROLOGY, V380, P285, DOI 10.1016/j.virol.2008.07.007; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	36	38	50	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e13916	10.1371/journal.pone.0013916	http://dx.doi.org/10.1371/journal.pone.0013916			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085486	Green Published, gold			2022-12-25	WOS:000284035900021
J	Yoon, H; Kim, TS; Braciale, TJ				Yoon, Heesik; Kim, Taeg S.; Braciale, Thomas J.			The Cell Cycle Time of CD8(+) T Cells Responding In Vivo Is Controlled by the Type of Antigenic Stimulus	PLOS ONE			English	Article							RETINOBLASTOMA PROTEIN; DIFFERENTIATION; NAIVE; ACTIVATION; RB; STIMULATION; PROGRESSION; INHIBITORS; INDUCTION; FREQUENCY	A hallmark of cells comprising the mammalian adaptive immune system is the requirement for these rare naive T (and B) lymphocytes directed to a specific microorganism to undergo proliferative expansion upon first encounter with this antigen. In the case of naive CD8(+) T cells the ability of these rare quiescent lymphocytes to rapidly activate and expand into effector T cells in numbers sufficient to control viral and certain bacterial infections can be essential for survival. In this report we examined the activation, cell cycle time and initial proliferative response of naive murine CD8(+) T cells responding in vivo to Influenza and Vaccinia virus infection or vaccination with viral antigens. Remarkably, we observed that CD8(+) T cells could divide and proliferate with an initial cell division time of as short as 2 hours. The initial cell cycle time of responding CD8(+) T cells is not fixed but is controlled by the antigenic stimulus provided by the APC in vivo. Initial cell cycle time influences the rate of T cell expansion and the numbers of effector T cells subsequently accumulating at the site of infection. The T cell cycle time varies with duration of the G(1) phase of the cell cycle. The duration of G(1) is inversely correlated with the phosphorylation state of the retinoblastoma (Rb) protein in the responding T cells. The implication of these findings for the development of adaptive immune responses and the regulation of cell cycle in higher eukaryotic cells is discussed.	[Yoon, Heesik; Kim, Taeg S.; Braciale, Thomas J.] Univ Virginia, Carter Immunol Ctr, Charlottesville, VA 22903 USA; [Braciale, Thomas J.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Kim, Taeg S.; Braciale, Thomas J.] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA	University of Virginia; University of Virginia; University of Virginia	Yoon, H (corresponding author), Univ Virginia, Carter Immunol Ctr, Charlottesville, VA 22903 USA.	tjb2r@virginia.edu			National Institutes of Health [R01 AI-15608, R01 AI-37293, R01 HL-33391, U-19 AI-83024]; American Lung Association [RT 82757 N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015608, R01AI037293, R37AI015608, U19AI083024] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were supported by grants from the National Institutes of Health (R01 AI-15608, R01 AI-37293, R01 HL-33391 and U-19 AI-83024) to T.J.B., and an American Lung Association fellowship (RT 82757 N) to T.S.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki K, 2003, NAT GENET, V35, P323, DOI 10.1038/ng1265; Bar JJ, 2008, IMMUNITY, V28, P859, DOI 10.1016/j.immuni.2008.04.010; Geginat J, 2002, ADV EXP MED BIOL, V512, P107; Hao XL, 2008, J VIROL, V82, P4908, DOI 10.1128/JVI.02367-07; Harbour JW, 2000, NAT CELL BIOL, V2, pE65, DOI 10.1038/35008695; Harty JT, 2000, ANNU REV IMMUNOL, V18, P275, DOI 10.1146/annurev.immunol.18.1.275; Hataye J, 2006, SCIENCE, V312, P114, DOI 10.1126/science.1124228; Hermeking H, 2000, P NATL ACAD SCI USA, V97, P2229, DOI 10.1073/pnas.050586197; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; Ivanchuk SM, 2004, NEUROSURGERY, V54, P692, DOI 10.1227/01.NEU.0000109534.28063.5D; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kim TS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004204; Knudsen ES, 1998, GENE DEV, V12, P2278, DOI 10.1101/gad.12.15.2278; Lanzavecchia A, 2000, SCIENCE, V290, P92, DOI 10.1126/science.290.5489.92; Lawrence CW, 2004, J IMMUNOL, V173, P1209, DOI 10.4049/jimmunol.173.2.1209; Lawrence CW, 2005, J IMMUNOL, V174, P5332, DOI 10.4049/jimmunol.174.9.5332; Lee WT, 2002, J IMMUNOL, V168, P1682, DOI 10.4049/jimmunol.168.4.1682; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Li LQ, 2006, NAT IMMUNOL, V7, P1157, DOI 10.1038/ni1398; Macagno A, 2007, TRENDS IMMUNOL, V28, P227, DOI 10.1016/j.it.2007.03.008; Mateyak MK, 1999, MOL CELL BIOL, V19, P4672; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; O'Farrell PH, 2004, CURR BIOL, V14, pR35, DOI 10.1016/j.cub.2003.12.022; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; Ream RM, 2010, J IMMUNOL, V184, P2401, DOI 10.4049/jimmunol.0902448; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Savatier P, 1996, ONCOGENE, V12, P309; SAVATIER P, 1994, ONCOGENE, V9, P809; Schorl C, 2003, MOL BIOL CELL, V14, P823, DOI 10.1091/mbc.E02-10-0649; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Veiga-Fernandes H, 2000, NAT IMMUNOL, V1, P47, DOI 10.1038/76907; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Wells AD, 1997, J CLIN INVEST, V100, P3173, DOI 10.1172/JCI119873; Whitmire JK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000041; Yoon H, 2007, J IMMUNOL, V179, P391, DOI 10.4049/jimmunol.179.1.391	41	67	67	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e15423	10.1371/journal.pone.0015423	http://dx.doi.org/10.1371/journal.pone.0015423			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	676NU	21079741	Green Published, Green Submitted, gold			2022-12-25	WOS:000283920000023
J	Goldhaber-Fiebert, JD; Lipsitch, M; Mahal, A; Zaslavsky, AM; Salomon, JA				Goldhaber-Fiebert, Jeremy D.; Lipsitch, Marc; Mahal, Ajay; Zaslavsky, Alan M.; Salomon, Joshua A.			Quantifying Child Mortality Reductions Related to Measles Vaccination	PLOS ONE			English	Article							HEALTH; COVERAGE	Background: This study characterizes the historical relationship between coverage of measles containing vaccines (MCV) and mortality in children under 5 years, with a view toward ongoing global efforts to reduce child mortality. Methodology/Principal Findings: Using country-level, longitudinal panel data, from 44 countries over the period 19602005, we analyzed the relationship between MCV coverage and measles mortality with (1) logistic regressions for no measles deaths in a country-year, and (2) linear regressions for the logarithm of the measles death rate. All regressions allowed a flexible, non-linear relationship between coverage and mortality. Covariates included birth rate, death rates from other causes, percent living in urban areas, population density, per-capita GDP, use of the two-dose MCV, year, and mortality coding system. Regressions used lagged covariates, country fixed effects, and robust standard errors clustered by country. The likelihood of no measles deaths increased nonlinearly with higher MCV coverage (ORs: 13.8 [1.6-122.7] for 80-89% to 40.7 [3.2-517.6] for >= 95%), compared to pre-vaccination risk levels. Measles death rates declined nonlinearly with higher MCV coverage, with benefits accruing more slowly above 90% coverage. Compared to no coverage, predicted average reductions in death rates were -79% at 70% coverage, -93% at 90%, and -95% at 95%. Conclusions/Significance: 40 years of experience with MCV vaccination suggests that extremely high levels of vaccination coverage are needed to produce sharp reductions in measles deaths. Achieving sustainable benefits likely requires a combination of extended vaccine programs and supplementary vaccine efforts.	[Goldhaber-Fiebert, Jeremy D.] Stanford Univ, Dept Med, Sch Med, Ctr Hlth Policy, Stanford, CA 94305 USA; [Goldhaber-Fiebert, Jeremy D.] Stanford Univ, Sch Med, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA; [Goldhaber-Fiebert, Jeremy D.; Salomon, Joshua A.] Harvard Univ, Sch Publ Hlth, Program Hlth Decis Sci, Boston, MA 02115 USA; [Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Mahal, Ajay; Salomon, Joshua A.] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Zaslavsky, Alan M.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA	Stanford University; Stanford University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Goldhaber-Fiebert, JD (corresponding author), Stanford Univ, Dept Med, Sch Med, Ctr Hlth Policy, Stanford, CA 94305 USA.	jeremygf@stanford.edu	Salomon, Joshua A/D-3898-2009; Salomon, Joshua/S-1929-2019	Salomon, Joshua A/0000-0003-3929-5515; Salomon, Joshua/0000-0003-3929-5515; Goldhaber-Fiebert, Jeremy/0000-0002-4007-5192; Lipsitch, Marc/0000-0003-1504-9213	United States' National Institutes of Health's (NIH) National Institute of Allergy and Infectious Disease	United States' National Institutes of Health's (NIH) National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research was supported in part by a training grant in the Epidemiology of Infectious Diseases and Biodefense from the United States' National Institutes of Health's (NIH) National Institute of Allergy and Infectious Disease administered via the Harvard School of Public Health made to Dr. Goldhaber-Fiebert during the final year of his doctoral dissertation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anand S, 2004, LANCET, V364, P1603, DOI 10.1016/S0140-6736(04)17313-3; Anand S, 2007, LANCET, V369, P1277, DOI 10.1016/S0140-6736(07)60599-6; Andrews N, 2008, B WORLD HEALTH ORGAN, V86, P197, DOI 10.2471/BLT.07.041129; [Anonymous], MMWR MORB MORTAL WKL; Barton M, 2010, PEDIATRICS, V125, P361, DOI 10.1542/peds.2009-2037; Bauch CT, 2009, VACCINE, V27, P4090, DOI 10.1016/j.vaccine.2009.04.079; Bloom DE, 2000, SCIENCE, V287, P1207, DOI 10.1126/science.287.5456.1207; Bryce J, 2006, LANCET, V368, P1067, DOI 10.1016/S0140-6736(06)69339-2; Burton A, 2009, B WORLD HEALTH ORGAN, V87, P535, DOI 10.2471/BLT.08.053819; de Melker H, 2001, EPIDEMIOL INFECT, V126, P249, DOI 10.1017/S0950268801005234; Edmunds WJ, 2000, EPIDEMIOL INFECT, V125, P635, DOI 10.1017/S0950268800004672; Ferrari MJ, 2008, NATURE, V451, P679, DOI 10.1038/nature06509; Filmer D, 1999, SOC SCI MED, V49, P1309, DOI 10.1016/S0277-9536(99)00150-1; FINE PEM, 1993, EPIDEMIOL REV, V15, P265, DOI 10.1093/oxfordjournals.epirev.a036121; FLEGG AT, 1982, POP STUD-J DEMOG, V36, P441, DOI 10.2307/2174055; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; HESTON A, 2006, PENN WORLD TABLES VE; Hutchins SS, 2001, AM J EPIDEMIOL, V154, P1064, DOI 10.1093/aje/154.11.1064; KEELE L, 2008, SEMIPARAMETRIC REGRE, pR16; Keeling MJ, 1997, SCIENCE, V275, P65, DOI 10.1126/science.275.5296.65; KEELING MJ, 2008, MODELING INFECT DIS, pR11; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; McLean AR, 1995, TRENDS MICROBIOL, V3, P458, DOI 10.1016/S0966-842X(00)89010-1; Murray CJL, 2007, LANCET, V370, P1040, DOI 10.1016/S0140-6736(07)61478-0; Murray Emily T, 2010, Am J Epidemiol, V171, P1099, DOI 10.1093/aje/kwq044; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; *UN, UN WORLD POP PROSP 2; *WHO, WHO YEAR INTR SEL VA; *WHO UNICEF, WHO UNICEF EST IMM C; Wolfson LJ, 2007, LANCET, V369, P191, DOI 10.1016/S0140-6736(07)60107-X; Wolfson LJ, 2009, INT J EPIDEMIOL, V38, P192, DOI 10.1093/ije/dyn224; WOOLDRIDGE JM, 2003, INTRO ECONOMETRICS M, pR27; *WORLD BANK, 2008, WORLD BANK WORLD DEV; 2009, WKLY EPIDEMIOL REC, V84, P509; 2004, WEEKLY EPIDEMIOLOGIC, V79, P129	36	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e13842	10.1371/journal.pone.0013842	http://dx.doi.org/10.1371/journal.pone.0013842			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079809	Green Published, gold, Green Submitted			2022-12-25	WOS:000283838600016
J	Kale, S; Yende, S; Kong, L; Perkins, A; Kellum, JA; Newman, AB; Vallejo, AN; Angus, DC				Kale, Sachin; Yende, Sachin; Kong, Lan; Perkins, Amy; Kellum, John A.; Newman, Anne B.; Vallejo, Abbe N.; Angus, Derek C.		GenIMS Investigators	The Effects of Age on Inflammatory and Coagulation-Fibrinolysis Response in Patients Hospitalized for Pneumonia	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; PLASMINOGEN-ACTIVATOR INHIBITOR-1; CYTOKINE PRODUCTION; TERM MORTALITY; UNITED-STATES; OLDER-ADULTS; SEPSIS; MARKERS; FRAILTY; BACTEREMIA	Objective: To determine whether inflammatory and hemostasis response in patients hospitalized for pneumonia varies by age and whether these differences explain higher mortality in the elderly. Methods: In an observational cohort of subjects with community-acquired pneumonia (CAP) recruited from emergency departments (ED) in 28 hospitals, we divided subjects into 5 age groups (<50, 51-64, 65-74, 75-84, and >= 85). We measured circulating levels of inflammatory (TNF, IL-6, and IL-10), hemostasis (D-dimer, Factor IX, thrombin-antithrombin complex, antithrombin and plasminogen-activator inhibitor-1), and cell-surface markers (TLR-2, TLR-4, and HLA-DR) during the first week of hospitalization and at discharge and compared 90-day mortality. We used logistic regression to compare odds ratios (OR) for 90-day mortality between age groups, adjusting for differences in pre-infection factors alone and then additionally adjusting for immune markers. Results: Of 2,183 subjects, 495, 444, 403, 583, and 258 subjects were,50, 51-64, 65-74, 75-84, and >= 85 years of age, respectively. Large age-related differences were observed in 90-day mortality (0.82% vs. 3.2% vs. 6.4% vs. 12.8% vs. 13.6%, p<0.01). No age-related differences in inflammatory and cell surface markers occurred during the first week. Older subjects had higher pro-coagulant markers on ED presentation and over first week (p <= 0.03), but these differences were modest (1.0-1.7-fold differences). Odds of death for older adults changed minimally in models incorporating differences in hemostasis and inflammatory markers (for subjects >= 85 compared to those,50, OR = 4.36, when adjusted for pre-infection factors and OR = 3.49 when additionally adjusted for hemostasis markers). At discharge, despite clinical recovery as evidenced by normal vital signs in >85% subjects, older subjects had modestly increased hemostasis markers and IL-6 levels (p<0.01). Conclusions: Modest age-related increases in coagulation response occur during hospitalization for CAP; however these differences do not explain the large differences in mortality. Despite clinical recovery, immune resolution may be delayed in older adults at discharge.	[Kale, Sachin; Yende, Sachin; Kellum, John A.; Angus, Derek C.] Univ Pittsburgh, Clin Res Invest & Syst Modeling Acute Illness CRI, Pittsburgh, PA USA; [Kale, Sachin; Yende, Sachin; Kellum, John A.; Angus, Derek C.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA; [Kong, Lan; Perkins, Amy] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Newman, Anne B.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Vallejo, Abbe N.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kale, S (corresponding author), Univ Pittsburgh, Clin Res Invest & Syst Modeling Acute Illness CRI, Pittsburgh, PA USA.	yendes@upmc.edu	Angus, Derek C/E-9671-2012; Newman, Anne B./C-6408-2013; Kellum, John A/HCH-2944-2022; Kellum, John/AAP-3072-2020	Newman, Anne B./0000-0002-0106-1150; Kellum, John A/0000-0003-1995-2653; Kellum, John/0000-0003-1995-2653	National Institute of General Medical Sciences (NIGMS) [R01 GM61992]; NIH [T32 AG021885];  [K23 GM083215]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K23GM083215, R01GM061992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG021885, P30AG024827] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	GenIMS was funded by National Institute of General Medical Sciences (NIGMS) R01 GM61992 with additional support from GlaxoSmithKline for enrollment and clinical data collection, and Diagnostic Products Corporation for the cytokine assays. Sachin Kale is supported by NIH T32 AG021885. Dr. Sachin Yende is supported by K23 GM083215. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bone RC, 1996, ANN INTERN MED, V125, P680, DOI 10.7326/0003-4819-125-8-199610150-00009; Bretz WA, 2005, J AM GERIATR SOC, V53, P1532, DOI 10.1111/j.1532-5415.2005.53468.x; Bruunsgaard H, 2003, IMMUNOL ALLERGY CLIN, V23, P15, DOI 10.1016/S0889-8561(02)00056-5; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Christ-Crain M, 2010, CRIT CARE, V14, DOI 10.1186/cc8155; Devaraj S, 2008, J CLIN ENDOCR METAB, V93, P578, DOI 10.1210/jc.2007-2185; Dhainaut JF, 2005, CLIN INFECT DIS, V41, pS481, DOI 10.1086/432001; Epstein MP, 2003, AM J HUM GENET, V72, P611, DOI 10.1086/367924; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Girard TD, 2007, CLIN GERIATR MED, V23, P633, DOI 10.1016/j.cger.2007.05.003; Halm EA, 2002, NEW ENGL J MED, V347, P2039, DOI 10.1056/NEJMcp020499; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; KANE RL, 1994, ESSENTIALS CLIN GERI; Kaplan V, 2003, ARCH INTERN MED, V163, P317, DOI 10.1001/archinte.163.3.317; Kaplan V, 2002, AM J RESP CRIT CARE, V165, P766, DOI 10.1164/ajrccm.165.6.2103038; Kellum JA, 2007, ARCH INTERN MED, V167, P1655, DOI 10.1001/archinte.167.15.1655; Kelly E, 2009, RESPIROLOGY, V14, P210, DOI 10.1111/j.1440-1843.2008.01423.x; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Krabbe KS, 2004, EXP GERONTOL, V39, P687, DOI 10.1016/j.exger.2004.01.009; Kumar AT, 2009, INDIAN J CRIT CARE M, V13, P74, DOI 10.4103/0972-5229.56052; Lekkou A, 2004, CLIN DIAGN LAB IMMUN, V11, P161, DOI 10.1128/CDLI.11.1.161-167.2004; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Marik PE, 2001, J AM GERIATR SOC, V49, P5, DOI 10.1046/j.1532-5415.2001.49003.x; Martin GS, 2006, CRIT CARE MED, V34, P15, DOI 10.1097/01.CCM.0000194535.82812.BA; MCDONALD AP, 2009, THROMB RES; Metersky ML, 2004, AM J RESP CRIT CARE, V169, P342, DOI 10.1164/rccm.200309-1248OC; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Nourhashemi F, 2001, J GERONTOL A-BIOL, V56, pM448, DOI 10.1093/gerona/56.7.M448; Opal SM, 2005, CLIN INFECT DIS, V41, pS504, DOI 10.1086/432007; Pajkrt D, 1997, BLOOD, V89, P2701, DOI 10.1182/blood.V89.8.2701; Pieper CF, 2000, J GERONTOL A-BIOL, V55, pM649, DOI 10.1093/gerona/55.11.M649; PRALONG G, 1989, THROMB HAEMOSTASIS, V61, P459; RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191; Roubenoff R, 1998, J GERONTOL A-BIOL, V53, pM20, DOI 10.1093/gerona/53A.1.M20; Samarakoon R, 2010, CELL SIGNAL, V22, P1413, DOI 10.1016/j.cellsig.2010.03.020; Saurwein-Teissl M, 2000, CYTOKINE, V12, P1160, DOI 10.1006/cyto.2000.0679; Singh M, 2008, MAYO CLIN PROC, V83, P1146, DOI 10.4065/83.10.1146; Sogaard M, 2008, J AM GERIATR SOC, V56, P1593, DOI 10.1111/j.1532-5415.2008.01855.x; Steinbach G, 2004, CLIN CHEM LAB MED, V42, P440, DOI 10.1515/CCLM.2004.077; STOWE RP, J GERONTOL A, V65, P429; Turnbull IR, 2009, CRIT CARE MED, V37, P1018, DOI 10.1097/CCM.0b013e3181968f3a; van Duin D, 2007, J AM GERIATR SOC, V55, P1438, DOI 10.1111/j.1532-5415.2007.01300.x; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Walston J, 2002, ARCH INTERN MED, V162, P2333, DOI 10.1001/archinte.162.20.2333; Waterer GW, 2004, AM J RESP CRIT CARE, V169, P910, DOI 10.1164/rccm.200310-1448OC; Yamamoto K, 2002, AM J PATHOL, V161, P1805, DOI 10.1016/S0002-9440(10)64457-4; Yende S, 2005, AM J RESP CRIT CARE, V172, P1440, DOI 10.1164/rccm.200506-888OC; Yende S, 2008, AM J RESP CRIT CARE, V177, P1242, DOI 10.1164/rccm.200712-1777OC; Yende S, 2007, J AM GERIATR SOC, V55, P518, DOI 10.1111/j.1532-5415.2007.01100.x; Yende Sachin, 2007, Curr Infect Dis Rep, V9, P382, DOI 10.1007/s11908-007-0059-3; Zeerleder S, 2006, THROMB RES, V118, P205, DOI 10.1016/j.thromres.2005.06.007	55	24	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e13852	10.1371/journal.pone.0013852	http://dx.doi.org/10.1371/journal.pone.0013852			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	675NY	21085465	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000283838600022
J	Buenemann, M; Lenz, P				Buenemann, Mathias; Lenz, Peter			A Geometrical Model for DNA Organization in Bacteria	PLOS ONE			English	Article							ESCHERICHIA-COLI CHROMOSOME; SEPARATE CELL HALVES; CAULOBACTER-CRESCENTUS; SUPERCOILED DNA; SEGREGATION; REPLICATION; DYNAMICS; PROTEINS; MOVEMENT; TERMINUS	Recent experimental studies have revealed that bacteria, such as C. crescentus, show a remarkable spatial ordering of their chromosome. A strong linear correlation has been found between the position of genes on the chromosomal map and their spatial position in the cellular volume. We show that this correlation can be explained by a purely geometrical model. Namely, self-avoidance of DNA, specific positioning of one or few DNA loci (such as origin or terminus) together with the action of DNA compaction proteins (that organize the chromosome into topological domains) are sufficient to get a linear arrangement of the chromosome along the cell axis. We develop a Monte-Carlo method that allows us to test our model numerically and to analyze the dependence of the spatial ordering on various physiologically relevant parameters. We show that the proposed geometrical ordering mechanism is robust and universal (i.e. does not depend on specific bacterial details). The geometrical mechanism should work in all bacteria that have compacted chromosomes with spatially fixed regions. We use our model to make specific and experimentally testable predictions about the spatial arrangement of the chromosome in mutants of C. crescentus and the growth-stage dependent ordering in E. coli.	[Buenemann, Mathias; Lenz, Peter] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Buenemann, Mathias; Lenz, Peter] Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA; [Buenemann, Mathias] Univ Marburg, Fachbereich Phys, D-3550 Marburg, Germany; [Buenemann, Mathias] Univ Marburg, Zentrum Synthet Mikrobiol, Marburg, Germany	University of California System; University of California San Diego; University of California System; University of California San Diego; Philipps University Marburg; Philipps University Marburg	Buenemann, M (corresponding author), Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA.	peter.lenz@Physik.Uni-Marburg.DE	Lenz, Peter/L-5980-2013	Lenz, Peter/0000-0001-7705-3950	DAAD	DAAD(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported (in part) by the DAAD (www.daad.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin RH, 1997, PHYS TODAY, V50, P32, DOI 10.1063/1.881674; Bates D, 2005, CELL, V121, P899, DOI 10.1016/j.cell.2005.04.013; Bowman GR, 2008, CELL, V134, P945, DOI 10.1016/j.cell.2008.07.015; Bremer H, 1996, ESCHERICHIA COLI SAL; DEGNEN ST, 1972, J MOL BIOL, V64, P671, DOI 10.1016/0022-2836(72)90090-3; Ebersbach G, 2008, CELL, V134, P956, DOI 10.1016/j.cell.2008.07.016; Hardy CD, 2005, MOL MICROBIOL, V57, P1636, DOI 10.1111/j.1365-2958.2005.04799.x; HAYS JB, 1969, BIOPOLYMERS, V8, P531, DOI 10.1002/bip.1969.360080410; HILHORST HJ, 1975, J CHEM PHYS, V63, P5153, DOI 10.1063/1.431297; Hirano T, 2002, GENE DEV, V16, P399, DOI 10.1101/gad.955102; Jensen RB, 1999, P NATL ACAD SCI USA, V96, P10661, DOI 10.1073/pnas.96.19.10661; Kornyshev AA, 2000, PHYS REV E, V62, P2576, DOI 10.1103/PhysRevE.62.2576; Kruse T, 2006, GENE DEV, V20, P113, DOI 10.1101/gad.366606; Li YF, 2003, MOL MICROBIOL, V50, P825, DOI 10.1046/j.1365-2958.2003.03746.x; Li YF, 2002, MOL MICROBIOL, V46, P985, DOI 10.1046/j.1365-2958.2002.03234.x; MADRAS N, 1990, J STAT PHYS, V58, P159, DOI 10.1007/BF01020290; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; MARR A. G., 1966, J BACTERIOL, V91, P2388; Nanninga N, 1985, MOL CYTOLOGY ESCHERI, P259; Nielsen HJ, 2007, J BACTERIOL, V189, P8660, DOI 10.1128/JB.01212-07; Nielsen HJ, 2006, MOL MICROBIOL, V62, P331, DOI 10.1111/j.1365-2958.2006.05346.x; Niki H, 2000, GENE DEV, V14, P212; NORRIS V, 1995, MOL MICROBIOL, V16, P1051, DOI 10.1111/j.1365-2958.1995.tb02330.x; Postow L, 2004, GENE DEV, V18, P1766, DOI 10.1101/gad.1207504; Rappaport SM, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.038101; Reyes-Lamothe R, 2008, CELL, V133, P90, DOI 10.1016/j.cell.2008.01.044; Rubinstein M, 2003, POLYM PHYS; Sawitzke J, 2001, MOL MICROBIOL, V40, P786, DOI 10.1046/j.1365-2958.2001.02350.x; Sherratt DJ, 2003, SCIENCE, V301, P780, DOI 10.1126/science.1084780; Skoko D, 2004, BIOCHEMISTRY-US, V43, P13867, DOI 10.1021/bi048428o; Strick TR, 1996, SCIENCE, V271, P1835, DOI 10.1126/science.271.5257.1835; Swinger KK, 2004, CURR OPIN STRUC BIOL, V14, P28, DOI 10.1016/j.sbi.2003.12.003; Teleman AA, 1998, CURR BIOL, V8, P1102, DOI 10.1016/S0960-9822(98)70464-6; Thanbichler M, 2005, J CELL BIOCHEM, V96, P506, DOI 10.1002/jcb.20519; Toro E, 2008, P NATL ACAD SCI USA, V105, P15435, DOI 10.1073/pnas.0807448105; Toro E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000349; TRUEBA FJ, 1982, ARCH MICROBIOL, V131, P235, DOI 10.1007/BF00405885; VERDIER PH, 1962, J CHEM PHYS, V36, P227, DOI 10.1063/1.1732301; Viollier PH, 2004, P NATL ACAD SCI USA, V101, P9257, DOI 10.1073/pnas.0402606101; VOLOGODSKII AV, 1994, ANNU REV BIOPH BIOM, V23, P609, DOI 10.1146/annurev.bb.23.060194.003141; Wang XD, 2006, GENE DEV, V20, P1727, DOI 10.1101/gad.388406; Weber SC, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011913; Weber SC, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.238102; White MA, 2008, NATURE, V455, P1248, DOI 10.1038/nature07282; Wiggins PA, 2010, P NATL ACAD SCI USA, V107, P4991, DOI 10.1073/pnas.0912062107; Yamaichi Y, 2004, EMBO J, V23, P221, DOI 10.1038/sj.emboj.7600028	46	21	21	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e13806	10.1371/journal.pone.0013806	http://dx.doi.org/10.1371/journal.pone.0013806			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21085464	gold, Green Published, Green Submitted			2022-12-25	WOS:000283780800009
J	Carmo, EVD; Katz, S; Barbieri, CL				de Souza Carmo, Erico Vinicius; Katz, Simone; Barbieri, Clara Lucia			Neutrophils Reduce the Parasite Burden in Leishmania (Leishmania) amazonensis-Infected Macrophages	PLOS ONE			English	Article							PLATELET-ACTIVATING-FACTOR; TUMOR-NECROSIS-FACTOR; MAJOR INFECTION; HUMAN-MONOCYTES; POLYMORPHONUCLEAR LEUKOCYTES; IMMUNE-RESPONSE; FACTOR-ALPHA; IFN-GAMMA; MICE; INVOLVEMENT	Background: Studies on the role of neutrophils in Leishmania infection were mainly performed with L. (L) major, whereas less information is available for L. (L) amazonensis. Previous results from our laboratory showed a large infiltrate of neutrophils in the site of infection in a mouse strain resistant to L. (L.) amazonensis (C3H/HePas). In contrast, the susceptible strain (BALB/c) displayed a predominance of macrophages harboring a high number of amastigotes and very few neutrophils. These findings led us to investigate the interaction of inflammatory neutrophils with L. (L.) amazonensis-infected macrophages in vitro. Methodology/Principal Findings: Mouse peritoneal macrophages infected with L. (L.) amazonensis were co-cultured with inflammatory neutrophils, and after four days, the infection was quantified microscopically. Data are representative of three experiments with similar results. The main findings were 1) intracellular parasites were efficiently destroyed in the co-cultures; 2) the leishmanicidal effect was similar when cells were obtained from mouse strains resistant (C3H/HePas) or susceptible (BALB/c) to L. (L.) amazonensis; 3) parasite destruction did not require contact between infected macrophages and neutrophils; 4) tumor necrosis factor alpha (TNF-alpha), neutrophil elastase and platelet activating factor (PAF) were involved with the leishmanicidal activity, and 5) destruction of the parasites did not depend on generation of oxygen or nitrogen radicals, indicating that parasite clearance did not involve the classical pathway of macrophage activation by TNF-alpha, as reported for other Leishmania species. Conclusions/Significance: The present results provide evidence that neutrophils in concert with macrophages play a previously unrecognized leishmanicidal effect on L. (L.) amazonensis. We believe these findings may help to understand the mechanisms involved in innate immunity in cutaneous infection by this Leishmania species.	[de Souza Carmo, Erico Vinicius; Katz, Simone; Barbieri, Clara Lucia] Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP)	Carmo, EVD (corresponding author), Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil.	barbieri.clara@unifesp.br	Barbiéri, Clara L./E-1505-2012	Barbiéri, Clara L./0000-0001-9426-2308	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso L, 2008, J LEUKOCYTE BIOL, V84, P389, DOI 10.1189/jlb.0108018; Appelberg R, 2007, TRENDS MICROBIOL, V15, P87, DOI 10.1016/j.tim.2006.11.009; Badolato R, 1996, EXP PARASITOL, V82, P21, DOI 10.1006/expr.1996.0003; BARBIERI CL, 1990, EXP PARASITOL, V71, P218, DOI 10.1016/0014-4894(90)90024-7; Bliss SK, 1999, J IMMUNOL, V163, P2081; CAMUSSI G, 1987, J EXP MED, V166, P1390, DOI 10.1084/jem.166.5.1390; CHANG KP, 1981, AM J TROP MED HYG, V30, P322, DOI 10.4269/ajtmh.1981.30.322; Charmoy M, 2007, J LEUKOCYTE BIOL, V82, P288, DOI 10.1189/jlb.0706440; Chen L, 2005, PARASITOL INT, V54, P109, DOI 10.1016/j.parint.2005.02.001; Fadok VA, 2001, J IMMUNOL, V166, P6847, DOI 10.4049/jimmunol.166.11.6847; FORDHUTCHINSON AW, 1980, NATURE, V286, P264, DOI 10.1038/286264a0; GOLDYNE ME, 1984, J BIOL CHEM, V259, P8815; GOOSSENS V, 1995, P NATL ACAD SCI USA, V92, P8115, DOI 10.1073/pnas.92.18.8115; Guimaraes-Costa AB, 2009, P NATL ACAD SCI USA, V106, P6748, DOI 10.1073/pnas.0900226106; LIEW FY, 1990, J IMMUNOL, V145, P4306; LONARDONI MVC, 1994, MEDIAT INFLAMM, V3, P137, DOI 10.1155/S0962935194000177; Lonardoni MVC, 2000, INFECT IMMUN, V68, P6355, DOI 10.1128/IAI.68.11.6355-6361.2000; Matte C, 2002, J INFECT DIS, V185, P673, DOI 10.1086/339260; McFarlane E, 2008, INFECT IMMUN, V76, P532, DOI 10.1128/IAI.01388-07; MURRAY HW, 1982, J IMMUNOL, V129, P351; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Novais FO, 2009, J IMMUNOL, V183, P8088, DOI 10.4049/jimmunol.0803720; PEARSON RD, 1981, J IMMUNOL, V127, P1438; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; PIMENTA PFP, 1987, J SUBMICR CYTOL PATH, V19, P387; POMPEU ML, 1991, ACTA TROP, V48, P185, DOI 10.1016/0001-706X(91)90046-M; POUBELLE PE, 1991, IMMUNOLOGY, V72, P181; RACCOSIN EL, 1997, EXP PARASITOL, V85, P283; Ribeiro-Gomes FL, 2004, J IMMUNOL, V172, P4454, DOI 10.4049/jimmunol.172.7.4454; Ribeiro-Gomes FL, 2007, J IMMUNOL, V179, P3988, DOI 10.4049/jimmunol.179.6.3988; Romani L, 1997, J IMMUNOL, V158, P2356; Rousseau D, 2001, BMC Microbiol, V1, P17, DOI 10.1186/1471-2180-1-17; SCHULZEOSTHOFF K, 1992, J BIOL CHEM, V267, P5317; Serezani CH, 2006, J IMMUNOL, V177, P3201, DOI 10.4049/jimmunol.177.5.3201; SORENSEN AL, 1989, APMIS, V97, P754, DOI 10.1111/j.1699-0463.1989.tb00474.x; SPEER CP, 1984, J IMMUNOL, V133, P2151; Tacchini-Cottier F, 2000, J IMMUNOL, V165, P2628, DOI 10.4049/jimmunol.165.5.2628; van Zandbergen G, 2004, J IMMUNOL, V173, P6521, DOI 10.4049/jimmunol.173.11.6521; Vasquez RE, 2006, INFECT IMMUN, V74, P6769, DOI 10.1128/IAI.01073-06	39	35	36	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e13815	10.1371/journal.pone.0013815	http://dx.doi.org/10.1371/journal.pone.0013815			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21082032	Green Submitted, gold, Green Published			2022-12-25	WOS:000283780800013
J	Kompier, LC; Lurkin, I; van der Aa, MNM; van Rhijn, BWG; van der Kwast, TH; Zwarthoff, EC				Kompier, Lucie C.; Lurkin, Irene; van der Aa, Madelon N. M.; van Rhijn, Bas W. G.; van der Kwast, Theo H.; Zwarthoff, Ellen C.			FGFR3, HRAS, KRAS, NRAS and PIK3CA Mutations in Bladder Cancer and Their Potential as Biomarkers for Surveillance and Therapy	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR-3; UROTHELIAL CELL-CARCINOMA; PHOSPHOINOSITIDE 3-KINASE; BIOLOGICAL BEHAVIOR; MULTIPLE-MYELOMA; ONCOGENE PRODUCT; MEK INHIBITORS; GENE-MUTATIONS; PI3K PATHWAY; PHASE-III	Background: Fifty percent of patients with muscle-invasive bladder cancer (MI-BC) die from their disease and current chemotherapy treatment only marginally increases survival. Novel therapies targeting receptor tyrosine kinases or activated oncogenes may improve outcome. Hence, it is necessary to stratify patients based on mutations in relevant oncogenes. Patients with non-muscle-invasive bladder cancer (NMI-BC) have excellent survival, however two-thirds develop recurrences. Tumor specific mutations can be used to detect recurrences in urine assays, presenting a more patient-friendly diagnostic procedure than cystoscopy. Methodology/Principal Findings: To address these issues, we developed a mutation assay for the simultaneous detection of 19 possible mutations in the HRAS, KRAS, and NRAS genes. With this assay and mutation assays for the FGFR3 and PIK3CA oncogenes, we screened primary bladder tumors of 257 patients and 184 recurrences from 54 patients. Additionally, in primary tumors p53 expression was obtained by immunohistochemistry. Of primary tumors 64% were mutant for FGFR3, 11% for RAS, 24% for PIK3CA, and 26% for p53. FGFR3 mutations were mutually exclusive with RAS mutations (p = 0.001) and co-occurred with PIK3CA mutations (p = 0.016). P53 overexpression was mutually exclusive with PIK3CA and FGFR3 mutations (p <= 0.029). Mutations in the RAS and PIK3CA genes were not predictors for recurrence-free, progression-free and disease-specific survival. In patients presenting with NMI-BC grade 3 and MI-BC, 33 and 36% of the primary tumors were mutant. In patients with low-grade NMI-BC, 88% of the primary tumors carried a mutation and 88% of the recurrences were mutant. Conclusions/Significance: The mutation assays present a companion diagnostic to define patients for targeted therapies. In addition, the assays are a potential biomarker to detect recurrences during surveillance. We showed that 88% of patients presenting with low-grade NMI-BC are eligible for such a follow-up. This may contribute to a reduction in the number of cystoscopical examinations.	[Kompier, Lucie C.; Lurkin, Irene; van der Aa, Madelon N. M.; Zwarthoff, Ellen C.] Erasmus MC, Dept Pathol, Rotterdam, Netherlands; [van Rhijn, Bas W. G.] Toronto Gen Hosp, Univ Hlth Network, Dept Urol, Toronto, ON, Canada; [van der Kwast, Theo H.] Toronto Gen Hosp, Univ Hlth Network, Dept Lab Med & Pathobiol, Toronto, ON, Canada	Erasmus University Rotterdam; Erasmus MC; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Kompier, LC (corresponding author), Erasmus MC, Dept Pathol, Rotterdam, Netherlands.	e.zwarthoff@erasmusmc.nl		Van der Kwast, Theodorus/0000-0001-8640-5786	Erasmus MC Breedtestrategie; Netherlands Organization for Health Research and Development (ZON-MW) [945-02-046]	Erasmus MC Breedtestrategie; Netherlands Organization for Health Research and Development (ZON-MW)(Netherlands Organization for Health Research and Development)	This study was supported by an Erasmus MC Breedtestrategie Grant (2002-2006) and The Netherlands Organization for Health Research and Development (ZON-MW, 945-02-046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agazie YM, 2003, ONCOGENE, V22, P6909, DOI 10.1038/sj.onc.1206798; Babjuk M, 2008, EUR UROL, V54, P303, DOI 10.1016/j.eururo.2008.04.051; Bakkar AA, 2003, CANCER RES, V63, P8108; Billerey C, 2001, AM J PATHOL, V158, P1955, DOI 10.1016/S0002-9440(10)64665-2; Birkhahn M, 2010, EUR UROL, V57, P12, DOI 10.1016/j.eururo.2009.09.013; Black PC, 2007, UROL ONCOL-SEMIN ORI, V25, P433, DOI 10.1016/j.urolonc.2007.05.011; Botteman MF, 2003, PHARMACOECONOMICS, V21, P1315, DOI 10.1007/BF03262330; Budman LI, 2008, CUAJ-CAN UROL ASSOC, V2, P212; Caraway NP, 2010, CANCER CYTOPATHOL, V118, P175, DOI 10.1002/cncy.20080; Chaussade C, 2009, BIOCHEM BIOPH RES CO, V381, P577, DOI 10.1016/j.bbrc.2009.02.081; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; di Martino E, 2009, ONCOGENE, V28, P4306, DOI 10.1038/onc.2009.280; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Gomez-Roman JJ, 2005, CLIN CANCER RES, V11, P459; Grossman HB, 2007, J UROLOGY, V178, P62, DOI 10.1016/j.juro.2007.03.034; Gymnopoulos M, 2007, P NATL ACAD SCI USA, V104, P5569, DOI 10.1073/pnas.0701005104; Hafner C, 2009, BRIT J DERMATOL, V160, P546, DOI 10.1111/j.1365-2133.2008.08963.x; Hafner C, 2007, P NATL ACAD SCI USA, V104, P13450, DOI 10.1073/pnas.0705218104; Hart KC, 2001, MOL BIOL CELL, V12, P931, DOI 10.1091/mbc.12.4.931; Hurst Carolyn D, 2009, BMC Res Notes, V2, P66, DOI 10.1186/1756-0500-2-66; Jebar AH, 2005, ONCOGENE, V24, P5218, DOI 10.1038/sj.onc.1208705; Jocham D, 2005, J UROLOGY, V174, P862, DOI 10.1097/01.ju.0000169257.19841.2a; Kanai M, 1997, J BIOL CHEM, V272, P6621, DOI 10.1074/jbc.272.10.6621; Kassouf W, 2005, CANCER RES, V65, P10524, DOI 10.1158/0008-5472.CAN-05-1536; Kassouf W, 2008, J UROLOGY, V179, P353, DOI 10.1016/j.juro.2007.08.087; KIEMENEY LALM, 1993, BRIT J CANCER, V67, P806, DOI 10.1038/bjc.1993.147; Knowles MA, 2009, CANCER METAST REV, V28, P305, DOI 10.1007/s10555-009-9198-3; Kompier LC, 2009, J PATHOL, V218, P104, DOI 10.1002/path.2507; Kozaki KI, 2006, CANCER SCI, V97, P1351, DOI 10.1111/j.1349-7006.2006.00343.x; Li WQ, 2004, J BIOL CHEM, V279, P37398, DOI 10.1074/jbc.M405730200; Lopez-Knowles E, 2006, CANCER RES, V66, P7401, DOI 10.1158/0008-5472.CAN-06-1182; Lotan Y, 2010, UROL ONCOL-SEMIN ORI, V28, P441, DOI 10.1016/j.urolonc.2009.11.004; Louhelainen J, 2000, INT J CANCER, V87, P522; Lurkin I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008802; Martinez-Torrecuadrada JL, 2008, MOL CANCER THER, V7, P862, DOI 10.1158/1535-7163.MCT-07-0394; Masih-Khan E, 2006, BLOOD, V108, P3465, DOI 10.1182/blood-2006-04-017087; MIAO TJ, 1991, EUR UROL, V20, P307; Mitra AP, 2009, ANNU REV PATHOL-MECH, V4, P251, DOI 10.1146/annurev.pathol.4.110807.092230; Miyake M, 2010, J PHARMACOL EXP THER, V332, P795, DOI 10.1124/jpet.109.162768; MORIYAMA N, 1989, UROL INT, V44, P260, DOI 10.1159/000281520; Mostofi FK, 1973, HISTOLOGICAL TYPING; Muller CI, 2007, LEUKEMIA RES, V31, P27, DOI 10.1016/j.leukres.2006.04.011; Muezzinoglu T, 2005, ONKOLOGIE, V28, P260, DOI 10.1159/00085110; NEAL DE, 1992, UROL INT, V48, P365, DOI 10.1159/000282357; Ogino S, 2009, J CLIN ONCOL, V27, P1477, DOI 10.1200/JCO.2008.18.6544; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Paterson JL, 2004, BRIT J HAEMATOL, V124, P595, DOI 10.1111/j.1365-2141.2004.04814.x; Platt FM, 2009, CLIN CANCER RES, V15, P6008, DOI 10.1158/1078-0432.CCR-09-0898; Pollard C, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001407; Rabbani F, 2007, BJU INT, V100, P259, DOI 10.1111/j.1464-410X.2007.06927.x; Ramjaun AR, 2007, CELL CYCLE, V6, P2902, DOI 10.4161/cc.6.23.4996; RILEY GF, 1995, MED CARE, V33, P828, DOI 10.1097/00005650-199508000-00007; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Samuels Y, 2006, CURR OPIN ONCOL, V18, P77, DOI 10.1097/01.cco.0000198021.99347.b9; Santarpia L, 2008, J CLIN ENDOCR METAB, V93, P278, DOI 10.1210/jc.2007-1076; Sartore-Bianchi A, 2009, CANCER RES, V69, P1851, DOI 10.1158/0008-5472.CAN-08-2466; Schulz WA, 2006, INT J CANCER, V119, P1513, DOI 10.1002/ijc.21852; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; SIDRANSKY D, 1992, NEW ENGL J MED, V326, P737, DOI 10.1056/NEJM199203123261104; Siena S, 2009, JNCI-J NATL CANCER I, V101, P1308, DOI 10.1093/jnci/djp280; Sobin LH, 1997, CANCER, V80, P1803, DOI 10.1002/(SICI)1097-0142(19971101)80:9<1803::AID-CNCR16>3.0.CO;2-9; Tomlinson D, 2007, ONCOGENE, V26, P5889, DOI 10.1038/sj.onc.1210399; Tomlinson DC, 2007, J PATHOL, V213, P91, DOI 10.1002/path.2207; van der Aa MNM, 2008, BJU INT, V101, P1106, DOI 10.1111/j.1464-410X.2007.07224.x; van Oers JMM, 2005, CLIN CANCER RES, V11, P7743, DOI 10.1158/1078-0432.CCR-05-1045; van Oers JMM, 2009, EUR UROL, V55, P650, DOI 10.1016/j.eururo.2008.06.013; van Rhijn BSW, 2004, CANCER RES, V64, P1911, DOI 10.1158/0008-5472.CAN-03-2421; van Rhijn BWG, 2003, J CLIN ONCOL, V21, P1912, DOI 10.1200/JCO.2003.05.073; van Tilborg AAG, 2000, HUM MOL GENET, V9, P2973, DOI 10.1093/hmg/9.20.2973; van Tilborg AAG, 2009, INT J UROL, V16, P23, DOI 10.1111/j.1442-2042.2008.02174.x; Villares GJ, 2007, WORLD J UROL, V25, P573, DOI 10.1007/s00345-007-0202-7; Vriesema JLJ, 2000, UROLOGY, V56, P793, DOI 10.1016/S0090-4295(00)00777-9; Wee S, 2009, CANCER RES, V69, P4286, DOI 10.1158/0008-5472.CAN-08-4765; Yan J, 1998, J BIOL CHEM, V273, P24052, DOI 10.1074/jbc.273.37.24052; Yasoda A, 2004, NAT MED, V10, P80, DOI 10.1038/nm971; YE DW, 1993, UROL RES, V21, P39; YE YK, 2010, CLIN EXP MED; Zhao L, 2008, P NATL ACAD SCI USA, V105, P2652, DOI 10.1073/pnas.0712169105; Zieger K, 2000, BJU INT, V85, P824, DOI 10.1046/j.1464-410x.2000.00547.x; ZUIVERLOON TCM, 2010, CLIN CANC RES; Zwarthoff EC, 2008, SCAND J UROL NEPHROL, V42, P147, DOI 10.1080/03008880802283953	82	219	238	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e13821	10.1371/journal.pone.0013821	http://dx.doi.org/10.1371/journal.pone.0013821			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21072204	Green Published, gold, Green Submitted			2022-12-25	WOS:000283780800019
J	Lee, JW; Park, S; Takahashi, Y; Wang, HG				Lee, Jong Woo; Park, Sungman; Takahashi, Yoshinori; Wang, Hong-Gang			The Association of AMPK with ULK1 Regulates Autophagy	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; INHIBITS CELL-GROWTH; SACCHAROMYCES-CEREVISIAE; COMPLEX; INDUCTION; ATG13; PHOSPHORYLATION; DEGENERATION; METABOLISM; MACHINERY	Autophagy is a highly orchestrated intracellular bulk degradation process that is activated by various environmental stresses. The serine/threonine kinase ULK1, like its yeast homologue Atg1, is a key initiator of autophagy that is negatively regulated by the mTOR kinase. However, the molecular mechanism that controls the inhibitory effect of mTOR on ULK1-mediated autophagy is not fully understood. Here we identified AMPK, a central energy sensor, as a new ULK1-binding partner. We found that AMPK binds to the PS domain of ULK1 and this interaction is required for ULK1-mediated autophagy. Interestingly, activation of AMPK by AICAR induces 14-3-3 binding to the AMPK-ULK1-mTORC1 complex, which coincides with raptor Ser792 phosphorylation and mTOR inactivation. Consistently, AICAR induces autophagy in TSC2-deficient cells expressing wild-type raptor but not the mutant raptor that lacks the AMPK phosphorylation sites (Ser722 and Ser792). Taken together, these results suggest that AMPK association with ULK1 plays an important role in autophagy induction, at least in part, by phosphorylation of raptor to lift the inhibitory effect of mTOR on the ULK1 autophagic complex.	[Lee, Jong Woo] Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA USA; Penn State Univ, Coll Med, Penn State Hershey Canc Inst, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Lee, JW (corresponding author), Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA USA.	huw11@psu.edu	Wang, Hong-Gang/A-3018-2015	Wang, Hong-Gang/0000-0003-0551-0571; Takahashi, Yoshinori/0000-0002-8004-4817	American Cancer Society [RSG-05-244-01-CCG]; Flight Attendant Medical Research Institute [FAMRI062463-CIA]; National Institutes of Health [CA82197, CA129682]; NATIONAL CANCER INSTITUTE [R01CA129682, R01CA082197] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Flight Attendant Medical Research Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from American Cancer Society (RSG-05-244-01-CCG), Flight Attendant Medical Research Institute (FAMRI062463-CIA), and National Institutes of Health (CA82197 and CA129682). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Chang YY, 2009, MOL BIOL CELL, V20, P2004, DOI 10.1091/mbc.E08-12-1250; Gan BY, 2005, J CELL BIOL, V170, P379, DOI 10.1083/jcb.200411106; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hosokawa N, 2009, AUTOPHAGY, V5, P973, DOI 10.4161/auto.5.7.9296; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kabeya Y, 2005, MOL BIOL CELL, V16, P2544, DOI 10.1091/mbc.e04-08-0669; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Lee SB, 2007, EMBO REP, V8, P360, DOI 10.1038/sj.embor.7400917; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Matsuura A, 1997, GENE, V192, P245, DOI 10.1016/S0378-1119(97)00084-X; Meijer AJ, 2007, AUTOPHAGY, V3, P238, DOI 10.4161/auto.3710; Meley D, 2006, J BIOL CHEM, V281, P34870, DOI 10.1074/jbc.M605488200; Mercer CA, 2009, AUTOPHAGY, V5, P649, DOI 10.4161/auto.5.5.8249; MIZUSHIMA N, 2010, CURR OPIN CELL BIOL; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Okazaki N, 2000, MOL BRAIN RES, V85, P1, DOI 10.1016/S0169-328X(00)00218-7; Samari HR, 2005, BIOCHEM J, V386, P237, DOI 10.1042/BJ20040609; Samari HR, 1998, J BIOL CHEM, V273, P23758, DOI 10.1074/jbc.273.37.23758; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Tomoda T, 2004, GENE DEV, V18, P541, DOI 10.1101/gad.1151204; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Viana R, 2008, BIOCHEM BIOPH RES CO, V369, P964, DOI 10.1016/j.bbrc.2008.02.126; Wang G, 2004, J VIROL, V78, P7097, DOI 10.1128/JVI.78.13.7097-7111.2004; Wang QJ, 2006, J NEUROSCI, V26, P8057, DOI 10.1523/JNEUROSCI.2261-06.2006; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yamaguchi H, 2009, J BIOL CHEM, V284, P11171, DOI 10.1074/jbc.M809268200	39	214	230	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e15394	10.1371/journal.pone.0015394	http://dx.doi.org/10.1371/journal.pone.0015394			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21072212	Green Published, gold, Green Submitted			2022-12-25	WOS:000283780800026
J	Kang, S; Kwon, H; Wen, H; Song, Y; Frueh, D; Ahn, HC; Yoo, SH; Wagner, G; Park, S				Kang, Sunmi; Kwon, Hyuknam; Wen, He; Song, Youngmin; Frueh, Dominique; Ahn, Hee-Chul; Yoo, Seung Hyun; Wagner, Gerhard; Park, Sunghyouk			Global dynamic conformational changes in the suppressor domain of IP3 receptor by stepwise binding of the two lobes of calmodulin	FASEB JOURNAL			English	Article						IP3R; protein interaction; regulation	INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; NUCLEAR-MAGNETIC-RESONANCE; LIGAND-BINDING; TRISPHOSPHATE RECEPTORS; CA2+ RELEASE; CALCIUM-BINDING; CA2+-INDEPENDENT INHIBITION; TARGET RECOGNITION; RYANODINE RECEPTOR; MOLECULAR-BASIS	The roles of calmodulin (CaM) have been key points of controversy in the regulation of inositol-1,4,5-trisphosphate receptor (IP3R). To address the issue, we studied the interaction between CaM and the suppressor domain of IP3R, a key allosteric regulatory domain. First, by means of a pulldown and a fluorescence titration experiment, we confirmed the interaction. Through subsequent NMR binding experiments, we observed dramatic peak disappearances of the suppressor domain on interaction with apo-CaM. The data indicated that apo-CaM induces large-scale dynamic conformational changes in the suppressor domain, involving partial unfolding and subdomain rearrangement. Analysis of the NMR data of CaM surprisingly revealed that its C lobe alone can cause such changes. Further binding experiments showed that calcium allows the free N lobe to bind to the suppressor domain, which induces extra conformational changes in both of the proteins. These results were also confirmed with CaM deletion mutants with either the N or C lobe. On the basis of this novel binding mechanism, we propose a model in which the partial unfolding of the suppressor domain by apo-CaM and the stepwise binding of the N lobe of CaM to the suppressor domain are important elements of calcium/CaM inhibition of IP3R. We believe that our working model encompasses previous regulation mechanisms of IP3R by calcium/CaM and provides new insights into the CaM-target interaction.-Kang, S., Kwon, H., Wen, H., Song, Y., Frueh, D., Ahn, H.-C., Yoo, S. H., Wagner, G., Park, S. Global dynamic conformational changes in the suppressor domain of IP3 receptor by stepwise binding of the two lobes of calmodulin. FASEB J. 25, 840-850 (2011). www.fasebj.org	[Kang, Sunmi; Kwon, Hyuknam; Wen, He; Song, Youngmin; Yoo, Seung Hyun; Park, Sunghyouk] Inha Univ, Sch Med, Dept Biochem, Inchon 400712, South Korea; [Kang, Sunmi; Kwon, Hyuknam; Wen, He; Song, Youngmin; Yoo, Seung Hyun; Park, Sunghyouk] Inha Univ, Sch Med, Ctr Adv Med Educ Project BK21, Inchon 400712, South Korea; [Frueh, Dominique; Wagner, Gerhard] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Ahn, Hee-Chul] Korea Inst Sci & Technol, Adv Anal Ctr, Seoul, South Korea	Inha University; Inha University; Harvard University; Harvard Medical School; Korea Institute of Science & Technology (KIST)	Park, S (corresponding author), Inha Univ, Sch Med, Dept Biochem, Chungsuk Bldg,Rm 505 Shinheung Dong, Inchon 400712, South Korea.	spark@inha.ac.kr	Kwon, Hyuk Nam/V-2301-2018; Wen, He/GZL-8825-2022; Frueh, Dominique P/A-6462-2008	Kwon, Hyuk Nam/0000-0003-4096-4712; Frueh, Dominique P/0000-0003-4605-3776	Korean government [2009-0076692]; Ministry for Health and Welfare, Republic of Korea [A092006]; Korean Ministry of Science and Technology [E28070]; KIST [2V01250]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007445] Funding Source: NIH RePORTER	Korean government(Korean Government); Ministry for Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Korean Ministry of Science and Technology(Ministry of Science & Technology (MOST), Republic of Korea); KIST(Korea Institute of Science & Technology Information (KISTI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a National Research Foundation of Korea grant, funded by the Korean government (2009-0076692). This study was also supported by a grant from the Korea Healthcare Technology R&D Project, Ministry for Health and Welfare, Republic of Korea (A092006). The authors sincerely appreciate the excellent technical support by Dr. Kyoung-Seok Ryu (Korea Basic Science Institute, Daejeon, Korea) in running the 900-MHz NMR machine there. The Korea Basic Science Institute NMR facility is supported by the Bio-MR Research Program of the Korean Ministry of Science and Technology (E28070). Time on the Korea Institute of Science and Technology (KIST) 900-MHz NMR was supported by KIST (grant 2V01250).	Adkins CE, 2000, BIOCHEM J, V345, P357, DOI 10.1042/0264-6021:3450357; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Bosanac I, 2004, BBA-MOL CELL RES, V1742, P89, DOI 10.1016/j.bbamcr.2004.09.016; Bosanac I, 2005, MOL CELL, V17, P193, DOI 10.1016/j.molcel.2004.11.047; Bultynck G, 2004, BIOCHEM J, V381, P87, DOI 10.1042/BJ20040072; Cardy TJA, 1998, BIOCHEM J, V334, P447, DOI 10.1042/bj3340447; Chan J, 2010, J BIOL CHEM, V285, P36092, DOI 10.1074/jbc.M110.140160; CRIVICI A, 1995, ANNU REV BIOPH BIOM, V24, P85, DOI 10.1146/annurev.bb.24.060195.000505; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Devogelaere B, 2008, CELL CALCIUM, V43, P17, DOI 10.1016/j.ceca.2007.04.005; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Furuichi Teiichi, 1994, Current Opinion in Neurobiology, V4, P294, DOI 10.1016/0959-4388(94)90089-2; GEISER JR, 1991, CELL, V65, P949, DOI 10.1016/0092-8674(91)90547-C; Ikura M, 1996, TRENDS BIOCHEM SCI, V21, P14, DOI 10.1016/0968-0004(96)80879-6; Ishida H, 2002, J BIOMOL NMR, V23, P323, DOI 10.1023/A:1020230712212; Iwai M, 2007, J BIOL CHEM, V282, P12755, DOI 10.1074/jbc.M609833200; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kainosho M, 2006, NATURE, V440, P52, DOI 10.1038/nature04525; Kang S, 2008, J BIOL CHEM, V283, P25567, DOI 10.1074/jbc.M803321200; Kang S, 2007, J PEPT SCI, V13, P237, DOI 10.1002/psc.837; Kasri NN, 2004, MOL PHARMACOL, V66, P276, DOI 10.1124/mol.66.2.276; Kasri NN, 2004, EMBO J, V23, P312, DOI 10.1038/sj.emboj.7600037; Li CM, 2009, J BIOL CHEM, V284, P2472, DOI 10.1074/jbc.M806513200; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; Mak DOD, 1998, P NATL ACAD SCI USA, V95, P15821, DOI 10.1073/pnas.95.26.15821; Mak DOD, 2001, J GEN PHYSIOL, V117, P435, DOI 10.1085/jgp.117.5.435; Matsubara M, 1997, J BIOL CHEM, V272, P23050, DOI 10.1074/jbc.272.37.23050; Maximciuc AA, 2006, STRUCTURE, V14, P1547, DOI 10.1016/j.str.2006.08.011; Mehboob S, 2001, BIOCHEMISTRY-US, V40, P12457, DOI 10.1021/bi010984k; Michikawa T, 1999, NEURON, V23, P799, DOI 10.1016/S0896-6273(01)80037-4; Missiaen L, 2000, MOL PHARMACOL, V57, P564, DOI 10.1124/mol.57.3.564; MONKAWA T, 1995, J BIOL CHEM, V270, P14700, DOI 10.1074/jbc.270.24.14700; Park S, 2002, BLOOD, V100, P283, DOI 10.1182/blood.V100.1.283; Patel S, 1997, P NATL ACAD SCI USA, V94, P11627, DOI 10.1073/pnas.94.21.11627; Patterson RL, 2004, P NATL ACAD SCI USA, V101, P2328, DOI 10.1073/pnas.0308567100; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Rodney GG, 2001, J BIOL CHEM, V276, P2069, DOI 10.1074/jbc.M008891200; Rodriguez-Castaneda F, 2010, EMBO J, V29, P680, DOI 10.1038/emboj.2009.373; Rossi AM, 2004, MOL PHARMACOL, V66, P199, DOI 10.1124/mol.104.002592; Schug ZT, 2006, J BIOL CHEM, V281, P24431, DOI 10.1074/jbc.M604190200; Sienaert I, 2002, BIOCHEM J, V365, P269, DOI 10.1042/BJ20020144; Tang RH, 2007, SCIENCE, V315, P1423, DOI 10.1126/science.1134457; Taylor CW, 1999, CELL CALCIUM, V26, P237, DOI 10.1054/ceca.1999.0090; Taylor CW, 2004, TRENDS BIOCHEM SCI, V29, P210, DOI 10.1016/j.tibs.2004.02.010; Taylor CW, 2002, CELL CALCIUM, V32, P321, DOI 10.1016/S0143416002001859; TJANDRA N, 1995, EUR J BIOCHEM, V230, P1014, DOI 10.1111/j.1432-1033.1995.tb20650.x; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Uchida K, 2003, J BIOL CHEM, V278, P16551, DOI 10.1074/jbc.M300646200; Velyvis A, 2003, NAT STRUCT BIOL, V10, P558, DOI 10.1038/nsb938; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; Wu N, 2006, J MOL BIOL, V364, P955, DOI 10.1016/j.jmb.2006.09.075; Xiong LW, 2010, J BIOL CHEM, V285, P8094, DOI 10.1074/jbc.M109.065243; Xiong LW, 2002, J BIOL CHEM, V277, P40862, DOI 10.1074/jbc.M206763200; YAMADA M, 1995, BIOCHEM J, V308, P83, DOI 10.1042/bj3080083; Yamazaki H, 2010, J BIOL CHEM, V285, P36081, DOI 10.1074/jbc.M110.140129; Yoo SH, 2000, TRENDS NEUROSCI, V23, P424, DOI 10.1016/S0166-2236(00)01621-0; Yoshikawa F, 1996, J BIOL CHEM, V271, P18277, DOI 10.1074/jbc.271.30.18277; Zhang HW, 2003, J BIOL CHEM, V278, P8348, DOI 10.1074/jbc.M209565200	59	14	14	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAR	2011	25	3					840	850		10.1096/fj.10-160705	http://dx.doi.org/10.1096/fj.10-160705			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	727MZ	21084695	Bronze			2022-12-25	WOS:000287806200005
J	Gangalum, RK; Atanasov, IC; Zhou, ZH; Bhat, SP				Gangalum, Rajendra K.; Atanasov, Ivo C.; Zhou, Z. Hong; Bhat, Suraj P.			alpha B-Crystallin Is Found in Detergent-resistant Membrane Microdomains and Is Secreted via Exosomes from Human Retinal Pigment Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; MACULAR DEGENERATION; MULTIPLE-SCLEROSIS; LIPID RAFTS; EXPRESSION; LENS; DRUSEN; MATURATION; PATHOLOGY; BIOMARKER	alpha B-crystallin (alpha B) is known as an intracellular Golgi membrane- associated small heat shock protein. Elevated levels of this protein have been linked with a myriad of neurodegenerative pathologies including Alzheimer disease, multiple sclerosis, and age-related macular degeneration. The membrane association of alpha B has been known for more than 3 decades, yet its physiological import has remained unexplained. In this investigation we show that alpha B is secreted from human adult retinal pigment epithelial cells via microvesicles (exosomes), independent of the endoplasmic reticulum-Golgi protein export pathway. The presence of alpha B in these lipoprotein structures was confirmed by its susceptibility to digestion by proteinase K only when exosomes were exposed to Triton X-100. Transmission electron microscopy was used to localize alpha B in immuno-gold- labeled intact and permeabilized microvesicles. The saucer- shaped exosomes, with a median diameter of 100-200 nm, were characterized by the presence of flotillin-1, alpha-enolase, and Hsp70, the same proteins that associate with detergent-resistant membrane microdomains (DRMs), which are known to be involved in their biogenesis. Notably, using polarized adult retinal pigment epithelial cells, we show that the secretion of alpha B is predominantly apical. Using OptiPrep gradients we demonstrate that alpha B resides in the DRM fraction. The secretion of alpha B is inhibited by the cholesterol-depleting drug, methyl beta-cyclodextrin, suggesting that the physiological function of this protein and the regulation of its export through exosomes may reside in its association with DRMs/lipid rafts.	[Bhat, Suraj P.] Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA; [Bhat, Suraj P.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Gangalum, Rajendra K.; Bhat, Suraj P.] Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Atanasov, Ivo C.; Zhou, Z. Hong] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA; [Zhou, Z. Hong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Bhat, SP (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, 100 Stein Plaza,Rm BH 623, Los Angeles, CA 90095 USA.	Bhat@jsei.ucla.edu	Zhou, Z Hong/HDN-0747-2022; Gangalum, Rajendra K/H-1369-2013	Gangalum, Rajendra K/0000-0002-8746-0266; Bhat, Suraj P/0000-0003-4707-5870	National Institutes of Health through NEI; National Institutes of Health [1S10RR23057]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023057] Funding Source: NIH RePORTER	National Institutes of Health through NEI; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health grants, through the NEI (to S. P. B.). This work was also supported by National Institutes of Health Grant 1S10RR23057 (to the Electron Imaging Center for Nanomachines and Z. H. Z.). A preliminary account was presented at the Association for Research in Vision and Ophthalmology Annual Meeting, Ft. Lauderdale, FL, May 3-7, 2009 (Bhat, S. P., Gangalum, R. K., and Jing, Z. (2009) Invest. Ophthalmol. Vis. Sci. 50, E-Abstr. 4183).	An E, 2006, J PROTEOME RES, V5, P2599, DOI 10.1021/pr060121j; Andley UP, 2007, PROG RETIN EYE RES, V26, P78, DOI 10.1016/j.preteyeres.2006.10.003; Bajramovic JJ, 2000, J IMMUNOL, V164, P4359, DOI 10.4049/jimmunol.164.8.4359; Barbash O, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-2; Bhat SP, 2003, PROG DRUG RES, V60, P205; Bhat SP, 1999, EUR J CELL BIOL, V78, P143, DOI 10.1016/S0171-9335(99)80016-8; BHAT SP, 1989, BIOCHEM BIOPH RES CO, V158, P319, DOI 10.1016/S0006-291X(89)80215-3; Boelens WC, 2001, BBA-PROTEIN STRUCT M, V1544, P311, DOI 10.1016/S0167-4838(00)00243-0; Broquet AH, 2003, J BIOL CHEM, V278, P21601, DOI 10.1074/jbc.M302326200; CHIESA R, 1989, CURR EYE RES, V8, P151, DOI 10.3109/02713688908995186; Chou YK, 2004, J NEUROSCI RES, V75, P516, DOI 10.1002/jnr.20000; Cobb BA, 2000, J BIOL CHEM, V275, P6664, DOI 10.1074/jbc.275.9.6664; D'Antonio M, 2006, GLIA, V53, P501, DOI 10.1002/glia.20309; De S, 2007, ARCH OPHTHALMOL-CHIC, V125, P641, DOI 10.1001/archopht.125.5.641; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; Gangalum RK, 2009, INVEST OPHTH VIS SCI, V50, P3283, DOI 10.1167/iovs.08-3052; Gangalum RK, 2004, J BIOL CHEM, V279, P43374, DOI 10.1074/jbc.C400371200; Hauck SM, 2005, PROTEOMICS, V5, P3623, DOI 10.1002/pmic.200401223; Holcakova J, 2008, INT J BIOL MARKER, V23, P48, DOI 10.1177/172460080802300108; Horwitz J, 2000, SEMIN CELL DEV BIOL, V11, P53, DOI 10.1006/scdb.1999.0351; HU JG, 1994, INVEST OPHTH VIS SCI, V35, P3582; Johnson PT, 2005, INVEST OPHTH VIS SCI, V46, P4788, DOI 10.1167/iovs.05-0767; JOHNSTONE RM, 1987, J BIOL CHEM, V262, P9412; Kamradt MC, 2001, J BIOL CHEM, V276, P16059, DOI 10.1074/jbc.C100107200; KIBBELAAR MA, 1979, EXP EYE RES, V29, P679, DOI 10.1016/0014-4835(79)90024-1; Kozawa O, 2001, CELL STRESS CHAPERON, V6, P21, DOI 10.1379/1466-1268(2001)006<0021:BCALMW>2.0.CO;2; Lancaster GI, 2005, J BIOL CHEM, V280, P23349, DOI 10.1074/jbc.M502017200; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Mao YW, 2004, CELL DEATH DIFFER, V11, P512, DOI 10.1038/sj.cdd.4401384; May CA, 2000, CURR EYE RES, V21, P588, DOI 10.1076/0271-3683(200007)21:1;1-Z;FT588; McKechnie NM, 2003, INVEST OPHTH VIS SCI, V44, P2650, DOI 10.1167/iovs.02-0765; Mor-Vaknin N, 2006, MOL CELL BIOL, V26, P9484, DOI 10.1128/MCB.01030-06; Moyano JV, 2006, J CLIN INVEST, V116, P261, DOI 10.1172/JCI25888; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; NISHIKAWA S, 1994, INVEST OPHTH VIS SCI, V35, P4159; Pap E, 2009, INFLAMM RES, V58, P1, DOI 10.1007/s00011-008-8210-7; Rajendran L, 2005, J CELL SCI, V118, P1099, DOI 10.1242/jcs.01681; Raoul W, 2008, OPHTHAL RES, V40, P115, DOI 10.1159/000119860; RENKAWEK K, 1994, ACTA NEUROPATHOL, V87, P155, DOI 10.1007/BF00296185; Roquemore EP, 1996, BIOCHEMISTRY-US, V35, P3578, DOI 10.1021/bi951918j; Sakaguchi H, 2003, EXP EYE RES, V76, P131, DOI 10.1016/S0014-4835(02)00249-X; Simo R, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/190724; Simpson RJ, 2008, PROTEOMICS, V8, P4083, DOI 10.1002/pmic.200800109; THERY C, 2006, CURR PROTOC CELL BIO, V3; van Noort JM, 2000, J NEUROIMMUNOL, V105, P46, DOI 10.1016/S0165-5728(00)00181-8; van Rijk AF, 2003, EUR J CELL BIOL, V82, P361, DOI 10.1078/0171-9335-00321; Wang AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004160; West KA, 2003, MOL CELL PROTEOMICS, V2, P37, DOI 10.1074/mcp.D200001-MCP200; Yaung J, 2007, MOL VIS, V13, P566	50	82	84	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3261	3269		10.1074/jbc.M110.160135	http://dx.doi.org/10.1074/jbc.M110.160135			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21097504	Green Published, hybrid			2022-12-25	WOS:000286653200011
J	Godinic-Mikulcic, V; Jaric, J; Hausmann, CD; Ibba, M; Weygand-Durasevic, I				Godinic-Mikulcic, Vlatka; Jaric, Jelena; Hausmann, Corinne D.; Ibba, Michael; Weygand-Durasevic, Ivana			An Archaeal tRNA-Synthetase Complex that Enhances Aminoacylation under Extreme Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARGINYL-TRANSFER-RNA; PROTEIN-PROTEIN INTERACTIONS; THERMOAUTOTROPHICUM DELTA-H; METHIONYL-TRANSFER-RNA; MACROMOLECULAR ASSEMBLAGE; MULTIENZYME COMPLEX; YBAK PROTEIN; RAT-LIVER; IN-VITRO; COMPONENT	Aminoacyl-tRNA synthetases (aaRSs) play an integral role in protein synthesis, functioning to attach the correct amino acid with its cognate tRNA molecule. AaRSs are known to associate into higher-order multi-aminoacyl-tRNA synthetase complexes (MSC) involved in archaeal and eukaryotic translation, although the precise biological role remains largely unknown. To gain further insights into archaeal MSCs, possible protein-protein interactions with the atypical Methanothermobacter thermautotrophicus seryl-tRNA synthetase (MtSerRS) were investigated. Yeast two-hybrid analysis revealed arginyl-tRNA synthetase (MtArgRS) as an interacting partner of MtSerRS. Surface plasmon resonance confirmed stable complex formation, with a dissociation constant (K-D) of 250 nM. Formation of the MtSerRS.MtArgRS complex was further supported by the ability of GST-MtArgRS to co-purify MtSerRS and by coelution of the two enzymes during gel filtration chromatography. The MtSerRS.MtArgRS complex also contained tRNA(Arg), consistent with the existence of a stable ribonucleoprotein complex active in aminoacylation. Steady-state kinetic analyses revealed that addition of MtArgRS to MtSerRS led to an almost 4-fold increase in the catalytic efficiency of serine attachment to tRNA, but had no effect on the activity of MtArgRS. Further, the most pronounced improvements in the aminoacylation activity of MtSerRS induced by MtArgRS were observed under conditions of elevated temperature and osmolarity. These data indicate that formation of a complex between MtSerRS and MtArgRS provides a means by which methanogenic archaea can optimize an early step in translation under a wide range of extreme environmental conditions.	[Weygand-Durasevic, Ivana] Univ Zagreb, Dept Chem, Fac Sci, HR-10000 Zagreb, Croatia; [Hausmann, Corinne D.; Ibba, Michael] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA	University of Zagreb; University System of Ohio; Ohio State University	Weygand-Durasevic, I (corresponding author), Univ Zagreb, Dept Chem, Fac Sci, Horvatovac 102A, HR-10000 Zagreb, Croatia.	weygand@chem.pmf.hr		Godinic Mikulcic, Vlatka/0000-0003-0319-8035	National Institutes of Health [GM65183]; Ministry of Science, Education and Sports of the Republic of Croatia [119-0982913-1358]; Unity through Knowledge Fund (UKF) [10/07]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science, Education and Sports of the Republic of Croatia(Ministry of Science, Education and Sports, Republic of Croatia); Unity through Knowledge Fund (UKF); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by grants from the National Institutes of Health (GM65183), from the Ministry of Science, Education and Sports of the Republic of Croatia (Project 119-0982913-1358), and the Unity through Knowledge Fund (UKF, Project 10/07).	An SG, 2004, J BIOL CHEM, V279, P42359, DOI 10.1074/jbc.C400304200; BEC G, 1994, J BIOL CHEM, V269, P2086; Bilokapic S, 2006, EMBO J, V25, P2498, DOI 10.1038/sj.emboj.7601129; Bilokapic S, 2009, CROAT CHEM ACTA, V82, P493; Bilokapic S, 2009, J BIOL CHEM, V284, P10706, DOI 10.1074/jbc.M808501200; BREVET A, 1982, EUR J BIOCHEM, V124, P483; Cavarelli J, 1998, EMBO J, V17, P5438, DOI 10.1093/emboj/17.18.5438; CIRAKOGLU B, 1985, BIOCHIM BIOPHYS ACTA, V829, P173, DOI 10.1016/0167-4838(85)90186-4; CIULLA R, 1994, J BACTERIOL, V176, P3177, DOI 10.1128/jb.176.11.3177-3187.1994; Deinert K, 2001, J BIOL CHEM, V276, P6000, DOI 10.1074/jbc.M008682200; Delagoutte B, 2000, EMBO J, V19, P5599, DOI 10.1093/emboj/19.21.5599; DEUTSCHER MP, 1982, J BIOL CHEM, V257, P6003; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Francin M, 2002, J BIOL CHEM, V277, P1762, DOI 10.1074/jbc.M109759200; Francklyn CS, 2008, METHODS, V44, P100, DOI 10.1016/j.ymeth.2007.09.007; Frechin M, 2010, FEBS LETT, V584, P427, DOI 10.1016/j.febslet.2009.11.037; Godinic V, 2007, FEBS J, V274, P2788, DOI 10.1111/j.1742-4658.2007.05812.x; GOLDGUR Y, 1994, BIOCHEM MOL BIOL INT, V32, P1075; Han JM, 2003, BIOCHEM BIOPH RES CO, V303, P985, DOI 10.1016/S0006-291X(03)00485-6; Han JM, 2006, J BIOL CHEM, V281, P38663, DOI 10.1074/jbc.M605211200; Hausmann CD, 2008, FEMS MICROBIOL REV, V32, P705, DOI 10.1111/j.1574-6976.2008.00119.x; Hausmann CD, 2007, NUCLEIC ACIDS RES, V35, P6094, DOI 10.1093/nar/gkm534; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Jaenicke R, 1998, CURR OPIN STRUC BIOL, V8, P738, DOI 10.1016/S0959-440X(98)80094-8; Kaminska M, 2009, J BIOL CHEM, V284, P13746, DOI 10.1074/jbc.M900480200; Kaminska M, 2009, J BIOL CHEM, V284, P6053, DOI 10.1074/jbc.M809636200; KELLERMANN O, 1982, J BIOL CHEM, V257, P1041; Kim T, 2000, J BIOL CHEM, V275, P21768, DOI 10.1074/jbc.M002404200; Ko YG, 2002, PROTEOMICS, V2, P1304, DOI 10.1002/1615-9861(200209)2:9<1304::AID-PROT1304>3.0.CO;2-E; Kuhner S, 2009, SCIENCE, V326, P1235, DOI 10.1126/science.1176343; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; Lee SW, 2004, J CELL SCI, V117, P3725, DOI 10.1242/jcs.01342; Levengood J, 2004, J BIOL CHEM, V279, P17707, DOI 10.1074/jbc.M313665200; Lipman RSA, 2003, BIOCHEMISTRY-US, V42, P7487, DOI 10.1021/bi0344533; Martin DD, 1999, APPL ENVIRON MICROB, V65, P1815; MIRANDE M, 1985, EUR J BIOCHEM, V147, P281, DOI 10.1111/j.1432-1033.1985.tb08748.x; MIRANDE M, 2005, AMINOACYL TRNA SYNTH, P298; Mocibob M, 2008, ARCH BIOCHEM BIOPHYS, V470, P129, DOI 10.1016/j.abb.2007.11.014; Morales AJ, 1999, EMBO J, V18, P3475, DOI 10.1093/emboj/18.12.3475; Nomanbhoy T, 2001, NAT STRUCT BIOL, V8, P344, DOI 10.1038/86228; NORCUM MT, 1989, J BIOL CHEM, V264, P15043; Park SG, 2005, TRENDS BIOCHEM SCI, V30, P569, DOI 10.1016/j.tibs.2005.08.004; Praetorius-Ibba M, 2005, J BIOL CHEM, V280, P26099, DOI 10.1074/jbc.M503539200; Praetorius-Ibba M, 2007, J BIOL CHEM, V282, P3680, DOI 10.1074/jbc.M609988200; Quevillon S, 1996, FEBS LETT, V395, P63, DOI 10.1016/0014-5793(96)01005-8; Quevillon S, 1999, J MOL BIOL, V285, P183, DOI 10.1006/jmbi.1998.2316; Quevillon S, 1997, J BIOL CHEM, V272, P32573, DOI 10.1074/jbc.272.51.32573; Ray PS, 2007, TRENDS BIOCHEM SCI, V32, P158, DOI 10.1016/j.tibs.2007.02.003; Robinson JC, 2000, J MOL BIOL, V304, P983, DOI 10.1006/jmbi.2000.4242; Rocak S, 2002, FEMS MICROBIOL LETT, V214, P101, DOI 10.1111/j.1574-6968.2002.tb11331.x; Ruan BF, 2005, J BIOL CHEM, V280, P25887, DOI 10.1074/jbc.M502174200; Simos G, 1996, EMBO J, V15, P5437, DOI 10.1002/j.1460-2075.1996.tb00927.x; Smith DR, 1997, J BACTERIOL, V179, P7135, DOI 10.1128/jb.179.22.7135-7155.1997; VENEMA RC, 1991, J BIOL CHEM, V266, P5298; Whelihan EF, 1997, EMBO J, V16, P2968, DOI 10.1093/emboj/16.10.2968; Wolfe CL, 2005, J BIOL CHEM, V280, P38870, DOI 10.1074/jbc.M502759200; Yuan J, 2010, FEBS LETT, V584, P2857, DOI 10.1016/j.febslet.2010.05.028; ZEIKUS JG, 1972, J BACTERIOL, V109, P707, DOI 10.1128/JB.109.2.707-713.1972	58	19	20	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3396	3404		10.1074/jbc.M110.168526	http://dx.doi.org/10.1074/jbc.M110.168526			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21098026	Green Published, hybrid			2022-12-25	WOS:000286653200026
J	Jenkins, RW; Idkowiak-Baldys, J; Simbari, F; Canals, D; Roddy, P; Riner, CD; Clarke, CJ; Hannun, YA				Jenkins, Russell W.; Idkowiak-Baldys, Jolanta; Simbari, Fabio; Canals, Daniel; Roddy, Patrick; Riner, Clarke D.; Clarke, Christopher J.; Hannun, Yusuf A.			A Novel Mechanism of Lysosomal Acid Sphingomyelinase Maturation REQUIREMENT FOR CARBOXYL-TERMINAL PROTEOLYTIC PROCESSING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NIEMANN-PICK-DISEASE; TRICYCLIC ANTIDEPRESSANT DESIPRAMINE; DELTA-MEDIATED PHOSPHORYLATION; HUMAN-PLACENTA; LIVING CELLS; CATHEPSIN-D; PURIFICATION; HOMOGENEITY; FIBROBLASTS; ACTIVATION	Acid sphingomyelinase (aSMase) catalyzes the hydrolysis of sphingomyelin (SM) to form the bioactive lipid ceramide (Cer). Notably, aSMase exists in two forms: a zinc (Zn2+)-independent lysosomal aSMase (L-SMase) and a Zn2+-dependent secreted aSMase (S-SMase) that arise from alternative trafficking of a single protein precursor. Despite extensive investigation into the maturation and trafficking of aSMase, the exact identity of mature L-SMase has remained unclear. Here, we describe a novel mechanism of aSMase maturation involving C-terminal proteolytic processing within, or in close proximity to, endolysosomes. Using two different C-terminal-tagged constructs of aSMase (V5, DsRed), we demonstrate that aSMase is processed from a 75-kDa, Zn2+-activated proenzyme to a mature 65 kDa, Zn2+-independent L-SMase. L-SMase is recognized by a polyclonal Ab to aSMase, but not by anti-V5 or anti-DsRed antibodies, suggesting that the C-terminal tag is lost during maturation. Furthermore, indirect immunofluorescence staining demonstrated that mature L-SMase colocalized with the lysosomal marker LAMP1, whereas V5-aSMase localized to the Golgi secretory pathway. Moreover, V5-aSMase possessed Zn2+-dependent activity suggesting it may represent the common protein precursor of S-SMase and L-SMase. Importantly, the 65-kDa L-SMase, but not V5-aSMase, was sensitive to the lysosomotropic inhibitor desipramine, co-fractionated with lysosomes, and migrated at the same M-r as partially purified human aSMase. Finally, three aSMase mutants containing C-terminal Niemann-Pick mutations (R600H, R600P, Delta R608) exhibited defective proteolytic maturation. Taken together, these results demonstrate that mature L-SMase arises from C-terminal proteo-lytic processing of pro-aSMase and suggest that impaired C-terminal proteolysis may lead to severe defects in L-SMase function.	[Jenkins, Russell W.; Idkowiak-Baldys, Jolanta; Canals, Daniel; Roddy, Patrick; Clarke, Christopher J.; Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Simbari, Fabio] Inst Adv Chem Catalonia CSIC, Dept Biomed Chem, Barcelona, Spain; [Riner, Clarke D.] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA	Medical University of South Carolina; Consejo Superior de Investigaciones Cientificas (CSIC); University of Tennessee System; University of Tennessee Knoxville	Hannun, YA (corresponding author), 173 Ashley Ave,POB 250509C, Charleston, SC 29425 USA.	hannun@musc.edu	Canals, Daniel/AAJ-8176-2021; Canals, Daniel/AAW-1998-2021	Canals, Daniel/0000-0002-9293-5123	NCI, National Institutes of Health [P01 CA097132, GM08716]; American Heart Association [AHA 081509E]; Medical University of South Carolina Hollings Cancer Center Abney Foundation; Ministerio de Educacion y Ciencia (Spain) [AP2006-02190]; Administrative Supplements Providing Summer Research Experiences for Students and Science Educators [HL043707-19S1]; National Institutes of Health NCI Medical University of South Carolina-Cancer Center [1P30 CA138313-01]; NATIONAL CANCER INSTITUTE [P01CA097132, P30CA138313] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008716] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Heart Association(American Heart Association); Medical University of South Carolina Hollings Cancer Center Abney Foundation; Ministerio de Educacion y Ciencia (Spain)(Spanish Government); Administrative Supplements Providing Summer Research Experiences for Students and Science Educators; National Institutes of Health NCI Medical University of South Carolina-Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 CA097132 from the NCI (to Y. A. H.), National Institutes of Health MSTP Training Grant GM08716 (to R. W. J.), American Heart Association Pre-doctoral Fellowship AHA 081509E (to R. W. J.), a Medical University of South Carolina Hollings Cancer Center Abney Foundation scholarship (to R. W. J.), Ministerio de Educacion y Ciencia (Spain) Predoctoral Fellowship AP2006-02190 (to F. S.), and Administrative Supplements Providing Summer Research Experiences for Students and Science Educators Grant HL043707-19S1 (to C. D. R.). The confocal core is supported in part by National Institutes of Health NCI Medical University of South Carolina-Cancer Center Support Grant 1P30 CA138313-01.	ALBOUZ S, 1981, BIOMED EXPRESS, V35, P218; Arunachalam B, 2000, P NATL ACAD SCI USA, V97, P745, DOI 10.1073/pnas.97.2.745; Baird GS, 2000, P NATL ACAD SCI USA, V97, P11984, DOI 10.1073/pnas.97.22.11984; Bartelsen O, 1998, J BIOTECHNOL, V63, P29, DOI 10.1016/S0168-1656(98)00070-4; ERICKSON AH, 1983, BIOCHEMISTRY-US, V22, P5201, DOI 10.1021/bi00291a021; FERLINZ K, 1994, BIOCHEM J, V301, P855, DOI 10.1042/bj3010855; He XX, 1999, BBA-PROTEIN STRUCT M, V1432, P251, DOI 10.1016/S0167-4838(99)00069-2; He XX, 2003, J BIOL CHEM, V278, P32978, DOI 10.1074/jbc.M301936200; HURWITZ R, 1994, J BIOL CHEM, V269, P5440; HURWITZ R, 1994, BIOL CHEM H-S, V375, P447, DOI 10.1515/bchm3.1994.375.7.447; Jenkins RW, 2010, J BIOL CHEM, V285, P35706, DOI 10.1074/jbc.M110.125609; JONES CS, 1981, BIOCHEM J, V195, P373, DOI 10.1042/bj1950373; Jones I, 2008, MOL GENET METAB, V95, P152, DOI 10.1016/j.ymgme.2008.08.004; Kolzer M, 2004, FEBS LETT, V559, P96, DOI 10.1016/S0014-5793(04)00033-X; KURTH J, 1991, BIOL CHEM H-S, V372, P215, DOI 10.1515/bchm3.1991.372.1.215; Lansmann S, 1996, FEBS LETT, V399, P227, DOI 10.1016/S0014-5793(96)01331-2; Lansmann S, 2003, EUR J BIOCHEM, V270, P1076, DOI 10.1046/j.1432-1033.2003.03435.x; Lee CL, 2007, JPN J APPL PHYS 2, V46, pL457, DOI 10.1143/JJAP.46.L457; Lee CY, 2006, J LIPID RES, V47, P622, DOI 10.1194/jlr.M500487-JLR200; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Pittis M G, 2004, Hum Mutat, V24, P186, DOI 10.1002/humu.9263; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Qiu HW, 2003, J BIOL CHEM, V278, P32744, DOI 10.1074/jbc.M303022200; QUINTERN LE, 1991, METHOD ENZYMOL, V197, P536; QUINTERN LE, 1987, BIOCHIM BIOPHYS ACTA, V922, P323, DOI 10.1016/0005-2760(87)90055-5; QUINTERN LE, 1989, BIOCHIM BIOPHYS ACTA, V1003, P121, DOI 10.1016/0005-2760(89)90244-0; Rotolo JA, 2005, J BIOL CHEM, V280, P26425, DOI 10.1074/jbc.M414569200; ROUSSON R, 1993, J IMMUNOL METHODS, V160, P199, DOI 10.1016/0022-1759(93)90178-A; SAKURAGAWA N, 1982, J BIOCHEM, V92, P637, DOI 10.1093/oxfordjournals.jbchem.a133974; Schissel SL, 1998, J BIOL CHEM, V273, P18250, DOI 10.1074/jbc.273.29.18250; Schissel SL, 1996, J BIOL CHEM, V271, P18431, DOI 10.1074/jbc.271.31.18431; Schuchman EH, 2007, J INHERIT METAB DIS, V30, P654, DOI 10.1007/s10545-007-0632-9; Simonaro CM, 2002, AM J HUM GENET, V71, P1413, DOI 10.1086/345074; SOUTHERN JA, 1991, J GEN VIROL, V72, P1551, DOI 10.1099/0022-1317-72-7-1551; Takahashi I, 2005, TOHOKU J EXP MED, V206, P333, DOI 10.1620/tjem.206.333; Toomre D, 1999, J CELL SCI, V112, P21; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; WISSELAAR HA, 1993, J BIOL CHEM, V268, P2223; YAMANAKA T, 1982, J NEUROCHEM, V38, P1753, DOI 10.1111/j.1471-4159.1982.tb06659.x; YONEZAWA S, 1988, J BIOL CHEM, V263, P16504; Zeidan YH, 2008, FASEB J, V22, P183, DOI 10.1096/fj.07-8967com; Zeidan YH, 2007, J BIOL CHEM, V282, P11549, DOI 10.1074/jbc.M609424200; ZOU L, 1989, BIOTECHNOL APPL BIOC, V11, P217	43	43	43	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3777	3788		10.1074/jbc.M110.155234	http://dx.doi.org/10.1074/jbc.M110.155234			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21098024	hybrid, Green Published			2022-12-25	WOS:000286653200059
J	Gomes, C; Smith, SC; Youssef, MN; Zheng, JJ; Hagg, T; Hetman, M				Gomes, Cynthia; Smith, Scott C.; Youssef, Mark N.; Zheng, Jing-Juan; Hagg, Theo; Hetman, Michal			RNA Polymerase 1-driven Transcription as a Mediator of BDNF-induced Neurite Outgrowth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOMAL-RNA; I TRANSCRIPTION; CORTICAL-NEURONS; DENDRITIC GROWTH; PHOSPHATIDYLINOSITOL 3-KINASE; DRIVEN TRANSCRIPTION; HIPPOCAMPAL-NEURONS; GENE-TRANSCRIPTION; NUCLEAR-FACTOR; TIF-IA	Neurite outgrowth is essential for development of the nervous system. Neurotrophins including BDNF are among extracellular signals that regulate neurite outgrowth. The ERK1/2 pathway contributes to intracellular signaling networks transducing the pro-neuritic effects of BDNF. In the nucleolus, RNA polymerase-1 (Pol1)-mediated transcription regulates ribosomal biogenesis, enabling cellular protein synthesis and growth. Hence, we tested the possibility that Pol1 is an effector for pro-neuritic signals such as BDNF. We report that Pol1-mediated nucleolar transcription was increased by BDNF in an ERK1/2-dependent manner in rat forebrain neurons. Conversely, in cultured hippocampal neurons, knockdown of a Pol1 coactivator, transcription initiation factor 1A (TIF1A), attenuated BDNF- or ERK1/2-induced neurite outgrowth. Also, upon overexpression, a constitutively active mutant of TIF1A strongly promoted neurite outgrowth, including increases in total neurite length and branching. Finally, overexpression of wild-type TIF1A enhanced the pro-neuritic effects of ERK1/2 activation. These observations indicate that the Pol1-mediated nucleolar transcription regulates neurite outgrowth and serves as a major pro-neuritic effector of the BDNF-activated ERK1/2 pathway. Thus, development of the nervous system appears critically dependent on the nucleolus.	[Gomes, Cynthia; Smith, Scott C.; Youssef, Mark N.; Zheng, Jing-Juan; Hagg, Theo; Hetman, Michal] Univ Louisville, Kentucky Spinal Cord Injury Res Ctr, Louisville, KY 40292 USA; [Gomes, Cynthia; Smith, Scott C.; Youssef, Mark N.; Zheng, Jing-Juan; Hagg, Theo; Hetman, Michal] Univ Louisville, Dept Neurol Surg, Louisville, KY 40292 USA; [Hagg, Theo; Hetman, Michal] Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA	University of Louisville; University of Louisville; University of Louisville	Hetman, M (corresponding author), Univ Louisville, Kentucky Spinal Cord Injury Res Ctr, 511 S Floyd St,MDR616, Louisville, KY 40292 USA.	michal.hetman@louisville.edu		Smith, Scott/0000-0003-2938-6202	National Institutes of Health [NS047341, RR015576]; National Science Foundation [IOS1021860]; Commonwealth of Kentucky Challenge for Excellence and Norton Healthcare; University of Louisville School of Medicine; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047341] Funding Source: NIH RePORTER; Direct For Biological Sciences [1021860] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Commonwealth of Kentucky Challenge for Excellence and Norton Healthcare; University of Louisville School of Medicine; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported, in whole or in part, by National Institutes of Health Grants NS047341 and RR015576 (to M. H.). This work was also supported by National Science Foundation Grant IOS1021860 (to M. H.), the Commonwealth of Kentucky Challenge for Excellence and Norton Healthcare (to M. H. and T. H.), and the University of Louisville School of Medicine Summer Research Student Program (to M. N. Y.).	Bierhoff H, 2008, MOL CELL BIOL, V28, P4988, DOI 10.1128/MCB.00492-08; CLARK P, 1990, J COMP NEUROL, V302, P749, DOI 10.1002/cne.903020407; Dijkhuizen PA, 2005, PROG BRAIN RES, V147, P17, DOI 10.1016/S0079-6123(04)47002-2; Dinman JD, 2009, J BIOL CHEM, V284, P11761, DOI 10.1074/jbc.R800074200; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Drygin D, 2010, ANNU REV PHARMACOL, V50, P131, DOI 10.1146/annurev.pharmtox.010909.105844; Dundr M, 2002, SCIENCE, V298, P1623, DOI 10.1126/science.1076164; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Gutierrez H, 2008, J NEUROSCI, V28, P8246, DOI 10.1523/JNEUROSCI.1941-08.2008; Habas A, 2006, J NEUROCHEM, V96, P335, DOI 10.1111/j.1471-4159.2005.03543.x; Han BH, 2000, J NEUROSCI, V20, P5775, DOI 10.1523/jneurosci.20-15-05775.2000; Hartwig CL, 2008, DEV NEUROBIOL, V68, P1225, DOI 10.1002/dneu.20655; Hetman M, 1999, J BIOL CHEM, V274, P22569, DOI 10.1074/jbc.274.32.22569; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; James MJ, 2004, J BIOL CHEM, V279, P8911, DOI 10.1074/jbc.M307735200; Jao CY, 2008, P NATL ACAD SCI USA, V105, P15779, DOI 10.1073/pnas.0808480105; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Jordan BA, 2007, NAT NEUROSCI, V10, P427, DOI 10.1038/nn1867; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kalita K, 2008, J NEUROCHEM, V105, P2286, DOI 10.1111/j.1471-4159.2008.05316.x; Kalita K, 2006, J NEUROSCI, V26, P10020, DOI 10.1523/JNEUROSCI.2644-06.2006; Kinderman NB, 1998, J COMP NEUROL, V401, P205; LAFARGA M, 1985, DEV BRAIN RES, V22, P310, DOI 10.1016/0165-3806(85)90185-3; Li SA, 2009, J NEUROSCI, V29, P2334, DOI 10.1523/JNEUROSCI.2296-08.2009; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Mayer C, 2004, GENE DEV, V18, P423, DOI 10.1101/gad.285504; McGowan PO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002085; Miller FD, 2003, CURR OPIN NEUROBIOL, V13, P391, DOI 10.1016/s0959-4388(03)00072-2; Parrish JZ, 2007, ANNU REV NEUROSCI, V30, P399, DOI 10.1146/annurev.neuro.29.051605.112907; Redmond L, 2002, NEURON, V34, P999, DOI 10.1016/S0896-6273(02)00737-7; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; SHAULIAN E, 1992, MOL CELL BIOL, V12, P5581, DOI 10.1128/MCB.12.12.5581; Stark LA, 2005, MOL CELL BIOL, V25, P5985, DOI 10.1128/MCB.25.14.5985-6004.2005; Stefanovsky VY, 2001, MOL CELL, V8, P1063, DOI 10.1016/S1097-2765(01)00384-7; Storer PD, 2003, J COMP NEUROL, V458, P326, DOI 10.1002/cne.10623; STOYKOVA AS, 1983, J NEUROCHEM, V41, P942, DOI 10.1111/j.1471-4159.1983.tb09038.x; Szatmari E, 2007, J NEUROSCI, V27, P11389, DOI 10.1523/JNEUROSCI.3473-07.2007; Szymanski J, 2009, BBA-MOL CELL RES, V1793, P1191, DOI 10.1016/j.bbamcr.2009.05.004; Uechi T, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000037; Vashishta A, 2009, J NEUROSCI, V29, P15331, DOI 10.1523/JNEUROSCI.4873-09.2009; Wayman GA, 2006, NEURON, V50, P897, DOI 10.1016/j.neuron.2006.05.008; Zhao J, 2003, MOL CELL, V11, P405, DOI 10.1016/S1097-2765(03)00036-4; Zhong SP, 2004, MOL CELL BIOL, V24, P5119, DOI 10.1128/MCB.24.12.5119-5129.2004	46	45	51	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4357	4363		10.1074/jbc.M110.170134	http://dx.doi.org/10.1074/jbc.M110.170134			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21098478	hybrid, Green Published			2022-12-25	WOS:000286975700035
J	Cha, SK; Huang, CF; Ding, YX; Qi, XP; Huang, CL; Miller, RT				Cha, Seung-Kuy; Huang, Chunfa; Ding, Yaxian; Qi, Xiaoping; Huang, Chou-Long; Miller, R. Tyler			Calcium-sensing Receptor Decreases Cell Surface Expression of the Inwardly Rectifying K+ Channel Kir4.1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THICK ASCENDING LIMB; RENAL ION-TRANSPORT; SENSORINEURAL DEAFNESS; BASOLATERAL MEMBRANE; BARTTERS-SYNDROME; PLASMA-MEMBRANE; MUTATIONS; REABSORPTION; CAVEOLIN-1; KCNJ10	The Ca2+-sensing receptor (CaR) regulates salt and water transport in the kidney as demonstrated by the association of gain of function CaR mutations with a Bartter syndrome-like, salt-wasting phenotype, but the precise mechanism for this effect is not fully established. We found previously that the CaR interacts with and inactivates an inwardly rectifying K+ channel, Kir4.1, which is expressed in the distal nephron that contributes to the basolateral K+ conductance, and in which loss of function mutations are associated with a complex phenotype that includes renal salt wasting. We now find that CaR inactivates Kir4.1 by reducing its cell surface expression. Mutant CaRs reduced Kir4.1 cell surface expression and current density in HEK-293 cells in proportion to their signaling activity. Mutant, activated G alpha(q) reduced cell surface expression and current density of Kir4.1, and these effects were blocked by RGS4, a protein that blocks signaling via G alpha(i) and G alpha(q). Other alpha subunits had insignificant effects. Knockdown of caveolin-1 blocked the effect of G alpha(q) on Kir4.1, whereas knockdown of the clathrin heavy chain had no effect. CaR had no comparable effect on the renal outer medullary K+ channel, an apical membrane distal nephron K+ channel that is internalized by clathrin-coated vesicles. Co-immunoprecipitation studies showed that the CaR and Kir4.1 physically associate with caveolin-1 in HEK cells and in kidney extracts. Thus, the CaR decreases cell surface expression of Kir4.1 channels via a mechanism that involves G alpha(q) and caveolin. These results provide a novel molecular basis for the inhibition of renal NaCl transport by the CaR.	[Miller, R. Tyler] Case Western Reserve Univ, Louis Stokes Vet Affairs Med Ctr, Div Nephrol, Dept Med, Cleveland, OH 44106 USA; [Miller, R. Tyler] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; Univ Texas SW Med Ctr Dallas, Dept Med, Dallas, TX 75390 USA; [Miller, R. Tyler] Rammelkamp Ctr Res & Educ, Cleveland, OH 44109 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Miller, RT (corresponding author), Case Western Reserve Univ, Louis Stokes Vet Affairs Med Ctr, Div Nephrol, Dept Med, 10701 E Blvd 151 W, Cleveland, OH 44106 USA.	rtm4@case.edu			National Institutes of Health [DK-59985, DK-59530]; University of Texas Southwestern O'Brien Center [P30DK079328]; Veterans Affairs Merit Review; Leonard Rosenberg Research Foundation; Rammelkamp Center for Research and Education; Case Western Reserve University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059530, P30DK079328, R01DK059985] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas Southwestern O'Brien Center; Veterans Affairs Merit Review(US Department of Veterans Affairs); Leonard Rosenberg Research Foundation; Rammelkamp Center for Research and Education; Case Western Reserve University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-59985 (to R.T.M.), DK-59530 (to C.-L.H.) and University of Texas Southwestern O'Brien Center grant P30DK079328. This was also supported by Veterans Affairs Merit Review grants (to C.H. and R.T.M.), the Leonard Rosenberg Research Foundation, and the Rammelkamp Center for Research and Education, Case Western Reserve University.	Bockenhauer D, 2009, NEW ENGL J MED, V360, P1960, DOI 10.1056/NEJMoa0810276; BONNARDEAUX A, 2000, KIDNEY, P1621; Breton S, 1998, J HISTOCHEM CYTOCHEM, V46, P205, DOI 10.1177/002215549804600209; Cao GW, 2003, AM J PATHOL, V162, P1241, DOI 10.1016/S0002-9440(10)63920-X; Cha SK, 2008, AM J PHYSIOL-RENAL, V294, pF1212, DOI 10.1152/ajprenal.00007.2008; Desfleurs E, 1998, KIDNEY BLOOD PRESS R, V21, P401, DOI 10.1159/000025892; Ferreira MCD, 1998, AM J PHYSIOL-RENAL, V275, pF198, DOI 10.1152/ajprenal.1998.275.2.F198; Friedman PA, 1998, ANNU REV PHYSIOL, V60, P179, DOI 10.1146/annurev.physiol.60.1.179; Gamba G, 2009, PFLUG ARCH EUR J PHY, V458, P61, DOI 10.1007/s00424-008-0607-1; GOTTARDI CJ, 1995, AM J PHYSIOL-RENAL, V268, pF285, DOI 10.1152/ajprenal.1995.268.2.F285; He GC, 2007, J CLIN INVEST, V117, P1078, DOI 10.1172/JCI30087; Hofer AM, 2003, NAT REV MOL CELL BIO, V4, P530, DOI 10.1038/nrm1154; Huang CF, 2007, CURR OPIN NEPHROL HY, V16, P437, DOI 10.1097/MNH.0b013e3282b974a6; Huang CF, 2007, AM J PHYSIOL-RENAL, V292, pF1073, DOI 10.1152/ajprenal.00269.2006; Huang C, 2010, CURR OPIN NEPHROL HY, V19, P106, DOI 10.1097/MNH.0b013e328332e7b2; Ito M, 1996, FEBS LETT, V388, P11, DOI 10.1016/0014-5793(96)00502-9; Jung SY, 2005, EXP MOL MED, V37, P91, DOI 10.1038/emm.2005.13; Kifor O, 1998, J BIOL CHEM, V273, P21708, DOI 10.1074/jbc.273.34.21708; Konrad M, 2000, J AM SOC NEPHROL, V11, P1449, DOI 10.1681/ASN.V1181449; Lajoie P, 2009, J CELL BIOL, V185, P381, DOI 10.1083/jcb.200811059; Lazrak A, 2006, P NATL ACAD SCI USA, V103, P1615, DOI 10.1073/pnas.0510609103; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Lopes CMB, 2005, J PHYSIOL-LONDON, V564, P117, DOI 10.1113/jphysiol.2004.081935; Motoyama HI, 2002, AM J PHYSIOL-RENAL, V283, pF399, DOI 10.1152/ajprenal.00346.2001; Oh P, 2001, MOL BIOL CELL, V12, P685, DOI 10.1091/mbc.12.3.685; Ookata K, 2000, J AM SOC NEPHROL, V11, P1987, DOI 10.1681/ASN.V11111987; Pearce SHS, 1998, QJM-MON J ASSOC PHYS, V91, P5, DOI 10.1093/qjmed/91.1.5; PETERSON LN, 1990, AM J PHYSIOL, V259, pF122, DOI 10.1152/ajprenal.1990.259.1.F122; Reichold M, 2010, P NATL ACAD SCI USA, V107, P14490, DOI 10.1073/pnas.1003072107; Rohacs T, 2003, P NATL ACAD SCI USA, V100, P745, DOI 10.1073/pnas.0236364100; Scholl UI, 2009, P NATL ACAD SCI USA, V106, P5842, DOI 10.1073/pnas.0901749106; Simon DB, 1998, CURR OPIN CELL BIOL, V10, P450, DOI 10.1016/S0955-0674(98)80057-4; Vargas-Poussou R, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000025781.16723.68; Wang WH, 2006, AM J PHYSIOL-RENAL, V290, pF14, DOI 10.1152/ajprenal.00093.2005; Watanabe S, 2002, LANCET, V360, P692, DOI 10.1016/S0140-6736(02)09842-2	35	39	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1828	1835		10.1074/jbc.M110.160390	http://dx.doi.org/10.1074/jbc.M110.160390			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21084311	hybrid, Green Published			2022-12-25	WOS:000286191500023
J	Kroczynska, B; Joshi, S; Eklund, EA; Verma, A; Kotenko, SV; Fish, EN; Platanias, LC				Kroczynska, Barbara; Joshi, Sonali; Eklund, Elizabeth A.; Verma, Amit; Kotenko, Sergei V.; Fish, Eleanor N.; Platanias, Leonidas C.			Regulatory Effects of Ribosomal S6 Kinase 1 (RSK1) in IFN lambda Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; MESSENGER-RNA TRANSLATION; INTERFERON-LAMBDA; MAMMALIAN TARGET; INITIATION-FACTORS; DOCKING SITE; PHOSPHORYLATION; INHIBITOR; PATHWAYS; COMPLEX	Although the mechanisms of generation of signals that control transcriptional activation of Type III IFN (IFN lambda)-regulated genes have been identified, very little is known about the mechanisms by which the IFN lambda receptor generates signals for mRNA translation of IFN lambda-activated genes. We provide evidence that IFN lambda activates the p90 ribosomal protein S6 kinase 1 (RSK1) and its downstream effector, initiation factor eIF4B. Prior to its engagement by the IFN lambda receptor, the non-active form of RSK1 is present in a complex with the translational repressor 4E-BP1 in IFN lambda-sensitive cells. IFN lambda-inducible phosphorylation/activation of RSK1 results in its dissociation from 4E-BP1 at the same time that 4E-BP1 dissociates from eIF4E to allow formation of eIF4F and initiation of cap-dependent translation. Our studies demonstrate that such IFN lambda-dependent engagement of RSK1 is essential for up-regulation of p21(WAF1/CIP1) expression, suggesting a mechanism for generation of growth-inhibitory responses. Altogether, our data provide evidence for a critical role for the activated RSK1 in IFN lambda signaling.	[Kroczynska, Barbara; Joshi, Sonali; Eklund, Elizabeth A.; Platanias, Leonidas C.] Northwestern Univ, Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Kroczynska, Barbara; Joshi, Sonali; Eklund, Elizabeth A.; Platanias, Leonidas C.] Northwestern Univ, Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA; [Kroczynska, Barbara; Joshi, Sonali; Eklund, Elizabeth A.; Platanias, Leonidas C.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60611 USA; [Verma, Amit] Albert Einstein Coll Med, Div Hematol Oncol, Dept Med, Bronx, NY 10461 USA; [Fish, Eleanor N.] Univ Toronto, Div Cell & Mol Biol, Toronto Res Inst, Univ Hlth Network, Toronto, ON M5G 2M1, Canada; [Fish, Eleanor N.] Univ Toronto, Dept Immunol, Toronto, ON M5G 2M1, Canada; [Kotenko, Sergei V.] Univ Med & Dent New Jersey, Dept Biochem & Mol Biol, Newark, NJ 07103 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Yeshiva University; Albert Einstein College of Medicine; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Rutgers State University New Brunswick; Rutgers State University Medical Center	Platanias, LC (corresponding author), Northwestern Univ, Sch Med, Robert H Lurie Comprehens Canc Ctr, 303 E Super St,Lurie 3-107, Chicago, IL 60611 USA.	l-platanias@northwestern.edu			National Institutes of Health [CA77816, AG029138, CA121192, HL082946, CA100579]; Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [R01CA121192, R01CA077816, R01CA100579, P30CA060553] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029138] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants CA77816, AG029138, CA121192, HL082946, and CA100579. This work was also supported by a Merit Review Grant from the Department of Veterans Affairs.	Altman JK, 2008, J BIOL CHEM, V283, P1992, DOI 10.1074/jbc.M705227200; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Bartlett NW, 2005, J GEN VIROL, V86, P1589, DOI 10.1099/vir.0.80904-0; Brand S, 2005, AM J PHYSIOL-GASTR L, V289, pG960, DOI 10.1152/ajpgi.00126.2005; Carriere A, 2008, CURR BIOL, V18, P1269, DOI 10.1016/j.cub.2008.07.078; Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014; Dalby KN, 1998, J BIOL CHEM, V273, P1496, DOI 10.1074/jbc.273.3.1496; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DAVID M, 1995, SCIENCE, V269, P1721, DOI 10.1126/science.7569900; Donnelly RP, 2010, J INTERF CYTOK RES, V30, P555, DOI 10.1089/jir.2010.0078; Dumoutier L, 2004, J BIOL CHEM, V279, P32269, DOI 10.1074/jbc.M404789200; ETCHISON D, 1982, J BIOL CHEM, V257, P4806; Fisher TL, 1996, MOL CELL BIOL, V16, P1212; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; Gavin AC, 1999, CURR BIOL, V9, P281, DOI 10.1016/S0960-9822(99)80120-1; Giafis N, 2006, CANCER RES, V66, P6763, DOI 10.1158/0008-5472.CAN-05-3699; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gingras AC, 2001, GENE DEV, V15, P2852; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Herbert TP, 2002, J BIOL CHEM, V277, P11591, DOI 10.1074/jbc.M110367200; Hernandez G, 2005, MECH DEVELOP, V122, P865, DOI 10.1016/j.mod.2005.04.002; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Hong SH, 2007, VIRUS RES, V126, P245, DOI 10.1016/j.virusres.2007.03.006; Ito A, 2000, EMBO J, V19, P562, DOI 10.1093/emboj/19.4.562; Itoh S, 2005, J BIOL CHEM, V280, P24135, DOI 10.1074/jbc.M413015200; JARAMILLO M, 1991, MOL CELL BIOL, V11, P5992, DOI 10.1128/MCB.11.12.5992; Jensen CJ, 1999, J BIOL CHEM, V274, P27168, DOI 10.1074/jbc.274.38.27168; JONES SW, 1988, P NATL ACAD SCI USA, V85, P3377, DOI 10.1073/pnas.85.10.3377; Kannan-Thulasiraman P, 2006, J BIOL CHEM, V281, P22446, DOI 10.1074/jbc.M603111200; Katayama T, 2007, INT J ONCOL, V31, P613; Kaur S, 2008, CELL CYCLE, V7, P2112, DOI 10.4161/cc.7.14.6258; Kaur S, 2008, P NATL ACAD SCI USA, V105, P4808, DOI 10.1073/pnas.0710907105; Kaur S, 2007, J BIOL CHEM, V282, P1757, DOI 10.1074/jbc.M607365200; Kotenko SV, 2004, INT IMMUNOPHARMACOL, V4, P593, DOI 10.1016/j.intimp.2004.01.003; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Krajcikova D, 2009, J BACTERIOL, V191, P3212, DOI 10.1128/JB.01807-08; Kroczynska B, 2009, MOL CELL BIOL, V29, P2865, DOI 10.1128/MCB.01537-08; La QH, 2010, EUR J CANCER, V46, P180, DOI 10.1016/j.ejca.2009.10.002; Lasfar A, 2006, CANCER RES, V66, P4468, DOI 10.1158/0008-5472.CAN-05-3653; Li W, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/15/155003; Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052; Meager A, 2005, CYTOKINE, V31, P109, DOI 10.1016/j.cyto.2005.04.003; Nguyen TL, 2008, ANTI-CANCER AGENT ME, V8, P710, DOI 10.2174/187152008785914770; Onoguchi K, 2007, J BIOL CHEM, V282, P7576, DOI 10.1074/jbc.M608618200; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Smith JA, 1999, J BIOL CHEM, V274, P2893, DOI 10.1074/jbc.274.5.2893; Smith JA, 2005, CANCER RES, V65, P1027; Thyrell L, 2004, J BIOL CHEM, V279, P24152, DOI 10.1074/jbc.M312219200; Tsukiyama-Kohara K, 2001, NAT MED, V7, P1128, DOI 10.1038/nm1001-1128; Uddin S, 1999, J BIOL CHEM, V274, P30127, DOI 10.1074/jbc.274.42.30127; UDDIN S, 1995, J BIOL CHEM, V270, P15938, DOI 10.1074/jbc.270.27.15938; Zhou ZL, 2007, J VIROL, V81, P7749, DOI 10.1128/JVI.02438-06; Zitzmann K, 2006, BIOCHEM BIOPH RES CO, V344, P1334, DOI 10.1016/j.bbrc.2006.04.043	59	17	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1147	1156		10.1074/jbc.M110.183566	http://dx.doi.org/10.1074/jbc.M110.183566			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21075852	Green Published, hybrid			2022-12-25	WOS:000286005000025
J	Kolata, S; Light, K; Wass, CD; Colas-Zelin, D; Roy, D; Matzel, LD				Kolata, Stefan; Light, Kenneth; Wass, Christopher D.; Colas-Zelin, Danielle; Roy, Debasri; Matzel, Louis D.			A Dopaminergic Gene Cluster in the Prefrontal Cortex Predicts Performance Indicative of General Intelligence in Genetically Heterogeneous Mice	PLOS ONE			English	Article							WORKING-MEMORY CAPACITY; INDIVIDUAL-DIFFERENCES; LEARNING-ABILITY; CELLULAR-DISTRIBUTION; STRESS REACTIVITY; BASAL GANGLIA; DARPP-32; BRAIN; FGF	Background: Genetically heterogeneous mice express a trait that is qualitatively and psychometrically analogous to general intelligence in humans, and as in humans, this trait co-varies with the processing efficacy of working memory (including its dependence on selective attention). Dopamine signaling in the prefrontal cortex (PFC) has been established to play a critical role in animals' performance in both working memory and selective attention tasks. Owing to this role of the PFC in the regulation of working memory, here we compared PFC gene expression profiles of 60 genetically diverse CD-1 mice that exhibited a wide range of general learning abilities (i.e., aggregate performance across five diverse learning tasks). Methodology/Principal Findings: Animals' general cognitive abilities were first determined based on their aggregate performance across a battery of five diverse learning tasks. With a procedure designed to minimize false positive identifications, analysis of gene expression microarrays (comprised of approximate to 25,000 genes) identified a small number (<20) of genes that were differentially expressed across animals that exhibited fast and slow aggregate learning abilities. Of these genes, one functional cluster was identified, and this cluster (Darpp-32, Drd1a, and Rgs9) is an established modulator of dopamine signaling. Subsequent quantitative PCR found that expression of these dopaminegic genes plus one vascular gene (Nudt6) were significantly correlated with individual animal's general cognitive performance. Conclusions/Significance: These results indicate that D1-mediated dopamine signaling in the PFC, possibly through its modulation of working memory, is predictive of general cognitive abilities. Furthermore, these results provide the first direct evidence of specific molecular pathways that might potentially regulate general intelligence.	[Kolata, Stefan; Light, Kenneth; Wass, Christopher D.; Colas-Zelin, Danielle; Roy, Debasri; Matzel, Louis D.] Rutgers State Univ, Dept Psychol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Kolata, S (corresponding author), Rutgers State Univ, Dept Psychol, Piscataway, NJ 08854 USA.	matzel@rci.rutgers.edu		Matzel, Louis/0000-0003-0462-7188	National Institute of Aging [AG022698]; Busch Foundation; NATIONAL INSTITUTE ON AGING [R03AG022698, R01AG029289] Funding Source: NIH RePORTER	National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Busch Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the National Institute of Aging (AG022698) and the Busch Foundation (to LDM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouhamdan M, 2004, BBA-MOL CELL RES, V1691, P141, DOI 10.1016/j.bbamcr.2004.01.005; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Colom R, 2004, INTELLIGENCE, V32, P277, DOI 10.1016/j.intell.2003.12.002; Conway ARA, 2003, TRENDS COGN SCI, V7, P547, DOI 10.1016/j.tics.2003.10.005; Conway ARA, 1996, MEMORY, V4, P577, DOI 10.1080/741940997; Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Engle RW, 1999, J EXP PSYCHOL GEN, V128, P309, DOI 10.1037/0096-3445.128.3.309; Fienberg AA, 1998, SCIENCE, V281, P838, DOI 10.1126/science.281.5378.838; Frank MJ, 2001, COGN AFFECT BEHAV NE, V1, P137, DOI 10.3758/CABN.1.2.137; Garzon J, 2001, EUR J NEUROSCI, V13, P801, DOI 10.1046/j.0953-816x.2000.01444.x; Genoux D, 2002, NATURE, V418, P970, DOI 10.1038/nature00928; GomezPinilla F, 1997, BRAIN RES, V764, P1, DOI 10.1016/S0006-8993(97)00375-2; GOMEZPINILLA F, 1992, J NEUROSCI, V12, P345; Gray JR, 2003, NAT NEUROSCI, V6, P316, DOI 10.1038/nn1014; Grossman HC, 2007, BEHAV NEUROSCI, V121, P949, DOI 10.1037/0735-7044.121.5.949; Jensen A.R., 1998, G FACTOR SCI MENTAL; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Kolata S, 2005, NEUROBIOL LEARN MEM, V84, P241, DOI 10.1016/j.nlm.2005.07.006; Kolata S, 2007, LEARN MEMORY, V14, P22, DOI 10.1101/lm.408507; Kolata S, 2008, INTELLIGENCE, V36, P619, DOI 10.1016/j.intell.2007.12.001; Light KR, 2010, CURR BIOL, V20, P777, DOI 10.1016/j.cub.2010.02.034; Mackintosh Nicholas J., 2011, IQ HUMAN INTELLIGENC; MARCHAL G, 1992, ARCH NEUROL-CHICAGO, V49, P1013, DOI 10.1001/archneur.1992.00530340029014; Matzel LD, 2003, J NEUROSCI, V23, P6423; Matzel LD, 2006, NEUROBIOL LEARN MEM, V86, P228, DOI 10.1016/j.nlm.2006.03.004; Mcnab F, 2008, NAT NEUROSCI, V11, P103, DOI 10.1038/nn2024; Meyer-Lindenberg A, 2007, J CLIN INVEST, V117, P672, DOI 10.1172/JCI30413; MORRISON RS, 1986, P NATL ACAD SCI USA, V83, P7537, DOI 10.1073/pnas.83.19.7537; Muzzio IA, 1999, BEHAV NEUROSCI, V113, P103, DOI 10.1037/0735-7044.113.1.103; Plomin R, 2006, INTELLIGENCE, V34, P513, DOI 10.1016/j.intell.2006.01.001; RACHMAN Z, 2003, NEURON US, V6, P941; RICE MC, 1980, NATURE, V283, P157, DOI 10.1038/283157a0; Rowe JB, 2000, SCIENCE, V288, P1656, DOI 10.1126/science.288.5471.1656; SAWAGUCHI T, 1991, SCIENCE, V251, P947, DOI 10.1126/science.1825731; SCHULTZ W, 1993, J NEUROSCI, V13, P900; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; Thurley K, 2008, J NEUROPHYSIOL, V99, P2985, DOI 10.1152/jn.01098.2007; WALAAS SI, 1984, J NEUROSCI, V4, P84; Wickens JR, 2007, J NEUROSCI, V27, P8181, DOI 10.1523/JNEUROSCI.1671-07.2007	41	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2010	5	11							e14036	10.1371/journal.pone.0014036	http://dx.doi.org/10.1371/journal.pone.0014036			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681OY	21103339	Green Submitted, gold, Green Published			2022-12-25	WOS:000284327800017
J	Cusini, A; Rampini, SK; Bansal, V; Ledergerber, B; Kuster, SP; Ruef, C; Weber, R				Cusini, Alexia; Rampini, Silvana K.; Bansal, Vineeta; Ledergerber, Bruno; Kuster, Stefan P.; Ruef, Christian; Weber, Rainer			Different Patterns of Inappropriate Antimicrobial Use in Surgical and Medical Units at a Tertiary Care Hospital in Switzerland: A Prevalence Survey	PLOS ONE			English	Article							ANTIBIOTIC RESTRICTION POLICY; INFECTIOUS-DISEASES; ECONOMIC-IMPACT; DRUG-USE; THERAPY; RESISTANCE; MISUSE; AUDIT; APPROPRIATENESS; BACTEREMIA	Background: Unnecessary or inappropriate use of antimicrobials is associated with the emergence of antimicrobial resistance, drug toxicity, increased morbidity and health care costs. Antimicrobial use has been reported to be incorrect or not indicated in 9-64% of inpatients. We studied the quality of antimicrobial therapy and prophylaxis in hospitalized patients at a tertiary care hospital to plan interventions to improve the quality of antimicrobial prescription. Methodology/Principal Findings: Experienced infectious diseases (ID) fellows performed audits of antimicrobial use at regular intervals among all patients-with or without antimicrobials-hospitalized in predefined surgical, medical, haemato-oncological, or intensive care units. Data were collected from medical and nursing patient charts with a standardized questionnaire. Appropriateness of antimicrobial use was evaluated using a modified algorithm developed by Gyssens et al.; the assessment was double-checked by a senior ID specialist. We evaluated 1577 patients of whom 700 (44.4%) had antimicrobials, receiving a total of 1270 prescriptions. 958 (75.4%) prescriptions were for therapy and 312 (24.6%) for prophylaxis. 37.0% of therapeutic and 16.6% of prophylactic prescriptions were found to be inappropriate. Most frequent characteristics of inappropriate treatments included: No indication (17.5%); incorrect choice of antimicrobials (7.6%); incorrect application of drugs (9.3%); and divergence from institutional guidelines (8%). Characteristics of inappropriate prophylaxes were: No indication (9%); incorrect choice of antimicrobials (1%); duration too long or other inappropriate use (6.7%). Patterns of inappropriate antimicrobial varied widely in the different hospital units; empirical prescriptions were more frequently incorrect than prescriptions based on available microbiological results. Conclusions/Significance: Audits of individual patient care provide important data to identify local problems in antimicrobial prescription practice. In our study, antimicrobial prescriptions without indication, and divergence from institutional guidelines were frequent errors. Based on these results, we will tailor education, amend institutional guidelines and further develop the infectious diseases consultation service.	[Cusini, Alexia; Bansal, Vineeta; Ledergerber, Bruno; Kuster, Stefan P.; Ruef, Christian; Weber, Rainer] Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, CH-8091 Zurich, Switzerland; [Rampini, Silvana K.] Univ Zurich Hosp, Div Internal Med, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Cusini, A (corresponding author), Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, CH-8091 Zurich, Switzerland.	infweb@usz.uzh.ch	Kuster, Stefan/T-7388-2019; Ledergerber, Bruno/B-5656-2009; Weber, Rainer/D-5175-2012	Kuster, Stefan/0000-0002-0525-6529; Ledergerber, Bruno/0000-0002-6881-4401; 	Abbott; Aventis; Bristol-Myers Squibb; Gilead Sciences; GlaxoSmithKline; Merck Sharp Dohme; Roche and Tibotec; Tibotec; Pfizer; Wyeth; Boehringer Ingelheim; Gilead; Merck; Roche; TRB Chemedica	Abbott(Abbott Laboratories); Aventis(Sanofi-Aventis); Bristol-Myers Squibb(Bristol-Myers Squibb); Gilead Sciences(Gilead Sciences); GlaxoSmithKline(GlaxoSmithKline); Merck Sharp Dohme(Merck & Company); Roche and Tibotec; Tibotec; Pfizer(Pfizer); Wyeth(Wyeth); Boehringer Ingelheim(Boehringer Ingelheim); Gilead(Gilead Sciences); Merck(Merck & Company); Roche(Roche Holding); TRB Chemedica	BL has received travel grants and/or speakers honoraria from Abbott, Aventis, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Merck Sharp & Dohme, and Roche and Tibotec. SPK has received travel grants from Tibotec. CR has received travel grants from Pfizer and Wyeth and honoraria for teaching from Merck Sharp & Dohme and is a member of the advisory board of Pfizer and Novartis. RW has received travel grants and honoraria for teaching from Abbott, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead, GlaxoSmithKline, Merck, Pfizer, Roche and TRB Chemedica. These competing interests do not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Albrich WC, 2004, EMERG INFECT DIS, V10, P514, DOI 10.3201/eid1003.030252; Bugnon-Reber AV, 2004, SWISS MED WKLY, V134, P481; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Dellit TH, 2007, CLIN INFECT DIS, V44, P159, DOI 10.1086/510393; Erbay A, 2005, J HOSP INFECT, V59, P53, DOI 10.1016/j.jhin.2004.07.026; Erbay AE, 2003, INT J ANTIMICROB AG, V21, P308, DOI 10.1016/S0924-8579(02)00392-8; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Gyssens IC, 2001, INT J ANTIMICROB AG, V17, P9, DOI 10.1016/S0924-8579(00)00208-9; GYSSENS IC, 1992, J ANTIMICROB CHEMOTH, V30, P724, DOI 10.1093/jac/30.5.724; Hecker MT, 2003, ARCH INTERN MED, V163, P972, DOI 10.1001/archinte.163.8.972; Hsueh PR, 2005, INT J ANTIMICROB AG, V26, P463, DOI 10.1016/j.ijantimicag.2005.08.016; JONES SR, 1977, AM J MED SCI, V273, P79, DOI 10.1097/00000441-197701000-00008; Kumarasamy Y, 2003, CLIN MICROBIOL INFEC, V9, P406, DOI 10.1046/j.1469-0691.2003.00577.x; KUNIN CM, 1973, ANN INTERN MED, V79, P555, DOI 10.7326/0003-4819-79-4-555; Kuster SP, 2008, INFECTION, V36, P549, DOI 10.1007/s15010-008-7462-z; Kuster SP, 2008, J ANTIMICROB CHEMOTH, V62, P1451, DOI 10.1093/jac/dkn384; Kuster SP, 2008, J ANTIMICROB CHEMOTH, V62, P837, DOI 10.1093/jac/dkn275; Lee NY, 2007, INFECT CONT HOSP EP, V28, P713, DOI 10.1086/517954; Lodise TP, 2005, DIAGN MICR INFEC DIS, V52, P113, DOI 10.1016/j.diagmicrobio.2005.02.007; Malhotra-Kumar S, 2007, LANCET, V369, P482, DOI 10.1016/S0140-6736(07)60235-9; Ozkurt Z, 2005, JPN J INFECT DIS, V58, P338; Paterson DL, 2004, CLIN INFECT DIS, V38, pS341, DOI 10.1086/382690; Pulcini C, 2007, EUR J CLIN MICROBIOL, V26, P277, DOI 10.1007/s10096-007-0277-5; Raineri E, 2008, AM J INFECT CONTROL, V36, P283, DOI 10.1016/j.ajic.2007.06.009; Raveh D, 2001, QJM-INT J MED, V94, P141, DOI 10.1093/qjmed/94.3.141; Seaton RA, 2007, INT J ANTIMICROB AG, V29, P693, DOI 10.1016/j.ijantimicag.2006.10.020; Tunger O, 2000, INT J ANTIMICROB AG, V15, P131, DOI 10.1016/S0924-8579(00)00158-8; Tunger O, 2009, J INFECT DEV COUNTR, V3, P88, DOI 10.3855/jidc.54; Vlahovic-Palcevski V, 2007, INT J CLIN PHARM TH, V45, P169; Vlahovic-Palevski V, 2005, PHARMACOEPIDEM DR S, V14, P561, DOI 10.1002/pds.1097; WHO Collaborating Center for Drug Statistics Methodology, 2010, ATC IND DDDS 2009; Willemsen I, 2007, ANTIMICROB AGENTS CH, V51, P864, DOI 10.1128/AAC.00994-06; Zahar JR, 2003, PRESSE MED, V32, P1208	33	79	79	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e14011	10.1371/journal.pone.0014011	http://dx.doi.org/10.1371/journal.pone.0014011			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103362	gold, Green Published, Green Submitted			2022-12-25	WOS:000284257400015
J	Scherag, A; Jarick, I; Grothe, J; Biebermann, H; Scherag, S; Volckmar, AL; Vogel, CIG; Greene, B; Hebebrand, J; Hinney, A				Scherag, Andre; Jarick, Ivonne; Grothe, Jessica; Biebermann, Heike; Scherag, Susann; Volckmar, Anna-Lena; Vogel, Carla Ivane Ganz; Greene, Brandon; Hebebrand, Johannes; Hinney, Anke			Investigation of a Genome Wide Association Signal for Obesity: Synthetic Association and Haplotype Analyses at the Melanocortin 4 Receptor Gene Locus	PLOS ONE			English	Article							PROOPIOMELANOCORTIN-DERIVED AGONISTS; DISEASE-ASSOCIATED VARIANTS; FUNCTIONAL-CHARACTERIZATION; PHARMACOLOGICAL CHARACTERIZATION; SYSTEMATIC ANALYSIS; RARE VARIANTS; BODY-MASS; MUTATIONS; POLYMORPHISMS; MC4R	Background: Independent genome-wide association studies (GWAS) showed an obesogenic effect of two single nucleotide polymorphisms (SNP; rs12970134 and rs17782313) more than 150 kb downstream of the melanocortin 4 receptor gene (MC4R). It is unclear if the SNPs directly influence MC4R function or expression, or if the SNPs are on a haplotype that predisposes to obesity or includes functionally relevant genetic variation (synthetic association). As both exist, functionally relevant mutations and polymorphisms in the MC4R coding region and a robust association downstream of the gene, MC4R is an ideal model to explore synthetic association. Methodology/Principal Findings: We analyzed a genomic region (364.9 kb) encompassing the MC4R in GWAS data of 424 obesity trios (extremely obese child/adolescent and both parents). SNP rs12970134 showed the lowest p-value (p = 0.004; relative risk for the obesity effect allele: 1.37); conditional analyses on this SNP revealed that 7 of 78 analyzed SNPs provided independent signals (p <= 0.05). These 8 SNPs were used to derive two-marker haplotypes. The three best (according to p-value) haplotype combinations were chosen for confirmation in 363 independent obesity trios. The confirmed obesity effect haplotype includes SNPs 39 and 59 of the MC4R. Including MC4R coding variants in a joint model had almost no impact on the effect size estimators expected under synthetic association. Conclusions/Significance: A haplotype reaching from a region 59 of the MC4R to a region at least 150 kb from the 39 end of the gene showed a stronger association to obesity than single SNPs. Synthetic association analyses revealed that MC4R coding variants had almost no impact on the association signal. Carriers of the haplotype should be enriched for relevant mutations outside the MC4R coding region and could thus be used for re-sequencing approaches. Our data also underscore the problems underlying the identification of relevant mutations depicted by GWAS derived SNPs.	[Scherag, Andre] Univ Duisburg Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Jarick, Ivonne; Greene, Brandon] Univ Marburg, Inst Med Biometry & Epidemiol, Marburg, Germany; [Grothe, Jessica; Biebermann, Heike] Charite, Inst Expt Paediat Endocrinol, D-13353 Berlin, Germany; [Scherag, Susann; Volckmar, Anna-Lena; Vogel, Carla Ivane Ganz; Hebebrand, Johannes; Hinney, Anke] Univ Duisburg Essen, Dept Child & Adolescent Psychiat & Psychotherapy, Essen, Germany	University of Duisburg Essen; Philipps University Marburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Duisburg Essen	Scherag, A (corresponding author), Univ Duisburg Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany.	UUanke.hinney@uni-due.deUU	Scherag, Andre/B-3805-2014; Hinney, Anke/D-6953-2011	Hinney, Anke/0000-0001-5659-0706; Scherag, Andre/0000-0002-9406-4704; Vogel, Carla/0000-0003-1715-2556; Biebermann, Heike/0000-0002-2024-7778	Bundesministerium fuer Bildung und Forschung [01GS0903, 01KU0903, NGFNplus 01GS0820, 01GS0830, 01GS0825]; Deutsche Forschungsgemeinschaft [HE 1446/4-1]; European Union [LSHMCT-2003-503041]	Bundesministerium fuer Bildung und Forschung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission)	This work was supported by grants from the Bundesministerium fuer Bildung und Forschung (01GS0903; 01KU0903; NGFNplus 01GS0820, 01GS0830, 01GS0825), the Deutsche Forschungsgemeinschaft (HE 1446/4-1) and the European Union (FP6 LSHMCT-2003-503041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Chen JM, 2006, HUM GENET, V120, P1, DOI 10.1007/s00439-006-0180-7; Chen JM, 2006, HUM GENET, V120, P301, DOI 10.1007/s00439-006-0218-x; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Dempfle A, 2004, J MED GENET, V41, P795, DOI 10.1136/jmg.2004.018614; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Fan ZC, 2009, J CELL MOL MED, V13, P3268, DOI 10.1111/j.1582-4934.2009.00726.x; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; FENG T, 2010, HUM GENET       0613; Geller F, 2004, AM J HUM GENET, V74, P572, DOI 10.1086/382490; Hebebrand J, 1994, AKTUELLE ERNAHRUNGSM, V19, P259; Heid IM, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.027011; Herold C, 2009, BIOINFORMATICS, V25, P134, DOI 10.1093/bioinformatics/btn581; Hinney A, 2006, J CLIN ENDOCR METAB, V91, P1761, DOI 10.1210/jc.2005-2056; Hinney A, 2003, J CLIN ENDOCR METAB, V88, P4258, DOI 10.1210/jc.2003-030233; Hinney A, 1999, J CLIN ENDOCR METAB, V84, P1483, DOI 10.1210/jc.84.4.1483; Hinney A, 2010, EUR CHILD ADOLES PSY, V19, P297, DOI 10.1007/s00787-010-0096-6; Hinney A, 2009, OBESITY FACTS, V2, P3, DOI 10.1159/000200020; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Larsen LH, 2005, J CLIN ENDOCR METAB, V90, P219, DOI 10.1210/jc.2004-0497; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Nijenhuis WAJ, 2003, J BIOL CHEM, V278, P22939, DOI 10.1074/jbc.M211326200; SPELIOTES EK, 2010, NAT GE IN PRESS 1010; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Stutzmann F, 2007, HUM MOL GENET, V16, P1837, DOI 10.1093/hmg/ddm132; Tao YX, 2003, ENDOCRINOLOGY, V144, P4544, DOI 10.1210/en.2003-0524; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Vaisse C, 2000, J CLIN INVEST, V106, P253, DOI 10.1172/JCI9238; Wang D, 2010, OBESITY, V18, P573, DOI 10.1038/oby.2009.268; Wang K, 2010, AM J HUM GENET, V86, P730, DOI 10.1016/j.ajhg.2010.04.003; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Xiang ZM, 2006, BIOCHEMISTRY-US, V45, P7277, DOI 10.1021/bi0600300; Xiang ZM, 2010, BIOCHEMISTRY-US, V49, P4583, DOI 10.1021/bi100068u; Ye S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.17.e88; Yeo GSH, 2003, HUM MOL GENET, V12, P561, DOI 10.1093/hmg/ddg057; Young EH, 2007, INT J OBESITY, V31, P1437, DOI 10.1038/sj.ijo.0803609	38	41	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e13967	10.1371/journal.pone.0013967	http://dx.doi.org/10.1371/journal.pone.0013967			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085626	Green Published, Green Submitted, gold			2022-12-25	WOS:000284231800006
J	Wittig, RM; Boesch, C				Wittig, Roman M.; Boesch, Christophe			Receiving Post-Conflict Affiliation from the Enemy's Friend Reconciles Former Opponents	PLOS ONE			English	Article							CHIMPANZEES PAN-TROGLODYTES; POSTCONFLICT 3RD-PARTY AFFILIATION; LONG-TAILED MACAQUES; WILD FEMALE BABOONS; SOCIAL BONDS; CAPTIVE CHIMPANZEES; COPING MECHANISMS; NATIONAL-PARK; CONSOLATION; PRIMATES	The adaptive function of bystander initiated post-conflict affiliation (also: consolation & appeasement) has been debated for 30 years. Three influential hypotheses compete for the most likely explanation but have not previously been tested with a single data set. The consolation hypothesis argues that bystander affiliation calms the victim and reduces their stress levels. The self-protection hypothesis proposes that a bystander offers affiliation to either opponent to protect himself from redirected aggression by this individual. The relationship-repair hypothesis suggests a bystander can substitute for a friend to reconcile the friend with the friend's former opponent. Here, we contrast all three hypotheses and tested their predictions with data on wild chimpanzees (Pan troglodytes verus) of the Tai National Park, Cote d'Ivoire. We examined the first and second post-conflict interactions with respect to both the dyadic and triadic relationships between the bystander and the two opponents. Results showed that female bystanders offered affiliation to their aggressor friends and the victims of their friends, while male bystanders offered affiliation to their victim friends and the aggressors of their friends. For both sexes, bystander affiliation resulted in a subsequent interaction pattern that is expected for direct reconciliation. Bystander affiliation offered to the opponent's friend was more likely to lead to affiliation among opponents in their subsequent interaction. Also, tolerance levels among former opponents were reset to normal levels. In conclusion, this study provides strong evidence for the relationship-repair hypothesis, moderate evidence for the consolation hypothesis and no evidence for the self-protection hypothesis. Furthermore, that bystanders can repair a relationship on behalf of their friend indicates that recipient chimpanzees are aware of the relationships between others, even when they are not kin. This presents a mechanism through which chimpanzees may gain benefits from social knowledge.	[Wittig, Roman M.; Boesch, Christophe] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany; [Wittig, Roman M.] Univ St Andrews, Sch Psychol, St Andrews, Fife, Scotland	Max Planck Society; University of St Andrews	Wittig, RM (corresponding author), Max Planck Inst Evolutionary Anthropol, Leipzig, Germany.	rmw12@st-andrews.ac.uk			Max Planck Society; Swiss National Foundation; German Research Foundation; Leverhulme Trust	Max Planck Society(Max Planck Society); Swiss National Foundation(Swiss National Science Foundation (SNSF)); German Research Foundation(German Research Foundation (DFG)); Leverhulme Trust(Leverhulme Trust)	This study was financed by the Max Planck Society (http://www.mpg.de), the Swiss National Foundation (http://www.snf.ch), the German Research Foundation (http://www.dfg.de) and the Leverhulme Trust (www.leverhulme.org.uk). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1984, BEHAV ECOLOGY; Aureli F, 2002, BEHAVIOUR, V139, P393, DOI 10.1163/156853902760102726; AURELI F, 1991, ETHOLOGY, V89, P89; BOESCH C, 1991, Behaviour, V117, P220, DOI 10.1163/156853991X00544; Boesch C, 2000, CHIMPANZEES TAI FORE; Boesch C, 2008, AM J PRIMATOL, V70, P519, DOI 10.1002/ajp.20524; Call J, 2002, ANIM BEHAV, V63, P209, DOI 10.1006/anbe.2001.1908; Cameron EZ, 2009, P NATL ACAD SCI USA, V106, P13850, DOI 10.1073/pnas.0900639106; Cheney DL, 2004, INT J PRIMATOL, V25, P401, DOI 10.1023/B:IJOP.0000019159.75573.13; Cheney DL, 2009, ADV STUD BEHAV, V39, P1, DOI 10.1016/S0065-3454(09)39001-4; Cools AKA, 2008, ETHOLOGY, V114, P53, DOI 10.1111/j.1439-0310.2007.01443.x; CORDS M, 1992, ANIM BEHAV, V44, P57, DOI 10.1016/S0003-3472(05)80754-7; Crockford C, 2008, HORM BEHAV, V53, P254, DOI 10.1016/j.yhbeh.2007.10.007; de Waal FBM, 2000, SCIENCE, V289, P586, DOI 10.1126/science.289.5479.586; De Waal Frans B. M., 1996, P80; DEWAAL FBM, 1981, BEHAVIOUR, V77, P164, DOI 10.1163/156853981X00211; DEWAAL FBM, 1979, BEHAV ECOL SOCIOBIOL, V5, P55, DOI 10.1007/BF00302695; DiCiccio TJ, 1996, STAT SCI, V11, P189; Efron B., 1994, INTRO BOOTSTRAP; Fraser ON, 2009, COMMUN INTEGR BIOL, V2, P1; Fraser ON, 2008, P NATL ACAD SCI USA, V105, P8557, DOI 10.1073/pnas.0804141105; Fraser ON, 2010, INT J PRIMATOL, V31, P39, DOI 10.1007/s10764-009-9377-7; Goodall J., 1986, CHIMPANZEES GOMBE PA; Hawkes K, 2004, NATURE, V428, P128, DOI 10.1038/428128a; Hill K, 2001, J HUM EVOL, V40, P437, DOI 10.1006/jhev.2001.0469; JUDGE PG, 1991, AM J PRIMATOL, V23, P225, DOI 10.1002/ajp.1350230403; Koski SE, 2007, ANIM BEHAV, V73, P133, DOI 10.1016/j.anbehav.2006.04.009; Koski SE, 2009, AM J PRIMATOL, V71, P409, DOI 10.1002/ajp.20668; Krause J, 2002, LIVING GROUPS; Kutsukake N, 2004, PRIMATES, V45, P157, DOI 10.1007/s10329-004-0082-z; Lewis S, 2007, BIOL LETTERS, V3, P386, DOI 10.1098/rsbl.2007.0258; Mitani JC, 2010, CURR BIOL, V20, pR507, DOI 10.1016/j.cub.2010.04.021; Nishida Toshisada, 1996, P114, DOI 10.1017/CBO9780511752414.011; Palagi E, 2004, AM J PRIMATOL, V62, P15, DOI 10.1002/ajp.20000; Preuschoft S, 2002, INT J PRIMATOL, V23, P29, DOI 10.1023/A:1013293623158; Romero T, 2010, P NATL ACAD SCI USA, V107, P12110, DOI 10.1073/pnas.1006991107; Seed AM, 2007, CURR BIOL, V17, P152, DOI 10.1016/j.cub.2006.11.025; Silk JB, 2003, SCIENCE, V302, P1231, DOI 10.1126/science.1088580; Silk JB, 2010, CURR BIOL, V20, P1359, DOI 10.1016/j.cub.2010.05.067; Silk JB, 2009, P ROY SOC B-BIOL SCI, V276, P3099, DOI 10.1098/rspb.2009.0681; WATTS DP, 1995, ETHOLOGY, V100, P158; Weidt A, 2008, ANIM BEHAV, V75, P801, DOI 10.1016/j.anbehav.2007.06.017; Wittig RM, 2005, ETHOLOGY, V111, P736, DOI 10.1111/j.1439-0310.2005.01093.x; Wittig RM, 2003, BEHAVIOUR, V140, P1527, DOI 10.1163/156853903771980701; Wittig RM, 2003, BEHAV ECOL SOCIOBIOL, V54, P491, DOI 10.1007/s00265-003-0654-8; Wittig RM, 2003, INT J PRIMATOL, V24, P847, DOI 10.1023/A:1024632923180; Wittig RM, 2008, HORM BEHAV, V54, P170, DOI 10.1016/j.yhbeh.2008.02.009; Wittig RM, 2007, P R SOC B, V274, P1109, DOI 10.1098/rspb.2006.0203; Wittig Roman M., 2010, P208	49	36	36	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e13995	10.1371/journal.pone.0013995	http://dx.doi.org/10.1371/journal.pone.0013995			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085592	gold, Green Published, Green Submitted			2022-12-25	WOS:000284231800024
J	Prell, J; Bourdes, A; Kumar, S; Lodwig, E; Hosie, A; Kinghorn, S; White, J; Poole, P				Prell, Jurgen; Bourdes, Alexandre; Kumar, Shalini; Lodwig, Emma; Hosie, Arthur; Kinghorn, Seonag; White, James; Poole, Philip			Role of Symbiotic Auxotrophy in the Rhizobium-Legume Symbioses	PLOS ONE			English	Article							LEGUMINOSARUM BV VICIAE; GRAM-NEGATIVE BACTERIA; ROOT-NODULES; SINORHIZOBIUM-MELILOTI; NITROGEN-FIXATION; TRANSPORT MUTANTS; GENE-EXPRESSION; DIFFERENTIATION; IDENTIFICATION; SPECIFICITY	Background: Rhizobium leguminosarum bv. viciae mutants unable to transport branched-chain amino acids via the two main amino acid ABC transport complexes AapJQMP and BraDEFGC produce a nitrogen starvation phenotype when inoculated on pea (Pisum sativum) plants [1,2]. Bacteroids in indeterminate pea nodules have reduced abundance and a lower chromosome number. They reduce transcription of pathways for branched-chain amino acid biosynthesis and become dependent on their provision by the host. This has been called "symbiotic auxotrophy''. Methodology/Principal Findings: A region important in solute specificity was identified in AapQ and changing P144D in this region reduced branched-chain amino acid transport to a very low rate. Strains carrying P144D were still fully effective for N(2) fixation on peas demonstrating that a low rate of branched amino acid transport in R. leguminosarum bv. viciae supports wild-type rates of nitrogen fixation. The importance of branched-chain amino acid transport was then examined in other legume-Rhizobium symbioses. An aap bra mutant of R. leguminosarum bv. phaseoli also showed nitrogen starvation symptoms when inoculated on French bean (Phaseolus vulgaris), a plant producing determinate nodules. The phenotype is different from that observed on pea and is accompanied by reduced nodule numbers and nitrogen fixation per nodule. However, an aap bra double mutant of Sinorhizobium meliloti 2011 showed no phenotype on alfalfa (Medicago sativa). Conclusions/Significance: Symbiotic auxotrophy occurs in both determinate pea and indeterminate bean nodules demonstrating its importance for bacteroid formation and nodule function in legumes with different developmental programmes. However, only small quantities of branched chain amino acids are needed and symbiotic auxotrophy did not occur in the Sinorhizobium meliloti-alfalfa symbiosis under the conditions measured. The contrasting symbiotic phenotypes of aap bra mutants inoculated on different legumes probably reflects altered timing of amino acid availability, development of symbiotic auxotrophy and nodule developmental programmes.	[Prell, Jurgen; Bourdes, Alexandre; Poole, Philip] John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England; [Kumar, Shalini; Lodwig, Emma; Hosie, Arthur; Kinghorn, Seonag; White, James] Univ Reading, Sch Biol Sci, Reading, Berks, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Reading	Prell, J (corresponding author), John Innes Ctr Plant Sci Res, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	philip.poole@bbsrc.ac.uk	Hosie, Arthur/J-9615-2012	Hosie, Arthur/0000-0002-1327-7901; Lodwig, Emma/0000-0001-6941-7996	Biotechnology and Biological Sciences Research Council UK [BB/F013159/1]; BBSRC [BB/F013159/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F013159/1, BB/C517025/1, BB/C517025/2, BBS/B/02916] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council UK (http://www.bbsrc.ac.uk/) with grant no BB/F013159/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi H, 2002, P NATL ACAD SCI USA, V99, P3695, DOI 10.1073/pnas.062526999; Allaway D, 2000, MOL MICROBIOL, V36, P508, DOI 10.1046/j.1365-2958.2000.01884.x; Barnett MJ, 2004, P NATL ACAD SCI USA, V101, P16636, DOI 10.1073/pnas.0407269101; Becker A, 2004, MOL PLANT MICROBE IN, V17, P292, DOI 10.1094/MPMI.2004.17.3.292; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Capela D, 2006, MOL PLANT MICROBE IN, V19, P363, DOI 10.1094/MPMI-19-0363; DOWNIE JA, 1983, MOL GEN GENET, V190, P359, DOI 10.1007/BF00331059; FELLAY R, 1987, GENE, V52, P147, DOI 10.1016/0378-1119(87)90041-2; FINAN TM, 1983, J BACTERIOL, V154, P1403, DOI 10.1128/JB.154.3.1403-1413.1983; FREIDMAN AM, 1982, GENE, V18, P289; Gage DJ, 2004, MICROBIOL MOL BIOL R, V68, P280, DOI 10.1128/MMBR.68.2.280-300.2004; HIRSCH PR, 1984, PLASMID, V12, P139, DOI 10.1016/0147-619X(84)90059-3; Hosie AHF, 2002, J BACTERIOL, V184, P4071, DOI 10.1128/JB.184.15.4071-4080.2002; Hosie AHF, 2001, MOL MICROBIOL, V40, P1449, DOI 10.1046/j.1365-2958.2001.02497.x; JOHNSTON AWB, 1975, J GEN MICROBIOL, V87, P343, DOI 10.1099/00221287-87-2-343; Karunakaran R, 2009, J BACTERIOL, V191, P4002, DOI 10.1128/JB.00165-09; LAMB JW, 1982, MOL GEN GENET, V186, P449, DOI 10.1007/BF00729468; Lodwig E, 2003, CRIT REV PLANT SCI, V22, P37, DOI 10.1080/713610850; Lodwig EM, 2003, NATURE, V422, P722, DOI 10.1038/nature01527; Lodwig EM, 2005, MOL PLANT MICROBE IN, V18, P67, DOI 10.1094/MPMI-18-0067; Mergaert P, 2006, P NATL ACAD SCI USA, V103, P5230, DOI 10.1073/pnas.0600912103; NEWTON WE, 2000, NITROGEN FIXATION MO, P3; Oldroyd GED, 2008, ANNU REV PLANT BIOL, V59, P519, DOI 10.1146/annurev.arplant.59.032607.092839; Oono R, 2010, NEW PHYTOL, V187, P508, DOI 10.1111/j.1469-8137.2010.03261.x; Pessi G, 2007, MOL PLANT MICROBE IN, V20, P1353, DOI 10.1094/MPMI-20-11-1353; Pobigaylo N, 2006, APPL ENVIRON MICROB, V72, P4329, DOI 10.1128/AEM.03072-05; POOLE PS, 1994, MICROBIOL-SGM, V140, P2787, DOI 10.1099/00221287-140-10-2787; Prell J, 2006, TRENDS MICROBIOL, V14, P161, DOI 10.1016/j.tim.2006.02.005; Prell J, 2009, P NATL ACAD SCI USA, V106, P12477, DOI 10.1073/pnas.0903653106; Prell J, 2002, MICROBIOL-SGM, V148, P615, DOI 10.1099/00221287-148-2-615; QUANDT HJ, 1993, MOL PLANT MICROBE IN, V6, P699, DOI 10.1094/MPMI-6-699; QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6; RONSON CW, 1981, P NATL ACAD SCI-BIOL, V78, P4284, DOI 10.1073/pnas.78.7.4284; TRINICK MJ, 1976, NEW PHYTOL, V77, P359, DOI 10.1111/j.1469-8137.1976.tb01525.x; Van de Velde W, 2010, SCIENCE, V327, P1122, DOI 10.1126/science.1184057; Walshaw DL, 1997, FEBS LETT, V414, P397, DOI 10.1016/S0014-5793(97)01023-5; White J, 2007, PLANT PHYSIOL, V144, P604, DOI 10.1104/pp.107.097741	37	42	43	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e13933	10.1371/journal.pone.0013933	http://dx.doi.org/10.1371/journal.pone.0013933			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21085630	Green Published, Green Submitted, gold			2022-12-25	WOS:000284087800007
J	Tassie, JM; Malateste, K; Pujades-Rodriguez, M; Poulet, E; Bennett, D; Harries, A; Mahy, M; Schechter, M; Souteyrand, Y; Dabis, F				Tassie, Jean-Michel; Malateste, Karen; Pujades-Rodriguez, Mar; Poulet, Elisabeth; Bennett, Diane; Harries, Anthony; Mahy, Mary; Schechter, Mauro; Souteyrand, Yves; Dabis, Francois		IeDEA Collaboration; MSF Collaboration	Evaluation of Three Sampling Methods to Monitor Outcomes of Antiretroviral Treatment Programmes in Low- and Middle-Income Countries	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; SUB-SAHARAN AFRICA; PATIENT RETENTION; THERAPY PROGRAMS; FOLLOW-UP; EXPERIENCE; MORTALITY; COVERAGE; QUALITY; TRENDS	Background: Retention of patients on antiretroviral therapy (ART) over time is a proxy for quality of care and an outcome indicator to monitor ART programs. Using existing databases (Antiretroviral in Lower Income Countries of the International Databases to Evaluate AIDS and Medecins Sans Frontieres),we evaluated three sampling approaches to simplify the generation of outcome indicators. Methods and Findings: We used individual patient data from 27 ART sites and included 27,201 ART-naive adults (>= 15 years) who initiated ART in 2005. For each site, we generated two outcome indicators at 12 months, retention on ART and proportion of patients lost to follow-up (LFU), first using all patient data and then within a smaller group of patients selected using three sampling methods (random, systematic and consecutive sampling). For each method and each site, 500 samples were generated, and the average result was compared with the unsampled value. The 95% sampling distribution (SD) was expressed as the 2.5(th) and 97.5(th) percentile values from the 500 samples. Overall, retention on ART was 76.5% (range 58.9-88.6) and the proportion of patients LFU, 13.5% (range 0.8-31.9). Estimates of retention from sampling (n = 5696) were 76.5% (SD 75.4-77.7) for random, 76.5% (75.3-77.5) for systematic and 76.0% (74.1-78.2) for the consecutive method. Estimates for the proportion of patients LFU were 13.5% (12.6-14.5), 13.5% (12.6-14.3) and 14.0% (12.5-15.5), respectively. With consecutive sampling, 50% of sites had SD within +/- 5% of the unsampled site value. Conclusions: Our results suggest that random, systematic or consecutive sampling methods are feasible for monitoring ART indicators at national level. However, sampling may not produce precise estimates in some sites.	[Tassie, Jean-Michel; Souteyrand, Yves] WHO, Dept HIV AIDS, CH-1211 Geneva, Switzerland; [Malateste, Karen; Dabis, Francois] Univ Victor Segalen, INSERM, U857, Bordeaux, France; [Malateste, Karen; Dabis, Francois] Univ Victor Segalen, ISPED, Bordeaux, France; [Pujades-Rodriguez, Mar; Poulet, Elisabeth] Epictr, Paris, France; [Bennett, Diane] Ctr Dis Control & Prevent, Atlanta, GA USA; [Harries, Anthony] Int Union TB & Lung Dis, Paris, France; [Harries, Anthony] London Sch Hyg & Trop Med, London WC1, England; [Mahy, Mary] Joint United Nat Programme HIV AIDS UNAIDS, Geneva, Switzerland; [Schechter, Mauro] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil	World Health Organization; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Centers for Disease Control & Prevention - USA; University of London; London School of Hygiene & Tropical Medicine; UNAIDS; Universidade Federal do Rio de Janeiro	Tassie, JM (corresponding author), WHO, Dept HIV AIDS, CH-1211 Geneva, Switzerland.	tassiej@who.int	Schechter, Mauro/AAG-7445-2020; Pujades-Rodriguez, Mar/G-4388-2014; DABIS, FRANCOIS/S-9298-2019; Pujades-Rodriguez, Mar/T-1129-2018	Pujades-Rodriguez, Mar/0000-0002-7778-3520; DABIS, FRANCOIS/0000-0002-1614-8857; Pujades-Rodriguez, Mar/0000-0002-1375-1028	World Health Organisation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069924] Funding Source: NIH RePORTER	World Health Organisation(World Health Organization); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this collaborative analysis using existing databases was provided by the World Health Organisation. The World Health Organisation participated in study design, data analysis, decision to publish, and preparation of the manuscript.	Alemayehu YK, 2009, INT J QUAL HEALTH C, V21, P356, DOI 10.1093/intqhc/mzp030; Bennett DE, 2008, ANTIVIR THER, V13, P1; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Cornell M, 2010, AIDS, V24, P2263, DOI 10.1097/QAD.0b013e32833d45c5; Dabis F, 2005, INT J EPIDEMIOL, V34, P979, DOI 10.1093/ije/dyi164; Douglas GP, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000319; Forster M, 2008, B WORLD HEALTH ORGAN, V86, P939, DOI 10.2471/BLT.07.049908; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Geng EH, 2008, JAMA-J AM MED ASSOC, V300, P506, DOI 10.1001/jama.300.5.506; Harries AD, 2010, TROP MED INT HEALTH, V15, P70, DOI 10.1111/j.1365-3156.2010.02506.x; HENDERSON RH, 1982, B WORLD HEALTH ORGAN, V60, P253; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2009, MON DECL COMM HIV AI; Mahy M, 2010, CURR OPIN HIV AIDS, V5, P97, DOI 10.1097/COH.0b013e328333b892; O'Brien DP, 2007, CLIN INFECT DIS, V44, P1245, DOI 10.1086/513433; Pujades-Rodriguez M, 2008, AIDS, V22, P1305, DOI 10.1097/QAD.0b013e3282fa75b9; Tassie JM, 2010, JAIDS-J ACQ IMM DEF, V54, P437, DOI 10.1097/QAI.0b013e3181d73e1b; *UNAIDS, WHO AIDS EP UPD 09; *WHO, UNICEF UN ACC SCAL P; Yiannoutsos CT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003843	19	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e13899	10.1371/journal.pone.0013899	http://dx.doi.org/10.1371/journal.pone.0013899			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085709	gold, Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000284036800009
J	Mougi, A				Mougi, Akihiko			Coevolution in a One Predator-Two Prey System	PLOS ONE			English	Article							RED-QUEEN DYNAMICS; POPULATION-DYNAMICS; QUANTITATIVE TRAITS; CHARACTER SHIFTS; EVOLUTION; ECOSYSTEMS; ENRICHMENT; STABILITY; BEHAVIOR	Background: Our understanding of coevolution in a predator-prey system is based mostly on pair-wise interactions. Methodology and Principal Findings: Here I analyze a one-predator-two-prey system in which the predator's attack ability and the defense abilities of the prey all evolve. The coevolutionary consequences can differ dramatically depending on the initial trait value and the timing of the alternative prey's invasion into the original system. If the invading prey species has relatively low defense ability when it invades, its defense is likely to evolve to a lower level, stabilizing the population dynamics. In contrast, if when it invades its defense ability is close to that of the resident prey, its defense can evolve to a higher level and that of the resident prey may suddenly cease to evolve, destabilizing the population dynamics. Destabilization due to invasion is likely when the invading prey is adaptively superior (evolution of its defense is less constrained and fast), and it can also occur in a broad condition even when the invading prey is adaptively inferior. In addition, invasion into a resident system far from equilibrium characterized by population oscillations is likely to cause further destabilization. Conclusions and Significance: An invading prey species is thus likely to destabilize a resident community.	Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan	Kyushu University	Mougi, A (corresponding author), Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan.	mougi@bio-math10.biology.kyushu-u.ac.jp			Japan Society for the Promotion of Science [20*01655]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	A Grant-in-Aid for a Research Fellow from the Japan Society for the Promotion of Science and a Research Fellowship for Young Scientists (no. 20*01655) to A.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram PA, 2000, AM NAT, V156, pS45, DOI 10.1086/303415; ABRAMS P, 1993, EVOL ECOL, V7, P312, DOI 10.1007/BF01237749; ABRAMS PA, 1991, THEOR POPUL BIOL, V39, P241, DOI 10.1016/0040-5809(91)90022-8; Abrams PA, 1997, EVOL ECOL, V11, P1, DOI 10.1023/A:1018445517101; ABRAMS PA, 1993, EVOL ECOL, V7, P465, DOI 10.1007/BF01237642; Abrams PA, 2000, ANNU REV ECOL SYST, V31, P79, DOI 10.1146/annurev.ecolsys.31.1.79; Abrams PA, 2006, AM NAT, V168, P645, DOI 10.1086/507878; Dercole F, 2006, P ROY SOC B-BIOL SCI, V273, P983, DOI 10.1098/rspb.2005.3398; DERCOLE F, 2010, P R SOC B IN PRESS; DERUITER PC, 1995, SCIENCE, V269, P1257, DOI 10.1126/science.269.5228.1257; DIECKMANN U, 1995, J THEOR BIOL, V176, P91, DOI 10.1006/jtbi.1995.0179; FAGAN WF, 1994, ECOLOGY, V75, P2022, DOI 10.2307/1941607; Ferriere R, 2007, ECOL LETT, V10, P115, DOI 10.1111/j.1461-0248.2006.01008.x; Fussmann GF, 2007, FUNCT ECOL, V21, P465, DOI 10.1111/j.1365-2435.2007.01275.x; Futuyma D. J., 1998, EVOLUTIONARY BIOL; Genkai-Kato M, 2000, P ROY SOC B-BIOL SCI, V267, P2397, DOI 10.1098/rspb.2000.1297; JANZEN DH, 1980, EVOLUTION, V34, P611, DOI 10.1111/j.1558-5646.1980.tb04849.x; Kopp M, 2006, EVOLUTION, V60, P1321, DOI 10.1111/j.0014-3820.2006.tb01212.x; MARROW P, 1992, P ROY SOC B-BIOL SCI, V250, P133, DOI 10.1098/rspb.1992.0141; Mougi A, 2008, P ROY SOC B-BIOL SCI, V275, P2563, DOI 10.1098/rspb.2008.0889; Mougi A, 2010, P ROY SOC B-BIOL SCI, V277, P3163, DOI 10.1098/rspb.2010.0691; Mougi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006731; Nuismer SL, 2007, EVOLUTION, V61, P1823, DOI 10.1111/j.1558-5646.2007.00158.x; Nuismer SL, 2004, EVOLUTION, V58, P1165, DOI 10.1111/j.0014-3820.2004.tb01697.x; PAINE RT, 1992, NATURE, V355, P73, DOI 10.1038/355073a0; Raffaelli David G., 1996, P185; Thompson J. N., 2005, INTERSPEC INTERACT; Urban MC, 2008, TRENDS ECOL EVOL, V23, P311, DOI 10.1016/j.tree.2008.02.007; Vamosi SM, 2004, EVOLUTION, V58, P376, DOI 10.1111/j.0014-3820.2004.tb01653.x; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; WINEMILLER KO, 1990, ECOL MONOGR, V60, P331, DOI 10.2307/1943061; WOOTTON T, 1997, ECOL MONOGR, V67, P45; Yamauchi A, 2005, ECOLOGY, V86, P2513, DOI 10.1890/04-1524; Yoshida T, 2003, NATURE, V424, P303, DOI 10.1038/nature01767	34	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e13887	10.1371/journal.pone.0013887	http://dx.doi.org/10.1371/journal.pone.0013887			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085473	Green Published, Green Submitted, gold			2022-12-25	WOS:000284035900006
J	Martinez-Sanchez, JM; Fernandez, E; Fu, M; Gallus, S; Martinez, C; Sureda, X; La Vecchia, C; Clancy, L				Martinez-Sanchez, Jose M.; Fernandez, Esteve; Fu, Marcela; Gallus, Silvano; Martinez, Cristina; Sureda, Xisca; La Vecchia, Carlo; Clancy, Luke			Smoking Behaviour, Involuntary Smoking, Attitudes towards Smoke-Free Legislations, and Tobacco Control Activities in the European Union	PLOS ONE			English	Article							CONTROL POLICIES; FREE WORKPLACES; HEALTH; IMPACT	Background: The six most important cost-effective policies on tobacco control can be measured by the Tobacco Control Scale (TCS). The objective of our study was to describe the correlation between the TCS and smoking prevalence, self-reported exposure to secondhand smoke (SHS) and attitudes towards smoking restrictions in the 27 countries of the European Union (EU27). Methods/Principal Findings: Ecologic study in the EU27. We used data from the TCS in 2007 and from the Eurobarometer on Tobacco Survey in 2008. We analysed the relations between the TCS and prevalence of smoking, self-reported exposure to SHS (home and work), and attitudes towards smoking bans by means of scatter plots and Spearman rank-correlation coefficients (r(sp)). Among the EU27, smoking prevalence varied from 22.6% in Slovenia to 42.1% in Greece. Austria was the country with the lowest TCS score (35) and the UK had the highest one (93). The correlation between smoking prevalence and TCS score was negative (r(sp) = -0.42, p = 0.03) and the correlation between TCS score and support to smoking bans in all workplaces was positive (r(sp) = 0.47, p = 0.01 in restaurants; r(sp) = 0.5, p = 0.008 in bars, pubs, and clubs; and r(sp) = 0.31, p = 0.12 in other indoor workplaces). The correlation between TCS score and self-reported exposure to SHS was negative, but statistically non-significant. Conclusions/Significance: Countries with a higher score in the TCS have higher support towards smoking bans in all workplaces (including restaurants, bars, pubs and clubs, and other indoor workplaces). TCS scores were strongly, but not statistically, associated with a lower prevalence of smokers and a lower self-reported exposure to SHS.	[Martinez-Sanchez, Jose M.; Fernandez, Esteve; Fu, Marcela; Martinez, Cristina; Sureda, Xisca] ICO, Tobacco Control Unit, Barcelona, Spain; [Martinez-Sanchez, Jose M.; Fernandez, Esteve; Fu, Marcela; Martinez, Cristina; Sureda, Xisca] Univ Barcelona, Dept Clin Sci, Sch Med, Barcelona, Spain; [Martinez-Sanchez, Jose M.; Fernandez, Esteve; Fu, Marcela; Martinez, Cristina; Sureda, Xisca] Inst Invest Biomed Bellvitge IDIBELL, Canc Prevent & Control Grp, Barcelona, Spain; [Gallus, Silvano; La Vecchia, Carlo] Ist Ric Farmacol Mario Negri, Dept Epidemiol, Milan, Italy; [La Vecchia, Carlo] Univ Milan, Sch Med, Dept Occupat Med, Milan, Italy; [Clancy, Luke] Tobacco Free Res Inst, Dublin, Ireland	University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Milan	Martinez-Sanchez, JM (corresponding author), ICO, Tobacco Control Unit, Barcelona, Spain.	efernandez@iconcologia.net	Fernandez, Esteve/A-9750-2008; Martínez-Sánchez, Jose M/ABH-3093-2020; Clancy, Luke/O-6597-2019; clancy, luke/ABA-1826-2020; Martinez, Cristina/AAG-4172-2020; Martínez-Sánchez, Jose/AAA-6343-2019; Martínez, Cristina/H-6103-2017; Gallus, Silvano/AAB-4127-2019	Fernandez, Esteve/0000-0003-4239-723X; Martínez-Sánchez, Jose M/0000-0002-9632-5701; Clancy, Luke/0000-0003-2407-2263; Martinez, Cristina/0000-0002-0108-3288; Martínez, Cristina/0000-0002-0108-3288; Gallus, Silvano/0000-0002-8967-0400; Sureda Llull, Francisca/0000-0002-6262-2257; Fu, Marcela/0000-0002-4962-0927; La Vecchia, Carlo/0000-0003-1441-897X	Instituto de Salud Carlos III (the Thematic Network of Cooperative Research on Cancer), Government of Spain [RD06/0020/0089]; Ministry of Universities and Research, Government of Catalonia [2009SGR192]; Escuela Nacional de Sanidad; University of Barcelona	Instituto de Salud Carlos III (the Thematic Network of Cooperative Research on Cancer), Government of Spain(Instituto de Salud Carlos III); Ministry of Universities and Research, Government of Catalonia; Escuela Nacional de Sanidad; University of Barcelona	This project was funded by the Instituto de Salud Carlos III (the Thematic Network of Cooperative Research on Cancer, RD06/0020/0089) from the Government of Spain; the Ministry of Universities and Research (2009SGR192), Government of Catalonia; the "V Ayuda Enrique Najera para jovenes epidemiologos'' of the Spanish Society of Epidemiology funded by the Escuela Nacional de Sanidad; and a grant for short pre-doctoral research stays from the University of Barcelona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, LANCET, V365, P1282; Callinan JE, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005992.pub2; Chapman S, 1999, AM J PUBLIC HEALTH, V89, P1018, DOI 10.2105/AJPH.89.7.1018; Chapman S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000216; Diez-Roux AV, 2000, ANNU REV PUBL HEALTH, V21, P171, DOI 10.1146/annurev.publhealth.21.1.171; Fichtenberg CM, 2002, BMJ-BRIT MED J, V325, P188, DOI 10.1136/bmj.325.7357.188; Fong GT, 2006, TOB CONTROL, V15, P3, DOI 10.1136/tc.2005.015438; *GALL ORG EUR COMM, 2009, FLASH EUR, V253; Gallus S, 2007, PREV MED, V45, P198, DOI 10.1016/j.ypmed.2007.03.009; GOODMAN P, 2009, INT J PUBLIC HLTH; Gorber SC, 2009, NICOTINE TOB RES, V11, P12, DOI 10.1093/ntr/ntn010; HILTON S, 2007, BMC PUBLIC HEALTH, V7, pNIL1; Hublet A, 2009, ADDICTION, V104, P1918, DOI 10.1111/j.1360-0443.2009.02686.x; IARC Working Group, 2009, IARC HDB CANC PREV T, P13; Jaakkola MS, 2006, EUR RESPIR J, V28, P397, DOI 10.1183/09031936.06.00001306; Joossens L, 2006, TOB CONTROL, V15, P247, DOI 10.1136/tc.2005.015347; JOOSSENS L, PROGR TOB CONTR 30 E; Lopez AD, 1994, TOB CONTROL, V3, P242, DOI [DOI 10.1136/TC.3.3.242, 10.1136/tc.3.3.242]; Martinez-Sanchez JM, 2010, GAC SANIT, V24, P241, DOI 10.1016/j.gaceta.2010.02.007; Muggli ME, 2010, TOB CONTROL, V19, P24, DOI 10.1136/tc.2009.031831; Pursell L, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-131; Schaap MM, 2008, TOB CONTROL, V17, P248, DOI 10.1136/tc.2007.024265; Sebrie EM, 2007, TOB CONTROL, V16, DOI 10.1136/tc.2006.018275; Thyrian JR, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-2; U. S. Department of Health and Human Services, 2006, HLTH CONS INV EXP TO; US Department of Health and Human Services, 2004, HLTH CONS SMOK; West R, 2010, ADDICTION, V105, P1867, DOI 10.1111/j.1360-0443.2010.03111.x; *WHO, 2008, MPOWER; WHO, PART WHO FRAM CONV T; *WORLD BANK, 2003, TOB CONTR GLANC	30	63	63	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e13881	10.1371/journal.pone.0013881	http://dx.doi.org/10.1371/journal.pone.0013881			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	676NU	21079729	Green Published, Green Submitted, gold			2022-12-25	WOS:000283920000014
J	Zhang, L; Pei, YF; Li, JA; Papasian, CJ; Deng, HW				Zhang, Lei; Pei, Yu-Fang; Li, Jian; Papasian, Christopher J.; Deng, Hong-Wen			Improved Detection of Rare Genetic Variants for Diseases	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; FREQUENCY-SPECTRUM; COMMON DISEASES; GENOME; ASSOCIATION; POWER; DISCOVERY; ELEMENTS; DATABASE; ALLELES	Technology advances have promoted gene-based sequencing studies with the aim of identifying rare mutations responsible for complex diseases. A complication in these types of association studies is that the vast majority of non-synonymous mutations are believed to be neutral to phenotypes. It is thus critical to distinguish potential causative variants from neutral variation before performing association tests. In this study, we used existing predicting algorithms to predict functional amino acid substitutions, and incorporated that information into association tests. Using simulations, we comprehensively studied the effects of several influential factors, including the sensitivity and specificity of functional variant predictions, number of variants, and proportion of causative variants, on the performance of association tests. Our results showed that incorporating information regarding functional variants obtained from existing prediction algorithms improves statistical power under certain conditions, particularly when the proportion of causative variants is moderate. The application of the proposed tests to a real sequencing study confirms our conclusions. Our work may help investigators who are planning to pursue gene-based sequencing studies.	[Zhang, Lei; Pei, Yu-Fang; Deng, Hong-Wen] Shanghai Univ Sci & Technol, Ctr Syst Biomed Sci, Shanghai 201800, Peoples R China; [Zhang, Lei; Pei, Yu-Fang] Xi An Jiao Tong Univ, Key Lab Biomed Informat Engn, Sch Life Sci & Technol, Minist Educ, Xian 710049, Shaanxi, Peoples R China; [Zhang, Lei; Pei, Yu-Fang] Xi An Jiao Tong Univ, Inst Mol Genet, Xian 710049, Shaanxi, Peoples R China; [Li, Jian; Papasian, Christopher J.; Deng, Hong-Wen] Univ Missouri, Sch Med, Kansas City, MO 64108 USA; [Deng, Hong-Wen] Beijing Jiao Tong Univ, Coll Life Sci & Engn, Beijing, Peoples R China	University of Shanghai for Science & Technology; Xi'an Jiaotong University; Xi'an Jiaotong University; University of Missouri System; University of Missouri Kansas City; Beijing Jiaotong University	Zhang, L (corresponding author), Shanghai Univ Sci & Technol, Ctr Syst Biomed Sci, Shanghai 201800, Peoples R China.	dengh@umkc.edu	Li, Jian/G-4445-2015; Zhang, Lei/L-1016-2016	Zhang, Lei/0000-0002-1007-4834; Deng, Hong-Wen/0000-0002-0387-8818	Xi'an Jiaotong University; National Science Foundation of China; Huo Ying Dong Education Foundation, Hunan Province; Ministry of Education of China; National Institutes of Health [R01 AR050496, R21 AG027110, R01 AG026564, P50 AR055081, R21 AA015973]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057049, P50AR055081, R01AR050496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026564, R21AG027110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA015973] Funding Source: NIH RePORTER	Xi'an Jiaotong University(Xi'an Jiaotong University); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Huo Ying Dong Education Foundation, Hunan Province; Ministry of Education of China(Ministry of Education, China); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The study was partially supported by Xi'an Jiaotong University. The investigators of this work also benefited from support of the grants from the National Science Foundation of China, National Institutes of Health (R01 AR050496, R21 AG027110, R01 AG026564, P50 AR055081 and R21 AA015973), Huo Ying Dong Education Foundation, Hunan Province, and the Ministry of Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AM, 2004, GENETICS, V168, P1699, DOI 10.1534/genetics.104.030171; Ahituv N, 2007, PLOS BIOL, V5, P1906, DOI 10.1371/journal.pbio.0050234; Ahituv N, 2007, AM J HUM GENET, V80, P779, DOI 10.1086/513471; Asthana S, 2007, PLOS COMPUT BIOL, V3, P2559, DOI 10.1371/journal.pcbi.0030254; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Chakravarti A, 1999, NAT GENET, V21, P56, DOI 10.1038/4482; Chang HG, 2001, BIOCHEM BIOPH RES CO, V287, P288, DOI 10.1006/bbrc.2001.5576; Chen GK, 2007, AM J HUM GENET, V81, P397, DOI 10.1086/519794; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Ferrer-Costa C, 2005, BIOINFORMATICS, V21, P3176, DOI 10.1093/bioinformatics/bti486; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Genovese CR, 2006, BIOMETRIKA, V93, P509, DOI 10.1093/biomet/93.3.509; Gorlov IP, 2008, AM J HUM GENET, V82, P100, DOI 10.1016/j.ajhg.2007.09.006; Hindorff LA, 2009, CATALOG PUBLISHED GE; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Kryukov GV, 2009, P NATL ACAD SCI USA, V106, P3871, DOI 10.1073/pnas.0812824106; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li BS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000481; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Marth GT, 2004, GENETICS, V166, P351, DOI 10.1534/genetics.166.1.351; Mooney SD, 2003, BIOINFORMATICS, V19, P1858, DOI 10.1093/bioinformatics/btg241; Morgenthaler S, 2007, MUTAT RES-FUND MOL M, V615, P28, DOI 10.1016/j.mrfmmm.2006.09.003; Ng PC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000160; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; NG SB, 2009, NATURE; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Reumers J, 2005, NUCLEIC ACIDS RES, V33, pD527; Reumers J, 2006, BIOINFORMATICS, V22, P2183, DOI 10.1093/bioinformatics/btl348; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Roeder K, 2006, AM J HUM GENET, V78, P243, DOI 10.1086/500026; Roeder K, 2007, GENET EPIDEMIOL, V31, P741, DOI 10.1002/gepi.20237; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Siva Nayanah, 2008, Nat Biotechnol, V26, P256, DOI 10.1038/nbt0308-256b; Stitziel NO, 2004, NUCLEIC ACIDS RES, V32, pD520, DOI 10.1093/nar/gkh104; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Sunyaev SR, 1999, PROTEIN ENG, V12, P387, DOI 10.1093/protein/12.5.387; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Tucker T, 2009, AM J HUM GENET, V85, P142, DOI 10.1016/j.ajhg.2009.06.022; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Yue P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-166	48	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e13857	10.1371/journal.pone.0013857	http://dx.doi.org/10.1371/journal.pone.0013857			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	676NU	21079782	gold, Green Submitted, Green Published			2022-12-25	WOS:000283920000002
J	Manetti, AGO; Koeller, T; Becherelli, M; Buccato, S; Kreikemeyer, B; Podbielski, A; Grandi, G; Margarit, I				Manetti, Andrea G. O.; Koeller, Thomas; Becherelli, Marco; Buccato, Scilla; Kreikemeyer, Bernd; Podbielski, Andreas; Grandi, Guido; Margarit, Immaculada			Environmental Acidification Drives S. pyogenes Pilus Expression and Microcolony Formation on Epithelial Cells in a FCT-Dependent Manner	PLOS ONE			English	Article							GROUP-A STREPTOCOCCUS; VIRULENCE GENE-EXPRESSION; GROUP-B STREPTOCOCCUS; STAPHYLOCOCCUS-AUREUS; FIBRONECTIN-BINDING; BIOFILM FORMATION; PATHOGENICITY REGION; REGULATORY NETWORKS; SEROTYPE M49; T-ANTIGENS	Group A Streptococcus (GAS, Streptococcus pyogenes) is a Gram-positive human pathogen responsible for a diverse variety of diseases, including pharyngitis, skin infections, invasive necrotizing fasciitis and autoimmune sequelae. We have recently shown that GAS cell adhesion and biofilm formation is associated with the presence of pili on the surface of these bacteria. GAS pilus proteins are encoded in the FCT (Fibronectin- Collagen-T antigen) genomic region, of which nine different variants have been identified so far. In the present study we undertook a global analysis of GAS isolates representing the majority of FCT-variants to investigate the effect of environmental growth conditions on their capacity to form multicellular communities. For FCT-types 2, 3, 5 and 6 and a subset of FCT-4 strains, we observed that acidification resulting from fermentative sugar metabolism leads to an increased ability of the bacteria to form biofilm on abiotic surfaces and microcolonies on epithelial cells. The higher biofilm forming capacity at low environmental pH was directly associated with an enhanced expression of the genes encoding the pilus components and of their transcription regulators. The data indicate that environmental pH affects the expression of most pilus types and thereby the formation of multicellular cell-adhering communities that assist the initial steps of GAS infection.	[Manetti, Andrea G. O.; Becherelli, Marco; Buccato, Scilla; Grandi, Guido; Margarit, Immaculada] Novartis Vaccines & Diagnost, Siena, Italy; [Koeller, Thomas; Kreikemeyer, Bernd; Podbielski, Andreas] Inst Med Microbiol Virol & Hyg, Rostock, Germany	Novartis	Manetti, AGO (corresponding author), Novartis Vaccines & Diagnost, Siena, Italy.	immaculada.margarit_y_ros@novartis.com		Grandi, Guido/0000-0001-9724-2185; Kreikemeyer, Bernd/0000-0001-9527-5098	Univerity of Bologna; Medical Faculty of the University of Rostock, Germany; Novartis Vaccines and Diagnostics	Univerity of Bologna; Medical Faculty of the University of Rostock, Germany; Novartis Vaccines and Diagnostics	Funding: M. B. is a recipient of a Novartis fellowship from the PhD program in cellular, molecular and industrial biology of the Univerity of Bologna. T. K. and B. K. acknowledge support by the 2008 FORUN program of the Medical Faculty of the University of Rostock, Germany. This work was funded by Novartis Vaccines and Diagnostics. The funders had a role in study design, data collection and analysis, preparation of the manuscript and decision to publish.	Abbot EL, 2007, CELL MICROBIOL, V9, P1822, DOI 10.1111/j.1462-5822.2007.00918.x; Akiyama H, 2003, J DERMATOL SCI, V32, P193, DOI 10.1016/S0923-1811(03)00096-3; Baldassarri L, 2006, J CLIN MICROBIOL, V44, P2721, DOI 10.1128/JCM.00512-06; Beckert S, 2001, INFECT IMMUN, V69, P534, DOI 10.1128/IAI.69.1.534-537.2001; Beenken KE, 2004, J BACTERIOL, V186, P4665, DOI 10.1128/JB.186.14.4665-4684.2004; Bessen DE, 2005, J BACTERIOL, V187, P4163, DOI 10.1128/JB.187.12.4163-4172.2005; Bessen DE, 2002, INFECT IMMUN, V70, P1159, DOI 10.1128/IAI.70.3.1159-1167.2002; Buccato S, 2006, J INFECT DIS, V194, P331, DOI 10.1086/505433; Cho KH, 2005, MOL MICROBIOL, V57, P1545, DOI 10.1111/j.1365-2958.2005.04786.x; Courtney HS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004166; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Dalton TL, 2004, J BACTERIOL, V186, P3928, DOI 10.1128/JB.186.12.3928-3937.2004; Dong YM, 1999, CARIES RES, V33, P428, DOI 10.1159/000016547; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Edwards AM, 2008, MOL MICROBIOL, V68, P1378, DOI 10.1111/j.1365-2958.2008.06220.x; Ehlers C, 2001, SKIN RES TECHNOL, V7, P90, DOI 10.1034/j.1600-0846.2001.70206.x; Falugi F, 2008, J INFECT DIS, V198, P1834, DOI 10.1086/593176; FOGG GC, 1994, MOL MICROBIOL, V11, P671, DOI 10.1111/j.1365-2958.1994.tb00345.x; Fogg GC, 1997, J BACTERIOL, V179, P6172, DOI 10.1128/jb.179.19.6172-6180.1997; Froehlich BJ, 2009, J BACTERIOL, V191, P673, DOI 10.1128/JB.01256-08; Granok AB, 2000, J BACTERIOL, V182, P1529, DOI 10.1128/JB.182.6.1529-1540.2000; Gryllos I, 2007, MOL MICROBIOL, V65, P671, DOI 10.1111/j.1365-2958.2007.05818.x; Hamilton IR, 1998, ORAL MICROBIOL IMMUN, V13, P292, DOI 10.1111/j.1399-302X.1998.tb00710.x; Hanski E, 1996, ADV EXP MED BIOL, V408, P141; KOLLER T, J MED MICROBIOL, V59, P442; Kratovac Z, 2007, J BACTERIOL, V189, P1299, DOI 10.1128/JB.01301-06; Kreikemeyer B, 2004, J BIOL CHEM, V279, P15850, DOI 10.1074/jbc.M313613200; Kreikemeyer B, 2003, TRENDS MICROBIOL, V11, P224, DOI 10.1016/S0966-842X(03)00098-2; Kreikemeyer B, 2007, INFECT IMMUN, V75, P5698, DOI 10.1128/IAI.00175-07; Li LP, 2002, P NATL ACAD SCI USA, V99, P12369, DOI 10.1073/pnas.192439499; Lizano S, 2007, J BACTERIOL, V189, P1426, DOI 10.1128/JB.01179-06; Loughman JA, 2006, J BACTERIOL, V188, P399, DOI 10.1128/JB.188.2.399-408.2006; Luo F, 2008, INFECT IMMUN, V76, P2490, DOI 10.1128/IAI.01567-07; Lyon WR, 1998, EMBO J, V17, P6263, DOI 10.1093/emboj/17.21.6263; Manetti AGO, 2007, MOL MICROBIOL, V64, P968, DOI 10.1111/j.1365-2958.2007.05704.x; Marsh Philip D, 2006, BMC Oral Health, V6 Suppl 1, pS14, DOI 10.1186/1472-6831-6-S1-S14; Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102; Moscoso M, 2006, J BACTERIOL, V188, P7785, DOI 10.1128/JB.00673-06; Musser JM, 2009, J CLIN INVEST, V119, P2455, DOI 10.1172/JCI38095; Nakata M, 2005, MOL MICROBIOL, V57, P786, DOI 10.1111/j.1365-2958.2005.04730.x; Nakata M, 2009, INFECT IMMUN, V77, P32, DOI 10.1128/IAI.00772-08; Neely MN, 2002, INFECT IMMUN, V70, P3904, DOI 10.1128/IAI.70.7.3904-3914.2002; O'Neill E, 2008, J BACTERIOL, V190, P3835, DOI 10.1128/JB.00167-08; Perez JC, 2007, MOL MICROBIOL, V63, P283, DOI 10.1111/j.1365-2958.2006.05512.x; Pflock M, 2006, J BIOTECHNOL, V126, P52, DOI 10.1016/j.jbiotec.2006.03.045; Podbielski A, 1999, MOL MICROBIOL, V31, P1051, DOI 10.1046/j.1365-2958.1999.01241.x; REGASSA LB, 1992, INFECT IMMUN, V60, P3381, DOI 10.1128/IAI.60.8.3381-3388.1992; Rice KC, 2005, J BACTERIOL, V187, P813, DOI 10.1128/JB.187.3.813-821.2005; Rippke F, 2004, AM J CLIN DERMATOL, V5, P217, DOI 10.2165/00128071-200405040-00002; Rippke Frank, 2002, Am J Clin Dermatol, V3, P261, DOI 10.2165/00128071-200203040-00004; Rosch JW, 2008, INFECT IMMUN, V76, P3187, DOI 10.1128/IAI.00054-08; Santi I, 2009, J BACTERIOL, V191, P5387, DOI 10.1128/JB.00370-09; Shelburne SA, 2008, P NATL ACAD SCI USA, V105, P1698, DOI 10.1073/pnas.0711767105; Simmen HP, 1995, J HAND SURG-BRIT EUR, V20B, P797, DOI 10.1016/S0266-7681(95)80050-6; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Weinrick B, 2004, J BACTERIOL, V186, P8407, DOI 10.1128/JB.186.24.8407-8423.2004	56	46	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2010	5	11							e13864	10.1371/journal.pone.0013864	http://dx.doi.org/10.1371/journal.pone.0013864			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675OD	21079780	Green Submitted, gold, Green Published			2022-12-25	WOS:000283839100016
J	Zhuang, J; Cai, GQ; Lin, QY; Wu, ZJ; Xie, LH				Zhuang, Jun; Cai, Guiqin; Lin, Qiying; Wu, Zujian; Xie, Lianhui			A Bacteriophage-Related Chimeric Marine Virus Infecting Abalone	PLOS ONE			English	Article							HALIOTIS-TUBERCULATA; HEMOCYANIN; GENOME; ORGANIZATION; SUBUNITS; SEQUENCE; HTH1	Marine viruses shape microbial communities with the most genetic diversity in the sea by multiple genetic exchanges and infect multiple marine organisms. Here we provide proof from experimental infection that abalone shriveling syndrome-associated virus (AbSV) can cause abalone shriveling syndrome. This malady produces histological necrosis and abnormally modified macromolecules (hemocyanin and ferritin). The AbSV genome is a 34.952-kilobase circular double-stranded DNA, containing putative genes with similarity to bacteriophages, eukaryotic viruses, bacteria and endosymbionts. Of the 28 predicted open reading frames (ORFs), eight ORF-encoded proteins have identifiable functional homologues. The 4 ORF products correspond to a predicted terminase large subunit and an endonuclease in bacteriophage, and both an integrase and an exonuclease from bacteria. The other four proteins are homologous to an endosymbiont-derived helicase, primase, single-stranded binding (SSB) protein, and thymidylate kinase, individually. Additionally, AbSV exhibits a common gene arrangement similar to the majority of bacteriophages. Unique to AbSV, the viral genome also contains genes associated with bacterial outer membrane proteins and may lack the structural protein-encoding ORFs. Genomic characterization of AbSV indicates that it may represent a transitional form of microbial evolution from viruses to bacteria.	[Zhuang, Jun; Cai, Guiqin; Lin, Qiying; Wu, Zujian; Xie, Lianhui] Fujian Agr & Forestry Univ, Inst Plant Virol, Key Lab Plant Virol Fujian Prov, Fuzhou, Peoples R China; [Zhuang, Jun; Lin, Qiying; Wu, Zujian; Xie, Lianhui] Fujian Agr & Forestry Univ, Key Lab Biopesticide & Chem Biol, Fuzhou, Peoples R China; [Zhuang, Jun; Lin, Qiying; Wu, Zujian; Xie, Lianhui] Minist Educ, Fuzhou, Peoples R China	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University	Zhuang, J (corresponding author), Fujian Agr & Forestry Univ, Inst Plant Virol, Key Lab Plant Virol Fujian Prov, Fuzhou, Peoples R China.	wuzujian@126.com; fjxlh@126.com			National Natural Science Foundations of China [30671357]; Fujian Provincial Department of Science and Technology [2006NZ0002-2]; Natural Science Foundation of Fujian Province, China [2010J01073]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Fujian Provincial Department of Science and Technology; Natural Science Foundation of Fujian Province, China(Natural Science Foundation of Fujian Province)	Funding: This work was supported by the National Natural Science Foundations of China 30671357 to L. H. X., the Key Project of Fujian Provincial Department of Science and Technology 2006NZ0002-2 to Z.J.W. and the Natural Science Foundation of Fujian Province, China (Grant No. 2010J01073) to J.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGH O, 1989, NATURE, V340, P467, DOI 10.1038/340467a0; Bezier A, 2009, SCIENCE, V323, P926, DOI 10.1126/science.1166788; Boyer M, 2009, P NATL ACAD SCI USA, V106, P21848, DOI 10.1073/pnas.0911354106; COSTANZI C, 1987, METHOD ENZYMOL, V152, P582; De Zoysa M, 2007, FISH SHELLFISH IMMUN, V23, P624, DOI 10.1016/j.fsi.2007.01.013; DEUFF RML, 1999, J GEN VIROL, V80, P1317; Favoreel HW, 2005, P NATL ACAD SCI USA, V102, P8990, DOI 10.1073/pnas.0409099102; FELSENSTEIN J, 2007, PHYLIP PHYLOGENY INF; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Fuller DN, 2007, P NATL ACAD SCI USA, V104, P11245, DOI 10.1073/pnas.0701323104; GARDNER GR, 1995, J INVERTEBR PATHOL, V66, P111, DOI 10.1006/jipa.1995.1072; Harris JR, 1998, MICRON, V29, P329, DOI 10.1016/S0968-4328(98)00019-5; Harris JR, 2000, MICRON, V31, P1, DOI 10.1016/S0968-4328(99)00059-1; Hendrix RW, 1999, P NATL ACAD SCI USA, V96, P2192, DOI 10.1073/pnas.96.5.2192; Hertveldt K, 2005, J MOL BIOL, V354, P536, DOI 10.1016/j.jmb.2005.08.075; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Igakura T, 2003, SCIENCE, V299, P1713, DOI 10.1126/science.1080115; Keller H, 1999, EUR J BIOCHEM, V264, P27, DOI 10.1046/j.1432-1327.1999.00564.x; Kwan T, 2005, P NATL ACAD SCI USA, V102, P5174, DOI 10.1073/pnas.0501140102; La Scola B, 2008, NATURE, V455, P100, DOI 10.1038/nature07218; Lieb B, 1999, EUR J BIOCHEM, V265, P134, DOI 10.1046/j.1432-1327.1999.00694.x; Lieb B, 2001, P NATL ACAD SCI USA, V98, P4546, DOI 10.1073/pnas.071049998; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Macia L, 2006, J IMMUNOL, V177, P5997, DOI 10.4049/jimmunol.177.9.5997; Meissner U, 2000, J MOL BIOL, V298, P21, DOI 10.1006/jmbi.2000.3631; Meissner U, 2007, MICRON, V38, P754, DOI 10.1016/j.micron.2006.11.005; Mesyanzhinov VV, 2002, J MOL BIOL, V317, P1, DOI 10.1006/jmbi.2001.5396; Miller ES, 2003, MICROBIOL MOL BIOL R, V67, P86, DOI 10.1128/MMBR.67.1.86-156.2003; Newsome TP, 2004, SCIENCE, V306, P124, DOI 10.1126/science.1101509; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; PROCTOR LM, 1990, NATURE, V343, P60, DOI 10.1038/343060a0; Stothard P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/bioinformatics/bti054; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Swerdlow RD, 1996, COMP BIOCHEM PHYS B, V113, P537, DOI 10.1016/0305-0491(95)02091-8; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; XING RL, 2003, J DALIAN FISH U, V18, P191; YE L, 1997, J FISHERY SCI CHINA, V4, P43	38	15	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2010	5	11							e13850	10.1371/journal.pone.0013850	http://dx.doi.org/10.1371/journal.pone.0013850			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675OD	21079776	Green Submitted, Green Published, gold			2022-12-25	WOS:000283839100009
J	Sun, ZK; He, WM				Sun, Zhen-Kai; He, Wei-Ming			Evidence for Enhanced Mutualism Hypothesis: Solidago canadensis Plants from Regular Soils Perform Better	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; CENTAUREA-MACULOSA; INVASIVE PLANT; COMPETITIVE ABILITY; ROOT EXUDATE; BIOTA; GROWTH; CHINA; PRODUCTIVITY; COMMUNITIES	The important roles of plant-soil microbe interactions have been documented in exotic plant invasion, but we know very little about how soil mutualists enhance this process (i.e. enhanced mutualism hypothesis). To test this hypothesis we conducted two greenhouse experiments with Solidago canadensis (hereafter Solidago), an invasive forb from North America, and Stipa bungeana (hereafter Stipa), a native Chinese grass. In a germination experiment, we found soil microbes from the rhizospheres of Solidago and Stipa exhibited much stronger facilitative effects on emergence of Solidago than that of Stipa. In a growth and competition experiment, we found that soil microbes strongly facilitated Solidago to outgrow Stipa, and greatly increased the competitive effects of Solidago on Stipa but decreased the competitive effects of Stipa on Solidago. These findings from two experiments suggest that in situ soil microbes enhance the recruitment potential of Solidago and its ability to outcompete native plants, thereby providing strong evidence for the enhanced mutualism hypothesis. On the other hand, to some extent this outperformance of Solidago in the presence of soil microbes seems to be unbeneficial to control its rapid expansion, particularly in some ranges where this enhanced mutualism dominates over other mechanisms.	[Sun, Zhen-Kai; He, Wei-Ming] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS	He, WM (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	weiminghe@ibcas.ac.cn			National Natural Science Foundation of China [30770335]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The National Natural Science Foundation of China grant (30770335) to Dr. WM He funded this research. The website is www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhilasha D, 2008, J ECOL, V96, P993, DOI 10.1111/j.1365-2745.2008.01413.x; Armas C, 2004, ECOLOGY, V85, P2682, DOI 10.1890/03-0650; Bennett AE, 2007, ECOLOGY, V88, P210, DOI 10.1890/0012-9658(2007)88[210:MSDAPG]2.0.CO;2; Bray SR, 2003, ECOL APPL, V13, P565, DOI 10.1890/1051-0761(2003)013[0565:MDAGPA]2.0.CO;2; Cai Xiaobu, 2006, Yingyong Shengtai Xuebao, V17, P2121; Callaway RM, 2006, TRENDS ECOL EVOL, V21, P369, DOI 10.1016/j.tree.2006.04.008; Callaway RM, 2004, ECOLOGY, V85, P1062, DOI 10.1890/02-0775; Callaway RM, 2004, NATURE, V427, P731, DOI 10.1038/nature02322; Callaway RM, 2003, ECOLOGY, V84, P129, DOI 10.1890/0012-9658(2003)084[0129:SFATEO]2.0.CO;2; Cui QG, 2009, WEED RES, V49, P201, DOI 10.1111/j.1365-3180.2008.00679.x; Diez JM, 2010, ECOL LETT, V13, P803, DOI 10.1111/j.1461-0248.2010.01474.x; Donath TW, 2008, J ECOL, V96, P272, DOI 10.1111/j.1365-2745.2007.01338.x; Dong M, 2006, ACTA PHYTOTAXON SIN, V44, P72, DOI 10.1360/aps050068; *ED BOARD FLOR CHI, 1987, FLOR CHIN, V9; Facelli E, 2010, NEW PHYTOL, V185, P1050, DOI 10.1111/j.1469-8137.2009.03162.x; Fayolle A, 2009, OECOLOGIA, V159, P817, DOI 10.1007/s00442-008-1254-0; He WM, 2009, OECOLOGIA, V159, P803, DOI 10.1007/s00442-008-1234-4; Klironomos JN, 2002, NATURE, V417, P67, DOI 10.1038/417067a; Klironomos JN, 2003, ECOLOGY, V84, P2292, DOI 10.1890/02-0413; KOLASA J, 1991, ECOLOGICAL HETEROGEN; Kulmatiski A, 2008, ECOL LETT, V11, P980, DOI 10.1111/j.1461-0248.2008.01209.x; Lu JZ, 2007, ACTA PHYTOTAXON SIN, V45, P670, DOI 10.1360/aps06200; Mangla S, 2008, J ECOL, V96, P58, DOI 10.1111/j.1365-2745.2007.01312.x; Marler MJ, 1999, ECOLOGY, V80, P1180, DOI 10.1890/0012-9658(1999)080[1180:MIECEO]2.0.CO;2; Nunez MA, 2009, ECOLOGY, V90, P2352, DOI 10.1890/08-2139.1; Pollock JL, 2009, J ECOL, V97, P1234, DOI 10.1111/j.1365-2745.2009.01553.x; Pringle A, 2009, ANNU REV ECOL EVOL S, V40, P699, DOI 10.1146/annurev.ecolsys.39.110707.173454; Reinhart KO, 2006, NEW PHYTOL, V170, P445, DOI 10.1111/j.1469-8137.2006.01715.x; Reinhart KO, 2004, ECOL APPL, V14, P1737, DOI 10.1890/03-5204; Reinhart KO, 2003, ECOL LETT, V6, P1046, DOI 10.1046/j.1461-0248.2003.00539.x; Rout ME, 2009, PLANT SOIL, V315, P163, DOI 10.1007/s11104-008-9740-z; Smith S.E., 2010, MYCORRHIZAL SYMBIOSI; Stuefer JF, 1996, VEGETATIO, V127, P55, DOI 10.1007/BF00054847; Thorpe AS, 2009, J ECOL, V97, P641, DOI 10.1111/j.1365-2745.2009.01520.x; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; van Kleunen M, 2003, ECOLOGY, V84, P2816, DOI 10.1890/02-0494; Vogelsang KM, 2009, ECOLOGY, V90, P399, DOI 10.1890/07-2144.1; Weber E., 2003, INVASIVE PLANT SPECI; Wolfe BE, 2005, BIOSCIENCE, V55, P477, DOI 10.1641/0006-3568(2005)055[0477:BNGSCA]2.0.CO;2; Xie YZ, 2004, ACTA OECOL, V25, P197, DOI 10.1016/j.actao.2004.01.004; Yang RY, 2007, ALLELOPATHY J, V19, P241; Yu YW, 2009, GRASS FORAGE SCI, V64, P395, DOI 10.1111/j.1365-2494.2009.00704.x; Zimmer K, 2007, NEW PHYTOL, V175, P166, DOI 10.1111/j.1469-8137.2007.02065.x	44	50	53	2	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e15418	10.1371/journal.pone.0015418	http://dx.doi.org/10.1371/journal.pone.0015418			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	800AR	21082028	Green Published, gold, Green Submitted			2022-12-25	WOS:000293329500003
J	Lees, JG; Bach, CTT; Bradbury, P; Paul, A; Gunning, PW; O'Neill, GM				Lees, J. G.; Bach, C. T. T.; Bradbury, P.; Paul, A.; Gunning, P. W.; O'Neill, G. M.			The actin-associating protein Tm5NM1 blocks mesenchymal motility without transition to amoeboid motility	ONCOGENE			English	Article						tropomyosin; amoeboid; mesenchymal; actin cytoskeleton; metastasis; adhesion	TUMOR-CELL INVASION; TROPOMYOSIN ISOFORM; CYTOSKELETON; MIGRATION; CANCER; SRC; PLASTICITY; ADHESIONS; DYNAMICS; PROMOTES	Cell migration is an integral component of metastatic disease. The ability of cells to transit between mesenchymal and amoeboid modes of migration has complicated the development of successful therapies designed to target cell migration as a means of inhibiting metastasis. Therefore, investigations of the mechanisms that regulate cell migration and render cells stationary are necessary. Tropomyosins are actin-associating proteins that regulate the activity of several effectors of actin filament dynamics. Previously, we have shown that the tropomyosin isoform Tm5NM1 stabilizes actin filaments and inhibits cell migration in a two-dimensional culture system. Here, we show that Tm5NM1 inhibits the mesenchymal migration of multiple cell lines in an isoform-specific manner. Tm5NM1 stimulates the downregulation of Src kinase activity and a rounded or elliptical morphology in three-dimensional collagen gels, and cells have dramatically reduced capacity to form pseudopodia. Importantly, we find that Tm5NM1 inhibits both the mesenchymal to amoeboid and amoeboid to mesenchymal transitions. Collectively, our data suggest that mimicking the action of Tm5NM1 overexpression represents an approach for effectively inhibiting the mesenchymal mode of migration. Oncogene (2011) 30, 1241-1251; doi:10.1038/onc.2010.516; published online 15 November 2010	[Lees, J. G.; Bach, C. T. T.; Bradbury, P.; Paul, A.; O'Neill, G. M.] Childrens Hosp, Childrens Canc Res Unit, Kids Res Inst, Westmead, NSW 2145, Australia; [Bach, C. T. T.; O'Neill, G. M.] Univ Sydney, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia; [Gunning, P. W.] Univ New S Wales, Sch Med Sci, Dept Pharmacol, Sydney, NSW, Australia	University of Sydney; University of Sydney; University of New South Wales Sydney	O'Neill, GM (corresponding author), Childrens Hosp, Childrens Canc Res Unit, Kids Res Inst, Locked Bag 4001, Westmead, NSW 2145, Australia.	geraldio@chw.edu.au	Bradbury, Peta/A-4864-2017; Gunning, Peter W/E-9058-2010; O'Neill, Geraldine/F-3112-2014	Bradbury, Peta/0000-0001-6360-9591; Lees, Justin/0000-0002-0874-2856; O'Neill, Geraldine/0000-0001-9997-8794; Gunning, Peter/0000-0003-0833-3128	National Health and Medical Research Council (NHMRC) [512251]; Ramaciotti Establishment grant; NSW Cancer Institute; Oncology Children's Foundation	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Ramaciotti Establishment grant; NSW Cancer Institute; Oncology Children's Foundation	This study was supported by National Health and Medical Research Council (NHMRC) grant 512251 (GO and PG). PG is a Principal Research Fellow of the NHMRC, JL is the recipient of a Ramaciotti Establishment grant, CB is the recipient of an NHMRC post-graduate scholarship and a NSW Cancer Institute Scholar award, and AP holds an Oncology Children's Foundation-C4 fellowship. We thank Rose Boutros for critical review of the paper and also gratefully acknowledge the generous support of Kaise Stephan and Channel Crossing for Life.	Bach CTT, 2009, MOL CELL BIOL, V29, P1506, DOI 10.1128/MCB.00857-08; Bargon SD, 2005, BBA-MOL CELL RES, V1746, P143, DOI 10.1016/j.bbamcr.2005.10.008; Blanchoin L, 2001, CURR BIOL, V11, P1300, DOI 10.1016/S0960-9822(01)00395-5; Bryce NS, 2003, MOL BIOL CELL, V14, P1002, DOI 10.1091/mbc.E02-04-0244; Carragher NO, 2006, ONCOGENE, V25, P5726, DOI 10.1038/sj.onc.1209582; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Creed SJ, 2008, EUR J CELL BIOL, V87, P709, DOI 10.1016/j.ejcb.2008.03.004; DesMarais V, 2002, J CELL SCI, V115, P4649, DOI 10.1242/jcs.00147; Drappatz J, 2009, EXPERT REV NEUROTHER, V9, P519, DOI [10.1586/ern.09.10, 10.1586/ERN.09.10]; Eichinger L, 1999, MICROSC RES TECHNIQ, V47, P124, DOI 10.1002/(SICI)1097-0029(19991015)47:2<124::AID-JEMT5>3.0.CO;2-8; Fath T, 2010, EUR J CELL BIOL, V89, P489, DOI 10.1016/j.ejcb.2009.11.028; Fidler IJ, 2002, SEMIN CANCER BIOL, V12, P89, DOI 10.1006/scbi.2001.0416; Fincham VJ, 1998, EMBO J, V17, P81, DOI 10.1093/emboj/17.1.81; Friedl P, 2004, CURR OPIN CELL BIOL, V16, P14, DOI 10.1016/j.ceb.2003.11.001; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Gunning P, 2008, PHYSIOL REV, V88, P1, DOI 10.1152/physrev.00001.2007; Gunning PW, 2005, TRENDS CELL BIOL, V15, P333, DOI 10.1016/j.tcb.2005.04.007; Gupton SL, 2005, J CELL BIOL, V168, P619, DOI 10.1083/jcb.200406063; Hillberg L, 2006, EUR J CELL BIOL, V85, P399, DOI 10.1016/j.ejcb.2005.12.005; ISHIKAWA R, 1989, J BIOL CHEM, V264, P7490; KITZING TM, 2010, ONCOGENE, V1, P1; Kruger A, 2001, CANCER RES, V61, P1272; O'Neill GM, 2009, CELL ADHES MIGR, V3, P355, DOI 10.4161/cam.3.4.9468; Percival JM, 2004, MOL BIOL CELL, V15, P268, DOI 10.1091/mbc.e03-03-0176; POSTE G, 1980, NATURE, V283, P139, DOI 10.1038/283139a0; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sahai E, 2007, NAT REV CANCER, V7, P737, DOI 10.1038/nrc2229; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Schevzov G, 2005, J HISTOCHEM CYTOCHEM, V53, P557, DOI 10.1369/jhc.4A6505.2005; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065; Yamazaki D, 2009, ONCOGENE, V28, P1570, DOI 10.1038/onc.2009.2; Zheng Q, 2008, INT J CANCER, V122, P78, DOI 10.1002/ijc.23025	36	20	20	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2011	30	10					1241	1251		10.1038/onc.2010.516	http://dx.doi.org/10.1038/onc.2010.516			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	732QD	21076470				2022-12-25	WOS:000288202400010
J	Pan, D; Pramanik, M; Senpan, A; Allen, JS; Zhang, HY; Wickline, SA; Wang, LV; Lanza, GM				Pan, Dipanjan; Pramanik, Manojit; Senpan, Angana; Allen, John S.; Zhang, Huiying; Wickline, Samuel A.; Wang, Lihong V.; Lanza, Gregory M.			Molecular photoacoustic imaging of angiogenesis with integrin-targeted gold nanobeacons	FASEB JOURNAL			English	Article						optoacoustics; molecular imaging; diagnostic imaging; gold nanoparticles	VX-2 RABBIT TUMORS; IN-VIVO; ALPHA(V)BETA(3); EXPRESSION; NANOPARTICLES; TOMOGRAPHY; NANOCAGES; NEOVASCULARIZATION; VASCULATURE; MELANOMA	Photoacoustic tomography (PAT) combines optical and acoustic imaging to generate high-resolution images of microvasculature. Inherent sensitivity to hemoglobin permits PAT to image blood vessels but precludes discriminating neovascular from maturing microvasculature. alpha(v)beta(3)-Gold nanobeacons (alpha(v)beta(3)-GNBs) for neovascular molecular PAT were developed, characterized, and demonstrated in vivo using a mouse Matrigel-plug model of angiogenesis. PAT results were microscopically corroborated with fluorescent alpha(v)beta(3)-GNB localization and supporting immunohistology in Rag1(tm1Mom) Tg(Tie-2-lacZ) 182-Sato mice. alpha(v)beta(3)-GNBs (154 nm) had 10-fold greater contrast than blood on an equivolume basis when imaged at 740 nm to 810 nm in blood. The lowest detectable concentration in buffer was 290 nM at 780 nm. Noninvasive PAT of angiogenesis using a 10-MHz ultrasound receiver with alpha(v)beta(3)-GNBs produced a 600% increase in signal in a Matrigel-plug mouse model relative to the inherent hemoglobin contrast pretreatment. In addition to increasing the contrast of neovessels detected at baseline, alpha(v)beta(3)-GNBs allowed visualization of numerous angiogenic sprouts and bridges that were undetectable before contrast injection. Competitive inhibition of alpha(v)beta(3)-GNBs with alpha(v)beta(3)-NBs (no gold particles) almost completely blocked contrast enhancement to pretreatment levels, similar to the signal from animals receiving saline only. Consistent with other studies, nontargeted GNBs passively accumulated in the tortuous neovascular but provided less than half of the contrast enhancement of the targeted agent. Microscopic studies revealed that the vascular constrained, rhodamine-labeled alpha(v)beta(3)-GNBs homed specifically to immature neovasculature (PECAM(+), Tie-2(-)) along the immediate tumor periphery, but not to nearby mature microvasculature (PECAM(+), Tie-2(+)). The combination of PAT and alpha(v)beta(3)-GNBs offered sensitive and specific discrimination and quantification of angiogenesis in vivo, which may be clinically applicable to a variety of highly prevalent diseases, including cancer and cardiovascular disease.-Pan, D., Pramanik, M., Senpan, A., Allen, J. S., Zhang, H., Wickline, S. A., Wang, L. V., Lanza, G. M. Molecular photoacoustic imaging of angiogenesis with integrin-targeted gold nanobeacons. FASEB J. 25, 875-882 (2011). www.fasebj.org	[Pan, Dipanjan; Senpan, Angana; Allen, John S.; Zhang, Huiying; Wickline, Samuel A.; Lanza, Gregory M.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63108 USA; [Pramanik, Manojit; Wickline, Samuel A.; Wang, Lihong V.; Lanza, Gregory M.] Washington Univ, Sch Med, Dept Biomed Engn, St Louis, MO 63108 USA	Washington University (WUSTL); Washington University (WUSTL)	Pan, D (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63108 USA.	dpan@dom.wustl.edu; lhwang@seas.wustl.edu	Wang, Lihong V./A-7147-2009; Pramanik, Manojit/F-7681-2013	Wang, Lihong V./0000-0001-9783-4383; Pramanik, Manojit/0000-0003-2865-5714; Pan, Dipanjan/0000-0003-0175-4704	American Heart Association [0835426N]; U.S. National Institutes of Health [NS059302, CA119342, HL073646, U54 CA136398, R01 EB000712, R01 EB008085]; Microphotoacoustics, Inc.; Endra, Inc.; NATIONAL CANCER INSTITUTE [U54CA119342, U54CA136398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008085, R01EB000712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059302] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Microphotoacoustics, Inc.; Endra, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors greatly appreciate the financial support from the American Heart Association (grant 0835426N, to D.P.) and the U.S. National Institutes of Health (grants NS059302 and CA119342, to G.M.L.; HL073646, to S.A.W.; and U54 CA136398, R01 EB000712, and R01 EB008085, to L.W.). L.W. has a financial interest in Microphotoacoustics, Inc., and Endra, Inc.; neither provided material, financial, or intellectual support. D.P., G.M.L., M.P., and L.V.W. conceived the research and contributed to the experimental design. D.P. and A.S.P. performed the chemical syntheses, and M.P. performed the PA imaging and postprocessing. J.S.A. and M.P. created and managed the Matrigel rodent model. All authors contributed analysis and interpretation of the data. D.P., M.P., and G.L. wrote the manuscript. All authors read and edited the manuscript.	BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; Carreiras F, 1996, GYNECOL ONCOL, V62, P260, DOI 10.1006/gyno.1996.0225; Cho EC, 2009, J PHYS CHEM C, V113, P9023, DOI 10.1021/jp903343p; Choi HS, 2010, NAT NANOTECHNOL, V5, P42, DOI [10.1038/NNANO.2009.314, 10.1038/nnano.2009.314]; De La Zerda A, 2008, NAT NANOTECHNOL, V3, P557, DOI 10.1038/nnano.2008.231; DENICHILO MO, 1993, P NATL ACAD SCI USA, V90, P2517, DOI 10.1073/pnas.90.6.2517; Dupas B, 2001, INVEST RADIOL, V36, P509, DOI 10.1097/00004424-200109000-00002; Fathers KE, 2005, AM J PATHOL, V167, P1753, DOI 10.1016/S0002-9440(10)61256-4; Helluin O, 2000, J BIOL CHEM, V275, P18337, DOI 10.1074/jbc.M001529200; Hu G, 2007, INT J CANCER, V120, P1951, DOI 10.1002/ijc.22581; Hu J, 2005, GUT, V54, P1473, DOI 10.1136/gut.2005.070904; HU S, 2010, P SPIE, V7564; Imhof BA, 2006, NAT MED, V12, P171, DOI 10.1038/nm0206-171; Itoh H, 1997, J VASC SURG, V25, P1061, DOI 10.1016/S0741-5214(97)70130-7; Jose J, 2009, J BIOPHOTONICS, V2, P701, DOI 10.1002/jbio.200910025; Kageshita T, 2000, INT J CANCER, V89, P153, DOI 10.1002/(SICI)1097-0215(20000320)89:2<153::AID-IJC9>3.0.CO;2-1; Ku G, 2005, APPL OPTICS, V44, P770, DOI 10.1364/AO.44.000770; Ku G, 2004, PHYS MED BIOL, V49, P1329, DOI 10.1088/0031-9155/49/7/018; Lao YQ, 2008, PHYS MED BIOL, V53, P4203, DOI 10.1088/0031-9155/53/15/013; Laser Institute of America, 2000, Z13612000 ANSI LAS I; Li ML, 2008, P IEEE, V96, P481, DOI 10.1109/JPROC.2007.913515; Lungu GF, 2007, INT J ONCOL, V30, P45; Maslov K, 2005, OPT LETT, V30, P625, DOI 10.1364/OL.30.6.000625; Maslov K, 2008, OPT LETT, V33, P929, DOI 10.1364/OL.33.000929; Meoli DF, 2004, J CLIN INVEST, V113, P1684, DOI 10.1172/JCI200420352; MIYAUCHI A, 1991, J BIOL CHEM, V266, P20369; Pan DPJ, 2010, BIOMATERIALS, V31, P4088, DOI 10.1016/j.biomaterials.2010.01.136; Pan DP, 2009, ANGEW CHEM INT EDIT, V48, P4170, DOI 10.1002/anie.200805947; Schmieder AH, 2005, MAGN RESON MED, V53, P621, DOI 10.1002/mrm.20391; Schmieder AH, 2008, FASEB J, V22, P4179, DOI 10.1096/fj.08-112060; Siphanto RI, 2005, OPT EXPRESS, V13, P89, DOI 10.1364/OPEX.13.000089; Siphanto RI, 2004, LASER SURG MED, V35, P354, DOI 10.1002/lsm.20100; Song KH, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2818045; Song KH, 2009, NANO LETT, V9, P183, DOI 10.1021/nl802746w; Song L, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2976141; Wang LHV, 2005, P ANN INT IEEE EMBS, P190, DOI 10.1109/IEMBS.2005.1616374; Wang XD, 2003, NAT BIOTECHNOL, V21, P803, DOI 10.1038/nbt839; Wang XD, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2192804; Weissleder R, 2001, BIOCONJUGATE CHEM, V12, P213, DOI 10.1021/bc000091p; Winter PM, 2008, FASEB J, V22, P2758, DOI 10.1096/fj.07-103929; Winter PM, 2006, ARTERIOSCL THROM VAS, V26, P2103, DOI 10.1161/01.ATV.0000235724.11299.76; Winter PM, 2003, CANCER RES, V63, P5838; Xiang LZ, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3078809; Xie XY, 2006, PROC SPIE, V6086, DOI 10.1117/12.645121; Xie XY, 2005, PROC SPIE, V5697, P107, DOI 10.1117/12.589670; Yavuz MS, 2009, NAT MATER, V8, P935, DOI [10.1038/NMAT2564, 10.1038/nmat2564]; Zhang EZ, 2009, PHYS MED BIOL, V54, P1035, DOI 10.1088/0031-9155/54/4/014	47	137	140	2	30	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2011	25	3					875	882		10.1096/fj.10-171728	http://dx.doi.org/10.1096/fj.10-171728			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	727MZ	21097518	Green Published			2022-12-25	WOS:000287806200008
J	Roy, LD; Sahraei, M; Subramani, DB; Besmer, D; Nath, S; Tinder, TL; Bajaj, E; Shanmugam, K; Lee, YY; Hwang, SIL; Gendler, SJ; Mukherjee, P				Roy, L. D.; Sahraei, M.; Subramani, D. B.; Besmer, D.; Nath, S.; Tinder, T. L.; Bajaj, E.; Shanmugam, K.; Lee, Y. Y.; Hwang, S. I. L.; Gendler, S. J.; Mukherjee, P.			MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition	ONCOGENE			English	Article						MUCI; pancreatic cancer; epithelial to mesenchymal transition; metastasis	CARCINOMA-ASSOCIATED ANTIGEN; TRANSCRIPTION FACTOR SNAIL; E-CADHERIN EXPRESSION; SOLUBLE P-SELECTIN; BETA-CATENIN; TUMOR PROGRESSION; CYTOPLASMIC TAIL; MAMMARY-GLAND; C-SRC; PROTEIN	Increased motility and invasiveness of pancreatic cancer cells are associated with epithelial to mesenchymal transition (EMT). Snai1 and Slug are zinc-finger transcription factors that trigger this process by repressing E-cadherin and enhancing vimentin and N-cadherin protein expression. However, the mechanisms that regulate this activation in pancreatic tumors remain elusive. MUC1, a transmembrane mucin glycoprotein, is associated with the most invasive forms of pancreatic ductal adenocarcinomas (PDA). In this study, we show that over expression of MUC1 in pancreatic cancer cells triggers the molecular process of EMT, which translates to increased invasiveness and metastasis. EMT was significantly reduced when MUC1 was genetically deleted in a mouse model of PDA or when all seven tyrosines in the cytoplasmic tail of MUC1 were mutated to phenylalanine (mutated MUC1 CT). Using proteomics, RT-PCR and western blotting, we revealed a significant increase in vimentin, Slug and Snail expression with repression of E-Cadherin in MUC1-expressing cells compared with cells expressing the mutated MUC1 CT. In the cells that carried the mutated MUC1 CT, MUC1 failed to co-immunoprecipitate with beta-catenin and translocate to the nucleus, thereby blocking transcription of the genes associated with EMT and metastasis. Thus, functional tyrosines are critical in stimulating the interactions between MUC1 and b-catenin and their nuclear translocation to initiate the process of EMT. This study signifies the oncogenic role of MUC1 CT and is the first to identify a direct role of the MUC1 in initiating EMT during pancreatic cancer. The data may have implications in future design of MUC1-targeted therapies for pancreatic cancer. Oncogene (2011) 30, 1449-1459; doi:10.1038/onc.2010.526; published online 22 November 2010	[Roy, L. D.; Sahraei, M.; Besmer, D.; Nath, S.; Mukherjee, P.] Univ N Carolina, Dept Biol, Charlotte, NC 28223 USA; [Subramani, D. B.; Tinder, T. L.; Bajaj, E.; Shanmugam, K.; Gendler, S. J.] Mayo Clin, Sch Med Arizona, Dept Biochem & Mol Biol, Scottsdale, AZ USA; [Lee, Y. Y.; Hwang, S. I. L.] Carolinas Healthcare Ctr, Charlotte, NC USA	University of North Carolina; University of North Carolina Charlotte; Mayo Clinic; Mayo Clinic Phoenix; Carolinas HealthCare System	Mukherjee, P (corresponding author), Univ N Carolina, Dept Biol, 9201 Univ City Blvd, Charlotte, NC 28223 USA.	pmukherj@uncc.edu	Nath, Sritama/J-7725-2019; Subramani, Durai/N-1448-2013	Subramani, Durai/0000-0002-2256-3096; Hwang, Sunil/0000-0003-0600-3694	NIH [CA R01CA118944]; NATIONAL CANCER INSTITUTE [R01CA064389, P50CA102701, R01CA118944] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Drs Mukherjee and Gendler work have been funded by the NIH. All other authors declare no conflict of interest.; We acknowledge the funding provided by NIH CA R01CA118944. We thank Dr Jennifer Curry for critically reviewing the manuscript. We thank Cathy S Madison and Carole M Viso for their technical help with the confocal microscopy. We also acknowledge all the technicians in the animal facility and in the histology core facilities at The Mayo Clinic.	Al Masri A, 2005, ONCOGENE, V24, P5799, DOI 10.1038/sj.onc.1208738; Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Carson DD, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.127pe35; Chang BW, 2010, J PANCREAS, V11, P313; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Das Roy L, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2345; Dymicka-Piekarska V, 2007, THROMB RES, V120, P585, DOI 10.1016/j.thromres.2006.11.002; Fujita N, 2003, CELL, V113, P207, DOI 10.1016/S0092-8674(03)00234-4; Glinskii AB, 2003, CANCER RES, V63, P4239; Guaita S, 2002, J BIOL CHEM, V277, P39209, DOI 10.1074/jbc.M206400200; Hattrup CL, 2008, ANNU REV PHYSIOL, V70, P431, DOI 10.1146/annurev.physiol.70.113006.100659; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Hwang SI, 2006, MOL CELL PROTEOMICS, V5, P1131, DOI 10.1074/mcp.M500162-MCP200; Justinger C, 2008, ONCOL REP, V20, P1527, DOI 10.3892/or_00000175; KAIKITA K, 1995, CIRCULATION, V92, P1726, DOI 10.1161/01.CIR.92.7.1726; Kufe DW, 2008, CANCER BIOL THER, V7, P81, DOI 10.4161/cbt.7.1.5631; LAN MS, 1990, J BIOL CHEM, V265, P15294; Li YQ, 2001, BIOCHEM BIOPH RES CO, V281, P440, DOI 10.1006/bbrc.2001.4383; Mroczko B, 2005, CLIN CHEM LAB MED, V43, P146, DOI 10.1515/CCLM.2005.024; Mukherjee P, 2005, J LEUKOCYTE BIOL, V77, P90, DOI 10.1189/jlb.0604333; Mukherjee P, 2009, J IMMUNOL, V182, P216, DOI 10.4049/jimmunol.182.1.216; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Patton S, 1995, BBA-REV BIOMEMBRANES, V1241, P407, DOI 10.1016/0304-4157(95)00014-3; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Quin RJ, 2000, INT J CANCER, V87, P499, DOI 10.1002/1097-0215(20000815)87:4<499::AID-IJC6>3.0.CO;2-9; Ren J, 2006, ONCOGENE, V25, P20, DOI 10.1038/sj.onc.1209012; Ren J, 2002, J BIOL CHEM, V277, P17616, DOI 10.1074/jbc.M200436200; Schroeder JA, 2003, ONCOGENE, V22, P1324, DOI 10.1038/sj.onc.1206291; Schroeder JA, 2001, J BIOL CHEM, V276, P13057, DOI 10.1074/jbc.M011248200; SIMPSONHERREN L, 1970, CANCER CHEMOTH REP 1, V54, P143; Singh PK, 2006, TRENDS CELL BIOL, V16, P467, DOI 10.1016/j.tcb.2006.07.006; SPICER AP, 1995, J BIOL CHEM, V270, P30093; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thompson EJ, 2006, MOL CANCER RES, V4, P489, DOI 10.1158/1541-7786.MCR-06-0038; Tinder TL, 2008, J IMMUNOL, V181, P3116, DOI 10.4049/jimmunol.181.5.3116; Wen YF, 2003, J BIOL CHEM, V278, P38029, DOI 10.1074/jbc.M304333200; Wolpin BM, 2007, BRIT J CANCER, V97, P98, DOI 10.1038/sj.bjc.6603826; Yamamoto M, 1997, J BIOL CHEM, V272, P12492, DOI 10.1074/jbc.272.19.12492; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	44	196	206	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR	2011	30	12					1449	1459		10.1038/onc.2010.526	http://dx.doi.org/10.1038/onc.2010.526			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	739UM	21102519	Green Accepted			2022-12-25	WOS:000288743800007
J	Mcnally, RS; Davis, BK; Clements, CM; Accavitti-Loper, MA; Mak, TW; Ting, JPY				Mcnally, R. Sean; Davis, Beckley K.; Clements, Casey M.; Accavitti-Loper, Mary Ann; Mak, Tak W.; Ting, Jenny P. -Y.			DJ-1 Enhances Cell Survival through the Binding of Cezanne, a Negative Regulator of NF-kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUNG-CARCINOMA; BREAST-CANCER; PARKINSONS-DISEASE; INDUCED APOPTOSIS; OXIDATIVE STRESS; EXPRESSION; INTERLEUKIN-8; ANGIOGENESIS; METASTASIS; PROTECTS	Heightened DJ-1 (Park7) expression is associated with a reduction in chemotherapeutic-induced cell death and poor prognosis in several cancers, whereas the loss of DJ-1 function is found in a subgroup of Parkinson disease associated with neuronal death. This study describes a novel pathway by which DJ-1 modulates cell survival. Mass spectrometry shows that DJ-1 interacts with BBS1, CLCF1, MTREF, and Cezanne/OTUD7B/Za20d1. Among these, Cezanne is a known deubiquitination enzyme that inhibits NF-kappa B activity. DJ-1/Cezanne interaction is confirmed by co-immunoprecipitation of over-expressed and endogenous proteins, maps to the amino-terminal 70 residues of DJ-1, and leads to the inhibition of the deubiquitinating activity of Cezanne. Microarray profiling of shRNA-transduced cells shows that DJ-1 and Cezanne regulate IL-8 and ICAM-1 expression in opposing directions. Similarly, DJ-1 enhances NF-kappa B nuclear translocation and cell survival, whereas Cezanne reduces these outcomes. Analysis of mouse Park7(-/-) primary cells confirms the regulation of ICAM-1 by DJ-1 and Cezanne. As NF-kappa B is important in cellular survival and transformation, IL-8 functions as an angiogenic factor and pro-survival signal, and ICAM-1 has been implicated in tumor progression, invasion, and metastasis; these data provide an additional modality by which DJ-1 controls cell survival and possibly tumor progression via interaction with Cezanne.	[Mcnally, R. Sean; Davis, Beckley K.; Clements, Casey M.; Ting, Jenny P. -Y.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Microbiol Immunol, Chapel Hill, NC 27599 USA; [Accavitti-Loper, Mary Ann] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Mak, Tak W.] Univ Hlth Network, Campbell Family Inst Breast Canc Res, Toronto, ON M5G 2C1, Canada	University of North Carolina; University of North Carolina Chapel Hill; University of Alabama System; University of Alabama Birmingham; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Ting, JPY (corresponding author), 450 West Dr,LCCC 22-004,CB 7295, Chapel Hill, NC 27599 USA.	jenny_ting@med.unc.edu	Clements, Casey M/X-6179-2019	Clements, Casey M/0000-0002-8634-7894	Lineberger Comprehensive Cancer Center; University Cancer Research Fund; UNC [5T32CA071341-15]; Crohn's and Colitis Foundation of America; NATIONAL CANCER INSTITUTE [T32CA071341] Funding Source: NIH RePORTER	Lineberger Comprehensive Cancer Center; University Cancer Research Fund; UNC(Secretaria de Ciencia y Tecnologia (SECYT)); Crohn's and Colitis Foundation of America; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Lineberger Comprehensive Cancer Center, the University Cancer Research Fund, and UNC Cancer Cell Biology Training Grant 5T32CA071341-15. This work was also supported by a grant from the Crohn's and Colitis Foundation of America (to B.K.D.).	Aleyasin H, 2010, P NATL ACAD SCI USA, V107, P3186, DOI 10.1073/pnas.0914876107; Anderson PC, 2008, BIOCHEMISTRY-US, V47, P9380, DOI 10.1021/bi800677k; Bargou RC, 1997, J CLIN INVEST, V100, P2961, DOI 10.1172/JCI119849; Blackinton J, 2009, J BIOL CHEM, V284, P6476, DOI 10.1074/jbc.M806599200; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Brown M, 2008, EXPERT OPIN THER TAR, V12, P1109, DOI 10.1517/14728222.12.9.1109 ; Chavey C, 2008, MOL PHARMACOL, V74, P1359, DOI 10.1124/mol.108.047332; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Collins TS, 2000, CANCER IMMUNOL IMMUN, V49, P78, DOI 10.1007/s002620050605; Davidson B, 2008, HUM PATHOL, V39, P87, DOI 10.1016/j.humpath.2007.05.014; Dong Cheng, 2005, Molecular & Cellular Biomechanics, V2, P145; Enesa K, 2008, J BIOL CHEM, V283, P7036, DOI 10.1074/jbc.M708690200; Evans PC, 2003, J BIOL CHEM, V278, P23180, DOI 10.1074/jbc.M301863200; Fan J, 2008, J BIOL CHEM, V283, P4022, DOI 10.1074/jbc.M707176200; Giaime E, 2010, CELL DEATH DIFFER, V17, P158, DOI 10.1038/cdd.2009.116; Ginestier C, 2010, J CLIN INVEST, V120, P485, DOI 10.1172/JCI39397; Hod Y, 2004, J CELL BIOCHEM, V92, P1221, DOI 10.1002/jcb.20159; Huang SY, 2002, AM J PATHOL, V161, P125, DOI 10.1016/S0002-9440(10)64164-8; Inden M, 2006, NEUROBIOL DIS, V24, P144, DOI 10.1016/j.nbd.2006.06.004; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kammerer S, 2004, CANCER RES, V64, P8906, DOI 10.1158/0008-5472.CAN-04-1788; Karashima T, 2003, CLIN CANCER RES, V9, P2786; Ke JJ, 2006, WORLD J GASTROENTERO, V12, P3609, DOI 10.3748/wjg.v12.i22.3609; Kim RH, 2005, CANCER CELL, V7, P263, DOI 10.1016/j.ccr.2005.02.010; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; La Starza R, 2007, CANCER GENET CYTOGEN, V175, P73, DOI 10.1016/j.cancergencyto.2007.01.011; Le Naour F, 2001, CLIN CANCER RES, V7, P3328; Lev N, 2009, J NEURAL TRANSM, V116, P151, DOI 10.1007/s00702-008-0134-4; Lin YC, 2006, CLIN CANCER RES, V12, P7165, DOI 10.1158/1078-0432.CCR-06-1393; Liu H, 2008, BIOCHEM BIOPH RES CO, V375, P477, DOI 10.1016/j.bbrc.2008.08.046; MacKeigan JP, 2003, CANCER RES, V63, P6928; Martinat C, 2004, PLOS BIOL, V2, P1754, DOI 10.1371/journal.pbio.0020327; Masuya D, 2001, CANCER, V92, P2628, DOI 10.1002/1097-0142(20011115)92:10<2628::AID-CNCR1616>3.0.CO;2-F; Millar HJ, 2008, CANCER EPIDEM BIOMAR, V17, P2180, DOI 10.1158/1055-9965.EPI-07-2915; MUKHOPADHYAY T, 1995, ONCOGENE, V11, P999; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Ooe H, 2006, NEUROSCI LETT, V406, P165, DOI 10.1016/j.neulet.2006.06.067; Pfister DG, 2004, J CLIN ONCOL, V22, P330, DOI 10.1200/JCO.2004.09.053; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Rosette C, 2005, CARCINOGENESIS, V26, P943, DOI 10.1093/carcin/bgi070; Rubie C, 2007, WORLD J GASTROENTERO, V13, P4996, DOI 10.3748/wjg.v13.i37.4996; Sher T, 2008, MAYO CLIN PROC, V83, P355, DOI 10.4065/83.3.355; Singh RK, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-57; Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Taxman DJ, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-7; TORII A, 1993, J SURG ONCOL, V53, P239, DOI 10.1002/jso.2930530410; Waak J, 2009, J BIOL CHEM, V284, P14245, DOI 10.1074/jbc.M806902200; Yokota T, 2003, BIOCHEM BIOPH RES CO, V312, P1342, DOI 10.1016/j.bbrc.2003.11.056; Yuen HF, 2008, CANCER EPIDEM BIOMAR, V17, P3593, DOI 10.1158/1055-9965.EPI-08-0214; Zhang HY, 2008, ENDOCR-RELAT CANCER, V15, P535, DOI 10.1677/ERC-07-0195	51	55	62	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4098	4106		10.1074/jbc.M110.147371	http://dx.doi.org/10.1074/jbc.M110.147371			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21097510	Green Published, hybrid			2022-12-25	WOS:000286975700008
J	Bassaganya-Riera, J; Guri, AJ; Lu, PY; Climent, M; Carbo, A; Sobral, BW; Horne, WT; Lewis, SN; Bevan, DR; Hontecillas, R				Bassaganya-Riera, Josep; Guri, Amir J.; Lu, Pinyi; Climent, Montse; Carbo, Adria; Sobral, Bruno W.; Horne, William T.; Lewis, Stephanie N.; Bevan, David R.; Hontecillas, Raquel			Abscisic Acid Regulates Inflammation via Ligand-binding Domain-independent Activation of Peroxisome Proliferator-activated Receptor gamma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA SYNTHETASE; CYCLIC ADP-RIBOSE; TEMPERATURE-SIGNALING CASCADE; CONJUGATED LINOLEIC-ACID; C-LIKE PROTEIN-1; PPAR-GAMMA; GENE-EXPRESSION; ULCERATIVE-COLITIS; ADIPOSE-TISSUE; PROBE LEVEL	Abscisic acid (ABA) has shown efficacy in the treatment of diabetes and inflammation; however, its molecular targets and the mechanisms of action underlying its immunomodulatory effects remain unclear. This study investigates the role of peroxisome proliferator-activated receptor gamma (PPAR gamma) and lanthionine synthetase C-like 2 (LANCL2) as molecular targets for ABA. We demonstrate that ABA increases PPAR gamma reporter activity in RAW 264.7 macrophages and increases ppar gamma expression in vivo, although it does not bind to the ligand-binding domain of PPAR gamma. LANCL2 knockdown studies provide evidence that ABA-mediated activation of macrophage PPAR gamma is dependent on lancl2 expression. Consistent with the association of LANCL2 with G proteins, we provide evidence that ABA increases cAMP accumulation in immune cells. ABA suppresses LPS-induced prostaglandin E-2 and MCP-1 production via a PPAR gamma-dependent mechanism possibly involving activation of PPAR gamma and suppression of NF-kappa B and nuclear factor of activated T cells. LPS challenge studies in PPAR gamma-expressing and immune cell-specific PPAR gamma null mice demonstrate that ABA down-regulates toll-like receptor 4 expression in macrophages and T cells in vivo through a PPAR gamma-dependent mechanism. Global transcriptomic profiling and confirmatory quantitative RT-PCR suggest novel candidate targets and demonstrate that ABA treatment mitigates the effect of LPS on the expression of genes involved in inflammation, metabolism, and cell signaling, in part, through PPAR gamma. In conclusion, ABA decreases LPS-mediated inflammation and regulates innate immune responses through a bifurcating pathway involving LANCL2 and an alternative, ligand-binding domain-independent mechanism of PPAR gamma activation.	[Bassaganya-Riera, Josep; Guri, Amir J.; Lu, Pinyi; Climent, Montse; Carbo, Adria; Sobral, Bruno W.; Horne, William T.; Lewis, Stephanie N.; Hontecillas, Raquel] Virginia Polytech Inst & State Univ, Nutrit Immunol & Mol Med Grp, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Lewis, Stephanie N.; Bevan, David R.] Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Bassaganya-Riera, J (corresponding author), Virginia Polytech Inst & State Univ, Nutrit Immunol & Mol Med Grp, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA.	jbassaga@vt.edu; rmagarzo@vt.edu	Lu, Pinyi/U-4513-2017; Sobral, Bruno/GVU-7637-2022; Climent, Montserrat/K-6490-2019	Sobral, Bruno/0000-0003-3908-577X; Climent, Montserrat/0000-0002-9029-7914; Lewis, Stephanie/0000-0001-8724-2069; Bevan, David/0000-0001-9974-1105	National Institutes of Health from National Center for Complementary and Alternative Medicine [5R01AT004308]; NIAID [HHSN272200900040C, HHSN272201000056C]; European Commission [224836]; Ramon y Cajal Program; Nutritional Immunology and Molecular Medicine Laboratory; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT004308] Funding Source: NIH RePORTER	National Institutes of Health from National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); European Commission(European CommissionEuropean Commission Joint Research Centre); Ramon y Cajal Program(Spanish Government); Nutritional Immunology and Molecular Medicine Laboratory; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01AT004308 from National Center for Complementary and Alternative Medicine (to J. B.-R.), NIAID Contract HHSN272200900040C (to B. W. S.), and NIAID Contract HHSN272201000056C (to J. B.-R.). This work was also supported by European Commission Grant 224836, the Ramon y Cajal Program, and funds from the Nutritional Immunology and Molecular Medicine Laboratory.	Adolfsson O, 2001, J IMMUNOL, V167, P3809, DOI 10.4049/jimmunol.167.7.3809; Agrawal A, 2007, AM J PHYSIOL-CELL PH, V293, pC621, DOI 10.1152/ajpcell.00538.2006; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Artis DR, 2009, P NATL ACAD SCI USA, V106, P262, DOI 10.1073/pnas.0811325106; Baillie RA, 1998, J LIPID RES, V39, P2048; Bassaganya-Riera J, 2004, GASTROENTEROLOGY, V127, P777, DOI 10.1053/j.gastro.2004.06.049; Bassaganya-Riera J, 2010, CURR MED CHEM, V17, P467, DOI 10.2174/092986710790226110; Bassaganya-Riera J, 2009, CELL IMMUNOL, V258, P138, DOI 10.1016/j.cellimm.2009.04.003; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Bruzzone S, 2008, J BIOL CHEM, V283, P32188, DOI 10.1074/jbc.M802603200; Bruzzone S, 2007, P NATL ACAD SCI USA, V104, P5759, DOI 10.1073/pnas.0609379104; Chung CHY, 2007, BIOCHEMISTRY-US, V46, P3262, DOI 10.1021/bi061888s; Chung SW, 2003, MOL PHARMACOL, V64, P1169, DOI 10.1124/mol.64.5.1169; Crosby MB, 2005, J PHARMACOL EXP THER, V312, P69, DOI 10.1124/jpet.104.074005; Dubuquoy L, 2003, GASTROENTEROLOGY, V124, P1265, DOI 10.1016/S0016-5085(03)00271-3; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Guri AJ, 2008, J NUTR BIOCHEM, V19, P216, DOI 10.1016/j.jnutbio.2007.02.010; Guri AJ, 2007, CLIN NUTR, V26, P107, DOI 10.1016/j.clnu.2006.07.008; Guri AJ, 2010, J NUTR BIOCHEM, V21, P1178, DOI 10.1016/j.jnutbio.2009.10.003; Guri AJ, 2010, CLIN NUTR, V29, P824, DOI 10.1016/j.clnu.2010.02.009; Guri AJ, 2010, CLIN NUTR, V29, P646, DOI 10.1016/j.clnu.2010.02.003; Hammad H, 2004, AM J PATHOL, V164, P263, DOI 10.1016/S0002-9440(10)63116-1; Hontecillas R, 2007, J IMMUNOL, V178, P2940, DOI 10.4049/jimmunol.178.5.2940; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Itoh T, 2008, NAT STRUCT MOL BIOL, V15, P924, DOI 10.1038/nsmb.1474; Jump DB, 1999, ANNU REV NUTR, V19, P63, DOI 10.1146/annurev.nutr.19.1.63; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Kim SR, 2005, MOL PHARMACOL, V68, P1568, DOI 10.1124/mol.105.017160; Landlinger C, 2006, BBA-BIOMEMBRANES, V1758, P1759, DOI 10.1016/j.bbamem.2006.07.018; Laszlo C, 2009, J GEN PHYSIOL, V133, P189, DOI 10.1085/jgp.200810109; Lazennec G, 2000, MOL ENDOCRINOL, V14, P1962, DOI 10.1210/me.14.12.1962; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Levine SM, 2003, CURR OPIN RHEUMATOL, V15, P708, DOI 10.1097/00002281-200311000-00005; Lewis JD, 2008, GASTROENTEROLOGY, V134, P688, DOI 10.1053/j.gastro.2007.12.012; LU P, 2010, J MOL MODEL IN PRESS; Magnone M, 2009, J BIOL CHEM, V284, P17808, DOI 10.1074/jbc.M809546200; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nechushtan H, 2009, ADV IMMUNOL, V103, P1, DOI 10.1016/S0065-2776(09)03001-6; Nesto RW, 2003, CIRCULATION, V108, P2941, DOI 10.1161/01.CIR.0000103683.99399.7E; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; O'Shea M, 2004, AM J CLIN NUTR, V79, p1199S, DOI 10.1093/ajcn/79.6.1199S; Park SG, 2005, P NATL ACAD SCI USA, V102, P6356, DOI 10.1073/pnas.0500226102; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Saito Y, 2010, AM J PHYSIOL-RENAL, V298, pF1436, DOI 10.1152/ajprenal.00512.2009; SAS Institute Inc, 2020, SAS STAT US GUID; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shirey KA, 2008, J IMMUNOL, V181, P4159, DOI 10.4049/jimmunol.181.6.4159; Sturla L, 2009, J BIOL CHEM, V284, P28045, DOI 10.1074/jbc.M109.035329; Szanto A, 2005, MOL PHARMACOL, V67, P1935, DOI 10.1124/mol.104.006445; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tsavkelova E A, 2006, Prikl Biokhim Mikrobiol, V42, P261; Welch JS, 2003, P NATL ACAD SCI USA, V100, P6712, DOI 10.1073/pnas.1031789100; Willems F, 2009, EUR J IMMUNOL, V39, P26, DOI 10.1002/eji.200838391; Yang CR, 2010, SHOCK, V33, P662, DOI 10.1097/SHK.0b013e3181cc0738; Yang TX, 2008, PPAR RES, V2008, DOI 10.1155/2008/943614; Zhang WC, 2009, GENE DEV, V23, P1387, DOI 10.1101/gad.1789209; Zocchi E, 2003, J CELL SCI, V116, P629, DOI 10.1242/jcs.00277; Zocchi E, 2001, P NATL ACAD SCI USA, V98, P14859, DOI 10.1073/pnas.261448698	63	78	87	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2504	2516		10.1074/jbc.M110.160077	http://dx.doi.org/10.1074/jbc.M110.160077			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21088297	Green Published, hybrid			2022-12-25	WOS:000286464300015
J	Herdendorf, TJ; Albrecht, DW; Benkovic, SJ; Nelson, SW				Herdendorf, Timothy J.; Albrecht, Dustin W.; Benkovic, Stephen J.; Nelson, Scott W.			Biochemical Characterization of Bacteriophage T4 Mre11-Rad50 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND-BREAK REPAIR; DEPENDENT DNA-REPLICATION; HOMOLOGOUS RECOMBINATION; NUCLEASE ACTIVITIES; ESCHERICHIA-COLI; GENE-32 PROTEIN; MULTIPLE ROLES; MRE11 NUCLEASE; UVSW PROTEIN; RAD50	The Mre11-Rad50 complex (MR) from bacteriophage T4 (gp46/47) is involved in the processing of DNA double-strand breaks. Here, we describe the activities of the T4 MR complex and its modulation by proteins involved in homologous recombination. T4 Mre11 is a Rad50- and Mn2+-dependent dsDNA exonuclease and ssDNA endonuclease. ATP hydrolysis is required for the removal of multiple nucleotides via dsDNA exonuclease activity but not for the removal of the first nucleotide or for ssDNA endonuclease activity, indicating ATP hydrolysis is only required for repetitive nucleotide removal. By itself, Rad50 is a relatively inefficient ATPase, but the presence of Mre11 and dsDNA increases ATP hydrolysis by 20-fold. The ATP hydrolysis reaction exhibits positive cooperativity with Hill coefficients ranging from 1.4 for Rad50 alone to 2.4 for the Rad50-Mre11-DNA complex. Kinetic assays suggest that approximately four nucleotides are removed per ATP hydrolyzed. Directionality assays indicate that the prevailing activity is a 3' to 5' dsDNA exonuclease, which is incompatible with the proposed role of MR in the production of 3' ssDNA ends. Interestingly, we found that in the presence of a recombination mediator protein (UvsY) and ssDNA-binding protein (gp32), Mre11 is capable of using Mg2+ as a cofactor for its nuclease activity. Additionally, the Mg2+-dependent nuclease activity, activated by UvsY and gp32, results in the formation of endonuclease reaction products. These results suggest that gp32 and UvsY may alter divalent cation preference and facilitate the formation of a 3' ssDNA overhang, which is a necessary intermediate for recombination-mediated double-strand break repair.	[Benkovic, Stephen J.] Penn State Univ, Dept Chem, Wartik Lab 414, University Pk, PA 16802 USA; [Herdendorf, Timothy J.; Albrecht, Dustin W.; Nelson, Scott W.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Iowa State University	Benkovic, SJ (corresponding author), Penn State Univ, Dept Chem, Wartik Lab 414, University Pk, PA 16802 USA.	sjb1@psu.edu; swn@iastate.edu			National Institutes of Health [GM013306]; Carver Trust [10-3603]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM013306] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carver Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM013306 (to S.J.B.). This work was also supported by Carver Trust Young Investigator Grant 10-3603 (to S.W.N.) and by Iowa State University institutional support (to S.W.N.).	Assenmacher N, 2004, CHROMOSOMA, V113, P157, DOI 10.1007/s00412-004-0306-4; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; Belanger KG, 1998, MOL CELL, V2, P693, DOI 10.1016/S1097-2765(00)80167-7; Benkovic SJ, 2001, ANNU REV BIOCHEM, V70, P181, DOI 10.1146/annurev.biochem.70.1.181; BERG JM, 1994, PRINCIPLES BIOINORGA, P103; Bhaskara V, 2007, MOL CELL, V25, P647, DOI 10.1016/j.molcel.2007.01.028; Bleuit JS, 2001, P NATL ACAD SCI USA, V98, P8298, DOI 10.1073/pnas.131007498; BLOOM LB, 1994, BIOCHEMISTRY-US, V33, P7576, DOI 10.1021/bi00190a010; Borde V, 2007, CHROMOSOME RES, V15, P551, DOI 10.1007/s10577-007-1147-9; Bressan DA, 1999, MOL CELL BIOL, V19, P7681; Buis J, 2008, CELL, V135, P85, DOI 10.1016/j.cell.2008.08.015; CarlesKinch K, 1997, EMBO J, V16, P4142, DOI 10.1093/emboj/16.13.4142; Chong SR, 1997, GENE, V192, P271, DOI 10.1016/S0378-1119(97)00105-4; Connelly JC, 2002, TRENDS BIOCHEM SCI, V27, P410, DOI 10.1016/S0968-0004(02)02144-8; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; DERR LK, 1990, J MOL BIOL, V214, P643, DOI 10.1016/0022-2836(90)90283-R; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; FORMOSA T, 1983, P NATL ACAD SCI-BIOL, V80, P2442, DOI 10.1073/pnas.80.9.2442; George JW, 1996, GENETICS, V143, P1507; George JW, 2001, P NATL ACAD SCI USA, V98, P8290, DOI 10.1073/pnas.131007598; Gilbert SP, 2000, METHODS, V22, P337, DOI 10.1006/meth.2000.1086; Helleday T, 2007, DNA REPAIR, V6, P923, DOI 10.1016/j.dnarep.2007.02.006; HINTON DM, 1986, J BIOL CHEM, V261, P5663; Hopfner KP, 2000, J BACTERIOL, V182, P6036, DOI 10.1128/JB.182.21.6036-6041.2000; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hopfner KP, 2003, CURR OPIN STRUC BIOL, V13, P249, DOI 10.1016/S0959-440X(03)00037-X; Hopfner KP, 2002, NATURE, V418, P562, DOI 10.1038/nature00922; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; Hopkins BB, 2008, CELL, V135, P250, DOI 10.1016/j.cell.2008.09.054; HOSODA J, 1974, FEBS LETT, V47, P338, DOI 10.1016/0014-5793(74)81043-4; IVANOV EL, 1994, MOL CELL BIOL, V14, P3414, DOI 10.1128/MCB.14.5.3414; Kinoshita E, 2009, CHROMOSOME RES, V17, P277, DOI 10.1007/s10577-008-9018-6; Kreuzer KN, 2005, ANNU REV MICROBIOL, V59, P43, DOI 10.1146/annurev.micro.59.030804.121255; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Lee JH, 2006, METHOD ENZYMOL, V408, P529, DOI 10.1016/S0076-6879(06)08033-5; LIELAUSIS A, 1963, COLD SPRING HARB SYM, P375; Miller ES, 2003, MICROBIOL MOL BIOL R, V67, P86, DOI 10.1128/MMBR.67.1.86-156.2003; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Moreno-Herrero F, 2005, NATURE, V437, P440, DOI 10.1038/nature03927; MORRICAL SW, 1990, J BIOL CHEM, V265, P15096; MOSIG G, 1968, COLD SPRING HARB SYM, V33, P361, DOI 10.1101/SQB.1968.033.01.042; Mosig G, 1998, ANNU REV GENET, V32, P379, DOI 10.1146/annurev.genet.32.1.379; MOSIG G, 1995, FEMS MICROBIOL REV, V17, P83, DOI 10.1111/j.1574-6976.1995.tb00190.x; MOSIG G, 1976, J VIROL, V17, P756, DOI 10.1128/JVI.17.3.756-761.1976; Myong S, 2007, SCIENCE, V317, P513, DOI 10.1126/science.1144130; Nelson SW, 2007, J BIOL CHEM, V282, P407, DOI 10.1074/jbc.M608153200; Nelson SW, 2009, VIRAL GENOME REPLICATION, P337, DOI 10.1007/b135974_16; NOSSAL NG, 1992, FASEB J, V6, P871, DOI 10.1096/fasebj.6.3.1310946; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Pant K, 2003, J MOL BIOL, V327, P571, DOI 10.1016/S0022-2836(03)00153-0; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Povirk LR, 2006, DNA REPAIR, V5, P1199, DOI 10.1016/j.dnarep.2006.05.016; Raaijmakers H, 1999, EMBO J, V18, P1447, DOI 10.1093/emboj/18.6.1447; Roca AI, 1997, PROG NUCLEIC ACID RE, V56, P129, DOI 10.1016/S0079-6603(08)61005-3; Sambrook J, 1989, MOL CLONING LAB MANU, V1 and 3; SHAMOO Y, 1995, NATURE, V376, P362, DOI 10.1038/376362a0; SHARPLES GJ, 1995, MOL MICROBIOL, V17, P1215, DOI 10.1111/j.1365-2958.1995.mmi_17061215_1.x; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Stohr BA, 2002, GENETICS, V162, P1019; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Trujillo KM, 1998, J BIOL CHEM, V273, P21447, DOI 10.1074/jbc.273.34.21447; Trujillo KM, 2001, J BIOL CHEM, V276, P35458, DOI 10.1074/jbc.M105482200; Valentine AM, 2001, BIOCHEMISTRY-US, V40, P15074, DOI 10.1021/bi0108554; Valerie K, 2003, ONCOGENE, V22, P5792, DOI 10.1038/sj.onc.1206679; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Williams RS, 2007, BIOCHEM CELL BIOL, V85, P509, DOI 10.1139/O07-069; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	69	44	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2382	2392		10.1074/jbc.M110.178871	http://dx.doi.org/10.1074/jbc.M110.178871			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21081488	Green Published, hybrid			2022-12-25	WOS:000286464300002
J	Martinez-Nunez, RT; Louafi, F; Sanchez-Elsner, T				Martinez-Nunez, Rocio T.; Louafi, Fethi; Sanchez-Elsner, Tilman			The Interleukin 13 (IL-13) Pathway in Human Macrophages Is Modulated by MicroRNA-155 via Direct Targeting of Interleukin 13 Receptor alpha 1 (IL13R alpha 1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; INFLAMMATORY RESPONSE; DENDRITIC CELLS; DOWN-REGULATION; T-CELLS; ACTIVATION; MICE; EXPRESSION; ASTHMA; GENE	Macrophages play a central role in the balance and efficiency of the immune response and are at the interface between innate and adaptive immunity. Their phenotype is a delicate equilibrium between the M1 (classical, pro-Th-1) and M2 (alternative, pro-Th-2) profiles. This balance is regulated by cytokines such as interleukin 13 (IL-13), a typical pro-M2-Th-2 cytokine that has been related to allergic disease and asthma. IL-13 binds to IL-13 receptor alpha 1 (IL13R alpha 1), a component of the Type II IL-4 receptor, and exerts its effects by activating the transcription factor signal transducer and activator of transcription 6 (STAT6) through phosphorylation. MicroRNAs are short (similar to 22 nucleotide) inhibitory non-coding RNAs that block the translation or promote the degradation of their specific mRNA targets. By bioinformatics analysis, we found that microRNA-155 (miR-155) is predicted to target IL13R alpha 1. This suggested that miR-155 might be involved in the regulation of the M1/M2 balance in macrophages by modulating IL-13 effects. miR-155 has been implicated in the development of a healthy immune system and function as well as in the inflammatory pro-Th-1/M1 immune profile. Here we have shown that in human macrophages, miR-155 directly targets IL13R alpha 1 and reduces the levels of IL13R alpha 1 protein, leading to diminished activation of STAT6. Finally we also demonstrate that miR-155 affects the IL-13-dependent regulation of several genes (SOCS1, DC-SIGN, CCL18, CD23, and SERPINE) involved in the establishment of an M2/pro-Th-2 phenotype in macrophages. Our work shows a central role for miR-155 in determining the M2 phenotype in human macrophages.	[Martinez-Nunez, Rocio T.; Louafi, Fethi; Sanchez-Elsner, Tilman] Univ Southampton, Southampton Gen Hosp, Sch Med, Div Infect Inflammat & Immun,JunkRNA Lab, Southampton SO16 6YD, Hants, England	University of Southampton	Sanchez-Elsner, T (corresponding author), Gen Hosp MP 813, Tremona Rd, Southampton SO16 6YD, Hants, England.	T.Sanchez-Elsner@soton.ac.uk		Martinez-Nunez, Rocio Teresa/0000-0003-2507-4738; Sanchez-Elsner, Tilman/0000-0003-1915-2410	Medical Research Council (MRC) [G0801984]; Medical Research Council [G0801984] Funding Source: researchfish; MRC [G0801984] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council (MRC) Grant G0801984 (to T.S.-E. and to F.L.).	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; De Nadai P, 2006, J IMMUNOL, V176, P6286, DOI 10.4049/jimmunol.176.10.6286; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Dominguez-Soto A, 2005, J BIOL CHEM, V280, P33123, DOI 10.1074/jbc.M503401200; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fuss IJ, 2008, MUCOSAL IMMUNOL, V1, pS31, DOI 10.1038/mi.2008.40; Gaspar NJ, 2007, MOL PHARMACOL, V72, P152, DOI 10.1124/mol.106.029025; Hebenstreit D, 2006, CYTOKINE GROWTH F R, V17, P173, DOI 10.1016/j.cytogfr.2006.01.004; Hershey GKK, 2003, J ALLERGY CLIN IMMUN, V111, P677, DOI 10.1067/mai.2003.1333; Hogan SP, 1997, J CLIN INVEST, V99, P1329, DOI 10.1172/JCI119292; Jiang H, 2000, J ALLERGY CLIN IMMUN, V105, P1063, DOI 10.1067/mai.2000.107604; Jiang SA, 2010, CANCER RES, V70, P3119, DOI 10.1158/0008-5472.CAN-09-4250; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Kolodsick JE, 2004, J IMMUNOL, V172, P4068, DOI 10.4049/jimmunol.172.7.4068; Lee C, 2009, CLIN EXP ALLERGY, V39, P897, DOI 10.1111/j.1365-2222.2009.03217.x; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Louafi F, 2010, J BIOL CHEM, V285, P41328, DOI 10.1074/jbc.M110.146852; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinez-Nunez RT, 2009, J BIOL CHEM, V284, P16334, DOI 10.1074/jbc.M109.011601; McCoy CE, 2010, J BIOL CHEM, V285, P20492, DOI 10.1074/jbc.M110.102111; MINTY A, 1993, NATURE, V362, P248, DOI 10.1038/362248a0; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; PUNNONEN J, 1993, P NATL ACAD SCI USA, V90, P3730, DOI 10.1073/pnas.90.8.3730; Ramalingam TR, 2008, NAT IMMUNOL, V9, P25, DOI 10.1038/ni1544; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Schutyser E, 2002, J BIOL CHEM, V277, P24584, DOI 10.1074/jbc.M112275200; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Watanabe Y, 2006, GENE, V365, P2, DOI 10.1016/j.gene.2005.09.035; Wills-Karp M, 2004, IMMUNOL REV, V202, P175, DOI 10.1111/j.0105-2896.2004.00215.x; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Worm J, 2009, NUCLEIC ACIDS RES, V37, P5784, DOI 10.1093/nar/gkp577; Wynn TA, 2003, ANNU REV IMMUNOL, V21, P425, DOI 10.1146/annurev.immunol.21.120601.141142	44	220	248	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1786	1794		10.1074/jbc.M110.169367	http://dx.doi.org/10.1074/jbc.M110.169367			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21097505	Green Published, hybrid			2022-12-25	WOS:000286191500018
J	Neumann, M; Seduk, F; Iobbi-Nivol, C; Leimkuhler, S				Neumann, Meina; Seduk, Farida; Iobbi-Nivol, Chantal; Leimkuehler, Silke			Molybdopterin Dinucleotide Biosynthesis in Escherichia coli IDENTIFICATION OF AMINO ACID RESIDUES OF MOLYBDOPTERIN DINUCLEOTIDE TRANSFERASES THAT DETERMINE SPECIFICITY FOR BINDING OF GUANINE OR CYTOSINE NUCLEOTIDES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLYBDENUM COFACTOR BIOSYNTHESIS; GUANINE DINUCLEOTIDE; CRYSTAL-STRUCTURE; CHAPERONE; MATURATION; COMPONENTS; DITHIOLENE; MECHANISM; REDUCTASE; INSIGHT	The molybdenum cofactor is modified by the addition of GMP or CMP to the C4' phosphate of molybdopterin forming the molybdopterin guanine dinucleotide or molybdopterin cytosine dinucleotide cofactor, respectively. The two reactions are catalyzed by specific enzymes as follows: the GTP: molybdopterin guanylyltransferase MobA and the CTP: molybdopterin cytidylyltransferase MocA. Both enzymes show 22% amino acid sequence identity and are specific for their respective nucleotides. Crystal structure analysis of MobA revealed two conserved motifs in the N-terminal domain of the protein involved in binding of the guanine base. Based on these motifs, we performed site-directed mutagenesis studies to exchange the amino acids to the sequence found in the paralogue MocA. Using a fully defined in vitro system, we showed that the exchange of five amino acids was enough to obtain activity with both GTP and CTP in either MocA or MobA. Exchange of the complete N-terminal domain of each protein resulted in the total inversion of nucleotide specificity activity, showing that the N-terminal domain determines nucleotide recognition and binding. Analysis of protein-protein interactions showed that the C-terminal domain of either MocA or MobA determines the specific binding to the respective acceptor protein.	[Neumann, Meina; Leimkuehler, Silke] Univ Potsdam, Inst Biochem & Biol, Dept Mol Enzymol, D-14476 Potsdam, Germany; [Seduk, Farida; Iobbi-Nivol, Chantal] CNRS, Chim Bacterienne Lab, IFR88, F-13402 Marseille 20, France	University of Potsdam; Centre National de la Recherche Scientifique (CNRS)	Leimkuhler, S (corresponding author), Univ Potsdam, Inst Biochem & Biol, Dept Mol Enzymol, D-14476 Potsdam, Germany.	sleim@uni-potsdam.de	Neumann-Schaal, Meina/AAM-6389-2021	Leimkuhler, Silke/0000-0003-3238-2122	Deutsche Forschungsgemeinschaft [LE1171/6-1]; DAAD	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DAAD(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by Deutsche Forschungsgemeinschaft Grant LE1171/6-1 and in part by DAAD PROCOPE program (to C.I.-N. and S.L.).	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Genes O, 2005, J BIOL CHEM, V280, P15644, DOI 10.1074/jbc.M501119200; Genest O, 2006, BIOCHEM BIOPH RES CO, V339, P991, DOI 10.1016/j.bbrc.2005.11.107; Genest O, 2008, J BIOL CHEM, V283, P21433, DOI 10.1074/jbc.M802954200; Guse A, 2003, J BIOL CHEM, V278, P25302, DOI 10.1074/jbc.M302639200; Gutzke G, 2001, J BIOL CHEM, V276, P36268, DOI 10.1074/jbc.M105321200; Hanzelmann P, 2004, P NATL ACAD SCI USA, V101, P12870, DOI 10.1073/pnas.0404624101; Hille R, 2002, TRENDS BIOCHEM SCI, V27, P360, DOI 10.1016/S0968-0004(02)02107-2; Ilbert M, 2003, J BIOL CHEM, V278, P28787, DOI 10.1074/jbc.M302730200; JOHNSON JL, 1991, J BIOL CHEM, V266, P12140; JOHNSON JL, 1990, P NATL ACAD SCI USA, V87, P3190, DOI 10.1073/pnas.87.8.3190; Joshi MS, 1996, J BACTERIOL, V178, P4310, DOI 10.1128/jb.178.14.4310-4312.1996; Lake MW, 2000, J BIOL CHEM, V275, P40211, DOI 10.1074/jbc.M007406200; McLuskey K, 2003, J BIOL CHEM, V278, P23706, DOI 10.1074/jbc.M301485200; Miller J.H., 1972, EXPT MOL GENETICS; Neumann M, 2006, J BIOL CHEM, V281, P15701, DOI 10.1074/jbc.M601617200; Neumann M, 2009, J BIOL CHEM, V284, P21891, DOI 10.1074/jbc.M109.008565; Neumann M, 2009, FEBS J, V276, P2762, DOI 10.1111/j.1742-4658.2009.07000.x; Nichols JD, 2007, BIOCHEMISTRY-US, V46, P78, DOI 10.1021/bi061551q; Nichols JD, 2005, J BIOL CHEM, V280, P7817, DOI 10.1074/jbc.M413783200; PALMER T, 1994, EUR J BIOCHEM, V222, P687, DOI 10.1111/j.1432-1033.1994.tb18913.x; PITTERLE DM, 1993, J BIOL CHEM, V268, P13506; Rajagopalan K. V., 1996, CELLULAR MOL BIOL, P674; RAJAGOPALAN KV, 1992, J BIOL CHEM, V267, P10199; Temple CA, 2000, ARCH BIOCHEM BIOPHYS, V383, P281, DOI 10.1006/abbi.2000.2089; Temple CA, 2000, J BIOL CHEM, V275, P40202, DOI 10.1074/jbc.M007407200; WUEBBENS MM, 1995, J BIOL CHEM, V270, P1082, DOI 10.1074/jbc.270.3.1082; Zhang Y, 2008, J MOL BIOL, V379, P881, DOI 10.1016/j.jmb.2008.03.051	29	21	24	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1400	1408		10.1074/jbc.M110.155671	http://dx.doi.org/10.1074/jbc.M110.155671			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21081498	hybrid, Green Published			2022-12-25	WOS:000286005000052
J	Gao, X; Shin, YH; Li, M; Wang, F; Tong, QA; Zhang, PM				Gao, Xue; Shin, Yong-Hyun; Li, Min; Wang, Fei; Tong, Qiang; Zhang, Pumin			The Fat Mass and Obesity Associated Gene FTO Functions in the Brain to Regulate Postnatal Growth in Mice	PLOS ONE			English	Article							ENERGY-INTAKE; FOOD-INTAKE; COMMON VARIANT; EXPRESSION; POLYMORPHISMS; POPULATION; MOUSE; BMI; REPLICATION; CHILDHOOD	FTO (fat mass and obesity associated) was identified as an obesity-susceptibility gene by several independent large-scale genome association studies. A cluster of SNPs (single nucleotide polymorphism) located in the first intron of FTO was found to be significantly associated with obesity-related traits, such as body mass index, hip circumference, and body weight. FTO encodes a protein with a novel C-terminal alpha-helical domain and an N-terminal double-strand beta-helix domain which is conserved in Fe(II) and 2-oxoglutarate-dependent oxygenase family. In vitro, FTO protein can demethylate single-stranded DNA or RNA with a preference for 3-methylthymine or 3-methyluracil. Its physiological substrates and function, however, remain to be defined. Here we report the generation and analysis of mice carrying a conditional deletion allele of Fto. Our results demonstrate that Fto plays an essential role in postnatal growth. The mice lacking Fto completely display immediate postnatal growth retardation with shorter body length, lower body weight, and lower bone mineral density than control mice, but their body compositions are relatively normal. Consistent with the growth retardation, the Fto mutant mice have reduced serum levels of IGF-1. Moreover, despite the ubiquitous expression of Fto, its specific deletion in the nervous system results in similar phenotypes as the whole body deletion, indicating that Fto functions in the central nerve system to regulate postnatal growth.	[Gao, Xue; Zhang, Pumin] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Shin, Yong-Hyun; Li, Min; Zhang, Pumin] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Wang, Fei; Tong, Qiang] Baylor Coll Med, Dept Pediat, Childrens Nutr Res Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Gao, X (corresponding author), Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA.	pzhang@bcm.tmc.edu			BCM Diabetes and Endocrinology Research Center (DERC) [P30 DK079638]; National Institutes of Health [CA116097, CA122623, EY019075]; NATIONAL CANCER INSTITUTE [R01CA116097, R01CA122623] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY019075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079638] Funding Source: NIH RePORTER	BCM Diabetes and Endocrinology Research Center (DERC); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The CLAMS experiments were performed using the service of the Mouse Metabolism Core at Baylor College of Medicine which is supported by the BCM Diabetes and Endocrinology Research Center (DERC) grant (P30 DK079638). XG is supported in part by a pilot grant from the DERC. PZ is supported by grants from National Institutes of Health (CA116097, CA122623, and EY019075). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassett JHD, 2008, BONE, V43, P418, DOI 10.1016/j.bone.2008.05.007; Berentzen T, 2008, J CLIN ENDOCR METAB, V93, P2904, DOI 10.1210/jc.2008-0007; Boissel S, 2009, AM J HUM GENET, V85, P106, DOI 10.1016/j.ajhg.2009.06.002; Cecil JE, 2008, NEW ENGL J MED, V359, P2558, DOI 10.1056/NEJMoa0803839; Cha SW, 2008, OBESITY, V16, P2185, DOI 10.1038/oby.2008.314; Chang YC, 2008, DIABETES, V57, P2245, DOI 10.2337/db08-0377; Church C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000599; Cornes BK, 2009, INT J OBESITY, V33, P75, DOI 10.1038/ijo.2008.223; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; FISCHER J, 2009, NATURE; Fischer J, 2010, NATURE, V464, pE2, DOI 10.1038/nature08808; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Gonzalez-Sanchez JL, 2009, CLIN ENDOCRINOL, V70, P390, DOI 10.1111/j.1365-2265.2008.03335.x; Grunnet LG, 2009, DIABETES, V58, P2402, DOI 10.2337/db09-0205; Hakanen M, 2009, J CLIN ENDOCR METAB, V94, P1281, DOI 10.1210/jc.2008-1199; HAN Z, NATURE, V464, P1205; Haupt A, 2009, EXP CLIN ENDOCR DIAB, V117, P194, DOI 10.1055/s-0028-1087176; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Hotta K, 2008, J HUM GENET, V53, P546, DOI 10.1007/s10038-008-0283-1; Hubacek JA, 2008, OBESITY, V16, P2764, DOI 10.1038/oby.2008.421; Jia GF, 2008, FEBS LETT, V582, P3313, DOI 10.1016/j.febslet.2008.08.019; Jonsson A, 2009, DIABETOLOGIA, V52, P1334, DOI 10.1007/s00125-009-1355-2; Kloting N, 2008, DIABETOLOGIA, V51, P641, DOI 10.1007/s00125-008-0928-9; Kreitschmann-Andermahr I, 2010, HORM RES PAEDIAT, V73, P153, DOI 10.1159/000284355; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Meyer CWE, 2004, ENDOCRINOLOGY, V145, P2531, DOI 10.1210/en.2003-1125; Meyre D, 2010, DIABETES, V59, P311, DOI 10.2337/db09-0703; Mishina Y, 2006, CHEM REV, V106, P215, DOI 10.1021/cr0404702; Mullis PE, 2005, EUR J ENDOCRINOL, V152, P11, DOI 10.1530/eje.1.01797; Ohashi J, 2007, J HUM GENET, V52, P1031, DOI 10.1007/s10038-007-0198-2; Ozer A, 2007, NAT CHEM BIOL, V3, P144, DOI 10.1038/nchembio863; Peeters A, 2008, MOL GENET METAB, V93, P481, DOI 10.1016/j.ymgme.2007.10.011; Peters T, 1999, MAMM GENOME, V10, P983, DOI 10.1007/s003359901121; Sanchez-Pulido Luis, 2007, BMC Biochemistry, V8, P23, DOI 10.1186/1471-2091-8-23; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Speakman JR, 2008, OBESITY, V16, P1961, DOI 10.1038/oby.2008.318; Speakman JR, 2010, NATURE, V464, pE1, DOI 10.1038/nature08807; SRIVENUGOPAL K, 1994, EXPERIENTIA, V50, P451, DOI 10.1007/BF01920745; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Timpson NJ, 2008, AM J CLIN NUTR, V88, P971, DOI 10.1093/ajcn/88.4.971; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tung YCL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008771; Villalobos-Comparan M, 2008, OBESITY, V16, P2296, DOI 10.1038/oby.2008.367; Wardle J, 2009, INT J OBESITY, V33, P42, DOI 10.1038/ijo.2008.174; Wardle J, 2008, J CLIN ENDOCR METAB, V93, P3640, DOI 10.1210/jc.2008-0472; Zabena C, 2009, OBES SURG, V19, P87, DOI 10.1007/s11695-008-9727-0; Zhang F, 2008, J ENDOCRINOL INVEST, V31, P1043, DOI 10.1007/BF03345646; Zhang PM, 2002, NAT GENET, V30, P31, DOI 10.1038/ng797	51	156	168	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e14005	10.1371/journal.pone.0014005	http://dx.doi.org/10.1371/journal.pone.0014005			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103374	Green Published, gold, Green Submitted			2022-12-25	WOS:000284257400009
J	Perez, PD; Hagen, SJ				Perez, Pablo Delfino; Hagen, Stephen J.			Heterogeneous Response to a Quorum-Sensing Signal in the Luminescence of Individual Vibrio fischeri	PLOS ONE			English	Article							GENE-EXPRESSION; BACTERIAL-CELLS; LIVING CELLS; BIOLUMINESCENCE; COLONIZATION; DIFFUSION; SYSTEMS; STOCHASTICITY; COMMUNICATION; REGULATOR	The marine bacterium Vibrio fischeri regulates its bioluminescence through a quorum sensing mechanism: the bacterium releases diffusible small molecules (autoinducers) that accumulate in the environment as the population density increases. This accumulation of autoinducer (AI) eventually activates transcriptional regulators for bioluminescence as well as host colonization behaviors. Although V. fischeri quorum sensing has been extensively characterized in bulk populations, far less is known about how it performs at the level of the individual cell, where biochemical noise is likely to limit the precision of luminescence regulation. We have measured the time-dependence and AI-dependence of light production by individual V. fischeri cells that are immobilized in a perfusion chamber and supplied with a defined concentration of exogenous AI. We use low-light level microscopy to record and quantify the photon emission from the cells over periods of several hours as they respond to the introduction of AI. We observe an extremely heterogeneous response to the AI signal. Individual cells differ widely in the onset time for their luminescence and in their resulting brightness, even in the presence of high AI concentrations that saturate the light output from a bulk population. The observed heterogeneity shows that although a given concentration of quorum signal may determine the average light output from a population of cells, it provides far weaker control over the luminescence output of each individual cell.	[Perez, Pablo Delfino; Hagen, Stephen J.] Univ Florida, Dept Phys, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Perez, PD (corresponding author), Univ Florida, Dept Phys, Gainesville, FL 32611 USA.	sjhagen@ufl.edu	Hagen, Stephen J/E-9737-2015	Hagen, Stephen J/0000-0002-3373-5033	National Science Foundation [MCB 0347124]	National Science Foundation(National Science Foundation (NSF))	National Science Foundation award MCB 0347124 (http://www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anetzberger C, 2009, MOL MICROBIOL, V73, P267, DOI 10.1111/j.1365-2958.2009.06768.x; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bose JL, 2008, ARCH MICROBIOL, V190, P169, DOI 10.1007/s00203-008-0387-1; Bose JL, 2007, MOL MICROBIOL, V65, P538, DOI 10.1111/j.1365-2958.2007.05809.x; Boyer M, 2009, FEMS MICROBIOL ECOL, V70, P1, DOI 10.1111/j.1574-6941.2009.00745.x; Cox Chris D., 2003, OMICS A Journal of Integrative Biology, V7, P317, DOI 10.1089/153623103322452422; Diggle SP, 2007, NATURE, V450, P411, DOI 10.1038/nature06279; Dunlap P.V., 1991, MICROBIAL CELL CELL, P219; Dunlap Paul V., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P5; Dunn AK, 2007, ANAL BIOANAL CHEM, V387, P391, DOI 10.1007/s00216-006-0730-9; EBERHARD A, 1972, J BACTERIOL, V109, P1101, DOI 10.1128/JB.109.3.1101-1105.1972; Goryachev AB, 2006, BIOSYSTEMS, V83, P178, DOI 10.1016/j.biosystems.2005.04.006; Greer LF, 2002, LUMINESCENCE, V17, P43, DOI 10.1002/bio.676; HAAS E, 1980, BIOPHYS J, V31, P301, DOI 10.1016/S0006-3495(80)85060-0; Hagen SJ, 2010, J BIOL PHYS, V36, P317, DOI 10.1007/s10867-010-9186-4; Hense BA, 2007, NAT REV MICROBIOL, V5, P230, DOI 10.1038/nrmicro1600; James S, 2000, J MOL BIOL, V296, P1127, DOI 10.1006/jmbi.1999.3484; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; KAPLAN HB, 1985, J BACTERIOL, V163, P1210, DOI 10.1128/JB.163.3.1210-1214.1985; Kuttler C, 2008, J THEOR BIOL, V251, P167, DOI 10.1016/j.jtbi.2007.11.015; Long T, 2009, PLOS BIOL, V7, P640, DOI 10.1371/journal.pbio.1000068; Lupp C, 2005, J BACTERIOL, V187, P3620, DOI 10.1128/JB.187.11.3620-3629.2005; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Mandel MJ, 2009, NATURE, V458, P215, DOI 10.1038/nature07660; Mehta P, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.79; Mihalcescu I, 2004, NATURE, V430, P81, DOI 10.1038/nature02533; Muller J, 2006, J MATH BIOL, V53, P672, DOI 10.1007/s00285-006-0024-z; Parent ME, 2008, COLLOID SURFACE B, V62, P180, DOI 10.1016/j.colsurfb.2007.09.031; Phiefer CB, 1999, LUMINESCENCE, V14, P147, DOI 10.1002/(SICI)1522-7243(199905/06)14:3<147::AID-BIO532>3.0.CO;2-C; Redfield RJ, 2002, TRENDS MICROBIOL, V10, P365, DOI 10.1016/S0966-842X(02)02400-9; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; RUBY EG, 1976, BIOL BULL, V151, P574, DOI 10.2307/1540507; Schwille P, 1999, BIOPHYS J, V77, P2251, DOI 10.1016/S0006-3495(99)77065-7; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Sternberg C, 1997, J BIOLUM CHEMILUM, V12, P7, DOI 10.1002/(SICI)1099-1271(199701/02)12:1<7::AID-BIO427>3.0.CO;2-3; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Tanouchi Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000167; Teng SW, 2010, BIOPHYS J, V98, P2024, DOI 10.1016/j.bpj.2010.01.031; Tong D, 2009, P NATL ACAD SCI USA, V106, P9836, DOI 10.1073/pnas.0904571106; Visick KL, 2000, J BACTERIOL, V182, P4578, DOI 10.1128/JB.182.16.4578-4586.2000; Visick KL, 2005, J BACTERIOL, V187, P3603, DOI 10.1128/JB.187.11.3603-3606.2005; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Williams JW, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.70; Yarwood JM, 2005, P NATL ACAD SCI USA, V102, P9008, DOI 10.1073/pnas.0503728102; Zhou TS, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.178103	45	47	48	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e15473	10.1371/journal.pone.0015473	http://dx.doi.org/10.1371/journal.pone.0015473			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103327	Green Submitted, gold, Green Published			2022-12-25	WOS:000284257400025
J	Havelaar, AH; van Rosse, F; Bucura, C; Toetenel, MA; Haagsma, JA; Kurowicka, D; Heesterbeek, JAP; Speybroeck, N; Langelaar, MFM; van der Giessen, JWB; Cooke, RM; Braks, MAH				Havelaar, Arie H.; van Rosse, Floor; Bucura, Catalin; Toetenel, Milou A.; Haagsma, Juanita A.; Kurowicka, Dorota; Heesterbeek, J. (Hans) A. P.; Speybroeck, Niko; Langelaar, Merel F. M.; van der Giessen, Johanna W. B.; Cooke, Roger M.; Braks, Marieta A. H.			Prioritizing Emerging Zoonoses in The Netherlands	PLOS ONE			English	Article							RISK; INFECTIONS; PATHOGENS; DISEASES	Background: To support the development of early warning and surveillance systems of emerging zoonoses, we present a general method to prioritize pathogens using a quantitative, stochastic multi-criteria model, parameterized for the Netherlands. Methodology/Principal Findings: A risk score was based on seven criteria, reflecting assessments of the epidemiology and impact of these pathogens on society. Criteria were weighed, based on the preferences of a panel of judges with a background in infectious disease control. Conclusions/Significance: Pathogens with the highest risk for the Netherlands included pathogens in the livestock reservoir with a high actual human disease burden (e.g.Campylobacter spp., Toxoplasma gondii, Coxiella burnetii) or a low current but higher historic burden (e.g. Mycobacterium bovis), rare zoonotic pathogens in domestic animals with severe disease manifestations in humans (e.g. BSE prion, Capnocytophaga canimorsus) as well as arthropod-borne and wildlife associated pathogens which may pose a severe risk in future (e.g. Japanese encephalitis virus and West-Nile virus). These agents are key targets for development of early warning and surveillance.	[Havelaar, Arie H.; Haagsma, Juanita A.; Heesterbeek, J. (Hans) A. P.; Langelaar, Merel F. M.; van der Giessen, Johanna W. B.; Braks, Marieta A. H.] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands; [Havelaar, Arie H.; van Rosse, Floor] Univ Utrecht, Utrecht, Netherlands; [Bucura, Catalin; Kurowicka, Dorota; Cooke, Roger M.] Delft Univ Technol, Delft, Netherlands; [Toetenel, Milou A.] Univ Wageningen & Res Ctr, Wageningen, Netherlands; [Haagsma, Juanita A.] Erasmus MC, Rotterdam, Netherlands; [Speybroeck, Niko] Inst Trop Med, B-2000 Antwerp, Belgium; [Speybroeck, Niko] Catholic Univ Louvain, Inst Hlth & Soc, B-1200 Brussels, Belgium	Netherlands National Institute for Public Health & the Environment; Utrecht University; Delft University of Technology; Wageningen University & Research; Erasmus University Rotterdam; Erasmus MC; Institute of Tropical Medicine (ITM); Universite Catholique Louvain	Havelaar, AH (corresponding author), Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands.	arie.havelaar@rivm.nl	Smith, Gary B/A-8235-2013; Zixuan, Huang/ABI-3557-2020; Havelaar, Arie H./P-8495-2014	Havelaar, Arie H./0000-0002-6456-5460; Heesterbeek, Hans/0000-0001-8537-6418; Speybroeck, Niko/0000-0003-3322-3502	Dutch Ministry of Agriculture, Nature and Food Quality	Dutch Ministry of Agriculture, Nature and Food Quality	The EmZoo project is funded by the Dutch Ministry of Agriculture, Nature and Food Quality (www.minlnv.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, other than guidance and feedback by the EmZoo Supervisory Committee on the relevance of criteria for policy decisions.	Brown C, 2004, REV SCI TECH OIE, V23, P435, DOI 10.20506/rst.23.2.1495; Cardoen S, 2009, FOODBORNE PATHOG DIS, V6, P1083, DOI 10.1089/fpd.2009.0291; Fauci AS, 2005, ACAD MED, V80, P1079, DOI 10.1097/00001888-200512000-00002; King LJ, 2004, REV SCI TECH OIE, V23, P717, DOI 10.20506/rst.23.2.1507; Krause G, 2008, EURO SURVEILL, V13; KUROWICKA D, 2010, RISK ANAL; McKenzie J, 2007, PREV VET MED, V81, P194, DOI 10.1016/j.prevetmed.2007.04.003; Morgan D, 2009, EPIDEMIOL INFECT, V137, P1521, DOI 10.1017/S0950268809990227; Mourits MCM, 2007, WAG UR FRON, V20, P131; NESLOO REJ, APPL STOCHASTIC MODE; Palmer S, 2005, BMJ-BRIT MED J, V331, P1256, DOI 10.1136/bmj.331.7527.1256; Speybroeck N, 2004, AGR SYST, V80, P133, DOI 10.1016/j.agsy.2003.06.006; Steinberg D., 1995, CART TREE STRUCTURED; Tait J., 2006, FORESIGHT INFECT DIS; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Valenciano M., 2001, DEFINITION PRIORITES; VANDERGIESSEN J, 2002, ZOONOSES EUROPE RISK; Vorou RM, 2007, EPIDEMIOL INFECT, V135, P1231, DOI 10.1017/S0950268807008527; Walsh AL, 2005, VET REC, V157, P684, DOI 10.1136/vr.157.22.684; 2004, WHOFAOOIEWHOCDSCPEZF	20	106	107	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e13965	10.1371/journal.pone.0013965	http://dx.doi.org/10.1371/journal.pone.0013965			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085625	Green Published, Green Submitted, gold			2022-12-25	WOS:000284231800005
J	Ruppender, NS; Merkel, AR; Martin, TJ; Mundy, GR; Sterling, JA; Guelcher, SA				Ruppender, Nazanin S.; Merkel, Alyssa R.; Martin, T. John; Mundy, Gregory R.; Sterling, Julie A.; Guelcher, Scott A.			Matrix Rigidity Induces Osteolytic Gene Expression of Metastatic Breast Cancer Cells	PLOS ONE			English	Article							HORMONE-RELATED PROTEIN; GROWTH-FACTOR; PEPTIDE GENE; IN-VIVO; BONE; HEDGEHOG; KINASE; ACTIVATION; MIGRATION; STIFFNESS	Nearly 70% of breast cancer patients with advanced disease will develop bone metastases. Once established in bone, tumor cells produce factors that cause changes in normal bone remodeling, such as parathyroid hormone-related protein (PTHrP). While enhanced expression of PTHrP is known to stimulate osteoclasts to resorb bone, the environmental factors driving tumor cells to express PTHrP in the early stages of development of metastatic bone disease are unknown. In this study, we have shown that tumor cells known to metastasize to bone respond to 2D substrates with rigidities comparable to that of the bone microenvironment by increasing expression and production of PTHrP. The cellular response is regulated by Rhodependent actomyosin contractility mediated by TGF-beta signaling. Inhibition of Rho-associated kinase (ROCK) using both pharmacological and genetic approaches decreased PTHrP expression. Furthermore, cells expressing a dominant negative form of the TGF-beta receptor did not respond to substrate rigidity, and inhibition of ROCK decreased PTHrP expression induced by exogenous TGF-beta. These observations suggest a role for the differential rigidity of the mineralized bone microenvironment in early stages of tumor-induced osteolysis, which is especially important in metastatic cancer since many cancers (such as those of the breast and lung) preferentially metastasize to bone.	[Ruppender, Nazanin S.; Guelcher, Scott A.] Vanderbilt Univ, Dept Chem & Biomol Engn, Nashville, TN 37235 USA; [Ruppender, Nazanin S.; Merkel, Alyssa R.; Martin, T. John; Mundy, Gregory R.; Sterling, Julie A.; Guelcher, Scott A.] Vanderbilt Univ, Med Ctr, Ctr Bone Biol, Nashville, TN USA; [Merkel, Alyssa R.; Mundy, Gregory R.] Vanderbilt Univ, Med Ctr, Dept Med, Div Clin Pharmacol, Nashville, TN USA; [Mundy, Gregory R.; Sterling, Julie A.] Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN USA; [Sterling, Julie A.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA; [Martin, T. John] St Vincents Inst, Melbourne, Vic, Australia	Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; St. Vincent's Institute of Medical Research	Ruppender, NS (corresponding author), Vanderbilt Univ, Dept Chem & Biomol Engn, Nashville, TN 37235 USA.	scott.guelcher@vanderbilt.edu		Merkel, Alyssa/0000-0001-6498-4211	National Institutes of Health Breast Cancer SPORE [P50 CA098131, P01 CA040035]; Tumor Microenvironment Network (TMEN) [U54 CA126505]; NATIONAL CANCER INSTITUTE [P50CA098131, P01CA040035, U54CA126505] Funding Source: NIH RePORTER	National Institutes of Health Breast Cancer SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tumor Microenvironment Network (TMEN); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors acknowledge financial support from the National Institutes of Health Breast Cancer SPORE (P50 CA098131), P01 CA040035, and Tumor Microenvironment Network (TMEN) (U54 CA126505) grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander NR, 2008, CURR BIOL, V18, P1295, DOI 10.1016/j.cub.2008.07.090; Baker AB, 2008, CIRC RES, V103, P289, DOI 10.1161/CIRCRESAHA.108.179465; Barman SA, 2009, VASC HEALTH RISK MAN, V5, P663, DOI 10.2147/VHRM.S4711; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Candiello J, 2007, FEBS J, V274, P2897, DOI 10.1111/j.1742-4658.2007.05823.x; Cuppone M, 2004, CALCIFIED TISSUE INT, V74, P302, DOI 10.1007/s00223-002-2123-1; DAIFOTIS AG, 1992, J BIOL CHEM, V267, P23455; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Eichberger T, 2008, J BIOL CHEM, V283, P12426, DOI 10.1074/jbc.M707117200; Enderling H, 2008, BIOPHYS J, V95, P2203, DOI 10.1529/biophysj.108.133199; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; GUELCHER S, 2008, TISSUE ENG IN PRESS; Guelcher SA, 2008, BIOMATERIALS, V29, P1762, DOI 10.1016/j.biomaterials.2007.12.046; Guise TA, 1996, J CLIN INVEST, V98, P1544, DOI 10.1172/JCI118947; GUISE TA, 1993, J CLIN ENDOCR METAB, V77, P40, DOI 10.1210/jc.77.1.40; Hafeman AE, 2008, PHARM RES-DORDR, V25, P2387, DOI 10.1007/s11095-008-9618-z; Hotte SJ, 2002, CANCER-AM CANCER SOC, V95, P506, DOI 10.1002/cncr.10709; Itoh K, 1999, NAT MED, V5, P221, DOI 10.1038/5587; Javelaud D, 2007, CANCER RES, V67, P2317, DOI 10.1158/0008-5472.CAN-06-3950; JOHNSON RW, CANC RES UNPUB; Kakonen SM, 2002, J BIOL CHEM, V277, P24571, DOI 10.1074/jbc.M202561200; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; KHATIWALA CB, 2006, J CELLULAR PHYSL, V211, P661; Kostic A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006361; Liu SJ, 2009, CANCER RES, V69, P8742, DOI 10.1158/0008-5472.CAN-09-1541; Miao DS, 2004, EXP CELL RES, V294, P210, DOI 10.1016/j.yexcr.2003.10.021; Mill P, 2003, GENE DEV, V17, P282, DOI 10.1101/gad.1038103; Moore SW, 2010, DEV CELL, V19, P194, DOI 10.1016/j.devcel.2010.07.018; Narumiya S, 2009, CANCER METAST REV, V28, P65, DOI 10.1007/s10555-008-9170-7; Nowlan NC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000250; OHNO M, 1995, J CLIN INVEST, V95, P1363, DOI 10.1172/JCI117787; Paszek MJ, 2004, J MAMMARY GLAND BIOL, V9, P325, DOI 10.1007/s10911-004-1404-x; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Philbrick WM, 1996, PHYSIOL REV, V76, P127, DOI 10.1152/physrev.1996.76.1.127; PIROLA CJ, 1994, ENDOCRINOLOGY, V134, P2230, DOI 10.1210/en.134.5.2230; POWELL GJ, 1991, CANCER RES, V51; Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682; Sakata R, 2004, EUR J CLIN INVEST, V34, P129, DOI 10.1111/j.1365-2362.2004.01302.x; SOUTHBY J, 1990, CANCER RES, V50, P7710; Sperling L. H., 2001, INTRO PHYS POLYM SCI; Sterling JA, 2006, CANCER RES, V66, P7548, DOI 10.1158/0008-5472.CAN-06-0452; Tang GH, 2004, J DENT RES, V83, P434, DOI 10.1177/154405910408300516; THIEDE MA, 1990, P NATL ACAD SCI USA, V87, P6969, DOI 10.1073/pnas.87.18.6969; THIEDE MA, 1988, SCIENCE, V242, P278, DOI 10.1126/science.3175653; VanderVeldeZimmermann D, 1997, EXP CELL RES, V230, P111, DOI 10.1006/excr.1996.3405; Wells RG, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.110pe13; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; YAMAMOTO M, 1992, P NATL ACAD SCI USA, V89, P5326, DOI 10.1073/pnas.89.12.5326; Yin JJ, 1999, J CLIN INVEST, V103, P197, DOI 10.1172/JCI3523; Zaman MH, 2005, BIOPHYS J, V89, P1389, DOI 10.1529/biophysj.105.060723; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103	51	59	60	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e15451	10.1371/journal.pone.0015451	http://dx.doi.org/10.1371/journal.pone.0015451			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085597	Green Published, Green Submitted, gold			2022-12-25	WOS:000284231800033
J	Brandariz-Nunez, A; Menaya-Vargas, R; Benavente, J; Martinez-Costas, J				Brandariz-Nunez, Alberto; Menaya-Vargas, Rebeca; Benavente, Javier; Martinez-Costas, Jose			A Versatile Molecular Tagging Method for Targeting Proteins to Avian Reovirus muNS Inclusions. Use in Protein Immobilization and Purification	PLOS ONE			English	Article							SIGMA-NS; VIRUS; MORPHOGENESIS; AGGRESOMES; SITES	Background: Avian reoviruses replicate in viral factories, which are dense cytoplasmic compartments estabilished by protein-protein interactions. The non-structural protein muNS forms the factory scaffold that attracts other viral components in a controlled fashion. To create such a three-dimensional network, muNS uses several different self-interacting domains. Methodology/Principal Findings: In this study we have devised a strategy to identify muNS regions containing self-interacting domains, based on the capacity of muNS-derived inclusions to recruit muNS fragments. The results revealed that the muNS region consisting of residues 477-542 was recruited with the best efficiency, and this raised the idea of using this fragment as a molecular tag for delivering foreign proteins to muNS inclusions. By combining such tagging system with our previously established method for purifying muNS inclusions from baculovirus-infected insect cells, we have developed a novel protein purification protocol. Conclusions/Significance: We show that our tagging and inclusion-targeting system can be a simple, versatile and efficient method for immobilizing and purifying active proteins expressed in baculovirus-infected cells. We also demonstrate that muNS inclusions can simultaneously recruit several tagged proteins, a finding which may be used to generate protein complexes and create multiepitope particulate material for immunization purposes.	[Brandariz-Nunez, Alberto] Univ Santiago de Compostela, Dept Biochem & Mol Biol, Fac Pharm, Santiago De Compostela, Spain; Univ Santiago de Compostela, Ctr Res Biol Chem & Mol Mat, Santiago De Compostela, Spain	Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; CiQUS	Brandariz-Nunez, A (corresponding author), Univ Santiago de Compostela, Dept Biochem & Mol Biol, Fac Pharm, Santiago De Compostela, Spain.		Brandariz, Alberto/S-2630-2016; Benavente, Javier/N-6475-2016; Martinez-Costas, Jose/E-9005-2011	Brandariz, Alberto/0000-0002-0640-1599; Benavente, Javier/0000-0003-4857-0312; Martinez-Costas, Jose/0000-0002-8877-7775	European Commission [ERAS-CT-2003-980409]; European Science Foundation; Spanish Ministerio de Ciencia y Tecnologia [BFU2007-61330, BFU 205-24982-E]; Xunta de Galicia [08CSA009203PR]	European Commission(European CommissionEuropean Commission Joint Research Centre); European Science Foundation(European Science Foundation (ESF)European Commission); Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Xunta de Galicia(Xunta de GaliciaEuropean Commission)	This work was supported by grants from the European Commission under contracts ERAS-CT-2003-980409 (as part of the European Science Foundation EUROCORES Programme EuroSCOPE, web: http://www.esf.org/euroscope); the Spanish Ministerio de Ciencia y Tecnologia (BFU2007-61330, BFU 205-24982-E, web: http://www.mityc.es/) and Xunta de Galicia (08CSA009203PR, web: http://www.conselleriaiei.org/ga/dxidi/index.php). ABN was the recipient of a predoctoral FPI fellowship from the Spanish Ministerio de Ciencia y Tecnologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attoui H, 2000, J GEN VIROL, V81, P1507, DOI 10.1099/0022-1317-81-6-1507; Baird GS, 2000, P NATL ACAD SCI USA, V97, P11984, DOI 10.1073/pnas.97.22.11984; Benavente J, 2006, CURR TOP MICROBIOL, V309, P67; Benavente J, 2007, VIRUS RES, V123, P105, DOI 10.1016/j.virusres.2006.09.005; Brandariz-Nunez A, 2010, J VIROL, V84, P4289, DOI 10.1128/JVI.02534-09; Broering TJ, 2005, J VIROL, V79, P6194, DOI 10.1128/JVI.79.10.6194-6206.2005; Broering TJ, 2002, J VIROL, V76, P8285, DOI 10.1128/JVI.76.16.8285-8297.2002; Duncan R, 1996, VIROLOGY, V224, P453, DOI 10.1006/viro.1996.0552; Friedlander P, 1996, MOL CELL BIOL, V16, P4961; Hsiao J, 2002, VIROLOGY, V296, P288, DOI 10.1006/viro.2002.1427; Jones RC, 2000, REV SCI TECH OIE, V19, P614, DOI 10.20506/rst.19.2.1237; Los GV, 2007, METH MOL B, V356, P195; MARTINEZCOSTAS J, 1995, VIROLOGY, V206, P1017, DOI 10.1006/viro.1995.1024; Mertens P, 2004, VIRUS RES, V101, P3, DOI 10.1016/j.virusres.2003.12.002; Miller CL, 2010, J VIROL, V84, P867, DOI 10.1128/JVI.01571-09; Roy P, 1996, INTERVIROLOGY, V39, P62, DOI 10.1159/000150476; Touris-Otero F, 2004, J MOL BIOL, V341, P361, DOI 10.1016/j.jmb.2004.06.026; Touris-Otero F, 2004, VIROLOGY, V319, P94, DOI 10.1016/j.virol.2003.10.034; van der Heide L, 2000, AVIAN DIS, V44, P638, DOI 10.2307/1593104; Wileman T, 2006, SCIENCE, V312, P875, DOI 10.1126/science.1126766; Wileman T, 2007, ANNU REV MICROBIOL, V61, P149, DOI 10.1146/annurev.micro.57.030502.090836; Zhang X, 2005, VIROLOGY, V343, P25, DOI 10.1016/j.virol.2005.08.002	22	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e13961	10.1371/journal.pone.0013961	http://dx.doi.org/10.1371/journal.pone.0013961			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103063	Green Published, gold, Green Submitted			2022-12-25	WOS:000284147700012
J	Sainsbury, F; Sack, M; Stadlmann, J; Quendler, H; Fischer, R; Lomonossoff, GP				Sainsbury, Frank; Sack, Markus; Stadlmann, Johannes; Quendler, Heribert; Fischer, Rainer; Lomonossoff, George P.			Rapid Transient Production in Plants by Replicating and Non-Replicating Vectors Yields High Quality Functional Anti-HIV Antibody	PLOS ONE			English	Article							COWPEA MOSAIC-VIRUS; MONOCLONAL-ANTIBODY; ENDOPLASMIC-RETICULUM; PASSIVE TRANSFER; VIRAL VECTORS; HIGH-LEVEL; FULL-LENGTH; PROTEINS; EXPRESSION; PROTECTION	Background: The capacity of plants and plant cells to produce large amounts of recombinant protein has been well established. Due to advantages in terms of speed and yield, attention has recently turned towards the use of transient expression systems, including viral vectors, to produce proteins of pharmaceutical interest in plants. However, the effects of such high level expression from viral vectors and concomitant effects on host cells may affect the quality of the recombinant product. Methodology/Principal Findings: To assess the quality of antibodies transiently expressed to high levels in plants, we have expressed and characterised the human anti-HIV monoclonal antibody, 2G12, using both replicating and non-replicating systems based on deleted versions of Cowpea mosaic virus (CPMV) RNA-2. The highest yield (approximately 100 mg/kg wet weight leaf tissue) of affinity purified 2G12 was obtained when the non-replicating CPMV-HT system was used and the antibody was retained in the endoplasmic reticulum (ER). Glycan analysis by mass-spectrometry showed that the glycosylation pattern was determined exclusively by whether the antibody was retained in the ER and did not depend on whether a replicating or non-replicating system was used. Characterisation of the binding and neutralisation properties of all the purified 2G12 variants from plants showed that these were generally similar to those of the Chinese hamster ovary (CHO) cell-produced 2G12. Conclusions: Overall, the results demonstrate that replicating and non-replicating CPMV-based vectors are able to direct the production of a recombinant IgG similar in activity to the CHO-produced control. Thus, a complex recombinant protein was produced with no apparent effect on its biochemical properties using either high-level expression or viral replication. The speed with which a recombinant pharmaceutical with excellent biochemical characteristics can be produced transiently in plants makes CPMV-based expression vectors an attractive option for biopharmaceutical development and production.	[Sainsbury, Frank; Lomonossoff, George P.] John Innes Ctr, Dept Biol Chem, Norwich, Norfolk, England; [Sack, Markus; Fischer, Rainer] Rhein Westfal TH Aachen, Inst Mol Biotechnol, Aachen, Germany; [Stadlmann, Johannes] Univ Nat Resources & Appl Life Sci, Dept Chem, Vienna, Austria; [Quendler, Heribert] Univ Nat Resources & Appl Life Sci, Inst Appl Microbiol, Vienna, Austria; [Fischer, Rainer] Fraunhofer Inst Mol Biol & Appl Ecol, Aachen, Germany	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; RWTH Aachen University; University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna; Fraunhofer Gesellschaft	Sainsbury, F (corresponding author), Univ Laval, Dept Phytol, Quebec City, PQ G1K 7P4, Canada.	frank.sainsbury.1@ulaval.ca	Sack, Markus/K-6681-2013; Sainsbury, Frank/I-2311-2013; Sack, Markus/AAP-9252-2021; Stadlmann, Johannes/AAC-3157-2021	Sack, Markus/0000-0002-7380-9228; Sainsbury, Frank/0000-0001-8152-3820; Stadlmann, Johannes/0000-0001-5693-6690	EU; Marie Curie Early Stage Training Fellowship [MEST-CT-2004-504273]; Trustees of the John Innes Foundation; Biotechnology and Biological Sciences Research Council, U.K.; Biotechnology and Biological Sciences Research Council [BBS/E/J/0000A182] Funding Source: researchfish	EU(European Commission); Marie Curie Early Stage Training Fellowship(European Commission); Trustees of the John Innes Foundation; Biotechnology and Biological Sciences Research Council, U.K.(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work described in this report was funded under the EU FP6 PharmaPlanta project. F. S. also acknowledges funding from a Marie Curie Early Stage Training Fellowship MEST-CT-2004-504273 and the Trustees of the John Innes Foundation. The John Innes Centre is supported by a Grant-in-Aid from the Biotechnology and Biological Sciences Research Council, U.K. (http://www.bbsrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlquist P, 2005, VACCINE, V23, P1784, DOI 10.1016/j.vaccine.2004.11.005; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Canizares MC, 2006, PLANT BIOTECHNOL J, V4, P183, DOI 10.1111/j.1467-7652.2005.00170.x; Canizares MC, 2005, IMMUNOL CELL BIOL, V83, P263, DOI 10.1111/j.1440-1711.2005.01339.x; Carette JE, 2000, J VIROL, V74, P6556, DOI 10.1128/JVI.74.14.6556-6563.2000; Carette JE, 2002, J VIROL, V76, P6235, DOI 10.1128/JVI.76.12.6235-6243.2002; Carette JE, 2002, J VIROL, V76, P6293, DOI 10.1128/JVI.76.12.6293-6301.2002; Castro C, 2005, VIRUS RES, V107, P141, DOI 10.1016/j.virusres.2004.11.004; Domingo E, 2000, VIROLOGY, V270, P251, DOI 10.1006/viro.2000.0320; Domingo E, 1996, FASEB J, V10, P859, DOI 10.1096/fasebj.10.8.8666162; Drake JW, 1999, P NATL ACAD SCI USA, V96, P13910, DOI 10.1073/pnas.96.24.13910; Giritch A, 2006, P NATL ACAD SCI USA, V103, P14701, DOI 10.1073/pnas.0606631103; Gleba Y, 2007, CURR OPIN BIOTECH, V18, P134, DOI 10.1016/j.copbio.2007.03.002; Gomord W, 2004, PLANT BIOTECHNOL J, V2, P83, DOI 10.1111/j.1467-7652.2004.00062.x; Goulet C, 2010, PROTEOMICS, V10, P2536, DOI 10.1002/pmic.200900382; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; HOLLAND J, 1982, SCIENCE, V215, P1577, DOI 10.1126/science.7041255; Holland T, 2010, BIOTECHNOL BIOENG, V107, P278, DOI 10.1002/bit.22800; Huang Z, 2010, BIOTECHNOL BIOENG, V106, P9, DOI 10.1002/bit.22652; Huang Z, 2009, BIOTECHNOL BIOENG, V103, P706, DOI 10.1002/bit.22299; Kathuria S, 2002, HUM REPROD, V17, P2054, DOI 10.1093/humrep/17.8.2054; KEESE P, 1993, CURR OPIN GENET DEV, V3, P873, DOI 10.1016/0959-437X(93)90007-C; Kolarich D, 2000, ANAL BIOCHEM, V285, P64, DOI 10.1006/abio.2000.4737; Komarova TV, 2006, BIOCHEMISTRY-MOSCOW+, V71, P846, DOI 10.1134/S0006297906080049; Kushner DB, 2003, P NATL ACAD SCI USA, V100, P15764, DOI 10.1073/pnas.2536857100; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laliberte JF, 2010, ANNU REV PHYTOPATHOL, V48, P69, DOI 10.1146/annurev-phyto-073009-114239; Lico C, 2008, J CELL PHYSIOL, V216, P366, DOI 10.1002/jcp.21423; Lindbo JA, 2007, PLANT PHYSIOL, V145, P1232, DOI 10.1104/pp.107.106377; Mascola JR, 2002, J VIROL, V76, P4810, DOI 10.1128/JVI.76.10.4810-4821.2002; Mascola JR, 2002, VACCINE, V20, P1922, DOI 10.1016/S0264-410X(02)00068-3; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Rademacher T, 2008, PLANT BIOTECHNOL J, V6, P189, DOI 10.1111/j.1467-7652.2007.00306.x; Ramessar K, 2008, P NATL ACAD SCI USA, V105, P3727, DOI 10.1073/pnas.0708841104; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sack M, 2007, FASEB J, V21, P1655, DOI 10.1096/fj.06-5863com; Sainsbury F, 2008, PLANT PHYSIOL, V148, P1212, DOI 10.1104/pp.108.126284; Sainsbury F, 2008, PLANT BIOTECHNOL J, V6, P82, DOI 10.1111/j.1467-7652.2007.00303.x; Sainsbury F, 2010, ANNU REV PHYTOPATHOL, V48, P437, DOI 10.1146/annurev-phyto-073009-114242; Sainsbury F, 2009, PLANT BIOTECHNOL J, V7, P682, DOI 10.1111/j.1467-7652.2009.00434.x; Sainsbury Frank, 2009, V483, P25, DOI 10.1007/978-1-59745-407-0_2; Schahs M, 2007, PLANT BIOTECHNOL J, V5, P657, DOI 10.1111/j.1467-7652.2007.00273.x; Sriraman R, 2004, PLANT BIOTECHNOL J, V2, P279, DOI 10.1111/j.1467-7652.2004.00078.x; Stevens LH, 2000, PLANT PHYSIOL, V124, P173, DOI 10.1104/pp.124.1.173; Stoger E, 2005, CURR PHARM DESIGN, V11, P2439, DOI 10.2174/1381612054367535; Strasser R, 2008, PLANT BIOTECHNOL J, V6, P392, DOI 10.1111/j.1467-7652.2008.00330.x; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; van der Hoorn RAL, 2004, CURR OPIN PLANT BIOL, V7, P400, DOI 10.1016/j.pbi.2004.04.003; VANENGELEN FA, 1995, TRANSGENIC RES, V4, P288, DOI 10.1007/BF01969123; Vaquero C, 1999, P NATL ACAD SCI USA, V96, P11128, DOI 10.1073/pnas.96.20.11128; Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833; Verch T, 1998, J IMMUNOL METHODS, V220, P69, DOI 10.1016/S0022-1759(98)00149-5; Vezina LP, 2009, PLANT BIOTECHNOL J, V7, P442, DOI 10.1111/j.1467-7652.2009.00414.x; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Villani ME, 2009, PLANT BIOTECHNOL J, V7, P59, DOI 10.1111/j.1467-7652.2008.00371.x; Walsh G, 2006, NAT BIOTECHNOL, V24, P1241, DOI 10.1038/nbt1252	58	58	59	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e13976	10.1371/journal.pone.0013976	http://dx.doi.org/10.1371/journal.pone.0013976			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103044	gold, Green Published, Green Submitted			2022-12-25	WOS:000284147700021
J	Sapir, N; Wikelski, M; McCue, MD; Pinshow, B; Nathan, R				Sapir, Nir; Wikelski, Martin; McCue, Marshall D.; Pinshow, Berry; Nathan, Ran			Flight Modes in Migrating European Bee-Eaters: Heart Rate May Indicate Low Metabolic Rate during Soaring and Gliding	PLOS ONE			English	Article							BLACK-BROWED ALBATROSSES; DOUBLY LABELED WATER; OXYGEN-CONSUMPTION; ENERGY-EXPENDITURE; WIND-TUNNEL; HERRING-GULLS; BIRDS; PENGUINS; THERMOREGULATION; RADIOTELEMETRY	Background: Many avian species soar and glide over land. Evidence from large birds (m(b) > 0.9 kg) suggests that soaring-gliding is considerably cheaper in terms of energy than flapping flight, and costs about two to three times the basal metabolic rate (BMR). Yet, soaring-gliding is considered unfavorable for small birds because migration speed in small birds during soaring-gliding is believed to be lower than that of flapping flight. Nevertheless, several small bird species routinely soar and glide. Methodology/Principal Findings: To estimate the energetic cost of soaring-gliding flight in small birds, we measured heart beat frequencies of free-ranging migrating European bee-eaters (Merops apiaster, m(b) similar to 55 g) using radio telemetry, and established the relationship between heart beat frequency and metabolic rate (by indirect calorimetry) in the laboratory. Heart beat frequency during sustained soaring-gliding was 2.2 to 2.5 times lower than during flapping flight, but similar to, and not significantly different from, that measured in resting birds. We estimated that soaring-gliding metabolic rate of European bee-eaters is about twice their basal metabolic rate (BMR), which is similar to the value estimated in the black-browed albatross Thalassarche (previously Diomedea) melanophrys, m(b) similar to 4 kg). We found that soaring-gliding migration speed is not significantly different from flapping migration speed. Conclusions/Significance: We found no evidence that soaring-gliding speed is slower than flapping flight in bee-eaters, contradicting earlier estimates that implied a migration speed penalty for using soaring-gliding rather than flapping flight. Moreover, we suggest that small birds soar and glide during migration, breeding, dispersal, and other stages in their annual cycle because it may entail a low energy cost of transport. We propose that the energy cost of soaring-gliding may be proportional to BMR regardless of bird size, as theoretically deduced by earlier studies.	[Sapir, Nir; Nathan, Ran] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Movement Ecol Lab, Dept Evolut Systemat & Ecol, Jerusalem, Israel; [Wikelski, Martin] Max Planck Inst Ornithol, Vogelwarte Radolfzell, Radolfzell, Germany; [McCue, Marshall D.] St Marys Univ, Dept Biol Sci, San Antonio, TX USA; [Pinshow, Berry] Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Mitrani Dept Desert Ecol, Midreshet Ben Gurion, Israel; [Wikelski, Martin] Univ Konstanz, Dept Biol, Constance, Germany	Hebrew University of Jerusalem; Max Planck Society; Ben Gurion University; University of Konstanz	Sapir, N (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	nir.sapir@mail.huji.ac.il	Sapir, Nir/V-9634-2019; Nathan, Ran/A-9380-2008; McCue, Marshall/A-6227-2011	Sapir, Nir/0000-0002-2477-0515; Nathan, Ran/0000-0002-5733-6715; McCue, Marshall/0000-0003-1255-285X	U.S. - Israel Binational Science Foundation [229/2002, 124/2004]; Ring Foundation; Robert Szold Fund; Rieger - JNF fellowships; Fulbright	U.S. - Israel Binational Science Foundation(US-Israel Binational Science Foundation); Ring Foundation; Robert Szold Fund; Rieger - JNF fellowships; Fulbright	This study was supported by the U.S. - Israel Binational Science Foundation (grants 229/2002 and 124/2004), the Ring Foundation and the Robert Szold Fund. N.S. was supported by Rieger - JNF fellowships (in 2005-2007) and a Fulbright doctoral dissertation grant (in 2004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS NJ, 1986, PHYSIOL ZOOL, V59, P583, DOI 10.1086/physzool.59.6.30158606; Alerstam T., 1990, P331; BAUDINETTE RV, 1974, NATURE, V248, P83, DOI 10.1038/248083b0; Bevan RM, 1995, PHILOS T R SOC B, V350, P119, DOI 10.1098/rstb.1995.0146; BEVAN RM, 1994, J EXP BIOL, V193, P119; Bowlin MS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002154; Butler PJ, 2004, FUNCT ECOL, V18, P168, DOI 10.1111/j.0269-8463.2004.00821.x; Castellan NJ, 1988, NONPARAMETRIC STAT B; Cochran W.W., 1975, HAWK CHALK, V14, P28; Cochran William W., 2005, P274; Cochran WW, 2004, SCIENCE, V304, P405, DOI 10.1126/science.1095844; Cochran WW, 1972, ANIMAL ORIENTATION N, P39; Ellis H.I., 1984, P203; Fry C. H., 1984, BEE EATERS; GESSAMAN JA, 1965, AM ZOOL, V5, P696; Green JA, 2008, COMP BIOCHEM PHYS A, V150, P222, DOI 10.1016/j.cbpa.2006.06.017; Green JA, 2001, J EXP BIOL, V204, P673; Jenni-Eiermann S, 2002, J EXP BIOL, V205, P2453; KANWISHER JW, 1978, AUK, V95, P288; Kish Leslie., 1992, J OFF STAT, V8, P183; KORN EL, 1995, AM STAT, V49, P291, DOI 10.2307/2684203; LORD RD, 1962, SCIENCE, V137, P39, DOI 10.1126/science.137.3523.39; LUSTICK S, 1978, SCIENCE, V200, P81, DOI 10.1126/science.635577; MAAS S, 1989, ERGONOMICS, V32, P141, DOI 10.1080/00140138908966074; McKechnie AE, 2004, PHYSIOL BIOCHEM ZOOL, V77, P502, DOI 10.1086/383511; NOLET BA, 1992, PHYSIOL ZOOL, V65, P1188, DOI 10.1086/physzool.65.6.30158275; Pennycuick CJ, 2008, THEOR ECOL SER, P1; Pennycuick CJ, 1997, J EXP BIOL, V200, P1441; PENNYCUICK CJ, 1972, IBIS, V114, P178, DOI 10.1111/j.1474-919X.1972.tb02603.x; PINSHOW B, 1976, AM J PHYSIOL, V231, P903, DOI 10.1152/ajplegacy.1976.231.3.903; RAIM A, 1978, Bird-Banding, V49, P326; Rayner JMV, 2001, AM ZOOL, V41, P188, DOI 10.1668/0003-1569(2001)041[0188:AAEOIF]2.0.CO;2; Ropert-Coudert Y, 2006, MAR ECOL PROG SER, V328, P275, DOI 10.3354/meps328275; Rosen M, 2001, J EXP BIOL, V204, P1153; Steiger SS, 2009, PHYSIOL BIOCHEM ZOOL, V82, P580, DOI 10.1086/605336; WALSBERG GE, 1995, J EXP BIOL, V198, P213; Ward S, 2002, J EXP BIOL, V205, P3347; Weimerskirch H, 2000, P ROY SOC B-BIOL SCI, V267, P1869, DOI 10.1098/rspb.2000.1223; Weimerskirch H, 2001, NATURE, V413, P697, DOI 10.1038/35099670; WHITE SB, 1980, J FIELD ORNITHOL, V51, P6; WITHERS PC, 1977, J APPL PHYSIOL, V42, P120, DOI 10.1152/jappl.1977.42.1.120; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	48	62	63	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e13956	10.1371/journal.pone.0013956	http://dx.doi.org/10.1371/journal.pone.0013956			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21085655	Green Published, Green Submitted, gold			2022-12-25	WOS:000284087800020
J	Zagami, CJ; Stifani, S				Zagami, Chrissandra J.; Stifani, Stefano			Molecular Characterization of the Mouse Superior Lateral Parabrachial Nucleus through Expression of the Transcription Factor Runx1	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; FOOD-INTAKE; BRAIN-STEM; SPINOPARABRACHIAL PATHWAY; REGULATES DEVELOPMENT; NOCICEPTIVE PROCESSES; NEUROPATHIC PAIN; SENSORY NEURONS; C-FOS; RAT	Background: The ability to precisely identify separate neuronal populations is essential to the understanding of the development and function of different brain structures. This necessity is particularly evident in regions such as the brainstem, where the anatomy is quite complex and little is known about the identity, origin, and function of a number of distinct nuclei due to the lack of specific cellular markers. In this regard, the gene encoding the transcription factor Runx1 has emerged as a specific marker of restricted neuronal populations in the murine central and peripheral nervous systems. The aim of this study was to precisely characterize the expression of Runx1 in the developing and postnatal mouse brainstem. Methods and Principal Findings: Anatomical and immunohistochemical studies were used to characterize mouse Runx1 expression in the brainstem. It is shown here that Runx1 is expressed in a restricted population of neurons located in the dorsolateral rostral hindbrain. These neurons define a structure that is ventromedial to the dorsal nucleus of the lateral lemniscus, dorsocaudal to the medial paralemniscal nucleus and rostral to the cerebellum. Runx1 expression in these cells is first observed at approximately gestational day 12.5, persists into the adult brain, and is lost in knockout mice lacking the transcription factor Atoh1, an important regulator of the development of neuronal lineages of the rhombic lip. Runx1-expressing neurons in the rostral hindbrain produce cholecystokinin and also co-express members of the Groucho/Transducin-like Enhancer of split protein family. Conclusion: Based on the anatomical and molecular characteristics of the Runx1-expressing cells in the rostral hindbrain, we propose that Runx1 expression in this region of the mouse brain defines the superior lateral parabrachial nucleus.	[Zagami, Chrissandra J.; Stifani, Stefano] McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, Montreal, PQ, Canada	McGill University	Zagami, CJ (corresponding author), McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, Montreal, PQ, Canada.	stefano.stifani@mcgill.ca		Stifani, Stefano/0000-0002-2376-7701	Canadian Institutes of Health Research [MOP-84577, MOP-42479]; Montreal Neurological Institute	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Montreal Neurological Institute	This research was supported by grants from the Canadian Institutes of Health Research-Neuromuscular Research Partnership to S. S. (MOP-84577 and MOP-42479). C.Z. was supported in part by a Montreal Neurological Institute J. Timmins Costello Fellowship and S. S. is a Chercheur National of the Fonds de la Recherche en Sante du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaban CD, 2002, PHYSIOL BEHAV, V77, P469, DOI 10.1016/S0031-9384(02)00935-6; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; Bermingham NA, 2001, NEURON, V30, P411, DOI 10.1016/S0896-6273(01)00305-1; BESTER H, 1995, J NEUROPHYSIOL, V73, P568, DOI 10.1152/jn.1995.73.2.568; Bester H, 1997, J COMP NEUROL, V383, P439; BLOCK CH, 1987, PEPTIDES, V8, P267, DOI 10.1016/0196-9781(87)90102-1; Buritova J, 1998, J COMP NEUROL, V397, P10, DOI 10.1002/(SICI)1096-9861(19980720)397:1<10::AID-CNE2>3.0.CO;2-L; Buscarlet M, 2007, TRENDS CELL BIOL, V17, P353, DOI 10.1016/j.tcb.2007.07.002; Chamberlin NL, 2004, RESP PHYSIOL NEUROBI, V143, P115, DOI 10.1016/j.resp.2004.03.015; Chen CL, 2006, NEURON, V49, P365, DOI 10.1016/j.neuron.2005.10.036; Cheng LP, 2004, NAT NEUROSCI, V7, P510, DOI 10.1038/nn1221; Dai JX, 2008, J COMP NEUROL, V509, P341, DOI 10.1002/cne.21759; DAY NC, 1986, NEUROPEPTIDES, V8, P1, DOI 10.1016/0143-4179(86)90059-4; Dobolyi A, 2003, J COMP NEUROL, V455, P547, DOI 10.1002/cne.10515; Dykes IM, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-3; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Fujiyama T, 2009, DEVELOPMENT, V136, P2049, DOI 10.1242/dev.033480; FULWILER CE, 1985, NEUROSCI LETT, V53, P289, DOI 10.1016/0304-3940(85)90553-1; Fulwiler CE, 1984, BRAIN RES, V319, P229; Gauriau C, 2002, EXP PHYSIOL, V87, P251, DOI 10.1113/eph8702357; GIBBS J, 1973, J COMP PHYSIOL PSYCH, V84, P488, DOI 10.1037/h0034870; GIBBS J, 1976, AM J PHYSIOL, V230, P15, DOI 10.1152/ajplegacy.1976.230.1.15; GLENDENNING KK, 1981, J COMP NEUROL, V197, P673, DOI 10.1002/cne.901970409; Hermanson O, 1998, J COMP NEUROL, V400, P255; Husain J, 1996, BIOCHEM J, V317, P523, DOI 10.1042/bj3170523; Kramer I, 2006, NEURON, V49, P379, DOI 10.1016/j.neuron.2006.01.008; Levanon D, 1998, P NATL ACAD SCI USA, V95, P11590, DOI 10.1073/pnas.95.20.11590; Levanon D, 2002, EMBO J, V21, P3454, DOI 10.1093/emboj/cdf370; Lohmann C, 1996, J COMP NEUROL, V367, P90, DOI 10.1002/(SICI)1096-9861(19960325)367:1<90::AID-CNE7>3.0.CO;2-E; Malick A, 2001, P NATL ACAD SCI USA, V98, P9930, DOI 10.1073/pnas.171616898; Marmigere F, 2006, NAT NEUROSCI, V9, P180, DOI 10.1038/nn1631; McLarren KW, 2000, J BIOL CHEM, V275, P530, DOI 10.1074/jbc.275.1.530; Mercer LD, 2000, NEUROSCI LETT, V293, P167, DOI 10.1016/S0304-3940(00)01504-4; NAGAI K, 1987, J CLIN BIOCHEM NUTR, V3, P103, DOI 10.3164/jcbn.3.103; North T, 1999, DEVELOPMENT, V126, P2563; Ray RS, 2009, CURR OPIN CELL BIOL, V21, P741, DOI 10.1016/j.ceb.2009.10.003; Rose MF, 2009, P NATL ACAD SCI USA, V106, P22462, DOI 10.1073/pnas.0911579106; Rose MF, 2009, NEURON, V64, P341, DOI 10.1016/j.neuron.2009.10.023; Samad OA, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-45; SIMEONE A, 1995, DEV DYNAM, V203, P61, DOI 10.1002/aja.1002030107; Stifani N, 2008, P NATL ACAD SCI USA, V105, P6451, DOI 10.1073/pnas.0711299105; Stifani S, 2009, BLOOD CELL MOL DIS, V43, P20, DOI 10.1016/j.bcmd.2009.03.001; STOYKOVA A, 1994, J NEUROSCI, V14, P1395, DOI 10.1523/JNEUROSCI.14-03-01395.1994; Theriault FM, 2005, J NEUROSCI, V25, P2050, DOI 10.1523/JNEUROSCI.5108-04.2005; Theriault FM, 2004, P NATL ACAD SCI USA, V101, P10343, DOI 10.1073/pnas.0400768101; Varga T, 2008, J COMP NEUROL, V511, P221, DOI 10.1002/cne.21829; Wang VY, 2005, NEURON, V48, P31, DOI 10.1016/j.neuron.2005.08.024; Yao J, 1998, DEV GROWTH DIFFER, V40, P133; Yao J, 2000, MECH DEVELOP, V93, P105, DOI 10.1016/S0925-4773(00)00278-1; Yates BJ, 1998, EXP BRAIN RES, V119, P269, DOI 10.1007/s002210050342; Yoshikawa M, 2007, DEV BIOL, V303, P663, DOI 10.1016/j.ydbio.2006.12.007; Zagami CJ, 2009, J CELL BIOCHEM, V107, P1063, DOI 10.1002/jcb.22221	52	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e13944	10.1371/journal.pone.0013944	http://dx.doi.org/10.1371/journal.pone.0013944			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21085653	Green Published, gold, Green Submitted			2022-12-25	WOS:000284087800011
J	Chen, EYT; Wang, YC; Chen, CS; Chin, WC				Chen, Eric Y. T.; Wang, Yung-Chen; Chen, Chi-Shuo; Chin, Wei-Chun			Functionalized Positive Nanoparticles Reduce Mucin Swelling and Dispersion	PLOS ONE			English	Article							CYSTIC-FIBROSIS; TITANIUM-DIOXIDE; MUCUS CLEARANCE; GASTRIC MUCIN; PULMONARY; SECRETION; LUNG; ULTRAFINE; RELEASE; NANOMEDICINE	Multi-functionalized nanoparticles (NPs) have been extensively investigated for their potential in household and commercial products, and biomedical applications. Previous reports have confirmed the cellular nanotoxicity and adverse inflammatory effects on pulmonary systems induced by NPs. However, possible health hazards resulting from mucus rheological disturbances induced by NPs are underexplored. Accumulation of viscous, poorly dispersed, and less transportable mucus leading to improper mucus rheology and dysfunctional mucociliary clearance are typically found to associate with many respiratory diseases such as asthma, cystic fibrosis (CF), and COPD (Chronic Obstructive Pulmonary Disease). Whether functionalized NPs can alter mucus rheology and its operational mechanisms have not been resolved. Herein, we report that positively charged functionalized NPs can hinder mucin gel hydration and effectively induce mucin aggregation. The positively charged NPs can significantly reduce the rate of mucin matrix swelling by a maximum of 7.5 folds. These NPs significantly increase the size of aggregated mucin by approximately 30 times within 24 hrs. EGTA chelation of indigenous mucin crosslinkers (Ca2+ ions) was unable to effectively disperse NP-induced aggregated mucins. Our results have demonstrated that positively charged functionalized NPs can impede mucin gel swelling by crosslinking the matrix. This report also highlights the unexpected health risk of NP-induced change in mucus rheological properties resulting in possible mucociliary transport impairment on epithelial mucosa and related health problems. In addition, our data can serve as a prospective guideline for designing nanocarriers for airway drug delivery applications.	[Chen, Eric Y. T.; Wang, Yung-Chen; Chen, Chi-Shuo; Chin, Wei-Chun] Univ Calif Merced, Merced, CA USA	University of California System; University of California Merced	Chen, EYT (corresponding author), Univ Calif Merced, Merced, CA USA.	wchin2@ucmerced.edu	Chin, Wei-Chun/A-6068-2008	Chin, Wei-Chun/0000-0003-4881-9085	NIH [1R15HL095039]; NSF [CBET-0932404]; UC CITRIS; UC Merced Center of Excellence on Health Disparities from the National Center on Minority Health and Health Disparities [1P20MD005049-01]; UC Merced; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P20MD005049] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R15HL095039] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); UC CITRIS; UC Merced Center of Excellence on Health Disparities from the National Center on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); UC Merced; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grants from NIH (1R15HL095039), NSF (CBET-0932404) and UC CITRIS Program. CSC was supported by UC Merced Center of Excellence on Health Disparities (1P20MD005049-01 from the National Center on Minority Health and Health Disparities). EYTC was supported by GRC summer fellowship from UC Merced. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro-Moreno E, 2007, CURR OPIN PULM MED, V13, P98, DOI 10.1097/MCP.0b013e328013f47e; BANSIL R, 1995, ANNU REV PHYSIOL, V57, P635, DOI 10.1146/annurev.ph.57.030195.003223; Berger JT, 1999, AM J RESP CELL MOL, V20, P500, DOI 10.1165/ajrcmb.20.3.3383; BHASKAR KR, 1991, AM J PHYSIOL, V261, pG827, DOI 10.1152/ajpgi.1991.261.5.G827; Boucher RC, 2007, ANNU REV MED, V58, P157, DOI 10.1146/annurev.med.58.071905.105316; Byrne James D, 2008, Mcgill J Med, V11, P43; Cao XX, 1999, BIOPHYS J, V76, P1250, DOI 10.1016/S0006-3495(99)77288-7; Card JW, 2008, AM J PHYSIOL-LUNG C, V295, pL400, DOI 10.1152/ajplung.00041.2008; Centi G, 2002, CATAL TODAY, V75, P3, DOI 10.1016/S0920-5861(02)00037-8; Chen E, 2008, J EXP NANOSCI, V3, P171, DOI 10.1080/17458080802412430; Chen EYT, 2010, AM J PHYSIOL-LUNG C, V299, pL542, DOI 10.1152/ajplung.00180.2010; Chin WC, 2005, MACROMOL SYMP, V227, P89, DOI 10.1002/masy.200550908; Chin WC, 1998, NATURE, V391, P568, DOI 10.1038/35345; Colvin VL, 2003, NAT BIOTECHNOL, V21, P1166, DOI 10.1038/nbt875; Cone RA, 2009, ADV DRUG DELIVER REV, V61, P75, DOI 10.1016/j.addr.2008.09.008; Dawson M, 2003, J BIOL CHEM, V278, P50393, DOI 10.1074/jbc.M309026200; Di Cola E, 2008, BIOMACROMOLECULES, V9, P3216, DOI 10.1021/bm800799u; Donaldson SH, 2006, NEW ENGL J MED, V354, P241, DOI 10.1056/NEJMoa043891; EDWARDS SF, 1973, J PHYS A-MATH GEN, V6, pL31, DOI 10.1088/0305-4470/6/4/001; Espinosa M, 2002, HUM REPROD, V17, P1964, DOI 10.1093/humrep/17.8.1964; Felgentreff K, 2006, PEPTIDES, V27, P3100, DOI 10.1016/j.peptides.2006.07.018; Gelis C, 2003, PHOTODERMATOL PHOTO, V19, P242, DOI 10.1034/j.1600-0781.2003.00045.x; Gwinn MR, 2006, ENVIRON HEALTH PERSP, V114, P1818, DOI 10.1289/ehp.8871; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Huang CC, 2010, TOXICOL IN VITRO, V24, P45, DOI 10.1016/j.tiv.2009.09.007; Hyun JS, 2008, TOXICOL LETT, V182, P24, DOI 10.1016/j.toxlet.2008.08.003; Kas HS, 1997, J MICROENCAPSUL, V14, P689, DOI 10.3109/02652049709006820; Klaine SJ, 2008, ENVIRON TOXICOL CHEM, V27, P1825, DOI 10.1897/08-090.1; Lai SK, 2007, P NATL ACAD SCI USA, V104, P1482, DOI 10.1073/pnas.0608611104; Levine KE, 2003, ANAL LETT, V36, P563, DOI 10.1081/AL-120018244; Liu K, 2006, LANGMUIR, V22, P9453, DOI 10.1021/la061729+; Lkhasuren O, 2007, INT J OCCUP ENV HEAL, V13, P195, DOI 10.1179/oeh.2007.13.2.195; Lodge TP, 1999, PHYS REV LETT, V83, P3218, DOI 10.1103/PhysRevLett.83.3218; Lomer MCE, 2002, P NUTR SOC, V61, P123, DOI 10.1079/PNS2001134; LORIMER WV, 1978, SCAND J WORK ENV HEA, V4, P220, DOI 10.5271/sjweh.2743; Lu L, 2006, J PHYS CHEM B, V110, P25013, DOI 10.1021/jp060155e; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Mayo L, 2008, EUR J PHARM BIOPHARM, V70, P199, DOI 10.1016/j.ejpb.2008.04.025; Mossman Brooke T, 2007, Part Fibre Toxicol, V4, P4, DOI 10.1186/1743-8977-4-4; Pirkanniemi K, 2002, CHEMOSPHERE, V48, P1047, DOI 10.1016/S0045-6535(02)00168-6; Pison U, 2006, EUR J PHARMACOL, V533, P341, DOI 10.1016/j.ejphar.2005.12.068; Quinton PM, 2008, LANCET, V372, P415, DOI 10.1016/S0140-6736(08)61162-9; Randell SH, 2006, AM J RESP CELL MOL, V35, P20, DOI 10.1165/rcmb.2006-0082SF; Rogers DF, 2006, ANN MED, V38, P116, DOI 10.1080/07853890600585795; Rogers DF, 2007, RESP CARE, V52, P46; Rogers DF, 2007, RESP CARE, V52, P1134; ROSE MC, 1992, AM J PHYSIOL, V263, pL413, DOI 10.1152/ajplung.1992.263.4.L413; Sandberg T, 2009, J BIOMED MATER RES A, V91A, P773, DOI 10.1002/jbm.a.32315; Sandberg T, 2009, J BIOMED MATER RES A, V91A, P762, DOI 10.1002/jbm.a.32266; Satija J, 2007, CRIT REV THER DRUG, V24, P257, DOI 10.1615/CritRevTherDrugCarrierSyst.v24.i3.20; Sethi S, 2004, CURR OPIN INFECT DIS, V17, P113, DOI 10.1097/00001432-200404000-00008; SHEEHAN JK, 1986, BIOCHEM J, V239, P147, DOI 10.1042/bj2390147; SHEEHAN JK, 1984, BIOCHEM J, V217, P93, DOI 10.1042/bj2170093; Song JS, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-28; Stone V, 2007, IEEE T NANOBIOSCI, V6, P331, DOI 10.1109/TNB.2007.909005; TANAKA T, 1979, J CHEM PHYS, V70, P1214, DOI 10.1063/1.437602; Truong-Le VL, 1999, ARCH BIOCHEM BIOPHYS, V361, P47, DOI 10.1006/abbi.1998.0975; VERDUGO P, 1987, BIORHEOLOGY, V24, P625; VERDUGO P, 1990, ANNU REV PHYSIOL, V52, P157, DOI 10.1146/annurev.ph.52.030190.001105; VERDUGO P, 1983, BIORHEOLOGY, V20, P223; Voynow JA, 2009, CHEST, V135, P505, DOI 10.1378/chest.08-0412; Wagner V, 2006, NAT BIOTECHNOL, V24, P1211, DOI 10.1038/nbt1006-1211; Wu DYC, 2007, AM J PATHOL, V170, P20, DOI 10.2353/ajpath.2007.060452; Xia T, 2009, ANNU REV PUBL HEALTH, V30, P137, DOI 10.1146/annurev.publhealth.031308.100155; Yakubov GE, 2007, BIOMACROMOLECULES, V8, P3467, DOI 10.1021/bm700607w	65	43	44	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e15434	10.1371/journal.pone.0015434	http://dx.doi.org/10.1371/journal.pone.0015434			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085670	gold, Green Published, Green Submitted			2022-12-25	WOS:000284036800029
J	Houk, P; Musburger, C; Wiles, P				Houk, Peter; Musburger, Craig; Wiles, Phil			Water Quality and Herbivory Interactively Drive Coral-Reef Recovery Patterns in American Samoa	PLOS ONE			English	Article							LONG-TERM; NUTRIENT ENRICHMENT; CLIMATE-CHANGE; PNEOPHYLLUM CONICUM; COMMUNITY DYNAMICS; FLORIDA-KEYS; RED ALGA; DIVERSITY; SCALE; MANAGEMENT	Background: Compared with a wealth of information regarding coral-reef recovery patterns following major disturbances, less insight exists to explain the cause(s) of spatial variation in the recovery process. Methodology/Principal Findings: This study quantifies the influence of herbivory and water quality upon coral reef assemblages through space and time in Tutuila, American Samoa, a Pacific high island. Widespread declines in dominant corals (Acropora and Montipora) resulted from cyclone Heta at the end of 2003, shortly after the study began. Four sites that initially had similar coral reef assemblages but differential temporal dynamics four years following the disturbance event were classified by standardized measures of 'recovery status', defined by rates of change in ecological measures that are known to be sensitive to localized stressors. Status was best predicted, interactively, by water quality and herbivory. Expanding upon temporal trends, this study examined if similar dependencies existed through space; building multiple regression models to identify linkages between similar status measures and local stressors for 17 localities around Tutuila. The results highlighted consistent, interactive interdependencies for coral reef assemblages residing upon two unique geological reef types. Finally, the predictive regression models produced at the island scale were graphically interpreted with respect to hypothesized site-specific recovery thresholds. Conclusions/Significance: Cumulatively, our study purports that moving away from describing relatively well-known patterns behind recovery, and focusing upon understanding causes, improves our foundation to predict future ecological dynamics, and thus improves coral reef management.	[Houk, Peter; Musburger, Craig] Pacific Marine Resources Inst, Saipan, CM USA; [Musburger, Craig] Univ Hawaii Manoa, Dept Zool, Honolulu, HI 96822 USA; [Wiles, Phil] Amer Samoa Environm Protect Agcy, Pago Pago, AS USA	University of Hawaii System; University of Hawaii Manoa	Houk, P (corresponding author), Pacific Marine Resources Inst, Saipan, CM USA.	peterhouk@pacmares.com			American Samoa Environmental Protection Agency; United States Environmental Protection Agency Region IX; NOAA	American Samoa Environmental Protection Agency; United States Environmental Protection Agency Region IX(United States Environmental Protection Agency); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA)	Thanks to the American Samoa Environmental Protection Agency and the United States Environmental Protection Agency Region IX for their funding and collaboration. Partial funding also originated from the NOAA coral reef management grant program awarded to American Samoa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjeroud M, 2009, CORAL REEFS, V28, P775, DOI 10.1007/s00338-009-0515-7; Antonius A, 1999, CORAL REEFS, V18, P301, DOI 10.1007/s003380050200; Antonius A, 2001, CORAL REEFS, V19, P418, DOI 10.1007/s003380000126; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Baskett ML, 2010, GLOBAL CHANGE BIOL, V16, P1229, DOI 10.1111/j.1365-2486.2009.02062.x; Birkeland C., 1997, LIFE DEATH CORAL REE; Bohnsack JA, 1986, STATIONARY VISUAL CE; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Brainard R., 2008, CORAL REEF ECOSYSTEM; Bruno JF, 2009, ECOLOGY, V90, P1478, DOI 10.1890/08-1781.1; Burkepile DE, 2006, ECOLOGY, V87, P3128, DOI 10.1890/0012-9658(2006)87[3128:HVNCOM]2.0.CO;2; Connell JH, 1997, CORAL REEFS, V16, pS101, DOI 10.1007/s003380050246; Connell JH, 2004, ECOL MONOGR, V74, P179, DOI 10.1890/02-4043; Cooper TF, 2009, CORAL REEFS, V28, P589, DOI 10.1007/s00338-009-0512-x; Costa OS, 2000, HYDROBIOLOGIA, V440, P307, DOI 10.1023/A:1004104118208; COTTINGHAM LJ, 2005, P NATL ACAD SCI BIOL, V3, P145; Crawley MJ., 2007, R BOOK; DeMartini EE, 2008, MAR ECOL PROG SER, V365, P199, DOI 10.3354/meps07501; DUTILLEUL P, 1993, ECOLOGY, V74, P1646, DOI 10.2307/1939923; Edmunds PJ, 2001, P NATL ACAD SCI USA, V98, P5067, DOI 10.1073/pnas.071524598; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.2307/3868116; Fowler-Walker MJ, 2005, MAR BIOL, V147, P823, DOI 10.1007/s00227-005-1605-x; Fraschetti S, 2006, J EXP MAR BIOL ECOL, V339, P148, DOI 10.1016/j.jembe.2006.07.007; Golbuu Y, 2007, CORAL REEFS, V26, P319, DOI 10.1007/s00338-007-0200-7; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Green A.L., 2009, MONITORING FUNCTIONA; Guillemot N, 2010, CORAL REEFS, V29, P445, DOI 10.1007/s00338-010-0587-4; Halford A, 2004, ECOLOGY, V85, P1892, DOI 10.1890/03-4017; Houk P, 2006, PAC SCI, V60, P177, DOI 10.1353/psc.2006.0005; Houk P, 2005, ENVIRON MONIT ASSESS, V107, P11, DOI 10.1007/s10661-005-2019-4; Houk P, 2010, CORAL REEFS, V29, P59, DOI 10.1007/s00338-009-0545-1; HOUK P, 2008, ASSESSING EFFE UNPUB; Houk P, 2010, MAR ECOL-EVOL PERSP, V31, P318, DOI 10.1111/j.1439-0485.2009.00301.x; Hughes TP, 2007, TRENDS ECOL EVOL, V22, P1, DOI 10.1016/j.tree.2006.10.009; Idjadi JA, 2010, MAR ECOL PROG SER, V403, P91, DOI 10.3354/meps08463; Insalaco E, 1998, SEDIMENT GEOL, V118, P159, DOI 10.1016/S0037-0738(98)00011-6; Johnson EA, 2008, ECOL LETT, V11, P419, DOI 10.1111/j.1461-0248.2008.01173.x; Keats DW, 1997, BOT MAR, V40, P263, DOI 10.1515/botm.1997.40.1-6.263; Keitt TH, 2006, ECOLOGY, V87, P2895, DOI 10.1890/0012-9658(2006)87[2895:DOSCDU]2.0.CO;2; KNOWLTON N, 1992, AM ZOOL, V32, P674; Lapointe BE, 2004, J EXP MAR BIOL ECOL, V308, P23, DOI 10.1016/j.jembe.2004.01.019; Lapointe BE, 2004, J EXP MAR BIOL ECOL, V298, P275, DOI 10.1016/S0022-0981(03)00363-0; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; McClanahan T, 2002, CONSERV ECOL, V6; McClanahan TR, 2008, OECOLOGIA, V155, P169, DOI 10.1007/s00442-007-0890-0; McClanahan TR, 2008, MAR BIOL, V153, P755, DOI 10.1007/s00227-007-0844-4; Mork E, 2009, ESTUAR COAST SHELF S, V84, P331, DOI 10.1016/j.ecss.2009.03.033; Mumby PJ, 2007, NATURE, V450, P98, DOI 10.1038/nature06252; Mumby PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008657; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Smith JE, 2001, CORAL REEFS, V19, P332, DOI 10.1007/s003380000124; Smith LD, 2005, MAR POLLUT BULL, V51, P399, DOI 10.1016/j.marpolbul.2004.11.021; Somerfield PJ, 2008, CORAL REEFS, V27, P951, DOI 10.1007/s00338-008-0390-7; TERBRAAK CJF, 1983, ECOLOGY, V64, P454, DOI 10.2307/1939964; *US FOR SERV, US FOR SERV LAND US; Veron J.E.N., 2009, Galaxea - Tokyo, V11, P91; Walker ND, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023716; WASHINGTON HG, 1984, WATER RES, V18, P653, DOI 10.1016/0043-1354(84)90164-7; Wooldridge SA, 2009, ECOL APPL, V19, P1492, DOI 10.1890/08-0963.1; Zvuloni A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009941; AM SAMOA GIS LAYERS; BIOMASS COEFFICIENTS	62	18	18	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e13913	10.1371/journal.pone.0013913	http://dx.doi.org/10.1371/journal.pone.0013913			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085715	gold, Green Published, Green Submitted			2022-12-25	WOS:000284036800011
J	Wu, W; Shen, OX; Qin, YF; Niu, XB; Lu, CC; Xia, YK; Song, L; Wang, SL; Wang, XR				Wu, Wei; Shen, Ouxi; Qin, Yufeng; Niu, Xiaobing; Lu, Chuncheng; Xia, Yankai; Song, Ling; Wang, Shoulin; Wang, Xinru			Idiopathic Male Infertility Is Strongly Associated with Aberrant Promoter Methylation of Methylenetetrahydrofolate Reductase (MTHFR)	PLOS ONE			English	Article							DNA METHYLATION; IMPRINTED LOCI; HUMAN SPERM; GENE; HYPERMETHYLATION; OLIGOZOOSPERMIA; EPIGENETICS; AZOOSPERMIA; POPULATION; CANCER	Background: Abnormal germline DNA methylation in males has been proposed as a possible mechanism compromising spermatogenesis of some men currently diagnosed with idiopathic infertility. Previous studies have been focused on imprinted genes with DNA methylation in poor quality human sperms. However, recent but limited data have revealed that sperm methylation abnormalities may involve large numbers of genes or shown that genes that are not imprinted are also affected. Methodology/Principal Findings: Using the methylation-specific polymerase chain reaction and bisulfite sequencing method, we examined methylation patterns of the promoter of methylenetetrahydrofolate reductase (MTHFR) gene (NG_013351: 1538-1719) in sperm DNA obtained from 94 idiopathic infertile men and 54 normal fertile controls. Subjects with idiopathic infertility were further divided into groups of normozoospermia and oligozoospermia. Overall, 45% (41/94) of idiopathic infertile males had MTHFR hypermethylation (both hemimethylation and full methylation), compared with 15% of fertile controls (P<0.05). Subjects with higher methylation level of MTHFR were more likely to have idiopathic male infertility (P-value for trend = 0.0007). Comparing the two groups of idiopathic infertile subjects with different sperm concentrations, a higher methylation pattern was found in the group with oligozoospermia. Conclusions: Hypermethylation of the promoter of MTHFR gene in sperms is associated with idiopathic male infertility. The functional relevance of hypermathylation of MTHFR to male fertility warrants further investigation.	[Wu, Wei; Shen, Ouxi; Qin, Yufeng; Lu, Chuncheng; Xia, Yankai; Song, Ling; Wang, Shoulin; Wang, Xinru] Nanjing Med Univ, Inst Toxicol, Key Lab Reprod Med, Nanjing, Peoples R China; [Niu, Xiaobing] Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing, Peoples R China	Nanjing Medical University; Nanjing Medical University	Wu, W (corresponding author), Nanjing Med Univ, Inst Toxicol, Key Lab Reprod Med, Nanjing, Peoples R China.	xrwang@njmu.edu.cn	Wu, Wei/C-4409-2012	Wu, Wei/0000-0002-0267-1284	National Basic Research Program of China (973 Program) [2009CB941703]; National Natural Science Foundation of China [30930079, 30800927]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported in part by National Basic Research Program of China (973 Program) (No. 2009CB941703); The Key Project of National Natural Science Foundation of China (No. 30930079) and National Natural Science Foundation of China (No. 30800927). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A ZC, 2007, ASIAN J ANDROL, V9, P57, DOI 10.1111/j.1745-7262.2007.00225.x; BAHNAK BR, 1988, NUCLEIC ACIDS RES, V16, P1208, DOI 10.1093/nar/16.3.1208; Biermann K, 2007, J ANDROL, V28, P466, DOI 10.2164/jandrol.106.002048; Calvanese V, 2009, AGEING RES REV, V8, P268, DOI 10.1016/j.arr.2009.03.004; Chen ZT, 2001, HUM MOL GENET, V10, P433, DOI 10.1093/hmg/10.5.433; Dallosso AR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000745; deKretser DM, 1997, LANCET, V349, P787, DOI 10.1016/S0140-6736(96)08341-9; Dhillon VS, 2007, MOL HUM REPROD, V13, P213, DOI 10.1093/molehr/gal118; Filipponi D, 2009, EPIGENETICS-US, V4, P27, DOI 10.4161/epi.4.1.7311; Gopalakrishnan S, 2008, MUTAT RES-FUND MOL M, V647, P30, DOI 10.1016/j.mrfmmm.2008.08.006; Handel AE, 2010, TRENDS MOL MED, V16, P7, DOI 10.1016/j.molmed.2009.11.003; Heard E, 1997, ANNU REV GENET, V31, P571, DOI 10.1146/annurev.genet.31.1.571; Henrique R, 2004, EUR UROL, V46, P660, DOI 10.1016/j.eururo.2004.06.014; Houshdaran S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001289; Jung AY, 2008, CANCER EPIDEM BIOMAR, V17, P330, DOI 10.1158/1055-9965.EPI-07-2608; Kelly TLJ, 2005, BIOL REPROD, V72, P667, DOI 10.1095/biolreprod.104.035238; Khazamipour N, 2009, HUM REPROD, V24, P2361, DOI 10.1093/humrep/dep194; Kobayashi H, 2007, HUM MOL GENET, V16, P2542, DOI 10.1093/hmg/ddm187; Kobayashi H, 2009, EUR J HUM GENET, V17, P1582, DOI 10.1038/ejhg.2009.68; Lee HC, 2006, HUM REPROD, V21, P3162, DOI 10.1093/humrep/del280; Marques CJ, 2008, MOL HUM REPROD, V14, P67, DOI 10.1093/molehr/gam093; Marques CJ, 2004, LANCET, V363, P1700, DOI 10.1016/S0140-6736(04)16256-9; Schuebel KE, 2007, PLOS GENET, V3, P1709, DOI 10.1371/journal.pgen.0030157; Schwahn BC, 2004, BIOCHEM J, V382, P831, DOI 10.1042/BJ20030822; Singh K, 2005, INT J ANDROL, V28, P115, DOI 10.1111/j.1365-2605.2004.00513.x; Ushijima C, 2000, HUM REPROD, V15, P1107, DOI 10.1093/humrep/15.5.1107; World Health Organization (WHO), 1999, WHO LAB MANUAL EXAMI, V4th; Wu B, 2007, HUM REPROD, V22, P1107, DOI 10.1093/humrep/del499	29	102	113	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e13884	10.1371/journal.pone.0013884	http://dx.doi.org/10.1371/journal.pone.0013884			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085488	Green Published, Green Submitted, gold			2022-12-25	WOS:000284035900005
J	Zhang, J; Cao, J; Weng, QJ; Wu, R; Yan, Y; Jing, H; Zhu, H; He, QJ; Yang, B				Zhang, Jun; Cao, Ji; Weng, Qinjie; Wu, Rui; Yan, Yan; Jing, Hui; Zhu, Hong; He, Qiaojun; Yang, Bo			Suppression of Hypoxia-Inducible Factor 1 alpha (HIF-1 alpha) by Tirapazamine Is Dependent on eIF2 alpha Phosphorylation Rather Than the mTORC1/4E-BP1 Pathway	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM-STRESS; UNFOLDED PROTEIN RESPONSE; ENDOTHELIAL GROWTH-FACTOR; MAMMALIAN TARGET; PROTEASOME INHIBITION; CERVICAL-CANCER; MOUSE MODEL; EXPRESSION; COMPLEX; FACTOR-1-ALPHA	Hypoxia-inducible factor 1 (HIF-1), a heterodimeric transcription factor that mediates the adaptation of tumor cells and tissues to the hypoxic microenvironment, has attracted considerable interest as a potential therapeutic target. Tirapazamine (TPZ), a well-characterized bioreductive anticancer agent, is currently in Phase II and III clinical trials. A major aspect of the anticancer activity of TPZ is its identity as a tumor-specific topoisomerase II alpha inhibitor. In the study, for the first time, we found that TPZ acts in a novel manner to inhibit HIF-1 alpha accumulation driven by hypoxia or growth factors in human cancer cells and in HepG2 cell-derived tumors in athymic nude mice. We investigated the mechanism of TPZ on HIF-1 alpha in HeLa human cervical cancer cells by western blot analysis, reverse transcription-PCR assay, luciferase reporter assay and small interfering RNA (siRNA) assay. Mechanistic studies demonstrated that neither HIF-1 alpha mRNA levels nor HIF-1 alpha protein degradation are affected by TPZ. However, TPZ was found to be involved in HIF-1 alpha translational regulation. Further studies revealed that the inhibitory effect of TPZ on HIF-1 alpha protein synthesis is dependent on the phosphorylation of translation initiation factor 2 alpha (eIF2 alpha) rather than the mTOR complex 1/eukaryotic initiation factor 4E-binding protein-1 (mTORC1/4E-BP1) pathway. Immunofluorescence analysis of tumor sections provide the in vivo evidences to support our hypothesis. Additionally, siRNA specifically targeting topoisomerase II alpha did not reverse the ability of TPZ to inhibit HIF-1 alpha expression, suggesting that the HIF-1 alpha inhibitory activity of TPZ is independent of its topoisomerase II alpha inhibition. In conclusion, our findings suggest that TPZ is a potent regulator of HIF-1 alpha and provide new insight into the potential molecular mechanism whereby TPZ serves to reduce HIF-1 alpha expression.	[Zhang, Jun; Cao, Ji; Weng, Qinjie; Wu, Rui; Yan, Yan; Jing, Hui; Zhu, Hong; He, Qiaojun; Yang, Bo] Zhejiang Univ, Inst Pharmacol & Toxicol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Zhang, J (corresponding author), Zhejiang Univ, Inst Pharmacol & Toxicol, Hangzhou 310003, Zhejiang, Peoples R China.	qiaojunhe@zju.edu.cn; yang924@zju.edu.cn	Jing, Hui/AAL-7810-2020; Jing, Hui/GXM-4109-2022	Jing, Hui/0000-0002-2129-7937; Jing, Hui/0000-0002-8389-8252; Zhu, Hong/0000-0002-2575-4031	National Natural Science Foundation [81072657]; Zhejiang Provincial Natural Science Foundation [Z2090053, R2080326]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by The National Natural Science Foundation (No. 81072657); Zhejiang Provincial Natural Science Foundation (No. Z2090053 and No. R2080326); Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharonowiz M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003145; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Craighead PS, 2000, INT J RADIAT ONCOL, V48, P791, DOI 10.1016/S0360-3016(00)00720-3; Creighton-Gutteridge M, 2007, CLIN CANCER RES, V13, P1010, DOI 10.1158/1078-0432.CCR-06-2301; DAI M, 2009, J CELL MOL MED; Delahoussaye YM, 2001, BIOCHEM PHARMACOL, V62, P1201, DOI 10.1016/S0006-2952(01)00784-5; Dunlop EA, 2009, CELL SIGNAL, V21, P827, DOI 10.1016/j.cellsig.2009.01.012; Duyndam MCA, 2007, BIOCHEM PHARMACOL, V74, P191, DOI 10.1016/j.bcp.2007.04.003; Fu BB, 2007, MOL CANCER THER, V6, P220, DOI 10.1158/1535-7163.MCT-06-0526; Hosoi T, 2010, CLIN SCI, V118, P19, DOI 10.1042/CS20080680; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Jeong JW, 2002, CELL, V111, P709, DOI 10.1016/S0092-8674(02)01085-1; Jiang BH, 2001, CELL GROWTH DIFFER, V12, P363; Jiang HY, 2005, J BIOL CHEM, V280, P14189, DOI 10.1074/jbc.M413660200; Kapoor A, 2009, CLIN LIVER DIS, V13, P581, DOI 10.1016/j.cld.2009.07.004; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Kim KM, 2007, CIRC RES, V101, P919, DOI 10.1161/CIRCRESAHA.107.154781; Li J, 2005, J BIOL CHEM, V280, P12041, DOI 10.1074/jbc.M412445200; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; LOWELL BB, 1986, BIOCHEM J, V234, P237, DOI 10.1042/bj2340237; Mabjeesh NJ, 2003, CANCER CELL, V3, P363, DOI 10.1016/S1535-6108(03)00077-1; Magagnin MG, 2008, PROTEOMICS, V8, P1019, DOI 10.1002/pmic.200700551; Maluf FC, 2006, INT J GYNECOL CANCER, V16, P1165, DOI 10.1111/j.1525-1438.2006.00454.x; Manolescu B, 2009, BIOCHIMIE, V91, P1347, DOI 10.1016/j.biochi.2009.08.005; Ogiso Y, 2000, CANCER RES, V60, P2429; Peters KB, 2002, CANCER RES, V62, P5248; Reck M, 2004, Pneumologie, V58, P845, DOI 10.1055/s-2004-830056; Roybal CN, 2004, J BIOL CHEM, V279, P14844, DOI 10.1074/jbc.M312948200; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Safran M, 2006, P NATL ACAD SCI USA, V103, P105, DOI 10.1073/pnas.0509459103; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; SEGLEN PO, 1979, EUR J BIOCHEM, V95, P215, DOI 10.1111/j.1432-1033.1979.tb12956.x; Semenza GL, 2009, CURR PHARM DESIGN, V15, P3839, DOI 10.2174/138161209789649402; Sun HL, 2007, ONCOGENE, V26, P3941, DOI 10.1038/sj.onc.1210169; Sun SY, 2005, CANCER RES, V65, P7052, DOI 10.1158/0008-5472.CAN-05-0917; Unruh A, 2003, ONCOGENE, V22, P3213, DOI 10.1038/sj.onc.1206385; Vega F, 2006, CANCER RES, V66, P6589, DOI 10.1158/0008-5472.CAN-05-3018; Zhu KY, 2009, CANCER RES, V69, P1836, DOI 10.1158/0008-5472.CAN-08-4103	40	35	37	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e13910	10.1371/journal.pone.0013910	http://dx.doi.org/10.1371/journal.pone.0013910			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085474	gold, Green Published, Green Submitted			2022-12-25	WOS:000284035900017
J	Cespedes, MA; Galindo, MI; Couso, JP				Cespedes, Miguel Angel; Galindo, Maximo Ibo; Couso, Juan Pablo			Dioxin Toxicity In Vivo Results from an Increase in the Dioxin-Independent Transcriptional Activity of the Aryl Hydrocarbon Receptor	PLOS ONE			English	Article							DROSOPHILA LEG DEVELOPMENT; AH RECEPTOR; SPINELESS-ARISTAPEDIA; SIGNALING PATHWAYS; TARSAL DEVELOPMENT; MICE LACKING; BINDING; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN; EXPRESSION; PROTEINS	The Aryl hydrocarbon receptor (Ahr) is the nuclear receptor mediating the toxicity of dioxins -widespread and persistent pollutants whose toxic effects include tumor promotion, teratogenesis, wasting syndrome and chloracne. Elimination of Ahr in mice eliminates dioxin toxicity but also produces adverse effects, some seemingly unrelated to dioxin. Thus the relationship between the toxic and dioxin-independent functions of Ahr is not clear, which hampers understanding and treatment of dioxin toxicity. Here we develop a Drosophila model to show that dioxin actually increases the in vivo dioxin-independent activity of Ahr. This hyperactivation resembles the effects caused by an increase in the amount of its dimerisation partner Ahr nuclear translocator (Arnt) and entails an increased transcriptional potency of Ahr, in addition to the previously described effect on nuclear translocation. Thus the two apparently different functions of Ahr, dioxin-mediated and dioxin-independent, are in fact two different levels (hyperactivated and basal, respectively) of a single function.	[Cespedes, Miguel Angel; Galindo, Maximo Ibo; Couso, Juan Pablo] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England	University of Sussex	Cespedes, MA (corresponding author), Univ Sussex, Sch Life Sci, Brighton, E Sussex, England.	j.p.couso@sussex.ac.uk	Couso, Juan Pablo/ABH-5860-2020; Galindo, Máximo Ibo/A-5299-2010	Galindo, Máximo Ibo/0000-0001-8448-9760	Wellcome Trust [087516]; University of Sussex	Wellcome Trust(Wellcome TrustEuropean Commission); University of Sussex	This work was funded by a Wellcome Trust Senior fellowship to JPC (ref. 087516) and a University of Sussex GTA studentship to MAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell DR, 2000, J BIOL CHEM, V275, P36407, DOI 10.1074/jbc.M004236200; Bock KW, 2006, BIOCHEM PHARMACOL, V72, P393, DOI 10.1016/j.bcp.2006.01.017; Butler RA, 2001, GENE, V278, P223, DOI 10.1016/S0378-1119(01)00724-7; Chan WK, 1999, J BIOL CHEM, V274, P12115, DOI 10.1074/jbc.274.17.12115; COUMAILLEAU P, 1995, J BIOL CHEM, V270, P25291, DOI 10.1074/jbc.270.42.25291; Duncan DM, 1998, GENE DEV, V12, P1290, DOI 10.1101/gad.12.9.1290; Emmons RB, 1999, DEVELOPMENT, V126, P3937; FERNANDEZSALGUERO P, 1995, SCIENCE, V268, P722, DOI 10.1126/science.7732381; FernandezSalguero PM, 1996, TOXICOL APPL PHARM, V140, P173, DOI 10.1006/taap.1996.0210; Fortini ME, 2000, TRENDS GENET, V16, P161, DOI 10.1016/S0168-9525(99)01939-3; Hahn ME, 2002, CHEM-BIOL INTERACT, V141, P131, DOI 10.1016/S0009-2797(02)00070-4; HOFFMAN EC, 1991, SCIENCE, V252, P954, DOI 10.1126/science.1852076; Ikuta T, 1998, J BIOL CHEM, V273, P2895, DOI 10.1074/jbc.273.5.2895; Kim MD, 2006, GENE DEV, V20, P2806, DOI 10.1101/gad.1459706; Kozu S, 2006, DEV BIOL, V294, P497, DOI 10.1016/j.ydbio.2006.03.015; Martinez AM, 2009, NAT GENET, V41, P1076, DOI 10.1038/ng.414; McMillan BJ, 2007, MOL PHARMACOL, V72, P487, DOI 10.1124/mol.107.037259; Meharg AA, 2003, NATURE, V421, P909, DOI 10.1038/421909a; Mimura J, 1997, GENES CELLS, V2, P645, DOI 10.1046/j.1365-2443.1997.1490345.x; Pueyo JI, 2008, DEV BIOL, V324, P192, DOI 10.1016/j.ydbio.2008.08.025; Qin HT, 2006, DEV BIOL, V298, P606, DOI 10.1016/j.ydbio.2006.07.017; Santiago-Josefat B, 2001, MOL CELL BIOL, V21, P1700, DOI 10.1128/MCB.21.5.1700-1709.2001; Schmidt JV, 1996, ANNU REV CELL DEV BI, V12, P55, DOI 10.1146/annurev.cellbio.12.1.55; St Pierre SE, 2002, DEVELOPMENT, V129, P1273; Steenland K, 2004, ENVIRON HEALTH PERSP, V112, P1265, DOI 10.1289/ehp.7219; SWANSON HI, 1995, J BIOL CHEM, V270, P26292, DOI 10.1074/jbc.270.44.26292; Tijet N, 2006, MOL PHARMACOL, V69, P140, DOI 10.1124/mol.105.018705; Wernet MF, 2006, NATURE, V440, P174, DOI 10.1038/nature04615; WHITLOCK JP, 1990, ANNU REV PHARMACOL, V30, P251	29	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e15382	10.1371/journal.pone.0015382	http://dx.doi.org/10.1371/journal.pone.0015382			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	676NU	21079739	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000283920000020
J	Zhang, JY; Song, CH; Shi, F; Zhang, Z; Fu, JL; Wang, FS				Zhang, Ji-Yuan; Song, Chun-Hui; Shi, Feng; Zhang, Zheng; Fu, Jun-Liang; Wang, Fu-Sheng			Decreased Ratio of Treg Cells to Th17 Cells Correlates with HBV DNA Suppression in Chronic Hepatitis B Patients Undergoing Entecavir Treatment	PLOS ONE			English	Article							REGULATORY T-CELLS; ANTIVIRAL IMMUNE-RESPONSE; LAMIVUDINE TREATMENT; VIRAL REPLICATION; CYTOKINE MILIEU; TGF-BETA; VIRUS; THERAPY; INHIBITION; INTERPLAY	Background: Treatment with nucleotide analogs is known to be effective in inhibiting HBV replication; however, patients with chronic hepatitis B (CHB) often show a wide range of clinical responses to these drugs. Therefore, the identification of an early immunologic marker associated with the clinical outcomes in such cases is critical for the improved clinical management. In our study, we aimed to investigate whether the viral load in CHB patients affected the ratio of the number of regulatory T cells (Tregs) to the number of interleukin-17-producing helper (Th17) cells. Further, we evaluated the clinical implications of the alterations in this ratio. Methodology/Principal Findings: Nine patients seropositive for hepatitis B e antigen received entecavir monotherapy for 12 months and the percentages of Tregs and Th17 cells as well as the HBV-specific IL-17 productions in these patients were longitudinally analyzed. The entecavir-induced suppression of HBV replication was accompanied by a rapid increase in the number of Th17 cells, together with a decrease in Treg cells, which lead to a significant reduction of Treg/Th17 ratios. In addition, peripheral blood mononuclear cells (PBMCs) exhibited a decreased IL-17 production upon stimulation with the HBV core antigen in vitro. Conclusions: The inhibition of viral replication results in an increase in Th17 cells and concomitant decrease in Treg cells. This imbalance of Treg cells to Th17 cells might have an important role in HBV persistence during entecavir treatment.	[Zhang, Ji-Yuan; Song, Chun-Hui; Zhang, Zheng; Fu, Jun-Liang; Wang, Fu-Sheng] Beijing 302 Hosp, Res Ctr Biol Therapy, Beijing, Peoples R China; [Shi, Feng] Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China	Fifth Medical Center of Chinese PLA General Hospital; Chinese Academy of Sciences; Institute of Microbiology, CAS	Zhang, JY (corresponding author), Beijing 302 Hosp, Res Ctr Biol Therapy, Beijing, Peoples R China.	fswang@public.bta.net.cn			National Natural Science Foundation of China [30801039]; National Grand Program on Key Infectious Disease [2009ZX10004-103, 2009ZX10004-309, 2008ZX10002-007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Grand Program on Key Infectious Disease	This study is supported by the National Natural Science Foundation of China (No. 30801039) and the National Grand Program on Key Infectious Disease (No. 2009ZX10004-103, No. 2009ZX10004-309 and 2008ZX10002-007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Billerbeck E, 2010, P NATL ACAD SCI USA, V107, P3006, DOI 10.1073/pnas.0914839107; Boni C, 2001, HEPATOLOGY, V33, P963, DOI 10.1053/jhep.2001.23045; Boni C, 1998, J CLIN INVEST, V102, P968, DOI 10.1172/JCI3731; Boni C, 2003, J HEPATOL, V39, P595, DOI 10.1016/S0168-8278(03)00292-7; Choe WH, 2009, ANTIVIR THER, V14, P985, DOI 10.3851/IMP1417; Dienstag JL, 2008, NEW ENGL J MED, V359, P1486, DOI 10.1056/NEJMra0801644; Franzese O, 2005, J VIROL, V79, P3322, DOI 10.1128/JVI.79.6.3322-3328.2005; Huang YW, 2010, ANTIVIR THER, V15, P177, DOI 10.3851/IMP1508; Karino Y, 2010, HEPATOL INT, V4, P414, DOI 10.1007/s12072-009-9162-x; Lee JM, 2009, ANTIVIR THER, V14, P705; Lemmers A, 2009, HEPATOLOGY, V49, P646, DOI 10.1002/hep.22680; Leung S, 2010, CELL MOL IMMUNOL, V7, P182, DOI 10.1038/cmi.2010.22; Marinos G, 1996, HEPATOLOGY, V24, P991; Oukka M, 2007, ANN RHEUM DIS, V66, P87, DOI 10.1136/ard.2007.078527; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Rowan AG, 2008, J IMMUNOL, V181, P4485, DOI 10.4049/jimmunol.181.7.4485; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sprengers D, 2007, ANTIVIR THER, V12, P1087; Stoop JN, 2007, VIROLOGY, V361, P141, DOI 10.1016/j.virol.2006.11.018; Stoop JN, 2005, HEPATOLOGY, V41, P771, DOI 10.1002/hep.20649; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wang FS, 2007, HEPATOL RES, V37, pS339, DOI 10.1111/j.1872-034X.2007.00222.x; Wang Fu-Sheng, 2009, Expert Rev Gastroenterol Hepatol, V3, P499, DOI 10.1586/egh.09.50; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Weaver CT, 2009, NAT REV IMMUNOL, V9, P883, DOI 10.1038/nri2660; Xu DP, 2006, J IMMUNOL, V177, P739, DOI 10.4049/jimmunol.177.1.739; Yasumi Y, 2007, HEPATOL RES, V37, P248, DOI 10.1111/j.1872-034X.2007.00040.x; Yokosuka O, 2010, J HEPATOL, V52, P791, DOI 10.1016/j.jhep.2009.12.036; Zhang JY, 2008, J IMMUNOL, V181, P3741, DOI 10.4049/jimmunol.181.6.3741; Zhang JY, 2010, HEPATOLOGY, V51, P81, DOI 10.1002/hep.23273; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	32	57	80	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e13869	10.1371/journal.pone.0013869	http://dx.doi.org/10.1371/journal.pone.0013869			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	676NU	21079784	Green Published, Green Submitted, gold			2022-12-25	WOS:000283920000004
J	Ahtiainen, L; Mirantes, C; Jahkola, T; Escutenaire, S; Diaconu, I; Osterlund, P; Kanerva, A; Cerullo, V; Hemminki, A				Ahtiainen, Laura; Mirantes, Cristina; Jahkola, Tiina; Escutenaire, Sophie; Diaconu, Iulia; Osterlund, Pamela; Kanerva, Anna; Cerullo, Vincenzo; Hemminki, Akseli			Defects in Innate Immunity Render Breast Cancer Initiating Cells Permissive to Oncolytic Adenovirus	PLOS ONE			English	Article							VESICULAR STOMATITIS-VIRUS; STEM-CELLS; OVARIAN-CANCER; IN-VIVO; RESPONSES; TLR9; DNA; IDENTIFICATION; EFFICACY; TRIGGERS	Background: Cancer stem cells/initiating cells (CSC/CIC), are thought to exist as a small population in malignant tissues. They are resistant to conventional cancer treatments and possibly underlie post-treatment relapse. The CIC population can be targeted with capsid modified oncolytic adenoviruses. Methodology/Principal Findings: We studied the mechanisms of innate immunity to oncolytic adenovirus Ad5/3-Delta24 in conventional treatment resistant non-CIC breast cancer cells, breast cancer CD44(+)/CD24(-/low) CIC population and normal breast tissue CD44(+)/CD24(-/low) stem cells. We compared virus recognition by pattern recognition receptors for adenovirus, Toll-like receptors (TLR) 2 and 9 and virus induced type I interferon (IFN) response regulation in these cell types. We show TLR mediated virus recognition in these non-immune cell types. Normal tissue stem cells have intact type I IFN signaling. Furthermore, TLR9 and TLR2 reside constantly in recognition sites, implying constant activation. In contrast, breast cancer CD44(+)/CD24(-/low) CIC have dysregulated innate immune responses featuring dysfunctional virus recognition caused by impaired trafficking of TLR9 and cofactor MyD88 and the absence of TLR2, having a deleterious impact on TLR pattern recognition receptor signaling. Furthermore, the CIC have increased inhibitory signaling via the suppressor of cytokine signaling/Tyro3/Axl/Mer receptor tyrosine kinase (SOCS/TAM) pathway. These defects in contribute to dysfunctional induction of type I IFN response in CIC and therefore permissivity to oncolytic adenovirus. Conclusions/Significance: CICs may underlie the incurable nature of relapsed or metastatic cancers and are therefore an important target regarding diagnostic and prognostic aspects as well as treatment of the disease. This study addresses the mechanisms of innate infection immunity in stem cells deepening the understanding of stem cell biology and may benefit not only virotherapy but also immunotherapy in general.	[Ahtiainen, Laura; Mirantes, Cristina; Escutenaire, Sophie; Diaconu, Iulia; Kanerva, Anna; Cerullo, Vincenzo; Hemminki, Akseli] Univ Helsinki, Transplantat Lab, Canc Gene Therapy Grp, Mol Canc Biol Program,Haartman Inst, Helsinki, Finland; [Ahtiainen, Laura; Mirantes, Cristina; Escutenaire, Sophie; Diaconu, Iulia; Kanerva, Anna; Cerullo, Vincenzo; Hemminki, Akseli] Univ Helsinki, Finnish Inst Mol Med, Helsinki, Finland; [Ahtiainen, Laura; Mirantes, Cristina; Escutenaire, Sophie; Diaconu, Iulia; Cerullo, Vincenzo; Hemminki, Akseli] Univ Helsinki, Cent Hosp, HUSLAB, Helsinki, Finland; [Jahkola, Tiina] Univ Helsinki, Cent Hosp, Dept Plast Surg, Helsinki, Finland; [Osterlund, Pamela] Natl Inst Hlth & Welf, Dept Vaccinat & Immune Protect, Viral Infect Unit, Helsinki, Finland; [Kanerva, Anna] Univ Helsinki, Cent Hosp, Dept Obstet & Gynaecol, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital	Ahtiainen, L (corresponding author), Univ Helsinki, Transplantat Lab, Canc Gene Therapy Grp, Mol Canc Biol Program,Haartman Inst, Helsinki, Finland.	laura.ahtiainen@helsinki.fi; akseli.hemminki@helsinki.fi	Österlund, Pamela/L-2528-2015; Österlund, Pamela/AGH-9008-2022; Cerullo, Vincenzo/B-9075-2015	Österlund, Pamela/0000-0002-2229-6661; Österlund, Pamela/0000-0002-2229-6661; Cerullo, Vincenzo/0000-0003-4901-3796; Ahtiainen, Laura/0000-0002-6636-1584	European Research Council; EU; Helsinki University Central Hospital; Finnish Cancer Society; Sigrid Juselius Foundation; K. Albin Johansson Fund; Academy of Finland; Biocentrum Helsinki; University of Helsinki	European Research Council(European Research Council (ERC)European Commission); EU(European Commission); Helsinki University Central Hospital; Finnish Cancer Society; Sigrid Juselius Foundation(Sigrid Juselius Foundation); K. Albin Johansson Fund; Academy of Finland(Academy of Finland); Biocentrum Helsinki; University of Helsinki	Funding: This study was supported by the European Research Council, EU FP6 APOTHERAPY, Helsinki University Central Hospital Research Funds (EVO), Finnish Cancer Society, Sigrid Juselius Foundation, K. Albin Johansson Fund, Academy of Finland, Biocentrum Helsinki and University of Helsinki. A. Hemminki is K. Albin Johansson Research Professor of the Foundation for the Finnish Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CURR TOP MICROBIOL, V311, P1; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Appledorn DM, 2008, J IMMUNOL, V181, P2134, DOI 10.4049/jimmunol.181.3.2134; Bauerschmitz GJ, 2008, CANCER RES, V68, P5533, DOI 10.1158/0008-5472.CAN-07-5288; Brendel C, 2007, LEUKEMIA, V21, P1267, DOI 10.1038/sj.leu.2404638; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Cerullo V, 2007, MOL THER, V15, P378, DOI 10.1038/sj.mt.6300031; Eriksson M, 2007, MOL THER, V15, P2088, DOI 10.1038/sj.mt.6300300; Fan X, 2006, CANCER RES, V66, P7445, DOI 10.1158/0008-5472.CAN-06-0858; Fernandez M, 2002, J VIROL, V76, P895, DOI 10.1128/JVI.76.2.895-904.2002; Fueyo J, 2000, ONCOGENE, V19, P2, DOI 10.1038/sj.onc.1203251; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Hakkarainen T, 2007, HUM GENE THER, V18, P627, DOI 10.1089/hum.2007.034; Heise C, 2000, NAT MED, V6, P1134, DOI 10.1038/80474; HUANG X, 2009, HUM GENE THER; Jiang H, 2007, J NATL CANCER I, V99, P1410, DOI 10.1093/jnci/djm102; Kakarala M, 2008, J CLIN ONCOL, V26, P2813, DOI 10.1200/JCO.2008.16.3931; Kanerva A, 2002, CLIN CANCER RES, V8, P275; Kanerva A, 2005, ANN MED, V37, P33, DOI 10.1080/07853890410018934; Kanerva A, 2003, MOL THER, V8, P449, DOI 10.1016/S1525-0016(03)00200-4; Kelly KJ, 2008, HUM GENE THER, V19, P774, DOI 10.1089/hum.2008.036; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Leifer CA, 2004, J IMMUNOL, V173, P1179, DOI 10.4049/jimmunol.173.2.1179; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Look DC, 1998, IMMUNITY, V9, P871, DOI 10.1016/S1074-7613(00)80652-4; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marcato P, 2009, MOL THER, V17, P972, DOI 10.1038/mt.2009.58; MUROHASHI M, 2009, BR J CANC; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Ribacka C, 2008, CURR GENE THER, V8, P88, DOI 10.2174/156652308784049372; Sagar J, 2007, CANCER CELL INT, V7, DOI 10.1186/1475-2867-7-9; Saitoh SI, 2009, IMMUNOL REV, V227, P32, DOI 10.1111/j.1600-065X.2008.00729.x; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Small EJ, 2006, MOL THER, V14, P107, DOI 10.1016/j.ymthe.2006.02.011; Szotek PP, 2006, P NATL ACAD SCI USA, V103, P11154, DOI 10.1073/pnas.0603672103; Takaoka A, 2008, ADV DRUG DELIVER REV, V60, P847, DOI 10.1016/j.addr.2007.12.002; Takaoka Akinori, 2008, Virus (Nagoya), V58, P37; Tu LC, 2009, CURR STEM CELL RES T, V4, P147, DOI 10.2174/157488809788167373; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976; Wollmann G, 2007, J VIROL, V81, P1479, DOI 10.1128/JVI.01861-06	41	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2010	5	11							e13859	10.1371/journal.pone.0013859	http://dx.doi.org/10.1371/journal.pone.0013859			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675OD	21079774	gold, Green Published, Green Submitted			2022-12-25	WOS:000283839100013
J	Jessup, JA; Lindsey, SH; Wang, H; Chappell, MC; Groban, L				Jessup, Jewell A.; Lindsey, Sarah H.; Wang, Hao; Chappell, Mark C.; Groban, Leanne			Attenuation of Salt-Induced Cardiac Remodeling and Diastolic Dysfunction by the GPER Agonist G-1 in Female mRen2.Lewis Rats	PLOS ONE			English	Article							VENTRICULAR FILLING PRESSURES; PRONE SHHF/MCC-FA(CP) RATS; RENIN-ANGIOTENSIN SYSTEM; HEART-FAILURE; ESTROGEN-RECEPTOR; BLOOD-PRESSURE; DOPPLER-ECHOCARDIOGRAPHY; SYSTOLIC FUNCTION; TISSUE DOPPLER; HYPERTENSION	Introduction: The G protein-coupled estrogen receptor (GPER) is expressed in various tissues including the heart. Since the mRen2.Lewis strain exhibits salt-dependent hypertension and early diastolic dysfunction, we assessed the effects of the GPER agonist (G-1, 40 nmol/kg/hr for 14 days) or vehicle (VEH, DMSO/EtOH) on cardiac function and structure. Methods: Intact female mRen2.Lewis rats were fed a normal salt (0.5% sodium; NS) diet or a high salt (4% sodium; HS) diet for 10 weeks beginning at 5 weeks of age. Results: Prolonged intake of HS in mRen2.Lewis females resulted in significantly increased blood pressure, mildly reduced systolic function, and left ventricular (LV) diastolic compliance (as signified by a reduced E deceleration time and E deceleration slope), increased relative wall thickness, myocyte size, and mid-myocardial interstitial and perivascular fibrosis. G-1 administration attenuated wall thickness and myocyte hypertrophy, with nominal effects on blood pressure, LV systolic function, LV compliance and cardiac fibrosis in the HS group. G-1 treatment significantly increased LV lusitropy [early mitral annular descent (e')] independent of prevailing salt, and improved the e'/a' ratio in HS versus NS rats (P < 0.05) as determined by tissue Doppler. Conclusion: Activation of GPER improved myocardial relaxation in the hypertensive female mRen2.Lewis rat and reduced cardiac myocyte hypertrophy and wall thickness in those rats fed a high salt diet. Moreover, these advantageous effects of the GPER agonist on ventricular lusitropy and remodeling do not appear to be associated with overt changes in blood pressure.	[Jessup, Jewell A.; Chappell, Mark C.] Wake Forest Univ, Bowman Gray Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27103 USA; [Lindsey, Sarah H.; Chappell, Mark C.; Groban, Leanne] Wake Forest Univ, Bowman Gray Sch Med, Hypertens & Vasc Res Ctr, Winston Salem, NC 27103 USA; [Wang, Hao; Groban, Leanne] Wake Forest Univ, Bowman Gray Sch Med, Dept Anesthesiol, Winston Salem, NC 27103 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Jessup, JA (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27103 USA.	lgroban@wfubmc.edu	Chappell, Mark/AAX-9087-2021; Lindsey, Sarah H/J-2593-2012; Lindsey, Sarah/AAG-4185-2021	Lindsey, Sarah H/0000-0002-9837-4582; Lindsey, Sarah/0000-0002-9837-4582; Wang, Hao/0000-0003-1537-661X; Groban, Leanne/0000-0001-8934-7358	National Institutes of Health [R01-AG033727-01, KO8-AG026764-05]; American Heart Association;  [LH-56973]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056973, R29HL056973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG026764, R01AG033727] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work described here was supported in part by grants from the National Institutes of Health grants R01-AG033727-01 (LG), KO8-AG026764-05 Paul Beeson award (LG), American Heart Association Postdoctoral Fellowship (SHL), and LH-56973 (MCC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPLETON CP, 1991, J AM COLL CARDIOL, V17, P227, DOI 10.1016/0735-1097(91)90731-N; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Bopassa JC, 2010, AM J PHYSIOL-HEART C, V298, pH16, DOI 10.1152/ajpheart.00588.2009; Brosnihan KB, 1997, J HYPERTENS, V15, P719, DOI 10.1097/00004872-199715070-00003; BUNAG RD, 1973, J APPL PHYSIOL, V34, P279, DOI 10.1152/jappl.1973.34.2.279; Chappell MC, 2008, GENDER MED, V5, pS65, DOI 10.1016/j.genm.2008.03.007; Chappell MC, 2006, AM J PHYSIOL-REG I, V291, pR1557, DOI 10.1152/ajpregu.00051.2006; Chappell MC, 2003, HYPERTENSION, V42, P781, DOI 10.1161/01.HYP.0000085210.66399.A3; CHOONG CY, 1987, J AM COLL CARDIOL, V10, P800, DOI 10.1016/S0735-1097(87)80273-5; Cleland JGF, 2003, EUR HEART J, V24, P442, DOI 10.1016/S0195-668X(02)00823-0; Dai QX, 2008, GENDER MED, V5, P74, DOI 10.1016/S1550-8579(08)80010-1; de Jager T, 2001, J BIOL CHEM, V276, P27873, DOI 10.1074/jbc.M010984200; Deschamps AM, 2009, AM J PHYSIOL-HEART C, V297, pH1806, DOI 10.1152/ajpheart.00283.2009; Devereux RB, 2000, AM J CARDIOL, V86, P1090, DOI 10.1016/S0002-9149(00)01165-6; Dubey RK, 2001, J APPL PHYSIOL, V91, P1868, DOI 10.1152/jappl.2001.91.4.1868; Dumesnil JG, 2002, J AM SOC ECHOCARDIOG, V15, P1226, DOI 10.1067/mje.2002.123396; Filardo E, 2007, ENDOCRINOLOGY, V148, P3236, DOI 10.1210/en.2006-1605; Filardo EJ, 2005, TRENDS ENDOCRIN MET, V16, P362, DOI 10.1016/j.tem.2005.08.005; GARAVAGLIA GE, 1989, EUR HEART J, V10, P1110, DOI 10.1093/oxfordjournals.eurheartj.a059434; Groban L, 2008, J GERONTOL A-BIOL, V63, P3, DOI 10.1093/gerona/63.1.3; Grohe C, 1997, FEBS LETT, V416, P107, DOI 10.1016/S0014-5793(97)01179-4; Haugen E, 2007, INT J CARDIOL, V115, P24, DOI 10.1016/j.ijcard.2006.01.031; HEIMANN JC, 1991, J CARDIOVASC PHARM, V17, pS122, DOI 10.1097/00005344-199117002-00028; Holycross BJ, 1997, AM J PHYSIOL-HEART C, V273, pH228, DOI 10.1152/ajpheart.1997.273.1.H228; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Kitzman DW, 2001, AM J CARDIOL, V87, P413, DOI 10.1016/S0002-9149(00)01393-X; Leenen FHH, 1998, J HYPERTENS, V16, P885, DOI 10.1097/00004872-199816060-00020; Lindsey SH, 2009, ENDOCRINOLOGY, V150, P3753, DOI 10.1210/en.2008-1664; Lombardi W L, 2000, Curr Cardiol Rep, V2, P90, DOI 10.1007/s11886-000-0004-7; Masoudi FA, 2003, J AM COLL CARDIOL, V41, P217, DOI 10.1016/S0735-1097(02)02696-7; Nagueh SF, 1996, CIRCULATION, V94, P2138, DOI 10.1161/01.CIR.94.9.2138; Nagueh SF, 1998, CIRCULATION, V98, P1644, DOI 10.1161/01.CIR.98.16.1644; Nagueh SF, 2001, J AM COLL CARDIOL, V37, P278, DOI 10.1016/S0735-1097(00)01056-1; NAKAGAWA O, 1995, J CLIN INVEST, V96, P1280, DOI 10.1172/JCI118162; Nickenig G, 1998, CIRCULATION, V97, P2197, DOI 10.1161/01.CIR.97.22.2197; Noorlander ML, 2002, J HISTOCHEM CYTOCHEM, V50, P1469, DOI 10.1177/002215540205001106; Oh JK, 2006, J AM COLL CARDIOL, V47, P500, DOI 10.1016/j.jacc.2005.09.032; Ommen SR, 2000, CIRCULATION, V102, P1788; Pelzer T, 1997, ADV EXP MED BIOL, V432, P83; Prossnitz ER, 2008, ANNU REV PHYSIOL, V70, P165, DOI 10.1146/annurev.physiol.70.113006.100518; Revankar CM, 2007, ACS CHEM BIOL, V2, P536, DOI 10.1021/cb700072n; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Roesch DM, 2000, ENDOCRINOLOGY, V141, P4629, DOI 10.1210/en.141.12.4629; Schunkert H, 1997, CIRCULATION, V95, P39, DOI 10.1161/01.CIR.95.1.39; Sharkey LC, 1999, J MOL CELL CARDIOL, V31, P1527, DOI 10.1006/jmcc.1999.0985; Silvestre JS, 1998, J BIOL CHEM, V273, P4883, DOI 10.1074/jbc.273.9.4883; SMITH SA, 1989, BRIT HEART J, V61, P344; Solomon SD, 2010, HYPERTENSION, V55, P241, DOI 10.1161/HYPERTENSIONAHA.109.138529; STODDARD MF, 1989, CIRCULATION, V79, P1226, DOI 10.1161/01.CIR.79.6.1226; Thohan V, 2009, CURR OPIN CARDIOL, V24, P230, DOI 10.1097/HCO.0b013e328329f8fd; WEINBERGER MH, 1991, AM J HYPERTENS, V4, pS615, DOI 10.1093/ajh/4.11S.615S; Whitesall SE, 2004, AM J PHYSIOL-HEART C, V286, pH2408, DOI 10.1152/ajpheart.01089.2003; Xu Y, 2003, CARDIOVASC RES, V57, P388, DOI 10.1016/S0008-6363(02)00705-8; Yang CM, 1997, CARDIOVASC RES, V36, P236, DOI 10.1016/S0008-6363(97)00186-7	54	74	78	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e15433	10.1371/journal.pone.0015433	http://dx.doi.org/10.1371/journal.pone.0015433			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	800AR	21082029	gold, Green Published, Green Submitted			2022-12-25	WOS:000293329500006
J	Fung, H; Demple, B				Fung, Hua; Demple, Bruce			Distinct Roles of Ape1 Protein in the Repair of DNA Damage Induced by Ionizing Radiation or Bleomycin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; DOUBLE-STRAND-BREAK; HUMAN APURINIC/APYRIMIDINIC ENDONUCLEASE; HUMAN CELL-EXTRACTS; SINGLE-STRAND; ABASIC SITES; IN-VITRO; SACCHAROMYCES-CEREVISIAE; CLUSTERED DAMAGE; CANCER	Ionizing radiation (IR) and bleomycin (BLM) are used to treat various types of cancers. Both agents generate cytotoxic double strand breaks (DSB) and abasic (apurinic/apyrimidinic (AP)) sites in DNA. The human AP endonuclease Ape1 acts on abasic or 3'-blocking DNA lesions such as those generated by IR or BLM. We examined the effect of siRNA-mediated Ape1 suppression on DNA repair and cellular resistance to IR or BLM in human B-lymphoblastoid TK6 cells and HCT116 colon tumor cells. Partial Ape1 deficiency (similar to 30% of normal levels) sensitized cells more dramatically to BLM than to IR cytotoxicity. In both cases, expression of the unrelated yeast AP endonuclease, Apn1, largely restored resistance. Ape1 deficiency increased DNA AP site accumulation due to IR treatment but reduced the number of DSB. In contrast, for BLM, there were more DSB under Ape1 deficiency, with little change in the accumulation of AP sites. Although the role of Ape1 in generating DSB was greater for IR, the enzyme facilitated removal of AP sites, which may mitigate the cytotoxic effects of IR. In contrast, BLM generates scattered AP sites, and the DSB have 3'-phosphoglycolate termini that require Ape1 processing. These DSB persist under Ape1 deficiency. Apoptosis induced by BLM (but not by IR) under Ape1 deficiency was partially p53-dependent, more dramatically in TK6 than HCT116 cells. Thus, Ape1 suppression or inhibition may be a more efficacious adjuvant for BLM than for IR cancer therapy, particularly for tumors with a functional p53 pathway.	[Demple, Bruce] SUNY Stony Brook, Dept Pharmacol Sci, Sch Med, Stony Brook, NY 11794 USA; [Fung, Hua] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Harvard University; Dana-Farber Cancer Institute	Demple, B (corresponding author), SUNY Stony Brook, Dept Pharmacol Sci, Sch Med, Stony Brook, NY 11794 USA.	bruce@pharm.stonybrook.edu			National Institutes of Health [R01 GM040000]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040000] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM040000 (to B. D.).	Bernier J, 2004, NAT REV CANCER, V4, P737, DOI 10.1038/nrc1451; Bernstein KA, 2009, CELL, V137, P807, DOI 10.1016/j.cell.2009.05.007; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chaudhry MA, 1999, BIOCHEM PHARMACOL, V57, P531, DOI 10.1016/S0006-2952(98)00327-X; CHEN CZ, 1989, ELECTROPHORESIS, V10, P318, DOI 10.1002/elps.1150100509; CHEN DS, 1991, NUCLEIC ACIDS RES, V19, P5907, DOI 10.1093/nar/19.21.5907; Chen JY, 2005, NAT REV CANCER, V5, P102, DOI 10.1038/nrc1547; Choucroun P, 2001, MUTAT RES-FUND MOL M, V478, P89, DOI 10.1016/S0027-5107(01)00123-3; DEMPLE B, 1994, ANNU REV BIOCHEM, V63, P915, DOI 10.1146/annurev.biochem.63.1.915; Demple B, 2002, ONCOGENE, V21, P8926, DOI 10.1038/sj.onc.1206178; Ding J, 2006, TRENDS PHARMACOL SCI, V27, P338, DOI 10.1016/j.tips.2006.04.007; Einhorn LH, 2002, P NATL ACAD SCI USA, V99, P4592, DOI 10.1073/pnas.072067999; Evans AR, 2000, MUTAT RES-DNA REPAIR, V461, P83, DOI 10.1016/S0921-8777(00)00046-X; FADOK VA, 1992, J IMMUNOL, V148, P2207; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Frosina G, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/845396; Fung H, 2005, MOL CELL, V17, P463, DOI 10.1016/j.molcel.2004.12.029; Georgakilas AG, 2004, NUCLEIC ACIDS RES, V32, P5609, DOI 10.1093/nar/gkh871; Ghotra VPS, 2009, INT J RADIAT BIOL, V85, P955, DOI 10.3109/09553000903242164; HENNER WD, 1983, J BIOL CHEM, V258, P711; Hopkins BB, 2008, CELL, V135, P250, DOI 10.1016/j.cell.2008.09.054; Izumi T, 2005, P NATL ACAD SCI USA, V102, P5739, DOI 10.1073/pnas.0500986102; Izumi T, 2000, CARCINOGENESIS, V21, P1329, DOI 10.1093/carcin/21.7.1329; JACKSON SP, 1995, TRENDS BIOCHEM SCI, V20, P412, DOI 10.1016/S0968-0004(00)89090-8; Johnson RE, 1998, GENE DEV, V12, P3137, DOI 10.1101/gad.12.19.3137; Kawai H, 2003, MOL CELL BIOL, V23, P4939, DOI 10.1128/MCB.23.14.4939-4947.2003; Kingma PS, 1997, J BIOL CHEM, V272, P1148, DOI 10.1074/jbc.272.2.1148; LITTLE JB, 1995, J BIOL CHEM, V270, P11033, DOI 10.1074/jbc.270.19.11033; Liu LL, 2002, CLIN CANCER RES, V8, P2985; Liu LL, 2003, MOL CANCER THER, V2, P1061; LOEB LA, 1986, ANNU REV GENET, V20, P201, DOI 10.1146/annurev.ge.20.120186.001221; Lomax ME, 2004, BIOCHEMISTRY-US, V43, P11017, DOI 10.1021/bi049560r; Madhusudan S, 2005, TRENDS MOL MED, V11, P503, DOI 10.1016/j.molmed.2005.09.004; Madhusudan S, 2005, NUCLEIC ACIDS RES, V33, P4711, DOI 10.1093/nar/gki781; Malyarchuk S, 2009, DNA REPAIR, V8, P1343, DOI 10.1016/j.dnarep.2009.08.008; Milligan JR, 2002, INT J RADIAT BIOL, V78, P733, DOI 10.1080/09553000210140109; Park CY, 2009, MOL THER, V17, P219, DOI 10.1038/mt.2008.254; Parsons JL, 2004, NUCLEIC ACIDS RES, V32, P3531, DOI 10.1093/nar/gkh676; Pastwa E, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.16.e78; Povirk LF, 2007, J BIOL CHEM, V282, P3547, DOI 10.1074/jbc.M607745200; RAMOTAR D, 1993, J BIOL CHEM, V268, P20533; Robertson KA, 2001, CANCER RES, V61, P2220; Singh NP, 1997, MUTAT RES-DNA REPAIR, V383, P167, DOI 10.1016/S0921-8777(96)00056-0; SKOPEK TR, 1978, BIOCHEM BIOPH RES CO, V84, P411, DOI 10.1016/0006-291X(78)90185-7; Suh D, 1997, NUCLEIC ACIDS RES, V25, P2495, DOI 10.1093/nar/25.12.2495; Sung JS, 2006, FEBS J, V273, P1620, DOI 10.1111/j.1742-4658.2006.05192.x; Sutherland BM, 2002, RADIAT RES, V157, P611, DOI 10.1667/0033-7587(2002)157[0611:CDDIBX]2.0.CO;2; Sutherland BM, 2000, P NATL ACAD SCI USA, V97, P103, DOI 10.1073/pnas.97.1.103; Sutherland BM, 2000, BIOCHEMISTRY-US, V39, P8026, DOI 10.1021/bi9927989; Von Sonntag C, 1987, CHEM BASIS RAD BIOL; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; Willers H, 2004, BRIT J CANCER, V90, P1297, DOI 10.1038/sj.bjc.6601729; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; WILSON DM, 1995, J BIOL CHEM, V270, P16002, DOI 10.1074/jbc.270.27.16002; Xu YJ, 1998, J BIOL CHEM, V273, P28837, DOI 10.1074/jbc.273.44.28837; Yang N, 2006, DNA REPAIR, V5, P43, DOI 10.1016/j.dnarep.2005.07.003; Yu YJ, 1997, ONCOGENE, V14, P1661, DOI 10.1038/sj.onc.1201026; Zhou T, 2009, DNA REPAIR, V8, P901, DOI 10.1016/j.dnarep.2009.05.003; ZHOU W, 1993, P NATL ACAD SCI USA, V90, P6601, DOI 10.1073/pnas.90.14.6601	60	60	61	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					4968	4977		10.1074/jbc.M110.146498	http://dx.doi.org/10.1074/jbc.M110.146498			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21081487	Green Published, hybrid			2022-12-25	WOS:000287230600005
J	Pifer, R; Benson, A; Sturge, CR; Yarovinsky, F				Pifer, Reed; Benson, Alicia; Sturge, Carolyn R.; Yarovinsky, Felix			UNC93B1 Is Essential for TLR11 Activation and IL-12-dependent Host Resistance to Toxoplasma gondii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; DENDRITIC CELLS; CPG-DNA; IMMUNE-RESPONSE; BACTERIAL FLAGELLIN; INNATE IMMUNITY; NUCLEIC-ACID; STRANDED-RNA; RECOGNITION; DISTINCT	Toll-like receptor (TLR) activation relies on biochemical recognition of microbial molecules and localization of the TLR within specific cellular compartments. Cell surface TLRs largely recognize bacterial membrane components, and intracellular TLRs are exclusively involved in sensing nucleic acids. Here we show that TLR11, an innate sensor for the Toxoplasma protein profilin, is an intracellular receptor that resides in the endoplasmic reticulum. The 12 membrane-spanning endoplasmic reticulum-resident protein UNC93B1 interacts directly with TLR11 and regulates the activation of dendritic cells in response to Toxoplasma gondii profilin and parasitic infection in vivo. A deficiency in functional UNC93B1 protein abolished TLR11-dependent IL-12 secretion by dendritic cells, attenuated Th1 responses against T. gondii, and dramatically enhanced susceptibility to the parasite. Our results reveal that the association with UNC93B1 and the intracellular localization of TLRs are not unique features of nucleic acid-sensing TLRs but is also essential for TLR11-dependent recognition of T. gondii profilin and for host protection against this parasite.	[Pifer, Reed; Benson, Alicia; Sturge, Carolyn R.; Yarovinsky, Felix] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Yarovinsky, F (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	felix.yarovinsky@utsouthwestern.edu		Yarovinsky, Felix/0000-0001-5825-8002; Reed, Pifer/0000-0002-9648-450X	National Institutes of Health [R01 AI085263, R21 AI079371]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI079371, R01AI085263] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI085263 and R21 AI079371.	Ahmad-Nejad P, 2002, EUR J IMMUNOL, V32, P1958, DOI 10.1002/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO;2-U; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Benson A, 2009, CELL HOST MICROBE, V6, P187, DOI 10.1016/j.chom.2009.06.005; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Chockalingam A, 2009, IMMUNOL CELL BIOL, V87, P209, DOI 10.1038/icb.2008.101; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; de Bouteiller O, 2005, J BIOL CHEM, V280, P38133, DOI 10.1074/jbc.M507163200; Denkers EY, 2004, INT J PARASITOL, V34, P411, DOI 10.1016/j.ijpara.2003.11.001; Dobrowolski JM, 1996, CELL, V84, P933, DOI 10.1016/S0092-8674(00)81071-5; Fairhurst AM, 2008, EUR J IMMUNOL, V38, P1971, DOI 10.1002/eji.200838138; Fukui R, 2009, J EXP MED, V206, P1339, DOI 10.1084/jem.20082316; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Hacker H, 1998, EMBO J, V17, P6230, DOI 10.1093/emboj/17.21.6230; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Heil F, 2003, EUR J IMMUNOL, V33, P2987, DOI 10.1002/eji.200324238; Hunter CA, 2000, CURR OPIN IMMUNOL, V12, P413, DOI 10.1016/S0952-7915(00)00110-2; Jankovic D, 2002, IMMUNITY, V16, P429, DOI 10.1016/S1074-7613(02)00278-9; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Kono DH, 2009, P NATL ACAD SCI USA, V106, P12061, DOI 10.1073/pnas.0905441106; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Leifer CA, 2006, J BIOL CHEM, V281, P35585, DOI 10.1074/jbc.M607511200; Leng J, 2009, PARASITE IMMUNOL, V31, P717, DOI 10.1111/j.1365-3024.2009.01122.x; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; McGettrick AF, 2010, CURR OPIN IMMUNOL, V22, P20, DOI 10.1016/j.coi.2009.12.002; McKee AS, 2004, J IMMUNOL, V173, P2632, DOI 10.4049/jimmunol.173.4.2632; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Nishiya T, 2004, J BIOL CHEM, V279, P19008, DOI 10.1074/jbc.M311618200; Nishiya T, 2005, J BIOL CHEM, V280, P37107, DOI 10.1074/jbc.M504951200; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; Palsson-McDermott EM, 2009, NAT IMMUNOL, V10, P579, DOI 10.1038/ni.1727; Pepper M, 2008, J IMMUNOL, V180, P6229, DOI 10.4049/jimmunol.180.9.6229; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Plattner F, 2008, CELL HOST MICROBE, V3, P77, DOI 10.1016/j.chom.2008.01.001; Pollard AM, 2009, TRENDS PARASITOL, V25, P491, DOI 10.1016/j.pt.2009.07.009; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Triantafilou M, 2002, J CELL SCI, V115, P2603; Wagner H, 2006, ADV IMMUNOL, V91, P159, DOI 10.1016/S0065-2776(06)91004-9; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893; Yarovinsky F, 2006, IMMUNITY, V25, P655, DOI 10.1016/j.immuni.2006.07.015; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707	47	80	89	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3307	3314		10.1074/jbc.M110.171025	http://dx.doi.org/10.1074/jbc.M110.171025			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21097503	Green Published, hybrid			2022-12-25	WOS:000286653200016
J	Gianakopoulos, PJ; Mehta, V; Voronova, A; Cao, Y; Yao, ZZ; Coutu, J; Wang, XN; Waddington, MS; Tapscott, SJ; Skerjanc, IS				Gianakopoulos, Peter J.; Mehta, Virja; Voronova, Anastassia; Cao, Yi; Yao, Zizhen; Coutu, Josee; Wang, Xiaonan; Waddington, Michelle S.; Tapscott, Stephen J.; Skerjanc, Ilona S.			MyoD Directly Up-regulates Premyogenic Mesoderm Factors during Induction of Skeletal Myogenesis in Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE SATELLITE CELLS; ENHANCER FACTOR 2C; EMBRYONAL CARCINOMA-CELLS; P19 CELLS; DNA-BINDING; GENE-EXPRESSION; MOUSE EMBRYO; NEURONAL DIFFERENTIATION; TRANSCRIPTION FACTORS; OTHERS EXPRESSION	Gain- and loss-of-function experiments have illustrated that the family of myogenic regulatory factors is necessary and sufficient for the formation of skeletal muscle. Furthermore, MyoD required cellular aggregation to induce myogenesis in P19 embryonal carcinoma stem cells. To determine the mechanism by which stem cells can be directed into skeletal muscle, a time course of P19 cell differentiation was examined in the presence and absence of exogenous MyoD. By quantitative PCR, the first MyoD up-regulated transcripts were the premyogenic mesoderm factors Meox1, Pax7, Six1, and Eya2 on day 4 of differentiation. Subsequently, the myoblast markers myogenin, MEF2C, and Myf5 were up-regulated, leading to skeletal myogenesis. These results were corroborated by Western blot analysis, showing up-regulation of Pax3, Six1, and MEF2C proteins, prior to myogenin protein expression. To determine at what stage a dominant-negative MyoD/EnR mutant could inhibit myogenesis, stable cell lines were created and examined. Interestingly, the premyogenic mesoderm factors, Meox1, Pax3/7, Six1, Eya2, and Foxc1, were down-regulated, and as expected, skeletal myogenesis was abolished. Finally, to identify direct targets of MyoD in this system, chromatin immunoprecipitation experiments were performed. MyoD was observed associated with regulatory regions of Meox1, Pax3/7, Six1, Eya2, and myogenin genes. Taken together, MyoD directs stem cells into the skeletal muscle lineage by binding and activating the expression of premyogenic mesoderm genes, prior to activating myoblast genes.	[Gianakopoulos, Peter J.; Mehta, Virja; Voronova, Anastassia; Coutu, Josee; Wang, Xiaonan; Skerjanc, Ilona S.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada; [Gianakopoulos, Peter J.; Waddington, Michelle S.; Skerjanc, Ilona S.] Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada; [Cao, Yi; Yao, Zizhen; Tapscott, Stephen J.] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98109 USA	University of Ottawa; Western University (University of Western Ontario); Fred Hutchinson Cancer Center	Skerjanc, IS (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	iskerjan@uottawa.ca	Skerjanc, Ilona/AAN-3318-2020; Voronova, Anastassia/GLR-8891-2022	Voronova, Anastassia/0000-0001-7504-1905; Yao, Zizhen/0000-0002-9361-5607; Tapscott, Stephen/0000-0002-0319-0968	Canadian Institutes of Health Research [MOP-84458]; Premier Research Excellence Award; Foundation for Gene and Cell Therapy; Canadian Institute of Aging; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045113] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Premier Research Excellence Award; Foundation for Gene and Cell Therapy; Canadian Institute of Aging; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by Grant MOP-84458 from Canadian Institutes of Health Research (to I.S.S.).; Supported by a Premier Research Excellence Award in partnership with the Foundation for Gene and Cell Therapy.; Supported by a Canadian Institute of Aging investigator award.	ADRA CN, 1987, GENE, V60, P65, DOI 10.1016/0378-1119(87)90214-9; Bergstrom DA, 2002, MOL CELL, V9, P587, DOI 10.1016/S1097-2765(02)00481-1; Berkes CA, 2004, MOL CELL, V14, P465, DOI 10.1016/S1097-2765(04)00260-6; BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; Borycki AG, 2000, DEVELOPMENT, V127, P2075; Borycki AG, 1998, DEVELOPMENT, V125, P777; BRAUN T, 1992, CELL, V71, P369, DOI 10.1016/0092-8674(92)90507-9; BRAUN T, 1989, EMBO J, V8, P701, DOI 10.1002/j.1460-2075.1989.tb03429.x; BRENNAN TJ, 1990, GENE DEV, V4, P582, DOI 10.1101/gad.4.4.582; BRENNAN TJ, 1990, J CELL BIOL, V110, P929, DOI 10.1083/jcb.110.4.929; BRENNAN TJ, 1991, P NATL ACAD SCI USA, V88, P5675, DOI 10.1073/pnas.88.13.5675; CANDIA AF, 1992, DEVELOPMENT, V116, P1123; Cao Y, 2010, DEV CELL, V18, P662, DOI 10.1016/j.devcel.2010.02.014; Capdevila J, 1998, DEV BIOL, V193, P182, DOI 10.1006/dbio.1997.8806; COSSU G, 1983, DEV BIOL, V98, P520, DOI 10.1016/0012-1606(83)90382-2; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DAVIS RL, 1990, CELL, V60, P733, DOI 10.1016/0092-8674(90)90088-V; DEBUS E, 1983, DIFFERENTIATION, V25, P193, DOI 10.1111/j.1432-0436.1984.tb01355.x; Dodou E, 2003, MECH DEVELOP, V120, P1021, DOI 10.1016/S0925-4773(03)00178-3; EDMONDSON DG, 1994, DEVELOPMENT, V120, P1251; Fan CM, 1997, DEV BIOL, V191, P160, DOI 10.1006/dbio.1997.8713; Fougerousse F, 2002, J MUSCLE RES CELL M, V23, P255, DOI 10.1023/A:1020990825644; Gianakopoulos PJ, 2009, IN VITRO CELL DEV-AN, V45, P566, DOI 10.1007/s11626-009-9228-z; Gianakopoulos PJ, 2005, J BIOL CHEM, V280, P21022, DOI 10.1074/jbc.M502977200; Goodrich LV, 1998, NEURON, V21, P1243, DOI 10.1016/S0896-6273(00)80645-5; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; Grifone R, 2005, DEVELOPMENT, V132, P2235, DOI 10.1242/dev.01773; Grifone R, 2007, DEV BIOL, V302, P602, DOI 10.1016/j.ydbio.2006.08.059; Gros J, 2005, NATURE, V435, P954, DOI 10.1038/nature03572; Gustafsson MK, 2002, GENE DEV, V16, P114, DOI 10.1101/gad.940702; HARTLEY RS, 1992, DEV BIOL, V153, P206, DOI 10.1016/0012-1606(92)90106-Q; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Heanue TA, 1999, GENE DEV, V13, P3231, DOI 10.1101/gad.13.24.3231; Heidt AB, 2007, MOL CELL BIOL, V27, P5910, DOI 10.1128/MCB.01700-06; Horton S, 1999, MOL CELL NEUROSCI, V14, P355, DOI 10.1006/mcne.1999.0791; Huang J, 1996, MOL CELL BIOL, V16, P3893; Ishibashi J, 2005, J CELL BIOL, V171, P471, DOI 10.1083/jcb.200502101; Kanisicak O, 2009, DEV BIOL, V332, P131, DOI 10.1016/j.ydbio.2009.05.554; Kassar-Duchossoy L, 2005, GENE DEV, V19, P1426, DOI 10.1101/gad.345505; Kassar-Duchossoy L, 2004, NATURE, V431, P466, DOI 10.1038/nature02876; Kume T, 2000, DEVELOPMENT, V127, P1387; Laclef C, 2003, DEVELOPMENT, V130, P2239, DOI 10.1242/dev.00440; LASSAR AB, 1989, CELL, V58, P823, DOI 10.1016/0092-8674(89)90935-5; LASSAR AB, 1991, CELL, V66, P305, DOI 10.1016/0092-8674(91)90620-E; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Liu YB, 2010, NUCLEIC ACIDS RES, V38, P6857, DOI 10.1093/nar/gkq585; Mankoo BS, 2003, DEVELOPMENT, V130, P4655, DOI 10.1242/dev.00687; MCBURNEY MW, 1982, NATURE, V299, P165, DOI 10.1038/299165a0; McDermott A, 2005, DEVELOPMENT, V132, P345, DOI 10.1242/dev.01537; MINER JH, 1990, P NATL ACAD SCI USA, V87, P1089, DOI 10.1073/pnas.87.3.1089; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; OLIVER G, 1995, DEVELOPMENT, V121, P693; OLSON EN, 1990, GENE DEV, V4, P1454, DOI 10.1101/gad.4.9.1454; PATAPOUTIAN A, 1995, DEVELOPMENT, V121, P3347; Petropoulos H, 2004, J BIOL CHEM, V279, P23874, DOI 10.1074/jbc.M312612200; Petropoulos H, 2002, J BIOL CHEM, V277, P15393, DOI 10.1074/jbc.M112141200; PETROPOULOS H, 2002, THESIS U W ONTARIO L; Polesskaya A, 2000, J BIOL CHEM, V275, P34359, DOI 10.1074/jbc.M003815200; Puri PL, 2000, J CELL PHYSIOL, V185, P155, DOI 10.1002/1097-4652(200011)185:2<155::AID-JCP1>3.0.CO;2-Z; Puri PL, 1997, MOL CELL, V1, P35, DOI 10.1016/S1097-2765(00)80005-2; Rampalli S, 2007, NAT STRUCT MOL BIOL, V14, P1150, DOI 10.1038/nsmb1316; Reecy JM, 1999, DEVELOPMENT, V126, P839; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Ridgeway AG, 2000, J BIOL CHEM, V275, P41, DOI 10.1074/jbc.275.1.41; Ridgeway AG, 2001, J BIOL CHEM, V276, P19033, DOI 10.1074/jbc.M011491200; Ridgeway AG, 2000, J BIOL CHEM, V275, P32398, DOI 10.1074/jbc.M004349200; Rogerson PJ, 2002, FEBS LETT, V524, P134, DOI 10.1016/S0014-5793(02)03024-7; RUDNICKI MA, 1992, CELL, V71, P383, DOI 10.1016/0092-8674(92)90508-A; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Sartorelli V, 1997, MOL CELL BIOL, V17, P1010, DOI 10.1128/MCB.17.2.1010; Savage J, 2010, DIFFERENTIATION, V79, P31, DOI 10.1016/j.diff.2009.08.008; Savage J, 2009, STEM CELLS, V27, P1231, DOI 10.1002/stem.57; Searcy RD, 1998, DEVELOPMENT, V125, P4461; SKERJANC IS, 1994, MOL CELL BIOL, V14, P8451, DOI 10.1128/MCB.14.12.8451; Skerjanc IS, 2000, FEBS LETT, V472, P53, DOI 10.1016/S0014-5793(00)01438-1; Skerjanc IS, 1998, J BIOL CHEM, V273, P34904, DOI 10.1074/jbc.273.52.34904; Skerjanc IS, 1999, TRENDS CARDIOVAS MED, V9, P139, DOI 10.1016/S1050-1738(99)00017-1; Spitz F, 1998, P NATL ACAD SCI USA, V95, P14220, DOI 10.1073/pnas.95.24.14220; Swiderski RE, 1999, DEV DYNAM, V216, P16, DOI 10.1002/(SICI)1097-0177(199909)216:1<16::AID-DVDY4>3.0.CO;2-1; Tajbakhsh S, 1997, CELL, V89, P127, DOI 10.1016/S0092-8674(00)80189-0; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; Tolkunova EN, 1998, MOL CELL BIOL, V18, P2804, DOI 10.1128/MCB.18.5.2804; Wagner J, 2000, DEV BIOL, V228, P86, DOI 10.1006/dbio.2000.9921; WEINTRAUB H, 1991, GENE DEV, V5, P1377, DOI 10.1101/gad.5.8.1377; WEINTRAUB H, 1994, GENE DEV, V8, P2203, DOI 10.1101/gad.8.18.2203; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; WILLIAMS BA, 1994, DEVELOPMENT, V120, P785; Wilton S, 1999, IN VITRO CELL DEV-AN, V35, P175; Winnier GE, 1997, GENE DEV, V11, P926, DOI 10.1101/gad.11.7.926; Winnier GE, 1999, DEV BIOL, V213, P418, DOI 10.1006/dbio.1999.9382; Wyzykowski JC, 2002, MOL CELL BIOL, V22, P6199, DOI 10.1128/MCB.22.17.6199-6208.2002; Xu PX, 1997, DEVELOPMENT, V124, P219; Zammit PS, 2006, J CELL SCI, V119, P1824, DOI 10.1242/jcs.02908; Zhang XM, 2001, CELL, V105, P781, DOI 10.1016/S0092-8674(01)00385-3	97	32	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2517	2525		10.1074/jbc.M110.163709	http://dx.doi.org/10.1074/jbc.M110.163709			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21078671	Green Published, hybrid			2022-12-25	WOS:000286464300016
J	Asano, R; Ikoma, K; Shimomura, I; Taki, S; Nakanishi, T; Umetsu, M; Kumagai, I				Asano, Ryutaro; Ikoma, Keiko; Shimomura, Ippei; Taki, Shintaro; Nakanishi, Takeshi; Umetsu, Mitsuo; Kumagai, Izumi			Cytotoxic Enhancement of a Bispecific Diabody by Format Conversion to Tandem Single-chain Variable Fragment (taFv) THE CASE OF THE hEx3 DIABODY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIGEN-BINDING; TUMOR-CELLS; V-H; MONOCLONAL-ANTIBODIES; SCFV MULTIMERS; FV FRAGMENT; CONSTRUCTION; LYSIS; ANTIBODY-528; ARRANGEMENT	Diabodies (Dbs) and tandem single-chain variable fragments (taFv) are the most widely used recombinant formats for constructing small bispecific antibodies. However, only a few studies have compared these formats, and none have discussed their binding kinetics and cross-linking ability. We previously reported the usefulness for cancer immunotherapy of a humanized bispecific Db (hEx3-Db) and its single-chain format (hEx3-scDb) that target epidermal growth factor receptor and CD3. Here, we converted hEx3-Db into a taFv format to investigate how format affects the function of a small bispecific antibody; our investigation included a cytotoxicity assay, surface plasmon resonance spectroscopy, thermodynamic analysis, and flow cytometry. The prepared taFv (hEx3-taFv) showed an enhanced cytotoxicity, which may be attributable to a structural superiority to the diabody format in cross-linking target cells but not to differences in the binding affinities of the formats. Comparable cross-linking ability for soluble antigens was observed among hEx3-Db, hEx3-scDb, and hEx3-taFv with surface plasmon resonance spectroscopy. Furthermore, drastic increases in cytotoxicity were found in the dimeric form of hEx3-taFv, especially when the two hEx3-taFv were covalently linked. Our results show that converting the format of small bispecific antibodies can improve their function. In particular, for small bispecific antibodies that target tumor and immune cells, a functional orientation that avoids steric hindrance in cross-linking two target cells may be important in enhancing the growth inhibition effect.	[Asano, Ryutaro; Ikoma, Keiko; Shimomura, Ippei; Taki, Shintaro; Nakanishi, Takeshi; Umetsu, Mitsuo; Kumagai, Izumi] Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Sendai, Miyagi 9808579, Japan	Tohoku University	Kumagai, I (corresponding author), Aoba 6-6-11-606,Aoba Ku, Sendai, Miyagi 9808579, Japan.	kmiz@kuma.che.tohoku.ac.jp	Asano, Ryutaro/G-7822-2016		Ministry of Education, Science, Sports, and Culture of Japan; New Energy and Industrial Technology Development Organization of Japan; National Institute of Biomedical Innovation	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization of Japan(New Energy and Industrial Technology Development Organization (NEDO)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation)	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Science, Sports, and Culture of Japan (to R.A. and I.K.) and by grants from the New Energy and Industrial Technology Development Organization of Japan. This work was also supported by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation.	Alt M, 1999, FEBS LETT, V454, P90, DOI 10.1016/S0014-5793(99)00782-6; Arakawa F, 1996, J BIOCHEM, V120, P657; Asano R, 2008, PROTEIN ENG DES SEL, V21, P597, DOI 10.1093/protein/gzn037; Asano R, 2008, J IMMUNOTHER, V31, P752, DOI 10.1097/CJI.0b013e3181849071; Asano R, 2007, J BIOL CHEM, V282, P27659, DOI 10.1074/jbc.M704719200; Asano R, 2006, CLIN CANCER RES, V12, P4036, DOI 10.1158/1078-0432.CCR-06-0059; Asano R, 2010, J BIOL CHEM, V285, P20844, DOI 10.1074/jbc.M110.120444; Asano R, 2010, FEBS J, V277, P477, DOI 10.1111/j.1742-4658.2009.07499.x; Brandao JG, 2003, VACCINE, V21, P2268, DOI 10.1016/S0264-410X(03)00050-1; Buhler P, 2008, CANCER IMMUNOL IMMUN, V57, P43, DOI 10.1007/s00262-007-0348-6; Cao Y, 2003, ADV DRUG DELIVER REV, V55, P171, DOI 10.1016/S0169-409X(02)00178-3; DeJonge J, 1995, MOL IMMUNOL, V32, P1405, DOI 10.1016/0161-5890(95)00089-5; Dolezal O, 2000, PROTEIN ENG, V13, P565, DOI 10.1093/protein/13.8.565; Holliger P, 1997, CANCER IMMUNOL IMMUN, V45, P128, DOI 10.1007/s002620050414; Kipriyanov SM, 1999, J MOL BIOL, V293, P41, DOI 10.1006/jmbi.1999.3156; Kipriyanov SM, 2003, J MOL BIOL, V330, P99, DOI 10.1016/S0022-2836(03)00526-6; Kontermann RE, 2005, ACTA PHARMACOL SIN, V26, P1, DOI 10.1111/j.1745-7254.2005.00008.x; Korn T, 2004, J GENE MED, V6, P642, DOI 10.1002/jgm.555; Kriangkum J, 2001, BIOMOL ENG, V18, P31, DOI 10.1016/S1389-0344(01)00083-1; Kufer P, 2004, TRENDS BIOTECHNOL, V22, P238, DOI 10.1016/j.tibtech.2004.03.006; Le Gall F, 2004, J IMMUNOL METHODS, V285, P111, DOI 10.1016/j.jim.2003.11.007; Lu D, 2004, BIOCHEM BIOPH RES CO, V318, P507, DOI 10.1016/j.bbrc.2004.04.060; Makabe K, 2008, J BIOL CHEM, V283, P1156, DOI 10.1074/jbc.M706190200; MALLENDER WD, 1994, J BIOL CHEM, V269, P199; McCall AM, 1999, MOL IMMUNOL, V36, P433, DOI 10.1016/S0161-5890(99)00057-7; Molhoj M, 2007, MOL IMMUNOL, V44, P1935, DOI 10.1016/j.molimm.2006.09.032; Pei XY, 1997, P NATL ACAD SCI USA, V94, P9637, DOI 10.1073/pnas.94.18.9637; Power BE, 2003, PROTEIN SCI, V12, P734, DOI 10.1110/ps.0228503; RASO V, 1981, CANCER RES, V41, P2073; Robinson MK, 2005, CANCER RES, V65, P1471, DOI 10.1158/0008-5472.CAN-04-2008; Schlereth B, 2005, CANCER RES, V65, P2882, DOI 10.1158/0008-5472.CAN-04-2637; Shahied LS, 2004, J BIOL CHEM, V279, P53907, DOI 10.1074/jbc.M407888200; Sundaresan G, 2003, J NUCL MED, V44, P1962; SURESH MR, 1986, METHOD ENZYMOL, V121, P210; TRILL JJ, 1995, CURR OPIN BIOTECH, V6, P553, DOI 10.1016/0958-1669(95)80092-1; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3	36	23	30	8	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1812	1818		10.1074/jbc.M110.172957	http://dx.doi.org/10.1074/jbc.M110.172957			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21097496	Green Published, hybrid			2022-12-25	WOS:000286191500021
J	Guderian, G; Peter, C; Wiesner, J; Sickmann, A; Schulze-Osthoff, K; Fischer, U; Grimmler, M				Guderian, Gernot; Peter, Christoph; Wiesner, Julia; Sickmann, Albert; Schulze-Osthoff, Klaus; Fischer, Utz; Grimmler, Matthias			RioK1, a New Interactor of Protein Arginine Methyltransferase 5 (PRMT5), Competes with pICln for Binding and Modulates PRMT5 Complex Composition and Substrate Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-RIBOSOMAL-RNA; SMN COMPLEX; SACCHAROMYCES-CEREVISIAE; CYTOPLASMIC MATURATION; SPLICEOSOMAL SNRNPS; SUBUNIT PRECURSORS; ASSEMBLY PATHWAY; IN-VITRO; METHYLATION; NUCLEOLIN	Protein arginine methylation plays a critical role in differential gene expression through modulating protein-protein and protein-DNA/RNA interactions. Although numerous proteins undergo arginine methylation, only limited information is available on how protein arginine methyltransferases (PRMTs) identify their substrates. The human PRMT5 complex consists of PRMT5, WD45/MEP50 (WD repeat domain 45/methylosome protein 50), and pICln and catalyzes the symmetrical arginine dimethylation of its substrate proteins. pICln recruits the spliceosomal Sm proteins to the PRMT5 complex for methylation, which allows their subsequent loading onto snRNA to form small nuclear ribonucleoproteins. To understand how the PRMT5 complex is regulated, we investigated its biochemical composition and identified RioK1 as a novel, stoichiometric component of the PRMT5 complex. We show that RioK1 and pICln bind to PRMT5 in a mutually exclusive fashion. This results in a PRMT5-WD45/MEP50 core structure that either associates with pICln or RioK1 in distinct complexes. Furthermore, we show that RioK1 functions in analogy to pICln as an adapter protein by recruiting the RNA-binding protein nucleolin to the PRMT5 complex for its symmetrical methylation. The exclusive interaction of PRMT5 with either pICln or RioK1 thus provides the first mechanistic insight into how a methyltransferase can distinguish between its substrate proteins.	[Guderian, Gernot; Peter, Christoph; Fischer, Utz; Grimmler, Matthias] Univ Wurzburg, Bioctr, Dept Biochem, D-97074 Wurzburg, Germany; [Wiesner, Julia; Sickmann, Albert] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, Prot Mass Spectrometry & Funct Prote Grp, D-97078 Wurzburg, Germany; [Schulze-Osthoff, Klaus] Univ Tubingen, Interfac Inst Biochem, D-72076 Tubingen, Germany	University of Wurzburg; University of Wurzburg; Eberhard Karls University of Tubingen	Grimmler, M (corresponding author), Johannes Gutenberg Univ Mainz, Dept Internal Med Expt & Translat Oncol 3, Obere Zahlbacherstr 63, D-55131 Mainz, Germany.	grimmler@uni-mainz.de	Peter, Christoph/ABB-4684-2020; Fischer, Utz/AAT-8422-2020; Schulze-Osthoff, Klaus/N-9025-2013; Fischer, Utz/A-4090-2016; Sickmann, Albert/A-1010-2011	Peter, Christoph/0000-0002-0048-2279; Fischer, Utz/0000-0002-1465-6591; Schulze-Osthoff, Klaus/0000-0003-1443-2720; Fischer, Utz/0000-0002-1465-6591; Sickmann, Albert/0000-0002-2388-5265; Grimmler, Matthias/0000-0003-2860-3391	German Research Foundation (Deutsche Forschungsgemeinschaft) [Fi573/4-1]; families of spinal muscle atrophy (FSMA)	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); families of spinal muscle atrophy (FSMA)	This work was supported by grants of the German Research Foundation (Deutsche Forschungsgemeinschaft Fi573/4-1) and families of spinal muscle atrophy (FSMA).	Allain FHT, 2000, EMBO J, V19, P6870, DOI 10.1093/emboj/19.24.6870; Angermayr M, 2007, FEBS J, V274, P4654, DOI 10.1111/j.1742-4658.2007.05993.x; Bachand F, 2007, EUKARYOT CELL, V6, P889, DOI 10.1128/EC.00099-07; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Brahms H, 2001, RNA, V7, P1531, DOI 10.1017/S135583820101442X; Branscombe TL, 2001, J BIOL CHEM, V276, P32971, DOI 10.1074/jbc.M105412200; Chari A, 2008, CELL, V135, P497, DOI 10.1016/j.cell.2008.09.020; Cook JR, 2006, BIOCHEM BIOPH RES CO, V342, P472, DOI 10.1016/j.bbrc.2006.01.167; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Friesen MJ, 2000, J BIOL CHEM, V275, P26370, DOI 10.1074/jbc.M003299200; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Friesen WJ, 2002, J BIOL CHEM, V277, P8243, DOI 10.1074/jbc.M109984200; Furuno K, 2006, BIOCHEM BIOPH RES CO, V345, P1051, DOI 10.1016/j.bbrc.2006.05.014; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Geerlings TH, 2003, J BIOL CHEM, V278, P22537, DOI 10.1074/jbc.M300759200; GHOSH SK, 1988, J BIOL CHEM, V263, P19024; Ginisty H, 2000, J BIOL CHEM, V275, P18845, DOI 10.1074/jbc.M002350200; Ginisty H, 1998, EMBO J, V17, P1476, DOI 10.1093/emboj/17.5.1476; Grimmler M, 2005, HUM MOL GENET, V14, P3099, DOI 10.1093/hmg/ddi343; Gubitz AK, 2004, EXP CELL RES, V296, P51, DOI 10.1016/j.yexcr.2004.03.022; Herrmann F, 2004, J BIOL CHEM, V279, P48774, DOI 10.1074/jbc.M407332200; Kambach C, 1999, CELL, V96, P375, DOI 10.1016/S0092-8674(00)80550-4; Kroiss M, 2008, P NATL ACAD SCI USA, V105, P10045, DOI 10.1073/pnas.0802287105; Leger-Silvestre I, 2004, EMBO J, V23, P2336, DOI 10.1038/sj.emboj.7600252; Meister G, 2001, CURR BIOL, V11, P1990, DOI 10.1016/S0960-9822(01)00592-9; Meister G, 2002, EMBO J, V21, P5853, DOI 10.1093/emboj/cdf585; Meister G, 2001, NAT CELL BIOL, V3, P945, DOI 10.1038/ncb1101-945; Miranda TB, 2004, J BIOL CHEM, V279, P22902, DOI 10.1074/jbc.M312904200; Mitulovic G, 2003, ANAL BIOANAL CHEM, V376, P946, DOI 10.1007/s00216-003-2047-2; Neuenkirchen N, 2008, FEBS LETT, V582, P1997, DOI 10.1016/j.febslet.2008.03.009; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; PAULMICHL M, 1992, NATURE, V356, P238, DOI 10.1038/356238a0; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Pellizzoni L, 2007, EMBO REP, V8, P340, DOI 10.1038/sj.embor.7400941; Pu WT, 1999, MOL CELL BIOL, V19, P4113; Raker VA, 1996, EMBO J, V15, P2256, DOI 10.1002/j.1460-2075.1996.tb00579.x; Raman B, 2001, NUCLEIC ACIDS RES, V29, P3377, DOI 10.1093/nar/29.16.3377; Ren JQ, 2010, J BIOL CHEM, V285, P12695, DOI 10.1074/jbc.M110.103911; Rouquette J, 2005, EMBO J, V24, P2862, DOI 10.1038/sj.emboj.7600752; Schafer T, 2003, EMBO J, V22, P1370, DOI 10.1093/emboj/cdg121; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Tang J, 2000, J BIOL CHEM, V275, P19866, DOI 10.1074/jbc.M000023200; Teng Y, 2007, CANCER RES, V67, P10491, DOI 10.1158/0008-5472.CAN-06-4206; Vanrobays E, 2003, MOL CELL BIOL, V23, P2083, DOI 10.1128/MCB.23.6.2083-2095.2003; Vanrobays E, 2001, EMBO J, V20, P4204, DOI 10.1093/emboj/20.15.4204; Winkler C, 2005, GENE DEV, V19, P2320, DOI 10.1101/gad.342005; Winkler C, 2007, ELECTROPHORESIS, V28, P2095, DOI 10.1002/elps.200600670; Zemp I, 2009, J CELL BIOL, V185, P1167, DOI 10.1083/jcb.200904048; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031	50	94	99	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1976	1986		10.1074/jbc.M110.148486	http://dx.doi.org/10.1074/jbc.M110.148486			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21081503	Green Published, hybrid			2022-12-25	WOS:000286191500039
J	Harmat, V; Domokos, K; Menyhard, DK; Pallo, A; Szeltner, Z; Szamosi, I; Beke-Somfai, T; Naray-Szabo, G; Polgar, L				Harmat, Veronika; Domokos, Klarissza; Menyhard, Dora K.; Pallo, Anna; Szeltner, Zoltan; Szamosi, Ilona; Beke-Somfai, Tamas; Naray-Szabo, Gabor; Polgar, Laszlo			Structure and Catalysis of Acylaminoacyl Peptidase CLOSED AND OPEN SUBUNITS OF A DIMER OLIGOPEPTIDASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AEROPYRUM-PERNIX K1; SERINE PROTEASE CATALYSIS; PROLYL OLIGOPEPTIDASE; ACYLPEPTIDE HYDROLASE; CRYSTAL-STRUCTURE; PYROCOCCUS-FURIOSUS; MECHANISM; ENDOPEPTIDASE; SPECIFICITY; TRIAD	Acylaminoacyl peptidase from Aeropyrum pernix is a homodimer that belongs to the prolyl oligopeptidase family. The monomer subunit is composed of one hydrolase and one propeller domain. Previous crystal structure determinations revealed that the propeller domain obstructed the access of substrate to the active site of both subunits. Here we investigated the structure and the kinetics of two mutant enzymes in which the aspartic acid of the catalytic triad was changed to alanine or asparagine. Using different substrates, we have determined the pH dependence of specificity rate constants, the rate-limiting step of catalysis, and the binding of substrates and inhibitors. The catalysis considerably depended both on the kind of mutation and on the nature of the substrate. The results were interpreted in terms of alterations in the position of the catalytic histidine side chain as demonstrated with crystal structure determination of the native and two mutant structures (D524N and D524A). Unexpectedly, in the homodimeric structures, only one subunit displayed the closed form of the enzyme. The other subunit exhibited an open gate to the catalytic site, thus revealing the structural basis that controls the oligopeptidase activity. The open form of the native enzyme displayed the catalytic triad in a distorted, inactive state. The mutations affected the closed, active form of the enzyme, disrupting its catalytic triad. We concluded that the two forms are at equilibrium and the substrates bind by the conformational selection mechanism.	[Harmat, Veronika; Menyhard, Dora K.; Beke-Somfai, Tamas; Naray-Szabo, Gabor] Eotvos Lorand Univ, Inst Chem, Lab Struct Chem & Biol, H-1117 Budapest, Hungary; [Harmat, Veronika; Menyhard, Dora K.; Beke-Somfai, Tamas; Naray-Szabo, Gabor] Eotvos Lorand Univ, Inst Chem, HAS ELTE Prot Modeling Grp, H-1117 Budapest, Hungary; [Domokos, Klarissza; Szeltner, Zoltan; Szamosi, Ilona; Polgar, Laszlo] Hungarian Acad Sci, Inst Enzymol, Biol Res Ctr, H-1113 Budapest, Hungary; [Pallo, Anna] Hungarian Acad Sci, Chem Res Ctr, Dept Neurochem, H-1025 Budapest, Hungary	Eotvos Lorand University; Hungarian Academy of Sciences; Eotvos Lorand University; Hungarian Academy of Sciences; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Research Centre for Natural Sciences; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Polgar, L (corresponding author), Hungarian Acad Sci, Inst Enzymol, Biol Res Ctr, POB 7, H-1518 Budapest, Hungary.	polgar@enzim.hu	Beke-Somfai, Tamas/R-3970-2019; Beke-Somfai, Tamás/A-8383-2012; Harmat, Veronika/B-8033-2016; Pallo, Anna/B-6658-2009; Menyhárd, Dóra K./AAE-4527-2021	Beke-Somfai, Tamas/0000-0002-4788-3758; Beke-Somfai, Tamás/0000-0002-4788-3758; Harmat, Veronika/0000-0002-1866-9904; Menyhárd, Dóra K./0000-0002-0095-5531	OTKA [NK67800, F67937, K72973]; European Union [223077, 226716]; European Social Fund [TAMOP 4.2.1./B-09/KMR-2010-0003]; ICTP-ELETTRA Users Programme	OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); European Union(European Commission); European Social Fund(European Social Fund (ESF)); ICTP-ELETTRA Users Programme	This work was supported by grants from the Hungarian Science Fund (OTKA NK67800, F67937, and K72973; European Union FP7 (223077 and 226716); the European Union and the European Social Fund (TAMOP 4.2.1./B-09/KMR-2010-0003); and the ICTP-ELETTRA Users Programme.	BACHOVCHIN WW, 1981, P NATL ACAD SCI-BIOL, V78, P7323, DOI 10.1073/pnas.78.12.7323; Bartlam M, 2004, STRUCTURE, V12, P1481, DOI 10.1016/j.str.2004.05.019; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BLOW DM, 1969, NATURE, V221, P337, DOI 10.1038/221337a0; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; CARTER P, 1987, SCIENCE, V237, P394, DOI 10.1126/science.3299704; CARTER P, 1988, NATURE, V332, P564, DOI 10.1038/332564a0; CRAIK CS, 1987, SCIENCE, V237, P909, DOI 10.1126/science.3303334; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Duysen EG, 2001, J PHARMACOL EXP THER, V299, P528; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engel M, 2003, P NATL ACAD SCI USA, V100, P5063, DOI 10.1073/pnas.0230620100; ERLANDSSON R, 1991, ONCOGENE, V6, P1293; Fersht A, 1998, STRUCTURE MECH PROTE, P103; FERSHT AR, 1973, J MOL BIOL, V74, P137, DOI 10.1016/0022-2836(73)90103-4; Fulop V, 2001, J BIOL CHEM, V276, P1262, DOI 10.1074/jbc.M007003200; Fulop V, 1998, CELL, V94, P161, DOI 10.1016/S0092-8674(00)81416-6; Harris MN, 2001, J BIOL CHEM, V276, P19310, DOI 10.1074/jbc.M010489200; Harwood VJ, 1997, J BACTERIOL, V179, P3613, DOI 10.1128/jb.179.11.3613-3618.1997; Hasebe T, 2001, J LEUKOCYTE BIOL, V69, P963; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Hiramatsu H, 2003, BIOCHEM BIOPH RES CO, V302, P849, DOI 10.1016/S0006-291X(03)00258-4; JAMES MNG, 1980, J MOL BIOL, V144, P43, DOI 10.1016/0022-2836(80)90214-4; JORDAN F, 1981, BIOCHEMISTRY-US, V20, P6366, DOI 10.1021/bi00525a013; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kiss AL, 2004, FEBS LETT, V571, P17, DOI 10.1016/j.febslet.2004.06.054; Kiss AL, 2007, J MOL BIOL, V368, P509, DOI 10.1016/j.jmb.2007.02.025; KOSSIAKOFF AA, 1981, BIOCHEMISTRY-US, V20, P6462, DOI 10.1021/bi00525a027; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leatherbarrow R. J., 2001, GRAFIT VERSION 5 0; Li M, 2010, J BIOL CHEM, V285, P21487, DOI 10.1074/jbc.M109.092692; Morty RE, 2002, J BACTERIOL, V184, P3329, DOI 10.1128/JB.184.12.3329-3337.2002; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAYLOR SL, 1989, GENOMICS, V4, P355, DOI 10.1016/0888-7543(89)90342-X; Park JE, 1999, J BIOL CHEM, V274, P36505, DOI 10.1074/jbc.274.51.36505; POLGAR L, 1969, P NATL ACAD SCI USA, V64, P1335, DOI 10.1073/pnas.64.4.1335; Polgar L, 2005, CELL MOL LIFE SCI, V62, P2161, DOI 10.1007/s00018-005-5160-x; POLGAR L, 1992, BIOCHEM J, V283, P647, DOI 10.1042/bj2830647; POLGAR L, 1972, ACTA BIOCHIMICA B A, V7, P29; POLGAR L, 1989, MECHANISMS PROTEASE, P87; Rasmussen HB, 2003, NAT STRUCT BIOL, V10, P19, DOI 10.1038/nsb882; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; Richards PG, 2000, MOL PHARMACOL, V58, P577, DOI 10.1124/mol.58.3.577; SCALONI A, 1992, J LAB CLIN MED, V120, P546; SEGEL IH, 1975, ENZYME KINETICS, P72; Shan L, 2005, P NATL ACAD SCI USA, V102, P3599, DOI 10.1073/pnas.0408286102; SPRANG S, 1987, SCIENCE, V237, P905, DOI 10.1126/science.3112942; St?cker, 1999, PROTEOLYTIC ENZYMES, P148, DOI 10.1007/978-3-642-59816-6; Szeltner Z, 2002, J BIOL CHEM, V277, P44597, DOI 10.1074/jbc.M207386200; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wang QY, 2006, J BIOL CHEM, V281, P18618, DOI 10.1074/jbc.M601015200; WARSHEL A, 1989, BIOCHEMISTRY-US, V28, P3629, DOI 10.1021/bi00435a001; WARSHEL A, 1978, P NATL ACAD SCI USA, V75, P5250, DOI 10.1073/pnas.75.11.5250; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yamaguchi M, 1999, BIOCHEM BIOPH RES CO, V263, P139, DOI 10.1006/bbrc.1999.1289; ZERNER B, 1964, J AM CHEM SOC, V86, P3669, DOI 10.1021/ja01072a015	56	37	37	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1987	1998		10.1074/jbc.M110.169862	http://dx.doi.org/10.1074/jbc.M110.169862			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21084296	Green Published, hybrid			2022-12-25	WOS:000286191500040
J	Khurana, S; Chakraborty, S; Cheng, XW; Su, YT; Kao, HY				Khurana, Simran; Chakraborty, Sharmistha; Cheng, Xiwen; Su, Yu-Ting; Kao, Hung-Ying			The Actin-binding Protein, Actinin Alpha 4 (ACTN4), Is a Nuclear Receptor Coactivator that Promotes Proliferation of MCF-7 Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVATION; MOTIF; ALPHA-ACTININ-4; SPECIFICITY; EXPRESSION	Alpha actinins (ACTNs) are known for their ability to modulate cytoskeletal organization and cell motility by cross-linking actin filaments. We show here that ACTN4 harbors a functional LXXLL receptor interaction motif, interacts with nuclear receptors in vitro and in mammalian cells, and potently activates transcription mediated by nuclear receptors. Whereas overexpression of ACTN4 potentiates estrogen receptor alpha (ER alpha)-mediated transcription in transient transfection reporter assays, knockdown of ACTN4 decreases it. In contrast, histone deacetylase 7 (HDAC7) inhibits estrogen receptor alpha (ER alpha)-mediated transcription. Moreover, the ACTN4 mutant lacking the CaM (calmodulin)-like domain that is required for its interaction with HDAC7 fails to activate transcription by ER alpha. Chromatin immunoprecipitation (ChIP) assays demonstrate that maximal associations of ACTN4 and HDAC7 with the pS2 promoter are mutually exclusive. Knockdown of ACTN4 significantly decreases the expression of ER alpha target genes including pS2 and PR and also affects cell proliferation of MCF-7 breast cancer cells with or without hormone, whereas knockdown of HDAC7 exhibits opposite effects. Interestingly, overexpression of wild-type ACTN4, but not the mutants defective in interacting with ER alpha or HDAC7, results in an increase in pS2 and PR mRNA accumulation in a hormone-dependent manner. In summary, we have identified ACTN4 as a novel, atypical coactivator that regulates transcription networks to control cell growth.	[Khurana, Simran; Chakraborty, Sharmistha; Cheng, Xiwen; Su, Yu-Ting; Kao, Hung-Ying] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Kao, Hung-Ying] Ctr Comprehens Canc, Cleveland, OH 44106 USA; [Kao, Hung-Ying] Univ Hosp Cleveland, Cleveland, OH 44106 USA	Case Western Reserve University; University Hospitals of Cleveland	Kao, HY (corresponding author), 10900 Euclid Ave, Cleveland, OH 44106 USA.	hxk43@cwru.edu	Cheng, Xiwen/B-8385-2014	Cheng, Xiwen/0000-0001-7398-1522	National Institutes of Health [R01 DK078965, HL093269]; Pardee Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078965] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pardee Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK078965, HL093269, and the Pardee Foundation (to H.-Y.K.).	Babakov VN, 2008, EXP CELL RES, V314, P1030, DOI 10.1016/j.yexcr.2007.12.001; Blessing CA, 2004, TRENDS CELL BIOL, V14, P435, DOI 10.1016/j.tcb.2004.07.009; Chakraborty S, 2006, J BIOL CHEM, V281, P35070, DOI 10.1074/jbc.M602474200; Chang CY, 1999, MOL CELL BIOL, V19, P8226; Chen MM, 2007, CURR OPIN CELL BIOL, V19, P326, DOI 10.1016/j.ceb.2007.04.009; Cheng XW, 2009, J BIOL CHEM, V284, P36395, DOI 10.1074/jbc.M109.062109; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; Djinovic-Carugo K, 2002, FEBS LETT, V513, P119, DOI 10.1016/S0014-5793(01)03304-X; Djinovic-Carugo K, 1999, CELL, V98, P537, DOI 10.1016/S0092-8674(00)81981-9; Francis GA, 2003, ANNU REV PHYSIOL, V65, P261, DOI 10.1146/annurev.physiol.65.092101.142528; Gao CZ, 2006, FEBS LETT, V580, P5096, DOI 10.1016/j.febslet.2006.08.038; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Huang SM, 2004, J MOL ENDOCRINOL, V32, P481, DOI 10.1677/jme.0.0320481; Kumeta M, 2010, J CELL SCI, V123, P1020, DOI 10.1242/jcs.059568; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; McInerney EM, 1998, GENE DEV, V12, P3357, DOI 10.1101/gad.12.21.3357; Miralles F, 2006, CURR OPIN CELL BIOL, V18, P261, DOI 10.1016/j.ceb.2006.04.009; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Olave IA, 2002, ANNU REV BIOCHEM, V71, P755, DOI 10.1146/annurev.biochem.71.110601.135507; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; RANA B, 1994, MOL CELL BIOL, V14, P5858, DOI 10.1128/MCB.14.9.5858; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695; Zheng B, 2009, FEBS J, V276, P2669, DOI 10.1111/j.1742-4658.2009.06986.x	26	71	73	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1850	1859		10.1074/jbc.M110.162107	http://dx.doi.org/10.1074/jbc.M110.162107			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21078666	Green Published, hybrid			2022-12-25	WOS:000286191500025
J	Liebscher, I; Muller, U; Teupser, D; Engemaier, E; Engel, KMY; Ritscher, L; Thor, D; Sangkuhl, K; Ricken, A; Wurm, A; Piehler, D; Schmutzler, S; Fuhrmann, H; Albert, FW; Reichenbach, A; Thiery, J; Schoneberg, T; Schulz, A				Liebscher, Ines; Mueller, Uwe; Teupser, Daniel; Engemaier, Eva; Engel, Kathrin M. Y.; Ritscher, Lars; Thor, Doreen; Sangkuhl, Katrin; Ricken, Albert; Wurm, Antje; Piehler, Daniel; Schmutzler, Sandra; Fuhrmann, Herbert; Albert, Frank W.; Reichenbach, Andreas; Thiery, Joachim; Schoeneberg, Torsten; Schulz, Angela			Altered Immune Response in Mice Deficient for the G Protein-coupled Receptor GPR34	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							V2 VASOPRESSIN RECEPTOR; CHEMOTACTIC MIGRATION; GLIAL-CELLS; IDENTIFICATION; ACTIVATION; EXPRESSION; INFLAMMATION; MACROPHAGES; PHENOTYPES; INFECTION	The X-chromosomal GPR34 gene encodes an orphan G(i) protein-coupled receptor that is highly conserved among vertebrates. To evaluate the physiological relevance of GPR34, we generated a GPR34-deficient mouse line. GPR34-deficient mice were vital, reproduced normally, and showed no gross abnormalities in anatomical, histological, laboratory chemistry, or behavioral investigations under standard housing. Because GPR34 is highly expressed in mononuclear cells of the immune system, mice were specifically tested for altered functions of these cell types. Following immunization with methylated BSA, the number of granulocytes and macrophages in spleens was significantly lower in GPR34-deficient mice as in wild-type mice. GPR34-deficient mice showed significantly increased paw swelling in the delayed type hypersensitivity test and higher pathogen burden in extrapulmonary tissues after pulmonary infection with Cryptococcus neoformans compared with wild-type mice. The findings in delayed type hypersensitivity and infection tests were accompanied by significantly different basal and stimulated TNF-alpha, GM-CSF, and IFN-gamma levels in GPR34-deficient animals. Our data point toward a functional role of GPR34 in the cellular response to immunological challenges.	[Sangkuhl, Katrin] Univ Leipzig, Inst Biochem, Fac Med, D-04103 Leipzig, Germany; [Teupser, Daniel; Thiery, Joachim] Univ Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, Fac Med, D-04103 Leipzig, Germany; [Ricken, Albert] Univ Leipzig, Inst Anat, Fac Med, D-04103 Leipzig, Germany; [Wurm, Antje; Reichenbach, Andreas] Univ Leipzig, Paul Flechsig Inst Brain Res, Fac Med, D-04103 Leipzig, Germany; [Mueller, Uwe; Piehler, Daniel] Univ Leipzig, Fac Vet Med, Inst Immunol, D-04103 Leipzig, Germany; [Schmutzler, Sandra; Fuhrmann, Herbert] Univ Leipzig, Fac Vet Med, Inst Biochem, D-04103 Leipzig, Germany; [Albert, Frank W.] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University; Leipzig University; Leipzig University; Leipzig University; Max Planck Society		schoberg@medizin.uni-leipzig.de	Grosche, Antje/N-1978-2014; Thor, Doreen/P-6778-2019; Reichenbach, Andreas/B-2510-2017; Liebscher, Ines/AAX-7478-2020; Engel, Kathrin M/AAQ-1309-2021	Grosche, Antje/0000-0003-0338-7530; Thor, Doreen/0000-0002-9522-5098; Liebscher, Ines/0000-0003-4480-8987; Engel, Kathrin M/0000-0003-0611-7042; Muller, Uwe/0000-0003-1502-9271; Albert, Frank/0000-0002-1380-8063	Deutsche Forschungsgemeinschaft [Scho 624/7-1, FOR 748]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft Grant Scho 624/7-1, FOR 748.	Albert FW, 2008, HORM BEHAV, V53, P413, DOI 10.1016/j.yhbeh.2007.11.010; Aoki J, 2002, BBA-MOL CELL BIOL L, V1582, P26, DOI 10.1016/S1388-1981(02)00134-8; Bae YS, 2003, J IMMUNOL, V171, P6807, DOI 10.4049/jimmunol.171.12.6807; Barbaric Ivana, 2007, Briefings in Functional Genomics & Proteomics, V6, P91, DOI 10.1093/bfgp/elm008; Bedard A, 2007, GLIA, V55, P777, DOI 10.1002/glia.20477; BELLINI F, 1990, BIOCHIM BIOPHYS ACTA, V1052, P216, DOI 10.1016/0167-4889(90)90079-S; BERRIDGE MJ, 1983, BIOCHEM J, V212, P849, DOI 10.1042/bj2120849; Black C A, 1999, Dermatol Online J, V5, P7; Boselt I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005573; Boucher CA, 2001, J MED GENET, V38, P591, DOI 10.1136/jmg.38.9.591; Ceglarek U, 2002, CLIN CHEM LAB MED, V40, P693, DOI 10.1515/CCLM.2002.119; Chambers JK, 2000, J BIOL CHEM, V275, P10767, DOI 10.1074/jbc.275.15.10767; Engemaier E, 2006, GENOMICS, V87, P254, DOI 10.1016/j.ygeno.2005.10.001; Foster CJ, 2001, J CLIN INVEST, V107, P1591, DOI 10.1172/JCI12242; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Hirrlinger PG, 2008, J NEUROCHEM, V105, P1405, DOI 10.1111/j.1471-4159.2008.05243.x; Hollopeter G, 2001, NATURE, V409, P202, DOI 10.1038/35051599; Housley GD, 2009, TRENDS NEUROSCI, V32, P128, DOI 10.1016/j.tins.2009.01.001; Iwashita M, 2009, J MED CHEM, V52, P5837, DOI 10.1021/jm900598m; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kleinschek MA, 2006, J IMMUNOL, V176, P1098, DOI 10.4049/jimmunol.176.2.1098; Kleinschek MA, 2010, INT IMMUNOL, V22, P81, DOI 10.1093/intimm/dxp117; Koguchi Yoshinobu, 2002, Int Rev Immunol, V21, P423, DOI 10.1080/08830180213274; Kostenis E, 2005, TRENDS PHARMACOL SCI, V26, P595, DOI 10.1016/j.tips.2005.09.007; Lee SY, 2008, BIOCHEM BIOPH RES CO, V374, P147, DOI 10.1016/j.bbrc.2008.06.117; LIVAK KJ, 2000, METHOD MOL BIOL, V132, P365; Marchese A, 1999, GENOMICS, V56, P12, DOI 10.1006/geno.1998.5655; Masuya H, 2005, MAMM GENOME, V16, P829, DOI 10.1007/s00335-005-2430-8; MODY CH, 1990, J IMMUNOL, V144, P1472; Mueller P, 2003, CLIN CHIM ACTA, V327, P47, DOI 10.1016/S0009-8981(02)00327-3; Muller U, 2007, J IMMUNOL, V179, P5367, DOI 10.4049/jimmunol.179.8.5367; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Nambu A, 2006, INT IMMUNOL, V18, P701, DOI 10.1093/intimm/dxl007; Nonaka Y, 2005, BIOCHEM BIOPH RES CO, V337, P281, DOI 10.1016/j.bbrc.2005.09.052; NOVAK A, 2008, 50 ANN M EXP DEC 6 2; OKAYAMA H, 1983, MOL CELL BIOL, V3, P280, DOI 10.1128/MCB.3.2.280; Park KS, 2006, MOL PHARMACOL, V69, P1066, DOI 10.1124/mol.105.018960; Park KS, 2005, BIOCHEM BIOPH RES CO, V333, P353, DOI 10.1016/j.bbrc.2005.05.109; Pausch MH, 2004, BIOCHEM BIOPH RES CO, V324, P171, DOI 10.1016/j.bbrc.2004.09.034; Pausch MH, 1997, TRENDS BIOTECHNOL, V15, P487, DOI 10.1016/S0167-7799(97)01119-0; Plyusnina I, 1997, PHYSIOL BEHAV, V61, P381, DOI 10.1016/S0031-9384(96)00445-3; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Rompler H, 2007, MOL INTERV, V7, P17, DOI 10.1124/mi.7.1.5; Rozen S, 2000, PRIMER3 WWW GEN USER; Schliebe N, 2008, AM J PHYSIOL-RENAL, V295, pF1177, DOI 10.1152/ajprenal.00465.2007; Schoneberg T, 2007, PURINERG SIGNAL, V3, P255, DOI 10.1007/s11302-007-9064-0; Schoneberg T, 1999, BBA-GENE STRUCT EXPR, V1446, P57, DOI 10.1016/S0167-4781(99)00081-0; Schoneberg T, 2004, PHARMACOL THERAPEUT, V104, P173, DOI 10.1016/j.pharmthera.2004.08.008; Schroder R, 2009, J BIOL CHEM, V284, P1324, DOI 10.1074/jbc.M806867200; Schulz A, 2003, J BIOL CHEM, V278, P35531, DOI 10.1074/jbc.M303346200; Stenzel W, 2009, AM J PATHOL, V174, P486, DOI 10.2353/ajpath.2009.080598; Sugo T, 2006, BIOCHEM BIOPH RES CO, V341, P1078, DOI 10.1016/j.bbrc.2006.01.069; Sunahara RK, 1997, J BIOL CHEM, V272, P22265, DOI 10.1074/jbc.272.35.22265; Tabata KI, 2007, BIOCHEM BIOPH RES CO, V363, P861, DOI 10.1016/j.bbrc.2007.09.063; Thor D, 2008, BIOCHEM J, V412, P103, DOI [10.1042/BJ20071366, 10.1042/bj20071366]; Uckermann O, 2004, GLIA, V45, P59, DOI 10.1002/glia.10305; WIGGLESWORTH MJ, 2006, FDN S P, P105; Wlodarska M, 2009, HAEMATOL-HEMATOL J, V94, P271; Wurm A, 2010, J NEUROCHEM, V112, P1261, DOI 10.1111/j.1471-4159.2009.06541.x; Yin H, 2009, J BIOL CHEM, V284, P12328, DOI 10.1074/jbc.M806516200	62	58	59	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2101	2110		10.1074/jbc.M110.196659	http://dx.doi.org/10.1074/jbc.M110.196659			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21097509	Green Published, hybrid			2022-12-25	WOS:000286191500052
J	Domagalska, MA; Sarnowska, E; Nagy, F; Davis, SJ				Domagalska, Malgorzata A.; Sarnowska, Elzbieta; Nagy, Ferenc; Davis, Seth J.			Genetic Analyses of Interactions among Gibberellin, Abscisic Acid, and Brassinosteroids in the Control of Flowering Time in Arabidopsis thaliana	PLOS ONE			English	Article							CROSS-TALK; EXPRESSION; MUTANTS; TRANSITION; OVEREXPRESSION; BIOSYNTHESIS; PATHWAY; GROWTH; LOCUS	Background: Genetic interactions between phytohormones in the control of flowering time in Arabidopsis thaliana have not been extensively studied. Three phytohormones have been individually connected to the floral-timing program. The inductive function of gibberellins (GAs) is the most documented. Abscisic acid (ABA) has been demonstrated to delay flowering. Finally, the promotive role of brassinosteroids (BRs) has been established. It has been reported that for many physiological processes, hormone pathways interact to ensure an appropriate biological response. Methodology: We tested possible genetic interactions between GA-, ABA-, and BR-dependent pathways in the control of the transition to flowering. For this, single and double mutants deficient in the biosynthesis of GAs, ABA, and BRs were used to assess the effect of hormone deficiency on the timing of floral transition. Also, plants that over-express genes encoding rate-limiting enzymes in each biosynthetic pathway were generated and the flowering time of these lines was investigated. Conclusions: Loss-of-function studies revealed a complex relationship between GAs and ABA, and between ABA and BRs, and suggested a cross-regulatory relation between GAs to BRs. Gain-of-function studies revealed that GAs were clearly limiting in their sufficiency of action, whereas increases in BRs and ABA led to a more modest phenotypic effect on floral timing. We conclude from our genetic tests that the effects of GA, ABA, and BR on timing of floral induction are only in partially coordinated action.	[Domagalska, Malgorzata A.; Sarnowska, Elzbieta; Davis, Seth J.] Max Planck Inst Plant Breeding Res, Cologne, Germany; [Nagy, Ferenc] Hungarian Acad Sci, Biol Res Ctr, Inst Plant Biol, H-6701 Szeged, Hungary; [Nagy, Ferenc] Univ Edinburgh, Sch Biol Sci, Inst Mol Plant Sci, Edinburgh, Midlothian, Scotland	Max Planck Society; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; University of Edinburgh	Domagalska, MA (corresponding author), Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England.	davis@mpipz.mpg.de	Nagy, Ferenc/D-3532-2015	Nagy, Ferenc/0000-0002-6157-9269; Sarnowska, Elzbieta/0000-0001-7723-1198	Deutsche Forschungsgemeinschaft [DA1061/2-1]; Max Planck Society; German Israeli Project Cooperation (DIP) [H 3.1]; IMPRS; OTKA [81399]; HHMI	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck Society); German Israeli Project Cooperation (DIP); IMPRS; OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); HHMI(Howard Hughes Medical Institute)	This work was supported in the SJD group by a grant from the Deutsche Forschungsgemeinschaft (DA1061/2-1), the German Israeli Project Cooperation (DIP project H 3.1), and from the Max Planck Society. MAD was supported by a fellowship within the IMPRS program. Funding in the FN group was supported by the grant OTKA 81399 and by a HHMI International Scholar Fellowship. The funders of this work had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Achard P, 2006, SCIENCE, V311, P91, DOI 10.1126/science.1118642; Azpiroz R, 1998, PLANT CELL, V10, P219, DOI 10.1105/tpc.10.2.219; Bernier G, 2005, PLANT BIOTECHNOL J, V3, P3, DOI 10.1111/j.1467-7652.2004.00114.x; Bouquin T, 2001, PLANT PHYSIOL, V127, P450, DOI 10.1104/pp.010173; Cheng WH, 2002, PLANT CELL, V14, P2723, DOI 10.1105/tpc.006494; Choe S, 2001, PLANT J, V26, P573, DOI 10.1046/j.1365-313x.2001.01055.x; CHORY J, 1991, PLANT CELL, V3, P445, DOI 10.1105/tpc.3.5.445; Coles JP, 1999, PLANT J, V17, P547, DOI 10.1046/j.1365-313X.1999.00410.x; Davis AM, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-3; Davis SJ, 2009, PLANT CELL ENVIRON, V32, P1201, DOI 10.1111/j.1365-3040.2009.01968.x; Domagalska MA, 2007, DEVELOPMENT, V134, P2841, DOI 10.1242/dev.02866; Finkelstein RR, 2002, CURR OPIN PLANT BIOL, V5, P26, DOI 10.1016/S1369-5266(01)00225-4; Gazzarrini S, 2003, ANN BOT-LONDON, V91, P605, DOI 10.1093/aob/mcg064; Gray WM, 2004, PLOS BIOL, V2, P1270, DOI 10.1371/journal.pbio.0020311; Hanano S, 2006, GENES CELLS, V11, P1381, DOI 10.1111/j.1365-2443.2006.01026.x; Huang SS, 1998, PLANT PHYSIOL, V118, P773, DOI 10.1104/pp.118.3.773; Iuchi S, 2001, PLANT J, V27, P325, DOI 10.1046/j.1365-313x.2001.01096.x; JACOBSEN SE, 1993, PLANT CELL, V5, P887, DOI 10.1105/tpc.5.8.887; Jager CE, 2005, PLANTA, V221, P141, DOI 10.1007/s00425-004-1454-8; JANG YH, 2008, PLANT CELL PHYSL, V14, P14; Kania T, 1997, PLANT CELL, V9, P1327, DOI 10.1105/tpc.9.8.1327; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; Koornneef M, 1998, GENETICS, V148, P885; Kuppusamy K, 2009, PLANT MOL BIOL, V69, P375, DOI 10.1007/s11103-008-9389-2; LANGRIDGE J, 1957, NATURE, V180, P36, DOI 10.1038/180036a0; LeonKloosterziel KM, 1996, PLANT J, V10, P655, DOI 10.1046/j.1365-313X.1996.10040655.x; Levy YY, 1998, PLANT CELL, V10, P1973, DOI 10.1105/tpc.10.12.1973; Liu YX, 2007, PLANT CELL, V19, P433, DOI 10.1105/tpc.106.049221; Martinez-Zapater JM, 1994, ARABIDOPSIS, P403; Noguchi T, 1999, PLANT PHYSIOL, V121, P743, DOI 10.1104/pp.121.3.743; Putterill J, 2004, BIOESSAYS, V26, P363, DOI 10.1002/bies.20021; Razem FA, 2006, NATURE, V439, P290, DOI 10.1038/nature04373; Razem FA, 2006, CURR OPIN PLANT BIOL, V9, P454, DOI 10.1016/j.pbi.2006.07.007; Razem FA, 2008, NATURE, V456, P824, DOI 10.1038/nature07645; Reid JB, 2004, PLANT HORMONES: BIOSYNTHESIS, SIGNAL TRANSDUCTION, ACTION, P179; Risk JM, 2008, NATURE, V456, DOI 10.1038/nature07646; Srivastava L.M, 2002, PLANT GROWTH DEV HOR, DOI 10.1016/B978-012660570-9/50152-0; Steber CM, 2001, PLANT PHYSIOL, V125, P763, DOI 10.1104/pp.125.2.763; SUN TP, 1992, PLANT CELL, V4, P119, DOI 10.1105/tpc.4.2.119; Szekeres M, 1996, CELL, V85, P171, DOI 10.1016/S0092-8674(00)81094-6; Turk EM, 2005, PLANT J, V42, P23, DOI 10.1111/j.1365-313X.2005.02358.x; Wang L, 2009, PLANT J, V57, P498, DOI 10.1111/j.1365-313X.2008.03707.x; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; WILSON RN, 1995, PLANT PHYSIOL, V108, P495, DOI 10.1104/pp.108.2.495; WILSON RN, 1992, PLANT PHYSIOL, V100, P403, DOI 10.1104/pp.100.1.403; Yu XF, 2008, P NATL ACAD SCI USA, V105, P7618, DOI 10.1073/pnas.0802254105; Zentella R, 2007, PLANT CELL, V19, P3037, DOI 10.1105/tpc.107.054999	49	85	96	9	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2010	5	11							e14012	10.1371/journal.pone.0014012	http://dx.doi.org/10.1371/journal.pone.0014012			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681OY	21103336	gold, Green Published, Green Submitted			2022-12-25	WOS:000284327800004
J	Parsons, JB; Lawrence, AD; McLean, KJ; Munro, AW; Rigby, SEJ; Warren, MJ				Parsons, Joshua B.; Lawrence, Andrew D.; McLean, Kirsty J.; Munro, Andrew W.; Rigby, Stephen E. J.; Warren, Martin J.			Characterisation of PduS, the pdu Metabolosome Corrin Reductase, and Evidence of Substructural Organisation within the Bacterial Microcompartment	PLOS ONE			English	Article							SEROVAR TYPHIMURIUM LT2; SALMONELLA-ENTERICA; ADENOSYLCOBALAMIN BIOSYNTHESIS; ENZYMATIC CONVERSION; COBALAMIN; ORGANELLES; ENZYMES; 1,2-PROPANEDIOL; VITAMIN-B-12; DEGRADATION	PduS is a corrin reductase and is required for the reactivation of the cobalamin-dependent diol dehydratase. It is one component encoded within the large propanediol utilisation (pdu) operon, which is responsible for the catabolism of 1,2-propanediol within a self-assembled proteinaceous bacterial microcompartment. The enzyme is responsible for the reactivation of the cobalamin coenzyme required by the diol dehydratase. The gene for the cobalamin reductase from Citrobacter freundii (pduS) has been cloned to allow the protein to be overproduced recombinantly in E. coli with an N-terminal His-tag. Purified recombinant PduS is shown to be a flavoprotein with a non-covalently bound FMN that also contains two coupled [4Fe-4S] centres. It is an NADH-dependent flavin reductase that is able to mediate the one-electron reductions of cob(III) alamin to cob(II) alamin and cob(II) alamin to cob(I) alamin. The [4Fe-4S] centres are labile to oxygen and their presence affects the midpoint redox potential of flavin. Evidence is presented that PduS is able to bind cobalamin, which is inconsistent with the view that PduS is merely a flavin reductase. PduS is also shown to interact with one of the shell proteins of the metabolosome, PduT, which is also thought to contain an [Fe-S] cluster. PduS is shown to act as a corrin reductase and its interaction with a shell protein could allow for electron passage out of the bacterial microcompartment.	[Parsons, Joshua B.; Lawrence, Andrew D.; Warren, Martin J.] Univ Kent, Ctr Mol Proc, Sch Biosci, Canterbury, Kent, England; [McLean, Kirsty J.; Munro, Andrew W.; Rigby, Stephen E. J.] Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester, Lancs, England	University of Kent; University of Manchester	Parsons, JB (corresponding author), Univ Kent, Ctr Mol Proc, Sch Biosci, Canterbury, Kent, England.	m.j.warren@kent.ac.uk	Munro, Andrew/G-5639-2019; McLean, Kirsty J/GXI-2853-2022	Munro, Andrew/0000-0002-4642-180X; McLean, Kirsty/0000-0002-7193-5044; Parsons, Joshua/0000-0002-0589-3587; Warren, Martin/0000-0002-6028-6456	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/E002889, BB/E024203]; Biotechnology and Biological Sciences Research Council [BB/E010563/1] Funding Source: researchfish; BBSRC [BB/E010563/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors acknowledge financial support from the Biotechnology and Biological Sciences Research Council (BBSRC) [BB/E002889 and BB/E024203]. The web site of the BBSRC can be found at www.bbsrc.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee R, 2003, ANNU REV BIOCHEM, V72, P209, DOI 10.1146/annurev.biochem.72.121801.161828; BLANCHE F, 1992, J BACTERIOL, V174, P7452, DOI 10.1128/jb.174.22.7452-7454.1992; Bobik TA, 1999, J BACTERIOL, V181, P5967, DOI 10.1128/JB.181.19.5967-5975.1999; Bobik TA, 1997, J BACTERIOL, V179, P6633, DOI 10.1128/jb.179.21.6633-6639.1997; Brinsmade SR, 2005, J BACTERIOL, V187, P8039, DOI 10.1128/JB.187.23.8039-8046.2005; CHENG S, J BACTERIOL, V192, P5071; Cheng SQ, 2008, BIOESSAYS, V30, P1084, DOI 10.1002/bies.20830; Dutton P L, 1978, Methods Enzymol, V54, P411; EMPTAGE MH, 1983, J BIOL CHEM, V258, P1106; Fonseca MV, 2001, J BIOL CHEM, V276, P32101, DOI 10.1074/jbc.M102510200; Fonseca MV, 2000, J BACTERIOL, V182, P4304, DOI 10.1128/JB.182.15.4304-4309.2000; Havemann GD, 2003, J BACTERIOL, V185, P5086, DOI 10.1128/JB.185.17.5086-5095.2003; Lawrence AD, 2008, J BIOL CHEM, V283, P10813, DOI 10.1074/jbc.M710431200; LEXA D, 1977, J AM CHEM SOC, V99, P2786, DOI 10.1021/ja00450a061; Mera PE, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.059485; Mera PE, 2009, BIOCHEMISTRY-US, V48, P3138, DOI 10.1021/bi9000134; Munro AW, 2001, BIOCHEMISTRY-US, V40, P1956, DOI 10.1021/bi001718u; Parsons JB, 2008, J BIOL CHEM, V283, P14366, DOI 10.1074/jbc.M709214200; Roth JR, 1996, ANNU REV MICROBIOL, V50, P137, DOI 10.1146/annurev.micro.50.1.137; Sampson EM, 2005, MICROBIOL-SGM, V151, P1169, DOI 10.1099/mic.0.27755-0; St Maurice M, 2008, BIOCHEMISTRY-US, V47, P5755, DOI 10.1021/bi800132d; Stich TA, 2005, J AM CHEM SOC, V127, P8710, DOI 10.1021/ja042142p; Toraya T, 2000, CELL MOL LIFE SCI, V57, P106, DOI 10.1007/s000180050502; WALKER GA, 1969, ARCH BIOCHEM BIOPHYS, V134, P95, DOI 10.1016/0003-9861(69)90255-0; Warren MJ, 2002, NAT PROD REP, V19, P390, DOI 10.1039/B108967F; Yeates TO, 2008, NAT REV MICROBIOL, V6, P681, DOI 10.1038/nrmicro1913	26	28	31	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e14009	10.1371/journal.pone.0014009	http://dx.doi.org/10.1371/journal.pone.0014009			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103360	Green Submitted, gold, Green Published			2022-12-25	WOS:000284257400013
J	White, RE; Groves, IJ; Turro, E; Yee, J; Kremmer, E; Allday, MJ				White, Robert E.; Groves, Ian J.; Turro, Ernest; Yee, Jade; Kremmer, Elisabeth; Allday, Martin J.			Extensive Co-Operation between the Epstein-Barr Virus EBNA3 Proteins in the Manipulation of Host Gene Expression and Epigenetic Chromatin Modification	PLOS ONE			English	Article							NUCLEAR ANTIGEN 3C; LYMPHOBLASTOID CELL-LINES; RBP-J-KAPPA; GENOMIC INSTABILITY; HISTONE DEACETYLASE; BURKITTS-LYMPHOMA; TARGET GENES; CYCLIN-A; TRANSCRIPTION; BINDING	Epstein-Barr virus (EBV) is able to drive the transformation of B-cells, resulting in the generation of lymphoblastoid cell lines (LCLs) in vitro. EBV nuclear proteins EBNA3A and EBNA3C are necessary for efficient transformation, while EBNA3B is dispensable. We describe a transcriptome analysis of BL31 cells infected with a series of EBNA3-knockout EBVs, including one deleted for all three EBNA3 genes. Using Affymetrix Exon 1.0 ST microarrays analysed with the MMBGX algorithm, we have identified over 1000 genes whose regulation by EBV requires one of the EBNA3s. Remarkably, a third of the genes identified require more than one EBNA3 for their regulation, predominantly EBNA3C co-operating with either EBNA3B, EBNA3A or both. The microarray was validated by real-time PCR, while ChIP analysis of a selection of co-operatively repressed promoters indicates a role for polycomb group complexes. Targets include genes involved in apoptosis, cell migration and B-cell differentiation, and show a highly significant but subtle alteration in genes involved in mitosis. In order to assess the relevance of the BL31 system to LCLs, we analysed the transcriptome of a set of EBNA3B knockout (3BKO) LCLs. Around a third of the genes whose expression level in LCLs was altered in the absence of EBNA3B were also altered in 3BKO-BL31 cell lines. Among these are TERT and TCL1A, implying that EBV-induced changes in the expression of these genes are not required for B-cell transformation. We also identify 26 genes that require both EBNA3A and EBNA3B for their regulation in LCLs. Together, this shows the complexity of the interaction between EBV and its host, whereby multiple EBNA3 proteins co-operate to modulate the behaviour of the host cell.	[White, Robert E.; Groves, Ian J.; Yee, Jade; Allday, Martin J.] Univ London Imperial Coll Sci Technol & Med, Virol Sect, London, England; [Turro, Ernest] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London, England; [Kremmer, Elisabeth] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Mol Immunol, Munich, Germany	Imperial College London; Imperial College London; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	White, RE (corresponding author), Univ London Imperial Coll Sci Technol & Med, Virol Sect, London, England.	robert.e.white@imperial.ac.uk	Groves, Ian John/HGU-5954-2022	Groves, Ian John/0000-0001-8882-6701; White, Robert/0000-0002-5115-2173; Turro, Ernest/0000-0002-1820-6563	Wellcome Trust [077489, 049293]; Biotechnology and Biological Sciences Research Council (BBSRC) [28EGM16093]	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This project was funded by program grant 077489 and project grant 049293 from the Wellcome Trust (http://www.wellcome.ac.uk). ET was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) 'Exploiting Genomics' grant 28EGM16093 (http://www.bbsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN GJ, 1989, VIROLOGY, V173, P489, DOI 10.1016/0042-6822(89)90561-8; Anderton E, 2008, ONCOGENE, V27, P421, DOI 10.1038/sj.onc.1210668; Baik SY, 2007, CELL PROLIFERAT, V40, P268, DOI 10.1111/j.1365-2184.2007.00429.x; Bain M, 1996, J VIROL, V70, P2481, DOI 10.1128/JVI.70.4.2481-2489.1996; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bourillot PY, 1998, J GEN VIROL, V79, P363, DOI 10.1099/0022-1317-79-2-363; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Burgess A, 2006, J GEN VIROL, V87, P789, DOI 10.1099/vir.0.81640-0; CALDERWOOD MA, 2010, EPSTEINBARR VIRUS LA, pCH6; Calderwood MA, 2007, P NATL ACAD SCI USA, V104, P7606, DOI 10.1073/pnas.0702332104; CALENDER A, 1987, P NATL ACAD SCI USA, V84, P8060, DOI 10.1073/pnas.84.22.8060; Chen A, 2005, J VIROL, V79, P4506, DOI 10.1128/JVI.79.7.4506-4509.2005; Chen A, 2006, J VIROL, V80, P10139, DOI 10.1128/JVI.00854-06; Cludts I, 1998, J VIROL, V72, P1862, DOI 10.1128/JVI.72.3.1862-1869.1998; COUNTER CM, 1995, BLOOD, V85, P2315, DOI 10.1182/blood.V85.9.2315.bloodjournal8592315; Crawford DH, 2001, PHILOS T R SOC B, V356, P461, DOI 10.1098/rstb.2000.0783; Delecluse HJ, 1998, P NATL ACAD SCI USA, V95, P8245, DOI 10.1073/pnas.95.14.8245; FINKE J, 1987, J VIROL, V61, P3870, DOI 10.1128/JVI.61.12.3870-3878.1987; Fossum E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000570; Gruhne B, 2009, ONCOGENE, V28, P3997, DOI 10.1038/onc.2009.258; Harada S, 1997, J VIROL, V71, P6611, DOI 10.1128/JVI.71.9.6611-6618.1997; HENKEL T, 1994, SCIENCE, V265, P92, DOI 10.1126/science.8016657; Hertle ML, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000506; Hickabottom M, 2002, J BIOL CHEM, V277, P47197, DOI 10.1074/jbc.M208116200; Kamranvar SA, 2007, ONCOGENE, V26, P5115, DOI 10.1038/sj.onc.1210324; Klein U, 2003, P NATL ACAD SCI USA, V100, P2639, DOI 10.1073/pnas.0437996100; Knight JS, 2005, P NATL ACAD SCI USA, V102, P18562, DOI 10.1073/pnas.0503886102; Knight JS, 2005, MOL CELL BIOL, V25, P1749, DOI 10.1128/MCB.25.5.1749-1763.2005; Knight JS, 2004, J VIROL, V78, P12857, DOI 10.1128/JVI.78.23.12857-12867.2004; Knight JS, 2004, J VIROL, V78, P1981, DOI 10.1128/JVI.78.4.1981-1991.2004; Knight JS, 2003, J VIROL, V77, P4261, DOI 10.1128/JVI.77.7.4261-4272.2003; Krauer KG, 2004, VIROLOGY, V318, P280, DOI 10.1016/j.virol.2003.09.032; KREMMER E, 1995, VIROLOGY, V208, P336, DOI 10.1006/viro.1995.1157; Lee JE, 2010, CELL PROLIFERAT, V43, P378, DOI 10.1111/j.1365-2184.2010.00687.x; Lee S, 2009, J VIROL, V83, P12368, DOI 10.1128/JVI.01403-09; LEROUX A, 1994, VIROLOGY, V205, P596, DOI 10.1006/viro.1994.1687; Ling PD, 2005, EMBO J, V24, P3565, DOI 10.1038/sj.emboj.7600820; Lucchesi W, 2008, J VIROL, V82, P7456, DOI 10.1128/JVI.00223-08; Maier S, 2006, J VIROL, V80, P9761, DOI 10.1128/JVI.00665-06; MARSHALL D, 1995, J VIROL, V69, P3624, DOI 10.1128/JVI.69.6.3624-3630.1995; Maruo S, 2006, P NATL ACAD SCI USA, V103, P19500, DOI 10.1073/pnas.0604919104; MURRAY RJ, 1988, J VIROL, V62, P894, DOI 10.1128/JVI.62.3.894-901.1988; Neuhierl B, 2002, P NATL ACAD SCI USA, V99, P15036, DOI 10.1073/pnas.232381299; Nitsche F, 1997, J VIROL, V71, P6619, DOI 10.1128/JVI.71.9.6619-6628.1997; Northrup DL, 2008, IMMUNOL RES, V42, P106, DOI 10.1007/s12026-008-8043-z; O'Nions F, 2004, ADV CANCER RES, V92, P119; Ochiai K, 2008, INT IMMUNOL, V20, P453, DOI 10.1093/intimm/dxn005; Parker GA, 1996, ONCOGENE, V13, P2541; Parker GA, 2000, ONCOGENE, V19, P700, DOI 10.1038/sj.onc.1203327; Paschos K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000492; Pillai S, 2009, NAT REV IMMUNOL, V9, P767, DOI 10.1038/nri2656; Radkov SA, 1999, J VIROL, V73, P5688, DOI 10.1128/JVI.73.7.5688-5697.1999; Radkov SA, 1997, J VIROL, V71, P8552, DOI 10.1128/JVI.71.11.8552-8562.1997; ROBERTSON ES, 1995, J VIROL, V69, P3108, DOI 10.1128/JVI.69.5.3108-3116.1995; Roughan JE, 2009, J VIROL, V83, P3968, DOI 10.1128/JVI.02609-08; ROWE M, 1987, EMBO J, V6, P2743, DOI 10.1002/j.1460-2075.1987.tb02568.x; Saha A, 2009, J VIROL, V83, P4652, DOI 10.1128/JVI.02408-08; Scheeren FA, 2008, J EXP MED, V205, P2033, DOI 10.1084/jem.20070447; Schmidlin H, 2009, TRENDS IMMUNOL, V30, P277, DOI 10.1016/j.it.2009.03.008; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Skalska L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000951; Souza TA, 2007, J IMMUNOL, V179, P3153, DOI 10.4049/jimmunol.179.5.3153; Spender LC, 2006, J GEN VIROL, V87, P2859, DOI 10.1099/vir.0.82128-0; Sugimoto M, 2004, CANCER RES, V64, P3361, DOI 10.1158/0008-5472.CAN-04-0079; Swaminathan S, 2008, J CELL PHYSIOL, V216, P321, DOI 10.1002/jcp.21480; TERRIN L, 2008, J VIROLOGY; Thorley-Lawson DA, 2004, NEW ENGL J MED, V350, P1328, DOI 10.1056/NEJMra032015; Thorley-Lawson DA, 2008, NAT REV MICROBIOL, V6, P913, DOI 10.1038/nrmicro2015; TOMKINSON B, 1992, J VIROL, V66, P2893, DOI 10.1128/JVI.66.5.2893-2903.1992; TOMKINSON B, 1993, J VIROL, V67, P2014, DOI 10.1128/JVI.67.4.2014-2025.1993; Touitou R, 2005, J GEN VIROL, V86, P1269, DOI 10.1099/vir.0.80763-0; Touitou R, 2001, J VIROL, V75, P7749, DOI 10.1128/JVI.75.16.7749-7755.2001; Turro E, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp853; Wade M, 2000, MOL CELL BIOL, V20, P1344, DOI 10.1128/MCB.20.4.1344-1360.2000; Waltzer L, 1996, J VIROL, V70, P5909, DOI 10.1128/JVI.70.9.5909-5915.1996; White RE, 2003, J GEN VIROL, V84, P3393, DOI 10.1099/vir.0.19387-0; Wu KJ, 1999, NAT GENET, V21, P220, DOI 10.1038/6010; Yang J, 2004, J EXP CLIN CANC RES, V23, P495; Yi FM, 2009, VIROLOGY, V388, P236, DOI 10.1016/j.virol.2009.03.027; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Young LS, 2003, ONCOGENE, V22, P5108, DOI 10.1038/sj.onc.1206556; Young P, 2008, J GEN VIROL, V89, P866, DOI 10.1099/vir.0.83414-0; Zimber-Strobl U, 2001, SEMIN CANCER BIOL, V11, P423, DOI 10.1006/scbi.2001.0409	83	65	66	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e13979	10.1371/journal.pone.0013979	http://dx.doi.org/10.1371/journal.pone.0013979			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085583	Green Published, gold, Green Submitted			2022-12-25	WOS:000284231800009
J	Brawley, CM; Uysal, S; Kossiakoff, AA; Rock, RS				Brawley, Crista M.; Uysal, Serdar; Kossiakoff, Anthony A.; Rock, Ronald S.			Characterization of Engineered Actin Binding Proteins That Control Filament Assembly and Structure	PLOS ONE			English	Article							SYNTHETIC ANTIBODIES; PHAGE DISPLAY; POINTED ENDS; TROPOMODULIN; LIBRARIES; MEMBRANE; RECEPTOR; COMPLEX; CAPS	Background: Eukaryotic cells strictly regulate the structure and assembly of their actin filament networks in response to various stimuli. The actin binding proteins that control filament assembly are therefore attractive targets for those who wish to reorganize actin filaments and reengineer the cytoskeleton. Unfortunately, the naturally occurring actin binding proteins include only a limited set of pointed-end cappers, or proteins that will block polymerization from the slow-growing end of actin filaments. Of the few that are known, most are part of large multimeric complexes that are challenging to manipulate. Methodology/Principal Findings: We describe here the use of phage display mutagenesis to generate of a new class of binding protein that can be targeted to the pointed-end of actin. These proteins, called synthetic antigen binders (sABs), are based on an antibody-like scaffold where sequence diversity is introduced into the binding loops using a novel "reduced genetic code" phage display library. We describe effective strategies to select and screen for sABs that ensure the generated sABs bind to the pointed-end surface of actin exclusively. Conclusions/Significance: From our set of pointed-end binders, we identify three sABs with particularly useful properties to systematically probe actin dynamics: one protein that caps the pointed end, a second that crosslinks actin filaments, and a third that severs actin filaments and promotes disassembly.	[Brawley, Crista M.; Uysal, Serdar; Kossiakoff, Anthony A.; Rock, Ronald S.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	University of Chicago	Brawley, CM (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 920 E 58th St, Chicago, IL 60637 USA.	koss@bsd.uchicago.edu; rrock@uchicago.edu			National Institutes of Health (NIH) [GM078450, GM072688]; AHA MWA; National Cancer Institute [T32CA009594]; NATIONAL CANCER INSTITUTE [T32CA009594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078450, R01GM072688] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA MWA; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grants GM078450 (to R. S. R.) and GM072688 (to A. A. K.); an AHA MWA postdoctoral fellowship (to C. M. B.); and a National Cancer Institute grant T32CA009594 (to C. M. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	COLUCCIO LM, 1994, J CELL BIOL, V127, P1497, DOI 10.1083/jcb.127.6.1497; Dominguez R, 2004, TRENDS BIOCHEM SCI, V29, P572, DOI 10.1016/j.tibs.2004.09.004; Dos Remedios CG, 2003, PHYSIOL REV, V83, P433, DOI 10.1152/physrev.00026.2002; EGELMAN EH, 1982, NATURE, V298, P131, DOI 10.1038/298131a0; Fellouse FA, 2004, P NATL ACAD SCI USA, V101, P12467, DOI 10.1073/pnas.0401786101; Fellouse FA, 2007, J MOL BIOL, V373, P924, DOI 10.1016/j.jmb.2007.08.005; Holaska JM, 2004, PLOS BIOL, V2, P1354, DOI 10.1371/journal.pbio.0020231; Howard J., 2001, MECH MOTOR PROTEINS; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; LairdOffringa IA, 1996, METHOD ENZYMOL, V267, P149; Lee CV, 2004, J IMMUNOL METHODS, V284, P119, DOI 10.1016/j.jim.2003.11.001; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Nagy S, 2008, P NATL ACAD SCI USA, V105, P9616, DOI 10.1073/pnas.0802592105; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; Palmgren S, 2001, J CELL BIOL, V155, P251, DOI 10.1083/jcb.200106157; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; PODOLSKI JL, 1988, J BIOL CHEM, V263, P638; POLLARD TD, 1986, ANNU REV BIOCHEM, V55, P987, DOI 10.1146/annurev.bi.55.070186.005011; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Qualmann B, 2009, TRENDS CELL BIOL, V19, P276, DOI 10.1016/j.tcb.2009.03.004; Rizk SS, 2009, P NATL ACAD SCI USA, V106, P11011, DOI 10.1073/pnas.0904907106; Rock RS, 2000, METHODS, V22, P373, DOI 10.1006/meth.2000.1089; Schafer DA, 1995, ANNU REV CELL DEV BI, V11, P497, DOI 10.1146/annurev.cellbio.11.1.497; Sidhu SS, 2000, METHOD ENZYMOL, V328, P333, DOI 10.1016/S0076-6879(00)28406-1; Statsuk AV, 2005, NAT CHEM BIOL, V1, P383, DOI 10.1038/nchembio748; WEBER A, 1994, J CELL BIOL, V127, P1627, DOI 10.1083/jcb.127.6.1627	26	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e13960	10.1371/journal.pone.0013960	http://dx.doi.org/10.1371/journal.pone.0013960			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103060	Green Published, Green Submitted, gold			2022-12-25	WOS:000284147700011
J	Greenland, KB; Ding, H; Costanzo, M; Boone, C; Davis, TN				Greenland, Kristen B.; Ding, Huiming; Costanzo, Michael; Boone, Charles; Davis, Trisha N.			Identification of Saccharomyces cerevisiae Spindle Pole Body Remodeling Factors	PLOS ONE			English	Article							NUCLEAR-PORE COMPLEX; GAMMA-TUBULIN; INTERACTION NETWORK; TRANSFER-RNA; YEAST; CENTROSOMES; EFFICIENT; PROTEINS; MULTIPOLARITY; AMPLIFICATION	The Saccharomyces cerevisiae centrosome or spindle pole body (SPB) is a dynamic structure that is remodeled in a cell cycle dependent manner. The SPB increases in size late in the cell cycle and during most cell cycle arrests and exchanges components during G1/S. We identified proteins involved in the remodeling process using a strain in which SPB remodeling is conditionally induced. This strain was engineered to express a modified SPB component, Spc110, which can be cleaved upon the induction of a protease. Using a synthetic genetic array analysis, we screened for genes required only when Spc110 cleavage is induced. Candidate SPB remodeling factors fell into several functional categories: mitotic regulators, microtubule motors, protein modification enzymes, and nuclear pore proteins. The involvement of candidate genes in SPB assembly was assessed in three ways: by identifying the presence of a synthetic growth defect when combined with an Spc110 assembly defective mutant, quantifying growth of SPBs during metaphase arrest, and comparing distribution of SPB size during asynchronous growth. These secondary screens identified four genes required for SPB remodeling: NUP60, POM152, and NCS2 are required for SPB growth during a mitotic cell cycle arrest, and UBC4 is required to maintain SPB size during the cell cycle. These findings implicate the nuclear pore, urmylation, and ubiquitination in SPB remodeling and represent novel functions for these genes.	[Greenland, Kristen B.; Davis, Trisha N.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Greenland, Kristen B.; Davis, Trisha N.] Univ Washington, Program Mol & Cellular Biol, Seattle, WA 98195 USA; [Ding, Huiming; Costanzo, Michael; Boone, Charles] Univ Toronto, Banting & Best Dept Med Res, Terrence Donnelly Ctr Cellular & Biomol, Toronto, ON, Canada	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Toronto	Greenland, KB (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	tdavis@u.washington.edu	Davis, Trisha/F-8584-2010	Greenland, Kristen/0000-0002-7491-5372; Davis, Trisha/0000-0003-4797-3152	Molecular & Cellular Biology, University of Washington; National Institute of General Medical Sciences [T32 GM07270, R01GM40506]; Genome Canada, Ontario Genomics Institute [2004-OGI-3-01]; Canadian Institutes of Health Research [GSP-41567]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270, R01GM040506] Funding Source: NIH RePORTER	Molecular & Cellular Biology, University of Washington(University of Washington); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Genome Canada, Ontario Genomics Institute(Genome Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Molecular & Cellular Biology, University of Washington and the Public Health Service, National Research Service Award, T32 GM07270, from the National Institute of General Medical Sciences (http://www.nigms.nih.gov/) to K. G. and Public Health Service grant R01GM40506 from the National Institute of General Medical Sciences to T.N.D. C. B. was supported by Genome Canada (http://www.genomecanada.ca/) through the Ontario Genomics Institute (2004-OGI-3-01) and the Canadian Institutes of Health Research (GSP-41567) (http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acilan C, 2008, CELL, V134, P572, DOI 10.1016/j.cell.2008.08.007; Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Ashraf SS, 1999, RNA, V5, P188, DOI 10.1017/S1355838299981529; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Basto R, 2008, CELL, V133, P1032, DOI 10.1016/j.cell.2008.05.039; Burke D., 2000, METHODS YEAST GENETI, P171; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; GEISER JR, 1993, MOL CELL BIOL, V13, P7913, DOI 10.1128/MCB.13.12.7913; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Goshima G, 2005, J CELL BIOL, V171, P229, DOI 10.1083/jcb.200505107; Hawkins KM, 2006, J BIOL CHEM, V281, P13485, DOI 10.1074/jbc.M512317200; Hazbun TR, 2003, MOL CELL, V12, P1353, DOI 10.1016/S1097-2765(03)00476-3; Leidel S, 2009, NATURE, V458, P228, DOI 10.1038/nature07643; Loeillet S, 2005, DNA REPAIR, V4, P459, DOI 10.1016/j.dnarep.2004.11.010; Niepel M, 2005, J CELL BIOL, V170, P225, DOI 10.1083/jcb.200504140; Onischenko E, 2009, J CELL BIOL, V185, P475, DOI 10.1083/jcb.200810030; Quintyne NJ, 2005, SCIENCE, V307, P127, DOI 10.1126/science.1104905; Sankaran S, 2007, CANCER BIOL THER, V6, P1853, DOI 10.4161/cbt.6.12.5164; Saunders W, 2005, SEMIN CANCER BIOL, V15, P25, DOI 10.1016/j.semcancer.2004.09.003; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; Sezen B, 2009, GENE DEV, V23, P1559, DOI 10.1101/gad.524209; SIKORSKI RS, 1989, GENETICS, V122, P19; Starita LM, 2004, MOL CELL BIOL, V24, P8457, DOI 10.1128/MCB.24.19.8457-8466.2004; Sundberg HA, 1996, J CELL BIOL, V133, P111, DOI 10.1083/jcb.133.1.111; Sundberg HA, 1997, MOL BIOL CELL, V8, P2575, DOI 10.1091/mbc.8.12.2575; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; WARGACKI MM, 2010, CELL CYCLE, V9; Xia Y, 2003, J BIOL CHEM, V278, P5255, DOI 10.1074/jbc.M204591200; Yang Z, 2008, NAT CELL BIOL, V10, P748, DOI 10.1038/ncb1738; Yoder TJ, 2005, MOL BIOL CELL, V16, P141, DOI 10.1091/mbc.E04-08-0703; Yoder TJ, 2003, MOL BIOL CELL, V14, P3494, DOI 10.1091/mbc.E02-10-0655; Young A, 2000, MOL BIOL CELL, V11, P2047, DOI 10.1091/mbc.11.6.2047; Zhao XL, 2004, J CELL BIOL, V167, P605, DOI 10.1083/jcb.200405168	34	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e15426	10.1371/journal.pone.0015426	http://dx.doi.org/10.1371/journal.pone.0015426			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103054	Green Published, gold, Green Submitted			2022-12-25	WOS:000284147700025
J	Starcevic, A; Dunlap, WC; Cullum, J; Shick, JM; Hranueli, D; Long, PF				Starcevic, Antonio; Dunlap, Walter C.; Cullum, John; Shick, J. Malcolm; Hranueli, Daslav; Long, Paul F.			Gene Expression in the Scleractinian Acropora microphthalma Exposed to High Solar Irradiance Reveals Elements of Photoprotection and Coral Bleaching	PLOS ONE			English	Article							GREAT-BARRIER-REEF; AMINO-ACIDS MAAS; OXIDATIVE STRESS; ULTRAVIOLET-RADIATION; MONTASTRAEA-FAVEOLATA; ABSORBING COMPOUNDS; ZOOXANTHELLAE; LIGHT; PATHWAY; GENOME	Background: The success of tropical reef-building corals depends on the metabolic co-operation between the animal host and the photosynthetic performance of endosymbiotic algae residing within its cells. To examine the molecular response of the coral Acropora microphthalma to high levels of solar irradiance, a cDNA library was constructed by PCR-based suppression subtractive hybridisation (PCR-SSH) from mRNA obtained by transplantation of a colony from a depth of 12.7 m to near-surface solar irradiance, during which the coral became noticeably paler from loss of endosymbionts in sun-exposed tissues. Methodology/Principal Findings: A novel approach to sequence annotation of the cDNA library gave genetic evidence for a hypothetical biosynthetic pathway branching from the shikimic acid pathway that leads to the formation of 4-deoxygadusol. This metabolite is a potent antioxidant and expected precursor of the UV-protective mycosporine-like amino acids (MAAs), which serve as sunscreens in coral phototrophic symbiosis. Empirical PCR based evidence further upholds the contention that the biosynthesis of these MAA sunscreens is a 'shared metabolic adaptation' between the symbiotic partners. Additionally, gene expression induced by enhanced solar irradiance reveals a cellular mechanism of light-induced coral bleaching that invokes a Ca2+-binding synaptotagmin-like regulator of SNARE protein assembly of phagosomal exocytosis, whereby algal partners are lost from the symbiosis. Conclusions/Significance: Bioinformatics analyses of DNA sequences obtained by differential gene expression of a coral exposed to high solar irradiance has revealed the identification of putative genes encoding key steps of the MAA biosynthetic pathway. Revealed also by this treatment are genes that implicate exocytosis as a cellular process contributing to a breakdown in the metabolically essential partnership between the coral host and endosymbiotic algae, which manifests as coral bleaching.	[Starcevic, Antonio; Hranueli, Daslav] Univ Zagreb, Sect Bioinformat, Dept Biochem Engn, Fac Food Technol & Biotechnol, Zagreb 41000, Croatia; [Dunlap, Walter C.] Australian Inst Marine Sci, Ctr Marine Microbiol & Genet, Townsville, Qld 4810, Australia; [Cullum, John] Univ Kaiserslautern, Dept Genet, Kaiserslautern, Germany; [Shick, J. Malcolm] Univ Maine, Sch Marine Sci, Orono, ME USA; [Long, Paul F.] Univ London, Sch Pharm, London WC1N 1AX, England	University of Zagreb; Australian Institute of Marine Science; University of Kaiserslautern; University of Maine System; University of Maine Orono; University of London; University College London; University of London School of Pharmacy	Starcevic, A (corresponding author), Univ Zagreb, Sect Bioinformat, Dept Biochem Engn, Fac Food Technol & Biotechnol, Zagreb 41000, Croatia.	paul.long@kcl.ac.uk	Starcevic, Antonio/AAB-9379-2021	Long, Paul/0000-0001-6698-4602	Australian Institute of Marine Science; German Academic Exchange Service (DAAD); Ministry of Science, Education and Sports, Republic of Croatia [058-0000000-3475]; University of Maine, USA; United Kingdom by The University of London School of Pharmacy; Leverhulme Trust; Royal Society of London; BBSRC [BB/H010009/2]; Biotechnology and Biological Sciences Research Council [BB/H010009/2] Funding Source: researchfish	Australian Institute of Marine Science; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Ministry of Science, Education and Sports, Republic of Croatia(Ministry of Science, Education and Sports, Republic of Croatia); University of Maine, USA; United Kingdom by The University of London School of Pharmacy; Leverhulme Trust(Leverhulme Trust); Royal Society of London(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Financial support for this work has come from the Australian Institute of Marine Science (WCD PFL); from a cooperation grant of the German Academic Exchange Service (DAAD, DH JC), by a stipendium of the DAAD (AS) and from the Ministry of Science, Education and Sports, Republic of Croatia (058-0000000-3475, DH); the University of Maine, USA (JMS) and from the United Kingdom by The University of London School of Pharmacy and grants from the Leverhulme Trust, the Royal Society of London (PFL) and the BBSRC (BB/H010009/2, PFL WCD JMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth TD, 2008, CORAL REEFS, V27, P593, DOI 10.1007/s00338-008-0355-x; BALSKUS EP, 2010, SCIENCE         0902, DOI DOI 10.1126/SCIENCE.1193637; Banaszak AT, 2006, J EXP MAR BIOL ECOL, V337, P131, DOI 10.1016/j.jembe.2006.06.014; Banaszak AT, 2000, J EXP MAR BIOL ECOL, V249, P219; Chen YB, 2004, PLANT PHYSIOL, V136, P3737, DOI 10.1104/pp.104.038919; Csaszar NBM, 2009, MAR ECOL PROG SER, V392, P93, DOI 10.3354/meps08194; Desalvo MK, 2008, MOL ECOL, V17, P3952, DOI 10.1111/j.1365-294X.2008.03879.x; DUNLAP WC, 1986, J EXP MAR BIOL ECOL, V104, P239, DOI 10.1016/0022-0981(86)90108-5; Dunn SR, 2007, P ROY SOC B-BIOL SCI, V274, P3079, DOI 10.1098/rspb.2007.0711; Edge SE, 2005, MAR POLLUT BULL, V51, P507, DOI 10.1016/j.marpolbul.2005.07.007; FAVREBONVIN J, 1987, PHYTOCHEMISTRY, V26, P2509, DOI 10.1016/S0031-9422(00)83866-2; Fitt WK, 2009, J EXP MAR BIOL ECOL, V373, P102, DOI 10.1016/j.jembe.2009.03.011; Foret S, 2007, CORAL REEFS, V26, P475, DOI 10.1007/s00338-007-0206-1; Garcia-Pichel F, 1998, ORIGINS LIFE EVOL B, V28, P321, DOI 10.1023/A:1006545303412; GORLICH D, 1996, EMBO J, V15, P5558; Harithsa S, 2005, CORAL REEFS, V24, P463, DOI 10.1007/s00338-005-0008-2; Jeffrey SW, 1999, MAR ECOL PROG SER, V189, P35, DOI 10.3354/meps189035; Jones AM, 2008, P ROY SOC B-BIOL SCI, V275, P1359, DOI 10.1098/rspb.2008.0069; Jones RJ, 1998, PLANT CELL ENVIRON, V21, P1219, DOI 10.1046/j.1365-3040.1998.00345.x; Kloepper TH, 2007, MOL BIOL CELL, V18, P3463, DOI 10.1091/mbc.E07-03-0193; KUHL M, 1995, MAR ECOL PROG SER, V117, P159, DOI 10.3354/meps117159; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; LESSER MP, 1990, CORAL REEFS, V8, P225, DOI 10.1007/BF00265015; Li HY, 2003, TRENDS CELL BIOL, V13, P553, DOI 10.1016/j.tcb.2003.09.003; Liu WF, 2009, J PROTEOME RES, V8, P1198, DOI 10.1021/pr800840x; MathieuDaude F, 1996, NUCLEIC ACIDS RES, V24, P2080, DOI 10.1093/nar/24.11.2080; Meesters EH, 2002, MAR ECOL PROG SER, V227, P233, DOI 10.3354/meps227233; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; MICHELMORE CL, 2002, MAR ENVIRON RES, V54, P345, DOI DOI 10.1016/S0141-1136(02)00201-5; MUSCATINE L, 1990, ECOSYSTEMS WORLD, V25, P75; Poretsky RS, 2009, ENVIRON MICROBIOL, V11, P1358, DOI 10.1111/j.1462-2920.2008.01863.x; Portwich A, 2003, PHYCOLOGIA, V42, P384, DOI 10.2216/i0031-8884-42-4-384.1; Rebrikov Denis V., 2004, V258, P107; Richier S, 2008, J EXP MAR BIOL ECOL, V357, P48, DOI 10.1016/j.jembe.2007.12.026; Rodriguez-Lanetty M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-23; Rodriguez-Lanetty M, 2008, J BIOCHEM BIOPH METH, V70, P985, DOI 10.1016/j.jbbm.2007.08.005; Rodriguez-Lanetty M, 2009, MOL ECOL, V18, P5101, DOI 10.1111/j.1365-294X.2009.04419.x; Seneca FO, 2010, MAR BIOTECHNOL, V12, P594, DOI 10.1007/s10126-009-9247-5; Shick JM, 2002, ANNU REV PHYSIOL, V64, P223, DOI 10.1146/annurev.physiol.64.081501.155802; Shick JM, 1999, LIMNOL OCEANOGR, V44, P1667, DOI 10.4319/lo.1999.44.7.1667; SHICK JM, 1995, MAR BIOL, V122, P41, DOI 10.1007/BF00349276; Shick JM, 2002, BIOL BULL-US, V203, P315, DOI 10.2307/1543574; SHICK JM, 1993, INT CONGR SER, V1021, P561; Singh SP, 2010, GENOMICS, V95, P120, DOI 10.1016/j.ygeno.2009.10.002; Singh SP, 2008, PHOTOCHEM PHOTOBIOL, V84, P1500, DOI 10.1111/j.1751-1097.2008.00376.x; Smith DJ, 2005, GLOBAL CHANGE BIOL, V11, P1, DOI 10.1111/j.1529-8817.2003.00895.x; Starcevic A, 2008, P NATL ACAD SCI USA, V105, P2533, DOI 10.1073/pnas.0707388105; Takahashi S, 2008, P NATL ACAD SCI USA, V105, P4203, DOI 10.1073/pnas.0708554105; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Ulstrup KE, 2003, MOL ECOL, V12, P3477, DOI 10.1046/j.1365-294X.2003.01988.x; VERON JEN, 1984, AUSTR I MARINE SCI M, V6, P242; Warner ME, 1999, P NATL ACAD SCI USA, V96, P8007, DOI 10.1073/pnas.96.14.8007; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Weis VM, 2008, J EXP BIOL, V211, P3059, DOI 10.1242/jeb.009597; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660	56	24	24	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e13975	10.1371/journal.pone.0013975	http://dx.doi.org/10.1371/journal.pone.0013975			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103042	gold, Green Submitted, Green Published			2022-12-25	WOS:000284147700020
J	Judah, D; Chang, WY; Dagnino, L				Judah, David; Chang, Wing Y.; Dagnino, Lina			EBP1 Is a Novel E2F Target Gene Regulated by Transforming Growth Factor-beta	PLOS ONE			English	Article							EXPRESSION; INSIGHTS; PATHWAY; PROTEIN; ERBB3	Regulation of gene expression requires transcription factor binding to specific DNA elements, and a large body of work has focused on the identification of such sequences. However, it is becoming increasingly clear that eukaryotic transcription factors can exhibit widespread, nonfunctional binding to genomic DNA sites. Conversely, some of these proteins, such as E2F, can also modulate gene expression by binding to non-consensus elements. E2F comprises a family of transcription factors that play key roles in a wide variety of cellular functions, including survival, differentiation, activation during tissue regeneration, metabolism, and proliferation. E2F factors bind to the Erb3-binding protein 1 (EBP1) promoter in live cells. We now show that E2F binding to the EBP1 promoter occurs through two tandem DNA elements that do not conform to typical consensus E2F motifs. Exogenously expressed E2F1 activates EBP1 reporters lacking one, but not both sites, suggesting a degree of redundancy under certain conditions. E2F1 increases the levels of endogenous EBP1 mRNA in breast carcinoma and other transformed cell lines. In contrast, in non-transformed primary epidermal keratinocytes, E2F, together with the retinoblastoma family of proteins, appears to be involved in decreasing EBP1 mRNA abundance in response to growth inhibition by transforming growth factor-beta 1. Thus, E2F is likely a central coordinator of multiple responses that culminate in regulation of EBP1 gene expression, and which may vary depending on cell type and context.	[Judah, David; Chang, Wing Y.; Dagnino, Lina] Univ Western Ontario, Dept Physiol & Pharmacol, Children Hlth Res Inst, London, ON, Canada; [Judah, David; Chang, Wing Y.; Dagnino, Lina] Univ Western Ontario, Lawson Hlth Res Inst, London, ON, Canada; [Dagnino, Lina] Univ Western Ontario, Dept Paediat, Children Hlth Res Inst, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Judah, D (corresponding author), Univ Western Ontario, Dept Physiol & Pharmacol, Children Hlth Res Inst, London, ON, Canada.	ldagnino@uwo.ca		Dagnino, Lina/0000-0003-1483-5159	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Funding was provided by the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JY, 2006, EMBO J, V25, P2083, DOI 10.1038/sj.emboj.7601111; Apostolova MD, 2002, J BIOL CHEM, V277, P34471, DOI 10.1074/jbc.M205827200; Burkhart DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001003; Chang WY, 2006, CELL CYCLE, V5, P1872, DOI 10.4161/cc.5.16.3136; Chang WY, 2004, METH MOL B, V289, P147; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DAGNINO L, 2009, METH MOL BI IN PRESS; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; DOBROWOLSKI SF, 1994, ONCOGENE, V9, P2605; Emmrich S, 2010, CELL CYCLE, V9, P2555, DOI 10.4161/cc.9.13.12061; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; GERARD C, 2009, P NATL ACAD SCI US; Hallstrom TC, 2009, CELL CYCLE, V8, P532, DOI 10.4161/cc.8.4.7609; Hamburger AW, 2008, J MAMMARY GLAND BIOL, V13, P225, DOI 10.1007/s10911-008-9077-5; Iavarone A, 1999, MOL CELL BIOL, V19, P916; Ivanova IA, 2006, ONCOGENE, V25, P430, DOI 10.1038/sj.onc.1208999; Kherrouche Z, 2006, BIOCHEM J, V396, P547, DOI 10.1042/BJ20051981; Lacerte A, 2008, CELL SIGNAL, V20, P50, DOI 10.1016/j.cellsig.2007.08.012; Lavrrar JL, 2004, J BIOL CHEM, V279, P46343, DOI 10.1074/jbc.M402692200; LU Y, 2010, BREAST CANC RES TREA; McLaughlin-Drubin ME, 2009, VIROLOGY, V384, P335, DOI 10.1016/j.virol.2008.10.006; Monie TP, 2007, EMBO J, V26, P3936, DOI 10.1038/sj.emboj.7601817; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; Rabinovich A, 2008, GENOME RES, V18, P1763, DOI 10.1101/gr.080622.108; RADOMSKI N, 1995, EXP CELL RES, V220, P434, DOI 10.1006/excr.1995.1335; Sacco A, 2003, ONCOGENE, V22, P4027, DOI 10.1038/sj.onc.1206353; SUN B, 2010, CELL CYCLE, V9; Swiss VA, 2010, GLIA, V58, P377, DOI 10.1002/glia.20933; Tao YX, 1997, MOL CELL BIOL, V17, P6994, DOI 10.1128/MCB.17.12.6994; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Xia XM, 2001, BIOCHEM BIOPH RES CO, V289, P240, DOI 10.1006/bbrc.2001.5942; Zhang YX, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-69; Zhang YX, 2005, NUCLEIC ACIDS RES, V33, P6024, DOI 10.1093/nar/gki903; Zheng N, 1999, GENE DEV, V13, P666, DOI 10.1101/gad.13.6.666; Zhu WC, 2005, CELL CYCLE, V4, P633, DOI 10.4161/cc.4.5.1650	36	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e13941	10.1371/journal.pone.0013941	http://dx.doi.org/10.1371/journal.pone.0013941			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085677	Green Submitted, gold, Green Published			2022-12-25	WOS:000284036800026
J	Yu, XT; Zhang, YJ; Lasky, RE; Datta, S; Parikh, NA; Narayana, PA				Yu, Xintian; Zhang, Yanjie; Lasky, Robert E.; Datta, Sushmita; Parikh, Nehal A.; Narayana, Ponnada A.			Comprehensive Brain MRI Segmentation in High Risk Preterm Newborns	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; INTRAUTERINE GROWTH RESTRICTION; WORKING-MEMORY DEFICITS; TERM-EQUIVALENT AGE; PREMATURE-INFANTS; WHITE-MATTER; NEURODEVELOPMENTAL OUTCOMES; AUTOMATIC SEGMENTATION; HIPPOCAMPAL VOLUMES; NEUROLEPTIC-NAIVE	Most extremely preterm newborns exhibit cerebral atrophy/growth disturbances and white matter signal abnormalities on MRI at term-equivalent age. MRI brain volumes could serve as biomarkers for evaluating the effects of neonatal intensive care and predicting neurodevelopmental outcomes. This requires detailed, accurate, and reliable brain MRI segmentation methods. We describe our efforts to develop such methods in high risk newborns using a combination of manual and automated segmentation tools. After intensive efforts to accurately define structural boundaries, two trained raters independently performed manual segmentation of nine subcortical structures using axial T2-weighted MRI scans from 20 randomly selected extremely preterm infants. All scans were re-segmented by both raters to assess reliability. High intra-rater reliability was achieved, as assessed by repeatability and intra-class correlation coefficients (ICC range: 0.97 to 0.99) for all manually segmented regions. Inter-rater reliability was slightly lower (ICC range: 0.93 to 0.99). A semi-automated segmentation approach was developed that combined the parametric strengths of the Hidden Markov Random Field Expectation Maximization algorithm with non-parametric Parzen window classifier resulting in accurate white matter, gray matter, and CSF segmentation. Final manual correction of misclassification errors improved accuracy (similarity index range: 0.87 to 0.89) and facilitated objective quantification of white matter signal abnormalities. The semi-automated and manual methods were seamlessly integrated to generate full brain segmentation within two hours. This comprehensive approach can facilitate the evaluation of large cohorts to rigorously evaluate the utility of regional brain volumes as biomarkers of neonatal care and surrogate endpoints for neurodevelopmental outcomes.	[Yu, Xintian; Zhang, Yanjie; Lasky, Robert E.; Parikh, Nehal A.] Univ Texas Hlth Sci Ctr Houston, Sch Med, Div Neonatal Perinatal Med, Dept Pediat, Houston, TX USA; [Lasky, Robert E.] Univ Texas Hlth Sci Ctr Houston, Sch Med, Ctr Clin Res & Evidence Based Med, Houston, TX USA; [Datta, Sushmita; Narayana, Ponnada A.] Univ Texas Hlth Sci Ctr Houston, Sch Med, Dept Diagnost & Intervent Imaging, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Yu, XT (corresponding author), Univ Texas Hlth Sci Ctr Houston, Sch Med, Div Neonatal Perinatal Med, Dept Pediat, Houston, TX USA.	Nehal.A.Parikh@uth.tmc.edu	Parikh, Nehal/AAB-9981-2022	Parikh, Nehal/0000-0002-1375-1247	NINDS/NIH [K23NS048152]; Center for Clinical Research and Evidence Based Medicine; NIBIB (National Institute of Biomedical Imaging and Bioengineering)/NIH [R01 EB02095]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS048152] Funding Source: NIH RePORTER	NINDS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Center for Clinical Research and Evidence Based Medicine; NIBIB (National Institute of Biomedical Imaging and Bioengineering)/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by NINDS/NIH, grant # K23NS048152 and a Clinical Investigator Award from the Center for Clinical Research and Evidence Based Medicine. The development of automatic algorithms that formed the basis for tissue segmentation was supported by NIBIB (National Institute of Biomedical Imaging and Bioengineering)/NIH, grant # R01 EB02095 awarded to PAN. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anbeek P, 2004, NEUROIMAGE, V21, P1037, DOI 10.1016/j.neuroimage.2003.10.012; Anbeek P, 2008, PEDIATR RES, V63, P158, DOI 10.1203/PDR.0b013e31815ed071; Anderson P, 2003, JAMA-J AM MED ASSOC, V289, P3264, DOI 10.1001/jama.289.24.3264; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; BAYER SA, 2003, HUMAN BRAIN DURING T; Beauchamp MH, 2008, BRAIN, V131, P2986, DOI 10.1093/brain/awn227; Benders MJNL, 2009, PEDIATR RES, V66, P555, DOI 10.1203/PDR.0b013e3181b3aec5; Bland JM, 1996, BRIT MED J, V313, P41, DOI 10.1136/bmj.313.7048.41; BLAND JM, 1996, MEASUREMENT, V313, P744; Cheong JLY, 2008, PEDIATRICS, V121, pE1534, DOI 10.1542/peds.2007-2671; Convit A, 1999, PSYCHIAT RES-NEUROIM, V90, P113, DOI 10.1016/S0925-4927(99)00007-4; Counsell SJ, 2006, PEDIATRICS, V117, P376, DOI 10.1542/peds.2005-0820; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; DUDA RO, 2001, PATTERN CLASSIFICATI, P164; Dyet LE, 2006, PEDIATRICS, V118, P536, DOI 10.1542/peds.2005-1866; Gao FQ, 2003, NEUROBIOL AGING, V24, P49, DOI 10.1016/S0197-4580(02)00013-1; Gur RE, 1998, AM J PSYCHIAT, V155, P1711, DOI 10.1176/ajp.155.12.1711; Hack M, 2005, JAMA-J AM MED ASSOC, V294, P318, DOI 10.1001/jama.294.3.318; Haines D., 1991, NEUROANATOMY ATLAS S; Harris DL, 2006, ARCH DIS CHILD-FETAL, V91, pF11, DOI 10.1136/adc.2005.079806; HART AR, 2010, PEDIAT RADIOL MAR, V24; Hastings RS, 2004, NEUROPSYCHOPHARMACOL, V29, P952, DOI 10.1038/sj.npp.1300371; Hintz SR, 2007, J PEDIATR-US, V150, P592, DOI 10.1016/j.jpeds.2007.02.012; Holland D, 2009, P NATL ACAD SCI USA, V106, P20954, DOI 10.1073/pnas.0906053106; Honeycutt NA, 1998, PSYCHIAT RES-NEUROIM, V83, P85, DOI 10.1016/S0925-4927(98)00035-3; Inder TE, 2005, PEDIATRICS, V115, P286, DOI 10.1542/peds.2004-0326; Institute of Medicine (IOM), 2010, EV BIOM SURR ENDP CH; Laptook AR, 2005, PEDIATRICS, V115, P673, DOI 10.1542/peds.2004-0667; Levitt JJ, 2002, AM J PSYCHIAT, V159, P1190, DOI 10.1176/appi.ajp.159.7.1190; Limperopoulos C, 2005, PEDIATRICS, V116, P844, DOI 10.1542/peds.2004-2282; Lind A, 2010, EUR CHILD ADOLES PSY, V19, P407, DOI 10.1007/s00787-009-0070-3; Lodygensky GA, 2008, PEDIATR RES, V63, P438, DOI 10.1203/PDR.0b013e318165c005; Maalouf EF, 1999, J PEDIATR-US, V135, P351, DOI 10.1016/S0022-3476(99)70133-2; Matsuzawa J, 2001, CEREB CORTEX, V11, P335, DOI 10.1093/cercor/11.4.335; *MI STAT U BRAIN B, HUM BRAIN ATL; NARAYANA PA, 1995, MAGNET RESON MED, V33, P396, DOI 10.1002/mrm.1910330312; Nishida M, 2006, NEUROIMAGE, V32, P1041, DOI 10.1016/j.neuroimage.2006.05.020; Noulhiane A, 2006, J NEUROSCI METH, V156, P293, DOI 10.1016/j.jneumeth.2006.02.021; Nyul LG, 2000, IEEE T MED IMAGING, V19, P143, DOI 10.1109/42.836373; Parikh NA, 2009, J PERINATOL, V29, P143, DOI 10.1038/jp.2008.184; Parikh NA, 2007, PEDIATRICS, V119, P265, DOI 10.1542/peds.2006-1354; PERONA P, 1990, IEEE T PATTERN ANAL, V12, P629, DOI 10.1109/34.56205; Peterson BS, 2003, PEDIATRICS, V111, P939, DOI 10.1542/peds.111.5.939; PINTOMARTIN JA, 1995, PEDIATRICS, V95, P249; Postle BR, 2003, COGN AFFECT BEHAV NE, V3, P133, DOI 10.3758/CABN.3.2.133; Prastawa M, 2005, MED IMAGE ANAL, V9, P457, DOI 10.1016/j.media.2005.05.007; Pruessner JC, 2000, CEREB CORTEX, V10, P433, DOI 10.1093/cercor/10.4.433; Sajja BR, 2006, ANN BIOMED ENG, V34, P142, DOI 10.1007/s10439-005-9009-0; Shah DK, 2006, INVEST OPHTH VIS SCI, V47, P3366, DOI 10.1167/iovs.05-0811; Shah DK, 2006, PEDIATR RES, V60, P97, DOI 10.1203/01.pdr.0000220324.27597.f0; Srinivasan L, 2007, PEDIATRICS, V119, P759, DOI 10.1542/peds.2006-2508; Stokking R, 2000, NEUROIMAGE, V12, P726, DOI 10.1006/nimg.2000.0661; Thompson DK, 2008, ANN NEUROL, V63, P642, DOI 10.1002/ana.21367; Thompson DK, 2007, BRAIN, V130, P667, DOI 10.1093/brain/awl277; Tolsa CB, 2004, PEDIATR RES, V56, P132, DOI 10.1203/01.PDR.0000128983.54614.7E; Tyson JE, 2008, NEW ENGL J MED, V358, P1672, DOI 10.1056/NEJMoa073059; *U WA, DIG AN INT BRAIN ATL; Van Leemput K, 1999, IEEE T MED IMAGING, V18, P897, DOI 10.1109/42.811270; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Warfield SK, 2000, MED IMAGE ANAL, V4, P43, DOI 10.1016/S1361-8415(00)00003-7; Weisenfeld NI, 2006, I S BIOMED IMAGING, P766; Weisenfeld NI, 2009, NEUROIMAGE, V47, P564, DOI 10.1016/j.neuroimage.2009.04.068; Wells WM, 1996, IEEE T MED IMAGING, V15, P429, DOI 10.1109/42.511747; Whitaker AH, 1996, PEDIATRICS, V98, P719; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x; Woodward LJ, 2006, NEW ENGL J MED, V355, P685, DOI 10.1056/NEJMoa053792; Woodward LJ, 2005, BRAIN, V128, P2578, DOI 10.1093/brain/awh618; Xue H, 2007, NEUROIMAGE, V38, P461, DOI 10.1016/j.neuroimage.2007.07.030; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	69	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e13874	10.1371/journal.pone.0013874	http://dx.doi.org/10.1371/journal.pone.0013874			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	676NU	21079730	Green Published, Green Submitted, gold			2022-12-25	WOS:000283920000008
J	Leao, RN; Reis, A; Emirandetti, A; Lewicka, M; Hermanson, O; Fisahn, A				Leao, Richardson N.; Reis, Amilcar; Emirandetti, Amanda; Lewicka, Michalina; Hermanson, Ola; Fisahn, Andre			A Voltage-Sensitive Dye-Based Assay for the Identification of Differentiated Neurons Derived from Embryonic Neural Stem Cell Cultures	PLOS ONE			English	Article							ACTION-POTENTIAL INITIATION; IN-VITRO; POPULATIONS; DYNAMICS; DENDRITES; RESPONSES; BRAIN; SITE; CNS	Background: Pluripotent and multipotent stem cells hold great therapeutical promise for the replacement of degenerated tissue in neurological diseases. To fulfill that promise we have to understand the mechanisms underlying the differentiation of multipotent cells into specific types of neurons. Embryonic stem cell (ESC) and embryonic neural stem cell (NSC) cultures provide a valuable tool to study the processes of neural differentiation, which can be assessed using immunohistochemistry, gene expression, Ca2+-imaging or electrophysiology. However, indirect methods such as protein and gene analysis cannot provide direct evidence of neuronal functionality. In contrast, direct methods such as electrophysiological techniques are well suited to produce direct evidence of neural functionality but are limited to the study of a few cells on a culture plate. Methodology/Principal Findings: In this study we describe a novel method for the detection of action potential-capable neurons differentiated from embryonic NSC cultures using fast voltage-sensitive dyes (VSD). We found that the use of extracellularly applied VSD resulted in a more detailed labeling of cellular processes compared to calcium indicators. In addition, VSD changes in fluorescence translated precisely to action potential kinetics as assessed by the injection of simulated slow and fast sodium currents using the dynamic clamp technique. We further demonstrate the use of a finite element model of the NSC culture cover slip for optimizing electrical stimulation parameters. Conclusions/Significance: Our method allows for a repeatable fast and accurate stimulation of neurons derived from stem cell cultures to assess their differentiation state, which is capable of monitoring large amounts of cells without harming the overall culture.	[Leao, Richardson N.; Fisahn, Andre] Karolinska Inst, Neuronal Oscillat Lab, Stockholm, Sweden; [Reis, Amilcar; Lewicka, Michalina; Hermanson, Ola] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Emirandetti, Amanda] Uppsala Univ, Dept Neurosci, Dev Genet Grp, Uppsala, Sweden	Karolinska Institutet; Karolinska Institutet; Uppsala University	Leao, RN (corresponding author), Karolinska Inst, Neuronal Oscillat Lab, Stockholm, Sweden.	andre.fisahn@ki.se	Leao, Richardson/AAX-4985-2020; , Ola/AAF-5126-2021	Leao, Richardson/0000-0001-8496-1965; Hermanson, Ola/0000-0001-9320-7921	International Human Frontier Science Program; Portuguese Foundation for Science and Technology; Bejers Foundation; Swedish Research Council; European Commission [LSHM-CT-2005-19063]	International Human Frontier Science Program(Human Frontier Science Program); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Bejers Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by a Long-Term Fellowship from the International Human Frontier Science Program (R.N.L.), a PhD fellowship from the Portuguese Foundation for Science and Technology (A. R.), a Bejers Foundation Grant to R.N.L. (A. E.), the Swedish Research Council (O.H. and A. F.) and the European Commission Coordination Action ENINET (contract number LSHM-CT-2005-19063, A. F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abranches E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006286; Albantakis L, 2009, J NEUROSCI METH, V184, P206, DOI 10.1016/j.jneumeth.2009.08.004; Anderson DJ, 2001, NAT MED, V7, P393, DOI 10.1038/86439; Andersson T, 2009, J BIOL CHEM, V284, P3672, DOI 10.1074/jbc.M808119200; Antic S, 1997, BIOL BULL, V193, P261, DOI 10.1086/BBLv193n2p261; Aponte Y, 2008, J PHYSIOL-LONDON, V586, P2061, DOI 10.1113/jphysiol.2007.147298; Billups B, 2002, PFLUG ARCH EUR J PHY, V444, P663, DOI 10.1007/s00424-002-0861-6; Chemla S, 2010, J PHYSIOL-PARIS, V104, P40, DOI 10.1016/j.jphysparis.2009.11.009; Davoine F, 1996, IEEE T IMAGE PROCESS, V5, P338, DOI 10.1109/83.480769; DUNCAN GH, 1977, ANAT REC, V188, P273, DOI 10.1002/ar.1091880211; HOLST G, 2009, LASER PHOTONICS; Homma R, 2009, PHILOS T R SOC B, V364, P2453, DOI 10.1098/rstb.2009.0084; Illes S, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-93; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; JOHNSON CR, 1995, BIOMEDICAL ENG HDB, P162; Knopfel T, 2006, TRENDS NEUROSCI, V29, P160, DOI 10.1016/j.tins.2006.01.004; Kuba H, 2006, NATURE, V444, P1069, DOI 10.1038/nature05347; Laeng P, 2004, J NEUROCHEM, V91, P238, DOI 10.1111/j.1471-4159.2004.02725.x; Lang SB, 2006, NAT PROTOC, V1, P1859, DOI 10.1038/nprot.2006.267; Leao RN, 2004, J NEUROSCI METH, V133, P115, DOI 10.1016/j.jneumeth.2003.10.003; Li HW, 2009, BMC NEUROSCI, V10, DOI [10.1186/1471-2202-10-122, 10.1186/1471-2105-10-418]; Liao CW, 2009, NEUROSCIENCE, V164, P1701, DOI 10.1016/j.neuroscience.2009.09.052; Matiukas A, 2006, AM J PHYSIOL-HEART C, V290, pH2633, DOI 10.1152/ajpheart.00884.2005; Meyer JS, 2009, CELL MOL NEUROBIOL, V29, P1191, DOI 10.1007/s10571-009-9413-3; Paemeleire K, 1999, EXP BRAIN RES, V126, P473, DOI 10.1007/s002210050755; Palmer LM, 2006, J NEUROSCI, V26, P1854, DOI 10.1523/JNEUROSCI.4812-05.2006; Rattay F, 2001, HEARING RES, V153, P64, DOI 10.1016/S0378-5955(00)00257-4; Rattay F, 1990, ELECT NERVE STIMULAT; Ravin R, 2008, CELL STEM CELL, V3, P670, DOI 10.1016/j.stem.2008.09.012; Rowe EW, 2005, STEM CELLS, V23, P1044, DOI 10.1634/stemcells.2005-0037; Smetters D, 1999, METHODS, V18, P215, DOI 10.1006/meth.1999.0774; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Waldau B, 2008, CELL MOL LIFE SCI, V65, P2372, DOI 10.1007/s00018-008-8053-y; Yermolaieva O, 2001, J NEUROSCI, V21, P7474, DOI 10.1523/JNEUROSCI.21-19-07474.2001; Zhou WL, 2007, J NEUROSCI METH, V164, P225, DOI 10.1016/j.jneumeth.2007.05.002	36	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e13833	10.1371/journal.pone.0013833	http://dx.doi.org/10.1371/journal.pone.0013833			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079795	Green Published, Green Submitted, gold			2022-12-25	WOS:000283838600008
J	Shen, CM; Zhu, BF; Deng, YJ; Ye, SH; Yan, JW; Yang, G; Wang, HD; Qin, HX; Huang, QZ; Zhang, JJ				Shen, Chun-mei; Zhu, Bo-feng; Deng, Ya-jun; Ye, Shi-hui; Yan, Jiang-wei; Yang, Guang; Wang, Hong-dan; Qin, Hai-xia; Huang, Qi-zhao; Zhang, Jing-Jing			Allele Polymorphism and Haplotype Diversity of HLA-A, -B and-DRB1 Loci in Sequence-Based Typing for Chinese Uyghur Ethnic Group	PLOS ONE			English	Article							CLASS-I POLYMORPHISM; HAN POPULATION; STRS HAPLOTYPES; GENES; FREQUENCIES; HLA-DRB1; UYGUR; DNA; GENETICS; JAPANESE	Background: Previous studies indicate that the frequency distributions of HLA alleles and haplotypes vary from one ethnic group to another or between the members of the same ethnic group living in different geographic areas. It is necessary and meaningful to study the high-resolution allelic and haplotypic distributions of HLA loci in different groups. Methodology/Principal Findings: High-resolution HLA typing for the Uyghur ethnic minority group using polymerase chain reaction-sequence-based-typing method was first reported. HLA-A, -B and -DRB1 allelic distributions were determined in 104 unrelated healthy Uyghur individuals and haplotypic frequencies and linkage disequilibrium parameters for HLA loci were estimated using the maximum-likelihood method. A total of 35 HLA-A, 51 HLA-B and 33 HLA-DRB1 alleles were identified at the four-digit level in the population. High frequency alleles were HLA-A*1101 (13.46%), A*0201 (12.50%), A*0301 (10.10%); HLA-B*5101(8.17%), B*3501(6.73%), B*5001 (6.25%); HLA-DRB1*0701 (16.35%), DRB1*1501 (8.65%) and DRB1*0301 (7.69%). The two-locus haplotypes at the highest frequency were HLA-A*3001-B*1302 (2.88%), A*2402-B*5101 (2.86%); HLA-B*5001-DRB1*0701 (4.14%) and B*0702-DRB1*1501 (3.37%). The three-locus haplotype at the highest frequency was HLA-A*3001-B*1302-DRB1*0701(2.40%). Significantly high linkage disequilibrium was observed in six two-locus haplotypes, with their corresponding relative linkage disequilibrium parameters equal to 1. Neighbor-joining phylogenetic tree between the Uyghur group and other previously reported populations was constructed on the basis of standard genetic distances among the populations calculated using the four-digit sequence-level allelic frequencies at HLA-A, HLA-B and HLA-DRB1 loci. The phylogenetic analyses reveal that the Uyghur group belongs to the northwestern Chinese populations and is most closely related to the Xibe group, and then to Kirgiz, Hui, Mongolian and Northern Han. Conclusions/Significance: The present findings could be useful to elucidate the genetic background of the population and to provide valuable data for HLA matching in clinical bone marrow transplantation, HLA-linked disease-association studies, population genetics, human identification and paternity tests in forensic sciences.	[Shen, Chun-mei; Zhu, Bo-feng; Wang, Hong-dan] Xi An Jiao Tong Univ, Minist Educ, Key Lab Environm & Gene Related Dis, Xian 710049, Shaanxi, Peoples R China; [Shen, Chun-mei; Zhu, Bo-feng; Ye, Shi-hui] Blood Ctr Shaanxi Prov, Xian, Shaanxi, Peoples R China; [Shen, Chun-mei; Zhu, Bo-feng; Wang, Hong-dan] Xi An Jiao Tong Univ, Sch Med, Key Lab Minist Hlth Forens Sci, Xian 710049, Shaanxi, Peoples R China; [Zhu, Bo-feng; Wang, Hong-dan] Xi An Jiao Tong Univ, Sch Med, Dept Forens Sci, Xian 710049, Shaanxi, Peoples R China; [Deng, Ya-jun] Beijing Genom Inst, Ctr Forens Sci, Beijing, Peoples R China; [Yan, Jiang-wei] Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China; [Yang, Guang] Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912 USA; [Qin, Hai-xia] Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA; [Huang, Qi-zhao] Third Mil Med Univ, Team Students Brigade 2, Chongqing, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University; Beijing Genomics Institute (BGI); Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Army Medical University	Zhu, BF (corresponding author), Xi An Jiao Tong Univ, Minist Educ, Key Lab Environm & Gene Related Dis, Xian 710049, Shaanxi, Peoples R China.	bfzhu2008@yahoo.com.cn		Shen, Chun mei/0000-0003-2039-0838	National Natural Science Foundation of China [30700470, 81072511]; Postdoctoral Science Foundation of China [20100471602]; Item of Science Technology Foundation of Shaanxi Province, PR China [2008K08-02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); Item of Science Technology Foundation of Shaanxi Province, PR China	This project was supported by National Natural Science Foundation of China (NSFC, No. 30700470,81072511), by the Postdoctoral Science Foundation of China (No. 20100471602), by the Item of Science Technology Foundation of Shaanxi Province, PR China (No. 2008K08-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai Ru-feng, 2008, Zhonghua Yixue Yichuanxue Zazhi, V25, P469; Cao K, 2001, HUM IMMUNOL, V62, P1009, DOI 10.1016/S0198-8859(01)00298-1; Chen S, 2007, INT J IMMUNOGENET, V34, P131, DOI 10.1111/j.1744-313X.2007.00669.x; Chen S, 2006, INT J IMMUNOGENET, V33, P439, DOI 10.1111/j.1744-313X.2006.00637.x; Chen S, 2007, HUM IMMUNOL, V68, P928, DOI 10.1016/j.humimm.2007.09.006; Chen SW, 2007, MOL IMMUNOL, V44, P2017, DOI 10.1016/j.molimm.2006.09.018; Deng Y.J., 2005, J FORENSIC MED, V21, P280; Deng Ya-jun, 2006, Zhonghua Yixue Yichuanxue Zazhi, V23, P103; Edinur HA, 2009, HUM IMMUNOL, V70, P518, DOI 10.1016/j.humimm.2009.04.003; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hahn ReinhardFriedrich., 1998, TURK LANG, P379; HATTEMER HH, 1982, THEOR APPL GENET, V62, P219, DOI 10.1007/BF00276242; Hoa BK, 2008, TISSUE ANTIGENS, V71, P127, DOI 10.1111/j.1399-0039.2007.00982.x; Hong WG, 2007, HUM IMMUNOL, V68, P439, DOI 10.1016/j.humimm.2007.01.020; Hu SP, 2007, AM J PHYS ANTHROPOL, V132, P140, DOI 10.1002/ajpa.20460; IMANISHI T, 1992, HLA 1991, P627; Jia Zong-Jian, 2002, Yichuan, V24, P131; Jinam TA, 2010, TISSUE ANTIGENS, V75, P151, DOI 10.1111/j.1399-0039.2009.01417.x; Katsuyama Y, 1998, HUM HERED, V48, P126, DOI 10.1159/000022793; Klitz W, 2009, TISSUE ANTIGENS, V74, P508, DOI 10.1111/j.1399-0039.2009.01374.x; Kurz B, 1999, TISSUE ANTIGENS, V53, P81, DOI 10.1034/j.1399-0039.1999.530109.x; Lee J, 1990, HLA SYSTEM NEW APPRO, V6, P141; Lee KW, 2005, TISSUE ANTIGENS, V65, P437, DOI 10.1111/j.1399-0039.2005.00386.x; Mack SJ, 2009, TISSUE ANTIGENS, V73, P17, DOI 10.1111/j.1399-0039.2008.01151.x; Middleton D, 2004, TISSUE ANTIGENS, V63, P555, DOI 10.1111/j.0001-2815.2004.00234.x; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mizuki N, 1997, TISSUE ANTIGENS, V50, P527, DOI 10.1111/j.1399-0039.1997.tb02909.x; Mizuki N, 1998, TISSUE ANTIGENS, V51, P287; NEI M, 1987, MOLECILAR EVOLUTIONA; Ogata S, 2007, TISSUE ANTIGENS, V69, P154, DOI 10.1111/j.1399-0039.2006.00698.x; Powell GT, 2007, FORENSIC SCI INT-GEN, V1, P115, DOI 10.1016/j.fsigen.2007.01.015; Pozzi S, 1999, TISSUE ANTIGENS, V53, P275, DOI 10.1034/j.1399-0039.1999.530308.x; Qiu Xiao-ping, 2006, Zhonghua Yixue Yichuanxue Zazhi, V23, P219; Saito S, 2000, TISSUE ANTIGENS, V56, P522, DOI 10.1034/j.1399-0039.2000.560606.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SALMON DB, 1978, AM J HUM GENET, V30, P65; Schipper RF, 1996, TISSUE ANTIGENS, V47, P169, DOI 10.1111/j.1399-0039.1996.tb02537.x; Schmidt AH, 2009, HUM IMMUNOL, V70, P895, DOI 10.1016/j.humimm.2009.08.006; Shen CM, 2010, HUM IMMUNOL, V71, P627, DOI 10.1016/j.humimm.2010.02.012; Shen Chun-Mei, 2008, Yichuan, V30, P164, DOI 10.3724/SP.J.1005.2008.00164; Shen CM, 2008, CROAT MED J, V49, P476, DOI 10.3325/cmj.2008.4.476; [沈春梅 SHEN ChunMei], 2008, [第四军医大学学报, Journal of the Fourth Military Medical University], V29, P1540; Shete S, 2000, THEOR POPUL BIOL, V57, P265, DOI 10.1006/tpbi.2000.1452; Shi L, 2010, TISSUE ANTIGENS, V75, P159, DOI 10.1111/j.1399-0039.2009.01407.x; Shi L, 2008, HUM IMMUNOL, V69, P58, DOI 10.1016/j.humimm.2007.11.007; Single RM, 2002, GENET EPIDEMIOL, V22, P186, DOI 10.1002/gepi.0163; Spinola H, 2006, MOL IMMUNOL, V43, P1726, DOI 10.1016/j.molimm.2005.10.001; Tereba A, 1999, PROFILES DNA, P14; Trachtenberg E, 2007, TISSUE ANTIGENS, V70, P455, DOI 10.1111/j.1399-0039.2007.00932.x; VOLZ A, 1994, GENOMICS, V21, P464, DOI 10.1006/geno.1994.1302; Wen SH, 2008, HUM IMMUNOL, V69, P430, DOI 10.1016/j.humimm.2008.05.012; Williams F, 2001, HUM IMMUNOL, V62, P645, DOI 10.1016/S0198-8859(01)00247-6; Williams F, 2004, HUM IMMUNOL, V65, P66, DOI 10.1016/j.humimm.2003.10.004; Xu Ming-Yan, 2006, Yichuan, V28, P913; YAKUP A, 2005, TURFAN DIALECT UYGHU, P63; Yan Chun-Xia, 2002, Acta Genetica Sinica, V29, P384; Yang G, 2006, TISSUE ANTIGENS, V67, P146, DOI 10.1111/j.1399-0039.2006.00529.x; Yao Y, 2009, TISSUE ANTIGENS, V73, P561, DOI 10.1111/j.1399-0039.2009.01237.x; YU MS, 1988, SCI CHINA SER B, V31, P860; Yuliwulandari R, 2009, TISSUE ANTIGENS, V73, P46, DOI 10.1111/j.1399-0039.2008.01178.x; Zhou RX, 2008, ANN HUM BIOL, V35, P198, DOI 10.1080/03014460801922927; Zhu BF, 2005, FORENSIC SCI INT, V153, P260, DOI 10.1016/j.forsciint.2004.11.002; Zhu BF, 2005, INT J LEGAL MED, V119, P306, DOI 10.1007/s00414-005-0549-5; Zhu BF, 2005, J FORENSIC SCI, V50, P1235; ZHU BF, 2005, ACAD J XJTU, V17, P49; Zhu BF, 2010, J ZHEJIANG UNIV-SC B, V11, P127, DOI 10.1631/jzus.B0900232; Zhu BF, 2006, FORENSIC SCI INT, V161, P78, DOI 10.1016/j.forsciint.2005.09.003	68	33	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e13458	10.1371/journal.pone.0013458	http://dx.doi.org/10.1371/journal.pone.0013458			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079793	Green Published, Green Submitted, gold			2022-12-25	WOS:000283838600002
J	Itzek, A; Gillen, CM; Fulde, M; Friedrichs, C; Rodloff, AC; Chhatwal, GS; Nitsche-Schmitz, DP				Itzek, Andreas; Gillen, Christine M.; Fulde, Marcus; Friedrichs, Claudia; Rodloff, Arne C.; Chhatwal, Gursharan S.; Nitsche-Schmitz, Daniel Patric			Contribution of Plasminogen Activation towards the Pathogenic Potential of Oral Streptococci	PLOS ONE			English	Article							GROUP-A STREPTOCOCCI; ALPHA-ENOLASE; BINDING-PROTEIN; MILLERI GROUP; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; VIRIDANS STREPTOCOCCI; SURFACE ENOLASE; LYS-PLASMINOGEN; GROUP-C; VIRULENCE	Oral streptococci are a heterogeneous group of human commensals, with a potential to cause serious infections. Activation of plasminogen has been shown to increase the virulence of typical human pathogenic streptococci such as S. pneumoniae. One important factor for plasminogen activation is the streptococcal alpha-enolase. Here we report that plasminogen activation is also common in oral streptococci species involved in clinical infection and that it depends on the action of human plasminogen activators. The ability to activate plasminogen did not require full conservation of the internal plasminogen binding sequence motif FYDKERKVY of alpha-enolase that was previously described as crucial for increased plasminogen binding, activation and virulence. Instead, experiments with recombinant alpha-enolase variants indicate that the naturally occurring variations do not impair plasminogen binding. In spite of these variations in the internal plasminogen binding motif oral streptococci showed similar activation of plasminogen. We conclude that the pathomechanism of plasminogen activation is conserved in oral streptococci that cause infections in human. This may contribute to their opportunistic pathogenic character that is unfurled in certain niches.	[Itzek, Andreas; Gillen, Christine M.; Fulde, Marcus; Chhatwal, Gursharan S.; Nitsche-Schmitz, Daniel Patric] Helmholtz Ctr Infect Res, Dept Med Microbiol, Braunschweig, Germany; [Friedrichs, Claudia; Rodloff, Arne C.] Univ Leipzig, Inst Med Microbiol & Epidemiol Infect Dis, Leipzig, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Leipzig University	Itzek, A (corresponding author), Helmholtz Ctr Infect Res, Dept Med Microbiol, Braunschweig, Germany.	Patric.Nitsche@helmholtz-hzi.de	Gillen, Christine M/A-2717-2014	Duplancic, Christine/0000-0002-1775-3055	Helmholtz Association	Helmholtz Association(Helmholtz Association)	This work was supported by the Presidential Fund of the Helmholtz Association in the framework of the Virtual Institute: Oral Streptococci (http://www.helmholtz.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1947, J EXP MED, V85, P441; Antikainen J, 2007, FEMS IMMUNOL MED MIC, V51, P526, DOI 10.1111/j.1574-695X.2007.00330.x; BENNASR A, 1994, EUR J BIOCHEM, V222, P267, DOI 10.1111/j.1432-1033.1994.tb18865.x; BERGE A, 1993, J BIOL CHEM, V268, P25417; Bergmann S, 2005, THROMB HAEMOSTASIS, V94, P304, DOI 10.1160/TH05-05-0369; Bergmann S, 2004, INFECT IMMUN, V72, P2416, DOI 10.1128/IAI.72.4.2416-2419.2004; Bergmann S, 2003, MOL MICROBIOL, V49, P411, DOI 10.1046/j.1365-2958.2003.03557.x; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; CHRISTENSEN LR, 1945, J GEN PHYSIOL, V28, P363, DOI 10.1085/jgp.28.4.363; Clarridge JE, 2001, CLIN INFECT DIS, V32, P1511, DOI 10.1086/320163; Coleman JL, 1999, J LAB CLIN MED, V134, P567, DOI 10.1016/S0022-2143(99)90095-1; Colombo AP, 1998, J CLIN PERIODONTOL, V25, P169, DOI 10.1111/j.1600-051X.1998.tb02424.x; Cork AJ, 2009, J BIOL CHEM, V284, P17129, DOI 10.1074/jbc.M109.004317; Derbise A, 2004, INFECT IMMUN, V72, P94, DOI 10.1128/IAI.72.1.94-105.2004; DOUGLAS CWI, 1993, J MED MICROBIOL, V39, P179, DOI 10.1099/00222615-39-3-179; Friedrichs C, 2007, J CLIN MICROBIOL, V45, P2392, DOI 10.1128/JCM.00556-07; JACOBS JA, 1994, CLIN INFECT DIS, V19, P704, DOI 10.1093/clinids/19.4.704; Jones MN, 2007, BIOCHEM BIOPH RES CO, V364, P924, DOI 10.1016/j.bbrc.2007.10.098; KAWAMURA Y, 1995, INT J SYST BACTERIOL, V45, P406, DOI 10.1099/00207713-45-2-406; Khil J, 2003, J INFECT DIS, V188, P497, DOI 10.1086/377100; KUUSELA P, 1992, INFECT IMMUN, V60, P196, DOI 10.1128/IAI.60.1.196-201.1992; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; Lottenberg Richard, 1994, Trends in Microbiology, V2, P20, DOI 10.1016/0966-842X(94)90340-9; MANGEL WF, 1990, SCIENCE, V248, P69, DOI 10.1126/science.2108500; MARKUS G, 1978, J BIOL CHEM, V253, P727; MARSHALL JM, 1994, BIOCHEMISTRY-US, V33, P3599, DOI 10.1021/bi00178a017; Nitsche DP, 2006, J BIOL CHEM, V281, P1670, DOI 10.1074/jbc.M506776200; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; Pancholi V, 2003, INT J MED MICROBIOL, V293, P391, DOI 10.1078/1438-4221-00283; PANCHOLI V, 1993, P NATL ACAD SCI USA, V90, P8154, DOI 10.1073/pnas.90.17.8154; Pancholi V, 2003, MICROB PATHOGENESIS, V35, P293, DOI 10.1016/j.micpath.2003.08.004; RAMAKRISHNAN V, 1991, BIOCHEMISTRY-US, V30, P3963, DOI 10.1021/bi00230a023; RUOFF K L, 1988, Clinical Microbiology Reviews, V1, P102; Sanderson-Smith ML, 2008, FASEB J, V22, P2715, DOI 10.1096/fj.07-105643; Sanderson-Smith ML, 2007, J BACTERIOL, V189, P1435, DOI 10.1128/JB.01218-06; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Walker MJ, 2005, TRENDS MICROBIOL, V13, P308, DOI 10.1016/j.tim.2005.05.006; Westling K, 2008, J INFECTION, V56, P204, DOI 10.1016/j.jinf.2007.12.006; WHILEY RA, 1992, J CLIN MICROBIOL, V30, P243, DOI 10.1128/JCM.30.1.243-244.1992	40	22	22	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e13826	10.1371/journal.pone.0013826	http://dx.doi.org/10.1371/journal.pone.0013826			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21072208	Green Published, Green Submitted, gold			2022-12-25	WOS:000283780800023
J	Prud'homme, GJ; Glinka, Y; Toulina, A; Ace, O; Subramaniam, V; Jothy, S				Prud'homme, Gerald J.; Glinka, Yelena; Toulina, Anna; Ace, Olga; Subramaniam, Venkateswaran; Jothy, Serge			Breast Cancer Stem-Like Cells Are Inhibited by a Non-Toxic Aryl Hydrocarbon Receptor Agonist	PLOS ONE			English	Article							IN-VITRO PROPAGATION; SIDE POPULATION; CYCLE PROGRESSION; ABC TRANSPORTERS; MAMMARY-GLAND; TRANILAST; DRUG; GROWTH; CHEMOTHERAPY; ACTIVATION	Background: Cancer stem cells (CSCs) have increased resistance to cancer chemotherapy. They can be enriched as drug-surviving CSCs (D-CSCs) by growth with chemotherapeutic drugs, and/or by sorting of cells expressing CSC markers such as aldehyde dehydrogenase-1 (ALDH). CSCs form colonies in agar, mammospheres in low-adherence cultures, and tumors following xenotransplantation in Scid mice. We hypothesized that tranilast, a non-toxic orally active drug with anti-cancer activities, would inhibit breast CSCs. Methodology/Findings: We examined breast cancer cell lines or D-CSCs generated by growth of these cells with mitoxantrone. Tranilast inhibited colony formation, mammosphere formation and stem cell marker expression. Mitoxantrone-selected cells were enriched for CSCs expressing stem cell markers ALDH, c-kit, Oct-4, and ABCG2, and efficient at forming mammospheres. Tranilast markedly inhibited mammosphere formation by D-CSCs and dissociated formed mammospheres, at pharmacologically relevant concentrations. It was effective against D-CSCs of both HER-2+ and triple-negative cell lines. Tranilast was also effective in vivo, since it prevented lung metastasis in mice injected i.v. with triple-negative (MDA-MB-231) mitoxantrone-selected cells. The molecular targets of tranilast in cancer have been unknown, but here we demonstrate it is an aryl hydrocarbon receptor (AHR) agonist and this plays a key role. AHR is a transcription factor activated by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), polycyclic aromatic hydrocarbons and other ligands. Tranilast induced translocation of the AHR to the nucleus and stimulated CYP1A1 expression (a marker of AHR activation). It inhibited binding of the AHR to CDK4, which has been linked to cell-cycle arrest. D-CSCs expressed higher levels of the AHR than other cells. Knockdown of the AHR with siRNA, or blockade with an AHR antagonist, entirely abrogated the anti-proliferative and anti-mammosphere activity of tranilast. Thus, the anti-cancer effects of tranilast are AHR dependent. Conclusion/Significance: We show that tranilast is an AHR agonist with inhibitory effects on breast CSCs. It is effective against CSCs of triple-negative breast cancer cells selected for anti-cancer drug resistance. These results suggest it might find applications in the treatment of breast cancer.	[Prud'homme, Gerald J.; Glinka, Yelena; Toulina, Anna; Ace, Olga; Subramaniam, Venkateswaran; Jothy, Serge] St Michaels Hosp, Dept Lab Med, Toronto, ON M5B 1W8, Canada; [Prud'homme, Gerald J.; Glinka, Yelena; Toulina, Anna; Ace, Olga; Subramaniam, Venkateswaran; Jothy, Serge] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Prud'homme, Gerald J.; Glinka, Yelena; Toulina, Anna; Ace, Olga; Subramaniam, Venkateswaran; Jothy, Serge] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Prud'homme, GJ (corresponding author), St Michaels Hosp, Dept Lab Med, 30 Bond St, Toronto, ON M5B 1W8, Canada.	prudhommeg@smh.ca			Canadian Breast Cancer Research Alliance [020644]; Ontario Institute for Cancer Research (Province of Ontario, Canada) [05NOV194]; Canadian Institutes of Health Research [III 94588]; Li Ka Shing Knowledge Institute and Keenan Research Centre of St. Michael's Hospital (Toronto, Canada)	Canadian Breast Cancer Research Alliance; Ontario Institute for Cancer Research (Province of Ontario, Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Li Ka Shing Knowledge Institute and Keenan Research Centre of St. Michael's Hospital (Toronto, Canada)	This study was funded by the Canadian Breast Cancer Research Alliance (grant # 020644; URL: www.breast.cancer.ca), the Ontario Institute for Cancer Research (Province of Ontario, Canada; grant # 05NOV194; URL: www.oicr.on.ca), the Canadian Institutes of Health Research (grant # III 94588; URL: www.cihr-irsc.gc.ca), and the Li Ka Shing Knowledge Institute and Keenan Research Centre of St. Michael's Hospital (Toronto, Canada) (URL: www.stmichaelshospital.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barhoover MA, 2010, MOL PHARMACOL, V77, P195, DOI 10.1124/mol.109.059675; Bencko V, 2009, NEOPLASMA, V56, P353, DOI 10.4149/neo_2009_04_353; Blum R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005722; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Brent PJ, 1996, BRAIN RES, V725, P155, DOI 10.1016/0006-8993(96)00170-9; Casado FL, 2010, BLOOD CELL MOL DIS, V44, P199, DOI 10.1016/j.bcmd.2010.01.005; Chakrabarti R, 2009, ANTI-CANCER DRUG, V20, P334, DOI 10.1097/CAD.0b013e328327994e; Chang XQ, 2007, MOL CELL BIOL, V27, P6127, DOI 10.1128/MCB.00323-07; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Chuthapisith S, 2010, SURG ONCOL, V19, P27, DOI 10.1016/j.suronc.2009.01.004; Croker AK, 2009, J CELL MOL MED, V13, P2236, DOI 10.1111/j.1582-4934.2008.00455.x; Dean M, 2009, J MAMMARY GLAND BIOL, V14, P3, DOI 10.1007/s10911-009-9109-9; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; Ding XW, 2010, LIFE SCI, V86, P631, DOI 10.1016/j.lfs.2010.02.012; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Fritz WA, 2007, CARCINOGENESIS, V28, P497, DOI 10.1093/carcin/bgl179; Furness SGB, 2009, PHARMACOL THERAPEUT, V124, P336, DOI 10.1016/j.pharmthera.2009.09.004; Glinka Y, 2006, MOL THER, V14, P578, DOI 10.1016/j.ymthe.2006.03.021; Gomez-Duran A, 2009, BIOCHEM PHARMACOL, V77, P700, DOI 10.1016/j.bcp.2008.08.032; Grimshaw MJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2106; Hall JM, 2010, MOL ENDOCRINOL, V24, P359, DOI 10.1210/me.2009-0346; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Holmes DR, 2002, CIRCULATION, V106, P1243, DOI 10.1161/01.CIR.0000028335.31300.DA; Isaji M, 1998, CARDIOVASC DRUG REV, V16, P288, DOI 10.1111/j.1527-3466.1998.tb00359.x; Izawa A, 2001, ARTERIOSCL THROM VAS, V21, P1172, DOI 10.1161/hq0701.092119; Jonker JW, 2005, STEM CELLS, V23, P1059, DOI 10.1634/stemcells.2005-0150; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Kerkvliet NI, 2009, BIOCHEM PHARMACOL, V77, P746, DOI 10.1016/j.bcp.2008.11.021; Kim M, 2002, CLIN CANCER RES, V8, P22; Konneh M, 1998, IDrugs, V1, P141; Korah RM, 2000, CANCER RES, V60, P733; Levina V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003077; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; McNamee JP, 1997, DRUG METAB DISPOS, V25, P437; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; O'Brien CA, 2009, SEMIN RADIAT ONCOL, V19, P71, DOI 10.1016/j.semradonc.2008.11.001; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Prud'homme GJ, 2007, LAB INVEST, V87, P1077, DOI 10.1038/labinvest.3700669; Puga A, 2000, J BIOL CHEM, V275, P2943, DOI 10.1074/jbc.275.4.2943; Ruby CE, 2002, MOL PHARMACOL, V62, P722, DOI 10.1124/mol.62.3.722; Savouret JF, 2001, J BIOL CHEM, V276, P3054, DOI 10.1074/jbc.M005988200; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Sladek NE, 2002, CANCER CHEMOTH PHARM, V49, P309, DOI 10.1007/s00280-001-0412-4; Steiniger SCJ, 2008, STEM CELLS, V26, P3037, DOI 10.1634/stemcells.2008-0397; Subramaniam V, 2003, BRIT J CANCER, V89, P1538, DOI 10.1038/sj.bjc.6601301; Subramaniam V, 2010, ANTI-CANCER DRUG, V21, P351, DOI 10.1097/CAD.0b013e328334992c; Tang C, 2007, FASEB J, V21, pA287; WANG T, 2010, INT J CANC; Winquist RJ, 2010, CURR OPIN PHARMACOL, V10, P385, DOI 10.1016/j.coph.2010.06.008; Zhang S, 2009, ENDOCR-RELAT CANCER, V16, P835, DOI 10.1677/ERC-09-0054; Zhou BBS, 2009, NAT REV DRUG DISCOV, V8, P806, DOI 10.1038/nrd2137; Zhou JB, 2008, BREAST CANCER RES TR, V111, P419, DOI 10.1007/s10549-007-9798-y; Zucchi I, 2007, P NATL ACAD SCI USA, V104, P10476, DOI 10.1073/pnas.0703071104	57	108	122	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e13831	10.1371/journal.pone.0013831	http://dx.doi.org/10.1371/journal.pone.0013831			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21072210	Green Submitted, gold, Green Published			2022-12-25	WOS:000283780800025
J	Piekielko-Witkowska, A; Wiszomirska, H; Wojcicka, A; Poplawski, P; Boguslawska, J; Tanski, Z; Nauman, A				Piekielko-Witkowska, Agnieszka; Wiszomirska, Hanna; Wojcicka, Anna; Poplawski, Piotr; Boguslawska, Joanna; Tanski, Zbigniew; Nauman, Alicja			Disturbed Expression of Splicing Factors in Renal Cancer Affects Alternative Splicing of Apoptosis Regulators, Oncogenes, and Tumor Suppressors	PLOS ONE			English	Article							PRE-MESSENGER-RNA; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEINS; GENE-EXPRESSION; IN-VIVO; TYROSINE KINASE; CELL CARCINOMA; VARIANTS; ADHESION; RAC1B; OVEREXPRESSION	Background: Clear cell renal cell carcinoma (ccRCC) is the most common type of renal cancer. One of the processes disturbed in this cancer type is alternative splicing, although phenomena underlying these disturbances remain unknown. Alternative splicing consists of selective removal of introns and joining of residual exons of the primary transcript, to produce mRNA molecules of different sequence. Splicing aberrations may lead to tumoral transformation due to synthesis of impaired splice variants with oncogenic potential. In this paper we hypothesized that disturbed alternative splicing in ccRCC may result from improper expression of splicing factors, mediators of splicing reactions. Methodology/Principal Findings: Using real-time PCR and Western-blot analysis we analyzed expression of seven splicing factors belonging to SR proteins family (SF2/ASF, SC35, SRp20, SRp75, SRp40, SRp55 and 9G8), and one non-SR factor, hnRNP A1 (heterogeneous nuclear ribonucleoprotein A1) in 38 pairs of tumor-control ccRCC samples. Moreover, we analyzed splicing patterns of five genes involved in carcinogenesis and partially regulated by analyzed splicing factors: RON, CEACAM1, Rac1, Caspase-9, and GLI1. Conclusions/Significance: We found that the mRNA expression of splicing factors was disturbed in tumors when compared to paired controls, similarly as levels of SF2/ASF and hnRNP A1 proteins. The correlation coefficients between expression levels of specific splicing factors were increased in tumor samples. Moreover, alternative splicing of five analyzed genes was also disturbed in ccRCC samples and splicing pattern of two of them, Caspase-9 and CEACAM1 correlated with expression of SF2/ASF in tumors. We conclude that disturbed expression of splicing factors in ccRCC may possibly lead to impaired alternative splicing of genes regulating tumor growth and this way contribute to the process of carcinogenesis.	[Piekielko-Witkowska, Agnieszka; Wiszomirska, Hanna; Wojcicka, Anna; Poplawski, Piotr; Boguslawska, Joanna; Nauman, Alicja] Med Ctr Postgrad Educ, Dept Biochem & Mol Biol, Warsaw, Poland; [Tanski, Zbigniew] Reg Hosp, Ostroleka, Poland	Centre of Postgraduate Medical Education - Poland	Piekielko-Witkowska, A (corresponding author), Med Ctr Postgrad Educ, Dept Biochem & Mol Biol, Warsaw, Poland.	anauman@cmkp.edu.pl	Poplawski, Piotr/V-1030-2019; Piekielko-Witkowska, Agnieszka/V-1011-2019; Wojcicka, Anna/K-4134-2012; Bogusławska, Joanna/I-7189-2019	Poplawski, Piotr/0000-0002-9477-7595; Piekielko-Witkowska, Agnieszka/0000-0002-5348-0760; Wojcicka, Anna/0000-0001-5803-6397; Boguslawska, Joanna/0000-0003-2568-1546	Polish State Committee for Scientific Research [NN401354733, NN401073636]; Medical Centre of Postgraduate Education [501-2-25-01/09]	Polish State Committee for Scientific Research(Polish State Committee for Scientific Research); Medical Centre of Postgraduate Education	The work was supported by: the Polish State Committee for Scientific Research Grants NN401354733 (to APW) and NN401073636 (to AN), and The Medical Centre of Postgraduate Education grant 501-2-25-01/09 (to APW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahram M, 2002, MOL CARCINOGEN, V33, P9, DOI 10.1002/mc.10019; Audebert M, 2000, CANCER RES, V60, P4740; Bardella C, 2004, CANCER RES, V64, P5154, DOI 10.1158/0008-5472.CAN-04-0600; Benvenuti S, 2007, J CELL PHYSIOL, V213, P316, DOI 10.1002/jcp.21183; Bosco EE, 2009, CELL MOL LIFE SCI, V66, P370, DOI 10.1007/s00018-008-8552-x; Brinkman BMN, 2004, CLIN BIOCHEM, V37, P584, DOI 10.1016/j.clinbiochem.2004.05.015; CACERES JF, 1994, SCIENCE, V265, P1706, DOI 10.1126/science.8085156; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chandradas S, 2010, J LEUKOCYTE BIOL, V87, P147, DOI 10.1189/jlb.0409252; Chen X, 2002, MOL BIOL CELL, V13, P1929, DOI 10.1091/mbc.02-02-0023; Dormoy V, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-123; Engers R, 2001, J BIOL CHEM, V276, P41889, DOI 10.1074/jbc.M105049200; Expert-Bezancon A, 2004, J BIOL CHEM, V279, P38249, DOI 10.1074/jbc.M405377200; Fackenthal JD, 2008, DIS MODEL MECH, V1, P37, DOI 10.1242/dmm.000331; Fernandez-Zapico ME, 2008, PANCREATOLOGY, V8, P227, DOI 10.1159/000134271; Gagne JP, 2003, BIOCHEM J, V371, P331, DOI 10.1042/BJ20021675; Gaur S, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-46; Gereben B, 2009, THYROID, V19, P1027, DOI 10.1089/thy.2009.1593; Ghigna C, 2005, MOL CELL, V20, P881, DOI 10.1016/j.molcel.2005.10.026; Goncalves V, 2009, HUM MOL GENET, V18, P3696, DOI 10.1093/hmg/ddp317; Hanamura A, 1998, RNA, V4, P430; Hartmann B, 2009, CURR OPIN CELL BIOL, V21, P377, DOI 10.1016/j.ceb.2009.02.006; He YW, 2009, CELL MOL LIFE SCI, V66, P1239, DOI 10.1007/s00018-008-8532-1; Ji YB, 2009, NUCLEIC ACIDS RES, V37, P3501, DOI 10.1093/nar/gkp218; Jordan P, 1999, ONCOGENE, V18, P6835, DOI 10.1038/sj.onc.1203233; Kammerer R, 2004, J PATHOL, V204, P258, DOI 10.1002/path.1657; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Kempkensteffen C, 2009, TUMOR BIOL, V30, P73, DOI 10.1159/000215826; Klein CA, 2002, LANCET, V360, P683, DOI 10.1016/S0140-6736(02)09838-0; Kleinerman DI, 1996, CANCER RES, V56, P3431; KLEINERMAN DI, 1995, CANCER RES, V55, P1215; LIU Q, 1995, MOL CELL BIOL, V15, P2800; LJUNGBERG B, 2009, GUIDELINES RENAL CEL; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Lopez-Beltran A, 2006, EUR UROL, V49, P798, DOI 10.1016/j.eururo.2005.11.035; Luo WP, 1997, ONCOGENE, V14, P1697, DOI 10.1038/sj.onc.1200999; Mahotka C, 2002, INT J CANCER, V100, P30, DOI 10.1002/ijc.10450; Malanga M, 2008, J BIOL CHEM, V283, P19991, DOI 10.1074/jbc.M709495200; Massiello A, 2006, J LIPID RES, V47, P892, DOI 10.1194/jlr.C600003-JLR200; Master A, 2010, BBA-MOL BASIS DIS, V1802, P995, DOI 10.1016/j.bbadis.2010.07.025; Matafora V, 2009, MOL CELL PROTEOMICS, V8, P2243, DOI 10.1074/mcp.M900079-MCP200; Matos P, 2008, MOL CANCER RES, V6, P1178, DOI 10.1158/1541-7786.MCR-08-0008; MCLAREN J, 1994, TOXICOLOGY, V88, P101, DOI 10.1016/0300-483X(94)90113-9; Merdzhanova G, 2008, CELL DEATH DIFFER, V15, P1815, DOI 10.1038/cdd.2008.135; Mizutani Y, 2007, INT J ONCOL, V30, P919; Mole S, 2009, J PATHOL, V219, P383, DOI 10.1002/path.2608; Muller MM, 2009, J CELL BIOL, V187, P569, DOI 10.1083/jcb.200904150; Novara G, 2007, J UROLOGY, V177, P430, DOI 10.1016/j.juro.2006.09.034; Obrink B, 2008, LUNG CANCER, V60, P309, DOI 10.1016/j.lungcan.2008.03.020; Patel NA, 2005, J BIOL CHEM, V280, P14302, DOI 10.1074/jbc.M411485200; Patry C, 2003, CANCER RES, V63, P7679; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Piekielko-Witkowska A, 2009, THYROID, V19, P1105, DOI 10.1089/thy.2008.0284; PIEKIELKOWITKOW.A, 2006, ADV BIOCH, V52, P383; Porta C, 2009, J UROLOGY, V182, P2569, DOI 10.1016/j.juro.2009.08.085; Schoffski P, 2006, ANN ONCOL, V17, P1185, DOI 10.1093/annonc/mdj133; Schwerk C, 2005, MOL CELL, V19, P1, DOI 10.1016/j.molcel.2005.05.026; Shiina H, 2003, CLIN CANCER RES, V9, P2121; Shimokawa T, 2008, J BIOL CHEM, V283, P14345, DOI 10.1074/jbc.M800299200; Singh A, 2004, ONCOGENE, V23, P9369, DOI 10.1038/sj.onc.1208182; Sinha R, 2010, MOL CELL BIOL, V30, P2762, DOI 10.1128/MCB.01270-09; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Sultmann H, 2005, CLIN CANCER RES, V11, P646; Takahashi M, 2001, P NATL ACAD SCI USA, V98, P9754, DOI 10.1073/pnas.171209998; Tun HW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010696; Turowska O, 2007, THYROID, V17, P1039, DOI 10.1089/thy.2007.0075; Venables JP, 2006, BIOESSAYS, V28, P378, DOI 10.1002/bies.20390; Warrenfeltz S, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-27; Wei T., CORRPLOT VISUALIZATI; Zhao HJ, 2006, PLOS MED, V3, P115, DOI 10.1371/journal.pmed.0030013; Zhou MI, 2005, P NATL ACAD SCI USA, V102, P11035, DOI 10.1073/pnas.0500757102; Zhou YQ, 2003, ONCOGENE, V22, P186, DOI 10.1038/sj.onc.1206075	72	40	43	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2010	5	10							e13690	10.1371/journal.pone.0013690	http://dx.doi.org/10.1371/journal.pone.0013690			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671UN	21082031	Green Published, gold, Green Submitted			2022-12-25	WOS:000283537000053
J	Light, SH; Minasov, G; Shuvalova, L; Duban, ME; Caffrey, M; Anderson, WF; Lavie, A				Light, Samuel H.; Minasov, George; Shuvalova, Ludmilla; Duban, Mark-Eugene; Caffrey, Michael; Anderson, Wayne F.; Lavie, Arnon			Insights into the Mechanism of Type I Dehydroquinate Dehydratases from Structures of Reaction Intermediates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI DEHYDROQUINASE; ACTIVE-SITE; SHIKIMATE PATHWAY; HIGH-THROUGHPUT; CATALYZED DEHYDRATION; ACID BIOSYNTHESIS; ENZYME; 3-DEHYDROQUINASE; PURIFICATION; INHIBITORS	The biosynthetic shikimate pathway consists of seven enzymes that catalyze sequential reactions to generate chorismate, a critical branch point in the synthesis of the aromatic amino acids. The third enzyme in the pathway, dehydroquinate dehydratase (DHQD), catalyzes the dehydration of 3-dehydroquinate to 3-dehydroshikimate. We present three crystal structures of the type I DHQD from the intestinal pathogens Clostridium difficile and Salmonella enterica. Structures of the enzyme with substrate and covalent pre- and post-dehydration reaction intermediates provide snapshots of successive steps along the type I DHQD-catalyzed reaction coordinate. These structures reveal that the position of the substrate within the active site does not appreciably change upon Schiff base formation. The intermediate state structures reveal a reaction state-dependent behavior of His-143 in which the residue adopts a conformation proximal to the site of catalytic dehydration only when the leaving group is present. We speculate that His-143 is likely to assume differing catalytic roles in each of its observed conformations. One conformation of His-143 positions the residue for the formation/hydrolysis of the covalent Schiff base intermediates, whereas the other conformation positions the residue for a role in the catalytic dehydration event. The fact that the shikimate pathway is absent from humans makes the enzymes of the pathway potential targets for the development of non-toxic antimicrobials. The structures and mechanistic insight presented here may inform the design of type I DHQD enzyme inhibitors.	[Anderson, Wayne F.] Northwestern Univ, Ctr Struct Genom Infect Dis, Chicago, IL 60611 USA; [Light, Samuel H.; Minasov, George; Shuvalova, Ludmilla; Anderson, Wayne F.] Northwestern Univ, Dept Mol Pharmacol & Biol Chem, Feinberg Sch Med, Chicago, IL 60611 USA; [Caffrey, Michael; Lavie, Arnon] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	Northwestern University; Northwestern University; Feinberg School of Medicine; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lavie, A (corresponding author), 900 S Ashland Ave,MBRB Room 1108, Chicago, IL 60607 USA.	Lavie@uic.edu	Lavie, Arnon/H-4927-2012	Lavie, Arnon/0000-0001-5591-8722; Light, Sam/0000-0002-8074-1348; Minasov, George/0000-0001-5460-3462	National Institutes of Health through the NIAID [HHSN272200700058C]; U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]	National Institutes of Health through the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor	This work was supported, in whole or in part, by National Institutes of Health Contract HHSN272200700058C (to W. F. A.) through the NIAID.; We thank Dr. Elisabetta Sabini for facilitating the communications with the groups involved in this work and Dr. Scott Peterson and Dr. Keehwan Kwon for providing DHQD expression clones. Use of the Advanced Photon Source at Argonne National Laboratory was supported by the U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357. Use of the Life Sciences Collaborative Access Team (LS-CAT) Sector 21 was supported in part by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor for the support of this research program (Grant 085P1000817).	BENTLEY R, 1990, CRIT REV BIOCHEM MOL, V25, P307, DOI 10.3109/10409239009090615; Blom N, 1997, NAT STRUCT BIOL, V4, P36, DOI 10.1038/nsb0197-36; BURGI HB, 1974, TETRAHEDRON, V30, P1563, DOI 10.1016/S0040-4020(01)90678-7; BUTLER JR, 1974, J AM CHEM SOC, V96, P1617, DOI 10.1021/ja00812a069; CHAUDHURI S, 1986, BIOCHEM J, V239, P699, DOI 10.1042/bj2390699; da Costa TPS, 2010, BIOCHIMIE, V92, P837, DOI 10.1016/j.biochi.2010.03.004; DEKA RK, 1992, J BIOL CHEM, V267, P22237; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fleming I., 2010, MOL ORBITALS ORGANIC, P214; Godsey MH, 2007, PROTEIN SCI, V16, P1285, DOI 10.1110/ps.062674007; Gourley DG, 1999, NAT STRUCT BIOL, V6, P521; HANSON KR, 1963, P NATL ACAD SCI USA, V50, P981, DOI 10.1073/pnas.50.5.981; Kim Y, 2008, ADV PROTEIN CHEM, V75, P85, DOI 10.1016/S0065-3233(07)75003-9; KISHORE GM, 1988, ANNU REV BIOCHEM, V57, P627, DOI 10.1146/annurev.bi.57.070188.003211; KLEANTHOUS C, 1990, J BIOL CHEM, V265, P10929; KLEANTHOUS C, 1992, BIOCHEM J, V282, P687, DOI 10.1042/bj2820687; Le Sann C, 2004, MINI-REV MED CHEM, V4, P747; Lee WH, 2002, ACTA CRYSTALLOGR D, V58, P798, DOI 10.1107/S0907444902003918; LEECH AP, 1995, J BIOL CHEM, V270, P25827, DOI 10.1074/jbc.270.43.25827; LUMSDEN J, 1977, BIOCHEM J, V161, P599, DOI 10.1042/bj1610599; Marques MR, 2007, CURR DRUG TARGETS, V8, P445; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nichols CE, 2004, PROTEINS, V56, P625, DOI 10.1002/prot.20165; Noble M, 2006, BIOTECHNOL BIOENG, V95, P560, DOI 10.1002/bit.20772; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parker EJ, 2000, BIOORG MED CHEM LETT, V10, P231, DOI 10.1016/S0960-894X(99)00660-5; POLLEY LD, 1978, BIOCHIM BIOPHYS ACTA, V526, P259, DOI 10.1016/0005-2744(78)90310-8; Radisky ES, 2002, P NATL ACAD SCI USA, V99, P10316, DOI 10.1073/pnas.112332899; REILLY A, 1994, J BIOL CHEM, V269, P5523; Smith NN, 2008, ACTA CRYSTALLOGR F, V64, P886, DOI 10.1107/S1744309108028546; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; TURNER MJ, 1975, J CHEM SOC P1, V1, P52; VAZ ADN, 1975, J AM CHEM SOC, V97, P5914, DOI 10.1021/ja00853a046; WHITE PJ, 1990, BIOCHEM J, V265, P735, DOI 10.1042/bj2650735	35	24	27	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3531	3539		10.1074/jbc.M110.192831	http://dx.doi.org/10.1074/jbc.M110.192831			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21087925	hybrid, Green Published			2022-12-25	WOS:000286653200038
J	Biswas, A; Mukherjee, S; Das, S; Shields, D; Chow, CW; Maitra, U				Biswas, Arunima; Mukherjee, Shaeri; Das, Supratik; Shields, Dennis; Chow, Chi Wing; Maitra, Umadas			Opposing Action of Casein Kinase 1 and Calcineurin in Nucleo-cytoplasmic Shuttling of Mammalian Translation Initiation Factor eIF6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE HOMOLOG; RIBOSOME DISSOCIATION FACTOR; TRANSCRIPTION FACTOR; EUKARYOTIC TRANSLATION; NUCLEAR-LOCALIZATION; WHEAT-GERM; PROTEIN; SUBUNIT; YEAST; ACTIVATION	Eukaryotic initiation factor 6 (eIF6), a highly conserved protein from yeast to mammals, is essential for 60 S ribosome biogenesis and assembly. Both yeast and mammalian eIF6 are phosphorylated at Ser-174 and Ser-175 by the nuclear isoform of casein kinase 1 (CK1). The molecular basis of eIF6 phosphorylation, however, remains elusive. In the present work, we show that subcellular distribution of eIF6 in the nuclei and the cytoplasm of mammalian cells is mediated by dephosphorylation and phosphorylation, respectively. This nucleo-cytoplasmic shuttling is dependent on the phosphorylation status at Ser-174 and Ser-175 of eIF6. We demonstrate that Ca2+-activated calcineurin phosphatase binds to and promotes nuclear localization of eIF6. Increase in intracellular concentration of Ca2+ leads to rapid translocation of eIF6 from the cytoplasm to the nucleus, an event that is blocked by specific calcineurin inhibitors cyclosporin A or FK520. Nuclear export of eIF6 is regulated by phosphorylation at Ser-174 and Ser-175 by the nuclear isoform of CK1. Mutation of eIF6 at the phosphorylatable Ser-174 and Ser-175 to alanine or treatment of cells with the CK1 inhibitor, D4476 inhibits nuclear export of eIF6 and results in nuclear accumulation of eIF6. Together, these results establish eIF6 as a substrate for calcineurin and suggest a novel paradigm for calcineurin function in 60 S ribosome biogenesis via regulating the nuclear accumulation of eIF6.	[Biswas, Arunima; Mukherjee, Shaeri; Das, Supratik; Shields, Dennis; Maitra, Umadas] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Chow, Chi Wing] Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Maitra, U (corresponding author), Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA.	umadas.maitra@einstein.yu.edu			National Institutes of Health [GM15399]; NCI [P30CA13330]; Albert Einstein College of Medicine; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM015399] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Albert Einstein College of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Grant GM15399 from the National Institutes of Health, by Cancer Core Support Grant P30CA13330 from the NCI, and institutional support from the Albert Einstein College of Medicine.	Aramburu J, 1998, MOL CELL, V1, P627, DOI 10.1016/S1097-2765(00)80063-5; Basu U, 2003, MOL CELL BIOL, V23, P6187, DOI 10.1128/MCB.23.17.6187-6199.2003; Basu U, 2001, MOL CELL BIOL, V21, P1453, DOI 10.1128/MCB.21.5.1453-1462.2001; Ceci M, 2003, NATURE, V426, P579, DOI 10.1038/nature02160; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Gross SD, 1998, CELL SIGNAL, V10, P699, DOI 10.1016/S0898-6568(98)00042-4; Harnpicharnchai P, 2001, MOL CELL, V8, P505, DOI 10.1016/S1097-2765(01)00344-6; Ho JHN, 2000, J CELL BIOL, V151, P1057, DOI 10.1083/jcb.151.5.1057; Johnson AW, 2002, TRENDS BIOCHEM SCI, V27, P580, DOI 10.1016/S0968-0004(02)02208-9; Kafadar KA, 2003, GENE DEV, V17, P2698, DOI 10.1101/gad.1140603; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Li HM, 2004, J MOL BIOL, V342, P1659, DOI 10.1016/j.jmb.2004.07.068; Liu J, 2001, J IMMUNOL, V167, P2677, DOI 10.4049/jimmunol.167.5.2677; Loh C, 1996, J BIOL CHEM, V271, P10884, DOI 10.1074/jbc.271.18.10884; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; Menne TF, 2007, NAT GENET, V39, P486, DOI 10.1038/ng1994; Mukherjee S, 2007, TRAFFIC, V8, P369, DOI 10.1111/j.1600-0854.2007.00542.x; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; Nilsson J, 2004, EMBO REP, V5, P1137, DOI 10.1038/sj.embor.7400291; Nissan TA, 2002, EMBO J, V21, P5539, DOI 10.1093/emboj/cdf547; Okamura H, 2004, MOL CELL BIOL, V24, P4184, DOI 10.1128/MCB.24.10.4184-4195.2004; PERRINO BA, 1992, J BIOL CHEM, V267, P15965; Ray P, 2008, J BIOL CHEM, V283, P9681, DOI 10.1074/jbc.M710294200; RAYCHAUDHURI P, 1984, J BIOL CHEM, V259, P1930; Rodriguez A, 2009, MOL CELL, V33, P616, DOI 10.1016/j.molcel.2009.01.030; RUSSELL DW, 1979, J BIOL CHEM, V254, P8796; RUSSELL DW, 1980, ARCH BIOCHEM BIOPHYS, V201, P518, DOI 10.1016/0003-9861(80)90540-8; Sanvito F, 1999, J CELL BIOL, V144, P823, DOI 10.1083/jcb.144.5.823; Senger B, 2001, MOL CELL, V8, P1363, DOI 10.1016/S1097-2765(01)00403-8; Sengupta J, 2004, NAT STRUCT MOL BIOL, V11, P957, DOI 10.1038/nsmb822; Shibasaki F, 1996, NATURE, V382, P370, DOI 10.1038/382370a0; Si K, 1997, P NATL ACAD SCI USA, V94, P14285, DOI 10.1073/pnas.94.26.14285; Si K, 1999, MOL CELL BIOL, V19, P1416; Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432; Stathopoulos-Gerontides A, 1999, GENE DEV, V13, P798, DOI 10.1101/gad.13.7.798; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; VALENZUELA DM, 1982, J BIOL CHEM, V257, P7712	37	30	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					3129	3138		10.1074/jbc.M110.188565	http://dx.doi.org/10.1074/jbc.M110.188565			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21084295	Green Published, hybrid			2022-12-25	WOS:000286464300074
J	Burkhard, KA; Chen, FM; Shapiro, P				Burkhard, Kimberly A.; Chen, Fengming; Shapiro, Paul			Quantitative Analysis of ERK2 Interactions with Substrate Proteins ROLES FOR KINASE DOCKING DOMAINS AND ACTIVITY IN DETERMINING BINDING AFFINITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATED KINASE; RIBOSOMAL S6 KINASE; MAP KINASE; C-FOS; TRANSCRIPTIONAL ACTIVATION; TRANSFORMING ACTIVITY; MEDIATED INTERACTIONS; RAF/MEK/ERK PATHWAY; PTP-SL; PHOSPHORYLATION	Extracellular signal-regulated kinase-1 and -2 (ERK1/2) proteins regulate a variety of cellular functions, including cell proliferation and differentiation, by interacting with and phosphorylating substrate proteins. Two docking sites, common docking (CD/ED) domain and F-site recruitment site (FRS), on ERK proteins have been identified. Specific interactions with the CD/ED domain and the FRS occur with substrates containing a docking site for ERK and JNK, LXL (DEJL) motif (D-domain) and a docking site for ERK, FXF (DEF) motif (F-site), respectively. However, the relative contributions of the ERK docking sites in mediating substrate interactions that allow efficient phosphate transfer are largely unknown. In these studies, we provide a quantitative analysis of ERK2 interactions with substrates using surface plasmon resonance to measure real time protein-protein interactions. ERK2 interacted with ELK-1 (DEF and DEJL motifs), RSK-1 (DEJL motif), and c-Fos (DEF motif) with K-D values of 0.25, 0.15, and 0.97 mu M, respectively. CD/ED domain mutations inhibited interactions with ELK-1 and RSK-1 by 6-fold but had no effect on interactions with c-Fos. Select mutations in FRS residues differentially inhibited ELK-1 or c-Fos interactions with ERK2 but had little effect on RSK-1 interactions. Mutations in both the ED and FRS docking sites completely inhibited ELK-1 interactions but had no effect on interactions with stathmin, an ERK substrate whose docking site is unknown. The phosphorylation status of ERK2 did not affect interactions with RSK-1 or c-Fos but did inhibit interactions with ELK-1 and stathmin. These studies provide a quantitative evaluation of specific docking domains involved in mediating interactions between ERK2 and protein substrates and define the contributions of these interactions to phosphate transfer.	[Burkhard, Kimberly A.; Chen, Fengming; Shapiro, Paul] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Shapiro, P (corresponding author), Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, 20 N Pine St, Baltimore, MD 21201 USA.	pshapiro@rx.umaryland.edu			National Institutes of Health [CA120215]; NATIONAL CANCER INSTITUTE [R01CA120215] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA120215.	Ahn NG, 2009, NAT STRUCT MOL BIOL, V16, P1004, DOI 10.1038/nsmb1009-1004; Akella R, 2008, BBA-PROTEINS PROTEOM, V1784, P48, DOI 10.1016/j.bbapap.2007.09.016; Bardwell L, 2006, BIOCHEM SOC T, V34, P837, DOI 10.1042/BST0340837; Barsyte-Lovejoy D, 2002, J BIOL CHEM, V277, P9896, DOI 10.1074/jbc.M108145200; Biondi RM, 2003, BIOCHEM J, V372, P1, DOI 10.1042/BJ20021641; Callaway K, 2005, BBA-PROTEINS PROTEOM, V1754, P316, DOI 10.1016/j.bbapap.2005.11.002; Callaway K, 2007, BIOCHEMISTRY-US, V46, P9187, DOI 10.1021/bi700206u; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; CHEN RH, 1993, P NATL ACAD SCI USA, V90, P10952, DOI 10.1073/pnas.90.23.10952; Chen RH, 1996, ONCOGENE, V12, P1493; Chuderland D, 2005, MOL BIOTECHNOL, V29, P57, DOI 10.1385/MB:29:1:57; Chuderland D, 2008, J BIOL CHEM, V283, P11176, DOI 10.1074/jbc.M709030200; Cobb MH, 1991, CURR OPIN CELL BIOL, V3, P1025, DOI 10.1016/0955-0674(91)90124-H; Cornish-Bowden A, 2001, METHODS, V24, P181, DOI 10.1006/meth.2001.1179; CURMI PA, 1994, BIOCHEM J, V300, P331, DOI 10.1042/bj3000331; Dimitri CA, 2005, CURR BIOL, V15, P1319, DOI 10.1016/j.cub.2005.06.037; Fantz DA, 2001, J BIOL CHEM, V276, P27256, DOI 10.1074/jbc.M102512200; Ferguson HA, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.20.e98; Fernandes N, 2009, BIOCHEM BIOPH RES CO, V387, P414, DOI 10.1016/j.bbrc.2009.07.049; Friday BB, 2008, CLIN CANCER RES, V14, P342, DOI 10.1158/1078-0432.CCR-07-4790; Fujioka A, 2006, J BIOL CHEM, V281, P8917, DOI 10.1074/jbc.M509344200; Galanis A, 2001, J BIOL CHEM, V276, P965, DOI 10.1074/jbc.M007697200; Gavin AC, 1999, CURR BIOL, V9, P281, DOI 10.1016/S0960-9822(99)80120-1; Hong SK, 2009, J BIOL CHEM, V284, P33006, DOI 10.1074/jbc.M109.012591; Hoofnagle AN, 2004, BIOPHYS J, V86, P395, DOI 10.1016/S0006-3495(04)74115-6; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Lee T, 2004, MOL CELL, V14, P43, DOI 10.1016/S1097-2765(04)00161-3; Ley R, 2005, J BIOL CHEM, V280, P17657, DOI 10.1074/jbc.M412342200; Lovric J, 1998, J BIOL CHEM, V273, P22848; MacKenzie SJ, 2000, J BIOL CHEM, V275, P16609, DOI 10.1074/jbc.275.22.16609; Martin MC, 2008, J BIOL CHEM, V283, P3854, DOI 10.1074/jbc.M705647200; McCubrey JA, 2008, CURR OPIN INVEST DR, V9, P614; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Monje P, 2003, MOL CELL BIOL, V23, P7030, DOI 10.1128/MCB.23.19.7030-7043.2003; Munoz JJ, 2003, BIOCHEM J, V372, P193, DOI 10.1042/BJ20021941; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; OKAZAKI K, 1995, EMBO J, V14, P5048, DOI 10.1002/j.1460-2075.1995.tb00187.x; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; PHILLIPS SK, 2008, MOL BIOMETHODS HDB, P809; Polychronopoulos S, 2006, J BIOL CHEM, V281, P25601, DOI 10.1074/jbc.M605185200; Richards SA, 1999, CURR BIOL, V9, P810, DOI 10.1016/S0960-9822(99)80364-9; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Schuck P, 1996, TRENDS BIOCHEM SCI, V21, P458, DOI 10.1016/S0968-0004(96)20025-8; Shapiro PS, 1999, MOL CELL BIOL, V19, P3551; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; Sheridan DL, 2008, J BIOL CHEM, V283, P19511, DOI 10.1074/jbc.M801074200; Smith JA, 1999, J BIOL CHEM, V274, P2893, DOI 10.1074/jbc.274.5.2893; Tanoue T, 2001, EMBO J, V20, P466, DOI 10.1093/emboj/20.3.466; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Yang SH, 1998, MOL CELL BIOL, V18, P710, DOI 10.1128/MCB.18.2.710; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zhou B, 2001, J BIOL CHEM, V276, P6506, DOI 10.1074/jbc.M009753200; Zhou TJ, 2006, STRUCTURE, V14, P1011, DOI 10.1016/j.str.2006.04.006; Zuniga A, 1999, J BIOL CHEM, V274, P21900, DOI 10.1074/jbc.274.31.21900	56	40	42	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2477	2485		10.1074/jbc.M110.177899	http://dx.doi.org/10.1074/jbc.M110.177899			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21098038	Green Published, hybrid			2022-12-25	WOS:000286464300012
J	Thomas, AM; Harmer, SC; Khambra, T; Tinker, A				Thomas, Alison M.; Harmer, Stephen C.; Khambra, Tapsi; Tinker, Andrew			Characterization of a Binding Site for Anionic Phospholipids on KCNQ1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-QT-SYNDROME; RECEPTOR-MEDIATED INHIBITION; KCNQ2/KCNQ3 K+ CHANNELS; POTASSIUM CHANNELS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; PHOSPHOINOSITIDE BINDING; STRUCTURAL DETERMINANTS; MUSCARINIC MODULATION; DISEASE PATHOGENESIS; PIP2 REGULATION	The KCNQ family of potassium channels underlie a repolarizing K+ current in the heart and the M-current in neurones. The assembly of KCNQ1 with KCNE1 generates the delayed rectifier current I-Ks in the heart. Characteristically these channels are regulated via G(q/11)-coupled receptors and the inhibition seen after phospholipase C activation is now thought to occur from membrane phosphatidylinositol (4,5)-bisphosphate (PIP2) depletion. It is not clear how KCNQ1 recognizes PIP2 and specifically which residues in the channel complex are important. Using biochemical techniques we identify a cluster of basic residues namely, Lys-354, Lys-358, Arg-360, and Lys-362, in the proximal C terminus as being involved in binding anionic phospholipids. The mutation of specific residues in combination, to alanine leads to the loss of binding to phosphoinositides. Functionally, the introduction of these mutations into KCNQ1 leads to shifts in the voltage dependence of channel activation toward depolarized potentials and reductions in current density. Additionally, the biophysical effects of the charge neutralizing mutations, which disrupt phosphoinositide binding, mirror the effects we see on channel function when we deplete cellular PIP2 levels through activation of a Gq/11-coupled receptor. Conversely, the addition of diC8-PIP2 to the wild-type channel, but not a PIP2 binding-deficient mutant, acts to shift the voltage dependence of channel activation toward hyperpolarized potentials and increase current density. In conclusion, we use a combined biochemical and functional approach to identify a cluster of basic residues important for the binding and action of anionic phospholipids on the KCNQ1/KCNE1 complex.	[Tinker, Andrew] UCL, Rayne Inst, BHF Labs, Dept Med, London WC1E 6JJ, England	University of London; King's College London; University College London	Tinker, A (corresponding author), UCL, Rayne Inst, BHF Labs, Dept Med, 5 Univ St, London WC1E 6JJ, England.	a.tinker@ucl.ac.uk	Harmer, Stephen/D-5512-2015	Harmer, Stephen/0000-0003-3909-6698	British Heart Foundation; British Heart Foundation [RG/10/10/28447] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This work was supported by the British Heart Foundation.	Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Bian JS, 2004, AM J PHYSIOL-HEART C, V287, pH2154, DOI 10.1152/ajpheart.00120.2004; Bian JS, 2001, CIRC RES, V89, P1168, DOI 10.1161/hh2401.101375; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; Brown DA, 2007, J PHYSIOL-LONDON, V582, P917, DOI 10.1113/jphysiol.2007.132498; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; DALEAU P, 1994, PFLUG ARCH EUR J PHY, V427, P553, DOI 10.1007/BF00374275; Fan Z, 1997, J BIOL CHEM, V272, P5388, DOI 10.1074/jbc.272.9.5388; Gamper N, 2007, NAT REV NEUROSCI, V8, P921, DOI 10.1038/nrn2257; Ghosh S, 2006, CIRC RES, V98, P1048, DOI 10.1161/01.RES.0000218863.44140.f2; Guy-David L, 2007, NEURON, V55, P537, DOI 10.1016/j.neuron.2007.08.001; Harmer SC, 2010, AM J PHYSIOL-CELL PH, V298, pC263, DOI 10.1152/ajpcell.00308.2009; Hernandez CC, 2008, J GEN PHYSIOL, V132, p20A; Hernandez CC, 2009, J GEN PHYSIOL, V134, P437, DOI 10.1085/jgp.200910313; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hilgemann DW, 2007, J PHYSIOL-LONDON, V582, P903, DOI 10.1113/jphysiol.2007.132746; Horowitz LF, 2005, J GEN PHYSIOL, V126, P243, DOI 10.1085/jgp.200509309; Hoshi N, 2003, NAT NEUROSCI, V6, P564, DOI 10.1038/nn1062; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Loussouarn G, 2003, EMBO J, V22, P5412, DOI 10.1093/emboj/cdg526; Manna D, 2008, J BIOL CHEM, V283, P26047, DOI 10.1074/jbc.M802617200; Marrion NV, 1997, ANNU REV PHYSIOL, V59, P483, DOI 10.1146/annurev.physiol.59.1.483; Mashanov GI, 2010, J BIOL CHEM, V285, P3664, DOI 10.1074/jbc.M109.039974; Matavel A, 2010, CHANNELS, V4, P3, DOI 10.4161/chan.4.1.10227; Matavel A, 2009, J MOL CELL CARDIOL, V46, P704, DOI 10.1016/j.yjmcc.2009.02.006; Moss AJ, 2005, J CLIN INVEST, V115, P2018, DOI 10.1172/JCI25537; Nerbonne JM, 2005, PHYSIOL REV, V85, P1205, DOI 10.1152/physrev.00002.2005; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Park KH, 2005, CIRC RES, V96, P730, DOI 10.1161/01.RES.0000161451.04649.a8; Rapedius M, 2007, NEURON, V55, P602, DOI 10.1016/j.neuron.2007.07.026; Rodriguez N, 2010, BIOPHYS J, V99, P1110, DOI 10.1016/j.bpj.2010.06.013; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; SANGUINETTI MC, 1990, J GEN PHYSIOL, V96, P195, DOI 10.1085/jgp.96.1.195; Santagata S, 2001, SCIENCE, V292, P2041, DOI 10.1126/science.1061233; Schroeder BC, 2000, J BIOL CHEM, V275, P24089, DOI 10.1074/jbc.M003245200; Schroeder BC, 1998, NATURE, V396, P687, DOI 10.1038/25367; Schroeder BC, 2000, NATURE, V403, P196, DOI 10.1038/35003200; Seebohm G, 2007, CIRC RES, V100, P686, DOI 10.1161/01.RES.0000260250.83824.8f; Selyanko AA, 2000, J PHYSIOL-LONDON, V522, P349, DOI 10.1111/j.1469-7793.2000.t01-2-00349.x; Shamgar L, 2006, CIRC RES, V98, P1055, DOI 10.1161/01.RES.0000218979.40770.69; Shapiro MS, 2000, J NEUROSCI, V20, P1710; Shyng SL, 2000, J GEN PHYSIOL, V116, P599, DOI 10.1085/jgp.116.5.599; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Suh BC, 2005, CURR OPIN NEUROBIOL, V15, P370, DOI 10.1016/j.conb.2005.05.005; Suh BC, 2004, J GEN PHYSIOL, V123, P663, DOI 10.1085/jgp.200409029; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Thomas AM, 2006, J MEMBRANE BIOL, V211, P43, DOI 10.1007/s00232-006-0014-5; Thomas Alison M., 2008, V491, P103, DOI 10.1007/978-1-59745-526-8_8; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Wilson AJ, 2005, CARDIOVASC RES, V67, P476, DOI 10.1016/j.cardiores.2005.04.036; Winks JS, 2005, J NEUROSCI, V25, P3400, DOI 10.1523/JNEUROSCI.3231-04.2005; Yang T, 2009, CIRC-ARRHYTHMIA ELEC, V2, P417, DOI 10.1161/CIRCEP.109.850149; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9	60	40	42	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2088	2100		10.1074/jbc.M110.153551	http://dx.doi.org/10.1074/jbc.M110.153551			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21084310	Green Published, hybrid			2022-12-25	WOS:000286191500051
J	Yoon, YJ; Kim, JA; Shin, KD; Shin, DS; Han, YM; Lee, YJ; Lee, JS; Kwon, BM; Han, DC				Yoon, Young Ju; Kim, Joo Ae; Shin, Ki Deok; Shin, Dae-Seop; Han, Young Min; Lee, Yu Jin; Lee, Jin Soo; Kwon, Byoung-Mog; Han, Dong Cho			KRIBB11 Inhibits HSP70 Synthesis through Inhibition of Heat Shock Factor 1 Function by Impairing the Recruitment of Positive Transcription Elongation Factor b to the hsp70 Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NON-ONCOGENE ADDICTION; DNA-BINDING ACTIVITY; GENE-EXPRESSION; HYDROGEN-PEROXIDE; HSP90 INHIBITORS; CANCER-CELLS; FACTOR HSF1; PHOSPHORYLATION; ACTIVATION; STRESS	Heat shock factor 1 (HSF1) is the master switch for heat shock protein (HSP) expression in eukaryotes. A synthetic chemical library was screened to identify inhibitors of HSF1 using a luciferase reporter under the control of a heat shock element. A compound named KRIBB11 (N-2-(1H-indazole-5-yl)-N-6-methyl-3-nitropyridine-2,6-diamine) was identified for its activity in abolishing the heat shock-induced luciferase activity with an IC50 of 1.2 mu mol/liter. When the cells were exposed to heat shock in the presence of KRIBB11, the induction of HSF1 downstream target proteins such as HSP27 and HSP70 was blocked. In addition, treatment of HCT-116 cells with KRIBB11 induced growth arrest and apoptosis. Markers of apoptosis, such as cleaved poly(ADP-ribose) polymerase, were detected after KRIBB11 treatment. Biotinyl-KRIBB11 was synthesized as an affinity probe for the identification of KRIBB11 target proteins. Using affinity chromatography and competition assays, KRIBB11 was shown to associate with HSF1 in vitro. Chromatin immuno-precipitation analysis showed that KRIBB11 inhibited HSF1-dependent recruitment of p-TEFb (positive transcription elongation factor b) to the hsp70 promoter. Finally, intraperitoneal treatment of nude mice with KRIBB11 at 50 mg/kg resulted in a 47.4% (p < 0.05) inhibition of tumor growth without body weight loss. Immunoblotting assays showed that the expression of HSP70 was lower in KRIBB11-treated tumor tissue than in control tissues. Because HSPs are expressed at high levels in a wide range of tumors, these results strengthen the rationale for targeting HSF1 in cancer therapy.	[Yoon, Young Ju; Kim, Joo Ae; Shin, Ki Deok; Shin, Dae-Seop; Han, Young Min; Lee, Yu Jin; Kwon, Byoung-Mog; Han, Dong Cho] Korea Res Inst Biosci & Biotechnol, Med Genom Res Ctr, Taejon 305806, South Korea; [Kim, Joo Ae; Han, Young Min; Lee, Yu Jin; Kwon, Byoung-Mog; Han, Dong Cho] Univ Sci & Technol, Taejon 305806, South Korea; [Lee, Jin Soo] Dong Wha Pharmaceut Co Ltd, Yongin 446902, Gyeonggi Do, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Kwon, BM (corresponding author), 111 Gwahangno, Taejon 305806, South Korea.	kwonbm@kribb.re.kr; dchan@kribb.re.kr			KRIBB Research Initiative; National Chemical Genomics Research Program; Center for Biological Modulators of the 21st Century Frontier Research Program	KRIBB Research Initiative; National Chemical Genomics Research Program; Center for Biological Modulators of the 21st Century Frontier Research Program(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the KRIBB Research Initiative Program, the National Chemical Genomics Research Program, and the Center for Biological Modulators of the 21st Century Frontier Research Program. Y.J. Yoon, J.S. Lee, B.-M. Kwon, and D.C. Han have applied for a patent using a part of this work.	AGOFF SN, 1993, SCIENCE, V259, P84, DOI 10.1126/science.8418500; Akagawa H, 1999, J ANTIBIOT, V52, P960, DOI 10.7164/antibiotics.52.960; Brown SA, 1996, GENE DEV, V10, P1479, DOI 10.1101/gad.10.12.1479; Burdine L, 2004, CHEM BIOL, V11, P593, DOI 10.1016/j.chembiol.2004.05.001; Chu BY, 1998, J BIOL CHEM, V273, P18640, DOI 10.1074/jbc.273.29.18640; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Elia G, 1996, CANCER RES, V56, P210; Garrido C, 1998, CANCER RES, V58, P5495; Guettouche Toumy, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-4; Guo F, 2005, CANCER RES, V65, P10536, DOI 10.1158/0008-5472.CAN-05-1799; Hoang AT, 2000, AM J PATHOL, V156, P857, DOI 10.1016/S0002-9440(10)64954-1; Holmberg CI, 1998, J CELL SCI, V111, P3357; Holmberg CI, 2002, TRENDS BIOCHEM SCI, V27, P619, DOI 10.1016/S0968-0004(02)02207-7; Holmberg CI, 2001, EMBO J, V20, P3800, DOI 10.1093/emboj/20.14.3800; JAATTELA M, 1995, INT J CANCER, V60, P689, DOI 10.1002/ijc.2910600520; Kim SA, 2005, J BIOL CHEM, V280, P12653, DOI 10.1074/jbc.M411908200; KINGSTON RE, 1986, MOL CELL BIOL, V6, P3180, DOI 10.1128/MCB.6.9.3180; KINGSTON RE, 1984, NATURE, V312, P280, DOI 10.1038/312280a0; Kline MP, 1997, MOL CELL BIOL, V17, P2107, DOI 10.1128/MCB.17.4.2107; Knauf U, 1996, GENE DEV, V10, P2782, DOI 10.1101/gad.10.21.2782; Lee JH, 2002, J BIOL CHEM, V277, P18411, DOI 10.1074/jbc.M201368200; Lee SA, 2005, CANCER RES, V65, P3072, DOI 10.1158/0008-5472.CAN-04-2865; Lee YJ, 2008, CANCER RES, V68, P7550, DOI 10.1158/0008-5472.CAN-08-0129; Leuenroth SJ, 2008, CANCER RES, V68, P5257, DOI 10.1158/0008-5472.CAN-07-6207; Lis JT, 2000, GENE DEV, V14, P792; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Mulholland PJ, 2001, ANN ONCOL, V12, P245, DOI 10.1023/A:1008372017097; Nakai A, 1997, MOL CELL BIOL, V17, P469, DOI 10.1128/MCB.17.1.469; Park JM, 2001, MOL CELL, V8, P9, DOI 10.1016/S1097-2765(01)00296-9; RABINDRAN SK, 1991, P NATL ACAD SCI USA, V88, P6906, DOI 10.1073/pnas.88.16.6906; Renner DB, 2001, J BIOL CHEM, V276, P42601, DOI 10.1074/jbc.M104967200; RITOSSA F, 1962, EXPERIENTIA, V18, P571, DOI 10.1007/BF02172188; Rocchi P, 2005, CANCER RES, V65, P11083, DOI 10.1158/0008-5472.CAN-05-1840; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; Sanchez-Serrano I, 2006, NAT REV DRUG DISCOV, V5, P107, DOI 10.1038/nrd1959; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Schulte TW, 1996, MOL CELL BIOL, V16, P5839; Seo JS, 1996, BIOCHEM BIOPH RES CO, V218, P582, DOI 10.1006/bbrc.1996.0103; Shamovsky I, 2008, CELL MOL LIFE SCI, V65, P855, DOI 10.1007/s00018-008-7458-y; Shin KD, 2005, J BIOL CHEM, V280, P41439, DOI 10.1074/jbc.M507209200; Solimini NL, 2007, CELL, V130, P986, DOI 10.1016/j.cell.2007.09.007; Solit DB, 2008, DRUG DISCOV TODAY, V13, P38, DOI 10.1016/j.drudis.2007.10.007; Stanhill A, 2006, ONCOGENE, V25, P1485, DOI 10.1038/sj.onc.1209193; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Taylor DM, 2007, MOL CELL NEUROSCI, V34, P20, DOI 10.1016/j.mcn.2006.09.007; Vilaboa NE, 2000, J BIOL CHEM, V275, P24970, DOI 10.1074/jbc.M909136199; Volloch VZ, 1999, ONCOGENE, V18, P3648, DOI 10.1038/sj.onc.1202525; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Westerheide SD, 2006, J BIOL CHEM, V281, P9616, DOI 10.1074/jbc.M512044200; WESTWOOD JT, 1993, MOL CELL BIOL, V13, P3481, DOI 10.1128/MCB.13.6.3481; Whitesell L, 2009, EXPERT OPIN THER TAR, V13, P469, DOI [10.1517/14728220902832697, 10.1517/14728220902832697 ]; Xavier IJ, 2000, J BIOL CHEM, V275, P29147, DOI 10.1074/jbc.M002169200; XIAO H, 1991, CELL, V64, P585, DOI 10.1016/0092-8674(91)90242-Q; Yokota S, 2000, CANCER RES, V60, P2942; Yoo HY, 1999, J BIOL CHEM, V274, P23887, DOI 10.1074/jbc.274.34.23887; Zaarur N, 2006, CANCER RES, V66, P1783, DOI 10.1158/0008-5472.CAN-05-3692; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	59	106	107	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1737	1747		10.1074/jbc.M110.179440	http://dx.doi.org/10.1074/jbc.M110.179440			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21078672	Green Published, hybrid			2022-12-25	WOS:000286191500013
J	Monecke, S; Kanig, H; Rudolph, W; Muller, E; Coombs, G; Hotzel, H; Slickers, P; Ehricht, R				Monecke, Stefan; Kanig, Hanna; Rudolph, Wolfram; Mueller, Elke; Coombs, Geoffrey; Hotzel, Helmut; Slickers, Peter; Ehricht, Ralf			Characterisation of Australian MRSA Strains ST75-and ST883-MRSA-IV and Analysis of Their Accessory Gene Regulator Locus	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; PANTON-VALENTINE LEUKOCIDIN; RNASE-P RNA; METHICILLIN-RESISTANT; VIRULENCE FACTORS; PHYLOGENETIC-RELATIONSHIPS; SEQUENCE DETERMINATION; COMPARATIVE GENOMICS; EVOLUTION; RNPB	Background: Community-acquired methicillin-resistant Staphylococcus aureus have become a major problem in Australia. These strains have now been isolated throughout Australia including remote Indigenous communities that have had minimal exposure to healthcare facilities. Some of these strains, belonging to sequence types ST75 and ST883, have previously been reported to harbour highly divergent alleles of the housekeeping genes used in multilocus sequence typing. Methodology/Principal Findings: ST75-MRSA-IV and ST883-MRSA-IV isolates were characterised in detail. Morphological features as well as 16S sequences were identical to other S. aureus strains. Although a partial rnpB gene sequence was not identical to previously known S. aureus sequences, it was found to be more closely related to S. aureus than to other staphylococci. Isolates also were screened using diagnostic DNA microarrays. These isolates yielded hybridisation results atypical for S. aureus. Primer directed amplification assays failed to detect species markers (femA, katA, sbi, spa). However, arbitrarily primed amplification indicated the presence of unknown alleles of these genes. Isolates could not be assigned to capsule types 1, 5 or 8. The allelic group of the accessory gene regulator (agr) locus was not determinable. Sequencing of a region of agrB, agrC and agrD (approximately 2,100 bp) revealed a divergent sequence. However, this sequence is more related to S. aureus agr alleles I and IV than to agr sequences from other Staphylococcus species. The predicted auto-inducing peptide (AIP) sequence of ST75 was identical to that of agr group I, while the predicted AIP sequence of ST883 was identical to agr group IV. Conclusions/Significance: The genetic properties of ST75/ST883-MRSA may be due to a series of evolutionary events in ancient insulated S. aureus strains including a convergent evolution leading to agr group I- or IV-like AIP sequences and a recent acquisition of SCCmec IV elements.	[Monecke, Stefan; Rudolph, Wolfram] Tech Univ Dresden, Fac Med Carl Gustav Carus, Inst Med Microbiol & Hyg, Dresden, Germany; [Kanig, Hanna] Tech Univ Dresden, Dept Appl Microbiol, Inst Microbiol, Dresden, Germany; [Mueller, Elke; Slickers, Peter; Ehricht, Ralf] Alere Technol GmbH, Jena, Germany; [Coombs, Geoffrey] Royal Perth Hosp, PathW Lab Med WA, Perth, WA, Australia; [Hotzel, Helmut] Inst Bacterial Infect & Zoonoses, Friedrich Loffler Inst, Jena, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Alere; Royal Perth Hospital; University of Western Australia; Friedrich Loeffler Institute	Monecke, S (corresponding author), Tech Univ Dresden, Fac Med Carl Gustav Carus, Inst Med Microbiol & Hyg, Dresden, Germany.	monecke@rocketmail.com	Wolfram, W. Rudolph/AAE-6287-2020; Rudolph, Wolfram W/O-8970-2018	Wolfram, W. Rudolph/0000-0002-6300-4717; Coombs, Geoffrey/0000-0003-1635-6506				BOHLANDER SK, 1992, GENOMICS, V13, P1322, DOI 10.1016/0888-7543(92)90057-Y; Coombs GW, 2010, ANTIMICROB AGENTS CH, V54, P1914, DOI 10.1128/AAC.01287-09; Ehricht Ralf, 2009, V509, P85, DOI 10.1007/978-1-59745-372-1_6; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Feng Y, 2008, FEMS MICROBIOL REV, V32, P23, DOI 10.1111/j.1574-6976.2007.00086.x; Ghebremedhin B, 2009, J CLIN MICROBIOL, V47, P2975, DOI 10.1128/JCM.00648-09; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Herrmann B, 2000, INT J SYST EVOL MICR, V50, P149, DOI 10.1099/00207713-50-1-149; Hotelling H, 1929, ECON J, V39, P41, DOI 10.2307/2224214; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jarraud S, 2002, INFECT IMMUN, V70, P631, DOI 10.1128/IAI.70.2.631-641.2002; Ji GY, 1997, SCIENCE, V276, P2027, DOI 10.1126/science.276.5321.2027; Korczak B, 2005, J CLIN MICROBIOL, V43, P1024, DOI 10.1128/JCM.43.3.1024-1031.2005; Korem M, 2005, INFECT IMMUN, V73, P6220, DOI 10.1128/IAI.73.10.6220-6228.2005; LUCK CP, 2009, INT J SYST EVOL MICR; McDonald M, 2006, J CLIN MICROBIOL, V44, P3720, DOI 10.1128/JCM.00836-06; Monecke S, 2008, CLIN MICROBIOL INFEC, V14, P534, DOI 10.1111/j.1469-0691.2008.01986.x; Monecke S, 2007, CLIN MICROBIOL INFEC, V13, P1157, DOI 10.1111/j.1469-0691.2007.01833.x; Monecke S, 2007, CLIN MICROBIOL INFEC, V13, P236, DOI 10.1111/j.1469-0691.2006.01635.x; Monecke S, 2006, CLIN MICROBIOL INFEC, V12, P718, DOI 10.1111/j.1469-0691.2006.01420.x; Monecke S, 2005, CLIN MICROBIOL INFEC, V11, P825, DOI 10.1111/j.1469-0691.2005.01243.x; Monecke S, 2003, GENOME LETT, V2, P106; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Munckhof Wendy J., 2003, International Journal of Infectious Diseases, V7, P259, DOI 10.1016/S1201-9712(03)90104-4; Ng JWS, 2009, J CLIN MICROBIOL, V47, P2295, DOI 10.1128/JCM.00122-09; Nimmo GR, 2008, INT J ANTIMICROB AG, V31, P401, DOI 10.1016/j.ijantimicag.2007.08.011; NODA M, 1988, METHOD ENZYMOL, V165, P22; NOVICK RP, 1995, MOL GEN GENET, V248, P446, DOI 10.1007/BF02191645; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; Nubel U, 2008, P NATL ACAD SCI USA, V105, P14130, DOI 10.1073/pnas.0804178105; O'Brien FG, 2006, NAT PROTOC, V1, P3028, DOI 10.1038/nprot.2006.382; Robinson DA, 2005, J BACTERIOL, V187, P8312, DOI 10.1128/JB.187.24.8312-8321.2005; Rubin CJ, 2005, INT J SYST EVOL MICR, V55, P2039, DOI 10.1099/ijs.0.63656-0; Schefold Joerg C, 2007, J Med Case Rep, V1, P165; Tapp J, 2003, INT J SYST EVOL MICR, V53, P1861, DOI 10.1099/ijs.0.02639-0; Vorobieva V, 2008, APMIS, V116, P877, DOI 10.1111/j.1600-0463.2008.01092.x; Watanabe S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005714	37	16	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2010	5	11							e14025	10.1371/journal.pone.0014025	http://dx.doi.org/10.1371/journal.pone.0014025			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681OY	21103340	Green Published, gold, Green Submitted			2022-12-25	WOS:000284327800011
J	Parachikova, A; Green, KN; Hendrix, C; LaFerla, FM				Parachikova, Anna; Green, Kim N.; Hendrix, Curt; LaFerla, Frank M.			Formulation of a Medical Food Cocktail for Alzheimer's Disease: Beneficial Effects on Cognition and Neuropathology in a Mouse Model of the Disease	PLOS ONE			English	Article							TEA POLYPHENOL (-)-EPIGALLOCATECHIN-3-GALLATE; TAU-PATHOLOGY; TRANSGENIC MODEL; MEMORY DEFICITS; AMYLOID-BETA; RECOGNITION MEMORY; MICE; PIPERINE; RATS; CURCUMIN	Background: Dietary supplements have been extensively studied for their beneficial effects on cognition and AD neuropathology. The current study examines the effect of a medical food cocktail consisting of the dietary supplements curcumin, piperine, epigallocatechin gallate, alpha-lipoic acid, N-acetylcysteine, B vitaminsvitamin C, and folate on cognitive functioning and the AD hallmark features and amyloid-beta (A beta) in the Tg2576 mouse model of the disease. Principal Findings: The study found that administering the medical food cocktail for 6 months improved cortical- and hippocampal- dependent learning in the transgenic mice, rendering their performance indistinguishable from non-transgenic controls. Coinciding with this improvement in learning and memory, we found that treatment resulted in decreased soluble A beta, including A beta oligomers, previously found to be linked to cognitive functioning. Conclusion: In conclusion, the current study demonstrates that combination diet consisting of natural dietary supplements improves cognitive functioning while decreasing AD neuropathology and may thus represent a safe, natural treatment for AD.	[Parachikova, Anna; Green, Kim N.; LaFerla, Frank M.] Univ Calif Irvine, Dept Neurobiol & Behav, Inst Memory Impairments & Neurol Disorders, Irvine, CA 92717 USA; [Hendrix, Curt] Akeso Hlth Sci LLC, Westlake Village, CA USA	University of California System; University of California Irvine	Parachikova, A (corresponding author), Univ Calif Irvine, Dept Neurobiol & Behav, Inst Memory Impairments & Neurol Disorders, Irvine, CA 92717 USA.	laferla@uci.edu			National Institutes of Health [AG-021982, R43AT003025-1]; NATIONAL INSTITUTE ON AGING [R01AG021982] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by grants from the National Institutes of Health (AG-021982 to FML, and Small Business Innovation Research grant R43AT003025-1 to CH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair JC, 2001, NEUROLOGY, V57, P1515, DOI 10.1212/WNL.57.8.1515; Aggleton JP, 1997, BRAIN RES BULL, V43, P279, DOI 10.1016/S0361-9230(97)00007-5; Billings LM, 2007, J NEUROSCI, V27, P751, DOI 10.1523/JNEUROSCI.4800-06.2007; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Frautschy SA, 2001, NEUROBIOL AGING, V22, P993, DOI 10.1016/S0197-4580(01)00300-1; Green KN, 2008, J NEUROSCI, V28, P11500, DOI 10.1523/JNEUROSCI.3203-08.2008; Green KN, 2007, J NEUROSCI, V27, P4385, DOI 10.1523/JNEUROSCI.0055-07.2007; Green KN, 2006, J NEUROSCI, V26, P9047, DOI 10.1523/JNEUROSCI.2797-06.2006; Hager K, 2001, ARCH GERONTOL GERIAT, V32, P275, DOI 10.1016/S0167-4943(01)00104-2; HENSLEY K, 1995, J NEUROCHEM, V65, P2146; Horie K, 1997, BIOCHEM BIOPH RES CO, V236, P327, DOI 10.1006/bbrc.1997.6944; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hsiao KK, 1997, J NEURAL TRANSM-SUPP, P135; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; King DL, 2002, PHYSIOL BEHAV, V75, P627, DOI 10.1016/S0031-9384(02)00639-X; Lambert JD, 2004, J NUTR, V134, P1948, DOI 10.1093/jn/134.8.1948; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001; Mandel S, 2004, J NEUROCHEM, V88, P1555, DOI 10.1046/j.1471-4159.2003.02291.x; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; Mumby DG, 1996, BEHAV NEUROSCI, V110, P266, DOI 10.1037/0735-7044.110.2.266; MYHRER T, 1988, BEHAV NEUROSCI, V102, P356, DOI 10.1037/0735-7044.102.3.356; Oddo S, 2005, P NATL ACAD SCI USA, V102, P3046, DOI 10.1073/pnas.0408500102; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Ono K, 2004, J NEUROSCI RES, V75, P742, DOI 10.1002/jnr.20025; PHILLIPS RR, 1988, BEHAV BRAIN RES, V27, P99, DOI 10.1016/0166-4328(88)90035-6; Rocchi A, 2003, BRAIN RES BULL, V61, P1, DOI 10.1016/S0361-9230(03)00067-4; Selvendiran K, 2004, BIOMED PHARMACOTHER, V58, P264, DOI 10.1016/j.biopha.2003.08.027; Shoba G, 1998, PLANTA MED, V64, P353, DOI 10.1055/s-2006-957450; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Sunila ES, 2004, J ETHNOPHARMACOL, V90, P339, DOI 10.1016/j.jep.2003.10.016; SUTHERLAND RJ, 1990, BEHAV BRAIN RES, V37, P57, DOI 10.1016/0166-4328(90)90072-M; Vaucher E, 2002, EXP NEUROL, V175, P398, DOI 10.1006/exnr.2002.7915; Vijayakumar RS, 2004, REDOX REP, V9, P105, DOI 10.1179/135100004225004742; Wan HM, 1999, J NEUROSCI, V19, P1142	38	66	72	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2010	5	11							e14015	10.1371/journal.pone.0014015	http://dx.doi.org/10.1371/journal.pone.0014015			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681OY	21103342	Green Published, gold			2022-12-25	WOS:000284327800007
J	Turse, JE; Marshall, MJ; Fredrickson, JK; Lipton, MS; Callister, SJ				Turse, Joshua E.; Marshall, Matthew J.; Fredrickson, James K.; Lipton, Mary S.; Callister, Stephen J.			An Empirical Strategy for Characterizing Bacterial Proteomes across Species in the Absence of Genomic Sequences	PLOS ONE			English	Article							SHEWANELLA-ONEIDENSIS MR-1; OUTER-MEMBRANE CYTOCHROMES; MASS-SPECTROMETRY; PROTEIN IDENTIFICATION; PUTREFACIENS MR-1; REDUCTION; TANDEM; CONSERVATION; DIVERGENCE; METABOLISM	Global protein identification through current proteomics methods typically depends on the availability of sequenced genomes. In spite of increasingly high throughput sequencing technologies, this information is not available for every microorganism and rarely available for entire microbial communities. Nevertheless, the protein-level homology that exists between related bacteria makes it possible to extract biological information from the proteome of an organism or microbial community by using the genomic sequences of a near neighbor organism. Here, we demonstrate a trans-organism search strategy for determining the extent to which near-neighbor genome sequences can be applied to identify proteins in unsequenced environmental isolates. In proof of concept testing, we found that within a CLUSTAL W distance of 0.089, near-neighbor genomes successfully identified a high percentage of proteins within an organism. Application of this strategy to characterize environmental bacterial isolates lacking sequenced genomes, but having 16S rDNA sequence similarity to Shewanella resulted in the identification of 300-500 proteins in each strain. The majority of identified pathways mapped to core processes, as well as to processes unique to the Shewanellae, in particular to the presence of c-type cytochromes. Examples of core functional categories include energy metabolism, protein and nucleotide synthesis and cofactor biosynthesis, allowing classification of bacteria by observation of conserved processes. Additionally, within these core functionalities, we observed proteins involved in the alternative lactate utilization pathway, recently described in Shewanella.	[Turse, Joshua E.; Marshall, Matthew J.; Fredrickson, James K.; Lipton, Mary S.; Callister, Stephen J.] Pacific NW Natl Lab, Biol Sci & Computat Sci & Math Div, Richland, WA 99352 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory	Turse, JE (corresponding author), Washington State Univ, Coll Vet Med, Pullman, WA 99164 USA.	stephen.callister@pnl.gov	Lipton, Mary S/H-3913-2012; , 0000-0001-7041-1823/B-9144-2014; Marshall, Matthew J./M-4120-2017	, 0000-0001-7041-1823/0000-0001-7041-1823; Marshall, Matthew J./0000-0002-2402-8003	Department of Energy Office of Biological and Environmental Research (DOE/BER) [ER63232-1018220-0007203]; National Institute of Allergy and Infectious Diseases (NIH/DHHS) [Y1-AI-4894-01]; NIH National Center for Research Resources [RR18522]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018522] Funding Source: NIH RePORTER	Department of Energy Office of Biological and Environmental Research (DOE/BER)(United States Department of Energy (DOE)); National Institute of Allergy and Infectious Diseases (NIH/DHHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Department of Energy Office of Biological and Environmental Research (DOE/BER; ER63232-1018220-0007203), the National Institute of Allergy and Infectious Diseases (NIH/DHHS through interagency agreement Y1-AI-4894-01), and the NIH National Center for Research Resources (RR18522). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; Beliaev Alex S., 2002, OMICS A Journal of Integrative Biology, V6, P39, DOI 10.1089/15362310252780834; Beliaev AS, 1998, J BACTERIOL, V180, P6292; Beliaev AS, 2001, MOL MICROBIOL, V39, P722, DOI 10.1046/j.1365-2958.2001.02257.x; Callister SJ, 2006, J MICROBIOL METH, V67, P424, DOI 10.1016/j.mimet.2006.04.021; Callister SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001542; Carpentier W, 2005, J BACTERIOL, V187, P3293, DOI 10.1128/JB.187.10.3293-3301.2005; Chain PSG, 2005, INFECT IMMUN, V73, P8353, DOI 10.1128/IAI.73.12.8353-8361.2005; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Craig R, 2006, J PROTEOME RES, V5, P1843, DOI 10.1021/pr0602085; Craig R, 2004, J PROTEOME RES, V3, P1234, DOI 10.1021/pr049882h; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Daraselia N., 2003, OMICS A Journal of Integrative Biology, V7, P171, DOI 10.1089/153623103322246566; den Hartigh AB, 2004, INFECT IMMUN, V72, P5143, DOI 10.1128/IAI.72.9.5143-5149.2004; Denef VJ, 2007, J PROTEOME RES, V6, P3152, DOI 10.1021/pr0701005; Dennis PC, 2003, CAN J MICROBIOL, V49, P15, DOI [10.1139/w03-008, 10.1139/W03-008]; Espariz M, 2007, MICROBIOL-SGM, V153, P2989, DOI 10.1099/mic.0.2007/006536-0; Ferguson PL, 2003, ANNU REV BIOPH BIOM, V32, P399, DOI 10.1146/annurev.biophys.32.110601.141854; Fredrickson JK, 2008, NAT REV MICROBIOL, V6, P592, DOI 10.1038/nrmicro1947; Fredrickson JK, 1998, GEOCHIM COSMOCHIM AC, V62, P3239, DOI 10.1016/S0016-7037(98)00243-9; Gascuel O, 2006, MOL BIOL EVOL, V23, P1997, DOI 10.1093/molbev/msl072; Grosse C, 1999, J BACTERIOL, V181, P2385; Guha H, 2003, CHEMOSPHERE, V52, P175, DOI 10.1016/S0045-6535(03)00104-8; Habermann B, 2004, MOL CELL PROTEOMICS, V3, P238, DOI 10.1074/mcp.M300073-MCP200; HAN SJ, J GEN VIROL; Heidelberg JF, 2002, NAT BIOTECHNOL, V20, P1118, DOI 10.1038/nbt749; HUGHES C, METHODS MOL BIOL, V604, P105; Jungblut PR, 2008, CHEM CENT J, V2, DOI 10.1186/1752-153X-2-16; KIEBEL GR, 2006, PROTEOMICS; Lipton Mary S, 2006, Methods Biochem Anal, V49, P113; Lipton MS, 2002, P NATL ACAD SCI USA, V99, P11049, DOI 10.1073/pnas.172170199; Liska AJ, 2005, PROTEOMICS, V5, P4118, DOI 10.1002/pmic.200401262; LIU P, MOL BIOL EVOL; Lo I, 2007, NATURE, V446, P537, DOI 10.1038/nature05624; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; Maier TM, 2003, J BASIC MICROB, V43, P312, DOI 10.1002/jobm.200390034; Marshall MJ, 2008, ENVIRON MICROBIOL, V10, P125, DOI 10.1111/j.1462-2920.2007.01438.x; Masselon C, 2005, ANAL CHEM, V77, P400, DOI 10.1021/ac049043e; Mertens B, 2007, CHEMOSPHERE, V66, P99, DOI 10.1016/j.chemosphere.2006.05.018; Meyer TE, 2004, OMICS, V8, P57, DOI 10.1089/153623104773547499; Miller J.H., 1972, EXPT MOL GENETICS; Myers CR, 2003, LETT APPL MICROBIOL, V37, P254, DOI 10.1046/j.1472-765X.2003.01389.x; Myers JM, 2003, LETT APPL MICROBIOL, V37, P21, DOI 10.1046/j.1472-765X.2003.01338.x; Myers JM, 2001, APPL ENVIRON MICROB, V67, P260, DOI 10.1128/AEM.67.1.260-269.2001; Nealson KH, 2002, ANTON LEEUW INT J G, V81, P215, DOI 10.1023/A:1020518818647; Pandhal J, 2008, PROTEOMICS, V8, P2266, DOI 10.1002/pmic.200700398; PASATOLIC L, 2002, GENE EXPRESSION, V37, P1185; Pinchuk GE, 2009, P NATL ACAD SCI USA, V106, P2874, DOI 10.1073/pnas.0806798106; Popa R, 2009, J MICROBIOL METH, V78, P111, DOI 10.1016/j.mimet.2009.06.005; REARDON CL, GEOBIOLOGY, V8, P56; SAINI G, 2007, BIOTECHNOL BIOENG; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanchez-Perez G, 2008, TRENDS GENET, V24, P154, DOI 10.1016/j.tig.2008.01.002; Sauro Herbert M., 2003, OMICS A Journal of Integrative Biology, V7, P355, DOI 10.1089/153623103322637670; Serres MH, 2006, J BACTERIOL, V188, P4601, DOI 10.1128/JB.01787-05; Shen YF, 2008, ANAL CHEM, V80, P1871, DOI 10.1021/ac702328x; Shevchenko A, 2001, ANAL CHEM, V73, P1917, DOI 10.1021/ac0013709; Subramaniam S, 1998, PROTEINS, V32, P1; Sunyaev S, 2003, ANAL CHEM, V75, P1307, DOI 10.1021/ac026199a; Tabb DL, 2003, ANAL CHEM, V75, P6415, DOI 10.1021/ac0347462; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toes ACM, 2008, MICROBIOL-SGM, V154, P2709, DOI 10.1099/mic.0.2008/016857-0; Villafane R, 2005, ARCH VIROL, V150, P2609, DOI 10.1007/s00705-005-0597-7; Wang ZM, 2008, APPL ENVIRON MICROB, V74, P6746, DOI 10.1128/AEM.01454-08; Wilkins MJ, 2009, APPL ENVIRON MICROB, V75, P6591, DOI 10.1128/AEM.01064-09; Xu CX, 2006, DRUG DISCOV TODAY, V11, P595, DOI 10.1016/j.drudis.2006.05.011	66	15	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e13968	10.1371/journal.pone.0013968	http://dx.doi.org/10.1371/journal.pone.0013968			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103051	Green Submitted, Green Published, gold			2022-12-25	WOS:000284147700016
J	Matrajt, L; Longini, IM				Matrajt, Laura; Longini, Ira M., Jr.			Optimizing Vaccine Allocation at Different Points in Time during an Epidemic	PLOS ONE			English	Article							INFLUENZA VACCINE; CHILDREN; SCHOOLCHILDREN; STRATEGIES; SPREAD; MODELS; TRIAL; RISK; AGE	Background: Pandemic influenza A(H1N1) 2009 began spreading around the globe in April of 2009 and vaccination started in October of 2009. In most countries, by the time vaccination started, the second wave of pandemic H1N1 2009 was already under way. With limited supplies of vaccine, we are left to question whether it may be a good strategy to vaccinate the high-transmission groups earlier in the epidemic, but it might be a better use of resources to protect instead the high-risk groups later in the epidemic. To answer this question, we develop a deterministic epidemic model with two age-groups (children and adults) and further subdivide each age group in low and high risk. Methods and Findings: We compare optimal vaccination strategies started at various points in time in two different settings: a population in a developed country where children account for 24% of the population, and a population in a less developed country where children make up the majority of the population, 55%. For each of these populations, we minimize mortality or hospitalizations and we find an optimal vaccination strategy that gives the best vaccine allocation given a starting vaccination time and vaccine coverage level. We find that population structure is an important factor in determining the optimal vaccine distribution. Moreover, the optimal policy is dynamic as there is a switch in the optimal vaccination strategy at some time point just before the peak of the epidemic. For instance, with 25% vaccine coverage, it is better to protect the high-transmission groups before this point, but it is optimal to protect the most vulnerable groups afterward. Conclusions: Choosing the optimal strategy before or early in the epidemic makes an important difference in minimizing the number of influenza infections, and consequently the number of influenza deaths or hospitalizations, but the optimal strategy makes little difference after the peak.	[Matrajt, Laura] Univ Washington, Dept Appl Math, Seattle, WA 98195 USA; [Longini, Ira M., Jr.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Ctr Stat & Quantitat Infect Dis, Seattle, WA 98104 USA; [Longini, Ira M., Jr.] Univ Washington, Sch Publ Hlth, Dept Biostat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Matrajt, L (corresponding author), Univ Washington, Dept Appl Math, Seattle, WA 98195 USA.	longini@scharp.org	Matrajt, Laura/AAV-5216-2020		National Institute of General Medical Sciences [U01-GM070749]; National Institute of Allergy and Infectious Diseases [R01-AI32042]; Consejo Nacional de Ciencia y Tecnologia, Mexico [196221]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM070749] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Consejo Nacional de Ciencia y Tecnologia, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partially supported by the National Institute of General Medical Sciences MIDAS grant U01-GM070749 and the National Institute of Allergy and Infectious Diseases grant R01-AI32042. LM is partially supported by Consejo Nacional de Ciencia y Tecnologia, Mexico, fellowship 196221. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], WORLD DEV INDICATORS; Balcan D, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-45; Bansal S, 2006, PLOS MED, V3, P1816, DOI 10.1371/journal.pmed.0030387; Brauer F., 2008, LECT NOTES MATH, V1945; *CDCP, 2010, MMWR-MORBID MORTAL W, V58, P1009; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Dushoff J, 2007, PLOS MED, V4, P921, DOI 10.1371/journal.pmed.0040174; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; *GLAXOSMITHKLINE, 2009, GLAXOSMITHKLINE UPD; Gojovic MZ, 2009, CAN MED ASSOC J, V181, P673, DOI 10.1503/cmaj.091641; Goldstein E, 2010, J R SOC INTERFACE, V7, P755, DOI 10.1098/rsif.2009.0393; Halloran ME, 1997, AM J EPIDEMIOL, V146, P789; Longini IM, 2005, AM J EPIDEMIOL, V161, P303, DOI 10.1093/aje/kwi053; MEDLOCK J, 2009, PLOS CURR INFLUENZA; Medlock J, 2009, SCIENCE, V325, P1705, DOI 10.1126/science.1175570; MONTO AS, 1970, J INFECT DIS, V122, P16, DOI 10.1093/infdis/122.1-2.16; Mylius SD, 2008, VACCINE, V26, P3742, DOI 10.1016/j.vaccine.2008.04.043; *NAT I ALL INF DIS, 2009, EARL RES CHILDR 2009; *NAT I ALL INF DIS, 2009, UPD RES YOUNG CHILDR; Nolan T, 2010, JAMA-J AM MED ASSOC, V303, P37, DOI 10.1001/jama.2009.1911; Piedra PA, 2005, PEDIATRICS, V116, pE397, DOI 10.1542/peds.2004-2258; Plennevaux E, 2010, LANCET, V375, P41, DOI 10.1016/S0140-6736(09)62026-2; Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat, WORLD POP PROSP 2008; Reichert TA, 2001, NEW ENGL J MED, V344, P889, DOI 10.1056/NEJM200103223441204; Sypsa V, 2009, EUROSURVEILLANCE, V14, P2; Tennenbaum S, 2008, J THEOR BIOL, V250, P673, DOI 10.1016/j.jtbi.2007.10.021; TUITE A, 2010, PLOS CURR INFLUENZA; *US DEP HHS, HHS 2009 H1N1 VACC D; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Wallinga J, 2010, P NATL ACAD SCI USA, V107, P923, DOI 10.1073/pnas.0908491107; *WHO, 2009, PROD AV PAND INFL A; *WHO, 2010, WHO TAK ACT PAND H1N; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373; [No title captured]	34	33	33	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e13767	10.1371/journal.pone.0013767	http://dx.doi.org/10.1371/journal.pone.0013767			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21085686	Green Published, gold, Green Submitted			2022-12-25	WOS:000284087800002
J	Xiong, JH; Liu, JA; Rayner, S; Tian, Z; Li, YH; Chen, SG				Xiong, Jianghui; Liu, Juan; Rayner, Simon; Tian, Ze; Li, Yinghui; Chen, Shanguang			Pre-Clinical Drug Prioritization via Prognosis-Guided Genetic Interaction Networks	PLOS ONE			English	Article							CELL LUNG-CANCER; BREAST-CANCER; TARGETED THERAPIES; IDENTIFICATION; PHARMACOLOGY; GEMCITABINE; ROBUSTNESS; MODULARITY; INHIBITORS; SIGNATURES	The high rates of failure in oncology drug clinical trials highlight the problems of using pre-clinical data to predict the clinical effects of drugs. Patient population heterogeneity and unpredictable physiology complicate pre-clinical cancer modeling efforts. We hypothesize that gene networks associated with cancer outcome in heterogeneous patient populations could serve as a reference for identifying drug effects. Here we propose a novel in vivo genetic interaction which we call 'synergistic outcome determination' (SOD), a concept similar to 'Synthetic Lethality'. SOD is defined as the synergy of a gene pair with respect to cancer patients' outcome, whose correlation with outcome is due to cooperative, rather than independent, contributions of genes. The method combines microarray gene expression data with cancer prognostic information to identify synergistic gene-gene interactions that are then used to construct interaction networks based on gene modules (a group of genes which share similar function). In this way, we identified a cluster of important epigenetically regulated gene modules. By projecting drug sensitivity-associated genes on to the cancer-specific intermodule network, we defined a perturbation index for each drug based upon its characteristic perturbation pattern on the inter-module network. Finally, by calculating this index for compounds in the NCI Standard Agent Database, we significantly discriminated successful drugs from a broad set of test compounds, and further revealed the mechanisms of drug combinations. Thus, prognosis-guided synergistic gene-gene interaction networks could serve as an efficient in silico tool for pre-clinical drug prioritization and rational design of combinatorial therapies.	[Xiong, Jianghui; Liu, Juan] Wuhan Univ, Sch Comp Sci, Wuhan 430072, Peoples R China; [Xiong, Jianghui; Li, Yinghui; Chen, Shanguang] China Astronaut Res & Training Ctr, State Key Lab Space Med Fundamentals & Applicat, Bioinformat Syst Biol & Translat Med Grp, Beijing, Peoples R China; [Rayner, Simon] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Bioinformat Grp, Wuhan, Peoples R China; [Tian, Ze] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	Wuhan University; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Xiong, JH (corresponding author), Wuhan Univ, Sch Comp Sci, Wuhan 430072, Peoples R China.	laserxiong@gmail.com; liujuan@whu.edu.cn	rayner, simon/N-7715-2013; tian, ze/HDM-4308-2022	rayner, simon/0000-0001-8703-9140; XIONG, JIANGHUI/0000-0002-3198-5303	National Natural Science Foundation of China [30600759, 60773010, 60970063]; State Key Lab of Space Medicine Fundamentals and Application [SMFA09A07]; Advanced Space Medico-Engineering Research Project of China [01105015, 01104099]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Lab of Space Medicine Fundamentals and Application; Advanced Space Medico-Engineering Research Project of China	This work was partly supported by the National Natural Science Foundation of China to J.X. (30600759) and J.L. (60773010 and 60970063), grant from State Key Lab of Space Medicine Fundamentals and Application to J.X. (SMFA09A07), and Advanced Space Medico-Engineering Research Project of China to J.X. (01105015, 01104099). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastassiou D, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100124; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Brock A, 2009, NAT REV GENET, V10, P336, DOI 10.1038/nrg2556; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Clegg A, 2002, THORAX, V57, P20, DOI 10.1136/thorax.57.1.20; Csermely P, 2005, TRENDS PHARMACOL SCI, V26, P178, DOI 10.1016/j.tips.2005.02.007; Davies AM, 2009, J THORAC ONCOL, V4, P87, DOI 10.1097/JTO.0b013e3181915052; DEVITA VT, 1989, CANC PRINCIPLES PRAC, V1; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; FONG PC, 2009, N ENGL J MED; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Janne PA, 2009, NAT REV DRUG DISCOV, V8, P709, DOI 10.1038/nrd2871; Jones D, 2009, NAT BIOTECHNOL, V27, P108, DOI 10.1038/nbt0209-108; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Kamat AM, 2004, MOL CANCER THER, V3, P279; Kamb A, 2005, NAT REV DRUG DISCOV, V4, P161, DOI 10.1038/nrd1635; Kemper C, 2007, NAT REV IMMUNOL, V7, P9, DOI 10.1038/nri1994; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kitano H, 2007, NAT REV DRUG DISCOV, V6, P202, DOI 10.1038/nrd2195; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lauss M, 2008, BRIT J CANCER, V98, P816, DOI 10.1038/sj.bjc.6604219; Markiewski MM, 2008, NAT IMMUNOL, V9, P1225, DOI 10.1038/ni.1655; Metzeler KH, 2008, BLOOD, V112, P4193, DOI 10.1182/blood-2008-02-134411; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Potti A, 2006, NEW ENGL J MED, V355, P570, DOI 10.1056/NEJMoa060467; Provencio M, 2010, CLIN LUNG CANCER, V11, P91, DOI 10.3816/CLC.2010.n.012; Radiloff Daniel R, 2008, Drug Discov Today Dis Models, V4, P83; Ruepp A, 2008, NUCLEIC ACIDS RES, V36, pD646, DOI 10.1093/nar/gkm936; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Watkinson J, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-10; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697; Wu M, 2009, P NATL ACAD SCI USA, V106, P7022, DOI 10.1073/pnas.0811785106; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338	49	6	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e13937	10.1371/journal.pone.0013937	http://dx.doi.org/10.1371/journal.pone.0013937			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085674	Green Published, Green Submitted, gold			2022-12-25	WOS:000284036800024
J	Xiao, SY; Manley, NR				Xiao, Shiyun; Manley, Nancy R.			Impaired Thymic Selection and Abnormal Antigen-Specific T Cell Responses in Foxn1(Delta/Delta) Mutant Mice	PLOS ONE			English	Article							THYMOCYTE POSITIVE SELECTION; EPITHELIAL-CELLS; IN-VIVO; PERIPHERAL TOLERANCE; NEGATIVE SELECTION; DEFICIENT MICE; ORAL ANTIGEN; DIFFERENTIATION; PROGENITORS; FIBROBLASTS	Background: Foxn1(Delta/Delta) mutant mice have a specific defect in thymic development, characterized by a block in TEC differentiation at an intermediate progenitor stage, and blocks in thymocyte development at both the DN1 and DP cell stages, resulting in the production of abnormally functioning T cells that develop from an atypical progenitor population. In the current study, we tested the effects of these defects on thymic selection. Methodology/Principal Findings: We used Foxn1(Delta/Delta); DO11 Tg and Foxn1(Delta/Delta); OT1 Tg mice as positive selection and Foxn1(Delta/Delta); MHCII I-E mice as negative selection models. We also used an in vivo system of antigen-specific reactivity to test the function of peripheral T cells. Our data show that the capacity for positive and negative selection of both CD4 and CD8 SP thymocytes was reduced in Foxn1(Delta/Delta) mutants compared to Foxn1(+/Delta) control mice. These defects were associated with reduction of both MHC Class I and Class II expression, although the resulting peripheral T cells have a broad TCR V beta repertoire. In this deficient thymic environment, immature CD4 and CD8 SP thymocytes emigrate from the thymus into the periphery. These T cells had an incompletely activated profile under stimulation of the TCR signal in vitro, and were either hypersensitive or hyporesponsive to antigen-specific stimulation in vivo. These cell-autonomous defects were compounded by the hypocellular peripheral environment caused by low thymic output. Conclusions/Significance: These data show that a primary defect in the thymic microenvironment can cause both direct defects in selection which can in turn cause indirect effects on the periphery, exacerbating functional defects in T cells.	[Xiao, Shiyun; Manley, Nancy R.] Univ Georgia, Dept Genet, Coverdell Ctr, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Xiao, SY (corresponding author), Univ Georgia, Dept Genet, Coverdell Ctr, Athens, GA 30602 USA.	shiyun@uga.edu			National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH) [AI055001]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055001] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant to N.R.M. from the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH). Grant No. is AI055001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON G, 1994, J EXP MED, V179, P2027, DOI 10.1084/jem.179.6.2027; Anderson G, 2001, NAT REV IMMUNOL, V1, P31, DOI 10.1038/35095500; ANDERSON G, 1993, NATURE, V362, P70, DOI 10.1038/362070a0; Bateman HE, 1999, J RHEUMATOL, V26, P2482; Blackburn CC, 1996, P NATL ACAD SCI USA, V93, P5742, DOI 10.1073/pnas.93.12.5742; CARDELL S, 1995, J EXP MED, V182, P993, DOI 10.1084/jem.182.4.993; Chen LZ, 2009, BLOOD, V113, P567, DOI 10.1182/blood-2008-05-156265; CHEN YH, 1995, NATURE, V376, P177, DOI 10.1038/376177a0; COSGROVE D, 1992, INT IMMUNOL, V4, P707, DOI 10.1093/intimm/4.6.707; DeKoning J, 1997, J IMMUNOL, V158, P2558; FOWLKES BJ, 1995, CURR OPIN IMMUNOL, V7, P188, DOI 10.1016/0952-7915(95)80003-4; Gordon J, 2004, NAT IMMUNOL, V5, P546, DOI 10.1038/ni1064; HUGO P, 1993, P NATL ACAD SCI USA, V90, P10335, DOI 10.1073/pnas.90.21.10335; HUGO P, 1992, NATURE, V360, P679, DOI 10.1038/360679a0; Itoi M, 2001, INT IMMUNOL, V13, P1203, DOI 10.1093/intimm/13.9.1203; Itoi M, 2007, INT IMMUNOL, V19, P127, DOI 10.1093/intimm/dxl129; Jameson SC, 1998, CURR OPIN IMMUNOL, V10, P214, DOI 10.1016/S0952-7915(98)80251-3; JENKINSON EJ, 1992, J EXP MED, V176, P845, DOI 10.1084/jem.176.3.845; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Kishimoto H, 1997, J EXP MED, V185, P263, DOI 10.1084/jem.185.2.263; Kurts C, 1999, P NATL ACAD SCI USA, V96, P12703, DOI 10.1073/pnas.96.22.12703; Laufer TM, 1996, NATURE, V383, P81, DOI 10.1038/383081a0; McCaughtry TM, 2007, J EXP MED, V204, P2513, DOI 10.1084/jem.20070601; MCCORMACK JE, 1994, J IMMUNOL, V180, P7305; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; Ortman CL, 2002, INT IMMUNOL, V14, P813, DOI 10.1093/intimm/dxf042; PAWLOWSKI T, 1993, NATURE, V364, P642, DOI 10.1038/364642a0; Peacock CD, 2003, J IMMUNOL, V171, P655, DOI 10.4049/jimmunol.171.2.655; Saijo K, 1997, J EXP MED, V185, P351, DOI 10.1084/jem.185.2.351; SCOLLAY R, 1995, IMMUNOL TODAY, V16, P268, DOI 10.1016/0167-5699(95)80179-0; Shakib S, 2009, J IMMUNOL, V182, P130, DOI 10.4049/jimmunol.182.1.130; Su DM, 2003, NAT IMMUNOL, V4, P1128, DOI 10.1038/ni983; Sun JB, 1999, J IMMUNOL, V163, P1045; Thorstenson KM, 2001, J IMMUNOL, V167, P188, DOI 10.4049/jimmunol.167.1.188; VUKMANOVIC S, 1992, NATURE, V359, P729, DOI 10.1038/359729a0; Winstead CJ, 2008, J IMMUNOL, V180, P7305, DOI 10.4049/jimmunol.180.11.7305; Xiao SY, 2008, J IMMUNOL, V180, P914, DOI 10.4049/jimmunol.180.2.914; Xiao SY, 2007, J IMMUNOL, V179, P8153, DOI 10.4049/jimmunol.179.12.8153; Yamazaki S, 2006, IMMUNOL REV, V212, P314, DOI 10.1111/j.0105-2896.2006.00422.x; Zhang XM, 2001, J IMMUNOL, V167, P4245, DOI 10.4049/jimmunol.167.8.4245	42	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e15396	10.1371/journal.pone.0015396	http://dx.doi.org/10.1371/journal.pone.0015396			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079757	Green Published, Green Submitted, gold			2022-12-25	WOS:000283838600025
J	Chen, L; Romero, L; Chuang, SM; Tournier, V; Joshi, KK; Lee, JA; Kovvali, G; Madura, K				Chen, Li; Romero, Lizbeth; Chuang, Show-Mei; Tournier, Vincent; Joshi, Kishore Kumar; Lee, Jung Ah; Kovvali, Gopala; Madura, Kiran			Sts1 Plays a Key Role in Targeting Proteasomes to the Nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; 26S PROTEASOME; UBIQUITIN/PROTEASOME PATHWAY; PROTEIN-DEGRADATION; KARYOPHERIN-ALPHA; UBA DOMAINS; UBIQUITIN; RAD23; LOCALIZATION; YEAST	The evidence that nuclear proteins can be degraded by cytosolic proteasomes has received considerable experimental support. However, the presence of proteasome subunits in the nucleus also suggests that protein degradation could occur within this organelle. We determined that Sts1 can target proteasomes to the nucleus and facilitate the degradation of a nuclear protein. Specific sts1 mutants showed reduced nuclear proteasomes at the nonpermissive temperature. In contrast, high expression of Sts1 increased the levels of nuclear proteasomes. Sts1 targets proteasomes to the nucleus by interacting with Srp1, a nuclear import factor that binds nuclear localization signals. Deletion of the NLS in Sts1 prevented its interaction with Srp1 and caused proteasome mislocalization. In agreement with this observation, a mutation in Srp1 that weakened its interaction with Sts1 also reduced nuclear targeting of proteasomes. We reported that Sts1 could suppress growth and proteolytic defects of rad23 Delta rpn10 Delta. We show here that Sts1 suppresses a previously undetected proteasome localization defect in this mutant. Taken together, these findings explain the suppression of rad23 Delta rpn10 Delta by Sts1 and suggest that the degradation of nuclear substrates requires efficient proteasome localization.	[Chen, Li; Romero, Lizbeth; Chuang, Show-Mei; Tournier, Vincent; Joshi, Kishore Kumar; Lee, Jung Ah; Kovvali, Gopala; Madura, Kiran] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Madura, K (corresponding author), SPH-383,683 Hoes Lane, Piscataway, NJ 08854 USA.	maduraki@umdnj.edu		Tournier, Vincent/0000-0002-3971-1972; Chuang, Show-Mei/0000-0003-2986-0736	National Institutes of Health [CA083875]; NATIONAL CANCER INSTITUTE [R01CA083875] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA083875 (to K. M.).	Bertolaet BL, 2001, NAT STRUCT BIOL, V8, P417, DOI 10.1038/87575; Chandra A, 2010, J BIOL CHEM, V285, P8330, DOI 10.1074/jbc.M109.076786; Chen L, 2001, EMBO REP, V2, P933, DOI 10.1093/embo-reports/kve203; Chen L, 2002, MOL CELL BIOL, V22, P4902, DOI 10.1128/MCB.22.13.4902-4913.2002; Cheong JK, 2008, J BIOL CHEM, V283, P11661, DOI 10.1074/jbc.M708365200; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; Enenkel C, 1998, EMBO J, V17, P6144, DOI 10.1093/emboj/17.21.6144; Enenkel C, 1999, MOL BIOL REP, V26, P131, DOI 10.1023/A:1006973803960; Garrenton LS, 2009, MOL CELL BIOL, V29, P582, DOI 10.1128/MCB.01019-08; Gilon T, 1998, EMBO J, V17, P2759, DOI 10.1093/emboj/17.10.2759; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Guerrero S., 2001, Innovative Food Science and Emerging Technologies, V2, P31, DOI 10.1016/S1466-8564(01)00020-0; Kim JH, 2009, J CELL BIOCHEM, V107, P557, DOI 10.1002/jcb.22157; Lambertson D, 1999, GENETICS, V153, P69; Lehmann A, 2002, J MOL BIOL, V317, P401, DOI 10.1006/jmbi.2002.5443; Raasi S, 2003, J BIOL CHEM, V278, P8951, DOI 10.1074/jbc.M212841200; Romero-Perez L, 2007, J BIOL CHEM, V282, P35574, DOI 10.1074/jbc.M704857200; Russell SJ, 1999, MOL CELL, V3, P687, DOI 10.1016/S1097-2765(01)80001-0; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; Stewart D, 2005, J VIROL, V79, P8773, DOI 10.1128/JVI.79.14.8773-8783.2005; Tabb MM, 2000, MOL CELL BIOL, V20, P6062, DOI 10.1128/MCB.20.16.6062-6073.2000; Takeda K, 2005, CELL, V122, P393, DOI 10.1016/j.cell.2005.05.023; Tatebe H, 2000, CURR BIOL, V10, P1329, DOI 10.1016/S0960-9822(00)00773-9; vanNocker S, 1996, MOL CELL BIOL, V16, P6020; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Wendler P, 2004, J BIOL CHEM, V279, P37751, DOI 10.1074/jbc.M403551200; Yen HCS, 2003, J BIOL CHEM, V278, P30669, DOI 10.1074/jbc.M302093200	30	32	35	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					3104	3118		10.1074/jbc.M110.135863	http://dx.doi.org/10.1074/jbc.M110.135863			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21075847	Green Published, hybrid			2022-12-25	WOS:000286464300072
J	Fortibuoni, T; Libralato, S; Raicevich, S; Giovanardi, O; Solidoro, C				Fortibuoni, Tomaso; Libralato, Simone; Raicevich, Sasa; Giovanardi, Otello; Solidoro, Cosimo			Coding Early Naturalists' Accounts into Long-Term Fish Community Changes in the Adriatic Sea (1800-2000)	PLOS ONE			English	Article							BASE-LINES; RESOURCES; ANECDOTES; DEPLETION	The understanding of fish communities' changes over the past centuries has important implications for conservation policy and marine resource management. However, reconstructing these changes is difficult because information on marine communities before the second half of the 20(th) century is, in most cases, anecdotal and merely qualitative. Therefore, historical qualitative records and modern quantitative data are not directly comparable, and their integration for long-term analyses is not straightforward. We developed a methodology that allows the coding of qualitative information provided by early naturalists into semi-quantitative information through an intercalibration with landing proportions. This approach allowed us to reconstruct and quantitatively analyze a 200-year-long time series of fish community structure indicators in the Northern Adriatic Sea (Mediterranean Sea). Our analysis provides evidence of long-term changes in fish community structure, including the decline of Chondrichthyes, large-sized and late-maturing species. This work highlights the importance of broadening the time-frame through which we look at marine ecosystem changes and provides a methodology to exploit, in a quantitative framework, historical qualitative sources. To the purpose, naturalists' eyewitness accounts proved to be useful for extending the analysis on fish community back in the past, well before the onset of field-based monitoring programs.	[Fortibuoni, Tomaso; Libralato, Simone; Solidoro, Cosimo] Ist Nazl Oceanog & Geofis Sperimentale, Dept Oceanog, Sgonico, Italy; [Fortibuoni, Tomaso; Raicevich, Sasa; Giovanardi, Otello] Ist Super Prot & Ric Ambientale, Chioggia, Italy	Istituto Nazionale di Oceanografia e di Geofisica Sperimentale; Italian Institute for Environmental Protection & Research (ISPRA)	Fortibuoni, T (corresponding author), Ist Nazl Oceanog & Geofis Sperimentale, Dept Oceanog, Sgonico, Italy.	tfortibuoni@ogs.trieste.it	Fortibuoni, Tomaso/L-1362-2019; Solidoro, Cosimo/A-3997-2009; Libralato, Simone/N-5668-2015; Libralato, Simone/AAR-2198-2020	Fortibuoni, Tomaso/0000-0003-3449-3475; Libralato, Simone/0000-0001-8112-1274; Libralato, Simone/0000-0001-8112-1274; Raicevich, Sasa/0000-0002-9323-031X; solidoro, cosimo/0000-0003-2354-4302; Giovanardi, Otello/0000-0002-3171-9099	Alfred P. Sloan Foundation; "Regione Veneto" administration; "Tegnue di Chioggia onlus" association; EC [GOCE-036949]; Sixth Framework Programme; Centro Euro-Mediterraneo per i Cambiamenti Climatici and ISPRA (Istituto Superiore per la Protezione e la Ricerca Ambientale, STS Chioggia)	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); "Regione Veneto" administration; "Tegnue di Chioggia onlus" association; EC(European CommissionEuropean Commission Joint Research Centre); Sixth Framework Programme(European Commission); Centro Euro-Mediterraneo per i Cambiamenti Climatici and ISPRA (Istituto Superiore per la Protezione e la Ricerca Ambientale, STS Chioggia)	TF was supported by the Alfred P. Sloan Foundation, History of Marine Animal Populations project(HMAP), the "Regione Veneto" administration and the "Tegnue di Chioggia onlus" association in the framework of the project "La pesca in Alto Adriatico e Laguna di Venezia dalla caduta della Serenissima ad oggi: unanalisi storica ed ecologica". This work was partially funded by the projects SESAME (EC Contract No. GOCE-036949, funded by the Sixth Framework Programme) and VECTOR (VulnErabilita delle Coste e degli ecosistemi marini italiani ai cambiamenti climaTici e loro ruolO nel ciclo del caRbonio mediterraneo) and by the Centro Euro-Mediterraneo per i Cambiamenti Climatici and ISPRA (Istituto Superiore per la Protezione e la Ricerca Ambientale, STS Chioggia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth CH, 2008, BIOL CONSERV, V141, P848, DOI 10.1016/j.biocon.2008.01.006; Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; BARMAWIDJAJA DM, 1995, MAR GEOL, V122, P367, DOI 10.1016/0025-3227(94)00121-Z; Botter L, 2006, J MEDITERR STUD, V16, P27; Cardinale M, 2009, MAR ECOL PROG SER, V386, P197, DOI 10.3354/meps08076; CROWLEY PH, 1992, ANNU REV ECOL SYST, V23, P405, DOI 10.1146/annurev.es.23.110192.002201; Cury P, 2003, RESPONSIBLE FISHERIES IN THE MARINE ECOSYSTEM, P103, DOI 10.1079/9780851996332.0103; DANCONA U, 1926, COMITATO TALASSOGRAF, V126, P5; Dehaene S, 2008, SCIENCE, V320, P1217, DOI 10.1126/science.1156540; Dulvy NK, 2003, FISH FISH, V4, P25, DOI 10.1046/j.1467-2979.2003.00105.x; EDMONDS M, 2005, HIST ECOLOGY HDB RES, P72; Ferretti F, 2008, CONSERV BIOL, V22, P952, DOI 10.1111/j.1523-1739.2008.00938.x; Froese R., 2018, FISHBASE WORLD WIDE; Holm P, 2005, HELGOLAND MAR RES, V59, P39, DOI 10.1007/s10152-004-0205-3; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jennings S, 1999, J ANIM ECOL, V68, P617, DOI 10.1046/j.1365-2656.1999.00312.x; Jukic-Peladic S, 2001, FISH RES, V53, P95, DOI 10.1016/S0165-7836(00)00232-0; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Lotze HK, 2009, TRENDS ECOL EVOL, V24, P254, DOI 10.1016/j.tree.2008.12.004; Mackinson S, 2001, ENVIRON MANAGE, V27, P533, DOI 10.1007/s002670010168; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; NARDO GD, 1924, MED ARTI, V7, P222; PALOMARES MLD, 2005, ENV HIST, V11, P835; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pauly D, 2005, B MAR SCI, V76, P197; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Pinnegar JK, 2002, J APPL ECOL, V39, P377, DOI 10.1046/j.1365-2664.2002.00723.x; Pinnegar JK, 2008, REV FISH BIOL FISHER, V18, P1, DOI 10.1007/s11160-007-9058-6; Pitcher TJ, 2001, ECOL APPL, V11, P601; Rosenberg AA, 2005, FRONT ECOL ENVIRON, V3, P84, DOI 10.2307/3868514; Saenz-Arroyo A, 2005, FISH FISH, V6, P121, DOI 10.1111/j.1467-2979.2005.00185.x; Saenz-Arroyo A, 2005, P ROY SOC B-BIOL SCI, V272, P1957, DOI 10.1098/rspb.2005.3175; SAEZARROYO A, 2006, FISH FISH, V7, P128; Schrope M, 2006, NATURE, V443, P622, DOI 10.1038/443622a; SENNEBOGEN E, 1997, NEPTUNIA, V12, P137; Vrgo N., 2004, ADRIAMED TECH DOC, V12, P91	38	84	85	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2010	5	11							e15502	10.1371/journal.pone.0015502	http://dx.doi.org/10.1371/journal.pone.0015502			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681OY	21103349	Green Published, Green Submitted, gold			2022-12-25	WOS:000284327800023
J	Vitry, AI; Roughead, EE; Preiss, AK; Ryan, P; Ramsay, EN; Gilbert, AL; Caughey, GE; Shakib, S; Esterman, A; Zhang, Y; McDermott, RA				Vitry, Agnes I.; Roughead, Elizabeth E.; Preiss, Adrian K.; Ryan, Philip; Ramsay, Emmae N.; Gilbert, Andrew L.; Caughey, Gillian E.; Shakib, Sepehr; Esterman, Adrian; Zhang, Ying; McDermott, Robyn A.			Influence of Comorbidities on Therapeutic Progression of Diabetes Treatment in Australian Veterans: A Cohort Study	PLOS ONE			English	Article							CLINICAL INERTIA; GLYCEMIC CONTROL; CARE; INTENSIFICATION; IMPACT	Background: This study assessed whether the number of comorbid conditions unrelated to diabetes was associated with a delay in therapeutic progression of diabetes treatment in Australian veterans. Methodology/Principal Findings: A retrospective cohort study was undertaken using data from the Australian Department of Veterans' Affairs (DVA) claims database between July 2000 and June 2008. The study included new users of metformin or sulfonylurea medicines. The outcome was the time to addition or switch to another antidiabetic treatment. The total number of comorbid conditions unrelated to diabetes was identified using the pharmaceutical-based comorbidity index, Rx-Risk-V. Competing risk regression analyses were conducted, with adjustments for a number of covariates that included age, gender, residential status, use of endocrinology service, number of hospitalisation episodes and adherence to diabetes medicines. Overall, 20134 veterans were included in the study. At one year, 23.5% of patients with diabetes had a second medicine added or had switched to another medicine, with 41.4% progressing by 4 years. The number of unrelated comorbidities was significantly associated with the time to addition of an antidiabetic medicine or switch to insulin (subhazard ratio [SHR] 0.87 [95% CI 0.84-0.91], P<0.001). Depression, cancer, chronic obstructive pulmonary disease, dementia, and Parkinson's disease were individually associated with a decreased likelihood of therapeutic progression. Age, residential status, number of hospitalisations and adherence to anti-diabetic medicines delayed therapeutic progression. Conclusions/Significance: Increasing numbers of unrelated conditions decreased the likelihood of therapeutic progression in veterans with diabetes. These results have implications for the development of quality measures, clinical guidelines and the construction of models of care for management of diabetes in elderly people with comorbidities.	[Vitry, Agnes I.; Roughead, Elizabeth E.; Preiss, Adrian K.; Gilbert, Andrew L.; Caughey, Gillian E.] Univ S Australia, Qual Use Med & Pharm Res Ctr, Sansom Inst Hlth Res, Adelaide, SA 5001, Australia; [Ryan, Philip; Ramsay, Emmae N.; Zhang, Ying] Univ Adelaide, Discipline Publ Hlth, Adelaide, SA, Australia; [Shakib, Sepehr] Royal Adelaide Hosp, Dept Clin Pharmacol, Adelaide, SA 5000, Australia; [Esterman, Adrian] Univ S Australia, Sch Nursing & Midwifery, Sansom Inst Hlth Res, Adelaide, SA 5001, Australia; [McDermott, Robyn A.] Univ S Australia, SA NT Datalink, Sansom Inst Hlth Res, Adelaide, SA 5001, Australia	University of South Australia; University of Adelaide; Royal Adelaide Hospital; Flinders University South Australia; University of South Australia; University of South Australia	Vitry, AI (corresponding author), Univ S Australia, Qual Use Med & Pharm Res Ctr, Sansom Inst Hlth Res, Adelaide, SA 5001, Australia.	agnes.vitry@unisa.edu.au	Esterman, Adrian J/D-1042-2009; Gilbert, Andrew L/C-6892-2009; McDermott, Robyn A/C-5824-2008; Roughead, Elizabeth E/G-4431-2010; Vitry, Agnes I/G-2822-2010; Ramsay, Emmae N/F-4494-2013; Preiss, Adrian K/A-4691-2011; Caughey, Gillian E/A-3041-2011; Zhang, Ying/ABE-2275-2021	Roughead, Elizabeth E/0000-0002-6811-8991; Vitry, Agnes I/0000-0003-1091-6453; Ramsay, Emmae N/0000-0002-8708-5910; Zhang, Ying/0000-0001-6214-2440; Esterman, Adrian/0000-0001-7324-9171; Caughey, Gillian/0000-0003-1192-4121	National Health and Medical Research Council/Australian Research Council [APP ID 401832]	National Health and Medical Research Council/Australian Research Council(Australian Research CouncilNational Health and Medical Research Council (NHMRC) of Australia)	This study was supported by funding from a National Health and Medical Research Council/Australian Research Council Ageing Well Ageing Productively (AWAP) Program grant (APP ID 401832) http://www.nhmrc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AIHW, 2002, HLTH CAR US COSTS CO, P1; Boccuzzi SJ, 2001, DIABETES CARE, V24, P1411, DOI 10.2337/diacare.24.8.1411; Brown AF, 2003, J AM GERIATR SOC, V51, P665, DOI 10.1034/j.1600-0579.2003.00211.x; Chaudhry SI, 2005, J AM GERIATR SOC, V53, P1214, DOI 10.1111/j.1532-5415.2005.53370.x; Colagiuri S, 2009, NATL EVIDENCE BASED; Dailey G, 2002, J INT MED RES, V30, P71, DOI 10.1177/147323000203000111; Davis TME, 2006, MED J AUSTRALIA, V184, P325, DOI 10.5694/j.1326-5377.2006.tb00264.x; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gardarsdottir H, 2010, J CLIN EPIDEMIOL, V63, P422, DOI 10.1016/j.jclinepi.2009.07.001; Grant RW, 2004, DIABETIC MED, V21, P150, DOI 10.1111/j.1464-5491.2004.01095.x; Greenfield S, 2009, ANN INTERN MED, V151, P854, DOI 10.7326/0003-4819-151-12-200912150-00005; Hooper L, 2004, BRIT MED J, V329, P948, DOI 10.1136/bmj.38232.680567.EB; Huang ES, 2008, ANN INTERN MED, V149, P11, DOI 10.7326/0003-4819-149-1-200807010-00005; Lagu T, 2008, J GEN INTERN MED, V23, P1208, DOI 10.1007/s11606-008-0647-4; McEwen LN, 2009, DIABETES CARE, V32, P971, DOI 10.2337/dc08-1911; Nichols Gregory A, 2007, Endocr Pract, V13, P37; Parchman ML, 2007, ANN FAM MED, V5, P196, DOI 10.1370/afm.679; Piette JD, 2006, DIABETES CARE, V29, P725, DOI 10.2337/diacare.29.03.06.dc05-2078; Plat A, 2009, PHARM WORLD SCI, V31, P622, DOI 10.1007/s11096-009-9321-0; *ROYAL AUSTR COLL, 2009, DIAB MAN GEN PRACT G; Sales AE, 2009, J GEN INTERN MED, V24, P1205, DOI 10.1007/s11606-009-1096-4; Selbly JV, 2009, MED CARE, V47, P395, DOI 10.1097/MLR.0b013e31818d775c; Shah BR, 2005, DIABETES CARE, V28, P600, DOI 10.2337/diacare.28.3.600; Turner BJ, 2008, ANN INTERN MED, V148, P578, DOI 10.7326/0003-4819-148-8-200804150-00002; Vitry A, 2009, AUST NZ J PUBL HEAL, V33, P126, DOI 10.1111/j.1753-6405.2009.00357.x; Wetzler HP, 2000, DIABETES CARE, V23, P1637, DOI 10.2337/diacare.23.11.1637	26	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2010	5	11							e14024	10.1371/journal.pone.0014024	http://dx.doi.org/10.1371/journal.pone.0014024			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681OY	21103337	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000284327800010
J	Ma, L; Han, SZ; Yang, J; Da, Y				Ma, Li; Han, Shizhong; Yang, Jing; Da, Yang			Multi-locus Test Conditional on Confirmed Effects Leads to Increased Power in Genome-wide Association Studies	PLOS ONE			English	Article							LOCI	Complex diseases or phenotypes may involve multiple genetic variants and interactions between genetic, environmental and other factors. Current genome-wide association studies (GWAS) mostly used single-locus analysis and had identified genetic effects with multiple confirmations. Such confirmed single-nucleotide polymorphism (SNP) effects were likely to be true genetic effects and ignoring this information in testing new effects of the same phenotype results in decreased statistical power due to increased residual variance that has a component of the omitted effects. In this study, a multi-locus association test (MLT) was proposed for GWAS analysis conditional on SNPs with confirmed effects to improve statistical power. Analytical formulae for statistical power were derived and were verified by simulation for MLT accounting for confirmed SNPs and for single-locus test (SLT) without accounting for confirmed SNPs. Statistical power of the two methods was compared by case studies with simulated and the Framingham Heart Study (FHS) GWAS data. Results showed that the MLT method had increased statistical power over SLT. In the GWAS case study on four cholesterol phenotypes and serum metabolites, the MLT method improved statistical power by 5% to 38% depending on the number and effect sizes of the conditional SNPs. For the analysis of HDL cholesterol (HDL-C) and total cholesterol (TC) of the FHS data, the MLT method conditional on confirmed SNPs from GWAS catalog and NCBI had considerably more significant results than SLT.	[Ma, Li; Yang, Jing; Da, Yang] Univ Minnesota, Dept Anim Sci, St Paul, MN 55108 USA; [Ma, Li] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY USA; [Han, Shizhong] Yale Univ, Sch Med, Dept Psychiat, Div Human Genet, New Haven, CT USA	University of Minnesota System; University of Minnesota Twin Cities; Cornell University; Yale University	Ma, L (corresponding author), Univ Minnesota, Dept Anim Sci, St Paul, MN 55108 USA.	maxxx131@umn.edu; yda@umn.edu	Han, Shizhong/H-5785-2011; Ma, Li/B-1844-2010	Han, Shizhong/0000-0002-5114-6742	Agricultural Experiment Station at the University of Minnesota [MN-16-043]; National Heart, Lung, and Blood Institute (NHLBI); Boston University	Agricultural Experiment Station at the University of Minnesota(University of Minnesota System); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Boston University	This research was supported in part by project MN-16-043 of the Agricultural Experiment Station at the University of Minnesota. The Framingham Heart Study is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with Boston University. This manuscript was not prepared in collaboration with investigators of the Framingham Heart Study and does not necessarily reflect the opinions or views of the Framingham Heart Study, Boston University, or the NHLBI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; JANSEN RC, 1994, GENETICS, V136, P1447; Li Y, 2006, AM J HUM GENET S, VS79, P2290; MA L, 2008, PLANT AN GEN 16 C JA; Ma L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-315; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Development Core Team, 2020, R LANGUAGE ENV STAT; Roeder K, 2006, AM J HUM GENET, V78, P243, DOI 10.1086/500026; Saccone NL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001053; Sandhu MS, 2008, LANCET, V371, P483, DOI 10.1016/S0140-6736(08)60208-1; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; ZENG ZB, 1994, GENETICS, V136, P1457	16	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e15006	10.1371/journal.pone.0015006	http://dx.doi.org/10.1371/journal.pone.0015006			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103364	Green Submitted, Green Published, gold			2022-12-25	WOS:000284257400020
J	Hein, E; Honore, C; Skjoedt, MO; Munthe-Fog, L; Hummelshoj, T; Garred, P				Hein, Estrid; Honore, Christian; Skjoedt, Mikkel-Ole; Munthe-Fog, Lea; Hummelshoj, Tina; Garred, Peter			Functional Analysis of Ficolin-3 Mediated Complement Activation	PLOS ONE			English	Article							MANNAN-BINDING LECTIN; FCN2 GENE; H-FICOLIN; RECOGNITION; DEFICIENCY; POLYMORPHISMS; PROPERDIN; MOLECULE; PATHWAY; INFECTIONS	The recognition molecules of the lectin complement pathway are mannose-binding lectin and Ficolin -1, -2 and -3. Recently deficiency of Ficolin-3 was found to be associated with life threatening infections. Thus, we aimed to develop a functional method based on the ELISA platform for evaluating Ficolin-3 mediated complement activation that could be applicable for research and clinical use. Bovine serum albumin (BSA) was acetylated (acBSA) and chosen as a solid phase ligand for Ficolins in microtiter wells. Binding of Ficolins on acBSA was evaluated, as was functional complement activation assessed by C4, C3 and terminal complement complex (TCC) deposition. Serum Ficolin-3 bound to acBSA in a calcium dependent manner, while only minimal binding of Ficolin-2 and no binding of Ficolin-1 were observed. No binding to normal BSA was seen for any of the Ficolins. Serum C4, C3 and TCC deposition on acBSA were dependent only on Ficolin-3 in appropriate serum dilutions. Deposition of down stream complement components correlated highly significantly with the serum concentration of Ficolin-3 but not with Ficolin-2 in healthy donors. To make the assay robust for clinical use a chemical compound was applied to the samples that inhibited interference from the classical pathway due to the presence of anti-BSA antibodies in some sera. We describe a novel functional method for measuring complement activation mediated by Ficolin-3 in human serum up to the formation of TCC. The assay provides the possibility to diagnose functional and genetic defects of Ficolin-3 and down stream components in the lectin complement pathway.	[Hein, Estrid; Honore, Christian; Skjoedt, Mikkel-Ole; Munthe-Fog, Lea; Hummelshoj, Tina; Garred, Peter] Univ Copenhagen, Fac Hlth Sci, Rigshosp, Lab Mol Med,Dept Clin Immunol, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Hein, E (corresponding author), Univ Copenhagen, Fac Hlth Sci, Rigshosp, Lab Mol Med,Dept Clin Immunol, Copenhagen, Denmark.	garred@post5.tele.dk		Munthe-Fog, Lea/0000-0003-1345-176X; Honore, Christian/0000-0003-4846-1319; Skjodt, Mikkel-Ole/0000-0003-1306-6482; Garred, Peter/0000-0002-2876-8586	Rigshospitalet; The Novo Nordisk Foundation; The Lundbeck Foundation; The Svend Andersen Foundation; The Capital Region of Denmark	Rigshospitalet; The Novo Nordisk Foundation(Novo Nordisk Foundation); The Lundbeck Foundation(Lundbeckfonden); The Svend Andersen Foundation; The Capital Region of Denmark	Funding was obtainet from Rigshospitalet, The Novo Nordisk Foundation, The Lundbeck Foundation, The Svend Andersen Foundation and The Capital Region of Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen DC, 2004, J IMMUNOASS IMMUNOCH, V25, P17, DOI 10.1081/IAS-120027223; Atkinson APM, 2004, CLIN EXP IMMUNOL, V138, P517, DOI 10.1111/j.1365-2249.2004.02634.x; Botto M, 2009, MOL IMMUNOL, V46, P2774, DOI 10.1016/j.molimm.2009.04.029; Cedzynski M, 2004, CLIN EXP IMMUNOL, V136, P304, DOI 10.1111/j.1365-2249.2004.02453.x; Chapman SJ, 2007, MOL IMMUNOL, V44, P3267, DOI 10.1016/j.molimm.2006.04.013; Cruyssen BV, 2007, RHEUMATOLOGY, V46, P1792, DOI 10.1093/rheumatology/kem266; de Messias-Reason I, 2009, J INFECT DIS, V199, P801, DOI 10.1086/597070; FEARON DT, 1975, J EXP MED, V142, P856, DOI 10.1084/jem.142.4.856; Fijen CAP, 1999, MOL IMMUNOL, V36, P863, DOI 10.1016/S0161-5890(99)00107-8; Frederiksen PD, 2005, SCAND J IMMUNOL, V62, P462, DOI 10.1111/j.1365-3083.2005.01685.x; Garcia-Laorden MI, 2006, J ALLERGY CLIN IMMUN, V118, P1383, DOI 10.1016/j.jaci.2006.08.004; Garlatti V, 2007, EMBO J, V26, P623, DOI 10.1038/sj.emboj.7601500; Garred P, 2003, MOL IMMUNOL, V40, P73, DOI 10.1016/S0161-5890(03)00104-4; Garred P, 2010, J INNATE IMMUN, V2, P3, DOI 10.1159/000242419; Honore C, 2008, MOL IMMUNOL, V45, P2782, DOI 10.1016/j.molimm.2008.02.005; Honore C, 2007, ARTHRITIS RHEUM, V56, P1598, DOI 10.1002/art.22564; Honore C, 2010, J LEUKOCYTE BIOL, V88, P145, DOI 10.1189/jlb.1209802; Hummelshoj T, 2005, HUM MOL GENET, V14, P1651, DOI 10.1093/hmg/ddi173; Hummelshoj T, 2008, MOL IMMUNOL, V45, P2508, DOI 10.1016/j.molimm.2008.01.003; Hummelshoj T, 2008, MOL IMMUNOL, V45, P1623, DOI 10.1016/j.molimm.2007.10.006; Hummelshoj T, 2007, MOL IMMUNOL, V44, P401, DOI 10.1016/j.molimm.2006.02.023; Kishore U, 2000, IMMUNOPHARMACOLOGY, V49, P159, DOI 10.1016/S0162-3109(00)80301-X; Krarup A, 2004, J BIOL CHEM, V279, P47513, DOI 10.1074/jbc.M407161200; Kuraya M, 2005, IMMUNOBIOLOGY, V209, P689, DOI 10.1016/j.imbio.2004.11.001; Lacroix M, 2009, J IMMUNOL, V182, P456, DOI 10.4049/jimmunol.182.1.456; Lappegard KT, 2009, P NATL ACAD SCI USA, V106, P15861, DOI 10.1073/pnas.0903613106; Mollnes TE, 2007, MOL IMMUNOL, V44, P3838, DOI 10.1016/j.molimm.2007.06.150; Munthe-Fog L, 2007, SCAND J IMMUNOL, V65, P383, DOI 10.1111/j.1365-3083.2007.01915.x; Munthe-Fog L, 2008, MOL IMMUNOL, V45, P2660, DOI 10.1016/j.molimm.2007.12.012; Munthe-Fog L, 2009, NEW ENGL J MED, V360, P2637, DOI 10.1056/NEJMoa0900381; Olesen HV, 2006, CLIN IMMUNOL, V121, P324, DOI 10.1016/j.clim.2006.08.014; Palarasah Y, 2010, J CLIN MICROBIOL, V48, P908, DOI 10.1128/JCM.01985-09; Roos A, 2003, MOL IMMUNOL, V39, P655, DOI 10.1016/S0161-5890(02)00254-7; Ruskamp JM, 2009, CLIN EXP IMMUNOL, V155, P433, DOI 10.1111/j.1365-2249.2008.03844.x; Schejbel L, 2009, CLIN IMMUNOL, V131, P456, DOI 10.1016/j.clim.2009.02.008; Seelen MA, 2005, J IMMUNOL METHODS, V296, P187, DOI 10.1016/j.jim.2004.11.016; Spitzer D, 2007, J IMMUNOL, V179, P2600, DOI 10.4049/jimmunol.179.4.2600; Sprong T, 2006, BLOOD, V107, P4865, DOI 10.1182/blood-2005-07-2820; Stengaard-Pedersen K, 2003, NEW ENGL J MED, V349, P554, DOI 10.1056/NEJMoa022836; Thiel S, 2007, MOL IMMUNOL, V44, P3875, DOI 10.1016/j.molimm.2007.06.005; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Wittenborn T, 2010, J INNATE IMMUN, V2, P167, DOI 10.1159/000218324	42	50	51	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e15443	10.1371/journal.pone.0015443	http://dx.doi.org/10.1371/journal.pone.0015443			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085669	gold, Green Published, Green Submitted			2022-12-25	WOS:000284036800031
J	Sirichandra, C; Davanture, M; Turk, BE; Zivy, M; Valot, B; Leung, J; Merlot, S				Sirichandra, Caroline; Davanture, Marlene; Turk, Benjamin E.; Zivy, Michel; Valot, Benoit; Leung, Jeffrey; Merlot, Sylvain			The Arabidopsis ABA-Activated Kinase OST1 Phosphorylates the bZIP Transcription Factor ABF3 and Creates a 14-3-3 Binding Site Involved in Its Turnover	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2C; ABSCISIC-ACID; SIGNAL-TRANSDUCTION; NEGATIVE REGULATOR; GENE-EXPRESSION; STOMATAL RESPONSE; STRESS; IDENTIFICATION; CHANNEL; GROWTH	Background: Genetic evidence in Arabidopsis thaliana indicates that members of the Snf1-Related Kinases 2 family (SnRK2) are essential in mediating various stress-adaptive responses. Recent reports have indeed shown that one particular member, OPEN STOMATA (OST) 1, whose kinase activity is stimulated by the stress hormone abscisic acid (ABA), is a direct target of negative regulation by the core ABA co-receptor complex composed of PYR/PYL/RCAR and clade A Protein Phosphatase 2C (PP2C) proteins. Methodology/Principal Findings: Here, the substrate preference of OST1 was interrogated at a genome-wide scale. We phosphorylated in vitro a bank of semi-degenerate peptides designed to assess the relative phosphorylation efficiency on a positionally fixed serine or threonine caused by systematic changes in the flanking amino acid sequence. Our results designate the ABA-responsive-element Binding Factor 3 (ABF3), which controls part of the ABA-regulated transcriptome, as a genuine OST1 substrate. Bimolecular Fluorescence Complementation experiments indicate that ABF3 interacts directly with OST1 in the nuclei of living plant cells. In vitro, OST1 phosphorylates ABF3 on multiple LXRXXpS/T preferred motifs including T451 located in the midst of a conserved 14-3-3 binding site. Using an antibody sensitive to the phosphorylated state of the preferred motif, we further show that ABF3 is phosphorylated on at least one such motif in response to ABA in vivo and that phospho-T451 is important for stabilization of ABF3. Conclusions/Significance: All together, our results suggest that OST1 phosphorylates ABF3 in vivo on T451 to create a 14-3-3 binding motif. In a wider physiological context, we propose that the long term responses to ABA that require sustained gene expression is, in part, mediated by the stabilization of ABFs driven by ABA-activated SnRK2s.	[Sirichandra, Caroline; Leung, Jeffrey; Merlot, Sylvain] CNRS, Inst Sci Vegetal, UPR 2355, Gif Sur Yvette, France; [Davanture, Marlene; Zivy, Michel; Valot, Benoit] Univ Paris 11, CNRS, INRA,Plate Forme Prote PAPPSO, UMR Genet Vegetale,UMR 0320,UMR 8120, Gif Sur Yvette, France; [Davanture, Marlene] Univ Paris 11, CNRS, INRA, La Plante & Son Environm IFR87, Gif Sur Yvette, France; [Turk, Benjamin E.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Yale University	Sirichandra, C (corresponding author), CNRS, Inst Sci Vegetal, UPR 2355, Gif Sur Yvette, France.	jeff.leung@isv.cnrs-gif.fr; sylvain.merlot@ird.fr	Valot, Benoit BV/G-3521-2018	Zivy, Michel/0000-0002-9814-3792; Merlot, Sylvain/0000-0002-9352-1184; Davanture, Marlene/0000-0001-5324-0583	CNRS; French Ministere de l'enseignement superieur et de la recherche; French Ministere des affaires etrangeres et europeennes (Partenariat Hubert Curien/SAKURA) [18721NB]; US National Institutes of Health [R01 GM079498]; Action de Soutien la Technologie et a la Recherche en Essonne (ASTRE) [IFR87 (FR-W2251)]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079498] Funding Source: NIH RePORTER	CNRS(Centre National de la Recherche Scientifique (CNRS)); French Ministere de l'enseignement superieur et de la recherche; French Ministere des affaires etrangeres et europeennes (Partenariat Hubert Curien/SAKURA); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Action de Soutien la Technologie et a la Recherche en Essonne (ASTRE); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the CNRS (SM, JL), a doctoral fellowship from the French Ministere de l'enseignement superieur et de la recherche (CS), financial support from the French Ministere des affaires etrangeres et europeennes (Partenariat Hubert Curien/SAKURA 18721NB to SM), and the US National Institutes of Health (grant R01 GM079498 to BT). The Imaging and Cell Biology facility of the IFR87 (FR-W2251) "La plante et son environnement'' is supported by Action de Soutien la Technologie et a la Recherche en Essonne (ASTRE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belin C, 2006, PLANT PHYSIOL, V141, P1316, DOI 10.1104/pp.106.079327; Boudsocq M, 2004, J BIOL CHEM, V279, P41758, DOI 10.1074/jbc.M405259200; Chen Y, 2010, PLANT J, V63, P1, DOI 10.1111/j.1365-313X.2010.04218.x; Choi HI, 2005, PLANT PHYSIOL, V139, P1750, DOI 10.1104/pp.105.069757; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Coblitz B, 2006, FEBS LETT, V580, P1531, DOI 10.1016/j.febslet.2006.02.014; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Doppler H, 2005, J BIOL CHEM, V280, P15013, DOI 10.1074/jbc.C400575200; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Finkelstein R, 2005, PLANT MOL BIOL, V59, P253, DOI 10.1007/s11103-005-8767-2; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Fujii H, 2007, PLANT CELL, V19, P485, DOI 10.1105/tpc.106.048538; Fujii H, 2009, NATURE, V462, P660, DOI 10.1038/nature08599; Fujii H, 2009, P NATL ACAD SCI USA, V106, P8380, DOI 10.1073/pnas.0903144106; Fujita Y, 2009, PLANT CELL PHYSIOL, V50, P2123, DOI 10.1093/pcp/pcp147; Furihata T, 2006, P NATL ACAD SCI USA, V103, P1988, DOI 10.1073/pnas.0505667103; Garcia ME, 2008, PLANT MOL BIOL, V67, P643, DOI 10.1007/s11103-008-9344-2; Geiger D, 2009, P NATL ACAD SCI USA, V106, P21425, DOI 10.1073/pnas.0912021106; Gosti F, 1999, PLANT CELL, V11, P1897, DOI 10.1105/tpc.11.10.1897; Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; Johnson RR, 2002, PLANT PHYSIOL, V130, P837, DOI 10.1104/pp.001354; Kagaya Y, 2002, PLANT CELL, V14, P3177, DOI 10.1105/tpc.005272; Kim TH, 2010, ANNU REV PLANT BIOL, V61, P561, DOI 10.1146/annurev-arplant-042809-112226; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kline KG, 2010, P NATL ACAD SCI USA, V107, P15986, DOI 10.1073/pnas.1007879107; Kobayashi Y, 2005, PLANT J, V44, P939, DOI 10.1111/j.1365-313X.2005.02583.x; Kwak JM, 2003, EMBO J, V22, P2623, DOI 10.1093/emboj/cdg277; Kwak JM, 2001, PLANT PHYSIOL, V127, P473, DOI 10.1104/pp.010428; Lee SC, 2009, P NATL ACAD SCI USA, V106, P21419, DOI 10.1073/pnas.0910601106; Leonhardt N, 2004, PLANT CELL, V16, P596, DOI 10.1105/tpc.019000; LEUNG J, 1994, SCIENCE, V264, P1448, DOI 10.1126/science.7910981; Li JX, 2000, SCIENCE, V287, P300, DOI 10.1126/science.287.5451.300; Lopez-Molina L, 2001, P NATL ACAD SCI USA, V98, P4782, DOI 10.1073/pnas.081594298; Lopez-Molina L, 2003, GENE DEV, V17, P410, DOI 10.1101/gad.1055803; Lopez-Molina L, 2002, PLANT J, V32, P317, DOI 10.1046/j.1365-313X.2002.01430.x; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; Merlot S, 2001, PLANT J, V25, P295, DOI 10.1046/j.1365-313x.2001.00965.x; MEYER K, 1994, SCIENCE, V264, P1452, DOI 10.1126/science.8197457; Miao YC, 2006, PLANT CELL, V18, P2749, DOI 10.1105/tpc.106.044230; Miyazono K, 2009, NATURE, V462, P609, DOI 10.1038/nature08583; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Nakashima K, 2009, PLANT CELL PHYSIOL, V50, P1345, DOI 10.1093/pcp/pcp083; Negi J, 2008, NATURE, V452, P483, DOI 10.1038/nature06720; Nishimura N, 2010, PLANT J, V61, P290, DOI 10.1111/j.1365-313X.2009.04054.x; Pandey S, 2002, NEW PHYTOL, V153, P517, DOI 10.1046/j.0028-646X.2001.00329.x; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Rubio S, 2009, PLANT PHYSIOL, V150, P1345, DOI 10.1104/pp.109.137174; Saez A, 2004, PLANT J, V37, P354, DOI 10.1046/j.1365-313X.2003.01966.x; Saji S, 2008, PLANT CELL PHYSIOL, V49, P2, DOI 10.1093/pcp/pcm174; Sato A, 2009, BIOCHEM J, V424, P439, DOI 10.1042/BJ20091221; Schoonheim PJ, 2007, PLANT PHYSIOL, V143, P670, DOI 10.1104/pp.106.090159; Schoonheim PJ, 2007, PLANT J, V49, P289, DOI 10.1111/j.1365-313X.2006.02955.x; Shin R, 2007, P NATL ACAD SCI USA, V104, P6460, DOI 10.1073/pnas.0610208104; Sirichandra C, 2009, FEBS LETT, V583, P2982, DOI 10.1016/j.febslet.2009.08.033; Stone SL, 2006, PLANT CELL, V18, P3415, DOI 10.1105/tpc.106.046532; Takahashi Y, 2007, PLANT CELL PHYSIOL, V48, pS159; Ton J, 2009, TRENDS PLANT SCI, V14, P310, DOI 10.1016/j.tplants.2009.03.006; Umezawa T, 2009, P NATL ACAD SCI USA, V106, P17588, DOI 10.1073/pnas.0907095106; Urano K, 2009, PLANT J, V57, P1065, DOI 10.1111/j.1365-313X.2008.03748.x; Vahisalu T, 2008, NATURE, V452, P487, DOI 10.1038/nature06608; Vahisalu T, 2010, PLANT J, V62, P442, DOI 10.1111/j.1365-313X.2010.04159.x; Vlad F, 2008, PLANT J, V55, P104, DOI 10.1111/j.1365-313X.2008.03488.x; Vlad F, 2009, PLANT CELL, V21, P3170, DOI 10.1105/tpc.109.069179; Wasilewska A, 2008, MOL PLANT, V1, P198, DOI 10.1093/mp/ssm022; WEEKES J, 1993, FEBS LETT, V334, P335, DOI 10.1016/0014-5793(93)80706-Z; Wydro M, 2006, ACTA BIOCHIM POL, V53, P289; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yang YZ, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-6; Yin P, 2009, NAT STRUCT MOL BIOL, V16, P1230, DOI 10.1038/nsmb.1730; Yoshida R, 2002, PLANT CELL PHYSIOL, V43, P1473, DOI 10.1093/pcp/pcf188; Yoshida T, 2010, PLANT J, V61, P672, DOI 10.1111/j.1365-313X.2009.04092.x; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976; Zhu SY, 2007, PLANT CELL, V19, P3019, DOI 10.1105/tpc.107.050666	76	150	163	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e13935	10.1371/journal.pone.0013935	http://dx.doi.org/10.1371/journal.pone.0013935			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085673	Green Published, gold, Green Submitted			2022-12-25	WOS:000284036800023
J	Brown, LJ; Alawoki, M; Crawford, ME; Reida, T; Sears, A; Torma, T; Albig, AR				Brown, Leslie J.; Alawoki, Mariam; Crawford, Mary E.; Reida, Tiffany; Sears, Allison; Torma, Tory; Albig, Allan R.			Lipocalin-7 Is a Matricellular Regulator of Angiogenesis	PLOS ONE			English	Article							ENDOTHELIAL-CELL PROLIFERATION; RECEPTOR-LIKE KINASE-1; GROWTH-FACTOR-BETA; B-RELATED PROTEIN; VASCULAR DEVELOPMENT; EXPRESSION; GENE; IDENTIFICATION; MIGRATION; ROLES	Background: Matricellular proteins are extracellular regulators of cellular adhesion, signaling and performing a variety of physiological behaviors such as proliferation, migration and differentiation. Within vascular microenvironments, matricellular proteins exert both positive and negative regulatory cues to vascular endothelium. The relative balance of these matricellular cues is believed to be critical for vascular homeostasis, angiogenesis activation or angiogenesis resolution. However, our knowledge of matricellular proteins within vascular microenvironments and the mechanisms by which these proteins impact vascular function remain largely undefined. The matricellular protein lipocalin-7 (LCN7) is found throughout vascular microenvironments, and circumstantial evidence suggests that LCN7 may be an important regulator of angiogenesis. Therefore, we hypothesized that LCN7 may be an important regulator of vascular function. Methodology and Principal Findings: To test this hypothesis, we examined the effect of LCN7 overexpression, recombinant protein and gene knockdown in a series of in vitro and in vivo models of angiogenesis. We found that overexpression of LCN7 in MB114 and SVEC murine endothelial cell lines or administration of highly purified recombinant LCN7 protein increased endothelial cell invasion. Similarly, LCN7 increased angiogenic sprouting from quiescent endothelial cell monolayers and ex vivo aortic rings. Moreover, LCN7 increased endothelial cell sensitivity to TGF-beta but did not affect sensitivity to other pro-angiogenic growth factors including bFGF and VEGF. Finally, morpholino based knockdown of LCN7 in zebrafish embryos specifically inhibited angiogenic sprouting but did not affect vasculogenesis within injected embryos. Conclusions and Significance: No functional analysis has previously been performed to elucidate the function of LCN7 in vascular or other cellular processes. Collectively, our results show for the first time that LCN7 is an important pro-angiogenic matricellular protein of vascular microenvironments.	[Brown, Leslie J.; Alawoki, Mariam; Crawford, Mary E.; Reida, Tiffany; Sears, Allison; Torma, Tory; Albig, Allan R.] Indiana State Univ, Dept Biol, Terre Haute, IN 47809 USA	Indiana State University	Brown, LJ (corresponding author), Indiana State Univ, Dept Biol, Terre Haute, IN 47809 USA.	allen.albig@indstate.edu			National Institutes of Health [3R15CA133829-01A1S1]; Indiana State University; Indiana State University Research Council [UNR286]; NATIONAL CANCER INSTITUTE [R15CA133829] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana State University; Indiana State University Research Council; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Institutes of Health (# 3R15CA133829-01A1S1), the Indiana State University Promising Scholars Fund, and the Indiana State University Research Council (UNR286) to ARA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albig Allan R., 2007, Angiogenesis, V10, P197, DOI 10.1007/s10456-007-9075-z; Albig AR, 2006, CANCER RES, V66, P2621, DOI 10.1158/0008-5472.CAN-04-4096; Albig AR, 2005, MOL BIOL CELL, V16, P609, DOI 10.1091/mbc.e04-06-0479; Albig AR, 2004, DNA CELL BIOL, V23, P367, DOI 10.1089/104454904323145254; ALBIG AR, 2008, MICROVASC RES; Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; David L, 2007, J CELL PHYSIOL, V213, P484, DOI 10.1002/jcp.21126; Favre CJ, 2003, AM J PHYSIOL-HEART C, V285, pH1917, DOI 10.1152/ajpheart.00983.2002; Fee D, 2000, CYTOKINE, V12, P655, DOI 10.1006/cyto.1999.0599; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; Folkman J, 2003, CURR MOL MED, V3, P643, DOI 10.2174/1566524033479465; Helton R, 2005, J NEUROSCI, V25, P4099, DOI 10.1523/JNEUROSCI.4555-04.2005; Igarashi T, 2009, BIOL REPROD, V81, P948, DOI 10.1095/biolreprod.109.078162; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Kobayashi M, 2001, J STEROID BIOCHEM, V77, P109, DOI 10.1016/S0960-0760(01)00039-5; Lamouille S, 2002, BLOOD, V100, P4495, DOI 10.1182/blood.V100.13.4495; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lebrin F, 2005, CARDIOVASC RES, V65, P599, DOI 10.1016/j.cardiores.2004.10.036; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Lee NY, 2008, J BIOL CHEM, V283, P32527, DOI 10.1074/jbc.M803059200; Li D, 2007, FEBS J, V274, P2506, DOI 10.1111/j.1742-4658.2007.05786.x; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Lutgens SPM, 2007, FASEB J, V21, P3029, DOI 10.1096/fj.06-7924com; Maquart FX, 2004, CRIT REV ONCOL HEMAT, V49, P199, DOI 10.1016/j.critrevonc.2003.06.007; Mettouchi A, 2006, EUR J CELL BIOL, V85, P243, DOI 10.1016/j.ejcb.2005.09.010; Mukai K, 2003, J BIOL CHEM, V278, P17084, DOI 10.1074/jbc.M301477200; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; OCONNELL KA, 1990, J IMMUNOL, V144, P521; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Sottile J, 2004, BBA-REV CANCER, V1654, P13, DOI 10.1016/j.bbcan.2003.07.002; Tajiri Y, 2010, BIOL REPROD, V82, P263, DOI 10.1095/biolreprod.109.080028; Tian MZ, 2009, TRANSL ONCOL, V2, P174, DOI 10.1593/tlo.09145; Tong ZM, 2008, CANCER RES, V68, P6100, DOI 10.1158/0008-5472.CAN-08-0540; Wex T, 2001, BIOCHEMISTRY-US, V40, P1350, DOI 10.1021/bi002266o	39	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e13905	10.1371/journal.pone.0013905	http://dx.doi.org/10.1371/journal.pone.0013905			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085487	Green Submitted, Green Published, gold			2022-12-25	WOS:000284035900013
J	Curchoe, CL; Maurer, J; McKeown, SJ; Cattarossi, G; Cimadamore, F; Nilbratt, M; Snyder, EY; Bronner-Fraser, M; Terskikh, AV				Curchoe, Carol Lynn; Maurer, Jochen; McKeown, Sonja J.; Cattarossi, Giulio; Cimadamore, Flavio; Nilbratt, Mats; Snyder, Evan Y.; Bronner-Fraser, Marianne; Terskikh, Alexey V.			Early Acquisition of Neural Crest Competence During hESCs Neuralization	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HORMONE GNRH CELLS; EXTRACELLULAR-MATRIX; NERVOUS-SYSTEM; AVIAN EMBRYOS; BMP GRADIENT; DANIO-RERIO; IN-VITRO; HUMAN ES; C-RET	Background: Neural crest stem cells (NCSCs) are a transient multipotent embryonic cell population that represents a defining characteristic of vertebrates. The neural crest (NC) gives rise to many derivatives including the neurons and glia of the sensory and autonomic ganglia of the peripheral nervous system, enteric neurons and glia, melanocytes, and the cartilaginous, bony and connective tissue of the craniofacial skeleton, cephalic neuroendocrine organs, and some heart vessels. Methodology/Principal Findings: We present evidence that neural crest (NC) competence can be acquired very early when human embryonic stem cells (hESCs) are selectively neuralized towards dorsal neuroepithelium in the absence of feeder cells in fully defined conditions. When hESC-derived neurospheres are plated on fibronectin, some cells emigrate onto the substrate. These early migratory Neural Crest Stem Cells (emNCSCs) uniformly upregulate Sox10 and vimentin, downregulate N-cadherin, and remodel F-actin, consistent with a transition from neuroepithelium to a mesenchymal NC cell. Over 13% of emNCSCs upregulate CD73, a marker of mesenchymal lineage characteristic of cephalic NC and connexin 43, found on early migratory NC cells. We demonstrated that emNCSCs give rise in vitro to all NC lineages, are multipotent on clonal level, and appropriately respond to developmental factors. We suggest that human emNCSC resemble cephalic NC described in model organisms. Ex vivo emNCSCs can differentiate into neurons in Ret.k(-) mouse embryonic gut tissue cultures and transplanted emNCSCs incorporate into NC-derived structures but not CNS tissues in chick embryos. Conclusions/Significance: These findings will provide a framework for further studying early human NC development including the epithelial to mesenchymal transition during NC delamination.	[Curchoe, Carol Lynn; Maurer, Jochen; Cattarossi, Giulio; Cimadamore, Flavio; Nilbratt, Mats; Snyder, Evan Y.; Terskikh, Alexey V.] Sanford Burnham Inst Med Res, La Jolla, CA USA; [McKeown, Sonja J.; Bronner-Fraser, Marianne] CALTECH, Pasadena, CA 91125 USA	Sanford Burnham Prebys Medical Discovery Institute; California Institute of Technology	Curchoe, CL (corresponding author), Sanford Burnham Inst Med Res, La Jolla, CA USA.	terskikh@burnham.org	Maurer, Jochen/G-4832-2018; Terskikh, Alexey/U-8407-2019; Curchoe, Carol/AAL-6318-2021	Maurer, Jochen/0000-0003-3962-3128; Bronner, Marianne/0000-0003-4274-1862; McKeown, Sonja/0000-0002-7318-116X; Cimadamore, Flavio/0000-0002-3649-0545	California Institute for Regenerative Medicine Seed [RS1-00466-1]	California Institute for Regenerative Medicine Seed	Funded by California Institute for Regenerative Medicine Seed grant RS1-00466-1 to Alexey V. Terskikh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DJ, 1997, COLD SPRING HARB SYM, V62, P493; Anderson RB, 2006, ADV EXP MED BIOL, V589, P181; Bajpai R, 2009, CELL DEATH DIFFER, V16, P807, DOI 10.1038/cdd.2009.18; Bannerman P, 2000, J NEUROSCI RES, V61, P605, DOI 10.1002/1097-4547(20000915)61:6<605::AID-JNR4>3.0.CO;2-U; Barembaum M, 2005, SEMIN CELL DEV BIOL, V16, P642, DOI 10.1016/j.semcdb.2005.06.006; BAROFFIO A, 1988, P NATL ACAD SCI USA, V85, P5325, DOI 10.1073/pnas.85.14.5325; Basch ML, 2006, NATURE, V441, P218, DOI 10.1038/nature04684; Bobola N, 2008, GENESIS, V46, P52, DOI 10.1002/dvg.20360; Bronner-Fraser M, 2002, J PHYSIOLOGY-PARIS, V96, P3, DOI 10.1016/S0928-4257(01)00074-2; Bronner-Fraser Marianne, 2003, Harvey Lect, V99, P129; BRONNERFRASER M, 1986, DEV BIOL, V115, P44, DOI 10.1016/0012-1606(86)90226-5; Burstyn-Cohen T, 2004, DEVELOPMENT, V131, P5327, DOI 10.1242/dev.01424; Carmona-Fontaine C, 2007, DEV BIOL, V309, P208, DOI 10.1016/j.ydbio.2007.07.006; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Cheung M, 2003, DEVELOPMENT, V130, P5681, DOI 10.1242/dev.00808; Colleoni S, 2010, EXP CELL RES, V316, P1148, DOI 10.1016/j.yexcr.2010.02.013; Creuzet S, 2005, J ANAT, V207, P447, DOI 10.1111/j.1469-7580.2005.00485.x; Dottori M, 2001, DEVELOPMENT, V128, P4127; Duband JL, 2006, ADV EXP MED BIOL, V589, P45; Durbec PL, 1996, DEVELOPMENT, V122, P349; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Engler A. J., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P335; Even-Ram S, 2006, CELL, V126, P645, DOI 10.1016/j.cell.2006.08.008; Fang D, 2006, STEM CELLS, V24, P1668, DOI 10.1634/stemcells.2005-0414; Garcia-Castro MI, 2002, SCIENCE, V297, P848, DOI 10.1126/science.1070824; Gossrau G, 2007, STEM CELLS, V25, P939, DOI 10.1634/stemcells.2006-0299; Grillet N, 2003, J NEUROSCI, V23, P10613; Hearn CJ, 1999, DEV DYNAM, V214, P239, DOI 10.1002/(SICI)1097-0177(199903)214:3<239::AID-AJA7>3.0.CO;2-O; Henderson DJ, 1997, J ANAT, V191, P507, DOI 10.1046/j.1469-7580.1997.19140507.x; Hong CS, 2007, MOL BIOL CELL, V18, P2192, DOI 10.1091/mbc.E06-11-1047; Ido A, 2006, DEV DYNAM, V235, P361, DOI 10.1002/dvdy.20635; JIANG X, 2008, STEM CELLS DEV; Kawaguchi J, 2010, DEVELOPMENT, V137, P693, DOI 10.1242/dev.046896; Kleber M, 2005, J CELL BIOL, V169, P309, DOI 10.1083/jcb.200411095; Knecht AK, 2002, NAT REV GENET, V3, P453, DOI 10.1038/nrg819; LaBonne C, 1999, ANNU REV CELL DEV BI, V15, P81, DOI 10.1146/annurev.cellbio.15.1.81; LaBonne C, 1998, DEVELOPMENT, V125, P2403; Lang D, 2000, J CLIN INVEST, V106, P963, DOI 10.1172/JCI10828; Lazzari G, 2006, STEM CELLS, V24, P2514, DOI 10.1634/stemcells.2006-0149; Le Douarin NM, 2008, CELL CYCLE, V7, P1013, DOI 10.4161/cc.7.8.5641; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; Marchant L, 1998, DEV BIOL, V198, P319, DOI 10.1006/dbio.1998.8902; Marsot-Dupuch K, 2004, AM J NEURORADIOL, V25, P285; Maurer J, 2007, DIFFERENTIATION, V75, P580, DOI 10.1111/j.1432-0436.2007.00164.x; McKeown SJ, 2003, DEV BIOL, V255, P62, DOI 10.1016/S0012-1606(02)00076-3; Meulemans D, 2004, DEV CELL, V7, P291, DOI 10.1016/j.devcel.2004.08.007; Mizuseki K, 2003, P NATL ACAD SCI USA, V100, P5828, DOI 10.1073/pnas.1037282100; Monsoro-Burq AH, 2005, DEV CELL, V8, P167, DOI 10.1016/j.devcel.2004.12.017; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; Newgreen DF, 1996, DEV BIOL, V176, P300, DOI 10.1006/dbio.1996.0135; NEWGREEN DF, 1985, CELL TISSUE RES, V239, P329; Nikopoulos GN, 2007, STEM CELLS, V25, P3133, DOI 10.1634/stemcells.2007-0327; O'Rahilly R, 2007, J ANAT, V211, P335, DOI 10.1111/j.1469-7580.2007.00773.x; Paratore C, 2001, DEVELOPMENT, V128, P3949; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Pla P, 2001, J CELL PHYSIOL, V189, P121, DOI 10.1002/jcp.10008; POMP O, 2005, STEM CELLS; PORTIER MM, 1984, DEV NEUROSCI-BASEL, V6, P335, DOI 10.1159/000112360; Raible DW, 2006, CURR OPIN CELL BIOL, V18, P698, DOI 10.1016/j.ceb.2006.09.003; Rao MS, 1997, J NEUROBIOL, V32, P722, DOI 10.1002/(SICI)1097-4695(19970620)32:7<722::AID-NEU7>3.0.CO;2-6; Relaix F, 2004, GENE DEV, V18, P1088, DOI 10.1101/gad.301004; Sakai D, 2006, DEVELOPMENT, V133, P1323, DOI 10.1242/dev.02297; Sander M, 2000, GENE DEV, V14, P2134, DOI 10.1101/gad.820400; Sato T, 2005, DEVELOPMENT, V132, P2355, DOI 10.1242/dev.01823; Selleck MAJ, 1998, DEVELOPMENT, V125, P4919; SERBEDZIJA GN, 1989, DEVELOPMENT, V106, P809; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; Shoval I, 2007, DEVELOPMENT, V134, P491, DOI 10.1242/dev.02742; Stanke M, 1999, DEVELOPMENT, V126, P4087; Tagra Sunita, 2006, Indian J Dermatol Venereol Leprol, V72, P326; Taneyhill LA, 2005, MOL BIOL CELL, V16, P5283, DOI 10.1091/mbc.E05-03-0210; Thomas S, 2008, HUM MOL GENET, V17, P3411, DOI 10.1093/hmg/ddn235; Tribulo C, 2003, DEVELOPMENT, V130, P6441, DOI 10.1242/dev.00878; Wakamatsu Y, 1997, DEVELOPMENT, V124, P3449; Whitlock KE, 2003, DEV BIOL, V257, P140, DOI 10.1016/S0012-1606(03)00039-3; Whitlock KE, 2005, DEVELOPMENT, V132, P5491, DOI 10.1242/dev.02158; Wilson YM, 2004, DEVELOPMENT, V131, P6153, DOI 10.1242/dev.01533; Wong CE, 2006, J CELL BIOL, V175, P1005, DOI 10.1083/jcb.200606062; Yoshida S, 2006, STEM CELLS, V24, P2714, DOI 10.1634/stemcells.2006-0156; Yu HS, 2002, J BIOMED SCI, V9, P564, DOI 10.1159/000037283	80	63	66	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e13890	10.1371/journal.pone.0013890	http://dx.doi.org/10.1371/journal.pone.0013890			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085480	Green Published, gold, Green Accepted			2022-12-25	WOS:000284035900007
J	Doitsidou, M; Poole, RJ; Sarin, S; Bigelow, H; Hobert, O				Doitsidou, Maria; Poole, Richard J.; Sarin, Sumeet; Bigelow, Henry; Hobert, Oliver			C. elegans Mutant Identification with a One-Step Whole-Genome-Sequencing and SNP Mapping Strategy	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS	Whole-genome sequencing (WGS) is becoming a fast and cost-effective method to pinpoint molecular lesions in mutagenized genetic model systems, such as Caenorhabditis elegans. As mutagenized strains contain a significant mutational load, it is often still necessary to map mutations to a chromosomal interval to elucidate which of the WGS-identified sequence variants is the phenotype-causing one. We describe here our experience in setting up and testing a simple strategy that incorporates a rapid SNP-based mapping step into the WGS procedure. In this strategy, a mutant retrieved from a genetic screen is crossed with a polymorphic C. elegans strain, individual F2 progeny from this cross is selected for the mutant phenotype, the progeny of these F2 animals are pooled and then whole-genome-sequenced. The density of polymorphic SNP markers is decreased in the region of the phenotype-causing sequence variant and therefore enables its identification in the WGS data. As a proof of principle, we use this strategy to identify the molecular lesion in a mutant strain that produces an excess of dopaminergic neurons. We find that the molecular lesion resides in the Pax-6/Eyeless ortholog vab-3. The strategy described here will further reduce the time between mutant isolation and identification of the molecular lesion.	[Doitsidou, Maria; Poole, Richard J.; Sarin, Sumeet; Bigelow, Henry; Hobert, Oliver] Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Med Ctr, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Doitsidou, M (corresponding author), Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Med Ctr, New York, NY 10032 USA.	md2398@columbia.edu; or38@columbia.edu		Hobert, Oliver/0000-0002-7634-2854; Poole, Richard/0000-0001-6414-2479	Howard Hughes Medical Institute; National Institutes of Health	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the Howard Hughes Medical Institute and the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bigelow H, 2009, NAT METHODS, V6, P549, DOI 10.1038/nmeth.f.260; CHISHOLM AD, 1995, NATURE, V377, P52, DOI 10.1038/377052a0; Davis MW, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-118; Doitsidou M, 2008, NAT METHODS, V5, P869, DOI 10.1038/NMETH.1250; Flowers EB, 2010, DEVELOPMENT, V137, P1799, DOI 10.1242/dev.046219; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; HOBERT O, 2010, GENETICS IN PRESS; Hodgkin J, 1997, GENETICS, V146, P149; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Rockman MV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000419; Sarin S, 2008, NAT METHODS, V5, P865, DOI 10.1038/NMETH.1249; Sarin S, 2010, GENETICS, V185, P417, DOI 10.1534/genetics.110.116319; Schneeberger K, 2009, NAT METHODS, V6, P550, DOI 10.1038/nmeth0809-550; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; WILLIAMS BD, 1992, GENETICS, V131, P609; Zuryn S, 2010, GENETICS, V186, P427, DOI 10.1534/genetics.110.119230	17	146	149	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e15435	10.1371/journal.pone.0015435	http://dx.doi.org/10.1371/journal.pone.0015435			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	676NU	21079745	Green Published, Green Submitted, gold			2022-12-25	WOS:000283920000025
J	Iken, K; Konar, B; Benedetti-Cecchi, L; Cruz-Motta, JJ; Knowlton, A; Pohle, G; Mead, A; Miloslavich, P; Wong, M; Trott, T; Mieszkowska, N; Riosmena-Rodriguez, R; Airoldi, L; Kimani, E; Shirayama, Y; Fraschetti, S; Ortiz-Touzet, M; Silva, A				Iken, Katrin; Konar, Brenda; Benedetti-Cecchi, Lisandro; Jose Cruz-Motta, Juan; Knowlton, Ann; Pohle, Gerhard; Mead, Angela; Miloslavich, Patricia; Wong, Melisa; Trott, Thomas; Mieszkowska, Nova; Riosmena-Rodriguez, Rafael; Airoldi, Laura; Kimani, Edward; Shirayama, Yoshihisa; Fraschetti, Simonetta; Ortiz-Touzet, Manuel; Silva, Angelica			Large-Scale Spatial Distribution Patterns of Echinoderms in Nearshore Rocky Habitats	PLOS ONE			English	Article							SEA STARS ECHINODERMATA; SPECIES-DIVERSITY; LATITUDINAL GRADIENTS; TAXONOMIC DISTINCTNESS; BIODIVERSITY PATTERNS; PARACENTROTUS-LIVIDUS; LYTECHINUS-VARIEGATUS; BENTHIC COMMUNITIES; ARBACIA-LIXULA; ASSEMBLAGES	This study examined echinoderm assemblages from nearshore rocky habitats for large-scale distribution patterns with specific emphasis on identifying latitudinal trends and large regional hotspots. Echinoderms were sampled from 76 globally-distributed sites within 12 ecoregions, following the standardized sampling protocol of the Census of Marine Life NaGISA project (www.nagisa.coml.org). Sample-based species richness was overall low (<1-5 species per site), with a total of 32 asteroid, 18 echinoid, 21 ophiuroid, and 15 holothuroid species. Abundance and species richness in intertidal assemblages sampled with visual methods (organisms >2 cm in 1 m(2) quadrats) was highest in the Caribbean ecoregions and echinoids dominated these assemblages with an average of 5 ind m(-2). In contrast, intertidal echinoderm assemblages collected from clearings of 0.0625 m(2) quadrats had the highest abundance and richness in the Northeast Pacific ecoregions where asteroids and holothurians dominated with an average of 14 ind 0.0625 m(-2). Distinct latitudinal trends existed for abundance and richness in intertidal assemblages with declines from peaks at high northern latitudes. No latitudinal trends were found for subtidal echinoderm assemblages with either sampling technique. Latitudinal gradients appear to be superseded by regional diversity hotspots. In these hotspots echinoderm assemblages may be driven by local and regional processes, such as overall productivity and evolutionary history. We also tested a set of 14 environmental variables (six natural and eight anthropogenic) as potential drivers of echinoderm assemblages by ecoregions. The natural variables of salinity, sea-surface temperature, chlorophyll a, and primary productivity were strongly correlated with echinoderm assemblages; the anthropogenic variables of inorganic pollution and nutrient contamination also contributed to correlations. Our results indicate that nearshore echinoderm assemblages appear to be shaped by a network of environmental and ecological processes, and by the differing responses of various echinoderm taxa, making generalizations about the patterns of nearshore rocky habitat echinoderm assemblages difficult.	[Iken, Katrin; Konar, Brenda; Knowlton, Ann] Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Fairbanks, AK USA; [Benedetti-Cecchi, Lisandro] Univ Pisa, Dept Biol, Pisa, Italy; [Jose Cruz-Motta, Juan; Miloslavich, Patricia] Univ Simon Bolivar, Ctr Biodiversidad Marina, Dept Estudios Ambientales, Caracas, Venezuela; [Pohle, Gerhard] Huntsman Marine Sci Ctr, Atlantic Reference Ctr, St Andrews, NB, Canada; [Mead, Angela] Univ Cape Town, Dept Zool, ZA-7700 Rondebosch, South Africa; [Wong, Melisa; Silva, Angelica] Bedford Inst Oceanog, Dartmouth, NS, Canada; [Trott, Thomas] Suffolk Univ, Dept Biol, Boston, MA 02114 USA; [Mieszkowska, Nova] Marine Biol Assoc UK, Plymouth, Devon, England; [Riosmena-Rodriguez, Rafael] Univ Bologna, Ctr Interdipartimentale Ric Sci Ambientali, Ravenna, Italy; [Airoldi, Laura] Kenya Marine & Fisheries Res Inst, Mombasa, Kenya; [Kimani, Edward] Univ Autonoma Baja California Sur, Dept Biol Marina, Programa Invest Bot Marina, La Paz, Baja Calif Sur, Mexico; [Shirayama, Yoshihisa] Kyoto Univ, Seto Marine Biol Lab, Wakayama, Japan; [Fraschetti, Simonetta] Univ Salento, Dipartimento Sci & Tecnol Biol & Ambientali, Lab Zool & Biol Marina, Lecce, Italy; [Ortiz-Touzet, Manuel] Univ La Habana, Ctr Invest Marinas, Havana, Cuba	University of Alaska System; University of Alaska Fairbanks; University of Pisa; Simon Bolivar University; University of Cape Town; Bedford Institute of Oceanography; Suffolk University; Marine Biological Association United Kingdom; University of Bologna; Universidad Autonoma de Baja California; Kyoto University; University of Salento; Universidad de la Habana	Iken, K (corresponding author), Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Fairbanks, AK USA.	iken@ims.uaf.edu	Benedetti-Cecchi, Lisandro/J-8225-2019; Mieszkowska, Nova/U-8479-2019; Fraschetti, Simonetta/R-8716-2019; Trott, Thomas J/N-4660-2018; Airoldi, Laura/I-3553-2019; Silva, Angelica J/GRO-4906-2022	Benedetti-Cecchi, Lisandro/0000-0001-5244-5202; Mieszkowska, Nova/0000-0002-9570-7759; Fraschetti, Simonetta/0000-0002-1780-1651; Trott, Thomas J/0000-0002-1851-5243; Airoldi, Laura/0000-0001-5046-0871; Cruz Motta, Juan Jose/0000-0001-6117-9014; Miloslavich, Patricia/0000-0001-5409-1401	Alfred P. Sloan Foundation; History of the Near Shore program; Suffolk University, Boston, Massachusetts, USA; Department of Fisheries and Oceans Canada; University of Bologna; Nippon Foundation; Japan Society for Promotion of Science; Gulf Ecosystem Monitoring Program; US Minerals Management Service; NERC [mba010003] Funding Source: UKRI; Natural Environment Research Council [mba010003] Funding Source: researchfish	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); History of the Near Shore program; Suffolk University, Boston, Massachusetts, USA; Department of Fisheries and Oceans Canada; University of Bologna; Nippon Foundation(Nippon Foundation); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Gulf Ecosystem Monitoring Program; US Minerals Management Service; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding: We would like to express our most sincere gratitude to the Alfred P. Sloan Foundation for funding. Support from the History of the Near Shore program was instrumental for collections in South Africa (AM), United Kingdom (NM), and Maine, USA (TT). For sampling in Maine, logistical support in the field and financial aid for data collection and processing was also provided by Suffolk University, Boston, Massachusetts, USA to TT. Collections at Canso, Canada were support by the Department of Fisheries and Oceans Canada to MS and AS. Collections at Conero Riviera, Italy were supported by the AdriaBio project (University of Bologna Strategic Project, 2007-2009) to LA. Support for sites in Japan was provided by the Nippon Foundation, Japan Society for Promotion of Science to YS. Funding for data collection in the Gulf of Alaska came from the Gulf Ecosystem Monitoring Program to BK and KI. Sampling in the Arctic was supported by the US Minerals Management Service to KI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDESSI L, 1994, ECOL APPL, V4, P786, DOI 10.2307/1942008; Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; Allen AP, 2006, P NATL ACAD SCI USA, V103, P9130, DOI 10.1073/pnas.0603587103; Allen AP, 2002, SCIENCE, V297, P1545, DOI 10.1126/science.1072380; Ambrose WG, 2001, MAR BIOL, V139, P937; Aronson RB, 2001, AM ZOOL, V41, P27, DOI 10.1668/0003-1569(2001)041[0027:GCCATO]2.0.CO;2; Barnes DKA, 1999, J MAR BIOL ASSOC UK, V79, P401, DOI 10.1017/S0025315498000514; Barnes DKA, 2003, MAR ECOL PROG SER, V259, P17, DOI 10.3354/meps259017; Barnes DKA, 2002, P ROY SOC B-BIOL SCI, V269, P2061, DOI 10.1098/rspb.2002.2105; BEAUCHAMP KA, 1982, MAR ENVIRON RES, V7, P279, DOI 10.1016/0141-1136(82)90020-4; Beck MW., 2003, ISSUES ECOL, V11, P1; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Benedetti-Cecchi L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012946; BENEDETTICECCHI L, 1995, MAR ECOL PROG SER, V126, P203, DOI 10.3354/meps126203; Benkendorff K, 2005, T ROY SOC SOUTH AUST, V129, P145; BILLETT DSM, 1991, OCEANOGR MAR BIOL, V29, P259; BLAKE DB, 1990, B MAR SCI, V46, P701; Blanchette CA, 2009, PROG OCEANOGR, V83, P107, DOI 10.1016/j.pocean.2009.07.038; BOLTON JJ, 1994, BOT MAR, V37, P241, DOI 10.1515/botm.1994.37.3.241; Brandt A, 2007, NATURE, V447, P307, DOI 10.1038/nature05827; BREY T, 1994, NATURE, V368, P297, DOI 10.1038/368297a0; Brickley PJ, 2004, DEEP-SEA RES PT II, V51, P229, DOI 10.1016/j.dsr2.2003.06.003; BUSTAMANTE RH, 1995, OECOLOGIA, V102, P189, DOI 10.1007/BF00333251; Carr ME, 2001, DEEP-SEA RES PT II, V49, P59; CHAPMAN ARO, 1981, MAR BIOL, V62, P307, DOI 10.1007/BF00397697; Chenelot Heloise, 2007, V8, P11; Chiarucci A, 2008, COMMUNITY ECOL, V9, P121, DOI 10.1556/ComEc.9.2008.1.14; Cintra-Buenrostro CE, 2005, REV BIOL TROP, V53, P245; Clarke A, 2004, ANTARCT SCI, V16, P559, DOI 10.1017/S0954102004002329; Clarke A, 2006, P ROY SOC B-BIOL SCI, V273, P2257, DOI 10.1098/rspb.2006.3545; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Coates M, 1998, GLOBAL ECOL BIOGEOGR, V7, P115, DOI 10.2307/2997814; CONNELL JH, 1964, AM NAT, V98, P399, DOI 10.1086/282335; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Coteur G, 2001, MAR POLLUT BULL, V42, P667, DOI 10.1016/S0025-326X(01)00063-7; Crame J. Alistair, 2001, Diversity and Distributions, V7, P175, DOI 10.1111/j.1472-4642.2001.00106.x; Crame JA, 2002, PALEOBIOLOGY, V28, P184; CRUZMOTTA JJ, 2010, PLOS ONE IN PRESS; DAFNI J, 1980, J EXP MAR BIOL ECOL, V47, P259, DOI 10.1016/0022-0981(80)90043-X; Dafni J., 2008, AQABA EILAT IMPROBAB, P225; De Domenico F, 2006, ANTARCT SCI, V18, P655, DOI 10.1017/S095410200600068X; Dimech M, 2002, B MAR SCI, V71, P1309; Dulvy NK, 2003, FISH FISH, V4, P25, DOI 10.1046/j.1467-2979.2003.00105.x; Ebert T.A., 1983, Echinoderm Studies, V1, P169; Edmunds PJ, 2001, P NATL ACAD SCI USA, V98, P5067, DOI 10.1073/pnas.071524598; Ellingsen KE, 2002, J ANIM ECOL, V71, P373, DOI 10.1046/j.1365-2656.2002.00606.x; Ellis JR, 2000, J MAR BIOL ASSOC UK, V80, P127, DOI 10.1017/S0025315499001642; ENGEMAN RM, 1994, ECOLOGY, V75, P1769, DOI 10.2307/1939636; ESTES JA, 1974, SCIENCE, V185, P1058, DOI 10.1126/science.185.4156.1058; FRANCOUR P, 1994, MAR POLLUT BULL, V28, P523, DOI 10.1016/0025-326X(94)90071-X; Fraser RH, 1996, AM NAT, V148, P138, DOI 10.1086/285915; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Gray JS, 1997, BIODIVERS CONSERV, V6, P153, DOI 10.1023/A:1018335901847; Gray JS, 2001, POLAR BIOL, V24, P633, DOI 10.1007/s003000100244; Gray JS, 2000, J EXP MAR BIOL ECOL, V250, P23, DOI 10.1016/S0022-0981(00)00178-7; Guidetti P, 2007, MAR ENVIRON RES, V63, P168, DOI 10.1016/j.marenvres.2006.08.002; Guidetti P, 2005, MAR BIOL, V147, P797, DOI 10.1007/s00227-005-1611-z; Guidetti P, 2007, MAR ECOL PROG SER, V335, P43, DOI 10.3354/meps335043; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Harrold C., 1987, Echinoderm Studies, V2, P137; Hickman Cleveland P. Jr., 2009, Galapagos Research, V66, P32; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Huston MA, 1999, OIKOS, V86, P393, DOI 10.2307/3546645; Iken K, 2001, PROG OCEANOGR, V50, P383, DOI 10.1016/S0079-6611(01)00062-3; Jennings LB, 2010, MAR BIOL, V157, P307, DOI 10.1007/s00227-009-1318-7; KENDALL MA, 1993, J EXP MAR BIOL ECOL, V172, P157, DOI 10.1016/0022-0981(93)90095-6; Kilpatrick KA, 2001, J GEOPHYS RES-OCEANS, V106, P9179, DOI 10.1029/1999JC000065; KOBAYASHI N, 1977, PUBL SETO MAR BIOL, V24, P9; KONAR B, 2010, PLOS ONE IN PRESS; Konar B, 2009, MAR ECOL-EVOL PERSP, V30, P63, DOI 10.1111/j.1439-0485.2008.00259.x; Kotwicki L, 2005, BIODIVERS CONSERV, V14, P461, DOI 10.1007/10531-004-6272-6; Kuklinski P, 2006, MAR BIOL, V149, P1577, DOI 10.1007/s00227-006-0311-7; LEIGH EG, 1987, P NATL ACAD SCI USA, V84, P1314, DOI 10.1073/pnas.84.5.1314; Lindeboom H, 2002, OCEANS 2020: SCIENCE TRENDS AND THE CHALLENGE OF SUSTAINABILITY, P49; Magurran Anne E., 2009, MEASURING BIOL DIVER; McClain CR, 2004, DEEP-SEA RES PT II, V51, P5, DOI 10.1016/j.dsr2.2003.11.001; MCCLANAHAN TR, 1990, OECOLOGIA, V83, P362, DOI 10.1007/BF00317561; MCCLINTOCK JB, 1986, PSZNI MAR ECOL, V7, P321, DOI 10.1111/j.1439-0485.1986.tb00167.x; Menge BA, 1997, P NATL ACAD SCI USA, V94, P14530, DOI 10.1073/pnas.94.26.14530; Miller AW, 2000, MAR ECOL PROG SER, V196, P1, DOI 10.3354/meps196001; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; Neira R, 2005, REV BIOL TROP, V53, P195; O'Hara TD, 2000, J BIOGEOGR, V27, P1321, DOI 10.1046/j.1365-2699.2000.00499.x; Okuda T, 2004, POPUL ECOL, V46, P159, DOI 10.1007/s10144-004-0185-9; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; PAINE RT, 1974, OECOLOGIA, V15, P93, DOI 10.1007/BF00345739; Pancucci M.A, 1993, QUANTIFIED PHENOTYPI, P247; PEARSE JS, 2009, J CORAL REEF STUD, V11, P1; PIANKA ER, 1966, AM NAT, V100, P33, DOI 10.1086/282398; Piepenburg D, 1997, POLAR BIOL, V17, P305, DOI 10.1007/PL00013372; PIEPENBURG D, 1995, MAR ECOL PROG SER, V118, P199, DOI 10.3354/meps118199; POORE GCB, 1993, NATURE, V361, P597, DOI 10.1038/361597a0; PORTER JW, 1972, AM NAT, V106, P487, DOI 10.1086/282789; PRICE ARG, 1982, J NAT HIST, V16, P519, DOI 10.1080/00222938200770421; Price ARG, 1999, BIOL J LINN SOC, V66, P187, DOI 10.1111/j.1095-8312.1999.tb01883.x; REX MA, 1993, NATURE, V365, P636, DOI 10.1038/365636a0; RIGBY PR, 2007, SAMPLING DIVERSITY C; Rivadeneira MM, 2002, MAR ECOL PROG SER, V245, P123, DOI 10.3354/meps245123; ROHDE K, 1992, OIKOS, V65, P514, DOI 10.2307/3545569; ROLLER RA, 1993, MAR BIOL, V116, P583, DOI 10.1007/BF00355477; Ronnback P, 2007, AMBIO, V36, P534, DOI 10.1579/0044-7447(2007)36[534:EGASFS]2.0.CO;2; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rowe FWE, 2004, J NAT HIST, V38, P3273, DOI 10.1080/002229301695105; Roy K, 2000, P ROY SOC B-BIOL SCI, V267, P293, DOI 10.1098/rspb.2000.0999; Sala E, 1998, OIKOS, V82, P425, DOI 10.2307/3546364; SAMMARCO PW, 1980, J EXP MAR BIOL ECOL, V45, P245, DOI 10.1016/0022-0981(80)90061-1; Santelices Bernabe, 1998, Diversity and Distributions, V4, P71, DOI 10.1046/j.1472-4642.1998.00005.x; Schoch GC, 2006, LIMNOL OCEANOGR, V51, P2564, DOI 10.4319/lo.2006.51.6.2564; SMITH EP, 1985, HYDROBIOLOGIA, V120, P167, DOI 10.1007/BF00032138; Sokal R. R., 2012, BIOMETRY; SOUSA WP, 1981, OECOLOGIA, V48, P297, DOI 10.1007/BF00346486; STARR M, 1993, CAN J FISH AQUAT SCI, V50, P894, DOI 10.1139/f93-103; Stickle W.B., 1987, Echinoderm Studies, V2, P235; Thompson RC, 2002, ENVIRON CONSERV, V29, P168, DOI 10.1017/S0376892902000115; Tsujino M, 2010, POPUL ECOL, V52, P171, DOI 10.1007/s10144-009-0150-8; UNDERWOOD AJ, 1989, PATTERNS PROCESSES H, P351; Vazquez-Dominguez E, 2003, REV BIOL TROP, V51, P183; Vidolin D, 2007, J MAR BIOL ASSOC UK, V87, P769, DOI 10.1017/S0025315407054124; Viejo RM, 2009, MAR ECOL PROG SER, V390, P55, DOI 10.3354/meps08171; Warwick RM, 1995, MAR ECOL PROG SER, V129, P301, DOI 10.3354/meps129301; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Witman JD, 2004, P NATL ACAD SCI USA, V101, P15664, DOI 10.1073/pnas.0404300101; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; WRIGHT DH, 1983, OIKOS, V41, P496, DOI 10.2307/3544109; Wulff A, 2009, BOT MAR, V52, P491, DOI 10.1515/BOT.2009.072; Zacharias MA, 2001, J BIOGEOGR, V28, P471, DOI 10.1046/j.1365-2699.2001.00559.x	127	31	34	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2010	5	11							e13845	10.1371/journal.pone.0013845	http://dx.doi.org/10.1371/journal.pone.0013845			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675OD	21079760	Green Published, gold			2022-12-25	WOS:000283839100006
J	Akagi, T; Thoennissen, NH; George, A; Crooks, G; Song, JH; Okamoto, R; Nowak, D; Gombart, AF; Koeffler, HP				Akagi, Tadayuki; Thoennissen, Nils H.; George, Ann; Crooks, Gay; Song, Jee Hoon; Okamoto, Ryoko; Nowak, Daniel; Gombart, Adrian F.; Koeffler, H. Phillip			In Vivo Deficiency of Both C/EBP beta and C/EBP epsilon Results in Highly Defective Myeloid Differentiation and Lack of Cytokine Response	PLOS ONE			English	Article							BINDING-PROTEIN-ALPHA; TRANSCRIPTION FACTOR; GENE LOCUS; EXPRESSION; GRANULOCYTE; MUTATIONS; MACROPHAGES; SUFFICIENT; INDUCTION; ABSENCE	The CCAAT/enhancer binding proteins (C/EBPs) are transcription factors involved in hematopoietic cell development and induction of several inflammatory mediators. Here, we generated C/EBP beta and C/EBP epsilon double-knockout (bbee) mice and compared their phenotypes to those of single deficient (bbEE and BBee) and wild-type (BBEE) mice. The bbee mice were highly susceptible to fatal infections and died within 2-3 months. Morphologically, their neutrophils were blocked at the myelocytes/metamyelocytes stage, and clonogenic assays of bone marrow cells indicated a significant decrease in the number of myeloid colonies of the bbee mice. In addition, the proportion of hematopoietic progenitor cells [Lin(2) Sca1(+) c-Kit(+)] in the bone marrow of the bbee mice was significantly increased, reflecting the defective differentiation of the myeloid compartment. Furthermore, microarray expression analysis of LPS- and IFN gamma-activated bone marrow-derived macrophages from bbee compared to single knockout mice revealed decreased expression of essential immune response-related genes and networks, including some direct C/EBP-targets such as Marco and Clec4e. Overall, the phenotype of the bbee mice is distinct from either the bbEE or BBee mice, demonstrating that both transcription factors are crucial for the maturation of neutrophils and macrophages, as well as the innate immune system, and can at least in part compensate for each other in the single knockout mice.	[Akagi, Tadayuki; Thoennissen, Nils H.; Song, Jee Hoon; Okamoto, Ryoko; Nowak, Daniel; Koeffler, H. Phillip] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Sch Med, Div Hematol & Oncol, Los Angeles, CA 90048 USA; [George, Ann] Childrens Hosp Los Angeles, Div Res Immunol BMT, Los Angeles, CA 90027 USA; [Crooks, Gay] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Gombart, Adrian F.] Oregon State Univ, Dept Biochem & Biophys, Linus Pauling Inst, Corvallis, OR 97331 USA; [Koeffler, H. Phillip] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Children's Hospital Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Oregon State University; National University of Singapore	Akagi, T (corresponding author), Univ Calif Los Angeles, Cedars Sinai Med Ctr, Sch Med, Div Hematol & Oncol, Los Angeles, CA 90048 USA.	tadayuki@staff.kanazawa-u.ac.jp	Gombart, Adrian/AAV-4738-2020; Akagi, Tadayuki/E-1078-2011	Gombart, Adrian/0000-0001-7830-0693; Akagi, Tadayuki/0000-0002-1733-9452; Nowak, Daniel/0000-0001-7130-7921	NIH [5R01CA026038-31, 5R01AI065604-04]; A*STAR; Inger Foundation; Tom Collier Memorial Regatta Foundation; Parker Hughes Fund; Deutsche Forschungsgemeinschaft (Bonn, Germany) [TH 1438/1-1]; Life Science Foundation of Japan; NATIONAL CANCER INSTITUTE [R01CA026038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065604] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); A*STAR(Agency for Science Technology & Research (A*STAR)); Inger Foundation; Tom Collier Memorial Regatta Foundation; Parker Hughes Fund; Deutsche Forschungsgemeinschaft (Bonn, Germany)(German Research Foundation (DFG)); Life Science Foundation of Japan(Life Science Foundation of Japan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant 5R01CA026038-31 and A*STAR grant from Singapore to H. P. K., NIH grant 5R01AI065604-04 to A. F. G., Inger Foundation (H. P. K.), the Tom Collier Memorial Regatta Foundation (H. P. K.), Parker Hughes Fund (H. P. K.), Deutsche Forschungsgemeinschaft (Bonn, Germany) [TH 1438/1-1 to N.H.T.], as well as Life Science Foundation of Japan (T. A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. H. P. K. is the holder of the Mark Goodson endowed Chair in Oncology Research and is a member of the Jonsson Cancer Center and the Molecular Biology Institute, UCLA.	Akagi T, 2008, BLOOD, V111, P2999, DOI 10.1182/blood-2007-04-087213; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Antonson P, 1996, GENOMICS, V35, P30, DOI 10.1006/geno.1996.0319; Bedi R, 2009, BLOOD, V113, P317, DOI 10.1182/blood-2008-02-139741; Begay V, 2004, MOL CELL BIOL, V24, P9744, DOI 10.1128/MCB.24.22.9744-9751.2004; Chen SS, 2000, MOL CELL BIOL, V20, P7292, DOI 10.1128/MCB.20.19.7292-7299.2000; Cloutier A, 2009, J IMMUNOL, V182, P563, DOI 10.4049/jimmunol.182.1.563; Friedman AD, 2002, ONCOGENE, V21, P3377, DOI 10.1038/sj.onc.1205324; Gery S, 2004, BLOOD, V103, P828, DOI 10.1182/blood-2003-01-0159; Gombart AF, 2002, BLOOD, V99, P1332, DOI 10.1182/blood.V99.4.1332; Gorgoni B, 2002, J IMMUNOL, V168, P4055, DOI 10.4049/jimmunol.168.8.4055; Hackanson B, 2008, CANCER RES, V68, P3142, DOI 10.1158/0008-5472.CAN-08-0483; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; Hu HM, 1998, J IMMUNOL, V160, P2334; Iwasaki H, 2007, IMMUNITY, V26, P726, DOI 10.1016/j.immuni.2007.06.004; Jones LC, 2002, BLOOD, V99, P2032, DOI 10.1182/blood.V99.6.2032; Lekstrom-Himes J, 1999, BLOOD, V93, P3096; McKnight SL, 2001, CELL, V107, P259, DOI 10.1016/S0092-8674(01)00543-8; Morosetti R, 1997, BLOOD, V90, P2591, DOI 10.1182/blood.V90.7.2591.2591_2591_2600; NATSUKA S, 1992, BLOOD, V79, P460; Pabst T, 2001, NAT GENET, V27, P263, DOI 10.1038/85820; Pizarro-Cerda J, 1999, J IMMUNOL, V162, P3519; POPE RM, 1994, J CLIN INVEST, V94, P1449, DOI 10.1172/JCI117482; Preudhomme C, 2002, BLOOD, V100, P2717, DOI 10.1182/blood-2002-03-0990; Radomska HS, 1998, MOL CELL BIOL, V18, P4301, DOI 10.1128/MCB.18.7.4301; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; SCOTT LM, 1992, BLOOD, V80, P1725; SCREPANTI I, 1995, EMBO J, V14, P1932, DOI 10.1002/j.1460-2075.1995.tb07185.x; Smith LT, 1996, BLOOD, V88, P1234, DOI 10.1182/blood.V88.4.1234.bloodjournal8841234; Sterneck E, 1997, GENE DEV, V11, P2153, DOI 10.1101/gad.11.17.2153; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; Tavor S, 2002, BLOOD, V99, P1794, DOI 10.1182/blood.V99.5.1794; Uematsu S, 2007, J IMMUNOL, V179, P5378, DOI 10.4049/jimmunol.179.8.5378; Verbeek W, 2001, LEUKEMIA, V15, P103, DOI 10.1038/sj.leu.2401995; Yamanaka R, 1997, P NATL ACAD SCI USA, V94, P13187, DOI 10.1073/pnas.94.24.13187; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006	37	42	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e15419	10.1371/journal.pone.0015419	http://dx.doi.org/10.1371/journal.pone.0015419			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21072215	Green Published, gold			2022-12-25	WOS:000283780800028
J	Wyatt, E; Wu, RX; Rabeh, W; Park, HW; Ghanefar, M; Ardehali, H				Wyatt, Eugene; Wu, Rongxue; Rabeh, Wael; Park, Hee-Won; Ghanefar, Mohsen; Ardehali, Hossein			Regulation and Cytoprotective Role of Hexokinase III	PLOS ONE			English	Article							RAT-BRAIN HEXOKINASE; C-TERMINAL HALVES; FUNCTIONAL-ORGANIZATION; MAMMALIAN HEXOKINASES; STRUCTURAL DOMAIN; GLUCOSE PHOSPHORYLATION; MITOCHONDRIAL BINDING; CATALYTIC-ACTIVITY; CELL-DEATH; N-TERMINUS	Background: Hexokinases (HKs) catalyze the first step in glucose metabolism. Of the three mammalian 100-kDa HK isoforms, HKI and II can bind to mitochondria and protect against cell death. HKIII does not bind mitochondria, and little is known about its regulation or cytoprotective effects. We studied the regulation of HKIII at the transcriptional and protein levels and investigated its role in cellular protection. Methodology/Principal Findings: We show that like HKII, HKIII expression is regulated by hypoxia, but other factors that regulate HKII expression have no effect on HKIII levels. This transcriptional regulation is partially dependent on hypoxia-inducible factor (HIF) signaling. We also demonstrate regulation at the protein level, as mutations in putative N-terminal substrate binding residues altered C-terminal catalytic activity, suggesting that HKIII activity is governed, in part, by interactions between these two domains. Overexpression of HKIII reduced oxidant-induced cell death, increased ATP levels, decreased the production of reactive oxygen species (ROS), and preserved mitochondrial membrane potential. HKIII overexpression was also associated with higher levels of transcription factors that regulate mitochondrial biogenesis, and greater total mitochondrial DNA content. Attempts to target HKIII to the mitochondria by replacing its N-terminal 32-aminoacid sequence with the mitochondrial-targeting sequence of HKII led to protein aggregation, suggesting that this region is necessary to maintain proper protein folding and solubility. Conclusions/Significance: These results suggest that HKIII is regulated by hypoxia and there are functional interactions between its two halves. Furthermore, HKIII exerts protective effects against oxidative stress, perhaps by increasing ATP levels, reducing oxidant-induced ROS production, preserving mitochondrial membrane potential, and increasing mitochondrial biogenesis.	[Wyatt, Eugene; Wu, Rongxue; Ghanefar, Mohsen; Ardehali, Hossein] Northwestern Univ, Dept Med, Feinberg Sch Med, Div Cardiol, Chicago, IL 60611 USA; [Rabeh, Wael; Park, Hee-Won] Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada; [Park, Hee-Won] Univ Toronto, Dept Pharmacol, Toronto, ON, Canada	Northwestern University; Feinberg School of Medicine; University of Toronto; Structural Genomics Consortium; University of Toronto	Wyatt, E (corresponding author), Northwestern Univ, Dept Med, Feinberg Sch Med, Div Cardiol, Chicago, IL 60611 USA.	h-ardehali@northwestern.edu	Rabeh, Wael/AAO-4647-2020; Wu, Rongxue/AAH-2858-2020	Rabeh, Wael/0000-0001-6071-8581; Wu, Rongxue/0000-0003-4857-4655	National Institutes of Health [K08 HL079387, R01 HL087149]; American Heart Association; Northwestern University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL079387, R01HL087149] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Northwestern University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	H.A. is supported by National Institutes of Health grants K08 HL079387 and R01 HL087149 http://grants.nih.gov/grants/oer.htm. E. W. and R. W. are supported by grants from the American Heart Association http://www.americanheart.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Graeme Bell (University of Chicago) for the HKIII plasmid and Dr. Mircea Ivan (Indiana University) for the HIF plasmids. We would also like to thank the Northwestern University Interdepartmental ImmunoBiology Flow Cytometry Core Facility for their support.	Ahmad A, 2002, AM J PHYSIOL-LUNG C, V283, pL573, DOI 10.1152/ajplung.00410.2001; Aleshin AE, 1998, J MOL BIOL, V282, P345, DOI 10.1006/jmbi.1998.2017; Aleshin AE, 2000, J MOL BIOL, V296, P1001, DOI 10.1006/jmbi.1999.3494; Ardehali H, 1996, J BIOL CHEM, V271, P1849, DOI 10.1074/jbc.271.4.1849; Ardehali H, 1999, J BIOL CHEM, V274, P15986, DOI 10.1074/jbc.274.23.15986; ARORA KK, 1993, J BIOL CHEM, V268, P18259; ARORA KK, 1991, J BIOL CHEM, V266, P5359; Azoulay-Zohar H, 2004, BIOCHEM J, V377, P347, DOI 10.1042/BJ20031465; BAIJAL M, 1992, ARCH BIOCHEM BIOPHYS, V298, P271, DOI 10.1016/0003-9861(92)90123-E; BELL GI, 1993, J BIOL CHEM, V268, P19161; Bryson JM, 2002, J BIOL CHEM, V277, P11392, DOI 10.1074/jbc.M110927200; Cardenas ML, 1998, BBA-MOL CELL RES, V1401, P242, DOI 10.1016/S0167-4889(97)00150-X; Furuta H, 1996, GENOMICS, V36, P206, DOI 10.1006/geno.1996.0448; GOULD GW, 1993, BIOCHEM J, V295, P329, DOI 10.1042/bj2950329; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; Holloszy JO, 2008, J PHYSIOL PHARMACOL, V59, P5; Holmes BF, 1999, J APPL PHYSIOL, V87, P1990, DOI 10.1152/jappl.1999.87.5.1990; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; MAGNANI M, 1992, BIOCHEM J, V285, P193, DOI 10.1042/bj2850193; Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014; MIDDLETON RJ, 1990, BIOCHEM SOC T, V18, P180, DOI 10.1042/bst0180180; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; Narayanan PK, 2003, CYTOM PART A, V52A, P28, DOI 10.1002/cyto.a.10011; NEMATGORGANI M, 1986, ARCH BIOCHEM BIOPHYS, V251, P97, DOI 10.1016/0003-9861(86)90055-X; Palma F, 2002, PREP BIOCHEM BIOTECH, V32, P393, DOI 10.1081/PB-120015469; Pastorino JG, 2003, CURR MED CHEM, V10, P1535, DOI 10.2174/0929867033457269; Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200; PRELLER A, 1992, ARCH BIOCHEM BIOPHYS, V294, P482, DOI 10.1016/0003-9861(92)90715-9; Printz RL, 1997, BIOCHEM SOC T, V25, P107, DOI 10.1042/bst0250107; Rempel A, 1996, CANCER RES, V56, P2468; Riordan MM, 2008, AM J PHYSIOL-HEART C, V294, pH1174, DOI 10.1152/ajpheart.01236.2007; SCHIRCH DM, 1987, ARCH BIOCHEM BIOPHYS, V254, P385, DOI 10.1016/0003-9861(87)90116-0; Sebastian S, 2001, ARCH BIOCHEM BIOPHYS, V395, P113, DOI 10.1006/abbi.2001.2584; Southworth R, 2007, AM J PHYSIOL-HEART C, V292, pH378, DOI 10.1152/ajpheart.00664.2006; Sui DX, 1997, ARCH BIOCHEM BIOPHYS, V345, P111, DOI 10.1006/abbi.1997.0241; Sun L, 2008, MOL CELL BIOL, V28, P1007, DOI 10.1128/MCB.00224-07; Tsai HJ, 1997, ARCH BIOCHEM BIOPHYS, V338, P183, DOI 10.1006/abbi.1996.9850; Tsai HJ, 1999, ARCH BIOCHEM BIOPHYS, V369, P149, DOI 10.1006/abbi.1999.1326; URETA T, 1982, COMP BIOCHEM PHYS B, V71, P549, DOI 10.1016/0305-0491(82)90461-8; WHITE TK, 1989, ARCH BIOCHEM BIOPHYS, V274, P375, DOI 10.1016/0003-9861(89)90451-7; WHITE TK, 1987, ARCH BIOCHEM BIOPHYS, V259, P402, DOI 10.1016/0003-9861(87)90506-6; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; WILSON JE, 1995, REV PHYSIOL BIOCH P, V126, P65, DOI 10.1007/BFb0049776; XIE GC, 1988, ARCH BIOCHEM BIOPHYS, V267, P803, DOI 10.1016/0003-9861(88)90090-2	44	43	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e13823	10.1371/journal.pone.0013823	http://dx.doi.org/10.1371/journal.pone.0013823			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21072205	Green Submitted, Green Published, gold			2022-12-25	WOS:000283780800020
J	Connelly, L; Barham, W; Onishko, HM; Sherrill, T; Chodosh, LA; Blackwell, TS; Yull, FE				Connelly, L.; Barham, W.; Onishko, H. M.; Sherrill, T.; Chodosh, L. A.; Blackwell, T. S.; Yull, F. E.			Inhibition of NF-kappa B activity in mammary epithelium increases tumor latency and decreases tumor burden	ONCOGENE			English	Article						NF-kappa B; mammary; tumorigenesis; apoptosis; proliferation	HUMAN BREAST-CANCER; TRANSCRIPTION FACTOR; CYCLIN D1; IN-VIVO; ACTIVATION; PATHWAY; TUMORIGENESIS; REQUIREMENT; PROGRESSION; GROWTH	The transcription factor nuclear factor kappa B (NF-kappa B) is activated in human breast cancer tissues and cell lines. However, it is unclear whether NF-kappa B activation is a consequence of tumor formation or a contributor to tumor development. We developed a doxycycline (dox)-inducible mouse model, termed DNMP, to inhibit NF-kappa B activity specifically within the mammary epithelium during tumor development in the polyoma middle T oncogene (PyVT) mouse mammary tumor model. DNMP females and PyVT littermate controls were treated with dox from 4 to 12 weeks of age. We observed an increase in tumor latency and a decrease in final tumor burden in DNMP mice compared with PyVT controls. A similar effect with treatment from 8 to 12 weeks indicates that outcome is independent of effects on postnatal virgin ductal development. In both cases, DNMP mice were less likely to develop lung metastases than controls. Treatment from 8 to 9 weeks was sufficient to impact primary tumor formation. Inhibition of NF-kappa B increases apoptosis in hyperplastic stages of tumor development and decreases proliferation at least in part by reducing Cyclin D1 expression. To test the therapeutic potential of NF-kappa B inhibition, we generated palpable tumors by orthotopic injection of PyVT cells and then treated systemically with the NF-kappa B inhibitor thymoquinone (TQ). TQ treatment resulted in a reduction in tumor volume and weight as compared with vehicle-treated control. These data indicate that epithelial NF-kappa B is an active contributor to tumor progression and demonstrate that inhibition of NF-kappa B could have a significant therapeutic impact even at later stages of mammary tumor progression. Oncogene (2011) 30, 1402-1412; doi:10.1038/onc.2010.521; published online 15 November 2010	[Connelly, L.; Barham, W.; Onishko, H. M.; Blackwell, T. S.; Yull, F. E.] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37232 USA; [Connelly, L.] Univ Hawaii, Dept Pharmaceut Sci, Coll Pharm, Hilo, HI 96720 USA; [Sherrill, T.; Blackwell, T. S.] Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA; [Chodosh, L. A.] Univ Penn, Dept Canc Biol, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Blackwell, T. S.] Dept Vet Affairs Med Ctr, Nashville, TN 37212 USA	Vanderbilt University; University of Hawaii System; University Hawaii Hilo; Vanderbilt University; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Yull, FE (corresponding author), Vanderbilt Univ, Dept Canc Biol, 771 Preston Res Bldg,2220 Pierce Ave, Nashville, TN 37232 USA.	fiona.yull@vanderbilt.edu	Connelly, Linda/GVS-4612-2022	Barham, Whitney/0000-0002-1130-1971	NIH [CA113734]; US Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [R01CA113734] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grant CA113734 awarded to FE Yull and a US Department of Veterans Affairs grant awarded to TS Blackwell.	BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Basseres DS, 2010, CANCER RES, V70, P3537, DOI 10.1158/0008-5472.CAN-09-4290; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Biswas DK, 2006, J CELL PHYSIOL, V209, P645, DOI 10.1002/jcp.20785; Biswas DK, 2004, P NATL ACAD SCI USA, V101, P10137, DOI 10.1073/pnas.0403621101; Bond M, 1998, FEBS LETT, V435, P29, DOI 10.1016/S0014-5793(98)01034-5; Brantley DM, 2001, MOL BIOL CELL, V12, P1445, DOI 10.1091/mbc.12.5.1445; Cao YX, 2007, P NATL ACAD SCI USA, V104, P15852, DOI 10.1073/pnas.0706728104; Cao YX, 2003, J MAMMARY GLAND BIOL, V8, P215, DOI 10.1023/A:1025905008934; Cheng DS, 2007, J IMMUNOL, V178, P6504, DOI 10.4049/jimmunol.178.10.6504; Connelly L, 2007, J BIOL CHEM, V282, P10028, DOI 10.1074/jbc.M611300200; Connelly L, 2010, J CELL PHYSIOL, V222, P73, DOI 10.1002/jcp.21922; Cude K, 2007, J CELL BIOL, V177, P253, DOI 10.1083/jcb.200609166; Everhart MB, 2006, J IMMUNOL, V176, P4995, DOI 10.4049/jimmunol.176.8.4995; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gunther EJ, 2002, FASEB J, V16, DOI 10.1096/fj.01-0551com; Han YP, 2001, J CELL SCI, V114, P131; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Jafri SH, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-87; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Liu MR, 2009, AM J PATHOL, V174, P1910, DOI 10.2353/ajpath.2009.080706; Meylan E, 2009, NATURE, V462, P104, DOI 10.1038/nature08462; Mistry P, 2004, J BIOL CHEM, V279, P1482, DOI 10.1074/jbc.M310413200; Nakshatri H, 1997, MOL CELL BIOL, V17, P3629, DOI 10.1128/MCB.17.7.3629; Patel NM, 2000, ONCOGENE, V19, P4159, DOI 10.1038/sj.onc.1203768; Pratt MAC, 2009, ONCOGENE, V28, P2710, DOI 10.1038/onc.2009.131; Roy PG, 2006, BREAST, V15, P718, DOI 10.1016/j.breast.2006.02.005; Sethi G, 2008, MOL CANCER RES, V6, P1059, DOI 10.1158/1541-7786.MCR-07-2088; Singh S, 2007, MOL CANCER THER, V6, P1973, DOI 10.1158/1535-7163.MCT-07-0063; Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848; Stathopoulos GT, 2007, P NATL ACAD SCI USA, V104, P18514, DOI 10.1073/pnas.0705316104; Tapia MA, 2007, CELL CYCLE, V6, P2284, DOI 10.4161/cc.6.18.4721; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; WANG TC, 1994, NATURE, V369, P669, DOI 10.1038/369669a0	38	56	59	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR	2011	30	12					1402	1412		10.1038/onc.2010.521	http://dx.doi.org/10.1038/onc.2010.521			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	739UM	21076466	Green Accepted			2022-12-25	WOS:000288743800003
J	Sestito, R; Madonna, S; Scarponi, C; Cianfarani, F; Failla, CM; Cavani, A; Girolomoni, G; Albanesi, C				Sestito, Rosanna; Madonna, Stefania; Scarponi, Claudia; Cianfarani, Francesca; Failla, Cristina M.; Cavani, Andrea; Girolomoni, Giampiero; Albanesi, Cristina			STAT3-dependent effects of IL-22 in human keratinocytes are counterregulated by sirtuin 1 through a direct inhibition of STAT3 acetylation	FASEB JOURNAL			English	Article						class III histone deacetylase (HDAC); post-translational modification; psoriasis; skin inflammation; IFN-gamma	T-CELL; SKIN INFLAMMATION; INTERFERON-GAMMA; PSORIATIC SKIN; INTERLEUKIN 22; DIFFERENTIATION; ACTIVATION; IDENTIFICATION; EXPRESSION; CYTOKINE	IL-22 has a pathogenetic role in psoriasis, where it is responsible for the altered proliferation and differentiation of keratinocytes and induces inflammatory molecules. The IL-22-induced effects are mediated by STAT3, whose activity is proportional to acetylation in lysine (Lys)685 and phosphorylation in tyrosine (Tyr)705. Lys 685 acetylation of STAT3 is inhibited by sirtuin (SIRT)1, a class III deacetylase promoting keratinocyte differentiation. Due to the opposite effects of IL-22 and SIRT1, we investigated whether IL-22-induced effects in keratinocytes could be regulated by SIRT1 through control of STAT3. We found that SIRT1 opposes the IL-22-induced STAT3 activity by deacetylating STAT3 and reducing STAT3 Tyr705 phosphorylation. By controlling STAT3, SIRT1 also influences the IL-22-induced expression of molecules involved in proliferation and inflammation as well as proliferation and migration processes in cultured keratinocytes. Although SIRT1 levels were similar in keratinocytes of healthy individuals and patients with psoriasis, they were reduced in psoriatic skin lesions, with the lymphokine IFN-gamma inhibiting SIRT1 expression. Concomitantly, IFN-gamma enhanced basal acetylation of STAT3 and its phosphorylation induced by IL-22. In conclusion, STAT3-dependent IL-22 signaling and effects in keratinocytes are negatively regulated by SIRT1. In skin affected by psoriasis, SIRT1 is down-regulated by IFN-gamma, which thus renders psoriatic keratinocytes more prone to respond to IL-22.-Sestito, R., Madonna, S., Scarponi, C., Cianfarani, F., Failla, C. M., Cavani, A., Girolomoni, G., Albanesi, C. STAT3-dependent effects of IL-22 in human keratinocytes are counterregulated by sirtuin 1 through a direct inhibition of STAT3 acetylation. FASEB J. 25, 916-927 (2011). www.fasebj.org	[Sestito, Rosanna; Madonna, Stefania; Scarponi, Claudia; Cavani, Andrea; Albanesi, Cristina] IDI, IRCCS, Expt Immunol Lab, I-00167 Rome, Italy; [Cianfarani, Francesca; Failla, Cristina M.] IDI, IRCCS, Mol & Cell Biol Lab, I-00167 Rome, Italy; [Sestito, Rosanna; Girolomoni, Giampiero] Univ Verona, Dept Med, I-37100 Verona, Italy	IRCCS Istituto Dermopatico dell'Immacolata (IDI); IRCCS Istituto Dermopatico dell'Immacolata (IDI); University of Verona	Albanesi, C (corresponding author), IDI, IRCCS, Expt Immunol Lab, Via Monti Creta 104, I-00167 Rome, Italy.	c.albanesi@idi.it	Sestito, Rosanna/K-2361-2018; Madonna, stefania/AAC-3381-2022; GIROLOMONI, Giampiero/AAC-3405-2022; Failla, Cristina M./AAA-2881-2019; Albanesi, Cristina/K-4699-2016	Sestito, Rosanna/0000-0001-5460-2777; Albanesi, Cristina/0000-0002-7537-6833; Cianfarani, Francesca/0000-0001-7859-2913; Failla, Cristina/0000-0001-5991-8914				BATACSORGO Z, 1993, J EXP MED, V178, P1271, DOI 10.1084/jem.178.4.1271; Blander G, 2009, J INVEST DERMATOL, V129, P41, DOI 10.1038/jid.2008.179; Boniface K, 2007, CLIN EXP IMMUNOL, V150, P407, DOI 10.1111/j.1365-2249.2007.03511.x; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Chan KS, 2004, CANCER RES, V64, P2382, DOI 10.1158/0008-5472.CAN-03-3197; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; Feige JN, 2008, CURR OPIN CELL BIOL, V20, P303, DOI 10.1016/j.ceb.2008.03.012; FIERLBECK G, 1990, ARCH DERMATOL, V126, P351, DOI 10.1001/archderm.126.3.351; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Genovese C, 2006, ONCOGENE, V25, P5201, DOI 10.1038/sj.onc.1209652; Guilloteau K, 2010, J IMMUNOL, V184, P5263, DOI 10.4049/jimmunol.0902464; HANCOCK GE, 1988, J EXP MED, V168, P1395, DOI 10.1084/jem.168.4.1395; Kotenko SV, 2001, J BIOL CHEM, V276, P2725, DOI 10.1074/jbc.M007837200; Lejeune D, 2002, J BIOL CHEM, V277, P33676, DOI 10.1074/jbc.M204204200; Madonna S, 2008, FASEB J, V22, P3287, DOI 10.1096/fj.08-106831; Miyoshi K, 2011, J INVEST DERMATOL, V131, P108, DOI 10.1038/jid.2010.255; Nie YZ, 2009, NAT CELL BIOL, V11, P492, DOI 10.1038/ncb1857; Nograles KE, 2008, BRIT J DERMATOL, V159, P1092, DOI 10.1111/j.1365-2133.2008.08769.x; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Pennino D, 2010, J IMMUNOL, V184, P4880, DOI 10.4049/jimmunol.0901767; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; Sano S, 2008, J DERMATOL SCI, V50, P1, DOI 10.1016/j.jdermsci.2007.05.016; SCHEYNIUS A, 1992, J INVEST DERMATOL, V98, P255, DOI 10.1111/1523-1747.ep12556086; Spolski R, 2009, EUR J IMMUNOL, V39, P658, DOI 10.1002/eji.200839066; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2006, CYTOKINE GROWTH F R, V17, P367, DOI 10.1016/j.cytogfr.2006.09.001; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhu BM, 2008, J INVEST DERMATOL, V128, P1821, DOI 10.1038/sj.jid.5701224	35	109	116	2	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2011	25	3					916	927		10.1096/fj.10-172288	http://dx.doi.org/10.1096/fj.10-172288			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	727MZ	21098725				2022-12-25	WOS:000287806200012
J	Egesten, A; Frick, IM; Morgelin, M; Olin, AI; Bjorck, L				Egesten, Arne; Frick, Inga-Maria; Morgelin, Matthias; Olin, Anders I.; Bjorck, Lars			Binding of Albumin Promotes Bacterial Survival at the Epithelial Surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOCOCCAL PROTEIN-G; IGG-BINDING; INNATE IMMUNITY; IDENTIFICATION; FOG; CHEMOKINES; MOLECULES; PYOGENES; STRAINS; REGIONS	Human serum albumin (HSA) is the dominating protein in human plasma. Many bacterial species, especially streptococci, express surface proteins that bind HSA with high specificity and affinity, but the biological consequences of these protein-protein interactions are poorly understood. Group G streptococci (GGS), carrying the HSA-binding protein G, colonize the skin and the mucosa of the upper respiratory tract, mostly without causing disease. In the case of bacterial invasion, pro-inflammatory cytokines are released that activate the epithelium to produce antibacterial peptides, in particular the chemokine MIG/CXCL9. In addition, the inflammation causes capillary leakage and extravasation of HSA and other plasma proteins, environmental changes at the epithelial surface to which the bacteria need to respond. In this study, we found that GGS adsorbed HSA from both saliva and plasma via binding to protein G and that HSA bound to protein G bound and inactivated the antibacterial MIG/CXCL9 peptide. Another surface protein of GGS, FOG, was found to mediate adherence of the bacteria to pharyngeal epithelial cells through interaction with glycosaminoglycans. This adherence was not affected by activation of the epithelium with a combination of IFN-gamma and TNF-alpha, leading to the production of MIG/CXCL9. However, at the activated epithelial surface, adherent GGS were protected against killing by MIG/CXCL9 through protein G-dependent HSA coating. The findings identify a previously unknown bacterial survival strategy that helps to explain the evolution of HSA-binding proteins among bacterial species of the normal human microbiota.	[Frick, Inga-Maria; Morgelin, Matthias; Olin, Anders I.; Bjorck, Lars] Lund Univ, Dept Clin Sci, Sect Infect Med, SE-22185 Lund, Sweden; [Egesten, Arne; Olin, Anders I.] Lund Univ, Dept Clin Sci, Sect Resp Med & Allergol, SE-22185 Lund, Sweden; [Frick, Inga-Maria; Morgelin, Matthias; Olin, Anders I.; Bjorck, Lars] Univ Lund Hosp, SE-22185 Lund, Sweden	Lund University; Lund University; Lund University; Skane University Hospital	Egesten, A (corresponding author), Lund Univ, BMC B14,Tornavagen 10, SE-22184 Lund, Sweden.	arne.egesten@med.lu.se			Swedish Research Council [7480, 20674]; Swedish Heart and Lung Foundation [20080246]; Medical Faculty at Lund University; Swedish Government Funds for Clinical Research (ALF); Foundations of Torsten; Ragnar Soderberg; Bergh; Crafoord; Greta and Johan Kock; Marianne and Marcus Wallenberg; Alfred Osterlund	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Medical Faculty at Lund University; Swedish Government Funds for Clinical Research (ALF); Foundations of Torsten; Ragnar Soderberg; Bergh; Crafoord; Greta and Johan Kock; Marianne and Marcus Wallenberg; Alfred Osterlund	The work was supported by grants from the Swedish Research Council (Projects 7480 and 20674); the Swedish Heart and Lung Foundation (Project 20080246); the Medical Faculty at Lund University; the Swedish Government Funds for Clinical Research (ALF); and the Foundations of Torsten and Ragnar Soderberg, Bergh, Crafoord, Greta and Johan Kock, Marianne and Marcus Wallenberg, and Alfred Osterlund.	AKERSTROM B, 1987, J BIOL CHEM, V262, P13388; Bengtson SH, 2009, J INNATE IMMUN, V1, P18, DOI 10.1159/000145543; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; BJORCK L, 1987, MOL IMMUNOL, V24, P1113, DOI 10.1016/0161-5890(87)90080-0; BJORCK L, 1984, J IMMUNOL, V133, P969; Boyle, 1990, BACTERIAL IMMUNOGLOB; CHRISTIE PJ, 1987, J BACTERIOL, V169, P2529, DOI 10.1128/jb.169.6.2529-2536.1987; Christner M, 2010, MOL MICROBIOL, V75, P187, DOI 10.1111/j.1365-2958.2009.06981.x; deChateau M, 1996, P NATL ACAD SCI USA, V93, P8490, DOI 10.1073/pnas.93.16.8490; DECHATEAU M, 1994, J BIOL CHEM, V269, P12147; Dorosz J, 2010, J PHYS CHEM B, V114, P11053, DOI 10.1021/jp1052248; Edens HA, 2003, CURR OPIN HEMATOL, V10, P25, DOI 10.1097/00062752-200301000-00005; Edgerton M, 2000, Adv Dent Res, V14, P16; Egesten A, 2007, J INFECT DIS, V195, P684, DOI 10.1086/510857; FAHNESTOCK SR, 1986, J BACTERIOL, V167, P870, DOI 10.1128/jb.167.3.870-880.1986; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; Frick IM, 2003, J BIOL CHEM, V278, P16561, DOI 10.1074/jbc.M301995200; Frick IM, 2003, EUR J BIOCHEM, V270, P2303, DOI 10.1046/j.1432-1033.2003.03600.x; Gautam N, 2001, NAT MED, V7, P1123, DOI 10.1038/nm1001-1123; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; GUSS B, 1986, EMBO J, V5, P1567, DOI 10.1002/j.1460-2075.1986.tb04398.x; Hamel DJ, 2009, METHOD ENZYMOL, V461, P71, DOI 10.1016/S0076-6879(09)05404-4; Hashikawa S, 2004, J CLIN MICROBIOL, V42, P186, DOI 10.1128/JCM.42.1.186-192.2004; Hieshima K, 2003, J IMMUNOL, V170, P1452, DOI 10.4049/jimmunol.170.3.1452; Hyland KA, 2009, FEMS IMMUNOL MED MIC, V55, P422, DOI 10.1111/j.1574-695X.2009.00540.x; Johansson HM, 2004, MICROBIOL-SGM, V150, P4211, DOI 10.1099/mic.0.27269-0; Johansson MU, 2002, J BIOL CHEM, V277, P8114, DOI 10.1074/jbc.M109943200; Kolls JK, 2008, NAT REV IMMUNOL, V8, P829, DOI 10.1038/nri2433; KRONVALL G, 1979, INFECT IMMUN, V25, P1; MCDONALD DM, 1992, AM REV RESPIR DIS, V146, pS40, DOI 10.1164/ajrccm/146.5_Pt_2.S40; Murdoch DA, 1998, CLIN MICROBIOL REV, V11, P81, DOI 10.1128/CMR.11.1.81; Nitsche DP, 2006, J BIOL CHEM, V281, P1670, DOI 10.1074/jbc.M506776200; Nitsche-Schmitz DP, 2007, J BIOL CHEM, V282, P17530, DOI 10.1074/jbc.M702612200; Nizet V, 2007, J ALLERGY CLIN IMMUN, V120, P13, DOI 10.1016/j.jaci.2007.06.005; Nygren P A, 1988, J Mol Recognit, V1, P69, DOI 10.1002/jmr.300010204; PATTHY L, 1994, CURR OPIN STRUC BIOL, V4, P383, DOI 10.1016/S0959-440X(94)90108-2; Patthy L, 1991, CURR OPIN STRUC BIOL, V1, P351, DOI 10.1016/0959-440X(91)90033-P; Potempa J, 2009, J INNATE IMMUN, V1, P70, DOI 10.1159/000181144; Raeder RH, 2000, J INFECT DIS, V181, P639, DOI 10.1086/315281; REIS KJ, 1984, J CLIN LAB IMMUNOL, V13, P75; SAMPSON PM, 1984, J APPL PHYSIOL, V57, P1648, DOI 10.1152/jappl.1984.57.6.1648; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; Sauty A, 1999, J IMMUNOL, V162, P3549; Schmidtchen A, 2002, MOL MICROBIOL, V46, P157, DOI 10.1046/j.1365-2958.2002.03146.x; Sylvetsky N, 2002, AM J MED, V112, P622, DOI 10.1016/S0002-9343(02)01117-8; Williams RJ, 2002, INFECT IMMUN, V70, P6805, DOI 10.1128/IAI.70.12.6805-6810.2002	46	31	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2469	2476		10.1074/jbc.M110.148171	http://dx.doi.org/10.1074/jbc.M110.148171			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21098039	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000286464300011
J	Hu, LL; Wang, JN; Liu, Y; Zhang, Y; Zhang, LL; Kong, RR; Zheng, ZF; Du, XJ; Ke, Y				Hu, Lelin; Wang, Jiangnan; Liu, Yun; Zhang, Ying; Zhang, Liangliang; Kong, Ruirui; Zheng, Zongfang; Du, Xiaojuan; Ke, Yang			A Small Ribosomal Subunit (SSU) Processome Component, the Human U3 Protein 14A (hUTP14A) Binds p53 and Promotes p53 Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; PROTEASOMAL DEGRADATION; CELL-CYCLE; RNA; MDM2; INHIBITION; PATHWAY; BIOGENESIS; RETROGENE; DEPLETION	Ribosome biogenesis is required for normal cell function, and aberrant ribosome biogenesis can lead to p53 activation. However, how p53 is activated by defects of ribosome biogenesis remains to be determined. Here, we identified human UTP14a as an SSU processome component by showing that hUTP14a is nucleolar, associated with U3 snoRNA and involved in 18 S rRNA processing. Interestingly, ectopic expression of hUTP14a resulted in a decrease and knockdown of hUTP14a led to an increase of p53 protein levels. We showed that hUTP14a physically interacts with p53 and functionally promotes p53 turn-over, and that hUTP14a promotion of p53 destabilization is sensitive to a proteasome inhibitor but independent of ubiquitination. Significantly, knockdown of hUTP14a led to cell cycle arrest and apoptosis. Our data identified a novel pathway for p53 activation through a defect in rRNA processing and suggest that a ribosome biogenesis factor itself could act as a sensor for nucleolar stress to regulate p53.	[Hu, Lelin; Wang, Jiangnan; Liu, Yun; Zhang, Ying; Zhang, Liangliang; Kong, Ruirui; Zheng, Zongfang; Du, Xiaojuan; Ke, Yang] Peking Univ, Hlth Sci Ctr, Canc Res Ctr, Beijing 100191, Peoples R China; [Hu, Lelin; Wang, Jiangnan; Liu, Yun; Zhang, Liangliang; Du, Xiaojuan] Peking Univ, Hlth Sci Ctr, Dept Cell Biol, Beijing 100191, Peoples R China; [Ke, Yang] Peking Univ, Sch Oncol, Genet Lab, Beijing Canc Hosp & Inst, Beijing 100142, Peoples R China; [Zhang, Ying; Kong, Ruirui; Zheng, Zongfang; Ke, Yang] Peking Univ, Sch Oncol, Beijing Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100142, Peoples R China	Peking University; Peking University; Peking University; Peking University	Du, XJ (corresponding author), Peking Univ, Hlth Sci Ctr, Canc Res Ctr, 38 Xue Yuan Rd, Beijing 100191, Peoples R China.	duxiaojuan100@hsc.pku.edu.cn; keyang@hsc.pku.edu.cn	Du, Xiaojuan/AAY-1186-2021		National Natural Science Foundation of China [30571038, 30771224]; Key Construction Program of the National "985" Project [985-2-016-24]; National High Technology Research and Development Program of China (863 Program) [2008AA02Z131, 2006AA02A402]; National Basic Research Program of China (973 Program) [2010CB529303]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Construction Program of the National "985" Project; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by grants from the National Natural Science Foundation of China (Grants No. 30571038 and 30771224), the Key Construction Program of the National "985" Project (Grant No. 985-2-016-24), Grants from the National High Technology Research and Development Program of China (863 Program) (Grant No. 2008AA02Z131 and 2006AA02A402), and from the National Basic Research Program of China (973 Program) (Grant No. 2010CB529303).	Asher G, 2005, GENE DEV, V19, P316, DOI 10.1101/gad.319905; Asher G, 2005, CELL CYCLE, V4, P1015, DOI 10.4161/cc.4.8.1900; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Bradley J, 2004, NAT GENET, V36, P872, DOI 10.1038/ng1390; Camus S, 2007, ONCOGENE, V26, P4059, DOI 10.1038/sj.onc.1210188; Chen D, 2007, ONCOGENE, V26, P5029, DOI 10.1038/sj.onc.1210327; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; FOURNIER MJ, 1993, TRENDS BIOCHEM SCI, V18, P131, DOI 10.1016/0968-0004(93)90020-N; Holzel M, 2010, J BIOL CHEM, V285, P6364, DOI 10.1074/jbc.M109.054734; HUGHES JMX, 1991, EMBO J, V10, P4231, DOI 10.1002/j.1460-2075.1991.tb05001.x; IAPALUCCIESPINOZA S, 1979, FEBS LETT, V107, P281, DOI 10.1016/0014-5793(79)80390-7; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; KASS S, 1990, CELL, V60, P897, DOI 10.1016/0092-8674(90)90338-F; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; LECHNER MS, 1994, J VIROL, V68, P4262, DOI 10.1128/JVI.68.7.4262-4273.1994; Li XQ, 1996, J VIROL, V70, P4509, DOI 10.1128/JVI.70.7.4509-4516.1996; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; MARECHAL V, 1994, MOL CELL BIOL, V14, P7414, DOI 10.1128/MCB.14.11.7414; PERRY RP, 1970, P NATL ACAD SCI USA, V65, P609, DOI 10.1073/pnas.65.3.609; Pestov DG, 2001, MOL CELL BIOL, V21, P4246, DOI 10.1128/MCB.21.13.4246-4255.2001; Pluk H, 1998, MOL CELL BIOL, V18, P488, DOI 10.1128/MCB.18.1.488; Rohozinski J, 2006, BIOL REPROD, V74, P644, DOI 10.1095/biolreprod.105.046698; Rohozinski J, 2004, P NATL ACAD SCI USA, V101, P11695, DOI 10.1073/pnas.0401130101; Rohozinski J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005064; Roth J, 1998, EMBO J, V17, P554, DOI 10.1093/emboj/17.2.554; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Sakaguchi K, 2000, J BIOL CHEM, V275, P9278, DOI 10.1074/jbc.275.13.9278; Scheer U, 1999, CURR OPIN CELL BIOL, V11, P385, DOI 10.1016/S0955-0674(99)80054-4; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; Shetty G, 2008, ENDOCRINOLOGY, V149, P2773, DOI 10.1210/en.2007-1338; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Strezoska Z, 2002, J BIOL CHEM, V277, P29617, DOI 10.1074/jbc.M204381200; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Unger T, 1999, EMBO J, V18, P1805, DOI 10.1093/emboj/18.7.1805; Venema J, 1995, YEAST, V11, P1629, DOI 10.1002/yea.320111607; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Volarevic S, 2000, SCIENCE, V288, P2045, DOI 10.1126/science.288.5473.2045; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wallace M, 2006, MOL CELL, V23, P251, DOI 10.1016/j.molcel.2006.05.029; Wang Y, 2007, BBA-MOL CELL RES, V1773, P863, DOI 10.1016/j.bbamcr.2007.04.002; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003; Zhu Y, 2009, MOL CELL, V35, P316, DOI 10.1016/j.molcel.2009.07.014	46	27	30	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					3119	3128		10.1074/jbc.M110.157842	http://dx.doi.org/10.1074/jbc.M110.157842			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21078665	Green Published, hybrid			2022-12-25	WOS:000286464300073
J	Mehrotra, P; Riley, JP; Patel, R; Li, F; Voss, L; Goenka, S				Mehrotra, Purvi; Riley, Jonathan P.; Patel, Ravi; Li, Fang; Voss, Le'erin; Goenka, Shreevrat			PARP-14 Functions as a Transcriptional Switch for Stat6-dependent Gene Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLY(ADP-RIBOSE) POLYMERASE-ACTIVITY; AGGRESSIVE LYMPHOMA FAMILY; HISTONE VARIANT MACROH2A; INACTIVE X-CHROMOSOME; STAT6; COLLABORATOR; COACTIVATOR; EXPRESSION; DOMAINS; SIGNAL	A subset of poly ADP-ribose polymerases (PARP) that also contain macro domains regulate transcription. One such macro PARP, PARP-14 alters interleukin 4 (IL-4) and Stat6-dependent transcription. Stat6, activated by IL-4 plays an important role in T helper cell immunity and B cell responses. Here we define the mechanism by which PARP-14 regulates Stat6-activated transcription. Under non-stimulating conditions, PARP-14 recruits HDAC 2 and 3 to IL-4 responsive promoters. In the presence of IL-4, PARP-14 promotes efficient binding of Stat6 to its target genes. Moreover, HDAC 2 and 3 are released from the promoter with an IL-4 signal, this is aided by the ADP-ribosylation of the HDACs by PARP-14. The HDACs and PARP-14 get replaced by coactivators containing HAT activity. Based on these observations we put forth a mechanism in which PARP-14 functions as a transcriptional switch for Stat6-dependent gene induction. Thus, in the absence of a signal PARP-14 acts as a transcriptional repressor by recruiting HDACs. In contrast, in the presence of IL-4 the catalytic activity of PARP-14 facilitates Stat6 binding to the promoter, and release of HDACs so as to activate transcription.	Indiana Univ Sch Med, Dept Pediat, HB Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Goenka, S (corresponding author), 1044 W Walnut Dr,R4 276, Indianapolis, IN 46202 USA.	goenkas@iupui.edu			National Institutes of Health [HL093105]; Showalter Foundation; Indiana University School of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093105] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Showalter Foundation; Indiana University School of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded, in whole or in part, by National Institutes of Health Grant HL093105, the Showalter Foundation Grant, and the Biomedical Research Grant awarded by the Indiana University School of Medicine.	Aguiar RCT, 2005, J BIOL CHEM, V280, P33756, DOI 10.1074/jbc.M505408200; Arimura A, 2004, J BIOL CHEM, V279, P31105, DOI 10.1074/jbc.M404428200; Butler AJ, 1999, MOL CELL BIOL, V19, P296; Chadwick BP, 2001, NUCLEIC ACIDS RES, V29, P2699, DOI 10.1093/nar/29.13.2699; Chakravarthy S, 2005, MOL CELL BIOL, V25, P7616, DOI 10.1128/MCB.25.17.7616-7624.2005; Cho SH, 2009, BLOOD, V113, P2416, DOI 10.1182/blood-2008-03-144121; Costanzi C, 1998, NATURE, V393, P599, DOI 10.1038/31275; Gingras S, 1999, NUCLEIC ACIDS RES, V27, P2722, DOI 10.1093/nar/27.13.2722; Goenka S, 2006, P NATL ACAD SCI USA, V103, P4210, DOI 10.1073/pnas.0506981103; Goenka S, 2003, J BIOL CHEM, V278, P50362, DOI 10.1074/jbc.M305854200; Goenka S, 2007, J BIOL CHEM, V282, P18732, DOI 10.1074/jbc.M611283200; Hottiger MO, 2010, TRENDS BIOCHEM SCI, V35, P208, DOI 10.1016/j.tibs.2009.12.003; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Ladurner AG, 2003, MOL CELL, V12, P1, DOI 10.1016/S1097-2765(03)00284-3; Litterst CM, 2001, J BIOL CHEM, V276, P45713, DOI 10.1074/jbc.M108132200; McDonald C, 1999, J INTERF CYTOK RES, V19, P711, DOI 10.1089/107999099313550; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Ouararhni K, 2006, GENE DEV, V20, P3324, DOI 10.1101/gad.396106; PEHRSON JR, 1992, SCIENCE, V257, P1398; Schindler C, 1999, EXP CELL RES, V253, P7, DOI 10.1006/excr.1999.4670; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Thieu VT, 2008, IMMUNITY, V29, P679, DOI 10.1016/j.immuni.2008.08.017; Tinnell SB, 1998, INT IMMUNOL, V10, P1529, DOI 10.1093/intimm/10.10.1529; Wurster AL, 2000, ONCOGENE, V19, P2577, DOI 10.1038/sj.onc.1203485; Yang J, 2002, EMBO J, V21, P4950, DOI 10.1093/emboj/cdf463; Yu Q, 2007, EMBO J, V26, P2052, DOI 10.1038/sj.emboj.7601653	26	106	108	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1767	1776		10.1074/jbc.M110.157768	http://dx.doi.org/10.1074/jbc.M110.157768			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21081493	Green Published, hybrid			2022-12-25	WOS:000286191500016
J	Nie, ZX; Merritt, A; Rouhi-Parkouhi, M; Tabernero, L; Garrod, D				Nie, Zhuxiang; Merritt, Anita; Rouhi-Parkouhi, Mansour; Tabernero, Lydia; Garrod, David			Membrane-impermeable Cross-linking Provides Evidence for Homophilic, Isoform-specific Binding of Desmosomal Cadherins in Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; DESMOGLEIN ISOFORMS; CYTOPLASMIC DOMAINS; ADHESION MOLECULES; PEMPHIGUS-VULGARIS; CRYSTAL-STRUCTURE; HUMAN-EPIDERMIS; CULTURED-CELLS; N-CADHERIN; CALCIUM	Desmosomes and adherens junctions are cadherin-based protein complexes responsible for cell-cell adhesion of epithelial cells. Type 1 cadherins of adherens junctions show specific homophilic adhesion that plays a major role in developmental tissue segregation. The desmosomal cadherins, desmocollin and desmoglein, occur as several different isoforms with overlapping expression in some tissues where different isoforms are located in the same desmosomes. Although adhesive binding of desmosomal cadherins has been investigated in a variety of ways, their interaction in desmosome-forming epithelial cells has not been studied. Here, using extracellular homobi-functional cross-linking, we provide evidence for homophilic and isoform-specific binding between the Dsc2, Dsc3, Dsg2, and Dsg3 isoforms in HaCaT keratinocytes and show that it represents trans interaction. Furthermore, the cross-linked adducts are present in the detergent-insoluble fraction, and electron microscopy shows that extracellular cross-linking probably occurs in desmosomes. We found no evidence for either heterophilic or cis interaction, but neither can be completely excluded by our data. Mutation of amino acid residues Trp-2 and Ala-80 that are important for trans interaction in classical cadherin adhesive binding abolished Dsc2 binding, indicating that these residues are also involved in desmosomal adhesion. These interactions of desmosomal cadherins may be of key importance for their ordered arrangement within desmosomes that we believe is essential for desmosomal adhesive strength and the maintenance of tissue integrity.	[Nie, Zhuxiang; Merritt, Anita; Rouhi-Parkouhi, Mansour; Tabernero, Lydia; Garrod, David] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Garrod, David] King Saud Univ, Riyadh 11451, Saudi Arabia	University of Manchester; King Saud University	Garrod, D (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	david.garrod@manchester.ac.uk	Tabernero, Lydia/F-3795-2018	Tabernero, Lydia/0000-0001-8867-455X; Garrod, David/0000-0003-0300-3947	Medical Research Council [G9630879, G0700074]; MRC [G0700074, G9630879] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council Grants G9630879 and G0700074.	Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; Al-Amoudi A, 2004, J STRUCT BIOL, V148, P131, DOI 10.1016/j.jsb.2004.03.010; Al-Amoudi A, 2007, NATURE, V450, P832, DOI 10.1038/nature05994; AMAGAI, 1994, J INVEST DERMATOL, V103, P608, DOI 10.1111/1523-1747.ep12397292; BLASCHUK OW, 1990, DEV BIOL, V139, P227, DOI 10.1016/0012-1606(90)90290-Y; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; Chen CP, 2005, P NATL ACAD SCI USA, V102, P8531, DOI 10.1073/pnas.0503319102; Chidgey M, 2001, J CELL BIOL, V155, P821, DOI 10.1083/jcb.200105009; Chidgey MAJ, 1996, J INVEST DERMATOL, V106, P689, DOI 10.1111/1523-1747.ep12345525; Chitaev NA, 1997, J CELL BIOL, V138, P193, DOI 10.1083/jcb.138.1.193; COLLINS JE, 1991, J CELL BIOL, V113, P381, DOI 10.1083/jcb.113.2.381; DEMLEHNER MP, 1995, J CELL BIOL, V131, P745, DOI 10.1083/jcb.131.3.745; Denning MF, 1998, EXP CELL RES, V239, P50, DOI 10.1006/excr.1997.3890; DUDEN R, 1988, J CELL BIOL, V107, P1049, DOI 10.1083/jcb.107.3.1049; Duguay D, 2003, DEV BIOL, V253, P309, DOI 10.1016/S0012-1606(02)00016-7; Dusek RL, 2007, J DERMATOL SCI, V45, P7, DOI 10.1016/j.jdermsci.2006.10.006; Garrod D, 2008, BBA-BIOMEMBRANES, V1778, P572, DOI 10.1016/j.bbamem.2007.07.014; Garrod D, 2010, DERMAT RES PRACT, V2010, DOI 10.1155/2010/212439; Garrod DR, 2005, J CELL SCI, V118, P5743, DOI 10.1242/jcs.02700; Garrod DR, 2002, MOL MEMBR BIOL, V19, P81, DOI 10.1080/09687680210132476; Garrod DR, 2002, CURR OPIN CELL BIOL, V14, P537, DOI 10.1016/S0955-0674(02)00366-6; Green KJ, 2007, J INVEST DERMATOL, V127, P2499, DOI 10.1038/sj.jid.5701015; Grossmann KS, 2004, J CELL BIOL, V167, P149, DOI 10.1083/jcb.200402096; Haussinger D, 2004, EMBO J, V23, P1699, DOI 10.1038/sj.emboj.7600192; He WZ, 2003, SCIENCE, V302, P109, DOI 10.1126/science.1086957; Huber O, 2003, CELL MOL LIFE SCI, V60, P1872, DOI 10.1007/s00018-003-3050-7; Kimura TE, 2007, J INVEST DERMATOL, V127, P775, DOI 10.1038/sj.jid.5700643; Klingelhofer J, 2002, MOL CELL BIOL, V22, P7449, DOI 10.1128/MCB.22.21.7449-7458.2002; Koeser J, 2003, EXP CELL RES, V285, P114, DOI 10.1016/S0014-4827(03)00016-8; Marcozzi C, 1998, J CELL SCI, V111, P495; MATTEY DL, 1990, J CELL SCI, V97, P689; MATTEY DL, 1986, J CELL SCI, V85, P113; Messenger AG, 2005, J INVEST DERMATOL, V125, P1077, DOI 10.1111/j.0022-202X.2005.23903.x; Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0; Niessen CM, 2002, J CELL BIOL, V156, P389, DOI 10.1083/jcb.200108040; Noe V, 1999, J CELL SCI, V112, P127; Nollet F, 2000, J MOL BIOL, V299, P551, DOI 10.1006/jmbi.2000.3777; North AJ, 1999, J CELL SCI, V112, P4325; North AJ, 1996, P NATL ACAD SCI USA, V93, P7701, DOI 10.1073/pnas.93.15.7701; NOSE A, 1990, CELL, V61, P147, DOI 10.1016/0092-8674(90)90222-Z; Nuber UA, 1996, EUR J CELL BIOL, V71, P1; OVERDUIN M, 1995, SCIENCE, V267, P386, DOI 10.1126/science.7824937; PARKER AE, 1991, J BIOL CHEM, V266, P10438; PARRISH EP, 1987, J PATHOL, V153, P265, DOI 10.1002/path.1711530311; Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738; RAYNS DG, 1969, J CELL BIOL, V42, P322, DOI 10.1083/jcb.42.1.322; Runswick SK, 2001, NAT CELL BIOL, V3, P823, DOI 10.1038/ncb0901-823; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Shimizu A, 2005, J INVEST DERMATOL, V124, P984, DOI 10.1111/j.0022-202X.2005.23706.x; SHIMIZU H, 1995, J INVEST DERMATOL, V105, P153, DOI 10.1111/1523-1747.ep12316695; SKERROW CJ, 1989, J CELL SCI, V92, P667; Syed SEH, 2002, BIOCHEM J, V362, P317, DOI 10.1042/0264-6021:3620317; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Tamura K, 1998, NEURON, V20, P1153, DOI 10.1016/S0896-6273(00)80496-1; Thomason HA, 2010, BIOCHEM J, V429, P419, DOI 10.1042/BJ20100567; Troyanovsky RB, 2003, MOL CELL BIOL, V23, P7965, DOI 10.1128/MCB.23.22.7965-7972.2003; TROYANOVSKY SM, 1993, CELL, V72, P561, DOI 10.1016/0092-8674(93)90075-2; Tselepis C, 1998, P NATL ACAD SCI USA, V95, P8064, DOI 10.1073/pnas.95.14.8064; Vasioukhin V, 2001, NAT CELL BIOL, V3, P1076, DOI 10.1038/ncb1201-1076; VILELA MJ, 1995, J CELL SCI, V108, P1743; Vleminckx K, 1999, BIOESSAYS, V21, P211, DOI 10.1002/(SICI)1521-1878(199903)21:3<211::AID-BIES5>3.3.CO;2-G; Waschke J, 2005, J CLIN INVEST, V115, P3157, DOI 10.1172/JCI23475; Waschke J, 2007, J MEMBRANE BIOL, V216, P83, DOI 10.1007/s00232-007-9037-9; Whittock NV, 2003, J INVEST DERMATOL, V120, P523, DOI 10.1046/j.1523-1747.2003.12113.x; Williams E, 2000, J BIOL CHEM, V275, P4007, DOI 10.1074/jbc.275.6.4007; Yin TF, 2004, SEMIN CELL DEV BIOL, V15, P665, DOI 10.1016/j.semcdb.2004.09.005	66	51	51	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2143	2154		10.1074/jbc.M110.192245	http://dx.doi.org/10.1074/jbc.M110.192245			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21098030	Green Published, hybrid			2022-12-25	WOS:000286191500056
J	Reed, AM; Husain, SZ; Thrower, E; Alexandre, M; Shah, A; Gorelick, FS; Nathanson, MH				Reed, Anamika M.; Husain, Sohail Z.; Thrower, Edwin; Alexandre, Martine; Shah, Ahsan; Gorelick, Fred S.; Nathanson, Michael H.			Low Extracellular pH Induces Damage in the Pancreatic Acinar Cell by Enhancing Calcium Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL TRISPHOSPHATE RECEPTORS; CARDIAC RYANODINE RECEPTOR; INTRACELLULAR PH; SARCOPLASMIC-RETICULUM; ZYMOGEN ACTIVATION; LACTIC-ACIDOSIS; RELEASE CHANNEL; CA2+ RELEASE; NITRIC-OXIDE; DIABETIC-KETOACIDOSIS	Low extracellular pH (pHe) occurs in a number of clinical conditions and sensitizes to the development of pancreatitis. The mechanisms responsible for this sensitization are unknown. Because abnormal Ca2+ signaling underlies many of the early steps in the pathogenesis of pancreatitis, we evaluated the effect of decreasing pHe from 7.4 to 7.0 on Ca2+ signals in the acinar cell. Low pHe significantly increased the amplitude of cerulein-induced Ca2+ signals. The enhancement in amplitude was localized to the basolateral region of the acinar cell and was reduced by pretreatment with ryanodine receptor (RYR) inhibitors. Because basolateral RYRs also have been implicated in the pathogenesis of pancreatitis, we evaluated the effects of RYR inhibitors on pancreatitis responses in acidic conditions. RYR inhibitors significantly reduced the sensitizing effects of low pHe on zymogen activation and cellular injury. These findings suggest that enhanced RYR-mediated Ca2+ signaling in the basolateral region of the acinar cell is responsible for the injurious effects of low pHe on the exocrine pancreas.	[Nathanson, Michael H.] Yale Univ, Dept Internal Med, Sect Digest Dis, New Haven, CT 06515 USA; [Husain, Sohail Z.; Shah, Ahsan] Yale Univ, Dept Pediat, New Haven, CT 06515 USA	Yale University; Yale University	Reed, AM (corresponding author), 333 Cedar St,LMP 1080, New Haven, CT 06515 USA.	amc78@omega.med.yale.edu		Gorelick, Fred/0000-0001-8293-6803	American Gastroenterological Association; National Institutes of Health [T32 DK007356-31, R01 DK083327, R03 DK078707, K08 DK68116, DK34989, R01 DK54021, DK57751, DK45710, DK61747]; Children's Digestive Health and Nutrition Young Investigator award; Veterans Affairs merit award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083327, K08DK068116, R29DK045710, R01DK093491, R03DK078707, R01DK061747, K08DK090104, P30DK034989, P01DK057751, R01DK054021, T32DK007356, R01DK045710] Funding Source: NIH RePORTER	American Gastroenterological Association; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Digestive Health and Nutrition Young Investigator award; Veterans Affairs merit award(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by an American Gastroenterological Association Fellowship to Faculty Transition Award and National Institutes of Health Training Grant T32 DK007356-31 (to A. M. R.), National Institutes of Health Grants R01 DK083327, R03 DK078707, K08 DK68116, and DK34989 (to the Yale Liver Center), a Children's Digestive Health and Nutrition Young Investigator award (to S. Z. H.), National Institutes of Health Grant R01 DK54021 and a Veterans Affairs merit award (to F. S. G.), and National Institutes of Health Grants DK34989, DK57751, DK45710, and DK61747 (to M. H. N.).	ANTHONY BL, 1986, J NEUROCHEM, V46, P556, DOI 10.1111/j.1471-4159.1986.tb13003.x; ASSELIN J, 1983, BIOCHEM J, V216, P11, DOI 10.1042/bj2160011; Audia P, 2008, CLIN TOXICOL, V46, P164, DOI 10.1080/15563650701355314; Balshaw DM, 2002, J MEMBRANE BIOL, V185, P1, DOI 10.1007/s00232-001-0111-4; Barouch LA, 2002, NATURE, V416, P337, DOI 10.1038/416337a; Behrendorff N, 2010, GASTROENTEROLOGY, V139, P1711, DOI 10.1053/j.gastro.2010.07.051; Bhoomagoud M, 2009, GASTROENTEROLOGY, V137, P1083, DOI 10.1053/j.gastro.2009.05.041; Bultron G, 2008, J PEDIATR GASTR NUTR, V47, P370, DOI 10.1097/MPG.0b013e3181132252; CARTER KJ, 1987, AM J PHYSIOL, V253, pG690, DOI 10.1152/ajpgi.1987.253.5.G690; Chaudhuri A, 2005, AM J PHYSIOL-GASTR L, V288, pG235, DOI 10.1152/ajpgi.00334.2004; Coghlan ME, 2001, CLIN INFECT DIS, V33, P1914, DOI 10.1086/323783; Criddle DN, 2004, P NATL ACAD SCI USA, V101, P10738, DOI 10.1073/pnas.0403431101; Criddle DN, 2006, GASTROENTEROLOGY, V130, P781, DOI 10.1053/j.gastro.2005.12.031; Fitzsimmons TJ, 2000, BIOCHEM J, V351, P265, DOI 10.1042/0264-6021:3510265; Gerasimenko JV, 2002, J CELL SCI, V115, P485; Gourine AV, 2010, SCIENCE, V329, P571, DOI 10.1126/science.1190721; Grady T, 1998, AM J PHYSIOL-GASTR L, V275, pG1010, DOI 10.1152/ajpgi.1998.275.5.G1010; Guillaumes S, 1997, PANCREAS, V14, P262, DOI 10.1097/00006676-199704000-00007; Hofbauer B, 1998, AM J PHYSIOL-GASTR L, V275, pG352, DOI 10.1152/ajpgi.1998.275.2.G352; Husain SZ, 2005, P NATL ACAD SCI USA, V102, P14386, DOI 10.1073/pnas.0503215102; Ito K, 1997, EMBO J, V16, P242, DOI 10.1093/emboj/16.2.242; JOSEPH SK, 1989, BIOCHEM J, V258, P261, DOI 10.1042/bj2580261; Kawakami M, 1998, MOL PHARMACOL, V53, P497, DOI 10.1124/mol.53.3.497; LEACH SD, 1993, PANCREAS, V8, P64, DOI 10.1097/00006676-199301000-00013; LEACH SD, 1991, J CLIN INVEST, V87, P362, DOI 10.1172/JCI114995; Lee MG, 1997, J BIOL CHEM, V272, P15765, DOI 10.1074/jbc.272.25.15765; Leite MF, 1999, BIOCHEM J, V337, P305, DOI 10.1042/0264-6021:3370305; Leite MF, 2002, GASTROENTEROLOGY, V122, P415, DOI 10.1053/gast.2002.30982; Lokuta AJ, 1997, J BIOL CHEM, V272, P25333, DOI 10.1074/jbc.272.40.25333; MA J, 1988, SCIENCE, V242, P99, DOI 10.1126/science.2459777; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Menshikova EV, 2000, J CARDIOVASC PHARM, V36, P656, DOI 10.1097/00005344-200011000-00016; Morad M, 2000, ANTIOXID REDOX SIGN, V2, P1, DOI 10.1089/ars.2000.2.1-1; Mori S, 2008, MOD RHEUMATOL, V18, P634, DOI 10.1007/s10165-008-0106-4; MUALLEM S, 1989, AM J PHYSIOL, V257, pG917, DOI 10.1152/ajpgi.1989.257.6.G917; MUALLEM S, 1990, J BIOL CHEM, V265, P12806; MUALLEM S, 1995, J CELL BIOL, V128, P589, DOI 10.1083/jcb.128.4.589; MUALLEM S, 1989, ANNU REV PHYSIOL, V51, P83; Muller Michael W, 2007, Pancreas, V35, pe30; Nair S, 2000, AM J GASTROENTEROL, V95, P2795, DOI 10.1016/S0002-9270(00)01981-X; NATHANSON MH, 1992, J BIOL CHEM, V267, P18118; NATHANSON MH, 1994, J BIOL CHEM, V269, P4693; Nishiguchi H, 1997, JPN J PHYSIOL, V47, P41, DOI 10.2170/jjphysiol.47.41; Noble MD, 2008, GUT, V57, P1566, DOI 10.1136/gut.2008.148551; Nyenwe EA, 2010, DIABETES CARE, V33, P1837, DOI 10.2337/dc10-0102; Orabi AI, 2010, AM J PHYSIOL-GASTR L, V299, pG196, DOI 10.1152/ajpgi.00498.2009; Petersen OH, 2005, CELL CALCIUM, V38, P171, DOI 10.1016/j.ceca.2005.06.024; Raraty M, 2000, P NATL ACAD SCI USA, V97, P13126, DOI 10.1073/pnas.97.24.13126; Rodriguez P, 2003, J BIOL CHEM, V278, P38593, DOI 10.1074/jbc.C301180200; Rohra DK, 2003, LIFE SCI, V72, P1259; Speake T, 1998, J PHYSIOL-LONDON, V506, P415, DOI 10.1111/j.1469-7793.1998.415bw.x; Speake T, 1998, EUR J MORPHOL, V36, P165; STAUFFER PL, 1993, J BIOL CHEM, V268, P19769; STRAND MA, 1993, BIOCHIM BIOPHYS ACTA, V1175, P319, DOI 10.1016/0167-4889(93)90224-D; STREB H, 1984, J MEMBRANE BIOL, V81, P241, DOI 10.1007/BF01868717; SUKO J, 1993, BIOCHIM BIOPHYS ACTA, V1175, P193, DOI 10.1016/0167-4889(93)90023-I; SZECOWKA J, 1985, REGUL PEPTIDES, V10, P71, DOI 10.1016/0167-0115(85)90001-1; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; THORN P, 1993, CELL, V74, P661, DOI 10.1016/0092-8674(93)90513-P; TSUKIOKA M, 1994, J PHYSIOL-LONDON, V475, P369, DOI 10.1113/jphysiol.1994.sp020078; WANG JX, 1992, NATURE, V359, P739, DOI 10.1038/359739a0; Waterford SD, 2005, J BIOL CHEM, V280, P5430, DOI 10.1074/jbc.M413513200; Wester CW, 2007, JAIDS-J ACQ IMM DEF, V46, P318, DOI 10.1097/QAI.0b013e3181568e3f; Whitcomb DC, 2006, NEW ENGL J MED, V354, P2142, DOI 10.1056/NEJMcp054958; WITCHER DR, 1991, J BIOL CHEM, V266, P11144; WORLEY PF, 1987, J BIOL CHEM, V262, P12132; Yamaguchi N, 2003, J BIOL CHEM, V278, P23480, DOI 10.1074/jbc.M301125200; Yule DI, 1996, AM J PHYSIOL-CELL PH, V271, pC1285, DOI 10.1152/ajpcell.1996.271.4.C1285; Yule DI, 1997, J BIOL CHEM, V272, P9093; Zhou L, 2002, BIOCHEM BIOPH RES CO, V294, P1030, DOI 10.1016/S0006-291X(02)00599-5; Ziolo MT, 2001, AM J PHYSIOL-HEART C, V281, pH2295, DOI 10.1152/ajpheart.2001.281.6.H2295	71	19	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1919	1926		10.1074/jbc.M110.158329	http://dx.doi.org/10.1074/jbc.M110.158329			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21084290	Green Published, hybrid			2022-12-25	WOS:000286191500033
J	Hammond-Martel, I; Pak, H; Yu, H; Rouget, R; Horwitz, AA; Parvin, JD; Drobetsky, EA; Affar, E				Hammond-Martel, Ian; Pak, Helen; Yu, Helen; Rouget, Raphael; Horwitz, Andrew A.; Parvin, Jeffrey D.; Drobetsky, Elliot A.; Affar, El Bachir			PI 3 Kinase Related Kinases-Independent Proteolysis of BRCA1 Regulates Rad51 Recruitment during Genotoxic Stress in Human Cells	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; NUCLEOTIDE EXCISION-REPAIR; S-PHASE CHECKPOINT; HISTONE H2AX; IN-VIVO; PHOSPHORYLATION; ATR; CYCLE; DEGRADATION; REPLICATION	Background: The function of BRCA1 in response to ionizing radiation, which directly generates DNA double strand breaks, has been extensively characterized. However previous investigations have produced conflicting data on mutagens that initially induce other classes of DNA adducts. Because of the fundamental and clinical importance of understanding BRCA1 function, we sought to rigorously evaluate the role of this tumor suppressor in response to diverse forms of genotoxic stress. Methodology/Principal Findings: We investigated BRCA1 stability and localization in various human cells treated with model mutagens that trigger different DNA damage signaling pathways. We established that, unlike ionizing radiation, either UVC or methylmethanesulfonate (MMS) (generating bulky DNA adducts or alkylated bases respectively) induces a transient downregulation of BRCA1 protein which is neither prevented nor enhanced by inhibition of PIKKs. Moreover, we found that the proteasome mediates early degradation of BRCA1, BARD1, BACH1, and Rad52 implying that critical components of the homologous recombinaion machinery need to be functionally abrogated as part of the early response to UV or MMS. Significantly, we found that inhibition of BRCA1/BARD1 downregulation is accompanied by the unscheduled recruitment of both proteins to chromatin along with Rad51. Consistently, treatment of cells with MMS engendered complete disassembly of Rad51 from pre-formed ionizing radiation-induced foci. Following the initial phase of BRCA1/BARD1 downregulation, we found that the recovery of these proteins in foci coincides with the formation of RPA and Rad51 foci. This indicates that homologous recombination is reactivated at later stage of the cellular response to MMS, most likely to repair DSBs generated by replication blocks. Conclusion/Significance: Taken together our results demonstrate that (i) the stabilities of BRCA1/BARD1 complexes are regulated in a mutagen-specific manner, and (ii) indicate the existence of mechanisms that may be required to prevent the simultaneous recruitment of conflicting signaling pathways to sites of DNA damage.	[Hammond-Martel, Ian; Pak, Helen; Yu, Helen; Rouget, Raphael; Drobetsky, Elliot A.; Affar, El Bachir] Univ Montreal, Dept Med, Maisonneuve Rosemont Hosp, Montreal, PQ H3C 3J7, Canada; [Horwitz, Andrew A.; Parvin, Jeffrey D.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Horwitz, Andrew A.; Parvin, Jeffrey D.] Brigham & Womens Hosp, Boston, MA 02115 USA	Universite de Montreal; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Hammond-Martel, I (corresponding author), Univ Montreal, Dept Med, Maisonneuve Rosemont Hosp, Montreal, PQ H3C 3J7, Canada.	aelbachir.hmr@ssss.gouv.qc.ca	Parvin, Jeffrey D/C-8955-2009		Terry Fox Foundation [018144]; Cancer Research Society (CRS); Cole foundation; NCI [CA111480]; NATIONAL CANCER INSTITUTE [R01CA111480] Funding Source: NIH RePORTER	Terry Fox Foundation; Cancer Research Society (CRS); Cole foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant (018144) to EBA from the Terry Fox Foundation and Cancer Research Society (CRS). EBA is a scholar of Le Fonds de la Recherche en Sante du Quebec (FRSQ). HY is supported by a PhD fellowship from the Cole foundation. JP was supported by NCI award CA111480. AH was a predoctoral fellow with the Department of Defense Breast Cancer Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Affar E, 2006, MOL CELL BIOL, V26, P3565, DOI 10.1128/MCB.26.9.3565-3581.2006; Anderson CW, 2001, RADIAT RES, V156, P2, DOI 10.1667/0033-7587(2001)156[0002:FMIPTG]2.0.CO;2; Au WWY, 2007, CELL SIGNAL, V19, P1879, DOI 10.1016/j.cellsig.2007.04.010; Bendjennat M, 2003, CELL, V114, P599, DOI 10.1016/j.cell.2003.08.001; Bennett CB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001448; Bochar DA, 2000, CELL, V102, P257, DOI 10.1016/S0092-8674(00)00030-1; Bolderson E, 2009, CLIN CANCER RES, V15, P6314, DOI 10.1158/1078-0432.CCR-09-0096; Brodie KM, 2010, CELL SIGNAL, V22, P291, DOI 10.1016/j.cellsig.2009.09.034; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Choudhury AD, 2004, J BIOL CHEM, V279, P33909, DOI 10.1074/jbc.M403646200; Clarkin CEK, 2000, CELL MOL LIFE SCI, V57, P1126, DOI 10.1007/PL00000749; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Dent P, 2003, ONCOGENE, V22, P5885, DOI 10.1038/sj.onc.1206701; Dizin E, 2008, APOPTOSIS, V13, P237, DOI 10.1007/s10495-007-0167-4; Drew Y, 2010, CURR OPIN OBSTET GYN, V22, P67, DOI 10.1097/GCO.0b013e328334ff57; Durocher D, 2001, CURR OPIN CELL BIOL, V13, P225, DOI 10.1016/S0955-0674(00)00201-5; Fan SJ, 1998, INT J CANCER, V77, P600, DOI 10.1002/(SICI)1097-0215(19980812)77:4<600::AID-IJC21>3.0.CO;2-8; Feki A, 2005, ONCOGENE, V24, P3726, DOI 10.1038/sj.onc.1208491; Fitch ME, 2003, DNA REPAIR, V2, P819, DOI 10.1016/S1568-7864(03)00066-1; Gatei M, 2001, J BIOL CHEM, V276, P17276, DOI 10.1074/jbc.M011681200; Harper Jane V., 2004, V296, P157; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Huen MSY, 2010, NAT REV MOL CELL BIO, V11, P138, DOI 10.1038/nrm2831; Irminger-Finger I, 2001, MOL CELL, V8, P1255, DOI 10.1016/S1097-2765(01)00406-3; Jacquemont C, 2007, CANCER RES, V67, P7395, DOI 10.1158/0008-5472.CAN-07-1015; Jensen DE, 1998, ONCOGENE, V16, P1097, DOI 10.1038/sj.onc.1201861; Jin Y, 1997, P NATL ACAD SCI USA, V94, P12075, DOI 10.1073/pnas.94.22.12075; Johnson N, 2009, MOL CELL, V35, P327, DOI 10.1016/j.molcel.2009.06.036; Kessler BM, 2001, CHEM BIOL, V8, P913, DOI 10.1016/S1074-5521(01)00069-2; Kranz D, 2008, J CELL BIOL, V182, P197, DOI 10.1083/jcb.200712014; Kuluncsics Z, 1999, J PHOTOCH PHOTOBIO B, V49, P71, DOI 10.1016/S1011-1344(99)00034-2; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lin SY, 2004, P NATL ACAD SCI USA, V101, P6484, DOI 10.1073/pnas.0401847101; Liu JS, 2003, MUTAT RES-FUND MOL M, V532, P215, DOI 10.1016/j.mrfmmm.2003.08.018; Liu ZG, 1996, NATURE, V384, P273, DOI 10.1038/384273a0; Manthey KC, 2007, J CELL SCI, V120, P4221, DOI 10.1242/jcs.004580; Marti TM, 2006, P NATL ACAD SCI USA, V103, P9891, DOI 10.1073/pnas.0603779103; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; O'Brien KA, 1999, BIOCHEM BIOPH RES CO, V260, P658, DOI 10.1006/bbrc.1999.0892; O'Donovan PJ, 2010, CARCINOGENESIS, V31, P961, DOI 10.1093/carcin/bgq069; Pageau GJ, 2006, J CELL BIOL, V175, P693, DOI 10.1083/jcb.200602055; Panier S, 2009, DNA REPAIR, V8, P436, DOI 10.1016/j.dnarep.2009.01.013; Rapic-Otrin V, 2002, NUCLEIC ACIDS RES, V30, P2588, DOI 10.1093/nar/30.11.2588; Ray A, 2009, MOL CELL BIOL, V29, P6206, DOI 10.1128/MCB.00503-09; Ruffner H, 1999, MOL CELL BIOL, V19, P4843; Rusin M, 2009, MECH AGEING DEV, V130, P528, DOI 10.1016/j.mad.2009.06.005; Sarkaria JN, 1999, CANCER RES, V59, P4375; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Shao RG, 1999, EMBO J, V18, P1397, DOI 10.1093/emboj/18.5.1397; Soria G, 2010, DNA REPAIR, V9, P358, DOI 10.1016/j.dnarep.2009.12.003; Staszewski O, 2008, ENVIRON MOL MUTAGEN, V49, P734, DOI 10.1002/em.20430; Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Tang YT, 1996, MOL CELL BIOL, V16, P1989; Thomas JE, 1997, CELL GROWTH DIFFER, V8, P801; Thornton TM, 2009, INT J BIOL SCI, V5, P44, DOI 10.7150/ijbs.5.44; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Vassin VM, 2009, J CELL SCI, V122, P4070, DOI 10.1242/jcs.053702; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Ward IM, 2004, J BIOL CHEM, V279, P9677, DOI 10.1074/jbc.C300554200; Wei LZ, 2008, MOL CELL BIOL, V28, P7380, DOI 10.1128/MCB.01075-08; WU X, 2000, SCIENCE, V289, pA11; Xu B, 2002, CANCER RES, V62, P4588; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Yan Y, 2008, CANCER RES, V68, P5113, DOI 10.1158/0008-5472.CAN-07-5818; Yang WW, 2007, CELL DEATH DIFFER, V14, P807, DOI 10.1038/sj.cdd.4402062; Yoon JH, 2000, J MOL BIOL, V299, P681, DOI 10.1006/jmbi.2000.3771; Zhan QM, 2002, ONCOGENE, V21, P5335, DOI 10.1038/sj.onc.1205665; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019; Zheng L, 2000, MOL CELL, V6, P757, DOI 10.1016/S1097-2765(00)00075-7	72	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2010	5	11							e14027	10.1371/journal.pone.0014027	http://dx.doi.org/10.1371/journal.pone.0014027			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681OY	21103343	Green Submitted, gold, Green Published			2022-12-25	WOS:000284327800013
J	Humphreys, EH; Williams, KT; Adams, DH; Afford, SC				Humphreys, Elizabeth H.; Williams, Kevin T.; Adams, David H.; Afford, Simon C.			Primary and Malignant Cholangiocytes Undergo CD40 Mediated Fas Dependent Apoptosis, but Are Insensitive to Direct Activation with Exogenous Fas Ligand	PLOS ONE			English	Article							PRIMARY BILIARY-CIRRHOSIS; CELL-DEATH; HUMAN-LIVER; ALLOGRAFT-REJECTION; EPITHELIAL-CELLS; CARCINOMA-CELLS; FACTOR RECEPTOR; TUMOR-GROWTH; C VIRUS; CHOLANGIOCARCINOMA	Introduction: Cholangiocarcinoma is a rare malignancy of the biliary tract, the incidence of which is rising, but the pathogenesis of which remains uncertain. No common genetic defects have been described but it is accepted that chronic inflammation is an important contributing factor. We have shown that primary human cholangiocyte and hepatocyte survival is tightly regulated via co-operative interactions between two tumour necrosis family (TNF) receptor family members; CD40 and Fas (CD95). Functional deficiency of CD154, the ligand for CD40, leads to a failure of clearance of biliary tract infections and a predisposition to cholangiocarcinoma implying a direct link between TNF receptor-mediated apoptosis and the development of cholangiocarcinoma. Aims: To determine whether malignant cholangiocytes display defects in CD40 mediated apoptosis. By comparing CD40 and Fas-mediated apoptosis and intracellular signalling in primary human cholangiocytes and three cholangiocyte cell lines. Results: Primary cholangiocytes and cholangiocyte cell lines were relatively insensitive to direct Fas-mediated killing with exogenous FasL when compared with Jurkat cells, which readily underwent Fas-mediated apoptosis, but were extremely sensitive to CD154 stimulation. The sensitivity of cells to CD40 activation was similar in magnitude in both primary and malignant cells and was STAT-3 and AP-1 dependent in both. Conclusions: 1) Both primary and malignant cholangiocytes are relatively resistant to Fas-mediated killing but show exquisite sensitivity to CD154, suggesting that the CD40 pathway is intact and fully functional in both primary and malignant cholangiocytes 2) The relative insensitivity of cholangiocytes to Fas activation demonstrates the importance of CD40 augmentation of Fas dependent death in these cells. Agonistic therapies which target CD40 and associated intracellular signalling pathways may be effective in promoting apoptosis of malignant cholangiocytes.	[Humphreys, Elizabeth H.; Williams, Kevin T.; Adams, David H.; Afford, Simon C.] Univ Birmingham, Liver Res Ctr, MRC Ctr Immune Regulat, Inst Biomed Res, Birmingham, W Midlands, England	University of Birmingham	Humphreys, EH (corresponding author), Univ Birmingham, Liver Res Ctr, MRC Ctr Immune Regulat, Inst Biomed Res, Birmingham, W Midlands, England.	s.c.afford@bham.ac.uk	Humphreys, Elizabeth/I-5090-2015; Adams, David H/C-9092-2009	Humphreys, Elizabeth/0000-0002-6742-7485; Adams, David H/0000-0001-6776-0336	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/E017096/1]; BBSRC [BB/E017096/1] Funding Source: UKRI; STFC [ST/H000429/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E017096/1] Funding Source: researchfish; Medical Research Council [G9818340B] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Biotechnology and Biological Sciences Research Council (BBSRC) grant BB/E017096/1. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abmayr S. M., 2006, CURRENT PROTOCOLS MO, P1211; Afford SC, 2005, GUT, V54, P1518, DOI 10.1136/gut.2005.067801; Afford SC, 1999, J EXP MED, V189, P441, DOI 10.1084/jem.189.2.441; AFFORD SC, 1995, J PATHOL, V176, P373, DOI 10.1002/path.1711760408; Afford SC, 2001, FASEB J, V15, P2345, DOI 10.1096/fj.01-0088com; Ahmed-Choudhury J, 2006, CELL SIGNAL, V18, P456, DOI 10.1016/j.cellsig.2005.05.015; Alabraba EB, 2008, HEPATOLOGY, V47, P552, DOI 10.1002/hep.22011; Alexandroff AB, 2000, MOL IMMUNOL, V37, P515, DOI 10.1016/S0161-5890(00)00079-1; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; ANSARI B, 1993, J PATHOL, V170, P1, DOI 10.1002/path.1711700102; ARMITAGE RJ, 1992, NATURE, V357, P80, DOI 10.1038/357080a0; Baxendale AJ, 2005, ONCOGENE, V24, P7913, DOI 10.1038/sj.onc.1208929; Bergamo A, 1997, BRIT J HAEMATOL, V97, P652, DOI 10.1046/j.1365-2141.1997.1032919.x; Bonfoco E, 1998, IMMUNITY, V9, P711, DOI 10.1016/S1074-7613(00)80668-8; Broome U, 1996, GUT, V38, P610, DOI 10.1136/gut.38.4.610; Bugajska U, 2002, J NATL CANCER I, V94, P1381; Cascino I, 1996, J IMMUNOL, V156, P13; Chapman RS, 1999, GENE DEV, V13, P2604, DOI 10.1101/gad.13.19.2604; Chu P, 2002, P NATL ACAD SCI USA, V99, P3854, DOI 10.1073/pnas.022604399; CLEARY AM, 1995, J IMMUNOL, V155, P3329; CLEMENT MV, 1994, J EXP MED, V180, P557, DOI 10.1084/jem.180.2.557; Dzojic H, 2006, PROSTATE, V66, P831, DOI 10.1002/pros.20344; Eliopoulos AG, 2000, MOL CELL BIOL, V20, P5503, DOI 10.1128/MCB.20.15.5503-5515.2000; Esche C, 1999, EUR J IMMUNOL, V29, P2148; Fan MY, 2001, CANCER RES, V61, P4450; Ferrant JL, 2004, INT IMMUNOL, V16, P1583, DOI 10.1093/intimm/dxh162; French LE, 1996, J CELL BIOL, V133, P335, DOI 10.1083/jcb.133.2.335; Gaur U, 2003, BIOCHEM PHARMACOL, V66, P1403, DOI 10.1016/S0006-2952(03)00490-8; Harada K, 1997, HEPATOLOGY, V26, P1399; Hayward AR, 1997, J IMMUNOL, V158, P977; Hess S, 1996, J EXP MED, V183, P159, DOI 10.1084/jem.183.1.159; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; Jakobson E, 1998, INT J CANCER, V77, P849, DOI 10.1002/(SICI)1097-0215(19980911)77:6<849::AID-IJC9>3.0.CO;2-U; JOPLIN R, 1989, IN VITRO CELL DEV B, V25, P1189; Khan SA, 2005, LANCET, V366, P1303, DOI 10.1016/S0140-6736(05)67530-7; Klimp AH, 2002, CRIT REV ONCOL HEMAT, V44, P143, DOI 10.1016/S1040-8428(01)00203-7; KUBO S, 1995, WORLD J SURG, V19, P637, DOI 10.1007/BF00294744; Le-Niculescu H, 1999, MOL CELL BIOL, V19, P751; LIPSETT PA, 1994, ANN SURG, V220, P644, DOI 10.1097/00000658-199411000-00007; Mach F, 1997, P NATL ACAD SCI USA, V94, P1931, DOI 10.1073/pnas.94.5.1931; Maxwell JR, 1999, J IMMUNOL, V162, P2024; Ochs H D, 1994, Semin Immunol, V6, P337, DOI 10.1006/smim.1994.1042; Ohtsuka T, 2001, ENDOSCOPY, V33, P614, DOI 10.1055/s-2001-15324; Ottaiano A, 2002, TUMORI J, V88, P361, DOI 10.1177/030089160208800502; Pan G, 2007, INT J ONCOL, V31, P843; PAULIE S, 1985, CANCER IMMUNOL IMMUN, V20, P23; Pickens A, 1999, J GASTROINTEST SURG, V3, P374, DOI 10.1016/S1091-255X(99)80053-5; Que FG, 1999, HEPATOLOGY, V30, p384A; Rissoan MC, 1996, CLIN EXP IMMUNOL, V106, P481, DOI 10.1046/j.1365-2249.1996.d01-858.x; Schonbeck U, 2001, CELL MOL LIFE SCI, V58, P4, DOI 10.1007/PL00000776; Schuler W, 2004, TRANSPLANTATION, V77, P717, DOI 10.1097/01.TP.0000116563.72763.83; Shimonishi T, 2000, HEPATOLOGY, V32, P761, DOI 10.1053/jhep.2000.18192; Shin HR, 1996, INT J EPIDEMIOL, V25, P933, DOI 10.1093/ije/25.5.933; STAMENKOVIC I, 1989, EMBO J, V8, P1403, DOI 10.1002/j.1460-2075.1989.tb03521.x; Starkel P, 2003, AM J PATHOL, V162, P587, DOI 10.1016/S0002-9440(10)63852-7; STEWART R, 2001, J IMMUNOL, V179, P2705; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; Vonderheide RH, 2001, J CLIN ONCOL, V19, P3280, DOI 10.1200/JCO.2001.19.13.3280; Wang DK, 1997, BRIT J HAEMATOL, V97, P409, DOI 10.1046/j.1365-2141.1997.422688.x; Watanapa P, 1996, BRIT J SURG, V83, P1062, DOI 10.1002/bjs.1800830809; Williams KT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000159; Wingett DG, 1998, BREAST CANCER RES TR, V50, P27, DOI 10.1023/A:1006012607452; ZONG YS, 1991, ONCOLOGY-BASEL, V48, P290	63	18	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2010	5	11							e14037	10.1371/journal.pone.0014037	http://dx.doi.org/10.1371/journal.pone.0014037			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681OY	21103345	gold, Green Published			2022-12-25	WOS:000284327800018
J	Fourrage, C; Chevalier, S; Houliston, E				Fourrage, Cecile; Chevalier, Sandra; Houliston, Evelyn			A Highly Conserved Poc1 Protein Characterized in Embryos of the Hydrozoan Clytia hemisphaerica: Localization and Functional Studies	PLOS ONE			English	Article							CENTRIOLE DUPLICATION; GERM PLASM; CNIDARIAN; DIFFERENTIATION; COMPONENT; XENOPUS; GENES	Poc1 (Protein of Centriole 1) proteins are highly conserved WD40 domain-containing centriole components, well characterized in the alga Chlamydomonas, the ciliated protazoan Tetrahymena, the insect Drosophila and in vertebrate cells including Xenopus and zebrafish embryos. Functions and localizations related to the centriole and ciliary axoneme have been demonstrated for Poc1 in a range of species. The vertebrate Poc1 protein has also been reported to show an additional association with mitochondria, including enrichment in the specialized "germ plasm" region of Xenopus oocytes. We have identified and characterized a highly conserved Poc1 protein in the cnidarian Clytia hemisphaerica. Clytia Poc1 mRNA was found to be strongly expressed in eggs and early embryos, showing a punctate perinuclear localization in young oocytes. Fluorescence-tagged Poc1 proteins expressed in developing embryos showed strong localization to centrioles, including basal bodies. Anti-human Poc1 antibodies decorated mitochondria in Clytia, as reported in human cells, but failed to recognise endogenous or fluorescent-tagged Clytia Poc1. Injection of specific morpholino oligonucleotides into Clytia eggs prior to fertilization to repress Poc1 mRNA translation interfered with cell division from the blastula stage, likely corresponding to when neosynthesis normally takes over from maternally supplied protein. Cell cycle lengthening and arrest were observed, phenotypes consistent with an impaired centriolar biogenesis or function. The specificity of the defects could be demonstrated by injection of synthetic Poc1 mRNA, which restored normal development. We conclude that in Clytia embryos, Poc1 has an essentially centriolar localization and function.	[Fourrage, Cecile] Univ Paris 06, Villefranche Sur Mer, France; CNRS, Dev Biol Unit, Villefranche Sur Mer, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS)	Fourrage, C (corresponding author), Univ Paris 06, Villefranche Sur Mer, France.	houliston@obs-vlfr.fr		Houliston, Evelyn/0000-0001-9264-2585	Centre National de Recherche Scientifique and Agence National Recherche de la Recherche [ANR-09-BLAN-0236-02]; French Ministere de l'Enseignement Superieur et de la Recherche	Centre National de Recherche Scientifique and Agence National Recherche de la Recherche; French Ministere de l'Enseignement Superieur et de la Recherche	Funding came from the Centre National de Recherche Scientifique and Agence National Recherche de la Recherche [ANR-09-BLAN-0236-02], and a studentship from the French Ministere de l'Enseignement Superieur et de la Recherche to CF. EST sequencing was performed at the Genoscope (Evry). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel A, 2009, DEV BIOL, V327, P191, DOI 10.1016/j.ydbio.2008.12.007; Amiel A, 2009, CURR BIOL, V19, P305, DOI 10.1016/j.cub.2008.12.054; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Blachon S, 2009, GENETICS, V182, P133, DOI 10.1534/genetics.109.101709; Chevalier S, 2006, DEV GENES EVOL, V216, P709, DOI 10.1007/s00427-006-0103-6; DEBEC A, 2010, CELL MOL LIFE SCI; Denker E, 2008, DEV BIOL, V315, P99, DOI 10.1016/j.ydbio.2007.12.023; EDDY EM, 1975, INT REV CYTOL, V43, P229; Harnes RS, 2008, EXP CELL RES, V314, P574, DOI 10.1016/j.yexcr.2007.10.019; Houliston E, 2010, TRENDS GENET, V26, P159, DOI 10.1016/j.tig.2010.01.008; Keller LC, 2009, MOL BIOL CELL, V20, P1150, DOI 10.1091/mbc.E08-06-0619; Keller LC, 2005, CURR BIOL, V15, P1090, DOI 10.1016/j.cub.2005.05.024; Kilburn CL, 2007, J CELL BIOL, V178, P905, DOI 10.1083/jcb.200703109; Liu Q, 2007, MOL CELL PROTEOMICS, V6, P1299, DOI 10.1074/mcp.M700054-MCP200; Machado RJ, 2005, DEV BIOL, V287, P289, DOI 10.1016/j.ydbio.2005.08.044; Momose T, 2008, DEVELOPMENT, V135, P2105, DOI 10.1242/dev.021543; Momose T, 2007, PLOS BIOL, V5, P889, DOI 10.1371/journal.pbio.0050070; Murray AW, 2001, SCIENCE, V291, P1499, DOI 10.1126/science.291.5508.1499; Pearson CG, 2009, J CELL BIOL, V187, P904, DOI 10.1083/jcb.200908019; Perez-Mongiovi D, 1998, J CELL SCI, V111, P385; ROOSENRU.EC, 1965, Z ZELLFORSCH MIK ANA, V68, P597, DOI 10.1007/BF00340088; Roure A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000916; Sharma N, 2008, CURR TOP DEV BIOL, V85, P371, DOI 10.1016/S0070-2153(08)00813-2; Woodland HR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003778	24	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e13994	10.1371/journal.pone.0013994	http://dx.doi.org/10.1371/journal.pone.0013994			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103375	Green Published, Green Submitted, gold			2022-12-25	WOS:000284257400004
J	Maricic, T; Whitten, M; Paabo, S				Maricic, Tomislav; Whitten, Mark; Paeaebo, Svante			Multiplexed DNA Sequence Capture of Mitochondrial Genomes Using PCR Products	PLOS ONE			English	Article								Background: To utilize the power of high-throughput sequencers, target enrichment methods have been developed. The majority of these require reagents and equipment that are only available from commercial vendors and are not suitable for the targets that are a few kilobases in length. Methodology/Principal Findings: We describe a novel and economical method in which custom made long-range PCR products are used to capture complete human mitochondrial genomes from complex DNA mixtures. We use the method to capture 46 complete mitochondrial genomes in parallel and we sequence them on a single lane of an Illumina GA(II) instrument. Conclusions/Significance: This method is economical and simple and particularly suitable for targets that can be amplified by PCR and do not contain highly repetitive sequences such as mtDNA. It has applications in population genetics and forensics, as well as studies of ancient DNA.	[Maricic, Tomislav; Whitten, Mark; Paeaebo, Svante] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, Leipzig, Germany	Max Planck Society	Maricic, T (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, Leipzig, Germany.	tomislav_maricic@eva.mpg.de		Maricic, Tomislav/0000-0003-3267-0474	Max Planck Society	Max Planck Society(Max Planck Society)	This study was funded by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802; Hodges E, 2007, NAT GENET, V39, P1522, DOI 10.1038/ng.2007.42; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kircher M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r83; Krause J, 2010, CURR BIOL, V20, P231, DOI 10.1016/j.cub.2009.11.068; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Meyer M., 2010, COLD SPRING HARB PRO; Meyer M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm566; MEYERHANS A, 1990, NUCLEIC ACIDS RES, V18, P1687, DOI 10.1093/nar/18.7.1687; Pakendorf B, 2005, ANNU REV GENOM HUM G, V6, P165, DOI 10.1146/annurev.genom.6.080604.162249; Pakendorf B, 2006, HUM GENET, V120, P334, DOI 10.1007/s00439-006-0213-2; Porreca GJ, 2007, NAT METHODS, V4, P931, DOI 10.1038/NMETH1110; Tewhey R, 2009, NAT BIOTECHNOL, V27, P1025, DOI 10.1038/nbt.1583	16	357	377	5	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e14004	10.1371/journal.pone.0014004	http://dx.doi.org/10.1371/journal.pone.0014004			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103372	Green Published, gold, Green Submitted			2022-12-25	WOS:000284257400008
J	Nunney, L; Yuan, XL; Bromley, R; Hartung, J; Montero-Astua, M; Moreira, L; Ortiz, B; Stouthamer, R				Nunney, Leonard; Yuan, Xiaoli; Bromley, Robin; Hartung, John; Montero-Astua, Mauricio; Moreira, Lisela; Ortiz, Beatriz; Stouthamer, Richard			Population Genomic Analysis of a Bacterial Plant Pathogen: Novel Insight into the Origin of Pierce's Disease of Grapevine in the US	PLOS ONE			English	Article							CITRUS VARIEGATED CHLOROSIS; XYLELLA-FASTIDIOSA STRAINS; LEAF SCORCH; GENETIC DIVERSITY; SEQUENCE; BIOLOGY	Invasive diseases present an increasing problem worldwide; however, genomic techniques are now available to investigate the timing and geographical origin of such introductions. We employed genomic techniques to demonstrate that the bacterial pathogen causing Pierce's disease of grapevine (PD) is not native to the US as previously assumed, but descended from a single genotype introduced from Central America. PD has posed a serious threat to the US wine industry ever since its first outbreak in Anaheim, California in the 1880s and continues to inhibit grape cultivation in a large area of the country. It is caused by infection of xylem vessels by the bacterium Xylella fastidiosa subsp. fastidiosa, a genetically distinct subspecies at least 15,000 years old. We present five independent kinds of evidence that strongly support our invasion hypothesis: 1) a genome-wide lack of genetic variability in X. fastidiosa subsp. fastidiosa found in the US, consistent with a recent common ancestor; 2) evidence for historical allopatry of the North American subspecies X. fastidiosa subsp. multiplex and X. fastidiosa subsp. fastidiosa; 3) evidence that X. fastidiosa subsp. fastidiosa evolved in a more tropical climate than X. fastidiosa subsp. multiplex; 4) much greater genetic variability in the proposed source population in Central America, variation within which the US genotypes are phylogenetically nested; and 5) the circumstantial evidence of importation of known hosts (coffee plants) from Central America directly into southern California just prior to the first known outbreak of the disease. The lack of genetic variation in X. fastidiosa subsp. fastidiosa in the US suggests that preventing additional introductions is important since new genetic variation may undermine PD control measures, or may lead to infection of other crop plants through the creation of novel genotypes via inter-subspecific recombination. In general, geographically mixing of previously isolated subspecies should be avoided.	[Nunney, Leonard; Yuan, Xiaoli] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; [Bromley, Robin; Stouthamer, Richard] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Hartung, John] USDA ARS, Plant Pathol Lab, Beltsville, MD USA; [Montero-Astua, Mauricio; Moreira, Lisela; Ortiz, Beatriz] Univ Costa Rica, Ctr Invest Biol Celular & Mol, San Jose, Costa Rica	University of California System; University of California Riverside; University of California System; University of California Riverside; United States Department of Agriculture (USDA); Universidad Costa Rica	Nunney, L (corresponding author), Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA.	leonard.nunney@ucr.edu	Moreira, Lisela/Y-8267-2019	Moreira, Lisela/0000-0003-3344-7979; Nunney, Leonard/0000-0002-4315-3694; Bromley, Robin/0000-0003-2738-2603	United States Department of Agriculture Cooperative State Research, Education, and Extension Service National Research Initiative [2007-55605-17834]	United States Department of Agriculture Cooperative State Research, Education, and Extension Service National Research Initiative(United States Department of Agriculture (USDA))	This study was supported by a United States Department of Agriculture Cooperative State Research, Education, and Extension Service National Research Initiative Plant Biosecurity grant 2007-55605-17834 to L.N. and R.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Almeida RPP, 2008, APPL ENVIRON MICROB, V74, P3690, DOI 10.1128/AEM.02388-07; Almeida RPP, 2003, APPL ENVIRON MICROB, V69, P7447, DOI 10.1128/AEM.69.12.7447-7452.2003; Berisha B, 1998, EUR J PLANT PATHOL, V104, P427, DOI 10.1023/A:1008655621235; Bhattacharyya A, 2002, P NATL ACAD SCI USA, V99, P12403, DOI 10.1073/pnas.132393999; Brasier CM, 2001, BIOSCIENCE, V51, P123, DOI 10.1641/0006-3568(2001)051[0123:REOIPP]2.0.CO;2; CHANG CJ, 1993, CURR MICROBIOL, V27, P137, DOI 10.1007/BF01576010; Chen J, 2007, PHYTOPATHOLOGY, V97, pS21; CHEN J, 1995, APPL ENVIRON MICROB, V61, P1688, DOI 10.1128/AEM.61.5.1688-1690.1995; GOHEEN AC, 1979, PLANT DIS REP, V63, P788; GUINN JM, 1915, HIST CALIFORNIA EXTE, V1; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hendson M, 2001, APPL ENVIRON MICROB, V67, P895, DOI 10.1128/AEM.67.2.895-903.2001; Hernandez-Martinez R, 2006, PLANT DIS, V90, P1382, DOI 10.1094/PD-90-1382; HERNANDEZMARTIN.R, 2007, SO CALIFORNIA PHYTOP, V97, P857; HEWITT W. B., 1958, PLANT DIS REPORTER, V42, P211; HOPKINS DL, 1989, ANNU REV PHYTOPATHOL, V27, P271, DOI 10.1146/annurev.py.27.090189.001415; Lin H, 2005, APPL ENVIRON MICROB, V71, P4888, DOI 10.1128/AEM.71.8.4888-4892.2005; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Montero-Astua M, 2008, J MICROBIOL, V46, P482, DOI 10.1007/s12275-008-0072-8; MONTEROASTU AM, 2007, UNITED STATES PHYTOP, V97, P1338; Pierce NB., 1892, CALIFORNIA VINE DIS; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Purcell AH, 1996, ANNU REV PHYTOPATHOL, V34, P131, DOI 10.1146/annurev.phyto.34.1.131; Redak RA, 2004, ANNU REV ENTOMOL, V49, P243, DOI 10.1146/annurev.ento.49.061802.123403; RODRIGUEZ CM, 2001, DIS NOTES, V85, P1027; Scally M, 2005, APPL ENVIRON MICROB, V71, P8491, DOI 10.1128/AEM.71.12.8491-8499.2005; Schaad NW, 2004, SYST APPL MICROBIOL, V27, P290, DOI 10.1078/0723-2020-00263; Schuenzel EL, 2005, APPL ENVIRON MICROB, V71, P3832, DOI 10.1128/AEM.71.7.3832-3839.2005; Simpson AJG, 2000, NATURE, V406, P151, DOI 10.1038/35018003; STONER WARREN N., 1952, FLORIDA ENT, V35, P62, DOI 10.2307/3492278; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Van Sluys MA, 2003, J BACTERIOL, V185, P1018, DOI 10.1128/JB.185.3.1018-1026.2003; Yuan X, 2010, PHYTOPATHOLOGY, V100, P601, DOI 10.1094/PHYTO-100-6-0601; 1863, T CALIFORNIA AGR SOC, P52	34	76	78	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e15488	10.1371/journal.pone.0015488	http://dx.doi.org/10.1371/journal.pone.0015488			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103383	Green Published, Green Submitted, gold			2022-12-25	WOS:000284257400027
J	Chae, HD; Siefring, JE; Hildeman, DA; Gu, Y; Williams, DA				Chae, Hee-Don; Siefring, Jamie E.; Hildeman, David A.; Gu, Yi; Williams, David A.			RhoH Regulates Subcellular Localization of ZAP-70 and Lck in T Cell Receptor Signaling	PLOS ONE			English	Article							HEMATOPOIETIC PROGENITOR CELLS; GTP-BINDING PROTEIN; IMMUNOLOGICAL SYNAPSE; TYROSINE KINASE; ZETA-CHAIN; LYMPHOCYTE-ACTIVATION; ACTIN CYTOSKELETON; ANTIGEN RECEPTOR; GENE-TRANSFER; PHOSPHORYLATION	RhoH is an hematopoietic-specific, GTPase-deficient Rho GTPase that plays a role in T development. We investigated the mechanisms of RhoH function in TCR signaling. We found that the association between Lck and CD3 zeta was impaired in RhoH-deficient T cells, due to defective translocation of both Lck and ZAP-70 to the immunological synapse. RhoH with Lck and ZAP-70 localizes in the detergent-soluble membrane fraction where the complex is associated with CD3 zeta phosphorylation. To determine if impaired translocation of ZAP-70 was a major determinant of defective T cell development, Rhoh(-/-) bone marrow cells were transduced with a chimeric myristoylation-tagged ZAP-70. Myr-ZAP-70 transduced cells partially reversed the in vivo defects of RhoH-associated thymic development and TCR signaling. Together, our results suggest that RhoH regulates TCR signaling via recruitment of ZAP-70 and Lck to CD3 zeta in the immunological synapse. Thus, we define a new function for a RhoH GTPase as an adaptor molecule in TCR signaling pathway.	[Chae, Hee-Don; Siefring, Jamie E.; Gu, Yi; Williams, David A.] Cincinnati Childrens Hosp Med Ctr, Cincinnati Childrens Res Fdn, Div Expt Hematol, Cincinnati, OH USA; [Chae, Hee-Don; Siefring, Jamie E.; Hildeman, David A.; Gu, Yi; Williams, David A.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Hildeman, David A.] Cincinnati Childrens Hosp Med Ctr, Cincinnati Childrens Res Fdn, Div Immunobiol, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati	Chae, HD (corresponding author), Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN USA.	DAWilliams@childrens.harvard.edu	Hildeman, David/I-4884-2015; Chae, Hee-Don/D-2620-2011; Hildeman, David/AAA-1757-2020	Hildeman, David/0000-0002-0421-8483; Hildeman, David/0000-0002-0421-8483	National Institutes of Health [R01 CA113969]; NATIONAL CANCER INSTITUTE [R01CA113969] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work in this manuscript was supported by grant R01 CA113969 from the National Institutes of Health to David Williams. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashe JM, 1999, J EXP MED, V189, P1163, DOI 10.1084/jem.189.7.1163; Aspenstrom P, 2007, EXP CELL RES, V313, P3673, DOI 10.1016/j.yexcr.2007.07.022; Brdicka T, 2005, MOL CELL BIOL, V25, P4924, DOI 10.1128/MCB.25.12.4924-4933.2005; Cannon JL, 2002, IMMUNOL REV, V186, P90, DOI 10.1034/j.1600-065X.2002.18609.x; Chae HD, 2008, BLOOD, V111, P2597, DOI 10.1182/blood-2007-06-093237; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; Cherry LK, 2004, NAT IMMUNOL, V5, P961, DOI 10.1038/ni1103; CLAYTON LK, 1991, P NATL ACAD SCI USA, V88, P5202, DOI 10.1073/pnas.88.12.5202; DALLERY E, 1995, ONCOGENE, V10, P2171; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; DORN T, 2007, THESIS L MAXIMILIANS; Dorn T, 2007, BLOOD, V109, P2346, DOI 10.1182/BLOOD-2006-04-019034; Dumont C, 2002, J IMMUNOL, V169, P1705, DOI 10.4049/jimmunol.169.4.1705; Friedl P, 2005, NAT REV IMMUNOL, V5, P532, DOI 10.1038/nri1647; Gaidano G, 2003, BLOOD, V102, P1833, DOI 10.1182/blood-2002-11-3606; Gallardo HF, 1997, BLOOD, V90, P952, DOI 10.1182/blood.V90.3.952.952_952_957; Garofalo T, 2002, J BIOL CHEM, V277, P11233, DOI 10.1074/jbc.M109601200; GAUEN LKT, 1994, MOL CELL BIOL, V14, P3729, DOI 10.1128/MCB.14.6.3729; Giannini A, 2004, MOL CELL BIOL, V24, P5667, DOI 10.1128/MCB.24.13.5667-5676.2004; Graef IA, 1997, EMBO J, V16, P5618, DOI 10.1093/emboj/16.18.5618; Gu Y, 2005, BLOOD, V105, P1467, DOI 10.1182/blood-2004-04-1604; Gu Y, 2006, NAT IMMUNOL, V7, P1182, DOI 10.1038/ni1396; Hermiston ML, 2002, J CLIN INVEST, V109, P9; Kobune M, 2001, CANCER RES, V61, P5116; Kumaraguru U, 2000, J IMMUNOL, V165, P750, DOI 10.4049/jimmunol.165.2.750; Li XY, 2002, MOL CELL BIOL, V22, P1158, DOI 10.1128/MCB.22.4.1158-1171.2002; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; MORITZ T, 1994, J CLIN INVEST, V93, P1451, DOI 10.1172/JCI117122; Nel AE, 2002, J ALLERGY CLIN IMMUN, V109, P901, DOI 10.1067/mai.2002.124965; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Preudhomme C, 2000, ONCOGENE, V19, P2023, DOI 10.1038/sj.onc.1203521; Roumier A, 2001, IMMUNITY, V15, P715, DOI 10.1016/S1074-7613(01)00225-4; Saito T, 2006, CURR OPIN IMMUNOL, V18, P305, DOI 10.1016/j.coi.2006.03.014; Steinberg M, 2004, BLOOD, V104, P760, DOI 10.1182/blood-2003-12-4314; THOME M, 1995, J EXP MED, V181, P1997, DOI 10.1084/jem.181.6.1997; Underhill DM, 2007, TRENDS IMMUNOL, V28, P66, DOI 10.1016/j.it.2006.12.004; vanOers NSC, 1996, J EXP MED, V183, P1053, DOI 10.1084/jem.183.3.1053; Villalba M, 2001, J CELL BIOL, V155, P331, DOI 10.1083/jcb.200107080; Wahlers A, 2001, GENE THER, V8, P477, DOI 10.1038/sj.gt.3301426; Wang L, 2007, TRENDS CELL BIOL, V17, P58, DOI 10.1016/j.tcb.2006.11.009; WANGE RL, 1992, J BIOL CHEM, V267, P11685; Xavier R, 2004, J CELL BIOL, V166, P173, DOI 10.1083/jcb.200309044; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Yamasaki S, 1996, MOL CELL BIOL, V16, P7151	45	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e13970	10.1371/journal.pone.0013970	http://dx.doi.org/10.1371/journal.pone.0013970			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103055	gold, Green Published, Green Submitted			2022-12-25	WOS:000284147700017
J	Phipps, W; Ssewankambo, F; Nguyen, H; Saracino, M; Wald, A; Corey, L; Orem, J; Kambugu, A; Casper, C				Phipps, Warren; Ssewankambo, Fred; Nguyen, Huong; Saracino, Misty; Wald, Anna; Corey, Lawrence; Orem, Jackson; Kambugu, Andrew; Casper, Corey			Gender Differences in Clinical Presentation and Outcomes of Epidemic Kaposi Sarcoma in Uganda	PLOS ONE			English	Article							HUMAN CHORIONIC-GONADOTROPIN; CANCER INCIDENCE; SOUTH-AFRICA; AIDS; HIV; WOMEN; MEN; DNA; ANTIBODIES; INFECTION	Introduction: The incidence of Kaposi sarcoma (KS) has increased dramatically among women in sub-Saharan Africa since the onset of the HIV pandemic, but data on KS disease in women are limited. To identify gender-related differences in KS presentation and outcomes, we evaluated the clinical manifestations and response in men and women with AIDS-associated KS in Uganda. Methods and Findings: HIV-infected adults with KS attending the Infectious Diseases Institute (IDI) and Uganda Cancer Institute (UCI) in Kampala, Uganda between 2004 and 2006 were included in a retrospective cohort. Evaluation of KS presentation was based on the clinical features described at the initial KS visit. Response was evaluated as the time to "improvement", as defined by any decrease in lesion size, lesion number, or edema. The cohort consisted of 197 adults with HIV and KS: 55% (108/197) were women. At presentation, the median CD4 T-cell count was significantly lower in women (58 cells/mm(3); IQR 11-156 cells/mm(3)) than men (124 cells/mm(3); IQR 22-254 cells/mm(3)) (p = 0.02). Women were more likely than men to present with lesions of the face (OR 2.8, 95% CI, 1.4, 5.7; p = 0.005) and hard palate (OR 2.0, 95% CI, 1.1, 3.7; p = 0.02), and were less likely than men to have lower extremity lesions (OR 0.54, 95% CI, 0.3, 0.99; p = 0.05). Women were less likely than men to demonstrate clinical improvement (HR = 0.52, CI 0.31, 0.88; p = 0.01) in multivariate analysis. Conclusions: The clinical presentation and response of KS differs between men and women in Uganda. These data suggest that gender affects the pathophysiology of KS, which may have implications for the prevention, diagnosis, and treatment of KS in both men and women. Prospective studies are needed to identify predictors of response and evaluate efficacy of treatment in women with KS, particularly in Africa where the disease burden is greatest.	[Phipps, Warren; Nguyen, Huong; Wald, Anna; Corey, Lawrence; Casper, Corey] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Saracino, Misty; Wald, Anna; Corey, Lawrence] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Wald, Anna; Casper, Corey] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Casper, Corey] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Phipps, Warren; Wald, Anna; Corey, Lawrence; Casper, Corey] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Ssewankambo, Fred; Kambugu, Andrew] Infect Dis Inst, Kampala, Uganda; [Orem, Jackson] Uganda Canc Inst, Kampala, Uganda; [Orem, Jackson] Makerere Univ, Coll Hlth Sci, Kampala, Uganda	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Makerere University	Phipps, W (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	wtphipps@fhcrc.org	Corey, Lawrence/AAE-1796-2020; Wald, Anna/B-6272-2012	Corey, Lawrence/0000-0002-2179-2436; Wald, Anna/0000-0003-3486-6438	Fred Hutchinson Cancer Research Center; Doris Duke Charitable Foundation; National Institutes of Health [K24 A1071113]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007140] Funding Source: NIH RePORTER	Fred Hutchinson Cancer Research Center; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Joel Meyers Infectious Disease Scholarship Grant, Fred Hutchinson Cancer Research Center; Doris Duke Charitable Foundation; National Institutes of Health K24 A1071113. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagiozoglou L, 2003, EPIDEMIOL INFECT, V131, P1125, DOI 10.1017/S0950268803001146; [Anonymous], 2000, TECHN REP SER WHO; BENEDETTI P, 1991, AIDS, V5, P466, DOI 10.1097/00002030-199104000-00025; Casper C, 2004, JAIDS-J ACQ IMM DEF, V35, P233, DOI 10.1097/00126334-200403010-00003; Chokunonga E, 2000, INT J CANCER, V85, P54, DOI 10.1002/(SICI)1097-0215(20000101)85:1&lt;54::AID-IJC10&gt;3.0.CO;2-D; Cooley TP, 1996, AIDS, V10, P1221, DOI 10.1097/00002030-199609000-00007; Gandhi M, 2004, J DENT RES, V83, P639, DOI 10.1177/154405910408300811; Gill PS, 1996, NEW ENGL J MED, V335, P1261, DOI 10.1056/NEJM199610243351702; Johnston C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004222; Karnofsky D, 1949, EVALUATION CHEMOTHER, P196; Krown SE, 1997, J CLIN ONCOL, V15, P3085, DOI 10.1200/JCO.1997.15.9.3085; KROWN SE, 1989, J CLIN ONCOL, V7, P1201, DOI 10.1200/JCO.1989.7.9.1201; Laney AS, 2007, AIDS, V21, P1541, DOI 10.1097/QAD.0b013e3282202b7d; Laney AS, 2004, AIDS, V18, P1819, DOI 10.1097/00002030-200409030-00011; LASSOUED K, 1991, AIDS, V5, P877, DOI 10.1097/00002030-199107000-00013; LUNARDIISKANDAR Y, 1995, NATURE, V375, P64, DOI 10.1038/375064a0; Mbulaiteye SM, 2006, INT J CANCER, V118, P985, DOI 10.1002/ijc.21443; Meditz AL, 2007, JAIDS-J ACQ IMM DEF, V44, P306, DOI 10.1097/QAI.0b013e31802c83d9; Mosam A, 2008, INT J STD AIDS, V19, P400, DOI 10.1258/ijsa.2008.007301; Mwanda OW, 2005, ANN TROP MED PARASIT, V99, P81, DOI 10.1179/136485905X19928; Nasti G, 1999, J ACQ IMMUN DEF SYND, V20, P337, DOI 10.1097/00042560-199904010-00003; Onyango J F, 2004, East Afr Med J, V81, P120; Parkin DM, 1999, AIDS, V13, P2563, DOI 10.1097/00002030-199912240-00010; RABKIN CS, 1995, NATURE, V377, P21, DOI 10.1038/377021a0; Smith MS, 1997, J INFECT DIS, V176, P84, DOI 10.1086/514043; Stanberry LR, 2002, NEW ENGL J MED, V347, P1652, DOI 10.1056/NEJMoa011915; Tavio M, 1998, EUR J CANCER, V34, P1634, DOI 10.1016/S0959-8049(98)00154-3; Wabinga HR, 2000, BRIT J CANCER, V82, P1585, DOI 10.1054/bjoc.1999.1071; Wang J, 2007, GENDER MED, V4, P266, DOI 10.1016/S1550-8579(07)80045-3; World Health Organization, 2009, RAP ADV ANT THER HIV; Yoo Deok Jong, 2005, Korean Journal of Internal Medicine, V20, P290; Ziegler J, 2003, INT J CANCER, V103, P233, DOI 10.1002/ijc.10818	32	29	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e13936	10.1371/journal.pone.0013936	http://dx.doi.org/10.1371/journal.pone.0013936			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103057	Green Submitted, gold, Green Published			2022-12-25	WOS:000284147700006
J	Gao, QA; Liu, FB; Zhang, TC; Zhang, J; Jia, SR; Yu, CY; Jiang, KY; Gao, NF				Gao, Qiang; Liu, Fabao; Zhang, Tongcun; Zhang, Jian; Jia, Shiru; Yu, Changyan; Jiang, Kunyu; Gao, Nianfa			The Role of Lactic Acid Adsorption by Ion Exchange Chromatography	PLOS ONE			English	Article							FERMENTATION; BIOREACTOR; RECOVERY; SORPTION	Background: The polyacrylic resin Amberlite IRA-67 is a promising adsorbent for lactic acid extraction from aqueous solution, but little systematic research has been devoted to the separation efficiency of lactic acid under different operating conditions. Methodology/Principal Findings: In this paper, we investigated the effects of temperature, resin dose and lactic acid loading concentration on the adsorption of lactic acid by Amberlite IRA-67 in batch kinetic experiments. The obtained kinetic data followed the pseudo-second order model well and both the equilibrium and ultimate adsorption slightly decreased with the increase of the temperature at 293-323K and 42.5 g/liter lactic acid loading concentration. The adsorption was a chemically heterogeneous process with a mean free energy value of 12.18 kJ/mol. According to the Boyd plot, the lactic acid uptake process was primarily found to be an intraparticle diffusion at a lower concentration (<50 g/liter) but a film diffusion at a higher concentration (>70 g/liter). The values of effective diffusion coefficient D-i increased with temperature. By using our Equation (21), the negative values of Delta G degrees and Delta H degrees revealed that the adsorption process was spontaneous and exothermic. Moreover, the negative value of Delta S degrees reflected the decrease of solid-liquid interface randomness at the solid-liquid interface when adsorbing lactic acid on IRA-67. Conclusions/Significance: With the weakly basic resin IRA-67, in situ product removal of lactic acid can be accomplished especially from an open and thermophilic fermentation system without sterilization.	[Gao, Qiang; Liu, Fabao; Zhang, Tongcun; Zhang, Jian; Jia, Shiru; Yu, Changyan; Jiang, Kunyu; Gao, Nianfa] Tianjin Univ Sci & Technol, Coll Biotechnol, Minist Educ & Tianjin City, Key Lab Ind Microbiol, Tianjin, Peoples R China	Tianjin University Science & Technology	Gao, QA (corresponding author), Tianjin Univ Sci & Technol, Coll Biotechnol, Minist Educ & Tianjin City, Key Lab Ind Microbiol, Tianjin, Peoples R China.	gaoqiang@tust.edu.cn	Zhang, Tong/HGC-1090-2022; jia, shi/HHS-4172-2022		National Basic Research Program of China [2007CB714305, 2011CB707401]; Tianjin Natural Science Foundation of China [08JCZDJC15100]	National Basic Research Program of China(National Basic Research Program of China); Tianjin Natural Science Foundation of China	The work for this manuscript is financially supported by National Basic Research Program of China (2007CB714305 and 2011CB707401) (973 Program: http://www.most.gov.cn/eng/programmes1/200610/t20061009_36223.htm), National High-Tech R & D Program of China (2008AA10Z336) (863 Program: http://www.most.gov.cn/eng/programmes1/200610/t20061009_36225.htm) and Key Project of Tianjin Natural Science Foundation of China (08JCZDJC15100) (http://www.tstc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation for this manuscript.	Beard DA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000144; BOYD GE, 1947, J AM CHEM SOC, V69, P2836, DOI 10.1021/ja01203a066; Chabani M, 2009, J HAZARD MATER, V165, P27, DOI 10.1016/j.jhazmat.2008.08.091; Chen CC, 1998, SEP SCI TECHNOL, V33, P1423, DOI 10.1080/01496399808545058; DUBININ MM, 1947, ZH FIZ KHIM+, V21, P1351; El-Beyrouty C, 2006, ANN PHARMACOTHER, V40, P1602, DOI 10.1345/aph.1G740; Fontes MPF, 2003, APPL GEOCHEM, V18, P795, DOI 10.1016/S0883-2927(02)00188-9; Freundlich H, 1906, Z PHYS CHEM-STOCH VE, V57, P385; Gupta VK, 2001, WATER RES, V35, P33, DOI 10.1016/S0043-1354(00)00232-3; Helfferich F., 1962, ION EXCHANGE; Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5; Ho YS, 1999, RESOUR CONSERV RECY, V25, P171, DOI 10.1016/S0921-3449(98)00053-6; Kasuga T, 2001, BIOMATERIALS, V22, P19, DOI 10.1016/S0142-9612(00)00091-0; KHAN AA, 1987, COLLOID SURFACE, V24, P33, DOI 10.1016/0166-6622(87)80259-7; Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004; Moldes AB, 2003, BIOPROC BIOSYST ENG, V25, P357, DOI 10.1007/s00449-002-0316-7; Patel M, 2008, BIOTECHNOL PROGR, V24, P821, DOI [10.1002/btpr.6, 10.1021/bp.6]; Qin JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004359; SARL A, 2009, J HAZARD MATER, V171, P973; SRIVASTAVA A, 1992, BIOTECHNOL BIOENG, V39, P607, DOI 10.1002/bit.260390604; Uslu H, 2010, J CHEM ENG DATA, V55, P1295, DOI 10.1021/je900635z; WANG E, 1988, J CHEM ENG JPN, V21, P36, DOI 10.1252/jcej.21.36	22	31	34	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e13948	10.1371/journal.pone.0013948	http://dx.doi.org/10.1371/journal.pone.0013948			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21085600	Green Published, Green Submitted, gold			2022-12-25	WOS:000284087800014
J	Sosa-Garcia, B; Gunduz, V; Vazquez-Rivera, V; Cress, WD; Wright, G; Bian, H; Hinds, PW; Santiago-Cardona, PG				Sosa-Garcia, Bernadette; Gunduz, Volkan; Vazquez-Rivera, Viviana; Cress, W. Douglas; Wright, Gabriela; Bian, Haikuo; Hinds, Philip W.; Santiago-Cardona, Pedro G.			A Role for the Retinoblastoma Protein As a Regulator of Mouse Osteoblast Cell Adhesion: Implications for Osteogenesis and Osteosarcoma Formation	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PROTEIN; E-CADHERIN; TRANSCRIPTIONAL REPRESSION; P35/CDK5 KINASE; METASTASIS; EXPRESSION; MERLIN; DIFFERENTIATION; CANCER; FAMILY	The retinoblastoma protein (pRb) is a cell cycle regulator inactivated in most human cancers. Loss of pRb function results from mutations in the gene coding for pRb or for any of its upstream regulators. Although pRb is predominantly known as a cell cycle repressor, our data point to additional pRb functions in cell adhesion. Our data show that pRb regulates the expression of a wide repertoire of cell adhesion genes and regulates the assembly of the adherens junctions required for cell adhesion. We conducted our studies in osteoblasts, which depend on both pRb and on cell-to-cell contacts for their differentiation and function. We generated knockout mice in which the RB gene was excised specifically in osteoblasts using the cre-lox P system and found that osteoblasts from pRb knockout mice did not assemble adherens junction at their membranes. pRb depletion in wild type osteoblasts using RNAi also disrupted adherens junctions. Microarrays comparing pRb-expressing and pRb-deficient osteoblasts showed that pRb controls the expression of a number of cell adhesion genes, including cadherins. Furthermore, pRb knockout mice showed bone abnormalities consistent with osteoblast adhesion defects. We also found that pRb controls the function of merlin, a well-known regulator of adherens junction assembly, by repressing Rac1 and its effector Pak1. Using qRT-PCR, immunoblots, co-immunoprecipitation assays, and immunofluorescent labeling, we observed that pRb loss resulted in Rac1 and Pak1 overexpression concomitant with merlin inactivation by Pak1, merlin detachment from the membrane, and adherens junction loss. Our data support a pRb function in cell adhesion while elucidating the mechanism for this function. Our work suggests that in some tumor types pRb inactivation results in both a loss of cell cycle control that promotes initial tumor growth as well as in a loss of cell-to-cell contacts, which contributes to later stages of metastasis.	[Sosa-Garcia, Bernadette; Vazquez-Rivera, Viviana; Santiago-Cardona, Pedro G.] Ponce Sch Med, Dept Biochem, Ponce, PR USA; [Gunduz, Volkan; Hinds, Philip W.] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA USA; [Cress, W. Douglas; Wright, Gabriela; Bian, Haikuo] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL USA; [Cress, W. Douglas; Wright, Gabriela; Bian, Haikuo] H Lee Moffitt Canc Ctr & Res Inst, Thorac Oncol Dept, Tampa, FL USA	Tufts Medical Center; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute	Sosa-Garcia, B (corresponding author), Ponce Sch Med, Dept Biochem, Ponce, PR USA.				Ponce School of Medicine [G12 RR003050]; American Cancer Society [93-032-13]; National Institutes of Health National Cancer Institute (NIH NCI) [U56CA118809]; NIH National Institute of General Medical Sciences (NIGMS) [R25GM082406]; Florida Department of Health [08BB-05]; NCI [P01CA119997, R01CA90489]; NIH/NIA [AG020208]; NATIONAL CANCER INSTITUTE [R01CA090489, P50CA119997, U56CA118809] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM082406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020208] Funding Source: NIH RePORTER	Ponce School of Medicine; American Cancer Society(American Cancer Society); National Institutes of Health National Cancer Institute (NIH NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Florida Department of Health; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Ponce School of Medicine institutional funds (RCMI Grant G12 RR003050) and American Cancer Society Institutional Research Grant 93-032-13 to PGSC, and National Institutes of Health National Cancer Institute (NIH NCI) Grant U56CA118809 to PGSC and WDC. BSG is supported by NIH National Institute of General Medical Sciences (NIGMS) MBRS-RISE Grant R25GM082406 (the content herein is solely the responsibility of the authors and does not necessarily represent the official views of the NIGMS). WDC is further supported by grants 08BB-05 (Florida Department of Health), P01CA119997 (NCI), R01CA90489 (NCI), and the Moffitt Cancer Center. PWH is supported by NIH/NIA grant AG020208. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander K, 2004, MOL CELL BIOL, V24, P2808, DOI 10.1128/MCB.24.7.2808-2819.2004; Arima Y, 2008, CANCER RES, V68, P5104, DOI 10.1158/0008-5472.CAN-07-5680; Batsche E, 1998, MOL CELL BIOL, V18, P3647, DOI 10.1128/MCB.18.7.3647; Braga VMM, 2000, MOL BIOL CELL, V11, P3703, DOI 10.1091/mbc.11.11.3703; Brown DM, 2004, CANCER CELL, V5, P365, DOI 10.1016/S1535-6108(04)00079-0; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Cheng SL, 2000, J BONE MINER RES, V15, P2362, DOI 10.1359/jbmr.2000.15.12.2362; Chou MM, 1996, CELL, V85, P573, DOI 10.1016/S0092-8674(00)81257-X; Curto M, 2004, CANCER CELL, V5, P113, DOI 10.1016/S1535-6108(04)00031-5; Du W, 2006, ONCOGENE, V25, P5190, DOI 10.1038/sj.onc.1209651; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Grigoriu B, 2009, CLIN BIOCHEM, V42, P1046, DOI 10.1016/j.clinbiochem.2009.03.007; Gutierrez GM, 2008, P NATL ACAD SCI USA, V105, P18402, DOI 10.1073/pnas.0805925105; Gutmann DH, 2001, HUM MOL GENET, V10, P1519, DOI 10.1093/hmg/10.14.1519; Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; Hay E, 2000, J CELL PHYSIOL, V183, P117, DOI 10.1002/(SICI)1097-4652(200004)183:1<117::AID-JCP14>3.0.CO;2-#; HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O; Ito T, 2007, CELL BIOL INT, V31, P1518, DOI 10.1016/j.cellbi.2007.06.017; Kashima T, 1999, AM J PATHOL, V155, P1549, DOI 10.1016/S0002-9440(10)65471-5; Kaye FJ, 2002, ONCOGENE, V21, P6908, DOI 10.1038/sj.onc.1205834; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; Kissil JL, 2002, J BIOL CHEM, V277, P10394, DOI 10.1074/jbc.M200083200; Knudsen ES, 2006, EXP BIOL MED, V231, P1271; Lallemand D, 2003, GENE DEV, V17, P1090, DOI 10.1101/gad.1054603; Lee EK, 2007, BIOINFORMATION, V1, P423, DOI 10.6026/97320630001423; Marie PJ, 2002, J CELL PHYSIOL, V190, P297, DOI 10.1002/jcp.10073; Nikolic M, 1998, NATURE, V395, P194, DOI 10.1038/26034; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Rashid T, 2001, J BIOL CHEM, V276, P49043, DOI 10.1074/jbc.M105599200; Rodriguez-Salas N, 2001, HISTOL HISTOPATHOL, V16, P353, DOI 10.14670/HH-16.353; Ross JF, 1999, MOL CELL, V3, P195, DOI 10.1016/S1097-2765(00)80310-X; Rothberg BEG, 2009, JNCI-J NATL CANCER I, V101, P452, DOI 10.1093/jnci/djp038; Sellers WR, 1998, GENE DEV, V12, P95, DOI 10.1101/gad.12.1.95; Shah CA, 2009, CANCER EPIDEM BIOMAR, V18, P1365, DOI 10.1158/1055-9965.EPI-08-1034; Shaw RJ, 1998, J BIOL CHEM, V273, P7757, DOI 10.1074/jbc.273.13.7757; Shaw RJ, 2001, DEV CELL, V1, P63, DOI 10.1016/S1534-5807(01)00009-0; Stains Joseph P, 2005, Birth Defects Res C Embryo Today, V75, P72, DOI 10.1002/bdrc.20034; Thomas DM, 2001, MOL CELL, V8, P303, DOI 10.1016/S1097-2765(01)00327-6; Thomas DM, 2003, CANCER BIOL THER, V2, P2; Van Aken EH, 2002, INVEST OPHTH VIS SCI, V43, P595; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; Wei Y, 2009, CELL CYCLE, V8, P2132; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; WEINTRAUB SJ, 1995, NATURE, V375, P812, DOI 10.1038/375812a0; Wu GJ, 2008, MOL CANCER RES, V6, P1666, DOI 10.1158/1541-7786.MCR-07-2200; Xiao GH, 2002, J BIOL CHEM, V277, P883, DOI 10.1074/jbc.C100553200; Xu HM, 1998, J NEUROSCI RES, V51, P403, DOI 10.1002/(SICI)1097-4547(19980201)51:3<403::AID-JNR13>3.0.CO;2-7; Yang HS, 2003, MOL CELL, V11, P1163, DOI 10.1016/S1097-2765(03)00135-7; Yang J, 2006, CANCER RES, V66, P4549, DOI 10.1158/0008-5472.CAN-05-3850; Zabouo G, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2215	52	30	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e13954	10.1371/journal.pone.0013954	http://dx.doi.org/10.1371/journal.pone.0013954			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21085651	gold, Green Published, Green Submitted			2022-12-25	WOS:000284087800018
J	Hamelryck, T; Borg, M; Paluszewski, M; Paulsen, J; Frellsen, J; Andreetta, C; Boomsma, W; Bottaro, S; Ferkinghoff-Borg, J				Hamelryck, Thomas; Borg, Mikael; Paluszewski, Martin; Paulsen, Jonas; Frellsen, Jes; Andreetta, Christian; Boomsma, Wouter; Bottaro, Sandro; Ferkinghoff-Borg, Jesper			Potentials of Mean Force for Protein Structure Prediction Vindicated, Formalized and Generalized	PLOS ONE			English	Article							KNOWLEDGE-BASED POTENTIALS; STATISTICAL POTENTIALS; 3-DIMENSIONAL STRUCTURES; STABILITY CHANGES; SCORING FUNCTION; REFERENCE STATE; FOLD; RECOGNITION; MODEL; MECHANICS	Understanding protein structure is of crucial importance in science, medicine and biotechnology. For about two decades, knowledge-based potentials based on pairwise distances - so-called "potentials of mean force'' (PMFs) - have been center stage in the prediction and design of protein structure and the simulation of protein folding. However, the validity, scope and limitations of these potentials are still vigorously debated and disputed, and the optimal choice of the reference state a necessary component of these potentials - is an unsolved problem. PMFs are loosely justified by analogy to the reversible work theorem in statistical physics, or by a statistical argument based on a likelihood function. Both justifications are insightful but leave many questions unanswered. Here, we show for the first time that PMFs can be seen as approximations to quantities that do have a rigorous probabilistic justification: they naturally arise when probability distributions over different features of proteins need to be combined. We call these quantities "reference ratio distributions'' deriving from the application of the "reference ratio method.'' This new view is not only of theoretical relevance but leads to many insights that are of direct practical use: the reference state is uniquely defined and does not require external physical insights; the approach can be generalized beyond pairwise distances to arbitrary features of protein structure; and it becomes clear for which purposes the use of these quantities is justified. We illustrate these insights with two applications, involving the radius of gyration and hydrogen bonding. In the latter case, we also show how the reference ratio method can be iteratively applied to sculpt an energy funnel. Our results considerably increase the understanding and scope of energy functions derived from known biomolecular structures.	[Hamelryck, Thomas; Borg, Mikael; Paluszewski, Martin; Paulsen, Jonas; Frellsen, Jes; Andreetta, Christian] Univ Copenhagen, Dept Biol, Bioinformat Ctr, Copenhagen, Denmark; [Boomsma, Wouter; Bottaro, Sandro; Ferkinghoff-Borg, Jesper] Tech Univ Denmark, Tech Univ Denmark DTU Elektro, DK-2800 Lyngby, Denmark; [Boomsma, Wouter] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Copenhagen; Technical University of Denmark; University of Cambridge	Hamelryck, T (corresponding author), Univ Copenhagen, Dept Biol, Bioinformat Ctr, Copenhagen, Denmark.	thamelry@binf.ku.dk; jfb@elektro.dtu.dk	Boomsma, Wouter/K-2903-2014; Bottaro, Sandro/H-5486-2013; Hamelryck, Thomas/A-3923-2012; Frellsen, Jes/K-4337-2014	Boomsma, Wouter/0000-0002-8257-3827; Bottaro, Sandro/0000-0003-1606-890X; Hamelryck, Thomas/0000-0003-2917-3602; Frellsen, Jes/0000-0001-9224-1271; Borg, Mikael/0000-0002-0646-4231	Danish Program Commission on Nanoscience, Biotechnology and IT (NaBiIT) [2106-06-0009]; Danish Research Council for Technology and Production Sciences (FTP) [274-09-0184]; Danish Council for Independent Research (FNU) [272-08-0315]	Danish Program Commission on Nanoscience, Biotechnology and IT (NaBiIT); Danish Research Council for Technology and Production Sciences (FTP); Danish Council for Independent Research (FNU)(Det Frie Forskningsrad (DFF)Danish Natural Science Research Council)	The authors acknowledge funding by the Danish Program Commission on Nanoscience, Biotechnology and IT (NaBiIT, project: Simulating proteins on a millisecond time-scale, 2106-06-0009), the Danish Research Council for Technology and Production Sciences (FTP, project: Protein structure ensembles from mathematical models, 274-09-0184) and the Danish Council for Independent Research (FNU, project: A Bayesian approach to protein structure determination, 272-08-0315). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; BenNaim A, 1997, J CHEM PHYS, V107, P3698, DOI 10.1063/1.474725; Bernard B, 2009, PROTEINS, V76, P115, DOI 10.1002/prot.22323; Boomsma W, 2008, P NATL ACAD SCI USA, V105, P8932, DOI 10.1073/pnas.0801715105; Borg M., 2009, LASR2009 STAT TOOLS, P65; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Bowman GR, 2009, PROTEINS, V74, P777, DOI 10.1002/prot.22210; BRYNGELSON JD, 1987, P NATL ACAD SCI USA, V84, P7524, DOI 10.1073/pnas.84.21.7524; Buchete NV, 2004, CURR OPIN STRUC BIOL, V14, P225, DOI 10.1016/j.sbi.2004.03.002; Chandler D, 2005, NATURE, V437, P640, DOI 10.1038/nature04162; Chandler D., 1987, INTRO MODERN STAT ME; Cheng J, 2007, BIOPHYS J, V92, P3868, DOI 10.1529/biophysj.106.102152; Colubri A, 2006, J MOL BIOL, V363, P835, DOI 10.1016/j.jmb.2006.08.035; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Eramian D, 2006, PROTEIN SCI, V15, P1653, DOI 10.1110/ps.062095806; Fain B, 2003, P NATL ACAD SCI USA, V100, P10700, DOI 10.1073/pnas.1732312100; Ferkinghoff-Borg J, 2002, EUR PHYS J B, V29, P481, DOI 10.1140/epjb/e2002-00328-1; FINKELSTEIN AV, 1995, PROTEINS, V23, P142, DOI 10.1002/prot.340230204; Gilis D, 2000, PROTEIN ENG, V13, P849, DOI 10.1093/protein/13.12.849; Gilis D, 1997, J MOL BIOL, V272, P276, DOI 10.1006/jmbi.1997.1237; Gilks WR, 1996, MARKOV CHAIN MONTE C; Gohlke H, 2000, J MOL BIOL, V295, P337, DOI 10.1006/jmbi.1999.3371; Hamelryck T, 2006, PLOS COMPUT BIOL, V2, P1121, DOI 10.1371/journal.pcbi.0020131; Hamelryck T, 2009, STAT METHODS MED RES, V18, P505, DOI 10.1177/0962280208099492; HESSELBO B, 1995, PHYS REV LETT, V74, P2151, DOI 10.1103/PhysRevLett.74.2151; Huang SY, 2006, J COMPUT CHEM, V27, P1866, DOI 10.1002/jcc.20504; JONES DT, 1992, NATURE, V358, P86, DOI 10.1038/358086a0; Kirtay CK, 2005, QSAR COMB SCI, V24, P527, DOI 10.1002/qsar.200430926; KOCHER JPA, 1994, J MOL BIOL, V235, P1598, DOI 10.1006/jmbi.1994.1109; Koppensteiner WA, 1998, BIOCHEMISTRY-MOSCOW+, V63, P247; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Lazaridis T, 2000, CURR OPIN STRUC BIOL, V10, P139, DOI 10.1016/S0959-440X(00)00063-4; LEOPOLD PE, 1992, P NATL ACAD SCI USA, V89, P8721, DOI 10.1073/pnas.89.18.8721; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Majek P, 2009, PROTEINS, V76, P822, DOI 10.1002/prot.22388; McQuarrie DA, 2000, STAT MECH; Miyazawa S, 1999, PROTEINS, V36, P357, DOI 10.1002/(SICI)1097-0134(19990815)36:3<357::AID-PROT10>3.3.CO;2-L; MIYAZAWA S, 1985, MACROMOLECULES, V18, P534, DOI 10.1021/ma00145a039; Moult J, 1997, CURR OPIN STRUC BIOL, V7, P194, DOI 10.1016/S0959-440X(97)80025-5; Muegge I, 2006, J MED CHEM, V49, P5895, DOI 10.1021/jm050038s; PEARL J, 1988, PROBABILISTIC REASON, P108; Reith D, 2003, J COMPUT CHEM, V24, P1624, DOI 10.1002/jcc.10307; ROOMAN MJ, 1991, J MOL BIOL, V221, P961, DOI 10.1016/0022-2836(91)80186-X; Rooman MJ, 1995, PROTEIN ENG, V8, P849, DOI 10.1093/protein/8.9.849; Rykunov D, 2007, PROTEINS, V67, P559, DOI 10.1002/prot.21279; Rykunov D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-128; Samudrala R, 1998, J MOL BIOL, V275, P895, DOI 10.1006/jmbi.1997.1479; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shmygelska A, 2009, P NATL ACAD SCI USA, V106, P1415, DOI 10.1073/pnas.0812510106; Shortle D, 2003, PROTEIN SCI, V12, P1298, DOI 10.1110/ps.0306903; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Simons KT, 1999, PROTEINS, V34, P82, DOI 10.1002/(SICI)1097-0134(19990101)34:1<82::AID-PROT7>3.0.CO;2-A; Sippl MJ, 1996, FOLD DES, V1, P289, DOI 10.1016/S1359-0278(96)00042-9; SIPPL MJ, 1992, PROTEIN SCI, V1, P625, DOI 10.1002/pro.5560010509; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; SIPPL MJ, 1990, J MOL BIOL, V213, P859, DOI 10.1016/S0022-2836(05)80269-4; Su Y, 2009, PROTEIN SCI, V18, P2550, DOI 10.1002/pro.257; TANAKA S, 1976, MACROMOLECULES, V9, P945, DOI 10.1021/ma60054a013; Thomas PD, 1996, J MOL BIOL, V257, P457, DOI 10.1006/jmbi.1996.0175; Thomas PD, 1996, P NATL ACAD SCI USA, V93, P11628, DOI 10.1073/pnas.93.21.11628; Zhang C, 2004, PROTEIN SCI, V13, P400, DOI 10.1110/ps.03348304; Zhao F, 2010, J COMPUT BIOL, V17, P783, DOI 10.1089/cmb.2009.0235; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002	64	48	49	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e13714	10.1371/journal.pone.0013714	http://dx.doi.org/10.1371/journal.pone.0013714			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21103041	Green Submitted, Green Published, gold			2022-12-25	WOS:000284036800006
J	Larsen, DA; Keating, J; Miller, J; Bennett, A; Changufu, C; Katebe, C; Eisele, TP				Larsen, David A.; Keating, Joseph; Miller, John; Bennett, Adam; Changufu, Cynthia; Katebe, Cecilia; Eisele, Thomas P.			Barriers to Insecticide-Treated Mosquito Net Possession 2 Years after a Mass Free Distribution Campaign in Luangwa District, Zambia	PLOS ONE			English	Article							MALARIA CONTROL	Background and Methods: Roll Back Malaria set the goal of 100% of households in malaria endemic countries in Africa owning an insecticide-treated mosquito net (ITN) by 2010. Zambia has used mass free distribution campaigns and distribution through antenatal care (ANC) clinics to achieve high coverage. Methodology and Principal Findings: We conducted a probability survey of 801 households in 2008 to assess factors associated with households that lacked an ITN after mass distribution. Community perceptions of barriers to ITN access were also obtained from in-depth interviews with household heads that reported not owning an ITN. Nearly 74% of households in Luangwa district reported owning >= 1 ITN. Logistic regression showed households without a child,5 years old during the ITN distribution campaigns were twice as likely to not have an ITN as those with a child,5 during distribution (Adjusted odds ratio (AOR) = 2.43; 95% confidence interval (CI): 1.67-3.55). Households without a woman who attended an ANC in the past 2 years were more likely to be without ITNs compared to households with a woman who attended an ANC in the past 2 years (AOR = 1.52; 95% CI: 1.04-2.21). In-depth interviews with heads of households without an ITN revealed that old age was a perceived barrier to receiving an ITN during distribution, and that ITNs wore out before they could be replaced. Conclusions and Significance: Delivery of a large number of ITNs does not translate directly into 100% household coverage. Due to their design, current ITN distribution strategies may miss households occupied by the elderly and those without children or ANC access. ITN distribution strategies targeting the elderly, those with limited access to distribution points, and others most likely to be missed are necessary if 100% ITN coverage of households is to be achieved.	[Larsen, David A.; Keating, Joseph; Miller, John; Bennett, Adam; Eisele, Thomas P.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Int Hlth & Dev, New Orleans, LA 70118 USA; [Miller, John] Malaria Control & Evaluat Partnership Africa MACE, PATH, Lusaka, Zambia; [Changufu, Cynthia] Soc Family Hlth, Lusaka, Zambia; [Katebe, Cecilia] Minist Hlth, Lusaka, Zambia	Tulane University	Larsen, DA (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Int Hlth & Dev, New Orleans, LA 70118 USA.	teisele@tulane.edu	Eisele, Thom/AAE-8958-2020; Larsen, David/D-4027-2016	Larsen, David/0000-0002-1876-6536	Centers for Disease Control and Prevention (CDC) [1R18CK000102-01]	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research was funded by a grant to TPE by the Centers for Disease Control and Prevention (CDC) (1R18CK000102-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], MAL CHILDR PROGR INT; [Anonymous], 2004, COCHRANE DB SYST REV; [Anonymous], 2009, WORLD MAL REP 2009; [Anonymous], 2005, MMWR MORB MORTAL WKL, V54, P994; Brentlinger PE, 2007, HEALTH POLICY PLANN, V22, P103, DOI 10.1093/heapol/czm002; Chuma J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-137; Eisele TP, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b1598; Grabowsky M, 2005, TROP MED INT HEALTH, V10, P1151, DOI 10.1111/j.1365-3156.2005.01502.x; Keating J, 2009, ACTA TROP, V112, P277, DOI 10.1016/j.actatropica.2009.08.011; Kilian A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-49; Killeen GF, 2007, PLOS MED, V4, P1246, DOI 10.1371/journal.pmed.0040229; Lengeler C, 2007, AM J TROP MED HYG, V77, P222, DOI 10.4269/ajtmh.2007.77.222; Lindblade KA, 2005, TROP MED INT HEALTH, V10, P1141, DOI 10.1111/j.1365-3156.2005.01501.x; Macintyre K, 2006, TROP MED INT HEALTH, V11, P824, DOI 10.1111/j.1365-3156.2006.01637.x; Matovu F, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-109; POPE C, 1995, BRIT MED J, V311, P42, DOI 10.1136/bmj.311.6996.42; RBM Partnership, 2008, GLOB MAL ACT PLAN MA; Rutstein S. O., 2004, DHS WEALTH INDEX; Steketee RW, 2008, AM J TROP MED HYG, V79, P45, DOI 10.4269/ajtmh.2008.79.45; Steketee RW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008409; ter Kuile FO, 2007, JAMA-J AM MED ASSOC, V297, P2603, DOI 10.1001/jama.297.23.2603; *UNICEF, 2008, WORLD MAL DAY NEW GO; Webster J, 2007, HEALTH POLICY PLANN, V22, P277, DOI 10.1093/heapol/czm021	23	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e13129	10.1371/journal.pone.0013129	http://dx.doi.org/10.1371/journal.pone.0013129			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085711	Green Published, gold			2022-12-25	WOS:000284036800002
J	McLaughlin, RL; Phukan, J; McCormack, W; Lynch, DS; Greenway, M; Cronin, S; Saunders, J; Slowik, A; Tomik, B; Andersen, PM; Bradley, DG; Jakeman, P; Hardiman, O				McLaughlin, Russell Lewis; Phukan, Julie; McCormack, William; Lynch, David S.; Greenway, Matthew; Cronin, Simon; Saunders, Jean; Slowik, Agnieska; Tomik, Barbara; Andersen, Peter M.; Bradley, Daniel G.; Jakeman, Phil; Hardiman, Orla			Angiogenin Levels and ANG Genotypes: Dysregulation in Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; SPORADIC ALS; GENOME; MUTATIONS; VEGF; ASSOCIATION; POPULATION; SERUM	Objective: To determine whether 5 single nucleotide polymorphisms (SNPs) associate with ALS in 3 different populations. We also assessed the contribution of genotype to angiogenin levels in plasma and CSF. Methods: Allelic association statistics were calculated for polymorphisms in the ANG gene in 859 patients and 1047 controls from Sweden, Ireland and Poland. Plasma, serum and CSF angiogenin levels were quantified and stratified according to genotypes across the ANG gene. The contribution of SNP genotypes to variance in circulating angiogenin levels was estimated in patients and controls. Results: All SNPs showed association with ALS in the Irish group. The SNP rs17114699 replicated in the Swedish cohort. No SNP associated in the Polish cohort. Age-and sex-corrected circulating angiogenin levels were significantly lower in patients than in controls (p<0.001). An allele dose-dependent regulation of angiogenin levels was observed in controls. This regulation was attenuated in the ALS cohort. A significant positive correlation between CSF plasma angiogenin levels was present in controls and abolished in ALS. Conclusions: ANG variants associate with ALS in the Irish and Swedish populations, but not in the Polish. There is evidence of dysregulation of angiogenin expression in plasma and CSF in sporadic ALS. Angiogenin expression is likely to be important in the pathogenesis of ALS.	[McLaughlin, Russell Lewis; Bradley, Daniel G.] Trinity Coll Dublin, Smurfit Inst Genet, Dublin, Ireland; [McLaughlin, Russell Lewis; Phukan, Julie; Lynch, David S.; Cronin, Simon; Hardiman, Orla] Beaumont Hosp, Dept Neurol, Dublin 9, Ireland; [Phukan, Julie; Hardiman, Orla] Trinity Coll Dublin, Trinity Coll Inst Neurosci, Dublin, Ireland; [McCormack, William; Jakeman, Phil] Univ Limerick, Fac Educ & Hlth Sci, Human Sci Res Unit, Limerick, Ireland; [Lynch, David S.; Greenway, Matthew; Cronin, Simon] Royal Coll Surgeons Ireland, Dublin 2, Ireland; [Saunders, Jean] Univ Limerick, Stat Consulting Unit, Limerick, Ireland; [Slowik, Agnieska; Tomik, Barbara] Jagiellonian Univ, Dept Neurol, Krakow, Poland; [Andersen, Peter M.] Umea Univ Hosp, Dept Pharmacol & Clin Neurosci, S-90185 Umea, Sweden	Trinity College Dublin; Trinity College Dublin; University of Limerick; Royal College of Surgeons - Ireland; University of Limerick; Jagiellonian University; Umea University	McLaughlin, RL (corresponding author), Trinity Coll Dublin, Smurfit Inst Genet, Dublin, Ireland.	mclaugr@tcd.ie	Hardiman, Orla/Y-3441-2019; Bradley, Daniel G/A-3240-2012; Jakeman, Philip/C-2308-2008	Hardiman, Orla/0000-0003-2610-1291; Jakeman, Philip/0000-0002-1199-080X; McCormack, William/0000-0002-8051-6853; McLaughlin, Russell/0000-0003-3915-2135; Bradley, Daniel G/0000-0001-7335-7092	Irish Health Research Board [HRB CSA 2007/3]; Irish Motor Neurone Disease Research Foundation [IMNDRF 07/01]; Muscular Dystrophy Association (United States of America) [2007/4252]	Irish Health Research Board; Irish Motor Neurone Disease Research Foundation; Muscular Dystrophy Association (United States of America)(Muscular Dystrophy Association)	This work was supported by the Irish Health Research Board (grant number HRB CSA 2007/3); the Irish Motor Neurone Disease Research Foundation (grant number IMNDRF 07/01) and the Muscular Dystrophy Association (United States of America, grant number 2007/4252). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; Cronin S, 2006, NEUROLOGY, V67, P1833, DOI 10.1212/01.wnl.0000244466.46020.47; Cronin S, 2009, EUR J HUM GENET, V17, P213, DOI 10.1038/ejhg.2008.194; Cronin S, 2008, HUM MOL GENET, V17, P768, DOI 10.1093/hmg/ddm361; Devos D, 2004, NEUROLOGY, V62, P2127, DOI 10.1212/01.WNL.0000129913.44351.A3; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gellera C, 2008, NEUROGENETICS, V9, P33, DOI 10.1007/s10048-007-0111-3; Greenway MJ, 2006, NAT GENET, V38, P411, DOI 10.1038/ng1742; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Ilzecka J, 2004, CLIN NEUROL NEUROSUR, V106, P289, DOI 10.1016/j.clineuro.2003.12.007; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Nygren I, 2002, NEUROREPORT, V13, P2199, DOI 10.1097/00001756-200212030-00007; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; Pantsulaia I, 2006, CLIN ENDOCRINOL, V64, P271, DOI 10.1111/j.1365-2265.2006.02456.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rademakers R, 2008, HUM MOL GENET, V17, P3631, DOI 10.1093/hmg/ddn257; Rosenstein JM, 2004, EXP NEUROL, V187, P246, DOI 10.1016/j.expneurol.2004.01.022; Strong MJ, 2008, AMYOTROPH LATERAL SC, V9, P323, DOI 10.1080/17482960802372371; Subramanian V, 2008, HUM MOL GENET, V17, P130, DOI 10.1093/hmg/ddm290; Wu D, 2007, ANN NEUROL, V62, P609, DOI 10.1002/ana.21221	25	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e15402	10.1371/journal.pone.0015402	http://dx.doi.org/10.1371/journal.pone.0015402			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085671	Green Published, Green Submitted, gold			2022-12-25	WOS:000284036800027
J	Fraser, A; Williams, D; Lawlor, DA				Fraser, Abigail; Williams, Dylan; Lawlor, Debbie A.			Associations of Serum 25-Hydroxyvitamin D, Parathyroid Hormone and Calcium with Cardiovascular Risk Factors: Analysis of 3 NHANES Cycles (2001-2006)	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; MIDDLE-AGED MEN; INSULIN-RESISTANCE; MYOCARDIAL-INFARCTION; INCIDENT HYPERTENSION; METABOLIC SYNDROME; BLOOD-PRESSURE; US ADULTS; DISEASE; PREVALENCE	Background: Increasing evidence suggests a role for mineral metabolism in cardiovascular disease risk. 25-hydroxyvitamin D (25(OH)D), parathyroid hormone (PTH), and calcium may be directly associated with cardiovascular risk factors or mediated by each other. Methodology/Principal Findings: We combined data for adult participants in three cycles of the National Health and Nutrition Examination Survey (2001-2, 2003-4, 2005-6), a representative sample of the civilian, non-institutionalized US population (N = 3,958). Using this data we examined joint associations of 25(OH)D, PTH and calcium with a range of cardiovascular risk factors. 25(OH)D was inversely associated with fasting insulin (mean difference in insulin per 1 standard deviation 25(OH)D: -0.053 (95%CI: -0.091, -0.015)), glucose (-0.046 95%CI: -0.081, -0.012) and systolic blood pressure (SBP) (-0.032 95%CI: -0.062, -0.001), and positively associated with high density lipoprotein cholesterol HDL-c (0.088 95%CI: 0.044, 0.148), after adjustment for ethnicity, smoking, socio-economic status and waist circumference. PTH was positively associated with diastolic blood pressure (0.110, 95%CI: 0.055, 0.164) in confounder adjusted models, but was not associated with other cardiovascular risk factors. Albumin adjusted calcium was associated with triglycerides (0.102 95%CI: 0.063, 0.141), postload glucose (0.078, 95%CI: 0.025, 0.130), fasting insulin (0.074, 95%CI: 0.044, 0.104), HbA1c (0.070, 95%CI: 0.036, 0.105), SBP (0.064, 95%CI: 0.028, 0.100), fasting glucose (0.055, 95%CI: 0.018, 0.092) and low density lipoprotein cholesterol (0.052, 95%CI: 0.014, 0.091). With mutual adjustment for each other, these associations remained essentially unchanged. Conclusions/Significance: Lower levels of 25(OH)D and higher levels of calcium and PTH appear to be associated with different cardiovascular risk factors and may therefore affect cardiovascular disease risk through different mechanisms.	[Fraser, Abigail; Williams, Dylan; Lawlor, Debbie A.] Univ Bristol, Dept Social Med, MRC, Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England	University of Bristol	Fraser, A (corresponding author), Univ Bristol, Dept Social Med, MRC, Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England.	Abigail.fraser@bristol.ac.uk		Lawlor, Debbie A/0000-0002-6793-2262; Fraser, Abigail/0000-0002-7741-9470; Williams, Dylan/0000-0002-3825-2487	UK MRC [G0701603]; University of Bristol; Wellcome Trust; Medical Research Council [G0701603, G0600705, G0701594] Funding Source: researchfish; MRC [G0701603, G0600705, G0701594] Funding Source: UKRI	UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Bristol; Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Work on this study is funded by an UK MRC Grant (G0701603). The UK Medical Research Council (MRC) and the University of Bristol provide core funding for the MRC Centre of Causal Analyses in Translational Epidemiology. AF is funded by a UK Medical Research Council research fellowship. DW is funded by a Wellcome Trust studentship. The views expressed in this paper are those of the authors and not necessarily those of any funding body or others whose support is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlstrom T, 2009, CLIN ENDOCRINOL, V71, P673, DOI 10.1111/j.1365-2265.2009.03558.x; BOLLAND MJ, 2010, BRIT MED J, V341, pNIL1; *CDCP, 2008, DOC COD PROC VIT D; *CDCP, 2008, DOC COD FREQ PLASM F; Cozzolino M, 2010, EUR J HEART FAIL, V12, P1031, DOI 10.1093/eurjhf/hfq112; Dobnig H, 2008, ARCH INTERN MED, V168, P1340, DOI 10.1001/archinte.168.12.1340; Forman JP, 2007, HYPERTENSION, V49, P1063, DOI 10.1161/HYPERTENSIONAHA.107.087288; Forouhi NG, 2008, DIABETES, V57, P2619, DOI 10.2337/db08-0593; Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174; Hagstrom E, 2009, CIRCULATION, V119, P2765, DOI 10.1161/CIRCULATIONAHA.108.808733; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Lind L, 1997, J CLIN EPIDEMIOL, V50, P967, DOI 10.1016/S0895-4356(97)00104-2; LIND L, 1995, AM J HYPERTENS, V8, P894, DOI 10.1016/0895-7061(95)00154-H; Martins D, 2007, ARCH INTERN MED, V167, P1159, DOI 10.1001/archinte.167.11.1159; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mattila C, 2007, DIABETES CARE, V30, P2569, DOI 10.2337/dc07-0292; Perkovic V, 2003, KIDNEY BLOOD PRESS R, V26, P27, DOI 10.1159/000069761; Poole KES, 2005, CURR OPIN PHARMACOL, V5, P612, DOI 10.1016/j.coph.2005.07.004; Reis JP, 2008, EUR J ENDOCRINOL, V159, P41, DOI 10.1530/EJE-08-0072; Reis JP, 2007, DIABETES CARE, V30, P1549, DOI 10.2337/dc06-2438; Rose G, 1982, CARDIOVASCULAR SURVE; Snijder MB, 2007, J INTERN MED, V261, P558, DOI 10.1111/j.1365-2796.2007.01778.x; Tai K, 2008, NUTRITION, V24, P279, DOI 10.1016/j.nut.2007.11.006; Taylor EN, 2008, J HYPERTENS, V26, P1390, DOI 10.1097/HJH.0b013e3282ffb43b; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Wang YT, 2009, AM J EPIDEMIOL, V170, P88, DOI 10.1093/aje/kwp086; Zhao GX, 2010, DIABETES CARE, V33, P344, DOI 10.2337/dc09-0924; Zittermann A, 2006, PROG BIOPHYS MOL BIO, V92, P39, DOI 10.1016/j.pbiomolbio.2006.02.001	30	66	68	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e13882	10.1371/journal.pone.0013882	http://dx.doi.org/10.1371/journal.pone.0013882			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085485	gold, Green Published			2022-12-25	WOS:000284035900004
J	Brennan, LA; Lee, W; Kantorow, M				Brennan, Lisa A.; Lee, Wanda; Kantorow, Marc			TXNL6 Is a Novel Oxidative Stress-Induced Reducing System for Methionine Sulfoxide Reductase A Repair of alpha-Crystallin and Cytochrome C in the Eye Lens	PLOS ONE			English	Article							PROTEIN OXIDATION; EPITHELIAL-CELLS; NUCLEAR CATARACT; MITOCHONDRIAL; MSRA; LOCALIZATION; THIOREDOXIN; RESIDUES; DISEASE; IDENTIFICATION	A key feature of many age-related diseases is the oxidative stress-induced accumulation of protein methionine sulfoxide (PMSO) which causes lost protein function and cell death. Proteins whose functions are lost upon PMSO formation can be repaired by the enzyme methionine sulfoxide reductase A (MsrA) which is a key regulator of longevity. One disease intimately associated with PMSO formation and loss of MsrA activity is age-related human cataract. PMSO levels increase in the eye lens upon aging and in age-related human cataract as much as 70% of total lens protein is converted to PMSO. MsrA is required for lens cell maintenance, defense against oxidative stress damage, mitochondrial function and prevention of lens cataract formation. Essential for MsrA action in the lens and other tissues is the availability of a reducing system sufficient to catalytically regenerate active MsrA. To date, the lens reducing system(s) required for MsrA activity has not been defined. Here, we provide evidence that a novel thioredoxin-like protein called thioredoxin-like 6 (TXNL6) can serve as a reducing system for MsrA repair of the essential lens chaperone alpha-crystallin/sHSP and mitochondrial cytochrome c. We also show that TXNL6 is induced at high levels in human lens epithelial cells exposed to H2O2-induced oxidative stress. Collectively, these data suggest a critical role for TXNL6 in MsrA repair of essential lens proteins under oxidative stress conditions and that TXNL6 is important for MsrA defense protection against cataract. They also suggest that MsrA uses multiple reducing systems for its repair activity that may augment its function under different cellular conditions.	[Brennan, Lisa A.; Lee, Wanda; Kantorow, Marc] Florida Atlantic Univ, Dept Biomed Sci, Charles E Schmidt Coll Med, Boca Raton, FL 33431 USA	State University System of Florida; Florida Atlantic University	Brennan, LA (corresponding author), Florida Atlantic Univ, Dept Biomed Sci, Charles E Schmidt Coll Med, Boca Raton, FL 33431 USA.	mkantoro@fau.edu			National Institutes of Health (NIH.gov) [RO1 EY13022, EY13022]; NATIONAL EYE INSTITUTE [R01EY013022] Funding Source: NIH RePORTER	National Institutes of Health (NIH.gov)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by RO1 EY13022 and EY13022 supplement grants from the National Institutes of Health (NIH.gov) awarded to Marc Kantorow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andley UP, 1996, INVEST OPHTH VIS SCI, V37, P142; Andley UP, 2000, J BIOL CHEM, V275, P36823, DOI 10.1074/jbc.M004233200; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; AUGUSTEYN RC, 2010, EXPT EYE RES, V90; Basova LV, 2007, BIOCHEMISTRY-US, V46, P3423, DOI 10.1021/bi061854k; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Boschi-Muller S, 2005, BBA-PROTEINS PROTEOM, V1703, P231, DOI 10.1016/j.bbapap.2004.09.016; Boschi-Muller S, 2008, ARCH BIOCHEM BIOPHYS, V474, P266, DOI 10.1016/j.abb.2008.02.007; BRADY J, 1997, SCIENCES, V94, P884; Brennan LA, 2009, MOL VIS, V15, P985; Brennan LA, 2009, BBA-GEN SUBJECTS, V1790, P1665, DOI 10.1016/j.bbagen.2009.08.011; Brennan LA, 2009, EXP EYE RES, V88, P195, DOI 10.1016/j.exer.2008.05.018; BROT N, 1981, P NATL ACAD SCI-BIOL, V78, P2155, DOI 10.1073/pnas.78.4.2155; BROT N, 1983, ARCH BIOCHEM BIOPHYS, V223, P271, DOI 10.1016/0003-9861(83)90592-1; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Cassina AM, 2000, J BIOL CHEM, V275, P21409, DOI 10.1074/jbc.M909978199; Chen YR, 2002, J BIOL CHEM, V277, P29781, DOI 10.1074/jbc.M200709200; Cronin T, 2010, CELL DEATH DIFFER, V17, P1199, DOI 10.1038/cdd.2010.2; DELAMERE NA, 2009, EXPT EYE RES, V88; Friguet B, 2006, FEBS LETT, V580, P2910, DOI 10.1016/j.febslet.2006.03.028; Gabbita SP, 1999, J NEUROCHEM, V73, P1660, DOI 10.1046/j.1471-4159.1999.0731660.x; GARNER MH, 1980, P NATL ACAD SCI-BIOL, V77, P1274, DOI 10.1073/pnas.77.3.1274; Glaser CB, 2005, BBA-PROTEINS PROTEOM, V1703, P157, DOI 10.1016/j.bbapap.2004.10.008; Goswami S, 2003, INVEST OPHTH VIS SCI, V44, P2084, DOI 10.1167/iovs.02-0882; Hawkins CL, 2003, AMINO ACIDS, V25, P259, DOI 10.1007/s00726-003-0016-x; Hawse JR, 2005, MOL VIS, V11, P274; Hejtmancik JF, 2004, EXP EYE RES, V79, P3, DOI 10.1016/j.exer.2004.03.014; HOLMGREN A, 2010, BIOCH BIOPHYSICAL RE, V396; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; Jacob C, 2003, ANGEW CHEM INT EDIT, V42, P4742, DOI 10.1002/anie.200300573; JAKOB U, 1993, J BIOL CHEM, V268, P1517; KAGAN V, 2009, FREE RADICAL BIO MED, V46; Kantorow M, 2004, P NATL ACAD SCI USA, V101, P9654, DOI 10.1073/pnas.0403532101; Kim G, 2010, J BIOL CHEM, V285, P18085, DOI 10.1074/jbc.M110.119701; Lee W, 2007, MOL VIS, V13, P1469; Leveillard T, 2004, NAT GENET, V36, P755, DOI 10.1038/ng1386; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Liu F, 2008, FREE RADICAL BIO MED, V45, P242, DOI 10.1016/j.freeradbiomed.2008.03.022; Lou MF, 2003, PROG RETIN EYE RES, V22, P657, DOI 10.1016/S1350-9462(03)00050-8; Marchetti MA, 2006, EXP EYE RES, V83, P1281, DOI 10.1016/j.exer.2006.07.005; Moskovitz J, 1998, P NATL ACAD SCI USA, V95, P14071, DOI 10.1073/pnas.95.24.14071; Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; PHELPSBROWN N, 1995, LENS DISORDERS CLIN, P91; PICOT R, 2005, FREE RADICAL BIO MED, V39, P1332, DOI DOI 10.1016/J.FREERADBI0MED.2005.06.017; REDDY VN, 1971, EXP EYE RES, V11, P310, DOI 10.1016/S0014-4835(71)80043-X; Ruan H, 2002, P NATL ACAD SCI USA, V99, P2748, DOI 10.1073/pnas.032671199; Saghert D, 2006, P NATL ACAD SCI USA, V103, P8656, DOI 10.1073/pnas.0602826103; Salm M, 2006, AM J OPHTHALMOL, V142, P976, DOI 10.1016/j.ajo.2006.07.057; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schoneich C, 2005, BBA-PROTEINS PROTEOM, V1703, P111, DOI 10.1016/j.bbapap.2004.09.009; SPECTOR A, 1995, FASEB J, V9, P1173, DOI 10.1096/fasebj.9.12.7672510; Stadtman ER, 2003, ANTIOXID REDOX SIGN, V5, P577, DOI 10.1089/152308603770310239; Truscott RJW, 2005, EXP EYE RES, V80, P709, DOI 10.1016/j.exer.2004.12.007; TRUSCOTT RJW, 1977, BIOCHIM BIOPHYS ACTA, V492, P43, DOI 10.1016/0005-2795(77)90212-4; Vinson Joe A, 2006, Pathophysiology, V13, P151, DOI 10.1016/j.pathophys.2006.05.006; VOGT W, 1995, FREE RADICAL BIO MED, V18, P93, DOI 10.1016/0891-5849(94)00158-G; Vougier S, 2003, BIOCHEM J, V373, P531, DOI 10.1042/BJ20030443; Wassef R, 2007, J NEUROSCI, V27, P12808, DOI 10.1523/JNEUROSCI.0322-07.2007; WEI XW, 2008, FREE RADICAL BIO MED, V45, P336, DOI DOI 10.1016/J.FREERADBI0MED.2008.04.028; XING K, 2010, INFOCOM, P1; Yegorova S, 2003, INVEST OPHTH VIS SCI, V44, P3263, DOI 10.1167/iovs.02-1322; Zhao H, 2010, FREE RADICAL BIO MED, V49, P641, DOI 10.1016/j.freeradbiomed.2010.05.017	65	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e15421	10.1371/journal.pone.0015421	http://dx.doi.org/10.1371/journal.pone.0015421			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079812	gold, Green Submitted, Green Published			2022-12-25	WOS:000283838600028
J	Kim, JH; Park, BL; Cheong, HS; Bae, JS; Park, JS; Jang, AS; Uh, ST; Choi, JS; Kim, YH; Kim, MK; Choi, IS; Cho, SH; Choi, BW; Park, CS; Shin, HD				Kim, Jeong-Hyun; Park, Byung-Lae; Cheong, Hyun Sub; Bae, Joon Seol; Park, Jong Sook; Jang, An Soo; Uh, Soo-Taek; Choi, Jae-Sung; Kim, Yong-Hoon; Kim, Mi-Kyeong; Choi, Inseon S.; Cho, Sang Heon; Choi, Byoung Whui; Park, Choon-Sik; Shin, Hyoung Doo			Genome-Wide and Follow-Up Studies Identify CEP68 Gene Variants Associated with Risk of Aspirin-Intolerant Asthma	PLOS ONE			English	Article							LEUKOTRIENE C-4 SYNTHASE; PROMOTER POLYMORPHISM; RECEPTOR ANTAGONIST; HAPLOTYPE; PHARMACOGENETICS; 5-LIPOXYGENASE; DISEQUILIBRIUM; REQUIREMENT; POPULATION; EXPRESSION	Aspirin-intolerant asthma (AIA) is a rare condition that is characterized by the development of bronchoconstriction in asthmatic patients after ingestion of non-steroidal anti-inflammatory drugs including aspirin. However, the underlying mechanisms of AIA occurrence are still not fully understood. To identify the genetic variations associated with aspirin intolerance in asthmatics, the first stage of genome-wide association study with 109,365 single nucleotide polymorphisms (SNPs) was undertaken in a Korean AIA (n = 80) cohort and aspirin-tolerant asthma (ATA, n = 100) subjects as controls. For the second stage of follow-up study, 150 common SNPs from 11 candidate genes were genotyped in 163 AIA patients including intermediate AIA (AIA-I) subjects and 429 ATA controls. Among 11 candidate genes, multivariate logistic analyses showed that SNPs of CEP68 gene showed the most significant association with aspirin intolerance (P values of co-dominant for CEP68, 6.0x10(-5) to 4.0x10(-5)). All seven SNPs of the CEP68 gene showed linkage disequilibrium (LD), and the haplotype of CEP68_ht4 (T-G-A-A-A-C-G) showed a highly significant association with aspirin intolerance (OR = 2.63; 95% CI = 1.64-4.21; P = 6.0x10(-5)). Moreover, the nonsynonymous CEP68 rs7572857G>A variant that replaces glycine with serine showed a higher decline of forced expiratory volume in 1s (FEV(1)) by aspirin provocation than other variants (P = 3.0x10(-5)). Our findings imply that CEP68 could be a susceptible gene for aspirin intolerance in asthmatics, suggesting that the nonsynonymous Gly74Ser could affect the polarity of the protein structure.	[Kim, Jeong-Hyun; Bae, Joon Seol; Shin, Hyoung Doo] Sogang Univ, Dept Life Sci, Seoul, South Korea; [Park, Byung-Lae; Cheong, Hyun Sub; Shin, Hyoung Doo] SNP Genet Inc, Dept Genet Epidemiol, Seoul, South Korea; [Park, Jong Sook; Jang, An Soo; Uh, Soo-Taek; Park, Choon-Sik] Soonchunhyang Univ, Bucheon Hosp, Div Allergy & Resp Med, Puchon, South Korea; [Choi, Jae-Sung; Kim, Yong-Hoon] Soonchunhyang Univ, Cheonan Hosp, Div Allergy & Resp Med, Cheonan, South Korea; [Kim, Mi-Kyeong] Chungbuk Natl Univ, Div Internal Med, Cheongju, South Korea; [Choi, Inseon S.] Chonnam Natl Univ, Dept Allergy, Kwangju, South Korea; [Cho, Sang Heon] Seoul Natl Univ, Dept Internal Med, Seoul, South Korea; [Choi, Byoung Whui] Chung Ang Univ, Dept Internal Med, Yongsan Hosp, Seoul 156756, South Korea	Sogang University; SNP Genetics; Soonchunhyang University; Soonchunhyang University; Chungbuk National University; Chonnam National University; Seoul National University (SNU); Chung Ang University	Kim, JH (corresponding author), Sogang Univ, Dept Life Sci, Seoul, South Korea.	schalr@schbc.ac.kr; hdshin@sogang.ac.kr	Cho, Sang Heon/J-2793-2012	Park, Choon-Sik/0000-0003-2977-0255	Korean government (MEST) [M1-0302-00-0073, 2009-0080157]; Ministry of Education, Science and Technology [2009-0093822]; Korea Health 21 RD Project [A010249]; Ministry of Health, Welfare and Family Affairs, Republic of Korea	Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Health 21 RD Project; Ministry of Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	Hyoung Doo Shin received grant number M1-0302-00-0073 from the Korea Science and Engineering Foundation (KOSEF) funded by the Korean government (MEST) (No. 2009-0080157), and a Priority Research Centers Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2009-0093822). Choon-Sik Park received a grant from the Korea Health 21 R&D Project (A010249). SNP Genetics, Inc. provided the Beadstation500 scanner instrument and BeadStudio 3.0 software used in the research. They also were involved in the study design, data collection and analysis, decision to publish and preparation of the manuscript.; The DNA samples were generously provided by the Soonchunhyang University, Bucheon Hospital Biobank, a member of the National Biobank of Korea, supported by the Ministry of Health, Welfare and Family Affairs, Republic of Korea.	Akahoshi M, 2005, HUM GENET, V117, P16, DOI 10.1007/s00439-005-1285-0; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Babu KS, 2000, CHEST, V118, P1470, DOI 10.1378/chest.118.5.1470; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Chen Y, 2007, PROTEOMICS, V7, P2384, DOI 10.1002/pmic.200600968; Choi JH, 2004, J ALLERGY CLIN IMMUN, V113, P562, DOI 10.1016/j.jaci.2003.12.012; Choi JH, 2004, HUM GENET, V114, P337, DOI 10.1007/s00439-004-1082-1; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Cormican LJ, 2005, CLIN EXP ALLERGY, V35, P717, DOI 10.1111/j.1365-2222.2005.02261.x; Dahlen SE, 2002, AM J RESP CRIT CARE, V165, P9, DOI 10.1164/ajrccm.165.1.2010080; Dekker JW, 1997, CLIN EXP ALLERGY, V27, P574, DOI 10.1046/j.1365-2222.1997.540848.x; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; Drazen JM, 1999, NEW ENGL J MED, V340, P197, DOI 10.1056/NEJM199901213400306; Duroudier NP, 2009, ALLERGY, V64, P823, DOI 10.1111/j.1398-9995.2009.02015.x; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Graser S, 2007, J CELL SCI, V120, P4321, DOI 10.1242/jcs.020248; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; HEDRICK PW, 1987, GENETICS, V117, P331; Himes BE, 2009, AM J HUM GENET, V84, P581, DOI 10.1016/j.ajhg.2009.04.006; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Hitomi Y, 2009, J ALLERGY CLIN IMMUN, V124, P779, DOI 10.1016/j.jaci.2009.07.044; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Jinnai N, 2004, HUM MOL GENET, V13, P3203, DOI 10.1093/hmg/ddh332; Kawagishi Y, 2002, J ALLERGY CLIN IMMUN, V109, P936, DOI 10.1067/mai.2002.124466; Kim S, 2005, BONE MARROW TRANSPL, V35, pS330; Kim SH, 2006, CLIN EXP ALLERGY, V36, P1247, DOI 10.1111/j.1365-2222.2006.02567.x; Kim SH, 2009, ALLERGY, V64, P1221, DOI 10.1111/j.1398-9995.2009.01989.x; Kim SH, 2007, PHARMACOGENOMICS, V8, P1143, DOI 10.2217/14622416.8.9.1143; Kim SH, 2006, CLIN EXP ALLERGY, V36, P433, DOI 10.1111/j.1365-2222.2006.02457.x; Kim SH, 2005, ALLERGY, V60, P760, DOI 10.1111/j.1398-9995.2005.00780.x; Kim TH, 2008, CLIN EXP ALLERGY, V38, P1727, DOI 10.1111/j.1365-2222.2008.03082.x; Kowalski Marek L, 2007, Clin Allergy Immunol, V19, P147; Kraft P, 2009, NEW ENGL J MED, V360, P1701, DOI 10.1056/NEJMp0810107; Leff AR, 2001, ANNU REV MED, V52, P1; Maheshwari R, 2004, J COLLOID INTERF SCI, V277, P79, DOI 10.1016/j.jcis.2004.04.023; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; *NIH, 1995, NIH PUBL, P95; Palikhe NS, 2008, J CLIN PHARM THER, V33, P465, DOI 10.1111/j.1365-2710.2008.00961.x; Park HS, 2004, J ALLERGY CLIN IMMUN, V114, P688, DOI 10.1016/j.jaci.2004.05.051; Park JS, 2010, ALLERGY ASTHMA IMMUN, V2, P48, DOI 10.4168/aair.2010.2.1.48; Park JS, 2005, PHARMACOGENET GENOM, V15, P483, DOI 10.1097/01.fpc.0000166456.84905.a0; Roses AD, 2008, NAT REV DRUG DISCOV, V7, P807, DOI 10.1038/nrd2593; Rouse RL, 2007, ENVIRON HEALTH PERSP, V115, P1757, DOI 10.1289/ehp.10358; Sanak M, 2001, J ALLERGY CLIN IMMUN, V107, P561, DOI 10.1067/mai.2001.112853; Sanak M, 1997, LANCET, V350, P1599, DOI 10.1016/S0140-6736(05)64015-9; Slatkin M, 2008, NAT REV GENET, V9, P477, DOI 10.1038/nrg2361; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; STEVENSON DD, 1997, ASTHMA, P2025; Szczeklik A, 2003, J ALLERGY CLIN IMMUN, V111, P913, DOI 10.1067/mai.2003.1487; Tantisira KG, 2009, J ALLERGY CLIN IMMUN, V124, P422, DOI 10.1016/j.jaci.2009.06.035; Van Sambeek R, 2000, J ALLERGY CLIN IMMUN, V106, P72, DOI 10.1067/mai.2000.107603; Weinshilboum R, 2004, NAT REV DRUG DISCOV, V3, P739, DOI 10.1038/nrd1497; WIDAL F, 1993, ALLERGY PROC, V14, P373, DOI 10.2500/108854193778774065; ZABANEH D, 2010, PLOS ONE IN PRESS	54	64	64	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e13818	10.1371/journal.pone.0013818	http://dx.doi.org/10.1371/journal.pone.0013818			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21072201	Green Submitted, Green Published, gold			2022-12-25	WOS:000283780800016
J	Durie, D; Lewis, SM; Liwak, U; Kisilewicz, M; Gorospe, M; Holcik, M				Durie, D.; Lewis, S. M.; Liwak, U.; Kisilewicz, M.; Gorospe, M.; Holcik, M.			RNA-binding protein HuR mediates cytoprotection through stimulation of XIAP translation	ONCOGENE			English	Article						translation; internal initiation; ITAF; HuR; XIAP; cancer	X-LINKED INHIBITOR; RIBOSOME-ENTRY-SITE; TRANS-ACTING FACTOR; MESSENGER-RNA; APOPTOSIS PROTEIN; PROGNOSTIC-FACTOR; HIGH EXPRESSION; UP-REGULATION; ELEMENT; OVEREXPRESSION	Expression of the intrinsic cellular caspase inhibitor XIAP is regulated primarily at the level of protein synthesis. The 50 untranslated region harbours an Internal Ribosome Entry Site (IRES) motif that supports cap-independent translation of XIAP mRNA during conditions of cellular stress. In this study, we show that the RNA-binding protein HuR, which is known to orchestrate an antiapoptotic cellular program, stimulates translation of XIAP mRNA through XIAP IRES. We further show that HuR binds to XIAP IRES in vitro and in vivo, and stimulates recruitment of the XIAP mRNA into polysomes. Importantly, protection from the apoptosis-inducing agent etoposide by overexpression of HuR requires the presence of XIAP, suggesting that HuR-mediated cytoprotection is partially executed through enhanced XIAP translation. Our data suggest that XIAP belongs to the HuR-regulated RNA operon of antiapoptotic genes, which, along with Bcl-2, Mcl-1 and ProT alpha, contributes to the regulation of cell survival. Oncogene (2011) 30, 1460-1469; doi:10.1038/onc.2010.527; published online 22 November 2010	[Durie, D.; Lewis, S. M.; Liwak, U.; Kisilewicz, M.; Holcik, M.] Childrens Hosp Eastern Ontario, Res Inst, Apoptosis Res Ctr, Ottawa, ON K1H 8L1, Canada; [Durie, D.; Liwak, U.; Kisilewicz, M.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Holcik, M.] Univ Ottawa, Dept Paediat, Ottawa, ON, Canada; [Gorospe, M.] NIA, Cellular & Mol Biol Lab, Intramural Res Program, NIH, Baltimore, MD 21224 USA	University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; University of Ottawa; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Holcik, M (corresponding author), Childrens Hosp Eastern Ontario, Res Inst, Apoptosis Res Ctr, 401 Smyth Rd, Ottawa, ON K1H 8L1, Canada.	martin@mgcheo.med.uottawa.ca	Holcik, Martin/E-5372-2011; Lewis, Stephen/E-5533-2010; Holcik, Martin/AAC-6660-2019	Lewis, Stephen/0000-0001-9537-5822; Holcik, Martin/0000-0002-1922-5299	Canadian Institutes of Health Research (CIHR) [MOP 89737]; National Institute on Aging, National Institutes of Health; NATIONAL INSTITUTE ON AGING [Z01AG000511, ZIAAG000511] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Drs Nehal Thakor and Stephen Baird for critical discussions. We are grateful to Drs P Anderson and R Screaton for the gift of anti-TIA-1/TIAR and anti-GST antibodies, respectively, and to Dr I Gallouzi for the GFP-HuR, GFP-HuR(CP1), GFP-HuR(CP2), AP-HuR-GST, AP-HuR(CP1)-GST and AP-HuR(CP2)-GST overexpression constructs. This work was supported by an operating grant from the Canadian Institutes of Health Research to MH (CIHR; MOP 89737); MG was supported by the Intramural Research Program of the National Institute on Aging, National Institutes of Health. MH is the CHEO Volunteer Association Endowed Scholar.	Abdelmohsen K, 2007, CELL CYCLE, V6, P1288, DOI 10.4161/cc.6.11.4299; Baird SD, 2007, NUCLEIC ACIDS RES, V35, P4664, DOI 10.1093/nar/gkm483; Braunstein S, 2007, MOL CELL, V28, P501, DOI 10.1016/j.molcel.2007.10.019; Coleman J, 2009, RNA BIOL, V6, P84, DOI 10.4161/rna.6.1.7572; Dean E, 2009, J CLIN ONCOL, V27, P1660, DOI 10.1200/JCO.2008.19.5677; Dean EJ, 2007, EXPERT OPIN THER TAR, V11, P1459, DOI 10.1517/14728222.11.11.1459; Denkert C, 2004, CLIN CANCER RES, V10, P5580, DOI 10.1158/1078-0432.CCR-04-0070; Denkert C, 2004, CANCER RES, V64, P189, DOI 10.1158/0008-5472.CAN-03-1987; DENKERT C, 2006, MODERN PATHOL, V23, P23; Dormoy-Raclet V, 2007, MOL CELL BIOL, V27, P5365, DOI 10.1128/MCB.00113-07; Dubrez-Daloz L, 2008, CELL CYCLE, V7, P1036, DOI 10.4161/cc.7.8.5783; ERKINHEIMO TL, 2005, GYNECOL ONCOL, V26, P26; Fialcowitz-White EJ, 2007, J BIOL CHEM, V282, P20948, DOI 10.1074/jbc.M701751200; Galban S, 2008, MOL CELL BIOL, V28, P93, DOI 10.1128/MCB.00973-07; Graber TE, 2010, CELL DEATH DIFFER, V17, P719, DOI 10.1038/cdd.2009.164; Gu LB, 2009, CANCER CELL, V15, P363, DOI 10.1016/j.ccr.2009.03.002; Heinonen M, 2005, CANCER RES, V65, P2157, DOI 10.1158/0008-5472.CAN-04-3765; Heinonen M, 2007, CLIN CANCER RES, V13, P6959, DOI 10.1158/1078-0432.CCR-07-1432; Hinman MN, 2008, CELL MOL LIFE SCI, V65, P3168, DOI 10.1007/s00018-008-8252-6; Holcik M, 2003, MOL CELL BIOL, V23, P280, DOI 10.1128/MCB.23.1.280-288.2003; Holcik M, 2000, ONCOGENE, V19, P4174, DOI 10.1038/sj.onc.1203765; Holcik M, 2000, TRENDS GENET, V16, P469, DOI 10.1016/S0168-9525(00)02106-5; Holcik M, 2000, MOL CELL BIOL, V20, P4648, DOI 10.1128/MCB.20.13.4648-4657.2000; Holcik M, 2005, RNA, V11, P1605, DOI 10.1261/rna.2158605; Holcik M, 2003, ANN NY ACAD SCI, V1010, P249, DOI 10.1196/annals.1299.043; Holcik M, 1999, NAT CELL BIOL, V1, P190, DOI 10.1038/11109; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Kullmann M, 2002, GENE DEV, V16, P3087, DOI 10.1101/gad.248902; Lal A, 2005, EMBO J, V24, P1852, DOI 10.1038/sj.emboj.7600661; Lewis SM, 2007, MOL BIOL CELL, V18, P1302, DOI 10.1091/mbc.E06-06-0515; Liston P, 2003, ONCOGENE, V22, P8568, DOI 10.1038/sj.onc.1207101; Liston P, 1996, NATURE, V379, P349, DOI 10.1038/379349a0; Macgregor G R, 1991, Methods Mol Biol, V7, P217, DOI 10.1385/0-89603-178-0:217; Mazroui R, 2008, J CELL BIOL, V180, P113, DOI 10.1083/jcb.200709030; Meisner NC, 2004, CHEMBIOCHEM, V5, P1432, DOI 10.1002/cbic.200400219; Meng Z, 2005, NUCLEIC ACIDS RES, V33, P2962, DOI 10.1093/nar/gki603; Myer VE, 1997, EMBO J, V16, P2130, DOI 10.1093/emboj/16.8.2130; Pardo OE, 2003, MOL CELL BIOL, V23, P7600, DOI 10.1128/MCB.23.21.7600-7610.2003; Rivas-Aravena A, 2009, VIROLOGY, V392, P178, DOI 10.1016/j.virol.2009.06.050; Schimmer AD, 2009, J CLIN ONCOL, V27, P4741, DOI 10.1200/JCO.2009.21.8172; Schimmer AD, 2006, CELL DEATH DIFFER, V13, P179, DOI 10.1038/sj.cdd.4401826; Silvera D, 2009, NAT CELL BIOL, V11, P903, DOI 10.1038/ncb1900; Tamm I, 2000, CLIN CANCER RES, V6, P1796; Tamm I, 2004, HEMATOL J, V5, P489, DOI 10.1038/sj.thj.6200549; Tamm I, 2004, CLIN CANCER RES, V10, P3737, DOI 10.1158/1078-0432.CCR-03-0642; Wilkinson JC, 2004, MOL CELL BIOL, V24, P7003, DOI 10.1128/MCB.24.16.7003-7014.2004; Yeh CH, 2008, MOL BIOL CELL, V25, P25; Yoo PS, 2009, ANN SURG ONCOL, V16, P200, DOI 10.1245/s10434-008-0209-3; Yoon A, 2006, SCIENCE, V312, P902, DOI 10.1126/science.1123835; Zhang X, 2009, NUCLEIC ACIDS RES, V37, P7623, DOI 10.1093/nar/gkp755	50	64	68	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2011	30	12					1460	1469		10.1038/onc.2010.527	http://dx.doi.org/10.1038/onc.2010.527			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	739UM	21102524	Green Accepted			2022-12-25	WOS:000288743800008
J	Bucholc, M; Ciesielski, A; Goch, G; Anielska-Mazur, A; Kulik, A; Krzywinska, E; Dobrowolska, G				Bucholc, Maria; Ciesielski, Arkadiusz; Goch, Grazyna; Anielska-Mazur, Anna; Kulik, Anna; Krzywinska, Ewa; Dobrowolska, Grazyna			SNF1-related Protein Kinases 2 Are Negatively Regulated by a Plant-specific Calcium Sensor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABSCISIC-ACID; BINDING PROTEINS; NITRIC-OXIDE; ION LUMINESCENCE; GENE-EXPRESSION; STRESS; ACTIVATION; PHOSPHORYLATION; IDENTIFICATION; CA2+	SNF1-related protein kinases 2 (SnRK2s) are plant-specific enzymes involved in environmental stress signaling and abscisic acid-regulated plant development. Here, we report that SnRK2s interact with and are regulated by a plant-specific calcium-binding protein. We screened a Nicotiana plumbaginifolia Matchmaker cDNA library for proteins interacting with Nicotiana tabacum osmotic stress-activated protein kinase (NtOSAK), a member of the SnRK2 family. A putative EF-hand calcium-binding protein was identified as a molecular partner of NtOSAK. To determine whether the identified protein interacts only with NtOSAK or with other SnRK2s as well, we studied the interaction of an Arabidopsis thaliana orthologue of the calcium-binding protein with selected Arabidopsis SnRK2s using a two-hybrid system. All kinases studied interacted with the protein. The interactions were confirmed by bimolecular fluorescence complementation assay, indicating that the binding occurs in planta, exclusively in the cytoplasm. Calcium binding properties of the protein were analyzed by fluorescence spectroscopy using Tb3+ as a spectroscopic probe. The calcium binding constant, determined by the protein fluorescence titration, was 2.5 +/- 0.9 x 10(5) M-1. The CD spectrum indicated that the secondary structure of the protein changes significantly in the presence of calcium, suggesting its possible function as a calcium sensor in plant cells. In vitro studies revealed that the activity of SnRK2 kinases analyzed is inhibited in a calcium-dependent manner by the identified calcium sensor, which we named SCS (SnRK2-interacting calcium sensor). Our results suggest that SCS is involved in response to abscisic acid during seed germination most probably by negative regulation of SnRK2s activity.	[Dobrowolska, Grazyna] Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland; [Ciesielski, Arkadiusz] Univ Warsaw, Fac Chem, PL-02093 Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of Warsaw	Dobrowolska, G (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Ul Pawinskiego 5A, PL-02106 Warsaw, Poland.	dobrowol@ibb.waw.pl	Kulik, Anna/AAG-6577-2020; Bucholc, Maria/ABF-5097-2020	Kulik, Anna/0000-0003-0073-0583; Bucholc, Maria/0000-0003-0237-1131; Dobrowolska, Grazyna/0000-0002-2598-9666; Ciesielski, Arkadiusz/0000-0003-3945-4723; Krzywinska, Ewa/0000-0003-2259-739X; Anielska-Mazur, Anna/0000-0003-3679-7595	Ministry of Science and Higher Education [N-N301-2540, 500/N-COST/2009/0]; European Union [COST FA0605]	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); European Union(European Commission)	This work was supported by Ministry of Science and Higher Education Grants N-N301-2540 and 500/N-COST/2009/0 (to G. D.) and European Union Grant COST FA0605.	Akaboshi M, 2008, J MOL BIOL, V377, P246, DOI 10.1016/j.jmb.2008.01.006; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Batistic O, 2009, BBA-MOL CELL RES, V1793, P985, DOI 10.1016/j.bbamcr.2008.10.006; Beard NA, 2004, PROG BIOPHYS MOL BIO, V85, P33, DOI 10.1016/j.pbiomolbio.2003.07.001; Belin C, 2006, PLANT PHYSIOL, V141, P1316, DOI 10.1104/pp.106.079327; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Boudsocq M, 2005, PLANT PHYSIOL, V138, P1185, DOI 10.1104/pp.105.061275; Boudsocq M, 2004, J BIOL CHEM, V279, P41758, DOI 10.1074/jbc.M405259200; Boudsocq M, 2007, PLANT MOL BIOL, V63, P491, DOI 10.1007/s11103-006-9103-1; BRITTAIN HG, 1976, J AM CHEM SOC, V98, P8255, DOI 10.1021/ja00441a060; Burza AM, 2006, J BIOL CHEM, V281, P34299, DOI 10.1074/jbc.M601977200; DADLEZ M, 1991, FEBS LETT, V282, P143, DOI 10.1016/0014-5793(91)80464-E; Day IS, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-10-research0056; DeFalco TA, 2010, BIOCHEM J, V425, P27, DOI 10.1042/BJ20091147; Diedhiou CJ, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-49; Ding XD, 2009, PLANT PHYSIOL, V149, P1478, DOI 10.1104/pp.108.128298; Dodd AN, 2010, ANNU REV PLANT BIOL, V61, P593, DOI 10.1146/annurev-arplant-070109-104628; Eftink MR, 1997, METHOD ENZYMOL, V278, P221; Fujii H, 2007, PLANT CELL, V19, P485, DOI 10.1105/tpc.106.048538; Fujii H, 2009, P NATL ACAD SCI USA, V106, P8380, DOI 10.1073/pnas.0903144106; Fujita Y, 2009, PLANT CELL PHYSIOL, V50, P2123, DOI 10.1093/pcp/pcp147; Furihata T, 2006, P NATL ACAD SCI USA, V103, P1988, DOI 10.1073/pnas.0505667103; Gilroy S, 2001, NAT REV MOL CELL BIO, V2, P307, DOI 10.1038/35067109; Goch G, 2005, FEBS J, V272, P2557, DOI 10.1111/j.1742-4658.2005.04680.x; Han SJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-179; HARMON AC, 2003, GRAVIT SPACE BIOL B, V16, P1; He Ping, 2007, Methods Mol Biol, V354, P1; HORROCKS WD, 1977, J AM CHEM SOC, V99, P2378, DOI 10.1021/ja00449a079; HORROCKS WD, 1980, J AM CHEM SOC, V102, P3650, DOI 10.1021/ja00530a069; Hrabak EM, 2003, PLANT PHYSIOL, V132, P666, DOI 10.1104/pp.102.011999; James P, 1996, GENETICS, V144, P1425; Johnson RR, 2002, PLANT PHYSIOL, V130, P837, DOI 10.1104/pp.001354; Kelner A, 2004, PLANT PHYSIOL, V136, P3255, DOI 10.1104/pp.104.046151; Kobayashi Y, 2005, PLANT J, V44, P939, DOI 10.1111/j.1365-313X.2005.02583.x; Kobayashi Y, 2004, PLANT CELL, V16, P1163, DOI 10.1105/tpc.019943; KRETSINGER RH, 1973, J BIOL CHEM, V248, P3313; Kudla J, 2010, PLANT CELL, V22, P541, DOI 10.1105/tpc.109.072686; Lamotte O, 2006, FREE RADICAL BIO MED, V40, P1369, DOI 10.1016/j.freeradbiomed.2005.12.006; Li JX, 2000, SCIENCE, V287, P300, DOI 10.1126/science.287.5451.300; Luan S, 2009, TRENDS PLANT SCI, V14, P37, DOI 10.1016/j.tplants.2008.10.005; MACH H, 1992, ANAL BIOCHEM, V200, P74, DOI 10.1016/0003-2697(92)90279-G; MARSDEN BJ, 1989, BIOCHEMISTRY-US, V28, P8839, DOI 10.1021/bi00448a024; MARUYAMA K, 1984, J BIOCHEM-TOKYO, V95, P511, DOI 10.1093/oxfordjournals.jbchem.a134633; Michiels J, 2002, TRENDS MICROBIOL, V10, P87, DOI 10.1016/S0966-842X(01)02284-3; Mikolajczyk M, 2000, PLANT CELL, V12, P165, DOI 10.1105/tpc.12.1.165; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; NAGATA T, 1992, INT REV CYTOL, V132, P1, DOI 10.1016/S0074-7696(08)62452-3; Nakashima K, 2009, PLANT CELL PHYSIOL, V50, P1345, DOI 10.1093/pcp/pcp083; Shin R, 2007, P NATL ACAD SCI USA, V104, P6460, DOI 10.1073/pnas.0610208104; Sokolovski S, 2005, PLANT J, V43, P520, DOI 10.1111/j.1365-313X.2005.02471.x; Umezawa T, 2004, P NATL ACAD SCI USA, V101, P17306, DOI 10.1073/pnas.0407758101; Umezawa T, 2009, P NATL ACAD SCI USA, V106, P17588, DOI 10.1073/pnas.0907095106; Vlad F, 2009, PLANT CELL, V21, P3170, DOI 10.1105/tpc.109.069179; Wawer I, 2010, BIOCHEM J, V429, P73, DOI 10.1042/BJ20100492; Yamada H, 2004, BIOSCI BIOTECH BIOCH, V68, P1966, DOI 10.1271/bbb.68.1966; Yoshida R, 2002, PLANT CELL PHYSIOL, V43, P1473, DOI 10.1093/pcp/pcf188	56	34	38	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3429	3441		10.1074/jbc.M110.115535	http://dx.doi.org/10.1074/jbc.M110.115535			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21098029	hybrid, Green Submitted, Green Published			2022-12-25	WOS:000286653200029
J	Sugita, A; Kawai, S; Hayashibara, T; Amano, A; Ooshima, T; Michigami, T; Yoshikawa, H; Yoneda, T				Sugita, Atsushi; Kawai, Shinji; Hayashibara, Tetsuyuki; Amano, Atsuo; Ooshima, Takashi; Michigami, Toshimi; Yoshikawa, Hideki; Yoneda, Toshiyuki			Cellular ATP Synthesis Mediated by Type III Sodium-dependent Phosphate Transporter Pit-1 Is Critical to Chondrogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED HYPOPHOSPHATEMIC MICE; BONE-INDUCING SUBSTANCE; D-RESISTANT RICKETS; GROWTH-PLATE; ENDOCHONDRAL OSSIFICATION; CHONDROCYTE APOPTOSIS; INORGANIC-PHOSPHATE; ELEMENTAL ANALYSIS; POTENTIAL ROLE; IN-VITRO	Disturbed endochondral ossification in X-linked hypophosphatemia indicates an involvement of P-i in chondrogenesis. We studied the role of the sodium-dependent P-i cotransporters (NPT), which are a widely recognized regulator of cellular P-i homeostasis, and the downstream events in chondrogenesis using Hyp mice, the murine homolog of human X-linked hypophosphatemia. Hyp mice showed reduced apoptosis and mineralization in hypertrophic cartilage. Hyp chondrocytes in culture displayed decreased apoptosis and mineralization compared with WT chondrocytes, whereas glycosaminoglycan synthesis, an early event in chondrogenesis, was not altered. Expression of the type III NPT Pit-1 and P-i uptake were diminished, and intracellular ATP levels were also reduced in parallel with decreased caspase-9 and caspase-3 activity in Hyp chondrocytes. The competitive NPT inhibitor phosphonoformic acid and ATP synthesis inhibitor 3-bromopyruvate disturbed endochondral ossification with reduced apoptosis in vivo and suppressed apoptosis and mineralization in conjunction with reduced P-i uptake and ATP synthesis in WT chondrocytes. Overexpression of Pit-1 in Hyp chondrocytes reversed P-i uptake and ATP synthesis and restored apoptosis and mineralization. Our results suggest that cellular ATP synthesis consequent to P-i uptake via Pit-1 plays an important role in chondrocyte apoptosis and mineralization, and that chondrogenesis is ATP-dependent.	[Yoneda, Toshiyuki] Osaka Univ, Grad Sch Dent, Dept Biochem, Osaka 5941101, Japan; [Kawai, Shinji; Amano, Atsuo] Osaka Univ, Grad Sch Dent, Dept Oral Frontier Biol, Osaka 5941101, Japan; [Hayashibara, Tetsuyuki; Ooshima, Takashi] Osaka Univ, Grad Sch Dent, Dept Pediat Dent, Osaka 5941101, Japan; [Michigami, Toshimi] Osaka Med Ctr, Dept Bone & Mineral Res, Osaka 5941101, Japan; [Michigami, Toshimi] Res Inst Maternal & Child Hlth, Izumi Ku, Osaka 5941101, Japan; [Sugita, Atsushi; Yoshikawa, Hideki] Osaka Univ, Dept Orthopaed Surg, Grad Sch Med, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University; Osaka Medical Center for Cancer & Cardiovascular Diseases; Osaka University	Yoneda, T (corresponding author), 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	tyoneda@dent.osaka-u.ac.jp	Michigami, Toshimi/AAU-2326-2021		Ministry of Education, Culture, Sports, Science, and Technology; Japanese Society for the Promotion of Science [A202290100]	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by the 21st Century COE Program entitled "Origination of Frontier BioDentistry" at Osaka University Graduate School of Dentistry, by the Ministry of Education, Culture, Sports, Science, and Technology, and by Grant-in-aid for Scientific Research A202290100 from the Japanese Society for the Promotion of Science (to T. Y.).	BOYDE A, 1980, HISTOCHEMISTRY, V69, P85, DOI 10.1007/BF00508369; Cecil DL, 2005, ARTHRITIS RHEUM-US, V52, P144, DOI 10.1002/art.20748; ECAROT B, 1992, J BONE MINER RES, V7, P523; Eguchi Y, 1999, CANCER RES, V59, P2174; EICHER EM, 1976, P NATL ACAD SCI USA, V73, P4667, DOI 10.1073/pnas.73.12.4667; Fujita T, 2001, JPN J PHARMACOL, V85, P278, DOI 10.1254/jjp.85.278; Fukumoto S, 2007, BONE, V40, P1190, DOI 10.1016/j.bone.2006.12.062; Geschwind JFH, 2002, CANCER RES, V62, P3909; Gibson G, 1998, MICROSC RES TECHNIQ, V43, P191, DOI 10.1002/(SICI)1097-0029(19981015)43:2<191::AID-JEMT10>3.0.CO;2-T; Guicheux J, 2000, BONE, V27, P69, DOI 10.1016/S8756-3282(00)00302-1; Hayashibara T, 2007, J BONE MINER RES, V22, P1743, DOI 10.1359/JBMR.070709; Holm IA, 1997, AM J HUM GENET, V60, P790; Ishibashi K, 2002, AM J PHYSIOL-RENAL, V282, pF367, DOI 10.1152/ajprenal.00364.2000; JONES AR, 1995, CONTRACEPTION, V52, P317, DOI 10.1016/0010-7824(95)00217-X; KAKUTA S, 1985, CALCIFIED TISSUE INT, V37, P293, DOI 10.1007/BF02554877; Ko YH, 2004, BIOCHEM BIOPH RES CO, V324, P269, DOI 10.1016/j.bbrc.2004.09.047; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; LoghmanAdham M, 1996, GEN PHARMACOL-VASC S, V27, P305, DOI 10.1016/0306-3623(95)02017-9; Magne D, 2003, J BONE MINER RES, V18, P1430, DOI 10.1359/jbmr.2003.18.8.1430; Mansfield K, 2001, BONE, V28, P1, DOI 10.1016/S8756-3282(00)00409-9; Miao DS, 2004, BONE, V34, P638, DOI 10.1016/j.bone.2003.12.015; MONTESSUIT C, 1991, J BIOL CHEM, V266, P17791; Mwale F, 2002, J BONE MINER RES, V17, P275, DOI 10.1359/jbmr.2002.17.2.275; Palmer G, 1999, BONE, V24, P1, DOI 10.1016/S8756-3282(98)00151-3; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Rao NN, 2009, ANNU REV BIOCHEM, V78, P605, DOI 10.1146/annurev.biochem.77.083007.093039; Rowe PSN, 1996, BONE, V18, P159, DOI 10.1016/8756-3282(95)00458-0; SHAPIRO IM, 1984, METAB BONE DIS RELAT, V5, P317, DOI 10.1016/0221-8747(84)90019-5; Shimada T, 2004, BIOCHEM BIOPH RES CO, V314, P409, DOI 10.1016/j.bbrc.2003.12.102; SHIMOMURA Y, 1975, CALC TISS RES, V19, P179, DOI 10.1007/BF02564002; SWENSON CL, 1991, CALCIFIED TISSUE INT, V48, P353, DOI 10.1007/BF02556155; TANAKA H, 1988, BONE MINER, V4, P237; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Virkki LV, 2007, AM J PHYSIOL-RENAL, V293, pF643, DOI 10.1152/ajprenal.00228.2007; Wang DS, 2001, J BIOL CHEM, V276, P33995, DOI 10.1074/jbc.M007757200; WINTERS RW, 1958, MEDICINE, V37, P97, DOI 10.1097/00005792-195805000-00001; Wu LNY, 2002, J CELL BIOCHEM, V86, P475, DOI 10.1002/jcb.10240; Wu SF, 2006, J BIOL CHEM, V281, P5120, DOI 10.1074/jbc.M506667200; Xu RH, 2005, CANCER RES, V65, P613; YOSHIKAWA H, 1985, BONE, V6, P235, DOI 10.1016/8756-3282(85)90006-7; Yoshiko Y, 2007, BONE, V40, P1565, DOI 10.1016/j.bone.2007.01.017; Yoshiko Y, 2007, MOL CELL BIOL, V27, P4465, DOI 10.1128/MCB.00104-07; Zalutskaya AA, 2009, J CELL BIOCHEM, V108, P668, DOI 10.1002/jcb.22302; Zuscik MJ, 2008, J CLIN INVEST, V118, P429, DOI 10.1172/JCI34174	45	33	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					3094	3103		10.1074/jbc.M110.148403	http://dx.doi.org/10.1074/jbc.M110.148403			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21075853	Green Published, hybrid			2022-12-25	WOS:000286464300071
J	Woolls, HA; Lamanna, AC; Karbstein, K				Woolls, Heather A.; Lamanna, Allison C.; Karbstein, Katrin			Roles of Dim2 in Ribosome Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KH-DOMAIN; RNA; CLEAVAGE; BINDING; IDENTIFICATION; ORGANIZATION; RECOGNITION; MODULES; 3'-END; SITES	In eukaryotes, ribosome assembly requires hundreds of conserved essential proteins not present in the mature particle. Despite their importance, the function of most factors remains unknown. This is because protein deletion often affects the composition of the entire particle. Additionally, many proteins are present in assembling ribosomes for extended times, which makes it difficult to pinpoint their role to a particular step. Here we have combined classical yeast biochemistry with experiments using recombinant proteins and RNA to study the role of Dim2 and its interaction with Nob1, the nuclease that generates the 3'-end of 18 S rRNA. Analysis of Dim2 mutants in which the interaction with Nob1 is disrupted demonstrates that this interaction between Dim2 and Nob1 is essential for optimal growth, and RNA binding experiments show that Dim2 increases Nob1 RNA affinity. Furthermore, our data indicate that Dim2 helps regulate Nob1 cleavage activity at the 3'-end of 18 S rRNA, as point mutants where this interaction is abolished in vitro accumulate pre-ribosomes containing Nob1 and 20 S rRNA in vivo. Interestingly, the site of interaction with Nob1 is mapped to the canonical RNA binding surface of a KH-like domain in Dim2, providing another example where an RNA-binding domain can be repurposed for protein interactions.	[Lamanna, Allison C.; Karbstein, Katrin] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Woolls, Heather A.; Karbstein, Katrin] Univ Michigan, Program Chem Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Karbstein, K (corresponding author), Scripps Res Inst, Dept Canc Biol, 130 Scripps Way 2C1, Jupiter, FL 33458 USA.	kkarbst@scripps.edu		Lamanna, Allison C./0000-0003-0436-7494; Karbstein, Katrin/0000-0002-4034-1331	National Institutes of Health [R01-GM086451]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086451] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM086451.	Beuth B, 2005, EMBO J, V24, P3576, DOI 10.1038/sj.emboj.7600829; Bohnsack MT, 2009, MOL CELL, V36, P583, DOI 10.1016/j.molcel.2009.09.039; CAMPBELL MG, 2011, PLOS ONE IN PRESS; Champion EA, 2008, MOL CELL BIOL, V28, P6547, DOI 10.1128/MCB.00906-08; Chmiel NH, 2006, RNA, V12, P283, DOI 10.1261/rna.2175706; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Diaz-Moreno I, 2010, NUCLEIC ACIDS RES, V38, P5193, DOI 10.1093/nar/gkq216; Fatica A, 2004, RNA, V10, P1698, DOI 10.1261/rna.7123504; Fatica A, 2003, MOL CELL BIOL, V23, P1798, DOI 10.1128/MCB.23.5.1798-1807.2003; Freed EF, 2010, NUCLEIC ACIDS RES, V38, P4798, DOI 10.1093/nar/gkq185; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Granneman S, 2005, MOL CELL BIOL, V25, P10352, DOI 10.1128/MCB.25.23.10352-10364.2005; Granneman S, 2010, EMBO J, V29, P2026, DOI 10.1038/emboj.2010.86; Granneman S, 2009, P NATL ACAD SCI USA, V106, P9613, DOI 10.1073/pnas.0901997106; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Jensen KB, 2000, P NATL ACAD SCI USA, V97, P5740, DOI 10.1073/pnas.090553997; Jia MZ, 2010, J MOL BIOL, V398, P774, DOI 10.1016/j.jmb.2010.03.055; Karbstein K, 2005, MOL CELL, V20, P633, DOI 10.1016/j.molcel.2005.09.017; Kielkopf CL, 2004, GENE DEV, V18, P1513, DOI 10.1101/gad.1206204; Kos M, 2010, MOL CELL, V37, P809, DOI 10.1016/j.molcel.2010.02.024; Lamanna AC, 2011, J MOL BIOL, V405, P3, DOI 10.1016/j.jmb.2010.09.064; Lamanna AC, 2009, P NATL ACAD SCI USA, V106, P14259, DOI 10.1073/pnas.0905403106; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Merl J, 2010, NUCLEIC ACIDS RES, V38, P3068, DOI 10.1093/nar/gkp1244; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Musco G, 1996, CELL, V85, P237, DOI 10.1016/S0092-8674(00)81100-9; Osheim YN, 2004, MOL CELL, V16, P943, DOI 10.1016/j.molcel.2004.11.031; Pertschy B, 2009, J BIOL CHEM, V284, P35079, DOI 10.1074/jbc.M109.040774; Schafer T, 2003, EMBO J, V22, P1370, DOI 10.1093/emboj/cdg121; Schafer T, 2006, NATURE, V441, P651, DOI 10.1038/nature04840; Senapin S, 2003, NUCLEIC ACIDS RES, V31, P2524, DOI 10.1093/nar/gkg366; Soudet J, 2010, EMBO J, V29, P80, DOI 10.1038/emboj.2009.307; TONE Y, 2002, GENE DEV, V16; Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x; Valverde R, 2007, STRUCTURE, V15, P1090, DOI 10.1016/j.str.2007.06.022; Vanrobays E, 2004, RNA, V10, P645, DOI 10.1261/rna.5162204; Vanrobays E, 2008, RNA, V14, P2061, DOI 10.1261/rna.1176708; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7	41	30	31	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2578	2586		10.1074/jbc.M110.191494	http://dx.doi.org/10.1074/jbc.M110.191494			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21075849	Green Published, hybrid			2022-12-25	WOS:000286464300023
J	Wu, K; Walukiewicz, HE; Glekas, GD; Ordal, GW; Rao, CV				Wu, Kang; Walukiewicz, Hanna E.; Glekas, George D.; Ordal, George W.; Rao, Christopher V.			Attractant Binding Induces Distinct Structural Changes to the Polar and Lateral Signaling Clusters in Bacillus subtilis Chemotaxis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL CHEMOTAXIS; ESCHERICHIA-COLI; CHEMORECEPTOR MODIFICATION; HELICOBACTER-PYLORI; RECEPTOR; PROTEIN; CHEW; TRANSDUCTION; COMPLEX; GENES	Bacteria employ a modified two-component system for chemotaxis, where the receptors form ternary complexes with CheA histidine kinases and CheW adaptor proteins. These complexes are arranged in semi-ordered arrays clustered predominantly at the cell poles. The prevailing models assume that these arrays are static and reorganize only locally in response to attractant binding. Recent studies have shown, however, that these structures may in fact be much more fluid. We investigated the localization of the chemotaxis signaling arrays in Bacillus subtilis using immunofluorescence and live cell fluorescence microscopy. We found that the receptors were localized in clusters at the poles in most cells. However, when the cells were exposed to attractant, the number exhibiting polar clusters was reduced roughly 2-fold, whereas the number exhibiting lateral clusters distinct from the poles increased significantly. These changes in receptor clustering were reversible as polar localization was reestablished in adapted cells. We also investigated the dynamic localization of CheV, a hybrid protein consisting of an N-terminal CheW-like adaptor domain and a C-terminal response regulator domain that is known to be phosphorylated by CheA, using immunofluorescence. Interestingly, we found that CheV was localized predominantly at lateral clusters in unstimulated cells. However, upon exposure to attractant, CheV was found to be predominantly localized to the cell poles. Moreover, changes in CheV localization are phosphorylation-dependent. Collectively, these results suggest that the chemotaxis signaling arrays in B. subtilis are dynamic structures and that feedback loops involving phosphorylation may regulate the positioning of individual proteins.	[Wu, Kang; Rao, Christopher V.] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; [Walukiewicz, Hanna E.; Glekas, George D.; Ordal, George W.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Rao, CV (corresponding author), Univ Illinois, Dept Chem & Biomol Engn, 600 S Mathews Ave, Urbana, IL 61801 USA.	chris@scs.uiuc.edu			National Institutes of Health [GM054365]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM054365, R01GM054365] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM054365 (to G. W. O. and C. V. R.).	Alexander RP, 2010, TRENDS MICROBIOL, V18, P494, DOI 10.1016/j.tim.2010.07.004; Besschetnova TY, 2008, P NATL ACAD SCI USA, V105, P12289, DOI 10.1073/pnas.0802868105; BORKOVICH KA, 1989, P NATL ACAD SCI USA, V86, P1208, DOI 10.1073/pnas.86.4.1208; Borrok MJ, 2008, ACS CHEM BIOL, V3, P101, DOI 10.1021/cb700211s; Bray D, 1998, NATURE, V393, P85, DOI 10.1038/30018; Briegel A, 2009, P NATL ACAD SCI USA, V106, P17181, DOI 10.1073/pnas.0905181106; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Erbse AH, 2009, BIOCHEMISTRY-US, V48, P6975, DOI 10.1021/bi900641c; FREDRICK KL, 1994, J BACTERIOL, V176, P2727, DOI 10.1128/JB.176.9.2727-2735.1994; Frye J, 2006, J BACTERIOL, V188, P2233, DOI 10.1128/JB.188.6.2233-2243.2006; FUHRER DK, 1991, J BACTERIOL, V173, P7443, DOI 10.1128/jb.173.23.7443-7448.1991; GEGNER JA, 1992, CELL, V70, P975, DOI 10.1016/0092-8674(92)90247-A; Gestwicki JE, 2002, NATURE, V415, P81, DOI 10.1038/415081a; Greenfield D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000137; GueroutFleury AM, 1996, GENE, V180, P57, DOI 10.1016/S0378-1119(96)00404-0; HANLON DW, 1992, J BIOL CHEM, V267, P12055; HANLON DW, 1994, J BIOL CHEM, V269, P14038; Hartley-Tassell LE, 2010, MOL MICROBIOL, V75, P710, DOI 10.1111/j.1365-2958.2009.07010.x; Hazelbauer GL, 2008, TRENDS BIOCHEM SCI, V33, P9, DOI 10.1016/j.tibs.2007.09.014; Homma M, 2004, P NATL ACAD SCI USA, V101, P3462, DOI 10.1073/pnas.0306660101; Hou SB, 2000, NATURE, V403, P540, DOI 10.1038/35000570; Jimenez-Pearson MA, 2005, MICROBIOL-SGM, V151, P3299, DOI 10.1099/mic.0.28217-0; Kaltwasser M, 2002, APPL ENVIRON MICROB, V68, P2624, DOI 10.1128/AEM.68.5.2624-2628.2002; Karatan E, 2001, J BIOL CHEM, V276, P43618, DOI 10.1074/jbc.M104955200; Kentner D, 2006, CURR OPIN MICROBIOL, V9, P619, DOI 10.1016/j.mib.2006.10.012; Kentner D, 2006, MOL MICROBIOL, V61, P407, DOI 10.1111/j.1365-2958.2006.05250.x; Kirby JR, 2000, MOL MICROBIOL, V35, P44, DOI 10.1046/j.1365-2958.2000.01676.x; Kristich CJ, 2002, J BIOL CHEM, V277, P25356, DOI 10.1074/jbc.M201334200; Lai RZ, 2005, BIOCHEMISTRY-US, V44, P14298, DOI 10.1021/bi050567y; Lamanna AC, 2005, MOL MICROBIOL, V57, P774, DOI 10.1111/j.1365-2958.2005.04728.x; Liberman L, 2004, J BACTERIOL, V186, P6643, DOI 10.1128/JB.186.19.6643-6646.2004; Lowenthal AC, 2009, MICROBIOL-SGM, V155, P1181, DOI 10.1099/mic.0.021857-0; Lybarger SR, 2005, MOL MICROBIOL, V56, P1078, DOI 10.1111/j.1365-2958.2005.04593.x; MADDOCK JR, 1993, SCIENCE, V259, P1717; Maki N, 2000, J BACTERIOL, V182, P4337, DOI 10.1128/JB.182.15.4337-4342.2000; PALMER BR, 1994, GENE, V143, P1, DOI 10.1016/0378-1119(94)90597-5; Pereira Maristela, 2004, Genet Mol Res, V3, P92; Ping LY, 2008, MOL MICROBIOL, V69, P1427, DOI 10.1111/j.1365-2958.2008.06372.x; Pittman MS, 2001, MICROBIOL-SGM, V147, P2493, DOI 10.1099/00221287-147-9-2493; Rao CV, 2008, TRENDS MICROBIOL, V16, P480, DOI 10.1016/j.tim.2008.07.003; Rao CV, 2009, CONTRIB MICROBIOL, V16, P33, DOI 10.1159/000219372; ROSARIO MML, 1994, J BACTERIOL, V176, P2736, DOI 10.1128/JB.176.9.2736-2739.1994; Schulmeister S, 2008, P NATL ACAD SCI USA, V105, P6403, DOI 10.1073/pnas.0710611105; Shiomi D, 2005, J BACTERIOL, V187, P7647, DOI 10.1128/JB.187.22.7647-7654.2005; Skidmore JM, 2000, J BACTERIOL, V182, P967, DOI 10.1128/JB.182.4.967-973.2000; Sourjik V, 2004, NATURE, V428, P437, DOI 10.1038/nature02406; Sourjik V, 2000, MOL MICROBIOL, V37, P740, DOI 10.1046/j.1365-2958.2000.02044.x; Szurmant L, 2004, MICROBIOL MOL BIOL R, V68, P301, DOI 10.1128/MMBR.68.2.301-319.2004; TAYLOR RG, 1993, NUCLEIC ACIDS RES, V21, P1677, DOI 10.1093/nar/21.7.1677; Thiem S, 2007, EMBO J, V26, P1615, DOI 10.1038/sj.emboj.7601610; Tindall MJ, 2008, B MATH BIOL, V70, P1525, DOI 10.1007/s11538-008-9321-6; ULLAH AHJ, 1981, J BACTERIOL, V145, P958, DOI 10.1128/JB.145.2.958-965.1981; Vaknin A, 2004, P NATL ACAD SCI USA, V101, P17072, DOI 10.1073/pnas.0407812101; Vaknin A, 2007, J MOL BIOL, V366, P1416, DOI 10.1016/j.jmb.2006.12.024; Wang QF, 2006, J BACTERIOL, V188, P7981, DOI 10.1128/JB.00852-06; Zimmer MA, 2002, MOL MICROBIOL, V45, P555, DOI 10.1046/j.1365-2958.2002.03035.x	56	15	15	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2587	2595		10.1074/jbc.M110.188664	http://dx.doi.org/10.1074/jbc.M110.188664			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21098025	Green Published, hybrid			2022-12-25	WOS:000286464300024
J	Namkung, W; Phuan, PW; Verkman, AS				Namkung, Wan; Phuan, Puay-Wah; Verkman, A. S.			TMEM16A Inhibitors Reveal TMEM16A as a Minor Component of Calcium-activated Chloride Channel Conductance in Airway and Intestinal Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTIC-FIBROSIS; PROTEIN; EXPRESSION; SECRETION; MECHANISMS; CFTR	TMEM16A (ANO1) functions as a calcium-activated chloride channel (CaCC). We developed pharmacological tools to investigate the contribution of TMEM16A to CaCC conductance in human airway and intestinal epithelial cells. A screen of similar to 110,000 compounds revealed four novel chemical classes of small molecule TMEM16A inhibitors that fully blocked TMEM16A chloride current with an IC50 < 10 mu M, without interfering with calcium signaling. Following structure-activity analysis, the most potent inhibitor, an aminophenylthiazole (T16A(inh)-A01), had an IC50 of similar to 1 mu M. Two distinct types of inhibitors were identified. Some compounds, such as tannic acid and the arylaminothiophene CaCCinh-A01, fully inhibited CaCC current in human bronchial and intestinal cells. Other compounds, including T16A(inh)-A01 and digallic acid, inhibited total CaCC current in these cells poorly, but blocked mainly an initial, agonist-stimulated transient chloride current. TMEM16A RNAi knockdown also inhibited mainly the transient chloride current. In contrast to the airway and intestinal cells, all TMEM16A inhibitors fully blocked CaCC current in salivary gland cells. We conclude that TMEM16A carries nearly all CaCC current in salivary gland epithelium, but is a minor contributor to total CaCC current in airway and intestinal epithelia. The small molecule inhibitors identified here permit pharmacological dissection of TMEM16A/CaCC function and are potential development candidates for drug therapy of hypertension, pain, diarrhea, and excessive mucus production.	[Verkman, A. S.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Verkman, AS (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	Alan.Verkman@ucsf.edu			National Institutes of Health [HL73856, DK72517, DK86125, DK35124, EB00415, EY13574]; Cystic Fibrosis Foundation; NATIONAL EYE INSTITUTE [R01EY013574] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000415, R37EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC1DK086125, R37DK035124, P30DK072517, R01DK035124] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL73856, DK72517, DK86125, DK35124, EB00415, and EY13574. This work was also supported by Research Development Program and Drug Discovery grants from the Cystic Fibrosis Foundation.	Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; De la Fuente R, 2008, MOL PHARMACOL, V73, P758, DOI 10.1124/mol.107.043208; Eggermont Jan, 2004, Proc Am Thorac Soc, V1, P22, DOI 10.1513/pats.2306010; Flores CA, 2009, BRAZ J MED BIOL RES, V42, P993, DOI 10.1590/S0100-879X2009005000028; Galietta LJV, 2009, BIOPHYS J, V97, P3047, DOI 10.1016/j.bpj.2009.09.024; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Huang F, 2009, P NATL ACAD SCI USA, V106, P21413, DOI 10.1073/pnas.0911935106; Hwang SJ, 2009, J PHYSIOL-LONDON, V587, P4887, DOI 10.1113/jphysiol.2009.176198; Jacquot J, 2008, INT J BIOCHEM CELL B, V40, P1703, DOI 10.1016/j.biocel.2008.02.002; Kahn MES, 2001, CLIN CANCER RES, V7, P343; Kunzelmann K, 2009, CELL CALCIUM, V46, P233, DOI 10.1016/j.ceca.2009.09.003; Lee CH, 2010, ADV ANAT PATHOL, V17, P222, DOI 10.1097/PAP.0b013e3181d973c2; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Manoury B, 2010, J PHYSIOL-LONDON, V588, P2305, DOI 10.1113/jphysiol.2010.189506; Namkung W, 2010, FASEB J, V24, P4178, DOI 10.1096/fj.10-160648; Namkung W, 2010, MOL BIOL CELL, V21, P2639, DOI 10.1091/mbc.E09-12-1004; Ramig RF, 2004, J VIROL, V78, P10213, DOI 10.1128/JVI.78.19.10213-10220.2004; Rock JR, 2008, DEV BIOL, V321, P141, DOI 10.1016/j.ydbio.2008.06.009; Rock JR, 2009, J BIOL CHEM, V284, P14875, DOI 10.1074/jbc.C109.000869; Romanenko VG, 2010, J BIOL CHEM, V285, P12990, DOI 10.1074/jbc.M109.068544; Rufo PA, 2004, AM J PHYSIOL-CELL PH, V286, pC998, DOI 10.1152/ajpcell.00357.2003; Schreiber R, 2010, J BIOL CHEM, V285, P7838, DOI 10.1074/jbc.M109.065367; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Stohr H, 2009, J NEUROSCI, V29, P6809, DOI 10.1523/JNEUROSCI.5546-08.2009; Storey S, 2008, NAT REV DRUG DISCOV, V7, P555, DOI 10.1038/nrd2603; Takahashi A, 2000, J MED MICROBIOL, V49, P801, DOI 10.1099/0022-1317-49-9-801; Tradtrantip L, 2009, J MED CHEM, V52, P6447, DOI 10.1021/jm9009873; Verkman AS, 2009, NAT REV DRUG DISCOV, V8, P153, DOI 10.1038/nrd2780; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Zeitlin PL, 2004, CHEST, V125, P143, DOI 10.1378/chest.125.1.143	30	266	286	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2365	2374		10.1074/jbc.M110.175109	http://dx.doi.org/10.1074/jbc.M110.175109			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21084298	Green Published, hybrid			2022-12-25	WOS:000286191500075
J	Ungethum, L; Kenis, H; Nicolaes, GA; Autin, L; Stoilova-McPhie, S; Reutelingsperger, CPM				Ungethum, Lisette; Kenis, Heidi; Nicolaes, Gerry A.; Autin, Ludovic; Stoilova-McPhie, Svetla; Reutelingsperger, Chris P. M.			Engineered Annexin A5 Variants Have Impaired Cell Entry for Molecular Imaging of Apoptosis Using Pretargeting Strategies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-BINDING; 2-DIMENSIONAL CRYSTALLIZATION; CRYSTAL-STRUCTURE; PHOSPHATIDYLSERINE; CALCIUM; BIODISTRIBUTION; CRYSTALLOGRAPHY; RECOGNITION; MONOLAYERS; RESOLUTION	Phosphatidylserine ( PS) on apoptotic cells is a target for diagnosis and therapy using annexin A5 (anxA5). Pretargeting is a strategy developed to improve signal to background ratio for molecular imaging and to minimize undesired side effects of pharmacological and radiotherapy. Pretargeting relies on accessibility of the target finder on the surface of the target cell. anxA5 binds PS and crystallizes in a two-dimensional network covering the PS-expressing cell surface. Two-dimensional crystallization is the driving force for anxA5 internalization by PS-expressing cells. Here, we report structure/function analysis of anxA5 internalization. Guided by structural bioinformatics including protein-protein docking, we revealed that the amino acids Arg(63), Lys(70), Lys(101), Glu(138), Asp(139), and Asn(160) engage in intermolecular salt bridges within the anxA5 trimer, which is the basic building block of the two-dimensional network. Disruption of the salt bridges by site-directed mutagenesis does not affect PS binding but inhibits trimer formation and cell entry of surface-bound anxA5. The anxA5 variants with impaired internalization are superior molecular imaging agents in pretargeting strategies as compared with wild-type anxA5.	[Reutelingsperger, Chris P. M.] Maastricht Univ, Dept Biochem, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [Autin, Ludovic] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Stoilova-McPhie, Svetla] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX USA	Maastricht University; Scripps Research Institute; University of Texas System; University of Texas Medical Branch Galveston	Reutelingsperger, CPM (corresponding author), POB 616, NL-6200 MD Maastricht, Netherlands.	c.reutelingsperger@maastrichtuniversity.nl	Nicolaes, Gerry A.F./A-8421-2016	Nicolaes, Gerry A.F./0000-0002-2482-0412; Autin, Ludovic/0000-0002-2197-191X	VIDI [916-046-330]; Netherlands Organization for Scientific Research [910-48-617/5]; European Union [IVA-VLANED-1.20]	VIDI(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Union(European Commission)	This work was supported by VIDI Grant 916-046-330 and the INSERM/NWO Collaborative Grant 910-48-617/5 from the Netherlands Organization for Scientific Research ( to G. N.). This work was also supported by the European Union through the Euregional PACT II Grant from the Interreg IV program of Grensregio Vlaanderen-Nederland (IVA-VLANED-1.20).	ANDREE HAM, 1990, J BIOL CHEM, V265, P4923; Balasubramanian K, 2003, ANNU REV PHYSIOL, V65, P701, DOI 10.1146/annurev.physiol.65.092101.142459; Belhocine TZ, 2006, CURR CLIN PHARMACOL, V1, P129, DOI 10.2174/157488406776872541; Boersma HH, 2005, J NUCL MED, V46, P2035; Brisson A, 1999, J CRYST GROWTH, V196, P456, DOI 10.1016/S0022-0248(98)00834-3; Cauchon N, 2007, EUR J NUCL MED MOL I, V34, P247, DOI 10.1007/s00259-006-0199-y; FADOK VA, 1992, J IMMUNOL, V148, P2207; Fernandez-Recio J, 2003, PROTEINS, V52, P113, DOI 10.1002/prot.10383; HOVMOLLER S, 1992, ULTRAMICROSCOPY, V41, P121, DOI 10.1016/0304-3991(92)90102-P; HUBER R, 1990, EMBO J, V9, P3867, DOI 10.1002/j.1460-2075.1990.tb07605.x; HUBER R, 1990, FEBS LETT, V275, P15, DOI 10.1016/0014-5793(90)81428-Q; Jeppesen B, 2008, J BIOL CHEM, V283, P6126, DOI 10.1074/jbc.M707637200; Kemerink GJ, 2003, J NUCL MED, V44, P947; Kenis H, 2004, J BIOL CHEM, V279, P52623, DOI 10.1074/jbc.M409009200; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mo Y, 2003, J BIOL CHEM, V278, P2437, DOI 10.1074/jbc.M210286200; MOSSER G, 1991, J MOL BIOL, V217, P241, DOI 10.1016/0022-2836(91)90538-H; Oling F, 2001, J STRUCT BIOL, V133, P55, DOI 10.1006/jsbi.2000.4337; Oling F, 2000, J MOL BIOL, V304, P561, DOI 10.1006/jmbi.2000.4183; Patel DR, 2005, BIOCHEMISTRY-US, V44, P2833, DOI 10.1021/bi047642+; Puts CF, 2009, BBA-MOL CELL BIOL L, V1791, P603, DOI 10.1016/j.bbalip.2009.02.005; Ran S, 2002, INT J RADIAT ONCOL, V54, P1479, DOI 10.1016/S0360-3016(02)03928-7; Rottey S, 2009, Q J NUCL MED MOL IM, V53, P127; Schutters K, 2010, APOPTOSIS, V15, P1072, DOI 10.1007/s10495-010-0503-y; SOPKOVA J, 1993, J MOL BIOL, V234, P816, DOI 10.1006/jmbi.1993.1627; Stoylova SS, 1999, J BIOL CHEM, V274, P36573, DOI 10.1074/jbc.274.51.36573; Tabas I, 2005, ARTERIOSCL THROM VAS, V25, P2255, DOI 10.1161/01.ATV.0000184783.04864.9f; van Genderen H, 2006, NAT PROTOC, V1, P363, DOI 10.1038/nprot.2006.55; van Genderen HO, 2008, BBA-MOL CELL RES, V1783, P953, DOI 10.1016/j.bbamcr.2008.01.030; Wu Y, 2006, TRENDS CELL BIOL, V16, P189, DOI 10.1016/j.tcb.2006.02.003	30	17	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1903	1910		10.1074/jbc.M110.163527	http://dx.doi.org/10.1074/jbc.M110.163527			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21078669	Green Published, hybrid			2022-12-25	WOS:000286191500031
J	Domingo, P; Torres-Torronteras, J; Pomar, V; Giralt, M; Domingo, JC; Gutierrez, MD; Gallego-Escuredo, JM; Mateo, MG; Cano-Soldado, P; Fernandez, I; Pastor-Anglada, M; Vidal, F; Villarroya, F; Andreu, A; Marti, R				Domingo, Pere; Torres-Torronteras, Javier; Pomar, Virginia; Giralt, Marta; Carles Domingo, Joan; del Mar Gutierrez, Maria; Gallego-Escuredo, Jose M.; Gracia Mateo, Maria; Cano-Soldado, Pedro; Fernandez, Irene; Pastor-Anglada, Marcal; Vidal, Francesc; Villarroya, Francesc; Andreu, Antoni; Marti, Ramon			Uridine Metabolism in HIV-1-Infected Patients: Effect of Infection, of Antiretroviral Therapy and of HIV-1/ART-Associated Lipodystrophy Syndrome	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; TOXICITY; RAT; SUPPLEMENTATION; PHOSPHORYLASE; LIPOATROPHY; INHIBITOR; STAVUDINE; DEPLETION; DISEASE	Background: Uridine has been advocated for the treatment of HIV-1/HAART-associated lipodystrophy (HALS), although its metabolism in HIV-1-infected patients is poorly understood. Methods: Plasma uridine concentrations were measured in 35 controls and 221 HIV-1-infected patients and fat uridine in 15 controls and 19 patients. The diagnosis of HALS was performed following the criteria of the Lipodystrophy Severity Grading Scale. Uridine was measured by a binary gradient-elution HPLC method. Analysis of genes encoding uridine metabolizing enzymes in fat was performed with TaqMan RT-PCR. Results: Median plasma uridine concentrations for HIV-1-infected patients were 3.80 mmol/l (interquartile range: 1.60), and for controls 4.60 mmol/l (IQR: 1.8) (P = 0.0009). In fat, they were of 6.0 (3.67), and 2.8 (4.65) nmol/mg of protein, respectively (P = 0.0118). Patients with a mixed HALS form had a median plasma uridine level of 4.0 (IC95%: 3.40-4.80) whereas in those with isolated lipoatrophy it was 3.25 (2.55-4.15) mmol/l/l (P = 0.0066). The expression of uridine cytidine kinase and uridine phosphorylase genes was significantly decreased in all groups of patients with respect to controls. A higher expression of the mRNAs for concentrative nucleoside transporters was found in HIV-1-infected patients with respect to healthy controls. Conclusions: HIV-1 infection is associated with a decrease in plasma uridine and a shift of uridine to the adipose tissue compartment. Antiretroviral therapy was not associated with plasma uridine concentrations, but pure lipoatrophic HALS was associated with significantly lower plasma uridine concentrations.	[Domingo, Pere; Pomar, Virginia; del Mar Gutierrez, Maria; Gracia Mateo, Maria; Fernandez, Irene] Hosp Santa Crue & St Pau, Infect Dis Unit, Barcelona, Spain; [Torres-Torronteras, Javier; Andreu, Antoni; Marti, Ramon] Inst Recerca Hosp Vall dHebron, Lab Mitochondrial Disorders, Barcelona, Spain; [Torres-Torronteras, Javier; Andreu, Antoni; Marti, Ramon] CIBERER, Barcelona, Spain; [Giralt, Marta; Carles Domingo, Joan; Gallego-Escuredo, Jose M.; Cano-Soldado, Pedro; Pastor-Anglada, Marcal; Villarroya, Francesc] Univ Barcelona, Dept Bioquim & Biol Mol, Barcelona, Spain; [Giralt, Marta; Carles Domingo, Joan; Gallego-Escuredo, Jose M.; Cano-Soldado, Pedro; Pastor-Anglada, Marcal; Villarroya, Francesc] Univ Barcelona, Inst Biomed, Barcelona, Spain; [Vidal, Francesc] Hosp Univ Joan XXIII, Infect Dis Unit, Tarragona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; University of Barcelona	Domingo, P (corresponding author), Hosp Santa Crue & St Pau, Infect Dis Unit, Barcelona, Spain.	pdomingo@santpau.cat	Domingo, Pere/CAF-3577-2022; Domingo, Pere/AAP-7571-2021; Villarroya, Francesc/K-4357-2014; Torres-Torronteras, Javier/K-4974-2014; Pedrol, Joan Carles C Domingo/A-4856-2019; Martí, Ramon/Q-3442-2016; Giralt, Marta/A-4756-2013	Domingo, Pere/0000-0003-1138-5770; Torres-Torronteras, Javier/0000-0002-6092-9458; Pedrol, Joan Carles C Domingo/0000-0002-6356-0836; Martí, Ramon/0000-0002-8273-9540; Giralt, Marta/0000-0001-7968-4190; ANDREU, antonio luis/0000-0002-3936-3234; Villarroya, Francesc/0000-0003-1266-9142; GALLEGO-ESCUREDO, JOSE MIGUEL/0000-0001-7899-8585; Vidal, Francesc/0000-0002-6692-6186	Fondo de Investigaciones Sanitarias (FIS) [02/1280, 05/1591, 07/0976, EC08/00256]; Fundacion para la Prevencion del SIDA en Espana (FIPSE) [36610, 36572/06, 36621/06]; Ministerio de Ciencia e Innovacion [SAF2008-00577]; Red de Investigacion en SIDA (RIS) [RD06/006/0022, RD06/0006/1004]	Fondo de Investigaciones Sanitarias (FIS)(Instituto de Salud Carlos III); Fundacion para la Prevencion del SIDA en Espana (FIPSE); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Red de Investigacion en SIDA (RIS)	This work was partially funded by the Fondo de Investigaciones Sanitarias (FIS 02/1280, 05/1591, 07/0976, EC08/00256), the Fundacion para la Prevencion del SIDA en Espana (FIPSE 36610, 36572/06, 36621/06), Ministerio de Ciencia e Innovacion (SAF2008-00577), and the Red de Investigacion en SIDA (RIS RD06/006/0022, RD06/0006/1004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSSEDAT J, 1983, CARDIOVASC RES, V17, P145, DOI 10.1093/cvr/17.3.145; BENZI G, 1984, J NEUROSCI RES, V11, P437, DOI 10.1002/jnr.490110410; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calzolari I, 2009, CURR PHARM DESIGN, V15, P4094, DOI 10.2174/138161209789909755; CDC, 1993, MMWR-MORBID MORTAL W, V41, P1; Connolly GP, 1999, TRENDS PHARMACOL SCI, V20, P218, DOI 10.1016/S0165-6147(99)01298-5; Cote HCF, 2002, NEW ENGL J MED, V346, P811, DOI 10.1056/NEJMoa012035; Domingo P, 2010, CLIN INFECT DIS, V50, P1033, DOI 10.1086/651117; GALLAI V, 1992, ACTA NEUROL SCAND, V86, P3, DOI 10.1111/j.1600-0404.1992.tb08045.x; GASSER T, 1981, SCIENCE, V213, P777, DOI 10.1126/science.7256279; GEIGER A, 1956, J NEUROCHEM, V1, P93, DOI 10.1111/j.1471-4159.1956.tb12059.x; Giralt M, 2006, ANTIVIR THER, V11, P729; Guggr JP, 2007, ANTIVIR THER, V12, P853; LANGMANN P, 2008, AIDS 2008 17 INT AID; LEPAGE G, 1986, J LIPID RES, V27, P114; LEWIS W, 1995, NAT MED, V1, P417, DOI 10.1038/nm0595-417; Loffler M, 2005, TRENDS MOL MED, V11, P430, DOI 10.1016/j.molmed.2005.07.003; Maagaard A, 2006, HIV MED, V7, P53, DOI 10.1111/j.1468-1293.2005.00336.x; McComsey G, 2010, 17 C RETR OPP INF SA; McComsey GA, 2010, AIDS, V24, P2503, DOI 10.1097/QAD.0b013e32833ea9bc; Moreno-Torres A, 2007, ANTIVIR THER, V12, P195; Mouton JW, 2008, J ANTIMICROB CHEMOTH, V61, P235, DOI 10.1093/jac/dkm476; MOYER JD, 1981, CANCER RES, V41, P3010; Pastor-Anglada M, 2004, LEUKEMIA, V18, P385, DOI 10.1038/sj.leu.2403271; Pizzorno G, 1998, CLIN CANCER RES, V4, P1165; Pizzorno G, 2002, BBA-MOL BASIS DIS, V1587, P133, DOI 10.1016/S0925-4439(02)00076-5; Setzer B, 2008, AM J PATHOL, V172, P681, DOI 10.2353/ajpath.2008.070613; Simmonds HA, 1995, BIOCHEM SOC T, V23, P877, DOI 10.1042/bst0230877; Sutinen J, 2007, ANTIVIR THER, V12, P97; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; VANGROENINGEN CJ, 1986, CANCER TREAT REP, V70, P745; Walker UA, 2006, ANTIVIR THER, V11, P25	32	10	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e13896	10.1371/journal.pone.0013896	http://dx.doi.org/10.1371/journal.pone.0013896			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085568	gold, Green Submitted, Green Published			2022-12-25	WOS:000284231800001
J	Jones, L; Holmans, PA; Hamshere, ML; Harold, D; Moskvina, V; Ivanov, D; Pocklington, A; Abraham, R; Hollingworth, P; Sims, R; Gerrish, A; Pahwa, JS; Jones, N; Stretton, A; Morgan, AR; Lovestone, S; Powell, J; Proitsi, P; Lupton, MK; Brayne, C; Rubinsztein, DC; Gill, M; Lawlor, B; Lynch, A; Morgan, K; Brown, KS; Passmore, PA; Craig, D; McGuinness, B; Todd, S; Holmes, C; Mann, D; Smith, AD; Love, S; Kehoe, PG; Mead, S; Fox, N; Rossor, M; Collinge, J; Maier, W; Jessen, F; Schurmann, B; van den Bussche, H; Heuser, I; Peters, O; Kornhuber, J; Wiltfang, J; Dichgans, M; Frolich, L; Hampel, H; Hull, M; Rujescu, D; Goate, AM; Kauwe, JSK; Cruchaga, C; Nowotny, P; Morris, JC; Mayo, K; Livingston, G; Bass, NJ; Gurling, H; McQuillin, A; Gwilliam, R; Deloukas, P; Al-Chalabi, A; Shaw, CE; Singleton, AB; Guerreiro, R; Muhleisen, TW; Nothen, MM; Moebus, S; Jockel, KH; Klopp, N; Wichmann, HE; Ruther, E; Carrasquillo, MM; Pankratz, VS; Younkin, SG; Hardy, J; O'Donovan, MC; Owen, MJ; Williams, J				Jones, Lesley; Holmans, Peter A.; Hamshere, Marian L.; Harold, Denise; Moskvina, Valentina; Ivanov, Dobril; Pocklington, Andrew; Abraham, Richard; Hollingworth, Paul; Sims, Rebecca; Gerrish, Amy; Pahwa, Jaspreet Singh; Jones, Nicola; Stretton, Alexandra; Morgan, Angharad R.; Lovestone, Simon; Powell, John; Proitsi, Petroula; Lupton, Michelle K.; Brayne, Carol; Rubinsztein, David C.; Gill, Michael; Lawlor, Brian; Lynch, Aoibhinn; Morgan, Kevin; Brown, Kristelle S.; Passmore, Peter A.; Craig, David; McGuinness, Bernadette; Todd, Stephen; Holmes, Clive; Mann, David; Smith, A. David; Love, Seth; Kehoe, Patrick G.; Mead, Simon; Fox, Nick; Rossor, Martin; Collinge, John; Maier, Wolfgang; Jessen, Frank; Schuermann, Britta; van den Bussche, Hendrik; Heuser, Isabella; Peters, Oliver; Kornhuber, Johannes; Wiltfang, Jens; Dichgans, Martin; Froelich, Lutz; Hampel, Harald; Huell, Michael; Rujescu, Dan; Goate, Alison M.; Kauwe, John S. K.; Cruchaga, Carlos; Nowotny, Petra; Morris, John C.; Mayo, Kevin; Livingston, Gill; Bass, Nicholas J.; Gurling, Hugh; McQuillin, Andrew; Gwilliam, Rhian; Deloukas, Panos; Al-Chalabi, Ammar; Shaw, Christopher E.; Singleton, Andrew B.; Guerreiro, Rita; Muehleisen, Thomas W.; Noethen, Markus M.; Moebus, Susanne; Joeckel, Karl-Heinz; Klopp, Norman; Wichmann, H. -Erich; Ruether, Eckhard; Carrasquillo, Minerva M.; Pankratz, V. Shane; Younkin, Steven G.; Hardy, John; O'Donovan, Michael C.; Owen, Michael J.; Williams, Julie			Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; IDENTIFIES VARIANTS; APOLIPOPROTEIN-E; DEMENTIA; RISK; INFLAMMATION; POPULATION; MICROGLIA; PATHWAYS; DATABASE	Background: Late Onset Alzheimer's disease (LOAD) is the leading cause of dementia. Recent large genome-wide association studies (GWAS) identified the first strongly supported LOAD susceptibility genes since the discovery of the involvement of APOE in the early 1990s. We have now exploited these GWAS datasets to uncover key LOAD pathophysiological processes. Methodology: We applied a recently developed tool for mining GWAS data for biologically meaningful information to a LOAD GWAS dataset. The principal findings were then tested in an independent GWAS dataset. Principal Findings: We found a significant overrepresentation of association signals in pathways related to cholesterol metabolism and the immune response in both of the two largest genome-wide association studies for LOAD. Significance: Processes related to cholesterol metabolism and the innate immune response have previously been implicated by pathological and epidemiological studies of Alzheimer's disease, but it has been unclear whether those findings reflected primary aetiological events or consequences of the disease process. Our independent evidence from two large studies now demonstrates that these processes are aetiologically relevant, and suggests that they may be suitable targets for novel and existing therapeutic approaches.	[Jones, Lesley; Holmans, Peter A.; Hamshere, Marian L.; Harold, Denise; Moskvina, Valentina; Ivanov, Dobril; Pocklington, Andrew; Abraham, Richard; Hollingworth, Paul; Sims, Rebecca; Gerrish, Amy; Pahwa, Jaspreet Singh; Jones, Nicola; Stretton, Alexandra; Morgan, Angharad R.; O'Donovan, Michael C.; Owen, Michael J.; Williams, Julie] Cardiff Univ, Sch Med, Dept Psychol Med & Neurol, Ctr Neuropsychiat Genet & Genom,MRC, Cardiff, S Glam, Wales; [Lovestone, Simon] Kings Coll London, S London & Maudsley Natl Hlth Serv Fdn Trust, Natl Inst Hlth Res, Biomed Res Ctr Mental Hlth, London WC2R 2LS, England; [Powell, John; Proitsi, Petroula; Lupton, Michelle K.] Kings Coll London, Inst Psychiat, Dept Neurosci, London WC2R 2LS, England; [Brayne, Carol] Univ Cambridge, Inst Publ Hlth, Cambridge, England; [Rubinsztein, David C.] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [Gill, Michael; Lawlor, Brian; Lynch, Aoibhinn] St James Hosp, Mercers Inst Res Aging, Dublin 8, Ireland; [Gill, Michael; Lawlor, Brian; Lynch, Aoibhinn] Trinity Coll Dublin, Dublin, Ireland; [Morgan, Kevin; Brown, Kristelle S.] Univ Nottingham, Queens Med Ctr, Inst Genet, Nottingham NG7 2RD, England; [Passmore, Peter A.; Craig, David; McGuinness, Bernadette; Todd, Stephen] Queens Univ Belfast, Ageing Grp, Ctr Publ Hlth, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland; [Holmes, Clive] Univ Southampton, Sch Med, Div Clin Neurosci, Southampton, Hants, England; [Mann, David] Univ Manchester, Greater Manchester Neurosci Ctr, Clin Neurosci Res Grp, Salford, Lancs, England; [Smith, A. David] Univ Oxford, John Radcliffe Hosp, Oxford Project Invest Memory & Ageing, Oxford OX3 9DU, England; [Love, Seth; Kehoe, Patrick G.] Univ Bristol, Frenchay Hosp, Inst Clin Neurosci, Dementia Res Grp, Bristol, Avon, England; [Mead, Simon; Collinge, John] UCL Inst Neurol, Dept Neurodegenerat Dis, MRC Prion Unit, London, England; [Fox, Nick; Rossor, Martin] UCL Inst Neurol, Dept Neurodegenerat Dis, Dementia Res Ctr, London, England; [Maier, Wolfgang; Jessen, Frank; Schuermann, Britta] Univ Bonn, Dept Psychiat, D-5300 Bonn, Germany; [van den Bussche, Hendrik; Heuser, Isabella; Peters, Oliver] Univ Med Ctr Hamburg Eppendorf, Inst Primary Med Care, Hamburg, Germany; [Kornhuber, Johannes] Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, Erlangen, Germany; [Wiltfang, Jens] Univ Duisburg Essen, Dept Psychiat & Psychotherapy, Landschaftsverband Rheinland Hosp Essen, Essen, Germany; [Dichgans, Martin] Klinikum Univ Munchen, Inst Stroke & Dementia Res, Munich, Germany; [Dichgans, Martin] Klinikum Univ Munchen, Dept Neurol, Munich, Germany; [Froelich, Lutz] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Geriatr Psychiat, D-6800 Mannheim, Germany; [Hampel, Harald] Univ Dublin Trinity Coll, Sch Med, Discipline Psychiat, Dublin 2, Ireland; [Hampel, Harald] Univ Dublin Trinity Coll, Trinity Coll Inst Neurosci, Lab Neuroimaging & Biomarker Res, Dublin 2, Ireland; [Hampel, Harald; Rujescu, Dan] Univ Munich, Alzheimer Mem Ctr, Munich, Germany; [Hampel, Harald; Rujescu, Dan] Univ Munich, Dept Psychiat, Geriatr Psychiat Branch, D-8000 Munich, Germany; [Huell, Michael] Univ Freiburg, Sch Med, Ctr Geriatr Med, Freiburg, Germany; [Huell, Michael] Univ Freiburg, Sch Med, Sect Gerontopsychiat & Neuropsychol, Freiburg, Germany; [Goate, Alison M.; Cruchaga, Carlos; Nowotny, Petra; Morris, John C.; Mayo, Kevin] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Goate, Alison M.; Cruchaga, Carlos; Nowotny, Petra; Morris, John C.; Mayo, Kevin] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Goate, Alison M.; Cruchaga, Carlos; Nowotny, Petra; Morris, John C.; Mayo, Kevin] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Kauwe, John S. K.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Livingston, Gill; Bass, Nicholas J.; Gurling, Hugh; McQuillin, Andrew] UCL, Dept Mental Hlth Sci, London, England; [Gwilliam, Rhian; Deloukas, Panos] Wellcome Trust Sanger Inst, Hinxton, England; [Al-Chalabi, Ammar; Shaw, Christopher E.] Kings Coll London, Inst Psychiat, Dept Clin Neurosci, MRC Ctr Neurodegenerat Res, London WC2R 2LS, England; [Singleton, Andrew B.; Guerreiro, Rita] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Muehleisen, Thomas W.; Noethen, Markus M.] Univ Bonn, Life & Brain Ctr, Dept Genom, D-5300 Bonn, Germany; [Muehleisen, Thomas W.; Noethen, Markus M.] Univ Bonn, Inst Human Genet, D-5300 Bonn, Germany; [Moebus, Susanne] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Klopp, Norman; Wichmann, H. -Erich] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol, Neuherberg, Germany; [Wichmann, H. -Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Ruether, Eckhard] Univ Gottingen, Dept Psychiat, Gottingen, Germany; [Wichmann, H. -Erich] Univ Munich, Klinikum Grosshadern, D-8000 Munich, Germany; [Carrasquillo, Minerva M.; Younkin, Steven G.] Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA; [Pankratz, V. Shane] Mayo Clin & Mayo Fdn, Div Biomed Stat & Informat, Rochester, MN 55905 USA; [Hardy, John] Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Hardy, John] Inst Neurol, Reta Lilla Weston Labs, London WC1N 3BG, England	Cardiff University; South London & Maudsley NHS Trust; University of London; King's College London; University of London; King's College London; University of Cambridge; University of Cambridge; Trinity College Dublin; Trinity College Dublin; University of Nottingham; Queens University Belfast; University of Southampton; University of Manchester; University of Oxford; University of Bristol; University of London; University College London; University of London; University College London; University of Bonn; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Erlangen Nuremberg; University of Duisburg Essen; University of Munich; University of Munich; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Trinity College Dublin; Trinity College Dublin; University of Munich; University of Munich; University of Freiburg; University of Freiburg; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Brigham Young University; University of London; University College London; Wellcome Trust Sanger Institute; University of London; King's College London; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Bonn; University of Bonn; University of Duisburg Essen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Gottingen; University of Munich; Mayo Clinic; Mayo Clinic; University of London; University College London; University of London; University College London	Jones, L (corresponding author), Cardiff Univ, Sch Med, Dept Psychol Med & Neurol, Ctr Neuropsychiat Genet & Genom,MRC, Cardiff, S Glam, Wales.	owenmj@cf.ac.uk; williamsj@cf.ac.uk	Cruchaga, Carlos/ABF-4065-2020; Todd, Stephen/AAF-6729-2020; McQuillin, Andrew/C-1623-2008; Smith, Anthony D./A-4233-2010; Livingston, G/C-7081-2008; Brayne, Carol/AAA-4285-2020; McGuinness, Bernadette/AAH-2755-2021; Kauwe, John/B-2034-2009; Deloukas, Panos/B-2922-2013; Morris, John C/A-1686-2012; Dichgans, Martin/HCH-3247-2022; Rujescu, Dan/GRS-3875-2022; Wichmann, Heinz Erich/AAA-5695-2022; Fox, Nick C/AAE-1849-2021; Fox, Nick C/B-1319-2009; Al-Chalabi, Ammar/E-5361-2010; Guerreiro, Rita J L/A-1327-2011; O'Donovan, Michael C/P-7005-2018; , beccie/AAM-3770-2021; Love, Seth/E-6545-2012; Mead, Simon/E-9414-2011; Kauwe, John/AAC-6646-2021; Hardy, John/C-2451-2009; Gurling, Hugh M/A-5029-2010; Cruz e Silva, Odete/AAH-5595-2020; Hüll, Michael/F-2618-2012; Rossor, Martin/C-1598-2008; Singleton, Andrew B/C-3010-2009; Jessen, Frank/AAK-6170-2020; Jessen, Frank/E-7655-2012; Rubinsztein, David C/C-3472-2011; Holmans, Peter/F-4518-2015; Kornhuber, Johannes/B-9613-2014; Powell, John F/G-4412-2011; Frölich, Lutz/AAA-6940-2019; Kehoe, Patrick/P-8760-2018	Cruchaga, Carlos/0000-0002-0276-2899; McQuillin, Andrew/0000-0003-1567-2240; Smith, Anthony D./0000-0002-1095-6722; Brayne, Carol/0000-0001-5307-663X; McGuinness, Bernadette/0000-0002-7028-5633; Kauwe, John/0000-0001-8641-2468; Deloukas, Panos/0000-0001-9251-070X; Dichgans, Martin/0000-0002-0654-387X; Fox, Nick C/0000-0002-6660-657X; Fox, Nick C/0000-0002-6660-657X; Al-Chalabi, Ammar/0000-0002-4924-7712; O'Donovan, Michael C/0000-0001-7073-2379; , beccie/0000-0002-3885-1199; Mead, Simon/0000-0002-4326-1468; Kauwe, John/0000-0001-8641-2468; Hardy, John/0000-0002-3122-0423; Holmans, Peter/0000-0003-0870-9412; Kornhuber, Johannes/0000-0002-8096-3987; Powell, John F/0000-0001-6124-439X; Frölich, Lutz/0000-0003-1494-0813; Goate, Alison/0000-0002-0576-2472; Proitsi, Petroula/0000-0002-2553-6974; Harold, Denise/0000-0001-5195-0143; Hampel, Harald/0000-0003-0894-8982; Love, Seth/0000-0001-8683-3625; Williams, Julie/0000-0002-4069-0259; Escott-Price, Valentina/0000-0003-1784-5483; Kehoe, Patrick/0000-0002-7542-1139; Lovestone, Simon/0000-0003-0473-4565; Denning, Nicola/0000-0001-8467-7382; Lupton, Michelle/0000-0002-7274-7299; Rossor, Martin/0000-0001-8215-3120; Gill, Michael/0000-0003-0206-5337; Guerreiro, Rita/0000-0001-5879-3486; Pocklington, Andrew/0000-0002-2137-0452; Moebus, Susanne/0000-0002-0072-5410; Todd, Stephen/0000-0002-2312-9195; Peters, Oliver/0000-0003-0568-2998; Livingston, Gill/0000-0001-6741-5516; Nothen, Markus/0000-0002-8770-2464; Ivanov, Dobril/0000-0001-6271-6301; Wiltfang, Jens/0000-0003-1492-5330; Shaw, Christopher/0000-0003-0251-0146; Morgan, Kevin/0000-0002-8217-2396	Wellcome Trust; Medical Research Council (MRC, UK); Alzheimer's Research Trust (ART); Welsh Assembly Government; Alzheimer's Society; Ulster Garden Villages; Northern Ireland Research and Development Office; Royal College of Physicians-Dunhill Medical Trust; Trinity College group; Bristol Research into Alzheimer's and Care of the Elderly; Oxford Project to Investigate Memory and Ageing (OPTIMA) group; Motor Neurone Disease Association; MRC; US National Institutes of Health (NIH); Barnes Jewish Foundation; Charles and Joanne Knight Alzheimer's Research Initiative; NIH; Robert and Clarice Smith and Abigail Van Buren AD Research Program; UCL Hospital/UCL Biomedical Centre; Helmholtz Zentrum Munchen; German Research Center for Environmental Health; BMBF; German National Genome Research Network; Munich Center of Health Sciences; National Institute on Aging (NIA); NIA, NIH, Department of Health and Human Services [Z01 AG000950-06]; University of Antwerp; Fund for Scientific Research-Flanders; Belgian Federal Science Policy Office [P6/43]; Alzheimers Research UK [ART-BIG2009-1, ART-PG2010-1, ART-RF2007-3, ART-NCG2008A-1] Funding Source: researchfish; Medical Research Council [G0300429, G0600974, G0701075, G0801418, G0801418B, MC_U123192748, MC_U123160651, G0601846, G0900688] Funding Source: researchfish; MRC [MC_U123192748, G0701075, G0801418, MC_U123160651, G0300429, G0601846, G0900688, G0600974] Funding Source: UKRI; NATIONAL INSTITUTE ON AGING [ZIAAG000950, Z01AG000950] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome Trust); Medical Research Council (MRC, UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer's Research Trust (ART); Welsh Assembly Government; Alzheimer's Society; Ulster Garden Villages; Northern Ireland Research and Development Office; Royal College of Physicians-Dunhill Medical Trust(Dunhill Medical Trust); Trinity College group; Bristol Research into Alzheimer's and Care of the Elderly; Oxford Project to Investigate Memory and Ageing (OPTIMA) group; Motor Neurone Disease Association; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barnes Jewish Foundation; Charles and Joanne Knight Alzheimer's Research Initiative; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert and Clarice Smith and Abigail Van Buren AD Research Program; UCL Hospital/UCL Biomedical Centre; Helmholtz Zentrum Munchen(Helmholtz Association); German Research Center for Environmental Health; BMBF(Federal Ministry of Education & Research (BMBF)); German National Genome Research Network; Munich Center of Health Sciences; National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA, NIH, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); University of Antwerp; Fund for Scientific Research-Flanders(FWO); Belgian Federal Science Policy Office(Belgian Federal Science Policy Office); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Cardiff University was supported by the Wellcome Trust, Medical Research Council (MRC, UK), Alzheimer's Research Trust (ART) and the Welsh Assembly Government. ART supported sample collections at the Institute of Psychiatry, the South West Dementia Bank and the Universities of Cambridge, Nottingham, Manchester and Belfast. The Belfast group acknowledges support from the Alzheimer's Society, Ulster Garden Villages, Northern Ireland Research and Development Office and the Royal College of Physicians-Dunhill Medical Trust. The MRC and Mercer's Institute for Research on Ageing supported the Trinity College group. The South West Dementia Brain Bank acknowledges support from Bristol Research into Alzheimer's and Care of the Elderly. The Charles Wolfson Charitable Trust supported the Oxford Project to Investigate Memory and Ageing (OPTIMA) group. A. A-C. and C. E. S. thank the Motor Neurone Disease Association and MRC for support. D. C. R. is a Wellcome Trust Senior Clinical Research Fellow. Washington University was funded by US National Institutes of Health (NIH) grants, the Barnes Jewish Foundation and the Charles and Joanne Knight Alzheimer's Research Initiative. The Mayo GWAS was supported by NIH grants, the Robert and Clarice Smith and Abigail Van Buren AD Research Program, and the Palumbo Professorship in AD Research. Patient recruitment for the MRC Prion Unit/University College London Department of Neurodegenerative Disease collection was supported by the UCL Hospital/UCL Biomedical Centre. London and the South East Region (LASER)-AD was funded by Lundbeck. The Bonn group was supported by the German Federal Ministry of Education and Research (BMBF), Competence Network Dementia and Competence Network Degenerative Dementia, and by the Alfried Krupp von Bohlen und Halbach-Stiftung. The Kooperative gesundheitsforschung in der region Augsburg (KORA) F4 studies were financed by Helmholtz Zentrum Munchen, the German Research Center for Environmental Health, BMBF, the German National Genome Research Network and the Munich Center of Health Sciences. The Heinz Nixdorf Recall cohort was funded by the Heinz Nixdorf Foundation (G. Schmidt, chairman) and BMBF. Coriell Cell Repositories is supported by the US National Institute of Neurological Disorders and Stroke and the Intramural Research Program (IRP) of the National Institute on Aging (NIA). Work on this sample was supported in part by the IRP of the NIA, NIH, Department of Health and Human Services; Z01 AG000950-06. The authors acknowledge use of DNA from the 1958 Birth Cohort collection, funded by the MRC and the Wellcome Trust, which was genotyped by the Wellcome Trust Case Control Consortium and the Type-1 Diabetes Genetics Consortium, sponsored by the US National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Allergy and Infectious Diseases, National Human Genome Research Institute, National Institute of Child Health and Human Development and Juvenile Diabetes Research Foundation International. The Antwerp site was supported by the VIB Genetic Service Facility, the Biobank of the Institute Born-Bunge, the Special Research Fund of the University of Antwerp, the Fund for Scientific Research-Flanders, the Foundation for Alzheimer Research and the Interuniversity Attraction Poles program P6/43 of the Belgian Federal Science Policy Office. K. S. is a postdoctoral fellow and K. B. a PhD fellow (Fund for Scientific Research-Flanders). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstey KJ, 2008, AM J GERIAT PSYCHIAT, V16, P343, DOI 10.1097/JGP.0b013e31816b72d4; Baranzini SE, 2009, HUM MOL GENET, V18, P2078, DOI 10.1093/hmg/ddp120; Bates KA, 2009, MOL PSYCHIATR, V14, P469, DOI 10.1038/mp.2008.96; Bertram L, 2009, INT REV NEUROBIOL, V84, P167, DOI 10.1016/S0074-7742(09)00409-7; Birks J, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001190.pub2, 10.1002/14651858.CD001190.pub3]; Blasko I, 2004, AGING CELL, V3, P169, DOI 10.1111/j.1474-9728.2004.00101.x; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Camon EB, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S17; Carrasquillo MM, 2010, ARCH NEUROL; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Corneveaux JJ, 2010, HUM MOL GENET; Duron E, 2008, VASC HEALTH RISK MAN, V4, P363; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hardy J, 2009, J NEUROCHEM, V110, P1129, DOI 10.1111/j.1471-4159.2009.06181.x; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; Hirschhorn JN, 2009, NEW ENGL J MED, V360, P1699, DOI 10.1056/NEJMp0808934; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Hong MG, 2009, HUM GENET, V126, P289, DOI 10.1007/s00439-009-0676-z; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Koudinov AR, 1998, CLIN CHIM ACTA, V270, P75, DOI 10.1016/S0009-8981(97)00207-6; LAMBERT JC, 2010, J ALZHEIMERS DIS; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; McGeer E G, 2001, Mol Interv, V1, P22; Moskvina V, 2008, GENET EPIDEMIOL, V32, P567, DOI 10.1002/gepi.20331; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reynolds CA, 2010, HUM MOL GENET, V19, P2068, DOI 10.1093/hmg/ddq079; Ritchie MD, 2009, GENOME MED, V1, DOI 10.1186/gm65; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Wancata J, 2003, EUR PSYCHIAT, V18, P306, DOI 10.1016/j.eurpsy.2003.03.003; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Weggen S, 2007, TRENDS PHARMACOL SCI, V28, P536, DOI 10.1016/j.tips.2007.09.004; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Yang J, 2010, NAT GENET	40	274	276	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e13950	10.1371/journal.pone.0013950	http://dx.doi.org/10.1371/journal.pone.0013950			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085570	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000284231800004
J	Yoshikawa, F; Banno, Y; Otani, Y; Yamaguchi, Y; Nagakura-Takagi, Y; Morita, N; Sato, Y; Saruta, C; Nishibe, H; Sadakata, T; Shinoda, Y; Hayashi, K; Mishima, Y; Baba, H; Furuichi, T				Yoshikawa, Fumio; Banno, Yoshiko; Otani, Yoshinori; Yamaguchi, Yoshihide; Nagakura-Takagi, Yuko; Morita, Noriyuki; Sato, Yumi; Saruta, Chihiro; Nishibe, Hirozumi; Sadakata, Tetsushi; Shinoda, Yo; Hayashi, Kanehiro; Mishima, Yuriko; Baba, Hiroko; Furuichi, Teiichi			Phospholipase D Family Member 4, a Transmembrane Glycoprotein with No Phospholipase D Activity, Expression in Spleen and Early Postnatal Microglia	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; WHITE-MATTER; PLD ACTIVITY; RAT-BRAIN; D DEFINES; MEMBRANE; LOCALIZATION; PROTEIN; CLONING; GENE	Background: Phospholipase D (PLD) catalyzes conversion of phosphatidylcholine into choline and phosphatidic acid, leading to a variety of intracellular signal transduction events. Two classical PLDs, PLD1 and PLD2, contain phosphatidylinositide-binding PX and PH domains and two conserved His-x-Lys-(x)(4)-Asp (HKD) motifs, which are critical for PLD activity. PLD4 officially belongs to the PLD family, because it possesses two HKD motifs. However, it lacks PX and PH domains and has a putative transmembrane domain instead. Nevertheless, little is known regarding expression, structure, and function of PLD4. Methodology/Principal Findings: PLD4 was analyzed in terms of expression, structure, and function. Expression was analyzed in developing mouse brains and non-neuronal tissues using microarray, in situ hybridization, immunohistochemistry, and immunocytochemistry. Structure was evaluated using bioinformatics analysis of protein domains, biochemical analyses of transmembrane property, and enzymatic deglycosylation. PLD activity was examined by choline release and transphosphatidylation assays. Results demonstrated low to modest, but characteristic, PLD4 mRNA expression in a subset of cells preferentially localized around white matter regions, including the corpus callosum and cerebellar white matter, during the first postnatal week. These PLD4 mRNA-expressing cells were identified as Iba1-positive microglia. In non-neuronal tissues, PLD4 mRNA expression was widespread, but predominantly distributed in the spleen. Intense PLD4 expression was detected around the marginal zone of the splenic red pulp, and splenic PLD4 protein recovered from subcellular membrane fractions was highly N-glycosylated. PLD4 was heterologously expressed in cell lines and localized in the endoplasmic reticulum and Golgi apparatus. Moreover, heterologously expressed PLD4 proteins did not exhibit PLD enzymatic activity. Conclusions/Significance: Results showed that PLD4 is a non-PLD, HKD motif-carrying, transmembrane glycoprotein localized in the endoplasmic reticulum and Golgi apparatus. The spatiotemporally restricted expression patterns suggested that PLD4 might play a role in common function(s) among microglia during early postnatal brain development and splenic marginal zone cells.	[Yoshikawa, Fumio; Nagakura-Takagi, Yuko; Morita, Noriyuki; Sato, Yumi; Saruta, Chihiro; Nishibe, Hirozumi; Sadakata, Tetsushi; Shinoda, Yo; Hayashi, Kanehiro; Mishima, Yuriko; Furuichi, Teiichi] RIKEN, Lab Mol Neurogenesis, Brain Sci Inst, Wako, Saitama, Japan; [Banno, Yoshiko] Gifu Univ, Grad Sch Med, Dept Cell Signaling, Gifu, Japan; [Otani, Yoshinori; Yamaguchi, Yoshihide; Baba, Hiroko] Tokyo Univ Pharm & Life Sci, Dept Mol Neurobiol, Tokyo, Japan; [Morita, Noriyuki] Yasuda Womens Univ, Hiroshima, Japan; [Sadakata, Tetsushi; Shinoda, Yo; Hayashi, Kanehiro; Mishima, Yuriko; Furuichi, Teiichi] CREST, JST, Kawaguchi, Saitama, Japan; [Furuichi, Teiichi] Saitama Univ, Grad Sch Sci & Engn, Saitama 3388570, Japan; [Furuichi, Teiichi] Hiroshima Univ, Grad Sch Biomed Sci, Hiroshima, Japan	RIKEN; Gifu University; Tokyo University of Pharmacy & Life Sciences; Japan Science & Technology Agency (JST); Saitama University; Hiroshima University	Yoshikawa, F (corresponding author), RIKEN, Lab Mol Neurogenesis, Brain Sci Inst, Wako, Saitama, Japan.	tfuruichi@brain.riken.jp	Shinoda, Yo/H-3091-2019; Hayashi, Kanehiro/L-2777-2013; Sadakata, Tetsushi/W-9324-2018; Furuichi, Teiichi/B-5086-2014	Shinoda, Yo/0000-0003-3253-2194; Sadakata, Tetsushi/0000-0003-0276-4162; Furuichi, Teiichi/0000-0002-9676-1888; Yamaguchi, Yoshihide/0000-0002-5686-9325; OTANI, YOSHINORI/0000-0002-3214-4637	Japanese Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science; Japan Science and Technology Agency	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This study was supported by grants from the Japanese Ministry of Education, Culture, Sports, Science and Technology, the Japan Society for the Promotion of Science, and the Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki J, 2008, BBA-MOL CELL BIOL L, V1781, P513, DOI 10.1016/j.bbalip.2008.06.005; Banno Y, 1999, J BIOL CHEM, V274, P27385, DOI 10.1074/jbc.274.39.27385; Banno Y, 1997, J BIOL CHEM, V272, P5208, DOI 10.1074/jbc.272.8.5208; Banno Y, 2008, J NEUROCHEM, V104, P1372, DOI 10.1111/j.1471-4159.2007.05085.x; Cao JX, 1997, VIRUS RES, V48, P11, DOI 10.1016/S0168-1702(96)01422-0; Cockcroft S, 2001, CELL MOL LIFE SCI, V58, P1674, DOI 10.1007/PL00000805; Colley WC, 1997, BIOCHEM J, V326, P745, DOI 10.1042/bj3260745; Dalmau I, 2003, J COMP NEUROL, V458, P144, DOI 10.1002/cne.10572; Du GW, 2003, J CELL BIOL, V162, P305, DOI 10.1083/jcb.200302033; Earle KL, 1997, J COMP NEUROL, V387, P371, DOI 10.1002/(SICI)1096-9861(19971027)387:3<371::AID-CNE4>3.0.CO;2-Y; Exton JH, 2002, FEBS LETT, V531, P58, DOI 10.1016/S0014-5793(02)03405-1; HAMMOND SM, 1995, J BIOL CHEM, V270, P29640; Hirasawa T, 2005, J NEUROSCI RES, V81, P357, DOI 10.1002/jnr.20480; Hodgkin MN, 2000, CURR BIOL, V10, P43, DOI 10.1016/S0960-9822(99)00264-X; Hristova M, 2010, GLIA, V58, P11, DOI 10.1002/glia.20896; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Kanaho Y, 2009, BBA-MOL CELL BIOL L, V1791, P898, DOI 10.1016/j.bbalip.2009.03.010; Klein J, 2005, J NEUROCHEM, V94, P1473, DOI 10.1111/j.1471-4159.2005.03315.x; Kodaki T, 1997, J BIOL CHEM, V272, P11408; Kraal G, 2006, INT REV CYTOL, V250, P175, DOI 10.1016/S0074-7696(06)50005-1; Leiros I, 2000, STRUCTURE, V8, P655, DOI 10.1016/S0969-2126(00)00150-7; Lopez I, 1998, J BIOL CHEM, V273, P12846, DOI 10.1074/jbc.273.21.12846; Munck A, 2005, FEBS J, V272, P1718, DOI 10.1111/j.1742-4658.2005.04601.x; Ogino C, 2007, BBA-PROTEINS PROTEOM, V1774, P671, DOI 10.1016/j.bbapap.2007.04.004; Pedersen KM, 1998, J BIOL CHEM, V273, P31494, DOI 10.1074/jbc.273.47.31494; Ponting CP, 1996, PROTEIN SCI, V5, P914; Riebeling C, 2009, BBA-MOL CELL BIOL L, V1791, P876, DOI 10.1016/j.bbalip.2009.04.003; Roth MG, 2008, TRAFFIC, V9, P1233, DOI 10.1111/j.1600-0854.2008.00742.x; Rudge SA, 2009, BBA-MOL CELL BIOL L, V1791, P856, DOI 10.1016/j.bbalip.2009.04.008; Saito S, 2000, DEV BRAIN RES, V120, P41, DOI 10.1016/S0165-3806(99)00189-3; Sato A, 2008, NEURAL NETWORKS, V21, P1056, DOI 10.1016/j.neunet.2008.05.004; Sciorra VA, 2002, J CELL BIOL, V159, P1039, DOI 10.1083/jcb.200205056; Stahelin RV, 2004, J BIOL CHEM, V279, P54918, DOI 10.1074/jbc.M407798200; Stuckey JA, 1999, NAT STRUCT BIOL, V6, P278; Sung TC, 1997, EMBO J, V16, P4519, DOI 10.1093/emboj/16.15.4519; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Wu MM, 2001, J BIOL CHEM, V276, P33027, DOI 10.1074/jbc.M103917200; Wu MM, 2000, CHEM BIOL, V7, P197, DOI 10.1016/S1074-5521(00)00088-0; Xie Z, 2000, J BIOL CHEM, V275, P24962, DOI 10.1074/jbc.M909745199; Yoshikawa F, 2008, J BIOL CHEM, V283, P20830, DOI 10.1074/jbc.M801314200	41	43	45	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e13932	10.1371/journal.pone.0013932	http://dx.doi.org/10.1371/journal.pone.0013932			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21085684	Green Submitted, Green Published, gold			2022-12-25	WOS:000284087800006
J	Poncelet, J; Rinck, F; Ziessel, A; Joussain, P; Thevenet, M; Rouby, C; Bensafi, M				Poncelet, Johan; Rinck, Fanny; Ziessel, Anne; Joussain, Pauline; Thevenet, Marc; Rouby, Catherine; Bensafi, Moustafa			Semantic Knowledge Influences Prewired Hedonic Responses to Odors	PLOS ONE			English	Article							OLFACTORY CORTEX; PLEASANTNESS; PERCEPTION; INTENSITY; HUMANS; SMELL; REPRESENTATIONS; DISCRIMINATION; IDENTIFICATION; THRESHOLDS	Background: Odor hedonic perception relies on decoding the physicochemical properties of odorant molecules and can be influenced in humans by semantic knowledge. The effect of semantic knowledge on such prewired hedonic processing over the life span has remained unclear. Methodology/Principal Findings: The present study measured hedonic response to odors in different age groups (children, teenagers, young adults, and seniors) and found that children and seniors, two age groups characterized by either low level of (children) or weak access to (seniors) odor semantic knowledge, processed odor hedonics more on the basis of their physicochemical properties. In contrast, in teenagers and young adults, who show better levels of semantic odor representation, the role of physicochemical properties was less marked. Conclusions/Significance: These findings demonstrate for the first time that the biological determinants that make an odor pleasant or unpleasant are more powerful at either end of the life span.	[Poncelet, Johan] Univ Lyon, Lyon, France; Ctr Natl Rech Sci, UMR5020, Lyon, France	Centre National de la Recherche Scientifique (CNRS)	Poncelet, J (corresponding author), Univ Lyon, Lyon, France.	bensafi@olfac.univ-lyon1.fr	Mutafungwa, Edward/C-5574-2013; Bensafi, Moustafa/H-6618-2017	Mutafungwa, Edward/0000-0002-4413-5631; Bensafi, Moustafa/0000-0002-2991-3036; Rinck, Fanny/0000-0002-3660-0716; Rouby, Catherine/0000-0002-5683-5491	French Centre National de la Recherche Scientifique (CNRS); Region Rhone Alpes in France; L'Oreal (France)	French Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Region Rhone Alpes in France(Region Auvergne-Rhone-Alpes); L'Oreal (France)	This work was supported by the French Centre National de la Recherche Scientifique (CNRS), Programme Longevite et Vieillissement 2009-2010); by the Region Rhone Alpes in France (Cluster HNV 2009-2010); and by L'Oreal (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; Ayabe-Kanamura S, 1998, CHEM SENSES, V23, P31, DOI 10.1093/chemse/23.1.31; Barkat S, 2008, NEUROSCI LETT, V434, P108, DOI 10.1016/j.neulet.2008.01.037; Bensafi M, 2007, CLIN NEUROPHYSIOL, V118, P696, DOI 10.1016/j.clinph.2006.10.022; Bensafi M, 2007, J NEUROPHYSIOL, V98, P3254, DOI 10.1152/jn.00349.2007; Bensafi M, 2007, CHEM SENSES, V32, P855, DOI 10.1093/chemse/bjm055; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; Boesveldt S, 2010, BIOL PSYCHOL, V84, P313, DOI 10.1016/j.biopsycho.2010.03.006; CAIN WS, 1978, PERCEPTION, V7, P459, DOI 10.1068/p070459; Dalton P, 1999, HEALTH PSYCHOL, V18, P579, DOI 10.1037/0278-6133.18.6.579; de Araujo IE, 2005, NEURON, V46, P671, DOI 10.1016/j.neuron.2005.04.021; DEWIJK RA, 1994, PERCEPT PSYCHOPHYS, V56, P12, DOI 10.3758/BF03211686; Distel H, 2001, CHEM SENSES, V26, P247, DOI 10.1093/chemse/26.3.247; Djordjevic J, 2008, J NEUROPHYSIOL, V99, P386, DOI 10.1152/jn.00896.2007; DOTY RL, 1986, CHEM SENSES, V11, P259, DOI 10.1093/chemse/11.2.259; DOTY RL, 1984, SCIENCE, V226, P1441, DOI 10.1126/science.6505700; Forestell CA, 2005, PSYCHOL ADDICT BEHAV, V19, P423, DOI 10.1037/0893-164X.19.4.423; Gottfried JA, 2002, J NEUROSCI, V22, P10819; HENION KE, 1971, J EXP PSYCHOL, V90, P275, DOI 10.1037/h0031549; Herz RS, 2003, J EXP PSYCHOL GEN, V132, P595, DOI 10.1037/0096-3445.132.4.595; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 2007, BEHAV BRAIN RES, V180, P133, DOI 10.1016/j.bbr.2007.02.040; Khan RM, 2007, J NEUROSCI, V27, P10015, DOI 10.1523/JNEUROSCI.1158-07.2007; Mandairon N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004209; Mennella JA, 2000, ALCOHOL CLIN EXP RES, V24, P1167, DOI 10.1111/j.1530-0277.2000.tb02079.x; Monnery-Patris S, 2009, Dev Psychobiol, V51, P268, DOI 10.1002/dev.20363; Moskowitz H. R., 1979, PREFERENCE BEHAV CHE, P131; MOSKOWITZ HR, 1974, J EXP PSYCHOL, V103, P216, DOI 10.1037/h0036793; MOSKOWITZ HR, 1976, PERCEPT PSYCHOPHYS, V19, P122, DOI 10.3758/BF03204218; Poncelet J, 2010, BEHAV BRAIN RES, V208, P458, DOI 10.1016/j.bbr.2009.12.011; RINCK F, 2010, CHEM SENSES IN PRESS; Rolls ET, 1997, PHYSIOL BEHAV, V61, P461, DOI 10.1016/S0031-9384(96)00464-7; Rolls ET, 2003, EUR J NEUROSCI, V18, P695, DOI 10.1046/j.1460-9568.2003.02779.x; Rouby C, 2009, ANN NY ACAD SCI, V1170, P333, DOI 10.1111/j.1749-6632.2009.03915.x; Rouby C, 2009, FOOD QUAL PREFER, V20, P545, DOI 10.1016/j.foodqual.2009.05.004; Schaal B, 2000, CHEM SENSES, V25, P729, DOI 10.1093/chemse/25.6.729; SCHIFFMAN SS, 1974, SCIENCE, V185, P112, DOI 10.1126/science.185.4146.112; Stevenson RJ, 2007, DEV PSYCHOL, V43, P253, DOI 10.1037/0012-1649.43.1.253; Sullivan RM, 2003, ANN NY ACAD SCI, V1008, P122, DOI 10.1196/annals.1301.013; Thomas-Danguin T, 2003, RHINOLOGY, V41, P142; Yeomans MR, 2006, PHYSIOL BEHAV, V89, P10, DOI [10.1016/j.physbeh.2006.04.010, 10.1016/j.physbeh.2006.01.029]; Zelano C, 2007, J NEUROPHYSIOL, V97, P1969, DOI 10.1152/jn.01122.2006	42	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e13878	10.1371/journal.pone.0013878	http://dx.doi.org/10.1371/journal.pone.0013878			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	676NU	21079734	Green Published, gold, Green Submitted			2022-12-25	WOS:000283920000011
J	Serbecic, N; Aboul-Enein, F; Beutelspacher, SC; Graf, M; Kircher, K; Geitzenauer, W; Brannath, W; Lang, P; Kristoferitsch, W; Lassmann, H; Reitner, A; Schmidt-Erfurth, U				Serbecic, Nermin; Aboul-Enein, Fahmy; Beutelspacher, Sven C.; Graf, Martin; Kircher, Karl; Geitzenauer, Wolfgang; Brannath, Werner; Lang, Priska; Kristoferitsch, Wolfgang; Lassmann, Hans; Reitner, Andreas; Schmidt-Erfurth, Ursula			Heterogeneous Pattern of Retinal Nerve Fiber Layer in Multiple Sclerosis. High Resolution Optical Coherence Tomography: Potential and Limitations	PLOS ONE			English	Article							THICKNESS MEASUREMENT; NEUROMYELITIS-OPTICA; SIGNAL STRENGTH; NEURITIS; ACCURACY; MS	Background: Recently the reduction of the retinal nerve fibre layer (RNFL) was suggested to be associated with diffuse axonal damage in the whole CNS of multiple sclerosis (MS) patients. However, several points are still under discussion. (1) Is high resolution optical coherence tomography (OCT) required to detect the partly very subtle RNFL changes seen in MS patients? (2) Can a reduction of RNFL be detected in all MS patients, even in early disease courses and in all MS subtypes? (3) Does an optic neuritis (ON) or focal lesions along the visual pathways, which are both very common in MS, limit the predication of diffuse axonal degeneration in the whole CNS? The purpose of our study was to determine the baseline characteristics of clinical definite relapsing-remitting (RRMS) and secondary progressive (SPMS) MS patients with high resolution OCT technique. Methodology: Forty-two RRMS and 17 SPMS patients with and without history of uni- or bilateral ON, and 59 age-and sex-matched healthy controls were analysed prospectively with the high resolution spectral-domain OCT device (SD-OCT) using the Spectralis 3.5mm circle scan protocol with locked reference images and eye tracking mode. Furthermore we performed tests for visual and contrast acuity and sensitivity (ETDRS, Sloan and Pelli-Robson-charts), for color vision (Lanthony D-15), the Humphrey visual field and visual evoked potential testing (VEP). Principal Findings: All 4 groups (RRMS and SPMS with or without ON) showed significantly reduced RNFL globally, or at least in one of the peripapillary sectors compared to age-/sex-matched healthy controls. In patients with previous ON additional RNFL reduction was found. However, in many RRMS patients the RNFL was found within normal range. We found no correlation between RNFL reduction and disease duration (range 9-540 months). Conclusions: RNFL baseline characteristics of RRMS and SPMS are heterogeneous (range from normal to markedly reduced levels).	[Serbecic, Nermin; Kircher, Karl; Geitzenauer, Wolfgang; Reitner, Andreas; Schmidt-Erfurth, Ursula] Med Univ Vienna, Dept Ophthalmol, Vienna, Austria; [Aboul-Enein, Fahmy; Graf, Martin; Kristoferitsch, Wolfgang] SMZ Ost Donauspital, Dept Neurol, Vienna, Austria; [Beutelspacher, Sven C.] Univ Heidelberg, Dept Ophthalmol, Fac Med Mannheim, D-6800 Mannheim, Germany; [Brannath, Werner; Lang, Priska] Med Univ Vienna, Dept Biostat, Vienna, Austria; [Lassmann, Hans] Med Univ Vienna, Brain Res Ctr, Vienna, Austria	Medical University of Vienna; Donauspital; Ruprecht Karls University Heidelberg; Medical University of Vienna; Medical University of Vienna	Serbecic, N (corresponding author), Med Univ Vienna, Dept Ophthalmol, Vienna, Austria.	fahmy.aboul-enein@telering.at	Lassmann, Hans/Z-2269-2019	Lassmann, Hans/0000-0001-8617-5052; Schmidt-Erfurth, Ursula/0000-0002-7788-7311	Medical Research Society Vienna, DC	Medical Research Society Vienna, DC	This study was funded by the Medical Research Society Vienna, DC (www.mfg22.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboul-Enein F, 2010, AM J NEURORADIOL, V31, P76, DOI 10.3174/ajnr.A1791; Aboul-Enein F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011625; Chen HY, 2005, J FORMOS MED ASSOC, V104, P927; Cheung CYL, 2008, OPHTHALMOLOGY, V115, P1347, DOI 10.1016/j.ophtha.2007.11.027; Costello F, 2006, ANN NEUROL, V59, P963, DOI 10.1002/ana.20851; Han IC, 2009, AM J OPHTHALMOL, V147, P847, DOI 10.1016/j.ajo.2008.11.019; Henderson APD, 2008, BRAIN, V131, P277, DOI 10.1093/brain/awm285; Henderson APD, 2010, J NEUROL, V257, P1083, DOI 10.1007/s00415-010-5467-x; Kallenbach K, 2007, EUR J NEUROL, V14, P841, DOI 10.1111/j.1468-1331.2007.01736.x; Kim JS, 2009, BRIT J OPHTHALMOL, V93, P1057, DOI 10.1136/bjo.2009.157875; Krampla W, 2009, EUR RADIOL, V19, P2535, DOI 10.1007/s00330-009-1425-3; LOWITZSCH K, 1991, EEG-EMG-Z ELEK ELEKT, V22, P230; Mader S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010455; Petzold A, 2010, LANCET NEUROL, V9, P921, DOI 10.1016/S1474-4422(10)70168-X; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Sepulcre J, 2007, NEUROLOGY, V68, P1488, DOI 10.1212/01.wnl.0000260612.51849.ed; SERBECIC N, 2010, BR J OPHTHA IN PRESS; Sergott RC, 2007, J NEUROL SCI, V263, P3, DOI 10.1016/j.jns.2007.05.024; Tinnefeld M, 2005, EUR ARCH PSY CLIN N, V255, P319, DOI 10.1007/s00406-005-0565-y; Wu ZQ, 2009, J GLAUCOMA, V18, P213, DOI 10.1097/IJG.0b013e31817eee20	20	28	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e13877	10.1371/journal.pone.0013877	http://dx.doi.org/10.1371/journal.pone.0013877			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	676NU	21079732	gold, Green Published, Green Submitted			2022-12-25	WOS:000283920000010
J	Eddy, TD; Gardner, JPA; Perez-Matus, A				Eddy, Tyler D.; Gardner, Jonathan P. A.; Perez-Matus, Alejandro			Applying Fishers' Ecological Knowledge to Construct Past and Future Lobster Stocks in the Juan Fernandez Archipelago, Chile	PLOS ONE			English	Article							JASUS-EDWARDSII; SPINY LOBSTER; MARINE-RESERVE; MANAGEMENT; COMANAGEMENT; SIZE; CONSERVATION; PALINURIDAE; ECOSYSTEMS; ABUNDANCE	Over-exploited fisheries are a common feature of the modern world and a range of solutions including area closures (marine reserves; MRs), effort reduction, gear changes, ecosystem-based management, incentives and co-management have been suggested as techniques to rebuild over-fished populations. Historic accounts of lobster (Jasus frontalis) on the Chilean Juan Fernandez Archipelago indicate a high abundance at all depths (intertidal to approximately 165 m), but presently lobsters are found almost exclusively in deeper regions of their natural distribution. Fishers' ecological knowledge (FEK) tells a story of serial depletion in lobster abundance at fishing grounds located closest to the fishing port with an associated decline in catch per unit effort (CPUE) throughout recent history. We have re-constructed baselines of lobster biomass throughout human history on the archipelago using historic data, the fishery catch record and FEK to permit examination of the potential effects of MRs, effort reduction and co-management (stewardship of catch) to restore stocks. We employed a bioeconomic model using FEK, fishery catch and effort data, underwater survey information, predicted population growth and response to MR protection (no-take) to explore different management strategies and their trade-offs to restore stocks and improve catches. Our findings indicate that increased stewardship of catch coupled with 30% area closure (MR) provides the best option to reconstruct historic baselines. Based on model predictions, continued exploitation under the current management scheme is highly influenced by annual fluctuations and unsustainable. We propose a community-based co-management program to implement a MR in order to rebuild the lobster population while also providing conservation protection for marine species endemic to the Archipelago.	[Eddy, Tyler D.; Gardner, Jonathan P. A.] Victoria Univ Wellington, Sch Biol Sci, Ctr Marine Environm & Econ Res, Wellington, New Zealand; [Perez-Matus, Alejandro] Victoria Univ Wellington, Sch Biol Sci, Victoria Univ Coastal Ecol Lab, Wellington, New Zealand	Victoria University Wellington; Victoria University Wellington	Eddy, TD (corresponding author), Victoria Univ Wellington, Sch Biol Sci, Ctr Marine Environm & Econ Res, Wellington, New Zealand.	tylereddy@gmail.com	Pérez-Matus, Alejandro/F-5019-2014; Gardner, Jonathan/M-3224-2016; Eddy, Tyler/ABE-7092-2021	Pérez-Matus, Alejandro/0000-0001-9591-6721; Eddy, Tyler/0000-0002-2833-9407; Gardner, Jonathan/0000-0002-6943-2413	Education New Zealand; Te Papa Museum of New Zealand; Victoria University of Wellington; CONICYT; FRST [C01X0501]	Education New Zealand; Te Papa Museum of New Zealand; Victoria University of Wellington; CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); FRST(New Zealand Foundation for Research, Science and Technology)	Funding: Funding for this research has been provided by Education New Zealand's Postgraduate Study Abroad Award and Te Papa Museum of New Zealand. T. D. Eddy is supported by a Victoria University of Wellington Doctoral Scholarship and a Victoria University of Wellington Submission Scholarship. A. Perez-Matus is supported by a CONICYT PhD Scholarship and a FRST contract C01X0501. The History of Marine Animal Populations Publications Group provided publication support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004570; Ainsworth CH, 2008, ECOL MODEL, V216, P354, DOI 10.1016/j.ecolmodel.2008.05.005; Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; ALBERT F, 1898, REV CHIL HIST NAT, V2, P6; ANNALA JH, 1980, NEW ZEAL J MAR FRESH, V14, P217, DOI 10.1080/00288330.1980.9515864; ANNALA JH, 1987, NEW ZEAL J MAR FRESH, V21, P591, DOI 10.1080/00288330.1987.9516263; ARANA P, 1985, CICLO REPROD TALLA P, P187; ARANA P, 1985, ANTECEDENTES GEN ACT, P125; ARANA P, 1985, DISTRIBUCION ESFUERZ, P157; Arana P.M., 2000, INVEST MAR, V28, P117; Beddington JR, 2007, SCIENCE, V316, P1713, DOI 10.1126/science.1137362; Blaikie P, 2006, WORLD DEV, V34, P1942, DOI 10.1016/j.worlddev.2005.11.023; Booth JD, 2000, MAR ECOL PROG SER, V200, P241, DOI 10.3354/meps200241; Browman HI, 2004, MAR ECOL PROG SER, V274, P269, DOI 10.3354/meps274269; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; CABRAL JM, 2004, FUNDAMENTACION PROYE; Castilla JC, 1998, ECOL APPL, V8, pS124, DOI 10.1890/1051-0761(1998)8[S124:SBFICO]2.0.CO;2; Cheung WWL, 2010, GLOBAL CHANGE BIOL, V16, P24, DOI 10.1111/j.1365-2486.2009.01995.x; Cinner JE, 2009, CONSERV BIOL, V23, P124, DOI 10.1111/j.1523-1739.2008.01041.x; Coll M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003881; Cudney-Bueno R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006253; Davidson RJ, 2002, AQUAT CONSERV, V12, P213, DOI 10.1002/aqc.505; DIAZ PO, 1985, ESTIMACIONES MORTALI, P237; Dupre EM, 2000, J SHELLFISH RES, V19, P711; Dupre M. Enrique, 1996, Investigaciones Marinas Universidad Catolica de Valparaiso, V24, P39; EDDY TD, 2008, JMBA GLOBAL MARINE E, V7, P16; ERNST B, 2010, SCIENCE, V86, P215; Freeman DJ, 2009, MAR FRESHWATER RES, V60, P140, DOI 10.1071/MF08091; Freeman DJ, 2009, MAR ECOL PROG SER, V388, P159, DOI 10.3354/meps08122; Game ET, 2009, ECOL LETT, V12, P1336, DOI 10.1111/j.1461-0248.2009.01384.x; Gelcich S, 2005, CONSERV BIOL, V19, P865, DOI 10.1111/j.1523-1739.2005.00534.x; Gelcich S, 2008, ECOL APPL, V18, P273, DOI 10.1890/06-1896.1; Gelcich S, 2007, ECOL ECON, V61, P246, DOI 10.1016/j.ecolecon.2006.02.017; Gelcich S, 2006, ECOSYSTEMS, V9, P951, DOI 10.1007/s10021-005-0007-8; Greenstreet SPR, 2009, ICES J MAR SCI, V66, P90, DOI 10.1093/icesjms/fsn214; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hilborn R, 2002, SCIENCE, V295, P1233; HILBORN R, 1992; Hilborn R, 2010, FISHERIES, V35, P113, DOI 10.1577/1548-8446-35.3.113; Jennings S, 2010, J MARINE SYST, V79, P418, DOI 10.1016/j.jmarsys.2008.12.016; Johannes RE, 2000, FISH FISH, V1, P257, DOI 10.1046/j.1467-2979.2000.00019.x; Kelly S, 2003, NEW ZEAL J MAR FRESH, V37, P149, DOI 10.1080/00288330.2003.9517153; Kelly S, 2002, COAST MANAGE, V30, P153, DOI 10.1080/089207502753504689; Kelly S, 2001, MAR FRESHWATER RES, V52, P323, DOI 10.1071/MF00028; Kelly S, 2000, BIOL CONSERV, V92, P359, DOI 10.1016/S0006-3207(99)00109-3; LUNDQUIST CJ, 2008, 288 NZ DEP CONS SCI; MACDIARMID AB, 1991, MAR ECOL PROG SER, V70, P129, DOI 10.3354/meps070129; McClanahan TR, 2006, CURR BIOL, V16, P1408, DOI 10.1016/j.cub.2006.05.062; Meltzoff SK, 2002, COAST MANAGE, V30, P85, DOI 10.1080/08920750252692634; MOLINA GI, 1808, GEOGRAPHICAL NATURAL, V1, pR1; Mora C, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000131; Murawski SA, 2005, ICES J MAR SCI, V62, P1150, DOI 10.1016/j.icesjms.2005.04.005; Pande A, 2008, MAR ECOL PROG SER, V366, P147, DOI 10.3354/meps07494; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Pequeno G, 2000, GLOBAL ECOL BIOGEOGR, V9, P431, DOI 10.1046/j.1365-2699.2000.00207.x; Petrillo Mario, 2005, Rev. biol. mar. oceanogr., V40, P63; Pitcher TJ, 2001, ECOL APPL, V11, P601; Pitcher T, 2009, NATURE, V457, P658, DOI 10.1038/457658a; POLLNAC R, 2010, P NATL ACAD IN PRESS, DOI DOI 10.1073/PNAS.09082661; Powers JE, 2009, FISH RES, V99, P216, DOI 10.1016/j.fishres.2009.06.011; Rivera Jorge, 2004, Investigaciones Marinas Universidad Catolica de Valparaiso, V32, P99; Rosenberg AA, 2005, FRONT ECOL ENVIRON, V3, P84, DOI 10.2307/3868514; Rosenberg AA, 2007, NATURE, V449, P989, DOI 10.1038/449989a; Rozbaczylo N, 1987, ISLAS OCEANICAS CHIL, P167; Ruth M., 2002, DYNAMIC MODELING MAR; Santelices B., 1992, Pacific Science, V46, P438; Schaefer MB., 1954, INT AM TROPICAL TUNA, V1, P23; *SERN, 2009, AN EST PESC 2009; Shears NT, 2006, BIOL CONSERV, V132, P222, DOI 10.1016/j.biocon.2006.04.001; SKOTTSBERG C, 1956, NATURAL HIST J FERNA, V1, P178; Stokstad E, 2009, SCIENCE, V324, P170, DOI 10.1126/science.324.5924.170; Sutinen J.G., 1999, INT J SOC ECON, V26, P174, DOI [10.1108/03068299910229569, DOI 10.1108/03068299910229569]; Thurstan RH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011767; WALTER R, 1776, VOYAGE ROUND WORLD Y, pR1; Wilen JE, 2002, B MAR SCI, V70, P553; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; YANEZ E, 1985, DINAMICA STOCK LANGO, P251; Yanez R. Eleuterio, 2000, Investigaciones Marinas Universidad Catolica de Valparaiso, V28, P135	79	39	40	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2010	5	11							e13670	10.1371/journal.pone.0013670	http://dx.doi.org/10.1371/journal.pone.0013670			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675OD	21079761	Green Published, Green Submitted, gold			2022-12-25	WOS:000283839100003
J	Kaida, A; Laher, F; Strathdee, SA; Money, D; Janssen, PA; Hogg, RS; Gray, G				Kaida, Angela; Laher, Fatima; Strathdee, Steffanie A.; Money, Deborah; Janssen, Patricia A.; Hogg, Robert S.; Gray, Glenda			Contraceptive Use and Method Preference among Women in Soweto, South Africa: The Influence of Expanding Access to HIV Care and Treatment Services	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; POSITIVE WOMEN; FERTILITY INTENTIONS; DISEASE PROGRESSION; SEXUAL-ACTIVITY; INFECTED WOMEN; TRANSMISSION; UGANDA; HAART; PREGNANCY	Objective: Preventing unintended pregnancy among HIV-positive women constitutes a critical and cost-effective approach to primary prevention of mother-to-child transmission of HIV and is a global public health priority for addressing the desperate state of maternal and child health in HIV hyper-endemic settings. We sought to investigate whether the prevalence of contraceptive use and method preferences varied by HIV status and receipt of highly active antiretroviral therapy (HAART) among women in Soweto, South Africa. Methods: We used survey data from 563 sexually active, non-pregnant women (18-44 years) recruited from the Perinatal HIV Research Unit in Soweto (May-December, 2007); 171 women were HIV-positive and receiving HAART (median duration of use = 31 months; IQR = 28, 33), 178 were HIV-positive and HAART-naive, and 214 were HIV-negative. Medical record review was conducted to confirm HIV status and clinical variables. Logistic regression models estimated adjusted associations between HIV status, receipt of HAART, and contraceptive use. Results: Overall, 78% of women reported using contraception, with significant variation by HIV status: 86% of HAART users, 82% of HAART-naive women, and 69% of HIV-negative women (p<0.0001). In adjusted models, compared with HIV-negative women, women receiving HAART were significantly more likely to use contraception while HAART-naive women were non-significantly more likely (AOR: 2.40; 95% CI: 1.25, 4.62 and AOR: 1.59; 95% CI: 0.88, 2.85; respectively). Among HIV-positive women, HAART users were non-significantly more likely to use contraception compared with HAART-naive women (AOR: 1.55; 95% CI: 0.84, 2.88). Similar patterns held for specific use of barrier (primarily male condoms), permanent, and dual protection contraceptive methods. Conclusion: Among HIV-positive women receiving HAART, the observed higher prevalence of contraceptive use overall and condoms in particular promises to yield fewer unintended pregnancies and reduced risks of vertical and sexual HIV transmission. These findings highlight the potential of integrated HIV and reproductive health services to positively impact maternal, partner, and child health.	[Kaida, Angela; Hogg, Robert S.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Laher, Fatima; Gray, Glenda] Univ Witwatersrand, Perinatal HIV Res Unit, Soweto, South Africa; [Strathdee, Steffanie A.] Univ Calif San Diego, Sch Med, Div Global Publ Hlth, San Diego, CA 92103 USA; [Money, Deborah] Womens Hlth Res Inst, Vancouver, BC, Canada; [Money, Deborah] Univ British Columbia, Dept Obstet & Gynaecol, Vancouver, BC V5Z 1M9, Canada; [Janssen, Patricia A.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Janssen, Patricia A.] Child & Family Res Inst, Vancouver, BC, Canada; [Hogg, Robert S.] BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada	Simon Fraser University; University of Witwatersrand; University of California System; University of California San Diego; University of British Columbia; University of British Columbia; Child & Family Research Institute; B.C. Centre for Excellence in HIV/AIDS	Kaida, A (corresponding author), Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada.	angela_kaida@sfu.ca	Janssen, Patricia/B-1036-2018; Hogg, Robert S/B-2783-2012; Strathdee, Steffanie A/B-9042-2009	Janssen, Patricia/0000-0002-4178-1195; Hogg, Robert S/0000-0003-3463-5488; Strathdee, Steffanie/0000-0002-7724-691X	Canadian Foundation for AIDS Research (CANFAR); University of California San Diego Center for AIDS Research (National Institute of Allergy and Infectious Diseases) [P30AI036214]; Social Sciences and Humanities Research Council (SSHRC) of Canada; Canadian Institutes of Health Research (CIHR); Michael Smith Foundation for Health Research (MSFHR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036214] Funding Source: NIH RePORTER	Canadian Foundation for AIDS Research (CANFAR); University of California San Diego Center for AIDS Research (National Institute of Allergy and Infectious Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Social Sciences and Humanities Research Council (SSHRC) of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding: This research was supported by the Canadian Foundation for AIDS Research (CANFAR), the University of California San Diego Center for AIDS Research (grant P30AI036214 from the National Institute of Allergy and Infectious Diseases), and the Social Sciences and Humanities Research Council (SSHRC) of Canada. A. K. is supported by the Canadian Institutes of Health Research (CIHR) and the Michael Smith Foundation for Health Research (MSFHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair T, 2009, J BIOSOC SCI, V41, P269, DOI 10.1017/S0021932008003076; ALLEN S, 1993, AM J PUBLIC HEALTH, V83, P705, DOI 10.2105/AJPH.83.5.705; Andia I, 2009, AM J PUBLIC HEALTH, V99, P340, DOI 10.2105/AJPH.2007.129528; Baeten JM, 2007, CLIN INFECT DIS, V45, P360, DOI 10.1086/519432; Balkus J, 2007, SEX TRANSM DIS, V34, P25, DOI 10.1097/01.olq.0000218880.88179.36; Barker PM, 2007, SAMJ S AFR MED J, V97, P916; Castilla J, 2005, JAIDS-J ACQ IMM DEF, V40, P96, DOI 10.1097/01.qai.0000157389.78374.45; Coll O, 2008, CURR OPIN HIV AIDS, V3, P186, DOI 10.1097/COH.0b013e3282f51219; Cooper D, 2007, SOC SCI MED, V65, P274, DOI 10.1016/j.socscimed.2007.03.019; Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484, DOI 10.1097/00126334-200204150-00009; *DEP HLTH SA, 2007, NAT HIV SYPH PREV SU; Department of Health SA, 2004, NAT ANT TREATM GUID; Desgrees-du-Lou A, 2002, INT J STD AIDS, V13, P462, DOI 10.1258/09564620260079617; Gruskin S, 2007, REPROD HEALTH MATTER, V15, P4, DOI 10.1016/S0968-8080(07)29028-7; Hladik W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007691; Hoffman IF, 2008, JAIDS-J ACQ IMM DEF, V47, P477, DOI 10.1097/QAI.0b013e318165dc52; Hogan M., LANCET, V375, P1609; Hogg RS, 1997, LANCET, V349, P1294, DOI 10.1016/S0140-6736(05)62505-6; Hogg RS, 1998, JAMA-J AM MED ASSOC, V279, P450, DOI 10.1001/jama.279.6.450; Hogg RS, 2001, JAMA-J AM MED ASSOC, V286, P2568, DOI 10.1001/jama.286.20.2568; Homsy J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004149; HORTON R, LANCET, V375, P1941; Kaida A, 2008, AIDS CARE, V20, P21, DOI 10.1080/09540120701426540; Kaida Angela, 2006, Curr HIV/AIDS Rep, V3, P187, DOI 10.1007/s11904-006-0015-0; Kaida A, 2009, AIDS BEHAV, V13, pS72, DOI 10.1007/s10461-009-9553-y; Laher F, 2009, AIDS BEHAV, V13, pS47, DOI 10.1007/s10461-009-9544-z; Mitchell HS, 2004, SEX TRANSM INFECT, V80, P167, DOI 10.1136/sti.2003.008441; Myer L, 2006, AIDS CARE, V18, P772, DOI 10.1080/09540120500409283; *NAT COMM CONF ENQ, 2003, SAV MOTH 1999 2001; PAGANO M, 2000, PRINC BIOST; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; *PAN ANT GUID AD A, 2008, GUID US ANT AG HIV 1; Peltzer K, 2009, AIDS BEHAV, V13, P973, DOI 10.1007/s10461-008-9365-5; Petruney T, 2008, B WHO, V86, pB; Rehle T, 2007, SAMJ S AFR MED J, V97, P194; Reynolds HW, 2006, SEX TRANSM DIS, V33, P350, DOI 10.1097/01.olq.0000194602.01058.e1; Rochat TJ, 2006, JAMA-J AM MED ASSOC, V295, P1376, DOI 10.1001/jama.295.12.1376; *SADHS, 2004, S AFR DEM HLTH SURV; Seiber EE, 2007, INT FAM PLAN PERSPEC, V33, P117, DOI 10.1363/3311707; UN, 2007, WORLD CONTR US; *UNAIDS, 2008, REP GLOB HIV AIDS EP; UNAIDS UNICEF & USAID, 2004, CHILDR BRINK 2004 JO; Van Ness PH, 2007, USING SAS INVESTIGAT; Wallerstein N., 2006, WHAT IS EVIDENCE EFF; [WHO UNAIDS UNICEF], 2009, UN ACC SCAL PRIOR HI; WHO, 2006, ANT DRUGS TREAT PREG; WHO, 1995, HLTH BEN FAM PLANN; Wilcher R, 2009, AIDS, V23, pS1, DOI 10.1097/01.aids.0000363772.45635.35; Williams HA, 1996, CLIN OBSTET GYNECOL, V39, P333, DOI 10.1097/00003081-199606000-00008; World Health Organization, 2002, PREV HIV INF YOUNG C; World Health Organization, 2008, UN ACC SCAL PRIOR HI	51	57	57	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2010	5	11							e13868	10.1371/journal.pone.0013868	http://dx.doi.org/10.1371/journal.pone.0013868			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	675OD	21079770	gold, Green Published, Green Submitted			2022-12-25	WOS:000283839100018
J	Tsai, MT; Chern, TC; Chuang, JH; Hsueh, CW; Kuo, HS; Liau, CJ; Riley, S; Shen, BJ; Shen, CH; Wang, DW; Hsu, TS				Tsai, Meng-Tsung; Chern, Tsurng-Chen; Chuang, Jen-Hsiang; Hsueh, Chih-Wen; Kuo, Hsu-Sung; Liau, Churn-Jung; Riley, Steven; Shen, Bing-Jie; Shen, Chih-Hao; Wang, Da-Wei; Hsu, Tsan-Sheng			Efficient Simulation of the Spatial Transmission Dynamics of Influenza	PLOS ONE			English	Article							PANDEMIC INFLUENZA; STRATEGIES; EPIDEMIC	Early data from the 2009 H1N1 pandemic (H1N1pdm) suggest that previous studies over-estimated the within-country rate of spatial spread of pandemic influenza. As large spatially resolved data sets are constructed, the need for efficient simulation code with which to investigate the spatial patterns of the pandemic becomes clear. Here, we present a significant improvement to the efficiency of an individual-based stochastic disease simulation framework commonly used in multiple previous studies. We quantify the efficiency of the revised algorithm and present an alternative parameterization of the model in terms of the basic reproductive number. We apply the model to the population of Taiwan and demonstrate how the location of the initial seed can influence spatial incidence profiles and the overall spread of the epidemic. Differences in incidence are driven by the relative connectivity of alternate seed locations. The ability to perform efficient simulation allows us to run a batch of simulations and take account of their average in real time. The averaged data are stable and can be used to differentiate spreading patterns that are not readily seen by only conducting a few runs.	[Tsai, Meng-Tsung; Chern, Tsurng-Chen; Liau, Churn-Jung; Wang, Da-Wei; Hsu, Tsan-Sheng] Acad Sinica, Inst Informat Sci, Taipei, Taiwan; [Chuang, Jen-Hsiang] Ctr Dis Control, Epidem Intelligence Ctr, Taipei, Taiwan; [Hsueh, Chih-Wen] Natl Taiwan Univ, Dept Comp Sci & Informat Engn, Taipei 10764, Taiwan; [Riley, Steven] Univ Hong Kong, Dept Infect Dis Epidemiol, Hong Kong, Hong Kong, Peoples R China; [Shen, Bing-Jie] Far Eastern Mem Hosp, Dept Radiat Oncol, Taipei, Taiwan; [Shen, Chih-Hao] Univ Virginia, Dept Comp Sci, Charlottesville, VA 22903 USA	Academia Sinica - Taiwan; Centers For Disease Control - Taiwan; National Taiwan University; University of Hong Kong; Far Eastern Memorial Hospital; University of Virginia	Tsai, MT (corresponding author), Acad Sinica, Inst Informat Sci, Taipei, Taiwan.	tshsu@iis.sinica.edu.tw	Liau, Churn-Jung/AAI-7047-2020; Tsai, Meng-Tsung/ABB-4079-2020; Chuang, Jen-Hsiang/G-4356-2010; Liau, Churn-Jung/ABA-7779-2020	Tsai, Meng-Tsung/0000-0002-2243-8666; Chuang, Jen-Hsiang/0000-0002-7114-3418; Liau, Churn-Jung/0000-0001-6842-9637; Riley, Steven/0000-0001-7904-4804	Centers for Disease Control, Department of Health, Taiwan, R.O.C. [DOH98-DC-2036]; National Science Council, Taiwan, R.O.C. [97-2221-E-001-011-MY3, 98-2221-E-001-013-MY3]; Fogarty International Centre with the Science and Technology Directorate Department of Homeland Security [R01 TW008246-01]; Government of the Hong Kong SAR; FOGARTY INTERNATIONAL CENTER [R01TW008246] Funding Source: NIH RePORTER	Centers for Disease Control, Department of Health, Taiwan, R.O.C.; National Science Council, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan); Fogarty International Centre with the Science and Technology Directorate Department of Homeland Security(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)United States Department of Homeland Security (DHS)); Government of the Hong Kong SAR; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported in part by the following grants: Jen-Hsiang Chuang is supported in part by DOH98-DC-2036 from the Centers for Disease Control, Department of Health, Taiwan, R.O.C.; Tsan-sheng Hsu and Bing-Jie Shen are supported in part by 97-2221-E-001-011-MY3 from National Science Council, Taiwan, R.O.C.; Churn-Jung Liau is supported in part by 98-2221-E-001-013-MY3 from National Science Council, Taiwan, R.O.C.; Steven Riley is supported in part by R01 TW008246-01 from Fogarty International Centre, RAPIDD program from Fogarty International Centre with the Science and Technology Directorate Department of Homeland Security, and Research Fund for the Control of Infectious Disease of the Government of the Hong Kong SAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; FLAHAULT A, 1988, STAT MED, V7, P1147, DOI 10.1002/sim.4780071107; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Halloran ME, 2002, VACCINE, V20, P3254; Halloran ME, 2002, SCIENCE, V298, P1428, DOI 10.1126/science.1074674; Heesterbeek JAP, 2002, ACTA BIOTHEOR, V50, P189, DOI 10.1023/A:1016599411804; Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Lee BY, 2010, J PUBLIC HEALTH MAN, V16, P252, DOI 10.1097/PHH.0b013e3181ce594e; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; NIST/SEMATECH, NIST SEMATECH E HDB; RILEY S, 2006, PNAS, V103, P12221; Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695; TSAI MT, 2010, P LNCS, V6196, P500; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373	19	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e13292	10.1371/journal.pone.0013292	http://dx.doi.org/10.1371/journal.pone.0013292			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079810	Green Submitted, gold, Green Published			2022-12-25	WOS:000283838600001
J	Wang, JH; Valo, Z; Bowers, CW; Smith, DD; Liu, Z; Singer-Sam, J				Wang, Jinhui; Valo, Zuzana; Bowers, Chauncey W.; Smith, David D.; Liu, Zheng; Singer-Sam, Judith			Dual DNA Methylation Patterns in the CNS Reveal Developmentally Poised Chromatin and Monoallelic Expression of Critical Genes	PLOS ONE			English	Article							HUMAN-CELLS; STEM-CELLS; ALLELIC EXCLUSION; TWINS DISCORDANT; GENOME BROWSER; MOUSE; WIDE; PROTEOGLYCAN; INACTIVATION; REGIONS	As a first step towards discovery of genes expressed from only one allele in the CNS, we used a tiling array assay for DNA sequences that are both methylated and unmethylated (the MAUD assay). We analyzed regulatory regions of the entire mouse brain transcriptome, and found that approximately 10% of the genes assayed showed dual DNA methylation patterns. They include a large subset of genes that display marks of both active and silent, i.e., poised, chromatin during development, consistent with a link between differential DNA methylation and lineage-specific differentiation within the CNS. Sixty-five of the MAUD hits and 57 other genes whose function is of relevance to CNS development and/or disorders were tested for allele-specific expression in F-1 hybrid clonal neural stem cell (NSC) lines. Eight MAUD hits and one additional gene showed such expression. They include Lgi1, which causes a subtype of inherited epilepsy that displays autosomal dominance with incomplete penetrance; Gfra2, a receptor for glial cell line-derived neurotrophic factor GDNF that has been linked to kindling epilepsy; Unc5a, a netrin-1 receptor important in neurodevelopment; and Cspg4, a membrane chondroitin sulfate proteoglycan associated with malignant melanoma and astrocytoma in human. Three of the genes, Camk2a, Kcnc4, and Unc5a, show preferential expression of the same allele in all clonal NSC lines tested. The other six genes show a stochastic pattern of monoallelic expression in some NSC lines and bi-allelic expression in others. These results support the estimate that 1-2% of genes expressed in the CNS may be subject to allelic exclusion, and demonstrate that the group includes genes implicated in major disorders of the CNS as well as neurodevelopment.	[Wang, Jinhui; Valo, Zuzana; Singer-Sam, Judith] City Hope Natl Med Ctr, Beckman Res Inst, Div Biol, Duarte, CA 91010 USA; [Bowers, Chauncey W.] City Hope Natl Med Ctr, Beckman Res Inst, Div Computat Biol, Duarte, CA 91010 USA; [Smith, David D.] City Hope Natl Med Ctr, Div Biostat, Duarte, CA 91010 USA; [Liu, Zheng] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Med, Bioinformat Core Facil, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; City of Hope; Beckman Research Institute of City of Hope	Wang, JH (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Div Biol, Duarte, CA 91010 USA.	jsam@coh.org	Smith, David/A-4115-2017	Smith, David/0000-0001-9644-2353; Liu, Zheng/0000-0002-1635-1556	National Institutes of Health [R21 MH073754]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH073754] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by National Institutes of Health grant R21 MH073754 to JSS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBADI N, 1994, AM J MED GENET, V52, P198, DOI 10.1002/ajmg.1320520215; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bartoe JL, 2006, J NEUROSCI, V26, P3192, DOI 10.1523/JNEUROSCI.3469-05.2006; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bix M, 1998, SCIENCE, V281, P1352, DOI 10.1126/science.281.5381.1352; Brekke C, 2006, NEUROIMAGE, V29, P965, DOI 10.1016/j.neuroimage.2005.08.026; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; CATTANACH BM, 1972, GENET RES, V19, P229, DOI 10.1017/S001667230001449X; CHEN C, 1994, SCIENCE, V266, P291, DOI 10.1126/science.7939668; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; GARTLER SM, 1964, COLD SPRING HARB SYM, V29, P253, DOI 10.1101/SQB.1964.029.01.028; Gimelbrant AA, 2005, J BIOL CHEM, V280, P1354, DOI 10.1074/jbc.M411283200; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Held W, 1997, EUR J IMMUNOL, V27, P2876, DOI 10.1002/eji.1830271120; Herculano-Houzel S, 2005, J NEUROSCI, V25, P2518, DOI 10.1523/JNEUROSCI.4526-04.2005; Hilgetag CC, 2009, BRAIN STRUCT FUNCT, V213, P365, DOI 10.1007/s00429-009-0202-z; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Irizarry RA, 2008, GENOME RES, V18, P780, DOI 10.1101/gr.7301508; JORGENSEN AL, 1992, AM J HUM GENET, V51, P291; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Khulan B, 2006, GENOME RES, V16, P1046, DOI 10.1101/gr.5273806; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Leonardo ED, 1997, NATURE, V386, P833, DOI 10.1038/386833a0; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mostoslavsky R, 1998, GENE DEV, V12, P1801, DOI 10.1101/gad.12.12.1801; Nanobashvili A, 2000, P NATL ACAD SCI USA, V97, P12312, DOI 10.1073/pnas.97.22.12312; Pluschke G, 1996, P NATL ACAD SCI USA, V93, P9710, DOI 10.1073/pnas.93.18.9710; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; RIMM IJ, 1989, MOL BIOL MED, V6, P355; Riviere I, 1998, IMMUNITY, V9, P217, DOI 10.1016/S1074-7613(00)80604-4; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Rosanoff MJ, 2008, NEUROLOGY, V71, P567, DOI 10.1212/01.wnl.0000323926.77565.ee; Rouhi A, 2006, J IMMUNOL, V176, P2991, DOI 10.4049/jimmunol.176.5.2991; Schumacher A, 2006, NUCLEIC ACIDS RES, V34, P528, DOI 10.1093/nar/gkj461; Seyfried NT, 2008, CANCER LETT, V263, P243, DOI 10.1016/j.canlet.2008.01.007; Shen L, 2007, PLOS GENET, V3, P2023, DOI 10.1371/journal.pgen.0030181; Shi YH, 2004, NATURE, V427, P78, DOI 10.1038/nature02211; Smith RJ, 2003, GENOME RES, V13, P558, DOI 10.1101/gr.781503; Song F, 2005, P NATL ACAD SCI USA, V102, P3336, DOI 10.1073/pnas.0408436102; Stegmuller J, 2003, J BIOL CHEM, V278, P3590, DOI 10.1074/jbc.M210010200; Suzuki M, 2007, GENES CELLS, V12, P1305, DOI 10.1111/j.1365-2443.2007.01136.x; Wang JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001293; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wen B, 2008, GENOME RES, V18, P1806, DOI 10.1101/gr.067587.108; Williams ME, 2006, NAT NEUROSCI, V9, P996, DOI 10.1038/nn1736; Wilson CB, 2005, SEMIN IMMUNOL, V17, P105, DOI 10.1016/j.smim.2005.01.005; Zampetaki A, 2006, BIOCHEM BIOPH RES CO, V347, P89, DOI 10.1016/j.bbrc.2006.06.055	52	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e13843	10.1371/journal.pone.0013843	http://dx.doi.org/10.1371/journal.pone.0013843			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079792	Green Submitted, gold, Green Published			2022-12-25	WOS:000283838600017
J	Abdelaziz, DH; Gavrilin, MA; Akhter, A; Caution, K; Kotrange, S; Abu Khweek, A; Abdulrahman, BA; Grandhi, J; Hassan, ZA; Marsh, C; Wewers, MD; Amer, AO				Abdelaziz, Dalia H.; Gavrilin, Mikhail A.; Akhter, Anwari; Caution, Kyle; Kotrange, Sheetal; Abu Khweek, Arwa; Abdulrahman, Basant A.; Grandhi, Jaykumar; Hassan, Zeinab A.; Marsh, Clay; Wewers, Mark D.; Amer, Amal O.			Apoptosis-associated Speck-like Protein (ASC) Controls Legionella pneumophila Infection in Human Monocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; HOST-CELL DEATH; LEGIONNAIRES-DISEASE; ACTIVATING ADAPTER; INFLAMMASOME; CASPASE-1; PHAGOSOME; BACTERIUM; FLAGELLIN; CARD	The ability of Legionella pneumophila to cause pneumonia is determined by its capability to evade the immune system and grow within human monocytes and their derived macrophages. Human monocytes efficiently activate caspase-1 in response to Salmonella but not to L. pneumophila. The molecular mechanism for the lack of inflammasome activation during L. pneumophila infection is unknown. Evaluation of the expression of several inflammasome components in human monocytes during L. pneumophila infection revealed that the expression of the apoptosis-associated speck-like protein (ASC) and the NOD-like receptor NLRC4 are significantly down-regulated in human monocytes. Exogenous expression of ASC maintained the protein level constant during L. pneumophila infection and conveyed caspase-1 activation and restricted the growth of the pathogen. Further depletion of ASC with siRNA was accompanied with improved NF-kappa B activation and enhanced L. pneumophila growth. Therefore, our data demonstrate that L. pneumophila manipulates ASC levels to evade inflammasome activation and grow in human monocytes. By targeting ASC, L. pneumophila modulates the inflammasome, the apoptosome, and NF-kappa B pathway simultaneously.	[Abdulrahman, Basant A.; Grandhi, Jaykumar; Marsh, Clay; Wewers, Mark D.; Amer, Amal O.] Ohio State Univ, Div Pulm Allergy Crit Care & Sleep Med, Ctr Microbial Interface Biol, Columbus, OH 43210 USA; [Abdulrahman, Basant A.; Grandhi, Jaykumar; Marsh, Clay; Wewers, Mark D.] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Abdelaziz, Dalia H.; Abdulrahman, Basant A.; Hassan, Zeinab A.] Helwan Univ, Fac Pharm, Dept Biochem & Mol Biol, Helwan, Egypt	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Egyptian Knowledge Bank (EKB); Helwan University	Amer, AO (corresponding author), Ohio State Univ, Div Pulm Allergy Crit Care & Sleep Med, Ctr Microbial Interface Biol, Biol Res Tower,460W 12th Ave,Rm 1014, Columbus, OH 43210 USA.	amal.amer@osumc.edu	Wewers, Mark/AAB-6202-2021; Amer, Amal/E-2643-2011	Abdulrahman, Basant/0000-0002-4970-6835; Gavrilin, Mikhail/0000-0003-2003-768X	National Institutes of Health [R01HL094586, R21AI083871]; American Lung Association [GRT00013604]; Egyptian Cultural and Educational Bureau; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083871] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association; Egyptian Cultural and Educational Bureau(Egyptian Cultural & Educational Bureau); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL094586 and R21AI083871. This work was also supported by Grant GRT00013604 from the American Lung Association.; Supported by the Egyptian Cultural and Educational Bureau.	Abdelaziz DH, 2010, INT J BIOCHEM CELL B, V42, P789, DOI 10.1016/j.biocel.2010.01.003; Abu-Zant A, 2007, CELL MICROBIOL, V9, P246, DOI 10.1111/j.1462-5822.2006.00785.x; Akhter A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000361; Amer A, 2006, J BIOL CHEM, V281, P35217, DOI 10.1074/jbc.M604933200; Amer AO, 2010, CELL MICROBIOL, V12, P140, DOI 10.1111/j.1462-5822.2009.01401.x; Bartfeld S, 2009, CELL MICROBIOL, V11, P1638, DOI 10.1111/j.1462-5822.2009.01354.x; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Chien MC, 2004, SCIENCE, V305, P1966, DOI 10.1126/science.1099776; Cianciotto NP, 2001, INT J MED MICROBIOL, V291, P331, DOI 10.1078/1438-4221-00139; CORDES LG, 1979, LANCET, V2, P927; Derre I, 2004, INFECT IMMUN, V72, P6221, DOI 10.1128/IAI.72.11.6221-6229.2004; Fahy RJ, 2008, AM J RESP CRIT CARE, V177, P983, DOI 10.1164/rccm.200703-418OC; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Gavrilin MA, 2006, P NATL ACAD SCI USA, V103, P141, DOI 10.1073/pnas.0504271103; Gavrilin MA, 2009, J IMMUNOL, V182, P7982, DOI 10.4049/jimmunol.0803073; Hall MW, 2007, PEDIATR RES, V62, P597, DOI 10.1203/PDR.0b013e3181559774; Hasegawa M, 2005, J BIOL CHEM, V280, P15122, DOI 10.1074/jbc.M412284200; HORWITZ MA, 1983, J EXP MED, V158, P1319, DOI 10.1084/jem.158.4.1319; Ippagunta SK, 2010, J BIOL CHEM, V285, P12454, DOI 10.1074/jbc.M109.093252; Isberg RR, 2009, NAT REV MICROBIOL, V7, P12, DOI 10.1038/nrmicro1967; Kagan JC, 2002, NAT CELL BIOL, V4, P945, DOI 10.1038/ncb883; Laguna RK, 2006, P NATL ACAD SCI USA, V103, P18745, DOI 10.1073/pnas.0609012103; Lamkanfi M, 2009, BLOOD, V113, P2742, DOI 10.1182/blood-2008-09-178038; Lamkanfi M, 2008, MOL CELL PROTEOMICS, V7, P2350, DOI 10.1074/mcp.M800132-MCP200; Lech M, 2010, INT IMMUNOL, V22, P717, DOI 10.1093/intimm/dxq058; Losick VP, 2006, J EXP MED, V203, P2177, DOI 10.1084/jem.20060766; Masumoto J, 2003, BIOCHEM BIOPH RES CO, V303, P69, DOI 10.1016/S0006-291X(03)00309-7; MCDADE JE, 1977, NEW ENGL J MED, V297, P1197, DOI 10.1056/NEJM197712012972202; Ohtsuka T, 2004, NAT CELL BIOL, V6, P121, DOI 10.1038/ncb1087; Petrilli V, 2005, CURR BIOL, V15, pR581, DOI 10.1016/j.cub.2005.07.049; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Sarkar A, 2006, J IMMUNOL, V176, P4979, DOI 10.4049/jimmunol.176.8.4979; Shin S, 2008, CELL MICROBIOL, V10, P1209, DOI 10.1111/j.1462-5822.2008.01145.x; Shiohara M, 2002, BIOCHEM BIOPH RES CO, V293, P1314, DOI 10.1016/S0006-291X(02)00384-4; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Stehlik C, 2002, J EXP MED, V196, P1605, DOI 10.1084/jem.20021552; Taniguchi S, 2007, SEMIN IMMUNOPATHOL, V29, P231, DOI 10.1007/s00281-007-0082-3; Taxman DJ, 2010, CELL HOST MICROBE, V8, P7, DOI 10.1016/j.chom.2010.06.005; Tilney LG, 2001, J CELL SCI, V114, P4637; Vinzing M, 2008, J IMMUNOL, V180, P6808, DOI 10.4049/jimmunol.180.10.6808; Yu HB, 2008, CELL HOST MICROBE, V4, P198, DOI 10.1016/j.chom.2008.08.007; Zamboni DS, 2006, NAT IMMUNOL, V7, P318, DOI 10.1038/ni1305	42	55	61	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3203	3208		10.1074/jbc.M110.197681	http://dx.doi.org/10.1074/jbc.M110.197681			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21097506	Green Published, hybrid			2022-12-25	WOS:000286653200004
J	Shah, CA; Wang, H; Bei, L; Platanias, LC; Eklund, EA				Shah, Chirag A.; Wang, Hao; Bei, Ling; Platanias, Leonidas C.; Eklund, Elizabeth A.			HoxA10 Regulates Transcription of the Gene Encoding Transforming Growth Factor beta 2 (TGF beta 2) in Myeloid Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-MARROW-CELLS; HUMAN HEMATOPOIETIC-CELLS; DNA-BINDING; IN-VITRO; ACTIVATES TRANSCRIPTION; PROGENITOR CELLS; EXPRESSION; LEUKEMIA; MLL; DIFFERENTIATION	HoxA10 is a homeodomain transcription factor that is maximally expressed in myeloid progenitor cells. HoxA10 is over-expressed in a poor prognosis subset of human acute myeloid leukemia (AML) and in vivo overexpression of HoxA10 in murine bone marrow induces myeloid leukemia. HoxA10 contributes to myeloid progenitor expansion and differentiation block, but few target genes have been identified that explain the influence of HoxA10 on these processes. The current study identifies the gene encoding transforming growth factor beta 2 (TGF beta 2) as a HoxA10 target gene. We found that HoxA10 activated TGF beta 2 transcription by interacting with tandem cis elements in the promoter. We also determined that HoxA10 overexpression in myeloid progenitor cells increased Tgf beta 2 production by the cells. Tgf beta 2 stimulates proliferation of hematopoietic stem and progenitor cells. Therefore, these studies identified autocrine stimulation of myeloid progenitors by Tgf beta 2 as one mechanism by which HoxA10 expands this population. Because HoxA proteins had not been previously known to influence expression of pro-proliferative cytokines, this has implications for understanding molecular mechanisms involved in progenitor expansion and the pathobiology of AML.	Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Bei, Ling; Platanias, Leonidas C.; Eklund, Elizabeth A.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Eklund, EA (corresponding author), 303 E Super St,Lurie 5-105, Chicago, IL 60611 USA.	e-eklund@northwestern.edu		Wang, Hao/0000-0003-2131-0377	National Institutes of Health [R01-HL87717]; Veterns Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterns Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-HL87717 and a Veterns Affairs Merit Review grant (to E.A.E.).	ACAMPORA D, 1989, NUCLEIC ACIDS RES, V17, P10385, DOI 10.1093/nar/17.24.10385; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Bei L, 2007, J BIOL CHEM, V282, P16846, DOI 10.1074/jbc.M609744200; Bjornsson JM, 2001, BLOOD, V98, P3301, DOI 10.1182/blood.V98.12.3301; Buske C, 2001, BLOOD, V97, P2286, DOI 10.1182/blood.V97.8.2286; Calvo KR, 2000, MOL CELL BIOL, V20, P3274, DOI 10.1128/MCB.20.9.3274-3285.2000; Camos M, 2006, CANCER RES, V66, P6947, DOI 10.1158/0008-5472.CAN-05-4601; CHEIFETZ S, 1990, J BIOL CHEM, V265, P20533; Chevronnay HPG, 2008, ENDOCRINOLOGY, V149, P1015, DOI 10.1210/en.2007-0849; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dubchak I, 2000, GENOME RES, V10, P1304, DOI 10.1101/gr.142200; Eklund EA, 1998, J BIOL CHEM, V273, P13957, DOI 10.1074/jbc.273.22.13957; Eklund EA, 2002, J BIOL CHEM, V277, P36878, DOI 10.1074/jbc.M203917200; Eklund EA, 2000, J BIOL CHEM, V275, P20117, DOI 10.1074/jbc.M907915199; Ernst P, 2004, CURR BIOL, V14, P2063, DOI 10.1016/j.cub.2004.11.012; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; GRZEGORZEWSKI K, 1994, J EXP MED, V180, P1047, DOI 10.1084/jem.180.3.1047; Guenther MG, 2005, P NATL ACAD SCI USA, V102, P8603, DOI 10.1073/pnas.0503072102; Henckaerts E, 2004, J IMMUNOL, V173, P2486, DOI 10.4049/jimmunol.173.4.2486; Horton SJ, 2005, CANCER RES, V65, P9245, DOI 10.1158/0008-5472.CAN-05-1691; Kawagoe H, 1999, LEUKEMIA, V13, P687, DOI 10.1038/sj.leu.2401410; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; LARRICK JW, 1980, J IMMUNOL, V125, P6; Lawrence HJ, 1997, BLOOD, V89, P1922, DOI 10.1182/blood.V89.6.1922; Lee SW, 2006, J CELL BIOCHEM, V98, P981, DOI 10.1002/jcb.20773; Lindsey S, 2005, J IMMUNOL, V175, P5269, DOI 10.4049/jimmunol.175.8.5269; Loots GG, 2002, GENOME RES, V12, P832, DOI 10.1101/gr.225502; LOWNEY P, 1991, NUCLEIC ACIDS RES, V19, P3443, DOI 10.1093/nar/19.12.3443; Majka M, 2001, BLOOD, V97, P3075, DOI 10.1182/blood.V97.10.3075; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Oberley MJ, 2003, METHOD ENZYMOL, V371, P577; PAREKH T, 1994, J IMMUNOL, V152, P2456; Salzman SA, 2002, CYTOKINES CELL MOL T, V7, P31, DOI 10.1080/13684730216400; SATOKATA I, 1995, NATURE, V374, P460, DOI 10.1038/374460a0; SAUVAGEAU G, 1994, P NATL ACAD SCI USA, V91, P12223, DOI 10.1073/pnas.91.25.12223; SAUVAGEAU G, 1995, GENE DEV, V9, P1753, DOI 10.1101/gad.9.14.1753; Szymkowiak CH, 2000, CYTOKINE, V12, P397, DOI 10.1006/cyto.1999.0572; Tefferi A, 2007, CELL CYCLE, V6, P550, DOI 10.4161/cc.6.5.3919; Thorsteinsdottir U, 2002, BLOOD, V99, P121, DOI 10.1182/blood.V99.1.121; Thorsteinsdottir U, 2001, MOL CELL BIOL, V21, P224, DOI 10.1128/MCB.21.1.224-234.2001; Wang H, 2007, J BIOL CHEM, V282, P16164, DOI 10.1074/jbc.M610556200; Wang H, 2009, J BIOL CHEM, V284, P2549, DOI 10.1074/jbc.M804704200; Zhu CL, 2004, J BIOL CHEM, V279, P50874, DOI 10.1074/jbc.M405736200	44	36	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					3161	3176		10.1074/jbc.M110.183251	http://dx.doi.org/10.1074/jbc.M110.183251			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21087928	Green Published, hybrid			2022-12-25	WOS:000286464300077
J	Chan, YC; Khanna, S; Roy, S; Sen, CK				Chan, Yuk Cheung; Khanna, Savita; Roy, Sashwati; Sen, Chandan K.			miR-200b Targets Ets-1 and Is Down-regulated by Hypoxia to Induce Angiogenic Response of Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTION FACTOR ETS-1; GROWTH-FACTOR; E-CADHERIN; CANCER-CELLS; MATRIX METALLOPROTEINASES; MICRORNA EXPRESSION; GENE-EXPRESSION; REPRESSORS ZEB1; ANGIOTENSIN-II	The miR-200 family plays a crucial role in epithelial to mesenchymal transition via controlling cell migration and polarity. We hypothesized that miR-200b, one miR-200 family member, could regulate angiogenic responses via modulating endothelial cell migration. Delivery of the miR-200b mimic in human microvascular endothelial cells (HMECs) suppressed the angiogenic response, whereas miR-200b-depleted HMECs exhibited elevated angiogenesis in vitro, as evidenced by Matrigel (R) tube formation and cell migration. Using in silico studies, miR target reporter assay, and Western blot analysis revealed that v-ets erythroblastosis virus E26 oncogene homolog 1 (Ets-1), a crucial angiogenesis-related transcription factor, serves as a novel direct target of miR-200b. Knocking down endogenous Ets-1 simulated an anti-angiogenic response of the miR-200b mimic-transfected cells. Certain Ets-1-associated genes, namely matrix metalloproteinase 1 and vascular endothelial growth factor receptor 2, were negatively regulated by miR-200b. Overexpression of Ets-1 rescued miR-200b-dependent impairment in angiogenic response and suppression of Ets-1-associated gene expression. Both hypoxia as well as HIF-1 alpha stabilization inhibited miR-200b expression and elevated Ets-1 expression. Experiments to identify how miR-200b modulates angiogenesis under a low oxygen environment illustrated that hypoxia-induced miR-200b down-regulation derepressed Ets-1 expression to promote angiogenesis. This study provides the first evidence that hypoxia-sensitive miR-200b is involved in induction of angiogenesis via directly targeting Ets-1 in HMECs.	[Chan, Yuk Cheung; Khanna, Savita; Roy, Sashwati; Sen, Chandan K.] Ohio State Univ, Med Ctr, Davis Heart & Lung Res Inst, Dept Surg, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Sen, CK (corresponding author), 473 W 12th Ave, Columbus, OH 43210 USA.	chandan.sen@osumc.edu	Sen, Chandan K/A-8762-2013; Roy, sashwati/E-3990-2011; Khanna, Savita/E-3378-2011		National Institutes of Health [GM077185, GM069589]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069589, R01GM077185] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM077185 and GM069589 (to C. K. S.).	Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Biswas S, 2010, P NATL ACAD SCI USA, V107, P6976, DOI 10.1073/pnas.1001653107; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Chen ZQ, 1997, CANCER RES, V57, P2013; Du CS, 2009, NAT IMMUNOL, V10, P1252, DOI 10.1038/ni.1798; Elvert G, 2003, J BIOL CHEM, V278, P7520, DOI 10.1074/jbc.M211298200; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Forough R, 2006, J VASC RES, V43, P327, DOI 10.1159/000093198; GLASSBERG MK, 1992, J APPL PHYSIOL, V72, P1681, DOI 10.1152/jappl.1992.72.5.1681; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hsu PWC, 2007, NUCLEIC ACIDS RES, V35, pD381, DOI 10.1093/nar/gkl1009; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; Hurteau GJ, 2009, CELL CYCLE, V8, P2064, DOI 10.4161/cc.8.13.8883; Inuzuka T, 2009, CANCER RES, V69, P1678, DOI 10.1158/0008-5472.CAN-08-3620; Inuzuka T, 2009, BIOCHEM BIOPH RES CO, V379, P510, DOI 10.1016/j.bbrc.2008.12.101; Jackson CJ, 1997, INT J BIOCHEM CELL B, V29, P1167, DOI 10.1016/S1357-2725(97)00061-7; Ji Z, 2007, ONCOGENE, V26, P395, DOI 10.1038/sj.onc.1209789; Jinnin M, 2005, NUCLEIC ACIDS RES, V33, P3540, DOI 10.1093/nar/gki648; Kappel A, 2000, BLOOD, V96, P3078; Khanna S, 2006, FREE RADICAL BIO MED, V40, P2147, DOI 10.1016/j.freeradbiomed.2006.02.010; Kong DJ, 2009, STEM CELLS, V27, P1712, DOI 10.1002/stem.101; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916; Lang I, 2003, EUR J CELL BIOL, V82, P163, DOI 10.1078/0171-9335-00306; Murakami Y, 2006, J BIOL CHEM, V281, P28113, DOI 10.1074/jbc.M602026200; Ni W, 2007, CIRC RES, V101, P985, DOI 10.1161/CIRCRESAHA.107.152439; Nishida T, 2007, BIOCHEM J, V405, P481, DOI 10.1042/BJ20070026; Oda N, 1999, J CELL PHYSIOL, V178, P121, DOI 10.1002/(SICI)1097-4652(199902)178:2<121::AID-JCP1>3.3.CO;2-6; Olszewska-Pazdrak B, 2009, AM J PHYSIOL-CELL PH, V296, pC1162, DOI 10.1152/ajpcell.00533.2008; Ono K, 2002, BRIT J CANCER, V86, P1803, DOI 10.1038/sj.bjc.6600307; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pearse DD, 2008, AM J PHYSIOL-RENAL, V294, pF1094, DOI 10.1152/ajprenal.00458.2007; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Rane S, 2009, CIRC RES, V104, P879, DOI 10.1161/CIRCRESAHA.108.193102; Romania P, 2008, BRIT J HAEMATOL, V143, P570, DOI 10.1111/j.1365-2141.2008.07382.x; Roy S, 2007, DNA CELL BIOL, V26, P627, DOI 10.1089/dna.2007.0617; Roy S, 2009, CARDIOVASC RES, V82, P21, DOI 10.1093/cvr/cvp015; Sachidanandam K, 2006, EXP BIOL MED, V231, P1016; Sen CK, 2009, J VASC RES, V46, P527, DOI 10.1159/000226221; Shilo S, 2008, ARTERIOSCL THROM VAS, V28, P471, DOI 10.1161/ATVBAHA.107.160655; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Suarez Y, 2008, P NATL ACAD SCI USA, V105, P14082, DOI 10.1073/pnas.0804597105; Suarez Y, 2007, CIRC RES, V100, P1164, DOI 10.1161/01.RES.0000265065.26744.17; Tanaka K, 1998, J CELL PHYSIOL, V176, P235, DOI 10.1002/(SICI)1097-4652(199808)176:2<235::AID-JCP2>3.0.CO;2-P; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Watanabe D, 2004, AM J PATHOL, V164, P1827, DOI 10.1016/S0002-9440(10)63741-8; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Yan HL, 2009, EMBO J, V28, P2719, DOI 10.1038/emboj.2009.214; Yang BS, 1996, MOL CELL BIOL, V16, P538	52	195	205	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2047	2056		10.1074/jbc.M110.158790	http://dx.doi.org/10.1074/jbc.M110.158790			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21081489	Green Published, hybrid			2022-12-25	WOS:000286191500047
J	Marinis, JM; Homer, CR; McDonald, C; Abbott, DW				Marinis, Jill M.; Homer, Craig R.; McDonald, Christine; Abbott, Derek W.			A Novel Motif in the Crohn's Disease Susceptibility Protein, NOD2, Allows TRAF4 to Down-regulate Innate Immune Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B ACTIVATION; MOLECULAR-MECHANISMS; STRUCTURAL BASIS; MEKK4; RECOGNITION; ASSOCIATION; RECEPTOR; BINDING; COMMON; RIP2	The Crohn's disease and early onset sarcoidosis susceptibility protein, NOD2, coordinates innate immune signaling pathways. Because dysregulation of this coordination can lead to inflammatory disease, maintaining appropriate activation of the NOD2 signaling pathway is paramount in immunologic homeostasis. In this work, we identify the atypical tumor necrosis factor-associated factor (TRAF) family member, TRAF4, as a key negative regulator of NOD2 signaling. TRAF4 inhibits NOD2-induced NF-kappa B activation and directly binds to NOD2 to inhibit NOD2-induced bacterial killing. We find that two consecutive glutamate residues in NOD2 are required for interaction with TRAF4 and inhibition of NOD2 signaling because mutation of these residues abrogated both TRAF4 binding and inhibition of NOD2. This work identifies a novel negative regulator of NOD2 signaling. Additionally, it defines a TRAF4 binding motif within NOD2 involved in termination of innate immune signaling responses.	[Marinis, Jill M.; Abbott, Derek W.] Case Western Reserve Univ, Dept Pathol, Sch Med, Cleveland, OH 44106 USA; [Homer, Craig R.; McDonald, Christine] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44195 USA	Case Western Reserve University; Cleveland Clinic Foundation	Abbott, DW (corresponding author), 2103 Cornell Rd,6533 WRB, Cleveland, OH 44106 USA.	dwa4@case.edu		Abbott, Derek/0000-0003-4387-8094; McDonald, Christine/0000-0002-6745-9487	National Institutes of Health (NIH) [R01GM86550-01, 5T32GM008056-28, R01DK082437]; Burroughs Wellcome Career Award for Biomedical Scientists [10061206.01]; Gerald and Nancy Goldberg; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076886] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082437, P01DK091222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086550, T32GM008056] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Career Award for Biomedical Scientists(Burroughs Wellcome Fund); Gerald and Nancy Goldberg; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grant R01GM86550-01 (to D. W. A.), NIH Cell and Molecular Biology Training Grant 5T32GM008056-28 (to J. M. M.), and NIH Research Grant R01DK082437 (to C. M.). This work was also supported by Burroughs Wellcome Career Award for Biomedical Scientists 10061206.01 (to D. W. A.) and the generosity of Gerald and Nancy Goldberg (to C. M.).	Abbott DW, 2007, MOL CELL BIOL, V27, P6012, DOI 10.1128/MCB.00270-07; Abbott DW, 2004, CURR BIOL, V14, P2217, DOI 10.1016/j.cub.2004.12.032; Abell AN, 2005, MOL CELL BIOL, V25, P8948, DOI 10.1128/MCB.25.20.8948-8959.2005; Abell AN, 2005, J BIOL CHEM, V280, P35793, DOI 10.1074/jbc.C500260200; Bertrand MJM, 2009, IMMUNITY, V30, P789, DOI 10.1016/j.immuni.2009.04.011; Chi HB, 2005, P NATL ACAD SCI USA, V102, P3846, DOI 10.1073/pnas.0500026102; Chung JY, 2007, ADV EXP MED BIOL, V597, P93; Chung JY, 2002, J CELL SCI, V115, P679; Clark NM, 2008, CURR BIOL, V18, P1402, DOI 10.1016/j.cub.2008.07.084; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Hisamatsu T, 2003, GASTROENTEROLOGY, V124, P993, DOI 10.1053/gast.2003.50153; Hitotsumatsu O, 2008, IMMUNITY, V28, P381, DOI 10.1016/j.immuni.2008.02.002; Homer CR, 2010, GASTROENTEROLOGY, V139, P1630, DOI 10.1053/j.gastro.2010.07.006; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hutti JE, 2007, MOL CELL BIOL, V27, P7451, DOI 10.1128/MCB.01101-07; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 2000, J BIOL CHEM, V275, P27823; Kanazawa N, 2005, BLOOD, V105, P1195, DOI 10.1182/blood-2004-07-2972; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Li JM, 2005, MOL CELL BIOL, V25, P2320, DOI 10.1128/MCB.25.6.2320-2330.2005; Lipinski S, 2009, J CELL SCI, V122, P3522, DOI 10.1242/jcs.050690; McDonald C, 2005, J BIOL CHEM, V280, P40301, DOI 10.1074/jbc.M508538200; Ogura Y, 2003, GENOMICS, V81, P369, DOI 10.1016/S0888-7543(03)00027-2; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Park YC, 1999, NATURE, V398, P533, DOI 10.1038/19110; Petnicki-Ocwieja T, 2009, P NATL ACAD SCI USA, V106, P15813, DOI 10.1073/pnas.0907722106; Regnier CH, 2002, P NATL ACAD SCI USA, V99, P5585, DOI 10.1073/pnas.052124799; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Takeshita F, 2005, EUR J IMMUNOL, V35, P2477, DOI 10.1002/eji.200526151; Tao MF, 2009, CURR BIOL, V19, P1255, DOI 10.1016/j.cub.2009.06.038; Tigno-Aranjuez JT, 2010, GENE DEV, V24, P2666, DOI 10.1101/gad.1964410; Voss E, 2006, J BIOL CHEM, V281, P2005, DOI 10.1074/jbc.M511044200; Windheim M, 2007, BIOCHEM J, V404, P179, DOI 10.1042/BJ20061704; Xu YX, 2002, J BIOL CHEM, V277, P28051, DOI 10.1074/jbc.M202665200; Yamamoto-Furusho JK, 2010, INFLAMM BOWEL DIS, V16, P736, DOI 10.1002/ibd.21144; Yang YB, 2007, J BIOL CHEM, V282, P36223, DOI 10.1074/jbc.M703079200; Ye H, 1999, MOL CELL, V4, P321, DOI 10.1016/S1097-2765(00)80334-2; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888	41	48	50	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1938	1950		10.1074/jbc.M110.189308	http://dx.doi.org/10.1074/jbc.M110.189308			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21097508	Green Published, hybrid			2022-12-25	WOS:000286191500035
J	Tsuda, E; Yang, HB; Nishimura, T; Uehara, Y; Sakai, T; Furutani, M; Koshiba, T; Hirose, M; Nozaki, H; Murphy, AS; Hayashi, K				Tsuda, Etsuko; Yang, Haibing; Nishimura, Takeshi; Uehara, Yukiko; Sakai, Tatsuya; Furutani, Masahiko; Koshiba, Tomokazu; Hirose, Masakazu; Nozaki, Hiroshi; Murphy, Angus S.; Hayashi, Ken-ichiro			Alkoxy-auxins Are Selective Inhibitors of Auxin Transport Mediated by PIN, ABCB, and AUX1 Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARABIDOPSIS HYPOCOTYLS; MAIZE COLEOPTILES; CHEMICAL GENOMICS; ROOT GRAVITROPISM; GENE-EXPRESSION; TWISTED DWARF1; PROTEIN; PLANT; EFFLUX; INFLUX	Polar auxin movement is a primary regulator of programmed and plastic plant development. Auxin transport is highly regulated at the cellular level and is mediated by coordinated transport activity of plasma membrane-localized PIN, ABCB, and AUX1/LAX transporters. The activity of these transporters has been extensively analyzed using a combination of pharmacological inhibitors, synthetic auxins, and knock-out mutants in Arabidopsis. However, efforts to analyze auxin-dependent growth in other species that are less tractable to genetic manipulation require more selective inhibitors than are currently available. In this report, we characterize the inhibitory activity of 5-alkoxy derivatives of indole 3-acetic acid and 7-alkoxy derivatives of naphthalene 1-acetic acid, finding that the hexyloxy and benzyloxy derivatives act as potent inhibitors of auxin action in plants. These alkoxy-auxin analogs inhibit polar auxin transport and tropic responses associated with asymmetric auxin distribution in Arabidopsis and maize. The alkoxy-auxin analogs inhibit auxin transport mediated by AUX1, PIN, and ABCB proteins expressed in yeast. However, these analogs did not inhibit or activate SCFTIR1 auxin signaling and had no effect on the subcellular trafficking of PIN proteins. Together these results indicate that alkoxy-auxins are inactive auxin analogs for auxin signaling, but are recognized by PIN, ABCB, and AUX1 auxin transport proteins. Alkoxy-auxins are powerful new tools for analyses of auxin-dependent development.	[Hirose, Masakazu; Nozaki, Hiroshi; Hayashi, Ken-ichiro] Okayama Univ Sci, Dept Biochem, Okayama 7000005, Japan; [Yang, Haibing; Murphy, Angus S.] Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA; [Nishimura, Takeshi; Koshiba, Tomokazu] Tokyo Metropolitan Univ, Dept Biol Sci, Hachioji, Tokyo 1920397, Japan; [Uehara, Yukiko] RIKEN Plant Sci Ctr, Tsurumi Ku, Kanagawa 2300045, Japan; [Sakai, Tatsuya] Niigata Univ, Grad Sch Sci & Technol, Nishi Ku, Niigata 9502181, Japan; Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan; [Furutani, Masahiko] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan	Okayama University of Science; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Tokyo Metropolitan University; RIKEN; Niigata University; Japan Science & Technology Agency (JST); Nara Institute of Science & Technology	Hayashi, K (corresponding author), Okayama Univ Sci, Dept Biochem, 1-1 Ridai Cho, Okayama 7000005, Japan.	hayashi@dbc.ous.ac.jp	Hayashi, Ken-ichiro/AAP-3513-2021; Furutani, Masahiko/P-2112-2015; Sakai, Tatsuya/A-8909-2010; Furutani, Masahiko/AAM-7080-2021	Hayashi, Ken-ichiro/0000-0002-9812-2801; Sakai, Tatsuya/0000-0002-1589-6247; Nishimura, Takeshi/0000-0002-1813-2832; Koshiba, Tomokazu/0000-0001-9264-4775; Furutani, Masahiko/0000-0002-6620-5151	Japan Ministry of Education, Culture, Sports, Science and Technology; United States Department of Energy [DE-FG02-06ER15804]; Grants-in-Aid for Scientific Research [22570058] Funding Source: KAKEN	Japan Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); United States Department of Energy(United States Department of Energy (DOE)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The work was supported by a grant from Japan Ministry of Education, Culture, Sports, Science and Technology (to K. H.) and United States Department of Energy Grant DE-FG02-06ER15804 (to A. S. M.).	Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Blakeslee JJ, 2007, PLANT CELL, V19, P131, DOI 10.1105/tpc.106.040782; Bouchard R, 2006, J BIOL CHEM, V281, P30603, DOI 10.1074/jbc.M604604200; Casimiro I, 2001, PLANT CELL, V13, P843, DOI 10.1105/tpc.13.4.843; De Rybel B, 2009, ACS CHEM BIOL, V4, P987, DOI 10.1021/cb9001624; Dhonukshe P, 2008, NATURE, V456, P962, DOI 10.1038/nature07409; Dhonukshe P, 2008, P NATL ACAD SCI USA, V105, P4489, DOI 10.1073/pnas.0711414105; Friml J, 2003, CURR OPIN PLANT BIOL, V6, P7, DOI 10.1016/S1369526602000031; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Geisler M, 2005, PLANT J, V44, P179, DOI 10.1111/j.1365-313X.2005.02519.x; Geisler M, 2003, MOL BIOL CELL, V14, P4238, DOI 10.1091/mbc.E02-10-0698; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Hayashi K, 2003, J BIOL CHEM, V278, P23797, DOI 10.1074/jbc.M300299200; Hayashi K, 2008, P NATL ACAD SCI USA, V105, P5632, DOI 10.1073/pnas.0711146105; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Imhoff V, 2000, PLANTA, V210, P580, DOI 10.1007/s004250050047; KATEKAR GF, 1980, PLANT PHYSIOL, V66, P1190, DOI 10.1104/pp.66.6.1190; KATEKAR GF, 1977, PLANT PHYSIOL, V60, P826, DOI 10.1104/pp.60.6.826; Kim JY, 2010, J BIOL CHEM, V285, P23307, DOI 10.1074/jbc.M110.105981; Marchant A, 1999, EMBO J, V18, P2066, DOI 10.1093/emboj/18.8.2066; Massa GD, 2003, PLANT J, V33, P435, DOI 10.1046/j.1365-313X.2003.01637.x; Mori Y, 2005, PLANT SCI, V168, P467, DOI 10.1016/j.plantsci.2004.09.010; Murphy A, 2000, PLANTA, V211, P315, DOI 10.1007/s004250000300; Murphy AS, 2002, PLANT PHYSIOL, V128, P935, DOI 10.1104/pp.010519; Nagashima A, 2008, PLANT CELL PHYSIOL, V49, P1250, DOI 10.1093/pcp/pcn092; Nagashima A, 2008, PLANT J, V53, P516, DOI 10.1111/j.1365-313X.2007.03358.x; Nishimura T, 2006, PLANTA, V224, P1427, DOI 10.1007/s00425-006-0311-3; Nishimura T, 2009, PLANT CELL PHYSIOL, V50, P1874, DOI 10.1093/pcp/pcp129; Noh B, 2001, PLANT CELL, V13, P2441, DOI 10.1105/tpc.13.11.2441; Ohgishi M, 2004, P NATL ACAD SCI USA, V101, P2223, DOI 10.1073/pnas.0305984101; OKADA K, 1992, AUST J PLANT PHYSIOL, V19, P439, DOI 10.1071/PP9920439; Oono Y, 1998, PLANT CELL, V10, P1649, DOI 10.1105/tpc.10.10.1649; Oono Y, 2003, PLANT PHYSIOL, V133, P1135, DOI 10.1104/pp.103.027847; Parry G, 2001, PLANT J, V25, P399, DOI 10.1046/j.1365-313x.2001.00970.x; Peer WA, 2009, PLANT CELL, V21, P1693, DOI 10.1105/tpc.108.059634; Petrasek J, 2009, DEVELOPMENT, V136, P2675, DOI 10.1242/dev.030353; Reinhardt D, 2000, PLANT CELL, V12, P507, DOI 10.1105/tpc.12.4.507; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Rojas-Pierce M, 2007, CHEM BIOL, V14, P1366, DOI 10.1016/j.chembiol.2007.10.014; Scarpella E, 2006, GENE DEV, V20, P1015, DOI 10.1101/gad.1402406; Soeno K, 2010, PLANT CELL PHYSIOL, V51, P524, DOI 10.1093/pcp/pcq032; Surpin M, 2005, P NATL ACAD SCI USA, V102, P4902, DOI 10.1073/pnas.0500222102; Surpin M, 2003, PLANT CELL, V15, P2885, DOI 10.1105/tpc.016121; Titapiwatanakun B, 2009, PLANT J, V57, P27, DOI 10.1111/j.1365-313X.2008.03668.x; Titapiwatanakun B, 2009, J EXP BOT, V60, P1093, DOI 10.1093/jxb/ern240; ULMASOV T, 1995, PLANT CELL, V7, P1611, DOI 10.1105/tpc.7.10.1611; Wisniewska J, 2006, SCIENCE, V312, P883, DOI 10.1126/science.1121356; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449; Yamazoe A, 2005, PLANT PHYSIOL, V139, P779, DOI 10.1104/pp.105.068924; Yang HB, 2009, PLANT J, V59, P179, DOI 10.1111/j.1365-313X.2009.03856.x; Yang YD, 2006, CURR BIOL, V16, P1123, DOI 10.1016/j.cub.2006.04.029; Zazimalova E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001552	54	46	47	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2354	2364		10.1074/jbc.M110.171165	http://dx.doi.org/10.1074/jbc.M110.171165			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21084292	Green Published, hybrid			2022-12-25	WOS:000286191500074
J	Clausing, E; Mayer, A; Chanarat, S; Muller, B; Germann, SM; Cramer, P; Lisby, M; Strasser, K				Clausing, Emanuel; Mayer, Andreas; Chanarat, Sittinan; Mueller, Barbara; Germann, Susanne M.; Cramer, Patrick; Lisby, Michael; Straesser, Katja			The Transcription Elongation Factor Bur1-Bur2 Interacts with Replication Protein A and Maintains Genome Stability during Replication Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; RNA-POLYMERASE-II; DNA-DAMAGE; IN-VIVO; HISTONE MODIFICATION; BUR1 KINASE; S-PHASE; COMPLEX; YEAST; REPAIR	Multiple DNA-associated processes such as DNA repair, replication, and recombination are crucial for the maintenance of genome integrity. Here, we show a novel interaction between the transcription elongation factor Bur1-Bur2 and replication protein A (RPA), the eukaryotic single-stranded DNA-binding protein with functions in DNA repair, recombination, and replication. Bur1 interacted via its C-terminal domain with RPA, and bur1-Delta C mutants showed a deregulated DNA damage response accompanied by increased sensitivity to DNA damage and replication stress as well as increased levels of persisting Rad52 foci. Interestingly, the DNA damage sensitivity of an rfa1 mutant was suppressed by bur1 mutation, further underscoring a functional link between these two protein complexes. The transcription elongation factor Bur1-Bur2 interacts with RPA and maintains genome integrity during DNA replication stress.	[Germann, Susanne M.; Lisby, Michael] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen N, Denmark; [Clausing, Emanuel; Mayer, Andreas; Chanarat, Sittinan; Mueller, Barbara; Cramer, Patrick; Straesser, Katja] Univ Munich, Dept Biochem, Gene Ctr, D-81377 Munich, Germany; [Clausing, Emanuel; Mayer, Andreas; Chanarat, Sittinan; Mueller, Barbara; Cramer, Patrick; Straesser, Katja] Univ Munich, Dept Biochem, CIPSM, D-81377 Munich, Germany	University of Copenhagen; University of Munich; University of Munich	Lisby, M (corresponding author), Univ Copenhagen, Dept Biol, Ole Maaloees Vej 5, DK-2200 Copenhagen N, Denmark.	mlisby@bio.ku.dk; strasser@lmb.uni-muenchen.de	Mayer, Andreas/AAA-5173-2021; Lisby, Michael/K-9814-2014; Germann, Susanne Manuela/K-9062-2014; Chanarat, Sittinan/M-6810-2018	Lisby, Michael/0000-0002-4830-5247; Germann, Susanne Manuela/0000-0002-4737-8452; Chanarat, Sittinan/0000-0001-6267-0040; Strasser, Katja/0000-0003-3533-5516; Mayer, Andreas/0000-0002-4532-9382	Deutscher Akademischer Austausch Dienst; European Molecular Biology Organization; Fonds der Chemischen Industrie; Danish Agency for Science, Technology and Innovation; Villum Kann Rasmussen Foundation; European Research Council; Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 646, Sonderforschungsbereich Transregio 5]; Nanoinitiative Munich (NIM); Elitenetzwerk Bayern; Jung Stiftung	Deutscher Akademischer Austausch Dienst(Deutscher Akademischer Austausch Dienst (DAAD)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Danish Agency for Science, Technology and Innovation; Villum Kann Rasmussen Foundation(Villum Fonden); European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Nanoinitiative Munich (NIM); Elitenetzwerk Bayern; Jung Stiftung	This work was supported by the Deutscher Akademischer Austausch Dienst (to S. M. G.); Sonderforschungsbereich 646, the European Molecular Biology Organization Young Investigator Programme, and the Fonds der Chemischen Industrie (to K. S.); the Danish Agency for Science, Technology and Innovation, the Villum Kann Rasmussen Foundation, and the European Research Council (to M. L.); and the Deutsche Forschungsgemeinschaft, Sonderforschungsbereich 646, Sonderforschungsbereich Transregio 5, the Nanoinitiative Munich (NIM), the Elitenetzwerk Bayern, the Jung Stiftung, and the Fonds der Chemischen Industrie (to P. C.).	ALANI E, 1992, J MOL BIOL, V227, P54, DOI 10.1016/0022-2836(92)90681-9; Barlow JH, 2008, MOL CELL, V30, P73, DOI 10.1016/j.molcel.2008.01.016; Bartkowiak B, 2010, GENE DEV, V24, P2303, DOI 10.1101/gad.1968210; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chang M, 2002, P NATL ACAD SCI USA, V99, P16934, DOI 10.1073/pnas.262669299; Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901; Chu YY, 2006, MOL CELL BIOL, V26, P3029, DOI 10.1128/MCB.26.8.3029-3038.2006; Dengl S, 2009, J MOL BIOL, V389, P211, DOI 10.1016/j.jmb.2009.04.016; Ding BJ, 2010, J BIOL CHEM, V285, P5317, DOI 10.1074/jbc.M109.082818; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Feng Q, 2007, DNA REPAIR, V6, P27, DOI 10.1016/j.dnarep.2006.08.007; Game JC, 2006, GENETICS, V173, P1951, DOI 10.1534/genetics.106.057794; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Keogh MC, 2003, MOL CELL BIOL, V23, P7005, DOI 10.1128/MCB.23.19.7005-7018.2003; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Laribee RN, 2005, CURR BIOL, V15, P1487, DOI 10.1016/j.cub.2005.07.028; Liao C, 2007, MOL PHARMACOL, V71, P416, DOI 10.1124/mol.106.030494; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Lisby M, 2001, P NATL ACAD SCI USA, V98, P8276, DOI 10.1073/pnas.121006298; Liu Y, 2009, MOL CELL BIOL, V29, P4852, DOI 10.1128/MCB.00609-09; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Mimitou EP, 2009, TRENDS BIOCHEM SCI, V34, P264, DOI 10.1016/j.tibs.2009.01.010; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Qiu HF, 2009, MOL CELL, V33, P752, DOI 10.1016/j.molcel.2009.02.018; REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Tietjen JR, 2010, NAT STRUCT MOL BIOL, V17, P1154, DOI 10.1038/nsmb.1900; Wood A, 2005, MOL CELL, V20, P589, DOI 10.1016/j.molcel.2005.09.010; Wood A, 2006, CELL CYCLE, V5, P1066, DOI 10.4161/cc.5.10.2769; Yao S, 2000, MOL CELL BIOL, V20, P7080, DOI 10.1128/MCB.20.19.7080-7087.2000; Yu DS, 2010, EMBO REP, V11, P876, DOI 10.1038/embor.2010.153; Zhou K, 2009, P NATL ACAD SCI USA, V106, P6956, DOI 10.1073/pnas.0806302106; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	37	15	15	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41665	41674		10.1074/jbc.M110.193292	http://dx.doi.org/10.1074/jbc.M110.193292			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21075850	Green Published, hybrid			2022-12-25	WOS:000285622600054
J	Beauquis, J; Roig, P; De Nicola, AF; Saravia, F				Beauquis, Juan; Roig, Paulina; De Nicola, Alejandro F.; Saravia, Flavia			Short-Term Environmental Enrichment Enhances Adult Neurogenesis, Vascular Network and Dendritic Complexity in the Hippocampus of Type 1 Diabetic Mice	PLOS ONE			English	Article							DENTATE GYRUS; SYNAPTIC PLASTICITY; CELL-PROLIFERATION; MOUSE MODEL; NERVOUS-SYSTEM; CHRONIC STRESS; STREPTOZOTOCIN; RATS; BRAIN; NEURONS	Background: Several brain disturbances have been described in association to type 1 diabetes in humans. In animal models, hippocampal pathological changes were reported together with cognitive deficits. The exposure to a variety of environmental stimuli during a certain period of time is able to prevent brain alterations and to improve learning and memory in conditions like stress, aging and neurodegenerative processes. Methodology/Principal Findings: We explored the modulation of hippocampal alterations in streptozotocin-induced type 1 diabetic mice by environmental enrichment. In diabetic mice housed in standard conditions we found a reduction of adult neurogenesis in the dentate gyrus, decreased dendritic complexity in CA1 neurons and a smaller vascular fractional area in the dentate gyrus, compared with control animals in the same housing condition. A short exposure - 10 days-to an enriched environment was able to enhance proliferation, survival and dendritic arborization of newborn neurons, to recover dendritic tree length and spine density of pyramidal CA1 neurons and to increase the vascular network of the dentate gyrus in diabetic animals. Conclusions/Significance: The environmental complexity seems to constitute a strong stimulator competent to rescue the diabetic brain from neurodegenerative progression.	[Beauquis, Juan; Roig, Paulina; De Nicola, Alejandro F.; Saravia, Flavia] Natl Res Council CONICET, Inst Biol & Expt Med, Buenos Aires, DF, Argentina; [De Nicola, Alejandro F.; Saravia, Flavia] Univ Buenos Aires, Fac Med, Dept Biochem, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; University of Buenos Aires	Beauquis, J (corresponding author), Natl Res Council CONICET, Inst Biol & Expt Med, Buenos Aires, DF, Argentina.	fsaravia@dna.uba.ar	Beauquis, Juan/AAT-5042-2020	Beauquis, Juan/0000-0003-1404-5632; Saravia, Flavia/0000-0002-0781-0140	National Research Council of Argentina (CONICET) [PIP 542]; National Agency for the Promotion of Science and Technology (ANPCYT) [1845]; University of Buenos Aires (UBACYT) [M437, M016]; CONICET	National Research Council of Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); National Agency for the Promotion of Science and Technology (ANPCYT)(ANPCyT); University of Buenos Aires (UBACYT)(University of Buenos Aires); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This study was done with the economical support of the National Research Council of Argentina (PIP 542, CONICET), the National Agency for the Promotion of Science and Technology (PICT 2006, # 1845, ANPCYT) and the University of Buenos Aires (UBACYT M437 and M016, UBA). JB is a recipient of a CONICET doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Alvarez EO, 2009, BEHAV BRAIN RES, V198, P224, DOI 10.1016/j.bbr.2008.11.001; Beauquis J, 2008, EXP NEUROL, V210, P359, DOI 10.1016/j.expneurol.2007.11.009; Beauquis J, 2006, EUR J NEUROSCI, V23, P1539, DOI 10.1111/j.1460-9568.2006.04691.x; Beauquis J, 2010, EXP NEUROL, V222, P125, DOI 10.1016/j.expneurol.2009.12.022; Biessels GJ, 2005, NEUROBIOL AGING, V26, pS36, DOI 10.1016/j.neurobiolaging.2005.08.015; Biessels GJ, 1998, BRAIN RES, V800, P125, DOI 10.1016/S0006-8993(98)00510-1; Biessels GJ, 1996, DIABETES, V45, P1259, DOI 10.2337/diabetes.45.9.1259; Bindu B, 2007, NEUROSCIENCE, V144, P412, DOI 10.1016/j.neuroscience.2006.09.057; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Costa DA, 2007, NEUROBIOL AGING, V28, P831, DOI 10.1016/j.neurobiolaging.2006.04.009; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; De Nicola AF, 2009, EXP GERONTOL, V44, P34, DOI 10.1016/j.exger.2008.03.005; During Matthew J., 2006, Current Alzheimer Research, V3, P29, DOI 10.2174/156720506775697133; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Ekstrand J, 2008, NEUROSCI LETT, V442, P203, DOI 10.1016/j.neulet.2008.06.085; Eriksson PS, 2004, ACTA NEUROL SCAND, V110, P275, DOI 10.1111/j.1600-0404.2004.00328.x; Faherty CJ, 2003, DEV BRAIN RES, V141, P55, DOI 10.1016/S0165-3806(02)00642-9; Fernandez CI, 2004, ANN NY ACAD SCI, V1019, P53, DOI 10.1196/annals.1297.012; Fox C, 2006, BEHAV BRAIN RES, V175, P1, DOI 10.1016/j.bbr.2006.08.016; Gibb R, 1998, J NEUROSCI METH, V79, P1, DOI 10.1016/S0165-0270(97)00163-5; GONZALEZBURGOS I, 1992, BIOTECH HISTOCHEM, V67, P288, DOI 10.3109/10520299209110037; Gould E, 1997, J NEUROSCI, V17, P2492; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; Hattiangady B, 2008, NEUROBIOL AGING, V29, P129, DOI 10.1016/j.neurobiolaging.2006.09.015; Hebb DO., 1947, AM PSYCHOL, V2, P306; Jackson-Guilford J, 2000, NEUROSCI LETT, V293, P91, DOI 10.1016/S0304-3940(00)01502-0; Jankowsky JL, 2005, J NEUROSCI, V25, P5217, DOI 10.1523/JNEUROSCI.5080-04.2005; Kamal A, 1999, NEUROSCIENCE, V90, P737, DOI 10.1016/S0306-4522(98)00485-0; Kempermann G, 1998, J NEUROSCI, V18, P3206; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G, 2002, ANN NEUROL, V52, P135, DOI 10.1002/ana.10262; KOLB B, 2008, NEUROBIOL LEARN MEM; KRECH D, 1962, J COMP PHYSIOL PSYCH, V55, P801, DOI 10.1037/h0044220; Kuczewski N, 2009, MOL NEUROBIOL, V39, P37, DOI 10.1007/s12035-009-8050-7; Kuhad A, 2007, EUR J PHARMACOL, V576, P34, DOI 10.1016/j.ejphar.2007.08.001; Kuhn HG, 1996, J NEUROSCI, V16, P2027; LEHMANN A, 1974, ATLAS STEREOTAXIQUE; Lenzen S, 2008, DIABETOLOGIA, V51, P216, DOI 10.1007/s00125-007-0886-7; Liu LP, 2009, SYNAPSE, V63, P636, DOI 10.1002/syn.20644; Llorens-Martin M, 2006, HIPPOCAMPUS, V16, P480, DOI 10.1002/hipo.20175; LOLOVA I, 1989, Acta Morphologica Hungarica, V37, P3; Magarinos AM, 2000, P NATL ACAD SCI USA, V97, P11056, DOI 10.1073/pnas.97.20.11056; Mankovsky BN, 1996, J DIABETES COMPLICAT, V10, P228, DOI 10.1016/S1056-8727(96)90006-9; Martinez-Tellez R, 2005, BRAIN RES, V1048, P108, DOI 10.1016/j.brainres.2005.04.048; MCCALL AL, 1992, DIABETES, V41, P557, DOI 10.2337/diabetes.41.5.557; MOSER MB, 1994, P NATL ACAD SCI USA, V91, P12673, DOI 10.1073/pnas.91.26.12673; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Nitta A, 2002, NEUROTOXICOL TERATOL, V24, P695, DOI 10.1016/S0892-0362(02)00220-9; Olson AK, 2006, HIPPOCAMPUS, V16, P250, DOI 10.1002/hipo.20157; Oomen CA, 2007, EUR J NEUROSCI, V26, P3395, DOI 10.1111/j.1460-9568.2007.05972.x; Oomen CA, 2010, J NEUROSCI, V30, P6635, DOI 10.1523/JNEUROSCI.0247-10.2010; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Piatti VC, 2006, NEUROSCIENTIST, V12, P463, DOI 10.1177/1073858406293538; Plumpe T, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-77; Reisi P, 2008, BRAIN RES, V1211, P30, DOI 10.1016/j.brainres.2008.03.024; Revsin Y, 2005, BRAIN RES, V1038, P22, DOI 10.1016/j.brainres.2004.12.032; Revsin Y, 2009, NEUROPSYCHOPHARMACOL, V34, P747, DOI 10.1038/npp.2008.136; Saravia F, 2004, J NEUROENDOCRINOL, V16, P704, DOI 10.1111/j.1365-2826.2004.01223.x; Saravia FE, 2002, BRAIN RES, V957, P345, DOI 10.1016/S0006-8993(02)03675-2; Saravia F, 2007, PSYCHONEUROENDOCRINO, V32, P480, DOI 10.1016/j.psyneuen.2007.02.012; SHOLL DA, 1953, J ANAT, V87, P387; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; SIREVAAG AM, 1988, DEV BRAIN RES, V43, P299, DOI 10.1016/0165-3806(88)90107-1; Stranahan AM, 2008, NAT NEUROSCI, V11, P309, DOI 10.1038/nn2055; Takeda S, 2010, P NATL ACAD SCI USA, V107, P7036, DOI 10.1073/pnas.1000645107; Tuzcu M, 2006, EUR J PHARMACOL, V537, P106, DOI 10.1016/j.ejphar.2006.03.024; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 2007, J NEUROSCI, V27, P5869, DOI 10.1523/JNEUROSCI.0914-07.2007; WATANABE Y, 1992, BRAIN RES, V588, P341, DOI 10.1016/0006-8993(92)91597-8; WILL BE, 1976, PHYSIOL BEHAV, V16, P603, DOI 10.1016/0031-9384(76)90221-3; Wright RL, 2008, BEHAV BRAIN RES, V187, P41, DOI 10.1016/j.bbr.2007.08.025; Zacchigna S, 2008, NAT REV NEUROSCI, V9, P169, DOI 10.1038/nrn2336; Zhang WJ, 2008, ACTA NEUROL SCAND, V117, P205, DOI 10.1111/j.1600-0404.2007.00928.x	74	90	93	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e13993	10.1371/journal.pone.0013993	http://dx.doi.org/10.1371/journal.pone.0013993			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085588	Green Published, Green Submitted, gold			2022-12-25	WOS:000284231800023
J	Hamed, S; Egozi, D; Kruchevsky, D; Teot, L; Gilhar, A; Ullmann, Y				Hamed, Saher; Egozi, Dana; Kruchevsky, Danny; Teot, Luc; Gilhar, Amos; Ullmann, Yehuda			Erythropoietin Improves the Survival of Fat Tissue after Its Transplantation in Nude Mice	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; ADIPOSE-TISSUE; PROGENITOR CELLS; STEM-CELLS; IN-VIVO; ANGIOGENESIS; VEGF; EXPRESSION; GRAFTS; NEOVASCULARIZATION	Background: Autologous transplanted fat has a high resorption rate, providing a clinical challenge for the means to reduce it. Erythropoietin (EPO) has non-hematopoietic targets, and we hypothesized that EPO may improve long-term fat graft survival because it has both pro-angiogenic and anti-apoptotic properties. We aimed to determine the effect of EPO on the survival of human fat tissue after its transplantation in nude mice. Methodology/Principal Findings: Human fat tissue was injected subcutaneously into immunologically-compromised nude mice, and the grafts were then treated with either 20 IU or 100 IU EPO. At the end of the 15-week study period, the extent of angiogenesis, apoptosis, and histology were assessed in the fat grafts. The results were compared to vascular endothelial growth factor(VEGF)-treated and phosphate-buffered saline (PBS)-treated fat grafts. The weight and volume of the EPO-treated grafts were higher than those of the PBS-treated grafts, whose weights and volumes were not different from those of the VEGF-treated grafts. EPO treatment also increased the expression of angiogenic factors and microvascular density, and reduced inflammation and apoptosis in a dose-dependent manner in the fat grafts. Conclusions/Significance: Our data suggest that stimulation of angiogenesis by a cluster of angiogenic factors and decreased fat cell apoptosis account for potential mechanisms that underlie the improved long-term survival of fat transplants following EPO treatment.	[Hamed, Saher; Kruchevsky, Danny; Gilhar, Amos] Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel; [Egozi, Dana; Ullmann, Yehuda] Rambam Hlth Care Campus, Dept Plast & Reconstruct Surg, Haifa, Israel; [Teot, Luc] Dept Plast & Reconstruct Surg & Wound Healing, Montpellier, France	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Rambam Health Care Campus; Universite de Montpellier	Hamed, S (corresponding author), Technion Israel Inst Technol, Bruce Rappaport Fac Med, POB 9649, IL-31096 Haifa, Israel.	www.saher@gmail.com		Hamed, Saher/0000-0003-4293-2001	Research & Development division of Remedor Biomed Ltd., Nazareth, Israel [514361310]; Remedor Biomed Ltd.	Research & Development division of Remedor Biomed Ltd., Nazareth, Israel; Remedor Biomed Ltd.	This work was supported by a grant to Dr. Saher Hamed from the Research & Development division of Remedor Biomed Ltd., Nazareth, Israel (#514361310). Remedor Biomed Ltd. financed the study, has rights to the results of the research and has no objections with respect to the publication of the manuscript.	Aicher A, 2005, HYPERTENSION, V45, P321, DOI 10.1161/01.HYP.0000154789.28695.ea; ANAGNOSTOU A, 1990, P NATL ACAD SCI USA, V87, P5978, DOI 10.1073/pnas.87.15.5978; Ayhan M, 2001, AESTHET PLAST SURG, V25, P338, DOI 10.1007/s002660010145; Bluher S, 2005, BEST PRACT RES CL EN, V19, P577, DOI 10.1016/j.beem.2005.07.011; CARLINI RG, 1995, KIDNEY INT, V47, P740, DOI 10.1038/ki.1995.113; Chong Zhao Zhong, 2003, Current Drug Targets - Cardiovascular & Haematological Disorders, V3, P141, DOI 10.2174/1568006033481483; Chong ZZ, 2003, BRIT J PHARMACOL, V138, P1107, DOI 10.1038/sj.bjp.0705161; Darland DC, 1999, J CLIN INVEST, V103, P157, DOI 10.1172/JCI6127; Hamed S, 2006, EUR HEART J, V27, P1876, DOI 10.1093/eurheartj/ehl044; Hamed S, 2010, J INVEST DERMATOL, V130, P287, DOI 10.1038/jid.2009.219; Hausman GJ, 2004, J ANIM SCI, V82, P925; Henry TD, 2003, CIRCULATION, V107, P1359, DOI 10.1161/01.CIR.0000061911.47710.8A; Jelkmann W, 2008, CRIT REV ONCOL HEMAT, V67, P39, DOI 10.1016/j.critrevonc.2008.03.006; Kuramochi D, 2008, EUR J CLIN INVEST, V38, P752, DOI 10.1111/j.1365-2362.2008.02023.x; Kurita M, 2008, PLAST RECONSTR SURG, V121, P1033, DOI 10.1097/01.prs.0000299384.53131.87; Lei M, 2008, CHIN J TRAUMATOL, V11, P49, DOI 10.1016/S1008-1275(08)60011-5; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Li FQ, 2004, NEUROSIGNALS, V13, P265, DOI 10.1159/000081963; Li ZJ, 2005, J CELL BIOCHEM, V95, P559, DOI 10.1002/jcb.20436; Locke MB, 2008, ANN PLAS SURG, V60, P98, DOI 10.1097/SAP.0b013e318038f74c; Lu F, 2009, PLAST RECONSTR SURG, V124, P1437, DOI 10.1097/PRS.0b013e3181babbb6; Nakano M, 2007, CIRC RES, V100, P662, DOI 10.1161/01.RES.0000260179.43672.fe; Nishimura T, 2000, LARYNGOSCOPE, V110, P1333, DOI 10.1097/00005537-200008000-00021; Pallua N, 2009, PLAST RECONSTR SURG, V123, P826, DOI 10.1097/PRS.0b013e318199ef31; Ribatti D, 1999, BLOOD, V93, P2627, DOI 10.1182/blood.V93.8.2627.408k21_2627_2636; Ribatti D, 2003, EUR J CLIN INVEST, V33, P891, DOI 10.1046/j.1365-2362.2003.01245.x; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Rophael JA, 2007, AM J PATHOL, V171, P2048, DOI 10.2353/ajpath.2007.070066; SCHWEIGERER L, 1987, NATURE, V325, P257, DOI 10.1038/325257a0; Shoshani O, 2005, PLAST RECONSTR SURG, V115, P853, DOI 10.1097/01.PRS.0000153036.71928.30; Siren AL, 2009, NEUROTHERAPEUTICS, V6, P108, DOI 10.1016/j.nurt.2008.10.041; Somervaille TCP, 2001, BLOOD, V98, P1374, DOI 10.1182/blood.V98.5.1374; Ullmann Y, 2005, DERMATOL SURG, V31, P1304, DOI 10.1097/00042728-200510000-00007; Wang L, 2008, J CEREBR BLOOD F MET, V28, P1361, DOI 10.1038/jcbfm.2008.32; Wen TC, 2002, J NEUROSCI RES, V67, P795, DOI 10.1002/jnr.10166; Westenbrink BD, 2007, EUR HEART J, V28, P2018, DOI 10.1093/eurheartj/ehm177; Yamaguchi M, 2005, EXP BIOL MED, V230, P742, DOI 10.1177/153537020523001007; Yi CG, 2007, J PLAST RECONSTR AES, V60, P272, DOI 10.1016/j.bjps.2006.01.052; Yoshimura K, 2008, DERMATOL SURG, V34, P1178, DOI 10.1111/j.1524-4725.2008.34256.x	39	56	59	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e13986	10.1371/journal.pone.0013986	http://dx.doi.org/10.1371/journal.pone.0013986			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085572	Green Submitted, Green Published, gold			2022-12-25	WOS:000284231800016
J	Li, TT; Du, PF; Xu, NF				Li, Tingting; Du, Pufeng; Xu, Nanfang			Identifying Human Kinase-Specific Protein Phosphorylation Sites by Integrating Heterogeneous Information from Various Sources	PLOS ONE			English	Article							CELL-CYCLE CONTROL; PREDICTION; SEQUENCE; PHOSPHO.ELM; FEATURES; DATABASE; COMPLEX; GENOME	Phosphorylation is an important type of protein post-translational modification. Identification of possible phosphorylation sites of a protein is important for understanding its functions. Unbiased screening for phosphorylation sites by in vitro or in vivo experiments is time consuming and expensive; in silico prediction can provide functional candidates and help narrow down the experimental efforts. Most of the existing prediction algorithms take only the polypeptide sequence around the phosphorylation sites into consideration. However, protein phosphorylation is a very complex biological process in vivo. The polypeptide sequences around the potential sites are not sufficient to determine the phosphorylation status of those residues. In the current work, we integrated various data sources such as protein functional domains, protein subcellular location and protein-protein interactions, along with the polypeptide sequences to predict protein phosphorylation sites. The heterogeneous information significantly boosted the prediction accuracy for some kinase families. To demonstrate potential application of our method, we scanned a set of human proteins and predicted putative phosphorylation sites for Cyclin-dependent kinases, Casein kinase 2, Glycogen synthase kinase 3, Mitogen-activated protein kinases, protein kinase A, and protein kinase C families (avaiable at http://cmbi.bjmu.edu.cn/huphospho). The predicted phosphorylation sites can serve as candidates for further experimental validation. Our strategy may also be applicable for the in silico identification of other post-translational modification substrates.	[Li, Tingting; Xu, Nanfang] Peking Univ, Hlth Sci Ctr, Dept Biomed Informat, Beijing 100871, Peoples R China; [Xu, Nanfang] Peking Univ, Hosp 1, Beijing 100871, Peoples R China; [Du, Pufeng] Tianjin Univ, Sch Comp Sci & Technol, Tianjin 300072, Peoples R China; [Li, Tingting; Du, Pufeng] Tsinghua Univ, Dept Automat, Tsinghua Natl Lab Informat Sci & Technol, Minist Educ,Key Lab Bioinformat & Bioinformat Div, Beijing 100084, Peoples R China	Peking University; Peking University; Tianjin University; Tsinghua University	Li, TT (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Biomed Informat, Beijing 100871, Peoples R China.	litt@hsc.pku.edu.cn	Du, Pu-Feng/R-9002-2019		NSFC [60905014, 60721003]	NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by NSFC 60905014 and 60721003 (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamine P, 2003, J MOL BIOL, V327, P159, DOI 10.1016/S0022-2836(02)01446-8; Andres V, 2004, CARDIOVASC RES, V63, P11, DOI 10.1016/j.cardiores.2004.02.009; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Chang EJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000656; Dang TH, 2008, BIOINFORMATICS, V24, P2857, DOI 10.1093/bioinformatics/btn546; Diella F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-79; Diella F, 2008, NUCLEIC ACIDS RES, V36, pD240, DOI 10.1093/nar/gkm772; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Kim JH, 2004, BIOINFORMATICS, V20, P3179, DOI 10.1093/bioinformatics/bth382; Kreegipuu A, 1998, FEBS LETT, V430, P45, DOI 10.1016/S0014-5793(98)00503-1; Li TT, 2008, PROTEINS, V70, P404, DOI 10.1002/prot.21563; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Oelgeschlager T, 2002, J CELL PHYSIOL, V190, P160, DOI 10.1002/JCP.10058; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Pinna LA, 1996, BBA-MOL CELL RES, V1314, P191, DOI 10.1016/S0167-4889(96)00083-3; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; Stillman B, 1996, SCIENCE, V274, P1659, DOI 10.1126/science.274.5293.1659; Team RDC, 2010, R LANG ENV STAT COMP; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Vapnik VN, 1999, IEEE T NEURAL NETWOR, V10, P988, DOI 10.1109/72.788640; Wagner M, 2005, J COMPUT BIOL, V12, P355, DOI 10.1089/cmb.2005.12.355; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Yao S, 2002, MOL CELL BIOL, V22, P6750, DOI 10.1128/MCB.22.19.6750-6758.2002; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; LIN C CCAC J LIBSVM	29	38	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e15411	10.1371/journal.pone.0015411	http://dx.doi.org/10.1371/journal.pone.0015411			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085571	Green Published, Green Submitted, gold			2022-12-25	WOS:000284231800031
J	Merico, D; Isserlin, R; Stueker, O; Emili, A; Bader, GD				Merico, Daniele; Isserlin, Ruth; Stueker, Oliver; Emili, Andrew; Bader, Gary D.			Enrichment Map: A Network-Based Method for Gene-Set Enrichment Visualization and Interpretation	PLOS ONE			English	Article							COLORECTAL-CANCER; EXPRESSION DATA; ONTOLOGY; BIOINFORMATICS; TOOLS; OVERREPRESENTATION; ANNOTATION; DISCOVERY; PATHWAYS; ESTROGEN	Background: Gene-set enrichment analysis is a useful technique to help functionally characterize large gene lists, such as the results of gene expression experiments. This technique finds functionally coherent gene-sets, such as pathways, that are statistically over-represented in a given gene list. Ideally, the number of resulting sets is smaller than the number of genes in the list, thus simplifying interpretation. However, the increasing number and redundancy of gene-sets used by many current enrichment analysis software works against this ideal. Principal Findings: To overcome gene-set redundancy and help in the interpretation of large gene lists, we developed "Enrichment Map", a network-based visualization method for gene-set enrichment results. Gene-sets are organized in a network, where each set is a node and edges represent gene overlap between sets. Automated network layout groups related gene-sets into network clusters, enabling the user to quickly identify the major enriched functional themes and more easily interpret the enrichment results. Conclusions: Enrichment Map is a significant advance in the interpretation of enrichment analysis. Any research project that generates a list of genes can take advantage of this visualization framework. Enrichment Map is implemented as a freely available and user friendly plug-in for the Cytoscape network visualization software (http://baderlab.org/Software/EnrichmentMap/).	[Merico, Daniele; Isserlin, Ruth; Stueker, Oliver; Emili, Andrew; Bader, Gary D.] Univ Toronto, Banting & Best Dept Med Res, Dept Mol Genet, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada	University of Toronto	Merico, D (corresponding author), Univ Toronto, Banting & Best Dept Med Res, Dept Mol Genet, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada.	daniele.merico@gmail.com; gary.bader@utoronto.ca	Bader, Gary/C-1176-2009	Bader, Gary/0000-0003-0185-8861; Merico, Daniele/0000-0002-3728-4401; Stueker, Oliver/0000-0003-2547-0140	US National Institutes of Health (NIH) via National Human Genome Research Institute (NHGRI) [P41 P41HG04118]; Canada Foundation for Innovation; Genome Canada via the Ontario Genomics Institute; Ontario Research Fund (ORF); Heart and Stroke Foundation of Canada; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P41HG004118] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) via National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Genome Canada via the Ontario Genomics Institute(Genome Canada); Ontario Research Fund (ORF); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Gary D. Bader acknowledges funding from the US National Institutes of Health (NIH) via National Human Genome Research Institute (NHGRI) grant P41 P41HG04118, the Canada Foundation for Innovation and Ontario Research Fund (ORF) and Genome Canada via the Ontario Genomics Institute. Andrew Emili acknowledges funding from the Ontario Research Fund and the Heart and Stroke Foundation of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Begleiter A, 2006, CANCER EPIDEM BIOMAR, V15, P2422, DOI 10.1158/1055-9965.EPI-06-0661; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Calarco JA, 2007, ADV EXP MED BIOL, V623, P64, DOI 10.1007/978-0-387-77374-2_5; Cary MP, 2005, FEBS LETT, V579, P1815, DOI 10.1016/j.febslet.2005.02.005; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; De Angelis PM, 2004, INT J ONCOL, V24, P1279; DEMIR E, 2010, NATURE BIOT IN PRESS; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Doisneau-Sixou SF, 2003, ENDOCR-RELAT CANCER, V10, P179, DOI 10.1677/erc.0.0100179; Draghici S, 2003, GENOMICS, V81, P98, DOI 10.1016/S0888-7543(02)00021-6; Draghici S, 2003, NUCLEIC ACIDS RES, V31, P3775, DOI 10.1093/nar/gkg624; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Efroni S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000425; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Glez-Pena D, 2009, NUCLEIC ACIDS RES, V37, pW329, DOI 10.1093/nar/gkp263; Gonzalez FJ, 2005, MUTAT RES-FUND MOL M, V569, P101, DOI 10.1016/j.mrfmmm.2004.04.021; Grossmann S, 2007, BIOINFORMATICS, V23, P3024, DOI 10.1093/bioinformatics/btm440; Hong Y, 2007, CLIN CANCER RES, V13, P1107, DOI 10.1158/1078-0432.CCR-06-1633; Horton Janet K, 2005, Clin Colorectal Cancer, V4, P302, DOI 10.3816/CCC.2005.n.002; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; ISSERLIN R, 2010, PROTEOMICS IN PRESS; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Kaiser S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r131; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Khatri P, 2002, GENOMICS, V79, P266, DOI 10.1006/geno.2002.6698; Kim JY, 2006, NEUROLOGY, V66, pA79; Lewin A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-426; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Nam D, 2008, BRIEF BIOINFORM, V9, P189, DOI 10.1093/bib/bbn001; Nesvizhskii AI, 2007, NAT METHODS, V4, P787, DOI 10.1038/NMETH1088; Pan KH, 2005, P NATL ACAD SCI USA, V102, P8961, DOI 10.1073/pnas.0502674102; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Pradines Joel, 2004, J Biopharm Stat, V14, P701, DOI 10.1081/BIP-200025678; Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576; Raman D, 2007, CANCER LETT, V256, P137, DOI 10.1016/j.canlet.2007.05.013; Rhodes DR, 2007, NEOPLASIA, V9, P443, DOI 10.1593/neo.07292; Rivals I, 2007, BIOINFORMATICS, V23, P401, DOI 10.1093/bioinformatics/btl633; Robinson MD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-35; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang H, 2007, INT J COLORECTAL DIS, V22, P1185, DOI 10.1007/s00384-007-0308-9	54	1261	1283	0	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e13984	10.1371/journal.pone.0013984	http://dx.doi.org/10.1371/journal.pone.0013984			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085593	gold, Green Published, Green Submitted			2022-12-25	WOS:000284231800014
J	Harrigan, RJ; Thomassen, HA; Buermann, W; Cummings, RF; Kahn, ME; Smith, TB				Harrigan, Ryan J.; Thomassen, Henri A.; Buermann, Wolfgang; Cummings, Robert F.; Kahn, Matthew E.; Smith, Thomas B.			Economic Conditions Predict Prevalence of West Nile Virus	PLOS ONE			English	Article							LOUIS ENCEPHALITIS-VIRUS; INFECTIOUS-DISEASE; UNITED-STATES; TRANSMISSION; ASSOCIATIONS; CULICIDAE; MOSQUITOS; VECTORS; DIPTERA; HOST	Understanding the conditions underlying the proliferation of infectious diseases is crucial for mitigating future outbreaks. Since its arrival in North America in 1999, West Nile virus (WNV) has led to population-wide declines of bird species, morbidity and mortality of humans, and expenditures of millions of dollars on treatment and control. To understand the environmental conditions that best explain and predict WNV prevalence, we employed recently developed spatial modeling techniques in a recognized WNV hotspot, Orange County, California. Our models explained 85-95% of the variation of WNV prevalence in mosquito vectors, and WNV presence in secondary human hosts. Prevalence in both vectors and humans was best explained by economic variables, specifically per capita income, and by anthropogenic characteristics of the environment, particularly human population and neglected swimming pool density. While previous studies have shown associations between anthropogenic change and pathogen presence, results show that poorer economic conditions may act as a direct surrogate for environmental characteristics related to WNV prevalence. Low-income areas may be associated with higher prevalence for a number of reasons, including variations in property upkeep, microhabitat conditions conducive to viral amplification in both vectors and hosts, host community composition, and human behavioral responses related to differences in education or political participation. Results emphasize the importance and utility of including economic variables in mapping spatial risk assessments of disease.	[Harrigan, Ryan J.; Thomassen, Henri A.; Smith, Thomas B.] Univ Calif Los Angeles, Inst Environm, Ctr Trop Res, Los Angeles, CA 90024 USA; [Cummings, Robert F.] Orange Cty Vector Control Dist, Garden Grove, CA USA; [Smith, Thomas B.] Univ Calif Los Angeles, Dept Ecol & Evolut Biol, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Harrigan, RJ (corresponding author), Univ Calif Los Angeles, Inst Environm, Ctr Trop Res, Los Angeles, CA 90024 USA.	iluvsa@ucla.edu			US Environmental Protection Agency [R 833778]; United States Environmental Protection Agency [R 833778]; Orange County Vector Control District	US Environmental Protection Agency(United States Environmental Protection Agency); United States Environmental Protection Agency(United States Environmental Protection Agency); Orange County Vector Control District	This work was supported by the Orange County Vector Control District and a US Environmental Protection Agency grant (R 833778). Although the research described in this article has been funded wholly or partially by the United States Environmental Protection Agency through grant/cooperative agreement R 833778, it has not been subjected to the Agency's required peer and policy review and therefore does not necessarily reflect the views of the Agency and no official endorsement should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], POOLEDINFRATE VERSIO; Bataille A, 2009, P ROY SOC B-BIOL SCI, V276, P3769, DOI 10.1098/rspb.2009.0998; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Breiman L., 2017, CLASSIFICATION REGRE; Brown HE, 2008, EMERG INFECT DIS, V14, P1539, DOI 10.3201/eid1410.071396; Calhoun LM, 2007, AM J TROP MED HYG, V77, P478, DOI 10.4269/ajtmh.2007.77.478; Causey D, 2003, SCIENCE, V299, P821; Cummings R.C., 1992, P MOSQ VECTOR CONTRO, V60, P170; CUMMINGS RF, 2009, P CALIF MOSQ VECTOR, V77, P116; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Enserink M, 2000, SCIENCE, V290, P1482, DOI 10.1126/science.290.5496.1482; Enserink M, 2002, SCIENCE, V297, P1988, DOI 10.1126/science.297.5589.1988; Epstein P.R., 2001, GLOBAL CHANGE HUMAN, V2, P105, DOI DOI 10.1023/A:1015089901425; Ezenwa VO, 2007, VECTOR-BORNE ZOONOT, V7, P173, DOI 10.1089/vbz.2006.0584; Ezenwa VO, 2006, P ROY SOC B-BIOL SCI, V273, P109, DOI 10.1098/rspb.2005.3284; Gujral IB, 2007, EMERG INFECT DIS, V13, P419, DOI 10.3201/eid1303.060941; Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Kilpatrick AM, 2006, P ROY SOC B-BIOL SCI, V273, P2327, DOI 10.1098/rspb.2006.3575; Kilpatrick AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000092; Kilpatrick AM, 2005, EMERG INFECT DIS, V11, P425, DOI 10.3201/eid1103.040364; Kramer LD, 2001, CURR OPIN INFECT DIS, V14, P519, DOI 10.1097/00001432-200110000-00004; LaDeau SL, 2007, NATURE, V447, P710, DOI 10.1038/nature05829; Landesman WJ, 2007, VECTOR-BORNE ZOONOT, V7, P337, DOI 10.1089/vbz.2006.0590; Lindsey NP, 2008, VECTOR-BORNE ZOONOT, V8, P35, DOI 10.1089/vbz.2007.0137; Marra PP, 2004, BIOSCIENCE, V54, P393, DOI 10.1641/0006-3568(2004)054[0393:WNVAW]2.0.CO;2; MCBRATNEY AB, 1986, J SOIL SCI, V37, P617, DOI 10.1111/j.1365-2389.1986.tb00392.x; Milligan K, 2004, J PUBLIC ECON, V88, P1667, DOI 10.1016/j.jpubeco.2003.10.005; Miramontes R, 2006, AM J PREV MED, V30, P160, DOI 10.1016/j.amepre.2005.10.008; MOLAEI G, 2010, AM J TROP M IN PRESS; Newhouse V. F., 1966, Mosquito News, V26, P30; Oliver M. A., 1990, International Journal of Geographical Information Systems, V4, P313, DOI 10.1080/02693799008941549; PANITZER CB, 2009, EMERG INFECT DIS, V15, P1668; Patnaik JL, 2007, EMERG INFECT DIS, V13, P1788, DOI 10.3201/eid1311.070506; Pecoraro HL, 2007, J VECTOR ECOL, V32, P22, DOI 10.3376/1081-1710(2007)32[22:CALCFP]2.0.CO;2; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Prasad AM, 2006, ECOSYSTEMS, V9, P181, DOI 10.1007/s10021-005-0054-1; R Core Team, 2021, R LANG ENV STAT COMP; Reisen WK, 2008, EMERG INFECT DIS, V14, P1747, DOI 10.3201/eid1411.080719; Reisen WK, 2008, J MED ENTOMOL, V45, P494, DOI 10.1603/0022-2585(2008)45[494:PWNVTA]2.0.CO;2; Reisen WK, 2005, J MED ENTOMOL, V42, P367, DOI 10.1603/0022-2585(2005)042[0367:AHAMDC]2.0.CO;2; REISEN WK, 1991, J MED ENTOMOL, V28, P357, DOI 10.1093/jmedent/28.3.357; Ripley B. D., 1996, PATTERN RECOGNITION; Ruiz MO, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-10; Shaman J, 2005, J MED ENTOMOL, V42, P134, DOI 10.1603/0022-2585(2005)042[0134:DAAETO]2.0.CO;2; Smith KF, 2007, ECOLOGY, V88, P1903, DOI 10.1890/06-1052.1; Su TY, 2003, J VECTOR ECOL, V28, P79; Swaddle JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002488; Van Riper C, 2002, AUK, V119, P929, DOI 10.1642/0004-8038(2002)119[0929:EAEOAP]2.0.CO;2; Wimberly MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003744; Zohrabian A, 2006, EMERG INFECT DIS, V12, P375, DOI 10.3201/eid1203.050782	55	41	41	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e15437	10.1371/journal.pone.0015437	http://dx.doi.org/10.1371/journal.pone.0015437			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103053	Green Published, Green Submitted, gold			2022-12-25	WOS:000284147700026
J	Joshi, R; Tawfik, A; Edeh, N; McCloud, V; Looney, S; Lewis, J; Hsu, S; Ogbureke, KUE				Joshi, Rajeshree; Tawfik, Amany; Edeh, Nneka; McCloud, Veronica; Looney, Stephen; Lewis, Jill; Hsu, Stephen; Ogbureke, Kalu U. E.			Dentin Sialophosphoprotein (DSPP) Gene-Silencing Inhibits Key Tumorigenic Activities in Human Oral Cancer Cell Line, OSC2	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES MMPS; LINKED GLYCOPROTEINS SIBLINGS; GROWTH-FACTOR VEGF; CARCINOMA-CELLS; EXPRESSION; PROTEINS; INTEGRIN; FAMILY; PHOSPHOPROTEIN; PROGRESSION	Background: We determined recently that dentin sialophosphoprotein (DSPP), a member of the SIBLING (Small integrin-binding ligand N-linked glycoproteins) family of phosphoglycoproteins, is highly upregulated in human oral squamous cell carcinomas (OSCCs) where upregulation is associated with tumor aggressiveness. To investigate the effects of DSPP-silencing on the tumorigenic profiles of the oral cancer cell line, OSC2, short-hairpin RNA (shRNA) interference was employed to silence DSPP in OSC2 cells. Methodology/Principal Findings: Multiple regions of DSPP transcript were targeted for shRNA interference using hDSP-shRNA lentiviral particles designed to silence DSPP gene expression. Control shRNA plasmid encoding a scrambled sequence incapable of degrading any known cellular mRNA was used for negative control. Following puromycin selection of stable lines of DSSP-silenced OSC2 cells, phenotypic hallmarks of oral carcinogenesis were assayed by western blot and RT-PCR analyses, MTT (cell-viability), colony-formation, modified Boyden-Chamber (migration and invasion), and flow cytometry (cell-cycle and apoptosis) analyses. DSPP-silenced OSC2 cells showed altered cell morphology, reduced viability, decreased colony-formation ability, decreased migration and invasion, G0/G1 cell-cycle arrest, and increased tumor cell sensitivity to cisplatin-induced apoptosis. Furthermore, MMP-2, MMP-3, MMP-9, VEGF, Ki-67, p53, and EGFR were down-regulated. There was a direct correlation between the degree of DSPP-silencing and MMP suppression, as indicated by least squares regression: MMP-2 {(y = 0.850x, p<0.001) (y = 1.156x, p<0.001)}, MMP-3 {(y = 0.994x, p<0.001) (y = 1.324x, p = 0.004)}, and MMP-9 {(y = 1.248x, p = 0.005, y = 0.809, p = 0.013)}. Conclusions/Significance: DSPP-silencing in OSC2 cell decreased salient hallmarks of oral tumorigenesis and provides the first functional evidence of a potential key role for DSPP in oral cancer biology. The down-regulation of MMP-2, MMP-3, MMP-9, p53 and VEGF in DSPP-silenced OSC2 cells provides a significant functional/molecular framework for deciphering the mechanisms of DSPP activities in oral cancer biology.	[Joshi, Rajeshree; Tawfik, Amany; Edeh, Nneka; McCloud, Veronica; Lewis, Jill; Hsu, Stephen; Ogbureke, Kalu U. E.] Med Coll Georgia, Sch Dent, Dept Oral Biol, Augusta, GA 30912 USA; [Ogbureke, Kalu U. E.] Med Coll Georgia, Sch Med, Dept Pathol, Augusta, GA 30912 USA; [Looney, Stephen; Ogbureke, Kalu U. E.] Med Coll Georgia, Sch Dent, Dept Oral Hlth & Diagnost Sci, Augusta, GA 30912 USA; [Looney, Stephen] Med Coll Georgia, Dept Biostat, Sch Grad Studies, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Joshi, R (corresponding author), Med Coll Georgia, Sch Dent, Dept Oral Biol, Augusta, GA 30912 USA.	kogbureke@mail.mcg.edu	Ogbureke, Kalu/AAI-9904-2020; Tawfik, Amany/AAN-9902-2020	Tawfik, Amany/0000-0002-0245-8256; Ogbureke, Kalu/0000-0001-9227-0718	National Institute of Dental and Craniofacial Research (NIDCR)/National Institutes of Health (NIH) [K23DE017791-01A1]; Medical College of Georgia Research Institute (MCGRI), Inc. [STP00105W005]; Wendy Will Case Cancer Foundation; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [K23DE017791] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research (NIDCR)/National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Medical College of Georgia Research Institute (MCGRI), Inc.; Wendy Will Case Cancer Foundation; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by the National Institute of Dental and Craniofacial Research (NIDCR)/National Institutes of Health (NIH) Grant # K23DE017791-01A1 (KUEO); Medical College of Georgia Research Institute (MCGRI), Inc. Grant # STP00105W005 (KUEO); and by Wendy Will Case Cancer Foundation (KUEO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora S, 2005, CLIN CANCER RES, V11, P2272, DOI 10.1158/1078-0432.CCR-04-0572; Bellahcene A, 2008, NAT REV CANCER, V8, P212, DOI 10.1038/nrc2345; CHANG SE, 1992, INT J CANCER, V52, P896, DOI 10.1002/ijc.2910520612; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Dang DM, 2004, BIOCHEM BIOPH RES CO, V316, P937, DOI 10.1016/j.bbrc.2004.02.143; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fedarko NS, 2004, FASEB J, V18, P734, DOI 10.1096/fj.03-0966fje; Fisher LW, 2004, CLIN CANCER RES, V10, P8501, DOI 10.1158/1078-0432.CCR-04-1072; Fisher LW, 2003, CONNECT TISSUE RES, V44, P33, DOI 10.1080/03008200390152061; GEORGE A, 1993, J BIOL CHEM, V268, P12624; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hiraishi Y, 2008, PATHOL ONCOL RES, V14, P39, DOI 10.1007/s12253-008-9020-5; Hsu S, 2005, ANTICANCER RES, V25, P63; Hunter GK, 1996, BIOCHEM J, V317, P59, DOI 10.1042/bj3170059; Jain A, 2009, CLIN CANCER RES, V15, P5199, DOI 10.1158/1078-0432.CCR-09-0783; Johnstone S, 2006, ORAL ONCOL, V42, P337, DOI 10.1016/j.oraloncology.2005.06.020; Karadag A, 2004, JNCI-J NATL CANCER I, V96, P956, DOI 10.1093/jnci/djh169; Kim SH, 2006, J SURG ONCOL, V93, P330, DOI 10.1002/jso.20461; Ogbureke KUE, 2007, ORAL ONCOL, V43, P920, DOI 10.1016/j.oraloncology.2006.11.011; Ogbureke KUE, 2007, J HISTOCHEM CYTOCHEM, V55, P403, DOI 10.1369/jhc.6A7075.2007; Ogbureke KUE, 2010, CANCER-AM CANCER SOC, V116, P1709, DOI 10.1002/cncr.24938; Ogbureke KUE, 2005, KIDNEY INT, V68, P155, DOI 10.1111/j.1523-1755.2005.00389.x; Ogbureke KUE, 2004, J DENT RES, V83, P664, DOI 10.1177/154405910408300902; OSAKI T, 1994, ORAL ONCOL, V30B, P296, DOI 10.1016/0964-1955(94)90028-0; Qin C, 2004, CRIT REV ORAL BIOL M, V15, P126, DOI 10.1177/154411130401500302; Tandon S, 2010, CANCER EPIDEM BIOMAR, V19, P574, DOI 10.1158/1055-9965.EPI-09-0981; VEIS A, 1967, BIOCHEMISTRY-US, V6, P2409, DOI 10.1021/bi00860a017; von Marschall Z, 2010, MATRIX BIOL, V29, P295, DOI 10.1016/j.matbio.2010.01.002; Yoneda K, 1999, EUR J CANCER, V35, P278, DOI 10.1016/S0959-8049(98)00291-3; Zhou XJ, 2009, INT J CANCER, V124, P483, DOI 10.1002/ijc.23964	30	18	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e13974	10.1371/journal.pone.0013974	http://dx.doi.org/10.1371/journal.pone.0013974			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103065	Green Published, Green Submitted, gold			2022-12-25	WOS:000284147700019
J	Kalappa, BI; Gusev, AG; Uteshev, VV				Kalappa, Bopanna I.; Gusev, Alexander G.; Uteshev, Victor V.			Activation of Functional alpha 7-Containing nAChRs in Hippocampal CA1 Pyramidal Neurons by Physiological Levels of Choline in the Presence of PNU-120596	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; TRANSIENT FOREBRAIN ISCHEMIA; TRAUMATIC BRAIN-INJURY; SYNAPTIC PLASTICITY; COGNITIVE IMPROVEMENT; ALPHA-7 RECEPTORS; RAT HIPPOCAMPUS; SPATIAL MEMORY; ACH RECEPTORS; INTERNEURONS	Background: The level of expression of functional alpha 7-containing nicotinic acetylcholine receptors (nAChRs) in hippocampal CA1 pyramidal neurons is believed to be very low compared to hippocampal CA1 interneurons, and for many years this expression was largely overlooked. However, high densities of expression of functional alpha 7-containing nAChRs in CA1 pyramidal neurons may not be necessary for triggering important cellular and network functions, especially if activation of alpha 7-containing nAChRs occurs in the presence of positive allosteric modulators such as PNU-120596. Methodology/Principal Findings: An approach previously developed for alpha 7-containing nAChRs expressed in tuberomammillary neurons was applied to investigate functional CA1 pyramidal alpha 7-containing nAChRs using rat coronal hippocampal slices and patch-clamp electrophysiology. The majority (similar to 71%) of tested CA1 pyramidal neurons expressed low densities of functional alpha 7-containing nAChRs as evidenced by small whole-cell responses to choline, a selective endogenous agonist of alpha 7 nAChRs. These responses were potentiated by PNU-120596, a novel positive allosteric modulator of alpha 7 nAChRs. The density of functional alpha 7-containing nAChRs expressed in CA1 pyramidal neurons (and thus, the normalized net effect of activation, i.e., response net charge per unit of membrane capacitance per unit of time) was estimated to be similar to 5% of the density observed in CA1 interneurons. The results of this study demonstrate that despite low levels of expression of functional pyramidal alpha 7-containing nAChRs, physiological levels of choline (similar to 10 mM) are sufficient to activate these receptors and transiently depolarize and even excite CA1 pyramidal neurons in the presence of PNU-120596. The observed effects are possible because in the presence of 10 mM choline and 1-5 mM PNU-120596, a single opening of an individual pyramidal alpha 7-containing nAChR ion channel appears to transiently depolarize (similar to 4 mV) the entire pyramidal neuron and occasionally trigger action potentials. Conclusions: 1) The majority of hippocampal CA1 pyramidal neurons express functional alpha 7-containing nAChRs. In the absence of PNU-120596, a positive allosteric modulator of alpha 7 nAChRs, a lack of responsiveness of some hippocampal CA1 pyramidal neurons to focal application of 0.5-1 mM choline does not imply a lack of expression of functional alpha 7-containing nAChRs in these neurons. Rather, it may indicate a lack of detection of alpha 7-containing nAChR-mediated currents by patch-clamp electrophysiology. 2) PNU-120596 can serve as a powerful tool for detection and enhancement of responsiveness of low densities of functional alpha 7-containing nAChRs such as those present in hippocampal CA1 pyramidal neurons. 3) In the presence of PNU-120596, physiological concentrations of choline activate functional CA1 pyramidal alpha 7-containing nAChRs and produce step-like currents that cause repetitive step-like depolarizations, occasionally triggering bursts of action potentials in CA1 pyramidal neurons. Therefore, the results of this study suggest that in the presence of PNU-120596 and possibly other positive allosteric modulators, endogenous choline may persistently activate CA1 pyramidal alpha 7-containing nAChRs, enhance the excitability of CA1 pyramidal neurons and thus act as a potent therapeutic agent with potential neuroprotective and cognition-enhancing properties.	[Kalappa, Bopanna I.; Gusev, Alexander G.; Uteshev, Victor V.] So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA	Southern Illinois University System; Southern Illinois University	Kalappa, BI (corresponding author), So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA.	vuteshev@siumed.edu			NIH [DA021216, DK082625]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA021216] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the NIH grants DA021216 (http://www.nida.nih.gov/) and DK082625 (http://www2.niddk.nih.gov/) to VU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CE, 2002, DEV BRAIN RES, V139, P175, DOI 10.1016/S0165-3806(02)00547-3; AKAIKE A, 1994, BRAIN RES, V644, P181, DOI 10.1016/0006-8993(94)91678-0; Akaike A, 2010, J MOL NEUROSCI, V40, P211, DOI 10.1007/s12031-009-9236-1; Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Albuquerque EX, 1997, J PHARMACOL EXP THER, V280, P1117; ALKONDON M, 1994, J PHARMACOL EXP THER, V271, P494; Alkondon M, 1997, EUR J NEUROSCI, V9, P2734, DOI 10.1111/j.1460-9568.1997.tb01702.x; ARENDASH GW, 1995, PHARMACOL BIOCHEM BE, V52, P517, DOI 10.1016/0091-3057(95)00119-H; BARRON SC, 2009, MOL PHARM; Bertrand N, 1996, NEUROCHEM INT, V28, P293, DOI 10.1016/0197-0186(95)00086-0; Bobinski M, 1998, BRAIN RES, V805, P267, DOI 10.1016/S0006-8993(98)00759-8; Buccafusco J, 2004, MOL INTERV, V4, P285, DOI 10.1124/mi.4.5.8; Buccafusco JJ, 2007, BIOCHEM PHARMACOL, V74, P1202, DOI 10.1016/j.bcp.2007.07.010; Buccafusco JJ, 2005, TRENDS PHARMACOL SCI, V26, P352, DOI 10.1016/j.tips.2005.05.007; Buccafusco JJ, 2004, J ALZHEIMERS DIS, V6, pS85; CASTRO NG, 1995, BIOPHYS J, V68, P516, DOI 10.1016/S0006-3495(95)80213-4; Chen C, 1997, ANNU REV NEUROSCI, V20, P157, DOI 10.1146/annurev.neuro.20.1.157; Disterhoft JF, 2007, AGING CELL, V6, P327, DOI 10.1111/j.1474-9726.2007.00297.x; Disterhoft JF, 2006, TRENDS NEUROSCI, V29, P587, DOI 10.1016/j.tins.2006.08.005; Egea J, 2007, NEUROSCIENCE, V145, P866, DOI 10.1016/j.neuroscience.2006.12.036; Faghih Ramin, 2007, Recent Pat CNS Drug Discov, V2, P99; Frazier CJ, 1998, J NEUROSCI, V18, P8228; Frazier CJ, 1998, J NEUROSCI, V18, P1187; Grimm D, 1998, HUM GENE THER, V9, P2745, DOI 10.1089/hum.1998.9.18-2745; Gronlien JH, 2007, MOL PHARMACOL, V72, P715, DOI 10.1124/mol.107.035410; Grybko M, 2010, J MOL NEUROSCI, V40, P114, DOI 10.1007/s12031-009-9266-8; GUSEV AG, 2009, J PHARM EXP THER; Guseva MV, 2008, J NEUROTRAUM, V25, P975, DOI 10.1089/neu.2008.0516; Hurst RS, 2005, J NEUROSCI, V25, P4396, DOI 10.1523/JNEUROSCI.5269-04.2005; Ji D, 2001, NEURON, V31, P131, DOI 10.1016/S0896-6273(01)00332-4; Ji DY, 2000, J NEUROPHYSIOL, V83, P2682, DOI 10.1152/jn.2000.83.5.2682; Jiang Z, 2010, J NEUROSCI, V30, P2582, DOI 10.1523/JNEUROSCI.3971-09.2010; Jones S, 1997, J PHYSIOL-LONDON, V504, P603, DOI 10.1111/j.1469-7793.1997.603bd.x; JOPE RS, 1991, NEUROCHEM RES, V16, P1219, DOI 10.1007/BF00966699; Kaczorowski CC, 2009, LEARN MEMORY, V16, P362, DOI 10.1101/lm.1365609; Kandel ER, 2009, J NEUROSCI, V29, P12748, DOI 10.1523/JNEUROSCI.3958-09.2009; Kem WR, 2000, BEHAV BRAIN RES, V113, P169, DOI 10.1016/S0166-4328(00)00211-4; Kihara T, 1997, ANN NEUROL, V42, P159, DOI 10.1002/ana.410420205; Kim HJ, 2002, FASEB J, V16, P118, DOI 10.1096/fj.01-0987fje; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; Kitagawa H, 2003, NEUROPSYCHOPHARMACOL, V28, P542, DOI 10.1038/sj.npp.1300028; Leiser SC, 2009, PHARMACOL THERAPEUT, V122, P302, DOI 10.1016/j.pharmthera.2009.03.009; Li YX, 1999, BRAIN RES, V830, P218, DOI 10.1016/S0006-8993(99)01372-4; LOPEZHERNANDEZ GY, 2009, NEUROPHARMACOLOGY; McQuiston AR, 1999, J NEUROSCI, V19, P2887; Meyer EM, 1997, BRAIN RES, V768, P49, DOI 10.1016/S0006-8993(97)00536-2; Meyer EM, 1998, J PHARMACOL EXP THER, V287, P918; Mielke JG, 2009, NEUROSCI RES, V65, P296, DOI 10.1016/j.neures.2009.08.003; Mike A, 2000, BRAIN RES, V882, P155, DOI 10.1016/S0006-8993(00)02863-8; Olincy A, 2007, BIOCHEM PHARMACOL, V74, P1192, DOI 10.1016/j.bcp.2007.07.015; Papke RL, 2002, BRIT J PHARMACOL, V137, P49, DOI 10.1038/sj.bjp.0704833; Parikh V, 2006, J NEUROCHEM, V97, P488, DOI 10.1111/j.1471-4159.2006.03766.x; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Rao AM, 2000, J NEUROCHEM, V75, P2528, DOI 10.1046/j.1471-4159.2000.0752528.x; Ren K, 2007, NEUROSCIENCE, V145, P314, DOI 10.1016/j.neuroscience.2006.11.023; Roncarati R, 2008, ASSAY DRUG DEV TECHN, V6, P181, DOI 10.1089/adt.2007.120; Ross RG, 2010, J CHILD PSYCHOL PSYC, V51, P535, DOI 10.1111/j.1469-7610.2009.02187.x; Sarter M, 2005, NAT REV NEUROSCI, V6, P48, DOI 10.1038/nrn1588; SCREMIN OU, 1991, STROKE, V22, P643, DOI 10.1161/01.STR.22.5.643; Shimohama S, 1998, BRAIN RES, V779, P359, DOI 10.1016/S0006-8993(97)00194-7; Shimohama S, 2001, BIOL PSYCHIAT, V49, P233, DOI 10.1016/S0006-3223(00)01100-8; Shimohama S, 2009, BIOL PHARM BULL, V32, P332, DOI 10.1248/bpb.32.332; Son JH, 2008, J COMP NEUROL, V511, P286, DOI 10.1002/cne.21828; Thomsen MS, 2010, CURR PHARM DESIGN, V16, P323, DOI 10.2174/138161210790170094; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Uteshev VV, 2010, ACTA BIOCH BIOPH SIN, V42, P8, DOI 10.1093/abbs/gmp101; Uteshev VV, 2003, J NEUROPHYSIOL, V89, P1797, DOI 10.1152/jn.00943.2002; Uteshev VV, 2002, BRAIN RES, V948, P33, DOI 10.1016/S0006-8993(02)02946-3; Verbois SL, 2003, NEUROPHARMACOLOGY, V44, P224, DOI 10.1016/S0028-3908(02)00366-0; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105; Zapata A, 1998, J NEUROSCI, V18, P3597	71	33	33	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e13964	10.1371/journal.pone.0013964	http://dx.doi.org/10.1371/journal.pone.0013964			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103043	Green Submitted, Green Published, gold			2022-12-25	WOS:000284147700014
J	Bettencourt, LMA; Lobo, J; Strumsky, D; West, GB				Bettencourt, Luis M. A.; Lobo, Jose; Strumsky, Deborah; West, Geoffrey B.			Urban Scaling and Its Deviations: Revealing the Structure of Wealth, Innovation and Crime across Cities	PLOS ONE			English	Article							INCREASING RETURNS; CITY; PRODUCTIVITY; GROWTH; LIFE	With urban population increasing dramatically worldwide, cities are playing an increasingly critical role in human societies and the sustainability of the planet. An obstacle to effective policy is the lack of meaningful urban metrics based on a quantitative understanding of cities. Typically, linear per capita indicators are used to characterize and rank cities. However, these implicitly ignore the fundamental role of nonlinear agglomeration integral to the life history of cities. As such, per capita indicators conflate general nonlinear effects, common to all cities, with local dynamics, specific to each city, failing to provide direct measures of the impact of local events and policy. Agglomeration nonlinearities are explicitly manifested by the superlinear power law scaling of most urban socioeconomic indicators with population size, all with similar exponents (similar to 1.15). As a result larger cities are disproportionally the centers of innovation, wealth and crime, all to approximately the same degree. We use these general urban laws to develop new urban metrics that disentangle dynamics at different scales and provide true measures of local urban performance. New rankings of cities and a novel and simpler perspective on urban systems emerge. We find that local urban dynamics display long-term memory, so cities under or outperforming their size expectation maintain such (dis)advantage for decades. Spatiotemporal correlation analyses reveal a novel functional taxonomy of U. S. metropolitan areas that is generally not organized geographically but based instead on common local economic models, innovation strategies and patterns of crime.	[Bettencourt, Luis M. A.; West, Geoffrey B.] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM USA; [Bettencourt, Luis M. A.; West, Geoffrey B.] Los Alamos Natl Lab, CNLS, Los Alamos, NM USA; [Bettencourt, Luis M. A.; West, Geoffrey B.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Lobo, Jose] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ USA; [Lobo, Jose] Arizona State Univ, WP Carey Sch Business, Tempe, AZ USA; [Strumsky, Deborah] Univ N Carolina, Dept Geog & Earth Sci, Charlotte, NC 28223 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; The Santa Fe Institute; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; University of North Carolina; University of North Carolina Charlotte	Bettencourt, LMA (corresponding author), Los Alamos Natl Lab, Div Theoret, Los Alamos, NM USA.	lmbett@lanl.gov	Bettencourt, Luis/R-9861-2019; Strumsky, Deborah/F-5795-2013; Lobo, Jose/AAG-2746-2021	Lobo, Jose/0000-0002-0814-7168	James S. McDonnell Foundation 21st Century Science Initiative; Rockefeller Foundation; National Science Foundation [CBET-0939958, PHY 0202180]; Los Alamos National Laboratory	James S. McDonnell Foundation 21st Century Science Initiative; Rockefeller Foundation; National Science Foundation(National Science Foundation (NSF)); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory)	This work was partially supported by a James S. McDonnell Foundation 21st Century Science Initiative in Studying Complex Systems Research Award (http://www.jsmf.org/programs/cs/), the Rockefeller Foundation (http://www.rockefellerfoundation.org/), the National Science Foundation grants CBET-0939958 and PHY 0202180, and the Los Alamos National Laboratory Laboratory Directed Research and Development (LDRD) program (http://www.lanl.gov/science/ldrd/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; [Anonymous], 1998, EC CITIES SUBURBS; [Anonymous], [No title captured], DOI DOI 10.5198/JFIU.V1I1.29; [Anonymous], 1999, NETWORKS GLOBAL VILL; Arbesman S, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.016115; Ash C, 2008, SCIENCE, V319, P739, DOI 10.1126/science.319.5864.739; Bairoch P., 1991, CITIES EC DEV DAWN H, DOI [10.5744/bi.2019.1010, DOI 10.5744/BI.2019.1010]; Batty M., 2007, CITIES COMPLEXITY UN; BATTY M, 2009, ENVIRON PLANN A, V8, P189; Batty M, 2008, SCIENCE, V319, P769, DOI 10.1126/science.1151419; Batty M, 2006, NATURE, V444, P592, DOI 10.1038/nature05302; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bettencourt LMA, 2007, RES POLICY, V36, P107, DOI 10.1016/j.respol.2006.09.026; Breschi S., 2001, IND CORP CHANGE, V10, P975, DOI DOI 10.1093/ICC/10.4.975; Carneiro RL, 2000, P NATL ACAD SCI USA, V97, P12926, DOI 10.1073/pnas.240462397; CHOWELL G, 1999, PHYS REV E, V68; CHRISTALLER W, 1933, ZENTRALEN ORTE DDEUT; Duranton G., 2004, HDB CITYAL URBAN EC, V4, P2063, DOI [DOI 10.1016/S1574-0080(04)80005-1, 10.1016/S1574-0080(04)80005-1]; DURANTON G, 2009, AM ECON REV, V97, P197; Enquist BJ, 2009, P NATL ACAD SCI USA, V106, P7046, DOI 10.1073/pnas.0812303106; *FBI, FBIS UN CRIM REP; Feldman MP, 1999, EUR ECON REV, V43, P409, DOI 10.1016/S0014-2921(98)00047-6; FISCHER CS, 1992, DWELL FRIENDS PERSON; Florida R., 2004, CITIES CREATIVE CLAS, P1, DOI [10.4324/9780203997673, DOI 10.4324/9780203997673]; Fujita M., 2001, SPATIAL EC CITIES RE; Glaeser EL, 2009, J ECON LIT, V47, P983, DOI 10.1257/jel.47.4.983; Glaeser EL, 1999, J POLIT ECON, V107, pS225, DOI 10.1086/250109; GLAESER EL, 2007, 13710 NBER; Gottdiener Mark, 2010, NEW URBAN SOCIOLOGY; Hall P., 1998, CITIES CIVILIZATION; Henderson JV, 2007, REG SCI URBAN ECON, V37, P497, DOI 10.1016/j.regsciurbeco.2006.11.010; Henderson JV, 1988, URBAN DEV THEORY FAC; Hou C, 2010, P NATL ACAD SCI USA, V107, P3634, DOI 10.1073/pnas.0908071107; Jacobs J., 1961, DEATH LIFE GREAT AM; KRUGMAN P, 1991, J POLIT ECON, V99, P483, DOI 10.1086/261763; Losch A., 1954, EC LOCATION; May RM, 2000, SCIENCE, V290, P2084, DOI 10.1126/science.290.5499.2084; MOOMAW RL, 1981, Q J ECON, V96, P675, DOI 10.2307/1880747; Mumford L., 1961, CITY HIST ITS ORIGIN, DOI DOI 10.1016/j.jaa.2011.06.005; *NAT RES COUNC NAT, 2008, UND CRIM TRENDS WORK; Newman M., 2005, STRUCTURE DYNAMICS N; SEGAL D, 1976, REV ECON STAT, V58, P339, DOI 10.2307/1924956; Soo KT, 2005, REG SCI URBAN ECON, V35, P239, DOI 10.1016/j.regsciurbeco.2004.04.004; SVEIKAUSKAS L, 1975, Q J ECON, V89, P393, DOI 10.2307/1885259; UN-HABITAT, 2009, STAT WORLDS CIT 2008; *US BUR EC AN, GMP INC WAG; Waters JS, 2010, AM NAT, V176, P501, DOI 10.1086/656266; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; Wirth L, 1938, AM J SOCIOL, V44, P1, DOI 10.1086/217913	50	286	293	21	130	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e13541	10.1371/journal.pone.0013541	http://dx.doi.org/10.1371/journal.pone.0013541			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	677ZN	21085659	gold, Green Submitted, Green Published			2022-12-25	WOS:000284036800004
J	Edwards, LA; Nistala, K; Mills, DC; Stephenson, HN; Zilbauer, M; Wren, BW; Dorrell, N; Lindley, KJ; Wedderburn, LR; Bajaj-Elliott, M				Edwards, Lindsey A.; Nistala, Kiran; Mills, Dominic C.; Stephenson, Holly N.; Zilbauer, Matthias; Wren, Brendan W.; Dorrell, Nick; Lindley, Keith J.; Wedderburn, Lucy R.; Bajaj-Elliott, Mona			Delineation of the Innate and Adaptive T-Cell Immune Outcome in the Human Host in Response to Campylobacter jejuni Infection	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; NATURAL-KILLER-CELLS; DENDRITIC CELLS; CYTOKINE PRODUCTION; INTESTINAL-MUCOSA; ESCHERICHIA-COLI; INTERLEUKIN 22; IN-VITRO; PATHOGENESIS; BETA-DEFENSIN-2	Background: Campylobacter jejuni is the most prevalent cause of bacterial gastroenteritis worldwide. Despite the significant health burden this infection presents, molecular understanding of C. jejuni-mediated disease pathogenesis remains poorly defined. Here, we report the characterisation of the early, innate immune response to C. jejuni using an ex-vivo human gut model of infection. Secondly, impact of bacterial-driven dendritic cell activation on T-cell mediated immunity was also sought. Methodology: Healthy, control paediatric terminal ileum or colonic biopsy tissue was infected with C. jejuni for 8-12 hours. Bacterial colonisation was followed by confocal microscopy and mucosal innate immune responses measured by ELISA. Marked induction of IFN gamma with modest increase in IL-22 and IL-17A was noted. Increased mucosal IL-12, IL-23, IL-1 beta and IL-6 were indicative of a cytokine milieu that may modulate subsequent T-cell mediated immunity. C. jejuni-driven human monocyte-derived dendritic cell activation was followed by analyses of T cell immune responses utilising flow cytometry and ELISA. Significant increase in Th-17, Th-1 and Th-17/Th-1 double-positive cells and corresponding cytokines was observed. The ability of IFN gamma, IL-22 and IL-17 cytokines to exert host defence via modulation of C. jejuni adhesion and invasion to intestinal epithelia was measured by standard gentamicin protection assay. Conclusions: Both innate and adaptive T cell-immunity to C. jejuni infection led to the release of IFN gamma, IL-22 and IL-17A; suggesting a critical role for this cytokine triad in establishing host anti-microbial immunity during the acute and effectors phase of infection. In addition, to their known anti-microbial functions; IL-17A and IL-17F reduced the number of intracellular C. jejuni in intestinal epithelia, highlighting a novel aspect of how IL-17 family members may contribute to protective immunity against C. jejuni.	[Edwards, Lindsey A.; Lindley, Keith J.] Inst Child Hlth, Autoimmun Unit, London, England; [Mills, Dominic C.; Wren, Brendan W.; Dorrell, Nick] London Sch Hyg & Trop Med, Pathogen Mol Biol Dept, London WC1, England; [Zilbauer, Matthias] Addenbrookes Hosp, Cambridge, England; [Lindley, Keith J.] Inst Child Hlth, Surg Unit, London, England	University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; University College London	Edwards, LA (corresponding author), Inst Child Hlth, Autoimmun Unit, London, England.	m.bajaj-elliott@ich.ucl.ac.uk	Edwards, Lindsey Ann/AAC-1156-2020; Zilbauer, Matthias/AAZ-2740-2020; Edwards, Lindsey/L-8536-2015	Edwards, Lindsey Ann/0000-0002-8222-4555; Zilbauer, Matthias/0000-0002-7272-0547; Edwards, Lindsey/0000-0002-8222-4555; Dorrell, Nick/0000-0003-1144-6502; Wedderburn, Lucy/0000-0002-7495-1429; Bajaj-Elliott, Mona/0000-0002-5234-576X	Institute of Child Health/Great Ormond Street Hospital Special Trustees [05ID04]; Bloomsbury Colleges; Biomedical Research Centre; MRC	Institute of Child Health/Great Ormond Street Hospital Special Trustees; Bloomsbury Colleges; Biomedical Research Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the Institute of Child Health/Great Ormond Street Hospital Special Trustees 05ID04 (to MB-E and KJL). KN is an Arthritis Research Campaign Clinical Fellow (ref 17998). The following were supported by PhD studentships: DCM (Bloomsbury Colleges), HNS (Biomedical Research Centre) and MZ (MRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awasthi A, 2009, INT IMMUNOL, V21, P489, DOI 10.1093/intimm/dxp021; Beaurepaire C, 2009, J INTERF CYTOK RES, V29, P133, DOI 10.1089/jir.2008.0057; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Ciccia F, 2009, ARTHRITIS RHEUM-US, V60, P955, DOI 10.1002/art.24389; Colonna M, 2009, IMMUNITY, V31, P15, DOI 10.1016/j.immuni.2009.06.008; Dixon GLJ, 2001, INFECT IMMUN, V69, P4351, DOI 10.1128/IAI.69.7.4351-4357.2001; Dorrell N, 2007, CURR OPIN INFECT DIS, V20, P514, DOI 10.1097/QCO.0b013e3282a56b15; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Fox JG, 2004, INFECT IMMUN, V72, P1116, DOI 10.1128/IAI.72.2.1116-1125.2004; Godinez I, 2009, INFECT IMMUN, V77, P387, DOI 10.1128/IAI.00933-08; Goriely S, 2008, NAT REV IMMUNOL, V8, P81, DOI 10.1038/nri2225; Gradel KO, 2009, GASTROENTEROLOGY, V137, P495, DOI 10.1053/j.gastro.2009.04.001; Gurney AL, 2004, INT IMMUNOPHARMACOL, V4, P669, DOI 10.1016/j.intimp.2004.01.016; HADDOCK G, 2010, MICROBIOLOGY    0708; Hicks S, 1996, INFECT IMMUN, V64, P4751, DOI 10.1128/IAI.64.11.4751-4760.1996; Hu L, 2006, INFECT IMMUN, V74, P2697, DOI 10.1128/IAI.74.5.2697-2705.2006; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Kamada N, 2008, J CLIN INVEST, V118, P2269, DOI [10.1172/JCI34610, 10.1172/JC134610]; Kao CY, 2004, J IMMUNOL, V173, P3482, DOI 10.4049/jimmunol.173.5.3482; Karlyshev AV, 2001, INFECT IMMUN, V69, P5921, DOI 10.1128/IAI.69.9.5921-5924.2001; Kubota K, 2010, SCAND J IMMUNOL, V71, P199, DOI 10.1111/j.1365-3083.2009.02366.x; Kuijf ML, 2010, J IMMUNOL, V185, P748, DOI 10.4049/jimmunol.0903014; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Liang SC, 2007, J IMMUNOL, V179, P7791, DOI 10.4049/jimmunol.179.11.7791; Lippert E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007413; Luangtongkum T, 2009, FUTURE MICROBIOL, V4, P189, DOI 10.2217/17460913.4.2.189; Ma HL, 2008, J CLIN INVEST, V118, P597, DOI 10.1172/JCI33263; MacCallum AJ, 2006, MICROBIOL-SGM, V152, P3661, DOI 10.1099/mic.0.29234-0; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Moe KK, 2010, J VET MED SCI, V72, P411, DOI 10.1292/jvms.09-0339; Monteiro MA, 2009, INFECT IMMUN, V77, P1128, DOI 10.1128/IAI.01056-08; Nistala K, 2008, ARTHRITIS RHEUM-US, V58, P875, DOI 10.1002/art.23291; Nistala K, 2010, P NATL ACAD SCI USA, V107, P14751, DOI 10.1073/pnas.1003852107; Oberhelman RA, 2003, J INFECT DIS, V187, P260, DOI 10.1086/367676; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Poly F, 2008, CURR OPIN GASTROEN, V24, P27, DOI 10.1097/MOG.0b013e3282f1dcb1; Rathinam VAK, 2009, INFECT IMMUN, V77, P2499, DOI 10.1128/IAI.01562-08; Rescigno M, 2009, J CLIN INVEST, V119, P2441, DOI 10.1172/JCI39134; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Schuller S, 2009, CELL MICROBIOL, V11, P521, DOI 10.1111/j.1462-5822.2008.01275.x; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Tecle T, 2007, J IMMUNOL, V178, P8046, DOI 10.4049/jimmunol.178.12.8046; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Vucic S, 2009, J CLIN NEUROSCI, V16, P733, DOI 10.1016/j.jocn.2008.08.033; Watson RO, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040014; Wolk K, 2010, SEMIN IMMUNOPATHOL, V32, P17, DOI 10.1007/s00281-009-0188-x; Young KT, 2007, NAT REV MICROBIOL, V5, P665, DOI 10.1038/nrmicro1718; Zilbauer M, 2005, INFECT IMMUN, V73, P7281, DOI 10.1128/IAI.73.11.7281-7289.2005; Zilbauer M, 2007, CELL MICROBIOL, V9, P2404, DOI 10.1111/j.1462-5822.2007.00969.x	49	46	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e15398	10.1371/journal.pone.0015398	http://dx.doi.org/10.1371/journal.pone.0015398			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085698	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000284035900027
J	Mejias, JF; Kappen, HJ; Torres, JJ				Mejias, Jorge F.; Kappen, Hilbert J.; Torres, Joaquin J.			Irregular Dynamics in Up and Down Cortical States	PLOS ONE			English	Article							TERM SYNAPTIC DEPRESSION; PERSISTENT ACTIVITY; BISTABLE SYSTEM; NEURAL-NETWORKS; NEURONS; SLOW; FACILITATION; MEMORY; MODEL; FLUCTUATIONS	Complex coherent dynamics is present in a wide variety of neural systems. A typical example is the voltage transitions between up and down states observed in cortical areas in the brain. In this work, we study this phenomenon via a biologically motivated stochastic model of up and down transitions. The model is constituted by a simple bistable rate dynamics, where the synaptic current is modulated by short-term synaptic processes which introduce stochasticity and temporal correlations. A complete analysis of our model, both with mean-field approaches and numerical simulations, shows the appearance of complex transitions between high (up) and low (down) neural activity states, driven by the synaptic noise, with permanence times in the up state distributed according to a power-law. We show that the experimentally observed large fluctuation in up and down permanence times can be explained as the result of sufficiently noisy dynamical synapses with sufficiently large recovery times. Static synapses cannot account for this behavior, nor can dynamical synapses in the absence of noise.	[Mejias, Jorge F.] Univ Ottawa, Ctr Neural Dynam, Ottawa, ON, Canada; [Mejias, Jorge F.; Torres, Joaquin J.] Univ Granada, Dept Electromagnetism & Matter Phys, Granada, Spain; [Kappen, Hilbert J.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands	University of Ottawa; University of Granada; Radboud University Nijmegen	Mejias, JF (corresponding author), Univ Ottawa, Ctr Neural Dynam, Ottawa, ON, Canada.	jmejias@uottawa.ca	Kappen, H.J./L-4425-2015; Torres, Joaquín J./AAE-6228-2019; Torres, Joaquín J./C-1385-2012	Torres, Joaquín J./0000-0001-6175-9676; Mejias, Jorge/0000-0002-8096-4891	MEyC-FEDER [FIS2009-08451]; Junta de Andalucia [P07-FQM-02725]	MEyC-FEDER; Junta de Andalucia(Junta de Andalucia)	This work was supported by the MEyC-FEDER project FIS2009-08451 and the Junta de Andalucia project P07-FQM-02725. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Alili A, 2005, STOCH MODELS, V21, P967, DOI 10.1080/15326340500294702; Anderson J, 2000, NAT NEUROSCI, V3, P617, DOI 10.1038/75797; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Beggs JM, 2003, J NEUROSCI, V23, P11167; Brunel N, 2000, J COMPUT NEUROSCI, V8, P183, DOI 10.1023/A:1008925309027; Chandrasekhar S, 1943, REV MOD PHYS, V15, P0001, DOI 10.1103/RevModPhys.15.1; Compte A, 2006, NEUROSCIENCE, V139, P135, DOI 10.1016/j.neuroscience.2005.06.011; Cortes JM, 2006, NEURAL COMPUT, V18, P614, DOI 10.1162/089976606775623342; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; de la Rocha J, 2005, J NEUROSCI, V25, P8416, DOI 10.1523/JNEUROSCI.0631-05.2005; Deco G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000587; DEFRANCISCIS S, 2010, UNPUB; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; FABER DS, 1992, SCIENCE, V258, P1494, DOI 10.1126/science.1279813; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; Gerstner W, 2000, NEURAL COMPUT, V12, P43, DOI 10.1162/089976600300015899; Gerstner W., 2002, SPIKING NEURON MODEL; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; GOMEZ V, 2009, ADV NEURAL INF PROCE, V22, P513; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Holcman D, 2006, PLOS COMPUT BIOL, V2, P174, DOI 10.1371/journal.pcbi.0020023; Johnson S, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/46006; Kandel E., 2000, PRINCIPLES NEURAL SC; Kang S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000022; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; Lazar A, 2007, NEURAL NETWORKS, V20, P312, DOI 10.1016/j.neunet.2007.04.020; Lazar A, 2009, FRONT COMPUT NEUROSC, V3, DOI 10.3389/neuro.10.023.2009; Li DX, 2008, COMMUN THEOR PHYS, V50, P669, DOI 10.1088/0253-6102/50/3/29; Lo CC, 2004, P NATL ACAD SCI USA, V101, P17545, DOI 10.1073/pnas.0408242101; Loewenstein Y, 2005, NAT NEUROSCI, V8, P202, DOI 10.1038/nn1393; MADUREIRA AJR, 1995, PHYS REV E, V51, P3849, DOI 10.1103/PhysRevE.51.3849; MAYOR G, 2004, CURR OPIN NEUROBIOL, V14, P675; McCormick DA, 2005, CURR BIOL, V15, pR294, DOI 10.1016/j.cub.2005.04.009; MEJIAS JF, 2010, ARXIV09060756; Mejias JF, 2008, J COMPUT NEUROSCI, V24, P222, DOI 10.1007/s10827-007-0052-8; Mejias JF, 2009, NEURAL COMPUT, V21, P851, DOI 10.1162/neco.2008.02-08-719; Melamed O, 2008, J COMPUT NEUROSCI, V25, P308, DOI 10.1007/s10827-008-0080-z; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Pantic L, 2002, NEURAL COMPUT, V14, P2903, DOI 10.1162/089976602760805331; Pearlmutter BA, 2009, NEURAL COMPUT, V21, P1622, DOI 10.1162/neco.2009.05-08-787; PECHUKAS P, 1994, PHYS REV LETT, V73, P2772, DOI 10.1103/PhysRevLett.73.2772; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Ping Z, 2006, CHINESE J PHYS, V44, P117; Puccini GD, 2006, J PHYSIOL-PARIS, V100, P1, DOI 10.1016/j.jphysparis.2006.09.005; Rotstein HG, 2005, J NEUROPHYSIOL, V94, P1509, DOI 10.1152/jn.00957.2004; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; SCANNELL JW, 1995, J NEUROSCI, V15, P1463; Seamari Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000888; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; STERIADE M, 1993, J NEUROSCI, V13, P3266; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Timofeev I, 2000, J PHYSIOLOGY-PARIS, V94, P343, DOI 10.1016/S0928-4257(00)01097-4; Torres JJ, 2007, NEURAL COMPUT, V19, P2739, DOI 10.1162/neco.2007.19.10.2739; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Tu YH, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.208101; Van Kampen N. G., 1990, STOCHASTIC PROCESSES; Vierling-Claassen D, 2008, J NEUROPHYSIOL, V99, P2656, DOI 10.1152/jn.00870.2007; Wang XJ, 1999, J NEUROSCI, V19, P9587; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5; Zador A, 1998, J NEUROPHYSIOL, V79, P1219, DOI 10.1152/jn.1998.79.3.1219; Zador AM, 1997, NEURON, V19, P1, DOI 10.1016/S0896-6273(00)80341-4	67	39	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e13651	10.1371/journal.pone.0013651	http://dx.doi.org/10.1371/journal.pone.0013651			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	676NU	21079740	Green Published, Green Submitted, gold			2022-12-25	WOS:000283920000001
J	Kelley, LC; Hayes, KE; Ammer, AG; Martin, KH; Weed, SA				Kelley, Laura C.; Hayes, Karen E.; Ammer, Amanda Gatesman; Martin, Karen H.; Weed, Scott A.			Cortactin Phosphorylated by ERK1/2 Localizes to Sites of Dynamic Actin Regulation and Is Required for Carcinoma Lamellipodia Persistence	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; TYROSINE PHOSPHORYLATION; ARP2/3 COMPLEX; N-WASP; CONTACT SITES; MATRIX-METALLOPROTEINASE; FACIOGENITAL DYSPLASIA; 11Q13 AMPLIFICATION; BINDING PROTEIN; FAMILY KINASES	Background: Tumor cell motility and invasion is governed by dynamic regulation of the cortical actin cytoskeleton. The actin-binding protein cortactin is commonly upregulated in multiple cancer types and is associated with increased cell migration. Cortactin regulates actin nucleation through the actin related protein (Arp) 2/3 complex and stabilizes the cortical actin cytoskeleton. Cortactin is regulated by multiple phosphorylation events, including phosphorylation of S405 and S418 by extracellular regulated kinases (ERK) 1/2. ERK1/2 phosphorylation of cortactin has emerged as an important positive regulatory modification, enabling cortactin to bind and activate the Arp2/3 regulator neuronal Wiskott-Aldrich syndrome protein (N-WASp), promoting actin polymerization and enhancing tumor cell movement. Methodology/Principal Findings: In this report we have developed phosphorylation-specific antibodies against phosphorylated cortactin S405 and S418 to analyze the subcellular localization of this cortactin form in tumor cells and patient samples by microscopy. We evaluated the interplay between cortactin S405 and S418 phosphorylation with cortactin tyrosine phosphorylation in regulating cortactin conformational forms by Western blotting. Cortactin is simultaneously phosphorylated at S405/418 and Y421 in tumor cells, and through the use of point mutant constructs we determined that serine and tyrosine phosphorylation events lack any co-dependency. Expression of S405/418 phosphorylation-null constructs impaired carcinoma motility and adhesion, and also inhibited lamellipodia persistence monitored by live cell imaging. Conclusions/Significance: Cortactin phosphorylated at S405/418 is localized to sites of dynamic actin assembly in tumor cells. Concurrent phosphorylation of cortactin by ERK1/2 and tyrosine kinases enables cells with the ability to regulate actin dynamics through N-WASp and other effector proteins by synchronizing upstream regulatory pathways, confirming cortactin as an important integration point in actin-based signal transduction. Reduced lamellipodia persistence in cells with S405/418A expression identifies an essential motility-based process reliant on ERK1/2 signaling, providing additional understanding as to how this pathway impacts tumor cell migration.	[Kelley, Laura C.; Hayes, Karen E.; Ammer, Amanda Gatesman; Martin, Karen H.; Weed, Scott A.] W Virginia Univ, Dept Neurobiol & Anat, Program Canc Cell Biol, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA	West Virginia University	Kelley, LC (corresponding author), W Virginia Univ, Dept Neurobiol & Anat, Program Canc Cell Biol, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA.	sweed@hsc.wvu.edu		Martin, Karen/0000-0001-8916-4092; Weed, Scott/0000-0001-7033-9999	National Institutes of Health [R01 DE014578, P20 RR16440]; West Virginia University Office of Research and Graduate Education; Protea Biosciences; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014578] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); West Virginia University Office of Research and Graduate Education; Protea Biosciences; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	These studies were supported by National Institutes of Health grants R01 DE014578 and P20 RR16440 to SAW. LCK was supported in part by the West Virginia University Office of Research and Graduate Education. Protea Biosciences provided exclusive funding for the production and validation of the pS405 and pS418 antibodies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMMER AG, 2009, J CANC SCI THERAPY, V1; Ammer AG, 2008, CELL MOTIL CYTOSKEL, V65, P687, DOI 10.1002/cm.20296; Ammer Amanda Gatesman, 2009, J Cancer Sci Ther, V1, P52; Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177; Ayala I., 2008, J CELL SCI; Bailly M, 1998, MICROSC RES TECHNIQ, V43, P433, DOI 10.1002/(SICI)1097-0029(19981201)43:5<433::AID-JEMT9>3.0.CO;2-2; Boguslavsky S, 2007, P NATL ACAD SCI USA, V104, P10882, DOI 10.1073/pnas.0702731104; Boyle SN, 2007, CURR BIOL, V17, P445, DOI 10.1016/j.cub.2007.01.057; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Campbell DH, 1999, CANCER RES, V59, P5376; Clark ES, 2007, CANCER RES, V67, P4227, DOI 10.1158/0008-5472.CAN-06-3928; Cosen-Binker LI, 2006, PHYSIOLOGY, V21, P352, DOI 10.1152/physiol.00012.2006; Cowieson NP, 2008, J BIOL CHEM, V283, P16187, DOI 10.1074/jbc.M708917200; Crostella L, 2001, ONCOGENE, V20, P3735, DOI 10.1038/sj.onc.1204474; Daly RJ, 2004, BIOCHEM J, V382, P13, DOI 10.1042/BJ20040737; Dry JR, 2010, CANCER RES, V70, P2264, DOI 10.1158/0008-5472.CAN-09-1577; Du YR, 1998, MOL CELL BIOL, V18, P5838, DOI 10.1128/MCB.18.10.5838; Eblen ST, 2002, MOL CELL BIOL, V22, P6023, DOI 10.1128/MCB.22.17.6023-6033.2002; El-Sibai M, 2007, J CELL SCI, V120, P3465, DOI 10.1242/jcs.005942; Gallet C, 1999, J BIOL CHEM, V274, P23610, DOI 10.1074/jbc.274.33.23610; Garcia-Castillo J, 2009, J BIOL CHEM, V284, P25302, DOI 10.1074/jbc.M109.001982; Grassart A, 2010, TRAFFIC; Head JA, 2003, MOL BIOL CELL, V14, P3216, DOI 10.1091/mbc.e02-11-0753; Helwani FM, 2004, J CELL BIOL, V164, P899, DOI 10.1083/jcb.200309034; Hou P, 2003, HUM MOL GENET, V12, P1981, DOI 10.1093/hmg/ddg209; Huang C, 1998, J BIOL CHEM, V273, P25770, DOI 10.1074/jbc.273.40.25770; Huang C, 1997, J BIOL CHEM, V272, P13911, DOI 10.1074/jbc.272.21.13911; Huang JH, 2003, J BIOL CHEM, V278, P48367, DOI 10.1074/jbc.M308213200; Insall RH, 2009, DEV CELL, V17, P310, DOI 10.1016/j.devcel.2009.08.012; Kapus A, 2000, J BIOL CHEM, V275, P32289, DOI 10.1074/jbc.M003172200; Kempiak SJ, 2005, J BIOL CHEM, V280, P5836, DOI 10.1074/jbc.M410713200; Kim K, 2004, BIOCHEMISTRY-US, V43, P2422, DOI 10.1021/bi036173t; Kinley AW, 2003, CURR BIOL, V13, P384, DOI 10.1016/S0960-9822(03)00107-6; Kowalski JR, 2005, J CELL SCI, V118, P79, DOI 10.1242/jcs.01586; KRAUSE CJ, 1981, ARCH OTOLARYNGOL, V107, P703; Kruchten AE, 2008, AM J PHYSIOL-CELL PH, V295, pC1113, DOI 10.1152/ajpcell.00238.2008; LAI FP, 2009, MOL BIOL CELL; Lapetina S, 2009, J CELL BIOL, V185, P503, DOI 10.1083/jcb.200809085; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Lua BL, 2005, FEBS LETT, V579, P577, DOI 10.1016/j.febslet.2004.12.055; Machesky LM, 2008, FEBS LETT, V582, P2102, DOI 10.1016/j.febslet.2008.03.039; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Martin KH, 2006, J CELL SCI, V119, P2851, DOI 10.1242/jcs03034; Martinez-Quiles N, 2004, MOL CELL BIOL, V24, P5269, DOI 10.1128/MCB.24.12.5269-5280.2004; McDermott U, 2007, P NATL ACAD SCI USA, V104, P19936, DOI 10.1073/pnas.0707498104; Ohoka Y, 1998, GENES CELLS, V3, P603, DOI 10.1046/j.1365-2443.1998.00216.x; Olson MF, 1996, CURR BIOL, V6, P1628, DOI 10.1016/S0960-9822(02)70786-0; Olson MF, 2009, CLIN EXP METASTAS, V26, P273, DOI 10.1007/s10585-008-9174-2; Oser M, 2009, J CELL BIOL, V186, P571, DOI 10.1083/jcb.200812176; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ren G, 2009, J BIOL CHEM, V284, P18913, DOI 10.1074/jbc.M109.000307; Rothsschild BL, 2006, CANCER RES, V66, P8017, DOI 10.1158/0008-5472.CAN-05-4490; SACKS PG, 1988, CANCER RES, V48, P2858; Sarmiento C, 2008, J CELL BIOL, V180, P1245, DOI 10.1083/jcb.200708123; SCHUURING E, 1993, MOL CELL BIOL, V13, P2891, DOI 10.1128/MCB.13.5.2891; Segall JE, 1996, CLIN EXP METASTAS, V14, P61, DOI 10.1007/BF00157687; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Smith SD, 2008, J CELL SCI, V121, P3729, DOI 10.1242/jcs.027680; Tehrani S, 2007, P NATL ACAD SCI USA, V104, P11933, DOI 10.1073/pnas.0701077104; Uruno T, 2001, NAT CELL BIOL, V3, P259, DOI 10.1038/35060051; van Rossum AGSH, 2006, EXP CELL RES, V312, P1658, DOI 10.1016/j.yexcr.2006.01.033; van Rossum AGSH, 2003, J BIOL CHEM, V278, P45672, DOI 10.1074/jbc.M306688200; vanDamme H, 1997, J BIOL CHEM, V272, P7374, DOI 10.1074/jbc.272.11.7374; Walker VG, 2007, AM J PHYSIOL-CELL PH, V293, pC119, DOI 10.1152/ajpcell.00525.2006; Weaver AM, 2008, CANCER LETT, V265, P157, DOI 10.1016/j.canlet.2008.02.066; Weaver AM, 2002, CURR BIOL, V12, P1270, DOI 10.1016/S0960-9822(02)01035-7; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; WU H, 1991, MOL CELL BIOL, V11, P5113, DOI 10.1128/MCB.11.10.5113; Xu XZ, 2010, MODERN PATHOL, V23, P187, DOI 10.1038/modpathol.2009.157; YAMAGUCHI H, 2006, BIOCH BIOPHYS ACTA; YILMAZ M, 2010, MOL CANC RES; Zhang LH, 2006, J CANCER RES CLIN, V132, P113, DOI 10.1007/s00432-005-0046-8	74	62	62	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e13847	10.1371/journal.pone.0013847	http://dx.doi.org/10.1371/journal.pone.0013847			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079800	Green Published, gold, Green Submitted			2022-12-25	WOS:000283838600019
J	Kusi, KA; Faber, BW; Riasat, V; Thomas, AW; Kocken, CHM; Remarque, EJ				Kusi, Kwadwo A.; Faber, Bart W.; Riasat, Vanessa; Thomas, Alan W.; Kocken, Clemens H. M.; Remarque, Edmond J.			Generation of Humoral Immune Responses to Multi-Allele PfAMA1 Vaccines; Effect of Adjuvant and Number of Component Alleles on the Breadth of Response	PLOS ONE			English	Article							APICAL MEMBRANE ANTIGEN-1; PLASMODIUM-FALCIPARUM APICAL-MEMBRANE-ANTIGEN-1; MALARIA VACCINE; ANTIBODY; SPECIFICITY; CANDIDATE; STAGE; PROTEIN; IMMUNIZATION; RECOGNITION	There is increasing interest in multi-allele vaccines to overcome strain-specificity against polymorphic vaccine targets such as Apical Membrane Antigen 1 (AMA1). These have been shown to induce broad inhibitory antibodies in vitro and formed the basis for the design of three Diversity-Covering (DiCo) proteins with similar immunological effects. The antibodies produced are to epitopes that are shared between vaccine alleles and theoretically, increasing the number of component AMA1 alleles is expected to broaden the antibody response. A plateau effect could however impose a limit on the number of alleles needed to achieve the broadest specificity. Moreover, production cost and the vaccine formulation process would limit the number of component alleles. In this paper, we compare rabbit antibody responses elicited with multi-allele vaccines incorporating seven (three DiCos and four natural AMA1 alleles) and three (DiCo mix) antigens for gains in broadened specificity. We also investigate the effect of three adjuvant platforms on antigen specificity and antibody functionality. Our data confirms a broadened response after immunisation with DiCo mix in all three adjuvants. Higher antibody titres were elicited with either CoVaccine HT (TM) or Montanide ISA 51, resulting in similar in vitro inhibition (65-82%) of five out of six culture-adapted P. falciparum strains. The antigen binding specificities of elicited antibodies were also similar and independent of the adjuvant used or the number of vaccine component alleles. Thus neither the four extra antigens nor adjuvant had any observable benefits with respect to specificity broadening, although adjuvant choice influenced the absolute antibody levels and thus the extent of parasite inhibition. Our data confirms the feasibility and potential of multi-allele PfAMA1 formulations, and highlights the need for adjuvants with improved antibody potentiation properties for AMA1-based vaccines.	[Kusi, Kwadwo A.; Faber, Bart W.; Riasat, Vanessa; Thomas, Alan W.; Kocken, Clemens H. M.; Remarque, Edmond J.] Biomed Primate Res Ctr, Dept Parasitol, Rijswijk, Netherlands; [Kusi, Kwadwo A.] Univ Ghana, Coll Hlth Sci, Noguchi Mem Inst Med Res, Dept Immunol, Accra, Ghana	University of Ghana	Kusi, KA (corresponding author), Biomed Primate Res Ctr, Dept Parasitol, Rijswijk, Netherlands.	remarque@bprc.nl	Remarque, Ed/AAE-8643-2020; Kusi, Kwadwo Asamoah/J-5941-2019	Kusi, Kwadwo Asamoah/0000-0001-5483-9985; Kocken, Clemens/0000-0002-4784-1734; Faber, Bart/0000-0001-6808-1204	European Malaria Vaccine Initiative (EMVI) [5-2007]; European Malaria Vaccine Development Association (EMVDA) [LSHP-CT-2007-037506]; Ghana Education Trust	European Malaria Vaccine Initiative (EMVI); European Malaria Vaccine Development Association (EMVDA)(European Commission); Ghana Education Trust	This work was funded by the European Malaria Vaccine Initiative (EMVI), grant number 5-2007, and the European Malaria Vaccine Development Association (EMVDA), grant number LSHP-CT-2007-037506. KAK was also supported by the Ghana Education Trust Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aide P, 2007, ARCH DIS CHILD, V92, P476, DOI 10.1136/adc.2005.092551; Andersen PH, 2006, PROTEIN SCI, V15, P2558, DOI 10.1110/ps.062405906; Aucouturier J, 2006, VACCINE, V24, pS44, DOI 10.1016/j.vaccine.2005.01.116; Aucouturier J, 2000, ANN NY ACAD SCI, V916, P600, DOI 10.1111/j.1749-6632.2000.tb05343.x; Barclay VC, 2008, VACCINE, V26, P6099, DOI 10.1016/j.vaccine.2008.09.004; Blom AG, 2004, VACCINE, V23, P743, DOI 10.1016/j.vaccine.2004.07.021; BONHOURE F, 2006, J IMMUNOTHERAPY, V29; Coley AM, 2006, INFECT IMMUN, V74, P2628, DOI 10.1128/IAI.74.5.2628-2636.2006; Collins CR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000273; COLLINS WE, 1994, AM J TROP MED HYG, V51, P711, DOI 10.4269/ajtmh.1994.51.711; Cortes A, 2005, INFECT IMMUN, V73, P422, DOI 10.1128/IAI.73.1.422-430.2005; Crewther PE, 1996, INFECT IMMUN, V64, P3310, DOI 10.1128/IAI.64.8.3310-3317.1996; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; DUBOIS P, 1995, RES IMMUNOL, V146, P263, DOI 10.1016/0923-2494(96)80261-6; Dutta S, 2007, P NATL ACAD SCI USA, V104, P12488, DOI 10.1073/pnas.0701464104; Dutta S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008138; FABER BW, 2008, VACCINE; Gatton ML, 2004, PARASITOLOGY, V128, P367, DOI 10.1017/S0031182003004608; Good MF, 2005, TRENDS PARASITOL, V21, P29, DOI 10.1016/j.pt.2004.10.006; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; Howell SA, 2001, J BIOL CHEM, V276, P31311, DOI 10.1074/jbc.M103076200; Hui G, 2008, CLIN VACCINE IMMUNOL, V15, P1145, DOI 10.1128/CVI.00058-08; Hui GS, 2008, INT IMMUNOPHARMACOL, V8, P1012, DOI 10.1016/j.intimp.2008.03.005; HUI GSN, 1991, J IMMUNOL, V147, P3935; Kennedy MC, 2002, INFECT IMMUN, V70, P6948, DOI 10.1128/IAI.70.12.6948-6960.2002; Kusi KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008110; Miura K, 2007, INFECT IMMUN, V75, P5827, DOI 10.1128/IAI.00593-07; Mullen GED, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002940; NARUM DL, 1994, MOL BIOCHEM PARASIT, V67, P59, DOI 10.1016/0166-6851(94)90096-5; Noedl H, 2009, NEW ENGL J MED, V361, P540, DOI 10.1056/NEJMc0900231; Polley SD, 2004, VACCINE, V23, P718, DOI 10.1016/j.vaccine.2004.05.031; Polley SD, 2001, GENETICS, V158, P1505; RAWLINGS DJ, 1992, J EXP MED, V176, P1483, DOI 10.1084/jem.176.5.1483; Remarque EJ, 2008, INFECT IMMUN, V76, P2660, DOI 10.1128/IAI.00170-08; Remarque EJ, 2008, TRENDS PARASITOL, V24, P74, DOI 10.1016/j.pt.2007.12.002; Richards JS, 2009, IMMUNOL CELL BIOL, V87, P377, DOI 10.1038/icb.2009.27; Spring MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005254; Struik SS, 2004, IMMUNOL REV, V201, P268, DOI 10.1111/j.0105-2896.2004.00181.x; Todryk SM, 2007, NAT REV MICROBIOL, V5, P487, DOI 10.1038/nrmicro1712; Van Bortel W, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-102	41	34	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e15391	10.1371/journal.pone.0015391	http://dx.doi.org/10.1371/journal.pone.0015391			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	800AR	21082025	gold, Green Published, Green Submitted			2022-12-25	WOS:000293329500001
J	Bomble, YJ; Beckham, GT; Matthews, JF; Nimlos, MR; Himmel, ME; Crowley, MF				Bomble, Yannick J.; Beckham, Gregg T.; Matthews, James F.; Nimlos, Mark R.; Himmel, Michael E.; Crowley, Michael F.			Modeling the Self-assembly of the Cellulosome Enzyme Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLOSTRIDIUM-THERMOCELLUM CELLULOSOME; INTEGRATING PROTEIN CIPA; CRYSTAL-STRUCTURE; CELLOBIOHYDROLASE CBHA; DISORDERED PROTEIN; INTRINSIC DISORDER; ENERGY LANDSCAPE; STRUCTURAL BASIS; DOCKERIN DOMAIN; ENDOGLUCANASE	Most bacteria use free enzymes to degrade plant cell walls in nature. However, some bacteria have adopted a different strategy wherein enzymes can either be free or tethered on a protein scaffold forming a complex called a cellulosome. The study of the structure and mechanism of these large macromolecular complexes is an active and ongoing research topic, with the goal of finding ways to improve biomass conversion using cellulosomes. Several mechanisms involved in cellulosome formation remain unknown, including how cellulosomal enzymes assemble on the scaffoldin and what governs the population of cellulosomes created during self-assembly. Here, we present a coarse-grained model to study the self-assembly of cellulosomes. The model captures most of the physical characteristics of three cellulosomal enzymes (Cel5B, CelS, and CbhA) and the scaffoldin (CipA) from Clostridium thermocellum. The protein structures are represented by beads connected by restraints to mimic the flexibility and shapes of these proteins. From a large simulation set, the assembly of cellulosomal enzyme complexes is shown to be dominated by their shape and modularity. The multimodular enzyme, CbhA, binds statistically more frequently to the scaffoldin than CelS or Cel5B. The enhanced binding is attributed to the flexible nature and multimodularity of this enzyme, providing a longer residence time around the scaffoldin. The characterization of the factors influencing the cellulosome assembly process may enable new strategies to create designers cellulosomes.	[Bomble, Yannick J.; Matthews, James F.; Himmel, Michael E.; Crowley, Michael F.] Colorado Sch Mines, Biosci Ctr, Golden, CO 80401 USA; [Beckham, Gregg T.; Nimlos, Mark R.] Colorado Sch Mines, Natl Bioenergy Ctr, Natl Renewable Energy Lab, Golden, CO 80401 USA; [Beckham, Gregg T.] Colorado Sch Mines, Dept Chem Engn, Golden, CO 80401 USA; [Bomble, Yannick J.; Nimlos, Mark R.; Himmel, Michael E.; Crowley, Michael F.] Oak Ridge Natl Lab, BioEnergy Sci Ctr, Oak Ridge, TN 37831 USA; [Beckham, Gregg T.; Himmel, Michael E.] Univ Colorado, Renewable & Sustainable Energy Inst, Boulder, CO 80309 USA	Colorado School of Mines; Colorado School of Mines; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; Colorado School of Mines; United States Department of Energy (DOE); Oak Ridge National Laboratory; BioEnergy Science Center (BESC); University of Colorado System; University of Colorado Boulder	Bomble, YJ (corresponding author), Colorado Sch Mines, Biosci Ctr, Golden, CO 80401 USA.	Yannick.Bomble@nrel.gov; Michael.Crowley@nrel.gov	crowley, michael F/A-4852-2013	crowley, michael F/0000-0001-5163-9398; Bomble, Yannick/0000-0001-7624-8000	Department of Energy (DOE) Office of Science, Office of the Biological and Environmental Research through the Bioenergy Science Center; DOE Bioenergy Research Center; DOE Office of Science ASCR SciDAC; Texas Advanced Computing Center Ranger cluster under National Science Foundation [MCB090159]; National Science Foundation; National Renewable Energy Laboratory	Department of Energy (DOE) Office of Science, Office of the Biological and Environmental Research through the Bioenergy Science Center(United States Department of Energy (DOE)); DOE Bioenergy Research Center(United States Department of Energy (DOE)); DOE Office of Science ASCR SciDAC; Texas Advanced Computing Center Ranger cluster under National Science Foundation; National Science Foundation(National Science Foundation (NSF)); National Renewable Energy Laboratory(United States Department of Energy (DOE))	This work was supported by the Department of Energy (DOE) Office of Science, Office of the Biological and Environmental Research through the Bioenergy Science Center, a DOE Bioenergy Research Center, and by the DOE Office of Science ASCR SciDAC program.; We thank the Texas Advanced Computing Center Ranger cluster under National Science Foundation Teragrid Grant MCB090159. We thank Qi Xu for helpful discussions. Access to PONDR (R) was provided by Molecular Kinetics. Computational time for this research was supported in part by the Golden Energy Computing Organization at the Colorado School of Mines using resources acquired with financial assistance from the National Science Foundation and the National Renewable Energy Laboratory.	Baugh L, 2004, J BIOMED MATER RES A, V69A, P525, DOI 10.1002/jbm.a.30026; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; Bayer EA, 1998, J STRUCT BIOL, V124, P221, DOI 10.1006/jsbi.1998.4065; Bayer EA, 1998, CURR OPIN STRUC BIOL, V8, P548, DOI 10.1016/S0959-440X(98)80143-7; Bayer EA, 2007, CURR OPIN BIOTECH, V18, P237, DOI 10.1016/j.copbio.2007.04.004; Beckham GT, 2010, BIOPHYS J, V99, P3773, DOI 10.1016/j.bpj.2010.10.032; Bellesia G, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3108461; Bellesia G, 2009, BIOPHYS J, V96, P875, DOI 10.1016/j.bpj.2008.10.040; BHAT S, 1994, INT J BIOL MACROMOL, V16, P335, DOI 10.1016/0141-8130(94)90066-3; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Carvalho AL, 2003, P NATL ACAD SCI USA, V100, P13809, DOI 10.1073/pnas.1936124100; Carvalho AL, 2007, P NATL ACAD SCI USA, V104, P3089, DOI 10.1073/pnas.0611173104; Caspi J, 2006, BIOCATAL BIOTRANSFOR, V24, P3, DOI 10.1080/10242420600598046; Cha J, 2007, J MICROBIOL BIOTECHN, V17, P1782; CHAUVAUX S, 1990, BIOCHEM J, V265, P261, DOI 10.1042/bj2650261; Chen JH, 2008, CURR OPIN STRUC BIOL, V18, P140, DOI 10.1016/j.sbi.2008.01.003; Ciruela A, 1998, FEBS LETT, V422, P221, DOI 10.1016/S0014-5793(97)01590-1; Demain AL, 2005, MICROBIOL MOL BIOL R, V69, P124, DOI 10.1128/MMBR.69.1.124-154.2005; Dill KA, 2008, ANNU REV BIOPHYS, V37, P289, DOI 10.1146/annurev.biophys.37.092707.153558; Doi RH, 2004, NAT REV MICROBIOL, V2, P541, DOI 10.1038/nrmicro925; DOMINGUEZ R, 1995, NAT STRUCT BIOL, V2, P569, DOI 10.1038/nsb0795-569; Dominguez R, 1996, J MOL BIOL, V257, P1042, DOI 10.1006/jmbi.1996.0222; Dunker AK, 2001, NAT BIOTECHNOL, V19, P805, DOI 10.1038/nbt0901-805; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Fierobe HP, 2005, J BIOL CHEM, V280, P16325, DOI 10.1074/jbc.M414449200; Fierobe HP, 2002, J BIOL CHEM, V277, P49621, DOI 10.1074/jbc.M207672200; Fierobe HP, 2001, J BIOL CHEM, V276, P21257, DOI 10.1074/jbc.M102082200; Gao M, 2003, P NATL ACAD SCI USA, V100, P14784, DOI 10.1073/pnas.2334390100; Gilbert HJ, 2007, MOL MICROBIOL, V63, P1568, DOI 10.1111/j.1365-2958.2007.05640.x; GREPINET O, 1986, NUCLEIC ACIDS RES, V14, P1791, DOI 10.1093/nar/14.4.1791; Guimaraes BG, 2002, J MOL BIOL, V320, P587, DOI 10.1016/S0022-2836(02)00497-7; Hagan MF, 2006, BIOPHYS J, V91, P42, DOI 10.1529/biophysj.105.076851; Hammel M, 2005, J BIOL CHEM, V280, P38562, DOI 10.1074/jbc.M503168200; Hills RD, 2009, INT J MOL SCI, V10, P889, DOI 10.3390/ijms10030889; Jindou S, 2006, FEMS MICROBIOL LETT, V254, P308, DOI 10.1111/j.1574-6968.2005.00040.x; Kataeva I, 1997, BIOCHEM J, V326, P617, DOI 10.1042/bj3260617; Kataeva IA, 2004, PROTEIN ENG DES SEL, V17, P759, DOI 10.1093/protein/gzh094; Kataeva IA, 2002, APPL ENVIRON MICROB, V68, P4292, DOI 10.1128/AEM.68.9.4292-4300.2002; Kivenson A, 2010, BIOPHYS J, V99, P619, DOI 10.1016/j.bpj.2010.04.035; Klotzsch E, 2009, P NATL ACAD SCI USA, V106, P18267, DOI 10.1073/pnas.0907518106; KRUUS K, 1995, P NATL ACAD SCI USA, V92, P9254, DOI 10.1073/pnas.92.20.9254; LAMED R, 1988, ADV APPL MICROBIOL, V33, P1, DOI 10.1016/S0065-2164(08)70203-X; Levy Y, 2005, J MOL BIOL, V346, P1121, DOI 10.1016/j.jmb.2004.12.021; Lytle BL, 2000, ARCH BIOCHEM BIOPHYS, V379, P237, DOI 10.1006/abbi.2000.1882; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MAYER F, 1987, APPL ENVIRON MICROB, V53, P2785, DOI 10.1128/AEM.53.12.2785-2792.1987; Mingardon F, 2007, APPL ENVIRON MICROB, V73, P7138, DOI 10.1128/AEM.01306-07; Morag E, 1996, J BIOTECHNOL, V51, P235, DOI 10.1016/S0168-1656(96)01601-X; Nguyen HD, 2007, NANO LETT, V7, P338, DOI 10.1021/nl062449h; Nguyen HD, 2009, J AM CHEM SOC, V131, P2606, DOI 10.1021/ja807730x; Noach I, 2009, J MOL BIOL, V391, P86, DOI 10.1016/j.jmb.2009.06.006; Oehler S, 2010, J MOL BIOL, V395, P242, DOI 10.1016/j.jmb.2009.10.056; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Pages S, 1997, PROTEINS, V29, P517, DOI 10.1002/(SICI)1097-0134(199712)29:4<517::AID-PROT11>3.3.CO;2-I; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Raman B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005271; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Schubot FD, 2004, BIOCHEMISTRY-US, V43, P1163, DOI 10.1021/bi030202i; Schwartz R, 1998, BIOPHYS J, V75, P2626, DOI 10.1016/S0006-3495(98)77708-2; Shea JE, 2001, ANNU REV PHYS CHEM, V52, P499, DOI 10.1146/annurev.physchem.52.1.499; Snow CD, 2005, ANNU REV BIOPH BIOM, V34, P43, DOI 10.1146/annurev.biophys.34.040204.144447; Strodel B, 2008, J CHEM THEORY COMPUT, V4, P657, DOI 10.1021/ct700305w; Strodel B, 2007, J AM CHEM SOC, V129, P16005, DOI 10.1021/ja075346p; Tavares GA, 1997, J MOL BIOL, V273, P701, DOI 10.1006/jmbi.1997.1326; Tormo J, 1996, EMBO J, V15, P5739, DOI 10.1002/j.1460-2075.1996.tb00960.x; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; WU JHD, 1988, BIOCHEMISTRY-US, V27, P1703, DOI 10.1021/bi00405a048; Xu JC, 2009, PROTEIN SCI, V18, P949, DOI 10.1002/pro.105; Zverlov VV, 1998, J BACTERIOL, V180, P3091, DOI 10.1128/JB.180.12.3091-3099.1998	71	37	37	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5614	5623		10.1074/jbc.M110.186031	http://dx.doi.org/10.1074/jbc.M110.186031			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21098021	Green Published, hybrid			2022-12-25	WOS:000287230600071
J	Juang, YT; Rauen, T; Wang, Y; Ichinose, K; Benedyk, K; Tenbrock, K; Tsokos, GC				Juang, Yuang-Taung; Rauen, Thomas; Wang, Ying; Ichinose, Kunihiro; Benedyk, Konrad; Tenbrock, Klaus; Tsokos, George C.			Transcriptional Activation of the cAMP-responsive Modulator Promoter in Human T Cells Is Regulated by Protein Phosphatase 2A-mediated Dephosphorylation of SP-1 and Reflects Disease Activity in Patients with Systemic Lupus Erythematosus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT MODULATOR; IL-2 PRODUCTION; EXPRESSION; BINDING; CREM	Systemic lupus erythematosus (SLE) is a complex autoimmune disease with numerous abnormalities recorded at the cellular, molecular, and genetic level. Expression of the basic leucine zipper transcription factor cAMP-responsive element modulator (CREM)alpha was reported to be abnormally increased in T cells from SLE patients. CREM alpha suppresses IL-2 and T cell receptor xi chain gene transcription by direct binding to the respective promoters. Here, we show that increased CREM expression is the result of enhanced promoter activity. DNA binding analyses reveal direct binding of transcription factor specificity protein-1 (SP-1) to the CREM promoter resulting in enhanced transcriptional activity and increased CREM expression. Protein phosphatase 2A is known to activate SP-1 through dephosphorylation at its serine residue 59. Our results show that nuclei from SLE T cells contain lower levels of Ser(59)-phosphorylated SP-1 protein and a stronger SP-1 binding to the CREM promoter. We conclude that protein phosphatase 2A accounts for enhanced SP-1 dephosphorylation at Ser(59) in SLE T cells. More importantly, CREM promoter activity mirrors reliably disease activity in SLE patients, underscoring its potential role as a biomarker for the prediction of flares in SLE patients.	[Juang, Yuang-Taung; Rauen, Thomas; Ichinose, Kunihiro; Tsokos, George C.] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Med, Div Rheumatol,Sch Med, Boston, MA 02115 USA; [Wang, Ying] Walter Reed Army Inst Res, Dept Cellular Injury, Silver Spring, MD 20910 USA; [Benedyk, Konrad; Tenbrock, Klaus] Univ Aachen, Rhein Westfael TH, Dept Pediat, D-52074 Aachen, Germany	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); RWTH Aachen University	Tsokos, GC (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Med, Div Rheumatol,Sch Med, CLS-937,330 Brookline Ave, Boston, MA 02115 USA.	gtsokos@bidmc.harvard.edu	tsokos, george C/O-3360-2013; Ichinose, Kunihiro/I-2126-2019	tsokos, george C/0000-0001-9589-2360; Ichinose, Kunihiro/0000-0001-8794-7106	National Institutes of Health [AI42269, AI68787]; Deutsche Forschungsgemeinschaft [RA1927-1/1]; Internationales Zentrum fur Klinische Forschung Munster [FG5]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042269, R01AI068787] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Internationales Zentrum fur Klinische Forschung Munster; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI42269 and AI68787 (to G.C.T.). This work was also supported by Deutsche Forschungsgemeinschaft Grant RA1927-1/1 (to T.R.) and Internationales Zentrum fur Klinische Forschung Munster Grant FG5 (to K.T.).	Della Fazia MA, 1998, FEBS LETT, V434, P33, DOI 10.1016/S0014-5793(98)00944-2; Evans DRH, 1999, J BIOL CHEM, V274, P24038, DOI 10.1074/jbc.274.34.24038; FOULKES NS, 1991, CELL, V64, P739, DOI 10.1016/0092-8674(91)90503-Q; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Iliopoulos AG, 1996, SEMIN ARTHRITIS RHEU, V25, P318, DOI 10.1016/S0049-0172(96)80018-7; Juang YT, 2005, J CLIN INVEST, V115, P996, DOI 10.1172/JCI22854; Katsiari CG, 2005, J CLIN INVEST, V115, P3193, DOI 10.1172/JCI24895; Kyttaris VC, 2006, LUPUS, V15, P840, DOI 10.1177/0961203306069985; Kyttaris VC, 2004, J IMMUNOL, V173, P3557, DOI 10.4049/jimmunol.173.5.3557; LAOIDE BM, 1993, EMBO J, V12, P1179, DOI 10.1002/j.1460-2075.1993.tb05759.x; Lieberman LA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/740619; Moulton VR, 2010, J BIOL CHEM, V285, P12490, DOI 10.1074/jbc.M109.091660; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; SassoneCorsi P, 1995, ANNU REV CELL DEV BI, V11, P355, DOI 10.1146/annurev.cellbio.11.1.355; Solomou EE, 2001, J IMMUNOL, V166, P4216, DOI 10.4049/jimmunol.166.6.4216; Solomou EE, 2001, J IMMUNOL, V166, P5665, DOI 10.4049/jimmunol.166.9.5665; Tenbrock K, 2007, RHEUMATOLOGY, V46, P1525, DOI 10.1093/rheumatology/kem154; Tenbrock K, 2005, J IMMUNOL, V175, P5975, DOI 10.4049/jimmunol.175.9.5975; Tenbrock K, 2002, J IMMUNOL, V169, P4147, DOI 10.4049/jimmunol.169.8.4147; Vicart A, 2006, J MOL BIOL, V364, P897, DOI 10.1016/j.jmb.2006.09.036	20	45	46	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1795	1801		10.1074/jbc.M110.166785	http://dx.doi.org/10.1074/jbc.M110.166785			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21097497	Green Published, hybrid			2022-12-25	WOS:000286191500019
J	Bodas, M; Min, T; Vij, N				Bodas, Manish; Min, Taehong; Vij, Neeraj			Early-Age-Related Changes in Proteostasis Augment Immunopathogenesis of Sepsis and Acute Lung Injury	PLOS ONE			English	Article							VALOSIN-CONTAINING PROTEIN; ENDOPLASMIC-RETICULUM; PROTEASOME ACTIVITY; CELL-PROLIFERATION; AAA ATPASE; DISEASE; DEGRADATION; EXPRESSION; REGULATOR; UBIQUITIN	Background: The decline of proteasomal activity is known to be associated with the age-related disorders but the early events involved in this process are not apparent. To address this, we investigated the early-age-related (pediatric vs. adult) mechanisms that augment immunopathogenesis of sepsis and acute lung injury. Methodology/Principal Findings: The 3-weeks (pediatric) and 6-months (adult) old C57BL/6 mice were selected as the study groups. Mice were subjected to 1x20 cecal ligation and puncture (CLP) mediated sepsis or intratracheal Psuedomonas aeruginosa (Pa)-LPS induced acute lung injury (ALI).We observed a significant increase in basal levels of pro-inflammatory cytokine, IL-6 and neutrophil activity marker, myeloperoxidase (MPO) in the adult mice compared to the pediatric indicating the age-related constitutive increase in inflammatory response. Next, we found that age-related decrease in PSMB6 (proteasomal subunit) expression in adult mice results in accumulation of ubiquitinated proteins that triggers the unfolded protein response (UPR). We identified that Pa-LPS induced activation of UPR modifier, p97/VCP (valosin-containing protein) in the adult mice lungs correlates with increase in Pa-LPS induced NF kappa B levels. Moreover, we observed a constitutive increase in p-eIF2 alpha indicating a protective ER stress response to accumulation of ubiquitinated-proteins. We used MG-132 treatment of HBE cells as an in vitro model to standardize the efficacy of salubrinal (inhibitor of eIF2 alpha de-phosphorylation) in controlling the accumulation of ubiquitinated proteins and the NF kappa B levels. Finally, we evaluated the therapeutic efficacy of salubrinal to correct proteostasis-imbalance in the adult mice based on its ability to control CLP induced IL-6 secretion or recruitment of pro-inflammatory cells. Conclusions/Significance: Our data demonstrate the critical role of early-age-related proteostasis-imbalance as a novel mechanism that augments the NF kappa B mediated inflammation in sepsis and ALI. Moreover, our data suggest the therapeutic efficacy of salubrinal in restraining NF kappa B mediated inflammation in the adult or older subjects.	[Bodas, Manish; Min, Taehong; Vij, Neeraj] Johns Hopkins Univ, Dept Pediat Resp Sci, Baltimore, MD 21218 USA; [Vij, Neeraj] Johns Hopkins Univ, Inst Clin & Translat Res, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Bodas, M (corresponding author), Johns Hopkins Univ, Dept Pediat Resp Sci, Baltimore, MD 21218 USA.	nvij1@jhmi.edu	Bodas, Manish/AAE-4016-2020	Bodas, Manish/0000-0002-1046-9799	Cystic Fibrosis Foundation [R025-CR07, VIJ07IO]; Flight Attendant Medical Research Institute (FAMRI); National Aeronautics and Space Administration (NASA) [NNJ06HI17G]; National Institutes of Health [CTSA UL RR 025005, RHL096931]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R03HL096931] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Flight Attendant Medical Research Institute (FAMRI); National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding support was provided by Cystic Fibrosis Foundation (R025-CR07 and VIJ07IO), Flight Attendant Medical Research Institute (FAMRI), National Aeronautics and Space Administration (NASA) (NNJ06HI17G) and National Institutes of Health (CTSA UL RR 025005 and RHL096931) grants to NV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai T, 2002, JPN J CANCER RES, V93, P296, DOI 10.1111/j.1349-7006.2002.tb02172.x; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Ben-Zvi A, 2009, P NATL ACAD SCI USA, V106, P14914, DOI 10.1073/pnas.0902882106; Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Breusing N, 2008, BIOL CHEM, V389, P203, DOI 10.1515/BC.2008.029; Carrard G, 2002, INT J BIOCHEM CELL B, V34, P1461, DOI 10.1016/S1357-2725(02)00085-7; Carson WF, 2010, EUR J IMMUNOL, V40, P998, DOI 10.1002/eji.200939739; CEBOTARU L, 2008, J BIOL CHEM; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Ciechanover A, 2000, J CELL BIOCHEM, P40; Dahlmann B, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S3; Dai RM, 1998, J BIOL CHEM, V273, P3562, DOI 10.1074/jbc.273.6.3562; GACZYNSKA M, 1993, ENZYME PROTEIN, V47, P354, DOI 10.1159/000468693; GIOVANNINI S, J GERONTOL A, V65, P369; Gomez CR, 2007, CRIT CARE MED, V35, P246, DOI 10.1097/01.CCM.0000251639.05135.E0; GRAY DA, 2003, SCI AGING KNOWLEDGE, pRE6; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Hinault MP, 2006, J MOL NEUROSCI, V30, P249, DOI 10.1385/JMN:30:3:249; Hirabayashi M, 2001, CELL DEATH DIFFER, V8, P977, DOI 10.1038/sj.cdd.4400907; Hobler SC, 1999, AM J PHYSIOL-REG I, V277, pR434, DOI 10.1152/ajpregu.1999.277.2.R434; Hussain SG, 2007, BIOCHEM BIOPH RES CO, V355, P365, DOI 10.1016/j.bbrc.2007.01.156; Ishigaki S, 2004, J BIOL CHEM, V279, P51376, DOI 10.1074/jbc.M406683200; Ito K, 2009, CHEST, V135, P173, DOI 10.1378/chest.08-1419; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Kobayashi T, 2007, GENES CELLS, V12, P889, DOI 10.1111/j.1365-2443.2007.01099.x; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Lindner AB, 2009, BBA-GEN SUBJECTS, V1790, P980, DOI 10.1016/j.bbagen.2009.06.005; MacNee William, 2009, Proc Am Thorac Soc, V6, P527, DOI 10.1513/pats.200905-027DS; Malhotra D, 2009, AM J RESP CRIT CARE, V180, P1196, DOI 10.1164/rccm.200903-0324OC; Martin GS, 2006, CRIT CARE MED, V34, P15, DOI 10.1097/01.CCM.0000194535.82812.BA; Martin Thomas R, 2005, Proc Am Thorac Soc, V2, P214, DOI 10.1513/pats.200504-031AC; McNaught KSP, 2001, NEUROSCI LETT, V297, P191, DOI 10.1016/S0304-3940(00)01701-8; Nakajima S, 2010, BIOCHEM BIOPH RES CO, V397, P176, DOI 10.1016/j.bbrc.2010.05.069; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Naujokat C, 2002, LAB INVEST, V82, P965, DOI 10.1097/01.LAB.0000022226.23741.37; Oh S, 2005, MECH AGEING DEV, V126, P1292, DOI 10.1016/j.mad.2005.07.006; Plemper RK, 1999, MOL BIOL REP, V26, P125, DOI 10.1023/A:1006913215484; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Son TG, 2005, FREE RADICAL RES, V39, P283, DOI 10.1080/10715760500053461; Tanaka K, 1998, GENES CELLS, V3, P499, DOI 10.1046/j.1365-2443.1998.00207.x; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790; Turnbull IR, 2004, SHOCK, V22, P364, DOI 10.1097/01.shk.0000142552.77473.7d; Turnbull IR, 2003, SHOCK, V19, P310, DOI 10.1097/00024382-200304000-00003; Turnbull IR, 2009, CRIT CARE MED, V37, P1018, DOI 10.1097/CCM.0b013e3181968f3a; Ujiie M, 2002, FRONT BIOSCI-LANDMRK, V7, pE42, DOI 10.2741/ujiie; van Huizen R, 2003, J BIOL CHEM, V278, P15558, DOI 10.1074/jbc.M212074200; Vasto S, 2007, MECH AGEING DEV, V128, P83, DOI 10.1016/j.mad.2006.11.015; Vij N, 2005, INVEST OPHTH VIS SCI, V46, P88, DOI 10.1167/iovs.04-0833; Vij N, 2004, EXP EYE RES, V78, P957, DOI 10.1016/j.exer.2003.12.006; Vij N, 2006, PEDIAT PULMONOLOGY, V41, P209; Vij N, 2006, J BIOL CHEM, V281, P17369, DOI 10.1074/jbc.M600509200; Vij N, 2008, J CELL MOL MED, V12, P2511, DOI 10.1111/j.1582-4934.2008.00462.x; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764; Wiseman RL, 2005, TRENDS MOL MED, V11, P347, DOI 10.1016/j.molmed.2005.06.011; Yamamoto S, 2004, ANN SURG ONCOL, V11, P697, DOI 10.1245/ASO.2004.10.018; Yamamoto S, 2004, ANN SURG ONCOL, V11, P165, DOI 10.1245/ASO.2004.05.012; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005; Zetterberg M, 2003, CURR EYE RES, V27, P45, DOI 10.1076/ceyr.27.2.45.15457	61	32	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e15480	10.1371/journal.pone.0015480	http://dx.doi.org/10.1371/journal.pone.0015480			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085581	Green Submitted, Green Published, gold			2022-12-25	WOS:000284231800036
J	Mendoza-Maldonado, R; Paolinelli, R; Galbiati, L; Giadrossi, S; Giacca, M				Mendoza-Maldonado, Ramiro; Paolinelli, Roberta; Galbiati, Laura; Giadrossi, Sara; Giacca, Mauro			Interaction of the Retinoblastoma Protein with Orc1 and Its Recruitment to Human Origins of DNA Replication	PLOS ONE			English	Article							HUMAN CYCLIN T1; BINDING DOMAIN; IN-VIVO; S-PHASE; PRB; E2F; COMPLEX; LOCALIZATION; ACETYLATION; CHROMATIN	Background: The retinoblastoma protein (Rb) is a crucial regulator of cell cycle progression by binding with E2F transcription factor and repressing the expression of a variety of genes required for the G1-S phase transition. Methodology/Principal Findings: Here we show that Rb and E2F1 directly participate in the control of initiation of DNA replication in human HeLa, U2OS and T98G cells by specifically binding to origins of DNA replication in a cell cycle regulated manner. We show that, both in vitro and inside the cells, the largest subunit of the origin recognition complex (Orc1) specifically binds hypo-phosphorylated Rb and that this interaction is competitive with the binding of Rb to E2F1. The displacement of Rb-bound Orc1 by E2F1 at origins of DNA replication marks the progression of the G1 phase of the cell cycle toward the G1-S border. Conclusions/Significance: The participation of Rb and E2F1 in the formation of the multiprotein complex that binds origins of DNA replication in mammalian cells appears to represent an effective mechanism to couple the expression of genes required for cell cycle progression to the activation of DNA replication.	[Mendoza-Maldonado, Ramiro; Galbiati, Laura; Giadrossi, Sara; Giacca, Mauro] Int Ctr Genet Engn & Biotechnol, Mol Med Lab, I-34012 Trieste, Italy; [Paolinelli, Roberta] Scuola Normale Super Pisa, Mol Biol Lab, Pisa, Italy; [Giacca, Mauro] Univ Trieste, Fac Med, Dept Biomed, Trieste, Italy	International Center for Genetic Engineering & Biotechnology (ICGEB); Scuola Normale Superiore di Pisa; University of Trieste	Mendoza-Maldonado, R (corresponding author), Int Ctr Genet Engn & Biotechnol, Mol Med Lab, Padriciano 99, I-34012 Trieste, Italy.	giacca@icgeb.org	Giacca, Mauro/J-9287-2016	Giacca, Mauro/0000-0003-2927-7225	International Centre for Genetic Engineering and Biotechnology	International Centre for Genetic Engineering and Biotechnology	This work was supported by the International Centre for Genetic Engineering and Biotechnology intramural support to the Molecular Medicine Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdurashidova G, 2000, SCIENCE, V287, P2023, DOI 10.1126/science.287.5460.2023; Ahlander J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002831; Avni D, 2003, MOL CELL, V12, P735, DOI 10.1016/S1097-2765(03)00355-1; Barbie DA, 2005, TRENDS CELL BIOL, V15, P378, DOI 10.1016/j.tcb.2005.05.005; Barbie DA, 2004, MOL CELL BIOL, V24, P595, DOI 10.1128/MCB.24.2.595-607.2004; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; BIAMONTI G, 1992, MOL CELL BIOL, V12, P3499, DOI 10.1128/MCB.12.8.3499; Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Bosco G, 2001, NAT CELL BIOL, V3, P289, DOI 10.1038/35060086; Chan HM, 2001, ONCOGENE, V20, P6152, DOI 10.1038/sj.onc.1204793; Claudio P, 2002, GENOME BIOL, V3; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; Dick FA, 2003, MOL CELL, V12, P639, DOI 10.1016/S1097-2765(03)00344-7; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Galbiati L, 2005, CELL CYCLE, V4, P930, DOI 10.4161/cc.4.7.1784; GIACCA M, 1994, P NATL ACAD SCI USA, V91, P7119, DOI 10.1073/pnas.91.15.7119; GIACCA M, 2002, CHEMTRACTS, V15, P519; Gladden AB, 2003, J BIOL CHEM, V278, P9754, DOI 10.1074/jbc.M212088200; Hauser PJ, 1997, J BIOL CHEM, V272, P22954, DOI 10.1074/jbc.272.36.22954; Kneissl M, 2003, J MOL BIOL, V327, P111, DOI 10.1016/S0022-2836(03)00079-2; Li CJ, 2002, MOL CELL BIOL, V22, P105, DOI 10.1128/MCB.22.1.105-116.2002; Lidonnici MR, 2004, J CELL SCI, V117, P5221, DOI 10.1242/jcs.01405; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; Marcello A, 2003, EMBO J, V22, P2156, DOI 10.1093/emboj/cdg205; Marcello A, 2001, J BIOL CHEM, V276, P39220, DOI 10.1074/jbc.M104830200; Marzio G, 2000, J BIOL CHEM, V275, P10887, DOI 10.1074/jbc.275.15.10887; Morris EJ, 2001, ADV CANCER RES, V82, P1, DOI 10.1016/S0065-230X(01)82001-7; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; Paolinelli R, 2009, NAT STRUCT MOL BIOL, V16, P412, DOI 10.1038/nsmb.1583; Pennaneach V, 2001, MOL CELL, V7, P715, DOI 10.1016/S1097-2765(01)00217-9; Royzman I, 1999, GENE DEV, V13, P827, DOI 10.1101/gad.13.7.827; Schmitz NMR, 2004, BIOCHEM BIOPH RES CO, V317, P779, DOI 10.1016/j.bbrc.2004.03.109; Sibani S, 2005, BIOCHEMISTRY-US, V44, P7885, DOI 10.1021/bi047327n; Sidle A, 1996, CRIT REV BIOCHEM MOL, V31, P237, DOI 10.3109/10409239609106585; Sterner JM, 1998, MOL CELL BIOL, V18, P2748, DOI 10.1128/MCB.18.5.2748; Stevaux O, 2002, CURR OPIN CELL BIOL, V14, P684, DOI 10.1016/S0955-0674(02)00388-5; Takahashi Y, 2000, GENE DEV, V14, P804; Takemura M, 1997, ONCOGENE, V15, P2483, DOI 10.1038/sj.onc.1201431; Tamrakar S, 2000, FRONT BIOSCI-LANDMRK, V5, pD121, DOI 10.2741/Tamrakar; Thangavel S, 2010, MOL CELL BIOL, V30, P1382, DOI 10.1128/MCB.01290-09; Todorovic V, 2005, MOL CELL, V19, P567, DOI 10.1016/j.molcel.2005.07.005; Vashee S, 2001, J BIOL CHEM, V276, P26666, DOI 10.1074/jbc.M102493200; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; WELCH PJ, 1993, CELL, V75, P779, DOI 10.1016/0092-8674(93)90497-E; Wells J, 2003, ONCOGENE, V22, P1445, DOI 10.1038/sj.onc.1206264	46	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e13720	10.1371/journal.pone.0013720	http://dx.doi.org/10.1371/journal.pone.0013720			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085491	Green Submitted, Green Published, gold			2022-12-25	WOS:000284035900001
J	Du, WW; Yang, BB; Shatseva, TA; Yang, BL; Deng, ZQ; Shan, SW; Lee, DY; Seth, A; Yee, AJ				Du, William Weidong; Yang, Burton B.; Shatseva, Tatiana A.; Yang, Bing L.; Deng, Zhaoqun; Shan, Sze Wan; Lee, Daniel Y.; Seth, Arun; Yee, Albert J.			Versican G3 Promotes Mouse Mammary Tumor Cell Growth, Migration, and Metastasis by Influencing EGF Receptor Signaling	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX COMPONENTS; GLYCOGEN-SYNTHASE KINASE-3; SULFATE PROTEOGLYCAN; CHONDROITIN SULFATE; BREAST-CANCER; PG-M; EXPRESSION; DOMAIN; BINDING; PROTEIN	Increased versican expression in breast tumors is predictive of relapse and has negative impact on survival rates. The C-terminal G3 domain of versican influences local and systemic tumor invasiveness in pre-clinical murine models. However, the mechanism(s) by which G3 influences breast tumor growth and metastasis is not well characterized. Here we evaluated the expression of versican in mouse mammary tumor cell lines observing that 4T1 cells expressed highest levels while 66c14 cells expressed low levels. We exogenously expressed a G3 construct in 66c14 cells and analyzed its effects on cell proliferation, migration, cell cycle progression, and EGFR signaling. Experiments in a syngeneic orthotopic animal model demonstrated that G3 promoted tumor growth and systemic metastasis in vivo. Activation of pERK correlated with high levels of G3 expression. In vitro, G3 enhanced breast cancer cell proliferation and migration by up-regulating EGFR signaling, and enhanced cell motility through chemotactic mechanisms to bone stromal cells, which was prevented by inhibitor AG 1478. G3 expressing cells demonstrated increased CDK2 and GSK-3 beta (S9P) expression, which were related to cell growth. The activity of G3 on mouse mammary tumor cell growth, migration and its effect on spontaneous metastasis to bone in an orthotopic model was modulated by up-regulating the EGFR-mediated signaling pathway. Taken together, EGFR-signaling appears to be an important pathway in versican G3-mediated breast cancer tumor invasiveness and metastasis.	[Du, William Weidong; Yang, Bing L.; Yee, Albert J.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Surg, Toronto, ON, Canada; [Du, William Weidong; Yang, Bing L.; Yee, Albert J.] Univ Toronto, Ctr Study Bone Metastasis, Odette Canc Ctr, Toronto, ON, Canada; [Du, William Weidong; Yang, Burton B.; Shatseva, Tatiana A.; Yang, Bing L.; Deng, Zhaoqun; Shan, Sze Wan; Lee, Daniel Y.; Seth, Arun] Univ Toronto, Sunnybrook Res Inst, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Du, WW (corresponding author), Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Surg, Toronto, ON, Canada.	albert.yee@sunnybrook.ca	Xie, Huangming/B-2260-2012	SHAN, SW/0000-0001-6876-9914	Canadian Breast Cancer Research Alliance; Canadian Breast Cancer Foundation Ontario Chapter; Heart and Stroke Foundation of Ontario [CI 5958, NA 6282]; National Sciences and Engineering Research Council of Canada [227937-01]	Canadian Breast Cancer Research Alliance; Canadian Breast Cancer Foundation Ontario Chapter; Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding: This work was partly supported by the Canadian Breast Cancer Research Alliance special program grant on metastasis, an operating grant from the Canadian Breast Cancer Foundation Ontario Chapter, and a Career Investigator Award (CI 5958) from Heart and Stroke Foundation of Ontario to BBY (NA 6282). A support grant was kindly provided by the National Sciences and Engineering Research Council of Canada (227937-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Ghiso JA, 2001, MOL BIOL CELL, V12, P863, DOI 10.1091/mbc.12.4.863; Akli S, 2003, CANCER BIOL THER, V2, pS38; Ang LC, 1999, J NEUROPATH EXP NEUR, V58, P597, DOI 10.1097/00005072-199906000-00004; Aspberg A, 1999, J BIOL CHEM, V274, P20444, DOI 10.1074/jbc.274.29.20444; ASPBERG A, 1995, P NATL ACAD SCI USA, V92, P10590, DOI 10.1073/pnas.92.23.10590; Berdiaki A, 2008, BBA-GEN SUBJECTS, V1780, P194, DOI 10.1016/j.bbagen.2007.10.005; Bhat RV, 2000, P NATL ACAD SCI USA, V97, P11074, DOI 10.1073/pnas.190297597; Bhatia P, 2005, CLIN CANCER RES, V11, P162; BINETTE F, 1994, J BIOL CHEM, V269, P19116; CAMPBELL JS, 1995, RECENT PROG HORM RES, V50, P131; Cattaruzza S, 2004, FASEB J, V18, P779, DOI 10.1096/fj.03-0660fje; Cervantes M, 1996, Ginecol Obstet Mex, V64, P230; Chen G, 2000, J BIOL CHEM, V275, P38973, DOI 10.1074/jbc.M002856200; CROSS DAE, 1994, BIOCHEM J, V303, P21, DOI 10.1042/bj3030021; Cross DAE, 2001, J NEUROCHEM, V77, P94, DOI 10.1046/j.1471-4159.2001.00251.x; DICKSON RB, 1995, ENDOCR REV, V16, P559, DOI 10.1210/er.16.5.559; DIFIORE PP, 1987, SCIENCE, V237, P178, DOI 10.1126/science.2885917; DOURSZIMMERMANN MT, 1994, J BIOL CHEM, V269, P32992; Dykxhoorn DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007181; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Hoshino R, 1999, ONCOGENE, V18, P813, DOI 10.1038/sj.onc.1202367; Isogai Z, 2002, J BIOL CHEM, V277, P4565, DOI 10.1074/jbc.M110583200; ITO K, 1995, J BIOL CHEM, V270, P958, DOI 10.1074/jbc.270.2.958; Jeffs AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008461; Jin G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010993; Kahai S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007535; Kawashima H, 2000, J BIOL CHEM, V275, P35448, DOI 10.1074/jbc.M003387200; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Kong A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002881; LaPierre DP, 2007, CANCER RES, V67, P4742, DOI 10.1158/0008-5472.CAN-06-3610; LEBARON RG, 1992, J BIOL CHEM, V267, P10003; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; Lee DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004527; Lelekakis M, 1999, CLIN EXP METASTAS, V17, P163, DOI 10.1023/A:1006689719505; Lemire JM, 1999, ARTERIOSCL THROM VAS, V19, P1630, DOI 10.1161/01.ATV.19.7.1630; Mi ZY, 2006, CARCINOGENESIS, V27, P1134, DOI 10.1093/carcin/bgi352; Nara Y, 1997, HISTOCHEM J, V29, P21, DOI 10.1023/A:1026460700592; NASO MF, 1994, J BIOL CHEM, V269, P32999; Paulus W, 1996, J NEUROPATH EXP NEUR, V55, P528, DOI 10.1097/00005072-199605000-00005; Ricciardelli C, 2002, CLIN CANCER RES, V8, P1054; SAINSBURY JRC, 1985, LANCET, V1, P364; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; Schmalfeldt M, 1998, J BIOL CHEM, V273, P15758, DOI 10.1074/jbc.273.25.15758; Schmidt M, 2002, DRUG RESIST UPDATE, V5, P11, DOI 10.1016/S1368-7646(02)00004-3; Sheng W, 2005, MOL BIOL CELL, V16, P1330, DOI 10.1091/mbc.e04-04-0295; SHINOMURA T, 1993, J BIOL CHEM, V268, P14461; Sloan EK, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1398; Smith RA, 2006, CURR TOP MED CHEM, V6, P1071, DOI 10.2174/156802606777812077; Suwiwat S, 2004, CLIN CANCER RES, V10, P2491, DOI 10.1158/1078-0432.CCR-03-0146; Tao K, 2001, INT J ONCOL, V19, P1333; Wang CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002420; Wu YJ, 2005, CELL RES, V15, P483, DOI 10.1038/sj.cr.7290318; Wu YJ, 2004, J CELL SCI, V117, P2227, DOI 10.1242/jcs.01057; Wu YJ, 2002, J BIOL CHEM, V277, P12294, DOI 10.1074/jbc.M110748200; Wu YJ, 2001, J BIOL CHEM, V276, P14178, DOI 10.1074/jbc.M100618200; Xiang YY, 2006, J BIOL CHEM, V281, P19358, DOI 10.1074/jbc.M512980200; YAMAGATA M, 1986, J BIOL CHEM, V261, P3526; Yamaguchi Y, 2000, CELL MOL LIFE SCI, V57, P276, DOI 10.1007/PL00000690; Yang BL, 2000, J BIOL CHEM, V275, P21255, DOI 10.1074/jbc.M001443200; Yee AJ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1751; Zhang Y, 2001, EXP CELL RES, V263, P33, DOI 10.1006/excr.2000.5095; Zheng PS, 2004, FASEB J, V18, P754, DOI 10.1096/fj.03-0545fje; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173; ZIMMERMANN DR, 1989, EMBO J, V8, P2975, DOI 10.1002/j.1460-2075.1989.tb08447.x	64	58	62	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2010	5	11							e13828	10.1371/journal.pone.0013828	http://dx.doi.org/10.1371/journal.pone.0013828			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675OD	21079779	Green Submitted, Green Published, gold			2022-12-25	WOS:000283839100004
J	Tschopp, M; Takamiya, M; Cerveny, KL; Gestri, G; Biehlmaier, O; Wilson, SW; Strahle, U; Neuhauss, SCF				Tschopp, Markus; Takamiya, Masanari; Cerveny, Kara L.; Gestri, Gaia; Biehlmaier, Oliver; Wilson, Stephen W.; Straehle, Uwe; Neuhauss, Stephan C. F.			Funduscopy in Adult Zebrafish and Its Application to Isolate Mutant Strains with Ocular Defects	PLOS ONE			English	Article							MOUSE MODEL; NEOVASCULARIZATION; MICE; EYE; SYSTEM; LOCI	Funduscopy is one of the most commonly used diagnostic tools in the ophthalmic practice, allowing for a ready assessment of pathological changes in the retinal vasculature and the outer retina. This non-invasive technique has so far been rarely used in animal model for ophthalmic diseases, albeit its potential as a screening assay in genetic screens. The zebrafish (Danio rerio) is well suited for such genetic screens for ocular alterations. Therefore we developed funduscopy in adult zebrafish and employed it as a screening tool to find alterations in the anterior segment and the fundus of the eye of genetically modified adult animals. A stereomicroscope with coaxial reflected light illumination was used to obtain fundus color images of the zebrafish. In order to find lens and retinal alterations, a pilot screen of 299 families of the F3 generation of ENU-treated adult zebrafish was carried out. Images of the fundus of the eye and the anterior segment can be rapidly obtained and be used to identify alterations in genetically modified animals. A number of putative mutants with cataracts, defects in the cornea, eye pigmentation, ocular vessels and retina were identified. This easily implemented method can also be used to obtain fundus images from rodent retinas. In summary, we present funduscopy as a valuable tool to analyse ocular abnormalities in adult zebrafish and other small animal models. A proof of principle screen identified a number of putative mutants, making funduscopy based screens in zebrafish feasible.	[Tschopp, Markus; Biehlmaier, Oliver; Neuhauss, Stephan C. F.] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland; [Takamiya, Masanari; Straehle, Uwe] Karlsruhe Inst Technol, Inst Toxicol & Genet, Karlsruhe, Germany; [Cerveny, Kara L.; Gestri, Gaia; Wilson, Stephen W.] UCL, Dept Cell & Dev Biol, London, England	University of Zurich; Helmholtz Association; Karlsruhe Institute of Technology; University of London; University College London	Tschopp, M (corresponding author), Univ Bern, Inselspital, Dept Ophthalmol, CH-3010 Bern, Switzerland.	stephan.neuhauss@imls.uzh.ch	Straehle, Uwe/K-7054-2013; Zebrafish, UCL/A-3125-2009; Neuhauss, Stephan/AAX-9915-2020; Wilson, Stephen W/B-9404-2008	Neuhauss, Stephan/0000-0002-9615-480X; Wilson, Stephen W/0000-0002-8557-5940; Cerveny, Kara/0000-0003-0667-827X; Tschopp, Markus/0000-0001-6684-7325; Biehlmaier, Oliver/0000-0003-0825-8500; Gestri, Gaia/0000-0001-8854-1546; Takamiya, Masanari/0000-0002-6524-5813	European Commission [LSHG-CT-2003-503496]; MRC; Wellcome Trust; Telethon Foundation; Damon Runyon Foundation; Novartis Stiftung fur medizinisch-biologische Forschung; MRC [G0501487] Funding Source: UKRI; Medical Research Council [G0501487] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Telethon Foundation(Fondazione Telethon); Damon Runyon Foundation; Novartis Stiftung fur medizinisch-biologische Forschung; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding: This work was supported by the European Commission as part of the ZF-MODELS Integrated Project in the 6th Framework Programme, Contract No. LSHG-CT-2003-503496, MRC, Wellcome Trust, Telethon and Damon Runyon Foundations (SW, GG and KC) and the Novartis Stiftung fur medizinisch-biologische Forschung (MT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez Y, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-114; Brand Michael, 2002, P7; Cohan BE, 2003, INVEST OPHTH VIS SCI, V44, P160, DOI 10.1167/iovs.02-0105; Curcio CA, 2009, PROG RETIN EYE RES, V28, P393, DOI 10.1016/j.preteyeres.2009.08.001; Dahm R, 2007, EXP EYE RES, V85, P74, DOI 10.1016/j.exer.2007.02.015; Fadool JM, 2008, PROG RETIN EYE RES, V27, P89, DOI 10.1016/j.preteyeres.2007.08.002; Hart WE, 1999, INT J MED INFORM, V53, P239, DOI 10.1016/S1386-5056(98)00163-4; HAWES NL, 1999, MOL VIS, V5, pIL1; Heckenlively JR, 2003, RETINA-J RET VIT DIS, V23, P518, DOI 10.1097/00006982-200308000-00012; Helmholtz H., 1851, BESCHREIBUNG AUGENSP; Hubert MF, 1999, LAB ANIM SCI, V49, P232; Imamura Y, 2006, P NATL ACAD SCI USA, V103, P11282, DOI 10.1073/pnas.0602131103; Klein BEK, 1998, ARCH OPHTHALMOL-CHIC, V116, P219, DOI 10.1001/archopht.116.2.219; Lee P, 1998, SURV OPHTHALMOL, V43, P245, DOI 10.1016/S0039-6257(98)00035-6; Li L, 1997, P NATL ACAD SCI USA, V94, P11645, DOI 10.1073/pnas.94.21.11645; LI ZY, 1995, OPHTHALMOLOGY, V102, P805, DOI 10.1016/S0161-6420(95)30953-0; Lyons BL, 2006, INVEST OPHTH VIS SCI, V47, P1201, DOI 10.1167/iovs.05-1161; Maaswinkel H, 2005, MECH AGEING DEV, V126, P1079, DOI 10.1016/j.mad.2005.03.025; Neuhauss SCF, 1999, J NEUROSCI, V19, P8603; Neuhauss SCF, 2003, J NEUROBIOL, V54, P148, DOI 10.1002/neu.10165; Pang JJ, 2005, MOL VIS, V11, P152; Paques M, 2006, VISION RES, V46, P1336, DOI 10.1016/j.visres.2005.09.037; Paques M, 2003, INVEST OPHTH VIS SCI, V44, P4960, DOI 10.1167/iovs.02-0738; Paques M, 2007, INVEST OPHTH VIS SCI, V48, P2769, DOI 10.1167/iovs.06-1099; Pinto LH, 2004, VISION RES, V44, P3335, DOI 10.1016/j.visres.2004.07.025; Ravin JG, 1999, ARCH OPHTHALMOL-CHIC, V117, P1634; Seeliger MW, 2005, VISION RES, V45, P3512, DOI 10.1016/j.visres.2005.08.014; Wong T, 2007, LANCET, V369, P425, DOI 10.1016/S0140-6736(07)60198-6	28	12	12	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2010	5	11							e15427	10.1371/journal.pone.0015427	http://dx.doi.org/10.1371/journal.pone.0015427			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675OD	21079775	Green Published, gold, Green Submitted			2022-12-25	WOS:000283839100023
J	Kaspar, JW; Jaiswal, AK				Kaspar, James W.; Jaiswal, Anil K.			Tyrosine phosphorylation controls nuclear export of Fyn, allowing Nrf2 activation of cytoprotective gene expression	FASEB JOURNAL			English	Article						INrf2; Keap1; oxidative stress; cytoprotective gene induction; cellular protection; cell survival	PROTEIN-KINASE-C; NF-E2-RELATED FACTOR-2; OXIDOREDUCTASE-1 GENE; SRC FAMILY; TRANSCRIPTION; DEGRADATION; CANCER; SIGNAL; ALPHA; KEAP1	Fyn, an Src kinase family member, acts as a negative regulator of NF-E2-related factor 2 (Nrf2). Under stressful conditions, Nrf2 translocates into the nucleus and binds to the antioxidant response element (ARE), activating defensive gene expression. Once Nrf2 completes activation, Fyn phosphorylates tyrosine 568 of Nrf2, resulting in the nuclear export and degradation of Nrf2. The present studies demonstrate that within 0.5 h of antioxidant treatment in human hepatoblastoma (HepG2) cells, Fyn exports out of the nucleus, allowing Nrf2 unimpeded movement to the ARE. Mutation of tyrosine 213 of Fyn stymied nuclear export, suggesting that tyrosine phosphorylation controls nuclear export. Mass spectrometry confirmed tyrosine 213 as the site of phosphorylation. ChIP and real-time PCR assays revealed that FynY213A mutant caused decreased binding of Nrf2 to the promoter of defensive gene NAD(P) H: quinone oxidoreductase 1 (NQO1) and decreased NQO1 expression by 5-fold (P < 0.0001) compared to wild-type Fyn. In addition, a putative nuclear export signal (NES) was identified, and mutation of it also inhibited nuclear export of Fyn. Furthermore, FynY213A caused an increased susceptibility to cell death following treatment with etoposide in mouse hepatoma (Hepa-1) cells. The preinduction regulation of Nrf2 is controlled by the nuclear export of Fyn, allowing for activation of defensive gene expression.-Kaspar, J. W., Jaiswal, A. K. Tyrosine phosphorylation controls nuclear export of Fyn, allowing Nrf2 activation of cytoprotective gene expression. FASEB J. 25, 1076-1087 (2011). www.fasebj.org	[Kaspar, James W.; Jaiswal, Anil K.] Univ Maryland, Dept Pharmacol & Expt Therapeut, Sch Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Jaiswal, AK (corresponding author), Univ Maryland, Dept Pharmacol & Expt Therapeut, Sch Med, 655 W Baltimore St, Baltimore, MD 21201 USA.	ajaiswal@som.umaryland.edu			U.S. National Institutes of Health [RO1 GM047466]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047466] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This investigation was supported by U.S. National Institutes of Health grant RO1 GM047466. The authors thank Dr. Suresh K. Niture (University of Maryland School of Medicine, Baltimore, MD, USA) for helpful suggestions.	Abe J, 1999, J BIOL CHEM, V274, P21003, DOI 10.1074/jbc.274.30.21003; ArenzanaSeisdedos F, 1997, J CELL SCI, V110, P369; Bloom DA, 2003, J BIOL CHEM, V278, P44675, DOI 10.1074/jbc.M307633200; Bromberg KD, 2003, J BIOL CHEM, V278, P7406, DOI 10.1074/jbc.M212056200; COURTNEIDGE SA, 1993, DEVELOPMENT, P57; Dhakshinamoorthy S, 2001, ONCOGENE, V20, P3906, DOI 10.1038/sj.onc.1204506; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Gao Y, 2009, J BIOL CHEM, V284, P7114, DOI 10.1074/jbc.M804801200; Hirota A, 2005, J INVEST DERMATOL, V124, P825, DOI 10.1111/j.0022-202X.2005.23670.x; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jain AK, 2007, J BIOL CHEM, V282, P16502, DOI 10.1074/jbc.M611336200; Jain AK, 2006, J BIOL CHEM, V281, P12132, DOI 10.1074/jbc.M511198200; Kaabeche K, 2004, J BIOL CHEM, V279, P36259, DOI 10.1074/jbc.M402469200; Kang MI, 2004, P NATL ACAD SCI USA, V101, P2046, DOI 10.1073/pnas.0308347100; Kannan S, 2006, CANCER RES, V66, P8421, DOI 10.1158/0008-5472.CAN-06-1181; Kaspar JW, 2010, J BIOL CHEM, V285, P21349, DOI 10.1074/jbc.M110.121863; Kaspar JW, 2010, J BIOL CHEM, V285, P153, DOI 10.1074/jbc.M109.040022; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; KIKUKO I, 2008, EXP CELL RES, V314, P3392; Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200; Mayer BJ, 1997, CURR BIOL, V7, pR295, DOI 10.1016/S0960-9822(06)00141-2; Niture SK, 2009, J BIOL CHEM, V284, P13856, DOI 10.1074/jbc.M808084200; Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013; Resh MD, 1998, INT J BIOCHEM CELL B, V30, P1159, DOI 10.1016/S1357-2725(98)00089-2; Sanguinetti AR, 2003, BIOCHEM J, V376, P159, DOI 10.1042/BJ20030336; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Stewart D, 2003, J BIOL CHEM, V278, P2396, DOI 10.1074/jbc.M209195200; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Strachan GD, 2005, BIOCHEM BIOPH RES CO, V336, P490, DOI 10.1016/j.bbrc.2005.08.127; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Wang XJ, 2008, CARCINOGENESIS, V29, P1235, DOI 10.1093/carcin/bgn095	32	70	72	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2011	25	3					1076	1087		10.1096/fj.10-171553	http://dx.doi.org/10.1096/fj.10-171553			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	727MZ	21097520	Green Published			2022-12-25	WOS:000287806200027
J	Li, J; Powell, SR; Wang, XJ				Li, Jie; Powell, Saul R.; Wang, Xuejun			Enhancement of proteasome function by PA28 alpha overexpression protects against oxidative stress	FASEB JOURNAL			English	Article						proteasome activator 28; green fluorescence protein; apoptosis; oxidized proteins; cell culture	PROTEOLYTIC FUNCTION; 26S PROTEASOME; DEGRADATION SIGNALS; INTERFERON-GAMMA; 20S PROTEASOMES; QUALITY-CONTROL; ACTIVATOR PA28; MICE LACKING; SYSTEM; REG	The principal function of the proteasome is targeted degradation of intracellular proteins. Proteasome dysfunction has been observed in experimental cardiomyopathies and implicated in human congestive heart failure. Measures to enhance proteasome proteolytic function are currently lacking but would be beneficial in testing the pathogenic role of proteasome dysfunction and could have significant therapeutic potential. The association of proteasome activator 28 (PA28) with the 20S proteasome may play a role in antigen processing. It is unclear, however, whether the PA28 plays any important role outside of antigen presentation, although up-regulation of PA28 has been observed in certain types of cardiomyopathy. Here, we show that PA28 alpha overexpression (PA28 alpha OE) stabilized PA28 beta, increased 11S proteasomes, and enhanced the degradation of a previously validated proteasome surrogate substrate (GFPu) in cultured neonatal rat cardiomyocytes. PA28 alpha OE significantly attenuated H2O2-induced increases in the protein carbonyls and markedly suppressed apoptosis in cultured cardiomyocytes under basal conditions or when stressed by H2O2. We conclude that PA28 alpha OE is sufficient to up-regulate 11S proteasomes, enhance proteasome-mediated removal of misfolded and oxidized proteins, and protect against oxidative stress in cardiomyocytes, providing a highly sought means to increase proteasomal degradation of abnormal cellular proteins.-Li, J., Powell, S. R., Wang, X. Enhancement of proteasome function by PA28 alpha overexpression protects against oxidative stress. FASEB J. 25, 883-893 (2011). www.fasebj.org	[Li, Jie; Wang, Xuejun] Univ S Dakota, Sanford Sch Med, Div Basic Biomed Sci, Vermillion, SD 57069 USA; [Li, Jie; Wang, Xuejun] Univ S Dakota, Sanford Sch Med, Cardiovasc Res Inst, Vermillion, SD 57069 USA; [Powell, Saul R.] Feinstein Inst Med Res, Cardiac Metab Lab, Manhasset, NY USA	University of South Dakota; University of South Dakota; Northwell Health	Wang, XJ (corresponding author), Univ S Dakota, Sanford Sch Med, Div Basic Biomed Sci, 414 E Clark St,Lee Med Bldg, Vermillion, SD 57069 USA.	xuejun.wang@usd.edu	Wang, Xuejun/AAT-9490-2021; Wang, Xuejun/K-8874-2013	Wang, Xuejun/0000-0001-9267-1343; Wang, Xuejun/0000-0001-9267-1343; LI, JIE/0000-0003-3902-642X	U.S. National Institutes of Health [R01HL072166, R01HL085629, R01HL068936]; American Heart Association [0740025N]; University of South Dakota; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068936, R01HL085629, R01HL072166] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); University of South Dakota; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Dr. Huabo Su for stimulating discussion over this manuscript and Ms. Kathleen Horak for technical assistance in creating Ad-PA28 alpha and Ad-PA28 beta. X.W. is an established investigator of the American Heart Association. This work was supported, in part, by U.S. National Institutes of Health grants R01HL072166 and R01HL085629 (to X.W.) and R01HL068936 (to S.R.P. and X.W.) and American Heart Association grant 0740025N (to X.W.), as well as by the Physician Scientist Program of the University of South Dakota.	Bahrudin U, 2008, J MOL BIOL, V384, P896, DOI 10.1016/j.jmb.2008.09.070; Barton LF, 2004, J IMMUNOL, V172, P3948, DOI 10.4049/jimmunol.172.6.3948; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Cascio P, 2005, METHOD ENZYMOL, V398, P336, DOI 10.1016/S0076-6879(05)98028-2; Cascio P, 2002, EMBO J, V21, P2636, DOI 10.1093/emboj/21.11.2636; Chen JZ, 2009, CELL IMMUNOL, V254, P85, DOI 10.1016/j.cellimm.2008.09.001; Chen QH, 2005, CIRC RES, V97, P1018, DOI 10.1161/01.RES.0000189262.92896.0b; Chen XY, 2007, MOL CELL, V26, P843, DOI 10.1016/j.molcel.2007.05.022; Divald A, 2010, CIRC RES, V106, P1829, DOI 10.1161/CIRCRESAHA.110.219485; Dong X, 2004, AM J PHYSIOL-HEART C, V287, pH1417, DOI 10.1152/ajpheart.01233.2003; Drews O, 2007, MOL CELL PROTEOMICS, V6, P2021, DOI 10.1074/mcp.M700187-MCP200; Ferrington DA, 2005, FASEB J, V19, P664, DOI 10.1096/fj.04-2578fje; Gilon T, 2000, MOL CELL BIOL, V20, P7214, DOI 10.1128/MCB.20.19.7214-7219.2000; Gomes AV, 2006, CIRC RES, V99, P362, DOI 10.1161/01.RES.0000237386.98506.f7; Gomes AV, 2009, MOL CELL PROTEOMICS, V8, P302, DOI 10.1074/mcp.M800058-MCP200; Groettrup M, 1996, NATURE, V381, P166, DOI 10.1038/381166a0; Herrmann J, 2007, CIRC RES, V101, P865, DOI 10.1161/CIRCRESAHA.107.152959; Huang HB, 2010, CELL RES, V20, P1372, DOI 10.1038/cr.2010.123; Husom AD, 2004, ARCH BIOCHEM BIOPHYS, V421, P67, DOI 10.1016/j.abb.2003.10.010; Imai J, 2003, EMBO J, V22, P3557, DOI 10.1093/emboj/cdg349; Kloetzel PM, 1999, BIOL CHEM, V380, P293, DOI 10.1515/BC.1999.040; Kloss A, 2010, CARDIOVASC RES, V85, P367, DOI 10.1093/cvr/cvp217; Kumarapeli ARK, 2005, FASEB J, V19, P2051, DOI 10.1096/fj.05-3973fje; Li XT, 2007, MOL CELL, V26, P831, DOI 10.1016/j.molcel.2007.05.028; Li XT, 2006, CELL, V124, P381, DOI 10.1016/j.cell.2005.11.037; Liu J, 2006, FASEB J, V20, pA966; Liu JB, 2006, J MOL CELL CARDIOL, V40, P451, DOI 10.1016/j.yjmcc.2005.12.011; Lu HJ, 2008, MOL CELL PROTEOMICS, V7, P2073, DOI 10.1074/mcp.M800064-MCP200; Lu XH, 2001, ARCH BIOCHEM BIOPHYS, V387, P163, DOI 10.1006/abbi.2001.2270; Mearini G, 2008, BBA-MOL BASIS DIS, V1782, P749, DOI 10.1016/j.bbadis.2008.06.009; Minami Y, 2000, J BIOL CHEM, V275, P9055, DOI 10.1074/jbc.275.12.9055; Murata S, 1999, J BIOL CHEM, V274, P38211, DOI 10.1074/jbc.274.53.38211; Murata S, 2001, EMBO J, V20, P5898, DOI 10.1093/emboj/20.21.5898; Patterson C, 2007, CIRCULATION, V115, P1456, DOI 10.1161/CIRCULATIONAHA.106.649863; Powell SR, 2008, J MOL CELL CARDIOL, V44, P618, DOI 10.1016/j.yjmcc.2007.12.009; Powell SR, 2007, J MOL CELL CARDIOL, V42, P265, DOI 10.1016/j.yjmcc.2006.10.010; Powell SR, 2006, AM J PHYSIOL-HEART C, V291, pH1, DOI 10.1152/ajpheart.00062.2006; Predmore JM, 2010, CIRCULATION, V121, P997, DOI 10.1161/CIRCULATIONAHA.109.904557; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Realini C, 1997, J BIOL CHEM, V272, P25483, DOI 10.1074/jbc.272.41.25483; Salomons FA, 2009, MOL CELL BIOL, V29, P1774, DOI 10.1128/MCB.01485-08; Sanbe A, 2004, P NATL ACAD SCI USA, V101, P10132, DOI 10.1073/pnas.0401900101; Sarikas A, 2005, CARDIOVASC RES, V66, P33, DOI 10.1016/j.cardiores.2005.01.004; Schwartzbauer G, 2001, J BIOL CHEM, V276, P35786, DOI 10.1074/jbc.M102479200; Song XL, 1996, J BIOL CHEM, V271, P26410, DOI 10.1074/jbc.271.42.26410; Stohwasser R, 2000, EUR J BIOCHEM, V267, P6221, DOI 10.1046/j.1432-1327.2000.01706.x; Su HB, 2010, CARDIOVASC RES, V85, P253, DOI 10.1093/cvr/cvp287; Su HB, 2009, INT J BIOCHEM CELL B, V41, P615, DOI 10.1016/j.biocel.2008.07.008; Tanahashi N, 2000, J BIOL CHEM, V275, P14336, DOI 10.1074/jbc.275.19.14336; Tang MX, 2010, CARDIOVASC RES, V88, P424, DOI 10.1093/cvr/cvq217; Tannous P, 2008, CIRCULATION, V117, P3070, DOI 10.1161/CIRCULATIONAHA.107.763870; Wang XJ, 2008, J MOL CELL CARDIOL, V45, P11, DOI 10.1016/j.yjmcc.2008.03.025; Wang XJ, 2006, CIRC RES, V99, P1315, DOI 10.1161/01.RES.0000252342.61447.a2; Weekes J, 2003, PROTEOMICS, V3, P208, DOI 10.1002/pmic.200390029; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; Whittier JE, 2004, J BIOL CHEM, V279, P46135, DOI 10.1074/jbc.M406048200; Yamano T, 2002, J EXP MED, V196, P185, DOI 10.1084/jem.20011922; Young GW, 2008, TRENDS CARDIOVAS MED, V18, P93, DOI 10.1016/j.tcm.2008.01.004; Zhang ZG, 1999, BIOCHEMISTRY-US, V38, P5651, DOI 10.1021/bi990056+; Zong C, 2006, CIRC RES, V99, P372, DOI 10.1161/01.RES.0000237389.40000.02	60	107	107	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2011	25	3					883	893		10.1096/fj.10-160895	http://dx.doi.org/10.1096/fj.10-160895			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	727MZ	21098724	Green Published			2022-12-25	WOS:000287806200009
J	Kashyap, V; Gudas, LJ; Brenet, F; Funk, P; Viale, A; Scandura, JM				Kashyap, Vasundhra; Gudas, Lorraine J.; Brenet, Fabienne; Funk, Patricia; Viale, Agnes; Scandura, Joseph M.			Epigenomic Reorganization of the Clustered Hox Genes in Embryonic Stem Cells Induced by Retinoic Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; HISTONE METHYLTRANSFERASE ACTIVITY; GROUP PROTEIN SUZ12; RESPONSE ELEMENTS; IN-VIVO; DEVELOPMENTAL REGULATORS; INDUCED DIFFERENTIATION; FUNCTIONAL-ANALYSIS; MOUSE DEVELOPMENT; EARLY HINDBRAIN	Retinoic acid (RA) regulates clustered Hox gene expression during embryogenesis and is required to establish the anterior- posterior body plan. Using mutant embryonic stem cell lines deficient in the RA receptor gamma(RAR gamma) or Hoxa1 3'-RA-responsive element, we studied the kinetics of transcriptional and epigenomic patterning responses to RA. RAR gamma is essential for RA-induced Hox transcriptional activation, and deletion of its binding site in the Hoxa1 enhancer attenuates transcriptional and epigenomic activation of both Hoxa and Hoxb gene clusters. The kinetics of epigenomic reorganization demonstrate that complete erasure of the polycomb repressive mark H3K27me3 is not necessary to initiate Hox transcription. RAR gamma is not required to establish the bivalent character of Hox clusters, but RA/RAR gamma signaling is necessary to erase H3K27me3 from activated Hox genes during embryonic stem cell differentiation. Highly coordinated, long range epigenetic Hox cluster reorganization is closely linked to transcriptional activation and is triggered by RAR gamma located at the Hoxa1 3'-RA-responsive element.	[Gudas, Lorraine J.; Brenet, Fabienne; Funk, Patricia; Scandura, Joseph M.] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA; [Viale, Agnes] Mem Sloan Kettering Canc Ctr, Genom Core Lab, New York, NY 10021 USA	Cornell University; Cornell University; Memorial Sloan Kettering Cancer Center	Scandura, JM (corresponding author), Weill Cornell Med Coll, Dept Med, 1300 York Ave, New York, NY 10065 USA.	jms2003@med.cornell.edu	Brenet, Fabienne/R-1881-2016; Kashyap, Vasundhra/H-8970-2019	Brenet, Fabienne/0000-0003-4098-1096; Scandura, Joseph/0000-0002-9525-143X	National Institutes of Health [R01CA043796]; Department of Defense [W81XWH-08-1-0317]; Cornell Belfer Family startup funds; NATIONAL CANCER INSTITUTE [R01CA043796] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Cornell Belfer Family startup funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA043796 (to L.J.G.). This work was also supported by Cornell Belfer Family startup funds (to J.M.S.).; Supported in part by Department of Defense Predoctoral Award W81XWH-08-1-0317.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Argiropoulos B, 2007, ONCOGENE, V26, P6766, DOI 10.1038/sj.onc.1210760; Atkinson SP, 2008, STEM CELLS, V26, P1174, DOI 10.1634/stemcells.2007-0497; Barrow JR, 2000, DEVELOPMENT, V127, P933; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; BONCINELLI E, 1991, TRENDS GENET, V7, P329, DOI 10.1016/0168-9525(91)90423-N; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Brookes E, 2009, EMBO REP, V10, P1213, DOI 10.1038/embor.2009.221; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Chen AC, 1996, J BIOL CHEM, V271, P14971, DOI 10.1074/jbc.271.25.14971; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Delacroix L, 2010, MOL CELL BIOL, V30, P231, DOI 10.1128/MCB.00756-09; Dilworth FJ, 2001, ONCOGENE, V20, P3047, DOI 10.1038/sj.onc.1204329; DUBOULE D, 1994, TRENDS GENET, V10, P358, DOI 10.1016/0168-9525(94)90132-5; Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065; Dupe V, 1997, DEVELOPMENT, V124, P399; FRASCH M, 1995, DEVELOPMENT, V121, P957; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Garcia-Fernandez J, 2005, NAT REV GENET, V6, P881, DOI 10.1038/nrg1723; Gaspar N, 2010, CANCER RES, V70, P9243, DOI 10.1158/0008-5472.CAN-10-1250; Gavalas A, 2003, DEVELOPMENT, V130, P5663, DOI 10.1242/dev.00802; Gavalas A, 1998, DEVELOPMENT, V125, P1123; Ghyselinck NB, 1997, INT J DEV BIOL, V41, P425; Giadrossi S, 2007, CURR OPIN GENET DEV, V17, P132, DOI 10.1016/j.gde.2007.02.012; Gillespie RF, 2007, J BIOL CHEM, V282, P33421, DOI 10.1074/jbc.M704845200; Gillespie RF, 2007, J MOL BIOL, V372, P298, DOI 10.1016/j.jmb.2007.06.079; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Huang D, 1998, DEVELOPMENT, V125, P3235; Huang DY, 2002, DEV DYNAM, V223, P353, DOI 10.1002/dvdy.10057; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Jung J, 2005, DEV DYNAM, V232, P21, DOI 10.1002/dvdy.20204; KAWASE E, 1994, INT J DEV BIOL, V38, P385; Ke XS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004687; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Kosak ST, 2004, GENE DEV, V18, P1371, DOI 10.1101/gad.1209304; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; LANGSTON AW, 1992, MECH DEVELOP, V38, P217, DOI 10.1016/0925-4773(92)90055-O; Langston AW, 1997, J BIOL CHEM, V272, P2167, DOI 10.1074/jbc.272.4.2167; LANGSTON AW, 1994, CURR OPIN GENET DEV, V4, P550, DOI 10.1016/0959-437X(94)90071-A; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Lee N, 2007, NAT STRUCT MOL BIOL, V14, P341, DOI 10.1038/nsmb1216; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lemons D, 2006, SCIENCE, V313, P1918, DOI 10.1126/science.1132040; Lengerke C, 2008, CELL STEM CELL, V2, P72, DOI 10.1016/j.stem.2007.10.022; LOHNES D, 1993, CELL, V73, P643, DOI 10.1016/0092-8674(93)90246-M; Loudig O, 2005, BIOCHEM J, V392, P241, DOI 10.1042/BJ20050874; Loudig O, 2000, MOL ENDOCRINOL, V14, P1483, DOI 10.1210/me.14.9.1483; Mainguy G, 2003, TRENDS GENET, V19, P476, DOI 10.1016/S0168-9525(03)00202-6; MARSHALL H, 1994, NATURE, V370, P567, DOI 10.1038/370567a0; Martinez-Ceballos E, 2005, J BIOL CHEM, V280, P16484, DOI 10.1074/jbc.M414397200; Martinez-Ceballos E, 2008, J NEUROSCI RES, V86, P2809, DOI 10.1002/jnr.21729; MEANS AL, 1995, ANNU REV BIOCHEM, V64, P201, DOI 10.1146/annurev.bi.64.070195.001221; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mongan NP, 2007, DIFFERENTIATION, V75, P853, DOI 10.1111/j.1432-0436.2007.00206.x; Norris JD, 2009, MOL CELL, V36, P405, DOI 10.1016/j.molcel.2009.10.020; Oosterveen T, 2003, J BIOL CHEM, V278, P24103, DOI 10.1074/jbc.M300774200; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Pfeifer GP, 2009, SEMIN CANCER BIOL, V19, P181, DOI 10.1016/j.semcancer.2009.02.008; POPPERL H, 1993, MOL CELL BIOL, V13, P257; Ren XJ, 2008, MOL CELL BIOL, V28, P2884, DOI 10.1128/MCB.00949-07; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Roelen BAJ, 2002, MECH DEVELOP, V119, P81, DOI 10.1016/S0925-4773(02)00329-5; Sakamoto Y, 2007, J BIOL CHEM, V282, P16391, DOI 10.1074/jbc.M700011200; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Sessa L, 2007, RNA, V13, P223, DOI 10.1261/rna.266707; Shah N, 2010, NAT REV CANCER, V10, P361, DOI 10.1038/nrc2826; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Soshnikova N, 2009, SCIENCE, V324, P1320, DOI 10.1126/science.1171468; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Studer M, 1998, DEVELOPMENT, V125, P1025; Su D, 2008, BIOCHEM PHARMACOL, V75, P1129, DOI 10.1016/j.bcp.2007.11.006; Suganuma T, 2008, CELL, V135, P604, DOI 10.1016/j.cell.2008.10.036; Sutherland H, 2009, NAT REV GENET, V10, P457, DOI 10.1038/nrg2592; Thompson JR, 1998, DEV DYNAM, V211, P97, DOI 10.1002/(SICI)1097-0177(199801)211:1<97::AID-AJA9>3.3.CO;2-M; Tumpel S, 2007, DEV BIOL, V302, P646, DOI 10.1016/j.ydbio.2006.10.029; Tvrdik P, 2006, DEV CELL, V11, P239, DOI 10.1016/j.devcel.2006.06.016; ZHANG MB, 1994, DEVELOPMENT, V120, P2431; Zhu P, 2007, MOL CELL, V27, P609, DOI 10.1016/j.molcel.2007.07.024	94	75	76	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3250	3260		10.1074/jbc.M110.157545	http://dx.doi.org/10.1074/jbc.M110.157545			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21087926	Green Published, hybrid			2022-12-25	WOS:000286653200010
J	Meen, AJ; Oynebraten, I; Reine, TM; Duelli, A; Svennevig, K; Pejler, G; Jenssen, T; Kolset, SO				Meen, Astri J.; Oynebraten, Inger; Reine, Trine M.; Duelli, Annette; Svennevig, Katja; Pejler, Gunnar; Jenssen, Trond; Kolset, Svein O.			Serglycin Is a Major Proteoglycan in Polarized Human Endothelial Cells and Is Implicated in the Secretion of the Chemokine GRO alpha/CXCL1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN UMBILICAL VEIN; CHONDROITIN SULFATE; HEPARAN-SULFATE; MAST-CELL; HEMATOPOIETIC-CELLS; GRANULE INTEGRITY; IN-VITRO; EXPRESSION; ALPHA; STORAGE	Proteoglycan (PG) expression was studied in primary human umbilical vein endothelial cells (HUVEC). RT-PCR analyses showed that the expression of the PG serglycin core protein was much higher than that of the extracellular matrix PG decorin and the cell surface PG syndecan-1. PG biosynthesis was further studied by biosynthetic [S-35] sulfate labeling of polarized HUVEC. Interestingly, a major part of S-35-PGs was secreted to the apical medium. A large portion of these PGs was trypsin-resistant, a typical feature of serglycin. The trypsin-resistant PGs were mainly of the chondroitin/dermatan sulfate type but also contained a minor heparan sulfate component. Secreted serglycin was identified by immunoprecipitation as a PG with a core protein of similar to 30 kDa. Serglycin was furthermore shown to be present in perinuclear regions and in two distinct types of vesicles throughout the cytoplasm using immunocytochemistry. To search for possible serglycin partner molecules, HUVEC were stained for the chemokine growth-related oncogene alpha(GRO alpha/CXCL1). Co-localization with serglycin could be demonstrated, although not in all vesicles. Serglycin did not show overt co-localization with tissue-type plasminogen activator-positive vesicles. When PG biosynthesis was abrogated using benzyl-beta-D-xyloside, serglycin secretion was decreased, and the number of vesicles with co-localized serglycin and GRO alpha was reduced. The level of GRO alpha in the apical medium was also reduced after xyloside treatment. Together, these findings indicate that serglycin is a major PG in human endothelial cells, mainly secreted to the apical medium and implicated in chemokine secretion.	[Oynebraten, Inger] Univ Oslo, Inst Immunol, Rikshosp, N-0424 Oslo, Norway; [Meen, Astri J.; Reine, Trine M.; Svennevig, Katja; Kolset, Svein O.] Univ Oslo, Dept Nutr, N-0316 Oslo, Norway; [Duelli, Annette; Pejler, Gunnar] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, BMC, S-75123 Uppsala, Sweden; [Jenssen, Trond] Natl Hosp Norway, Kidney Sect, Dept Internal Med, Oslo Univ Hosp, N-0027 Oslo, Norway; [Jenssen, Trond] Univ Tromso, Inst Clin Med, N-9037 Tromso, Norway	University of Oslo; National Hospital Norway; University of Oslo; Swedish University of Agricultural Sciences; University of Oslo; National Hospital Norway; UiT The Arctic University of Tromso	Oynebraten, I (corresponding author), Univ Oslo, Inst Immunol, Rikshosp, Box 4950, N-0424 Oslo, Norway.	inger.oynebraten@rr-research.no; s.o.kolset@medisin.uio.no	Øynebråten, Inger/W-3369-2019	Øynebråten, Inger/0000-0001-8914-5676	Throne Holst Foundation; Helse Sor-Ost; Norwegian Cancer Society; Swedish Research Council	Throne Holst Foundation; Helse Sor-Ost; Norwegian Cancer Society(Norwegian Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by grants from the Throne Holst Foundation, Helse Sor-Ost, the Norwegian Cancer Society and the Swedish Research Council.	Abrink M, 2004, J BIOL CHEM, V279, P40897, DOI 10.1074/jbc.M405856200; BOURDON MA, 1985, P NATL ACAD SCI USA, V82, P1321, DOI 10.1073/pnas.82.5.1321; Braga T, 2007, BIOCHEM J, V403, P49, DOI 10.1042/BJ20061257; Braga T, 2009, MOL IMMUNOL, V46, P422, DOI 10.1016/j.molimm.2008.10.019; Breland UM, 2008, ARTERIOSCL THROM VAS, V28, P1005, DOI 10.1161/ATVBAHA.108.162305; Cattaruzza S, 2002, J BIOL CHEM, V277, P47626, DOI 10.1074/jbc.M206521200; Chappell D, 2009, CIRC RES, V104, P1313, DOI 10.1161/CIRCRESAHA.108.187831; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Falkowska-Hansen B, 2006, MOL CELL BIOCHEM, V287, P43, DOI 10.1007/s11010-005-9024-3; Graham GJ, 1996, EMBO J, V15, P6506, DOI 10.1002/j.1460-2075.1996.tb01041.x; Grujic M, 2008, J IMMUNOL, V181, P1043, DOI 10.4049/jimmunol.181.2.1043; Han SY, 2006, NEPHROL DIAL TRANSPL, V21, P2406, DOI 10.1093/ndt/gfl238; Iozzo RV, 2001, J CLIN INVEST, V108, P349, DOI 10.1172/JCI13738; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Kolset SO, 2008, CELL MOL LIFE SCI, V65, P1073, DOI 10.1007/s00018-007-7455-6; Kolset SO, 2004, BIOCHEM J, V379, P217, DOI 10.1042/BJ20031230; KOLSET SO, 1990, BIOCHEM J, V265, P637, DOI 10.1042/bj2650637; Kolset SO, 1999, J CELL SCI, V112, P1797; Kolset SO, 1996, J LEUKOCYTE BIOL, V59, P545, DOI 10.1002/jlb.59.4.545; KOLSET SO, 1990, BIOCHIM BIOPHYS ACTA, V1032, P191, DOI 10.1016/0304-419X(90)90004-K; Kolset SO, 2008, GLYCOCONJUGATE J, V25, P305, DOI 10.1007/s10719-007-9073-9; Kulseth MA, 1999, BBA-GEN SUBJECTS, V1428, P225, DOI 10.1016/S0304-4165(99)00096-3; Lemire JM, 2007, J CELL BIOCHEM, V101, P753, DOI 10.1002/jcb.21235; Liu DG, 2001, HISTOCHEM J, V33, P621, DOI 10.1023/A:1016398200087; LUGEMWA FN, 1991, J BIOL CHEM, V266, P6674; Niemann CU, 2007, LEUKEMIA, V21, P2406, DOI 10.1038/sj.leu.2404975; Niemann CU, 2007, BLOOD, V109, P4478, DOI 10.1182/blood-2006-02-001719; Oynebraten I, 2005, J IMMUNOL, V175, P5358, DOI 10.4049/jimmunol.175.8.5358; Oynebraten I, 2004, BLOOD, V104, P314, DOI 10.1182/blood-2003-08-2891; Oynebraten I, 2000, J LEUKOCYTE BIOL, V67, P183, DOI 10.1002/jlb.67.2.183; Pejler G, 2009, BIOFACTORS, V35, P61, DOI 10.1002/biof.11; Prydz K, 2009, GLYCOCONJUGATE J, V26, P1117, DOI 10.1007/s10719-009-9232-2; Raats CJI, 1999, J AM SOC NEPHROL, V10, P1689; Rehm M, 2007, CIRCULATION, V116, P1896, DOI 10.1161/CIRCULATIONAHA.106.684852; Ringvall M, 2008, J ALLERGY CLIN IMMUN, V121, P1020, DOI 10.1016/j.jaci.2007.11.031; Schick BP, 2001, BLOOD, V97, P449, DOI 10.1182/blood.V97.2.449; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; STEVENS RL, 1985, J BIOL CHEM, V260, P4194; Suzuki D, 2002, NEPHRON, V92, P564, DOI 10.1159/000064110; Svennevig K, 2008, PERFUSION-UK, V23, P165, DOI 10.1177/0267659108098215; Theocharis AD, 2006, J BIOL CHEM, V281, P35116, DOI 10.1074/jbc.M601061200; ToyamaSorimachi N, 1997, J BIOL CHEM, V272, P26714, DOI 10.1074/jbc.272.42.26714; Valiyaveettil M, 2004, MOL BIOCHEM PARASIT, V134, P115, DOI 10.1016/j.molbiopara.2003.11.009; Whitelock JM, 1996, J BIOL CHEM, V271, P10079, DOI 10.1074/jbc.271.17.10079; Yasuo T, 2008, J REPROD IMMUNOL, V78, P1, DOI 10.1016/j.jri.2007.09.002; Zernichow L, 2006, J BIOL CHEM, V281, P26792, DOI 10.1074/jbc.M512889200	46	45	46	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2636	2647		10.1074/jbc.M110.151944	http://dx.doi.org/10.1074/jbc.M110.151944			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21075844	Green Published, hybrid			2022-12-25	WOS:000286464300029
J	Rousselet, E; Benjannet, S; Hamelin, J; Canuel, M; Seidah, NG				Rousselet, Estelle; Benjannet, Suzanne; Hamelin, Josee; Canuel, Maryssa; Seidah, Nabil G.			The Proprotein Convertase PC7 UNIQUE ZYMOGEN ACTIVATION AND TRAFFICKING PATHWAYS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE; IN-VITRO; PROHORMONE CONVERTASES; ENDOPLASMIC-RETICULUM; FLUOROGENIC PEPTIDES; POTENT INHIBITORS; FURIN; PROTEIN; GLYCOPROTEIN; PROSEGMENT	The zymogen activation mechanism and physiological functions of the most ancient and highly conserved basic amino acid-specific proprotein convertase 7 (PC7) are not known. Herein, we characterized the biosynthesis, subcellular localization, and trafficking of the membrane-bound full-length rat and human PC7. The prosegment of PC7 is primarily secreted alone as a non-inhibitory protein via the conventional, Golgi-dependent, secretory pathway. Mature PC7 is partially sulfated and thus reaches the cell surface via the conventional route. However, a fraction of PC7 reaches the cell surface through a brefeldin A-and COPII-independent unconventional secretory pathway. The latter trafficking may explain the rapid (< 10 min) transit of a fraction of PC7 from the ER to the cell surface. Electron microscopy further confirmed the localization of PC7 to the cell surface of HEK293 cells. Within the cytosolic tail, only two cysteines (Cys(699) and Cys(704)) are palmitoylated, but this modification does not affect the choice of trafficking pathway. Swapping the transmembrane-cytosolic tail (TMCT) sequences of the convertases Furin and PC7 revealed that PC7(TMCT-Furin) is much more sulfated and hence traffics more efficiently through the conventional secretory pathway. In contrast, the Furin(TMCT-PC7) is no longer sulfated and thus reaches the cell surface by the unconventional pathway. Because trafficking of PC7(CT-Furin) and Furin(CT-PC7) resemble their wild type counterparts, we deduce that the transmembrane domain of PC7 regulates the sorting of PC7 toward the unconventional secretory pathway. In conclusion, PC7 is distinct from other proprotein convertases in its zymogen activation, subcellular localization, and trafficking.	[Rousselet, Estelle; Benjannet, Suzanne; Hamelin, Josee; Canuel, Maryssa; Seidah, Nabil G.] Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Seidah, NG (corresponding author), Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	seidahn@ircm.qc.ca	Seidah, Nabil/I-3596-2013	Seidah, Nabil/0000-0001-6503-9342	CIHR [MOP-44363]; Strauss Foundation; Canada Chair [216684]	CIHR(Canadian Institutes of Health Research (CIHR)); Strauss Foundation; Canada Chair	This research was supported by CIHR Grants MOP-44363, a Strauss Foundation grant, and a Canada Chair Grant 216684.	ALVAREZ E, 1990, J BIOL CHEM, V265, P16644; ARIDOR M, 1995, J CELL BIOL, V131, P875, DOI 10.1083/jcb.131.4.875; Arolas JL, 2007, CURR PHARM DESIGN, V13, P349, DOI 10.2174/138161207780162980; Baldwin TA, 2002, J BIOL CHEM, V277, P50333, DOI 10.1074/jbc.M209075200; Basak A, 2001, BIOCHEM J, V353, P537, DOI 10.1042/0264-6021:3530537; Basak S, 2004, BIOCHEM J, V380, P505, DOI 10.1042/BJ20031405; BENJANNET S, 1991, P NATL ACAD SCI USA, V88, P3564, DOI 10.1073/pnas.88.9.3564; Benjannet S, 2001, J BIOL CHEM, V276, P10879, DOI 10.1074/jbc.M009899200; Bhattacharjya S, 2000, BIOCHEMISTRY-US, V39, P2868, DOI 10.1021/bi9923961; Blais V, 2002, FEBS LETT, V524, P43, DOI 10.1016/S0014-5793(02)02998-8; BOS CR, 1995, J BIOL CHEM, V270, P665, DOI 10.1074/jbc.270.2.665; Canaff L, 1999, ENDOCRINOLOGY, V140, P3633, DOI 10.1210/en.140.8.3633; Creemers JWM, 2008, FRONT BIOSCI-LANDMRK, V13, P4960, DOI 10.2741/3055; Decroly E, 1997, FEBS LETT, V405, P68, DOI 10.1016/S0014-5793(97)00156-7; Decroly E, 1996, J BIOL CHEM, V271, P30442, DOI 10.1074/jbc.271.48.30442; Fugere M, 2007, MOL PHARMACOL, V71, P323, DOI 10.1124/mol.106.027946; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Honke K, 2002, MED RES REV, V22, P637, DOI 10.1002/med.10020; Khatib AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011438; Leonhardt RM, 2010, J IMMUNOL, V184, P2985, DOI 10.4049/jimmunol.0900308; Levine T, 2006, CURR OPIN CELL BIOL, V18, P371, DOI 10.1016/j.ceb.2006.06.011; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; Longpre JM, 2009, INT J BIOCHEM CELL B, V41, P1116, DOI 10.1016/j.biocel.2008.10.008; Lopez-Perez E, 1999, J NEUROCHEM, V73, P2056; MALIDE D, 1995, J HISTOCHEM CYTOCHEM, V43, P11, DOI 10.1177/43.1.7822759; MARCINKIEWICZ M, 1994, ENDOCRINOLOGY, V135, P1651, DOI 10.1210/en.135.4.1651; Marie M, 2008, CELL MOL LIFE SCI, V65, P2859, DOI 10.1007/s00018-008-8355-0; McColl BK, 2007, FASEB J, V21, P1088, DOI 10.1096/fj.06-7060com; Meerabux J, 1996, CANCER RES, V56, P448; Munzer JS, 1997, J BIOL CHEM, V272, P19672, DOI 10.1074/jbc.272.32.19672; Nelsen SM, 2009, J BIOL CHEM, V284, P27157, DOI 10.1074/jbc.M109.028506; Nickel W, 2008, ANNU REV CELL DEV BI, V24, P287, DOI 10.1146/annurev.cellbio.24.110707.175320; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Nour N, 2003, J BIOL CHEM, V278, P2886, DOI 10.1074/jbc.M208009200; Ong E, 1998, J BIOL CHEM, V273, P5190, DOI 10.1074/jbc.273.9.5190; Ozden S, 2008, J BIOL CHEM, V283, P21899, DOI 10.1074/jbc.M802444200; Plaimauer B, 2001, BIOCHEM J, V354, P689, DOI 10.1042/0264-6021:3540689; Roebroek AJM, 1998, DEVELOPMENT, V125, P4863; Scamuffa N, 2008, GUT, V57, P1573, DOI 10.1136/gut.2007.141812; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seidah NG, 2007, J MOL MED, V85, P685, DOI 10.1007/s00109-007-0172-7; Seidah NG, 1999, BRAIN RES, V848, pA14; Seidah NG, 1996, P NATL ACAD SCI USA, V93, P3388, DOI 10.1073/pnas.93.8.3388; SEIDAH NG, 2011, ANN NEW YOR IN PRESS; Siegfried G, 2003, J CLIN INVEST, V111, P1723, DOI 10.1172/JCI200317220; Siezen RJ, 1997, PROTEIN SCI, V6, P501; Staehelin LA, 1997, PLANT J, V11, P1151, DOI 10.1046/j.1365-313X.1997.11061151.x; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; TOKUYASU KT, 1980, HISTOCHEM J, V12, P381, DOI 10.1007/BF01011956; Toure BB, 2000, J BIOL CHEM, V275, P2349, DOI 10.1074/jbc.275.4.2349; van de Loo JWHP, 2000, BIOCHEM J, V352, P827, DOI 10.1042/0264-6021:3520827; vandeLoo JWHP, 1997, J BIOL CHEM, V272, P27116, DOI 10.1074/jbc.272.43.27116; Villeneuve P, 2002, J NEUROCHEM, V82, P783, DOI 10.1046/j.1471-4159.2002.00988.x; Wouters S, 1999, FEBS LETT, V456, P97, DOI 10.1016/S0014-5793(99)00938-2; Zaid A, 2008, HEPATOLOGY, V48, P646, DOI 10.1002/hep.22354; Zhong M, 1999, J BIOL CHEM, V274, P33913, DOI 10.1074/jbc.274.48.33913	59	40	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2728	2738		10.1074/jbc.M110.192344	http://dx.doi.org/10.1074/jbc.M110.192344			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21075846	Green Published, hybrid			2022-12-25	WOS:000286464300039
J	Zhang, YW; Rudnick, G				Zhang, Yuan-Wei; Rudnick, Gary			Myristoylation of cGMP-dependent Protein Kinase Dictates Isoform Specificity for Serotonin Transporter Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLACENTAL CHORIOCARCINOMA CELLS; OBSESSIVE-COMPULSIVE DISORDER; CYCLIC-GMP; NITRIC-OXIDE; RAT-BRAIN; IN-VITRO; PHOSPHORYLATION; ACTIVATION; RECEPTORS; STIMULATION	By transporting serotonin (5-HT) into neurons and other cells, serotonin transporter (SERT) modulates the action of 5-HT at cell surface receptors. SERT itself is modulated by several processes, including the cGMP signaling pathway. Activation of SERT by cGMP requires the cGMP-dependent protein kinase (PKG). Here we show that in HeLa cells lacking endogenous PKG, expression of PKGI alpha or PKGI beta was required for 8-bromoguanosine-3',5'-cyclic monophosphate (8-Br-cGMP) to stimulate SERT phosphorylation and 5-HT influx. Catalytically inactive PKG mutants and wild-type PKGII did not support this stimulation. However, a mutant PKGII (G2A) that was not myristoylated substituted for functional PKGI, suggesting that myristoylation and subsequent membrane association blocked productive interaction with SERT. PKG also influenced SERT expression and localization. PKGI isoforms increased total and cell surface SERT levels, and PKGII decreased cell surface SERT without altering total expression. Remarkably, these changes did not require 8-Br-cGMP or functional kinase activity and were also observed with a SERT mutant resistant to activation by PKG. Both PKGI alpha and PKGI beta formed detergent-stable complexes with SERT, and this association did not require catalytic activity. The nonmyr-istoylated PKGII G2A mutant stimulated SERT expression similar to PKGI isoforms. These results suggest multiple mechanisms by which PKG can modulate SERT and demonstrate that the functional difference between PKG isoforms results from myristoylation of PKGII.	[Zhang, Yuan-Wei; Rudnick, Gary] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	Yale University	Rudnick, G (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	gary.rudnick@yale.edu		ZHANG, YUAN-WEI/0000-0002-4276-9251	National Institutes of Health [DA008213]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA008213] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant DA008213 (to G.R.).	Bauman AL, 2000, J NEUROSCI, V20, P7571; BLAKELY RD, 1991, ANAL BIOCHEM, V194, P302, DOI 10.1016/0003-2697(91)90233-J; BUTT E, 1994, J BIOL CHEM, V269, P14509; Chanrion B, 2007, P NATL ACAD SCI USA, V104, P8119, DOI 10.1073/pnas.0610964104; Ciccone MA, 2008, NEUROPHARMACOLOGY, V55, P763, DOI 10.1016/j.neuropharm.2008.06.018; De Vente J, 2001, NEUROSCIENCE, V108, P27, DOI 10.1016/S0306-4522(01)00401-8; Delorme R, 2005, MOL PSYCHIATR, V10, P1059, DOI 10.1038/sj.mp.4001728; ELHUSSEINI AED, 1995, J NEUROCHEM, V64, P2814; Gambaryan S, 2003, J BIOL CHEM, V278, P29640, DOI 10.1074/jbc.M302143200; Geiselhoringer A, 2004, FEBS LETT, V575, P19, DOI 10.1016/j.febslet.2004.08.030; Hoenderop JGJ, 1999, P NATL ACAD SCI USA, V96, P6084, DOI 10.1073/pnas.96.11.6084; JAYANTHI LD, 1994, J BIOL CHEM, V269, P14424; Kilic F, 2003, MOL PHARMACOL, V64, P440, DOI 10.1124/mol.64.2.440; Lincoln T M, 1995, Adv Pharmacol, V34, P305; Lohmann SM, 1997, TRENDS BIOCHEM SCI, V22, P307, DOI 10.1016/S0968-0004(97)01086-4; MILLER KJ, 1994, J BIOL CHEM, V269, P27351; Murphy DL, 1998, J CLIN PSYCHIAT, V59, P4; Ozaki N, 2003, MOL PSYCHIATR, V8, P933, DOI 10.1038/sj.mp.4001365; Prasad HC, 2005, P NATL ACAD SCI USA, V102, P11545, DOI 10.1073/pnas.0501432102; Qian Y, 1997, J NEUROSCI, V17, P45, DOI 10.1523/JNEUROSCI.17-01-00045.1997; RAMAMOORTHY S, 1993, J BIOL CHEM, V268, P21626; Ramamoorthy S, 1998, J BIOL CHEM, V273, P2458, DOI 10.1074/jbc.273.4.2458; Ramamoorthy S, 2007, J BIOL CHEM, V282, P11639, DOI 10.1074/jbc.M611353200; Smolenski A, 1998, N-S ARCH PHARMACOL, V358, P134, DOI 10.1007/PL00005234; Smolenski A, 1998, J BIOL CHEM, V273, P20029, DOI 10.1074/jbc.273.32.20029; Stahl SM, 1998, J AFFECT DISORDERS, V51, P215, DOI 10.1016/S0165-0327(98)00221-3; Steiner JA, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-26; Vaandrager AB, 1996, J BIOL CHEM, V271, P7025, DOI 10.1074/jbc.271.12.7025; Vaandrager AB, 2005, FRONT BIOSCI-LANDMRK, V10, P2150, DOI 10.2741/1687; Vaandrager AB, 1996, MOL CELL BIOCHEM, V157, P23, DOI 10.1007/BF00227877; Vaandrager AB, 1998, P NATL ACAD SCI USA, V95, P1466, DOI 10.1073/pnas.95.4.1466; Zhang YW, 2007, J NEUROSCI, V27, P10878, DOI 10.1523/JNEUROSCI.0034-07.2007; Zhang YW, 2006, J BIOL CHEM, V281, P36213, DOI 10.1074/jbc.M605468200; Zhang YW, 2005, J BIOL CHEM, V280, P30807, DOI 10.1074/jbc.M504087200; Zhu CB, 2004, MOL PHARMACOL, V65, P1462, DOI 10.1124/mol.65.6.1462; Zhu CB, 2005, J BIOL CHEM, V280, P15649, DOI 10.1074/jbc.M410858200; Zhu CB, 2004, EUR J PHARMACOL, V504, P1, DOI 10.1016/j.ejphar.2004.09.023; Zhu CB, 2007, J PHARMACOL EXP THER, V322, P332, DOI 10.1124/jpet.107.121665	38	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2461	2468		10.1074/jbc.M110.203935	http://dx.doi.org/10.1074/jbc.M110.203935			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21097501	hybrid, Green Published			2022-12-25	WOS:000286464300010
J	Lalle, M; Curra, C; Ciccarone, F; Pace, T; Cecchetti, S; Fantozzi, L; Ay, B; Breton, CB; Ponzi, M				Lalle, Marco; Curra, Chiara; Ciccarone, Fabio; Pace, Tomasino; Cecchetti, Serena; Fantozzi, Luca; Ay, Bernhard; Breton, Catherine Braun; Ponzi, Marta			Dematin, a Component of the Erythrocyte Membrane Skeleton, Is Internalized by the Malaria Parasite and Associates with Plasmodium 14-3-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-BLOOD-CELLS; DEPENDENT PROTEIN-KINASE; INFECTED ERYTHROCYTES; EXPORTED PROTEINS; HOST ERYTHROCYTE; STREPTOLYSIN-O; GLYCOPHORIN-C; FALCIPARUM; PHOSPHORYLATION; BINDING	The malaria parasite invades the terminally differentiated erythrocytes, where it grows and multiplies surrounded by a parasitophorous vacuole. Plasmodium blood stages translocate newly synthesized proteins outside the parasitophorous vacuole and direct them to various erythrocyte compartments, including the cytoskeleton and the plasma membrane. Here, we show that the remodeling of the host cell directed by the parasite also includes the recruitment of dematin, an actin-binding protein of the erythrocyte membrane skeleton and its repositioning to the parasite. Internalized dematin was found associated with Plasmodium 14-3-3, which belongs to a family of conserved multitask molecules. We also show that, in vitro, the dematin-14-3-3 interaction is strictly dependent on phosphorylation of dematin at Ser(124) and Ser(333), belonging to two 14-3-3 putative binding motifs. This study is the first report showing that a component of the erythrocyte spectrin-based membrane skeleton is recruited by the malaria parasite following erythrocyte infection.	[Lalle, Marco; Curra, Chiara; Ciccarone, Fabio; Pace, Tomasino; Fantozzi, Luca; Ponzi, Marta] Ist Super Sanita, Dipartimento Malattie Infett Parassitarie & Immun, I-00161 Rome, Italy; [Cecchetti, Serena] Ist Super Sanita, Dipartimento Biol Cellulare & Neurosci, I-00161 Rome, Italy; [Ay, Bernhard] Charite, Inst Med Immunol, D-10115 Berlin, Germany; [Breton, Catherine Braun] Univ Montpellier 2, F-34095 Montpellier, France	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Universite de Montpellier	Ponzi, M (corresponding author), Ist Super Sanita, Dipartimento Malattie Infett Parassitarie & Immun, Viale Regina Elena 299, I-00161 Rome, Italy.	marta.ponzi@iss.it	Cecchetti, Serena/N-1061-2015; CICCARONE, FABIO/K-4225-2016; Ciccarone, Fabio/AAR-9128-2021; Lalle, Marco/O-2287-2015	Cecchetti, Serena/0000-0002-3601-176X; Ciccarone, Fabio/0000-0002-2425-2240; Lalle, Marco/0000-0001-5168-2150; Ponzi, Marta/0000-0003-0936-3548; Curra, Chiara/0000-0001-7851-1087	European Commission [242095]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by grants from the European Commission Seventh Framework Programme (FP7/2007-2013) under Grant Agreement 242095.	Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Al-Khedery B, 1999, MOL BIOCHEM PARASIT, V102, P117, DOI 10.1016/S0166-6851(99)00090-0; Anong WA, 2009, BLOOD, V114, P1904, DOI 10.1182/blood-2009-02-203216; Ansorge I, 1996, BIOCHEM J, V315, P307, DOI 10.1042/bj3150307; AZIM AC, 1995, J BIOL CHEM, V270, P17407, DOI 10.1074/jbc.270.29.17407; BEHARI R, 1994, EXP PARASITOL, V79, P250, DOI 10.1006/expr.1994.1088; Birago C, 2003, MOL BIOCHEM PARASIT, V126, P209, DOI 10.1016/S0166-6851(02)00275-X; Blisnick T, 2000, MOL BIOCHEM PARASIT, V111, P107, DOI 10.1016/S0166-6851(00)00301-7; Bruce LJ, 2003, BLOOD, V101, P4180, DOI 10.1182/blood-2002-09-2824; Chandramohanadas R, 2009, SCIENCE, V324, P794, DOI 10.1126/science.1171085; Chishti AH, 1996, BLOOD, V87, P3462, DOI 10.1182/blood.V87.8.3462.bloodjournal8783462; Coblitz B, 2005, J BIOL CHEM, V280, P36263, DOI 10.1074/jbc.M507559200; Collins MO, 2005, J BIOL CHEM, V280, P5972, DOI 10.1074/jbc.M411220200; Cortes A, 2004, BLOOD, V104, P2961, DOI 10.1182/blood-2004-06-2136; Dat MHQ, 2000, PARASITE IMMUNOL, V22, P535, DOI 10.1046/j.1365-3024.2000.00333.x; Dhermy D, 2007, CURR OPIN HEMATOL, V14, P198, DOI 10.1097/MOH.0b013e3280d21afd; Di Girolamo F, 2008, PROTEOMICS, V8, P2500, DOI 10.1002/pmic.200700763; Gilligan DM, 1999, P NATL ACAD SCI USA, V96, P10717, DOI 10.1073/pnas.96.19.10717; Gonzalez V, 2009, CELL HOST MICROBE, V5, P259, DOI 10.1016/j.chom.2009.01.011; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; HOSEY MM, 1976, BIOCHEMISTRY-US, V15, P1561, DOI 10.1021/bi00652a029; HUSAINCHISHTI A, 1988, NATURE, V334, P718, DOI 10.1038/334718a0; Jackson KE, 2007, BIOCHEM J, V403, P167, DOI 10.1042/BJ20061725; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; JANSE CJ, 1995, PARASITOL TODAY, V11, P138, DOI 10.1016/0169-4758(95)80133-2; Khan AA, 2008, J BIOL CHEM, V283, P14600, DOI 10.1074/jbc.M707818200; Khanna R, 2002, P NATL ACAD SCI USA, V99, P6637, DOI 10.1073/pnas.052155999; Lalle M, 2006, J BIOL CHEM, V281, P5137, DOI 10.1074/jbc.M509673200; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Maier AG, 2009, NAT REV MICROBIOL, V7, P341, DOI 10.1038/nrmicro2110; MARFATIA SM, 1994, J BIOL CHEM, V269, P8631; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Muro AF, 2000, BLOOD, V95, P3978; Petosa C, 1998, J BIOL CHEM, V273, P16305, DOI 10.1074/jbc.273.26.16305; PLUT DA, 1978, EUR J BIOCHEM, V82, P333, DOI 10.1111/j.1432-1033.1978.tb12027.x; READ LK, 1991, MOL BIOCHEM PARASIT, V45, P109, DOI 10.1016/0166-6851(91)90032-2; Rubio MP, 2003, EMBO J, V22, P3514, DOI 10.1093/emboj/cdg363; Sudo A, 2008, MOL BIOCHEM PARASIT, V160, P138, DOI 10.1016/j.molbiopara.2008.03.011; Syin C, 2001, EUR J BIOCHEM, V268, P4842, DOI 10.1046/j.1432-1327.2001.02403.x; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Trasarti E, 2007, MOL BIOCHEM PARASIT, V152, P159, DOI 10.1016/j.molbiopara.2006.12.010; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0	43	25	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1227	1236		10.1074/jbc.M110.194613	http://dx.doi.org/10.1074/jbc.M110.194613			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21084299	Green Published, hybrid			2022-12-25	WOS:000286005000034
J	Nogues, L; Salcedo, A; Mayor, F; Penela, P				Nogues, Laura; Salcedo, Alicia; Mayor, Federico, Jr.; Penela, Petronila			Multiple Scaffolding Functions of beta-Arrestins in the Degradation of G Protein-coupled Receptor Kinase 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT DEGRADATION; ERK ACTIVATION; MDM2; GRKS; UBIQUITINATION; EXPRESSION; ROLES; TRAFFICKING; BETA-ARRESTIN-2; INTERACTOME	G protein-coupled receptor kinase 2 (GRK2) plays a fundamental role in the regulation of G protein-coupled receptors (GPCRs), and changes in GRK2 expression levels can have an important impact on cell functions. GRK2 is known to be degraded by the proteasome pathway. We have shown previously that beta-arrestins participate in enhanced kinase turnover upon GPCR stimulation by facilitating GRK2 phosphorylation by c-Src or by MAPK or by recruiting the Mdm2 E3 ubiquitin ligase to the receptor complex. In this report, we have investigated how such diverse beta-arrestin scaffold functions are integrated to modulate GRK2 degradation. Interestingly, we found that in the absence of GPCR activation, beta-arrestins do not perform an adaptor role for GRK2/Mdm2 association, but rather compete with GRK2 for direct Mdm2 binding to regulate basal kinase turnover. Upon agonist stimulation, beta-arrestins-mediated phosphorylation of GRK2 at serine 670 by MAPK facilitates Mdm2-mediated GRK2 degradation, whereas c-Src-dependent phosphorylation would support the action of an undetermined beta-arrestin-recruited ligase in the absence of GPCR activation. The ability of beta-arrestins to play different scaffold functions would allow coordination of both Mdm2-dependent and-independent processes aimed at the specific modulation of GRK2 turnover in different signaling contexts.	[Penela, Petronila] Univ Autonoma Madrid, CSIC, Dept Biol Mol, Madrid 28049, Spain; Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Madrid 28049, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Penela, P (corresponding author), Univ Autonoma Madrid, CSIC, Dept Biol Mol, Madrid 28049, Spain.	ppenela@cbm.uam.es	Mayor, Federico/N-7644-2016	Mayor Menendez, Federico/0000-0003-1434-8449	Ministerio de Educacion y Ciencia [SAF2008-00552]; Fundacion Mutua Madrilena; Fundacion Ramon Areces; Cardiovascular Network (RECAVA) of Ministerio Sanidad y Consumo-Instituto Carlos III [RD06-0014/0037]; Comunidad de Madrid [S-SAL-0159-2006]; Comunidad de Madrid and Universidad Autonoma de Madrid [CCG08-UAM/BIO-4452]	Ministerio de Educacion y Ciencia(Spanish Government); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Fundacion Ramon Areces; Cardiovascular Network (RECAVA) of Ministerio Sanidad y Consumo-Instituto Carlos III; Comunidad de Madrid(Comunidad de Madrid); Comunidad de Madrid and Universidad Autonoma de Madrid	This work was supported by Ministerio de Educacion y Ciencia Grant SAF2008-00552, Fundacion Mutua Madrilena, Fundacion Ramon Areces, the Cardiovascular Network (RECAVA) of Ministerio Sanidad y Consumo-Instituto Carlos III Grant RD06-0014/0037, Comunidad de Madrid Grant S-SAL-0159-2006 (to F.M., Jr.), and Comunidad de Madrid and Universidad Autonoma de Madrid Grant CCG08-UAM/BIO-4452 (to P.P.).	Berthouze M, 2009, EMBO J, V28, P1684, DOI 10.1038/emboj.2009.128; Bezard E, 2005, NEUROBIOL DIS, V18, P323, DOI 10.1016/j.nbd.2004.10.005; Buchanan FG, 2006, P NATL ACAD SCI USA, V103, P1492, DOI 10.1073/pnas.0510562103; Bychkov ER, 2008, NEUROBIOL AGING, V29, P379, DOI 10.1016/j.neurobiolaging.2006.10.012; Chen ZG, 2003, CELL SIGNAL, V15, P843, DOI 10.1016/S0898-6568(03)00056-1; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Elorza A, 2003, J BIOL CHEM, V278, P29164, DOI 10.1074/jbc.M304314200; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Girnita L, 2005, J BIOL CHEM, V280, P24412, DOI 10.1074/jbc.M501129200; Gu L, 2003, FEBS LETT, V544, P218, DOI 10.1016/S0014-5793(03)00502-7; Hanson SM, 2007, J MOL BIOL, V368, P375, DOI 10.1016/j.jmb.2007.02.053; Ho J, 2005, EMBO J, V24, P3247, DOI 10.1038/sj.emboj.7600794; Hupfeld CJ, 2005, J BIOL CHEM, V280, P1016, DOI 10.1074/jbc.M403674200; Hurle MA, 2001, J NEUROCHEM, V77, P486, DOI 10.1046/j.1471-4159.2001.00268.x; Jiang X, 2009, P NATL ACAD SCI USA, V106, P10183, DOI 10.1073/pnas.0812105106; Jimenez-Sainz MC, 2003, MOL PHARMACOL, V64, P773, DOI 10.1124/mol.64.3.773; Kovacs JJ, 2009, DEV CELL, V17, P443, DOI 10.1016/j.devcel.2009.09.011; Krupnick JG, 1997, J BIOL CHEM, V272, P32507, DOI 10.1074/jbc.272.51.32507; Lakshmikanthan V, 2009, P NATL ACAD SCI USA, V106, P9379, DOI 10.1073/pnas.0900258106; Li X, 2009, J BIOL CHEM, V284, P16170, DOI 10.1074/jbc.M109.008078; Lombardi MS, 2004, STROKE, V35, P981, DOI 10.1161/01.STR.0000121644.82596.7e; Loniewski K, 2008, MOL IMMUNOL, V45, P2312, DOI 10.1016/j.molimm.2007.11.012; Metaye T, 2005, CELL SIGNAL, V17, P917, DOI 10.1016/j.cellsig.2005.01.002; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Penela P, 2006, CARDIOVASC RES, V69, P46, DOI 10.1016/j.cardiores.2005.09.011; Penela P, 2003, CELL SIGNAL, V15, P973, DOI 10.1016/S0898-6568(03)00099-8; Penela P, 1998, J BIOL CHEM, V273, P35238, DOI 10.1074/jbc.273.52.35238; Penela P, 2001, ENDOCRINOLOGY, V142, P987, DOI 10.1210/en.142.3.987; Penela P, 2001, EMBO J, V20, P5129, DOI 10.1093/emboj/20.18.5129; Penela P, 2008, EMBO J, V27, P1206, DOI 10.1038/emboj.2008.55; Penela P, 2010, BRIT J PHARMACOL, V160, P821, DOI 10.1111/j.1476-5381.2010.00727.x; Penela P, 2010, P NATL ACAD SCI USA, V107, P1118, DOI 10.1073/pnas.0905778107; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Ribas C, 2007, BBA-BIOMEMBRANES, V1768, P913, DOI 10.1016/j.bbamem.2006.09.019; Salcedo A, 2006, EMBO J, V25, P4752, DOI 10.1038/sj.emboj.7601351; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2009, P NATL ACAD SCI USA, V106, P6650, DOI 10.1073/pnas.0901083106; Song XF, 2006, J BIOL CHEM, V281, P21491, DOI 10.1074/jbc.M603659200; Vinge LE, 2001, AM J PHYSIOL-HEART C, V281, pH2490, DOI 10.1152/ajpheart.2001.281.6.H2490; Vroon A, 2006, J LEUKOCYTE BIOL, V80, P1214, DOI 10.1189/jlb.0606373; Wang P, 2003, J BIOL CHEM, V278, P6363, DOI 10.1074/jbc.M210350200; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676	44	24	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1165	1173		10.1074/jbc.M110.203406	http://dx.doi.org/10.1074/jbc.M110.203406			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21081496	Green Published, hybrid			2022-12-25	WOS:000286005000027
J	Agot, KE; Stoep, AV; Tracy, M; Obare, BA; Bukusi, EA; Ndinya-Achola, JO; Moses, S; Weiss, NS				Agot, Kawango E.; Stoep, Ann Vander; Tracy, Melissa; Obare, Billy A.; Bukusi, Elizabeth A.; Ndinya-Achola, Jeckoniah O.; Moses, Stephen; Weiss, Noel S.			Widow Inheritance and HIV Prevalence in Bondo District, Kenya: Baseline Results from a Prospective Cohort Study	PLOS ONE			English	Article							HIV/AIDS	Background: Widow Inheritance is a widespread cultural practice in sub-Saharan Africa that has been postulated as contributing to risk of HIV transmission. We present baseline results from a study designed to investigate the association between widow inheritance and HIV acquisition. Methods and Findings: We performed a cross-sectional analysis of baseline data from a prospective cohort study to investigate if widow inheritance is a risk practice for HIV infection. Study participants were 1,987 widows who were interviewed regarding their inheritance status and sexual behavior profile and tested for HIV. Of these widows, 56.3% were inherited. HIV prevalence, at 63%, was similar among non-inherited and inherited widows. We stratified exposure status by the relationship of the widow to the inheritor and the reason for inheritance, and reexamined the HIV status of four subgroups of inherited women relative to the HIV status of non-inherited women. When adjusting for age and level of formal education, widows who were inherited by non-relatives for sexual ritual were significantly more likely to be infected than widows who were not inherited (OR = 2.07; 95% CI 1.49-2.86); widows who were inherited by relatives for sexual ritual also had elevated odds of HIV infection (OR = 1.34; 95% CI = 1.07-1.70). Widows who were inherited by relatives for companionship were less likely than women who were not inherited to be infected with HIV (OR = 0.85; 95% CI 0.63-1.14). Conclusions: HIV prevalence among inherited widows varied depending upon why and by whom they were inherited. The cohort study will determine the risk for HIV acquisition among the HIV seronegative widows in this sample.	[Agot, Kawango E.; Obare, Billy A.] Dept Res Impact Res & Dev Org, Kisumu, Kenya; [Stoep, Ann Vander; Weiss, Noel S.] Univ Washington, Dept Epidemiol, Sch Publ Hlth, Seattle, WA 98195 USA; [Tracy, Melissa] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Bukusi, Elizabeth A.] Kenya Govt Med Res Ctr, Ctr Microbiol Res, Nairobi, Kenya; [Ndinya-Achola, Jeckoniah O.] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya; [Moses, Stephen] Univ Manitoba, Dept Community Hlth Sci & Med Microbiol, Winnipeg, MB, Canada	University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; Kenya Medical Research Institute; University of Nairobi; University of Manitoba	Agot, KE (corresponding author), Dept Res Impact Res & Dev Org, Kisumu, Kenya.	mamagifto@yahoo.com			Fogarty International Center, National Institutes of Health (NIH) [TW06230]; FOGARTY INTERNATIONAL CENTER [R01TW006230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER	Fogarty International Center, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported by the Fogarty International Center, National Institutes of Health (NIH), Research Grant # TW06230. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Hence the opinions expressed herein are those of the authors and do not necessarily reflect the views of the NIH or the Fogarty International Center.	AGOT EK, 2005, COMPANION FEMINIST G, P363; Agot KE, 2008, ROUTL RES GEND SOC, V14, P287; Agot KE, 2004, EPIDEMIOLOGY, V15, P157, DOI 10.1097/01.ede.0000112220.16977.82; Ambasa-Shisanya C R, 2007, SAHARA J, V4, P606; Amornkul PN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006470; Ayikukwei R, 2008, CULT HEALTH SEX, V10, P587, DOI 10.1080/13691050802012601; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; *GOV NETW, 1997, 4 GOV NETW; GUNGA SO, 2009, J PHILOS ASS KENYA, V1, P161; Gwako ELM, 1998, J ANTHROPOL RES, V54, P173; *INT REG INF NETW, 2007, SAT WIF INH WID CLEA; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2009, AIDS EP UPD 2009; Kenya national Bureau of statistics (KNBS) and ICF macro, 2010, KEN DEM HLTH SURV 20; Lopman BA, 2009, SEX TRANSM INFECT, V85, pI41, DOI 10.1136/sti.2008.033043; Luginaah I, 2005, SOC SCI MED, V60, P1219, DOI 10.1016/j.socscimed.2004.07.010; Mabumba ED, 2007, TROP DOCT, V37, P229, DOI 10.1258/004947507782332955; Mboya Paul, 1997, LUO KITGI GI TIMBEGI; *MIN HLTH CENTR BU, 2004, KEN DEM HLTH SURV; *NASCOP, 2007, KEN AIDS IND SURV FI; Ntozi J P, 1997, Health Transit Rev, V7 Suppl, P125; Nyanzi S, 2009, CAN J AFR STUDIES, V43, P12, DOI 10.1080/00083968.2010.9707581; Okeyo T M, 1994, Afr J Med Pract, V1, P20; Stover J, 2004, SEX TRANSM INFECT, V80, DOI 10.1136/sti.2004.010157; *UN HIGH COMM REF, 2000, ZIMB WID INH MEMB DE; *UN HIGH COMM REF, 2008, KEN WID INH KIS SUBT	25	32	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2010	5	11							e14028	10.1371/journal.pone.0014028	http://dx.doi.org/10.1371/journal.pone.0014028			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681OY	21103347	Green Submitted, Green Published, gold			2022-12-25	WOS:000284327800014
J	Bittner, T; Fuhrmann, M; Burgold, S; Ochs, SM; Hoffmann, N; Mitteregger, G; Kretzschmar, H; LaFerla, FM; Herms, J				Bittner, Tobias; Fuhrmann, Martin; Burgold, Steffen; Ochs, Simon M.; Hoffmann, Nadine; Mitteregger, Gerda; Kretzschmar, Hans; LaFerla, Frank M.; Herms, Jochen			Multiple Events Lead to Dendritic Spine Loss in Triple Transgenic Alzheimer's Disease Mice	PLOS ONE			English	Article							AMYLOID-PRECURSOR-PROTEIN; NEOCORTEX IN-VIVO; A-BETA; SYNAPSE LOSS; LONG-TERM; NEUROFIBRILLARY TANGLES; MOUSE MODEL; COGNITIVE IMPAIRMENT; SENILE PLAQUES; ADULT CORTEX	The pathology of Alzheimer's disease (AD) is characterized by the accumulation of amyloid-beta (A beta) peptide, hyperphosphorylated tau protein, neuronal death, and synaptic loss. By means of long-term two-photon in vivo imaging and confocal imaging, we characterized the spatio-temporal pattern of dendritic spine loss for the first time in 3xTg-AD mice. These mice exhibit an early loss of layer III neurons at 4 months of age, at a time when only soluble A beta is abundant. Later on, dendritic spines are lost around amyloid plaques once they appear at 13 months of age. At the same age, we observed spine loss also in areas apart from amyloid plaques. This plaque independent spine loss manifests exclusively at dystrophic dendrites that accumulate both soluble A beta and hyperphosphorylated tau intracellularly. Collectively, our data shows that three spatio-temporally independent events contribute to a net loss of dendritic spines. These events coincided either with the occurrence of intracellular soluble or extracellular fibrillar A beta alone, or the combination of intracellular soluble A beta and hyperphosphorylated tau.	[Bittner, Tobias; Fuhrmann, Martin; Burgold, Steffen; Ochs, Simon M.; Hoffmann, Nadine; Mitteregger, Gerda; Kretzschmar, Hans; Herms, Jochen] Univ Munich, Ctr Neuropathol & Pr Res, Munich, Germany; [LaFerla, Frank M.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA USA	University of Munich; University of California System; University of California Irvine	Bittner, T (corresponding author), Univ Munich, Ctr Neuropathol & Pr Res, Munich, Germany.	jochen.herms@med.uni-muenchen.de	Herms, Jochen/D-3518-2011; Fuhrmann, Martin/J-2707-2018; Fuhrmann, Martin/E-4565-2011	Fuhrmann, Martin/0000-0001-7672-2913; 	Deutsche Forschungsgemeinschaft [SFB 596, A13]; Bavarian State Ministry for Science, Research and Arts (ForNeuroCell); German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung) [01GZ0713, 13N10644]; German Federal Ministry of Economics and Technology (Bundesministerium fur Wirtschaft und Technologie) [16IN0675]; European Union [Neuro.GSK3, FP-7-223276]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bavarian State Ministry for Science, Research and Arts (ForNeuroCell); German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Economics and Technology (Bundesministerium fur Wirtschaft und Technologie)(Federal Ministry for Economic Affairs and Energy (BMWi)); European Union(European Commission)	This work was supported by grants to JH from the Deutsche Forschungsgemeinschaft (SFB 596, A13), the Bavarian State Ministry for Science, Research and Arts (ForNeuroCell), the German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, 01GZ0713, 13N10644), the German Federal Ministry of Economics and Technology (Bundesministerium fur Wirtschaft und Technologie, 16IN0675), and the European Union (Neuro.GSK3, FP-7-223276). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akram A, 2008, NEUROBIOL AGING, V29, P1296, DOI 10.1016/j.neurobiolaging.2007.03.007; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Bittner T, 2009, J NEUROSCI, V29, P10405, DOI 10.1523/JNEUROSCI.2288-09.2009; Blennow K, 1996, J NEURAL TRANSM, V103, P603, DOI 10.1007/BF01273157; BRION JP, 1985, J SUBMICR CYTOL PATH, V17, P89; DAVIES CA, 1987, J NEUROL SCI, V78, P151, DOI 10.1016/0022-510X(87)90057-8; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; DICKSON DW, 1995, NEUROBIOL AGING, V16, P285, DOI 10.1016/0197-4580(95)00013-5; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fuhrmann M, 2007, J NEUROSCI, V27, P6224, DOI 10.1523/JNEUROSCI.5062-06.2007; Fuhrmann M, 2010, NAT NEUROSCI, V13, P411, DOI 10.1038/nn.2511; GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/pnas.85.11.4051; Gogolla N, 2006, NAT PROTOC, V1, P2452, DOI 10.1038/nprot.2006.180; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Grutzendler J, 2007, ANN NY ACAD SCI, V1097, P30, DOI 10.1196/annals.1379.003; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; HORN G, 1985, J NEUROSCI, V5, P3161; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Knafo S, 2009, CEREB CORTEX, V19, P586, DOI 10.1093/cercor/bhn111; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lanz TA, 2003, NEUROBIOL DIS, V13, P246, DOI 10.1016/S0969-9961(03)00079-2; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; MASLIAH E, 1989, NEUROSCI LETT, V103, P234, DOI 10.1016/0304-3940(89)90582-X; Moechars D, 1999, J BIOL CHEM, V274, P6483, DOI 10.1074/jbc.274.10.6483; MOSER MB, 1994, P NATL ACAD SCI USA, V91, P12673, DOI 10.1073/pnas.91.26.12673; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Oddo S, 2006, J BIOL CHEM, V281, P1599, DOI 10.1074/jbc.M507892200; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Scheff SW, 2006, NEUROBIOL AGING, V27, P1372, DOI 10.1016/j.neurobiolaging.2005.09.012; Segal M, 2002, PROG BRAIN RES, V138, P53, DOI 10.1016/S0079-6123(02)38070-1; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Spires TL, 2005, J NEUROSCI, V25, P7278, DOI 10.1523/JNEUROSCI.1879-05.2005; Spires-Jones TL, 2007, AM J PATHOL, V171, P1304, DOI 10.2353/ajpath.2007.070055; Sze CI, 1997, J NEUROPATH EXP NEUR, V56, P933, DOI 10.1097/00005072-199708000-00011; TERRY RD, 1981, ANN NEUROL, V10, P184, DOI 10.1002/ana.410100209; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Tsai J, 2004, NAT NEUROSCI, V7, P1181, DOI 10.1038/nn1335; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wei W, 2010, NAT NEUROSCI, V13, P190, DOI 10.1038/nn.2476; Zuo Y, 2005, NATURE, V436, P261, DOI 10.1038/nature03715	54	113	116	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e15477	10.1371/journal.pone.0015477	http://dx.doi.org/10.1371/journal.pone.0015477			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103384	gold, Green Published			2022-12-25	WOS:000284257400026
J	Rusciani, A; Duca, L; Sartelet, H; Chatron-Colliet, A; Bobichon, H; Ploton, D; Le Naour, R; Blaise, S; Martiny, L; Debelle, L				Rusciani, Anthony; Duca, Laurent; Sartelet, Herve; Chatron-Colliet, Aurore; Bobichon, Helene; Ploton, Dominique; Le Naour, Richard; Blaise, Sebastien; Martiny, Laurent; Debelle, Laurent			Elastin Peptides Signaling Relies on Neuraminidase-1-Dependent Lactosylceramide Generation	PLOS ONE			English	Article							CULTURED FIBROBLASTS; ENDOTHELIAL-CELLS; LIPID DOMAINS; UP-REGULATION; RECEPTOR; RAFTS; PROTEIN; MATRIX; GROWTH; PROLIFERATION	The sialidase activity of neuraminidase-1 (Neu-1) is responsible for ERK 1/2 pathway activation following binding of elastin peptide on the elastin receptor complex. In this work, we demonstrate that the receptor and lipid rafts colocalize at the plasma membrane. We also show that the disruption of these microdomains as well as their depletion in glycolipids blocks the receptor signaling. Following elastin peptide treatment, the cellular GM(3) level decreases while lactosylceramide (LacCer) content increases consistently with a GM(3)/LacCer conversion. The use of lactose or Neu-1 siRNA blocks this process suggesting that the elastin receptor complex is responsible for this lipid conversion. Flow cytometry analysis confirms this elastin peptide-driven LacCer generation. Further, the use of a monoclonal anti-GM(3) blocking antibody shows that GM(3) is required for signaling. In conclusion, our data strongly suggest that Neu-1-dependent GM(3)/LacCer conversion is the key event leading to signaling by the elastin receptor complex. As a consequence, we propose that LacCer is an early messenger for this receptor.	[Rusciani, Anthony; Duca, Laurent; Sartelet, Herve; Blaise, Sebastien; Martiny, Laurent; Debelle, Laurent] Univ Reims, Fac Sci, UMR CNRS 6237, Lab Signalisat & Recepteurs Matriciels SiRMa, Reims, France; [Chatron-Colliet, Aurore; Bobichon, Helene; Ploton, Dominique] Univ Reims, Fac Pharm, UMR CNRS 6237, Lab Medicament Dynam Intracellulaire Architecture, Reims, France; [Le Naour, Richard] Fac Pharm, EA Inflammat & Immun Appareil Resp 4303, Lab Immunol & Microbiol, Reims, France	Universite de Reims Champagne-Ardenne; Universite de Reims Champagne-Ardenne; Universite de Reims Champagne-Ardenne	Rusciani, A (corresponding author), Univ Reims, Fac Sci, UMR CNRS 6237, Lab Signalisat & Recepteurs Matriciels SiRMa, Reims, France.	laurent.duca@univ-reims.fr	Ploton, Dominique DP/W-7169-2018; MARTINY, Laurent/ABI-5531-2020; BLAISE, Sebastien/AAS-1022-2020	Ploton, Dominique DP/0000-0002-4541-3146; BLAISE, Sebastien/0000-0003-3012-1500; DUCA, Laurent/0000-0002-6035-4906; LE NAOUR, Richard/0000-0003-1925-6041	Fond National pour la Sante ACI; Ligue contre le Cancer (comit departemental de l'Aube), CNRS; Ministere de l'Enseignement Superieur et de la Recherche	Fond National pour la Sante ACI; Ligue contre le Cancer (comit departemental de l'Aube), CNRS(Centre National de la Recherche Scientifique (CNRS)); Ministere de l'Enseignement Superieur et de la Recherche	This work was supported by grants from the Fond National pour la Sante ACI 2007 (Cancerop'le Grand-Est Project), the Ligue contre le Cancer (comit departemental de l'Aube), CNRS and the Ministere de l'Enseignement Superieur et de la Recherche. Anthony Rusciani is a fellow of the Ministere de l'Enseignement Superieur et de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achyuthan KE, 2001, COMP BIOCHEM PHYS B, V129, P29, DOI 10.1016/S1096-4959(01)00372-4; Allende ML, 2002, CURR OPIN STRUC BIOL, V12, P587, DOI 10.1016/S0959-440X(02)00376-7; Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Antonicelli F, 2007, CURR TOP DEV BIOL, V79, P99, DOI 10.1016/S0070-2153(06)79005-6; Bhunia AK, 1998, J BIOL CHEM, V273, P34349, DOI 10.1074/jbc.273.51.34349; Brassart B, 1998, CLIN EXP METASTAS, V16, P489, DOI 10.1023/A:1006550503612; Brassart B, 2001, J BIOL CHEM, V276, P5222, DOI 10.1074/jbc.M003642200; Callahan JW, 1999, BBA-MOL BASIS DIS, V1455, P85, DOI 10.1016/S0925-4439(99)00075-7; Chatterjee S, 1998, ARTERIOSCL THROM VAS, V18, P1523, DOI 10.1161/01.ATV.18.10.1523; Chigorno V, 2006, GLYCOCONJUGATE J, V23, P159, DOI 10.1007/s10719-006-7921-7; Cremesti AE, 2002, FEBS LETT, V531, P47, DOI 10.1016/S0014-5793(02)03489-0; DEBELLE L, 1995, J BIOL CHEM, V270, P26099, DOI 10.1074/jbc.270.44.26099; Duca L, 2005, MOL PHARMACOL, V67, P1315, DOI 10.1124/mol.104.002725; Duca L, 2004, CRIT REV ONCOL HEMAT, V49, P235, DOI 10.1016/j.critrevonc.2003.09.007; Duca L, 2007, J BIOL CHEM, V282, P12484, DOI 10.1074/jbc.M609505200; GHUYSENITARD AF, 1992, CR ACAD SCI III-VIE, V315, P473; Gillery P, 1996, BIOCHEM BIOPH RES CO, V228, P94, DOI 10.1006/bbrc.1996.1621; Iwamoto T, 2001, J BIOL CHEM, V276, P46031, DOI 10.1074/jbc.M104464200; Kielty CM, 2002, J CELL SCI, V115, P2817; Kolter T, 2002, J BIOL CHEM, V277, P25859, DOI 10.1074/jbc.R200001200; Korade Z, 2008, NEUROPHARMACOLOGY, V55, P1265, DOI 10.1016/j.neuropharm.2008.02.019; Makino A, 2006, BIOCHEMISTRY-US, V45, P4530, DOI 10.1021/bi052104y; Marks DL, 2005, METHODS, V36, P186, DOI 10.1016/j.ymeth.2004.12.001; MASTICK CC, 1995, J CELL BIOL, V129, P1523, DOI 10.1083/jcb.129.6.1523; MECHAM RP, 1989, J BIOL CHEM, V264, P16652; Mochizuki S, 2002, J BIOL CHEM, V277, P44854, DOI 10.1074/jbc.M205630200; OGURA K, 1992, EXP CELL RES, V199, P169, DOI 10.1016/0014-4827(92)90475-N; ONO K, 1988, CANCER RES, V48, P2730; OOYAMA T, 1987, ARTERIOSCLEROSIS, V7, P593, DOI 10.1161/01.ATV.7.6.593; Pocza P, 2008, INT J CANCER, V122, P1972, DOI 10.1002/ijc.23296; Rajesh M, 2005, CIRC RES, V97, P796, DOI 10.1161/01.RES.0000185327.45463.A8; RIBONI L, 1992, EUR J BIOCHEM, V203, P107, DOI 10.1111/j.1432-1033.1992.tb19834.x; ROBERT L, 2009, ARCH GERONTOL GERIAT; Robinet A, 2005, J CELL SCI, V118, P343, DOI 10.1242/jcs.01613; Seyrantepe V, 2003, HUM MUTAT, V22, P343, DOI 10.1002/humu.10268; Sharma DK, 2005, CANCER RES, V65, P8233, DOI 10.1158/0008-5472.CAN-05-0803; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; Waugh MG, 1999, BIOCHEM J, V337, P591, DOI 10.1042/0264-6021:3370591; Yuyama K, 2007, J BIOL CHEM, V282, P26392, DOI 10.1074/jbc.M705046200	40	37	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e14010	10.1371/journal.pone.0014010	http://dx.doi.org/10.1371/journal.pone.0014010			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103358	gold, Green Published, Green Submitted			2022-12-25	WOS:000284257400014
J	Sawada, T; Miyoshi, H; Shimada, K; Suzuki, A; Okamatsu-Ogura, Y; Perfield, JW; Kondo, T; Nagai, S; Shimizu, C; Yoshioka, N; Greenberg, AS; Kimura, K; Koike, T				Sawada, Takashi; Miyoshi, Hideaki; Shimada, Kohei; Suzuki, Akira; Okamatsu-Ogura, Yuko; Perfield, James W., II; Kondo, Takuma; Nagai, So; Shimizu, Chikara; Yoshioka, Narihito; Greenberg, Andrew S.; Kimura, Kazuhiro; Koike, Takao			Perilipin Overexpression in White Adipose Tissue Induces a Brown Fat-Like Phenotype	PLOS ONE			English	Article							HORMONE-SENSITIVE LIPASE; LIPID DROPLET PROTEIN; ADIPOCYTE LIPOLYSIS; KINASE; OBESITY; STORAGE	Background: Perilipin A (PeriA) exclusively locates on adipocyte lipid droplets and is essential for lipid storage and lipolysis. Previously, we reported that adipocyte specific overexpression of PeriA caused resistance to diet-induced obesity and resulted in improved insulin sensitivity. In order to better understand the biological basis for this observed phenotype, we performed additional studies in this transgenic mouse model. Methodology and Principal Findings: When compared to control animals, whole body energy expenditure was increased in the transgenic mice. Subsequently, we performed DNA microarray analysis and real-time PCR on white adipose tissue. Consistent with the metabolic chamber data, we observed increased expression of genes associated with fatty acid beta-oxidation and heat production, and a decrease in the genes associated with lipid synthesis. Gene expression of Pgc1a, a regulator of fatty acid oxidation and Ucp1, a brown adipocyte specific protein, was increased in the white adipose tissue of the transgenic mice. This observation was subsequently verified by both Western blotting and histological examination. Expression of RIP140, a regulator of white adipocyte differentiation, and the lipid droplet protein FSP27 was decreased in the transgenic mice. Importantly, FSP27 has been shown to control gene expression of these crucial metabolic regulators. Overexpression of PeriA in 3T3-L1 adipocytes also reduced FSP27 expression and diminished lipid droplet size. Conclusions: These findings demonstrate that overexpression of PeriA in white adipocytes reduces lipid droplet size by decreasing FSP27 expression and thereby inducing a brown adipose tissue-like phenotype. Our data suggest that modulation of lipid droplet proteins in white adipocytes is a potential therapeutic strategy for the treatment of obesity and its related disorders.	[Sawada, Takashi; Miyoshi, Hideaki; Kondo, Takuma; Nagai, So; Shimizu, Chikara; Yoshioka, Narihito; Koike, Takao] Hokkaido Univ, Grad Sch Med, Dept Internal Med 2, Sapporo, Hokkaido, Japan; [Shimada, Kohei; Okamatsu-Ogura, Yuko; Kimura, Kazuhiro] Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Sapporo, Hokkaido, Japan; [Suzuki, Akira] KKR Sapporo Med Ctr, Dept Pathol, Sapporo, Hokkaido, Japan; [Perfield, James W., II] Univ Missouri, Dept Nutr & Exercise Physiol & Food Sci, Columbia, MO USA; [Greenberg, Andrew S.] Tufts Univ, Jean Mayer US Dept Agr Human Nutr Res Ctr Aging, Boston, MA 02111 USA	Hokkaido University; Hokkaido University; University of Missouri System; University of Missouri Columbia; Tufts University	Sawada, T (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Internal Med 2, Sapporo, Hokkaido, Japan.	hmiyoshi@med.hokudai.ac.jp	Okamatsu-Ogura, Yuko/AAI-5602-2020; MIYOSHI, HIDEAKI/G-3971-2012		Japanese Ministry of Education, Culture, Sports, Science, and Technology Foundation; Takeda Science Foundation; Kanae Foundation for the Promotion of Medical Science; Kissei Pharmaceutical Foundation	Japanese Ministry of Education, Culture, Sports, Science, and Technology Foundation(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Kanae Foundation for the Promotion of Medical Science; Kissei Pharmaceutical Foundation(Kissei Pharmaceutical Co LtdMukai Science and Technology FoundationInoue Research Award for Young ScientistsKayamori Foundation of Informational Science AdvancementInoue Foundation for ScienceKayamori FoundationSENSHIN Medical Research FoundationFukuda Foundation for Medical Technology)	This work was supported by grants from the Japanese Ministry of Education, Culture, Sports, Science, and Technology Foundation (http://www.mext.go.jp/), Takeda Science Foundation (http://www.takeda-sci.or.jp/), Kanae Foundation for the Promotion of Medical Science (http://kanae.sanofi-aventis.co.jp/), and Kissei Pharmaceutical Foundation (http://www.kissei.co.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; DeFronzo RA, 2004, INT J CLIN PRACT, V58, P9, DOI 10.1111/j.1368-504X.2004.00389.x; Gauthier MS, 2008, J BIOL CHEM, V283, P16514, DOI 10.1074/jbc.M708177200; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; Hallberg M, 2008, MOL CELL BIOL, V28, P6785, DOI 10.1128/MCB.00504-08; Kahn CR, 2008, SCIENCE, V322, P542, DOI 10.1126/science.1165667; Kahn R, 2005, DIABETES CARE, V28, P2289, DOI 10.2337/diacare.28.9.2289; Lazar MA, 2008, SCIENCE, V321, P1048, DOI 10.1126/science.1164094; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Londos C, 2005, BIOCHIMIE, V87, P45, DOI 10.1016/j.biochi.2004.12.010; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Miyoshi H, 2007, J BIOL CHEM, V282, P996, DOI 10.1074/jbc.M605770200; Miyoshi H, 2006, J BIOL CHEM, V281, P15837, DOI 10.1074/jbc.M601097200; Miyoshi H, 2010, J LIPID RES, V51, P975, DOI 10.1194/jlr.M002352; Miyoshi H, 2008, J CELL BIOCHEM, V105, P1430, DOI 10.1002/jcb.21964; Morganstein DL, 2008, J LIPID RES, V49, P679, DOI 10.1194/jlr.D700029-JLR200; Nedergaard J, 2010, CELL METAB, V11, P268, DOI 10.1016/j.cmet.2010.03.007; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Okamatsu-Ogura Y, 2007, AM J PHYSIOL-ENDOC M, V292, pE1135, DOI 10.1152/ajpendo.00425.2006; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Souza SC, 2002, J BIOL CHEM, V277, P8267, DOI 10.1074/jbc.M108329200; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Toh SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002890; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Yoshida T, 1999, INT J OBESITY, V23, P570, DOI 10.1038/sj.ijo.0800870	28	69	70	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e14006	10.1371/journal.pone.0014006	http://dx.doi.org/10.1371/journal.pone.0014006			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103377	gold, Green Published			2022-12-25	WOS:000284257400010
J	Awad, O; Yustein, JT; Shah, P; Gul, N; Katuri, V; O'Neill, A; Kong, YL; Brown, ML; Toretsky, JA; Loeb, DM				Awad, Ola; Yustein, Jason T.; Shah, Preeti; Gul, Naheed; Katuri, Varalakshmi; O'Neill, Alison; Kong, Yali; Brown, Milton L.; Toretsky, Jeffrey A.; Loeb, David M.			High ALDH Activity Identifies Chemotherapy-Resistant Ewing's Sarcoma Stem Cells That Retain Sensitivity to EWS-FLI1 Inhibition	PLOS ONE			English	Article							PRIMITIVE NEUROECTODERMAL TUMOR; ALDEHYDE DEHYDROGENASE 1; BREAST-CANCER CELLS; PANCREATIC-CANCER; SIDE POPULATION; RNA HELICASE; IN-VITRO; BONE; MARKER; PROLIFERATION	Background: Cancer stem cells are a chemotherapy-resistant population capable of self-renewal and of regenerating the bulk tumor, thereby causing relapse and patient death. Ewing's sarcoma, the second most common form of bone tumor in adolescents and young adults, follows a clinical pattern consistent with the Cancer Stem Cell model - remission is easily achieved, even for patients with metastatic disease, but relapse remains frequent and is usually fatal. Methodology/Principal Findings: We have isolated a subpopulation of Ewing's sarcoma cells, from both human cell lines and human xenografts grown in immune deficient mice, which express high aldehyde dehydrogenase (ALDH(high)) activity and are enriched for clonogenicity, sphere-formation, and tumor initiation. The ALDH(high) cells are resistant to chemotherapy in vitro, but this can be overcome by the ATP binding cassette transport protein inhibitor, verapamil. Importantly, these cells are not resistant to YK-4-279, a small molecule inhibitor of EWS-FLI1 that is selectively toxic to Ewing's sarcoma cells both in vitro and in vivo. Conclusions/Significance: Ewing's sarcoma contains an ALDH(high) stem-like population of chemotherapy-resistant cells that retain sensitivity to EWS-FLI1 inhibition. Inhibiting the EWS-FLI1 oncoprotein may prove to be an effective means of improving patient outcomes by targeting Ewing's sarcoma stem cells that survive standard chemotherapy.	[Awad, Ola; Yustein, Jason T.; Shah, Preeti; Gul, Naheed; Katuri, Varalakshmi; Loeb, David M.] Johns Hopkins Univ, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Div Pediat Oncol, Baltimore, MD USA; [O'Neill, Alison; Kong, Yali; Brown, Milton L.; Toretsky, Jeffrey A.] Georgetown Univ, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC USA; [O'Neill, Alison; Toretsky, Jeffrey A.] Georgetown Univ, Dept Pediat, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA	Johns Hopkins University; Johns Hopkins Medicine; Georgetown University; Georgetown University	Awad, O (corresponding author), Suez Canal Univ, Sch Med, Dept Histol & Genet, Ismailia, Egypt.	loebda@jhmi.edu		O'Neill, Alison Brianna/0000-0003-2369-2655	Liddy Shriver Sarcoma Initiative; Children's Cancer Foundation of Baltimore; Amschwand Sarcoma Cancer Foundation; Go4theGoal Foundation; Dani's Foundation of Denver, CO; Burroughs-Wellcome Clinical Scientist Award; National Institutes of Health (NIH) [R01CA138212, R01CA133662, P30 CA051008]; Ruth L. Kirschstein National Research Service Award (NRSA); Institutional Research Training Grant [5T32CA060441-15]; Maryland Stem Cell Research Foundation; Georgetown University Medical Center; NATIONAL CANCER INSTITUTE [R01CA133662, T32CA060441, P30CA051008, R01CA138212] Funding Source: NIH RePORTER	Liddy Shriver Sarcoma Initiative; Children's Cancer Foundation of Baltimore; Amschwand Sarcoma Cancer Foundation; Go4theGoal Foundation; Dani's Foundation of Denver, CO; Burroughs-Wellcome Clinical Scientist Award(Burroughs Wellcome Fund); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institutional Research Training Grant; Maryland Stem Cell Research Foundation; Georgetown University Medical Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was generously supported by grants from the Liddy Shriver Sarcoma Initiative to J.T. and D. M. L., grants from the Children's Cancer Foundation of Baltimore, MD to J.T. and to J.T.Y., the Amschwand Sarcoma Cancer Foundation (J.T.), Go4theGoal Foundation (J.T.), Dani's Foundation of Denver, CO (J.T.), Burroughs-Wellcome Clinical Scientist Award in Translational Research (J.T.), National Institutes of Health (NIH) R01CA138212 (J.T. and D. M. L.), R01CA133662 (J.T.), the Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (T32), #5T32CA060441-15 (J.T.Y.), the Maryland Stem Cell Research Foundation (D. M. L.), and the Georgetown University Medical Center Drug Discovery Program. NIH support through the following grants Cancer Center Support Grant P30 CA051008 for use of Flow Cytometry Core. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Beauchamp E, 2009, J BIOL CHEM, V284, P9074, DOI 10.1074/jbc.M806233200; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Cironi L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002634; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; DENG S, PLOS ONE, V5; Dylla SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002428; Erkizan HV, 2009, NAT MED, V15, P750, DOI 10.1038/nm.1983; Feldmann G, 2008, MOL CANCER THER, V7, P2725, DOI 10.1158/1535-7163.MCT-08-0573; Feldmann G, 2007, CANCER RES, V67, P2187, DOI 10.1158/0008-5472.CAN-06-3281; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Grier HE, 2003, NEW ENGL J MED, V348, P694, DOI 10.1056/NEJMoa020890; GULATI SC, 1989, CANCER INVEST, V7, P411; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; Jiang X, BMC CANC, V10, P116; Kovar H, 1996, CELL GROWTH DIFFER, V7, P429; LADENSTEIN R, J CLIN ONCOL, V28, P3284; Liedtke S, 2007, CELL STEM CELL, V1, P364, DOI 10.1016/j.stem.2007.09.003; Mahadevan D, 2004, BLOOD, V104, P1940, DOI 10.1182/blood-2003-07-2490; MAY WA, 1993, MOL CELL BIOL, V13, P7393, DOI 10.1128/MCB.13.12.7393; Miser JS, 2007, PEDIATR BLOOD CANCER, V49, P894, DOI 10.1002/pbc.21233; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; OUCHIDA M, 1995, ONCOGENE, V11, P1049; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Riggi N, 2005, CANCER RES, V65, P11459, DOI 10.1158/0008-5472.CAN-05-1696; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Singh SK, 2003, CANCER RES, V63, P5821; SOHN EJ, CANC RES, V70, P1154; Suva ML, 2009, CANCER RES, V69, P1776, DOI 10.1158/0008-5472.CAN-08-2242; Tanaka K, 1997, J CLIN INVEST, V99, P239, DOI 10.1172/JCI119152; Toretsky JA, 2006, CANCER RES, V66, P5574, DOI 10.1158/0008-5472.CAN-05-3293; Vasiliou V, 2004, DRUG METAB REV, V36, P279, DOI 10.1081/DMR-120034001; VONEITZEN U, 1994, CANCER LETT, V76, P45, DOI 10.1016/0304-3835(94)90132-5; Wakahara K, 2008, MOL CANCER RES, V6, P1937, DOI 10.1158/1541-7786.MCR-08-0054; Yajima T, 2009, INT J ONCOL, V35, P273, DOI 10.3892/ijo_00000337	40	102	106	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e13943	10.1371/journal.pone.0013943	http://dx.doi.org/10.1371/journal.pone.0013943			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21085683	Green Published, gold, Green Submitted			2022-12-25	WOS:000284087800010
J	Desvignes, T; Pontarotti, P; Bobe, J				Desvignes, Thomas; Pontarotti, Pierre; Bobe, Julien			Nme Gene Family Evolutionary History Reveals Pre-Metazoan Origins and High Conservation between Humans and the Sea Anemone, Nematostella vectensis	PLOS ONE			English	Article							NUCLEOSIDE DIPHOSPHATE KINASE; MULTIPLE SEQUENCE ALIGNMENT; TUMOR-METASTASIS; ESCHERICHIA-COLI; NM23 HOMOLOG; SUPPRESSOR; GENOME; ANNOTATION; COMPLEXITY; EXPRESSION	Background: The Nme gene family is involved in multiple physiological and pathological processes such as cellular differentiation, development, metastatic dissemination, and cilia functions. Despite the known importance of Nme genes and their use as clinical markers of tumor aggressiveness, the associated cellular mechanisms remain poorly understood. Over the last 20 years, several non-vertebrate model species have been used to investigate Nme functions. However, the evolutionary history of the family remains poorly understood outside the vertebrate lineage. The aim of the study was thus to elucidate the evolutionary history of the Nme gene family in Metazoans. Methodology/Principal Findings: Using a total of 21 eukaryote species including 14 metazoans, the evolutionary history of Nme genes was reconstructed in the metazoan lineage. We demonstrated that the complexity of the Nme gene family, initially thought to be restricted to chordates, was also shared by the metazoan ancestor. We also provide evidence suggesting that the complexity of the family is mainly a eukaryotic innovation, with the exception of Nme8 that is likely to be a choanoflagellate/metazoan innovation. Highly conserved gene structure, genomic linkage, and protein domains were identified among metazoans, some features being also conserved in eukaryotes. When considering the entire Nme family, the starlet sea anemone is the studied metazoan species exhibiting the most conserved gene and protein sequence features with humans. In addition, we were able to show that most of the proteins known to interact with human NME proteins were also found in starlet sea anemone. Conclusion/Significance: Together, our observations further support the association of Nme genes with key cellular functions that have been conserved throughout metazoan evolution. Future investigations of evolutionarily conserved Nme gene functions using the starlet sea anemone could shed new light on a wide variety of key developmental and cellular processes.	[Desvignes, Thomas; Pontarotti, Pierre; Bobe, Julien] Univ Provence Aix Marseille, IFR48, CNRS 1, UMR 6632, F-13000 Marseille, France; [Desvignes, Thomas] LALR, IFREMER, F-34250 Palavas Les Flots, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Ifremer	Desvignes, T (corresponding author), Univ Provence Aix Marseille, IFR48, CNRS 1, UMR 6632, F-13000 Marseille, France.	Julien.Bobe@rennes.inra.fr	Bobe, Julien/I-6851-2017; , pontarotti/ABB-1753-2021; Thomas, Desvignes/AAX-3526-2020	Bobe, Julien/0000-0002-9355-8227; Thomas, Desvignes/0000-0001-5126-8785; Pierre, Pontarotti/0000-0001-7202-3648	INRA; European Community [222719 - LIFECYCLE]	INRA; European Community(European Commission)	This work was supported by an INRA - IFREMER PhD fellowship to TD. The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 222719 - LIFECYCLE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boissan M, 2009, MOL CELL BIOCHEM, V329, P51, DOI 10.1007/s11010-009-0120-7; Catchen JM, 2009, GENOME RES, V19, P1497, DOI 10.1101/gr.090480.108; CHERFILS J, 1994, BIOCHEMISTRY-US, V33, P9062, DOI 10.1021/bi00197a006; Choi YJ, 2009, FEBS LETT, V583, P1292, DOI 10.1016/j.febslet.2009.03.023; Degnan BM, 2009, CURR OPIN GENET DEV, V19, P591, DOI 10.1016/j.gde.2009.09.008; Desvignes T, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-256; Duriez B, 2007, P NATL ACAD SCI USA, V104, P3336, DOI 10.1073/pnas.0611405104; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Flicek P, 2010, NUCLEIC ACIDS RES, V38, pD557, DOI 10.1093/nar/gkp972; Gouret P, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-198; HAMA H, 1991, GENE, V105, P31, DOI 10.1016/0378-1119(91)90510-I; Hammargren J, 2007, PHYSIOL PLANTARUM, V129, P79, DOI 10.1111/j.1399-3054.2006.00794.x; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Hwang KC, 2003, BIOCHEM BIOPH RES CO, V306, P198, DOI 10.1016/S0006-291X(03)00916-1; Ikeda T, 2010, CELL STRUCT FUNCT, V35, P23, DOI 10.1247/csf.09016; Ishikawa N, 2003, J BIOENERG BIOMEMBR, V35, P7, DOI 10.1023/A:1023433504713; Jung H, 2008, J BIOL CHEM, V283, P32669, DOI 10.1074/jbc.M806225200; Jung HY, 2007, J BIOL CHEM, V282, P35293, DOI 10.1074/jbc.M705181200; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Lascu I, 2000, J BIOENERG BIOMEMBR, V32, P227, DOI 10.1023/A:1005580828141; LU Q, 1995, J MOL BIOL, V254, P337, DOI 10.1006/jmbi.1995.0620; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Mehta A, 2009, MOL CELL BIOCHEM, V329, P3, DOI 10.1007/s11010-009-0114-5; Munier A, 1998, FEBS LETT, V434, P289, DOI 10.1016/S0014-5793(98)00996-X; Napolitano F, 2008, NEUROCHEM RES, V33, P2547, DOI 10.1007/s11064-008-9683-z; Nikolaidis N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000204; Ogawa K, 1996, MOL BIOL CELL, V7, P1895, DOI 10.1091/mbc.7.12.1895; Otsuki Y, 2001, P NATL ACAD SCI USA, V98, P4385, DOI 10.1073/pnas.071411598; Pankow S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000782; Polosina YY, 1998, EXTREMOPHILES, V2, P333, DOI 10.1007/s007920050076; POSTEL EH, 1993, SCIENCE, V261, P478, DOI 10.1126/science.8392752; Postel EH, 2000, J BIOENERG BIOMEMBR, V32, P277, DOI 10.1023/A:1005541114029; Postel EH, 2003, J BIOENERG BIOMEMBR, V35, P31, DOI 10.1023/A:1023485505621; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; ROSENGARD AM, 1989, NATURE, V342, P177, DOI 10.1038/342177a0; Ryan JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000153; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; Takahashi T, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-240; TROLL H, 1993, J BIOL CHEM, V268, P25469; Vogel P, 2010, VET PATHOL, V47, P120, DOI 10.1177/0300985809353553; Woolworth JA, 2009, MOL CELL BIOL, V29, P4679, DOI 10.1128/MCB.00297-09; Yamada A, 2007, EVOL DEV, V9, P220, DOI 10.1111/j.1525-142X.2007.00154.x; Yang MM, 2009, MUTAT RES-FUND MOL M, V660, P74, DOI 10.1016/j.mrfmmm.2008.09.015	46	26	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e15506	10.1371/journal.pone.0015506	http://dx.doi.org/10.1371/journal.pone.0015506			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21085602	Green Published, gold			2022-12-25	WOS:000284087800028
J	Iovino, M; Patani, R; Watts, C; Chandran, S; Spillantini, MG				Iovino, Mariangela; Patani, Rickie; Watts, Colin; Chandran, Siddharthan; Spillantini, Maria Grazia			Human Stem Cell-Derived Neurons: A System to Study Human Tau Function and Dysfunction	PLOS ONE			English	Article							FRONTOTEMPORAL DEMENTIA; ISOFORMS; PROTEIN; AGGREGATION; MATURATION; GENE; MICE	Background: Intracellular filamentous deposits containing microtubule-associated protein tau constitute a defining characteristic of many neurodegenerative disorders. Current experimental models to study tau pathology in vitro do not usually recapitulate the tau expression pattern characteristic of adult human brain. In this study, we have investigated whether human embryonic stem cell-derived neurons could be a good model to study human tau distribution, function and dysfunction. Methodology/Principal Findings: Using RT-PCR, immunohistochemistry, western blotting and cell transfections we have investigated whether all 6 adult human brain tau isoforms are expressed in neurons derived from human embryonic and fetal stem cells and whether 4 repeat tau over-expression alone, or with the F3 tau repeat fragment, (amino acid 258-380 of the 2N4R tau isoform with the Delta K280 mutation) affects tau distribution. We found that the shortest 3 repeat tau isoform, similarly to human brain, is the first to be expressed during neuronal differentiation while the other 5 tau isoforms are expressed later. Over expression of tau with 4 repeats affects tau cellular distribution and the short tau F3 fragment appears to increase tau phosphorylation but this effect does not appear to be toxic for the cell. Conclusions: Our results indicate that human embryonic stem cell-derived neurons express all 6 tau isoforms and are a good model in which to study tau physiology and pathology.	[Iovino, Mariangela; Patani, Rickie; Watts, Colin; Chandran, Siddharthan; Spillantini, Maria Grazia] Univ Cambridge, Cambridge Ctr Brain Repair, Dept Clin Neurosci, Cambridge, England; [Patani, Rickie; Chandran, Siddharthan] Univ Cambridge, Anne McLaren Lab Regenerat Med, Cambridge, England; [Chandran, Siddharthan] Univ Edinburgh, MRC, Ctr Clin Brain Sci, Ctr Regenerat Med, Edinburgh, Midlothian, Scotland	University of Cambridge; University of Cambridge; University of Edinburgh	Iovino, M (corresponding author), Univ Cambridge, Cambridge Ctr Brain Repair, Dept Clin Neurosci, Cambridge, England.	mgs11@cam.ac.uk	Patani, R/J-3107-2018	Patani, R/0000-0002-3825-7675	Alzheimer's Research Trust; NIHR Biomedical Research Centre; Wellcome Trust; Sir David Walker Trust; Beverley and Raymond Sackler Scholarship; Alzheimers Research UK [ART-PPG2008A-6] Funding Source: researchfish; Medical Research Council [G0800784, G0700711B, G0800784B] Funding Source: researchfish; MRC [G0800784] Funding Source: UKRI	Alzheimer's Research Trust; NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); Sir David Walker Trust; Beverley and Raymond Sackler Scholarship; Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a pilot grant of the Alzheimer's Research Trust (MI, MGS), NIHR Biomedical Research Centre (SC) and Wellcome Trust Clinical Research Training Fellowship, Sir David Walker Trust Scholarship and Beverley and Raymond Sackler Scholarship (RP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Dawson HN, 2001, J CELL SCI, V114, P1179; Gasparini L, 2007, NEURODEGENER DIS, V4, P236, DOI 10.1159/000101848; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Joannides AJ, 2007, BRAIN, V130, P1263, DOI 10.1093/brain/awm070; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Magnani E, 2007, EMBO J, V26, P4546, DOI 10.1038/sj.emboj.7601878; Patani R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007327; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Wang YP, 2007, P NATL ACAD SCI USA, V104, P10252, DOI 10.1073/pnas.0703676104	13	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e13947	10.1371/journal.pone.0013947	http://dx.doi.org/10.1371/journal.pone.0013947			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21085657	Green Published, Green Submitted, gold			2022-12-25	WOS:000284087800013
J	Slater, GJ; Figueirido, B; Louis, L; Yang, P; Van Valkenburgh, B				Slater, Graham J.; Figueirido, Borja; Louis, Leeann; Yang, Paul; Van Valkenburgh, Blaire			Biomechanical Consequences of Rapid Evolution in the Polar Bear Lineage	PLOS ONE			English	Article							FINITE-ELEMENT-ANALYSIS; COMPUTER-SIMULATION; CRANIAL MECHANICS; FEEDING-BEHAVIOR; FRONTAL SINUSES; GRIZZLY BEARS; BONE-CRACKING; URSUS-ARCTOS; BROWN BEARS; CARNIVORA	The polar bear is the only living ursid with a fully carnivorous diet. Despite a number of well-documented craniodental adaptations for a diet of seal flesh and blubber, molecular and paleontological data indicate that this morphologically distinct species evolved less than a million years ago from the omnivorous brown bear. To better understand the evolution of this dietary specialization, we used phylogenetic tests to estimate the rate of morphological specialization in polar bears. We then used finite element analysis (FEA) to compare the limits of feeding performance in the polar bear skull to that of the phylogenetically and geographically close brown bear. Results indicate that extremely rapid evolution of semi-aquatic adaptations and dietary specialization in the polar bear lineage produced a cranial morphology that is weaker than that of brown bears and less suited to processing tough omnivorous or herbivorous diets. Our results suggest that continuation of current climate trends could affect polar bears by not only eliminating their primary food source, but also through competition with northward advancing, generalized brown populations for resources that they are ill-equipped to utilize.	[Slater, Graham J.; Yang, Paul; Van Valkenburgh, Blaire] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90024 USA; [Figueirido, Borja] Univ Malaga, Fac Ciencias, Area Paleontol, Dept Ecol & Geol, E-29071 Malaga, Spain; [Louis, Leeann] Cornell Univ, Museum Vertebrates, Ithaca, NY USA	University of California System; University of California Los Angeles; Universidad de Malaga; Cornell University	Slater, GJ (corresponding author), Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90024 USA.	gslater@ucla.edu	Figueirido, Borja/G-9665-2015; Figueirido, Borja/AAV-7882-2020	Figueirido, Borja/0000-0003-2542-3977; Figueirido, Borja/0000-0003-2542-3977; Louis, Leeann/0000-0002-0796-1838	National Science Foundation [NSF 0709792, 0517748]; Ministerio de Cinencia E Innovacion	National Science Foundation(National Science Foundation (NSF)); Ministerio de Cinencia E Innovacion	Funding: The work was funded by the National Science Foundation (http://www.nsf.gov/) NSF 0709792, 0517748; Ministerio de Cinencia E Innovacion (http://www.micinn.es/portal/site/MICINN/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Barnes I, 2002, SCIENCE, V295, P2267, DOI 10.1126/science.1067814; Christiansen P, 2005, J ZOOL, V266, P133, DOI 10.1017/S0952836905006643; COOK SD, 1982, J DENT RES, V61, P25, DOI 10.1177/00220345820610010501; DAVIS D. DWIGHT, 1955, FIELDIANA ZOOL, V37, P25; Derocher AE, 2004, INTEGR COMP BIOL, V44, P163, DOI 10.1093/icb/44.2.163; DESSEM D, 1989, J ANAT, V164, P101; Dumont ER, 2009, J THEOR BIOL, V256, P96, DOI 10.1016/j.jtbi.2008.08.017; Dumont ER, 2005, ANAT REC PART A, V283A, P319, DOI 10.1002/ar.a.20165; Evans AR, 2007, NATURE, V445, P78, DOI 10.1038/nature05433; Farke AA, 2008, J EXP BIOL, V211, P3085, DOI 10.1242/jeb.019042; Figueirido B, 2009, J ZOOL, V277, P70, DOI 10.1111/j.1469-7998.2008.00511.x; Grosse IR, 2007, ANAT REC, V290, P1069, DOI 10.1002/ar.20568; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Howell A.B., 1930, AQUAT MAMM; Jasinoski SC, 2010, J VERTEBR PALEONTOL, V30, P1283, DOI 10.1080/02724634.2010.483556; Joeckel RM, 1998, J VERTEBR PALEONTOL, V18, P627, DOI 10.1080/02724634.1998.10011089; Kangas AT, 2004, NATURE, V432, P211, DOI 10.1038/nature02927; Kavanagh KD, 2007, NATURE, V449, P427, DOI 10.1038/nature06153; Killengreen ST, 2007, BIOL CONSERV, V135, P459, DOI 10.1016/j.biocon.2006.10.039; Krause J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-220; Kurten B., 1964, Acta Zoologica Fennica, V108, P1; Lindqvist C, 2010, P NATL ACAD SCI USA, V107, P5053, DOI 10.1073/pnas.0914266107; Lister AM, 2004, PHILOS T R SOC B, V359, P221, DOI 10.1098/rstb.2003.1436; McHenry CR, 2007, P NATL ACAD SCI USA, V104, P16010, DOI 10.1073/pnas.0706086104; McPeek MA, 2008, AM NAT, V171, pE158, DOI 10.1086/587076; Moazen M, 2009, P ROY SOC B-BIOL SCI, V276, P39, DOI 10.1098/rspb.2008.0863; Nalla RK, 2003, NAT MATER, V2, P164, DOI 10.1038/nmat832; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Polly PD, 2007, NATURE, V449, P413, DOI 10.1038/449413a; Rayfield EJ, 2004, P ROY SOC B-BIOL SCI, V271, P1451, DOI 10.1098/rspb.2004.2755; Rockwell R, 2008, CAN FIELD NAT, V122, P323, DOI 10.22621/cfn.v122i4.639; Rode KD, 2001, OECOLOGIA, V128, P62, DOI 10.1007/s004420100637; Sacco T, 2004, J ZOOL, V263, P41, DOI 10.1017/S0952836904004856; Slater GJ, 2009, J EVOLUTION BIOL, V22, P2278, DOI 10.1111/j.1420-9101.2009.01845.x; Slater GJ, 2009, J ZOOL, V278, P181, DOI 10.1111/j.1469-7998.2009.00567.x; STIRLING I, 1977, J FISH RES BOARD CAN, V34, P1126, DOI 10.1139/f77-169; Strait DS, 2009, P NATL ACAD SCI USA, V106, P2124, DOI 10.1073/pnas.0808730106; Strait DS, 2005, ANAT REC PART A, V283A, P275, DOI 10.1002/ar.a.20172; Talbot SL, 1996, MOL PHYLOGENET EVOL, V5, P477, DOI 10.1006/mpev.1996.0044; Tanner JB, 2008, BIOL J LINN SOC, V95, P246, DOI 10.1111/j.1095-8312.2008.01052.x; Tannerfeldt M, 2002, OECOLOGIA, V132, P213, DOI 10.1007/s00442-002-0967-8; Tseng ZJ, 2009, BIOL J LINN SOC, V96, P51, DOI 10.1111/j.1095-8312.2008.01095.x; TURNBULL WD, 1970, FIELDIANA GEOLOGY, V18, P149; Verrue V, 2001, EUR J ORTHODONT, V23, P517, DOI 10.1093/ejo/23.5.517; WALL WP, 1983, J PALEONTOL, V57, P197; WERDELIN L, 1989, PALEOBIOLOGY, V15, P387, DOI 10.1017/S009483730000957X; Wroe S, 2008, J ZOOL, V274, P332, DOI 10.1111/j.1469-7998.2007.00389.x; Wroe S, 2007, P ROY SOC B-BIOL SCI, V274, P2819, DOI 10.1098/rspb.2007.0906; [No title captured]; [No title captured]	52	51	51	10	143	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2010	5	11							e13870	10.1371/journal.pone.0013870	http://dx.doi.org/10.1371/journal.pone.0013870			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675OD	21079768	Green Submitted, gold, Green Published			2022-12-25	WOS:000283839100019
J	Kispersky, T; White, JA; Rotstein, HG				Kispersky, Tilman; White, John A.; Rotstein, Horacio G.			The Mechanism of Abrupt Transition between Theta and Hyper-Excitable Spiking Activity in Medial Entorhinal Cortex Layer II Stellate Cells	PLOS ONE			English	Article							SYNCHRONIZED HIPPOCAMPAL BURSTS; MIXED-MODE OSCILLATIONS; GATED ION CHANNELS; SUBTHRESHOLD OSCILLATIONS; INHIBITION; NEURONS; RHYTHM; INTERNEURONS; BIFURCATION; NOISE	Recent studies have shown that stellate cells (SCs) of the medial entorhinal cortex become hyper-excitable in animal models of temporal lobe epilepsy. These studies have also demonstrated the existence of recurrent connections among SCs, reduced levels of recurrent inhibition in epileptic networks as compared to control ones, and comparable levels of recurrent excitation among SCs in both network types. In this work, we investigate the biophysical and dynamic mechanism of generation of the fast time scale corresponding to hyper-excitable firing and the transition between theta and fast firing frequency activity in SCs. We show that recurrently connected minimal networks of SCs exhibit abrupt, threshold-like transition between theta and hyper-excitable firing frequencies as the result of small changes in the maximal synaptic (AMPAergic) conductance. The threshold required for this transition is modulated by synaptic inhibition. Similar abrupt transition between firing frequency regimes can be observed in single, self-coupled SCs, which represent a network of recurrently coupled neurons synchronized in phase, but not in synaptically isolated SCs as the result of changes in the levels of the tonic drive. Using dynamical systems tools (phase-space analysis), we explain the dynamic mechanism underlying the genesis of the fast time scale and the abrupt transition between firing frequency regimes, their dependence on the intrinsic SC's currents and synaptic excitation. This abrupt transition is mechanistically different from others observed in similar networks with different cell types. Most notably, there is no bistability involved. 'In vitro' experiments using single SCs self-coupled with dynamic clamp show the abrupt transition between firing frequency regimes, and demonstrate that our theoretical predictions are not an artifact of the model. In addition, these experiments show that high-frequency firing is burst-like with a duration modulated by an M-current.	[Kispersky, Tilman] Boston Univ, Program Neurosci, Boston, MA 02215 USA; [Kispersky, Tilman] Boston Univ, Ctr BioDynam, Boston, MA 02215 USA; [White, John A.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Rotstein, Horacio G.] New Jersey Inst Technol, Dept Math Sci, Newark, NJ 07102 USA; [Rotstein, Horacio G.] New Jersey Inst Technol, Ctr Appl Math & Stat, Newark, NJ 07102 USA	Boston University; Boston University; Utah System of Higher Education; University of Utah; New Jersey Institute of Technology; New Jersey Institute of Technology	Kispersky, T (corresponding author), Boston Univ, Program Neurosci, Boston, MA 02215 USA.	horacio@njit.edu		White, John/0000-0003-1073-2638; Rotstein, Horacio/0000-0002-4387-5160	National Science Foundation [DMS-0817241]; National Institute of Neurological Disorders and Stroke; National Institue of Mental Health; National Center for Research Resources; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR020115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085074] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institue of Mental Health; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was partially supported by the National Science Foundation DMS-0817241 (HGR), National Institute of Neurological Disorders and Stroke (JW and TK), National Institue of Mental Health (JW and TK) and National Center for Research Resources (JW and TK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker CD, 2003, J COMPUT NEUROSCI, V15, P71, DOI 10.1023/A:1024474819512; ALONSO A, 1989, NATURE, V342, P175, DOI 10.1038/342175a0; ALONSO A, 1987, EXP BRAIN RES, V67, P493, DOI 10.1007/BF00247282; Amaral David G., 1995, P443; BAER SM, 1992, SIAM J APPL MATH, V52, P1651, DOI 10.1137/0152095; Bear J, 1996, J NEUROPHYSIOL, V76, P2928, DOI 10.1152/jn.1996.76.5.2928; BEKENSTEIN JW, 1993, SCIENCE, V259, P97, DOI 10.1126/science.8093417; Ben-Menachem Elinor, 2007, Epilepsy Curr, V7, P153, DOI 10.1111/j.1535-7511.2007.00209.x; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; Burden RL., 1980, NUMERICAL ANAL; Destexhe A, 1994, J Comput Neurosci, V1, P195, DOI 10.1007/BF00961734; Dickson CT, 2000, J NEUROPHYSIOL, V83, P2562, DOI 10.1152/jn.2000.83.5.2562; Dorval AD, 2005, J NEUROSCI, V25, P10025, DOI 10.1523/JNEUROSCI.3557-05.2005; Drover J, 2004, SIAM J APPL MATH, V65, P69, DOI 10.1137/S0036139903431233; DU F, 1995, J NEUROSCI, V15, P6301; Dudman JT, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000290; Eid T, 1999, EXP BRAIN RES, V125, P463, DOI 10.1007/s002210050704; Engel TA, 2008, J NEUROPHYSIOL, V100, P1576, DOI 10.1152/jn.01282.2007; Ermentrout G. B., 2002, SIMULATING ANAL ANIM; Fernandez FR, 2008, J NEUROSCI, V28, P3790, DOI 10.1523/JNEUROSCI.5658-07.2008; Fransen E, 2004, HIPPOCAMPUS, V14, P368, DOI 10.1002/hipo.10198; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Haas JS, 2002, J NEUROPHYSIOL, V88, P2422, DOI 10.1152/jn.00598.2002; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Izhikevich EM, 2001, NEURAL NETWORKS, V14, P883, DOI 10.1016/S0893-6080(01)00078-8; Jalics J, 2010, DYNAM SYST, V25, P445, DOI 10.1080/14689360903535760; Johnston D., 2004, SYNAPTIC ORG BRAIN, V5th, P455; Kahana MJ, 1999, NATURE, V399, P781, DOI 10.1038/21645; Klink R, 1997, J NEUROPHYSIOL, V77, P1829, DOI 10.1152/jn.1997.77.4.1829; Kobayashi M, 2003, J NEUROSCI, V23, P2440; Krupa M, 2001, SIAM J MATH ANAL, V33, P286, DOI 10.1137/S0036141099360919; Kumar SS, 2007, J NEUROSCI, V27, P1239, DOI 10.1523/JNEUROSCI.3182-06.2007; Kumar SS, 2006, J NEUROSCI, V26, P4613, DOI 10.1523/JNEUROSCI.0064-06.2006; Middleton S, 2008, P NATL ACAD SCI USA, V105, P18572, DOI 10.1073/pnas.0809302105; Moser EI, 2008, HIPPOCAMPUS, V18, P1142, DOI 10.1002/hipo.20483; Netoff TI, 2005, J NEUROPHYSIOL, V93, P1197, DOI 10.1152/jn.00982.2004; Richardson MJE, 2003, J NEUROPHYSIOL, V89, P2538, DOI 10.1152/jn.00955.2002; Rotstein HG, 2005, J NEUROPHYSIOL, V94, P1509, DOI 10.1152/jn.00957.2004; Rotstein HG, 2006, J COMPUT NEUROSCI, V21, P271, DOI 10.1007/s10827-006-8096-8; Rotstein HG, 2008, SIAM J APPL DYN SYST, V7, P1582, DOI 10.1137/070699093; Rutishauser U, 2010, NATURE, V464, P903, DOI 10.1038/nature08860; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Scharfman HE, 1998, J NEUROPHYSIOL, V80, P3031, DOI 10.1152/jn.1998.80.6.3031; SCHARFMAN HE, 2000, ANN NEW YORK ACAD SC, V911; Schreiber S, 2004, J NEUROPHYSIOL, V92, P408, DOI 10.1152/jn.01116.2003; Schwarcz R, 2000, ANN NY ACAD SCI, V911, P328; SLOVITER RS, 1987, SCIENCE, V235, P73, DOI 10.1126/science.2879352; Sutherland C, 2009, BIOL CYBERN, V100, P475, DOI 10.1007/s00422-009-0298-5; Tolner EA, 2005, J NEUROSCI, V25, P8755, DOI 10.1523/JNEUROSCI.1165-05.2005; TRAUB RD, 1989, SCIENCE, V243, P1319, DOI 10.1126/science.2646715; TRAUB RD, 1987, J NEUROPHYSIOL, V58, P752, DOI 10.1152/jn.1987.58.4.752; TRAUB RD, 1987, J NEUROPHYSIOL, V58, P739, DOI 10.1152/jn.1987.58.4.739; TRAUB RD, 1988, J NEUROPHYSIOL, V60, P1481; Wang XJ, 1999, J NEUROSCI, V19, P9587; Wang XJ, 1996, J NEUROSCI, V16, P6402; Wechselberger M, 2005, SIAM J APPL DYN SYST, V4, P101, DOI 10.1137/030601995; WHITE JA, 1995, BIOPHYS J, V69, P1203, DOI 10.1016/S0006-3495(95)79995-7; White JA, 1998, J NEUROPHYSIOL, V80, P262, DOI 10.1152/jn.1998.80.1.262; White JA., 2001, HDB BIOL PHYS, V4, P257, DOI 10.1016/S1383-8121(01)80011-7; WINSON J, 1978, SCIENCE, V201, P160, DOI 10.1126/science.663646; Yoshida M, 2007, J NEUROPHYSIOL, V98, P2779, DOI 10.1152/jn.00033.2007; Yue CY, 2004, J NEUROSCI, V24, P4614, DOI 10.1523/JNEUROSCI.0765-04.2004	62	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e13697	10.1371/journal.pone.0013697	http://dx.doi.org/10.1371/journal.pone.0013697			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079802	Green Published, gold			2022-12-25	WOS:000283838600003
J	Marzec, M; Liu, X; Wong, W; Yang, Y; Pasha, T; Kantekure, K; Zhang, P; Woetmann, A; Cheng, M; Odum, N; Wasik, MA				Marzec, M.; Liu, X.; Wong, W.; Yang, Y.; Pasha, T.; Kantekure, K.; Zhang, P.; Woetmann, A.; Cheng, M.; Odum, N.; Wasik, M. A.			Oncogenic kinase NPM/ALK induces expression of HIF1 alpha mRNA	ONCOGENE			English	Article						oncogenic tyrosine kinase; anaplastic lymphoma kinase; STAT3; HIF1 alpha	ANAPLASTIC LYMPHOMA KINASE; NON-HODGKINS-LYMPHOMA; TYROSINE KINASE; NPM-ALK; STAT3 EXPRESSION; TUMOR-SUPPRESSOR; CANCER-THERAPY; CELL LYMPHOMA; PROTEIN; ACTIVATION	The mechanisms of malignant cell transformation mediated by the oncogenic anaplastic lymphoma kinase (ALK) tyrosine kinase remain only partially understood. In this study, we report that T-cell lymphoma (TCL) cells carrying the nucleophosmin (NPM)/ALK fusion protein (ALK + TCL) strongly express hypoxia-induced factor 1 alpha (HIF1 alpha) mRNA, even under normoxic conditions, and markedly upregulate HIF1 alpha protein expression under hypoxia. HIF1 alpha expression is strictly dependent on the expression and enzymatic activity of NPM/ALK, as shown in BaF3 cells transfected with wild-type NPM/ALK and kinase-inactive NPM/ALK K210R mutant and by the inhibition of the NPM/ALK function in ALK + TCL cells by a small-molecule ALK inhibitor. NPM/ALK induces HIF1 alpha expression by upregulating its gene transcription through its key signal transmitter signal transducer and activator of transcription 3 (STAT3), which binds to the HIF1 alpha gene promoter as shown by the chromatin immunoprecipitation assay and is required for HIF1 alpha gene expression as demonstrated by its small interfering RNA-mediated depletion. In turn, depletion of HIF1 alpha increases mammalian target of rapamycin complex 1 activation, cell growth and proliferation and decreases vascular endothelial growth factor synthesis. These results identify a novel cell-transforming property of NPM/ALK, namely its ability to induce the expression of HIF1 alpha, a protein with an important role in carcinogenesis. These results also provide another rationale to therapeutically target NPM/ALK and STAT3 in ALK + TCL. Oncogene (2011) 30, 1372-1378; doi:10.1038/onc.2010.505; published online 22 November 2010	[Wasik, M. A.] Univ Penn, Dept Pathol & Lab Med, Med Ctr, Stellar Chance Labs 413A, Philadelphia, PA 19104 USA; [Wong, W.] Univ Penn, Dept Canc Biol, Philadelphia, PA 19104 USA; [Wong, W.] Univ Penn, Abramson Canc Res Inst, Philadelphia, PA 19104 USA; [Woetmann, A.; Odum, N.] Univ Copenhagen, Inst Mol Biol, Copenhagen, Denmark; [Cheng, M.] Cephalon Inc, W Chester, PA USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Copenhagen; Teva Pharmaceutical Industries; Cephalon Inc.	Wasik, MA (corresponding author), Univ Penn, Dept Pathol & Lab Med, Med Ctr, Stellar Chance Labs 413A, 422 Curie Blvd, Philadelphia, PA 19104 USA.	wasik@mail.med.upenn.edu	Woetmann, Anders/AAJ-3171-2020; Marzec, Michal/O-6387-2016	Marzec, Michal/0000-0001-9698-6019; Woetmann, Anders/0000-0002-3008-735X	National Cancer Institute [R01-CA89194, R01-CA96856]; NATIONAL CANCER INSTITUTE [R01CA096856, R01CA089194] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by grants from the National Cancer Institute- R01-CA89194 and R01-CA96856.	Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Bischof D, 1997, MOL CELL BIOL, V17, P2312, DOI 10.1128/MCB.17.4.2312; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Chiarle R, 2003, BLOOD, V101, P1919, DOI 10.1182/blood-2002-05-1343; Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291; Evens AM, 2008, BRIT J HAEMATOL, V141, P676, DOI 10.1111/j.1365-2141.2008.07093.x; Fujimoto J, 1996, P NATL ACAD SCI USA, V93, P4181, DOI 10.1073/pnas.93.9.4181; Galkin AV, 2007, P NATL ACAD SCI USA, V104, P270, DOI 10.1073/pnas.0609412103; Giatromanolaki A, 2008, HEMATOL ONCOL, V26, P219, DOI 10.1002/hon.861; Kasprzycka M, 2006, P NATL ACAD SCI USA, V103, P9964, DOI 10.1073/pnas.0603507103; Kuefer MU, 1997, BLOOD, V90, P2901, DOI 10.1182/blood.V90.8.2901; Li RS, 2008, MED RES REV, V28, P372, DOI 10.1002/med.20109; Ling XY, 2005, CANCER RES, V65, P2532, DOI 10.1158/0008-5472.CAN-04-2425; Lu LH, 2009, BIOCHEMISTRY-US, V48, P3600, DOI 10.1021/bi8020923; Marzec M, 2007, ONCOGENE, V26, P5606, DOI 10.1038/sj.onc.1210346; Marzec M, 2005, LAB INVEST, V85, P1544, DOI 10.1038/labinvest.3700348; Marzec M, 2008, P NATL ACAD SCI USA, V105, P20852, DOI 10.1073/pnas.0810958105; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Morris SW, 1997, ONCOGENE, V14, P2175, DOI 10.1038/sj.onc.1201062; Niu GL, 2008, MOL CANCER RES, V6, P1099, DOI 10.1158/1541-7786.MCR-07-2177; Passam FH, 2009, PATHOL RES PRACT, V205, P11, DOI 10.1016/j.prp.2008.07.007; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; SHIOTA M, 1994, ONCOGENE, V9, P1567; Wasik MA, 2009, SEMIN ONCOL, V36, pS27, DOI 10.1053/j.seminoncol.2009.02.007; Wright CW, 2009, SCIENCE, V323, P251, DOI 10.1126/science.1162818; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yue P, 2009, EXPERT OPIN INV DRUG, V18, P45, DOI 10.1517/13543780802565791 ; Zhang Q, 2002, J IMMUNOL, V168, P466, DOI 10.4049/jimmunol.168.1.466; Zhang Q, 2007, NAT MED, V13, P1341, DOI 10.1038/nm1659	29	26	26	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2011	30	11					1372	1378		10.1038/onc.2010.505	http://dx.doi.org/10.1038/onc.2010.505			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	736JX	21102525				2022-12-25	WOS:000288492100011
J	Artz, JD; Wernimont, AK; Dunford, JE; Schapira, M; Dong, AP; Zhao, Y; Lew, J; Russell, RGG; Ebetino, FH; Oppermann, U; Hui, R				Artz, Jennifer D.; Wernimont, Amy K.; Dunford, James E.; Schapira, Matthieu; Dong, Aiping; Zhao, Yong; Lew, Jocelyne; Russell, R. Graham G.; Ebetino, F. Hal; Oppermann, Udo; Hui, Raymond			Molecular Characterization of a Novel Geranylgeranyl Pyrophosphate Synthase from Plasmodium Parasites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FARNESYL DIPHOSPHATE SYNTHASE; NITROGEN-CONTAINING BISPHOSPHONATES; PRODUCT CHAIN-LENGTH; CRYSTAL-STRUCTURE; IN-VITRO; TOXOPLASMA-GONDII; TRYPANOSOMA-CRUZI; POTENT INHIBITORS; MECHANISM; GROWTH	We present here a study of a eukaryotic trans-prenylsynthase from the malaria pathogen Plasmodium vivax. Based on the results of biochemical assays and contrary to previous indications, this enzyme catalyzes the production of geranylgeranyl pyrophosphate (GGPP) rather than farnesyl pyrophosphate (FPP). Structural analysis shows that the product length is constrained by a hydrophobic cavity formed primarily by a set of residues from the same subunit as the product as well as at least one other from the dimeric partner. Furthermore, Plasmodium GGPP synthase (GGPPS) can bind nitrogen-containing bisphosphonates (N-BPs) strongly with the energetically favorable cooperation of three Mg2+, resulting in inhibition by this class of compounds at IC50 concentrations below 100 nM. In contrast, human and yeast GGPPSs do not accommodate a third magnesium atom in the same manner, resulting in their insusceptibility to N-BPs. This differentiation is in part attributable to a deviation in a conserved motif known as the second aspartate-rich motif: whereas the aspartates at the start and end of the five-residue motif in FFPP synthases and P. vivax GGPPSs both participate in the coordination of the third Mg2+, an asparagine is featured as the last residue in human and yeast GGPPSs, resulting in a different manner of interaction with nitrogen-containing ligands.	[Lew, Jocelyne; Hui, Raymond] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Dunford, James E.; Oppermann, Udo] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England; [Dunford, James E.; Russell, R. Graham G.; Oppermann, Udo] Botnar Res Ctr, Oxford Biomed Res Unit, Oxford OX3 7LD, England; [Schapira, Matthieu] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON M5S 1A8, Canada; [Ebetino, F. Hal] Procter & Gamble Pharmaceut Inc, Mason, OH 45040 USA	University of Toronto; Structural Genomics Consortium; University of Oxford; University of Oxford; University of Toronto; Procter & Gamble	Hui, R (corresponding author), Univ Toronto, Struct Genom Consortium, 101 Coll St,MaRS South Tower, Toronto, ON M5G 1L7, Canada.	raymond.hui@utoronto.ca	Artz, Jennifer/G-5515-2014	Artz, Jennifer/0000-0003-0500-6156; Russell, Robert Graham G/0000-0002-4136-1828; Dunford, James/0000-0002-9932-4042	Canadian Institutes for Health Research; Canadian Foundation for Innovation, Genome Canada through Ontario Genomics Institute, GlaxoSmithKline; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation, Merck Co., Inc.; Novartis Research Foundation; Petrus and Augusta Hedlund's Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust [1097737]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation, Genome Canada through Ontario Genomics Institute, GlaxoSmithKline(Genome CanadaCanada Foundation for InnovationGlaxoSmithKline); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation, Merck Co., Inc.(Ministry of Research and Innovation, OntarioMerck & Company); Novartis Research Foundation; Petrus and Augusta Hedlund's Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Petrus and Augusta Hedlund's Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust (all to the Structural Genomics Consortium, registered charity number 1097737).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Artz JD, 2008, CHEM BIOL, V15, P1296, DOI 10.1016/j.chembiol.2008.10.017; Bahl A, 2003, NUCLEIC ACIDS RES, V31, P212, DOI 10.1093/nar/gkg081; Chakrabarti D, 1998, MOL BIOCHEM PARASIT, V94, P175, DOI 10.1016/S0166-6851(98)00065-6; Chakrabarti D, 2002, J BIOL CHEM, V277, P42066, DOI 10.1074/jbc.M202860200; Chang TH, 2006, J BIOL CHEM, V281, P14991, DOI 10.1074/jbc.M512886200; CHEN AJ, 1994, PROTEIN SCI, V3, P600; Chen CKM, 2008, J MED CHEM, V51, P5594, DOI 10.1021/jm800325y; Clastre M, 2007, EXP PARASITOL, V116, P375, DOI 10.1016/j.exppara.2007.02.002; Dunford JE, 2008, J MED CHEM, V51, P2187, DOI 10.1021/jm7015733; Dunford JE, 2001, J PHARMACOL EXP THER, V296, P235; Gabelli SB, 2006, PROTEINS, V62, P80, DOI 10.1002/prot.20754; Ghosh S, 2004, J MED CHEM, V47, P175, DOI 10.1021/jm030084x; Guo RT, 2007, P NATL ACAD SCI USA, V104, P10022, DOI 10.1073/pnas.0702254104; Kavanagh KL, 2006, P NATL ACAD SCI USA, V103, P7829, DOI 10.1073/pnas.0601643103; Kavanagh KL, 2006, J BIOL CHEM, V281, P22004, DOI 10.1074/jbc.M602603200; Ling Y, 2005, J MED CHEM, V48, P3130, DOI 10.1021/jm040132t; Ling Y, 2007, J BIOL CHEM, V282, P30804, DOI 10.1074/jbc.M703178200; Martin MB, 2001, J MED CHEM, V44, P909, DOI 10.1021/jm0002578; Montalvetti A, 2001, J BIOL CHEM, V276, P33930, DOI 10.1074/jbc.M103950200; Moreno B, 2001, BIOCHEM BIOPH RES CO, V284, P632, DOI 10.1006/bbrc.2001.5009; Mukkamala D, 2008, J MED CHEM, V51, P7827, DOI 10.1021/jm8009074; Ohnuma S, 1996, J BIOL CHEM, V271, P30748, DOI 10.1074/jbc.271.48.30748; REED BC, 1975, BIOCHEMISTRY-US, V14, P50, DOI 10.1021/bi00672a009; Rondeau JM, 2006, CHEMMEDCHEM, V1, P267, DOI 10.1002/cmdc.200500059; Singh AP, 2010, ANTIMICROB AGENTS CH, V54, P2987, DOI 10.1128/AAC.00198-10; Szabo CM, 2002, J MED CHEM, V45, P2185, DOI 10.1021/jm010412y; TARSHIS LC, 1994, BIOCHEMISTRY-US, V33, P10871, DOI 10.1021/bi00202a004; Tarshis LC, 1996, P NATL ACAD SCI USA, V93, P15018, DOI 10.1073/pnas.93.26.15018; Vedadi M, 2007, MOL BIOCHEM PARASIT, V151, P100, DOI 10.1016/j.molbiopara.2006.10.011	30	46	47	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3315	3322		10.1074/jbc.M109.027235	http://dx.doi.org/10.1074/jbc.M109.027235			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21084289	Green Published, hybrid			2022-12-25	WOS:000286653200017
J	Bocik, WE; Sircar, A; Gray, JJ; Tolman, JR				Bocik, William E.; Sircar, Aroop; Gray, Jeffrey J.; Tolman, Joel R.			Mechanism of Polyubiquitin Chain Recognition by the Human Ubiquitin Conjugating Enzyme Ube2g2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; ENDOPLASMIC-RETICULUM; NMR-SPECTROSCOPY; PROTEIN; BINDING; GP78; PROTEASOME; SITE; CONFORMATIONS; ROSETTADOCK	Ube2g2 is a human ubiquitin conjugating (E2) enzyme involved in the endoplasmic reticulum-associated degradation pathway, which is responsible for the identification and degradation of unfolded and misfolded proteins in the endoplasmic reticulum compartment. The Ube2g2-specific role is the assembly of Lys-48-linked polyubiquitin chains, which constitutes a signal for proteasomal degradation when attached to a substrate protein. NMR chemical shift perturbation and paramagnetic relaxation enhancement approaches were employed to characterize the binding interaction between Ube2g2 and ubiquitin, Lys-48-linked diubiquitin, and Lys-63-linked diubiquitin. Results demonstrate that ubiquitin binds to Ube2g2 with an affinity of 90 mu M in two different orientations that are rotated by 180 degrees in models generated by the RosettaDock modeling suite. The binding of Ube2g2 to Lys-48- and Lys-63-linked diubiquitin is primarily driven by interactions with individual ubiquitin subunits, with a clear preference for the subunit containing the free Lys-48 or Lys-63 side chain (i.e. the distal subunit). This preference is particularly striking in the case of Lys-48-linked diubiquitin, which exhibits an similar to 3-fold difference in affinities between the two ubiquitin subunits. This difference can be attributed to the partial steric occlusion of the subunit whose Lys-48 side chain is involved in the isopeptide linkage. As such, these results suggest that Lys-48-linked polyubiquitin chains may be designed to bind certain proteins like Ube2g2 such that the terminal ubiquitin subunit carrying the reactive Lys-48 side chain can be positioned properly for chain elongation regardless of chain length.	[Bocik, William E.; Gray, Jeffrey J.; Tolman, Joel R.] Johns Hopkins Univ, Dept Chem, Baltimore, MD 21218 USA; [Bocik, William E.; Gray, Jeffrey J.; Tolman, Joel R.] Johns Hopkins Univ, Program Mol Biophys, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University	Gray, JJ (corresponding author), Johns Hopkins Univ, Dept Chem, Charles & 34Th St, Baltimore, MD 21218 USA.	jgray@jhu.edu; tolman@jhu.edu	Gray, Jeffrey J./B-5682-2008	Gray, Jeffrey J./0000-0001-6380-2324; Bocik, William/0000-0002-0183-7051; Chen, Lu/0000-0002-9580-8576	National Institutes of Health [T32GM008403, GM075310-04S1, GM078221]; UCB SA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075310, R01GM078221, T32GM008403] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCB SA(UCB Pharma SA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants T32GM008403 (to W. E. B.), GM075310-04S1 (to J. R. T.), and GM078221 (to J. J. G.). This work was also supported by UCB SA (to A. S., J. J. G., and J. R. T.).	Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Beal R, 1996, P NATL ACAD SCI USA, V93, P861, DOI 10.1073/pnas.93.2.861; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chaudhury S, 2007, PROTEINS, V69, P793, DOI 10.1002/prot.21731; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; Das R, 2009, MOL CELL, V34, P674, DOI 10.1016/j.molcel.2009.05.010; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Goddard T.D., 2004, SPARKY 3; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; HAAS AL, 1982, J BIOL CHEM, V257, P329; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hofmann RM, 2001, J BIOL CHEM, V276, P27936, DOI 10.1074/jbc.M103378200; Iwahara J, 2006, NATURE, V440, P1227, DOI 10.1038/nature04673; Ju TT, 2010, PROTEINS, V78, P1291, DOI 10.1002/prot.22648; KALBITZER H, 2007, PROTEIN REV, V5, P189; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kostova Z, 2003, EMBO J, V22, P2309, DOI 10.1093/emboj/cdg227; Lewis LK, 2010, BIOTECHNIQUES, V48, P297, DOI 10.2144/000113387; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Li W, 2009, P NATL ACAD SCI USA, V106, P3722, DOI 10.1073/pnas.0808564106; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; McDonald GR, 2008, SCIENCE, V322, P917, DOI 10.1126/science.1162395; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Miura T, 1999, J MOL BIOL, V290, P213, DOI 10.1006/jmbi.1999.2859; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Piotrowski J, 1997, J BIOL CHEM, V272, P23712, DOI 10.1074/jbc.272.38.23712; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Raasi Shahri, 2005, V301, P47; Sims JJ, 2009, NAT STRUCT MOL BIOL, V16, P883, DOI 10.1038/nsmb.1637; Sims JJ, 2009, MOL CELL, V33, P775, DOI 10.1016/j.molcel.2009.02.011; Sircar A, 2010, PROTEINS, V78, P3115, DOI 10.1002/prot.22765; Sircar A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000644; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Tanaka K, 2004, BBA-MOL CELL RES, V1695, P235, DOI 10.1016/j.bbamcr.2004.09.026; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Tsai YC, 2007, NAT MED, V13, P1504, DOI 10.1038/nm1686; Tsutsumi S, 2004, CLIN CANCER RES, V10, P7775, DOI 10.1158/1078-0432.CCR-04-1015; Varadan R, 2004, J BIOL CHEM, V279, P7055, DOI 10.1074/jbc.M309184200; Varadan R, 2005, MOL CELL, V18, P687, DOI 10.1016/j.molcel.2005.05.013; Varadan R, 2002, J MOL BIOL, V324, P637, DOI 10.1016/S0022-2836(02)01198-1; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b	46	12	12	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3981	3991		10.1074/jbc.M110.189050	http://dx.doi.org/10.1074/jbc.M110.189050			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21098018	Green Published, hybrid			2022-12-25	WOS:000286653200078
J	Ben-Yona, A; Bendahan, A; Kanner, BI				Ben-Yona, Assaf; Bendahan, Annie; Kanner, Baruch I.			A Glutamine Residue Conserved in the Neurotransmitter: Sodium: Symporters Is Essential for the Interaction of Chloride with the GABA Transporter GAT-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOBUTYRIC-ACID TRANSPORTER; RAT-BRAIN; BACTERIAL HOMOLOG; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; ION-BINDING; SUBTYPE-A; IDENTIFICATION; SITE; PERMEATION	Neurotransmitter: sodium symporters are crucial for efficient synaptic transmission. The transporter GAT-1 mediates electrogenic cotransport of GABA, sodium, and chloride. The presence of chloride enables the transporter to couple the transport of the neurotransmitter to multiple sodium ions, thereby enabling its accumulation against steep concentration gradients. Here we study the functional impact of mutations of the putative chloride-binding residues on transport by GAT-1, with the emphasis on a conserved glutamine residue. In contrast to another putative chloride coordinating residue, Ser331, where mutation to glutamate led to chloride-independent GABA transport, the Q291E mutant was devoid of any transport activity, despite substantial expression at the plasma membrane. Low but significant transport activity was observed with substitution mutants with small side chains such as Q291S/A/G. Remarkably, when these mutations were combined with the S331E mutation, transport was increased significantly, even though the activity of the S331E single mutant was only similar to 25% of that of wild type GAT-1. Transport by these double mutants was largely chloride-independent. Like mutants of other putative chloride coordinating residues, the apparent affinity of the active Gln-291 single mutants for chloride was markedly reduced along with a change their anion selectivity. In addition to the interaction of the transporter with chloride, Gln-291 is also required at an additional step during transport. Electrophysiological analysis of the Q291N and Q291S mutants, expressed in Xenopus laevis oocytes, is consistent with the idea that this additional step is associated with the gating of the transporter.	[Ben-Yona, Assaf; Bendahan, Annie; Kanner, Baruch I.] Hebrew Univ Jerusalem, Dept Biochem & Mol Biol, Inst Med Res Israel Canada, Hadassah Med Sch, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Kanner, BI (corresponding author), Hebrew Univ Jerusalem, Dept Biochem & Mol Biol, Inst Med Res Israel Canada, Hadassah Med Sch, POB 12272, IL-91120 Jerusalem, Israel.	kannerb@cc.huji.ac.il			Israel Science Foundation; European Union Consortium European Drug Initiative on Channels and Transporters	Israel Science Foundation(Israel Science Foundation); European Union Consortium European Drug Initiative on Channels and Transporters(European Commission)	This work was supported by grants from the Israel Science Foundation and the European Union Consortium European Drug Initiative on Channels and Transporters.	Androutsellis-Theotokis A, 2003, J BIOL CHEM, V278, P12703, DOI 10.1074/jbc.M206563200; Bennett ER, 2000, J BIOL CHEM, V275, P34106, DOI 10.1074/jbc.M004229200; Bismuth Y, 1997, J BIOL CHEM, V272, P16096, DOI 10.1074/jbc.272.26.16096; Borre L, 2004, J BIOL CHEM, V279, P2513, DOI 10.1074/jbc.M311446200; Dodd JR, 2007, J BIOL CHEM, V282, P15528, DOI 10.1074/jbc.M611705200; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Kanner BI, 2003, J BIOL CHEM, V278, P3705, DOI 10.1074/jbc.M210525200; KANNER BI, 1994, J EXP BIOL, V196, P237; KEYNAN S, 1988, BIOCHEMISTRY-US, V27, P12, DOI 10.1021/bi00401a003; KEYNAN S, 1992, BIOCHEMISTRY-US, V31, P1974, DOI 10.1021/bi00122a011; KLEINBERGERDORON N, 1994, J BIOL CHEM, V269, P3063; Krause S, 2005, MOL PHARMACOL, V68, P1728, DOI 10.1124/mol.105.013870; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Mager S, 1996, J NEUROSCI, V16, P5405; Mari SA, 2006, CELL MOL LIFE SCI, V63, P100, DOI 10.1007/s00018-005-5512-6; Nelson N, 1998, J NEUROCHEM, V71, P1785; PANTANOWITZ S, 1993, J BIOL CHEM, V268, P3222; Quick M, 2006, J BIOL CHEM, V281, P26444, DOI 10.1074/jbc.M602438200; RADIAN R, 1986, J BIOL CHEM, V261, P5437; Rosenberg A, 2008, J BIOL CHEM, V283, P14376, DOI 10.1074/jbc.M801093200; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Tavoulari S, 2011, J BIOL CHEM, V286, P2834, DOI 10.1074/jbc.M110.186064; Vandenberg RJ, 2007, J BIOL CHEM, V282, P14447, DOI 10.1074/jbc.M609158200; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhang YW, 2006, J BIOL CHEM, V281, P36213, DOI 10.1074/jbc.M605468200; Zhao YF, 2010, NAT CHEM BIOL, V6, P109, DOI [10.1038/NCHEMBIO.284, 10.1038/nchembio.284]; Zhou YG, 2006, J BIOL CHEM, V281, P22092, DOI 10.1074/jbc.M602319200; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	31	29	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2826	2833		10.1074/jbc.M110.149732	http://dx.doi.org/10.1074/jbc.M110.149732			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21098479	hybrid, Green Published			2022-12-25	WOS:000286464300048
J	Darshi, M; Mendiola, VL; Mackey, MR; Murphy, AN; Koller, A; Perkins, GA; Ellisman, MH; Taylor, SS				Darshi, Manjula; Mendiola, Vincent L.; Mackey, Mason R.; Murphy, Anne N.; Koller, Antonius; Perkins, Guy A.; Ellisman, Mark H.; Taylor, Susan S.			ChChd3, an Inner Mitochondrial Membrane Protein, Is Essential for Maintaining Crista Integrity and Mitochondrial Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; INTERMEMBRANE SPACE; COILED-COIL; ELECTRON TOMOGRAPHY; ASSEMBLY PATHWAY; MAMMALIAN-CELLS; OUTER-MEMBRANE; MORPHOLOGY; IMPORT; FUSION	The mitochondrial inner membrane (IM) serves as the site for ATP production by hosting the oxidative phosphorylation complex machinery most notably on the crista membranes. Disruption of the crista structure has been implicated in a variety of cardiovascular and neurodegenerative diseases. Here, we characterize ChChd3, a previously identified PKA substrate of unknown function (Schauble, S., King, C. C., Darshi, M., Koller, A., Shah, K., and Taylor, S. S. (2007) J. Biol. Chem. 282, 14952-14959), and show that it is essential for maintaining crista integrity and mitochondrial function. In the mitochondria, ChChd3 is a peripheral protein of the IM facing the intermembrane space. RNAi knockdown of ChChd3 in HeLa cells resulted in fragmented mitochondria, reduced OPA1 protein levels and impaired fusion, and clustering of the mitochondria around the nucleus along with reduced growth rate. Both the oxygen consumption and glycolytic rates were severely restricted. Ultrastructural analysis of these cells revealed aberrant mitochondrial IM structures with fragmented and tubular cristae or loss of cristae, and reduced crista membrane. Additionally, the crista junction opening diameter was reduced to 50% suggesting remodeling of cristae in the absence of ChChd3. Analysis of the ChChd3-binding proteins revealed that ChChd3 interacts with the IM proteins mitofilin and OPA1, which regulate crista morphology, and the outer membrane protein Sam50, which regulates import and assembly of beta-barrel proteins on the outer membrane. Knockdown of ChChd3 led to almost complete loss of both mitofilin and Sam50 proteins and alterations in several mitochondrial proteins, suggesting that ChChd3 is a scaffolding protein that stabilizes protein complexes involved in maintaining crista architecture and protein import and is thus essential for maintaining mitochondrial structure and function.	[Darshi, Manjula; Koller, Antonius; Taylor, Susan S.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Mendiola, Vincent L.; Mackey, Mason R.; Perkins, Guy A.; Ellisman, Mark H.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Mendiola, Vincent L.; Mackey, Mason R.; Perkins, Guy A.; Ellisman, Mark H.] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA; [Murphy, Anne N.; Taylor, Susan S.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Taylor, Susan S.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Taylor, SS (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Leichtag 415, La Jolla, CA 92093 USA.	staylor@ucsd.edu	; Murphy, Anne N/H-3217-2016	Mendiola, Vincent Louie/0000-0001-5287-0743; Perkins, Guy/0000-0002-1834-6646; Murphy, Anne N/0000-0002-5222-9902	National Institutes of Health [P01 DK54441, P21 RR04050]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 DK54441 (to S. S. T.) and P21 RR04050 (to M. H. E.).	Banci L, 2008, J BIOL CHEM, V283, P7912, DOI 10.1074/jbc.M708016200; Banci L, 2009, FEBS LETT, V583, P1699, DOI 10.1016/j.febslet.2009.03.061; Banci L, 2009, NAT STRUCT MOL BIOL, V16, P198, DOI 10.1038/nsmb.1553; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Dreger M, 2005, J PROTEOME RES, V4, P238, DOI 10.1021/pr049870w; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Fukada K, 2004, MOL CELL PROTEOMICS, V3, P1211, DOI 10.1074/mcp.M400094-MCP200; Gerencser AA, 2009, J NEUROCHEM, V110, P990, DOI 10.1111/j.1471-4159.2009.06194.x; Habib SJ, 2007, J CELL BIOL, V176, P77, DOI 10.1083/jcb.200602050; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Humphries AD, 2005, J BIOL CHEM, V280, P11535, DOI 10.1074/jbc.M413816200; John GB, 2005, MOL BIOL CELL, V16, P1543, DOI 10.1091/mbc.e04-08-0697; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kavazis AN, 2009, AM J PHYSIOL-HEART C, V297, pH144, DOI 10.1152/ajpheart.01278.2008; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Knott AB, 2008, ANN NY ACAD SCI, V1147, P283, DOI 10.1196/annals.1427.030; Kozjak-Pavlovic V, 2007, EMBO REP, V8, P576, DOI 10.1038/sj.embor.7400982; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lawrence A, 2006, J STRUCT BIOL, V154, P144, DOI 10.1016/j.jsb.2005.12.012; Meisinger C, 2004, DEV CELL, V7, P61, DOI 10.1016/j.devcel.2004.06.003; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Odgren PR, 1996, J CELL SCI, V109, P2253; Oka T, 2008, MOL BIOL CELL, V19, P2597, DOI 10.1091/mbc.E07-12-1205; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Olichon A, 2002, FEBS LETT, V523, P171, DOI 10.1016/S0014-5793(02)02985-X; Pagliarini DJ, 2005, MOL CELL, V19, P197, DOI 10.1016/j.molcel.2005.06.008; Palumaa P, 2004, BIOCHEM J, V382, P307, DOI 10.1042/BJ20040360; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Perkins G, 1997, J STRUCT BIOL, V119, P260, DOI 10.1006/jsbi.1997.3885; Perkins GA, 1997, J STRUCT BIOL, V120, P219, DOI 10.1006/jsbi.1997.3920; Perkins GA, 2001, J NEUROSCI RES, V66, P857, DOI 10.1002/jnr.10050; Perkins G, 2009, EXP NEUROL, V218, P183, DOI 10.1016/j.expneurol.2009.05.021; Reichert AS, 2002, BBA-MOL CELL RES, V1592, P41, DOI 10.1016/S0167-4889(02)00263-X; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Rigby K, 2007, J BIOL CHEM, V282, P10233, DOI 10.1074/jbc.M610082200; Schauble S, 2007, J BIOL CHEM, V282, P14952, DOI 10.1074/jbc.M609221200; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Song ZY, 2007, J CELL BIOL, V178, P749, DOI 10.1083/jcb.200704110; Stojanovski D, 2006, BBA-MOL CELL RES, V1763, P414, DOI 10.1016/j.bbamcr.2006.02.008; Sun MG, 2007, NAT CELL BIOL, V9, P1057, DOI 10.1038/ncb1630; Wiedemann N, 2004, J BIOL CHEM, V279, P18188, DOI 10.1074/jbc.M400050200; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Xie J, 2007, FEBS LETT, V581, P3545, DOI 10.1016/j.febslet.2007.06.052; Yamaguchi R, 2008, MOL CELL, V31, P557, DOI 10.1016/j.molcel.2008.07.010; Yamaguchi R, 2009, BBA-BIOENERGETICS, V1787, P963, DOI 10.1016/j.bbabio.2009.02.005; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Zick M, 2009, FEBS LETT, V583, P2237, DOI 10.1016/j.febslet.2009.05.053	52	223	238	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2918	2932		10.1074/jbc.M110.171975	http://dx.doi.org/10.1074/jbc.M110.171975			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21081504	Green Published, hybrid			2022-12-25	WOS:000286464300056
J	Tomasiak, TM; Archuleta, TL; Andrell, J; Luna-Chavez, C; Davis, TA; Sarwar, M; Ham, AJ; McDonald, WH; Yankovskaya, V; Stern, HA; Johnston, JN; Maklashina, E; Cecchini, G; Iverson, TM				Tomasiak, Thomas M.; Archuleta, Tara L.; Andrell, Juni; Luna-Chavez, Cesar; Davis, Tyler A.; Sarwar, Maruf; Ham, Amy J.; McDonald, W. Hayes; Yankovskaya, Victoria; Stern, Harry A.; Johnston, Jeffrey N.; Maklashina, Elena; Cecchini, Gary; Iverson, Tina M.			Geometric Restraint Drives On- and Off-pathway Catalysis by the Escherichia coli Menaquinol:Fumarate Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL-COA DEHYDROGENASE; AMINO-ACID OXIDASE; FUMARATE REDUCTASE; ACTIVE-SITE; COMPLEX-II; SUCCINATE-DEHYDROGENASE; CRYSTAL-STRUCTURES; 3-NITROPROPIONIC ACID; RESPIRATORY COMPLEX; LIVER MITOCHONDRIA	Complex II superfamily members catalyze the kinetically difficult interconversion of succinate and fumarate. Due to the relative simplicity of complex II substrates and their similarity to other biologically abundant small molecules, substrate specificity presents a challenge in this system. In order to identify determinants for on-pathway catalysis, off-pathway catalysis, and enzyme inhibition, crystal structures of Escherichia coli menaquinol: fumarate reductase (QFR), a complex II superfamily member, were determined bound to the substrate, fumarate, and the inhibitors oxaloacetate, glutarate, and 3-nitropropionate. Optical difference spectroscopy and computational modeling support a model where QFR twists the dicarboxylate, activating it for catalysis. Orientation of the C2-C3 double bond of activated fumarate parallel to the C(4a)-N5 bond of FAD allows orbital overlap between the substrate and the co-factor, priming the substrate for nucleophilic attack. Off-pathway catalysis, such as the conversion of malate to oxaloacetate or the activation of the toxin 3-nitropropionate may occur when inhibitors bind with a similarly activated bond in the same position. Conversely, inhibitors that do not orient an activatable bond in this manner, such as glutarate and citrate, are excluded from catalysis and act as inhibitors of substrate binding. These results support a model where electronic interactions via geometric constraint and orbital steering underlie catalysis by QFR.	[Luna-Chavez, Cesar; Yankovskaya, Victoria; Maklashina, Elena; Cecchini, Gary] Vet Affairs Med Ctr, Div Mol Biol, San Francisco, CA 94121 USA; [Andrell, Juni] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Ham, Amy J.; McDonald, W. Hayes; Iverson, Tina M.] Vanderbilt Univ, Dept Biochem, Med Ctr, Nashville, TN 37232 USA; [Davis, Tyler A.; Johnston, Jeffrey N.; Iverson, Tina M.] Vanderbilt Univ, Med Ctr, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA; Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Johnston, Jeffrey N.] Vanderbilt Univ, Dept Chem, Nashville, TN 37235 USA; [Sarwar, Maruf; Stern, Harry A.] Univ Rochester, Dept Chem, Rochester, NY 14627 USA; [Maklashina, Elena; Cecchini, Gary] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); MRC Laboratory Molecular Biology; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Rochester; University of California System; University of California San Francisco	Cecchini, G (corresponding author), Vet Affairs Med Ctr, Div Mol Biol, San Francisco, CA 94121 USA.	gary.cecchini@ucsf.edu; tina.iverson@vanderbilt.edu	McDonald, W. Hayes/B-4109-2016; Johnston, Jeff/AAW-1271-2021	McDonald, W. Hayes/0000-0002-3510-426X; Johnston, Jeff/0000-0002-0885-636X	National Institutes of Health (NIH) [GM61606, GM079419, GM084333, P30 ES000267, T32 GM65086]; Department of Energy, Office of Biological and Environmental Research; National Center for Research Resources; Biomedical Technology Program; NIGMS; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Vanderbilt Core Grant in Vision Research [P30EY008126]; Department of Veterans Affairs; Ellison Medical Foundation [AG-NS-0325]; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079419, T32GM065086, R01GM084333, R01GM061606] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Biomedical Technology Program; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Vanderbilt Core Grant in Vision Research; Department of Veterans Affairs(US Department of Veterans Affairs); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grants GM61606 (to G. C.), GM079419 (to T. M. I.), and GM084333 (to J. N. J.) and a pilot award funded by NIH Grant P30 ES000267 (to T. M. I.). Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, a national user facility operated by Stanford University on behalf of the United States Department of Energy, Office of Basic Energy Sciences. The Stanford Synchrotron Radiation Lightsource Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by the NIH, National Center for Research Resources, Biomedical Technology Program, and NIGMS, NIH. Use of the LS-CAT beamline at the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357. A portion of this work used facilities that were supported by the Vanderbilt Core Grant in Vision Research (P30EY008126). Part of this work is based upon research conducted at the European Synchrotron Radiation Facility. This work was supported by the Department of Veterans Affairs and by Ellison Medical Foundation Grant AG-NS-0325 (to T. M. I.).; Supported by National Institutes of Health Grant T32 GM65086 (Chemistry-Biology Interface training grant).	ACKRELL BAC, 1974, J BIOL CHEM, V249, P2021; ACKRELL BAC, 1989, ARCH BIOCHEM BIOPHYS, V268, P26, DOI 10.1016/0003-9861(89)90561-4; ALSTON TA, 1977, P NATL ACAD SCI USA, V74, P3767, DOI 10.1073/pnas.74.9.3767; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BEAL MF, 1993, J NEUROSCI, V13, P4181; BELIKOVA YO, 1988, BIOCHIM BIOPHYS ACTA, V936, P1, DOI 10.1016/0005-2728(88)90245-9; Benson TE, 1997, BIOCHEMISTRY-US, V36, P806, DOI 10.1021/bi962221g; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUSH MT, 1951, J BIOL CHEM, V188, P685; Cecchini G, 2003, ANNU REV BIOCHEM, V72, P77, DOI 10.1146/annurev.biochem.72.121801.161700; COLES CJ, 1979, J BIOL CHEM, V254, P5161; DAFFORN A, 1971, P NATL ACAD SCI USA, V68, P2463, DOI 10.1073/pnas.68.10.2463; Doherty MK, 2000, BIOCHEMISTRY-US, V39, P10695, DOI 10.1021/bi000871l; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FOX KM, 1994, STRUCTURE, V2, P1089, DOI 10.1016/S0969-2126(94)00111-1; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; HALL LH, 1987, BIOCHEMISTRY-US, V26, P7401, DOI 10.1021/bi00397a031; Huang LS, 2006, BBA-BIOENERGETICS, V1757, P1073, DOI 10.1016/j.bbabio.2006.06.015; Huang LS, 2006, J BIOL CHEM, V281, P5965, DOI 10.1074/jbc.M511270200; Iverson TM, 2002, J BIOL CHEM, V277, P16124, DOI 10.1074/jbc.M200815200; Iverson TM, 1999, SCIENCE, V284, P1961, DOI 10.1126/science.284.5422.1961; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KIM JJP, 1993, P NATL ACAD SCI USA, V90, P7523, DOI 10.1073/pnas.90.16.7523; Kolker S, 2004, J INHERIT METAB DIS, V27, P805, DOI 10.1023/B:BOLI.0000045762.37248.28; Lancaster CRD, 1999, NATURE, V402, P377, DOI 10.1038/46483; Leys D, 1999, NAT STRUCT BIOL, V6, P1113; LI JY, 1993, BIOCHEMISTRY-US, V32, P11507, DOI 10.1021/bi00094a006; Luna-Chavez C, 2000, PROTEIN EXPRES PURIF, V19, P188, DOI 10.1006/prep.2000.1238; Maklashina E, 2006, J BIOL CHEM, V281, P11357, DOI 10.1074/jbc.M512544200; Maklashina E, 2006, J BIOL CHEM, V281, P26655, DOI 10.1074/jbc.M602938200; Mattevi A, 1997, STRUCTURE, V5, P907, DOI 10.1016/S0969-2126(97)00245-1; Mesecar AD, 1997, SCIENCE, V277, P202, DOI 10.1126/science.277.5323.202; Miura R, 1996, J BIOCHEM-TOKYO, V119, P512; MORRIS MP, 1954, SCIENCE, V119, P322, DOI 10.1126/science.119.3088.322; Mowat CG, 2001, BIOCHEMISTRY-US, V40, P12292, DOI 10.1021/bi011360h; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NISHINA Y, 1995, J BIOCHEM-TOKYO, V118, P614, DOI 10.1093/oxfordjournals.jbchem.a124954; Ostrander EL, 2009, BIOCHEMISTRY-US, V48, P951, DOI 10.1021/bi802094k; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OTWINOWSKI Z, 1993, CCP4 STUDY WEEKEND D, P56; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pankhurst KL, 2006, J BIOL CHEM, V281, P20589, DOI 10.1074/jbc.M603077200; Reid GA, 2000, BBA-BIOENERGETICS, V1459, P310, DOI 10.1016/S0005-2728(00)00166-3; Shen B, 2010, NATURE, V465, P1027, DOI 10.1038/nature09125; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Taylor P, 1999, NAT STRUCT BIOL, V6, P1108; Tomasiak TM, 2008, J BIOL CHEM, V283, P15460, DOI 10.1074/jbc.M801372200; Ullrich K, 1999, J INHERIT METAB DIS, V22, P392, DOI 10.1023/A:1005595921323; Umhau S, 2000, P NATL ACAD SCI USA, V97, P12463, DOI 10.1073/pnas.97.23.12463; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020	51	17	18	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					3047	3056		10.1074/jbc.M110.192849	http://dx.doi.org/10.1074/jbc.M110.192849			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21098488	hybrid, Green Published			2022-12-25	WOS:000286464300067
J	Wang, J; Wu, JW; Wang, ZX				Wang, Jue; Wu, Jia-Wei; Wang, Zhi-Xin			Mechanistic Studies of the Autoactivation of PAK2 A TWO-STEP MODEL OF CIS INITIATION FOLLOWED BY TRANS AMPLIFICATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATION-LOOP AUTOPHOSPHORYLATION; KINASE GAMMA-PAK; P21-ACTIVATED KINASE; PROTEIN-KINASE; SUBSTRATE REACTION; ASSAYS; PHOSPHORYLATION; CONFORMATION; CDC42	Protein kinase activation, via autophosphorylation of the activation loop, is a common regulatory mechanism in phosphorylation- dependent signaling cascades. Despite the prevalence of this reaction and its importance in biological regulation, the molecular mechanisms of autophosphorylation are poorly understood. In this study, we developed a kinetic approach to distinguish quantitatively between cis- and trans-pathways in an autocatalytic reaction. Using this method, we have undertaken a detailed kinetic analysis for the autoactivation mechanism of p21-activated protein kinase 2 (PAK2). PAK2 is regulated in vivo and in vitro by small GTP-binding proteins, Cdc42 and Rac. Full activation of PAK2 requires autophosphorylation of the conserved threonine, Thr(402), in the activation loop of its catalytic kinase domain. Analyses of the time courses of substrate reaction during PAK2 autoactivation suggest that autophosphorylation of Thr(402) in PAK2 obeys a two-step mechanism of cis initiation, followed by trans amplification. The unphosphorylated PAK2 undergoes an intramolecular (cis) autophosphorylation on Thr(402) to produce phosphorylated PAK2, and this newly formed active PAK2 then phosphorylates other PAK2 molecules at Thr(402) in an intermolecular (trans) manner. Based on the kinetic equation derived, all microscopic kinetic constants for the cis and trans autophosphorylation have been estimated quantitatively. The advantage of the new method is not only its usefulness in the study of fast activation reactions, but its convenience in the study of substrate effects on modification reaction. It would be particularly useful when the regulatory mechanism of the autophosphorylation reaction toward certain enzymes is being assessed.	[Wang, Jue; Wu, Jia-Wei; Wang, Zhi-Xin] Tsinghua Univ, Sch Life Sci, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China; [Wang, Zhi-Xin] Acad Sinica, Inst Biophys, Beijing 100101, Peoples R China	Tsinghua University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Wang, ZX (corresponding author), Tsinghua Univ, Sch Life Sci, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China.	zhixinwang@mail.tsinghua.edu.cn	wang, zhixin/GZH-2500-2022		Roche R&D Center (China) Ltd., MOST [2006CB503900, 2007CB914400]; NSFC [30770476]	Roche R&D Center (China) Ltd., MOST; NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by the RRDCC basic research grant of Roche R&D Center (China) Ltd., MOST Grants 2006CB503900 and 2007CB914400, and NSFC Grant 30770476.	Adams JA, 2001, CHEM REV, V101, P2271, DOI 10.1021/cr000230w; Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Buchwald G, 2001, MOL CELL BIOL, V21, P5179, DOI 10.1128/MCB.21.15.5179-5189.2001; Buck M, 2004, J MOL BIOL, V338, P271, DOI 10.1016/j.jmb.2004.02.036; Chew TL, 1998, J MUSCLE RES CELL M, V19, P839, DOI 10.1023/A:1005417926585; Deacon SW, 2008, CHEM BIOL, V15, P322, DOI 10.1016/j.chembiol.2008.03.005; Gatti A, 1999, J BIOL CHEM, V274, P8022, DOI 10.1074/jbc.274.12.8022; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Lochhead PA, 2005, CELL, V121, P925, DOI 10.1016/j.cell.2005.03.034; Lochhead PA, 2006, MOL CELL, V24, P627, DOI 10.1016/j.molcel.2006.10.009; Lochhead PA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.254pe4; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; MCCLURE WR, 1969, BIOCHEMISTRY-US, V8, P2782, DOI 10.1021/bi00835a014; Molli PR, 2009, ONCOGENE, V28, P2545, DOI 10.1038/onc.2009.119; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Nomanbhoy T, 1999, BIOCHEMISTRY-US, V38, P15878, DOI 10.1021/bi9916832; Oliver AW, 2007, TRENDS BIOCHEM SCI, V32, P351, DOI 10.1016/j.tibs.2007.06.004; ROSKOSKI R, 1983, METHOD ENZYMOL, V99, P3; Stevens WK, 1999, BIOCHEMISTRY-US, V38, P5968, DOI 10.1021/bi990426u; Thompson G, 1998, BIOCHEMISTRY-US, V37, P7885, DOI 10.1021/bi980140+; TIAN WX, 1982, BIOCHEMISTRY-US, V21, P1028, DOI 10.1021/bi00534a031; TSOU CL, 1988, ADV ENZYMOL RAMB, V61, P381; Wu H, 2003, J BIOL CHEM, V278, P41768, DOI 10.1074/jbc.M308196200; Yu JS, 1998, BIOCHEM J, V334, P121, DOI 10.1042/bj3340121	28	11	12	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2689	2695		10.1074/jbc.M110.156505	http://dx.doi.org/10.1074/jbc.M110.156505			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21098037	Green Published, hybrid			2022-12-25	WOS:000286464300035
J	Chi, YY; Zhang, CY; Zong, HL; Hong, Y; Kong, XF; Liu, HO; Zou, WY; Wang, YL; Yun, XJ; Gu, JX				Chi, Yayun; Zhang, Chunyi; Zong, Hongliang; Hong, Yi; Kong, Xiangfei; Liu, Haiou; Zou, Weiying; Wang, Yanlin; Yun, Xiaojing; Gu, Jianxin			Thr-370 Is Responsible for CDK11(p58) Autophosphorylation, Dimerization, and Kinase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; CELL-CYCLE; ANDROGEN RECEPTOR; DOWN-REGULATION; MAP KINASE; APOPTOSIS; ACTIVATION; PROMOTES; PHOSPHORYLATION; TRANSLOCATION	CDK11(p58), a member of the p34(cdc2)-related kinase family, is associated with cell cycle progression, tumorigenesis, and proapoptotic signaling. It is also required for the maintenance of chromosome cohesion, the maturation of centrosome, the formation of bipolar spindle, and the completion of mitosis. Here we identified that CDK11(p58) interacted with itself to form homodimers in cells, whereas D224N, the kinase-dead mutant, failed to form homodimers. CDK11(p58) was autophosphorylated, and the main functions of CDK11(p58), such as kinase activity, transactivation of nuclear receptors, and proapoptotic signal transduction, were dependent on its autophosphorylation. Furthermore, the in vitro kinase assay indicated that CDK11(p58) was autophosphorylated at Thr-370. By mutagenesis, we created CDK11(p58) T370A and CDK11(p58) T370D, which mimic the dephosphorylated and phosphorylated forms of CDK11(p58), respectively. The T370A mutant could not form dimers and be phosphorylated by the wild type CDK11(p58) and finally lost the kinase activity. Further functional research revealed that T370A failed to repress the transactivition of androgen receptor and enhance the cell apoptosis. Overall, our data indicated that Thr-370 is responsible for the autophosphorylation, dimerization, and kinase activity of CDK11(p58). Moreover, Thr-370 mutants might affect CDK11(p58)-mediated signaling pathways.	[Wang, Yanlin; Yun, Xiaojing; Gu, Jianxin] Fudan Univ, Shanghai Med Coll, Ctr Gene Res, Shanghai 200032, Peoples R China; [Wang, Yanlin; Yun, Xiaojing; Gu, Jianxin] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Chi, Yayun] Fudan Univ, Canc Hosp, Res Ctr, Shanghai 200032, Peoples R China	Fudan University; Fudan University; Fudan University	Gu, JX (corresponding author), Fudan Univ, Shanghai Med Coll, Ctr Gene Res, 138 Yi Xue Yuan Rd, Shanghai 200032, Peoples R China.	jxgu@shmu.edu.cn	Zong, Hongliang/F-9366-2013	Zong, Hongliang/0000-0002-5855-5733; Gu, Jianxin/0000-0002-7454-6722	National Natural Scientific Foundation of China [30770426, 30930025, 30900266, J0730860]; Shanghai Leading Academic Discipline Project [B110]; State Key Project Specialized for Infectious Diseases [2008ZX10002-015, 2008ZX10002-021, 2008ZX10001-02, 2008ZX10004-014]; National Basic Research Program of China (973 Program) [2010CB912100, 2010CB912104]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); State Key Project Specialized for Infectious Diseases; National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by National Natural Scientific Foundation of China Grants 30770426, 30930025, and 30900266; Shanghai Leading Academic Discipline Project (B110); National Science Foundation for Fostering Talents in Basic Research of the National Natural Science Foundation of China Grant J0730860; State Key Project Specialized for Infectious Diseases Grants 2008ZX10002-015, 2008ZX10002-021, 2008ZX10001-02, and 2008ZX10004-014; and National Basic Research Program of China (973 Program) Grants 2010CB912100 and 2010CB912104.	Adachi M, 1999, EMBO J, V18, P5347, DOI 10.1093/emboj/18.19.5347; Ariza ME, 1999, J BIOL CHEM, V274, P28505, DOI 10.1074/jbc.274.40.28505; Beyaert R, 1997, J BIOL CHEM, V272, P11694, DOI 10.1074/jbc.272.18.11694; BUNNELL BA, 1990, P NATL ACAD SCI USA, V87, P7467, DOI 10.1073/pnas.87.19.7467; Cai MM, 2002, MOL CELL BIOCHEM, V238, P49, DOI 10.1023/A:1019950819784; Chen C, 2006, FEBS LETT, V580, P813, DOI 10.1016/j.febslet.2005.12.097; Cheng CM, 2009, J BIOL CHEM, V284, P8786, DOI 10.1074/jbc.M806144200; Chi YY, 2009, BIOCHEM BIOPH RES CO, V386, P493, DOI 10.1016/j.bbrc.2009.06.061; Cornelis S, 2000, MOL CELL, V5, P597, DOI 10.1016/S1097-2765(00)80239-7; Dey M, 2005, CELL, V122, P901, DOI 10.1016/j.cell.2005.06.041; Harper JW, 2001, CHEM REV, V101, P2511, DOI 10.1021/cr0001030; Hu DL, 2003, J BIOL CHEM, V278, P8623, DOI 10.1074/jbc.M210057200; Hu DL, 2007, J CELL SCI, V120, P2424, DOI 10.1242/jcs.007963; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; Kong XF, 2009, J BIOCHEM, V146, P417, DOI 10.1093/jb/mvp089; LAHTI JM, 1995, MOL CELL BIOL, V15, P1; Li ZJ, 2005, BIOCHEM BIOPH RES CO, V327, P628, DOI 10.1016/j.bbrc.2004.12.047; Lim JTE, 2005, P NATL ACAD SCI USA, V102, P5156, DOI 10.1073/pnas.0501203102; Miyake Z, 2007, MOL CELL BIOL, V27, P2765, DOI 10.1128/MCB.01435-06; Nitta RT, 2008, J BIOL CHEM, V283, P34935, DOI 10.1074/jbc.M804970200; Petretti C, 2006, EMBO REP, V7, P418, DOI 10.1038/sj.embor.7400639; Pike ACW, 2008, EMBO J, V27, P704, DOI 10.1038/emboj.2008.8; Tang D, 1998, J BIOL CHEM, V273, P28549, DOI 10.1074/jbc.273.44.28549; Trembley JH, 2004, PROG NUCLEIC ACID RE, V77, P263, DOI 10.1016/S0079-6603(04)77007-5; Trembley JH, 2002, J BIOL CHEM, V277, P2589, DOI 10.1074/jbc.M109755200; Yun XJ, 2007, MOL CELL BIOCHEM, V304, P213, DOI 10.1007/s11010-007-9502-x; Zhang SW, 2002, J BIOL CHEM, V277, P35314, DOI 10.1074/jbc.M202179200; Zong HL, 2007, MOL CELL BIOL, V27, P7125, DOI 10.1128/MCB.01753-06	28	18	18	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1748	1757		10.1074/jbc.M110.107367	http://dx.doi.org/10.1074/jbc.M110.107367			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21078675	hybrid, Green Published			2022-12-25	WOS:000286191500014
J	Zong, ZY; Lu, XJ				Zong, Zhiyong; Lue, Xiaoju			Characterization of a New SCCmec Element in Staphylococcus cohnii	PLOS ONE			English	Article							CASSETTE-CHROMOSOME-MEC; COAGULASE-NEGATIVE STAPHYLOCOCCI; GENETIC DIVERSITY; RESISTANT; AUREUS; EPIDERMIDIS; SAPROPHYTICUS; STRAINS; CLASSIFICATION; HAEMOLYTICUS	Background: Many SCCmec elements of coagulase-negative staphylococci (CoNS) could not be typed using multiplex PCR. Such a 'non-typable' SCCmec was encountered in a Staphylococcus cohnii isolate. Methodology/Principal Findings: The SCCmec type of methicillin-resistant S. cohnii clinical isolate WC28 could not be assigned using multiplex PCR. Newly-designed primers were used to amplify ccrA and ccrB genes. The whole SCCmec was obtained by three overlapping long-range PCR, targeting regions from left-hand inverted repeat (IRL) to ccrA/B, from ccrA/B to mecA and from mecA to orfX. The region abutting IRL was identified using inverse PCR with self-ligated enzyme-restricted WC28 fragments as the template. WC28 SCCmec had a class A mec gene complex (mecI-mecR1-mecA). The ccrA and ccrB genes were closest (89.7% identity) to ccrA(SHP) of Staphylococcus haemolyticus strain H9 and to ccrB3 (90% identity) of Staphylococcus pseudintermedius strain KM241, respectively. Two new genes potentially encoding AAA-type ATPase were found in J1 region and a psi Tn554 transposon was present in J2 region, while J3 region was the same as many SCCmec of Staphylococcus aureus. WC28 SCCmec abutted an incomplete SCC element with a novel allotype of ccrC, which was closest (82% identity) to ccrC1 allele 9 in Staphylococcus saprophyticus strain ATCC 15305. Only two direct target repeat sequences, one close to the 3'-end of orfX and the other abutting the left end of WC28 SCCmec, could be detected. Conclusions/Significance: A new 35-kb SCCmec was characterized in a S. cohnii isolate, carrying a class A mec gene complex, new variants of ccrA5 and ccrB3 and two novel genes in the J1 region. This element is flanked by 8-bp perfect inverted repeats and is similar to type III SCCmec in S. aureus and a SCCmec in S. pseudintermedius but with different J1 and J3 regions. WC28 SCCmec was arranged in tandem with an additional SCC element with ccrC, SCC(WC28), but the two elements might have integrated independently rather than constituted a composite. This study adds new evidence of the diversity of SCCmec in CoNS and highlights the need for characterizing the 'non-typable' SCCmec to reveal the gene pool associated with mecA.	[Zong, Zhiyong; Lue, Xiaoju] Sichuan Univ, Ctr Infect Dis, W China Hosp, Chengdu 610064, Peoples R China; [Zong, Zhiyong] Div Infect Dis, State Key Lab Biotherapy, Chengdu, Peoples R China	Sichuan University	Zong, ZY (corresponding author), Sichuan Univ, Ctr Infect Dis, W China Hosp, Chengdu 610064, Peoples R China.	zongzhiyong@gmail.com	Zong, Zhiyong/C-6142-2013	ZONG, ZHIYONG/0000-0002-7675-260X	National Natural Science Foundation of China [30900052]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is partially supported by a grant (no. 30900052) from the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Descloux S, 2008, J CLIN MICROBIOL, V46, P1818, DOI 10.1128/JCM.02255-07; Diekema DJ, 2001, CLIN INFECT DIS, V32, pS114, DOI 10.1086/320184; Hanssen AM, 2006, FEMS IMMUNOL MED MIC, V46, P8, DOI 10.1111/j.1574-695X.2005.00009.x; HARTMAN BJ, 1984, J BACTERIOL, V158, P513, DOI 10.1128/JB.158.2.513-516.1984; Higashide M, 2008, ANTIMICROB AGENTS CH, V52, P2061, DOI 10.1128/AAC.01150-07; Huebner J, 1999, ANNU REV MED, V50, P223, DOI 10.1146/annurev.med.50.1.223; Ibrahem S, 2008, CLIN MICROBIOL INFEC, V14, P1020, DOI 10.1111/j.1469-0691.2008.02080.x; Ito T, 2004, ANTIMICROB AGENTS CH, V48, P2637, DOI 10.1128/AAC.48.7.2637-2651.2004; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Jamaluddin TZMT, 2008, J CLIN MICROBIOL, V46, P3778, DOI 10.1128/JCM.02262-07; Katayama Y, 2000, ANTIMICROB AGENTS CH, V44, P1549, DOI 10.1128/AAC.44.6.1549-1555.2000; Kuroda M, 2005, P NATL ACAD SCI USA, V102, P13272, DOI 10.1073/pnas.0502950102; Kwon NH, 2005, J ANTIMICROB CHEMOTH, V56, P624, DOI 10.1093/jac/dki306; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Li M, 2009, J MED MICROBIOL, V58, P456, DOI 10.1099/jmm.0.007567-0; MATSUHASHI M, 1986, J BACTERIOL, V167, P975, DOI 10.1128/jb.167.3.975-980.1986; Miragaia M, 2007, J BACTERIOL, V189, P2540, DOI 10.1128/JB.01484-06; Miragaia M, 2005, MICROB DRUG RESIST, V11, P83, DOI 10.1089/mdr.2005.11.83; Machado ABP, 2007, J MED MICROBIOL, V56, P1328, DOI 10.1099/jmm.0.47294-0; Oliveira DC, 2000, ANTIMICROB AGENTS CH, V44, P1906, DOI 10.1128/AAC.44.7.1906-1910.2000; Pi BR, 2009, J MED MICROBIOL, V58, P731, DOI 10.1099/jmm.0.007351-0; Ruppe E, 2009, ANTIMICROB AGENTS CH, V53, P442, DOI 10.1128/AAC.00724-08; Soderquist B, 2009, CLIN MICROBIOL INFEC, V15, P1176, DOI 10.1111/j.1469-0691.2009.02771.x; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005; Zhang Y, 2009, J APPL MICROBIOL, V107, P1375, DOI 10.1111/j.1365-2672.2009.04322.x	27	27	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2010	5	11							e14016	10.1371/journal.pone.0014016	http://dx.doi.org/10.1371/journal.pone.0014016			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681OY	21103346	Green Published, gold, Green Submitted			2022-12-25	WOS:000284327800008
J	Widgren, K; Nielsen, J; Molbak, K				Widgren, Katarina; Nielsen, Jens; Molbak, Kare			Registry-Based Surveillance of Influenza-Associated Hospitalisations during the 2009 Influenza Pandemic in Denmark: The Hidden Burden on the Young	PLOS ONE			English	Article								Background: To follow the impact of the 2009 influenza pandemic in Denmark, influenza surveillance was extended with a system monitoring potentially influenza-associated hospitalisations. Methodology/Principal Findings: National administrative data from 2004-2010 from the automatic reporting of all hospital visits and admissions in Denmark (population 5.5 million) were used. In-patient hospitalisations linked to ICD-10 codes for potentially influenza-associated conditions (influenza, viral and bacterial pneumonia, respiratory distress, and febrile convulsion) were aggregated by week and age groups; <5 years, 5-24 years, 25-64 years and >= 65 years. Weekly numbers of influenza-associated hospitalisations were plotted to follow the course of the pandemic. We calculated the total numbers of influenza-associated hospitalisations in each influenza season (week 30 to week 15, the following year). Risk ratios of being admitted with an influenza-associated condition in this season (2009/2010) compared to the previous five seasons (2004/2005-2008/2009) were calculated using binary regression. During the pandemic season, influenza-associated hospitalisations peaked in week 47, 2009. The total number of influenza-associated hospitalisations was 38,273 compared to the median of previous seasons of 35,662 (p = 0.28). The risk ratio of influenza-associated hospitalisations during the pandemic season compared to previous seasons was 1.63 (95% CI 1.49-1.78) for 5-24 year-olds and ranged between 0.98 and 1.08 for the other three age groups. Conclusions: The 2009 pandemic influenza did not lead to an overall increase in the number of influenza-associated hospitalisations in Denmark in the 2009/2010 season and could be managed within existing hospital capacity. However, there was a disproportionally large impact on the age group 5-24 years. The influenza-associated hospitalisations during the 2009/2010 pandemic influenza	[Widgren, Katarina; Nielsen, Jens; Molbak, Kare] Statens Serum Inst, Dept Epidemiol, DK-2300 Copenhagen, Denmark; [Widgren, Katarina] European Ctr Dis Prevent & Control ECDC, EPIET, Stockholm, Sweden	Statens Serum Institut; European Centre for Disease Prevention & Control	Widgren, K (corresponding author), Statens Serum Inst, Dept Epidemiol, DK-2300 Copenhagen, Denmark.	widgren.katarina@gmail.com		Molbak, Kare/0000-0002-3100-4990				Ahmed R, 2007, NAT IMMUNOL, V8, P1188, DOI 10.1038/ni1530; Andreasen V, 2008, J INFECT DIS, V197, P270, DOI 10.1086/524065; *CDCP, 2010, EM INF PROGR; *CDCP, 2010, FLUVIEW; CHAN M, 2010, WORLD NOW START 2009; CULLEN G, 2009, EURO SURVEILL, V14; *DANM STAT, 2010, POP COUNTS; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; *EUR CTR DIS PREV, 2010, INFL SURV NETW EISN; *EURO MOMO, 2010, EUR MON EXC MORT PUB; GLISMANN S, 2010, INFLUENZA SEASON 200; Ikonen N, 2010, EURO SURVEILL, V15; Mazick A, 2010, EURO SURVEILL, V15; Miller MA, 2009, NEW ENGL J MED, V360, P2595, DOI 10.1056/NEJMp0903906; Millichap JG, 2006, PEDIATR NEUROL, V35, P165, DOI 10.1016/j.pediatrneurol.2006.06.004; MOLBAK K, EPINEWS, V49; *NEW S WAL PUBL HL, 2009, EURO SURVEILL, V14; Nickelsen T N, 2001, Ugeskr Laeger, V164, P33; SERFLING RE, 1963, PUBLIC HEALTH REP, V78, P494, DOI 10.2307/4591848; Simonsen L, 1998, J INFECT DIS, V178, P53, DOI 10.1086/515616; Simonsen L, 2000, J INFECT DIS, V181, P831, DOI 10.1086/315320; *STATACORP LP, 2010, STAT DAT AN STAT SOF; *SUNDH, 2010, NAT PAT REG; *SUNDH, 2006, PREP PAND INFL; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Van 't Klooster TM, 2010, EUROSURVEILLANCE, V15; *WHO, 2009, WKLY EPIDEMIOL REC, V84, P173; Wilson N, 2009, EUROSURVEILLANCE, V14; World Health Organization, 2010, INT CLASS DIS ICD	29	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e13939	10.1371/journal.pone.0013939	http://dx.doi.org/10.1371/journal.pone.0013939			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21085646	Green Published, gold, Green Submitted			2022-12-25	WOS:000284087800009
J	van der Sluis, S; Verhage, M; Posthuma, D; Dolan, CV				van der Sluis, Sophie; Verhage, Matthijs; Posthuma, Danielle; Dolan, Conor V.			Phenotypic Complexity, Measurement Bias, and Poor Phenotypic Resolution Contribute to the Missing Heritability Problem in Genetic Association Studies	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MEASUREMENT INVARIANCE; RISK; POLYMORPHISMS; INTELLIGENCE; METAANALYSIS; CHILDHOOD; DISORDER; CANCER; MODEL	Background: The variance explained by genetic variants as identified in (genome-wide) genetic association studies is typically small compared to family-based heritability estimates. Explanations of this 'missing heritability' have been mainly genetic, such as genetic heterogeneity and complex (epi-) genetic mechanisms. Methodology: We used comprehensive simulation studies to show that three phenotypic measurement issues also provide viable explanations of the missing heritability: phenotypic complexity, measurement bias, and phenotypic resolution. We identify the circumstances in which the use of phenotypic sum-scores and the presence of measurement bias lower the power to detect genetic variants. In addition, we show how the differential resolution of psychometric instruments (i.e., whether the instrument includes items that resolve individual differences in the normal range or in the clinical range of a phenotype) affects the power to detect genetic variants. Conclusion: We conclude that careful phenotypic data modelling can improve the genetic signal, and thus the statistical power to identify genetic variants by 20-99%.	[van der Sluis, Sophie; Verhage, Matthijs; Posthuma, Danielle] Vrije Univ Amsterdam, CNCR, Dept Clin Genet, Funct Genom Sect, Amsterdam, Netherlands; [van der Sluis, Sophie; Verhage, Matthijs; Posthuma, Danielle] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands; [Posthuma, Danielle] Vrije Univ Amsterdam, CNCR, Dept Clin Genet, Med Genom Sect, Amsterdam, Netherlands; [Dolan, Conor V.] Univ Amsterdam, Fac Social & Behav Sci FMG, Dept Psychol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; University of Amsterdam	van der Sluis, S (corresponding author), Vrije Univ Amsterdam, CNCR, Dept Clin Genet, Funct Genom Sect, Amsterdam, Netherlands.	sophie.van.der.sluis@cncr.vu.nl		Posthuma, Danielle/0000-0001-7582-2365; verhage, matthijs/0000-0002-6085-7503; van der Sluis, Sophie/0000-0001-9958-7216	Netherlands Scientific Organization (Nederlandse Organisatie voor Wetenschappelijk Onderzoek, gebied Maatschappij-en Gedragswetenschappen: NWO/MaGW) [NWO/MaGW VENI-451-08-025, NWO/MaGW VIDI-016-065-318]	Netherlands Scientific Organization (Nederlandse Organisatie voor Wetenschappelijk Onderzoek, gebied Maatschappij-en Gedragswetenschappen: NWO/MaGW)(Netherlands Organization for Scientific Research (NWO))	SvdS (NWO/MaGW VENI-451-08-025) and DP (NWO/MaGW VIDI-016-065-318) are financially supported by the Netherlands Scientific Organization (Nederlandse Organisatie voor Wetenschappelijk Onderzoek, gebied Maatschappij-en Gedragswetenschappen: NWO/MaGW: http://www.nwo.nl/). The funders had no role in study design, data simulation and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, MANUAL CHILD BEHAV C; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bartholomew DJ, 2009, PSYCHOL REV, V116, P567, DOI 10.1037/a0016262; BOLLEN K, 1991, PSYCHOL BULL, V110, P305, DOI 10.1037/0033-2909.110.2.305; Borsboom D, 2003, PSYCHOL REV, V110, P203, DOI 10.1037/0033-295X.110.2.203; Borsboom D, 2008, MEAS-INTERDISCIP RES, V6, P25, DOI 10.1080/15366360802035497; CASTO SD, 1995, BEHAV GENET, V25, P25, DOI 10.1007/BF02197239; Craddock N, 2009, BRIT J PSYCHIAT, V195, P97, DOI 10.1192/bjp.bp.108.063156; Cramer A, 2010, BEHAV BRAIN IN PRESS; Embretson S, 2000, MULTIVARIATE APPL BO; Faraone SV, 2005, BIOL PSYCHIAT, V57, P1313, DOI 10.1016/j.biopsych.2004.11.024; Franke B, 2009, HUM GENET, V126, P13, DOI 10.1007/s00439-009-0663-4; Galvan A, 2010, TRENDS GENET, V26, P132, DOI 10.1016/j.tig.2009.12.008; Hoekstra RA, 2007, LEARN INDIVID DIFFER, V17, P97, DOI 10.1016/j.lindif.2007.05.005; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Ioannidis JPA, 2007, HUM HERED, V64, P203, DOI 10.1159/000103512; Larsson H, 2006, J AM ACAD CHILD PSY, V45, P973, DOI 10.1097/01.chi.0000222787.57100.d8; Li J, 2010, AM J EPIDEMIOL, V171, P1, DOI 10.1093/aje/kwp318; Lubke GH, 2004, TWIN RES, V7, P292, DOI 10.1375/136905204774200578; LUX V, 2010, PSYCH MED; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McDonald RP, 1999, TEST THEORY UNIFIED; McLoughlin G, 2007, J ABNORM CHILD PSYCH, V35, P999, DOI 10.1007/s10802-007-9149-9; Medland S, 2010, EUR J HUM GENET, V18, P233, DOI 10.1038/ejhg.2009.133; Mellenbergh G.J., 1989, INT J EDUC RES, V13, P127, DOI [10.1016/0883-0355(89)90002-5, DOI 10.1016/0883-0355(89)90002-5]; Mellenbergh GJ, 1996, PSYCHOL METHODS, V1, P293, DOI 10.1037/1082-989X.1.3.293; MEREDITH W, 1993, PSYCHOMETRIKA, V58, P525, DOI 10.1007/BF02294825; Neale M. C, 2003, MX STAT MODELING, V6th; Neale MC, 2005, TWIN RES HUM GENET, V8, P553, DOI 10.1375/183242705774860231; Peng B, 2010, MUTAGENESIS, V25, P41, DOI 10.1093/mutage/gep041; Plomin R, 2002, TRENDS COGN SCI, V6, P169, DOI 10.1016/S1364-6613(00)01853-2; Polderman TJC, 2007, J CHILD PSYCHOL PSYC, V48, P1080, DOI 10.1111/j.1469-7610.2007.01783.x; Posthuma D, 2001, BEHAV GENET, V31, P593, DOI 10.1023/A:1013349512683; Price TS, 2000, CHILD DEV, V71, P948, DOI 10.1111/1467-8624.00201; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; R Core Team, 2022, R LANG ENV STAT COMP; Rasch G., 1980, PROBABILISTIC MODELS; Rijsdijk FV, 2002, BEHAV GENET, V32, P199, DOI 10.1023/A:1016021128949; Ruano D, 2010, AM J HUM GENET, V86, P113, DOI 10.1016/j.ajhg.2009.12.006; Sebastiani P, 2009, AM J HEMATOL, V84, P504, DOI 10.1002/ajh.21440; SORBOM D, 1989, PSYCHOMETRIKA, V54, P371, DOI 10.1007/BF02294623; Sullivan PF, 2009, MOL PSYCHIATR, V14, P359, DOI 10.1038/mp.2008.125; Tian Y, 2010, INT J COLORECTAL DIS, V25, P161, DOI 10.1007/s00384-009-0809-9; van den Berg SM, 2007, BEHAV GENET, V37, P604, DOI 10.1007/s10519-007-9156-1; van der Maas HLJ, 2006, PSYCHOL REV, V113, P842, DOI 10.1037/0033-295X.113.4.842; van der Sluis S, 2008, BEHAV GENET, V38, P202, DOI 10.1007/s10519-007-9184-x; Wechsler D., 2012, WAIS 4 KASIKIRJA; Wicherts JM, 2009, P R SOC B, V276, P2675, DOI 10.1098/rspb.2009.0238; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zhang HF, 2009, HUM GENET, V125, P627, DOI 10.1007/s00439-009-0660-7; Zondervan KT, 2007, NAT PROTOC, V2, P2492, DOI 10.1038/nprot.2007.366	54	81	83	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e13929	10.1371/journal.pone.0013929	http://dx.doi.org/10.1371/journal.pone.0013929			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085666	Green Published, Green Submitted, gold			2022-12-25	WOS:000284036800020
J	Wagner, J; Sim, WH; Ellis, JA; Ong, EK; Catto-Smith, AG; Cameron, DJS; Bishop, RF; Kirkwood, CD				Wagner, Josef; Sim, Winnie H.; Ellis, Justine A.; Ong, Eng K.; Catto-Smith, Anthony G.; Cameron, Donald J. S.; Bishop, Ruth F.; Kirkwood, Carl D.			Interaction of Crohn's Disease Susceptibility Genes in an Australian Paediatric Cohort	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; IBD5 LOCUS; OCTN1/2 VARIANTS; HARDY-WEINBERG; DLG5 VARIANTS; ADULT-ONSET; IRGM; POLYMORPHISMS; POPULATION	Genetic susceptibility is an important contributor to the pathogenesis of Crohn's disease (CD). We investigated multiple CD susceptibility genes in an Australian paediatric onset CD cohort. Newly diagnosed paediatric onset CD patients (n = 72) and controls (n = 98) were genotyped for 34 single nucleotide polymorphisms (SNPs) in 18 genetic loci. Gene-gene interaction analysis, gene-disease phenotype analysis and genetic risk profiling were performed for all SNPs and all genes. Of the 34 SNPs analysed, four polymorphisms on three genes (NOD2, IL23R, and region 3p21) were significantly associated with CD status (p<0.05). All three CD specific paediatric polymorphisms on PSMG1 and TNFRSF6B showed a trend of association with p<0.1. An additive gene-gene interaction involving TLR4, PSMG1, TNFRSF6B and IRGM was identified with CD. Genes involved in microbial processing (TLR4, PSMG1, NOD2) were significantly associated either at the individual level or in gene-gene interactive roles. Colonic disease was significantly associated with disease SNP rs7517847 (IL23R) (p<0.05) and colonic and ileal/colonic disease was significantly associated with disease SNP rs125221868 (IBD5) and SLC22A4 & SLC22A4/5 variants (p<0.05). We were able to demonstrate genetic association of several genes to CD in a paediatric onset cohort. Several of the observed associations have not been reported previously in association with paediatric CD patients. Our findings demonstrate that CD genetic susceptibility in paediatric patients presents as a complex interaction between numerous genes.	[Wagner, Josef; Sim, Winnie H.; Bishop, Ruth F.; Kirkwood, Carl D.] Murdoch Childrens Res Inst, Enter Virus Grp, Melbourne, Vic, Australia; [Ong, Eng K.] Murdoch Childrens Res Inst, Sequenom Platform Facil, Melbourne, Vic, Australia; [Catto-Smith, Anthony G.; Bishop, Ruth F.; Kirkwood, Carl D.] Univ Melbourne, Dept Paediat, Melbourne, Vic 3010, Australia; [Catto-Smith, Anthony G.; Cameron, Donald J. S.] Royal Childrens Hosp, Dept Gastroenterol & Clin Nutr, Melbourne, Vic, Australia	Murdoch Children's Research Institute; Murdoch Children's Research Institute; University of Melbourne; Royal Children's Hospital Melbourne	Wagner, J (corresponding author), Murdoch Childrens Res Inst, Enter Virus Grp, Melbourne, Vic, Australia.	josef.wagner@mcri.edu.au	Catto-Smith, Anthony G/H-3698-2012; Ellis, Justine A/G-5006-2011; Catto-Smith, Anthony/AAG-1485-2019	Ellis, Justine/0000-0003-4103-4445	Jack Brockhoff Foundation, Australia; Murdoch Children Research Institute, Australia; Eli and Edythe Broad Foundation, USA; National Health and Medical Research Council, Australia [607347]; National Health and Medical Research Council	Jack Brockhoff Foundation, Australia; Murdoch Children Research Institute, Australia; Eli and Edythe Broad Foundation, USA; National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The project was supported by research grants from the Jack Brockhoff Foundation, Australia, the Murdoch Children Research Institute, Australia, and from the Broad Medical Research Program, The Eli and Edythe Broad Foundation, USA. C. Kirkwood is supported by a Career Development Awards fellowship from the National Health and Medical Research Council, Australia (607347). J Ellis is supported by a National Health and Medical Research Council Capacity Building Grant in Population Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation to the manuscript.	Amre DK, 2008, AM J GASTROENTEROL, V103, P615, DOI 10.1111/j.1572-0241.2007.01661.x; Amre DK, 2009, AM J GASTROENTEROL, V104, P2824, DOI 10.1038/ajg.2009.430; Amre DK, 2009, INFLAMM BOWEL DIS, V15, P501, DOI 10.1002/ibd.20785; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bonen DK, 2003, GASTROENTEROLOGY, V124, P140, DOI 10.1053/gast.2003.50019; Browning BL, 2007, INFLAMM BOWEL DIS, V13, P1069, DOI 10.1002/ibd.20157; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cosgrove M, 1996, ARCH DIS CHILD-FETAL, V74, pF122, DOI 10.1136/fn.74.2.F122; Cucchiara S, 2007, WORLD J GASTROENTERO, V13, P1221, DOI 10.3748/wjg.v13.i8.1221; Cummings JRF, 2007, INFLAMM BOWEL DIS, V13, P941, DOI 10.1002/ibd.20162; de Ridder L, 2007, INFLAMM BOWEL DIS, V13, P1083, DOI 10.1002/ibd.20171; Deng HW, 2000, AM J HUM GENET, V66, P1027, DOI 10.1086/302804; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Economou M, 2008, INFLAMM BOWEL DIS, V14, P709, DOI 10.1002/ibd.20352; Ferraris A, 2005, J PEDIATR-US, V147, P272, DOI 10.1016/j.jpeds.2005.03.039; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Fitzpatrick LR, 2007, DIS COLON RECTUM, V50, P337, DOI 10.1007/s10350-006-0796-7; Franchimont D, 2004, GUT, V53, P987, DOI 10.1136/gut.2003.030205; Franke A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000691; Gasche C, 2003, J IMMUNOL, V170, P5578, DOI 10.4049/jimmunol.170.11.5578; Glas J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000819; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hausmann M, 2002, GASTROENTEROLOGY, V122, P1987, DOI 10.1053/gast.2002.33662; Hayashi T, 2000, J BIOL CHEM, V275, P5238, DOI 10.1074/jbc.275.7.5238; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hugot JP, 1996, NATURE, V379, P821, DOI 10.1038/379821a0; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Jurinke Christian, 2002, Methods Mol Biol, V187, P179; Kirkwood CD, 2009, INFLAMM BOWEL DIS, V15, P1643, DOI 10.1002/ibd.20967; KRUPOVES A, 2008, INFLAMM BOWEL DIS; Kugathasan S, 2008, NAT GENET, V40, P1211, DOI 10.1038/ng.203; Lakner L, 2009, INT J COLORECTAL DIS, V24, P503, DOI 10.1007/s00384-009-0670-x; Latiano A, 2008, ALIMENT PHARM THER, V27, P241, DOI 10.1111/j.1365-2036.2007.03551.x; LATIANO A, 2010, INFLAMM BOWEL DIS; LATIANO A, 2009, INFLAMM BOWEL DIS; Latiano A, 2008, WORLD J GASTROENTERO, V14, P4643, DOI 10.3748/wjg.14.4643; Lee WC, 2003, AM J EPIDEMIOL, V158, P397, DOI 10.1093/aje/kwg150; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Marquez A, 2009, GENES IMMUN, V10, P631, DOI 10.1038/gene.2009.56; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; McGovern DPB, 2005, HUM MOL GENET, V14, P1245, DOI 10.1093/hmg/ddi135; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Newman WG, 2006, HUM MUTAT, V27, P353, DOI 10.1002/humu.20301; Noble CL, 2005, GASTROENTEROLOGY, V129, P1854, DOI 10.1053/j.gastro.2005.09.025; Noble CL, 2005, GUT, V54, pA96; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Peltekova VD, 2004, NAT GENET, V36, P471, DOI 10.1038/ng1339; Peterson N, 2008, GUT, V57, P1336, DOI 10.1136/gut.2008.152207; Phavichitr N, 2003, J GASTROEN HEPATOL, V18, P329, DOI 10.1046/j.1440-1746.2003.02975.x; Prescott NJ, 2007, GASTROENTEROLOGY, V132, P1665, DOI 10.1053/j.gastro.2007.03.034; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rigoli L, 2008, WORLD J GASTROENTERO, V14, P4454, DOI 10.3748/wjg.14.4454; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Roberts RL, 2008, GENES IMMUN, V9, P561, DOI 10.1038/gene.2008.49; Rosenzweig R, 2008, BIOCHEM SOC T, V36, P807, DOI 10.1042/BST0360807; Russell RK, 2006, GUT, V55, P1114, DOI 10.1136/gut.2005.082107; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Shanahan F, 2002, LANCET, V359, P62, DOI 10.1016/S0140-6736(02)07284-7; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Stohwasser R, 2000, GLIA, V29, P355, DOI 10.1002/(SICI)1098-1136(20000215)29:4<355::AID-GLIA6>3.0.CO;2-4; Stoll M, 2004, NAT GENET, V36, P476, DOI 10.1038/ng1345; Tomer G, 2003, AM J GASTROENTEROL, V98, P2479, DOI 10.1016/S0002-9270(03)01706-4; Van Limbergen J, 2009, GUT, V58, P610, DOI 10.1136/gut.2008.160721; Van Limbergen JE, 2007, GUT, V56, pA122; Vind I, 2006, AM J GASTROENTEROL, V101, P1274, DOI 10.1111/j.1572-0241.2006.00552.x; Visekruna A, 2009, INT J COLORECTAL DIS, V24, P1133, DOI 10.1007/s00384-009-0679-1; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wagner J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003578; Waller S, 2006, GUT, V55, P809, DOI 10.1136/gut.2005.084574; Waschke KA, 2005, AM J GASTROENTEROL, V100, P1126, DOI 10.1111/j.1572-0241.2005.40534.x; Weersma RK, 2009, AM J GASTROENTEROL, V104, P630, DOI 10.1038/ajg.2008.112; Yamazaki K, 2009, GUT, V58, P228, DOI 10.1136/gut.2007.140764; Yamazaki K, 2002, J HUM GENET, V47, P469, DOI 10.1007/s100380200067; Yu W, 2009, J CROHNS COLITIS, V3, P189, DOI 10.1016/j.crohns.2009.04.003	79	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e15376	10.1371/journal.pone.0015376	http://dx.doi.org/10.1371/journal.pone.0015376			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	676NU	21079743	Green Submitted, Green Published, gold			2022-12-25	WOS:000283920000019
J	Gronberg, A; Zettergren, L; Bergh, K; Stahle, M; Heilborn, J; Angeby, K; Small, PL; Akuffo, H; Britton, S				Gronberg, Alvar; Zettergren, Louise; Bergh, Kerstin; Stahle, Mona; Heilborn, Johan; Angeby, Kristian; Small, Pamela L.; Akuffo, Hannah; Britton, Sven			Antioxidants Protect Keratinocytes against M-ulcerans Mycolactone Cytotoxicity	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION PATHWAY; MONOCYTES IN-VITRO; REACTIVE OXYGEN; OXIDATIVE STRESS; BURULI ULCER; ANTIMYCIN-A; PULMONARY TUBERCULOSIS; CYTOKINE PRODUCTION; IMMUNE-RESPONSE; IRON OVERLOAD	Background: Mycobacterium ulcerans is the causative agent of necrotizing skin ulcerations in distinctive geographical areas. M. ulcerans produces a macrolide toxin, mycolactone, which has been identified as an important virulence factor in ulcer formation. Mycolactone is cytotoxic to fibroblasts and adipocytes in vitro and has modulating activity on immune cell functions. The effect of mycolactone on keratinocytes has not been reported previously and the mechanism of mycolactone toxicity is presently unknown. Many other macrolide substances have cytotoxic and immunosuppressive activities and mediate some of their effects via production of reactive oxygen species (ROS). We have studied the effect of mycolactone in vitro on human keratinocytes-key cells in wound healing-and tested the hypothesis that the cytotoxic effect of mycolactone is mediated by ROS. Methodology/Principal Findings: The effect of mycolactone on primary skin keratinocyte growth and cell numbers was investigated in serum free growth medium in the presence of different antioxidants. A concentration and time dependent reduction in keratinocyte cell numbers was observed after exposure to mycolactone. Several different antioxidants inhibited this effect partly. The ROS inhibiting substance deferoxamine, which acts via chelation of Fe2+, completely prevented mycolactone mediated cytotoxicity. Conclusions/Significance: This study demonstrates that mycolactone mediated cytotoxicity can be inhibited by deferoxamine, suggesting a role of iron and ROS in mycolactone induced cytotoxicity of keratinocytes. The data provide a basis for the understanding of Buruli ulcer pathology and the development of improved therapies for this disease.	[Gronberg, Alvar; Zettergren, Louise; Bergh, Kerstin; Stahle, Mona] Karolinska Inst, Ctr Mol Med, Dept Med, Stockholm, Sweden; [Stahle, Mona; Heilborn, Johan] Karolinska Univ Hosp, Dept Dermatol & Venereol, Stockholm, Sweden; [Angeby, Kristian] Karolinska Univ Hosp, Dept Clin Microbiol, Stockholm, Sweden; [Angeby, Kristian; Akuffo, Hannah] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Small, Pamela L.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Britton, Sven] Karolinska Univ Hosp, Unit Infect Med, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; University of Tennessee System; University of Tennessee Knoxville; Karolinska Institutet; Karolinska University Hospital	Gronberg, A (corresponding author), Karolinska Inst, Ctr Mol Med, Dept Med, Stockholm, Sweden.	alvar.gronberg@ki.se		Akuffo, Hannah/0000-0003-1854-3591	Sida/SAREC Grant [SWE-2008-088]; Lipopeptide AB	Sida/SAREC Grant; Lipopeptide AB	The study was supported by Sida/SAREC Grant no. SWE-2008-088 (www. sida. se) and by Lipopeptide AB (www. lipopeptide. se). The funder had a role in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Adusumilli S, 2005, CELL MICROBIOL, V7, P1295, DOI 10.1111/j.1462-5822.2005.00557.x; Boulkroun S, 2010, J IMMUNOL, V184, P1436, DOI 10.4049/jimmunol.0902854; BOZZO C, 2010, MICROBES INFECT 0825; Cemerski S, 2002, J BIOL CHEM, V277, P19585, DOI 10.1074/jbc.M111451200; Choi SJN, 2008, TRANSPL P, V40, P2737, DOI 10.1016/j.transproceed.2008.08.029; Choi SJN, 2008, TRANSPL P, V40, P2734, DOI 10.1016/j.transproceed.2008.08.028; Coutanceau E, 2007, J EXP MED, V204, P1395, DOI 10.1084/jem.20070234; Cronje L, 2005, FEMS IMMUNOL MED MIC, V45, P103, DOI 10.1016/j.femsim.2005.02.007; Dobos KM, 2001, INFECT IMMUN, V69, P7182, DOI 10.1128/IAI.69.11.7182-7186.2001; Gangaidzo IT, 2001, J INFECT DIS, V184, P936, DOI 10.1086/323203; Gelderman KA, 2007, J CLIN INVEST, V117, P3020, DOI 10.1172/JCI31935; Gelderman KA, 2006, P NATL ACAD SCI USA, V103, P12831, DOI 10.1073/pnas.0604571103; George KM, 1998, INFECT IMMUN, V66, P587, DOI 10.1128/IAI.66.2.587-593.1998; George KM, 1999, SCIENCE, V283, P854, DOI 10.1126/science.283.5403.854; George KM, 2000, INFECT IMMUN, V68, P877, DOI 10.1128/IAI.68.2.877-883.2000; Gil J, 2003, FREE RADICAL BIO MED, V35, P1500, DOI 10.1016/j.freeradbiomed.2003.08.022; Gooding TM, 2003, CLIN INFECT DIS, V36, P1076, DOI 10.1086/368315; Gooding TM, 2002, INFECT IMMUN, V70, P5562, DOI 10.1128/IAI.70.10.5562-5567.2002; Gooding TM, 2001, INFECT IMMUN, V69, P1704, DOI 10.1128/IAI.69.3.1704-1707.2001; Gordeuk VR, 2009, INT J TUBERC LUNG D, V13, P1267; Gordeuk VR, 2003, BLOOD CELL MOL DIS, V31, P299, DOI 10.1016/S1079-9796(03)00164-5; Gordeuk VR, 2002, SEMIN HEMATOL, V39, P263, DOI 10.1053/shem.2002.35636; Han SY, 2006, TRANSPL P, V38, P2242, DOI 10.1016/j.transproceed.2006.06.033; Han YH, 2008, ONCOL REP, V20, P689, DOI 10.3892/or_00000061; Han YH, 2008, LIFE SCI, V83, P346, DOI 10.1016/j.lfs.2008.06.023; HARDWICK JS, 1995, P NATL ACAD SCI USA, V92, P4527, DOI 10.1073/pnas.92.10.4527; HERCBERG S, 1988, PUBLIC HEALTH, V102, P73, DOI 10.1016/S0033-3506(88)80013-1; Hong F, 2002, FASEB J, V16, P1633, DOI 10.1096/fj.02-0060fje; Hong H, 2008, NAT PROD REP, V25, P447, DOI 10.1039/b803101k; Hong H, 2007, CHEMBIOCHEM, V8, P2043, DOI 10.1002/cbic.200700411; Karbowski M, 1999, FREE RADICAL BIO MED, V26, P396, DOI 10.1016/S0891-5849(98)00209-3; Laochumroonvorapong P, 1997, INFECT IMMUN, V65, P4850, DOI 10.1128/IAI.65.11.4850-4857.1997; Lee HM, 2009, CELL MICROBIOL, V11, P678, DOI 10.1111/j.1462-5822.2009.01285.x; Manca C, 1999, INFECT IMMUN, V67, P74, DOI 10.1128/IAI.67.1.74-79.1999; Mve-Obiang A, 2003, INFECT IMMUN, V71, P774, DOI 10.1128/IAI.71.2.774-783.2003; NAKAMURA K, 1993, ONCOGENE, V8, P3133; Navarro-Antolin J, 1998, KIDNEY INT, V54, pS20, DOI 10.1046/j.1523-1755.1998.06807.x; Pahlevan AA, 1999, J IMMUNOL, V163, P3928; Park WH, 2007, J CELL BIOCHEM, V102, P98, DOI 10.1002/jcb.21280; Phillips R, 2006, CLIN VACCINE IMMUNOL, V13, P253, DOI 10.1128/CVI.13.2.253-257.2006; Phillips R, 2004, ANTIMICROB AGENTS CH, V48, P3130, DOI 10.1128/AAC.48.8.3130-3132.2004; Phillips R, 2004, ANTIMICROB AGENTS CH, V48, P2866, DOI 10.1128/AAC.48.8.2866-2870.2004; Piskemik C, 2008, BBA-MOL BASIS DIS, V1782, P280, DOI 10.1016/j.bbadis.2008.01.007; Prevot G, 2004, PRESSE MED, V33, P1516, DOI 10.1016/S0755-4982(04)98974-9; Ray RS, 2001, DRUG CHEM TOXICOL, V24, P191, DOI 10.1081/DCT-100102610; Reddan J, 1992, Lens Eye Toxic Res, V9, P385; Roberts B, 1996, J MED MICROBIOL, V45, P383, DOI 10.1099/00222615-45-5-383; SARFO FS, PLOS NEGL TROP DIS, V4, pE577; Schafer M, 2008, PHARMACOL RES, V58, P165, DOI 10.1016/j.phrs.2008.06.004; Simmonds RE, 2009, J IMMUNOL, V182, P2194, DOI 10.4049/jimmunol.0802294; Sinha A, 2006, J IMMUNOL, V177, P468, DOI 10.4049/jimmunol.177.1.468; Srinivasan S, 2004, CLIN CHIM ACTA, V350, P57, DOI 10.1016/j.cccn.2004.07.001; Stienstra Y, 2006, GENES IMMUN, V7, P185, DOI 10.1038/sj.gene.6364281; Subbian S, 2007, INFECT IMMUN, V75, P127, DOI 10.1128/IAI.01000-06; Tunon MJ, 2003, BIOCHEM PHARMACOL, V66, P439, DOI 10.1016/S0006-2952(03)00288-0; Van Zandt KE, 2008, J LEUKOCYTE BIOL, V84, P689, DOI 10.1189/jlb.1107781; Vijayaraghavan R, 2005, EUR J CLIN NUTR, V59, P1121, DOI 10.1038/sj.ejcn.1602221; Westenbrink BD, 2005, CLIN DIAGN LAB IMMUN, V12, P125, DOI 10.1128/CDLI.12.1.125-129.2005; Yeboah-Manu D, 2006, J LEUKOCYTE BIOL, V79, P1150, DOI 10.1189/jlb.1005581; Zahrt TC, 2002, ANTIOXID REDOX SIGN, V4, P141, DOI 10.1089/152308602753625924; Zhou XM, 2004, KIDNEY INT, V65, P139, DOI 10.1111/j.1523-1755.2004.00380.x	61	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e13839	10.1371/journal.pone.0013839	http://dx.doi.org/10.1371/journal.pone.0013839			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079804	Green Submitted, Green Published, gold			2022-12-25	WOS:000283838600014
J	Han, ST; Fukazawa, T; Yamatsuji, T; Matsuoka, J; Miyachi, H; Maeda, Y; Durbin, M; Naomoto, Y				Han, Shaoteng; Fukazawa, Takuya; Yamatsuji, Tomoki; Matsuoka, Junji; Miyachi, Hiroyuki; Maeda, Yutaka; Durbin, Mary; Naomoto, Yoshio			Anti-Tumor Effect in Human Lung Cancer by a Combination Treatment of Novel Histone Deacetylase Inhibitors: SL142 or SL325 and Retinoic Acids	PLOS ONE			English	Article							PML-RAR-ALPHA; GROWTH-INHIBITION; RESPONSE ELEMENT; HDAC INHIBITOR; RECEPTOR-BETA; CELL-LINES; ALL-TRANS; APOPTOSIS; EXPRESSION; GENE	Histone deacetylase (HDAC) inhibitors arrest cancer cell growth and cause apoptosis with low toxicity thereby constituting a promising treatment for cancer. In this study, we investigated the anti-tumor activity in lung cancer cells of the novel cyclic amide-bearing hydroxamic acid based HDAC inhibitors SL142 and SL325. In A549 and H441 lung cancer cells both SL142 and SL325 induced more cell growth inhibition and cell death than the hydroxamic acid-based HDAC inhibitor suberoylanilide hydroxamic acid (SAHA). Moreover, the combination treatment using retinoid drugs ATRA or 9-cis RA along with SL142 or SL325 significantly induced more apoptosis and suppressed colony formation than the single use of either. The expression of the retinoic acid receptors RAR alpha, RAR beta, RXR alpha and RXR beta were unchanged with the treatment. However a luciferase reporter construct (pGL4. RARE 7x) containing seven tandem repeats of the retinoic acid responsible element (RARE) generated significant transcriptional activity after the combination treatment of retinoic acids and SL142 or SL325 in H441 lung cancer cells. Moreover, apoptosis-promoting Bax expression and caspase-3 activity was increased after the combination treatment. These results suggest that the combination treatment of SL142 or SL325 with retinoic acids exerts significant anti-tumor activity and is a promising therapeutic candidate to treat human lung cancer.	[Han, Shaoteng; Matsuoka, Junji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Surg Gastroenterol, Okayama 7008530, Japan; [Miyachi, Hiroyuki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Div Pharmaceut Sci, Okayama 7008530, Japan; [Fukazawa, Takuya; Yamatsuji, Tomoki; Naomoto, Yoshio] Kawasaki Med Sch, Dept Gen Surg, Okayama, Japan; [Han, Shaoteng] China Med Univ, Shengjing Hosp, Dept Hepatobiliary Surg, Shenyang, Peoples R China; [Maeda, Yutaka] Cincinnati Childrens Hosp, Med Ctr, Div Pulm Biol, Cincinnati, OH USA; [Durbin, Mary] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA	Okayama University; Okayama University; Kawasaki Medical School; China Medical University; Cincinnati Children's Hospital Medical Center; University of California System; University of California Irvine	Han, ST (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Surg Gastroenterol, Okayama 7008530, Japan.	FukazawaT@aol.com	Fukazawa, Takuya/GLR-7099-2022		Ministry of Education, Science, and Culture, Japan	Ministry of Education, Science, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The Ministry of Education, Science, and Culture, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; BOEHM MF, 1994, J MED CHEM, V37, P408, DOI 10.1021/jm00029a013; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Brabender J, 2005, CARCINOGENESIS, V26, P525, DOI 10.1093/carcin/bgi006; Brabender J, 2002, CLIN CANCER RES, V8, P438; Chambon Pierre, 1994, Seminars in Cell Biology, V5, P115, DOI 10.1006/scel.1994.1015; Coffey DC, 2000, MED PEDIATR ONCOL, V35, P577, DOI 10.1002/1096-911X(20001201)35:6<577::AID-MPO18>3.0.CO;2-3; Santos MDL, 2007, MOL CANCER THER, V6, P1425, DOI 10.1158/1535-7163.MCT-06-0623; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; Eck-Enriquez K, 2000, BREAST CANCER RES TR, V61, P229, DOI 10.1023/A:1006442017658; Epping MT, 2007, P NATL ACAD SCI USA, V104, P17777, DOI 10.1073/pnas.0702518104; Ferrara FF, 2001, CANCER RES, V61, P2; Giannini F, 1997, INT J CANCER, V70, P194; Grignani F, 1998, NATURE, V391, P815, DOI 10.1038/35901; Gui CY, 2004, P NATL ACAD SCI USA, V101, P1241, DOI 10.1073/pnas.0307708100; HALL RK, 1992, MOL CELL BIOL, V12, P5527, DOI 10.1128/MCB.12.12.5527; He LZ, 1998, NAT GENET, V18, P126, DOI 10.1038/ng0298-126; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hoang T, 2002, SURG ONCOL, V11, P229, DOI 10.1016/S0960-7404(02)00056-7; Hoffman AD, 1996, CLIN CANCER RES, V2, P1077; Horn L, 2009, J CLIN ONCOL, V27, P4232, DOI 10.1200/JCO.2009.23.6661; HUSMANN M, 1992, BIOCHEM BIOPH RES CO, V187, P1558, DOI 10.1016/0006-291X(92)90480-9; Imre G, 2006, CANCER RES, V66, P5409, DOI 10.1158/0008-5472.CAN-05-4225; Javelaud D, 2002, J BIOL CHEM, V277, P37949, DOI 10.1074/jbc.M204497200; Jetten A M, 1992, J Natl Cancer Inst Monogr, P93; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; Joung KE, 2006, CANCER RES, V66, P5394, DOI 10.1158/0008-5472.CAN-05-3835; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Kato Y, 2007, MOL CANCER THER, V6, P70, DOI 10.1158/1535-7163.MCT-06-0125; KELLOFF GJ, 1993, J CELL BIOCHEM, P2; Kelly WK, 2005, NAT CLIN PRACT ONCOL, V2, P150, DOI 10.1038/ncponc0106; Komatsu N, 2006, ONCOL REP, V15, P187; Kumagai T, 2007, INT J CANCER, V121, P656, DOI 10.1002/ijc.22558; Lavelle D, 2001, AM J HEMATOL, V68, P170, DOI 10.1002/ajh.1174; Levkau B, 1998, MOL CELL, V1, P553, DOI 10.1016/S1097-2765(00)80055-6; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; Liu M, 1996, J BIOL CHEM, V271, P31723, DOI 10.1074/jbc.271.49.31723; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; Marks PA, 2000, JNCI-J NATL CANCER I, V92, P1210, DOI 10.1093/jnci/92.15.1210; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; MITCHELL CE, 1995, ANAL BIOCHEM, V224, P148, DOI 10.1006/abio.1995.1020; Miyachi H, 1998, J MED CHEM, V41, P263, DOI 10.1021/jm970624o; MIYASHITA T, 1995, CELL, V80, P293; Monneret C, 2005, EUR J MED CHEM, V40, P1, DOI 10.1016/j.ejmech.2004.10.001; Monneret C, 2007, ANTI-CANCER DRUG, V18, P363, DOI 10.1097/CAD.0b013e328012a5db; Muraoka M, 1996, ONCOGENE, V12, P1565; Nagpal S, 2004, J INVEST DERMATOL, V123, pXX, DOI 10.1111/j.0022-202X.2004.23533.x; Orlandi A, 2004, J INVEST DERMATOL, V122, P1037, DOI 10.1111/j.0022-202X.2004.22414.x; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Parmigiani RB, 2008, P NATL ACAD SCI USA, V105, P9633, DOI 10.1073/pnas.0803749105; PASTORINO U, 1993, J CLIN ONCOL, V11, P1216, DOI 10.1200/JCO.1993.11.7.1216; Pettersson F, 2002, BRIT J CANCER, V87, P555, DOI 10.1038/sj.bjc.6600496; Pfahl Magnus, 1994, Seminars in Cell Biology, V5, P95, DOI 10.1006/scel.1994.1013; Picard E, 1999, J NATL CANCER I, V91, P1059, DOI 10.1093/jnci/91.12.1059; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; Rosato RR, 2003, CANCER BIOL THER, V2, P30; Roth W, 2002, NAT MED, V8, P216, DOI 10.1038/nm0302-216; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Shinji C, 2005, BIOORG MED CHEM LETT, V15, P4427, DOI 10.1016/j.bmcl.2005.07.048; Shinji C, 2006, BIOORGAN MED CHEM, V14, P7625, DOI 10.1016/j.bmc.2006.07.008; Steinman RA, 2000, MOL MED, V6, P736, DOI 10.1007/BF03402190; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Tanvetyanon T, 2007, J THORAC ONCOL, V2, P1091, DOI 10.1097/JTO.0b013e31815cff64; Wang XF, 2005, CLIN CANCER RES, V11, P3535, DOI 10.1158/1078-0432.CCR-04-1092; Wang ZG, 1998, SCIENCE, V279, P1547; Weber E, 1999, INT J CANCER, V80, P935, DOI 10.1002/(SICI)1097-0215(19990315)80:6<935::AID-IJC21>3.0.CO;2-E; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Zhang H, 2004, INT J ONCOL, V25, P303; Zhang XH, 2008, CANCER BIOL THER, V7, P1390, DOI 10.4161/cbt.7.9.6415; Zhang YA, 2000, GENE THER, V7, P2041, DOI 10.1038/sj.gt.3301331	71	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e13834	10.1371/journal.pone.0013834	http://dx.doi.org/10.1371/journal.pone.0013834			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079797	Green Published, gold			2022-12-25	WOS:000283838600009
J	Sugimoto, M; Sasaki, S; Watanabe, T; Nishimura, S; Ideta, A; Yamazaki, M; Matsuda, K; Yuzaki, M; Sakimura, K; Aoyagi, Y; Sugimoto, Y				Sugimoto, Mayumi; Sasaki, Shinji; Watanabe, Toshio; Nishimura, Shota; Ideta, Atsushi; Yamazaki, Maya; Matsuda, Keiko; Yuzaki, Michisuke; Sakimura, Kenji; Aoyagi, Yoshito; Sugimoto, Yoshikazu			Ionotropic Glutamate Receptor AMPA 1 Is Associated with Ovulation Rate	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; D-ASPARTATE RECEPTORS; LUTEINIZING-HORMONE; LINKAGE DISEQUILIBRIUM; PLASMA-CONCENTRATIONS; EMBRYO-TRANSFER; NR2 SUBUNITS; DAIRY-CATTLE; PROGESTERONE; ESTRADIOL	Ionotropic glutamate receptors mediate most excitatory neurotransmission in the central nervous system by opening ion channels upon the binding of glutamate. Despite the essential roles of glutamate in the control of reproduction and anterior pituitary hormone secretion, there is a limited understanding of how glutamate receptors control ovulation. Here we reveal the function of the ionotropic glutamate receptor AMPA-1 (GRIA1) in ovulation. Based on a genome-wide association study in Bos taurus, we found that ovulation rate is influenced by a variation in the N-terminal leucine/isoleucine/valine-binding protein (LIVBP) domain of GRIA1, in which serine is replaced by asparagine. GRIA1(Asn) has a weaker affinity to glutamate than GRIA1(Ser), both in Xenopus oocytes and in the membrane fraction of bovine brain. This single amino acid substitution leads to the decreased release of gonadotropin-releasing hormone (GnRH) in immortalized hypothalamic GT1-7 cells. Cows with GRIA1(Asn) have a slower luteinizing hormone (LH) surge than cows with GRIA1(Ser). In addition, cows with GRIA1(Asn) possess fewer immature ovarian follicles before superovulation and have a lower response to hormone treatment than cows with GRIA1(Ser). Our work identified that GRIA1 is a critical mediator of ovulation and that GRIA1 might be a useful target for reproductive therapy.	[Sugimoto, Mayumi] Natl Livestock Breeding Ctr, Nishigo, Japan; [Sasaki, Shinji; Watanabe, Toshio; Nishimura, Shota; Sugimoto, Yoshikazu] Shirakawa Inst Anim Genet, Nishigo, Japan; [Ideta, Atsushi; Aoyagi, Yoshito] Embryo Transfer Ctr ZEN NOH, Kamishihoro, Japan; [Yamazaki, Maya; Sakimura, Kenji] Niigata Univ, Brain Res Inst, Niigata, Japan; [Matsuda, Keiko; Yuzaki, Michisuke] Keio Univ, Sch Med, Dept Physiol, Tokyo 160, Japan	Niigata University; Keio University	Sugimoto, M (corresponding author), Natl Livestock Breeding Ctr, Nishigo, Japan.	kazusugi@siag.or.jp	Yamazaki, Maya/C-6952-2012; Yuzaki, Michisuke/K-5328-2013	Yuzaki, Michisuke/0000-0002-5750-3544	Japan Racing and Livestock Promotion Foundation	Japan Racing and Livestock Promotion Foundation	This work was supported by the Japan Racing and Livestock Promotion Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEVERS MM, 1987, ANIM REPROD SCI, V15, P37, DOI 10.1016/0378-4320(87)90004-2; Brann DW, 1997, ENDOCR REV, V18, P678, DOI 10.1210/er.18.5.678; Chen GQ, 1997, P NATL ACAD SCI USA, V94, P13431, DOI 10.1073/pnas.94.25.13431; Choi JH, 2006, J CLIN ENDOCR METAB, V91, P4562, DOI 10.1210/jc.2006-1147; CROSIGNANI PG, 1991, HUM REPROD, V6, P953, DOI 10.1093/oxfordjournals.humrep.a137468; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; Dingledine R, 1999, PHARMACOL REV, V51, P7; El-Etr M, 2006, ENDOCRINOLOGY, V147, P2737, DOI 10.1210/en.2005-1191; FELIG P, ENDOCRINOLOGY METABO; Fortune JE, 2000, MOL CELL ENDOCRINOL, V163, P53, DOI 10.1016/S0303-7207(99)00240-3; FUNAHASHI T, 2008, 31 ANN M JAP NEUR SO; Gielen M, 2009, NATURE, V459, P703, DOI 10.1038/nature07993; Gonda MG, 2004, ANIM GENET, V35, P298, DOI 10.1111/j.1365-2052.2004.01162.x; HASLER JF, 1992, J DAIRY SCI, V75, P2857, DOI 10.3168/jds.S0022-0302(92)78049-7; Heifetz EM, 2005, GENETICS, V171, P1173, DOI 10.1534/genetics.105.040782; Ihara N, 2004, GENOME RES, V14, P1987, DOI 10.1101/gr.2741704; Ikeno K, 2001, NEUROSCI RES, V41, P193, DOI 10.1016/S0168-0102(01)00277-2; Ireland JJ, 2009, BIOL REPROD, V80, P954, DOI 10.1095/biolreprod.108.073791; Kengaku K, 2007, J REPROD DEVELOP, V53, P987, DOI 10.1262/jrd.18107; Konig S, 2007, J DAIRY SCI, V90, P3945, DOI 10.3168/jds.2007-0089; Madry C, 2007, MOL PHARMACOL, V72, P1535, DOI 10.1124/mol.107.040071; Matsuda S, 2005, J BIOL CHEM, V280, P20021, DOI 10.1074/jbc.M410513200; Matsuda S, 2002, EUR J NEUROSCI, V16, P1507, DOI 10.1046/j.1460-9568.2002.02219.x; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; MIKOSHIBA K, 1990, MANUALS NEUROBIOCHEM; MORI Y, 1984, J REPROD FERTIL, V72, P223, DOI 10.1530/jrf.0.0720223; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Nomura T, 2001, J ANIM SCI, V79, P366; Ojeda SR, 2006, ENDOCRINOLOGY, V147, P1166, DOI 10.1210/en.2005-1136; Pritchard JK, 2000, GENETICS, V155, P945; Schally A V, 1970, Res Reprod, V2, P2; Shimshek DR, 2006, MOL ENDOCRINOL, V20, P219, DOI 10.1210/me.2005-0262; SVED J A, 1971, Theoretical Population Biology, V2, P125; Taft R, 1996, J ANIM SCI, V74, P2985; Wang Y, 2003, EUR J NEUROSCI, V17, P1581, DOI 10.1046/j.1460-9568.2003.02595.x; Watanabe T, 2008, ANIM GENET, V39, P374, DOI 10.1111/j.1365-2052.2008.01742.x; WETSEL WC, 1992, P NATL ACAD SCI USA, V89, P4149, DOI 10.1073/pnas.89.9.4149; Yamazaki M, 2004, NEUROSCI RES, V50, P369, DOI 10.1016/j.neures.2004.10.002; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805	39	25	25	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e13817	10.1371/journal.pone.0013817	http://dx.doi.org/10.1371/journal.pone.0013817			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21072200	gold, Green Submitted, Green Published			2022-12-25	WOS:000283780800015
J	Rai, P; Young, JJ; Burton, DGA; Giribaldi, MG; Onder, TT; Weinberg, RA				Rai, P.; Young, J. J.; Burton, D. G. A.; Giribaldi, M. G.; Onder, T. T.; Weinberg, R. A.			Enhanced elimination of oxidized guanine nucleotides inhibits oncogenic RAS-induced DNA damage and premature senescence	ONCOGENE			English	Article						cellular senescence; DNA damage; oxidative stress; 8-oxoguanine; MTH1; RAS oncogene	LABILE IRON POOL; CANCER-CELLS; HUMAN FIBROBLASTS; MECHANISM	Approximately 20% of tumors contain activating mutations in the RAS family of oncogenes. As tumors progress to higher grades of malignancy, the expression of oncogenic RAS has been reported to increase, leading to an oncogene-induced senescence (OIS) response. Evasion of this senescence barrier is a hallmark of advanced tumors indicating that OIS serves a critical tumor-suppressive function. Induction of OIS has been attributed to either RAS-mediated production of reactive oxygen species (ROS) or to induction of a DNA damage response (DDR). However, functional links between these two processes in triggering the senescent phenotype have not been explicitly described. Our previous work has shown that, in cultured untransformed cells, preventing elimination of oxidized guanine deoxyribonucleotides, which was achieved by suppressing expression of the cellular 8-oxo-dGTPase, human MutT homolog 1 (MTH1), sufficed to induce a DDR as well as premature senescence. Here, we demonstrate that overexpression of MTH1 can prevent the oncogenic H-RAS-induced DDR and attendant premature senescence, although it does not affect the observed elevation in ROS levels produced by RAS oncoprotein expression. Conversely, we find that loss of MTH1 preferentially induces an in vitro proliferation defect in tumorigenic cells overexpressing oncogenic RAS. These results indicate that the guanine nucleotide pool is a critical target for intracellular ROS produced by oncogenic RAS and that RAS-transformed cells require robust MTH1 expression to proliferate. Oncogene (2011) 30, 1489-1496; doi:10.1038/onc.2010.520; published online 15 November 2010	[Rai, P.; Burton, D. G. A.; Giribaldi, M. G.] Univ Miami, Miller Sch Med, Div Gerontol & Geriatr Med, Dept Med, Miami, FL 33136 USA; [Young, J. J.; Onder, T. T.; Weinberg, R. A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Young, J. J.; Onder, T. T.; Weinberg, R. A.] MIT, Dept Biol, Cambridge, MA USA; [Weinberg, R. A.] Ludwig Ctr Mol Oncol, Cambridge, MA USA	University of Miami; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Rai, P (corresponding author), Univ Miami, Miller Sch Med, Div Gerontol & Geriatr Med, Dept Med, 1600 NW 10th Ave,RMSB 7094,Locator Code D-503, Miami, FL 33136 USA.	prai@med.miami.edu	Burton, Dominick/C-5282-2013; Onder, Tamer T/H-3330-2013; Onder, Tamer/O-3669-2019	Burton, Dominick/0000-0003-3631-6448; Onder, Tamer T/0000-0002-2372-9158; Onder, Tamer/0000-0002-2372-9158; Young-Glazer, Jennifer/0000-0002-3265-9112; Rai, Priyamvada/0000-0001-7822-7553	Leukemia and Lymphoma Society; James and Esther King Florida Biomedical Research Program; Howard Hughes Medical Institute; Ellison Medical Foundation for Aging Research; Ludwig Center for Molecular Oncology; Breast Cancer Research Fund	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); James and Esther King Florida Biomedical Research Program; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Ellison Medical Foundation for Aging Research; Ludwig Center for Molecular Oncology; Breast Cancer Research Fund	We are grateful to Anisleidys Munoz for experimental assistance. We thank Dr Carlos Perez-Stable and Dr Ramiro Verdun for helpful comments on this manuscript. RAW is a Professor at American Cancer Society Research and at Daniel K Ludwig Cancer Research. This work was supported by a Leukemia and Lymphoma Society Postdoctoral fellowship and a James and Esther King Florida Biomedical Research Program New Investigator grant (to PR), a Howard Hughes Medical Institute summer undergraduate fellowship (to JJY) and grants from the Ellison Medical Foundation for Aging Research, The Ludwig Center for Molecular Oncology and the Breast Cancer Research Fund (to RAW).	Algarra Ignacio, 1998, Invasion and Metastasis, V18, P261, DOI 10.1159/000024519; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Benanti JA, 2004, MOL CELL BIOL, V24, P2842, DOI 10.1128/MCB.24.7.2842-2852.2004; Buchholz M, 2005, ONCOGENE, V24, P6626, DOI 10.1038/sj.onc.1208804; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Gackowski D, 2002, J BIOL INORG CHEM, V7, P548, DOI 10.1007/s00775-001-0335-x; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Haghdoost S, 2006, FREE RADICAL BIO MED, V41, P620, DOI 10.1016/j.freeradbiomed.2006.05.003; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; KASAI H, 1984, NUCLEIC ACIDS RES, V12, P2137, DOI 10.1093/nar/12.4.2137; KASID A, 1985, SCIENCE, V228, P725, DOI 10.1126/science.4039465; Kawanishi S, 2001, MUTAT RES-REV MUTAT, V488, P65, DOI 10.1016/S1383-5742(00)00059-4; Kruszewski M, 2003, MUTAT RES-FUND MOL M, V531, P81, DOI 10.1016/j.mrfmmm.2003.08.004; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; Mitsushita J, 2004, CANCER RES, V64, P3580, DOI 10.1158/0008-5472.CAN-03-3909; Moiseeva O, 2009, MOL CELL BIOL, V29, P4495, DOI 10.1128/MCB.01868-08; Nakabeppu Y, 2001, MUTAT RES-FUND MOL M, V477, P59, DOI 10.1016/S0027-5107(01)00096-3; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Rai P, 2009, P NATL ACAD SCI USA, V106, P169, DOI 10.1073/pnas.0809834106; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Serra V, 2003, J BIOL CHEM, V278, P6824, DOI 10.1074/jbc.M207939200; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Struthers L, 1998, ANAL BIOCHEM, V255, P20, DOI 10.1006/abio.1997.2354; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Yagoda N, 2007, NATURE, V447, P864, DOI 10.1038/nature05859; Yang WS, 2008, CHEM BIOL, V15, P234, DOI 10.1016/j.chembiol.2008.02.010; Yoon SH, 2005, BIOCHEM BIOPH RES CO, V327, P342, DOI 10.1016/j.bbrc.2004.12.013	32	92	94	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2011	30	12					1489	1496		10.1038/onc.2010.520	http://dx.doi.org/10.1038/onc.2010.520			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	739UM	21076467				2022-12-25	WOS:000288743800011
J	Wahlgren, WY; Pal, G; Kardos, J; Porrogi, P; Szenthe, B; Patthy, A; Graf, L; Katona, G				Wahlgren, Weixiao Yuan; Pal, Gabor; Kardos, Jozsef; Porrogi, Palma; Szenthe, Borbala; Patthy, Andras; Graf, Laszlo; Katona, Gergely			The Catalytic Aspartate Is Protonated in the Michaelis Complex Formed between Trypsin and an in Vitro Evolved Substrate-like Inhibitor A REFINED MECHANISM OF SERINE PROTEASE ACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; BARRIER HYDROGEN-BOND; ALPHA-LYTIC PROTEASE; ATOMIC-RESOLUTION; PEPTIDE-BOND; 3-DIMENSIONAL STRUCTURE; PHAGE-DISPLAY; CHYMOTRYPSIN; ANGSTROM; TRIAD	The mechanism of serine proteases prominently illustrates how charged amino acid residues and proton transfer events facilitate enzyme catalysis. Here we present an ultrahigh resolution (0.93 angstrom) x-ray structure of a complex formed between trypsin and a canonical inhibitor acting through a substrate-like mechanism. The electron density indicates the protonation state of all catalytic residues where the catalytic histidine is, as expected, in its neutral state prior to the acylation step by the catalytic serine. The carboxyl group of the catalytic aspartate displays an asymmetric electron density so that the O-delta 2-C gamma bond appears to be a double bond, with O-delta 2 involved in a hydrogen bond to His-57 and Ser-214. Only when Asp-102 is protonated on O-delta 1 atom could a density functional theory simulation reproduce the observed electron density. The presence of a putative hydrogen atom is also confirmed by a residual mF(obs) - DFcalc density above 2.5 sigma next to O-delta 1. As a possible functional role for the neutral aspartate in the active site, we propose that in the substrate-bound form, the neutral aspartate residue helps to keep the pK(a) of the histidine sufficiently low, in the active neutral form. When the histidine receives a proton during the catalytic cycle, the aspartate becomes simultaneously negatively charged, providing additional stabilization for the protonated histidine and indirectly to the tetrahedral intermediate. This novel proposal unifies the seemingly conflicting experimental observations, which were previously seen as either supporting the charge relay mechanism or the neutral pK(a) histidine theory.	[Pal, Gabor; Kardos, Jozsef; Porrogi, Palma; Szenthe, Borbala; Patthy, Andras; Graf, Laszlo] Eotvos Lorand Univ, Dept Biochem, H-1117 Budapest, Hungary; [Katona, Gergely] Univ Gothenburg, Dept Chem, S-40530 Gothenburg, Sweden; [Porrogi, Palma; Szenthe, Borbala; Patthy, Andras; Graf, Laszlo] Hungarian Acad Sci, Biotechnol Lab, Chem Res Ctr, H-1117 Budapest, Hungary	Eotvos Lorand University; University of Gothenburg; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Graf, L (corresponding author), Eotvos Lorand Univ, Dept Biochem, H-1117 Budapest, Hungary.	graf@elte.hu; gergely.katona@chem.gu.se	Yuan Wahlgren, Weixiao/D-5589-2011; Katona, Gergely/B-3491-2008; Pal, Gabor/A-6244-2009; Kardos, József/J-1035-2017	Katona, Gergely/0000-0002-2031-8716; Pal, Gabor/0000-0001-7868-7971; Kardos, József/0000-0002-2135-2932	Swedish Science Research Council; Harald and Greta Jeanssons Foundation; OTKA [68408, 81950]; Janos Bolyai Research Fellowship	Swedish Science Research Council; Harald and Greta Jeanssons Foundation; OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Janos Bolyai Research Fellowship(Hungarian Academy of Sciences)	This work was supported by the Swedish Science Research Council, the Harald and Greta Jeanssons Foundation, and OTKA Grants 68408 and 81950.; Supported by the Janos Bolyai Research Fellowship Program.	Ahmed HU, 2007, ACTA CRYSTALLOGR D, V63, P906, DOI 10.1107/S0907444907029976; Ash EL, 1997, SCIENCE, V278, P1128, DOI 10.1126/science.278.5340.1128; BACHOVCHIN WW, 1978, J AM CHEM SOC, V100, P8041, DOI 10.1021/ja00494a001; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BLOW DM, 1969, NATURE, V221, P337, DOI 10.1038/221337a0; BORGSTROM B, 1957, J CLIN INVEST, V36, P1521, DOI 10.1172/JCI103549; Born M, 1920, Z PHYS, V1, P45, DOI 10.1007/BF01881023; Burgess SG, 2008, BIOCHEMISTRY-US, V47, P5168, DOI 10.1021/bi800127d; COREY DR, 1992, J AM CHEM SOC, V114, P4905, DOI 10.1021/ja00038a067; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DEREWENDA ZS, 1994, J MOL BIOL, V241, P83, DOI 10.1006/jmbi.1994.1475; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Dullweber F, 2001, J MOL BIOL, V313, P593, DOI 10.1006/jmbi.2001.5062; ELROD JP, 1980, J AM CHEM SOC, V102, P3917, DOI 10.1021/ja00531a039; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fenn TD, 2003, J APPL CRYSTALLOGR, V36, P944, DOI 10.1107/S0021889803006721; FINKENSTADT WR, 1967, J BIOL CHEM, V242, P771; Fodor K, 2006, BIOCHEMISTRY-US, V45, P2114, DOI 10.1021/bi0517133; Fodor K, 2005, J MOL BIOL, V350, P156, DOI 10.1016/j.jmb.2005.04.039; Frey PA, 2004, J PHYS ORG CHEM, V17, P511, DOI 10.1002/poc.769; FREY PA, 1994, SCIENCE, V264, P1927, DOI 10.1126/science.7661899; Fuhrmann CN, 2004, J MOL BIOL, V338, P999, DOI 10.1016/j.jmb.2004.03.018; HENDERSON R, 1990, P ROY SOC B-BIOL SCI, V241, P6, DOI 10.1098/rspb.1990.0057; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Katona G, 2002, J BIOL CHEM, V277, P21962, DOI 10.1074/jbc.M200676200; KOEPPE RE, 1976, BIOCHEMISTRY-US, V15, P3450, DOI 10.1021/bi00661a009; KOSSIAKOFF AA, 1981, BIOCHEMISTRY-US, V20, P6462, DOI 10.1021/bi00525a027; KRAUT J, 1977, ANNU REV BIOCHEM, V46, P331, DOI 10.1146/annurev.bi.46.070177.001555; Kuhn P, 1998, BIOCHEMISTRY-US, V37, P13446, DOI 10.1021/bi9813983; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li H, 2005, ACTA CRYSTALLOGR E, V61, pM761, DOI 10.1107/S1600536805009098; Liu B, 2006, J BIOL CHEM, V281, P24024, DOI 10.1074/jbc.M600495200; Malik Z, 1999, BBA-PROTEIN STRUCT M, V1434, P143, DOI 10.1016/S0167-4838(99)00167-3; Maqbool S, 2009, DIGEST DIS SCI, V54, P2167, DOI 10.1007/s10620-009-0899-9; MARKLEY JL, 1978, BIOCHEMISTRY-US, V17, P4627, DOI 10.1021/bi00615a008; MARKLEY JL, 1976, J MOL BIOL, V102, P487, DOI 10.1016/0022-2836(76)90330-2; MATTHEWS BW, 1967, NATURE, V214, P652, DOI 10.1038/214652a0; MATTHEWS DJ, 1993, SCIENCE, V260, P1113, DOI 10.1126/science.8493554; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MCGRATH ME, 1992, BIOCHEMISTRY-US, V31, P3059, DOI 10.1021/bi00127a005; Merritt EA, 1999, ACTA CRYSTALLOGR D, V55, P1109, DOI 10.1107/S0907444999003789; Neutze R, 2002, BBA-BIOMEMBRANES, V1565, P144, DOI 10.1016/S0005-2736(02)00566-7; Paithankar KS, 2009, J SYNCHROTRON RADIAT, V16, P152, DOI 10.1107/S0909049508040430; Radisky ES, 2006, P NATL ACAD SCI USA, V103, P6835, DOI 10.1073/pnas.0601910103; ROBILLARD G, 1972, J MOL BIOL, V71, P507, DOI 10.1016/0022-2836(72)90366-X; Schaftenaar G, 2000, J COMPUT AID MOL DES, V14, P123, DOI 10.1023/A:1008193805436; Schmidt A, 2003, J BIOL CHEM, V278, P43357, DOI 10.1074/jbc.M306944200; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Schneider TR, 2000, ACTA CRYSTALLOGR D, V56, P714, DOI 10.1107/S0907444900003723; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; SHOTTON D M, 1970, Nature (London), V225, P802, DOI 10.1038/225802a0; SPRANG S, 1987, SCIENCE, V237, P905, DOI 10.1126/science.3112942; Szenthe B, 2007, J MOL BIOL, V370, P63, DOI 10.1016/j.jmb.2007.04.029; Thurlkill RL, 2006, J MOL BIOL, V362, P594, DOI 10.1016/j.jmb.2006.07.056; Uritski A, 2009, J PHYS CHEM C, V113, P10285, DOI 10.1021/jp901971q; Vrielink A, 2003, CURR OPIN STRUC BIOL, V13, P709, DOI 10.1016/j.sbi.2003.10.012; WARSHEL A, 1989, BIOCHEMISTRY-US, V28, P3629, DOI 10.1021/bi00435a001; Warshel A, 1998, J BIOL CHEM, V273, P27035, DOI 10.1074/jbc.273.42.27035; Williams DH, 2004, ANGEW CHEM INT EDIT, V43, P6596, DOI 10.1002/anie.200300644; Wohri AB, 2010, SCIENCE, V328, P630, DOI 10.1126/science.1186159; Wurtele M, 2000, ACTA CRYSTALLOGR D, V56, P520, DOI 10.1107/S0907444900000299; You TJ, 1995, BIOPHYS J, V69, P1721, DOI 10.1016/S0006-3495(95)80042-1; Zakharova E, 2009, P NATL ACAD SCI USA, V106, P11034, DOI 10.1073/pnas.0902463106	65	20	20	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3587	3596		10.1074/jbc.M110.161604	http://dx.doi.org/10.1074/jbc.M110.161604			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21097875	hybrid, Green Published			2022-12-25	WOS:000286653200043
J	Roepke, TK; King, EC; Purtell, K; Kanda, VA; Lerner, DJ; Abbott, GW				Roepke, Torsten K.; King, Elizabeth C.; Purtell, Kerry; Kanda, Vikram A.; Lerner, Daniel J.; Abbott, Geoffrey W.			Genetic dissection reveals unexpected influence of beta subunits on KCNQ1 K+ channel polarized trafficking in vivo	FASEB JOURNAL			English	Article						gastric acid; MiRP1; potassium channel	GASTRIC-ACID-SECRETION; POTASSIUM CHANNEL; PARIETAL-CELLS; MDCK CELLS; GASTROINTESTINAL EPITHELIA; MEMBRANE; LOCALIZATION; DISRUPTION; REPOLARIZATION; MECHANISM	Targeted deletion of the Kcne2 potassium channel beta subunit gene ablates gastric acid secretion and predisposes to gastric neoplasia in mice. Here, we discovered that Kcne2 deletion basolaterally reroutes the Kcnq1 alpha subunit in vivo in parietal cells (PCs), in which the normally apical location of the Kcnq1-Kcne2 channel facilitates its essential role in gastric acid secretion. Quantitative RT-PCR and Western blotting revealed that Kcne2 deletion remodeled fundic Kcne3 (2.9 +/- 0.8-fold mRNA increase, n = 10; 5.3 +/- 0.4-fold protein increase, n=7) but not Kcne1, 4, or 5, and resulted in basolateral Kcnq1-Kcne3 complex formation in Kcne2(-/-) PCs. Concomitant targeted deletion of Kcne3 (creating Kcne2(-/-) Kcne3(-/-) mice) restored PC apical Kcnq1 localization without Kcne1, 4, or 5 remodeling (assessed by quantitative RT-PCR; n = 5-10), indicating Kcne3 actively, basolaterally rerouted Kcnq1 in Kcne2(-/-) PCs. Despite this, Kcne3 deletion exacerbated gastric hyperplasia in Kcne2(-/-) mice, and both hypochlorhydria and hyperplasia in Kcne2(-/-) mice, suggesting that Kcne3 up-regulation was beneficial in Kcne2-depleted PCs. The findings reveal, in vivo, Kcne-dependent alpha subunit polarized trafficking and the existence and consequences of potassium channel beta subunit remodeling.-Roepke, T. K., King, E. C., Purtell, K., Kanda, V. A., Lerner, D. J., Abbott, G. W. Genetic dissection reveals unexpected influence of beta subunits on KCNQ1K K+ channel polarized trafficking in vivo. FASEB J. 25, 727-736 (2011). www.fasebj.org	[Roepke, Torsten K.; King, Elizabeth C.; Purtell, Kerry; Kanda, Vikram A.; Abbott, Geoffrey W.] Cornell Univ, Dept Pharmacol, Weill Med Coll, New York, NY 10021 USA; [Roepke, Torsten K.; Lerner, Daniel J.; Abbott, Geoffrey W.] Cornell Univ, Dept Med, Weill Med Coll, New York, NY 10021 USA	Cornell University; Cornell University	Abbott, GW (corresponding author), Cornell Univ, Dept Pharmacol, Weill Med Coll, New York, NY 10021 USA.	gwa2001@med.cornell.edu		Abbott, Geoffrey/0000-0003-4552-496X	National Institutes of Health (NIH) [R01 HL079275, T32GM073546]; American Heart Association [0855756D]; Irma T. Hirschl Career Scientist Award; National Heart, Lung, and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM073546] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Irma T. Hirschl Career Scientist Award; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are grateful for expert technical assistance from S. Backovic, L. Cohen-Gould (Director of the Electron Microscopy and Histology Core Facility at Weill Cornell Medical College), M. S. Jiao, the Molecular Cytology Core Facility of Memorial Sloan-Kettering Cancer Center, Sloan-Kettering Institute Mouse Genetics Core Facility, and Rockefeller University Transgenic Mouse Facility. G. W. A. is thankful for support from the National Heart, Lung, and Blood Institute; the National Institutes of Health (NIH; R01 HL079275); the American Heart Association (grant-in-aid 0855756D); and an Irma T. Hirschl Career Scientist Award. K. P. is supported by an NIH predoctoral training grant (T32GM073546).	Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Clancy SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006330; CourtoisCoutry N, 1997, CELL, V90, P501, DOI 10.1016/S0092-8674(00)80510-3; Dedek K, 2001, PFLUG ARCH EUR J PHY, V442, P896, DOI 10.1007/s004240100609; Duffield A, 2004, TRAFFIC, V5, P449, DOI 10.1111/j.1398-9219.2004.00192.x; Fujita A, 2002, J PHYSIOL-LONDON, V540, P85, DOI 10.1113/jphysiol.2001.013439; Heitzmann D, 2004, J PHYSIOL-LONDON, V561, P547, DOI 10.1113/jphysiol.2004.075168; Heitzmann D, 2008, PHYSIOL REV, V88, P1119, DOI 10.1152/physrev.00020.2007; Jespersen T, 2004, J CELL SCI, V117, P4517, DOI 10.1242/jcs.01318; Kaufhold MA, 2008, GASTROENTEROLOGY, V134, P1058, DOI 10.1053/j.gastro.2008.01.033; Lee MP, 2000, J CLIN INVEST, V106, P1447, DOI 10.1172/JCI10897; Malinowska DH, 2004, AM J PHYSIOL-CELL PH, V286, pC495, DOI 10.1152/ajpcell.00386.2003; MATTER K, 1992, CELL, V71, P741, DOI 10.1016/0092-8674(92)90551-M; McCrossan ZA, 2004, NEUROPHARMACOLOGY, V47, P787, DOI 10.1016/j.neuropharm.2004.06.018; McDaniel N, 2005, AM J PHYSIOL-GASTR L, V289, pG550, DOI 10.1152/ajpgi.00095.2005; Odorizzi G, 1996, J CELL BIOL, V135, P139, DOI 10.1083/jcb.135.1.139; OKADA Y, 1984, J PHYSIOL-LONDON, V354, P109, DOI 10.1113/jphysiol.1984.sp015366; Panaghie G, 2007, J GEN PHYSIOL, V129, P121, DOI 10.1085/jgp.200609612; Porcello DM, 2002, J NEUROPHYSIOL, V87, P1303, DOI 10.1152/jn.00556.2001; Preston P, 2010, J BIOL CHEM, V285, P7165, DOI 10.1074/jbc.M109.047829; Roepke TK, 2008, FASEB J, V22, P3648, DOI 10.1096/fj.08-110171; Roepke TK, 2006, J BIOL CHEM, V281, P23740, DOI 10.1074/jbc.M604155200; Roepke TK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011451; Roepke TK, 2009, NAT MED, V15, P1186, DOI 10.1038/nm.2029; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schroeder BC, 2000, NATURE, V403, P196, DOI 10.1038/35003200; Spandidos A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-633; Tinel N, 2000, EMBO J, V19, P6326, DOI 10.1093/emboj/19.23.6326; Vallon V, 2005, P NATL ACAD SCI USA, V102, P17864, DOI 10.1073/pnas.0505860102	31	25	25	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	FEB	2011	25	2					727	736		10.1096/fj.10-173682	http://dx.doi.org/10.1096/fj.10-173682			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	713GZ	21084694	Green Published			2022-12-25	WOS:000286724800030
J	Liu, AYC; Mathur, R; Mei, N; Langhammer, CG; Babiarz, B; Firestein, BL				Liu, Alice Y. C.; Mathur, Rohan; Mei, Newton; Langhammer, Christopher G.; Babiarz, Bruce; Firestein, Bonnie L.			Neuroprotective Drug Riluzole Amplifies the Heat Shock Factor 1 (HSF1)- and Glutamate Transporter 1 (GLT1)-dependent Cytoprotective Mechanisms for Neuronal Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME-WIDE ANALYSIS; AMYOTROPHIC-LATERAL-SCLEROSIS; TRANSCRIPTION FACTOR; NEURODEGENERATIVE DISEASES; CAENORHABDITIS-ELEGANS; MOLECULAR CHAPERONES; GENE-EXPRESSION; HUMAN HSF1; STRESS; ACID	Heat shock factor 1 (HSF1) mediates the cellular response to stress to increase the production of heat shock protein (HSP) chaperones for proper protein folding, trafficking, and degradation; failure of this homeostatic mechanism likely contributes to neurodegeneration. We show that the neuroprotective drug riluzole increased the amount of HSF1 in NG108-15 neuroprogenitor cells by slowing the specific turnover of HSF1 and supporting a more robust and sustained activation of HSF1. Using Hsp70-luciferase as a functional readout of the activity of HSF1, we show that riluzole amplified the heat shock induction of the reporter gene with an optimal increase at 1 mu M. Immunocytochemical staining and Western blot quantitation of HSP70 in NG108-15 neuroprogenitor cells and embryonic spinal cord neurons provided corroborative evidence that riluzole amplified the HSF1-dependent regulation of HSP70 expression. Parallel studies on the GLT1 glutamate transporter showed that riluzole increased GLT1-reporter and GLT1 protein expression and that the increase was enhanced by heat shock and coincident with the increased expression of HSP70 and HSP90. This result is consistent with the anti-glutamatergic profile of riluzole and the presence of multiple heat shock elements on the GLT1 gene promoter, suggesting that riluzole may modulate GLT1 expression through HSF1. The increased HSP chaperones and GLT1 transporter blunted glutamate-induced and N-methyl D-aspartate receptor-mediated excitotoxic death. In summary, we show that riluzole increased the amount and activity of HSF1 to boost the expression of HSPs and GLT1 for neuroprotection under stress.	[Liu, Alice Y. C.; Mathur, Rohan; Mei, Newton; Langhammer, Christopher G.; Babiarz, Bruce; Firestein, Bonnie L.] Rutgers State Univ, Dept Cell Biol & Neurosci, Div Life Sci, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Liu, AYC (corresponding author), Rutgers State Univ, Dept Cell Biol & Neurosci, Div Life Sci, 604 Allison Rd, Piscataway, NJ 08854 USA.	liu@biology.rutgers.edu		Firestein, Bonnie/0000-0002-1679-3565; Mei, Newton/0000-0001-8240-5113; Mathur, Rohan/0000-0001-5246-8543; Liu, Alice Y./0000-0002-6984-1671	National Science Foundation [MCB0240009]; New Jersey Commission on Spinal Cord Research [05-3037-SCR-E-0, 07A-019-SCR1]	National Science Foundation(National Science Foundation (NSF)); New Jersey Commission on Spinal Cord Research	This work was supported in part by grants from the Busch Biomedical Research Grant Program, National Science Foundation Grant MCB0240009 (to A. Y. C. L.), and New Jersey Commission on Spinal Cord Research Grants 05-3037-SCR-E-0 (to A. Y. C. L.) and 07A-019-SCR1 (to B. L. F.).	AUTERI JS, 1983, J CELL PHYSIOL, V115, P167, DOI 10.1002/jcp.1041150210; Batulan Z, 2003, J NEUROSCI, V23, P5789; Bryson HM, 1996, DRUGS, V52, P549, DOI 10.2165/00003495-199652040-00010; Chen WZ, 2002, J NEUROSCI, V22, P2142, DOI 10.1523/JNEUROSCI.22-06-02142.2002; Cotto JJ, 1997, J CELL SCI, V110, P2925; Du YZ, 2007, GLIA, V55, P463, DOI 10.1002/glia.20472; Eastmond DL, 2006, J BIOL CHEM, V281, P32909, DOI 10.1074/jbc.M602454200; ESTEVEZ AG, 1995, EUR J PHARMACOL, V280, P47, DOI 10.1016/0014-2999(95)00186-O; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; Frizzo MED, 2004, CELL MOL NEUROBIOL, V24, P123, DOI 10.1023/B:CEMN.0000012717.37839.07; Fuertes G, 2003, BIOCHEM J, V375, P75, DOI 10.1042/BJ20030282; Fumagalli E, 2008, EUR J PHARMACOL, V578, P171, DOI 10.1016/j.ejphar.2007.10.023; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Heiser V, 2002, P NATL ACAD SCI USA, V99, P16400, DOI 10.1073/pnas.182426599; Heurteaux C, 2006, NEUROSCIENCE, V137, P241, DOI 10.1016/j.neuroscience.2005.08.083; Ishiyama T, 2004, BRAIN RES, V1019, P226, DOI 10.1016/j.brainres.2004.06.002; Jensen LT, 2008, CELL STRESS CHAPERON, V13, P177, DOI 10.1007/s12192-008-0020-x; Jolly C, 1997, J CELL SCI, V110, P2935; Jolly C, 1999, P NATL ACAD SCI USA, V96, P6769, DOI 10.1073/pnas.96.12.6769; Khalil S, 2006, J CELL PHYSIOL, V207, P562, DOI 10.1002/jcp.20599; Kieran D, 2004, NAT MED, V10, P402, DOI 10.1038/nm1021; Killestein J, 2005, J NEUROL SCI, V233, P113, DOI 10.1016/j.jns.2005.03.011; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Lips J, 2000, ANESTHESIOLOGY, V93, P1303, DOI 10.1097/00000542-200011000-00025; Maragakis NJ, 2001, ARCH NEUROL-CHICAGO, V58, P365, DOI 10.1001/archneur.58.3.365; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637; MORIMOTO RI, 1992, J BIOL CHEM, V267, P21987; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Morimoto RI, 2006, NEW ENGL J MED, V355, P2254, DOI 10.1056/NEJMcibr065573; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Mu TW, 2008, CELL, V134, P769, DOI 10.1016/j.cell.2008.06.037; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; NIRENBERG M, 1983, SCIENCE, V222, P794, DOI 10.1126/science.6314503; Nirmalananthan N, 2005, CURR OPIN NEUROL, V18, P712, DOI 10.1097/01.wco.0000187248.21103.c5; Oza J, 2008, CELL STRESS CHAPERON, V13, P73, DOI 10.1007/s12192-008-0013-9; Page TJ, 2006, MOL BIOSYST, V2, P627, DOI 10.1039/b606129j; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; RABINDRAN SK, 1993, SCIENCE, V259, P230, DOI 10.1126/science.8421783; Rea SL, 2005, NAT GENET, V37, P894, DOI 10.1038/ng1608; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Sakurai H, 2007, J BIOL CHEM, V282, P13334, DOI 10.1074/jbc.M611801200; Schwartz G, 2001, J NEUROSURG, V94, P245, DOI 10.3171/spi.2001.94.2.0245; Song JH, 1997, J PHARMACOL EXP THER, V282, P707; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Stover JF, 2000, J NEUROTRAUM, V17, P1171, DOI 10.1089/neu.2000.17.1171; Voellmy Richard, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P357; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; WESTWOOD JT, 1991, NATURE, V353, P822, DOI 10.1038/353822a0; WONG EHF, 1986, P NATL ACAD SCI USA, V83, P7104, DOI 10.1073/pnas.83.18.7104; Xiao XZ, 1999, EMBO J, V18, P5943, DOI 10.1093/emboj/18.21.5943; Yang JX, 2008, BRAIN RES, V1203, P39, DOI 10.1016/j.brainres.2008.01.082; Yang JX, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002864	53	46	48	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2785	2794		10.1074/jbc.M110.158220	http://dx.doi.org/10.1074/jbc.M110.158220			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21098017	Green Published, hybrid			2022-12-25	WOS:000286464300044
J	Markandeya, YS; Fahey, JM; Pluteanu, F; Cribbs, LL; Balijepalli, RC				Markandeya, Yogananda S.; Fahey, Jonathan M.; Pluteanu, Florentina; Cribbs, Leanne L.; Balijepalli, Ravi C.			Caveolin-3 Regulates Protein Kinase A Modulation of the Ca(v)3.2 (alpha(1H)) T-type Ca2+ Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-CHANNEL; VENTRICULAR MYOCYTES; CARDIAC-HYPERTROPHY; SMOOTH-MUSCLE; HUMAN HEART; EXPRESSION; CELLS; LOCALIZATION; COMPONENT; RECEPTOR		[Balijepalli, Ravi C.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Cellular & Mol Arrhythmia Res Program, Madison, WI 53706 USA; [Pluteanu, Florentina; Cribbs, Leanne L.] Loyola Univ, Med Ctr, Cardiovasc Inst, Maywood, IL 60153 USA	University of Wisconsin System; University of Wisconsin Madison; Loyola University Chicago	Balijepalli, RC (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Cellular & Mol Arrhythmia Res Program, B370,1300 Univ Ave, Madison, WI 53706 USA.	rcb@medicine.wisc.edu	Pluteanu, Florentina/R-8630-2018	Pluteanu, Florentina/0000-0003-0743-0129	American Heart Association [0730010N]	American Heart Association(American Heart Association)	This work was supported by Scientist Development Grant 0730010N from the American Heart Association (to R.C.B.).	ALVAREZ JL, 1992, J GEN PHYSIOL, V100, P519, DOI 10.1085/jgp.100.3.519; Balijepalli RC, 2007, CHANNELS, V1, P263, DOI 10.4161/chan.4946; Balijepalli RC, 2006, P NATL ACAD SCI USA, V103, P7500, DOI 10.1073/pnas.0503465103; Balijepalli RC, 2008, PROG BIOPHYS MOL BIO, V98, P149, DOI 10.1016/j.pbiomolbio.2009.01.012; Balijepalli RC, 2003, CARDIOVASC RES, V59, P67, DOI 10.1016/S0008-6363(03)00325-0; Ball CJ, 2009, HYPERTENSION, V53, P654, DOI 10.1161/HYPERTENSIONAHA.108.125831; Becker AJ, 2008, J NEUROSCI, V28, P13341, DOI 10.1523/JNEUROSCI.1421-08.2008; Beetz N, 2009, CARDIOVASC RES, V84, P396, DOI 10.1093/cvr/cvp251; Bossuyt J, 2002, ANN NY ACAD SCI, V976, P197; Boulware MI, 2007, J NEUROSCI, V27, P9941, DOI 10.1523/JNEUROSCI.1647-07.2007; Brueggemann LI, 2005, AM J PHYSIOL-HEART C, V288, pH923, DOI 10.1152/ajpheart.01126.2003; Chemin J, 2002, J PHYSIOL-LONDON, V540, P3, DOI 10.1113/jphysiol.2001.013269; Chiang CS, 2009, CIRC RES, V104, P522, DOI 10.1161/CIRCRESAHA.108.184051; Cohen RM, 2005, AM J PHYSIOL-HEART C, V288, pH2363, DOI 10.1152/ajpheart.00348.2004; Cribbs LL, 2000, FEBS LETT, V466, P54, DOI 10.1016/S0014-5793(99)01756-1; Cribbs LL, 2001, CIRC RES, V88, P403; David LS, 2010, CHANNELS, V4, P375, DOI 10.4161/chan.4.5.12874; Depuy SD, 2006, P NATL ACAD SCI USA, V103, P14590, DOI 10.1073/pnas.0603945103; Ferron L, 2003, CIRC RES, V93, P1241, DOI 10.1161/01.RES.0000106134.69300.B7; Foell JD, 2004, PHYSIOL GENOMICS, V17, P183, DOI 10.1152/physiolgenomics.00207.2003; GLENNEY JR, 1992, FEBS LETT, V314, P45, DOI 10.1016/0014-5793(92)81458-X; Hare JM, 2000, CIRC RES, V86, P1085, DOI 10.1161/01.RES.86.10.1085; Hu CL, 2009, J BIOL CHEM, V284, P7465, DOI 10.1074/jbc.M808049200; Huc S, 2009, BBA-MOL CELL RES, V1793, P947, DOI 10.1016/j.bbamcr.2008.11.003; Iftinca MC, 2009, TRENDS PHARMACOL SCI, V30, P32, DOI 10.1016/j.tips.2008.10.004; Insel PA, 2009, CURR OPIN NEPHROL HY, V18, P50, DOI 10.1097/MNH.0b013e3283186f82; Khosravani H, 2005, ANN NEUROL, V57, P745, DOI 10.1002/ana.20458; Khosravani H, 2004, J BIOL CHEM, V279, P9681, DOI 10.1074/jbc.C400006200; Kikuchi T, 2005, J CARDIOVASC PHARM, V45, P204, DOI 10.1097/01.fjc.0000152029.53997.57; Kim JA, 2006, J PHARMACOL EXP THER, V318, P230, DOI 10.1124/jpet.106.101402; Kinoshita H, 2009, CIRCULATION, V120, P743, DOI 10.1161/CIRCULATIONAHA.109.857011; Klockner U, 1999, EUR J NEUROSCI, V11, P4171, DOI 10.1046/j.1460-9568.1999.00849.x; Koga A, 2003, HYPERTENSION, V42, P213, DOI 10.1161/01.HYP.0000082926.08268.5D; Kozlov AS, 1999, EUR J NEUROSCI, V11, P4149, DOI 10.1046/j.1460-9568.1999.00841.x; Lee JH, 1999, BIOPHYS J, V77, P3034, DOI 10.1016/S0006-3495(99)77134-1; Lee JH, 1999, J NEUROSCI, V19, P1912; Lenglet S, 2002, ENDOCRINOLOGY, V143, P1748, DOI 10.1210/en.143.5.1748; Lyon AR, 2009, P NATL ACAD SCI USA, V106, P6854, DOI 10.1073/pnas.0809777106; Maeda Y, 2009, PAIN, V142, P127, DOI 10.1016/j.pain.2008.12.021; Martin RL, 2000, J PHARMACOL EXP THER, V295, P302; Martinez ML, 1999, J MOL CELL CARDIOL, V31, P1617, DOI 10.1006/jmcc.1999.0998; McGivern JG, 2006, DRUG DISCOV TODAY, V11, P245, DOI 10.1016/S1359-6446(05)03662-7; NUSS HB, 1994, J PHYSIOL-LONDON, V479, P265, DOI 10.1113/jphysiol.1994.sp020294; NUSS HB, 1993, CIRC RES, V73, P777, DOI 10.1161/01.RES.73.4.777; Ono K, 2005, J PHARMACOL SCI, V99, P197, DOI 10.1254/jphs.FMJ05002X2; Ono K, 2010, J MOL CELL CARDIOL, V48, P65, DOI 10.1016/j.yjmcc.2009.08.021; Ostadal B, 1999, PHYSIOL REV, V79, P635, DOI 10.1152/physrev.1999.79.3.635; Pani B, 2009, CELL CALCIUM, V45, P625, DOI 10.1016/j.ceca.2009.02.009; Patel H. H., 2008, V186, P167, DOI 10.1007/978-3-540-72843-6_7; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Powell KL, 2009, J NEUROSCI, V29, P371, DOI 10.1523/JNEUROSCI.5295-08.2009; Rangel A, 2010, MOL PHARMACOL, V77, P202, DOI 10.1124/mol.109.058727; Ratajczak P, 2005, J APPL PHYSIOL, V99, P244, DOI 10.1152/japplphysiol.01292.2004; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Scherer PE, 1996, P NATL ACAD SCI USA, V93, P131, DOI 10.1073/pnas.93.1.131; Song KS, 1996, J BIOL CHEM, V271, P15160, DOI 10.1074/jbc.271.25.15160; Steinberg SE, 2004, J MOL CELL CARDIOL, V37, P407, DOI 10.1016/j.yjmcc.2004.04.018; Talavera K, 2001, J BIOL CHEM, V276, P45628, DOI 10.1074/jbc.M103047200; Tao J, 2008, MOL PHARMACOL, V73, P1596, DOI 10.1124/mol.107.043612; Vassort G, 2006, CELL CALCIUM, V40, P205, DOI 10.1016/j.ceca.2006.04.025; Wagoner LE, 1996, CIRCULATION, V93, P111, DOI 10.1161/01.CIR.93.1.111; Wei S, 2010, CIRC RES, V107, P520, DOI 10.1161/CIRCRESAHA.109.212324; Welsby PJ, 2003, J NEUROSCI, V23, P10116, DOI 10.1523/jneurosci.23-31-10116.2003; Wolfe JT, 2003, NATURE, V424, P209, DOI 10.1038/nature01772; Wolfe JT, 2002, J PHYSIOL-LONDON, V538, P343, DOI 10.1113/jphysiol.2001.012839; Xiao L, 2006, STEM CELLS, V24, P1476, DOI 10.1634/stemcells.2005-0299; Yao Q, 2005, J MOL BIOL, V348, P491, DOI 10.1016/j.jmb.2005.02.003; Yarbrough TL, 2002, CIRC RES, V90, P443, DOI 10.1161/hh0402.105177; Ye B, 2008, BIOCHEMISTRY-US, V47, P12312, DOI 10.1021/bi8009295; You HT, 2010, MOL PHARMACOL, V77, P211, DOI 10.1124/mol.109.059022	71	33	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2433	2444		10.1074/jbc.M110.182550	http://dx.doi.org/10.1074/jbc.M110.182550			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21084288	Green Published, hybrid			2022-12-25	WOS:000286464300007
J	Mokkapati, S; Fleger-Weckmann, A; Bechtel, M; Koch, M; Breitkreutz, D; Mayer, U; Smyth, N; Nischt, R				Mokkapati, Sharada; Fleger-Weckmann, Anja; Bechtel, Manuela; Koch, Manuel; Breitkreutz, Dirk; Mayer, Ulrike; Smyth, Neil; Nischt, Roswitha			Basement Membrane Deposition of Nidogen 1 but Not Nidogen 2 Requires the Nidogen Binding Module of the Laminin gamma 1 Chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EGF-LIKE MOTIF; EPITHELIAL MORPHOGENESIS; GLOBULAR DOMAINS; EXPRESSION; SKIN; ADHESION; PROTEIN; CELLS; PROLIFERATION; COMPONENTS	The nidogen-laminin interaction is proposed to play a key role in basement membrane (BM) assembly. However, though there are similarities, the phenotypes in mice lacking nidogen 1 and 2 (nidogen double null) differ to those of mice lacking the nidogen binding module (gamma 1III4) of the laminin gamma 1 chain. This indicates different cell- and tissue-specific functions for nidogens and their interaction with laminin and poses the question of whether the phenotypes in nidogen double null mice are caused by the loss of the laminin-nidogen interaction or rather by other unknown nidogen functions. To investigate this, we analyzed BMs, in particular those in the skin of mice lacking the nidogen binding module. In contrast to nidogen double null mice, all skin BMs in gamma 1III4-deficient mice appeared normal. Furthermore, although nidogen 1 deposition was strongly reduced, nidogen 2 appeared unchanged. Mice with additional deletion of the laminin gamma 3 chain, which contains a gamma 1-like nidogen binding module, showed a further reduction of nidogen 1 in the dermoepidermal BM; however, this again did not affect nidogen 2. This demonstrates that in vivo only nidogen 1 deposition is critically dependent on the nidogen binding modules of the laminin gamma 1 and gamma 3 chains, whereas nidogen 2 is independently recruited either by binding to an alternative site on laminin or to other BM proteins.	[Mokkapati, Sharada; Fleger-Weckmann, Anja; Bechtel, Manuela; Nischt, Roswitha] Univ Hosp Cologne, Dept Dermatol, D-50937 Cologne, Germany; [Koch, Manuel] Univ Cologne, Inst Oral & Musculoskeletal Biol, Fac Med, Ctr Biochem,Ctr Mol Med Cologne,Ctr Dent Med, D-5000 Cologne 41, Germany; [Breitkreutz, Dirk] German Canc Res Ctr, Div A110 A080, D-69120 Heidelberg, Germany; [Mayer, Ulrike] Univ E Anglia, Sch Biol Sci, Biomed Res Ctr, Norwich NR4 7TJ, Norfolk, England; [Smyth, Neil] Univ Southampton, Sch Biol Sci, Southampton SO17 1BJ, Hants, England	University of Cologne; University of Cologne; Helmholtz Association; German Cancer Research Center (DKFZ); University of East Anglia; University of Southampton	Nischt, R (corresponding author), Univ Hosp Cologne, Dept Dermatol, Kerpener Str 62, D-50937 Cologne, Germany.	Roswitha.Nischt@uni-koeln.de	Koch, Manuel/AAG-9914-2021	Koch, Manuel/0000-0002-2962-7814; Smyth, Neil/0000-0002-3734-2149; Mayer, Ulrike/0000-0003-2328-0052	Deutsche Forschungsgemeinschaft through Sonderforschungsbereich 589 and 829 at the University of Cologne [NI 304/11-1]; Maria Pesch Stiftung; Medical Research Council (MRC) [BJ10R141]; MRC [G0501515] Funding Source: UKRI; Medical Research Council [G0501515] Funding Source: researchfish	Deutsche Forschungsgemeinschaft through Sonderforschungsbereich 589 and 829 at the University of Cologne(German Research Foundation (DFG)); Maria Pesch Stiftung; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Deutsche Forschungsgemeinschaft through Sonderforschungsbereich 589 and 829 at the University of Cologne (to R. N.) and Grant NI 304/11-1 (to R. N.). This work was also supported by the Maria Pesch Stiftung (to R. N.). N. S. is funded by the Medical Research Council (MRC) through grant BJ10R141.	AUMAILLEY M, 1993, KIDNEY INT, V43, P7, DOI 10.1038/ki.1993.3; Aumailley M, 1999, MATRIX BIOL, V18, P19, DOI 10.1016/S0945-053X(98)00004-3; Bader BL, 2005, MOL CELL BIOL, V25, P6846, DOI 10.1128/MCB.25.15.6846-6856.2005; Baranowsky A, 2010, MATRIX BIOL, V29, P15, DOI 10.1016/j.matbio.2009.09.004; BICKENBACH JR, 1995, J INVEST DERMATOL, V104, P405, DOI 10.1111/1523-1747.ep12665896; Bose K, 2006, J BIOL CHEM, V281, P39620, DOI 10.1074/jbc.M607886200; Borradori L, 1999, J INVEST DERMATOL, V112, P411, DOI 10.1046/j.1523-1747.1999.00546.x; Breitkreutz D, 1998, EUR J CELL BIOL, V75, P273, DOI 10.1016/S0171-9335(98)80123-4; Breitkreutz D, 2004, J CELL SCI, V117, P2611, DOI 10.1242/jcs.01127; CARLIN B, 1981, J BIOL CHEM, V256, P5209; Denes V, 2007, VISUAL NEUROSCI, V24, P549, DOI 10.1017/S0952523807070514; DiPersio CM, 1997, J CELL BIOL, V137, P729, DOI 10.1083/jcb.137.3.729; EKBLOM P, 1994, DEVELOPMENT, V120, P2003; Ettner N, 1998, FEBS LETT, V430, P217, DOI 10.1016/S0014-5793(98)00601-2; FOX JW, 1991, EMBO J, V10, P3137, DOI 10.1002/j.1460-2075.1991.tb04875.x; FUJIWARA S, 1984, EUR J BIOCHEM, V143, P145, DOI 10.1111/j.1432-1033.1984.tb08353.x; Gerharz M, 2007, WOUND REPAIR REGEN, V15, P105, DOI 10.1111/j.1524-475X.2006.00191.x; Gersdorff N, 2005, J BIOL CHEM, V280, P22146, DOI 10.1074/jbc.M501875200; Iivanainen A, 1999, J BIOL CHEM, V274, P14107, DOI 10.1074/jbc.274.20.14107; Kadoya Y, 1997, DEVELOPMENT, V124, P683; Kikkawa Y, 2004, EXP CELL RES, V300, P94, DOI 10.1016/j.yexcr.2004.06.031; Kimura N, 1998, EXP CELL RES, V241, P36, DOI 10.1006/excr.1998.4016; Koch M, 1999, J CELL BIOL, V145, P605, DOI 10.1083/jcb.145.3.605; Kohfeldt E, 1998, J MOL BIOL, V282, P99, DOI 10.1006/jmbi.1998.2004; Mayer U, 1998, ANN NY ACAD SCI, V857, P130, DOI 10.1111/j.1749-6632.1998.tb10113.x; MAYER U, 1995, FEBS LETT, V365, P129, DOI 10.1016/0014-5793(95)00438-F; MAYER U, 1993, EMBO J, V12, P1879, DOI 10.1002/j.1460-2075.1993.tb05836.x; Mckee KK, 2007, J BIOL CHEM, V282, P21437, DOI 10.1074/jbc.M702963200; McMillan JR, 2003, J HISTOCHEM CYTOCHEM, V51, P1299, DOI 10.1177/002215540305101007; Miosge N, 2000, HISTOCHEM CELL BIOL, V113, P115, DOI 10.1007/s004180050014; Mokkapati S, 2008, J INVEST DERMATOL, V128, P2259, DOI 10.1038/jid.2008.65; Murshed M, 2000, MOL CELL BIOL, V20, P7007, DOI 10.1128/MCB.20.18.7007-7012.2000; Niessen CM, 1996, J CELL SCI, V109, P1695; Nischt R, 2007, J INVEST DERMATOL, V127, P545, DOI 10.1038/sj.jid.5700562; POSCHL E, 1994, EMBO J, V13, P3741, DOI 10.1002/j.1460-2075.1994.tb06683.x; Pouliot N, 2002, EXP DERMATOL, V11, P387, DOI 10.1034/j.1600-0625.2002.110501.x; Salmivirta K, 2002, EXP CELL RES, V279, P188, DOI 10.1006/excr.2002.5611; TIMPL R, 1983, EUR J BIOCHEM, V137, P455, DOI 10.1111/j.1432-1033.1983.tb07849.x; Timpl R, 1996, BIOESSAYS, V18, P123, DOI 10.1002/bies.950180208; Tomakidi P, 1999, DIFFERENTIATION, V64, P263, DOI 10.1046/j.1432-0436.1999.6450263.x; Tunggal J, 2003, J CELL SCI, V116, P803, DOI 10.1242/jcs.00293; Willem M, 2002, DEVELOPMENT, V129, P2711	42	12	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1911	1918		10.1074/jbc.M110.149864	http://dx.doi.org/10.1074/jbc.M110.149864			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21084308	Green Published, hybrid			2022-12-25	WOS:000286191500032
J	Bancells, C; Benitez, S; Ordonez-Llanos, J; Oorni, K; Kovanen, PT; Milne, RW; Sanchez-Quesada, JL				Bancells, Cristina; Benitez, Sonia; Ordonez-Llanos, Jordi; Oorni, Katariina; Kovanen, Petri T.; Milne, Ross W.; Sanchez-Quesada, Jose L.			Immunochemical Analysis of the Electronegative LDL Subfraction Shows That Abnormal N-terminal Apolipoprotein B Conformation Is Involved in Increased Binding to Proteoglycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; MONOCLONAL-ANTIBODIES; RECEPTOR; B-100; AGGREGATION; PARTICLES; EPITOPES; PLASMA; CELLS; SITE	Electronegative LDL (LDL(-)) is a minor subfraction of modified LDL present in plasma. Among its atherogenic characteristics, low affinity to the LDL receptor and high binding to arterial proteoglycans (PGs) could be related to abnormalities in the conformation of its main protein, apolipoprotein B-100 (apoB-100). In the current study, we have performed an immunochemical analysis using monoclonal antibody (mAb) probes to analyze the conformation of apoB-100 in LDL(-). The study, performed with 28 anti-apoB-100 mAbs, showed that major differences of apoB-100 immunoreactivity between native LDL and LDL(-) concentrate in both terminal extremes. The mAbs Bsol 10, Bsol 14 (which recognize the amino-terminal region), Bsol 2, and Bsol 7 (carboxyl-terminal region) showed increased immunoreactivity in LDL(-), suggesting that both terminal extremes are more accessible in LDL(-) than in native LDL. The analysis of in vitro-modified LDLs, including LDL lipolyzed with sphingomyelinase (SMase-LDL) or phospholipase A(2) (PLA(2)-LDL) and oxidized LDL (oxLDL), suggested that increased amino-terminal immunoreactivity was related to altered conformation due to aggregation. This was confirmed when the aggregated subfractions of LDL(-) (agLDL(-)) and oxLDL (ag-oxLDL) were isolated and analyzed. Thus, Bsol 10 and Bsol 14 immunoreactivity was high in SMase-LDL, ag-oxLDL, and agLDL(-). The altered amino-terminal apoB-100 conformation was involved in the increased PG binding affinity of agLDL(-) because Bsol 10 and Bsol 14 blocked its high PG-binding. These observations suggest that an abnormal conformation of the amino-terminal region of apoB-100 is responsible for the increased PG binding affinity of agLDL(-).	[Bancells, Cristina; Benitez, Sonia; Ordonez-Llanos, Jordi; Sanchez-Quesada, Jose L.] Hosp Santa Creu & Sant Pau, Dept Biochem, Biomed Res Inst IIB St Pau, Barcelona 08025, Spain; [Bancells, Cristina; Ordonez-Llanos, Jordi] Univ Autonoma Barcelona, Dept Biochem & Mol Biol, Cerdanyola Del Valles 08193, Catalonia, Spain; [Oorni, Katariina; Kovanen, Petri T.] Wihuri Res Inst, SF-00140 Helsinki, Finland; [Milne, Ross W.] Univ Ottawa, Inst Heart, Atherosclerosis Genet & Cell Biol Grp, Ottawa, ON K1Y 4W7, Canada	Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona; Wihuri Research Institute; University of Ottawa; University of Ottawa Heart Institute	Bancells, C (corresponding author), Hosp Santa Creu & Sant Pau, Dept Biochem, Res Inst, C St Antoni Maria Claret 167, Barcelona 08025, Spain.	cbancells@santpau.cat; RMilne@ottawaheart.ca; jsanchezq@santpau.cat	Oorni, Katariina/G-2484-2011; Ordonez-Llanos, Jorge/N-1126-2019; Ordonez-Llanos, Jorge/AAE-3088-2020; Ordonez-Llanos, Jordi/B-4961-2011; Ordonez-Llanos, Jorge/A-9335-2010	Oorni, Katariina/0000-0002-9525-0250; Ordonez-Llanos, Jorge/0000-0003-4896-5832; Ordonez-Llanos, Jorge/0000-0003-4896-5832; Ordonez-Llanos, Jordi/0000-0003-4896-5832; Bancells, Cristina/0000-0003-4819-218X; Sanchez-Quesada, Jose Luis/0000-0003-0224-591X	Spanish Ministry of Health (Instituto de Salud Carlos III/Fondo de Investigacion Sanitaria (ISCIII/FIS)) [PI06/0500, PI09/0160]; Heart and Stroke Foundation of Canada [T6110]; Spanish Ministry of Education and Science (MEC) [AP-2004-1468]; ISCIII/FIS [CP04/0110, CP06/0220]	Spanish Ministry of Health (Instituto de Salud Carlos III/Fondo de Investigacion Sanitaria (ISCIII/FIS))(Instituto de Salud Carlos IIISpanish Government); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Spanish Ministry of Education and Science (MEC)(Spanish Government); ISCIII/FIS(Instituto de Salud Carlos III)	This work was supported by Spanish Ministry of Health (Instituto de Salud Carlos III/Fondo de Investigacion Sanitaria (ISCIII/FIS)) Grants PI06/0500 and PI09/0160 and from the Heart and Stroke Foundation of Canada (Grant T6110).; Recipient of Predoctoral Fellowship AP-2004-1468 from the Spanish Ministry of Education and Science (MEC).; Supported by ISCIII/FIS CP04/0110.; Supported by ISCIII/FIS CP06/0220.	Asatryan L, 2005, J LIPID RES, V46, P115, DOI 10.1194/jlr.M400306-JLR200; AVOGARO P, 1988, ARTERIOSCLEROSIS, V8, P79, DOI 10.1161/01.ATV.8.1.79; Bancells C, 2008, BIOCHEMISTRY-US, V47, P8186, DOI 10.1021/bi800537h; Bancells C, 2010, J BIOL CHEM, V285, P32425, DOI 10.1074/jbc.M110.139691; Bancells C, 2009, J LIPID RES, V50, P446, DOI 10.1194/jlr.M800318-JLR200; Benitez S, 2004, ATHEROSCLEROSIS, V177, P299, DOI 10.1016/j.atherosclerosis.2004.07.027; Benitez S, 2004, BIOCHEMISTRY-US, V43, P15863, DOI 10.1021/bi048825z; Benitez S, 2007, BBA-MOL CELL BIOL L, V1771, P613, DOI 10.1016/j.bbalip.2007.03.001; Benitez S, 2006, BBA-MOL CELL BIOL L, V1761, P1014, DOI 10.1016/j.bbalip.2006.03.020; Blanco FJ, 2010, J LIPID RES, V51, P1560, DOI 10.1194/jlr.D002642; Boren J, 1998, J CLIN INVEST, V101, P1084, DOI 10.1172/JCI1847; CHATTERTON JE, 1995, J LIPID RES, V36, P2027; Chen CH, 2003, CIRCULATION, V107, P2102, DOI 10.1161/01.CIR.0000065220.70220.F7; Demuth K, 1996, ARTERIOSCL THROM VAS, V16, P773, DOI 10.1161/01.ATV.16.6.773; Flood C, 2002, J BIOL CHEM, V277, P32228, DOI 10.1074/jbc.M204053200; Goldberg IJ, 1998, J BIOL CHEM, V273, P35355, DOI 10.1074/jbc.273.52.35355; Gustafsson M, 2004, CURR OPIN LIPIDOL, V15, P505, DOI 10.1097/00041433-200410000-00003; Hevonoja T, 2000, BBA-MOL CELL BIOL L, V1488, P189, DOI 10.1016/S1388-1981(00)00123-2; HOFF HF, 1992, J BIOL CHEM, V267, P602; Johs A, 2006, J BIOL CHEM, V281, P19732, DOI 10.1074/jbc.M601688200; MARCEL YL, 1988, ARTERIOSCLEROSIS, V8, pA593; MILNE R, 1989, J BIOL CHEM, V264, P19754; MILNE RW, 1983, ARTERIOSCLEROSIS, V3, P23, DOI 10.1161/01.ATV.3.1.23; Oorni K, 1998, J BIOL CHEM, V273, P29127, DOI 10.1074/jbc.273.44.29127; Parasassi T, 2001, FREE RADICAL BIO MED, V31, P82, DOI 10.1016/S0891-5849(01)00555-X; PEASE RJ, 1990, J BIOL CHEM, V265, P553; READE R, 1989, AM J NEPHROL, V9, P110, DOI 10.1159/000167948; Sanchez-Quesada JL, 1999, AM J CARDIOL, V84, P655, DOI 10.1016/S0002-9149(99)00411-7; Sanchez-Quesada JL, 2004, CURR OPIN LIPIDOL, V15, P329, DOI [10.1097/00041433-200406000-00014, 10.1097/01.mol.0000130093.54381.22]; Sanchez-Quesada JL, 2003, ATHEROSCLEROSIS, V166, P261, DOI 10.1016/S0021-9150(02)00374-X; Sanchez-Quesada JL, 2002, J LIPID RES, V43, P699; Sanchez-Quesada JL, 2001, J CLIN ENDOCR METAB, V86, P3243, DOI 10.1210/jc.86.7.3243; Segrest JP, 2001, J LIPID RES, V42, P1346; Sevanian A, 1997, J LIPID RES, V38, P419; Wang XY, 1998, P NATL ACAD SCI USA, V95, P7643, DOI 10.1073/pnas.95.13.7643; Wang XY, 2000, ARTERIOSCL THROM VAS, V20, P1301, DOI 10.1161/01.ATV.20.5.1301; Witztum JL, 1997, ANN NY ACAD SCI, V811, P88, DOI 10.1111/j.1749-6632.1997.tb51992.x; ZAWADZKI Z, 1991, J LIPID RES, V32, P243; ZAWADZKI Z, 1989, J LIPID RES, V30, P885; Ziegler O, 1996, DIABETES METAB, V22, P179; Ziouzenkova O, 1999, J BIOL CHEM, V274, P18916, DOI 10.1074/jbc.274.27.18916	41	22	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1125	1133		10.1074/jbc.M110.175315	http://dx.doi.org/10.1074/jbc.M110.175315			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21078674	Green Published, hybrid			2022-12-25	WOS:000286005000023
J	Im, SS; Kim, MY; Kwon, SK; Kim, TH; Bae, JS; Kim, H; Kim, KS; Oh, GT; Ahn, YH				Im, Seung-Soon; Kim, Mi-Young; Kwon, Sool-Ki; Kim, Tae-Hyun; Bae, Jin-Sik; Kim, Hail; Kim, Kyung-Sup; Oh, Goo-Taeg; Ahn, Yong-Ho			Peroxisome Proliferator-activated Receptor alpha Is Responsible for the Up-regulation of Hepatic Glucose-6-phosphatase Gene Expression in Fasting and db/db Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE FATTY-ACIDS; PHOSPHOENOLPYRUVATE CARBOXYKINASE GENE; RAT-LIVER GLUCOSE-6-PHOSPHATASE; TYPE-2 DIABETES-MELLITUS; PPAR-ALPHA; INSULIN-RESISTANCE; CATALYTIC SUBUNIT; H4IIE CELLS; TRANSCRIPTIONAL COACTIVATOR; NUCLEAR FACTOR-4-ALPHA	Glucose-6-phosphatase (G6Pase) is a key enzyme that is responsible for the production of glucose in the liver during fasting or in type 2 diabetes mellitus (T2DM). During fasting or in T2DM, peroxisome proliferator-activated receptor alpha (PPAR alpha) is activated, which may contribute to increased hepatic glucose output. However, the mechanism by which PPAR alpha up-regulates hepatic G6Pase gene expression in these states is not well understood. We evaluated the mechanism by which PPAR alpha up-regulates hepatic G6Pase gene expression in fasting and T2DM states. In PPAR alpha-null mice, both hepatic G6Pase and phosphoenolpyruvate carboxykinase levels were not increased in the fasting state. Moreover, treatment of primary cultured hepatocytes with Wy14,643 or fenofibrate increased the G6Pase mRNA level. In addition, we have localized and characterized a PPAR-responsive element in the promoter region of the G6Pase gene. Chromatin immunoprecipitation (ChIP) assay revealed that PPAR alpha binding to the putative PPAR-responsive element of the G6Pase promoter was increased in fasted wild-type mice and db/db mice. These results indicate that PPAR alpha is responsible for glucose production through the up-regulation of hepatic G6Pase gene expression during fasting or T2DM animal models.	[Im, Seung-Soon; Kim, Mi-Young; Kwon, Sool-Ki; Kim, Tae-Hyun; Bae, Jin-Sik; Kim, Hail; Kim, Kyung-Sup; Ahn, Yong-Ho] Yonsei Univ, Coll Med, Dept Biochem & Mol Biol, Seoul 120752, South Korea; [Kim, Tae-Hyun; Kim, Kyung-Sup; Ahn, Yong-Ho] Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul 120752, South Korea; [Im, Seung-Soon; Kim, Mi-Young; Kwon, Sool-Ki; Kim, Tae-Hyun; Bae, Jin-Sik; Kim, Hail; Kim, Kyung-Sup; Ahn, Yong-Ho] Yonsei Univ, Coll Med, Ctr Chron Metab Dis Res, Seoul 120752, South Korea; [Im, Seung-Soon] Sanford Burnham Med Res Inst, Metab Signaling & Dis Program, Orlando, FL 32827 USA; [Oh, Goo-Taeg] Ewha Womans Univ, Div Life & Pharmaceut Sci, Lab Cardiovasc Genom, Seoul 120750, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Sanford Burnham Prebys Medical Discovery Institute; Ewha Womans University	Ahn, YH (corresponding author), Yonsei Univ, Coll Med, Dept Biochem & Mol Biol, 134 Shinchon Dong, Seoul 120752, South Korea.	yha111@yuhs.ac	Kim, Hail/C-5608-2018; Oh, Goo Taeg/AAQ-9995-2021; AHN, Yong Ho/H-6712-2017; Kim, Hail/C-1849-2011	AHN, Yong Ho/0000-0002-4133-0757; Kim, Hail/0000-0002-6652-1349; Kim, Kyung-sup/0000-0001-8483-8537	Ministry of Education, Science, and Technology [2009-0080655]; Ministry for Health, Welfare, and Family Affairs, Republic of Korea [A091014]	Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry for Health, Welfare, and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by the Basic Science Research Program of the National Research Foundation of Korea, funded by the Ministry of Education, Science, and Technology Grant 2009-0080655 (Y.-H. A.) and by Korea Healthcare Technology R&D Project, Ministry for Health, Welfare, and Family Affairs, Republic of Korea, Grant A091014 (M.-Y. K.).	Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678; Argaud D, 1996, DIABETES, V45, P1563, DOI 10.2337/diabetes.45.11.1563; Argaud D, 1997, J BIOL CHEM, V272, P12854, DOI 10.1074/jbc.272.19.12854; Asayama K, 1999, MOL CELL BIOCHEM, V194, P227, DOI 10.1023/A:1006930513476; Bandsma RHJ, 2004, J BIOL CHEM, V279, P8930, DOI 10.1074/jbc.M310067200; Barthel A, 2003, AM J PHYSIOL-ENDOC M, V285, pE685, DOI 10.1152/ajpendo.00253.2003; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Bergman RN, 2000, TRENDS ENDOCRIN MET, V11, P351, DOI 10.1016/S1043-2760(00)00323-4; Bernal-Mizrachi C, 2003, NAT MED, V9, P1069, DOI 10.1038/nm898; Bihan H, 2005, FEBS LETT, V579, P2284, DOI 10.1016/j.febslet.2005.03.020; Blanquart C, 2002, J BIOL CHEM, V277, P37254, DOI 10.1074/jbc.M110598200; Boden G, 2001, AM J PHYSIOL-ENDOC M, V280, pE23, DOI 10.1152/ajpendo.2001.280.1.E23; Boustead JN, 2003, BIOCHEM J, V369, P17, DOI 10.1042/BJ20021382; Cassuto H, 2005, J BIOL CHEM, V280, P33873, DOI 10.1074/jbc.M504119200; Chen XH, 1999, J CLIN INVEST, V103, P365, DOI 10.1172/JCI5479; Cherrington AD, 1999, DIABETES, V48, P1198, DOI 10.2337/diabetes.48.5.1198; Chou CJ, 2002, J BIOL CHEM, V277, P24484, DOI 10.1074/jbc.M202449200; Chu RY, 2004, MOL CELL BIOL, V24, P6288, DOI 10.1128/MCB.24.14.6288-6297.2004; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; GOODRIDGE AG, 1987, ANNU REV NUTR, V7, P157, DOI 10.1146/annurev.nu.07.070187.001105; Grempler R, 2004, BIOCHEM J, V382, P471, DOI 10.1042/BJ20040160; Guerre-Millo M, 2000, J BIOL CHEM, V275, P16638, DOI 10.1074/jbc.275.22.16638; HABER BA, 1995, J CLIN INVEST, V95, P832, DOI 10.1172/JCI117733; Hsu MH, 2001, J BIOL CHEM, V276, P27950, DOI 10.1074/jbc.M100258200; JugeAubry C, 1997, J BIOL CHEM, V272, P25252, DOI 10.1074/jbc.272.40.25252; KELLY DP, 1994, NEW ENGL J MED, V330, P913; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Kim HJ, 2003, DIABETES, V52, pA290; Kim TH, 2009, J BIOL CHEM, V284, P15071, DOI 10.1074/jbc.M109.006742; Lam TKT, 2003, AM J PHYSIOL-ENDOC M, V284, pE281, DOI 10.1152/ajpendo.00332.2002; LANGE AJ, 1994, BIOCHEM BIOPH RES CO, V201, P302, DOI 10.1006/bbrc.1994.1702; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; LEMBERGER T, 1994, J BIOL CHEM, V269, P24527; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Massillon D, 1997, DIABETES, V46, P153, DOI 10.2337/diabetes.46.1.153; Massillon D, 2003, J BIOL CHEM, V278, P40694, DOI 10.1074/jbc.M303182200; Massillon D, 1996, J BIOL CHEM, V271, P9871, DOI 10.1074/jbc.271.17.9871; Memon RA, 2000, ENDOCRINOLOGY, V141, P4021, DOI 10.1210/en.141.11.4021; Metzger S, 1997, AM J PHYSIOL-ENDOC M, V273, pE262, DOI 10.1152/ajpendo.1997.273.2.E262; Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5; Mithieux G, 1997, EUR J ENDOCRINOL, V136, P137, DOI 10.1530/eje.0.1360137; Motojima K, 1998, J BIOL CHEM, V273, P16710, DOI 10.1074/jbc.273.27.16710; Oakes ND, 1997, DIABETES, V46, P1768, DOI 10.2337/diabetes.46.11.1768; Patsouris D, 2004, J CLIN INVEST, V114, P94, DOI 10.1172/JC1200420468; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Roe C. R., 1995, METABOLIC MOL BASES, P1501; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Schoonjans K, 1996, J LIPID RES, V37, P907; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Sugden MC, 2004, DIABETES, V53, pS71, DOI 10.2337/diabetes.53.2007.S71; Sugiyama T, 1998, MOL ENDOCRINOL, V12, P1487, DOI 10.1210/me.12.10.1487; Suh HN, 2008, AM J PHYSIOL-CELL PH, V295, pC1518, DOI 10.1152/ajpcell.00368.2008; Trinh KY, 1998, J BIOL CHEM, V273, P31615, DOI 10.1074/jbc.273.47.31615; Xu C, 2007, J NUTR, V137, P554, DOI 10.1093/jn/137.3.554; YANUKAKASHLES O, 1994, MOL CELL BIOL, V14, P7124, DOI 10.1128/MCB.14.11.7124; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	59	41	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1157	1164		10.1074/jbc.M110.157875	http://dx.doi.org/10.1074/jbc.M110.157875			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21081500	Green Published, hybrid			2022-12-25	WOS:000286005000026
J	Pelechano, V; Chavez, S; Perez-Ortin, JE				Pelechano, Vicent; Chavez, Sebastian; Perez-Ortin, Jose E.			A Complete Set of Nascent Transcription Rates for Yeast Genes	PLOS ONE			English	Article							RNA-POLYMERASE-II; POSTTRANSCRIPTIONAL CONTROL; INITIATION; ELONGATION; EXPRESSION; STABILITY; CHROMATIN; STRESS; NUMBER	The amount of mRNA in a cell is the result of two opposite reactions: transcription and mRNA degradation. These reactions are governed by kinetics laws, and the most regulated step for many genes is the transcription rate. The transcription rate, which is assumed to be exercised mainly at the RNA polymerase recruitment level, can be calculated using the RNA polymerase densities determined either by run-on or immunoprecipitation using specific antibodies. The yeast Saccharomyces cerevisiae is the ideal model organism to generate a complete set of nascent transcription rates that will prove useful for many gene regulation studies. By combining genomic data from both the GRO (Genomic Run-on) and the RNA pol ChIP-on-chip methods we generated a new, more accurate nascent transcription rate dataset. By comparing this dataset with the indirect ones obtained from the mRNA stabilities and mRNA amount datasets, we are able to obtain biological information about posttranscriptional regulation processes and a genomic snapshot of the location of the active transcriptional machinery. We have obtained nascent transcription rates for 4,670 yeast genes. The median RNA polymerase II density in the genes is 0.078 molecules/kb, which corresponds to an average of 0.096 molecules/gene. Most genes have transcription rates of between 2 and 30 mRNAs/hour and less than 1% of yeast genes have > 1 RNA polymerase molecule/gene. Histone and ribosomal protein genes are the highest transcribed groups of genes and other than these exceptions the transcription of genes is an infrequent phenomenon in a yeast cell.	[Pelechano, Vicent; Perez-Ortin, Jose E.] Univ Valencia, Fac Ciencias Biol, Dept Bioquim & Biol Mol, E-46100 Burjassot, Spain; [Chavez, Sebastian] Univ Seville, Fac Biol, Dept Genet, Seville, Spain	University of Valencia; University of Sevilla	Pelechano, V (corresponding author), EMBL, Heidelberg, Germany.	jose.e.perez@uv.es	Pérez-Ortín, José E./K-8582-2014; Pelechano, Vicent/ABF-2597-2020; Pelechano, Vicent/A-8431-2011; Chavez, Sebastian S/F-7574-2011; Chávez, Sebastián/GXF-7069-2022; IBIS, GENICA/O-1906-2015	Pérez-Ortín, José E./0000-0002-1992-513X; Pelechano, Vicent/0000-0002-9415-788X; Pelechano, Vicent/0000-0002-9415-788X; Chavez, Sebastian S/0000-0002-8064-4839; 	Generalitat Valenciana (Regional Valencian Government); Spanish Ministry of Science and Innovation; Spanish Ministry of Education and Science [BFU2007-67575-CO3-02/BMC, BFU2007-67575-CO3-01/BMC]; Regional Andalusian Government [P07-CVI02623]; Generalitat Valenciana [ACOMP/2009/368]	Generalitat Valenciana (Regional Valencian Government)(Center for Forestry Research & Experimentation (CIEF)); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Education and Science(Spanish Government); Regional Andalusian Government; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	VP was partially covered by a Formacion del Personal Investigador (F.P.I.) fellowship from the Generalitat Valenciana (Regional Valencian Government) and by an Especializacion en Organismos Internacionales (E.O.I.) fellowship from Spanish Ministry of Science and Innovation. This work was supported by grants from the Spanish Ministry of Education and Science BFU2007-67575-CO3-02/BMC to SC and BFU2007-67575-CO3-01/BMC to JEP-O; P07-CVI02623 from Regional Andalusian Government to SC and ACOMP/2009/368 from Generalitat Valenciana to JEP-O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bon M, 2006, FASEB J, V20, P1721, DOI 10.1096/fj.06-6087fje; Borggrefe T, 2001, J BIOL CHEM, V276, P47150, DOI 10.1074/jbc.M109581200; Carter DRF, 2008, BIOCHEM SOC T, V36, P585, DOI 10.1042/BST0360585; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; EDWARDS AM, 1991, J BIOL CHEM, V266, P71; Fan JS, 2002, P NATL ACAD SCI USA, V99, P10611, DOI 10.1073/pnas.162212399; French SL, 2003, MOL CELL BIOL, V23, P1558, DOI 10.1128/MCB.23.5.1558-1568.2003; Garcia-Martinez J, 2004, MOL CELL, V15, P303, DOI 10.1016/j.molcel.2004.06.004; Garcia-Martinez J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r222; GARCIAMARTINEZ J, 2010, YEAST GENET IN PRESS; Ginsburg DS, 2009, MOL CELL BIOL, V29, P6473, DOI 10.1128/MCB.01033-09; Grigull J, 2004, MOL CELL BIOL, V24, P5534, DOI 10.1128/MCB.24.12.5534-5547.2004; HEREFORD LM, 1977, CELL, V10, P453, DOI 10.1016/0092-8674(77)90032-0; Hirayoshi K, 1999, METHOD ENZYMOL, V304, P351; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Iyer V, 1996, P NATL ACAD SCI USA, V93, P5208, DOI 10.1073/pnas.93.11.5208; Jasiak AJ, 2008, J BIOL CHEM, V283, P26423, DOI 10.1074/jbc.M803237200; Koerber RT, 2009, MOL CELL, V35, P889, DOI 10.1016/j.molcel.2009.09.011; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Kulaeva OI, 2007, MUTAT RES-FUND MOL M, V618, P116, DOI 10.1016/j.mrfmmm.2006.05.040; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; LEWIN B, 2007, GENES, V9; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Lucchini R, 1998, TRANSCRIPTION RIBOSO, P255; Marin A, 2003, YEAST, V20, P703, DOI 10.1002/yea.992; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; Mata J, 2005, TRENDS BIOCHEM SCI, V30, P506, DOI 10.1016/j.tibs.2005.07.005; Miura F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-574; Molina-Navarro MM, 2008, J BIOL CHEM, V283, P17908, DOI 10.1074/jbc.M800295200; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Niemisto A, 2007, EURASIP J BIOINFORM, DOI 10.1155/2007/46150; Pelechano V, 2010, YEAST, V27, P413, DOI 10.1002/yea.1768; Pelechano V, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000614; Perez-Ortin JE, 2002, J BIOTECHNOL, V98, P227, DOI 10.1016/S0168-1656(02)00134-7; Perez-Ortin JE, 2007, TRENDS GENET, V23, P250, DOI 10.1016/j.tig.2007.03.006; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Rando OJ, 2009, ANNU REV BIOCHEM, V78, P245, DOI 10.1146/annurev.biochem.78.071107.134639; Rodriguez-Gil A, 2010, NUCLEIC ACIDS RES, V38, P4651, DOI 10.1093/nar/gkq215; Romero-Santacreu L, 2009, RNA, V15, P1110, DOI 10.1261/rna.1435709; Rosaleny LE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r119; Schwabish MA, 2004, MOL CELL BIOL, V24, P10111, DOI 10.1128/MCB.24.23.10111-10117.2004; Sigurdsson S, 2010, MOL CELL, V38, P202, DOI 10.1016/j.molcel.2010.02.026; Singh J, 2009, NAT STRUCT MOL BIOL, V16, P1128, DOI 10.1038/nsmb.1666; Sprouse RO, 2008, P NATL ACAD SCI USA, V105, P13304, DOI 10.1073/pnas.0801901105; Steinmetz EJ, 2006, MOL CELL, V24, P735, DOI 10.1016/j.molcel.2006.10.023; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; VAN BH, 2010, PLOS BIOL, V8; Venters BJ, 2009, GENOME RES, V19, P360, DOI 10.1101/gr.084970.108; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514	52	108	109	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e15442	10.1371/journal.pone.0015442	http://dx.doi.org/10.1371/journal.pone.0015442			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103382	Green Published, Green Submitted, gold			2022-12-25	WOS:000284257400023
J	Caillier, M; Thenot, S; Tribollet, V; Birot, AM; Samarut, J; Mey, A				Caillier, Maia; Thenot, Sandrine; Tribollet, Violaine; Birot, Anne-Marie; Samarut, Jacques; Mey, Anne			Role of the Epigenetic Regulator HP1 gamma in the Control of Embryonic Stem Cell Properties	PLOS ONE			English	Article							HETEROCHROMATIN PROTEIN-1 HP1; H3 LYSINE-9 METHYLATION; SELF-RENEWAL; IN-VIVO; RNAI SCREEN; ES CELLS; CHROMATIN; DIFFERENTIATION; PLURIPOTENCY; EXPRESSION	The unique properties of embryonic stem cells (ESC) rely on long-lasting self-renewal and their ability to switch in all adult cell type programs. Recent advances have shown that regulations at the chromatin level sustain both ESC properties along with transcription factors. We have focused our interest on the epigenetic modulator HP1 gamma (Heterochromatin Protein 1, isoform gamma) that binds histones H3 methylated at lysine 9 (meH3K9) and is highly plastic in its distribution and association with the transcriptional regulation of specific genes during cell fate transitions. These characteristics of HP1 gamma make it a good candidate to sustain the ESC flexibility required for rapid program changes during differentiation. Using RNA interference, we describe the functional role of HP1 gamma in mouse ESC. The analysis of HP1 gamma deprived cells in proliferative and in various differentiating conditions was performed combining functional assays with molecular approaches (RT-qPCR, microarray). We show that HP1 gamma deprivation slows down the cell cycle of ESC and decreases their resistance to differentiating conditions, rendering the cells poised to differentiate. In addition, HP1 gamma depletion hampers the differentiation to the endoderm as compared with the differentiation to the neurectoderm or the mesoderm. Altogether, our results reveal the role of HP1 gamma in ESC self-renewal and in the balance between the pluripotent and the differentiation programs.	[Caillier, Maia; Thenot, Sandrine; Tribollet, Violaine; Birot, Anne-Marie; Samarut, Jacques; Mey, Anne] Univ Lyon 1, Ecole Normale Super Lyon, CNRS,INRA, Inst Genom Fonct Lyon, F-69622 Villeurbanne, France	INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON)	Caillier, M (corresponding author), Univ Lyon 1, Ecole Normale Super Lyon, CNRS,INRA, Inst Genom Fonct Lyon, F-69622 Villeurbanne, France.	Jacques.Samarut@ens-lyon.fr; Anne.Mey@lyon.inra.fr	Samarut, Jacques/AAD-2587-2019	MEY, Anne/0000-0002-2643-5702	ANR (Agence Nationale por la Recherche) Genanimal [ANR-06-GANI-007-01]; INRA (Institut National pour la Recherche Agronomique); ABIES doctoral school; FRM (Fondation pour la Recherche Medicale)	ANR (Agence Nationale por la Recherche) Genanimal(French National Research Agency (ANR)); INRA (Institut National pour la Recherche Agronomique); ABIES doctoral school; FRM (Fondation pour la Recherche Medicale)(Fondation pour la Recherche Medicale)	This work was supported by a grant from the ANR (Agence Nationale por la Recherche) Genanimal (ANR-06-GANI-007-01). Maia Caillier was supported by a PhD fellowship from INRA (Institut National pour la Recherche Agronomique), the ABIES doctoral school and the FRM (Fondation pour la Recherche Medicale) PhD program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold SJ, 2000, MECH DEVELOP, V91, P249, DOI 10.1016/S0925-4773(99)00309-3; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bartova E, 2008, DIFFERENTIATION, V76, P24, DOI 10.1111/j.1432-0436.2007.00192.x; Blomen VA, 2007, CELL MOL LIFE SCI, V64, P3084, DOI 10.1007/s00018-007-7271-z; Cammas F, 2004, GENE DEV, V18, P2147, DOI 10.1101/gad.302904; Cammas F, 2007, DIFFERENTIATION, V75, P627, DOI 10.1111/j.1432-0436.2007.00166.x; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Dialynas GK, 2007, J CELL SCI, V120, P3415, DOI 10.1242/jcs.012914; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Francastel C, 2000, NAT REV MOL CELL BIO, V1, P137, DOI 10.1038/35040083; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Hediger F, 2006, CURR OPIN GENET DEV, V16, P143, DOI 10.1016/j.gde.2006.02.013; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Kourmouli N, 2005, BIOCHEM BIOPH RES CO, V337, P901, DOI 10.1016/j.bbrc.2005.09.132; Kwon SH, 2008, MOL CELLS, V26, P217; Lavigne M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000769; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Lomberk G, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-228; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Mateescu B, 2008, EMBO REP, V9, P267, DOI 10.1038/embor.2008.1; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; METEZEAU P., 1988, CYTOMETRIE FLUX ETUD; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Minc E, 2000, CYTOGENET CELL GENET, V90, P279, DOI 10.1159/000056789; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Negre D, 2000, GENE THER, V7, P1613, DOI 10.1038/sj.gt.3301292; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nielsen AL, 1999, EMBO J, V18, P6385, DOI 10.1093/emboj/18.22.6385; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; O'Shea KS, 2004, BIOL REPROD, V71, P1755, DOI 10.1095/biolreprod.104.028100; Obuse C, 2004, NAT CELL BIOL, V6, P1135, DOI 10.1038/ncb1187; Peters AHFM, 2002, NAT GENET, V30, P77, DOI 10.1038/ng789; SINGH PB, 1991, NUCLEIC ACIDS RES, V19, P789, DOI 10.1093/nar/19.4.789; Smallwood A, 2008, NAT STRUCT MOL BIOL, V15, P318, DOI 10.1038/nsmb.1385; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Takanashi M, 2009, AM J PATHOL, V174, P309, DOI 10.2353/ajpath.2009.080148; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Yeap LS, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-12; YEE JK, 1994, METHOD CELL BIOL, V43, P99; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	51	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e15507	10.1371/journal.pone.0015507	http://dx.doi.org/10.1371/journal.pone.0015507			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085495	Green Published, gold, Green Submitted			2022-12-25	WOS:000284231800039
J	Ling, KKY; Lin, MY; Zingg, B; Feng, ZH; Ko, CP				Ling, Karen K. Y.; Lin, Ming-Yi; Zingg, Brian; Feng, Zhihua; Ko, Chien-Ping			Synaptic Defects in the Spinal and Neuromuscular Circuitry in a Mouse Model of Spinal Muscular Atrophy	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURON DEGENERATION; WERDNIG-HOFFMANN DISEASE; ANTERIOR HORN; AXONAL NEUROPATHY; SENSORY NEURONS; END-PLATE; MOTONEURONS; PROTEIN; MICE	Spinal muscular atrophy (SMA) is a major genetic cause of death in childhood characterized by marked muscle weakness. To investigate mechanisms underlying motor impairment in SMA, we examined the spinal and neuromuscular circuitry governing hindlimb ambulatory behavior in SMA model mice (SMN Delta 7). In the neuromuscular circuitry, we found that nearly all neuromuscular junctions (NMJs) in hindlimb muscles of SMN Delta 7 mice remained fully innervated at the disease end stage and were capable of eliciting muscle contraction, despite a modest reduction in quantal content. In the spinal circuitry, we observed a similar to 28% loss of synapses onto spinal motoneurons in the lateral column of lumbar segments 3-5, and a significant reduction in proprioceptive sensory neurons, which may contribute to the 50% reduction in vesicular glutamate transporter 1(VGLUT1)-positive synapses onto SMN Delta 7 motoneurons. In addition, there was an increase in the association of activated microglia with SMN Delta 7 motoneurons. Together, our results present a novel concept that synaptic defects occur at multiple levels of the spinal and neuromuscular circuitry in SMN Delta 7 mice, and that proprioceptive spinal synapses could be a potential target for SMA therapy.	[Ling, Karen K. Y.; Lin, Ming-Yi; Zingg, Brian; Feng, Zhihua; Ko, Chien-Ping] Univ So Calif, Dept Biol Sci, Neurobiol Sect, Los Angeles, CA 90089 USA	University of Southern California	Ling, KKY (corresponding author), Univ So Calif, Dept Biol Sci, Neurobiol Sect, Los Angeles, CA 90089 USA.	cko@college.usc.edu	Ko, Chien-Ping/AAN-2314-2020		NIH [NS063296]; Muscular Dystrophy Association; Spinal Muscular Atrophy Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS063296] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Spinal Muscular Atrophy Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grant NS063296, Muscular Dystrophy Association, http://www.mdausa.org/ and Spinal Muscular Atrophy Foundation, http://www.smafoundation.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez FJ, 2010, ANN NY ACAD SCI, V1198, P231, DOI 10.1111/j.1749-6632.2010.05459.x; Anagnostou E, 2005, J CHILD NEUROL, V20, P147, DOI 10.1177/08830738050200022101; Bessis A, 2007, GLIA, V55, P233, DOI 10.1002/glia.20459; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Butchbach MER, 2007, NEUROBIOL DIS, V27, P207, DOI 10.1016/j.nbd.2007.04.009; Chang Q, 2009, AM J PATHOL, V174, P574, DOI 10.2353/ajpath.2009.080557; Chaudhry FA, 1998, J NEUROSCI, V18, P9733; CHEN DH, 1978, J COMP NEUROL, V177, P635, DOI 10.1002/cne.901770407; Cifuentes-Diaz C, 2002, HUM MOL GENET, V11, P1439, DOI 10.1093/hmg/11.12.1439; Crawford TO, 1996, NEUROBIOL DIS, V3, P97, DOI 10.1006/nbdi.1996.0010; CRUZ LJ, 1985, J BIOL CHEM, V260, P9280; DEL CASTILLO J, 1954, J Physiol, V123, P7; Dubowitz V, 1978, Major Probl Clin Pediatr, V16, piii; ELMQVIST D, 1965, J PHYSIOL-LONDON, V178, P505, DOI 10.1113/jphysiol.1965.sp007639; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Feng ZH, 2007, CURR OPIN PHARMACOL, V7, P316, DOI 10.1016/j.coph.2006.12.003; Foran E, 2009, ANTIOXID REDOX SIGN, V11, P1587, DOI 10.1089/ars.2009.2444; Friese A, 2009, P NATL ACAD SCI USA, V106, P13588, DOI 10.1073/pnas.0906809106; FYFFE REW, 2001, SPINAL MOTONEURONS S; Graeber MB, 2010, ACTA NEUROPATHOL, V119, P89, DOI 10.1007/s00401-009-0622-0; GRAEBER MB, 1993, ACTA NEUROPATHOL, V86, P179, DOI 10.1007/BF00334886; HARDING AE, 1983, J NEUROL SCI, V59, P69, DOI 10.1016/0022-510X(83)90082-5; HONDA CN, 1995, NEUROSCIENCE, V68, P883, DOI 10.1016/0306-4522(95)00180-Q; Ikemoto A, 2002, ACTA NEUROPATHOL, V103, P179, DOI 10.1007/s004010100449; Ikemoto A, 1996, J NEUROL SCI, V136, P94, DOI 10.1016/0022-510X(95)00297-F; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Jablonka S, 2006, HUM MOL GENET, V15, P511, DOI 10.1093/hmg/ddi467; Jiang MC, 2009, J NEUROSCI, V29, P15031, DOI 10.1523/JNEUROSCI.0574-09.2009; Juttner R, 2005, NEURON, V46, P233, DOI 10.1016/j.neuron.2005.02.027; Kang H, 2003, J NEUROCYTOL, V32, P975, DOI 10.1023/B:NEUR.0000020636.27222.2d; Kariya S, 2008, HUM MOL GENET, V17, P2552, DOI 10.1093/hmg/ddn156; KERNS JM, 1973, J COMP NEUROL, V151, P237, DOI 10.1002/cne.901510303; Kong LL, 2009, J NEUROSCI, V29, P842, DOI 10.1523/JNEUROSCI.4434-08.2009; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; LINDA H, 1992, J COMP NEUROL, V318, P188, DOI 10.1002/cne.903180205; McGovern VL, 2008, HUM MOL GENET, V17, P2900, DOI 10.1093/hmg/ddn189; MCLACHLAN EM, 1981, J PHYSIOL-LONDON, V311, P307, DOI 10.1113/jphysiol.1981.sp013586; MENDELL LM, 1971, J NEUROPHYSIOL, V34, P171, DOI 10.1152/jn.1971.34.1.171; Michaud M, 2010, NEUROBIOL DIS, V38, P125, DOI 10.1016/j.nbd.2010.01.006; Monani UR, 2005, NEURON, V48, P885, DOI 10.1016/j.neuron.2005.12.001; Murray LM, 2010, NEUROPATH APPL NEURO, V36, P133, DOI [10.1111/j.1365-2990.2009.01061.x, 10.1111/j.1365-2990.2010.01061.x]; Murray LM, 2008, HUM MOL GENET, V17, P949, DOI 10.1093/hmg/ddm367; Nagao M, 1998, J NEUROPATH EXP NEUR, V57, P329, DOI 10.1097/00005072-199804000-00004; NICOLOPOULOSSTOURNARAS S, 1983, J COMP NEUROL, V217, P75, DOI 10.1002/cne.902170107; Oliveira ALR, 2003, SYNAPSE, V50, P117, DOI 10.1002/syn.10249; Omran H, 1998, J CHILD NEUROL, V13, P327, DOI 10.1177/088307389801300704; Park GH, 2010, J NEUROSCI, V30, P12005, DOI 10.1523/JNEUROSCI.2208-10.2010; Park GH, 2010, CURR NEUROL NEUROSCI, V10, P108, DOI 10.1007/s11910-010-0095-5; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Renault F, 1983, Rev Electroencephalogr Neurophysiol Clin, V13, P301, DOI 10.1016/S0370-4475(83)80042-2; Rudnik-Schoneborn S, 2003, NEUROLOGY, V60, P983, DOI 10.1212/01.WNL.0000052788.39340.45; Ruiz R, 2010, J NEUROSCI, V30, P849, DOI 10.1523/JNEUROSCI.4496-09.2010; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; SASAKI S, 1994, ACTA NEUROPATHOL, V88, P222; Schutz B, 2005, NEUROBIOL DIS, V20, P131, DOI 10.1016/j.nbd.2005.02.006; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; SOLIVEN B, 1992, MUSCLE NERVE, V15, P656, DOI 10.1002/mus.880150604; SUMNER BEH, 1975, EXP NEUROL, V49, P406, DOI 10.1016/0014-4886(75)90097-7; Sumner CJ, 2007, J CHILD NEUROL, V22, P979, DOI 10.1177/0883073807305787; Trapp BD, 2007, GLIA, V55, P360, DOI 10.1002/glia.20462; VAUGHN JE, 1977, J COMP NEUROL, V175, P79, DOI 10.1002/cne.901750106; Wishart TM, 2006, J NEUROPATH EXP NEUR, V65, P733, DOI 10.1097/01.jnen.0000228202.35163.c4; Wood SJ, 2001, PROG NEUROBIOL, V64, P393, DOI 10.1016/S0301-0082(00)00055-1; Yamanouchi Y, 1996, PEDIATR NEUROL, V15, P32, DOI 10.1016/0887-8994(96)00123-3; Zang DW, 2005, J NEUROSCI RES, V79, P694, DOI 10.1002/jnr.20379; Zhang HM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011696; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	67	145	145	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e15457	10.1371/journal.pone.0015457	http://dx.doi.org/10.1371/journal.pone.0015457			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21085654	Green Published, Green Submitted, gold			2022-12-25	WOS:000284087800025
J	Lindhagen-Persson, M; Brannstrom, K; Vestling, M; Steinitz, M; Olofsson, A				Lindhagen-Persson, Malin; Brannstrom, Kristoffer; Vestling, Monika; Steinitz, Michael; Olofsson, Anders			Amyloid-beta Oligomer Specificity Mediated by the IgM Isotype - Implications for a Specific Protective Mechanism Exerted by Endogenous Auto-Antibodies	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; LONG-TERM POTENTIATION; ALZHEIMERS-DISEASE; A-BETA; PROTEIN-PRECURSOR; MOUSE MODEL; MONOCLONAL-ANTIBODIES; TRANSGENIC MICE; MEMORY LOSS; PEPTIDE	Background: Alzheimers disease (AD) has been strongly linked to an anomalous self-assembly of the amyloid-beta peptide (A beta). The correlation between clinical symptoms of AD and A beta depositions is, however, weak. Instead small and soluble A beta oligomers are suggested to exert the major pathological effects. In strong support of this notion, immunological targeting of A beta oligomers in AD mice-models shows that memory impairments can be restored without affecting the total burden of A beta deposits. Consequently a specific immunological targeting of A beta oligomers is of high therapeutic interest. Methodology/Principal Findings: Previously the generation of conformational-dependent oligomer specific anti-A beta antibodies has been described. However, to avoid the difficult task of identifying a molecular architecture only present on oligomers, we have focused on a more general approach based on the hypothesis that all oligomers expose multiple identical epitopes and therefore would have an increased binding to a multivalent receptor. Using the polyvalent IgM immunoglobulin we have developed a monoclonal anti-A beta antibody (OMAB). OMAB only demonstrates a weak interaction with A beta monomers and dimers having fast on and off-rate kinetics. However, as an effect of avidity, its interaction with A beta-oligomers results in a strong complex with an exceptionally slow off-rate. Through this mechanism a selectivity towards A beta oligomers is acquired and OMAB fully inhibits the cytotoxic effect exerted by A beta(1-42) at highly substoichiometric ratios. Anti-A beta auto-antibodies of IgM isotype are frequently present in the sera of humans. Through a screen of endogenous anti-A beta IgM auto-antibodies from a group of healthy individuals we show that all displays a preference for oligomeric A beta. Conclusions/Significance: Taken together we provide a simple and general mechanism for targeting of oligomers without the requirement of conformational-dependent epitopes. In addition, our results suggest that IgM anti-A beta auto-antibodies may exert a more specific protective mechanism in vivo than previously anticipated.	[Lindhagen-Persson, Malin; Brannstrom, Kristoffer; Vestling, Monika; Olofsson, Anders] Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden; [Steinitz, Michael] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Pathol, IL-91010 Jerusalem, Israel	Umea University; Hebrew University of Jerusalem	Lindhagen-Persson, M (corresponding author), Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden.	anders.olofsson@medchem.umu.se	Brännström, Kristoffer/AAC-1204-2020; Brännström, Kristoffer/D-3648-2009		Ernst and Lili Rosenhain fund, Bruxelles, Belgium; J. C. Kempe; Swedish research council; Socialstyrelsen; FAMY; Medical Faculty of Umea University	Ernst and Lili Rosenhain fund, Bruxelles, Belgium; J. C. Kempe; Swedish research council(Swedish Research CouncilEuropean Commission); Socialstyrelsen; FAMY; Medical Faculty of Umea University	This work was supported by Ernst and Lili Rosenhain fund, Bruxelles, Belgium, J. C. Kempe, the Swedish research council, Socialstyrelsen, FAMY and the Medical Faculty of Umea University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asami-Odaka A, 2005, NEURODEGENER DIS, V2, P36, DOI 10.1159/000086429; Banks WA, 2007, EXP NEUROL, V206, P248, DOI 10.1016/j.expneurol.2007.05.005; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Chauhan NB, 2003, J NEUROSCI RES, V74, P142, DOI 10.1002/jnr.10721; DaSilva KA, 2009, VACCINE, V27, P1365, DOI 10.1016/j.vaccine.2008.12.044; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; Dodel RC, 2004, J NEUROL NEUROSUR PS, V75, P1472, DOI 10.1136/jnnp.2003.033399; Dodel R, 2010, DRUGS, V70, P513, DOI 10.2165/11533070-000000000-00000; Geylis V, 2005, NEUROBIOL AGING, V26, P597, DOI 10.1016/j.neurobiolaging.2004.06.008; Giuffrida ML, 2009, J NEUROSCI, V29, P10582, DOI 10.1523/JNEUROSCI.1736-09.2009; Hartley DM, 2008, J BIOL CHEM, V283, P16790, DOI 10.1074/jbc.M802215200; Hasegawa K, 2002, BIOCHEMISTRY-US, V41, P13489, DOI 10.1021/bi020369w; Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; KATZMAN R, 1986, NEUROL CLIN, V4, P329, DOI 10.1016/S0733-8619(18)30972-1; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kim HJ, 2002, FASEB J, V16, P118, DOI 10.1096/fj.01-0987fje; Kotilinek LA, 2002, J NEUROSCI, V22, P6331; Kuo YM, 1996, J BIOL CHEM, V271, P4077; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Lambert MP, 2001, J NEUROCHEM, V79, P595, DOI 10.1046/j.1471-4159.2001.00592.x; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; MARCELLO A, 2009, NEUROBIOL AGING; Marcello A, 2009, J NEURAL TRANSM, V116, P913, DOI 10.1007/s00702-009-0224-y; Moechars D, 1999, J BIOL CHEM, V274, P6483, DOI 10.1074/jbc.274.10.6483; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Munch G, 2002, J NEURAL TRANSM, V109, P1081, DOI 10.1007/s007020200091; Myagkova MA, 2001, B EXP BIOL MED+, V131, P127, DOI 10.1023/A:1017527508878; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Nath A, 2003, NEUROMOL MED, V3, P29, DOI 10.1385/NMM:3:1:29; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; O'Nuallain B, 2008, BIOCHEMISTRY-US, V47, P12254, DOI 10.1021/bi801767k; Olofsson A, 2007, BIOCHEM J, V404, P63, DOI 10.1042/BJ20061561; Olofsson A, 2009, ANAL BIOCHEM, V385, P374, DOI 10.1016/j.ab.2008.10.034; ONUALLAIN B, J CLIN IMMUNOL S1, V30, pS37; PAUL S, J CLIN IMMUNOL S1, V30, pS43; Raby CA, 1998, J NEUROCHEM, V71, P2505; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; ROCH JM, 1994, P NATL ACAD SCI USA, V91, P7450, DOI 10.1073/pnas.91.16.7450; SAITOH T, 1989, CELL, V58, P615, DOI 10.1016/0092-8674(89)90096-2; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-48; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Sudol KL, 2009, MOL THER, V17, P2031, DOI 10.1038/mt.2009.174; Szabo P, 2008, AUTOIMMUN REV, V7, P415, DOI 10.1016/j.autrev.2008.03.007; Taguchi H, 2008, J BIOL CHEM, V283, P4714, DOI 10.1074/jbc.M707983200; Wang QW, 2004, J NEUROSCI, V24, P3370, DOI 10.1523/JNEUROSCI.1633-03.2004; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Wilcock DM, 2003, J NEUROSCI, V23, P3745, DOI 10.1523/jneurosci.23-09-03745.2003; Younkin SG, 2001, NAT MED, V7, P18, DOI 10.1038/83292	55	50	54	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e13928	10.1371/journal.pone.0013928	http://dx.doi.org/10.1371/journal.pone.0013928			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085663	Green Published, Green Submitted, gold			2022-12-25	WOS:000284036800019
J	Fossette, S; Girard, C; Lopez-Mendilaharsu, M; Miller, P; Domingo, A; Evans, D; Kelle, L; Plot, V; Prosdocimi, L; Verhage, S; Gaspar, P; Georges, JY				Fossette, Sabrina; Girard, Charlotte; Lopez-Mendilaharsu, Milagros; Miller, Philip; Domingo, Andres; Evans, Daniel; Kelle, Laurent; Plot, Virginie; Prosdocimi, Laura; Verhage, Sebastian; Gaspar, Philippe; Georges, Jean-Yves			Atlantic Leatherback Migratory Paths and Temporary Residence Areas	PLOS ONE			English	Article							TURTLES DERMOCHELYS-CORIACEA; SEA-TURTLES; FORAGING BEHAVIOR; MARINE PREDATOR; SATELLITE TRACKING; DIVING BEHAVIOR; THERMAL NICHE; GREEN TURTLES; MOVEMENTS; PREY	Background: Sea turtles are long-distance migrants with considerable behavioural plasticity in terms of migratory patterns, habitat use and foraging sites within and among populations. However, for the most widely migrating turtle, the leatherback turtle Dermochelys coriacea, studies combining data from individuals of different populations are uncommon. Such studies are however critical to better understand intra- and inter-population variability and take it into account in the implementation of conservation strategies of this critically endangered species. Here, we investigated the movements and diving behaviour of 16 Atlantic leatherback turtles from three different nesting sites and one foraging site during their post-breeding migration to assess the potential determinants of intra- and inter-population variability in migratory patterns. Methodology/Principal Findings: Using satellite-derived behavioural and oceanographic data, we show that turtles used Temporary Residence Areas (TRAs) distributed all around the Atlantic Ocean: 9 in the neritic domain and 13 in the oceanic domain. These TRAs did not share a common oceanographic determinant but on the contrary were associated with mesoscale surface oceanographic features of different types (i.e., altimetric features and/or surface chlorophyll a concentration). Conversely, turtles exhibited relatively similar horizontal and vertical behaviours when in TRAs (i.e., slow swimming velocity/sinuous path/shallow dives) suggesting foraging activity in these productive regions. Migratory paths and TRAs distribution showed interesting similarities with the trajectories of passive satellite-tracked drifters, suggesting that the general dispersion pattern of adults from the nesting sites may reflect the extent of passive dispersion initially experienced by hatchlings. Conclusions/Significance: Intra- and inter-population behavioural variability may therefore be linked with initial hatchling drift scenarios and be highly influenced by environmental conditions. This high degree of behavioural plasticity in Atlantic leatherback turtles makes species-targeted conservation strategies challenging and stresses the need for a larger dataset (>100 individuals) for providing general recommendations in terms of conservation.	[Fossette, Sabrina; Girard, Charlotte; Plot, Virginie; Georges, Jean-Yves] Univ Strasbourg, IPHC, Dept Ecol Physiol & Ethol, Strasbourg, France; [Fossette, Sabrina; Girard, Charlotte; Plot, Virginie; Georges, Jean-Yves] CNRS, UMR7178, Strasbourg, France; [Girard, Charlotte; Gaspar, Philippe] Collecte Localisat Satellites, Satellite Oceanog Div, Ramonville St Agne, France; [Lopez-Mendilaharsu, Milagros] Univ Estado Rio de Janeiro, Dept Ecol, BR-20550011 Rio De Janeiro, Brazil; [Lopez-Mendilaharsu, Milagros] Villa Dolores Zoo, Karumbe, Montevideo, Uruguay; [Miller, Philip] Ctr Invest & Conservac Marina, El Pinar, Canelones, Uruguay; [Domingo, Andres] Direcc Nacl Recursos Acuat, Montevideo, Uruguay; [Evans, Daniel] Sea Turtle Conservancy, Gainesville, FL USA; [Kelle, Laurent] WWF Guianas, Cayenne, French Guiana; [Prosdocimi, Laura] PRICTMA, Reg Program Sea Turtles Res & Conservat Argentina, Buenos Aires, DF, Argentina; [Verhage, Sebastian] WWF Gabon, Libreville, Gabon	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universidade do Estado do Rio de Janeiro; World Wildlife Fund; World Wildlife Fund	Fossette, S (corresponding author), Swansea Univ, Dept Pure & Appl Ecol, Swansea, W Glam, Wales.	sabrina.fossette@gmail.com	Prosdocimi, Laura LP/H-5988-2013	Prosdocimi, Laura LP/0000-0001-7565-9713; GEORGES, Jean Yves/0000-0003-1161-2275; Miller, Philip/0000-0003-4908-2716; Fossette, Sabrina/0000-0001-8580-9084	French Ministry of Research; French Spatial Agency (CNES); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Agence Nationale pour la Recherche (ANR); Convention on Migratory Species; CNRS for French Guiana; People Trust for Endangered Species for Uruguay; WWF	French Ministry of Research(Ministry of Research, FranceEuropean Commission); French Spatial Agency (CNES)(Centre National D'etudes Spatiales); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); Convention on Migratory Species; CNRS for French Guiana; People Trust for Endangered Species for Uruguay; WWF	S.F. was supported by a studentship from the French Ministry of Research. C.G. was supported by a postdoctoral grant from the French Spatial Agency (CNES). M.L.M. was supported by a grant from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). V.P. is supported by a studentship from the French Ministry of Research as part of the project MIRETTE (http://projetmirette.fr) funded by Agence Nationale pour la Recherche (ANR). Funding was provided by grants from the Convention on Migratory Species and the WWF as part of the Trans-Atlantic Leatherback Conservation Initiative (www.panda.org/atlantic_leatherbacks), from Programme Amazonie du CNRS for French Guiana and from People Trust for Endangered Species for Uruguay. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acha EM, 2008, CONT SHELF RES, V28, P1579, DOI 10.1016/j.csr.2007.01.031; Billes Alexis, 2006, Marine Turtle Newsletter, V111, P13; Bjorndal Karen A., 1997, P199; Bost CA, 2009, J MARINE SYST, V78, P363, DOI 10.1016/j.jmarsys.2008.11.022; Bowen WD, 2001, FUNCT ECOL, V15, P325, DOI 10.1046/j.1365-2435.2001.00530.x; Boyd IL, 1997, TRENDS ECOL EVOL, V12, P213, DOI 10.1016/S0169-5347(97)01054-9; Brandini FP, 2000, DEEP-SEA RES PT I, V47, P1015, DOI 10.1016/S0967-0637(99)00075-8; Broderick AC, 2007, P ROY SOC B-BIOL SCI, V274, P1533, DOI 10.1098/rspb.2007.0211; Cabreira AG, 2006, ICES J MAR SCI, V63, P1718, DOI 10.1016/j.icesjms.2006.04.026; Colombo GA, 2003, ICES J MAR SCI, V60, P650, DOI 10.1016/S1054-3139(03)00051-1; Cotte C, 2007, P R SOC B, V274, P2385, DOI 10.1098/rspb.2007.0775; Doyle Thomas K., 2008, Endangered Species Research, V4, P23, DOI 10.3354/esr00076; Doyle TK, 2007, HYDROBIOLOGIA, V579, P29, DOI 10.1007/s10750-006-0362-2; Eckert SA, 2006, CHELONIAN CONSERV BI, V5, P239, DOI 10.2744/1071-8443(2006)5[239:IAPMAF]2.0.CO;2; Eckert SA, 2006, MAR BIOL, V149, P1257, DOI 10.1007/s00227-006-0262-z; EVANS D, 2008, SATELLITE TRACKING L; Ferraroli S, 2004, NATURE, V429, P521, DOI 10.1038/429521a; Fossette Sabrina, 2008, Endangered Species Research, V4, P33, DOI 10.3354/esr00039; Fossette S, 2010, J MARINE SYST, V81, P225, DOI 10.1016/j.jmarsys.2009.12.002; Gaspar P, 2006, P ROY SOC B-BIOL SCI, V273, P2697, DOI 10.1098/rspb.2006.3623; Georges JY, 2000, ECOLOGY, V81, P295, DOI 10.2307/177427; Girard C, 2006, MAR ECOL PROG SER, V322, P281, DOI 10.3354/meps322281; Girard C, 2009, MAR BIOL, V156, P1827, DOI 10.1007/s00227-009-1216-z; Godley B. J., 2008, Endangered Species Research, V4, P3, DOI 10.3354/esr00060; Graham WM, 2001, HYDROBIOLOGIA, V451, P199, DOI 10.1023/A:1011876004427; Gremillet D, 2004, FUNCT ECOL, V18, P793, DOI 10.1111/j.0269-8463.2004.00914.x; Hamer KC, 2001, MAR ECOL PROG SER, V224, P283, DOI 10.3354/meps224283; Hays GC, 2000, ANIM BEHAV, V59, P577, DOI 10.1006/anbe.1999.1326; Hays GC, 2004, NATURE, V429, P522, DOI 10.1038/429522a; Hays GC, 2006, ECOLOGY, V87, P2647, DOI 10.1890/0012-9658(2006)87[2647:FFMOLT]2.0.CO;2; Hays GC, 2010, J R SOC INTERFACE, V7, P1319, DOI 10.1098/rsif.2010.0009; James MC, 2005, MAR BIOL, V147, P845, DOI 10.1007/s00227-005-1581-1; James MC, 2005, ECOL LETT, V8, P195, DOI 10.1111/j.1461-0248.2004.00710.x; James MC, 2005, P ROY SOC B-BIOL SCI, V272, P1547, DOI 10.1098/rspb.2005.3110; James MC, 2006, J EXP MAR BIOL ECOL, V335, P221, DOI 10.1016/j.jembe.2006.03.013; Jonsen ID, 2007, MAR ECOL PROG SER, V337, P255, DOI 10.3354/meps337255; Laidre KL, 2003, MAR ECOL PROG SER, V261, P269, DOI 10.3354/meps261269; Lopez-Mendilaharsu M, 2009, J EXP MAR BIOL ECOL, V378, P31, DOI 10.1016/j.jembe.2009.07.010; Luschi P, 2006, S AFR J SCI, V102, P51; McMahon CR, 2006, GLOBAL CHANGE BIOL, V12, P1330, DOI 10.1111/j.1365-2486.2006.01174.x; Mianzan H, 2001, ECOL STU AN, V144, P185; MITTELSTAEDT E, 1991, PROG OCEANOGR, V26, P307, DOI 10.1016/0079-6611(91)90011-A; Monzon-Arguello C, 2010, J BIOGEOGR, V37, P1752, DOI 10.1111/j.1365-2699.2010.02326.x; O'Donoghue M, 1998, OIKOS, V82, P169, DOI 10.2307/3546927; Olson D., 1994, OCEANOGRAPHY, V7, P52, DOI DOI 10.5670/OCEANOG.1994.03; Paiva VH, 2010, MAR ECOL PROG SER, V398, P259, DOI 10.3354/meps08319; Pichegru L, 2009, MAR ECOL PROG SER, V391, P199, DOI 10.3354/meps08283; Pichegru L., 2010, BIOL LETT; Pichegru L, 2007, MAR ECOL PROG SER, V350, P127, DOI 10.3354/meps07128; Sale A, 2006, J EXP MAR BIOL ECOL, V328, P197, DOI 10.1016/j.jembe.2005.07.006; Schofield G, 2007, J EXP MAR BIOL ECOL, V347, P58, DOI 10.1016/j.jembe.2007.03.009; Shillinger GL, 2008, PLOS BIOL, V6, P1408, DOI 10.1371/journal.pbio.0060171; Sims DW, 2006, P ROY SOC B-BIOL SCI, V273, P1195, DOI 10.1098/rspb.2005.3444; Sims DW, 1998, NATURE, V393, P460, DOI 10.1038/30959; Tremblay Y, 2003, MAR ECOL PROG SER, V251, P279, DOI 10.3354/meps251279; Tremblay Y, 2007, J EXP BIOL, V210, P935, DOI 10.1242/jeb.02710; Votier SC, 2004, NATURE, V427, P727, DOI 10.1038/nature02315; Weimerskirch H, 2007, AM NAT, V170, P734, DOI 10.1086/522059; Weimerskirch H, 2007, DEEP-SEA RES PT II, V54, P211, DOI 10.1016/j.dsr2.2006.11.013; Witt MJ, 2007, MAR ECOL PROG SER, V337, P231, DOI 10.3354/meps337231; Zavala-Hidalgo J, 2006, OCEAN DYNAM, V56, P333, DOI 10.1007/s10236-006-0072-3	61	40	43	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e13908	10.1371/journal.pone.0013908	http://dx.doi.org/10.1371/journal.pone.0013908			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085472	Green Published, Green Submitted, gold			2022-12-25	WOS:000284035900015
J	Xu, MZ; Chan, SW; Liu, AM; Wong, KF; Fan, ST; Chen, J; Poon, RT; Zender, L; Lowe, SW; Hong, W; Luk, JM				Xu, M. Z.; Chan, S. W.; Liu, A. M.; Wong, K. F.; Fan, S. T.; Chen, J.; Poon, R. T.; Zender, L.; Lowe, S. W.; Hong, W.; Luk, J. M.			AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma	ONCOGENE			English	Article						cancer signaling; Hippo pathway; YAP1 oncogene; AXL receptor kinase; HCC; hepatocellular carcinoma	HIPPO SIGNALING PATHWAY; CELL CONTACT INHIBITION; YES-ASSOCIATED PROTEIN; ORGAN SIZE CONTROL; NF-KAPPA-B; LIVER-CANCER; TYROSINE KINASES; GROWTH-CONTROL; TUMOR-GROWTH; EXPRESSION	Yes-associated protein (YAP) is a downstream effector of the Hippo signaling pathway, which controls organ expansion and tissue development. We have recently defined the tumorigenic potential and clinical significance of the YAP1 oncogene in human hepatocellular carcinoma (HCC). The present study aims to define the tumorigenic properties of YAP in HCC and elucidate the related downstream signaling mechanism. In a gain-of-function study, we demonstrated that ectopic increased expression of YAP in the immortalized non-tumorigenic hepatocyte cell line MIHA confers tumorigenic and metastatic potentials, as evidenced by (1) enhanced aptitudes in cell viability, anchorage-independent growth, migration and invasion; (2) tumor formation in a xenograft mouse model; and (3) induction of HCC biomarker alpha-fetoprotein and activation of mitogen-activated protein kinase. Furthermore, we have identified AXL, a receptor tyrosine kinase, as a key downstream target that drives YAP-dependent oncogenic functions. RNAi-mediated knockdown of AXL expression decreased the ability of YAP-expressing MIHA cells and of the primary HCC cell line to proliferate and invade. These results indicate that AXL is a mediator of YAP-dependent oncogenic activities and implicates it as a potential therapeutic target for HCC. Oncogene (2011) 30, 1229-1240; doi: 10.1038/onc.2010.504; published online 15 November 2010	[Xu, M. Z.; Chen, J.; Luk, J. M.] Nanjing Med Univ, Dept Oncol, Affiliated Nanjing Hosp 1, Nanjing, Peoples R China; [Xu, M. Z.; Liu, A. M.; Wong, K. F.; Fan, S. T.; Poon, R. T.; Luk, J. M.] Univ Hong Kong, Dept Surg, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China; [Chan, S. W.; Hong, W.] ASTAR, Canc & Dev Cell Biol Div, Inst Mol & Cell Biol, Singapore, Singapore; [Liu, A. M.; Wong, K. F.; Luk, J. M.] Natl Univ Singapore, Canc Sci Inst, Singapore 117597, Singapore; [Zender, L.] Helmholtz Ctr Infect Res, Dept Cell Biol, Braunschweig, Germany; [Lowe, S. W.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; [Lowe, S. W.] Cold Spring Harbor Lab, CSHL Canc Ctr, Cold Spring Harbor, NY 11724 USA	Nanjing Medical University; University of Hong Kong; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; Helmholtz Association; Helmholtz-Center for Infection Research; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Cold Spring Harbor Laboratory	Luk, JM (corresponding author), Natl Univ Singapore, Dept Pharmacol, Clin Res Ctr MD11 05 30B, Dept Surg, 10 Med Dr, Singapore 117597, Singapore.	jmluk@nus.edu.sg	HONG, Wanjin/E-9927-2010; Luk, John/A-4085-2008	Luk, John/0000-0002-6323-7940	Biomedical Research Grants Council of Singapore; National University Cancer Institute (NCIS) Centre; National Natural Science Foundation of China [81000880]; National Cancer Institute of NIH [CA13106]; A*STAR; NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER	Biomedical Research Grants Council of Singapore; National University Cancer Institute (NCIS) Centre; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Cancer Institute of NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); A*STAR(Agency for Science Technology & Research (A*STAR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Sources of support: The work was supported by grants to JML from the Biomedical Research Grants Council of Singapore and by the National University Cancer Institute (NCIS) Centre Grant; WH was supported by the A*STAR and MX by the National Natural Science Foundation of China (Grant No. 81000880). SWL is an investigator in the Howard Hughes Medical Institute and Dr Lowe's work is supported by a program grant (CA13106) from the National Cancer Institute of NIH.	Bandura JL, 2008, DEV CELL, V14, P315, DOI 10.1016/j.devcel.2008.02.010; Berclaz G, 2001, ANN ONCOL, V12, P819, DOI 10.1023/A:1011126330233; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Bueno L, 2008, EUR J CANCER, V44, P142, DOI 10.1016/j.ejca.2007.10.008; Buttitta LA, 2007, NAT CELL BIOL, V9, P1225, DOI 10.1038/ncb1107-1225; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Cao XW, 2008, GENE DEV, V22, P3320, DOI 10.1101/gad.1726608; Chan SW, 2009, J BIOL CHEM, V284, P14347, DOI 10.1074/jbc.M901568200; CRAVEN RJ, 1995, INT J CANCER, V60, P791, DOI 10.1002/ijc.2910600611; Demarchi F, 2001, J BIOL CHEM, V276, P31738, DOI 10.1074/jbc.M104457200; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Edgar BA, 2006, CELL, V124, P267, DOI 10.1016/j.cell.2006.01.005; Goruppi S, 1996, ONCOGENE, V12, P471; Hafizi S, 2006, CYTOKINE GROWTH F R, V17, P295, DOI 10.1016/j.cytogfr.2006.04.004; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Hasanbasic I, 2004, AM J PHYSIOL-HEART C, V287, pH1207, DOI 10.1152/ajpheart.00020.2004; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Lay JD, 2007, CANCER RES, V67, P3878, DOI 10.1158/0008-5472.CAN-06-3191; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Liu AM, 2010, EXPERT OPIN THER TAR, V14, P855, DOI 10.1517/14728222.2010.499361; Liu LX, 2009, HEPATOLOGY, V50, P1453, DOI 10.1002/hep.23143; Luk JM, 2005, J IMMUNOL METHODS, V305, P39, DOI 10.1016/j.jim.2005.07.006; Oh H, 2010, TRENDS CELL BIOL, V20, P410, DOI 10.1016/j.tcb.2010.04.005; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Peeper D, 2006, CELL, V125, P1230, DOI 10.1016/j.cell.2006.06.018; Sainaghi PP, 2005, J CELL PHYSIOL, V204, P36, DOI 10.1002/jcp.20265; Sawabu T, 2007, MOL CARCINOGEN, V46, P155, DOI 10.1002/mc.20211; Shieh YS, 2005, NEOPLASIA, V7, P1058, DOI 10.1593/neo.05640; Steinhardt AA, 2008, HUM PATHOL, V39, P1582, DOI 10.1016/j.humpath.2008.04.012; Tai KY, 2008, ONCOGENE, V27, P4044, DOI 10.1038/onc.2008.57; Thompson BJ, 2006, CELL, V126, P767, DOI 10.1016/j.cell.2006.07.013; Tsou AP, 1998, GENOMICS, V50, P331, DOI 10.1006/geno.1998.5338; Wong BW, 2003, BIOCHEM BIOPH RES CO, V311, P618, DOI 10.1016/j.bbrc.2003.10.032; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; Xu MZ, 2009, CANCER-AM CANCER SOC, V115, P4576, DOI 10.1002/cncr.24495; YIN F, 2007, SCI STKE, pPE12, DOI DOI 10.1126/STKE.3802007PE12; Zender L, 2008, CURR OPIN ONCOL, V20, P72, DOI 10.1097/CCO.0b013e3282f31d5d; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Zhang YX, 2008, CANCER RES, V68, P1905, DOI 10.1158/0008-5472.CAN-07-2661; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001	46	162	166	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2011	30	10					1229	1240		10.1038/onc.2010.504	http://dx.doi.org/10.1038/onc.2010.504			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	732QD	21076472	Green Accepted			2022-12-25	WOS:000288202400009
J	Adebiyi, A; Narayanan, D; Jaggar, JH				Adebiyi, Adebowale; Narayanan, Damodaran; Jaggar, Jonathan H.			Caveolin-1 Assembles Type 1 Inositol 1,4,5-Trisphosphate Receptors and Canonical Transient Receptor Potential 3 Channels into a Functional Signaling Complex in Arterial Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBRAL-ARTERIES; CHOLESTEROL DEPLETION; ENDOTHELIAL-CELLS; PLASMA-MEMBRANE; SKELETAL-MUSCLE; CA2+ RELEASE; CONTRACTION; ACTIVATION; PROTEINS; MICE	Physical coupling of sarcoplasmic reticulum (SR) type 1 inositol 1,4,5-trisphosphate receptors (IP(3)R1) to plasma membrane canonical transient receptor potential 3 (TRPC3) channels activates a cation current (I-Cat) in arterial smooth muscle cells that induces vasoconstriction. However, structural components that enable IP(3)R1 and TRPC3 channels to communicate locally are unclear. Caveolae are plasma membrane microdomains that can compartmentalize proteins. Here, we tested the hypothesis that caveolae and specifically caveolin-1 (cav-1), a caveolae scaffolding protein, facilitate functional IP(3)R1 to TRPC3 coupling in smooth muscle cells of resistance-size cerebral arteries. Methyl-beta-cyclodextrin (M beta CD), which disassembles caveolae, reduced IP3-induced I-Cat activation in smooth muscle cells and vasoconstriction in pressurized arteries. Cholesterol replenishment reversed these effects. Cav-1 knockdown using shRNA attenuated IP3-induced vasoconstriction, but did not alter TRPC3 and IP(3)R1 expression. A synthetic peptide corresponding to the cav-1 scaffolding domain (CSD) sequence (amino acids 82-101) also attenuated IP3-induced I-Cat activation and vasoconstriction. A cav-1 antibody co-immunoprecipitated cav-1, TRPC3, and IP(3)R1 from cerebral artery lysate. ImmunoFRET indicated that cav-1, TRPC3 channels and IP(3)R1 are spatially co-localized in arterial smooth muscle cells. IP(3)R1 and TRPC3 channel spatial localization was disrupted by M beta CD and a CSD peptide. Cholesterol replenishment re-established IP(3)R1 and TRPC3 channel close spatial proximity. Taken together, these data indicate that in arterial smooth muscle cells, cav-1 co-localizes SR IP(3)R1 and plasma membrane TRPC3 channels in close spatial proximity thereby enabling IP3-induced physical coupling of these proteins, leading to I-Cat generation and vasoconstriction.	[Adebiyi, Adebowale; Narayanan, Damodaran; Jaggar, Jonathan H.] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Jaggar, JH (corresponding author), 894 Union Ave, Memphis, TN 38163 USA.	jjaggar@uthsc.edu		Adebiyi, Adebowale/0000-0002-7033-1871	National Institutes of Health [R01 HL67061, HL094378, K01 HL096411]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094378, K01HL096411, R01HL067061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health NHLBI Grants R01 HL67061 and HL094378 (to J. H. J.), and K01 HL096411 (to A. A.).	Adebiyi A, 2008, MOL PHARMACOL, V74, P736, DOI 10.1124/mol.108.048165; Adebiyi A, 2007, AM J PHYSIOL-HEART C, V292, pH1584, DOI 10.1152/ajpheart.00584.2006; Adebiyi A, 2010, CIRC RES, V106, P1603, DOI 10.1161/CIRCRESAHA.110.216804; Albert AP, 2007, J PHYSIOL-LONDON, V583, P25, DOI 10.1113/jphysiol.2007.137802; Albert AP, 2009, CURR MED CHEM, V16, P1158, DOI 10.2174/092986709787581815; Ambudkar Indu S, 2004, Novartis Found Symp, V258, P63; Bergdahl A, 2005, AM J PHYSIOL-CELL PH, V288, pC872, DOI 10.1152/ajpcell.00334.2004; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BLONDEL O, 1993, J BIOL CHEM, V268, P11356; Bray D, 1998, ANNU REV BIOPH BIOM, V27, P59, DOI 10.1146/annurev.biophys.27.1.59; Cheng XY, 2006, AM J PHYSIOL-HEART C, V290, pH2309, DOI 10.1152/ajpheart.01226.2005; Christian AE, 1997, J LIPID RES, V38, P2264; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Dreja K, 2002, ARTERIOSCL THROM VAS, V22, P1267, DOI 10.1161/01.ATV.0000023438.32585.A1; Dubroca C, 2007, CARDIOVASC RES, V73, P190, DOI 10.1016/j.cardiores.2006.10.020; Flemming R, 2002, J PHYSIOL-LONDON, V543, P455, DOI 10.1113/jphysiol.2002.023366; Hotta S, 2007, J PHARMACOL SCI, V103, P121, DOI 10.1254/jphs.SC0060213; Jaggar JH, 2001, AM J PHYSIOL-CELL PH, V281, pC439, DOI 10.1152/ajpcell.2001.281.2.C439; Je HD, 2004, AM J PHYSIOL-HEART C, V286, pH91, DOI 10.1152/ajpheart.00472.2003; Kim JY, 2006, J BIOL CHEM, V281, P32540, DOI 10.1074/jbc.M602496200; Kwiatek AM, 2006, MOL PHARMACOL, V70, P1174, DOI 10.1124/mol.105.021741; Launikonis BS, 2001, J PHYSIOL-LONDON, V534, P71, DOI 10.1111/j.1469-7793.2001.00071.x; LESH RE, 1995, CIRC RES, V77, P220, DOI 10.1161/01.RES.77.2.220; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; Liu M, 2005, J PHYSIOL-LONDON, V566, P161, DOI 10.1113/jphysiol.2005.088260; Lohn M, 2000, CIRC RES, V87, P1034, DOI 10.1161/01.RES.87.11.1034; MORGAN JP, 1984, PFLUG ARCH EUR J PHY, V400, P338, DOI 10.1007/BF00581571; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Patel HH, 2007, FASEB J, V21, P2970, DOI 10.1096/fj.07-8424com; Potocnik SJ, 2007, J VASC RES, V44, P292, DOI 10.1159/000101451; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Razani B, 2001, J BIOL CHEM, V276, P38121; ROSS CA, 1992, P NATL ACAD SCI USA, V89, P4265, DOI 10.1073/pnas.89.10.4265; Sanders KM, 2001, J APPL PHYSIOL, V91, P1438, DOI 10.1152/jappl.2001.91.3.1438; Shaw L, 2006, CARDIOVASC RES, V69, P825, DOI 10.1016/j.cardiores.2005.12.016; Shmygol A, 2007, J PHYSIOL-LONDON, V581, P445, DOI 10.1113/jphysiol.2007.129452; Sundivakkam PC, 2009, AM J PHYSIOL-CELL PH, V296, pC403, DOI 10.1152/ajpcell.00470.2008; Xi Q, 2008, CIRC RES, V102, P1118, DOI 10.1161/CIRCRESAHA.108.173948; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Zhao GL, 2008, AM J PHYSIOL-CELL PH, V295, pC1376, DOI 10.1152/ajpcell.00362.2008; Zhao YY, 2002, P NATL ACAD SCI USA, V99, P11375, DOI 10.1073/pnas.172360799	41	62	67	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4341	4348		10.1074/jbc.M110.179747	http://dx.doi.org/10.1074/jbc.M110.179747			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21098487	Green Published, hybrid			2022-12-25	WOS:000286975700033
J	Guth, E; Thommen, M; Weber-Ban, E				Guth, Ethan; Thommen, Michael; Weber-Ban, Eilika			Mycobacterial Ubiquitin-like Protein Ligase PafA Follows a Two-step Reaction Pathway with a Phosphorylated Pup Intermediate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI GLUTAMINE-SYNTHETASE; GAMMA-GLUTAMYLCYSTEINE SYNTHETASE; IN-VIVO; TUBERCULOSIS; PROTEASOME; PHOSPHATE; MECHANISM; SITE; MICE	In Mycobacterium tuberculosis, the enzyme PafA is responsible for the activation and conjugation of the proteasome-targeting molecule Pup to protein substrates. As the proteasomal pathway has been shown to be vital to the persistence of M. tuberculosis, understanding the reaction mechanism of PafA is critical to the design of antituberculous agents. In this study, we have developed novel techniques to study the activity of PafA and have characterized fundamental features of the reaction mechanism. We show that PafA catalyzes a two-step reaction mechanism proceeding through a gamma-glutamyl phosphate-mixed anhydride intermediate that is formed on the C-terminal glutamate of Pup before transfer of Pup to the substrate acceptor lysine. SDS-PAGE analysis of formation of the phosphorylated intermediate revealed that the rate of Pup activation matched the maximal steady-state rate of product formation in the overall reaction and suggested that Pup activation was rate-limiting when all substrates were present at saturating concentrations. Following activation, both ADP and the phosphorylated intermediate remained associated with the enzyme awaiting nucleophilic attack by a lysine residue of the target protein. The PafA reaction mechanism appeared to be noticeably biased toward the stable activation of Pup in the absence of additional substrate and required very low concentrations of ATP and Pup relative to other carboxylate-amine/ammonia ligase family members. The bona fide nucleophilic substrate PanB showed a 3 orders of magnitude stronger affinity than free lysine, promoting Pup conjugation to occur close to the rate limit of activation with physiologically relevant concentrations of substrate.	[Guth, Ethan; Thommen, Michael; Weber-Ban, Eilika] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Weber-Ban, E (corresponding author), ETH, Inst Mol Biol & Biophys, Schafmattstr 20, CH-8093 Zurich, Switzerland.	eilika@mol.biol.ethz.ch		Thommen, Michael/0000-0001-5760-0697; Weber-Ban, Eilika/0000-0002-5773-9274	Swiss National Science Foundation; ETH; National Center for Excellence in Research Structural Biology Program of the Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH(ETH Zurich); National Center for Excellence in Research Structural Biology Program of the Swiss National Science Foundation	This work was supported by the Swiss National Science Foundation, the National Center for Excellence in Research Structural Biology Program of the Swiss National Science Foundation, an ETH research grant, and an ETH postdoctoral fellowship (to E. G.).	Abell LM, 1995, BIOCHEMISTRY-US, V34, P16695, DOI 10.1021/bi00051a018; ALIBHAI M, 1994, BIOCHEMISTRY-US, V33, P682, DOI 10.1021/bi00169a008; ARMSTRONG JA, 1975, J EXP MED, V142, P1, DOI 10.1084/jem.142.1.1; ATKINSON DE, 1968, BIOCHEMISTRY-US, V7, P4030, DOI 10.1021/bi00851a033; Burns KE, 2010, J BACTERIOL, V192, P2933, DOI 10.1128/JB.01639-09; Burns KE, 2009, J BIOL CHEM, V284, P3069, DOI 10.1074/jbc.M808032200; Cerda-Maira FA, 2010, MOL MICROBIOL, V77, P1123, DOI 10.1111/j.1365-2958.2010.07276.x; CLARK DD, 1985, BIOCHEMISTRY-US, V24, P5147, DOI 10.1021/bi00340a029; Clemente MT, 1999, EUR J BIOCHEM, V264, P453, DOI 10.1046/j.1432-1327.1999.00636.x; Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176; Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0; Feng L, 2005, J BIOL CHEM, V280, P8150, DOI 10.1074/jbc.M411098200; Gandotra S, 2007, NAT MED, V13, P1515, DOI 10.1038/nm1683; Gandotra S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001040; HILDEBRAND JG, 1969, J BIOL CHEM, V244, P2606; Horiuchi KY, 2001, BIOCHEMISTRY-US, V40, P6450, DOI 10.1021/bi002599l; Imkamp F, 2010, MOL MICROBIOL, V75, P744, DOI 10.1111/j.1365-2958.2009.07013.x; Iyer LM, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-45; Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558; KRISHNASWAMY R, 1960, J BIOL CHEM, V235, pPC39; Li ZM, 1998, J INFECT DIS, V177, P1030, DOI 10.1086/515254; LIAW SH, 1994, BIOCHEMISTRY-US, V33, P675, DOI 10.1021/bi00169a007; Lin G, 2009, NATURE, V461, P621, DOI 10.1038/nature08357; MEEK TD, 1980, BIOCHEMISTRY-US, V19, P5513, DOI 10.1021/bi00565a008; MEEK TD, 1982, BIOCHEMISTRY-US, V21, P2158, DOI 10.1021/bi00538a027; MIDELFORT CF, 1976, J BIOL CHEM, V251, P5881; NISHIMURA JS, 1964, J BIOL CHEM, V239, P2553; NISHIMURA JS, 1963, J BIOL CHEM, V238, P1179; ORLOWSKI M, 1971, J BIOL CHEM, V246, P7095; Pearce MJ, 2008, SCIENCE, V322, P1104, DOI 10.1126/science.1163885; Pieters J, 2008, CELL HOST MICROBE, V3, P399, DOI 10.1016/j.chom.2008.05.006; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; SEKURA R, 1977, J BIOL CHEM, V252, P2606; SEKURA R, 1977, J BIOL CHEM, V252, P2599; Striebel F, 2010, EMBO J, V29, P1262, DOI 10.1038/emboj.2010.23; Striebel F, 2009, NAT STRUCT MOL BIOL, V16, P647, DOI 10.1038/nsmb.1597; Sutter M, 2010, J AM CHEM SOC, V132, P5610, DOI 10.1021/ja910546x; WILCOX M, 1969, EUR J BIOCHEM, V11, P405, DOI 10.1111/j.1432-1033.1969.tb00788.x	38	68	70	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4412	4419		10.1074/jbc.M110.189282	http://dx.doi.org/10.1074/jbc.M110.189282			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21081505	Green Published, hybrid			2022-12-25	WOS:000286975700041
J	Duan, L; Motchoulski, N; Danzer, B; Davidovich, I; Shariat-Madar, Z; Levenson, VV				Duan, Lei; Motchoulski, Natalia; Danzer, Brian; Davidovich, Irina; Shariat-Madar, Zia; Levenson, Victor V.			Prolylcarboxypeptidase Regulates Proliferation, Autophagy, and Resistance to 4-Hydroxytamoxifen-induced Cytotoxicity in Estrogen Receptor-positive Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIESTROGEN RESISTANCE; ENDOCRINE THERAPY; PROLYL OLIGOPEPTIDASE; PROTEIN-KINASE; TAMOXIFEN; DEATH; MACROAUTOPHAGY; INHIBITION; MECHANISMS; SENSITIVITY	Endocrine therapy with tamoxifen (TAM) significantly improves outcomes for patients with estrogen receptor-positive breast cancer. However, intrinsic (de novo) or acquired resistance to TAM occurs in a significant proportion of treated patients. To identify genes involved in resistance to TAM, we introduced full-length cDNA expression library into estrogen receptor-positive MCF7 cells and exposed them to a cytotoxic dose of 4-hydroxytamoxifen (4OHTAM). Four different library inserts were isolated from surviving clones. Re-introduction of the genes individually into naive MCF7 cells made them resistant to 4OHTAM. Cells overexpressing these genes had an increase in acidic autophagic vacuoles induced by 4OHTAM, suggesting their role in autophagy. One of them, prolylcarboxypeptidase (PRCP), was investigated further. Overexpression of PRCP increased cell proliferation, boosted several established markers of autophagy, including expression of LC3-2, sequestration of monodansylcadaverine, and proteolysis of BSA in an ER-alpha dependent manner, and increased resistance to 4OHTAM. Conversely, knockdown of endogenous PRCP in MCF7 cells increased cell sensitivity to 4OHTAM and at the same time decreased cell proliferation and expression of LC3-2, sequestration of monodansylcadaverine, and proteolysis of BSA. Inhibition of enzymatic activity of PRCP enhanced 4OHTAM-induced cytotoxicity in MCF7 cells. Cells with acquired resistance to 4OHTAM exhibited increased PRCP activity, although inhibition of PRCP prevented development of 4OHTAM resistance in parental MCF7 cells and restored response to 4OHTAM in MCF7 cells with acquired resistance to 4OHTAM. Thus, we have for the first time identified PRCP as a resistance factor for 4OHTAM resistance in estrogen receptor-positive breast cancer cells.	[Duan, Lei; Danzer, Brian; Levenson, Victor V.] Rush Univ, Med Ctr, Dept Radiat Oncol, Chicago, IL 60612 USA; [Motchoulski, Natalia; Davidovich, Irina] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Shariat-Madar, Zia] Univ Mississippi, Dept Pharmacol, University, MS 38677 USA	Rush University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; University of Mississippi	Levenson, VV (corresponding author), Rush Univ, Med Ctr, Dept Radiat Oncol, 1750 W Harrison St, Chicago, IL 60612 USA.	victor_levenson@rush.edu			NCRR [P20RR021929]; Susan G. Komen Breast Cancer Foundation [BCTR 0100916, BCTR 0504311]; Department of Defense [W81XWH-07-1-0505]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104932] Funding Source: NIH RePORTER	NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Department of Defense(United States Department of Defense); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P20RR021929 from NCRR (to Z. S.-M.). This work was also supported by Susan G. Komen Breast Cancer Foundation Grants BCTR 0100916 and BCTR 0504311 (to V. V. L.) and Department of Defense Grant W81XWH-07-1-0505 (to V. V. L.).	Adamo V, 2007, ANN ONCOL, V18, P53, DOI 10.1093/annonc/mdm225; ARAFAH BM, 1986, CANCER RES, V46, P3268; Arpino G, 2009, ONCOLOGY-BASEL, V77, P23, DOI 10.1159/000258493; Azad MB, 2009, ANTIOXID REDOX SIGN, V11, P777, DOI [10.1089/ars.2008.2270, 10.1089/ARS.2008.2270]; Brodie A, 2010, J STEROID BIOCHEM, V118, P283, DOI 10.1016/j.jsbmb.2009.09.004; Bursch W, 2000, ANN NY ACAD SCI, V926, P1, DOI 10.1111/j.1749-6632.2000.tb05594.x; Bursch W, 1996, CARCINOGENESIS, V17, P1595, DOI 10.1093/carcin/17.8.1595; Cecconi F, 2008, DEV CELL, V15, P344, DOI 10.1016/j.devcel.2008.08.012; Choi JY, 2009, CLIN CANCER RES, V15, P5258, DOI 10.1158/1078-0432.CCR-09-0685; Clarke R, 2003, ONCOGENE, V22, P7316, DOI 10.1038/sj.onc.1206937; Clarke R, 2001, PHARMACOL REV, V53, P25; Duan L, 2010, J BIOL CHEM, V285, P1555, DOI 10.1074/jbc.M109.057976; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; Garcia-Horsman JA, 2007, NEUROPEPTIDES, V41, P1, DOI 10.1016/j.npep.2006.10.004; Gass J, 2007, CELL MOL LIFE SCI, V64, P345, DOI 10.1007/s00018-006-6317-y; Goldman SJ, 2010, MITOCHONDRION, V10, P309, DOI 10.1016/j.mito.2010.01.005; Gururaj AE, 2006, CLIN CANCER RES, V12, p1001S, DOI 10.1158/1078-0432.CCR-05-2110; Gutierrez MC, 2005, J CLIN ONCOL, V23, P2469, DOI 10.1200/JCO.2005.01.172; Jordan VC, 2004, CANCER CELL, V5, P207, DOI 10.1016/S1535-6108(04)00059-5; Kim SK, 2008, FREE RADICAL BIO MED, V45, P537, DOI 10.1016/j.freeradbiomed.2008.05.011; Levenson AS, 1997, CANCER RES, V57, P3071; Liang XH, 2001, CANCER RES, V61, P3443; LIEN EA, 1989, CANCER RES, V49, P2175; Livesey KM, 2009, CURR OPIN INVEST DR, V10, P1269; Massarweh S, 2006, ENDOCR-RELAT CANCER, V13, pS15, DOI 10.1677/erc.1.01273; Mele DA, 2009, CELL CYCLE, V8, P2425, DOI 10.4161/cc.8.15.9144; Miyoshi Y, 2010, BREAST CANCER-TOKYO, V17, P86, DOI 10.1007/s12282-009-0177-x; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Normanno N, 2005, ENDOCR-RELAT CANCER, V12, P721, DOI 10.1677/erc.1.00857; ODYA CE, 1978, J BIOL CHEM, V253, P5927; Poole R, 2007, CURR OPIN ONCOL, V19, P564, DOI 10.1097/CCO.0b013e3282f1c523; Purohit A, 2002, STEROIDS, V67, P979, DOI 10.1016/S0039-128X(02)00046-6; Qadir MA, 2008, BREAST CANCER RES TR, V112, P389, DOI 10.1007/s10549-007-9873-4; REDDEL RR, 1985, CANCER RES, V45, P1525; Riggins RB, 2007, CANCER LETT, V256, P1, DOI 10.1016/j.canlet.2007.03.016; Rosenblum JS, 2003, CURR OPIN CHEM BIOL, V7, P496, DOI 10.1016/S1367-5931(03)00084-X; Samaddar JS, 2008, MOL CANCER THER, V7, P2977, DOI 10.1158/1535-7163.MCT-08-0447; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scarlatti F, 2004, J BIOL CHEM, V279, P18384, DOI 10.1074/jbc.M313561200; Schoenlein PV, 2009, AUTOPHAGY, V5, P400, DOI 10.4161/auto.5.3.7784; Shariat-Madar Z, 2005, AM J PHYSIOL-HEART C, V289, pH2697, DOI 10.1152/ajpheart.00715.2005; Shariat-Madar Z, 2002, J BIOL CHEM, V277, P17962, DOI 10.1074/jbc.M106101200; Skidgel RA, 1998, IMMUNOL REV, V161, P129, DOI 10.1111/j.1600-065X.1998.tb01577.x; Wang JR, 2009, J BIOL CHEM, V284, P21412, DOI 10.1074/jbc.M109.026013; Williams RSB, 1999, EMBO J, V18, P2734, DOI 10.1093/emboj/18.10.2734	45	29	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2864	2876		10.1074/jbc.M110.143271	http://dx.doi.org/10.1074/jbc.M110.143271			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21087932	hybrid, Green Published			2022-12-25	WOS:000286464300052
J	Lefort, CT; Wojciechowski, K; Hocking, DC				Lefort, Craig T.; Wojciechowski, Katherine; Hocking, Denise C.			N-cadherin Cell-Cell Adhesion Complexes Are Regulated by Fibronectin Matrix Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UVOMORULIN-CATENIN COMPLEX; ADHERENS JUNCTIONS; SMOOTH-MUSCLE; CYCLE PROGRESSION; MEDIATED ADHESION; PHYSICAL STATE; FIBROBLASTS; GROWTH; MORPHOGENESIS; INTEGRINS	Fibronectin is a principal component of the extracellular matrix. Soluble fibronectin molecules are assembled into the extracellular matrix as insoluble, fibrillar strands via a cell-dependent process. In turn, the interaction of cells with the extracellular matrix form of fibronectin stimulates cell functions critical for tissue repair. Cross-talk between cell-cell and cell-extracellular matrix adhesion complexes is essential for the organization of cells into complex, functional tissue during embryonic development and tissue remodeling. Here, we demonstrate that fibronectin matrix assembly affects the organization, composition, and function of N-cadherin-based adherens junctions. Using fibronectin-null mouse embryonic myofibro-blasts, we identified a novel quaternary complex composed of N-cadherin, beta-catenin, tensin, and actin that exists in the absence of a fibronectin matrix. In the absence of fibronectin, homophilic N-cadherin ligation recruited both tensin and alpha 5 beta 1 integrins into nascent cell-cell adhesions. Initiation of fibronectin matrix assembly disrupted the association of tensin and actin with N-cadherin, released alpha 5 beta 1 integrins and tensin from cell-cell contacts, stimulated N-cadherin reorganization into thin cellular protrusions, and decreased N-cadherin adhesion. Fibronectin matrix assembly has been shown to recruit alpha 5 beta 1 integrins and tensin into fibrillar adhesions. Taken together, these studies suggest that tensin serves as a common cytoskeletal link for integrin- and cadherin-based adhesions and that the translocation of alpha 5 beta 1 integrins from cell-cell contacts into fibrillar adhesions during fibronectin matrix assembly is a novel mechanism by which cell-cell and cell-matrix adhesions are coordinated.	Univ Rochester, Sch Med & Dent, Dept Biomed Engn, Rochester, NY 14642 USA; [Wojciechowski, Katherine; Hocking, Denise C.] Univ Rochester, Sch Med & Dent, Dept Physiol & Pharmacol, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Hocking, DC (corresponding author), Box 711,601 Elmwood Ave, Rochester, NY 14642 USA.	denise_hocking@urmc.rochester.edu	Hocking, Denise/H-7903-2012	Hocking, Denise/0000-0003-2337-0357	National Institutes of Health [EB008368, GM081513, T32HL066988]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL066988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008368] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081513] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant EB008368 and GM081513.; Supported by National Institutes of Health Grant T32HL066988 and a pre-doctoral fellowship from the American Heart Association. Present address: La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037.	Angres B, 1996, J CELL BIOL, V134, P549, DOI 10.1083/jcb.134.2.549; BOCKHOLT SM, 1992, EXP CELL RES, V203, P39, DOI 10.1016/0014-4827(92)90037-9; Bourdoulous S, 1998, J CELL BIOL, V143, P267, DOI 10.1083/jcb.143.1.267; BROWN S, 1976, J SUPRAMOL STR CELL, V5, P119, DOI 10.1002/jss.400050203; Chen X, 2006, CURR OPIN CELL BIOL, V18, P572, DOI 10.1016/j.ceb.2006.07.002; CHERNOUSOV MA, 1991, J BIOL CHEM, V266, P10851; Delon I, 2007, CURR OPIN CELL BIOL, V19, P43, DOI 10.1016/j.ceb.2006.12.013; Dzamba BJ, 2009, DEV CELL, V16, P421, DOI 10.1016/j.devcel.2009.01.008; El Sayegh TY, 2007, FEBS LETT, V581, P167, DOI 10.1016/j.febslet.2006.12.029; Gates J, 2005, CELL, V123, P769, DOI 10.1016/j.cell.2005.11.009; Gavard J, 2004, J CELL SCI, V117, P257, DOI 10.1242/jcs.00857; George EL, 1997, BLOOD, V90, P3073, DOI 10.1182/blood.V90.8.3073; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Gerhardt H, 2000, DEV DYNAM, V218, P472, DOI 10.1002/1097-0177(200007)218:3<472::AID-DVDY1008>3.0.CO;2-#; Gui LQ, 2006, J BIOL CHEM, V281, P34816, DOI 10.1074/jbc.M608611200; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hazan RB, 1997, J BIOL CHEM, V272, P32448, DOI 10.1074/jbc.272.51.32448; HINCK L, 1994, J CELL BIOL, V125, P1327, DOI 10.1083/jcb.125.6.1327; Hocking DC, 2000, J BIOL CHEM, V275, P10673, DOI 10.1074/jbc.275.14.10673; Hocking DC, 2003, AM J PHYSIOL-LUNG C, V285, pL169, DOI 10.1152/ajplung.00371.2002; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; HYNES RO, 1982, J CELL BIOL, V95, P369, DOI 10.1083/jcb.95.2.369; Jones M, 2002, ARTERIOSCL THROM VAS, V22, P1972, DOI 10.1161/01.ATV.0000036416.14084.5A; Katz BZ, 2000, MOL BIOL CELL, V11, P1047, DOI 10.1091/mbc.11.3.1047; KINCH MS, 1995, J CELL BIOL, V130, P461, DOI 10.1083/jcb.130.2.461; Ko KS, 2001, J BIOL CHEM, V276, P35967, DOI 10.1074/jbc.M104106200; Kostetskii I, 2005, CIRC RES, V96, P346, DOI 10.1161/01.RES.0000156274.72390.2c; LINASK KK, 1988, DEV BIOL, V129, P315, DOI 10.1016/0012-1606(88)90378-8; Linask KK, 1997, DEV BIOL, V185, P148, DOI 10.1006/dbio.1997.8570; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; LO SH, 1994, J BIOL CHEM, V269, P22310; Lo SH, 2004, INT J BIOCHEM CELL B, V36, P31, DOI 10.1016/S1357-2725(03)00171-7; Magnusson MK, 1998, ARTERIOSCL THROM VAS, V18, P1363, DOI 10.1161/01.ATV.18.9.1363; Marsden M, 2003, CURR BIOL, V13, P1182, DOI 10.1016/S0960-9822(03)00433-0; MCKEOWNLONGO PJ, 1985, J CELL BIOL, V100, P364, DOI 10.1083/jcb.100.2.364; Mege RM, 2006, CURR OPIN CELL BIOL, V18, P541, DOI 10.1016/j.ceb.2006.08.004; Mercurius KO, 1998, CIRC RES, V82, P548, DOI 10.1161/01.RES.82.5.548; MIEKKA SI, 1982, THROMB RES, V27, P1, DOI 10.1016/0049-3848(82)90272-9; NAKAMURA K, 1995, J CELL BIOL, V129, P1691, DOI 10.1083/jcb.129.6.1691; NORTH AJ, 1993, J CELL BIOL, V120, P1159, DOI 10.1083/jcb.120.5.1159; Owens DW, 2000, MOL BIOL CELL, V11, P51, DOI 10.1091/mbc.11.1.51; OZAWA M, 1989, EMBO J, V8, P1711, DOI 10.1002/j.1460-2075.1989.tb03563.x; OZAWA M, 1992, J CELL BIOL, V116, P989, DOI 10.1083/jcb.116.4.989; OZAWA M, 1990, P NATL ACAD SCI USA, V87, P4246, DOI 10.1073/pnas.87.11.4246; Pankov R, 2000, J CELL BIOL, V148, P1075, DOI 10.1083/jcb.148.5.1075; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Pierres A, 2007, FEBS LETT, V581, P1841, DOI 10.1016/j.febslet.2007.03.077; QUADE BJ, 1988, J BIOL CHEM, V263, P19602; Radice GL, 1997, DEV BIOL, V181, P64, DOI 10.1006/dbio.1996.8443; Rozario T, 2009, DEV BIOL, V327, P386, DOI 10.1016/j.ydbio.2008.12.025; Sakai T, 2003, NATURE, V423, P876, DOI 10.1038/nature01712; Sakamoto Y, 2008, J BIOL CHEM, V283, P496, DOI 10.1074/jbc.M704195200; Sechler JL, 1998, J BIOL CHEM, V273, P25533, DOI 10.1074/jbc.273.40.25533; Sottile J, 1998, J CELL SCI, V111, P2933; Sottile J, 2002, MOL BIOL CELL, V13, P3546, DOI 10.1091/mbc.E02-01-0048; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Tomasini-Johansson BR, 2001, J BIOL CHEM, V276, P23430, DOI 10.1074/jbc.M103467200; VOLK T, 1986, J CELL BIOL, V103, P1441, DOI 10.1083/jcb.103.4.1441; Wang YX, 2006, P NATL ACAD SCI USA, V103, P1774, DOI 10.1073/pnas.0510774103; Wanner IB, 2002, J NEUROSCI, V22, P4066, DOI 10.1523/JNEUROSCI.22-10-04066.2002; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yano H, 2004, J CELL BIOL, V166, P283, DOI 10.1083/jcb.200312013; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119; YONEMURA S, 1995, J CELL SCI, V108, P127; Zamir E, 2000, NAT CELL BIOL, V2, P191, DOI 10.1038/35008607	66	31	31	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					3149	3160		10.1074/jbc.M110.115733	http://dx.doi.org/10.1074/jbc.M110.115733			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21084302	Green Published, hybrid			2022-12-25	WOS:000286464300076
J	Ota, R; Kotani, T; Yamashita, M				Ota, Ryoma; Kotani, Tomoya; Yamashita, Masakane			Biochemical Characterization of Pumilio1 and Pumilio2 in Xenopus Oocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; CYTOPLASMIC POLYADENYLATION; CELL-CYCLE; MEIOTIC MATURATION; BINDING PROTEINS; TEMPORAL CONTROL; MAP KINASE; PUM2 GENES; IDENTIFICATION; ACTIVATION	Precise control of the timing of translational activation of dormant mRNAs stored in oocytes is required for normal progression of oocyte maturation. We previously showed that Pumilio1 (Pum1) is specifically involved in the translational control of cyclin B1 mRNA during Xenopus oocyte maturation, in cooperation with cytoplasmic polyadenylation element-binding protein (CPEB). It was reported that another Pumilio, Pumilio2 (Pum2), exists in Xenopus oocytes and that this protein regulates the translation of RINGO mRNA, together with Deleted in Azoospermia-like protein (DAZL). In this study, we characterized Pum1 and Pum2 biochemically by using newly produced antibodies that discriminate between them. Pum1 and Pum2 are bound to several key proteins involved in translational control of dormant mRNAs, including CPEB and DAZL, in immature oocytes. However, Pum1 and Pum2 themselves have no physical interaction. Injection of anti-Pum1 or anti-Pum2 antibody accelerated CPEB phosphorylation, cyclin B1 translation, and oocyte maturation. Pum1 phosphorylation coincides with the dissociation of CPEB from Pum1 and the translational activation of cyclin B1 mRNA, a target of Pum1, whereas Pum2 phosphorylation occurred at timing earlier than that for Pum1. Some, but not all, of cyclin B1 mRNAs release the deadenylase PARN during oocyte maturation, whereas Pum1 remains associated with the mRNA. On the basis of these findings, we discuss the functions of Pum1 and Pum2 in translational control of mRNAs during oocyte maturation.	[Kotani, Tomoya; Yamashita, Masakane] Hokkaido Univ, Fac Sci, Dept Biol Sci, Lab Reprod & Dev Biol, Sapporo, Hokkaido 0600810, Japan; Hokkaido Univ, Fac Sci, Grad Sch Life Sci, Lab Reprod & Dev Biol, Sapporo, Hokkaido 0600810, Japan	Hokkaido University; Hokkaido University	Yamashita, M (corresponding author), North 10,West 8, Sapporo, Hokkaido 0600810, Japan.	myama@sci.hokudai.ac.jp	Yamashita, Masakane/A-4556-2012	Yamashita, Masakane/0000-0002-3696-451X; Kotani, Tomoya/0000-0003-1930-6635	Japan Society for the Promotion of Science for Young Scientists; Grants-in-Aid for Scientific Research [23770196, 23013001] Funding Source: KAKEN	Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by research fellowships from the Japan Society for the Promotion of Science for Young Scientists (to R. O.).	Arumugam K, 2010, EMBO J, V29, P387, DOI 10.1038/emboj.2009.337; Ballantyne S, 1997, MOL BIOL CELL, V8, P1633, DOI 10.1091/mbc.8.8.1633; Barnard DC, 2005, MOL CELL BIOL, V25, P7605, DOI 10.1128/MCB.25.17.7605-7615.2005; Belloc E, 2008, NATURE, V452, P1017, DOI 10.1038/nature06809; Blower MD, 2007, J CELL BIOL, V179, P1365, DOI 10.1083/jcb.200705163; Cao QP, 2002, EMBO J, V21, P3852, DOI 10.1093/emboj/cdf353; Charlesworth A, 2004, J BIOL CHEM, V279, P17650, DOI 10.1074/jbc.M313837200; Charlesworth A, 2000, DEV BIOL, V227, P706, DOI 10.1006/dbio.2000.9922; deMoor CH, 1997, MOL CELL BIOL, V17, P6419, DOI 10.1128/MCB.17.11.6419; Fox M, 2005, GENOMICS, V85, P92, DOI 10.1016/j.ygeno.2004.10.003; Git A, 2009, RNA, V15, P1121, DOI 10.1261/rna.1195709; HIRAI T, 1992, MOL REPROD DEV, V33, P131, DOI 10.1002/mrd.1080330204; Kim JS, 2006, J HYPERTENS, V24, pS177; Korner CG, 1998, EMBO J, V17, P5427, DOI 10.1093/emboj/17.18.5427; Kotani T, 2002, DEV BIOL, V252, P271, DOI 10.1006/dbio.2002.0853; Kurisaki I, 2007, CELL TISSUE RES, V327, P33, DOI 10.1007/s00441-006-0260-y; Lee JY, 2008, MOL REPROD DEV, V75, P184, DOI 10.1002/mrd.20765; Lee MH, 2007, PLOS GENET, V3, P2540, DOI 10.1371/journal.pgen.0030233; Macnicol MC, 2010, MOL REPROD DEV, V77, P662, DOI 10.1002/mrd.21191; Mendez R, 2002, EMBO J, V21, P1833, DOI 10.1093/emboj/21.7.1833; Mendez R, 2001, NAT REV MOL CELL BIO, V2, P521, DOI 10.1038/35080081; Mita K, 2000, MECH DEVELOP, V94, P251, DOI 10.1016/S0925-4773(00)00295-1; Nagahama Y, 2008, DEV GROWTH DIFFER, V50, pS195, DOI 10.1111/j.1440-169X.2008.01019.x; Nakahata S, 2003, MECH DEVELOP, V120, P865, DOI 10.1016/S0925-4773(03)00160-6; Nakahata S, 2001, J BIOL CHEM, V276, P20945, DOI 10.1074/jbc.M010528200; Ota R, 2008, ZOOL SCI, V25, P773, DOI 10.2108/zsj.25.773; Padmanabhan K, 2006, GENE DEV, V20, P199, DOI 10.1101/gad.1383106; Perdiguero E, 2003, EMBO J, V22, P5746, DOI 10.1093/emboj/cdg559; Radford HE, 2008, BBA-GENE REGUL MECH, V1779, P217, DOI 10.1016/j.bbagrm.2008.02.002; Richter JD, 2007, TRENDS BIOCHEM SCI, V32, P279, DOI 10.1016/j.tibs.2007.04.004; Rouhana L, 2005, RNA, V11, P1117, DOI 10.1261/rna.2630205; Sakamoto I, 1998, DEV BIOL, V195, P60, DOI 10.1006/dbio.1997.8835; Spassov DS, 2003, BLOOD CELL MOL DIS, V30, P55, DOI 10.1016/S1079-9796(03)00003-2; Spassov DS, 2002, GENE, V299, P195, DOI 10.1016/S0378-1119(02)01060-0; TANAKA T, 1995, DEV GROWTH DIFFER, V37, P387, DOI 10.1046/j.1440-169X.1995.t01-3-00005.x; Vessey JP, 2010, P NATL ACAD SCI USA, V107, P3222, DOI 10.1073/pnas.0907128107; Wang YY, 2008, DEV BIOL, V317, P454, DOI 10.1016/j.ydbio.2008.02.033; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; YAMASHITA M, 1991, DEV GROWTH DIFFER, V33, P617; Yasuda K, 2010, DEV BIOL, V348, P76, DOI 10.1016/j.ydbio.2010.09.015	40	37	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2853	2863		10.1074/jbc.M110.155523	http://dx.doi.org/10.1074/jbc.M110.155523			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21098481	Green Published, hybrid			2022-12-25	WOS:000286464300051
J	Liu, KD; Cho, YY; Yao, K; Nadas, J; Kim, DJ; Cho, EJ; Lee, MH; Pugliese, A; Zhang, JSA; Bode, AM; Dong, ZM; Dong, ZG				Liu, Kangdong; Cho, Yong-Yeon; Yao, Ke; Nadas, Janos; Kim, Dong Joon; Cho, Eun-Jin; Lee, Mee-Hyun; Pugliese, Angelo; Zhang, Jishuai; Bode, Ann M.; Dong, Ziming; Dong, Zigang			Eriodictyol Inhibits RSK2-ATF1 Signaling and Suppresses EGF-induced Neoplastic Cell Transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATING TRANSCRIPTION FACTOR-1; ELEMENT-BINDING PROTEIN; GENOME-WIDE ANALYSIS; GENE ACTIVATION; MAPK PATHWAY; HISTONE H3; FACTOR-I; PHOSPHORYLATION; KINASE; RSK2	RSK2 is a widely expressed serine/threonine kinase, and its activation enhances cell proliferation. Here, we report that ATF1 is a novel substrate of RSK2 and that RSK2-ATF1 signaling plays an important role in EGF-induced neoplastic cell transformation. RSK2 phosphorylated ATF1 at Ser-63 and enhanced ATF1 transcriptional activity. Docking experiments using the crystal structure of the RSK2 N-terminal kinase domain combined with in vitro pulldown assays demonstrated that eriodictyol, a flavanone found in fruits, bound with the N-terminal kinase domain of RSK2 to inhibit RSK2 N-terminal kinase activity. In cells, eriodictyol inhibited phosphorylation of ATF1 but had no effect on the phosphorylation of RSK, MEK1/2, ERK1/2, p38 or JNKs, indicating that eriodictyol specifically suppresses RSK2 signaling. Furthermore, eriodictyol inhibited RSK2-mediated ATF1 transactivation and tumor promoter-induced transformation of JB6 Cl41 cells. Eriodictyol or knockdown of RSK2 or ATF1 also suppressed Ras-mediated focus formation. Overall, these results indicate that RSK2-ATF1 signaling plays an important role in neoplastic cell transformation and that eriodictyol is a novel natural compound for suppressing RSK2 kinase activity.	[Pugliese, Angelo; Zhang, Jishuai; Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Liu, Kangdong; Yao, Ke; Dong, Ziming] Zhengzhou Univ, Basic Med Coll, Zhengzhou 450001, Peoples R China	University of Minnesota System; Zhengzhou University	Dong, ZG (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	zgdong@hi.umn.edu	Cho, Yong-Yeon/AAD-4263-2020; Kim, Dong Joon/AAL-8967-2020; pugliese, angelo/C-1729-2008	Cho, Yong-Yeon/0000-0003-1107-2651	National Institutes of Health [CA111536, CA120388, CA077646, R37CA081064, ES016548]; The Hormel Foundation; NATIONAL CANCER INSTITUTE [R37CA081064, R01CA077646, R01CA111536, R01CA120388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016548] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Hormel Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, National Institutes of Health Grants CA111536, CA120388, CA077646, R37CA081064, and ES016548. This work was also supported by The Hormel Foundation.	Ahmad N, 1997, JNCI-J NATL CANCER I, V89, P1881, DOI 10.1093/jnci/89.24.1881; Arthur JSC, 2000, FEBS LETT, V482, P44, DOI 10.1016/S0014-5793(00)02031-7; BLENIS J, 1993, P NATL ACAD SCI USA, V90, P5889, DOI 10.1073/pnas.90.13.5889; BROWN AD, 1995, ONCOGENE, V10, P1749; Cho YY, 2007, CANCER RES, V67, P8104, DOI 10.1158/0008-5472.CAN-06-4668; Cho YY, 2007, J BIOL CHEM, V282, P8380, DOI 10.1074/jbc.M611322200; Cho YY, 2009, CANCER RES, V69, P4398, DOI 10.1158/0008-5472.CAN-08-4959; Cho YY, 2005, CANCER RES, V65, P3596, DOI 10.1158/0008-5472.CAN-04-3935; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Clavin M, 2007, J ETHNOPHARMACOL, V112, P585, DOI 10.1016/j.jep.2007.04.007; COLBURN NH, 1981, P NATL ACAD SCI-BIOL, V78, P6912, DOI 10.1073/pnas.78.11.6912; David JP, 2005, J CLIN INVEST, V115, P664, DOI 10.1172/JCI200522877; DAVIS RJ, 1995, MOL REPROD DEV, V42, P459, DOI 10.1002/mrd.1080420414; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Gupta P, 2002, J BIOL CHEM, V277, P50550, DOI 10.1074/jbc.M209799200; Hollman PCH, 1999, FOOD CHEM TOXICOL, V37, P937, DOI 10.1016/S0278-6915(99)00079-4; HSUEH YP, 1995, J IMMUNOL, V154, P5675; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Jean D, 2000, ONCOGENE, V19, P2721, DOI 10.1038/sj.onc.1203569; JONES SW, 1988, P NATL ACAD SCI USA, V85, P3377, DOI 10.1073/pnas.85.10.3377; Kang SM, 2009, MOL CELL BIOL, V29, P2105, DOI 10.1128/MCB.00998-08; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li ZD, 2009, FEBS LETT, V583, P1999, DOI 10.1016/j.febslet.2009.05.013; LIU F, 1993, J BIOL CHEM, V268, P6714; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Nebreda AR, 1999, SCIENCE, V286, P1309, DOI 10.1126/science.286.5443.1309; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; *SCHROG SUIT, 2009, IND FIT DOCK PROT GL; Shimomura A, 1996, J BIOL CHEM, V271, P17957, DOI 10.1074/jbc.271.30.17957; Wang Y, 2000, ONCOGENE, V19, P1379, DOI 10.1038/sj.onc.1203443; WARD GE, 1990, CELL, V61, P561, DOI 10.1016/0092-8674(90)90469-U; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102; Zheng D, 2008, CANCER RES, V68, P7650, DOI 10.1158/0008-5472.CAN-08-1137; Zhou Q, 2009, MOL CANCER THER, V8, P1684, DOI 10.1158/1535-7163.MCT-09-0191; ZUCMAN J, 1993, NAT GENET, V4, P341, DOI 10.1038/ng0893-341	40	43	46	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2057	2066		10.1074/jbc.M110.147306	http://dx.doi.org/10.1074/jbc.M110.147306			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21098035	Green Published, hybrid			2022-12-25	WOS:000286191500048
J	Choi, HS; Su, WM; Morgan, JM; Han, GS; Xu, Z; Karanasios, E; Siniossoglou, S; Carman, GM				Choi, Hyeon-Son; Su, Wen-Min; Morgan, Jeanelle M.; Han, Gil-Soo; Xu, Zhi; Karanasios, Eleftherios; Siniossoglou, Symeon; Carman, George M.			Phosphorylation of Phosphatidate Phosphatase Regulates Its Membrane Association and Physiological Functions in Saccharomyces cerevisiae IDENTIFICATION OF SER602, THR723, AND SER744 AS THE SITES PHOSPHORYLATED BY CDC28 (CDK1)-ENCODED CYCLIN-DEPENDENT KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYSTROPHY FLD MUTATION; PHOSPHOLIPID BIOSYNTHESIS; PROTEIN-PHOSPHORYLATION; ACID PHOSPHATASE; LIPID-METABOLISM; SHUTTLE VECTORS; GLOBAL ANALYSIS; CTP SYNTHETASE; YEAST; GENE	The Saccharomyces cerevisiae PAH1-encoded phosphatidate phosphatase (PAP) catalyzes the penultimate step in the synthesis of triacylglycerol and plays a role in the transcriptional regulation of phospholipid synthesis genes. PAP is phosphorylated at multiple Ser and Thr residues and is dephosphorylated for in vivo function by the Nem1p-Spo7p protein phosphatase complex localized in the nuclear/endoplasmic reticulum membrane. In this work, we characterized seven previously identified phosphorylation sites of PAP that are within the Ser/Thr-Pro motif. When expressed on a low copy plasmid, wild type PAP could not complement the pah1 Delta mutant in the absence of the Nem1p-Spo7p complex. However, phosphorylation-deficient PAP (PAP-7A) containing alanine substitutions for the seven phosphorylation sites bypassed the requirement of the phosphatase complex and complemented the pah1 Delta nem1 Delta mutant phenotypes, such as temperature sensitivity, nuclear/endoplasmic reticulum membrane expansion, decreased triacylglycerol synthesis, and derepression of INO1 expression. Subcellular fractionation coupled with immunoblot analysis showed that PAP-7A was highly enriched in the membrane fraction. In fluorescence spectroscopy analysis, the PAP-7A showed tighter association with phospholipid vesicles than wild type PAP. Using site-directed mutagenesis of PAP, we identified Ser(602), Thr(723), and Ser(744), which belong to the seven phosphorylation sites, as the sites phosphorylated by the CDC28 (CDK1)-encoded cyclin-dependent kinase. Compared with the dephosphorylation mimic of the seven phosphorylation sites, alanine substitution for Ser(602), Thr(723), and/or Ser(744) had a partial effect on circumventing the requirement for the Nem1p-Spo7p complex.	[Choi, Hyeon-Son; Su, Wen-Min; Morgan, Jeanelle M.; Han, Gil-Soo; Xu, Zhi; Carman, George M.] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA; [Choi, Hyeon-Son; Su, Wen-Min; Morgan, Jeanelle M.; Han, Gil-Soo; Xu, Zhi; Carman, George M.] Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA; [Karanasios, Eleftherios; Siniossoglou, Symeon] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England	Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of Cambridge	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	carman@aesop.rutgers.edu		Su, Wen-Min/0000-0002-1861-6335	National Institutes of Health [GM-50679]; Medical Research Council [G0701446]; MRC [G0701446] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050679] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-50679 (to G.M.C.). This work was also supported by Medical Research Council Grant G0701446 (to S.S.).	BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; CARMAN GM, 1991, METHOD ENZYMOL, V197, P548; Carman GM, 1996, J BIOL CHEM, V271, P13293, DOI 10.1074/jbc.271.23.13293; CASALS C, 1993, BIOCHEM J, V296, P585, DOI 10.1042/bj2960585; Chi A, 2007, P NATL ACAD SCI USA, V104, P2193, DOI 10.1073/pnas.0607084104; Choi HS, 2010, J BIOL CHEM, V285, P11526, DOI 10.1074/jbc.M110.100727; CULBERTSON MR, 1975, GENETICS, V80, P23; DAVIS FM, 1983, P NATL ACAD SCI-BIOL, V80, P2926, DOI 10.1073/pnas.80.10.2926; Dephoure N, 2005, P NATL ACAD SCI USA, V102, P17940, DOI 10.1073/pnas.0509080102; DONAHUE TF, 1981, J BIOL CHEM, V256, P7077; Donkor J, 2009, J BIOL CHEM, V284, P29968, DOI 10.1074/jbc.M109.023663; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Grimsey N, 2008, J BIOL CHEM, V283, P29166, DOI 10.1074/jbc.M804278200; HAID A, 1983, METHOD ENZYMOL, V96, P192; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Han GS, 2005, J BIOL CHEM, V280, P38328, DOI 10.1074/jbc.M509622200; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; Henderson RJ, 1992, LIPID ANAL PRACTICAL, P65; Huffman TA, 2002, P NATL ACAD SCI USA, V99, P1047, DOI 10.1073/pnas.022634399; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; Kohlwein SD, 2010, J BIOL CHEM, V285, P15663, DOI 10.1074/jbc.R110.118356; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; Kurat CF, 2009, MOL CELL, V33, P53, DOI 10.1016/j.molcel.2008.12.019; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGNER CA, 1991, J BIOL CHEM, V266, P11955; LANGNER CA, 1989, J BIOL CHEM, V264, P7994; LEAR JD, 1987, J BIOL CHEM, V262, P6500; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; LIN YP, 1989, J BIOL CHEM, V264, P8641; Liu GH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007031; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; MACDONALD JIS, 1994, J BIOL CHEM, V269, P10529; MACDONALD RC, 1991, BIOCHIM BIOPHYS ACTA, V1061, P297, DOI 10.1016/0005-2736(91)90295-J; Mah Angie S., 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-22; MEYERSON M, 1992, EMBO J, V11, P2909, DOI 10.1002/j.1460-2075.1992.tb05360.x; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; MORLOCK KR, 1988, J BACTERIOL, V170, P3561, DOI 10.1128/jb.170.8.3561-3566.1988; Nadra K, 2008, GENE DEV, V22, P1647, DOI 10.1101/gad.1638008; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Peterfy M, 2010, J BIOL CHEM, V285, P3857, DOI 10.1074/jbc.M109.072488; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Reue K, 2008, J LIPID RES, V49, P2493, DOI 10.1194/jlr.R800019-JLR200; Reue K, 2008, FEBS LETT, V582, P90, DOI 10.1016/j.febslet.2007.11.014; Reue K, 2007, DIABETES, V56, P2842, DOI 10.2337/db07-1288; Reue K, 2009, J LIPID RES, V50, pS109, DOI 10.1194/jlr.R800052-JLR200; ROACH PJ, 1991, J BIOL CHEM, V266, P14139; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SIKORSKI RS, 1989, GENETICS, V122, P19; Siniossoglou S, 1998, EMBO J, V17, P6449, DOI 10.1093/emboj/17.22.6449; Siniossoglou S, 2000, J CELL BIOL, V149, P41, DOI 10.1083/jcb.149.1.41; Takeuchi K, 2009, AM J PHYSIOL-ENDOC M, V296, pE1195, DOI 10.1152/ajpendo.90958.2008; Toke DA, 1998, J BIOL CHEM, V273, P3278, DOI 10.1074/jbc.273.6.3278; Toke DA, 1998, J BIOL CHEM, V273, P14331, DOI 10.1074/jbc.273.23.14331; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; YANG WL, 1995, J BIOL CHEM, V270, P14983, DOI 10.1074/jbc.270.25.14983	71	88	94	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1486	1498		10.1074/jbc.M110.155598	http://dx.doi.org/10.1074/jbc.M110.155598			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21081492	Green Published, hybrid			2022-12-25	WOS:000286005000061
J	Ballinger, MN; Welliver, T; Straight, S; Peters-Golden, M; Swanson, JA				Ballinger, Megan N.; Welliver, Timothy; Straight, Samuel; Peters-Golden, Marc; Swanson, Joel A.			Transient Increase in Cyclic AMP Localized to Macrophage Phagosomes	PLOS ONE			English	Article							RECEPTOR-MEDIATED PHAGOCYTOSIS; COMPARTMENTALIZED PHOSPHODIESTERASES; ALVEOLAR MACROPHAGES; CAMP SYNTHESIS; LIVING CELLS; DEGRADATION; SHIP-1; BURST; CGMP	Cyclic AMP (cAMP) regulates many biological processes and cellular functions. The importance of spatially localized intracellular gradients of cAMP is increasingly appreciated. Previous work in macrophages has shown that cAMP is produced during phagocytosis and that elevated cAMP levels suppress host defense functions, including generation of proinflammatory mediators, phagocytosis and killing. However, the spatial and kinetic characteristics of cAMP generation in phagocytosing macrophages have yet to be examined. Using a Forster resonance energy transfer (FRET)-based cAMP biosensor, we measured the generation of cAMP in live macrophages. We detected no difference in bulk intracellular cAMP levels between resting cells and cells actively phagocytosing IgG-opsonized particles. However, analysis with the biosensor revealed a rapid decrease in FRET signal corresponding to a transient burst of cAMP production localized to the forming phagosome. cAMP levels returned to baseline after the particle was internalized. These studies indicate that localized increases in cAMP accompany phagosome formation and provide a framework for a more complete understanding of how cAMP regulates macrophage host defense functions.	[Ballinger, Megan N.; Peters-Golden, Marc] Univ Michigan Hlth Syst, Div Pulm & Crit Care Med, Dept Med, Ann Arbor, MI USA; [Welliver, Timothy; Straight, Samuel; Swanson, Joel A.] Univ Michigan Hlth Syst, Dept Microbiol & Immunol, Ann Arbor, MI USA; [Welliver, Timothy; Peters-Golden, Marc; Swanson, Joel A.] Univ Michigan Hlth Syst, Program Immunol, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Ballinger, MN (corresponding author), Univ Michigan Hlth Syst, Div Pulm & Crit Care Med, Dept Med, Ann Arbor, MI USA.	jswan@umich.edu	Swanson, Joel A/P-4362-2014	Swanson, Joel A/0000-0003-0900-8212; Ballinger, Megan/0000-0002-2202-3049	National Institutes of Health [HL58897, AI64668]; Hartwell Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058897, R56HL058897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064668, R01AI035950] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hartwell Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants HL58897 (M. P. G.), National Institutes of Health AI64668 (J.A.S.) and The Hartwell Foundation (M.N.B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronoff DM, 2005, J IMMUNOL, V174, P595, DOI 10.4049/jimmunol.174.2.595; Aronoff DM, 2004, J IMMUNOL, V173, P559, DOI 10.4049/jimmunol.173.1.559; Baillie GS, 2009, FEBS J, V276, P1790, DOI 10.1111/j.1742-4658.2009.06926.x; Beemiller P, 2006, PLOS BIOL, V4, P987, DOI 10.1371/journal.pbio.0040162; BIRMELIN M, 1984, EUR J BIOCHEM, V142, P219, DOI 10.1111/j.1432-1033.1984.tb08274.x; BROOKER G, 1988, METHOD ENZYMOL, V159, P45; Campagne MV, 2007, CELL MICROBIOL, V9, P2095, DOI 10.1111/j.1462-5822.2007.00981.x; Cheng XD, 2008, ACTA BIOCH BIOPH SIN, V40, P651, DOI 10.1111/j.1745-7270.2008.00438.x; Cooper DMF, 2005, BIOCHEM SOC T, V33, P1319, DOI 10.1042/BST0331319; Forman HJ, 2002, AM J RESP CRIT CARE, V166, pS4, DOI 10.1164/rccm.2206007; FULOP T, 1984, MECH AGEING DEV, V27, P233; HERLIN T, 1983, IMMUNOLOGY, V48, P17; Hoppe A, 2002, BIOPHYS J, V83, P3652, DOI 10.1016/S0006-3495(02)75365-4; Hoppe AD, 2004, MOL BIOL CELL, V15, P3509, DOI 10.1091/mbc.E03-11-0847; Kalamidas SA, 2006, J CELL SCI, V119, P3686, DOI 10.1242/jcs.03091; Kamen LA, 2008, J IMMUNOL, V180, P7497, DOI 10.4049/jimmunol.180.11.7497; Kamen LA, 2007, MOL BIOL CELL, V18, P2463, DOI 10.1091/mbc.e07-01-0061; KNAPP PE, 1990, J CELL SCI, V95, P433; Lee SP, 2009, J IMMUNOL, V182, P530, DOI 10.4049/jimmunol.182.1.530; Lissandron V, 2006, J MUSCLE RES CELL M, V27, P399, DOI 10.1007/s10974-006-9077-2; Medzhitov R, 2009, IMMUNITY, V30, P766, DOI 10.1016/j.immuni.2009.06.004; Nikolaev VO, 2006, PHYSIOLOGY, V21, P86, DOI 10.1152/physiol.00057.2005; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Peters-Golden M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.275pe37; Pryzwansky Katherine B., 1998, Cell Biochemistry and Biophysics, V28, P251, DOI 10.1007/BF02737813; PRYZWANSKY KB, 1981, SCIENCE, V211, P407, DOI 10.1126/science.6261328; Serezani CH, 2008, AM J RESP CELL MOL, V39, P127, DOI 10.1165/rcmb.2008-0091TR; Serezani CH, 2007, AM J RESP CELL MOL, V37, P562, DOI 10.1165/rcmb.2007-0153OC; Swanson JA, 2004, J LEUKOCYTE BIOL, V76, P1093, DOI 10.1189/jlb.0804439; TANG WJ, 2009, MOL ASPECTS MED; Terrin A, 2006, J CELL BIOL, V175, P441, DOI 10.1083/jcb.200605050; Willoughby D, 2008, NAT METHODS, V5, P29, DOI 10.1038/NMETH1135	33	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e13962	10.1371/journal.pone.0013962	http://dx.doi.org/10.1371/journal.pone.0013962			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21085604	Green Published, gold, Green Submitted			2022-12-25	WOS:000284087800021
J	Biffi, A; Plourde, A; Shen, YP; Onofrio, R; Smith, EE; Frosch, M; Prada, CM; Gusella, J; Greenberg, SM; Rosand, J				Biffi, Alessandro; Plourde, Anna; Shen, Yiping; Onofrio, Robert; Smith, Eric E.; Frosch, Matthew; Prada, Claudia M.; Gusella, James; Greenberg, Steven M.; Rosand, Jonathan			Screening for Familial APP Mutations in Sporadic Cerebral Amyloid Angiopathy	PLOS ONE			English	Article							WHITE-MATTER LESIONS; INTRACEREBRAL HEMORRHAGE; DIAGNOSIS; SUBSTITUTIONS; HEREDITARY; COGNITION; DEMENTIA; GENE	Background: Advances in genetic technology have revealed that variation in the same gene can cause both rare familial and common sporadic forms of the same disease. Cerebral amyloid angiopathy (CAA), a common cause of symptomatic intracerebral hemorrhage (ICH) in the elderly, can also occur in families in an autosomal dominant pattern. The majority of affected families harbor mutations in the Beta amyloid Peptide (Ab) coding region of the gene for amyloid precursor protein (APP) or have duplications of chromosomal segments containing APP. Methodology/Principal Findings: A total of 58 subjects with a diagnosis of probable or definite CAA according to validated criteria were included in the present study. We sequenced the Ab coding region of APP in 58 individuals and performed multiplex ligation-dependent probe amplification to determine APP gene dosage in 60. No patient harbored a known or novel APP mutation or gene duplication. The frequency of mutations investigated in the present study is estimated to range from 0% to 8% in individuals with probable CAA in the general population, based on the ascertained sample size. Conclusions/Significance: We found no evidence that variants at loci associated with familial CAA play a role in sporadic CAA. Based on our findings, these rare highly-penetrant mutations are unlikely to be seen in sporadic CAA patients. Therefore, our results do not support systematic genetic screening of CAA patients who lack a strong family history of hemorrhage or dementia.	[Biffi, Alessandro; Plourde, Anna; Shen, Yiping; Gusella, James; Rosand, Jonathan] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Biffi, Alessandro; Plourde, Anna; Greenberg, Steven M.; Rosand, Jonathan] Massachusetts Gen Hosp, Hemorrhag Stroke Res Grp, Boston, MA 02114 USA; [Biffi, Alessandro; Plourde, Anna; Onofrio, Robert; Gusella, James; Rosand, Jonathan] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Smith, Eric E.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Frosch, Matthew; Prada, Claudia M.] Massachusetts Gen Hosp, Inst Neurodegenerat Dis, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Calgary; Harvard University; Massachusetts General Hospital	Biffi, A (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.	jrosand@partners.org	Demchuk, Andrew M/E-1103-2012; Smith, Eric E/C-5443-2012; Frosch, Matthew P/ABD-7456-2021	Demchuk, Andrew M/0000-0002-4930-7789; Smith, Eric E/0000-0003-3956-1668; Frosch, Matthew P/0000-0002-3940-9861	National Institute of Neurological Disorders and Stroke (NINDS) [K23NS042695]; Massachusetts General Hospital Deane Institute for Integrative Research in Atrial Fibrillation and Stroke; American Heart Association/Bugher Foundation for Stroke Prevention Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS042695] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Massachusetts General Hospital Deane Institute for Integrative Research in Atrial Fibrillation and Stroke; American Heart Association/Bugher Foundation for Stroke Prevention Research(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by National Institute of Neurological Disorders and Stroke (NINDS) grant K23NS042695 awarded to Dr. Rosand and by the Massachusetts General Hospital Deane Institute for Integrative Research in Atrial Fibrillation and Stroke. Dr Biffi receives support from the American Heart Association/Bugher Foundation for Stroke Prevention Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; BAKKER E, 1991, AM J HUM GENET, V49, P518; Chen YW, 2006, NEUROLOGY, V67, P83, DOI 10.1212/01.wnl.0000223613.57229.24; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Fernando MS, 2004, J NEUROL SCI, V226, P13, DOI 10.1016/j.jns.2004.09.004; Florez JC, 2004, DIABETES, V53, P1360, DOI 10.2337/diabetes.53.5.1360; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Grabowski TJ, 2001, ANN NEUROL, V49, P697, DOI 10.1002/ana.1009; Greenberg SM, 1997, STROKE, V28, P1418, DOI 10.1161/01.STR.28.7.1418; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; Knudsen KA, 2001, NEUROLOGY, V56, P537, DOI 10.1212/WNL.56.4.537; Miravalle L, 2000, J BIOL CHEM, V275, P27110; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Nilsberth C., 1999, Society for Neuroscience Abstracts, V25, P297; Obici L, 2005, ANN NEUROL, V58, P639, DOI 10.1002/ana.20571; Rosner B., 2000, FUNDAMENTAL BIOSTATI; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Smith EE, 2004, NEUROLOGY, V63, P1606, DOI 10.1212/01.WNL.0000142966.22886.20; Vaxillaire M, 2008, ENDOCR REV, V29, P254, DOI 10.1210/er.2007-0024; VONSATTEL JPG, 1991, ANN NEUROL, V30, P637, DOI 10.1002/ana.410300503; Woo D, 2002, STROKE, V33, P1190, DOI 10.1161/01.STR.0000014774.88027.22; Zhang-Nunes SX, 2006, BRAIN PATHOL, V16, P30, DOI 10.1111/j.1750-3639.2006.tb00559.x	22	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e13949	10.1371/journal.pone.0013949	http://dx.doi.org/10.1371/journal.pone.0013949			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21085603	Green Published, gold			2022-12-25	WOS:000284087800015
J	Greving, MP; Belcher, PE; Diehnelt, CW; Gonzalez-Moa, MJ; Emery, J; Fu, JL; Johnston, SA; Woodbury, NW				Greving, Matthew P.; Belcher, Paul E.; Diehnelt, Chris W.; Gonzalez-Moa, Maria J.; Emery, Jack; Fu, Jinglin; Johnston, Stephen Albert; Woodbury, Neal W.			Thermodynamic Additivity of Sequence Variations: An Algorithm for Creating High Affinity Peptides Without Large Libraries or Structural Information	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; TNF-ALPHA; COMPUTATIONAL DESIGN; BINDING INTERFACES; BINARY-CODE; RECEPTOR; GENERATION; TARGET; ENERGY; RECOGNITION	Background: There is a significant need for affinity reagents with high target affinity/specificity that can be developed rapidly and inexpensively. Existing affinity reagent development approaches, including protein mutagenesis, directed evolution, and fragment-based design utilize large libraries and/or require structural information thereby adding time and expense. Until now, no systematic approach to affinity reagent development existed that could produce nanomolar affinity from small chemically synthesized peptide libraries without the aid of structural information. Methodology/Principal Findings: Based on the principle of additivity, we have developed an algorithm for generating high affinity peptide ligands. In this algorithm, point-variations in a lead sequence are screened and combined in a systematic manner to achieve additive binding energies. To demonstrate this approach, low-affinity lead peptides for multiple protein targets were identified from sparse random sequence space and optimized to high affinity in just two chemical steps. In one example, a TNF-alpha binding peptide with K-d = 90 nM and high target specificity was generated. The changes in binding energy associated with each variation were generally additive upon combining variations, validating the basis of the algorithm. Interestingly, cooperativity between point-variations was not observed, and in a few specific cases, combinations were less than energetically additive. Conclusions/Significance: By using this additivity algorithm, peptide ligands with high affinity for protein targets were generated. With this algorithm, one of the highest affinity TNF-alpha binding peptides reported to date was produced. Most importantly, high affinity was achieved from small, chemically-synthesized libraries without the need for structural information at any time during the process. This is significantly different than protein mutagenesis, directed evolution, or fragment-based design approaches, which rely on large libraries and/or structural guidance. With this algorithm, high affinity/specificity peptide ligands can be developed rapidly, inexpensively, and in an entirely chemical manner.	[Greving, Matthew P.; Belcher, Paul E.; Diehnelt, Chris W.; Gonzalez-Moa, Maria J.; Emery, Jack; Fu, Jinglin; Johnston, Stephen Albert; Woodbury, Neal W.] Arizona State Univ, Ctr BioOpt Nanotechnol, Tempe, AZ USA; [Greving, Matthew P.; Belcher, Paul E.; Diehnelt, Chris W.; Gonzalez-Moa, Maria J.; Emery, Jack; Fu, Jinglin; Johnston, Stephen Albert; Woodbury, Neal W.] Arizona State Univ, Ctr Innovat Med, Biodesign Inst, Tempe, AZ USA; [Johnston, Stephen Albert] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Woodbury, Neal W.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Greving, MP (corresponding author), Scripps Res Inst, La Jolla, CA 92037 USA.	nwoodbury@asu.edu	Diehnelt, Chris/AAT-9271-2020; Fu, Jinglin/F-3589-2012; Moa, Maria Gonzalez/AAB-6368-2019		Arizona Technology Research Initiative; National Science Foundation	Arizona Technology Research Initiative; National Science Foundation(National Science Foundation (NSF))	This work was supported by start-up funds to S.A.J., including from the Arizona Technology Research Initiative Fund. M. P. G. was supported by a National Science Foundation Integrative Graduate Education and Research Traineeship (IGERT) Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALKWILL FR, 1989, IMMUNOL TODAY, V10, P299, DOI 10.1016/0167-5699(89)90085-6; Blow N, 2007, NATURE, V447, P741, DOI 10.1038/447741a; Carothers JM, 2006, J AM CHEM SOC, V128, P7929, DOI 10.1021/ja060952q; Chirinos-Rojas CL, 1998, J IMMUNOL, V161, P5621; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; DEVLIN JJ, 1990, SCIENCE, V249, P404, DOI 10.1126/science.2143033; Diehnelt CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010728; Dill KA, 1997, J BIOL CHEM, V272, P701, DOI 10.1074/jbc.272.2.701; Fellouse FA, 2005, J MOL BIOL, V348, P1153, DOI 10.1016/j.jmb.2005.03.041; Fellouse FA, 2004, P NATL ACAD SCI USA, V101, P12467, DOI 10.1073/pnas.0401786101; GREGORET LM, 1993, P NATL ACAD SCI USA, V90, P4246, DOI 10.1073/pnas.90.9.4246; Greving MP, 2010, ANAL BIOCHEM, V402, P93, DOI 10.1016/j.ab.2010.03.002; Hajduk PJ, 2007, NAT REV DRUG DISCOV, V6, P211, DOI 10.1038/nrd2220; He MM, 2005, SCIENCE, V310, P1022, DOI 10.1126/science.1116304; Jackel C, 2008, ANNU REV BIOPHYS, V37, P153, DOI 10.1146/annurev.biophys.37.032807.125832; Janin J, 1996, PROTEINS, V25, pR1, DOI 10.1002/prot.340250302; JENCKS WP, 1981, P NATL ACAD SCI-BIOL, V78, P4046, DOI 10.1073/pnas.78.7.4046; Karanicolas J, 2009, CURR OPIN STRUC BIOL, V19, P458, DOI 10.1016/j.sbi.2009.07.005; Koide A, 2007, P NATL ACAD SCI USA, V104, P6632, DOI 10.1073/pnas.0700149104; Kortemme T, 2004, CURR OPIN CHEM BIOL, V8, P91, DOI 10.1016/j.cbpa.2003.12.008; Kossiakoff AA, 2008, CURR OPIN STRUC BIOL, V18, P499, DOI 10.1016/j.sbi.2008.06.004; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAM KS, 1991, NATURE, V354, P82, DOI 10.1038/354082a0; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Looger LL, 2003, NATURE, V423, P185, DOI 10.1038/nature01556; Pal G, 2006, J BIOL CHEM, V281, P22378, DOI 10.1074/jbc.M603826200; Palladino MA, 2003, NAT REV DRUG DISCOV, V2, P736, DOI 10.1038/nrd1175; Papoian GA, 2003, BIOPOLYMERS, V68, P333, DOI 10.1002/bip.10286; Pluckthun A, 2007, CURR OPIN STRUC BIOL, V17, P451, DOI 10.1016/j.sbi.2007.08.020; Reichmann D, 2005, P NATL ACAD SCI USA, V102, P57, DOI 10.1073/pnas.0407280102; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; SCHREIER B, 2009, P NATL ACAD SCI US, P1; Sidhu SS, 2007, CURR OPIN CHEM BIOL, V11, P347, DOI 10.1016/j.cbpa.2007.05.001; Smith GP, 1997, CHEM REV, V97, P391, DOI 10.1021/cr960065d; Stoltenburg R, 2007, BIOMOL ENG, V24, P381, DOI 10.1016/j.bioeng.2007.06.001; Takasaki W, 1997, NAT BIOTECHNOL, V15, P1266, DOI 10.1038/nbt1197-1266; Taussig MJ, 2007, NAT METHODS, V4, P13, DOI 10.1038/nmeth0107-13; TRACEY KJ, 1994, ANNU REV MED, V45, P491, DOI 10.1146/annurev.med.45.1.491; Uhlen M, 2009, J MOL RECOGNIT, V22, P57, DOI 10.1002/jmr.891; WELLS JA, 1990, BIOCHEMISTRY-US, V29, P8509, DOI 10.1021/bi00489a001; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Williams BAR, 2009, J AM CHEM SOC, V131, P17233, DOI 10.1021/ja9051735; Yin H, 2007, SCIENCE, V315, P1817, DOI 10.1126/science.1136782; Zhang J, 2003, BIOCHEM BIOPH RES CO, V310, P1181, DOI 10.1016/j.bbrc.2003.09.141; Zichi D, 2008, CURR OPIN CHEM BIOL, V12, P78, DOI 10.1016/j.cbpa.2008.01.016	46	10	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e15432	10.1371/journal.pone.0015432	http://dx.doi.org/10.1371/journal.pone.0015432			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21085650	gold, Green Published, Green Submitted			2022-12-25	WOS:000284087800022
J	Suhre, K; Meisinger, C; Doring, A; Altmaier, E; Belcredi, P; Gieger, C; Chang, D; Milburn, MV; Gall, WE; Weinberger, KM; Mewes, HW; de Angelis, MH; Wichmann, HE; Kronenberg, F; Adamski, J; Illig, T				Suhre, Karsten; Meisinger, Christa; Doering, Angela; Altmaier, Elisabeth; Belcredi, Petra; Gieger, Christian; Chang, David; Milburn, Michael V.; Gall, Walter E.; Weinberger, Klaus M.; Mewes, Hans-Werner; de Angelis, Martin Hrabe; Wichmann, H. -Erich; Kronenberg, Florian; Adamski, Jerzy; Illig, Thomas			Metabolic Footprint of Diabetes: A Multiplatform Metabolomics Study in an Epidemiological Setting	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; TARGETED METABOLOMICS; QUANTITATIVE-ANALYSIS; ACID CONCENTRATIONS; BIOLOGICAL-SYSTEMS; RENAL-FAILURE; AMINO-ACIDS; PLASMA; MELLITUS; METABONOMICS	Background: Metabolomics is the rapidly evolving field of the comprehensive measurement of ideally all endogenous metabolites in a biological fluid. However, no single analytic technique covers the entire spectrum of the human metabolome. Here we present results from a multiplatform study, in which we investigate what kind of results can presently be obtained in the field of diabetes research when combining metabolomics data collected on a complementary set of analytical platforms in the framework of an epidemiological study. Methodology/Principal Findings: 40 individuals with self-reported diabetes and 60 controls (male, over 54 years) were randomly selected from the participants of the population-based KORA (Cooperative Health Research in the Region of Augsburg) study, representing an extensively phenotyped sample of the general German population. Concentrations of over 420 unique small molecules were determined in overnight-fasting blood using three different techniques, covering nuclear magnetic resonance and tandem mass spectrometry. Known biomarkers of diabetes could be replicated by this multiple metabolomic platform approach, including sugar metabolites (1,5-anhydroglucoitol), ketone bodies (3-hydroxybutyrate), and branched chain amino acids. In some cases, diabetes-related medication can be detected (pioglitazone, salicylic acid). Conclusions/Significance: Our study depicts the promising potential of metabolomics in diabetes research by identification of a series of known and also novel, deregulated metabolites that associate with diabetes. Key observations include perturbations of metabolic pathways linked to kidney dysfunction (3-indoxyl sulfate), lipid metabolism (glycerophospholipids, free fatty acids), and interaction with the gut microflora (bile acids). Our study suggests that metabolic markers hold the potential to detect diabetes-related complications already under sub-clinical conditions in the general population.	[Suhre, Karsten; Altmaier, Elisabeth; Mewes, Hans-Werner] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol, Neuherberg, Germany; [Suhre, Karsten] Univ Munich, Fac Biol, Planegg Martinsried, Germany; [Meisinger, Christa; Doering, Angela; Belcredi, Petra; Gieger, Christian; Wichmann, H. -Erich; Illig, Thomas] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol, Neuherberg, Germany; [Chang, David] Chenomx, Edmonton, AB, Canada; [Milburn, Michael V.; Gall, Walter E.] Metabolon Inc, Durham, NC USA; [Weinberger, Klaus M.] Biocrates Life Sci AG, Innsbruck, Austria; [Mewes, Hans-Werner] Tech Univ Munich, Dept Genome Oriented Bioinformat, Life & Food Sci Ctr Weihenstephan, D-8050 Freising Weihenstephan, Germany; [de Angelis, Martin Hrabe; Adamski, Jerzy] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Expt Genet, Genome Anal Ctr, Neuherberg, Germany; [de Angelis, Martin Hrabe; Adamski, Jerzy] Tech Univ Munich, Life & Food Sci Ctr Weihenstephan, Inst Expt Genet, D-8050 Freising Weihenstephan, Germany; [Wichmann, H. -Erich] Ludwig Maximilians Univ Munchen, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Wichmann, H. -Erich] Univ Munich, Klinikum Grosshadern, D-8000 Munich, Germany; [Kronenberg, Florian] Innsbruck Med Univ, Div Genet Epidemiol, Dept Med Genet Mol & Clin Pharmacol, Innsbruck, Austria	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Metabolon; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Munich; University of Munich; Medical University of Innsbruck	Suhre, K (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol, Neuherberg, Germany.	karsten.suhre@helmholtz-muenchen.de	Meisinger, Christine/B-5358-2014; de Angelis, Martin Hrabe/F-5531-2012; Suhre, Karsten/AAF-1778-2020; Kronenberg, Florian/B-1736-2008; Wichmann, Heinz Erich/AAA-5695-2022; Mewes, Hans-Werner/A-8204-2019	de Angelis, Martin Hrabe/0000-0002-7898-2353; Suhre, Karsten/0000-0001-9638-3912; Kronenberg, Florian/0000-0003-2229-1120; Meisinger, Christa/0000-0002-9026-6544; Adamski, Jerzy/0000-0001-9259-0199; Weinberger, Klaus/0000-0002-8947-5306; Gieger, Christian/0000-0001-6986-9554; Mewes, Hans-Werner/0000-0002-9713-6398	German Federal Ministry of Education, Science, Research and Technology [NGFNPlus: 01GS0823]; State of Bavaria; German National Genome Research Network [01GS0823]; Austrian Genome Research Programme GEN-AU; Munich Center of Health Sciences (MC Health); German Federal Ministry of Education and Research (BMBF) [0315494A]; German Center Diabetes Research (DZD e.V.)	German Federal Ministry of Education, Science, Research and Technology; State of Bavaria; German National Genome Research Network; Austrian Genome Research Programme GEN-AU; Munich Center of Health Sciences (MC Health); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Center Diabetes Research (DZD e.V.)	The Kooperative Gesundheitsforschung in der Region Augsburg (KORA) research platform and the Monitoring trends and determinants on cardiovascular diseases (MONICA) Augsburg studies were initiated and financed by the Helmholtz Zentrum Munchen - National Research Center for Environmental Health, which is funded by the German Federal Ministry of Education, Science, Research and Technology and by the State of Bavaria. Part of this work was financed by the German National Genome Research Network (NGFNPlus: 01GS0823) and by grants from the Genomics of Lipid-associated Disorders "GOLD" of the "Austrian Genome Research Programme GEN-AU". Part of this research was supported within the Munich Center of Health Sciences (MC Health) as part of LMUinnovativ. This study was also supported in part by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center Diabetes Research (DZD e.V.). E. Altmaier is supported by project SysMBo under BMBF MedSys grant No. 0315494A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADROGUE HJ, 1982, NEW ENGL J MED, V307, P1603, DOI 10.1056/NEJM198212233072603; Altmaier E, 2008, ENDOCRINOLOGY, V149, P3478, DOI 10.1210/en.2007-1747; Altmaier E, 2009, MOL NUTR FOOD RES, V53, P1357, DOI 10.1002/mnfr.200900116; Assfalg M, 2008, P NATL ACAD SCI USA, V105, P1420, DOI 10.1073/pnas.0705685105; Bain JR, 2009, DIABETES, V58, P2429, DOI 10.2337/db09-0580; Bijlsma S, 2006, ANAL CHEM, V78, P567, DOI 10.1021/ac051495j; BORGHI L, 1985, DIABETES, V34, P812, DOI 10.2337/diabetes.34.8.812; Buse John B, 2003, Diabetes Technol Ther, V5, P355, DOI 10.1089/152091503765691839; Cani PD, 2009, CURR PHARM DESIGN, V15, P1546, DOI 10.2174/138161209788168164; Doring A, 2008, NAT GENET, V40, P430, DOI 10.1038/ng.107; Dumas ME, 2007, NAT GENET, V39, P666, DOI 10.1038/ng2026; Dumas ME, 2006, ANAL CHEM, V78, P2199, DOI 10.1021/ac0517085; Dungan KM, 2006, DIABETES CARE, V29, P1214, DOI 10.2337/dc06-1910; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Fujimoto Wilfred Y., 2000, American Journal of Medicine, V108, p9S; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Gieger C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000282; GLANVILLE NT, 1985, CAN J PHYSIOL PHARM, V63, P487, DOI 10.1139/y85-084; GOLAY A, 1988, DIABETES METAB REV, V4, P727, DOI 10.1002/dmr.5610040803; Griffin JL, 2006, PHILOS T R SOC B, V361, P147, DOI 10.1098/rstb.2005.1734; Griffin JL, 2006, PHARMACOGENOMICS, V7, P1095, DOI 10.2217/14622416.7.7.1095; Holmes E, 2008, NATURE, V453, P396, DOI 10.1038/nature06882; Holmes E, 2007, ANAL CHEM, V79, P2629, DOI 10.1021/ac062305n; ILLIG T, 2009, NAT GENET; Jankowski J, 2003, J CLIN INVEST, V112, P256, DOI 10.1172/JCI200315524; Lanza IR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010538; Lawton KA, 2008, PHARMACOGENOMICS, V9, P383, DOI 10.2217/14622416.9.4.383; Layman DK, 2003, J NUTR, V133, p261S, DOI 10.1093/jn/133.1.261S; Layman DK, 2006, J NUTR, V136, p319S, DOI 10.1093/jn/136.1.319S; Leahy JL, 2005, ARCH MED RES, V36, P197, DOI 10.1016/j.arcmed.2005.01.003; Li X, 2009, ANAL CHIM ACTA, V633, P257, DOI 10.1016/j.aca.2008.11.058; Lindon JC, 2007, FEBS J, V274, P1140, DOI 10.1111/j.1742-4658.2007.05673.x; Madsen R, 2010, ANAL CHIM ACTA, V659, P23, DOI 10.1016/j.aca.2009.11.042; Maier EM, 2009, CLIN GENET, V76, P179, DOI 10.1111/j.1399-0004.2009.01217.x; McGill JRB, 2004, DIABETES CARE, V27, P1859, DOI 10.2337/diacare.27.8.1859; Mooradian AD, 2009, NAT CLIN PRACT ENDOC, V5, P150, DOI 10.1038/ncpendmet1066; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; Niwa T, 1996, SEMIN NEPHROL, V16, P167; NIWA T, 1994, J LAB CLIN MED, V124, P96; Norlund L, 1998, CLIN CHEM LAB MED, V36, P175, DOI 10.1515/CCLM.1998.032; PAULING L, 1971, P NATL ACAD SCI USA, V68, P2374, DOI 10.1073/pnas.68.10.2374; Rimer JD, 2010, SCIENCE, V330, P337, DOI 10.1126/science.1191968; Roschinger W, 2003, EUR J PEDIATR, V162, pS67, DOI 10.1007/s00431-003-1356-y; RUDERMAN NB, 1975, ANNU REV MED, V26, P245, DOI 10.1146/annurev.me.26.020175.001333; SMITH EB, 1995, EUR HEART J, V16, P11, DOI 10.1093/eurheartj/16.suppl_A.11; SMITH EB, 1992, EUR J EPIDEMIOL, V8, P83, DOI 10.1007/BF00145356; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; VANNINI P, 1982, DIABETOLOGIA, V22, P217, DOI 10.1007/BF00283757; VINAYAVEKHIN N, 2009, ACS CHEM BIOL; Wang-Sattler R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003863; Watson AD, 2006, J LIPID RES, V47, P2101, DOI 10.1194/jlr.R600022-JLR200; Weljie AM, 2006, ANAL CHEM, V78, P4430, DOI 10.1021/ac060209g; Wenk MR, 2005, NAT REV DRUG DISCOV, V4, P594, DOI 10.1038/nrd1776; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS2; Wiesner P, 2009, J LIPID RES, V50, P574, DOI 10.1194/jlr.D800028-JLR200; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Wollesen F, 1999, KIDNEY INT, V55, P1028, DOI 10.1046/j.1523-1755.1999.0550031028.x; Yared Z, 2003, Minerva Med, V94, P409	60	418	426	1	143	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e13953	10.1371/journal.pone.0013953	http://dx.doi.org/10.1371/journal.pone.0013953			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21085649	Green Published, Green Submitted, gold			2022-12-25	WOS:000284087800017
J	Wang, ZY; Che, PL; Du, JA; Ha, B; Yarema, KJ				Wang, Zhiyun; Che, Pao-Lin; Du, Jian; Ha, Barbara; Yarema, Kevin J.			Static Magnetic Field Exposure Reproduces Cellular Effects of the Parkinson's Disease Drug Candidate ZM241385	PLOS ONE			English	Article							ADENOSINE A(2A) RECEPTORS; RAT PC12 CELLS; BOUND IRON UPTAKE; NEURITE OUTGROWTH; PROTEIN-KINASE; NITRIC-OXIDE; DOWN-REGULATION; CALCIUM; EXPRESSION; ACTIVATION	Background: This study was inspired by coalescing evidence that magnetic therapy may be a viable treatment option for certain diseases. This premise is based on the ability of moderate strength fields (i. e., 0.1 to 1 Tesla) to alter the biophysical properties of lipid bilayers and in turn modulate cellular signaling pathways. In particular, previous results from our laboratory (Wang et al., BMC Genomics, 10, 356 (2009)) established that moderate strength static magnetic field (SMF) exposure altered cellular endpoints associated with neuronal function and differentiation. Building on this background, the current paper investigated SMF by focusing on the adenosine A(2A) receptor (A(2A)R) in the PC12 rat adrenal pheochromocytoma cell line that displays metabolic features of Parkinson's disease (PD). Methodology and Principal Findings: SMF reproduced several responses elicited by ZM241385, a selective A(2A)R antagonist, in PC12 cells including altered calcium flux, increased ATP levels, reduced cAMP levels, reduced nitric oxide production, reduced p44/42 MAPK phosphorylation, inhibited proliferation, and reduced iron uptake. SMF also counteracted several PD-relevant endpoints exacerbated by A(2A)R agonist CGS21680 in a manner similar to ZM241385; these include reduction of increased expression of A(2A)R, reversal of altered calcium efflux, dampening of increased adenosine production, reduction of enhanced proliferation and associated p44/42 MAPK phosphorylation, and inhibition of neurite outgrowth. Conclusions and Significance: When measured against multiple endpoints, SMF elicited qualitatively similar responses as ZM241385, a PD drug candidate. Provided that the in vitro results presented in this paper apply in vivo, SMF holds promise as an intriguing non-invasive approach to treat PD and potentially other neurological disorders.	[Wang, Zhiyun; Che, Pao-Lin; Du, Jian; Ha, Barbara; Yarema, Kevin J.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA	Johns Hopkins University	Wang, ZY (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.	kyarema1@jhu.edu	RIVADULLA, CASTO/K-8425-2012; Yarema, Kevin/A-3329-2010	RIVADULLA, CASTO/0000-0001-5580-3917; DU, JIAN/0000-0001-7154-8987	Arnold and Mabel Beckman Foundation; Whitaker Biomedical Institute (through the Department of Biomedical Engineering at the Johns Hopkins University); National Institutes of Health (NIBIB) [5R01EB5692]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005692] Funding Source: NIH RePORTER	Arnold and Mabel Beckman Foundation; Whitaker Biomedical Institute (through the Department of Biomedical Engineering at the Johns Hopkins University); National Institutes of Health (NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Funding for this project was provided by the Arnold and Mabel Beckman Foundation, the Whitaker Biomedical Institute (through the Department of Biomedical Engineering at the Johns Hopkins University) and from the National Institutes of Health (NIBIB, 5R01EB5692). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendash GW, 2010, J ALZHEIMERS DIS, V19, P191, DOI 10.3233/JAD-2010-1228; Arslan G, 1997, NEUROPHARMACOLOGY, V36, P1319, DOI 10.1016/S0028-3908(97)00090-7; Arslan G, 2002, N-S ARCH PHARMACOL, V365, P150, DOI 10.1007/s002100100456; AZANZA MJ, 1989, BRAIN RES, V489, P195, DOI 10.1016/0006-8993(89)90025-5; Beitner-Johnson D, 1998, BIOCHEM BIOPH RES CO, V242, P61, DOI 10.1006/bbrc.1997.7907; Belcastro V, 2009, EXP NEUROL, V217, P231, DOI 10.1016/j.expneurol.2009.01.010; Benabid AL, 2009, LANCET NEUROL, V8, P67, DOI 10.1016/S1474-4422(08)70291-6; Biber K, 2001, NEUROPSYCHOPHARMACOL, V24, P86, DOI 10.1016/S0893-133X(00)00169-X; Blum D, 2000, NEUROSCI LETT, V283, P193, DOI 10.1016/S0304-3940(00)00948-4; BRAGANZA LF, 1984, BIOCHIM BIOPHYS ACTA, V801, P66, DOI 10.1016/0304-4165(84)90213-7; Brambilla R, 2003, GLIA, V43, P190, DOI 10.1002/glia.10243; Cen S, 2004, J BIOL CHEM, V279, P33177, DOI 10.1074/jbc.M402062200; Chan SL, 2000, J BIOL CHEM, V275, P18195, DOI 10.1074/jbc.M000040200; Charles MP, 2003, BIOCHEM BIOPH RES CO, V304, P795, DOI 10.1016/S0006-291X(03)00666-1; Cheng HC, 2002, J BIOL CHEM, V277, P33930, DOI 10.1074/jbc.M201206200; Colbert AP, 2009, EVID-BASED COMPL ALT, V6, P133, DOI 10.1093/ecam/nem131; Cunha RA, 1997, BRIT J PHARMACOL, V122, P1279, DOI 10.1038/sj.bjp.0701507; De Nicola M, 2006, ANN NY ACAD SCI, V1090, P59, DOI 10.1196/annals.1378.006; Engstrom S, 2002, BIOELECTROMAGNETICS, V23, P475, DOI 10.1002/bem.10035; FERRE S, 1993, J NEUROSCI, V13, P5402, DOI 10.1523/JNEUROSCI.13-12-05402.1993; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Hattori N, 2009, PARKINSONISM RELAT D, V15, pS35, DOI 10.1016/S1353-8020(09)70010-0; Hernan MA, 2002, ANN NEUROL, V52, P276, DOI 10.1002/ana.10277; Hove-Madsen L, 2006, CARDIOVASC RES, V72, P292, DOI 10.1016/j.cardiores.2006.07.020; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jang JH, 2005, BIOCHEM BIOPH RES CO, V331, P1421, DOI 10.1016/j.bbrc.2005.04.057; Kanda T, 1998, NEUROREPORT, V9, P2857, DOI 10.1097/00001756-199808240-00032; Karcz-Kubicha M, 2003, NEUROPSYCHOPHARMACOL, V28, P1281, DOI 10.1038/sj.npp.1300167; Kobayashi S, 1998, J PHYSIOL-LONDON, V512, P351, DOI 10.1111/j.1469-7793.1998.351be.x; Kobayashi S, 1998, J PHYSIOL-LONDON, V508, P95, DOI 10.1111/j.1469-7793.1998.095br.x; Kobayashi S, 2000, J NEUROCHEM, V74, P621, DOI 10.1046/j.1471-4159.2000.740621.x; LeWitt PA, 2008, NEW ENGL J MED, V359, P2468, DOI 10.1056/NEJMct0800326; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Gatto EM, 2002, NEUROTOX RES, V4, P141, DOI 10.1080/10298420290015881; MALLY J, 1994, J PHARM PHARMACOL, V46, P515, DOI 10.1111/j.2042-7158.1994.tb03840.x; Mandel S, 2003, CNS DRUGS, V17, P729, DOI 10.2165/00023210-200317100-00004; Mckay JC, 2007, BIOELECTROMAGNETICS, V28, P81, DOI 10.1002/bem.20284; Meng HW, 2007, INT J DEV NEUROSCI, V25, P509, DOI 10.1016/j.ijdevneu.2007.09.010; Moreau JL, 1999, BRAIN RES REV, V31, P65, DOI 10.1016/S0165-0173(99)00059-4; Mori Y, 2004, CELL STRUCT FUNCT, V29, P101, DOI 10.1247/csf.29.101; Morris CE, 2007, J APPL PHYSIOL, V103, P629, DOI 10.1152/japplphysiol.01133.2006; Mwanjewe J, 2000, J BIOL CHEM, V275, P33512, DOI 10.1074/jbc.M005435200; Mwanjewe J, 2004, BIOCHEM J, V378, P975, DOI 10.1042/BJ20031187; Narkar VA, 2001, J AM SOC NEPHROL, V12, P1844, DOI 10.1681/ASN.V1291844; Nuccitelli S, 2006, ANN NY ACAD SCI, V1090, P217, DOI 10.1196/annals.1378.024; O'Driscoll CM, 2005, NEUROSCIENCE, V131, P321, DOI 10.1016/j.neuroscience.2004.11.015; Okano H, 2008, BIOELECTROMAGNETICS, V29, P233, DOI 10.1002/bem.20376; Okano H, 2007, BIOELECTROMAGNETICS, V28, P497, DOI 10.1002/bem.20330; Okano H, 2006, BIOELECTROMAGNETICS, V27, P628, DOI 10.1002/bem.20246; OLAH ME, 1995, ANNU REV PHARMACOL, V35, P581, DOI 10.1146/annurev.pa.35.040195.003053; Park TJ, 1998, J NEUROCHEM, V71, P1251; Petrov E, 2007, EUR BIOPHYS J BIOPHY, V36, P95, DOI 10.1007/s00249-006-0109-z; Pilla Arthur A., 1994, Reviews on Environmental Health, V10, P155; Popoli P, 2007, PROG NEUROBIOL, V81, P331, DOI 10.1016/j.pneurobio.2006.12.005; POUCHER SM, 1995, BRIT J PHARMACOL, V115, P1096, DOI 10.1111/j.1476-5381.1995.tb15923.x; Regaya I, 2004, LIFE SCI, V76, P367, DOI 10.1016/j.lfs.2004.06.023; Riemer J, 2004, ANAL BIOCHEM, V331, P370, DOI 10.1016/j.ab.2004.03.049; Rosen AD, 2003, CELL BIOCHEM BIOPHYS, V39, P163, DOI 10.1385/CBB:39:2:163; Rosen AD, 2003, BIOELECTROMAGNETICS, V24, P517, DOI 10.1002/bem.10124; Rozen S, 2000, Methods Mol Biol, V132, P365; SANDYK R, 1992, INT J NEUROSCI, V63, P141, DOI 10.3109/00207459208986664; Schonfeld E, 2007, NEUROCHEM RES, V32, P1673, DOI 10.1007/s11064-007-9378-x; Strehler B. L., 1974, METHOD ENZYMAT AN, P2112, DOI [10.1016/b978-0-12-091304-6.50065-3, DOI 10.1016/B978-0-12-091304-6.50065-3]; STURROCK A, 1990, J BIOL CHEM, V265, P3139; Takahashi RN, 2008, FRONT BIOSCI-LANDMRK, V13, P2614, DOI 10.2741/2870; Taniguchi N, 2004, EVID-BASED COMPL ALT, V1, P187, DOI 10.1093/ecam/neh024; Tenuzzo B, 2009, TISSUE CELL, V41, P169, DOI 10.1016/j.tice.2008.09.004; Tenuzzo B, 2006, BIOELECTROMAGNETICS, V27, P560, DOI 10.1002/bem.20252; Theodosis DT, 1999, J NEUROSCI, V19, P10228; TRACEY WR, 1990, J PHARMACOL EXP THER, V252, P922; Triantafilou M, 2004, J CELL SCI, V117, P4007, DOI 10.1242/jcs.01270; VAJANAPHANICH M, 1995, J CLIN INVEST, V96, P386, DOI 10.1172/JCI118046; Vu CB, 2004, J MED CHEM, V47, P4291, DOI 10.1021/jm0498405; Wang ZY, 2006, J BIOL CHEM, V281, P27016, DOI 10.1074/jbc.M604903200; Wang ZY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-356; WRIGHT TL, 1986, J BIOL CHEM, V261, P909; Wyatt AW, 2002, FASEB J, V16, P1584, DOI 10.1096/fasebj.16.12.1584; Yang M, 2007, N-S ARCH PHARMACOL, V375, P133, DOI 10.1007/s00210-007-0135-0; Zhang L, 2006, PHARMACOL THERAPEUT, V109, P33, DOI 10.1016/j.pharmthera.2005.05.007; Zhang XJ, 1998, CHEM PHYS LIPIDS, V97, P55, DOI 10.1016/S0009-3084(98)00092-9; ZHANG Y, 1991, AM J PHYSIOL, V260, pG658, DOI 10.1152/ajpgi.1991.260.4.G658	81	39	39	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e13883	10.1371/journal.pone.0013883	http://dx.doi.org/10.1371/journal.pone.0013883			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	676NU	21079735	Green Published, Green Submitted, gold			2022-12-25	WOS:000283920000015
J	Creech, CC; Neumann, DM				Creech, Clinton C.; Neumann, Donna M.			Changes to Euchromatin on LAT and ICP4 Following Reactivation Are More Prevalent in an Efficiently Reactivating Strain of HSV-1	PLOS ONE			English	Article							SIMPLEX-VIRUS TYPE-1; FACULTATIVE HETEROCHROMATIN; LYTIC INFECTION; GENE PROMOTERS; EARLY TIMES; HISTONE H3; VIRAL-DNA; LATENCY; PROTEIN; ESTABLISHMENT	Background: Epigenetic mechanisms, via post-translational histone modifications, have roles in the establishment and maintenance of latency of the HSV-1 genome in the sensory neurons. Considering that many post-translational histone marks are reversible in nature, epigenetic mechanisms may also play a critical role in the process of induced HSV-1 reactivation. Methodology/Principal Findings: This study utilized the rabbit ocular model of HSV-1 infection and reactivation, induced by the transcorneal iontophoresis of epinephrine (TCIE), to characterize changes to chromatin that occur between 0.5 and 4 h following the application of the reactivation stimulus. Our goal was to explore the hypothesis that chromatin remodeling is an early and essential step in the process of HSV-1 reactivation. Analysis of the HSV-1 latently infected rabbit trigeminal ganglia (TG) showed that enrichment of the euchromatic marker H3K4me2 significantly decreased in the LAT 5'exon region (similar to 2.5-fold) and significantly increased in the lytic ICP4 promoter region (similar to 3-fold) by 1 h post-TCIE in the highly efficient reactivating McKrae strain of HSV-1. In contrast, we observed no significant change in the euchromatic marks of H3K4me2 associated with LAT 5'exon or ICP4 promoter regions of the poorly reactivating KOS strain of HSV-1 following TCIE through 4 h. The implication that these observed epigenetic changes were linked to transcriptional activity was confirmed by qRT-PCR examining both LAT and lytic transcript abundance following TCIE. We found a significant decrease in the abundance of LAT RNA by 2 h post-iontophoresis of epinephrine coupled to an increase in the transcript abundance of ICP4 in the McKrae strain of HSV-1. By comparison, we observed no change in the LAT or ICP4 transcript abundance of the poor reactivator KOS following iontophoresis of epinephrine through 4 h. Conclusions/Significance: Our results implicate that chromatin remodeling is an early and essential step involved in the process of in vivo HSV-1 reactivation.	[Creech, Clinton C.; Neumann, Donna M.] Louisiana State Univ, Hlth Sci Ctr, Dept Ophthalmol, LSU Eye Ctr Excellence, New Orleans, LA USA; [Neumann, Donna M.] Louisiana State Univ, Hlth Sci Ctr, Dept Genet, New Orleans, LA USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Creech, CC (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Ophthalmol, LSU Eye Ctr Excellence, New Orleans, LA USA.	dneum1@lsuhsc.edu			Louisiana State University Health Sciences Center Eye Center Core [P30EY002377]; Louisiana State University Health Sciences Center Chancellor's Translational Research Initiative; Louisiana Lions Eye Foundation; Research to Prevent Blindness, New York, NY (Louisiana State University Health Sciences Center Department of Ophthalmology); NATIONAL EYE INSTITUTE [P30EY002377] Funding Source: NIH RePORTER	Louisiana State University Health Sciences Center Eye Center Core; Louisiana State University Health Sciences Center Chancellor's Translational Research Initiative; Louisiana Lions Eye Foundation; Research to Prevent Blindness, New York, NY (Louisiana State University Health Sciences Center Department of Ophthalmology)(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by the P30EY002377 (Louisiana State University Health Sciences Center Eye Center Core), Louisiana State University Health Sciences Center Chancellor's Translational Research Initiative award (DMN), funding from the Louisiana Lions Eye Foundation and by an unrestricted grant from Research to Prevent Blindness, New York, NY (Louisiana State University Health Sciences Center Department of Ophthalmology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott K C, 1986, J Ocul Pharmacol, V2, P41, DOI 10.1089/jop.1986.2.41; Amelio AL, 2006, J VIROL, V80, P2358, DOI 10.1128/JVI.80.5.2358-2368.2006; Amelio AL, 2006, J VIROL, V80, P2063, DOI 10.1128/JVI.80.4.2063-2068.2006; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bloom DC, 2010, BBA-GENE REGUL MECH, V1799, P246, DOI 10.1016/j.bbagrm.2009.12.001; Bloom DC, 2004, INT REV IMMUNOL, V23, P187, DOI 10.1080/08830180490265592; Bloom DC, 1996, J VIROL, V70, P2449, DOI 10.1128/JVI.70.4.2449-2459.1996; Bloom DC, 2006, ALPHA HERPESVIRUSES, P325; CAI WH, 1993, J VIROL, V67, P7501, DOI 10.1128/JVI.67.12.7501-7512.1993; CAI WZ, 1992, J VIROL, V66, P2904, DOI 10.1128/JVI.66.5.2904-2915.1992; Chen SH, 1997, J VIROL, V71, P5878, DOI 10.1128/JVI.71.8.5878-5884.1997; Cliffe AR, 2009, J VIROL, V83, P8182, DOI 10.1128/JVI.00712-09; Cliffe AR, 2008, J VIROL, V82, P12030, DOI 10.1128/JVI.01575-08; Coleman HM, 2008, J GEN VIROL, V89, P68, DOI 10.1099/vir.0.83272-0; Danaher RJ, 2005, J NEUROVIROL, V11, P306, DOI 10.1080/13550280590952817; Davido DJ, 1996, J GEN VIROL, V77, P1853, DOI 10.1099/0022-1317-77-8-1853; DESHMANE SL, 1989, J VIROL, V63, P943, DOI 10.1128/JVI.63.2.943-947.1989; Ellis DJP, 2008, BIOCHEM BIOPH RES CO, V367, P656, DOI 10.1016/j.bbrc.2007.12.157; Giordani NV, 2008, J VIROL, V82, P6056, DOI 10.1128/JVI.02661-07; Gu HD, 2007, P NATL ACAD SCI USA, V104, P17134, DOI 10.1073/pnas.0707266104; Halford WP, 2001, J VIROL, V75, P6143, DOI 10.1128/JVI.75.13.6143-6153.2001; Halford WP, 2001, J VIROL, V75, P3240, DOI 10.1128/JVI.75.7.3240-3249.2001; Herrera FJ, 2004, J VIROL, V78, P9689, DOI 10.1128/JVI.78.18.9689-9696.2004; HILL JM, 1985, INVEST OPHTH VIS SCI, V26, P1299; HILL JM, 1987, CURR EYE RES, V6, P91, DOI 10.3109/02713688709020074; HILL JM, 1983, INVEST OPHTH VIS SCI, V24, P243; HILL JM, 1993, OPHTHALMIC DRUG DELI, P331; Ho AK, 2007, ENDOCRINOLOGY, V148, P4592, DOI 10.1210/en.2007-0578; Huang J, 2006, J VIROL, V80, P5740, DOI 10.1128/JVI.00169-06; Kent JR, 2004, J VIROL, V78, P10178, DOI 10.1128/JVI.78.18.10178-10186.2004; Kubat NJ, 2004, J VIROL, V78, P1139, DOI 10.1128/JVI.78.3.1139-1149.2004; Kubat NJ, 2004, J VIROL, V78, P12508, DOI 10.1128/JVI.78.22.12508-12518.2004; Kwiatkowski DL, 2009, J VIROL, V83, P8173, DOI 10.1128/JVI.00686-09; LEIB DA, 1989, J VIROL, V63, P759, DOI 10.1128/JVI.63.2.759-768.1989; Liang Y, 2009, NAT MED, V15, P1312, DOI 10.1038/nm.2051; Miller CS, 2006, J VIROL, V80, P3360, DOI 10.1128/JVI.80.7.3360-3368.2006; Narayanan A, 2007, P NATL ACAD SCI USA, V104, P10835, DOI 10.1073/pnas.0704351104; Neumann DM, 2007, J VIROL, V81, P13248, DOI 10.1128/JVI.01569-07; Neumann DM, 2007, J VIROL, V81, P6106, DOI 10.1128/JVI.00070-07; Newton SS, 2006, MOL PHARMACOL, V70, P440, DOI 10.1124/mol.106.027078; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Perng GC, 2000, SCIENCE, V287, P1500, DOI 10.1126/science.287.5457.1500; Perng GC, 2000, J VIROL, V74, P1885, DOI 10.1128/JVI.74.4.1885-1891.2000; Perng GC, 1999, J VIROL, V73, P920, DOI 10.1128/JVI.73.2.920-929.1999; Poon APW, 2006, P NATL ACAD SCI USA, V103, P9993, DOI 10.1073/pnas.0604142103; Reston CAP, 2007, J VIROL, V81, P11781, DOI 10.1128/JVI.01234-07; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Sawtell NM, 1998, J VIROL, V72, P5343, DOI 10.1128/JVI.72.7.5343-5350.1998; SPIVACK JG, 1987, J VIROL, V61, P3841, DOI 10.1128/JVI.61.12.3841-3847.1987; SPIVACK JG, 1988, J VIROL, V62, P663; STEVENS JG, 1987, SCIENCE, V235, P1056, DOI 10.1126/science.2434993; Thompson RL, 2006, J VIROL, V80, P10919, DOI 10.1128/JVI.01253-06; Thompson RL, 1997, J VIROL, V71, P5432, DOI 10.1128/JVI.71.7.5432-5440.1997; Thompson RL, 2001, J VIROL, V75, P6660, DOI 10.1128/JVI.75.14.6660-6675.2001; Toma Hassanain S, 2008, Semin Ophthalmol, V23, P249, DOI 10.1080/08820530802111085; Trojer P, 2007, MOL CELL, V28, P1, DOI 10.1016/j.molcel.2007.09.011; Wagner EK, 1997, CLIN MICROBIOL REV, V10, P419, DOI 10.1128/CMR.10.3.419; Wang QY, 2005, P NATL ACAD SCI USA, V102, P16055, DOI 10.1073/pnas.0505850102; Wilcox CL, 1997, J VIROL, V71, P6777, DOI 10.1128/JVI.71.9.6777-6785.1997	59	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e15416	10.1371/journal.pone.0015416	http://dx.doi.org/10.1371/journal.pone.0015416			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079815	gold, Green Submitted, Green Published			2022-12-25	WOS:000283838600027
J	Hegyi, G; Herenyi, M; Wilson, AJ; Garamszegi, LZ; Rosivall, B; Eens, M; Torok, J				Hegyi, Gergely; Herenyi, Marton; Wilson, Alastair J.; Garamszegi, Laszlo Zsolt; Rosivall, Balazs; Eens, Marcel; Toeroek, Janos			Breeding Experience and the Heritability of Female Mate Choice in Collared Flycatchers	PLOS ONE			English	Article							SEXUALLY SELECTED TRAIT; WILD BIRD POPULATION; MATING PREFERENCES; PIED FLYCATCHERS; PASSERINE BIRD; ZEBRA FINCH; LEK PARADOX; QUANTITATIVE GENETICS; PHENOTYPIC PLASTICITY; REPRODUCTIVE SUCCESS	Background: Heritability in mate preferences is assumed by models of sexual selection, and preference evolution may contribute to adaptation to changing environments. However, mate preference is difficult to measure in natural populations as detailed data on mate availability and mate sampling are usually missing. Often the only available information is the ornamentation of the actual mate. The single long-term quantitative genetic study of a wild population found low heritability in female mate ornamentation in Swedish collared flycatchers. One potentially important cause of low heritability in mate ornamentation at the population level is reduced mate preference expression among inexperienced individuals. Methodology/Principal Findings: Applying animal model analyses to 21 years of data from a Hungarian collared flycatcher population, we found that additive genetic variance was 50 percent and significant for ornament expression in males, but less than 5 percent and non-significant for mate ornamentation treated as a female trait. Female breeding experience predicted breeding date and clutch size, but mate ornamentation and its variance components were unrelated to experience. Although we detected significant area and year effects on mate ornamentation, more than 85 percent of variance in this trait remained unexplained. Moreover, the effects of area and year on mate ornamentation were also highly positively correlated between inexperienced and experienced females, thereby acting to remove difference between the two groups. Conclusions/Significance: The low heritability of mate ornamentation was apparently not explained by the presence of inexperienced individuals. Our results further indicate that the expression of mate ornamentation is dominated by temporal and spatial constraints and unmeasured background factors. Future studies should reduce unexplained variance or use alternative measures of mate preference. The heritability of mate preference in the wild remains a principal but unresolved question in evolutionary ecology.	[Hegyi, Gergely; Herenyi, Marton; Rosivall, Balazs; Toeroek, Janos] Eotvos Lorand Univ, Dept Systemat Zool & Ecol, Behav Ecol Grp, Budapest, Hungary; [Wilson, Alastair J.] Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland; [Garamszegi, Laszlo Zsolt] CSIC, Estac Biol Donana, Dept Evolutionary Ecol, E-41080 Seville, Spain; [Eens, Marcel] Univ Antwerp, Dept Biol, Antwerp, Belgium	Eotvos Lorand University; University of Edinburgh; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Antwerp	Hegyi, G (corresponding author), Eotvos Lorand Univ, Dept Systemat Zool & Ecol, Behav Ecol Grp, Budapest, Hungary.	everest@ludens.elte.hu	Rosivall, Balázs/T-1057-2017; Hegyi, Gergely/AAG-4988-2021; Eens, Marcel/AAC-8466-2020; Torok, Janos/C-6144-2008; Garamszegi, Laszlo/M-1488-2015; Garamszegi, Laszlo Z/B-5089-2011; Wilson, Alastair/F-3118-2010	Rosivall, Balázs/0000-0002-0732-1160; Hegyi, Gergely/0000-0002-4906-3550; Torok, Janos/0000-0002-4799-5522; Garamszegi, Laszlo/0000-0001-8920-2183; Wilson, Alastair/0000-0002-5045-2051	Orszagos Tudomanyos Kutatasi Alapprogramok [T49650, T49678, K75618, PD72117]; Bolyai Janos fellowship; Pilis Park Forestry; Erdok a Kozjoert Alapitvany	Orszagos Tudomanyos Kutatasi Alapprogramok(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Bolyai Janos fellowship(Hungarian Academy of Sciences); Pilis Park Forestry; Erdok a Kozjoert Alapitvany	This study was supported by Orszagos Tudomanyos Kutatasi Alapprogramok (grants T49650, T49678, K75618 and PD72117 to J.T., L.Z.G. and G.H.), a Bolyai Janos fellowship to G. H., the Pilis Park Forestry, and the Erdok a Kozjoert Alapitvany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALATALO RV, 1986, NATURE, V323, P152, DOI 10.1038/323152a0; Badyaev AV, 2000, EVOLUTION, V54, P2134, DOI 10.1111/j.0014-3820.2000.tb01255.x; BAKKER TCM, 1995, J EVOLUTION BIOL, V8, P129, DOI 10.1046/j.1420-9101.1995.8020129.x; Balbontin J, 2007, J ANIM ECOL, V76, P915, DOI 10.1111/j.1365-2656.2007.01269.x; BENSCH S, 1992, ANIM BEHAV, V44, P301, DOI 10.1016/0003-3472(92)90036-9; Benton TG, 1998, BEHAV ECOL SOCIOBIOL, V44, P91, DOI 10.1007/s002650050520; Blums P, 1997, AUK, V114, P737, DOI 10.2307/4089293; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Both C, 2001, NATURE, V411, P296, DOI 10.1038/35077063; Boughman JW, 2001, NATURE, V411, P944, DOI 10.1038/35082064; Brooks R, 2001, EVOLUTION, V55, P1644, DOI 10.1111/j.0014-3820.2001.tb00684.x; Buchholz R, 2004, BEHAV ECOL, V15, P687, DOI 10.1093/beheco/arh066; Bussiere LF, 2008, GENETICA, V134, P69, DOI 10.1007/s10709-007-9220-z; Charmantier A, 2005, MOL ECOL, V14, P2839, DOI 10.1111/j.1365-294X.2005.02619.x; Chenoweth SF, 2006, NAT REV GENET, V7, P681, DOI 10.1038/nrg1924; Cichon M, 2003, OECOLOGIA, V134, P78, DOI 10.1007/s00442-002-1099-x; Coltman DW, 2003, NATURE, V426, P655, DOI 10.1038/nature02177; Cotton S, 2006, CURR BIOL, V16, pR755, DOI 10.1016/j.cub.2006.08.022; DALE S, 1992, BEHAV ECOL SOCIOBIOL, V30, P165, DOI 10.1007/BF00166699; Dale S, 1996, BEHAVIOUR, V133, P903, DOI 10.1163/156853996X00305; Doligez B, 2002, SCIENCE, V297, P1168, DOI 10.1126/science.1072838; FORSLUND P, 1995, TRENDS ECOL EVOL, V10, P374, DOI 10.1016/S0169-5347(00)89141-7; Forstmeier W, 2004, ANIM BEHAV, V68, P1017, DOI 10.1016/j.anbehav.2004.02.007; Forstmeier W, 2004, EVOLUTION, V58, P2574; Garamszegi LZ, 2004, BEHAV ECOL, V15, P148, DOI 10.1093/beheco/arg108; GOMULKIEWICZ R, 1991, AM NAT, V138, P1396, DOI 10.1086/285293; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; Greene E, 2000, NATURE, V407, P1000, DOI 10.1038/35039500; Griffith SC, 1999, P ROY SOC B-BIOL SCI, V266, P765; Hedrick A, 1998, BEHAV ECOL, V9, P582, DOI 10.1093/beheco/9.6.582; Hegyi G, 2006, J EVOLUTION BIOL, V19, P228, DOI 10.1111/j.1420-9101.2005.00970.x; Hegyi G, 2002, J EVOLUTION BIOL, V15, P710, DOI 10.1046/j.1420-9101.2002.00449.x; Hegyi G, 2008, NATURWISSENSCHAFTEN, V95, P993, DOI 10.1007/s00114-008-0408-6; Hegyi G, 2008, ANIM BEHAV, V75, P977, DOI 10.1016/j.anbehav.2007.08.009; Hegyi G, 2007, BEHAV ECOL, V18, P1116, DOI 10.1093/beheco/arm085; Hegyi G, 2007, EVOL ECOL RES, V9, P905; Hegyi G, 2010, NATURWISSENSCHAFTEN, V97, P567, DOI 10.1007/s00114-010-0672-0; HEISLER IL, 1987, SEXUAL SELECTION TES, P96; Hoekstra HE, 2001, P NATL ACAD SCI USA, V98, P9157, DOI 10.1073/pnas.161281098; HOELZER GA, 1989, ANIM BEHAV, V38, P1067, DOI 10.1016/S0003-3472(89)80146-0; Hoglund J., 1995, LEKS, DOI DOI 10.1515/9781400864157; Holland B, 1998, EVOLUTION, V52, P1, DOI 10.1111/j.1558-5646.1998.tb05132.x; Holveck MJ, 2010, P ROY SOC B-BIOL SCI, V277, P153, DOI 10.1098/rspb.2009.1222; Jang YW, 2000, HEREDITY, V84, P73, DOI 10.1046/j.1365-2540.2000.00631.x; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Johnstone RA, 1996, EVOLUTION, V50, P1382, DOI [10.2307/2410876, 10.1111/j.1558-5646.1996.tb03912.x]; Kirkpatrick M, 2002, AM NAT, V159, pS22, DOI 10.1086/338370; KLOMP H, 1970, ARDEA, V58, P1; Kokko H, 2006, ANNU REV ECOL EVOL S, V37, P43, DOI 10.1146/annurev.ecolsys.37.091305.110259; Kraaijeveld K, 2007, ANIM BEHAV, V74, P657, DOI 10.1016/j.anbehav.2006.12.027; Kruger O, 2001, EVOLUTION, V55, P1207; Kruuk LEB, 2007, J EVOLUTION BIOL, V20, P1890, DOI 10.1111/j.1420-9101.2007.01377.x; Kruuk LEB, 2004, PHILOS T R SOC B, V359, P873, DOI 10.1098/rstb.2003.1437; Lorch PD, 2003, EVOL ECOL RES, V5, P867; Ludwig SC, 2008, BEHAV ECOL SOCIOBIOL, V62, P1601, DOI 10.1007/s00265-008-0589-1; Lynch M., 1998, GENETICS ANAL QUANTI; McGuigan K, 2008, AM NAT, V172, P194, DOI 10.1086/588075; Michl G, 2002, P NATL ACAD SCI USA, V99, P5466, DOI 10.1073/pnas.082036699; Mitchell DP, 2007, ANIM BEHAV, V73, P165, DOI 10.1016/j.anbehav.2006.07.006; Moller AP, 2006, EVOLUTION, V60, P856; Moller AP, 2005, J EVOLUTION BIOL, V18, P481, DOI 10.1111/j.1420-9101.2004.00807.x; Moller AP, 1999, P ROY SOC B-BIOL SCI, V266, P85, DOI 10.1098/rspb.1999.0607; Moller AP, 2002, J EVOLUTION BIOL, V15, P495, DOI 10.1046/j.1420-9101.2002.00386.x; Murphy CG, 2000, EVOLUTION, V54, P660; NEWTON I, 1994, BIOL CONSERV, V70, P265, DOI 10.1016/0006-3207(94)90172-4; POMIANKOWSKI A, 1995, P ROY SOC B-BIOL SCI, V260, P21, DOI 10.1098/rspb.1995.0054; Postma E, 2006, NATURE, V444, pE16, DOI 10.1038/nature05501; POTTI J, 1991, ORNIS SCAND, V22, P45, DOI 10.2307/3676620; Price TD, 2008, AM NAT, V172, pS49, DOI 10.1086/588257; Qvarnstrom A, 2006, NATURE, V441, P84, DOI 10.1038/nature04564; Qvarnstrom A, 2000, NATURE, V405, P344, DOI 10.1038/35012605; Qvarnstrom A, 2004, BEHAV ECOL, V15, P543, DOI 10.1093/beheco/arh043; Qvarnstrom A, 2006, NATURE, V444, pE16, DOI 10.1038/nature05502; Radwan J, 2008, GENETICA, V134, P113, DOI 10.1007/s10709-007-9203-0; REID ML, 1990, ANIM BEHAV, V40, P538, DOI 10.1016/S0003-3472(05)80534-2; Reinhold K, 2002, ANIM BEHAV, V64, P245, DOI 10.1006/anbe.2002.3061; Ritchie MG, 1996, P NATL ACAD SCI USA, V93, P14628, DOI 10.1073/pnas.93.25.14628; Robertson RJ, 2001, J ANIM ECOL, V70, P1014, DOI 10.1046/j.0021-8790.2001.00555.x; Rosivall B, 2009, ANIM BEHAV, V77, P611, DOI 10.1016/j.anbehav.2008.11.009; Roulin A, 1999, BEHAV ECOL, V10, P688, DOI 10.1093/beheco/10.6.688; Roulin A, 2007, J ETHOL, V25, P99, DOI 10.1007/s10164-006-0006-z; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; Rutstein AN, 2007, ANIM BEHAV, V74, P1277, DOI 10.1016/j.anbehav.2007.02.022; Saetre GP, 1997, NATURE, V387, P589; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; SHAW RG, 1987, EVOLUTION, V41, P812, DOI 10.1111/j.1558-5646.1987.tb05855.x; Svensson EI, 2007, FUNCT ECOL, V21, P422, DOI 10.1111/j.1365-2435.2007.01265.x; Tomkins JL, 2004, TRENDS ECOL EVOL, V19, P323, DOI 10.1016/j.tree.2004.03.029; TOROK J, 1988, J ANIM ECOL, V57, P251, DOI 10.2307/4776; Torok J, 2004, OECOLOGIA, V141, P432, DOI 10.1007/s00442-004-1667-3; vonSchantz T, 1996, P ROY SOC B-BIOL SCI, V263, P265, DOI 10.1098/rspb.1996.0041; Wagner WE, 1998, ANIM BEHAV, V55, P1029, DOI 10.1006/anbe.1997.0635; Widemo F, 1999, TRENDS ECOL EVOL, V14, P26, DOI 10.1016/S0169-5347(98)01531-6; Wilson AJ, 2008, J EVOLUTION BIOL, V21, P647, DOI 10.1111/j.1420-9101.2008.01500.x	94	5	5	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e13855	10.1371/journal.pone.0013855	http://dx.doi.org/10.1371/journal.pone.0013855			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079813	Green Published, Green Submitted, gold			2022-12-25	WOS:000283838600023
J	Schildknecht, S; Pape, R; Muller, N; Robotta, M; Marquardt, A; Burkle, A; Drescher, M; Leist, M				Schildknecht, Stefan; Pape, Regina; Mueller, Nathalie; Robotta, Marta; Marquardt, Andreas; Buerkle, Alexander; Drescher, Malte; Leist, Marcel			Neuroprotection by Minocycline Caused by Direct and Specific Scavenging of Peroxynitrite	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; MICROGLIAL ACTIVATION; TYROSINE NITRATION; OXIDATIVE STRESS; UP-REGULATION; DOPAMINERGIC NEURODEGENERATION; PROSTANOID SYNTHESIS; ALZHEIMERS-DISEASE; LATERAL-SCLEROSIS; SUBSTANTIA-NIGRA	Minocycline prevents oxidative protein modifications and damage in disease models associated with inflammatory glial activation and oxidative stress. Although the drug has been assumed to act by preventing the up-regulation of proinflammatory enzymes, we probed here its direct chemical interaction with reactive oxygen species. The antibiotic did not react with superoxide or (NO)-N-center dot radicals, but peroxynitrite (PON) was scavenged in the range of similar to 1 mu M minocycline and below. The interaction of pharmacologically relevant minocycline concentrations with PON was corroborated in several assay systems and significantly exceeded the efficacy of other antibiotics. Minocycline was degraded during the reaction with PON, and the resultant products lacked antioxidant properties. The antioxidant activity of minocycline extended to cellular systems, because it prevented neuronal mitochondrial DNA damage and glutathione depletion. Maintenance of neuronal viability under PON stress was shown to be solely dependent on direct chemical scavenging by minocycline. We chose alpha-synuclein (ASYN), known from Parkinsonian pathology as a biologically relevant target in chemical and cellular nitration reactions. Submicromolar concentrations of minocycline prevented tyrosine nitration of ASYN by PON. Mass spectrometric analysis revealed that minocycline impeded nitrations more effectively than methionine oxidations and dimerizations of ASYN, which are secondary reactions under PON stress. Thus, PON scavenging at low concentrations is a novel feature of minocycline and may help to explain its pharmacological activity.	[Schildknecht, Stefan; Pape, Regina; Leist, Marcel] Univ Konstanz, Dept Vitro Toxicol & Biomed, Fac Biol, D-78457 Constance, Germany; [Mueller, Nathalie; Buerkle, Alexander] Univ Konstanz, Dept Mol Toxicol, Fac Biol, D-78457 Constance, Germany; [Robotta, Marta; Drescher, Malte] Univ Konstanz, Emmy Noether EPR Grp, D-78457 Constance, Germany; [Marquardt, Andreas] Univ Konstanz, Mass Spectrometry Facil, Fac Chem, D-78457 Constance, Germany	University of Konstanz; University of Konstanz; University of Konstanz; University of Konstanz	Schildknecht, S (corresponding author), Univ Konstanz, Dept Vitro Toxicol & Biomed, Fac Biol, POB M657, D-78457 Constance, Germany.	Stefan.Schildknecht@uni-konstanz.de	Leist, Marcel/D-2133-2010; Drescher, Malte/B-2578-2012	Leist, Marcel/0000-0002-3778-8693; 	Doerenkamp-Zbinden foundation; Land Baden-Wurttemberg; KoRS-CB; IRTG [1331]; Deutsche Forschungsgemeinschaft	Doerenkamp-Zbinden foundation; Land Baden-Wurttemberg; KoRS-CB; IRTG; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Doerenkamp-Zbinden foundation, the Land Baden-Wurttemberg, KoRS-CB, IRTG 1331, and the Deutsche Forschungsgemeinschaft.	Agostini S, 2010, GASTROENTEROLOGY, V139, P553, DOI 10.1053/j.gastro.2010.03.046; Arimoto T, 2003, NEUROBIOL DIS, V12, P35, DOI 10.1016/S0969-9961(02)00017-7; Beckman JS, 1996, CHEM RES TOXICOL, V9, P836, DOI 10.1021/tx9501445; Brades S, 2009, GASTROENTEROLOGY, V136, P1339, DOI 10.1053/j.gastro.2008.12.044; Brundula V, 2002, BRAIN, V125, P1297, DOI 10.1093/brain/awf133; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; Cho Y, 2009, NEUROTOX RES, V16, P361, DOI 10.1007/s12640-009-9078-1; Choi SH, 2005, J NEUROCHEM, V95, P1755, DOI 10.1111/j.1471-4159.2005.03503.x; Du YS, 2001, P NATL ACAD SCI USA, V98, P14669, DOI 10.1073/pnas.251341998; Falsig J, 2008, J NEUROSCI RES, V86, P1434, DOI 10.1002/jnr.21590; Familian A, 2006, GLIA, V53, P233, DOI 10.1002/glia.20268; Fillpovic R, 2008, EXP NEUROL, V211, P41, DOI 10.1016/j.expneurol.2007.12.024; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Gieseler A, 2009, BIOCHEM PHARMACOL, V77, P888, DOI 10.1016/j.bcp.2008.11.003; Goulden V, 1996, BRIT J DERMATOL, V134, P693, DOI 10.1111/j.1365-2133.1996.tb06972.x; Hodara R, 2004, J BIOL CHEM, V279, P47746, DOI 10.1074/jbc.M408906200; Imam SZ, 2001, ANN NY ACAD SCI, V939, P366; Iravani MM, 2002, NEUROSCIENCE, V110, P49, DOI 10.1016/S0306-4522(01)00562-0; Jope RS, 2000, ARCH BIOCHEM BIOPHYS, V376, P365, DOI 10.1006/abbi.2000.1728; KASS GEN, 1988, ARCH BIOCHEM BIOPHYS, V260, P789, DOI 10.1016/0003-9861(88)90509-7; KELLY RG, 1967, TOXICOL APPL PHARM, V11, P171, DOI 10.1016/0041-008X(67)90036-1; Kim HS, 2009, BEHAV BRAIN RES, V196, P168, DOI 10.1016/j.bbr.2008.09.040; Koch H, 2001, J INVEST DERMATOL, V117, P892, DOI 10.1046/j.0022-202x.2001.01513.x; Kraus RL, 2005, J NEUROCHEM, V94, P819, DOI 10.1111/j.1471-4159.2005.03219.x; Kriz J, 2002, NEUROBIOL DIS, V10, P268, DOI 10.1006/nbdi.2002.0487; Leist M, 1998, EXP CELL RES, V239, P183, DOI 10.1006/excr.1997.4026; Lin SZ, 2001, NEUROSCI LETT, V315, P61, DOI 10.1016/S0304-3940(01)02324-2; Lotharius J, 2005, J NEUROSCI, V25, P6329, DOI 10.1523/JNEUROSCI.1746-05.2005; Machado LS, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-56; Moreno-Villanueva M, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-39; Nicotera P, 1999, TRENDS PHARMACOL SCI, V20, P46, DOI 10.1016/S0165-6147(99)01304-8; Perrin D, 2000, ARCH BIOCHEM BIOPHYS, V377, P266, DOI 10.1006/abbi.2000.1787; PRYOR WA, 1994, P NATL ACAD SCI USA, V91, P11173, DOI 10.1073/pnas.91.23.11173; SAIVIN S, 1988, CLIN PHARMACOKINET, V15, P355, DOI 10.2165/00003088-198815060-00001; Schildknecht S, 2008, FASEB J, V22, P215, DOI 10.1096/fj.06-8015com; Schildknecht S, 2009, TOXICOL APPL PHARM, V241, P23, DOI 10.1016/j.taap.2009.07.027; Schildknecht S, 2009, ARCH BIOCHEM BIOPHYS, V484, P183, DOI 10.1016/j.abb.2008.10.023; Schoneich C, 2005, BBA-PROTEINS PROTEOM, V1703, P111, DOI 10.1016/j.bbapap.2004.09.009; Schulz JB, 1997, MOL CELL BIOCHEM, V174, P193, DOI 10.1023/A:1006852306789; Su JH, 1997, BRAIN RES, V774, P193, DOI 10.1016/S0006-8993(97)81703-9; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; Tikka TM, 2001, J IMMUNOL, V166, P7527, DOI 10.4049/jimmunol.166.12.7527; Tomas-Camardiel M, 2004, NEUROBIOL DIS, V16, P190, DOI 10.1016/j.nbd.2004.01.010; VANDERVLIET A, 1995, ARCH BIOCHEM BIOPHYS, V319, P341, DOI 10.1006/abbi.1995.1303; Wang CX, 2002, BMC NEUROL, V2, DOI 10.1186/1471-2377-2-2; Wenzel P, 2008, CARDIOVASC RES, V80, P280, DOI 10.1093/cvr/cvn182; Whiteman M, 1997, FREE RADICAL RES, V26, P49, DOI 10.3109/10715769709097783; Wilkins A, 2004, NEURON GLIA BIOL, V1, P297, DOI 10.1017/S1740925X05000104; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; Yakovlev VA, 2007, BIOCHEMISTRY-US, V46, P11671, DOI 10.1021/bi701107z; Yong VW, 2004, LANCET NEUROL, V3, P744, DOI 10.1016/S1474-4422(04)00937-8; Yrjanheikki J, 1999, P NATL ACAD SCI USA, V96, P13496, DOI 10.1073/pnas.96.23.13496; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769; Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a	54	85	88	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					4991	5002		10.1074/jbc.M110.169565	http://dx.doi.org/10.1074/jbc.M110.169565			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21081502	hybrid, Green Submitted, Green Published			2022-12-25	WOS:000287230600007
J	Buhrman, G; Kumar, VSS; Cirit, M; Haugh, JM; Mattos, C				Buhrman, Greg; Kumar, V. S. Senthil; Cirit, Murat; Haugh, Jason M.; Mattos, Carla			Allosteric Modulation of Ras-GTP Is Linked to Signal Transduction through RAF Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H-RAS; STRUCTURAL BASIS; 3-DIMENSIONAL STRUCTURES; QUANTITATIVE-ANALYSIS; TRANSITION-STATE; PROTEIN-KINASE; BINDING; SWITCH; ACTIVATION; HYDROLYSIS	Ras is a key signal transduction protein in the cell. Mutants of Gly(12) and Gln(61) impair GTPase activity and are found prominently in cancers. In wild type Ras-GTP, an allosteric switch promotes disorder to order transition in switch II, placing Gln(61) in the active site. We show that the "on" and "off" conformations of the allosteric switch can also be attained in RasG12V and RasQ61L. Although both mutants have similarly impaired active sites in the on state, RasQ61L stabilizes an anti- catalytic conformation of switch II in the off state of the allosteric switch when bound to Raf. This translates into more potent activation of the MAPK pathway involving Ras, Raf kinase, MEK, and ERK (Ras/Raf/MEK/ERK) in cells transfected with RasQ61L relative to RasG12V. This differential is not observed in the Raf-independent pathway involving Ras, phosphoinositide 3-kinase (PI3K), and Akt (Ras/PI3K/Akt). Using a combination of structural analysis, hydrolysis rates, and experiments in NIH-3T3 cells, we link the allosteric switch to the control of signaling in the Ras/Raf/MEK/ERK pathway, supporting a GTPase-activating protein-independent model for duration of the Ras-Raf complex.	[Mattos, Carla] N Carolina State Univ, Dept Mol & Struct Biochem, Raleigh, NC 27695 USA; [Cirit, Murat; Haugh, Jason M.] N Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Mattos, C (corresponding author), N Carolina State Univ, Dept Mol & Struct Biochem, Box 7622,128 Polk Hall, Raleigh, NC 27695 USA.	carla_mattos@ncsu.edu		Haugh, Jason/0000-0002-2476-4027	National Institutes of Health [R01-CA096867, R56-CA096867]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W31-109-Eng-38]; NATIONAL CANCER INSTITUTE [R01CA096867, R56CA096867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088987] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-CA096867 and R56-CA096867.; Kathleen Davis and Susan Fetics made the RasG12V and RasQ61L mutants of the full-length protein inserted into the pBM-IRES-Puro vector for expression in NIH-3T3 cells. Stephanie Holsenbeck made the truncated RasG12V mutant in pET21a. Use of the Advanced Photon Source at the Argonne National Laboratory was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract W31-109-Eng-38.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Akasaka K, 1996, J BIOL CHEM, V271, P5353, DOI 10.1074/jbc.271.10.5353; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Buhrman G, 2003, STRUCTURE, V11, P747, DOI 10.1016/S0969-2126(03)00128-X; Buhrman G, 2007, STRUCTURE, V15, P1618, DOI 10.1016/j.str.2007.10.011; Buhrman G, 2010, P NATL ACAD SCI USA, V107, P4931, DOI 10.1073/pnas.0912226107; CASEY PJ, 1989, P NATL ACAD SCI USA, V86, P8323, DOI 10.1073/pnas.86.21.8323; CHUANG E, 1994, MOL CELL BIOL, V14, P5318, DOI 10.1128/MCB.14.8.5318; Cirit M, 2010, J BIOL CHEM, V285, P36736, DOI 10.1074/jbc.M110.148759; Cox AD, 2003, ONCOGENE, V22, P8999, DOI 10.1038/sj.onc.1207111; DER CJ, 1986, CELL, V44, P167, DOI 10.1016/0092-8674(86)90495-2; Du XL, 2009, BIOCHEMISTRY-US, V48, P4538, DOI 10.1021/bi802359b; Du XL, 2004, P NATL ACAD SCI USA, V101, P8858, DOI 10.1073/pnas.0401675101; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FRANKEN SM, 1993, BIOCHEMISTRY-US, V32, P8411, DOI 10.1021/bi00084a005; Gorfe AA, 2007, J MED CHEM, V50, P674, DOI 10.1021/jm061053f; Herrmann C, 1996, J BIOL CHEM, V271, P6794, DOI 10.1074/jbc.271.12.6794; HERRMANN C, 1995, J BIOL CHEM, V270, P2901, DOI 10.1074/jbc.270.7.2901; Huang L, 1998, NAT STRUCT BIOL, V5, P422, DOI 10.1038/nsb0698-422; JOHN J, 1989, J BIOL CHEM, V264, P13086; Kaur H, 2006, BIOCHEM J, V393, P235, DOI 10.1042/BJ20051022; KRENGEL U, 1990, CELL, V62, P539, DOI 10.1016/0092-8674(90)90018-A; Loupakis F, 2009, BRIT J CANCER, V101, P715, DOI 10.1038/sj.bjc.6605177; Maegley KA, 1996, P NATL ACAD SCI USA, V93, P8160, DOI 10.1073/pnas.93.16.8160; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; MINATO T, 1994, J BIOL CHEM, V269, P20845; Nassar N, 1996, NAT STRUCT BIOL, V3, P723, DOI 10.1038/nsb0896-723; NEAL SE, 1988, J BIOL CHEM, V263, P19718; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; SEEBURG PH, 1984, NATURE, V312, P71, DOI 10.1038/312071a0; Thapar R, 2004, J MOL BIOL, V343, P1391, DOI 10.1016/j.jmb.2004.08.106; TONG L, 1989, NATURE, V337, P90, DOI 10.1038/337090a0; TONG L, 1991, J MOL BIOL, V217, P503, DOI 10.1016/0022-2836(91)90753-S; VOGEL US, 1988, NATURE, V335, P90, DOI 10.1038/335090a0; Wang CC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.4	40	60	60	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3323	3331		10.1074/jbc.M110.193854	http://dx.doi.org/10.1074/jbc.M110.193854			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21098031	Green Published, hybrid			2022-12-25	WOS:000286653200018
J	Ralat, LA; Guo, Q; Ren, M; Funke, T; Dickey, DM; Potter, LR; Tang, WJ				Ralat, Luis A.; Guo, Qing; Ren, Min; Funke, Todd; Dickey, Deborah M.; Potter, Lincoln R.; Tang, Wei-Jen			Insulin-degrading Enzyme Modulates the Natriuretic Peptide-mediated Signaling Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COOH-TERMINAL TRIPEPTIDE; RAT; RECEPTORS; ENDOPEPTIDASE-24.11; DEGRADATION; SUBSTRATE; RECOGNITION; NEPRILYSIN; INSULYSIN; CLEAVAGE	Natriuretic peptides (NPs) are cyclic vasoactive peptide hormones with high therapeutic potential. Three distinct NPs (ANP, BNP, and CNP) can selectively activate natriuretic peptide receptors, NPR-A and NPR-B, raising the cyclic GMP (cGMP) levels. Insulin-degrading enzyme (IDE) was found to rapidly cleave ANP, but the functional consequences of such cleavages in the cellular environment and the molecular mechanism of recognition and cleavage remain unknown. Here, we show that reducing expression levels of IDE profoundly alters the response of NPR-A and NPR-B to the stimulation of ANP, BNP, and CNP in cultured cells. IDE rapidly cleaves ANP and CNP, thus inactivating their ability to raise intracellular cGMP. Conversely, reduced IDE expression enhances the stimulation of NPR-A and NPR-B by ANP and CNP, respectively. Instead of proteolytic inactivation, IDE cleavage can lead to hyperactivation of BNP toward NPR-A. Conversely, decreasing IDE expression reduces BNP-mediated signaling. Additionally, the cleavages of ANP and BNP by IDE render them active with NPR-B and a reduction of IDE expression diminishes the ability of ANP and BNP to stimulate NPR-B. Our kinetic and crystallographic analyses offer the molecular basis for the selective degradation of NPs and their variants by IDE. Furthermore, our studies reveal how IDE utilizes its catalytic chamber and exosite to engulf and bind up to two NPs leading to biased stochastic, non-sequential cleavages and the ability of IDE to switch its substrate selectivity. Thus, the evolutionarily conserved IDE may play a key role in modulating and reshaping the strength and duration of NP-mediated signaling.	[Ralat, Luis A.; Guo, Qing; Ren, Min; Funke, Todd; Tang, Wei-Jen] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Dickey, Deborah M.; Potter, Lincoln R.] Univ Minnesota, Dept Biochem, Minneapolis, MN 55455 USA; [Dickey, Deborah M.; Potter, Lincoln R.] Univ Minnesota, Dept Mol Biol, Minneapolis, MN 55455 USA; [Dickey, Deborah M.; Potter, Lincoln R.] Univ Minnesota, Dept Biophys, Minneapolis, MN 55455 USA	University of Chicago; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Tang, WJ (corresponding author), Univ Chicago, Ben May Dept Canc Res, 929 E 57th St, Chicago, IL 60637 USA.	wtang@uchicago.edu		Tang, Wei-Jen/0000-0002-8267-8995	National Institutes of Health [GM81539, F32 GM87093, 5T32HL07237-33, R21HL093402-01]; U.S. Dept. of Energy, Office of Basic Energy Sciences [W-31-109-ENG-38]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL093402, T32HL007237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081539, F32GM087093] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Dept. of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM81539 (to W.-J. T.), F32 GM87093 (to L. A. R.), 5T32HL07237-33 (to T. F.), and R21HL093402-01 (to L. R. P.).; We thank the staff of APS SBC for help in data collection. The use of the Advanced Photon Source was supported by the U.S. Dept. of Energy, Office of Basic Energy Sciences, under Contract No. W-31-109-ENG-38. The use of the proteomics service facility was supported by Chicago Biomedical Consortium.	CHINKERS M, 1989, NATURE, V338, P78, DOI 10.1038/338078a0; Dickey DM, 2009, J BIOL CHEM, V284, P19196, DOI 10.1074/jbc.M109.010777; DUCKWORTH WC, 1989, AM J PHYSIOL, V256, pE208, DOI 10.1152/ajpendo.1989.256.2.E208; Guo Q, 2010, J MOL BIOL, V395, P430, DOI 10.1016/j.jmb.2009.10.072; Hersh LB, 2006, CELL MOL LIFE SCI, V63, P2432, DOI 10.1007/s00018-006-6238-9; Hodgson-Zingman DM, 2008, NEW ENGL J MED, V359, P158, DOI 10.1056/NEJMoa0706300; JOHNSON GR, 1989, J BIOL CHEM, V264, P11637; JOHNSON GR, 1990, BIOCHEM BIOPH RES CO, V167, P110, DOI 10.1016/0006-291X(90)91737-D; KENNY AJ, 1993, BIOCHEM J, V291, P83, DOI 10.1042/bj2910083; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Malito E, 2008, CELL MOL LIFE SCI, V65, P2574, DOI 10.1007/s00018-008-8112-4; Malito E, 2008, BIOCHEMISTRY-US, V47, P12822, DOI 10.1021/bi801192h; Manolopoulou M, 2009, J BIOL CHEM, V284, P14177, DOI 10.1074/jbc.M900068200; Matsukawa N, 1999, P NATL ACAD SCI USA, V96, P7403, DOI 10.1073/pnas.96.13.7403; MULLER D, 1992, BIOCHEMISTRY-US, V31, P11138; MULLER D, 1991, EUR J BIOCHEM, V202, P285, DOI 10.1111/j.1432-1033.1991.tb16374.x; NUSSENZVEIG DR, 1990, J BIOL CHEM, V265, P20952; Pankow K, 2007, CIRC RES, V101, P875, DOI 10.1161/CIRCRESAHA.107.153585; Potter Lincoln R., 2009, V191, P341, DOI 10.1007/978-3-540-68964-5_15; Potter LR, 2006, ENDOCR REV, V27, P47, DOI 10.1210/er.2005-0014; Rubattu S, 2008, AM J HYPERTENS, V21, P733, DOI 10.1038/ajh.2008.174; SAXENHOFER H, 1990, AM J PHYSIOL, V259, pF832, DOI 10.1152/ajprenal.1990.259.5.F832; SCHWEITZ H, 1992, J BIOL CHEM, V267, P13928; SEYMOUR AA, 1991, J PHARMACOL EXP THER, V256, P1002; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; SHIMEKAKE Y, 1992, FEBS LETT, V309, P185, DOI 10.1016/0014-5793(92)81091-Y; Song ES, 2003, J BIOL CHEM, V278, P49789, DOI 10.1074/jbc.M308983200; Song ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009719; TOLL L, 1991, BIOCHEM BIOPH RES CO, V175, P886, DOI 10.1016/0006-291X(91)91648-V; VANNESTE Y, 1990, BIOCHEM J, V269, P801, DOI 10.1042/bj2690801; WEBB RL, 1989, J CARDIOVASC PHARM, V14, P285, DOI 10.1097/00005344-198908000-00015	31	54	57	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4670	4679		10.1074/jbc.M110.173252	http://dx.doi.org/10.1074/jbc.M110.173252			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21098034	hybrid, Green Published			2022-12-25	WOS:000286975700066
J	Bier, C; Knauer, SK; Klapthor, A; Schweitzer, A; Rekik, A; Kramer, OH; Marschalek, R; Stauber, RH				Bier, Carolin; Knauer, Shirley K.; Klapthor, Alexander; Schweitzer, Andrea; Rekik, Alexander; Kraemer, Oliver H.; Marschalek, Rolf; Stauber, Roland H.			Cell-based Analysis of Structure-Function Activity of Threonine Aspartase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPORT FACTOR FAMILY; NUCLEAR EXPORT; TRANSCRIPTIONAL ACTIVATION; PROTEIN STABILITY; FUSION PROTEIN; MLL; COMPLEX; LEUKEMIA; TASPASE1; SURVIVIN	Taspase1 is a threonine protease responsible for cleaving intracellular substrates. As such, (de) regulated Taspase1 function is expected not only to be vital for ordered development but may also be relevant for disease. However, the full repertoires of Taspase1 targets as well as the exact biochemical requirements for its efficient and substrate-specific cleavage are not yet resolved. Also, no cellular assays for this protease are currently available, hampering the exploitation of the (patho)biological relevance of Taspase1. Here, we developed highly efficient cell-based translocation biosensor assays to probe Taspase1 trans-cleavage in vivo. These modular sensors harbor variations of Taspase1 cleavage sites and localize to the cytoplasm. Expression of Taspase1 but not of inactive Taspase1 mutants or of unrelated proteases triggers proteolytic cleavage and nuclear accumulation of the biosensors. Employing our assay combined with scanning mutagenesis, we identified the sequence and spatial requirements for efficient Taspase1 processing in liquid and solid tumor cell lines. Collectively, our results defined an improved Taspase1 consensus recognition sequence, Q(3)(F/I/L/V)D-2(1) down arrow G(1)' X-2' D-3' D-4', allowing the first genome-wide bioinformatic identification of the human Taspase1 degradome. Among the 27 most likely Taspase1 targets are cytoplasmic but also nuclear proteins, such as the up-stream stimulatory factor 2 (USF2) or the nuclear RNA export factors 2/5 (NXF2/5). Cleavage site recognition and proteolytic processing of selected targets were verified in the context of the biosensor and for the full-length proteins. We provide novel mechanistic insights into the function and bona fide targets of Taspase1 allowing for a focused investigation of the (patho)biological relevance of this type 2 asparaginase.	[Stauber, Roland H.] Univ Hosp Mainz, Mol & Cellular Oncol Mainzer Screening Ctr, D-55101 Mainz, Germany; [Knauer, Shirley K.] Univ Duisburg Essen, Ctr Med Biotechnol, Inst Mol Biol, D-45117 Essen, Germany; [Kraemer, Oliver H.] Univ Jena, Ctr Mol Biomed, Inst Biochem & Biophys, D-07745 Jena, Germany; [Marschalek, Rolf] Goethe Univ Frankfurt, Inst Pharmaceut Biol ZAFES, D-60438 Frankfurt, Germany	University Hospital Mainz; University of Duisburg Essen; Friedrich Schiller University of Jena; Goethe University Frankfurt		bier@uni-mainz.de; shirley.knauer@uni-due.de; rstauber@uni-mainz.de	Krämer, Oliver H/L-9266-2015; Marschalek, Rolf/D-3404-2011; Knauer, Shirley K/E-7931-2012	Krämer, Oliver H/0000-0003-3973-045X; Marschalek, Rolf/0000-0003-4870-3445; Knauer, Shirley K/0000-0003-4321-0924; Stauber, Roland/0000-0002-1341-4523	German Cancer Aid [FKZ102362]; Head and Neck Cancer Foundation; Wilhelm-Sander Foundation; Chemical Industry, Stiftung Rheinland-Pfalz fur Innovationen [DFG KN973/1-1, DFG INST371/5-1FUGG]; Mainz Screening Center; Dr. Krieg; Inneruniversity; MAIFOR	German Cancer Aid(Deutsche Krebshilfe); Head and Neck Cancer Foundation; Wilhelm-Sander Foundation; Chemical Industry, Stiftung Rheinland-Pfalz fur Innovationen; Mainz Screening Center; Dr. Krieg; Inneruniversity; MAIFOR	This work was supported by German Cancer Aid Grant FKZ102362 (to R. H. S. and R. M.), Head and Neck Cancer Foundation (to C. B.), Wilhelm-Sander Foundation, Funds of the Chemical Industry, Stiftung Rheinland-Pfalz fur Innovationen Grants DFG KN973/1-1 and DFG INST371/5-1FUGG, Mainz Screening Center, donation from Dr. Krieg, and the Inneruniversity and MAIFOR Mainz Support Program.	Bursen A, 2004, ONCOGENE, V23, P6237, DOI 10.1038/sj.onc.1207837; Bursen A, 2010, BLOOD, V115, P3570, DOI 10.1182/blood-2009-06-229542; Capotosti F, 2007, MOL CELL BIOL, V27, P7063, DOI 10.1128/MCB.00769-07; Chen N, 2006, ONCOGENE, V25, P579, DOI 10.1038/sj.onc.1209079; DAHLQUIST KD, 2004, CURR PROTOC BIOINFOR, P1; Dubovsky JA, 2009, CLIN CANCER RES, V15, P3406, DOI 10.1158/1078-0432.CCR-08-2099; Eldridge AG, 2006, CELL, V124, P367, DOI 10.1016/j.cell.2005.10.038; Engels K, 2007, J PATHOL, V211, P532, DOI 10.1002/path.2134; Engels K, 2008, CANCER RES, V68, P5159, DOI 10.1158/0008-5472.CAN-08-0406; Fetz V, 2009, SENSORS-BASEL, V9, P5423, DOI 10.3390/s90705423; Fetz V, 2009, INT J CANCER, V124, P2033, DOI 10.1002/ijc.24182; Gaussmann A, 2007, ONCOGENE, V26, P3352, DOI 10.1038/sj.onc.1210125; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Heger P, 2001, TRAFFIC, V2, P544, DOI 10.1034/j.1600-0854.2001.20804.x; Hoiby T, 2007, BBA-GENE STRUCT EXPR, V1769, P429, DOI 10.1016/j.bbaexp.2007.04.008; Hsieh JJD, 2003, CELL, V115, P293, DOI 10.1016/S0092-8674(03)00816-X; Hsieh JJD, 2003, MOL CELL BIOL, V23, P186, DOI 10.1128/MCB.23.1.186-194.2003; Jacob B, 2010, BLOOD, V115, P1610, DOI 10.1182/blood-2009-07-232249; Jun L, 2001, CURR BIOL, V11, P1381, DOI 10.1016/S0960-9822(01)00419-5; Khan JA, 2005, STRUCTURE, V13, P1443, DOI 10.1016/j.str.2005.07.006; Knauer SK, 2007, CELL CYCLE, V6, P1502; Knauer SK, 2007, FASEB J, V21, P207, DOI 10.1096/fj.06-5741com; Knauer SK, 2006, EMBO REP, V7, P1259, DOI 10.1038/sj.embor.7400824; Knauer SK, 2005, ANAL CHEM, V77, P4815, DOI 10.1021/ac050413o; Knauer SK, 2005, TRAFFIC, V6, P594, DOI 10.1111/j.1600-0854.2005.00298.x; Knauer SK, 2005, MOL CELL BIOL, V25, P2573, DOI 10.1128/MCB.25.7.2573-2582.2005; Kramer OH, 2008, ONCOGENE, V27, P732, DOI 10.1038/sj.onc.1210677; Kramer OH, 2009, GENE DEV, V23, P223, DOI 10.1101/gad.479209; Lai DM, 2006, RNA, V12, P1446, DOI 10.1261/rna.94306; Landa I, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000637; Lee JT, 2009, BIOORG MED CHEM LETT, V19, P5086, DOI 10.1016/j.bmcl.2009.07.045; Liu H, 2007, GENE DEV, V21, P2385, DOI 10.1101/gad.1574507; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; Marg A, 2004, J CELL BIOL, V165, P823, DOI 10.1083/jcb.200403057; Marschalek R, 2010, FEBS J, V277, P1822, DOI 10.1111/j.1742-4658.2010.07608.x; Meyer C, 2006, LEUKEMIA, V20, P777, DOI 10.1038/sj.leu.2404150; Ocejo-Garcia M, 2005, J PATHOL, V206, P151, DOI 10.1002/path.1775; Overall CM, 2006, CANCER METAST REV, V25, P69, DOI 10.1007/s10555-006-7890-0; Schilling O, 2008, NAT BIOTECHNOL, V26, P685, DOI 10.1038/nbt1408; Schlingemann J, 2005, LAB INVEST, V85, P1024, DOI 10.1038/labinvest.3700293; Takeda S, 2006, GENE DEV, V20, P2397, DOI 10.1101/gad.1449406; Taki T, 2005, ONCOGENE, V24, P5191, DOI 10.1038/sj.onc.1208711; Tretyakova I, 2005, J BIOL CHEM, V280, P31981, DOI 10.1074/jbc.M502736200; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; van Deursen D, 2009, BBA-MOL CELL BIOL L, V1791, P229, DOI 10.1016/j.bbalip.2009.01.017; Yokoyama A, 2002, BLOOD, V100, P3710, DOI 10.1182/blood-2002-04-1015; Zadro C, 2009, BBA-MOL BASIS DIS, V1792, P27, DOI 10.1016/j.bbadis.2008.10.017; Zhou HQ, 2006, MOL CELL BIOL, V26, P2728, DOI 10.1128/MCB.26.7.2728-2735.2006	48	37	37	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					3007	3017		10.1074/jbc.M110.161646	http://dx.doi.org/10.1074/jbc.M110.161646			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21084304	hybrid, Green Published			2022-12-25	WOS:000286464300064
J	Idro, R; Gwer, S; Williams, TN; Otieno, T; Uyoga, S; Fegan, G; Kager, PA; Maitland, K; Kirkham, F; Neville, BGR; Newton, CRJ				Idro, Richard; Gwer, Samson; Williams, Thomas N.; Otieno, Tuda; Uyoga, Sophie; Fegan, Gregory; Kager, Piet A.; Maitland, Kathryn; Kirkham, Fenella; Neville, Brian G. R.; Newton, Charles R. J.			Iron Deficiency and Acute Seizures: Results from Children Living in Rural Kenya and a Meta-Analysis	PLOS ONE			English	Article							SOLUBLE TRANSFERRIN RECEPTOR; FEBRILE CONVULSIONS; MALARIA; ANEMIA	Background: There are conflicting reports on whether iron deficiency changes susceptibility to seizures. We examined the hypothesis that iron deficiency is associated with an increased risk of acute seizures in children in a malaria endemic area. Methods: We recruited 133 children, aged 3-156 months, who presented to a district hospital on the Kenyan coast with acute seizures and frequency-matched these to children of similar ages but without seizures. We defined iron deficiency according to the presence of malarial infection and evidence of inflammation. In patients with malaria, we defined iron deficiency as plasma ferritin<30 mu g/ml if plasma C-reactive protein (CRP) was<50mg/ml or ferritin<273 mu g/ml if CRP >= 50mg/ ml, and in those without malaria, as ferritin, 12 mu g/ml if CRP<10mg/ml or ferritin<30 mu g/ml if CRP >= 10mg/ml. In addition, we performed a meta-analysis of case-control studies published in English between January 1966 and December 2009 and available through PUBMED that have examined the relationship between iron deficiency and febrile seizures in children. Results: In our Kenyan case control study, cases and controls were similar, except more cases reported past seizures. Malaria was associated with two-thirds of all seizures. Eighty one (30.5%) children had iron deficiency. Iron deficiency was neither associated with an increased risk of acute seizures (45/133[33.8%] cases were iron deficient compared to 36/133[27.1%] controls, p=0.230) nor status epilepticus and it did not affect seizure semiology. Similar results were obtained when children with malaria, known to cause acute symptomatic seizures in addition to febrile seizures were excluded. However, in a meta-analysis that combined all eight case-control studies that have examined the association between iron deficiency and acute/febrile seizures to-date, iron deficiency, described in 310/1,018(30.5%) cases and in 230/1,049(21.9%) controls, was associated with a significantly increased risk of seizures, weighted OR 1.79(95%CI 1.03-3.09). Conclusions: Iron deficiency is not associated with an increased risk of all acute seizures in children but of febrile seizures. Further studies should examine mechanisms involved and the implications for public health.	[Idro, Richard] Makerere Univ, Mulago Hosp, Dept Paediat & Child Hlth, Kampala, Uganda; [Idro, Richard; Gwer, Samson; Williams, Thomas N.; Otieno, Tuda; Uyoga, Sophie; Fegan, Gregory; Maitland, Kathryn; Newton, Charles R. J.] Kenya Govt Med Res Ctr, Ctr Geog Med Res Coast, Kilifi, Kenya; [Williams, Thomas N.] John Radcliffe Hosp, Dept Paediat, Oxford OX3 9DU, England; [Fegan, Gregory] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Infect Dis Epidemiol Unit, London WC1, England; [Kager, Piet A.] Univ Amsterdam, Acad Med Ctr, Dept Infect Dis Trop Med & AIDS, NL-1105 AZ Amsterdam, Netherlands; [Maitland, Kathryn] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Paediat, London, England; [Maitland, Kathryn] Univ London Imperial Coll Sci Technol & Med, Fac Med, Wellcome Trust Ctr Clin Trop Med, London, England; [Kirkham, Fenella] Southampton Gen Hosp, Dept Paediat Neurol, Southampton SO9 4XY, Hants, England; [Kirkham, Fenella; Neville, Brian G. R.; Newton, Charles R. J.] UCL, Inst Child Hlth, Wolfson Ctr, Neurosci Unit, London, England; [Newton, Charles R. J.] London Sch Hyg & Trop Med, Clin Res Unit, London WC1, England	Makerere University; Mulago National Referral Hospital; Kenya Medical Research Institute; University of Oxford; University of London; London School of Hygiene & Tropical Medicine; University of Amsterdam; Academic Medical Center Amsterdam; Imperial College London; Imperial College London; University of London; London School of Hygiene & Tropical Medicine; University of Southampton; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Idro, R (corresponding author), Makerere Univ, Mulago Hosp, Dept Paediat & Child Hlth, Kampala, Uganda.	ridro1@gmail.com	Newton, Charles/V-7872-2019; , Ridro/ABD-3556-2020; Newton, Charles RJC/B-7578-2014; Kirkham, Fenella/C-2442-2009; Fegan, Greg W/O-8079-2018	Newton, Charles/0000-0002-6999-5507; Newton, Charles RJC/0000-0002-6999-5507; Kirkham, Fenella/0000-0002-2443-7958; Fegan, Greg W/0000-0002-2663-2765; Uyoga, Sophie/0000-0003-1746-7873; Maitland, Kathryn/0000-0002-0007-0645; Idro, Richard/0000-0003-4728-4605	Wellcome Trust [070114]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust through a fellowship to Prof. Newton (070114). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The study is published with the permission of the Director of KEMRI.	AKPEDE GO, 1993, J TROP PEDIATRICS, V39, P350, DOI 10.1093/tropej/39.6.350; BARZIDEH O, 1995, PSYCHOL REP, V76, P971, DOI 10.2466/pr0.1995.76.3.971; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Bidabadi E, 2009, SEIZURE-EUR J EPILEP, V18, P347, DOI 10.1016/j.seizure.2009.01.008; Daoud AS, 2002, EPILEPSIA, V43, P740, DOI 10.1046/j.1528-1157.2002.32501.x; Das BS, 1997, BRIT J NUTR, V78, P751, DOI 10.1079/BJN19970192; Hartfield DS, 2009, CLIN PEDIATR, V48, P420, DOI 10.1177/0009922809331800; Idro R, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-5; Idro R, 2008, EPILEPSY RES, V81, P114, DOI 10.1016/j.eplepsyres.2008.04.021; Idro R, 2007, JAMA-J AM MED ASSOC, V297, P2232, DOI 10.1001/jama.297.20.2232; Kivibidila S, 1999, J TROP PEDIATRICS, V45, P166, DOI 10.1093/tropej/45.3.166; KOBRINSKY NL, 1995, J CHILD NEUROL, V10, P105, DOI 10.1177/088307389501000207; Lozoff B, 2006, NUTR REV, V64, pS34, DOI 10.1301/nr.2006.may.S34-S43; Macdonald CE, 1996, BRIT MED J, V313, P1205, DOI 10.1136/bmj.313.7066.1205a; Menendez C, 2001, AM J TROP MED HYG, V65, P138, DOI 10.4269/ajtmh.2001.65.138; Mwaniki M, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-16; NAVEEDUR R, 2005, JCPSP-J COLL PHYSICI, V15, P338; Newton CRJC, 1997, TROP MED INT HEALTH, V2, P165, DOI 10.1046/j.1365-3156.1997.d01-238.x; OSKI FA, 1992, DIFFERENTIAL DIAGNOS, P346; PARKS YA, 1989, ACTA PAEDIATR SCAND, P71; Phiri KS, 2009, J CLIN PATHOL, V62, P1103, DOI 10.1136/jcp.2009.066498; Pisacane A, 1996, BMJ-BRIT MED J, V313, P343, DOI 10.1136/bmj.313.7053.343; Sadlier LG, 2007, BMJ-BRIT MED J, V334, P307, DOI 10.1136/bmj.39087.691817.AE; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; SKIKNE BS, 1990, BLOOD, V75, P1870; Smith H.J., COCHRANE DB SYST REV, V2, P2003, DOI [10.1002/14651858.CD001474, DOI 10.1002/14651858.CD001474]; Vaswani RK, 2010, INDIAN PEDIATR, V47, P437, DOI 10.1007/s13312-010-0080-8; Wambua S, 2006, BRIT J HAEMATOL, V133, P206, DOI 10.1111/j.1365-2141.2006.06006.x; Wang XS, 2004, J NEUROL SCI, V220, P59, DOI 10.1016/j.jns.2004.02.004; Waruiru CM, 1996, T ROY SOC TROP MED H, V90, P152, DOI 10.1016/S0035-9203(96)90120-0; Wike WM, 1996, BRIT MED J, V313, P1205, DOI 10.1136/bmj.313.7066.1205; World Health Organization (WHO), 2005, POCK BOOK HOSP CAR C; Zimmermann MB, 2005, AM J CLIN NUTR, V81, P615; 2000, ZHONGGUO JI SHENG CH, V18, P129	35	63	64	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e14001	10.1371/journal.pone.0014001	http://dx.doi.org/10.1371/journal.pone.0014001			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103365	Green Published, gold, Green Submitted			2022-12-25	WOS:000284257400006
J	Doerck, S; Gobel, K; Weise, G; Schneider-Hohendorf, T; Reinhardt, M; Hauff, P; Schwab, N; Linker, R; Maurer, M; Meuth, SG; Wiendl, H				Doerck, Sebastian; Goebel, Kerstin; Weise, Gesa; Schneider-Hohendorf, Tilman; Reinhardt, Michael; Hauff, Peter; Schwab, Nicholas; Linker, Ralf; Maeurer, Mathias; Meuth, Sven G.; Wiendl, Heinz			Temporal Pattern of ICAM-I Mediated Regulatory T Cell Recruitment to Sites of Inflammation in Adoptive Transfer Model of Multiple Sclerosis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IMMUNOLOGICAL SELF-TOLERANCE; BLOOD-BRAIN-BARRIER; IMMUNE-RESPONSES; ANIMAL-MODELS; MIGRATION; DISEASE; CNS; INHIBITION	Migration of immune cells to the target organ plays a key role in autoimmune disorders like multiple sclerosis (MS). However, the exact underlying mechanisms of this active process during autoimmune lesion pathogenesis remain elusive. To test if pro-inflammatory and regulatory T cells migrate via a similar molecular mechanism, we analyzed the expression of different adhesion molecules, as well as the composition of infiltrating T cells in an in vivo model of MS, adoptive transfer experimental autoimmune encephalomyelitis in rats. We found that the upregulation of ICAM-I and VCAM-I parallels the development of clinical disease onset, but persists on elevated levels also in the phase of clinical remission. However, the composition of infiltrating T cells found in the developing versus resolving lesion phase changed over time, containing increased numbers of regulatory T cells (FoxP3) only in the phase of clinical remission. In order to test the relevance of the expression of cell adhesion molecules, animals were treated with purified antibodies to ICAM-I and VCAM-I either in the phase of active disease or in early remission. Treatment with a blocking ICAM-I antibody in the phase of disease progression led to a milder disease course. However, administration during early clinical remission aggravates clinical symptoms. Treatment with anti-VCAM-I at different timepoints had no significant effect on the disease course. In summary, our results indicate that adhesion molecules are not only important for capture and migration of pro-inflammatory T cells into the central nervous system, but also permit access of anti-inflammatory cells, such as regulatory T cells. Therefore it is likely to assume that intervention at the blood brain barrier is time dependent and could result in different therapeutic outcomes depending on the phase of CNS lesion development.	[Doerck, Sebastian; Weise, Gesa; Meuth, Sven G.] Univ Wurzburg, Dept Neurol, D-8700 Wurzburg, Germany; [Goebel, Kerstin; Schneider-Hohendorf, Tilman; Schwab, Nicholas; Meuth, Sven G.; Wiendl, Heinz] Univ Munster, Dept Neurol Inflammatory Disorders Nervous Syst &, Munster, Germany; [Reinhardt, Michael; Hauff, Peter] Schering AG, Res Labs, D-1000 Berlin, Germany; [Linker, Ralf] Univ Erlangen Nurnberg, Dept Neurol, D-8520 Erlangen, Germany; [Maeurer, Mathias] Caritas Hosp Bad Mergentheim, Bad Mergentheim, Germany; [Meuth, Sven G.] Inst Physiol I Neuropathophysiol, Munster, Germany	University of Wurzburg; University of Munster; Schering AG; University of Erlangen Nuremberg; Caritas Hospital Bad Mergentheim	Doerck, S (corresponding author), Univ Wurzburg, Dept Neurol, Josef Schneider Str 11, D-8700 Wurzburg, Germany.	Heinz.wiendl@ukmuenster.de	Wiendl, Heinz/AAX-6041-2021; Meuth, Sven G/HHM-8941-2022; Schwab, Nicholas/H-4516-2019; Linker, Ralf/AAD-8884-2020	Meuth, Sven G/0000-0003-2571-3501; Wiendl, Heinz/0000-0003-4310-3432; Schwab, Nicholas/0000-0001-5494-9885; Schneider-Hohendorf, Tilman/0000-0002-3717-5176	Deutsche Forschungsgemeinschaft [1722/7-1];  [SFB581];  [TP A8]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ; 	This work was supported by SFB581, TP A8, and Deutsche Forschungsgemeinschaft grant 1722/7-1 to HW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Archelos JJ, 1999, TRENDS NEUROSCI, V22, P30, DOI 10.1016/S0166-2236(98)01287-9; ARCHELOS JJ, 1993, ANN NEUROL, V34, P145, DOI 10.1002/ana.410340209; Beyersdorf N, 2005, J EXP MED, V202, P445, DOI 10.1084/jem.20051060; Bluestone JA, 2005, CURR OPIN IMMUNOL, V17, P638, DOI 10.1016/j.coi.2005.09.002; Correale J, 2010, ANN NEUROL, V67, P625, DOI 10.1002/ana.21944; Engelhardt B, 2006, J NEURAL TRANSM, V113, P477, DOI 10.1007/s00702-005-0409-y; Engelhardt B, 2003, CELL TISSUE RES, V314, P119, DOI 10.1007/s00441-003-0751-z; Engelhardt B, 1998, CURR TOP MICROBIOL, V231, P51; Engelhardt B, 1998, J CLIN INVEST, V102, P2096, DOI 10.1172/JCI4271; Feger U, 2007, CLIN EXP IMMUNOL, V147, P412, DOI 10.1111/j.1365-2249.2006.03271.x; Gartner D, 2006, J NEUROIMMUNOL, V172, P73, DOI 10.1016/j.jneuroim.2005.11.003; Gold R, 2000, MOL MED TODAY, V6, P88, DOI 10.1016/S1357-4310(99)01639-1; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; Herman AE, 2004, J EXP MED, V199, P1479, DOI 10.1084/jem.20040179; Hiura T, 2005, J IMMUNOL, V175, P5058, DOI 10.4049/jimmunol.175.8.5058; Huang YH, 2009, ANN NEUROL, V66, P171, DOI 10.1002/ana.21705; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Laschinger M, 2002, EUR J IMMUNOL, V32, P3598, DOI 10.1002/1521-4141(200212)32:12<3598::AID-IMMU3598>3.0.CO;2-6; Lee JH, 2007, J IMMUNOL, V178, P301, DOI 10.4049/jimmunol.178.1.301; Linker RA, 2005, J AUTOIMMUN, V25, P199, DOI 10.1016/j.jaut.2005.09.019; Linker RA, 2002, NAT MED, V8, P620, DOI 10.1038/nm0602-620; Magnus T, 2005, J NEUROSCI, V25, P2537, DOI 10.1523/JNEUROSCI.4794-04.2005; Man SM, 2007, BRAIN PATHOL, V17, P243, DOI 10.1111/j.1750-3639.2007.00067.x; McGeachy MJ, 2005, J IMMUNOL, V175, P3025, DOI 10.4049/jimmunol.175.5.3025; Morgan ME, 2003, ARTHRITIS RHEUM, V48, P1452, DOI 10.1002/art.11063; Morrissey SP, 1996, J NEUROIMMUNOL, V69, P85; O'Connor RA, 2007, J IMMUNOL, V179, P958, DOI 10.4049/jimmunol.179.2.958; Piccirillo CA, 2005, ANN NY ACAD SCI, V1051, P72, DOI 10.1196/annals.1361.048; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Reinhardt M, 2005, INVEST RADIOL, V40, P2; Rose JW, 1999, J NEUROIMMUNOL, V97, P110, DOI 10.1016/S0165-5728(99)00064-8; Rudick RA, 2006, NEW ENGL J MED, V354, P911, DOI 10.1056/NEJMoa044396; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Tischner D, 2006, BRAIN, V129, P2635, DOI 10.1093/brain/awl213; Vajkoczy P, 2001, J CLIN INVEST, V108, P557; WILLENBORG DO, 1993, J NEUROIMMUNOL, V45, P147, DOI 10.1016/0165-5728(93)90175-X; Zozulya AL, 2008, NAT CLIN PRACT NEURO, V4, P384, DOI 10.1038/ncpneuro0832	41	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e15478	10.1371/journal.pone.0015478	http://dx.doi.org/10.1371/journal.pone.0015478			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085578	gold, Green Published, Green Submitted			2022-12-25	WOS:000284231800035
J	Rybczynski, N; Ross, EM; Samuels, JX; Korth, WW				Rybczynski, Natalia; Ross, Elizabeth M.; Samuels, Joshua X.; Korth, William W.			Re-Evaluation of Sinocastor (Rodentia: Castoridae) with Implications on the Origin of Modern Beavers	PLOS ONE			English	Article							GEOMETRIC MORPHOMETRICS; CRANIAL MORPHOLOGY; POSTNATAL ONTOGENY; MOLAR SHAPE; MIOCENE; SKULL; ADAPTATIONS; EVOLUTION; PALEOPHYLOGEOGRAPHY; SYSTEMATICS	The extant beaver, Castor, has played an important role shaping landscapes and ecosystems in Eurasia and North America, yet the origins and early evolution of this lineage remain poorly understood. Here we use a geometric morphometric approach to help re-evaluate the phylogenetic affinities of a fossil skull from the Late Miocene of China. This specimen was originally considered Sinocastor, and later transferred to Castor. The aim of this study was to determine whether this form is an early member of Castor, or if it represents a lineage outside of Castor. The specimen was compared to 38 specimens of modern Castor (both C. canadensis and C. fiber) as well as fossil specimens of C. fiber (Pleistocene), C. californicus (Pliocene) and the early castorids Steneofiber eseri (early Miocene). The results show that the specimen falls outside the Castor morphospace and that compared to Castor, Sinocastor possesses a: 1) narrower post-orbital constriction, 2) anteroposteriorly shortened basioccipital depression, 3) shortened incisive foramen, 4) more posteriorly located palatine foramen, 5) longer rostrum, and 6) longer braincase. Also the specimen shows a much shallower basiocciptal depression than what is seen in living Castor, as well as prominently rooted molars. We conclude that Sinocastor is a valid genus. Given the prevalence of apparently primitive traits, Sinocastor might be a near relative of the lineage that gave rise to Castor, implying a possible Asiatic origin for Castor.	[Rybczynski, Natalia] Canadian Museum Nat, Ottawa, ON K1P 6P4, Canada; [Ross, Elizabeth M.] Carleton Univ, Ottawa, ON K1S 5B6, Canada; [Samuels, Joshua X.] John Day Fossil Beds Natl Monument, Kimberly, OR USA; [Korth, William W.] Rochester Inst Vertebrate Paleontol, Rochester, NY USA	Carleton University	Rybczynski, N (corresponding author), Canadian Museum Nat, POB 3443 Stn D, Ottawa, ON K1P 6P4, Canada.	nrybczynski@mus-nature.ca			National Science and Engineering Research Council (Canada)	National Science and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by a National Science and Engineering Research Council (Canada) Discovery Grant (http://www.nserc-crsng.gc.ca/) awarded to NR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, ZOOGEOMORPHOLOGY ANI; BARISONE G, 2003, BEAVER BACCINELLO V3; Barnosky AD, 2003, P ROY SOC B-BIOL SCI, V270, P2585, DOI 10.1098/rspb.2003.2543; Cardini A, 2006, J MAMMAL, V87, P201, DOI 10.1644/05-MAMM-A-242R1.1; Cardini A, 2005, ZOOMORPHOLOGY, V124, P189, DOI 10.1007/s00435-005-0008-3; Cardini A, 2009, ETHOL ECOL EVOL, V21, P209, DOI 10.1080/08927014.2009.9522476; Caumul R, 2005, EVOLUTION, V59, P2460; DECHARDIN PT, 1942, I GEOBIOLOGIE, V9, P4; Depecker M, 2006, J ANAT, V208, P35, DOI 10.1111/j.1469-7580.2006.00512.x; Durka W, 2005, MOL ECOL, V14, P3843, DOI 10.1111/j.1365-294X.2005.02704.x; Flynn LJ, 2008, EVOLUTION OF TERTIARY MAMMALS OF NORTH AMERICA, VOL 2, P391; GINGERICH PD, 1985, PALEOBIOLOGY, V11, P27, DOI 10.1017/S0094837300011374; Grine FE, 2007, SCIENCE, V315, P226, DOI 10.1126/science.1136294; Guy F, 2003, AM J PHYS ANTHROPOL, V121, P198, DOI 10.1002/ajpa.10261; Harvati K, 2007, J HUM EVOL, V53, P732, DOI 10.1016/j.jhevol.2007.09.009; Hemprich W., 1820, GRUNDRISS NATURGESCH; HUGUENEY M, 1999, MIOCENE LAND MAMMALS; Ives Ronald L., 1942, JOUR GEOMORPH, V5, P191; Korth W.W., 1994, TERTIARY RECORD RODE; Korth WW, 2008, ACTA PALAEONTOL POL, V53, P169, DOI 10.4202/app.2008.0201; Korth WW, 2007, J PALEONTOL, V81, P1533, DOI 10.1666/05-110.1; Korth WW, 2007, ANN CARNEGIE MUS, V76, P117, DOI 10.2992/0097-4463(2007)76[117:ANGOBR]2.0.CO;2; Korth WW, 2006, ANN CARNEGIE MUS, V75, P237, DOI 10.2992/0097-4463(2006)75[237:ECBRCF]2.0.CO;2; Korth WW, 2003, J VERTEBR PALEONTOL, V23, P667, DOI 10.1671/2371; KORTH WW, 2002, J MAMMAL EVOL, V0008, P00279; Linnaeus C, 1766, SYSTEMA NATURAE REGN; Lucas S.G., 2002, CHINESE FOSSIL VERTE; MARTIN JE, 2008, PALUDICOLA, V6, P115; Martin Larry D., 1987, Dakoterra, V3, P73; MARTIN LD, 1977, PALAEOGEOGR PALAEOCL, V22, P173, DOI 10.1016/0031-0182(77)90027-X; Mayr E., 1991, PRINCIPLES SYSTEMATI; McKenna MC, 1997, CLASSIFICATION MAMMA; Monteiro LR, 2005, J ZOOL SYST EVOL RES, V43, P332, DOI 10.1111/j.1439-0469.2005.00323.x; Mors T, 2010, ACTA PALAEONTOL POL, V55, P189, DOI 10.4202/app.2009.0013; Muller-Schwarze D., 2003, BEAVER NATURAL HIST; NAIMAN RJ, 1988, BIOSCIENCE, V38, P753, DOI 10.2307/1310784; Novak M., 1987, WILD FURBEARER MANAG, P283; Odling-Smee FJ, 2003, NICHE CONSTRUCTION N; Polly PD, 2003, MAMMALIA, V67, P233, DOI 10.1515/mamm.2003.67.2.233; Polly PD, 2003, J MAMMAL, V84, P369, DOI 10.1644/1545-1542(2003)084<0369:PTTOGD>2.0.CO;2; Rekovets Leonid, 2009, Acta Zoologica Cracoviensia Ser. A - Vertebrata, V52A, P95, DOI 10.3409/azc.52a_1-2.95-105; ROBERTSON RA, 1954, J MAMMAL, V35, P197, DOI 10.2307/1376033; Rohlf F. J., 2006, TPSRELW VERSION 1 44; ROHLF FJ, 2006, TPSDIG2 VERSION 2 05; ROHLF FJ, 2004, TPSREGR VERSION 1 28; Rybczynski Natalia, 2007, Journal of Mammalian Evolution, V14, P1, DOI 10.1007/s10914-006-9017-3; Samuels JX, 2008, J MORPHOL, V269, P1387, DOI 10.1002/jmor.10662; Samuels JX, 2009, ZOOL J LINN SOC-LOND, V156, P864, DOI 10.1111/j.1096-3642.2009.00502.x; Samuels JX, 2009, J VERTEBR PALEONTOL, V29, P254, DOI 10.1080/02724634.2009.10010376; Schlosser M., 1924, Palaeontologia Sinica Series C, V1, P1; Schreuder A., 1931, Palaeontologische Zeitschrift Berlin, V13, P148; SHOTWELL JA, 1970, B MUSEUM NATURAL HIS, V17, P1; Singleton M, 2009, J HUM EVOL, V56, P25, DOI 10.1016/j.jhevol.2008.07.012; Stayton CT, 2006, PALAEONTOLOGY, V49, P307, DOI 10.1111/j.1475-4983.2006.00523.x; Stefen C, 2005, NEUES JAHRB GEOL P-M, P577; Stefen Clara, 2009, Kaupia Darmstaedter Beitraege zur Naturgeschichte, V16, P161; Stirton R. A., 1935, University of California Publications in Geology, V23, P391; Teilhard de Chardin P, 1931, PALAEONTOLOGIA SIN C, V9, P1; Wright JP, 2002, OECOLOGIA, V132, P96, DOI 10.1007/s00442-002-0929-1; XU XF, 1994, RODENT LAGOMORPH FAM, P77; Young C. C., 1934, Palaeontologia Sinica, VC8, P1; YOUNG CC, 1927, PALAEONTOLOGIA SIN C, V5, P10; Zelditch ML, 2004, EVOL DEV, V6, P194, DOI 10.1111/j.1525-142X.2004.04025.x; ZELDITCH ML, 1992, EVOLUTION, V46, P1164, DOI 10.1111/j.1558-5646.1992.tb00626.x; ZELDITCH ML, 1993, J EVOLUTION BIOL, V6, P621, DOI 10.1046/j.1420-9101.1993.6050621.x	65	14	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e13990	10.1371/journal.pone.0013990	http://dx.doi.org/10.1371/journal.pone.0013990			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085579	Green Published, gold, Green Submitted			2022-12-25	WOS:000284231800020
J	Keramari, M; Razavi, J; Ingman, KA; Patsch, C; Edenhofer, F; Ward, CM; Kimber, SJ				Keramari, Maria; Razavi, Janet; Ingman, Karen A.; Patsch, Christoph; Edenhofer, Frank; Ward, Christopher M.; Kimber, Susan J.			Sox2 Is Essential for Formation of Trophectoderm in the Preimplantation Embryo	PLOS ONE			English	Article							CELL SELF-RENEWAL; PLURIPOTENT STEM-CELLS; DOUBLE-STRANDED-RNA; TRANSCRIPTIONAL REGULATION; PROTEIN TRANSDUCTION; GENE-EXPRESSION; TROPHOBLAST DEVELOPMENT; PRIMITIVE ENDODERM; MOUSE EMBRYO; NANOG	Background: In preimplantation mammalian development the transcription factor Sox2 (SRY-related HMG-box gene 2) forms a complex with Oct4 and functions in maintenance of self-renewal of the pluripotent inner cell mass (ICM). Previously it was shown that Sox2-/- embryos die soon after implantation. However, maternal Sox2 transcripts may mask an earlier phenotype. We investigated whether Sox2 is involved in controlling cell fate decisions at an earlier stage. Methods and Findings: We addressed the question of an earlier role for Sox2 using RNAi, which removes both maternal and embryonic Sox2 mRNA present during the preimplantation period. By depleting both maternal and embryonic Sox2 mRNA at the 2-cell stage and monitoring embryo development in vitro we show that, in the absence of Sox2, embryos arrest at the morula stage and fail to form trophectoderm (TE) or cavitate. Following knock-down of Sox2 via three different short interfering RNA (siRNA) constructs in 2-cell stage mouse embryos, we have shown that the majority of embryos (76%) arrest at the morula stage or slightly earlier and only 18.7-21% form blastocysts compared to 76.2-83% in control groups. In Sox2 siRNA-treated embryos expression of pluripotency associated markers Oct4 and Nanog remained unaffected, whereas TE associated markers Tead4, Yap, Cdx2, Eomes, Fgfr2, as well as Fgf4, were downregulated in the absence of Sox2. Apoptosis was also increased in Sox2 knock-down embryos. Rescue experiments using cell-permeant Sox2 protein resulted in increased blastocyst formation from 18.7% to 62.6% and restoration of Sox2, Oct4, Cdx2 and Yap protein levels in the rescued Sox2-siRNA blastocysts. Conclusion and Significance: We conclude that the first essential function of Sox2 in the preimplantation mouse embryo is to facilitate establishment of the trophectoderm lineage. Our findings provide a novel insight into the first differentiation event within the preimplantation embryo, namely the segregation of the ICM and TE lineages.	[Keramari, Maria; Razavi, Janet; Ingman, Karen A.; Kimber, Susan J.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Patsch, Christoph; Edenhofer, Frank] Univ Bonn, Life & Brain Ctr, Stem Cell Engn Grp, Inst Reconstruct Neurobiol, D-5300 Bonn, Germany; [Patsch, Christoph; Edenhofer, Frank] Hertie Fdn, Bonn, Germany; [Ward, Christopher M.] Univ Manchester, Fac Med & Human Sci, Manchester, Lancs, England	University of Manchester; University of Bonn; University of Manchester	Keramari, M (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	sue.kimber@manchester.ac.uk	Edenhofer, Frank/ABG-9458-2020	Edenhofer, Frank/0000-0002-6489-714X; Keramari, Maria/0000-0001-5545-1763; Ward, Christopher/0000-0001-7389-4488; Kimber, Susan/0000-0002-0568-6342	Greek State's Scholarship Foundation (IKY-Greece); Infertility Research Trust (UK); Medical Research Council (MRC/UK) [R107358]; Deutsche Forschungsgemeinschaft (DFG) [ED79/1-1]; Biotechnology and Biological Sciences Research Council [BB/E527239/1] Funding Source: researchfish; Medical Research Council [G0300484, G0801057, G0700092] Funding Source: researchfish; BBSRC [BB/E527239/1] Funding Source: UKRI; MRC [G0801057, G0300484, G0700092] Funding Source: UKRI	Greek State's Scholarship Foundation (IKY-Greece); Infertility Research Trust (UK); Medical Research Council (MRC/UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Greek State's Scholarship Foundation (IKY-Greece), Infertility Research Trust (UK), Medical Research Council (MRC/UK, R107358) and Deutsche Forschungsgemeinschaft (DFG, ED79/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosetti DC, 1997, MOL CELL BIOL, V17, P6321, DOI 10.1128/MCB.17.11.6321; Arman E, 1998, P NATL ACAD SCI USA, V95, P5082, DOI 10.1073/pnas.95.9.5082; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Batchu RB, 2005, CANCER RES, V65, P10041, DOI 10.1158/0008-5472.CAN-05-1383; Becker-Hapak M, 2001, METHODS, V24, P247, DOI 10.1006/meth.2001.1186; BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; Bosnali M, 2008, BIOL CHEM, V389, P851, DOI 10.1515/BC.2008.106; Brison DR, 1997, BIOL REPROD, V56, P1088, DOI 10.1095/biolreprod56.5.1088; Brook FA, 1997, P NATL ACAD SCI USA, V94, P5709, DOI 10.1073/pnas.94.11.5709; Brooks H, 2005, ADV DRUG DELIVER REV, V57, P559, DOI 10.1016/j.addr.2004.12.001; Chai N, 1998, DEV BIOL, V198, P105, DOI 10.1016/S0012-1606(98)80031-6; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Chickarmane V, 2006, PLOS COMPUT BIOL, V2, P1080, DOI 10.1371/journal.pcbi.0020123; Collignon J, 1996, DEVELOPMENT, V122, P509; Dominguez-Bendala J, 2005, DIABETES, V54, P720, DOI 10.2337/diabetes.54.3.720; Elling U, 2006, P NATL ACAD SCI USA, V103, P16319, DOI 10.1073/pnas.0607884103; Episkopou V, 2005, TRENDS NEUROSCI, V28, P219, DOI 10.1016/j.tins.2005.03.003; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; FELDMAN B, 1995, SCIENCE, V267, P246, DOI 10.1126/science.7809630; FLEMING TP, 1994, HISTOCHEMISTRY, V101, P1, DOI 10.1007/BF00315824; Grabarek JB, 2002, GENESIS, V32, P269, DOI 10.1002/gene.10076; Griffin KJP, 1998, DEVELOPMENT, V125, P3379; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Haffner-Krausz R, 1999, MECH DEVELOP, V85, P167, DOI 10.1016/S0925-4773(99)00082-9; Hardy K, 1997, MOL HUM REPROD, V3, P919, DOI 10.1093/molehr/3.10.919; Hardy K, 2003, BIOL REPROD, V68, P1165, DOI 10.1095/biolreprod.102.010090; JOHNSON MH, 1981, CELL, V24, P71, DOI 10.1016/0092-8674(81)90502-X; JOHNSON MH, 1982, DEV BIOL, V91, P431, DOI 10.1016/0012-1606(82)90049-5; KAMACHI Y, 1995, EMBO J, V14, P3510, DOI 10.1002/j.1460-2075.1995.tb07357.x; Kamjoo M, 2002, MOL REPROD DEV, V61, P67, DOI 10.1002/mrd.1132; Keenan ID, 2006, DEV BIOL, V299, P478, DOI 10.1016/j.ydbio.2006.08.040; Kelberman D, 2006, J CLIN INVEST, V116, P2442, DOI 10.1172/JCI28658; Kiernan AE, 2005, NATURE, V434, P1031, DOI 10.1038/nature03487; Kim MH, 2002, BIOCHEM BIOPH RES CO, V296, P1372, DOI 10.1016/S0006-291X(02)02070-3; KIMBER SJ, 1990, INT REV CYTOL, V120, P53; Koutsourakis M, 1999, DEVELOPMENT, V126, P723; Kunath T, 2004, PLACENTA, V25, pS32, DOI 10.1016/j.placenta.2004.01.015; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Li J, 2007, J BIOL CHEM, V282, P19481, DOI 10.1074/jbc.M702056200; Li XP, 2005, MOL REPROD DEV, V72, P152, DOI 10.1002/mrd.20346; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Lim CY, 2008, CELL STEM CELL, V3, P543, DOI 10.1016/j.stem.2008.08.004; Luster TA, 2000, MOL REPROD DEV, V57, P4, DOI 10.1002/1098-2795(200009)57:1<4::AID-MRD3>3.0.CO;2-I; Luster TA, 2003, GENE, V323, P163, DOI 10.1016/j.gene.2003.09.019; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nishimoto M, 1999, MOL CELL BIOL, V19, P5453; Nishioka N, 2008, MECH DEVELOP, V125, P270, DOI 10.1016/j.mod.2007.11.002; NISWANDER L, 1992, DEVELOPMENT, V114, P755; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Okubo T, 2006, GENE DEV, V20, P2654, DOI 10.1101/gad.1457106; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; Pevny LH, 1997, CURR OPIN GENET DEV, V7, P338, DOI 10.1016/S0959-437X(97)80147-5; Plusa B, 2008, DEVELOPMENT, V135, P3081, DOI 10.1242/dev.021519; Pownall ME, 1998, CURR BIOL, V8, P673, DOI 10.1016/S0960-9822(98)70257-X; Que J, 2007, DEVELOPMENT, V134, P2521, DOI 10.1242/dev.003855; Ragge NK, 2005, AM J MED GENET A, V135A, P1, DOI 10.1002/ajmg.a.30642; Ralston A, 2005, CLIN GENET, V68, P106, DOI 10.1111/j.1399-0004.2005.00478.x; Ralston A, 2010, DEVELOPMENT, V137, P395, DOI 10.1242/dev.038828; RAPPOLEE DA, 1994, DEVELOPMENT, V120, P2259; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Scaffidi P, 2001, J BIOL CHEM, V276, P47296, DOI 10.1074/jbc.M107619200; SENNER CE, 2010, PLACENTA, P1; Sharova LV, 2007, DEV BIOL, V307, P446, DOI 10.1016/j.ydbio.2007.05.004; Shi WJ, 2006, J BIOL CHEM, V281, P23319, DOI 10.1074/jbc.M601811200; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Stein P, 2005, DEV BIOL, V286, P464, DOI 10.1016/j.ydbio.2005.08.015; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Sun Y, 2006, CRIT REV EUKAR GENE, V16, P211, DOI 10.1615/CritRevEukarGeneExpr.v16.i3.20; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Tatematsu M, 2003, CANCER SCI, V94, P135, DOI 10.1111/j.1349-7006.2003.tb01409.x; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tokuzawa Y, 2003, MOL CELL BIOL, V23, P2699, DOI 10.1128/MCB.23.8.2699-2708.2003; Tsukamoto T, 2004, J CANCER RES CLIN, V130, P135, DOI 10.1007/s00432-003-0519-6; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wianny F, 2000, NAT CELL BIOL, V2, P70, DOI 10.1038/35000016; Wiebe MS, 2000, GENE, V246, P383, DOI 10.1016/S0378-1119(00)00086-X; Wilson M, 2002, CURR OPIN GENET DEV, V12, P441, DOI 10.1016/S0959-437X(02)00323-4; Yamanaka Y, 2006, DEV DYNAM, V235, P2301, DOI 10.1002/dvdy.20844; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481	90	141	147	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e13952	10.1371/journal.pone.0013952	http://dx.doi.org/10.1371/journal.pone.0013952			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103067	Green Published, Green Submitted, gold			2022-12-25	WOS:000284147700007
J	Sirbu, A; Ruskin, HJ; Crane, M				Sirbu, Alina; Ruskin, Heather J.; Crane, Martin			Cross-Platform Microarray Data Normalisation for Regulatory Network Inference	PLOS ONE			English	Article							TRANSCRIPTION; EXPRESSION; GENES; PHASE	Background: Inferring Gene Regulatory Networks (GRNs) from time course microarray data suffers from the dimensionality problem created by the short length of available time series compared to the large number of genes in the network. To overcome this, data integration from diverse sources is mandatory. Microarray data from different sources and platforms are publicly available, but integration is not straightforward, due to platform and experimental differences. Methods: We analyse here different normalisation approaches for microarray data integration, in the context of reverse engineering of GRN quantitative models. We introduce two preprocessing approaches based on existing normalisation techniques and provide a comprehensive comparison of normalised datasets. Conclusions: Results identify a method based on a combination of Loess normalisation and iterative K-means as best for time series normalisation for this problem.	[Sirbu, Alina; Ruskin, Heather J.; Crane, Martin] Dublin City Univ, Ctr Sci Comp & Complex Syst Modelling, Dublin 9, Ireland	Dublin City University	Sirbu, A (corresponding author), Dublin City Univ, Ctr Sci Comp & Complex Syst Modelling, Dublin 9, Ireland.	asirbu@computing.dcu.ie	Sirbu, Alina/I-3288-2014; Crane, Martin/V-6823-2019	Sirbu, Alina/0000-0002-3947-7143; Crane, Martin/0000-0001-7598-3126	Irish Research Council for Science, Engineering and Technology	Irish Research Council for Science, Engineering and Technology(Irish Research Council for Science, Engineering and Technology)	This work was supported by the Irish Research Council for Science, Engineering and Technology (http://www.ircset.ie/), under the Embark Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alterovitz G, 2010, BRIEF BIOINFORM, V11, P80, DOI 10.1093/bib/bbp054; Aoki-Kinoshita Kiyoko F., 2007, V396, P71; BOSLAUGH S, STAT NUTSHELL; Do JH, 2006, MOL CELLS, V22, P254; DONOHO D, 1995, WAVELAB REPRODUCIBLE; Fomekong-Nanfack Y, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-94; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kaiser G., 1994, FRIENDLY GUIDE WAVEL; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lim WK, 2007, BIOINFORMATICS, V23, pI282, DOI 10.1093/bioinformatics/btm201; Noman N, 2006, GECCO 2006: GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, VOL 1 AND 2, P263; Noman N, 2007, IEEE ACM T COMPUT BI, V4, P634, DOI 10.1109/TCBB.2007.1058; Orlando DA, 2008, NATURE, V453, P944, DOI 10.1038/nature06955; Pramila T, 2002, GENE DEV, V16, P3034, DOI 10.1101/gad.1034302; Pramila T, 2006, GENE DEV, V20, P2266, DOI 10.1101/gad.1450606; Przytycka TM, 2010, BRIEF BIOINFORM, V11, P15, DOI 10.1093/bib/bbp057; SAVAGEAU MA, 1988, MATH COMPUT MODEL, V11, P546, DOI 10.1016/0895-7177(88)90553-5; Shabalin AA, 2008, BIOINFORMATICS, V24, P1154, DOI 10.1093/bioinformatics/btn083; SHAKYA K, 2009, ADV COMPUTA IN PRESS; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Spieth C, 2005, IEEE C EVOL COMPUTAT, P660; Wang Y, 2006, BIOINFORMATICS, V22, P2413, DOI 10.1093/bioinformatics/btl396; Xulvi-Brunet R, 2010, BIOINFORMATICS, V26, P205, DOI 10.1093/bioinformatics/btp632	25	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e13822	10.1371/journal.pone.0013822	http://dx.doi.org/10.1371/journal.pone.0013822			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103045	Green Published, Green Submitted, gold			2022-12-25	WOS:000284147700004
J	Marko, AJ; Miller, RA; Kelman, A; Frauwirth, KA				Marko, Aimee J.; Miller, Rebecca A.; Kelman, Alina; Frauwirth, Kenneth A.			Induction of Glucose Metabolism in Stimulated T Lymphocytes Is Regulated by Mitogen-Activated Protein Kinase Signaling	PLOS ONE			English	Article							HUMAN PERIPHERAL LYMPHOCYTES; CELL-ACTIVATION; PHYTOHEMAGGLUTININ STIMULATION; PHOSPHATIDYLINOSITOL 3-KINASE; CARBOHYDRATE METABOLISM; GLUTAMINE-METABOLISM; CANCER-CELLS; GLYCOLYSIS; AKT; TRANSLOCATION	T lymphocytes play a critical role in cell-mediated immune responses. During activation, extracellular and intracellular signals alter T cell metabolism in order to meet the energetic and biosynthetic needs of a proliferating, active cell, but control of these phenomena is not well defined. Previous studies have demonstrated that signaling from the costimulatory receptor CD28 enhances glucose utilization via the phosphatidylinositol-3-kinase ( PI3K) pathway. However, since CD28 ligation alone does not induce glucose metabolism in resting T cells, contributions from T cell receptor-initiated signaling pathways must also be important. We therefore investigated the role of mitogen-activated protein kinase (MAPK) signaling in the regulation of mouse T cell glucose metabolism. T cell stimulation strongly induces glucose uptake and glycolysis, both of which are severely impaired by inhibition of extracellular signal-regulated kinase (ERK), whereas p38 inhibition had a much smaller effect. Activation also induced hexokinase activity and expression in T cells, and both were similarly dependent on ERK signaling. Thus, the ERK signaling pathway cooperates with PI3K to induce glucose utilization in activated T cells, with hexokinase serving as a potential point for coordinated regulation.	[Marko, Aimee J.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; Univ Maryland, Maryland Pathogen Res Inst, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Marko, AJ (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA.	kfrauwir@umd.edu			National Cancer Institute [K01 CA092156]; Leukemia Research Foundation; NATIONAL CANCER INSTITUTE [K01CA092156] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by a Howard Temin K01 Career Development Award (grant number K01 CA092156) from the National Cancer Institute (www.cancer.gov) and a New Investigator Grant from the Leukemia Research Foundation (www.leukemia-research.org) to K.A.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; ARDAWI MSM, 1983, BIOCHEM J, V212, P835, DOI 10.1042/bj2120835; ARDAWI MSM, 1988, METABOLISM, V37, P99, DOI 10.1016/0026-0495(88)90036-4; Barthel A, 1999, J BIOL CHEM, V274, P20281, DOI 10.1074/jbc.274.29.20281; BRAND K, 1989, METABOLISM, V38, P29, DOI 10.1016/0026-0495(89)90136-4; BRAND K, 1984, BIOCHEM J, V221, P471, DOI 10.1042/bj2210471; Carr EL, 2010, J IMMUNOL, V185, P1037, DOI 10.4049/jimmunol.0903586; Cham CM, 2005, J IMMUNOL, V174, P4670, DOI 10.4049/jimmunol.174.8.4670; Cong LN, 1997, MOL ENDOCRINOL, V11, P1881, DOI 10.1210/me.11.13.1881; COOPER EH, 1963, BRIT J HAEMATOL, V9, P101, DOI 10.1111/j.1365-2141.1963.tb05446.x; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; CULVENOR JG, 1976, BIOCHIM BIOPHYS ACTA, V437, P354, DOI 10.1016/0304-4165(76)90005-2; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Deng HB, 2008, J BIOL CHEM, V283, P20754, DOI 10.1074/jbc.M800024200; Denton RM, 2009, BBA-BIOENERGETICS, V1787, P1309, DOI 10.1016/j.bbabio.2009.01.005; Doughty CA, 2006, BLOOD, V107, P4458, DOI 10.1182/blood-2005-12-4788; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Franchi-Gazzola R, 1999, J BIOL CHEM, V274, P28922, DOI 10.1074/jbc.274.41.28922; Frauwirth KA, 2002, FASEB J, V16, pA711; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; HEDESKOV CJ, 1968, BIOCHEM J, V110, P373, DOI 10.1042/bj1100373; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; HUME DA, 1978, BIOCHEM J, V174, P703, DOI 10.1042/bj1740703; Hyde R, 2007, J BIOL CHEM, V282, P19788, DOI 10.1074/jbc.M611520200; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; KOCH B, 1990, J CELL PHYSIOL, V143, P94, DOI 10.1002/jcp.1041430112; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Lopez-Fontanals M, 2003, J GEN PHYSIOL, V122, P5, DOI 10.1085/jgp.200308800; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Parry RV, 1997, EUR J IMMUNOL, V27, P2495, DOI 10.1002/eji.1830271006; Quintana A, 2007, P NATL ACAD SCI USA, V104, P14418, DOI 10.1073/pnas.0703126104; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; Rathmell JC, 2001, J IMMUNOL, V167, P6869, DOI 10.4049/jimmunol.167.12.6869; Rathmell JC, 2000, MOL CELL, V6, P683, DOI 10.1016/S1097-2765(00)00066-6; Robey RB, 1999, AM J PHYSIOL-RENAL, V277, pF742, DOI 10.1152/ajprenal.1999.277.5.F742; ROOS D, 1970, BIOCHIM BIOPHYS ACTA, V222, P565, DOI 10.1016/0304-4165(70)90182-0; ROOS D, 1973, EXP CELL RES, V77, P127, DOI 10.1016/0014-4827(73)90561-2; SAGONE AL, 1974, CELL IMMUNOL, V14, P443, DOI 10.1016/0008-8749(74)90195-6; Taha C, 1999, J BIOL CHEM, V274, P33085, DOI 10.1074/jbc.274.46.33085; Ueki K, 1998, J BIOL CHEM, V273, P5315, DOI 10.1074/jbc.273.9.5315; Vaughn AE, 2008, NAT CELL BIOL, V10, P1477, DOI 10.1038/ncb1807; Wang QH, 1999, MOL CELL BIOL, V19, P4008; WARBURG O, 1956, SCIENCE, V124, P269; Zhou Q, 2008, J NEUROCHEM, V104, P325, DOI 10.1111/j.1471-4159.2007.04957.x	45	68	69	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e15425	10.1371/journal.pone.0015425	http://dx.doi.org/10.1371/journal.pone.0015425			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085672	Green Submitted, Green Published, gold			2022-12-25	WOS:000284036800028
J	Dimon, MT; Sorber, K; DeRisi, JL				Dimon, Michelle T.; Sorber, Katherine; DeRisi, Joseph L.			HMMSplicer: A Tool for Efficient and Sensitive Discovery of Known and Novel Splice Junctions in RNA-Seq Data	PLOS ONE			English	Article							MESSENGER-RNA; SEQUENCE; TRANSCRIPTOME; ALIGNMENT	Background: High-throughput sequencing of an organism's transcriptome, or RNA-Seq, is a valuable and versatile new strategy for capturing snapshots of gene expression. However, transcriptome sequencing creates a new class of alignment problem: mapping short reads that span exon-exon junctions back to the reference genome, especially in the case where a splice junction is previously unknown. Methodology/Principal Findings: Here we introduce HMMSplicer, an accurate and efficient algorithm for discovering canonical and non-canonical splice junctions in short read datasets. HMMSplicer identifies more splice junctions than currently available algorithms when tested on publicly available A. thaliana, P. falciparum, and H. sapiens datasets without a reduction in specificity. Conclusions/Significance: HMMSplicer was found to perform especially well in compact genomes and on genes with low expression levels, alternative splice isoforms, or non-canonical splice junctions. Because HHMSplicer does not rely on pre-built gene models, the products of inexact splicing are also detected. For H. sapiens, we find 3.6% of 3' splice sites and 1.4% of 5' splice sites are inexact, typically differing by 3 bases in either direction. In addition, HMMSplicer provides a score for every predicted junction allowing the user to set a threshold to tune false positive rates depending on the needs of the experiment. HMMSplicer is implemented in Python. Code and documentation are freely available at http://derisilab.ucsf.edu/software/hmmsplicer.	[Dimon, Michelle T.; Sorber, Katherine; DeRisi, Joseph L.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Dimon, Michelle T.] Univ Calif San Francisco, Biol & Med Informat Program, San Francisco, CA 94143 USA; [DeRisi, Joseph L.] Howard Hughes Med Inst, Bethesda, MD 20817 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute	Dimon, MT (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	joe@derisilab.ucsf.edu		Lontok, Katherine/0000-0001-7127-340X	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameur A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r34; AU KF, 2010, NUCL ACIDS RES; BAUM LE, 1970, ANN MATH STAT, V41, P164, DOI 10.1214/aoms/1177697196; Benson DA, 2004, NUCLEIC ACIDS RES, V32, pD23, DOI 10.1093/nar/gkh045; BRYANT DW, 2010, BIOINFORMATICS; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; De Bona F, 2008, BIOINFORMATICS, V24, pI174, DOI 10.1093/bioinformatics/btn300; Deutsch M, 1999, NUCLEIC ACIDS RES, V27, P3219, DOI 10.1093/nar/27.15.3219; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Heap GA, 2010, HUM MOL GENET, V19, P122, DOI 10.1093/hmg/ddp473; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lu FL, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-255; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nagasaki H, 2005, GENE, V364, P53, DOI 10.1016/j.gene.2005.07.027; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Richard H, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq041; SEN S, 2010, J BIOL CHEM; Shepard PJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-242; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; Sorber K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003495; Stamm S, 2006, NUCLEIC ACIDS RES, V34, pD46, DOI 10.1093/nar/gkj031; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Yano M, 2010, NEURON, V66, P848, DOI 10.1016/j.neuron.2010.05.007; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	42	37	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e13875	10.1371/journal.pone.0013875	http://dx.doi.org/10.1371/journal.pone.0013875			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	676NU	21079731	Green Published, gold			2022-12-25	WOS:000283920000009
J	Zhang, J				Zhang, Jun			Ancestral Informative Marker Selection and Population Structure Visualization Using Sparse Laplacian Eigenfunctions	PLOS ONE			English	Article							MISSPECIFIED RELATIONSHIPS; ADMIXTURE; STRATIFICATION; DIVERSITY; INFERENCE; SAMPLES; MODEL	Identification of a small panel of population structure informative markers can reduce genotyping cost and is useful in various applications, such as ancestry inference in association mapping, forensics and evolutionary theory in population genetics. Traditional methods to ascertain ancestral informative markers usually require the prior knowledge of individual ancestry and have difficulty for admixed populations. Recently Principal Components Analysis (PCA) has been employed with success to select SNPs which are highly correlated with top significant principal components (PCs) without use of individual ancestral information. The approach is also applicable to admixed populations. Here we propose a novel approach based on our recent result on summarizing population structure by graph Laplacian eigenfunctions, which differs from PCA in that it is geometric and robust to outliers. Our approach also takes advantage of the priori sparseness of informative markers in the genome. Through simulation of a ring population and the real global population sample HGDP of 650K SNPs genotyped in 940 unrelated individuals, we validate the proposed algorithm at selecting most informative markers, a small fraction of which can recover the similar underlying population structure efficiently. Employing a standard Support Vector Machine (SVM) to predict individuals' continental memberships on HGDP dataset of seven continents, we demonstrate that the selected SNPs by our method are more informative but less redundant than those selected by PCA. Our algorithm is a promising tool in genome-wide association studies and population genetics, facilitating the selection of structure informative markers, efficient detection of population substructure and ancestral inference.	Univ Chicago, Dept Radiol, Chicago, IL 60637 USA	University of Chicago	Zhang, J (corresponding author), Univ Chicago, Dept Radiol, Chicago, IL 60637 USA.	junzhang@galton.uchicago.edu	zhang, jun/B-5061-2012					Bauchet M, 2007, AM J HUM GENET, V80, P948, DOI 10.1086/513477; BELKIN M, 2002, P ADV NEURAL INFORM, V14; Candes EJ, 2008, IEEE SIGNAL PROC MAG, V25, P21, DOI 10.1109/MSP.2007.914731; Carvalho CM, 2008, J AM STAT ASSOC, V103, P1438, DOI 10.1198/016214508000000869; CAVALLISFORZA L, 1965, GENETICS TODAY, V3; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen HS, 2003, ANN HUM GENET, V67, P250, DOI 10.1046/j.1469-1809.2003.00036.x; Chung F., 1997, SPECTRAL GRAPH THEOR, DOI DOI 10.1090/CBMS/092; Collins-Schramm HE, 2002, AM J HUM GENET, V70, P737, DOI 10.1086/339368; Coop G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000500; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Lao O, 2006, AM J HUM GENET, V78, P680, DOI 10.1086/501531; LEE A, 2009, GENETIC EPIDEMIOLOGY, V33; MANTEL N, 1967, CANCER RES, V27, P209; McPeek MS, 2000, AM J HUM GENET, V66, P1076, DOI 10.1086/302800; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Paschou P, 2007, PLOS GENET, V3, P1672, DOI 10.1371/journal.pgen.0030160; Paschou P, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000114; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Rosenberg NA, 2006, ANN HUM GENET, V70, P841, DOI 10.1111/j.1469-1809.2006.00285.x; SHAMEEK B, 2009, AM J HUM GENET, V84, P641; Shawe-Taylor J, 2004, KERNEL METHODS PATTE; Sun L, 2002, HUM HERED, V54, P99, DOI 10.1159/000067666; Sun L, 2001, GENET EPIDEMIOL, V21, pS36, DOI 10.1002/gepi.2001.21.s1.s36; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Vapnik VN, 1998, STAT LEARNING THEORY, DOI DOI 10.1007/978-1-4419-1428-6_5864; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Zhang J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006274; Zhang Jun, 2009, BMC Proc, V3 Suppl 7, pS110; Zhu XF, 2002, GENET EPIDEMIOL, V23, P181, DOI 10.1002/gepi.210; Zou H, 2006, J COMPUT GRAPH STAT, V15, P265, DOI 10.1198/106186006X113430	39	7	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e13734	10.1371/journal.pone.0013734	http://dx.doi.org/10.1371/journal.pone.0013734			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079796	Green Published, gold, Green Submitted			2022-12-25	WOS:000283838600005
J	Dellisanti, CD; Hanson, SM; Chen, L; Czajkowski, C				Dellisanti, Cosma D.; Hanson, Sonya M.; Chen, Lin; Czajkowski, Cynthia			Packing of the Extracellular Domain Hydrophobic Core Has Evolved to Facilitate Pentameric Ligand-gated Ion Channel Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; GAMMA-AMINOBUTYRIC-ACID; X-RAY-STRUCTURE; BINDING-PROTEIN; CRYSTAL-STRUCTURE; GATING MECHANISM; PARTIAL AGONISTS; STABILITY; ACTIVATION; MUTATIONS	Protein function depends on conformational flexibility and folding stability. Loose packing of hydrophobic cores is not infrequent in proteins, as the enhanced flexibility likely contributes to their biological function. Here, using experimental and computational approaches, we show that eukaryotic pentameric ligand-gated ion channels are characterized by loose packing of their extracellular domain beta-sandwich cores, and that loose packing contributes to their ability to rapidly switch from closed to open channel states in the presence of ligand. Functional analyses of GABA(A) receptors show that increasing the beta-core packing disrupted GABA-mediated currents, with impaired GABA efficacy and slowed GABA current activation and desensitization. We propose that loose packing of the hydrophobic beta-core developed as an evolutionary strategy aimed to facilitate the allosteric mechanisms of eukaryotic pentameric ligand-gated ion channels.	[Dellisanti, Cosma D.; Czajkowski, Cynthia] Univ Wisconsin, Dept Physiol, Madison, WI 53711 USA; [Hanson, Sonya M.; Chen, Lin] Univ So Calif 90089, Los Angeles, CA 90089 USA	University of Wisconsin System; University of Wisconsin Madison	Czajkowski, C (corresponding author), 601 Sci Dr,Rm 135, Madison, WI 53711 USA.	czajkowski@physiology.wisc.edu	chen, Lin/A-3392-2008	chen, Lin/0000-0003-4798-6199	NIGMS NIH HHS [R01 GM064642] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064642] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; Ahmad S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-51; AMIN J, 1993, NATURE, V366, P565, DOI 10.1038/366565a0; Auerbach A, 2010, J PHYSIOL-LONDON, V588, P573, DOI 10.1113/jphysiol.2009.182774; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Canadillas JMP, 2006, P NATL ACAD SCI USA, V103, P2109, DOI 10.1073/pnas.0510941103; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Chakrapani S, 2004, J GEN PHYSIOL, V123, P341, DOI 10.1085/jgp.200309004; Chen J, 1998, CELL, V95, P409, DOI 10.1016/S0092-8674(00)81771-7; Cheng XL, 2009, BIOPHYS J, V96, P4502, DOI 10.1016/j.bpj.2009.03.018; CHOTHIA C, 1984, ANNU REV BIOCHEM, V53, P537; Chothia C, 2009, BIOCHEM J, V419, P15, DOI 10.1042/BJ20090122; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Daniel RM, 2003, ANNU REV BIOPH BIOM, V32, P69, DOI 10.1146/annurev.biophys.32.110601.142445; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; ERIKSSON AE, 1992, SCIENCE, V255, P178, DOI 10.1126/science.1553543; ERIKSSON AE, 1993, J MOL BIOL, V229, P747, DOI 10.1006/jmbi.1993.1077; Fields PA, 2001, COMP BIOCHEM PHYS A, V129, P417, DOI 10.1016/S1095-6433(00)00359-7; Fischer S, 1999, P NATL ACAD SCI USA, V96, P9613, DOI 10.1073/pnas.96.17.9613; Gleitsman KR, 2009, BIOPHYS J, V96, P3168, DOI 10.1016/j.bpj.2008.12.3949; Grutter T, 2005, CR BIOL, V328, P223, DOI 10.1016/j.crvi.2004.11.004; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hibbs RE, 2009, EMBO J, V28, P3040, DOI 10.1038/emboj.2009.227; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Horovitz A, 1996, FOLD DES, V1, pR121, DOI 10.1016/S1359-0278(96)00056-9; JACKSON MB, 1982, J NEUROSCI, V2, P889; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; KELLIS JT, 1988, NATURE, V333, P784, DOI 10.1038/333784a0; Law RJ, 2005, P NATL ACAD SCI USA, V102, P6813, DOI 10.1073/pnas.0407739102; Lee C, 2000, P NATL ACAD SCI USA, V97, P7727, DOI 10.1073/pnas.97.14.7727; Maltsev AS, 2010, J BIOL CHEM, V285, P10154, DOI 10.1074/jbc.M109.088641; McLaughlin JT, 2007, MOL PHARMACOL, V71, P1312, DOI 10.1124/mol.106.033092; Mercado J, 2008, J BIOL CHEM, V283, P15250, DOI 10.1074/jbc.M708638200; MILLA ME, 1994, NAT STRUCT BIOL, V1, P518, DOI 10.1038/nsb0894-518; Miller PS, 2008, NAT STRUCT MOL BIOL, V15, P1084, DOI 10.1038/nsmb.1492; Morley KL, 2005, TRENDS BIOTECHNOL, V23, P231, DOI 10.1016/j.tibtech.2005.03.005; Mortensen M, 2004, J PHYSIOL-LONDON, V557, P389, DOI 10.1113/jphysiol.2003.054734; Nury H, 2010, J MOL BIOL, V395, P1114, DOI 10.1016/j.jmb.2009.11.024; Olano LR, 2004, J AM CHEM SOC, V126, P7991, DOI 10.1021/ja049701c; PAKULA AA, 1989, ANNU REV GENET, V23, P289, DOI 10.1146/annurev.ge.23.120189.001445; Pal C, 2006, NAT REV GENET, V7, P337, DOI 10.1038/nrg1838; SANDBERG WS, 1991, P NATL ACAD SCI USA, V88, P1706, DOI 10.1073/pnas.88.5.1706; SANDBERG WS, 1989, SCIENCE, V245, P54, DOI 10.1126/science.2787053; SHORTLE D, 1990, BIOCHEMISTRY-US, V29, P8033, DOI 10.1021/bi00487a007; SOMERO GN, 1995, ANNU REV PHYSIOL, V57, P43, DOI 10.1146/annurev.ph.57.030195.000355; Sonavane S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000188; Taly A, 2005, BIOPHYS J, V88, P3954, DOI 10.1529/biophysj.104.050229; Tasneem A, 2005, GENOME BIOL, V6; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002; Tokuriki N, 2007, J MOL BIOL, V369, P1318, DOI 10.1016/j.jmb.2007.03.069; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Unwin N, 2002, J MOL BIOL, V319, P1165, DOI 10.1016/S0022-2836(02)00381-9; WILLIAMS MA, 1994, PROTEIN SCI, V3, P1224, DOI 10.1002/pro.5560030808	64	14	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3658	3670		10.1074/jbc.M110.156851	http://dx.doi.org/10.1074/jbc.M110.156851			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21098036	Green Published, hybrid			2022-12-25	WOS:000286653200049
J	Durpes, MC; Hardy-Dessources, MD; El Nemer, W; Picot, J; Lemonne, N; Elion, J; Decastel, M				Durpes, Marie-Claude; Hardy-Dessources, Marie-Dominique; El Nemer, Wassim; Picot, Julien; Lemonne, Nathalie; Elion, Jacques; Decastel, Monique			Activation State of alpha 4 beta 1 Integrin on Sickle Red Blood Cells Is Linked to the Duffy Antigen Receptor for Chemokines(DARC) Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA(4)BETA(1) INTEGRIN; ERYTHROCYTE ADHERENCE; CLINICAL SEVERITY; ADHESION; ENDOTHELIUM; RETICULOCYTES; INTERLEUKIN-8; MECHANISMS; SEQUENCE	In sickle cell anemia, reticulocytes express enhanced levels of alpha 4 beta 1 integrin that interact mainly with vascular cell adhesion molecule-1 and fibronectin, promoting vaso-occlusion. These interactions are known to be highly sensitive to the inflammatory chemokine IL-8. The Duffy antigen receptor for chemokines (DARC) modulates the function of inflammatory processes. However, the link between alpha 4 beta 1 activation by chemokines and DARC erythroid expression is not or poorly explored. Therefore, the capacity of alpha 4 beta 1 to mediate Duffy-negative and Duffy-positive sickle reticulocyte (SRe) adhesion to immobilized vascular cell adhesion molecule-1 and fibronectin was evaluated. Using static adhesion assays, we found that, under basal conditions, Duffy-positive SRe adhesion was 2-fold higher than that of Duffy-negative SRes. Incubating the cells with IL-8 or RANTES (regulated on activation normal T cell expressed and secreted) increased Duffy-positive SRe adhesion only, whereas Mn2+ increased cell adhesion independently of the Duffy phenotype. Flow cytometry analyses performed with anti-beta 1 and anti-alpha 4 antibodies, including a conformation-sensitive one, in the presence or absence of IL-8, revealed that Duffy-positive and Duffy-negative SRes displayed similar erythroid alpha 4 beta 1 expression levels, but with distinct activation states. IL-8 did not affect alpha 4 beta 1 affinity in Duffy-positive SRes but induced its clustering as corroborated by immunofluorescence microscopy. Our results indicate that in Duffy-negative SRes alpha 4 beta 1 integrin is constitutively expressed in a low affinity state, whereas in Duffy-positive SRes alpha 4 beta 1 is expressed in a higher chemokine-sensitive affinity state. This activation state associated with DARC RBC expression may influence the intensity of the inflammatory responses encountered in sickle cell anemia and participate in its interindividual clinical expression variability.	[Durpes, Marie-Claude; Hardy-Dessources, Marie-Dominique; Elion, Jacques; Decastel, Monique] INSERM, UMR S763, F-97159 Pointe A Pitre, Guadeloupe, France; [Durpes, Marie-Claude; Hardy-Dessources, Marie-Dominique; Elion, Jacques; Decastel, Monique] Univ Antilles Guyane, F-97159 Pointe A Pitre, Guadeloupe, France; [El Nemer, Wassim; Picot, Julien] INSERM, UMR S665, F-75015 Paris, France; [El Nemer, Wassim; Picot, Julien] Univ Paris Diderot, F-75013 Paris, France; [El Nemer, Wassim; Picot, Julien] Inst Natl Transfus Sanguine, F-75015 Paris, France; [Lemonne, Nathalie] Ctr Hosp Univ Pointe A Pitre, Unite Transversale, Ctr Drepanocytose CRMR SDM Antilles Guyane, F-97159 Pointe A Pitre, Guadeloupe, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite des Antilles; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Guadeloupe	Decastel, M (corresponding author), Univ Antilles Guyane, Hop RICOU, CHU Pointe A Pitre, INSERM,UMR S763,CNRS,SD401, F-97159 Pointe A Pitre, Guadeloupe, France.	moniquedecastel@yahoo.fr	Elion, Jacques/A-1048-2014; , Hardy-dessources/K-9189-2017; Nemer, Wassim El/N-4247-2017	Elion, Jacques/0000-0002-8407-1783; , Hardy-dessources/0000-0003-0861-3648; Nemer, Wassim El/0000-0001-8184-427X	Region Guadeloupe; Fond Social Europeen; Association Francaise d'Hematologie; Agence Nationale de la Recherche; Region Guadeloupe; Fond Social Europeen; Association Francaise d'Hematologie; Agence Nationale de la Recherche	Region Guadeloupe; Fond Social Europeen; Association Francaise d'Hematologie; Agence Nationale de la Recherche(French National Research Agency (ANR)); Region Guadeloupe; Fond Social Europeen; Association Francaise d'Hematologie; Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by a grant from Region Guadeloupe, Fond Social Europeen and Association Francaise d'Hematologie (to M.-C. D.) and from the Agence Nationale de la Recherche (SCADHESION 2007).	Afenyi-Annan A, 2008, TRANSFUSION, V48, P917, DOI 10.1111/j.1537-2995.2007.01622.x; Brittain JE, 2008, TRANSFUS CLIN BIOL, V15, P19, DOI 10.1016/j.tracli.2008.03.013; Brittain JE, 2004, J BIOL CHEM, V279, P42393, DOI 10.1074/jbc.M407631200; Cartron JP, 1998, VOX SANG, V74, P29, DOI 10.1111/j.1423-0410.1998.tb05397.x; Chaar V, 2010, HAEMATOL-HEMATOL J, V95, P1841, DOI 10.3324/haematol.2010.026294; CHAUDHURI A, 1995, BLOOD, V85, P615, DOI 10.1182/blood.V85.3.615.bloodjournal853615; Connors WL, 2007, J BIOL CHEM, V282, P14675, DOI 10.1074/jbc.M700759200; DARBONNE WC, 1991, J CLIN INVEST, V88, P1362, DOI 10.1172/JCI115442; Dormond O, 2004, THROMB HAEMOSTASIS, V92, P151, DOI 10.1160/th03-11-0728; Duits AJ, 1998, EUR J HAEMATOL, V61, P302; Durpes MC, 2010, BLOOD CELL MOL DIS, V44, P219, DOI 10.1016/j.bcmd.2010.02.001; El Nemer W, 2007, BLOOD, V109, P3544, DOI 10.1182/blood-2006-07-035139; Etienne-Julan M, 2004, HAEMATOLOGICA, V89, P863; Fukuma N, 2003, BIOCHEM BIOPH RES CO, V303, P137, DOI 10.1016/S0006-291X(03)00293-6; GEE BE, 1995, BLOOD, V85, P268, DOI 10.1182/blood.V85.1.268.bloodjournal851268; Grabovsky V, 2000, J EXP MED, V192, P495, DOI 10.1084/jem.192.4.495; Hadley TJ, 1997, BLOOD, V89, P3077, DOI 10.1182/blood.V89.9.3077; Hebbel RP, 1997, J CLIN INVEST, V100, pS83; KORNBERG LJ, 1991, P NATL ACAD SCI USA, V88, P8392, DOI 10.1073/pnas.88.19.8392; Kumar A, 1996, BLOOD, V88, P4348; Laudanna C, 2002, IMMUNOL REV, V186, P37, DOI 10.1034/j.1600-065X.2002.18604.x; Lee K, 2001, BLOOD, V98, P966, DOI 10.1182/blood.V98.4.966; MASUMOTO A, 1993, J BIOL CHEM, V268, P228; Montes RAO, 2002, AM J HEMATOL, V70, P216, DOI 10.1002/ajh.10145; Nebor D, 2010, CLIN IMMUNOL, V136, P116, DOI 10.1016/j.clim.2010.02.023; Pantaleo A, 2010, J PROTEOMICS, V73, P445, DOI 10.1016/j.jprot.2009.08.011; Schnog JB, 2000, CLIN IMMUNOL, V96, P264, DOI 10.1006/clim.2000.4884; Telen MJ, 2005, TRANSFUS MED REV, V19, P32, DOI 10.1016/j.tmrv.2004.09.006; Tournamille C, 2004, IMMUNOGENETICS, V55, P682, DOI 10.1007/s00251-003-0633-2; Walmet PS, 2003, AM J HEMATOL, V73, P215, DOI 10.1002/ajh.10360; WAUTIER JL, 1985, AM J HEMATOL, V19, P121, DOI 10.1002/ajh.2830190203; Weber C, 1996, J CELL BIOL, V134, P1063, DOI 10.1083/jcb.134.4.1063; Yazdanbakhsh K, 2000, TRANSFUSION, V40, P310, DOI 10.1046/j.1537-2995.2000.40030310.x	33	7	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					3057	3064		10.1074/jbc.M110.173229	http://dx.doi.org/10.1074/jbc.M110.173229			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21088296	hybrid, Green Published			2022-12-25	WOS:000286464300068
J	Gordon, CS; Serino, AS; Krause, MP; Campbell, JE; Cafarelli, E; Adegoke, OAJ; Hawke, TJ; Riddell, MC				Gordon, Carly S.; Serino, Antonio S.; Krause, Matthew P.; Campbell, Jonathan E.; Cafarelli, Enzo; Adegoke, Olasunkanmi A. J.; Hawke, Thomas J.; Riddell, Michael C.			Impaired Growth and Force Production in Skeletal Muscles of Young Partially Pancreatectomized Rats: A Model of Adolescent Type 1 Diabetic Myopathy?	PLOS ONE			English	Article							PROTEIN-SYNTHESIS; MORPHOLOGICAL ABNORMALITIES; CARBOHYDRATE-METABOLISM; MORPHOMETRIC-ANALYSIS; CONTRACTILE ACTIVITY; CELLULAR MECHANISMS; ENDOCRINE FUNCTION; PHYSICAL-FITNESS; SINGLE-FIBER; FINAL HEIGHT	This present study investigated the temporal effects of type 1 diabetes mellitus (T1DM) on adolescent skeletal muscle growth, morphology and contractile properties using a 90% partial pancreatecomy (Px) model of the disease. Four week-old male Sprague-Dawley rats were randomly assigned to Px (n = 25) or Sham (n = 24) surgery groups and euthanized at 4 or 8 weeks following an in situ assessment of muscle force production. Compared to Shams, Px were hyperglycemic (>15 mM) and displayed attenuated body mass gains by days 2 and 4, respectively (both P<0.05). Absolute maximal force production of the gastrocnemius plantaris soleus complex (GPS) was 30% and 50% lower in Px vs. Shams at 4 and 8 weeks, respectively (P<0.01). GP mass was 35% lower in Px vs Shams at 4 weeks (1.24 +/- 0.06 g vs. 1.93 +/- 0.03 g, P<0.05) and 45% lower at 8 weeks (1.57 +/- 0.12 vs. 2.80 +/- 0.06, P<0.05). GP fiber area was 15-20% lower in Px vs. Shams at 4 weeks in all fiber types. At 8 weeks, GP type I and II fiber areas were similar to 25% and 40% less, respectively, in Px vs. Shams (group by fiber type interactions, P<0.05). Phosphorylation states of 4E-BP1 and S6K1 following leucine gavage increased 2.0- and 3.5-fold, respectively, in Shams but not in Px. Px rats also had impaired rates of muscle protein synthesis in the basal state and in response to gavage. Taken together, these data indicate that exposure of growing skeletal muscle to uncontrolled T1DM significantly impairs muscle growth and function largely as a result of impaired protein synthesis in type II fibers.	[Gordon, Carly S.; Serino, Antonio S.; Campbell, Jonathan E.; Cafarelli, Enzo; Adegoke, Olasunkanmi A. J.; Riddell, Michael C.] York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada; [Gordon, Carly S.; Serino, Antonio S.; Krause, Matthew P.; Campbell, Jonathan E.; Cafarelli, Enzo; Adegoke, Olasunkanmi A. J.; Hawke, Thomas J.; Riddell, Michael C.] York Univ, Muscle Hlth Res Ctr, Toronto, ON M3J 2R7, Canada; [Krause, Matthew P.; Hawke, Thomas J.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada	York University - Canada; York University - Canada; McMaster University	Gordon, CS (corresponding author), York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada.	mriddell@yorku.ca		Hawke, Thomas/0000-0003-4974-4820; Campbell, Jonathan/0000-0001-8223-1600	National Science and Engineering Research Council of Canada (NSERC); Canadian Diabetes Association	National Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Diabetes Association	This research was supported by grants from National Science and Engineering Research Council of Canada (NSERC) and the Canadian Diabetes Association to MCR. CG is the recipient of the NSERC Canada Graduate Scholarship award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegoke OAJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE105, DOI 10.1152/ajpendo.90752.2008; Andersen H, 1997, DIABETOLOGIA, V40, P1062, DOI 10.1007/s001250050788; Andersen H, 2004, DIABETES CARE, V27, P2382, DOI 10.2337/diacare.27.10.2382; Andersen H, 1996, DIABETES, V45, P440, DOI 10.2337/diabetes.45.4.440; Andersen H, 1998, DIABETES CARE, V21, P604, DOI 10.2337/diacare.21.4.604; Anthony JC, 2002, DIABETES, V51, P928, DOI 10.2337/diabetes.51.4.928; Anthony JC, 2002, AM J PHYSIOL-ENDOC M, V282, pE1092, DOI 10.1152/ajpendo.00208.2001; ARMSTRONG RB, 1975, CELL TISSUE RES, V162, P387; Attaix D, 2005, ESSAYS BIOCHEM, V41, P173, DOI 10.1042/EB0410173; BARALDI E, 1992, PEDIATR PULM, V13, P155, DOI 10.1002/ppul.1950130306; Bognetti E, 1998, DIABETES CARE, V21, P1226, DOI 10.2337/diacare.21.8.1226; BONNERWEIR S, 1983, J CLIN INVEST, V71, P1544, DOI 10.1172/JCI110910; BROWN M, 1994, DIABETIC MED, V11, P182, DOI 10.1111/j.1464-5491.1994.tb02017.x; BURKE RE, 1973, J PHYSIOL-LONDON, V234, P723, DOI 10.1113/jphysiol.1973.sp010369; CAPRIO S, 1994, AM J PHYSIOL, V266, pE885, DOI 10.1152/ajpendo.1994.266.6.E885; Caso G, 2010, CURR OPIN CLIN NUTR, V13, P93, DOI 10.1097/MCO.0b013e328333294d; Charlton M, 1998, J NUTR, V128, p323S, DOI 10.1093/jn/128.2.323S; Chiarelli F, 2004, EUR J ENDOCRINOL, V151, pU109, DOI 10.1530/eje.0.151U109; Chonkar A, 2006, ANN NY ACAD SCI, V1084, P442, DOI 10.1196/annals.1372.006; COTTER MA, 1993, EXP PHYSIOL, V78, P139, DOI 10.1113/expphysiol.1993.sp003675; Crowther GJ, 2003, AM J PHYSIOL-ENDOC M, V284, pE655, DOI 10.1152/ajpendo.00343.2002; Crozier SJ, 2005, J NUTR, V135, P376, DOI 10.1093/jn/135.3.376; DARR KC, 1989, J APPL PHYSIOL, V67, P1827, DOI 10.1152/jappl.1989.67.5.1827; Donaghue KC, 2009, PEDIATR DIABETES, V10, P195, DOI 10.1111/j.1399-5448.2009.00576.x; DUCAJU MVL, 1995, PEDIATR RES, V38, P607, DOI 10.1203/00006450-199510000-00022; Fahim MA, 1998, ANAT RECORD, V251, P240, DOI 10.1002/(SICI)1097-0185(199806)251:2<240::AID-AR13>3.0.CO;2-O; Fricke O., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P188; Fritzsche K, 2008, EXP CLIN ENDOCR DIAB, V116, P606, DOI 10.1055/s-2008-1073126; GARLICK PJ, 1980, BIOCHEM J, V192, P719, DOI 10.1042/bj1920719; GOLDBERG AL, 1979, DIABETES, V28, P18, DOI 10.2337/diab.28.1.S18; Gordon JW, 2001, J APPL PHYSIOL, V90, P389, DOI 10.1152/jappl.2001.90.1.389; Gunczler P, 1999, DIABETES CARE, V22, P1012, DOI 10.2337/diacare.22.6.1012; Gusso S, 2008, DIABETOLOGIA, V51, P1317, DOI 10.1007/s00125-008-1012-1; Hamilton J, 2002, J PEDIATR ENDOCR MET, V15, P115; HUTTUNEN NP, 1984, ANN CLIN RES, V16, P1; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; JAKOBSEN J, 1986, CLIN NEUROPATHOL, V5, P73; Johnston APW, 2007, AM J PHYSIOL-CELL PH, V292, pC1033, DOI 10.1152/ajpcell.00338.2006; KLUEBER KM, 1994, ANAT REC, V239, P18, DOI 10.1002/ar.1092390104; Krause MP, 2011, PEDIATR DIABETES, V12, P345, DOI 10.1111/j.1399-5448.2010.00699.x; Krause MP, 2009, J APPL PHYSIOL, V106, P1650, DOI 10.1152/japplphysiol.91565.2008; LARSSON Y, 1964, J APPL PHYSIOL, V19, P629, DOI 10.1152/jappl.1964.19.4.629; Lesniewski LA, 2003, MUSCLE NERVE, V28, P493, DOI 10.1002/mus.10468; McGuire M, 1999, EXP PHYSIOL, V84, P1051, DOI 10.1111/j.1469-445X.1999.01916.x; Miyazaki M, 2009, J APPL PHYSIOL, V106, P1367, DOI 10.1152/japplphysiol.91355.2008; MIZUMOTO R, 1982, AM J SURG, V143, P237, DOI 10.1016/0002-9610(82)90077-0; Mozdziak PE, 2000, J APPL PHYSIOL, V88, P158, DOI 10.1152/jappl.2000.88.1.158; OERTEL G, 1988, J NEUROL SCI, V88, P303, DOI 10.1016/0022-510X(88)90227-4; OGILVIE RW, 1990, STAIN TECHNOL, V65, P231, DOI 10.3109/10520299009105613; POORTMANS JR, 1986, INT J SPORTS MED, V7, P232, DOI 10.1055/s-2008-1025765; RESKENIELSEN E, 1970, DIABETOLOGIA, V6, P104, DOI 10.1007/BF00421437; RESKENIELSEN E, 1970, DIABETOLOGIA, V6, P98, DOI 10.1007/BF00421436; RESKENIELSEN E, 1977, ACTA NEUROL SCAND, V55, P345, DOI 10.1111/j.1600-0404.1977.tb05654.x; Riddell MC, 2006, PEDIATR DIABETES, V7, P60, DOI 10.1111/j.1399-543X.2006.00146.x; Rosa JS, 2009, PEDIATR DIABETES, V10, P213, DOI 10.1111/j.1399-5448.2008.00452.x; Sanchez OA, 2005, J APPL PHYSIOL, V99, P472, DOI 10.1152/japplphysiol.01233.2004; Shah OJ, 2000, AM J PHYSIOL-ENDOC M, V279, pE74, DOI 10.1152/ajpendo.2000.279.1.E74; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Snow LM, 2006, PATHOBIOLOGY, V73, P244, DOI 10.1159/000098210; SOMMER H, 1987, EUR SURG RES, V19, P318, DOI 10.1159/000128716; Spangenburg EE, 2008, J PHYSIOL-LONDON, V586, P283, DOI 10.1113/jphysiol.2007.141507; STEPHENSON GMM, 1994, DIABETES, V43, P622, DOI 10.2337/diabetes.43.5.622; STERKY G, 1963, ACTA PAEDIATR, V52, P1, DOI 10.1111/j.1651-2227.1963.tb04073.x; SUZUKI O, 1976, ANAL BIOCHEM, V75, P192, DOI 10.1016/0003-2697(76)90070-1; TATTERSALL RB, 1973, LANCET, V2, P1105; VANELLI M, 1992, HORM RES, V37, P65, DOI 10.1159/000182404; Vignaud A, 2007, PATHOBIOLOGY, V74, P291, DOI 10.1159/000105812; YASUGI H, 1976, AM J SURG, V132, P577, DOI 10.1016/0002-9610(76)90346-9	68	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2010	5	11							e14032	10.1371/journal.pone.0014032	http://dx.doi.org/10.1371/journal.pone.0014032			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681OY	21103335	Green Published, gold, Green Submitted			2022-12-25	WOS:000284327800016
J	Barbagallo, APM; Weldon, R; Tamayev, R; Zhou, DW; Giliberto, L; Foreman, O; D'Adamio, L				Barbagallo, Alessia P. M.; Weldon, Richard; Tamayev, Robert; Zhou, Dawang; Giliberto, Luca; Foreman, Oded; D'Adamio, Luciano			Tyr(682) in the Intracellular Domain of APP Regulates Amyloidogenic APP Processing In Vivo	PLOS ONE			English	Article							BETA PRECURSOR PROTEIN; RECEPTOR-RELATED PROTEIN; C-TERMINAL FRAGMENTS; KINESIN LIGHT-CHAIN; ALZHEIMERS-DISEASE; AXONAL-TRANSPORT; GAMMA-SECRETASE; FE65; PHOSPHORYLATION; TYROSINE	Background: The pathogenesis of Alzheimer's disease is attributed to misfolding of Amyloid-beta (A beta) peptides. A beta is generated during amyloidogenic processing of A beta-precursor protein (APP). Another characteristic of the AD brain is increased phosphorylation of APP amino acid Tyr(682). Tyr(682) is part of the Y-682 ENPTY687 motif, a docking site for interaction with cytosolic proteins that regulate APP metabolism and signaling. For example, normal A beta generation and secretion are dependent upon Tyr(682) in vitro. However, physiological functions of Tyr(682) are unknown. Methodology/Principal Findings: To this end, we have generated an APP Y682G knock-in (KI) mouse to help dissect the role of APP Tyr(682) in vivo. We have analyzed proteolytic products from both the amyloidogenic and non-amyloidogenic processing of APP and measure a profound shift towards non-amyloidogenic processing in APP KI mice. In addition, we demonstrate the essential nature of amino acid Tyr(682) for the APP/Fe65 interaction in vivo. Conclusions/Significance: Together, these observations point to an essential role of APP intracellular domain for normal APP processing and function in vivo, and provide rationale for further studies into physiological functions associated with this important phosphorylation site.	[Barbagallo, Alessia P. M.; Weldon, Richard; Tamayev, Robert; Zhou, Dawang; D'Adamio, Luciano] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Foreman, Oded] Jackson Lab, Dept Lab Anim Hlth, Bar Harbor, ME 04609 USA; [Giliberto, Luca] N Shore LIJ, Feinstein Inst Med Res, Litwin Zucker Res Ctr Study Alzheimers Dis, Manhasset, NY USA	Yeshiva University; Albert Einstein College of Medicine; Jackson Laboratory; Northwell Health	Barbagallo, APM (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA.	luciano.dadamio@einstein.yu.edu		Zhou, Dawang/0000-0002-9053-5249; D'Adamio, Luciano/0000-0002-2204-9441; D'Adamio, Luciano/0000-0002-9820-4882	Alzheimer's Association [IIRG-09-129984]; NIH [R01AG033007]; Training Program in Cellular and Molecular Biology and Genetics [T32 GM007491]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288, T32GM007491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033007] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Training Program in Cellular and Molecular Biology and Genetics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Alzheimer's Association IIRG-09-129984 grant (LD), NIH Grants R01AG033007 (LD) and Training Program in Cellular and Molecular Biology and Genetics T32 GM007491 (RT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando K, 2001, J BIOL CHEM, V276, P40353, DOI 10.1074/jbc.M104059200; AUSTIN SA, 2008, NEUROBIOL AGING; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Balastik M, 2007, BBA-MOL BASIS DIS, V1772, P422, DOI 10.1016/j.bbadis.2007.01.006; Buxbaum JD, 1998, J NEUROSCI, V18, P9629; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cao XW, 2004, J BIOL CHEM, V279, P24601, DOI 10.1074/jbc.M402248200; Cash AD, 2003, AM J PATHOL, V162, P1623, DOI 10.1016/S0002-9440(10)64296-4; Checler F, 2007, CURR ALZHEIMER RES, V4, P423, DOI 10.2174/156720507781788945; Cupers P, 2001, J NEUROCHEM, V78, P1168, DOI 10.1046/j.1471-4159.2001.00516.x; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Fiore F, 1995, J BIOL CHEM, V270, P30853, DOI 10.1074/jbc.270.52.30853; Galvan V, 2006, P NATL ACAD SCI USA, V103, P7130, DOI 10.1073/pnas.0509695103; Giliberto L, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-12; Giliberto L, 2009, J BIOL CHEM, V284, P9027, DOI 10.1074/jbc.M805685200; Hamid R, 2007, J NEUROCHEM, V102, P1264, DOI 10.1111/j.1471-4159.2007.04627.x; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Huttunen HJ, 2009, J MOL NEUROSCI, V37, P6, DOI 10.1007/s12031-008-9088-0; Inomata H, 2003, J BIOL CHEM, V278, P22946, DOI 10.1074/jbc.M212160200; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaether C, 2006, TRAFFIC, V7, P408, DOI 10.1111/j.1600-0854.2006.00396.x; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; Kim HS, 2003, FASEB J, V17, P1951, DOI 10.1096/fj.03-0106fje; Kimura A, 1998, GENES CELLS, V3, P789, DOI 10.1046/j.1365-2443.1998.00229.x; King GD, 2004, EXP NEUROL, V185, P208, DOI 10.1016/j.expneurol.2003.10.011; King GD, 2004, J NEUROCHEM, V88, P971, DOI 10.1046/j.1471-4159.2003.02234.x; Kins S, 2006, NEURODEGENER DIS, V3, P218, DOI 10.1159/000095259; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; Lanz TA, 2006, J NEUROSCI METH, V157, P71, DOI 10.1016/j.jneumeth.2006.03.023; Lazarov O, 2005, J NEUROSCI, V25, P2386, DOI 10.1523/JNEUROSCI.3089-04.2005; Lee MS, 2003, J CELL BIOL, V163, P83, DOI 10.1083/jcb.200301115; Leissring MA, 2002, P NATL ACAD SCI USA, V99, P4697, DOI 10.1073/pnas.072033799; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; Madeira A, 2005, FASEB J, V19, P1905, DOI 10.1096/fj.05-3839fje; Matsuda S, 2003, J BIOL CHEM, V278, P38601, DOI 10.1074/jbc.M304379200; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; Minopoli G, 2007, J BIOL CHEM, V282, P831, DOI 10.1074/jbc.C600276200; MORIN PJ, 1993, J NEUROCHEM, V61, P464; MOYA KL, 1994, J NEUROCHEM, V63, P1971; Muresan Z, 2005, J CELL BIOL, V171, P615, DOI 10.1083/jcb.200502043; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Passer Brent, 2000, Journal of Alzheimer's Disease, V2, P289; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Pietrzik CU, 2004, J NEUROSCI, V24, P4259, DOI 10.1523/JNEUROSCI.5451-03.2004; Praprotnik D, 1996, ACTA NEUROPATHOL, V91, P226, DOI 10.1007/s004010050420; Puzzo D, 2008, J NEUROSCI, V28, P14537, DOI 10.1523/JNEUROSCI.2692-08.2008; Reinhard C, 2005, EMBO J, V24, P3996, DOI 10.1038/sj.emboj.7600860; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; Russo C, 2002, J BIOL CHEM, V277, P35282, DOI 10.1074/jbc.M110785200; Russo C, 2001, NEUROBIOL DIS, V8, P173, DOI 10.1006/nbdi.2000.0357; Russo T, 1998, FEBS LETT, V434, P1, DOI 10.1016/S0014-5793(98)00941-7; Sano Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000051; Scheinfeld MH, 2003, J BIOL CHEM, V278, P42058, DOI 10.1074/jbc.M304853200; Scheinfeld MH, 2003, P NATL ACAD SCI USA, V100, P1729, DOI 10.1073/pnas.0437908100; Schmidt Stephen D., 2004, V299, P279; Selkoe DJ, 2000, NEUROL CLIN, V18, P903, DOI 10.1016/S0733-8619(05)70232-2; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 1996, ANN NY ACAD SCI, V777, P57, DOI 10.1111/j.1749-6632.1996.tb34401.x; SIMONS M, 1995, J NEUROSCI RES, V41, P121, DOI 10.1002/jnr.490410114; SISODIA SS, 1993, J NEUROSCI, V13, P3136; Stokin GB, 2006, J PHYSIOL-PARIS, V99, P193, DOI 10.1016/j.jphysparis.2005.12.085; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Stokin GB, 2006, ANNU REV BIOCHEM, V75, P607, DOI 10.1146/annurev.biochem.75.103004.142637; Tamayev R, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-28; Tarr PE, 2002, J BIOL CHEM, V277, P16798, DOI 10.1074/jbc.M110286200; Terry RD, 1996, J NEUROPATH EXP NEUR, V55, P1023, DOI 10.1097/00005072-199655100-00001; Tienari PJ, 1996, EMBO J, V15, P5218, DOI 10.1002/j.1460-2075.1996.tb00907.x; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; Turner PR, 2003, PROG NEUROBIOL, V70, P1, DOI 10.1016/S0301-0082(03)00089-3; Ulery PG, 2000, J BIOL CHEM, V275, P7410, DOI 10.1074/jbc.275.10.7410; von Rotz RC, 2004, J CELL SCI, V117, P4435, DOI 10.1242/jcs.01323; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X; Zheng H, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-5; Zhou DW, 2009, J ALZHEIMERS DIS, V16, P301, DOI 10.3233/JAD-2009-0970; Zhou DW, 2004, J BIOL CHEM, V279, P25374, DOI 10.1074/jbc.M400488200	78	48	54	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e15503	10.1371/journal.pone.0015503	http://dx.doi.org/10.1371/journal.pone.0015503			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103325	Green Published, Green Submitted, gold			2022-12-25	WOS:000284257400028
J	Kirin, M; McQuillan, R; Franklin, CS; Campbell, H; McKeigue, PM; Wilson, JF				Kirin, Mirna; McQuillan, Ruth; Franklin, Christopher S.; Campbell, Harry; McKeigue, Paul M.; Wilson, James F.			Genomic Runs of Homozygosity Record Population History and Consanguinity	PLOS ONE			English	Article							QUANTITATIVE TRAITS; PAKISTAN; SCHIZOPHRENIA; MARRIAGES; DISEASE	The human genome is characterised by many runs of homozygous genotypes, where identical haplotypes were inherited from each parent. The length of each run is determined partly by the number of generations since the common ancestor: offspring of cousin marriages have long runs of homozygosity (ROH), while the numerous shorter tracts relate to shared ancestry tens and hundreds of generations ago. Human populations have experienced a wide range of demographic histories and hold diverse cultural attitudes to consanguinity. In a global population dataset, genome-wide analysis of long and shorter ROH allows categorisation of the mainly indigenous populations sampled here into four major groups in which the majority of the population are inferred to have: (a) recent parental relatedness (south and west Asians); (b) shared parental ancestry arising hundreds to thousands of years ago through long term isolation and restricted effective population size (N-e), but little recent inbreeding (Oceanians); (c) both ancient and recent parental relatedness (Native Americans); and (d) only the background level of shared ancestry relating to continental N-e (predominantly urban Europeans and East Asians; lowest of all in sub-Saharan African agriculturalists), and the occasional cryptically inbred individual. Moreover, individuals can be positioned along axes representing this demographic historic space. Long runs of homozygosity are therefore a globally widespread and under-appreciated characteristic of our genomes, which record past consanguinity and population isolation and provide a distinctive record of the demographic history of an individual's ancestors. Individual ROH measures will also allow quantification of the disease risk arising from polygenic recessive effects.	[Kirin, Mirna; McQuillan, Ruth; Franklin, Christopher S.; Campbell, Harry; McKeigue, Paul M.; Wilson, James F.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland	University of Edinburgh	Kirin, M (corresponding author), Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland.	jim.wilson@hgu.mrc.ac.uk	Campbell, Harry/E-2959-2010; Wilson, James F/A-5704-2009	Campbell, Harry/0000-0002-6169-6262; Wilson, James F/0000-0001-5751-9178	Royal Society; MS Society UK; University of Edinburgh; Economic and Social Research Council	Royal Society(Royal Society of London); MS Society UK; University of Edinburgh; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	There was no specific funding for this project. JFW is supported by the Royal Society, RM by the MS Society UK, MK by the University of Edinburgh and CSF by the Economic and Social Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auton A, 2009, GENOME RES, V19, P795, DOI 10.1101/gr.088898.108; Bittles A, GLOBAL PREVALENCE CO; Broman KW, 1999, AM J HUM GENET, V65, P1493, DOI 10.1086/302661; Campbell H, 2007, HUM MOL GENET, V16, P233, DOI 10.1093/hmg/ddl473; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Curtis D, 2008, ANN HUM GENET, V72, P261, DOI 10.1111/j.1469-1809.2007.00411.x; Dawson KP, 2000, QJM-MON J ASSOC PHYS, V93, P313, DOI 10.1093/qjmed/93.5.313; Fentress Elizabeth, 1996, BERBERS; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gibson J, 2006, HUM MOL GENET, V15, P789, DOI 10.1093/hmg/ddi493; Hartl D., 2007, PRINCIPLES POPULATIO; Hussain R, 1998, J BIOSOC SCI, V30, P261, DOI 10.1017/S0021932098002612; Hussain R, 1999, J BIOSOC SCI, V31, P449, DOI 10.1017/S0021932099004496; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; Knight HM, 2008, EUR J HUM GENET, V16, P750, DOI 10.1038/ejhg.2008.11; Lencz T, 2007, P NATL ACAD SCI USA, V104, P19942, DOI 10.1073/pnas.0710021104; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Li LH, 2006, HUM MUTAT, V27, P1115, DOI 10.1002/humu.20399; McQuillan R, 2008, AM J HUM GENET, V83, P359, DOI 10.1016/j.ajhg.2008.08.007; Mohyuddin A, 2003, TISSUE ANTIGENS, V61, P286, DOI 10.1034/j.1399-0039.2003.00049.x; PASTNER S, 1972, MAN, V7, P128, DOI 10.2307/2799861; Pedersen J, 2002, Community Genet, V5, P178, DOI 10.1159/000066333; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rudan I, 2003, GENETICS, V163, P1011; Sheffield VC, 1998, TRENDS GENET, V14, P391, DOI 10.1016/S0168-9525(98)01556-X; SHI W, 2009, MOL BIOL EVOL   1012; Shlush LI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002105; Weiss LA, 2006, NAT GENET, V38, P218, DOI 10.1038/ng1726; Woods CG, 2006, AM J HUM GENET, V78, P889, DOI 10.1086/503875	30	283	293	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e13996	10.1371/journal.pone.0013996	http://dx.doi.org/10.1371/journal.pone.0013996			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085596	Green Submitted, gold, Green Published			2022-12-25	WOS:000284231800025
J	Ropelewski, AJ; Nicholas, HB; Mendez, RRG				Ropelewski, Alexander J.; Nicholas, Hugh B., Jr.; Mendez, Ricardo R. Gonzalez			MPI-PHYLIP: Parallelizing Computationally Intensive Phylogenetic Analysis Routines for the Analysis of Large Protein Families	PLOS ONE			English	Article							ALDEHYDE DEHYDROGENASE; TREE; RECONSTRUCTION; PHYLOGENOMICS; ALGORITHM	Background: Phylogenetic study of protein sequences provides unique and valuable insights into the molecular and genetic basis of important medical and epidemiological problems as well as insights about the origins and development of physiological features in present day organisms. Consensus phylogenies based on the bootstrap and other resampling methods play a crucial part in analyzing the robustness of the trees produced for these analyses. Methodology: Our focus was to increase the number of bootstrap replications that can be performed on large protein datasets using the maximum parsimony, distance matrix, and maximum likelihood methods. We have modified the PHYLIP package using MPI to enable large-scale phylogenetic study of protein sequences, using a statistically robust number of bootstrapped datasets, to be performed in a moderate amount of time. This paper discusses the methodology used to parallelize the PHYLIP programs and reports the performance of the parallel PHYLIP programs that are relevant to the study of protein evolution on several protein datasets. Conclusions: Calculations that currently take a few days on a state of the art desktop workstation are reduced to calculations that can be performed over lunchtime on a modern parallel computer. Of the three protein methods tested, the maximum likelihood method scales the best, followed by the distance method, and then the maximum parsimony method. However, the maximum likelihood method requires significant memory resources, which limits its application to more moderately sized protein datasets.	[Ropelewski, Alexander J.; Nicholas, Hugh B., Jr.] Carnegie Mellon Univ, Pittsburgh Supercomp Ctr, Pittsburgh, PA 15213 USA; [Mendez, Ricardo R. Gonzalez] Univ Puerto Rico, Sch Med, Dept Radiol Sci, San Juan, PR 00936 USA	Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Ropelewski, AJ (corresponding author), Carnegie Mellon Univ, Pittsburgh Supercomp Ctr, Pittsburgh, PA 15213 USA.	ropelews@psc.edu			United States National Institutes of Health National Institute of General Medical Sciences [2 T36GM008789]; Pittsburgh Supercomputing Center National Resource for Biomedical Supercomputing through the United States National Institutes of Health National Center for Research Resources [2 P41 RR06009]; United States National Institutes of Health through the National Center for Research Resources; United States National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR006009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T36GM008789] Funding Source: NIH RePORTER	United States National Institutes of Health National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Pittsburgh Supercomputing Center National Resource for Biomedical Supercomputing through the United States National Institutes of Health National Center for Research Resources; United States National Institutes of Health through the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); United States National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported through the United States National Institutes of Health National Institute of General Medical Sciences grant No. 2 T36GM008789 and the Pittsburgh Supercomputing Center National Resource for Biomedical Supercomputing funded through the United States National Institutes of Health National Center for Research Resources grant 2 P41 RR06009. Funding for the shared-memory parallel Altix systems used for the tests in this paper was provided through grants from the United States National Institutes of Health through the National Center for Research Resources and the United States National Science Foundation through TeraGrid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; Bridgham JT, 2006, SCIENCE, V312, P97, DOI 10.1126/science.1123348; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Darling AE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000128; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; Douady CJ, 2003, MOL BIOL EVOL, V20, P248, DOI 10.1093/molbev/msg042; Durand D, 2006, TRENDS GENET, V22, P156, DOI 10.1016/j.tig.2006.01.002; Durand D, 2006, J COMPUT BIOL, V13, P320, DOI 10.1089/cmb.2006.13.320; Felsenstein J, 1996, MOL BIOL EVOL, V13, P93, DOI 10.1093/oxfordjournals.molbev.a025575; Felsenstein J., 2004, INFERRING PHYLOGENIE; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Hamacher K, 2010, BIONFORMATICS 2010: PROCEEDINGS OF THE FIRST INTERNATIONAL CONFERENCE ON BIOINFORMATICS, P114; HEDGES SB, 1992, MOL BIOL EVOL, V9, P366; Hempel J, 2003, CHEM-BIOL INTERACT, V143, P23, DOI 10.1016/S0009-2797(02)00165-5; Janies DA, 2002, MOLECULAR SYSTEMATICS AND EVOLUTION: THEORY AND PRACTICE, P115; Keane TM, 2007, NUCLEIC ACIDS RES, V35, pW33, DOI 10.1093/nar/gkm359; Keane TM, 2005, BIOINFORMATICS, V21, P969, DOI 10.1093/bioinformatics/bti100; Kordis D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-266; Li KB, 2003, BIOINFORMATICS, V19, P1585, DOI 10.1093/bioinformatics/btg192; Mayr E., 2001, WHAT EVOLUTION IS; Minh BQ, 2005, BIOINFORMATICS, V21, P3794, DOI 10.1093/bioinformatics/bti594; OLSEN GJ, 1994, COMPUT APPL BIOSCI, V10, P41; Opperdoes FR, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P313; Perozich J, 1999, PROTEIN SCI, V8, P137, DOI 10.1110/ps.8.1.137; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Reva B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r232; Russo CAM, 1996, MOL BIOL EVOL, V13, P525, DOI 10.1093/oxfordjournals.molbev.a025613; Sanderson MJ, 2003, TRENDS PLANT SCI, V8, P374, DOI 10.1016/S1360-1385(03)00165-1; Sankararaman S, 2008, BIOINFORMATICS, V24, P2445, DOI 10.1093/bioinformatics/btn474; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Sheps JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r15; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stamatakis AP, 2002, CSB2002: IEEE COMPUTER SOCIETY BIOINFORMATICS CONFERENCE, P21, DOI 10.1109/CSB.2002.1039325; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; WILLIAMS TL, 2006, PARALLEL COMPUTING B, P369; Wymore T, 2003, CHEM-BIOL INTERACT, V143, P75, DOI 10.1016/S0009-2797(02)00175-8; Yang S, 2005, P NATL ACAD SCI USA, V102, P373, DOI 10.1073/pnas.0408810102	40	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e13999	10.1371/journal.pone.0013999	http://dx.doi.org/10.1371/journal.pone.0013999			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085574	Green Published, Green Submitted, gold			2022-12-25	WOS:000284231800026
J	Etemadmoghadam, D; George, J; Cowin, PA; Cullinane, C; Kansara, M; Gorringe, KL; Smyth, GK; Bowtell, DDL				Etemadmoghadam, Dariush; George, Joshy; Cowin, Prue A.; Cullinane, Carleen; Kansara, Maya; Gorringe, Kylie L.; Smyth, Gordon K.; Bowtell, David D. L.		Australian Ovarian Canc Study Grp	Amplicon-Dependent CCNE1 Expression Is Critical for Clonogenic Survival after Cisplatin Treatment and Is Correlated with 20q11 Gain in Ovarian Cancer	PLOS ONE			English	Article							POTENTIAL THERAPEUTIC TARGET; CYCLIN-E; COPY-NUMBER; CELL-CYCLE; GENE AMPLIFICATION; 19Q12 AMPLICON; LUNG; PREDICTOR; LANDSCAPE; STABILITY	Genomic amplification of 19q12 occurs in several cancer types including ovarian cancer where it is associated with primary treatment failure. We systematically attenuated expression of genes within the minimally defined 19q12 region in ovarian cell lines using short-interfering RNAs (siRNA) to identify driver oncogene(s) within the amplicon. Knockdown of CCNE1 resulted in G1/S phase arrest, reduced cell viability and apoptosis only in amplification-carrying cells. Although CCNE1 knockdown increased cisplatin resistance in short-term assays, clonogenic survival was inhibited after treatment. Gain of 20q11 was highly correlated with 19q12 amplification and spanned a 2.5 Mb region including TPX2, a centromeric protein required for mitotic spindle function. Expression of TPX2 was highly correlated with gene amplification and with CCNE1 expression in primary tumors. siRNA inhibition of TPX2 reduced cell viability but this effect was not amplicon-dependent. These findings demonstrate that CCNE1 is a key driver in the 19q12 amplicon required for survival and clonogenicity in cells with locus amplification. Co-amplification at 19q12 and 20q11 implies the presence of a cooperative mutational network. These observations have implications for the application of targeted therapies in CCNE1 dependent ovarian cancers.	[Etemadmoghadam, Dariush; George, Joshy; Cowin, Prue A.; Kansara, Maya; Gorringe, Kylie L.; Bowtell, David D. L.] Peter MacCallum Canc Ctr, Canc Genom Program, Melbourne, Australia; [George, Joshy; Bowtell, David D. L.] Univ Melbourne, Dept Biochem, Parkville, Vic 3052, Australia; [Cullinane, Carleen] Peter MacCallum Canc Ctr, Translat Res Program, Melbourne, Australia; [Gorringe, Kylie L.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Smyth, Gordon K.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic 3050, Australia	Peter Maccallum Cancer Center; University of Melbourne; Peter Maccallum Cancer Center; University of Melbourne; Royal Melbourne Hospital; Walter & Eliza Hall Institute	Etemadmoghadam, D (corresponding author), Peter MacCallum Canc Ctr, Canc Genom Program, Melbourne, Australia.	david.bowtell@petermac.org	Smyth, Gordon/B-5276-2008; Gorringe, Kylie L/H-3264-2019; George, Joshy/K-4841-2019; Bowtell, David/H-1007-2016	Smyth, Gordon/0000-0001-9221-2892; Gorringe, Kylie L/0000-0001-5681-2022; Bowtell, David/0000-0001-9089-7525; George, Joshy/0000-0001-8510-8229; Cullinane, Carleen/0000-0001-5833-6605	National Health and Medical Research Council (NHMRC) [628779]; U.S. Army Medical Research and Materiel Command [DAMD17-01-1-0729]; Cancer Council Victoria; Queensland Cancer Fund; Cancer Council New South Wales; Cancer Council South Australia; Cancer Foundation of Western Australia; Cancer Council Tasmania	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); U.S. Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Queensland Cancer Fund; Cancer Council New South Wales(Cancer Council New South Wales); Cancer Council South Australia(Cancer Council South Australia); Cancer Foundation of Western Australia(Cancer Council Western Australia); Cancer Council Tasmania(Cancer Council Tasmania)	This study was funded by a National Health and Medical Research Council (NHMRC) project grant 628779 (www.nhmrc.gov.au). The Australian Ovarian Cancer Study is supported by the U.S. Army Medical Research and Materiel Command under DAMD17-01-1-0729, The Cancer Council Victoria, Queensland Cancer Fund, The Cancer Council New South Wales, The Cancer Council South Australia, The Cancer Foundation of Western Australia, The Cancer Council Tasmania and the NHMRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2009, CLIN CANCER RES, V15, P3654, DOI 10.1158/1078-0432.CCR-08-3293; AKAMA Y, 1995, JPN J CANCER RES, V86, P617, DOI 10.1111/j.1349-7006.1995.tb02442.x; Akli S, 2003, CANCER BIOL THER, V2, pS38; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Bedrosian I, 2004, ONCOGENE, V23, P2648, DOI 10.1038/sj.onc.1207408; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bredel M, 2009, JAMA-J AM MED ASSOC, V302, P261, DOI 10.1001/jama.2009.997; Chia W, 2008, J CELL BIOL, V180, P267, DOI 10.1083/jcb.200708159; Cui WW, 2007, NUCLEIC ACIDS RES, V35, pD805, DOI 10.1093/nar/gkl767; Djouder N, 2007, MOL CELL, V28, P28, DOI 10.1016/j.molcel.2007.08.010; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Etemadmoghadam D, 2009, CLIN CANCER RES, V15, P1417, DOI 10.1158/1078-0432.CCR-08-1564; Farley J, 2003, CANCER RES, V63, P1235; Geng Y, 2003, CELL, V114, P431, DOI 10.1016/S0092-8674(03)00645-7; Gorringe KL, 2005, GENE CHROMOSOME CANC, V42, P247, DOI 10.1002/gcc.20136; Gorringe KL, 2007, CLIN CANCER RES, V13, P4731, DOI 10.1158/1078-0432.CCR-07-0502; Gorringe KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011408; Gruss OJ, 2004, J CELL BIOL, V166, P949, DOI 10.1083/jcb.200312112; Haverty PM, 2008, GENE CHROMOSOME CANC, V47, P530, DOI 10.1002/gcc.20558; Hwang HC, 2005, ONCOGENE, V24, P2776, DOI 10.1038/sj.onc.1208613; Kwek SS, 2009, ONCOGENE, V28, P1892, DOI 10.1038/onc.2009.34; Leung SY, 2006, MODERN PATHOL, V19, P854, DOI 10.1038/modpathol.3800593; Lin L, 2000, CANCER RES, V60, P7021; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Marchetti C, 2010, EXPERT REV ANTICANC, V10, P47, DOI 10.1586/ERA.09.167; Mayr D, 2006, AM J CLIN PATHOL, V126, P101, DOI 10.1309/N6X5MB24BP42KP20; Mull BB, 2009, ONCOGENE, V28, P3167, DOI 10.1038/onc.2009.182; Nakayama K, 2007, INT J CANCER, V120, P2613, DOI 10.1002/ijc.22609; Nakayama N, 2010, CANCER-AM CANCER SOC, V116, P2621, DOI 10.1002/cncr.24987; Nikolsky Y, 2008, CANCER RES, V68, P9532, DOI 10.1158/0008-5472.CAN-08-3082; Parusel CT, 2006, DEVELOPMENT, V133, P621, DOI 10.1242/dev.02235; Ramos AH, 2009, CANCER BIOL THER, V8, P2042, DOI 10.4161/cbt.8.21.9764; Rozen S, 2000, Methods Mol Biol, V132, P365; Salvesen HB, 2009, P NATL ACAD SCI USA, V106, P4834, DOI 10.1073/pnas.0806514106; SEHDEV AS, 2010, MOD PATHOL; Shapiro GI, 2006, J CLIN ONCOL, V24, P1770, DOI 10.1200/JCO.2005.03.7689; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Sos ML, 2009, J CLIN INVEST, V119, P1727, DOI 10.1172/JCI37127; Swarbrick A, 2005, ONCOGENE, V24, P381, DOI 10.1038/sj.onc.1208188; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Warner SL, 2009, CLIN CANCER RES, V15, P6519, DOI 10.1158/1078-0432.CCR-09-0077; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; WEIR BA, 2007, NATURE	44	79	82	5	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e15498	10.1371/journal.pone.0015498	http://dx.doi.org/10.1371/journal.pone.0015498			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103391	gold, Green Published			2022-12-25	WOS:000284147700036
J	Shaltiel-Karyo, R; Frenkel-Pinter, M; Egoz-Matia, N; Frydman-Marom, A; Shalev, DE; Segal, D; Gazit, E				Shaltiel-Karyo, Ronit; Frenkel-Pinter, Moran; Egoz-Matia, Nirit; Frydman-Marom, Anat; Shalev, Deborah E.; Segal, Daniel; Gazit, Ehud			Inhibiting alpha-Synuclein Oligomerization by Stable Cell-Penetrating beta-Synuclein Fragments Recovers Phenotype of Parkinson's Disease Model Flies	PLOS ONE			English	Article							AGGREGATION; FIBRILLIZATION; PROTEINS; PATHOGENESIS; STRATEGY; NMR	The intracellular oligomerization of alpha-synuclein is associated with Parkinson's disease and appears to be an important target for disease-modifying treatment. Yet, to date, there is no specific inhibitor for this aggregation process. Using unbiased systematic peptide array analysis, we indentified molecular interaction domains within the beta-synuclein polypeptide that specifically binds alpha-synuclein. Adding such peptide fragments to alpha-synuclein significantly reduced both amyloid fibrils and soluble oligomer formation in vitro. A retro-inverso analogue of the best peptide inhibitor was designed to develop the identified molecular recognition module into a drug candidate. While this peptide shows indistinguishable activity as compared to the native peptide, it is stable in mouse serum and penetrates alpha-synuclein over-expressing cells. The interaction interface between the D-amino acid peptide and alpha-synuclein was mapped by Nuclear Magnetic Resonance spectroscopy. Finally, administering the retro-inverso peptide to a Drosophila model expressing mutant A53T alpha-synuclein in the nervous system, resulted in a significant recovery of the behavioral abnormalities of the treated flies and in a significant reduction in alpha-synuclein accumulation in the brains of the flies. The engineered retro-inverso peptide can serve as a lead for developing a novel class of therapeutic agents to treat Parkinson's disease.	[Shaltiel-Karyo, Ronit; Frenkel-Pinter, Moran; Egoz-Matia, Nirit; Frydman-Marom, Anat; Segal, Daniel; Gazit, Ehud] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel; [Shalev, Deborah E.] Hebrew Univ Jerusalem, Wolfson Ctr Appl Struct Biol, Jerusalem, Israel	Tel Aviv University; Hebrew University of Jerusalem	Shaltiel-Karyo, R (corresponding author), Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel.	vpr@tauex.tau.ac.il	Gazit, Ehud/C-3715-2011; Gazit, Ehud/M-8026-2019; Gazit, Ehud/AHE-9332-2022; Shalev, Deborah E/AAY-2873-2021	Gazit, Ehud/0000-0001-5764-1720; Gazit, Ehud/0000-0001-5764-1720; Segal, Daniel/0000-0002-6777-505X	Israeli Science Foundation (ISF); German-Israeli Project Cooperation (DIP)	Israeli Science Foundation (ISF)(Israel Science Foundation); German-Israeli Project Cooperation (DIP)	This work was supported by funding from the Israeli Science Foundation (ISF) and the German-Israeli Project Cooperation (DIP) to UG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashe KH, 2001, LEARN MEMORY, V8, P301, DOI 10.1101/lm.43701; Bertoncini CW, 2007, J MOL BIOL, V372, P708, DOI 10.1016/j.jmb.2007.07.009; Biere AL, 2000, J BIOL CHEM, V275, P34574, DOI 10.1074/jbc.M005514200; Chiti F, 2002, P NATL ACAD SCI USA, V99, P16419, DOI 10.1073/pnas.212527999; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Cookson MR, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-9; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Dobson CM, 2002, NATURE, V418, P729, DOI 10.1038/418729a; El-Agnaf OMA, 2004, FASEB J, V18, P1315, DOI 10.1096/fj.03-1346fje; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Gazit E, 2002, FASEB J, V16, P77, DOI 10.1096/fj.01-0442hyp; GRIFFEY RH, 1985, J BIOL CHEM, V260, P9734; Harrison RS, 2007, REV PHYSIOL BIOCH P, V159, P1, DOI 10.1007/112_2007_0701; Hashimoto M, 1999, NEUROREPORT, V10, P717, DOI 10.1097/00001756-199903170-00011; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; JENSEN PH, 1995, BIOCHEM J, V310, P91, DOI 10.1042/bj3100091; Kaytor MD, 1999, J BIOL CHEM, V274, P37507, DOI 10.1074/jbc.274.53.37507; Kessler JC, 2003, BIOCHEMISTRY-US, V42, P672, DOI 10.1021/bi020429y; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lev N, 2006, NEUROSCI LETT, V399, P27, DOI 10.1016/j.neulet.2005.09.086; Liu ML, 1998, J MAGN RESON, V132, P125, DOI 10.1006/jmre.1998.1405; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Park JY, 2003, BIOCHEMISTRY-US, V42, P3696, DOI 10.1021/bi020604a; Pawar AP, 2005, J MOL BIOL, V350, P379, DOI 10.1016/j.jmb.2005.04.016; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Porat Y, 2004, BIOCHEMISTRY-US, V43, P14454, DOI 10.1021/bi048582a; Porat Y, 2003, BIOCHEMISTRY-US, V42, P10971, DOI 10.1021/bi034889i; Rochet JC, 2000, BIOCHEMISTRY-US, V39, P10619, DOI 10.1021/bi001315u; SACCHETTINI JC, 2002, THERAPEUTIC STRATEGI, P267; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Thomas B, 2007, HUM MOL GENET, V16, pR183, DOI 10.1093/hmg/ddm159; Tsigelny IF, 2007, FEBS J, V274, P1862, DOI 10.1111/j.1742-4658.2007.05733.x; Tugyi R, 2005, P NATL ACAD SCI USA, V102, P413, DOI 10.1073/pnas.0407677102; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Uversky VN, 2002, J BIOL CHEM, V277, P11970, DOI 10.1074/jbc.M109541200; Volles MJ, 2007, J MOL BIOL, V366, P1510, DOI 10.1016/j.jmb.2006.12.044; WAXMAN EA, 2008, BIOCH BIOPHYS ACTA; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Windisch M, 2004, J MOL NEUROSCI, V24, P155, DOI 10.1385/JMN:24:1:155; Wuthrich K, 1986, NMR PROTEINS NUCL AC	53	73	76	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e13863	10.1371/journal.pone.0013863	http://dx.doi.org/10.1371/journal.pone.0013863			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085664	Green Published, Green Submitted, gold			2022-12-25	WOS:000284036800008
J	Kress, WJ; Erickson, DL; Swenson, NG; Thompson, J; Uriarte, M; Zimmerman, JK				Kress, W. John; Erickson, David L.; Swenson, Nathan G.; Thompson, Jill; Uriarte, Maria; Zimmerman, Jess K.			Advances in the Use of DNA Barcodes to Build a Community Phylogeny for Tropical Trees in a Puerto Rican Forest Dynamics Plot	PLOS ONE			English	Article							PLANT DIVERSITY; MECHANISMS; SEQUENCES; ALIGNMENT	Background: Species number, functional traits, and phylogenetic history all contribute to characterizing the biological diversity in plant communities. The phylogenetic component of diversity has been particularly difficult to quantify in species-rich tropical tree assemblages. The compilation of previously published (and often incomplete) data on evolutionary relationships of species into a composite phylogeny of the taxa in a forest, through such programs as Phylomatic, has proven useful in building community phylogenies although often of limited resolution. Recently, DNA barcodes have been used to construct a robust community phylogeny for nearly 300 tree species in a forest dynamics plot in Panama using a supermatrix method. In that study sequence data from three barcode loci were used to generate a well-resolved species-level phylogeny. Methodology/Principal Findings: Here we expand upon this earlier investigation and present results on the use of a phylogenetic constraint tree to generate a community phylogeny for a diverse, tropical forest dynamics plot in Puerto Rico. This enhanced method of phylogenetic reconstruction insures the congruence of the barcode phylogeny with broadly accepted hypotheses on the phylogeny of flowering plants (i.e., APG III) regardless of the number and taxonomic breadth of the taxa sampled. We also compare maximum parsimony versus maximum likelihood estimates of community phylogenetic relationships as well as evaluate the effectiveness of one-versus two-versus three-gene barcodes in resolving community evolutionary history. Conclusions/Significance: As first demonstrated in the Panamanian forest dynamics plot, the results for the Puerto Rican plot illustrate that highly resolved phylogenies derived from DNA barcode sequence data combined with a constraint tree based on APG III are particularly useful in comparative analysis of phylogenetic diversity and will enhance research on the interface between community ecology and evolution.	[Kress, W. John; Erickson, David L.] Smithsonian Inst, Natl Museum Nat Hist, Dept Bot, Washington, DC 20560 USA; [Swenson, Nathan G.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Thompson, Jill; Zimmerman, Jess K.] Univ Puerto Rico, Inst Trop Ecosyst Studies, San Juan, PR 00936 USA; [Uriarte, Maria] Columbia Univ, New York, NY USA	Smithsonian Institution; Smithsonian National Museum of Natural History; Michigan State University; University of Puerto Rico; University of Puerto Rico Rio Piedras; Columbia University	Kress, WJ (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Bot, Washington, DC 20560 USA.	kressj@si.edu	Swenson, Nathan/A-3514-2012; Thompson, Jill/K-2200-2012; Uriarte, Maria/L-8944-2013	Swenson, Nathan/0000-0003-3819-9767; Thompson, Jill/0000-0002-4370-2593; 	Center for Tropical Forest Science; Smithsonian Institution Global Earth Observatories; U.S. Forest Service; University of Puerto Rico; National Science Foundation [DEB-0516066, DEB-0218039, DEB-0620910]; Mellon Foundation; Natural Environment Research Council [CEH010021] Funding Source: researchfish	Center for Tropical Forest Science(Smithsonian InstitutionSmithsonian Tropical Research Institute); Smithsonian Institution Global Earth Observatories; U.S. Forest Service(United States Department of Agriculture (USDA)United States Forest Service); University of Puerto Rico; National Science Foundation(National Science Foundation (NSF)); Mellon Foundation; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the Center for Tropical Forest Science, the Smithsonian Institution Global Earth Observatories, the U.S. Forest Service, the University of Puerto Rico, the National Science Foundation (DEB-0516066, DEB-0218039 and DEB-0620910), and the Mellon Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; Bininda-Emonds ORP, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-156; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Carolan JC, 2006, ANN BOT-LONDON, V98, P141, DOI 10.1093/aob/mcl079; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Condit R., 1998, Tropical forest census plots: methods and results from Barro Colorado Island, Panama and a comparison with other plots.; Dick CW, 2009, BIOSCIENCE, V59, P745, DOI 10.1525/bio.2009.59.9.6; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ewel J.J., 1973, ITF18 US FOR SERV; Fazekas AJ, 2009, MOL ECOL RESOUR, V9, P130, DOI 10.1111/j.1755-0998.2009.02652.x; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Forest F, 2007, NATURE, V445, P757, DOI 10.1038/nature05587; Gonzalez MA, 2010, J ECOL, V98, P137, DOI 10.1111/j.1365-2745.2009.01607.x; Hardy OJ, 2007, J ECOL, V95, P493, DOI 10.1111/j.1365-2745.2007.01222.x; Hubbell Stephen P., 2001, V32, pi; Kembel SW, 2006, ECOLOGY, V87, pS86, DOI 10.1890/0012-9658(2006)87[86:TPSOAN]2.0.CO;2; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Losos EC, 2004, TROPICAL FOREST DIVERSITY AND DYNAMISM: FINDINGS FROM A LARGE-SCALE PLOT NETWORK, P3; Maddison D.R., 2007, MESQUITE 2 MODULAR S; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Savolainen V, 2005, PHILOS T R SOC B, V360, P1805, DOI 10.1098/rstb.2005.1730; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Swenson NG, 2009, ECOLOGY, V90, P2161, DOI 10.1890/08-1025.1; Swenson NG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004390; Swofford D. L., 2003, PAUP PHYLOGENETIC AN; Thompson J, 2002, ECOL APPL, V12, P1344, DOI 10.1890/1051-0761(2002)012[1344:LUHEAT]2.0.CO;2; Vamosi SM, 2009, MOL ECOL, V18, P572, DOI 10.1111/j.1365-294X.2008.04001.x; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809	32	110	123	2	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e15409	10.1371/journal.pone.0015409	http://dx.doi.org/10.1371/journal.pone.0015409			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085700	Green Published, gold			2022-12-25	WOS:000284035900028
J	Martinkova, N; Backor, P; Bartonicka, T; Blazkova, P; Cerveny, J; Falteisek, L; Gaisler, J; Hanzal, V; Horacek, D; Hubalek, Z; Jahelkova, H; Kolarik, M; Korytar, L; Kubatova, A; Lehotska, B; Lehotsky, R; Lucan, RK; Majek, O; Mateju, J; Rehak, Z; Safar, J; Tajek, P; Tkadlec, E; Uhrin, M; Wagner, J; Weinfurtova, D; Zima, J; Zukal, J; Horacek, I				Martinkova, Natalia; Backor, Peter; Bartonicka, Tomas; Blazkova, Pavla; Cerveny, Jaroslav; Falteisek, Lukas; Gaisler, Jiri; Hanzal, Vladimir; Horacek, Daniel; Hubalek, Zdenek; Jahelkova, Helena; Kolarik, Miroslav; Korytar, L'ubos; Kubatova, Alena; Lehotska, Blanka; Lehotsky, Roman; Lucan, Radek K.; Majek, Ondrej; Mateju, Jan; Rehak, Zdenek; Safar, Jiri; Tajek, Premysl; Tkadlec, Emil; Uhrin, Marcel; Wagner, Josef; Weinfurtova, Dita; Zima, Jan; Zukal, Jan; Horacek, Ivan			Increasing Incidence of Geomyces destructans Fungus in Bats from the Czech Republic and Slovakia	PLOS ONE			English	Article							WHITE-NOSE SYNDROME	Background: White-nose syndrome is a disease of hibernating insectivorous bats associated with the fungus Geomyces destructans. It first appeared in North America in 2006, where over a million bats died since then. In Europe, G. destructans was first identified in France in 2009. Its distribution, infection dynamics, and effects on hibernating bats in Europe are largely unknown. Methodology/Principal Findings: We screened hibernacula in the Czech Republic and Slovakia for the presence of the fungus during the winter seasons of 2008/2009 and 2009/2010. In winter 2009/2010, we found infected bats in 76 out of 98 surveyed sites, in which the majority had been previously negative. A photographic record of over 6000 hibernating bats, taken since 1994, revealed bats with fungal growths since 1995; however, the incidence of such bats increased in Myotis myotis from 2% in 2007 to 14% by 2010. Microscopic, cultivation and molecular genetic evaluations confirmed the identity of the recently sampled fungus as G. destructans, and demonstrated its continuous distribution in the studied area. At the end of the hibernation season we recorded pathologic changes in the skin of the affected bats, from which the fungus was isolated. We registered no mass mortality caused by the fungus, and the recorded population decline in the last two years of the most affected species, M. myotis, is within the population trend prediction interval. Conclusions/Significance: G. destructans was found to be widespread in the Czech Republic and Slovakia, with an epizootic incidence in bats during the most recent years. Further development of the situation urgently requires a detailed pan-European monitoring scheme.	[Martinkova, Natalia; Hubalek, Zdenek; Tkadlec, Emil; Zima, Jan; Zukal, Jan] Acad Sci Czech Republic, Inst Vertebrate Biol, Brno, Czech Republic; [Martinkova, Natalia; Majek, Ondrej] Masaryk Univ, Inst Biostat & Anal, Brno, Czech Republic; [Backor, Peter] Matej Bel Univ, Dept Biol & Ecol, Banska Bystrica, Slovakia; [Bartonicka, Tomas; Gaisler, Jiri; Rehak, Zdenek; Zukal, Jan] Masaryk Univ, Dept Bot & Zool, Brno, Czech Republic; [Blazkova, Pavla; Tajek, Premysl] Agcy Nat Conservat & Landscape Protect Czech Repu, Marianske Lazne, Czech Republic; [Blazkova, Pavla] Univ S Bohemia, Dept Zool, Ceske Budejovice, Czech Republic; [Cerveny, Jaroslav] Czech Univ Life Sci Prague, Dept Forest Protect & Game Management, Prague, Czech Republic; [Falteisek, Lukas; Jahelkova, Helena; Lucan, Radek K.; Mateju, Jan; Weinfurtova, Dita; Horacek, Ivan] Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic; [Hanzal, Vladimir] Agcy Nat Conservat & Landscape Protect Czech Repu, Prague, Czech Republic; [Kolarik, Miroslav; Kubatova, Alena] Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic; [Korytar, L'ubos] Univ Vet Med & Pharm, Kosice, Slovakia; [Lehotska, Blanka] Comenius Univ, Dept Landscape Ecol, Bratislava, Slovakia; [Lehotsky, Roman] Miniopterus Principal Org Slovak Union Nat & Land, Bratislava, Slovakia; [Mateju, Jan] Agcy Nat Conservat & Landscape Protect Czech Repu, Karlovy Vary, Czech Republic; [Safar, Jiri] Agcy Nat Conservat & Landsape Protect Czech Repub, Olomouc, Czech Republic; [Tkadlec, Emil] Palacky Univ, Dept Ecol & Environm Sci, CR-77147 Olomouc, Czech Republic; [Uhrin, Marcel] Safarik Univ, Inst Biol & Ecol, Kosice, Slovakia; [Wagner, Josef] Czech Speleol Soc, ZO CSS ORCUS Bohumin 7 01, Bohumin, Czech Republic	Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences; Institute of Biostatistics & Analyses; Masaryk University Brno; Matej Bel University; Masaryk University Brno; University of South Bohemia Ceske Budejovice; Czech University of Life Sciences Prague; Charles University Prague; Charles University Prague; University of Veterinary Medicine Kosice; Comenius University Bratislava; Palacky University Olomouc; University of Pavol Jozef Safarik Kosice	Martinkova, N (corresponding author), Acad Sci Czech Republic, Inst Vertebrate Biol, Brno, Czech Republic.	martinkova@ivb.cz	Korytár, Ľuboš/AAR-5966-2021; Červený, Jaroslav/A-2809-2015; Martínková, Natália/C-2939-2008; Bartonička, Tomáš/J-2756-2014; Falteisek, Lukáš/P-9293-2017; Hubalek, Zdenek/AAF-8071-2019; Korytár, Ľuboš/GRE-9414-2022; Horacek, Ivan/V-9741-2017; Zima, Jan/G-1118-2011; Uhrin, Marcel/C-7211-2011; Lucan, Radek/B-7412-2015; Červený, Jaroslav/AGZ-6188-2022; Kolařík, Miroslav/A-1680-2008; Majek, Ondrej/E-4521-2011; Zukal, Jan/G-1180-2014; Hubalek, Zdenek/G-1111-2014; Kubatova, Alena/D-7918-2016; Tkadlec, Emil/A-6230-2014	Korytár, Ľuboš/0000-0002-8559-3559; Martínková, Natália/0000-0003-4556-4363; Falteisek, Lukáš/0000-0003-1585-4140; Korytár, Ľuboš/0000-0002-8559-3559; Horacek, Ivan/0000-0002-8356-5554; Lucan, Radek/0000-0002-9575-3173; Červený, Jaroslav/0000-0002-2723-0936; Kolařík, Miroslav/0000-0003-4016-0335; Majek, Ondrej/0000-0002-0034-3084; Zukal, Jan/0000-0003-4967-6880; Hubalek, Zdenek/0000-0003-4732-0987; Kubatova, Alena/0000-0002-2837-1087; Tkadlec, Emil/0000-0003-3782-8867; Lehotska, Blanka/0000-0002-1154-5183	Ministry of Education, Youth and Sports of the Czech Republic [MSM0021620828, LC06073]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	Funding: This study was supported by grants MSM0021620828 and LC06073 provided by Ministry of Education, Youth and Sports of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauerova Z., 1989, P499; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Boyles JG, 2010, FRONT ECOL ENVIRON, V8, P92, DOI 10.1890/080187; Boyles JG, 2009, J MAMMAL, V90, P9, DOI 10.1644/08-MAMM-A-205.1; Chaturvedi V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010783; Courtin F, 2010, VET PATHOL, V47, P214, DOI 10.1177/0300985809358614; DENNIS B, 1991, ECOL MONOGR, V61, P115, DOI 10.2307/1943004; FELDMANN R, 1984, TEICHFLEDERMAUS MYOT, P107; Fenton MB, 2006, SCIENCE, V311, P1098; Fernandes EKK, 2009, J APPL MICROBIOL, V107, P760, DOI 10.1111/j.1365-2672.2009.04258.x; Fournier A, 2010, FUNGAL BIOL-UK, V114, P498, DOI 10.1016/j.funbio.2010.03.012; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Frick WF, 2010, J ANIM ECOL, V79, P128, DOI 10.1111/j.1365-2656.2009.01615.x; GAISLER J, 1975, ACTA SCI NAT BRNO, V9, P1; Gargas A, 2009, MYCOTAXON, V108, P147, DOI 10.5248/108.147; HAKULINEN T, 1994, STAT MED, V13, P1513, DOI 10.1002/sim.4780131503; HORACEK I., 2000, P 8 EBRS, V1, P11; HORACEK I, 2001, VESPERTILIO, V5, P3; Hutson A. M., 2008, IUCN 2010 IUCN RED L; Lorch JM, 2010, J VET DIAGN INVEST, V22, P224, DOI 10.1177/104063871002200208; Meteyer CU, 2009, J VET DIAGN INVEST, V21, P411, DOI 10.1177/104063870902100401; Puechmaille SJ, 2010, EMERG INFECT DIS, V16, P290, DOI 10.3201/eid1602.091391; Reichard JD, 2009, ACTA CHIROPTEROL, V11, P457, DOI 10.3161/150811009X485684; Samson R., 2004, INTRO FOOD AIRBORNE; Uhrin M, 2010, BIOLOGIA, V65, P349, DOI 10.2478/s11756-010-0020-z; *WHIT NOS SYNDR CO, 2010, POT THREAT WHIT NOS; Wibbelt G, 2010, EMERG INFECT DIS, V16, P1237, DOI 10.3201/eid1608.100002; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	28	73	78	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2010	5	11							e13853	10.1371/journal.pone.0013853	http://dx.doi.org/10.1371/journal.pone.0013853			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675OD	21079781	Green Submitted, gold, Green Published			2022-12-25	WOS:000283839100010
J	Mason, OU; Nakagawa, T; Rosner, M; Van Nostrand, JD; Zhou, JZ; Maruyama, A; Fisk, MR; Giovannoni, SJ				Mason, Olivia U.; Nakagawa, Tatsunori; Rosner, Martin; Van Nostrand, Joy D.; Zhou, Jizhong; Maruyama, Akihiko; Fisk, Martin R.; Giovannoni, Stephen J.			First Investigation of the Microbiology of the Deepest Layer of Ocean Crust	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; MID-ATLANTIC RIDGE; CITY HYDROTHERMAL FIELD; GRADIENT GEL-ELECTROPHORESIS; RALSTONIA-PICKETTII PKO1; SEA-FLOOR BASALT; SP-NOV; METHYLOCOCCUS-CAPSULATUS; ALKANE HYDROXYLASE; SEQUENCE-ANALYSIS	The gabbroic layer comprises the majority of ocean crust. Opportunities to sample this expansive crustal environment are rare because of the technological demands of deep ocean drilling; thus, gabbroic microbial communities have not yet been studied. During the Integrated Ocean Drilling Program Expeditions 304 and 305, igneous rock samples were collected from 0.45-1391.01 meters below seafloor at Hole 1309D, located on the Atlantis Massif (30 degrees N, 42 degrees W). Microbial diversity in the rocks was analyzed by denaturing gradient gel electrophoresis and sequencing (Expedition 304), and terminal restriction fragment length polymorphism, cloning and sequencing, and functional gene microarray analysis (Expedition 305). The gabbroic microbial community was relatively depauperate, consisting of a low diversity of proteobacterial lineages closely related to Bacteria from hydrocarbon-dominated environments and to known hydrocarbon degraders, and there was little evidence of Archaea. Functional gene diversity in the gabbroic samples was analyzed with a microarray for metabolic genes ("GeoChip"), producing further evidence of genomic potential for hydrocarbon degradation - genes for aerobic methane and toluene oxidation. Genes coding for anaerobic respirations, such as nitrate reduction, sulfate reduction, and metal reduction, as well as genes for carbon fixation, nitrogen fixation, and ammonium-oxidation, were also present. Our results suggest that the gabbroic layer hosts a microbial community that can degrade hydrocarbons and fix carbon and nitrogen, and has the potential to employ a diversity of non-oxygen electron acceptors. This rare glimpse of the gabbroic ecosystem provides further support for the recent finding of hydrocarbons in deep ocean gabbro from Hole 1309D. It has been hypothesized that these hydrocarbons might originate abiotically from serpentinization reactions that are occurring deep in the Earth's crust, raising the possibility that the lithic microbial community reported here might utilize carbon sources produced independently of the surface biosphere.	[Mason, Olivia U.; Fisk, Martin R.] Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Nakagawa, Tatsunori] Tohoku Univ, Dept Earth Sci, Sendai, Miyagi 980, Japan; [Rosner, Martin] Univ Bremen, Bremen, Germany; [Van Nostrand, Joy D.; Zhou, Jizhong] Univ Oklahoma, Dept Bot & Microbiol, Inst Environm Genom, Norman, OK 73019 USA; [Maruyama, Akihiko] Natl Inst Adv Ind Sci & Technol, Res Inst Biol Resources, Tsukuba, Japan; [Giovannoni, Stephen J.] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA	Oregon State University; Tohoku University; University of Bremen; University of Oklahoma System; University of Oklahoma - Norman; National Institute of Advanced Industrial Science & Technology (AIST); Oregon State University	Mason, OU (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Earth Sci, Berkeley, CA 94720 USA.	steve.giovannoni@oregonstate.edu	Van Nostrand, Joy D/F-1740-2016; 吴, 昊/AAB-1620-2020; Rosner, Martin/B-9264-2009; Mason, Olivia/AAP-2627-2021	Van Nostrand, Joy D/0000-0001-9548-6450; 	Joint Oceanographic Institutions award; Gordon and Betty Moore Foundation; National Science Foundation IGERT; United States Department of Energy under Virtual Institute of Microbial Stress and Survival of the Office of Biological and Environmental Research, Office of Science	Joint Oceanographic Institutions award; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); National Science Foundation IGERT(National Science Foundation (NSF)); United States Department of Energy under Virtual Institute of Microbial Stress and Survival of the Office of Biological and Environmental Research, Office of Science(United States Department of Energy (DOE))	Funding: This work was supported by a Joint Oceanographic Institutions award to M. R. Fisk, a Marine Microbiology Initiative Investigator Award from the Gordon and Betty Moore Foundation to S. J. Giovannoni, and a National Science Foundation IGERT Subsurface Biosphere Fellowship to O. U. Mason. The GeoChip microarray analysis was supported in part by the United States Department of Energy under the Genomics: GTL Program to J. Z. Zhou through the Virtual Institute of Microbial Stress and Survival (VIMSS; http://vimss.lbl.gov) of the Office of Biological and Environmental Research, Office of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashelford KE, 2005, APPL ENVIRON MICROB, V71, P7724, DOI 10.1128/AEM.71.12.7724-7736.2005; Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; Atreya SK, 2007, PLANET SPACE SCI, V55, P358, DOI 10.1016/j.pss.2006.02.005; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Benson DA, 2005, NUCLEIC ACIDS RES, V33, pD34, DOI 10.1093/nar/gki063; Berndt ME, 1996, GEOLOGY, V24, P351, DOI 10.1130/0091-7613(1996)024<0351:ROCDSO>2.3.CO;2; BIRD CW, 1971, NATURE, V230, P473, DOI 10.1038/230473a0; Blackman DK, 2002, MAR GEOPHYS RES, V23, P443, DOI 10.1023/B:MARI.0000018232.14085.75; Blackman DK., 2006, P IODP, DOI [10.2204/iodp.proc.304305.2006, DOI 10.2204/IODP.PROC.304305.2006]; Bodour AA, 2003, ENVIRON MICROBIOL, V5, P888, DOI 10.1046/j.1462-2920.2003.00481.x; Brazelton WJ, 2006, APPL ENVIRON MICROB, V72, P6257, DOI 10.1128/AEM.00574-06; Busigny V, 2005, CHEM GEOL, V223, P249, DOI 10.1016/j.chemgeo.2005.08.002; CACCAVO F, 1994, APPL ENVIRON MICROB, V60, P3752, DOI 10.1128/AEM.60.10.3752-3759.1994; Cann JR, 1997, NATURE, V385, P329, DOI 10.1038/385329a0; Casamayor EO, 2000, APPL ENVIRON MICROB, V66, P499, DOI 10.1128/AEM.66.2.499-508.2000; Coenye T, 2003, INT J SYST EVOL MICR, V53, P1075, DOI 10.1099/ijs.0.02555-0; Dekas AE, 2009, SCIENCE, V326, P422, DOI 10.1126/science.1178223; DELACOUR A, 2008, SYSTEM, V72, P3681; DELACOUR A, 2008, GEOPH RES ABSTR, V10; Delacour A, 2008, CHEM GEOL, V254, P19, DOI 10.1016/j.chemgeo.2008.05.018; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Deutsch C, 2007, NATURE, V445, P163, DOI 10.1038/nature05392; Einen J, 2008, FEMS MICROBIOL LETT, V282, P182, DOI 10.1111/j.1574-6968.2008.01119.x; Fisk MR, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000387; Formisano V, 2004, SCIENCE, V306, P1758, DOI 10.1126/science.1101732; Gallego V, 2005, INT J SYST EVOL MICR, V55, P281, DOI 10.1099/ijs.0.63319-0; Hallam SJ, 2004, SCIENCE, V305, P1457, DOI 10.1126/science.1100025; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; He ZL, 2007, ISME J, V1, P67, DOI 10.1038/ismej.2007.2; Huber JA, 2006, ENVIRON MICROBIOL, V8, P88, DOI 10.1111/j.1462-2920.2005.00872.x; Huber JA, 2009, ENVIRON MICROBIOL, V11, P1292, DOI 10.1111/j.1462-2920.2008.01857.x; Ibrahim A, 1997, INT J SYST BACTERIOL, V47, P837, DOI 10.1099/00207713-47-3-837; JANECKY DR, 1986, GEOCHIM COSMOCHIM AC, V50, P1357, DOI 10.1016/0016-7037(86)90311-X; Kahng HY, 2000, J BACTERIOL, V182, P1232, DOI 10.1128/JB.182.5.1232-1242.2000; Kelley DS, 1999, J GEOPHYS RES-SOL EA, V104, P10439, DOI 10.1029/1999JB900058; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Lanoil BD, 2001, APPL ENVIRON MICROB, V67, P5143, DOI 10.1128/AEM.67.11.5143-5153.2001; Ludwig W, 1998, ELECTROPHORESIS, V19, P554, DOI 10.1002/elps.1150190416; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; LYSNES K, 2004, P OCEAN DRILLING PRO, V0187; Lysnes K, 2004, FEMS MICROBIOL ECOL, V50, P213, DOI 10.1016/j.femsec.2004.06.014; Mason OU, 2007, ENVIRON MICROBIOL, V9, P2539, DOI 10.1111/j.1462-2920.2007.01372.x; Mason OU, 2009, ISME J, V3, P231, DOI 10.1038/ismej.2008.92; Massana R, 1997, APPL ENVIRON MICROB, V63, P50, DOI 10.1128/AEM.63.1.50-56.1997; McCollom TM, 2006, EARTH PLANET SC LETT, V243, P74, DOI 10.1016/j.epsl.2006.01.027; Mikesell Mark D., 1993, Biodegradation, V4, P249, DOI 10.1007/BF00695973; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; NEUNLIST S, 1985, BIOCHEM J, V231, P635, DOI 10.1042/bj2310635; Orcutt B, 2009, ENVIRON MICROBIOL, V11, P1728, DOI 10.1111/j.1462-2920.2009.01899.x; Orphan VJ, 2000, APPL ENVIRON MICROB, V66, P700, DOI 10.1128/AEM.66.2.700-711.2000; Park J, 2002, APPL ENVIRON MICROB, V68, P5231, DOI 10.1128/AEM.68.11.5231-5240.2002; Perner M, 2007, ENVIRON MICROBIOL, V9, P1186, DOI 10.1111/j.1462-2920.2007.01241.x; Proskurowski G, 2008, SCIENCE, V319, P604, DOI 10.1126/science.1151194; ROHMER M, 1979, P NATL ACAD SCI USA, V76, P847, DOI 10.1073/pnas.76.2.847; Rojo F, 2005, J BACTERIOL, V187, P19, DOI 10.1128/JB.187.1.19-22.2005; RUETER P, 1994, NATURE, V372, P455, DOI 10.1038/372455a0; Santelli CM, 2008, NATURE, V453, P653, DOI 10.1038/nature06899; Santelli CM, 2009, ENVIRON MICROBIOL, V11, P86, DOI 10.1111/j.1462-2920.2008.01743.x; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schouten S, 2000, FEMS MICROBIOL LETT, V186, P193, DOI 10.1111/j.1574-6968.2000.tb09103.x; Schrenk MO, 2010, ANNU REV MAR SCI, V2, P279, DOI 10.1146/annurev-marine-120308-081000; Schrenk MO, 2004, ENVIRON MICROBIOL, V6, P1086, DOI 10.1111/j.1462-2920.2004.00650.x; Sentchilo VS, 2000, APPL ENVIRON MICROB, V66, P2842, DOI 10.1128/AEM.66.7.2842-2852.2000; Smits THM, 1999, ENVIRON MICROBIOL, V1, P307, DOI 10.1046/j.1462-2920.1999.00037.x; Spotl C, 2003, RAPID COMMUN MASS SP, V17, P1004, DOI 10.1002/rcm.1010; Thorseth IH, 2001, EARTH PLANET SC LETT, V194, P31, DOI 10.1016/S0012-821X(01)00537-4; Throne-Holst M, 2006, APPL MICROBIOL BIOT, V72, P353, DOI 10.1007/s00253-005-0262-9; TORNABENE TG, 1979, J MOL EVOL, V13, P73, DOI 10.1007/BF01732755; Van Aken B, 2004, INT J SYST EVOL MICR, V54, P1191, DOI 10.1099/ijs.0.02796-0; Volkman JK, 2003, APPL MICROBIOL BIOT, V60, P495, DOI 10.1007/s00253-002-1172-8; Wu LY, 2006, APPL ENVIRON MICROB, V72, P4931, DOI 10.1128/AEM.02738-05	72	100	101	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2010	5	11							e15399	10.1371/journal.pone.0015399	http://dx.doi.org/10.1371/journal.pone.0015399			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675OD	21079766	Green Submitted, Green Published, gold			2022-12-25	WOS:000283839100021
J	Huang, YQ; Liu, ZR				Huang, Yongqi; Liu, Zhirong			Nonnative Interactions in Coupled Folding and Binding Processes of Intrinsically Disordered Proteins	PLOS ONE			English	Article							DENATURED STATE ENSEMBLE; FLY-CASTING MECHANISM; TRANSITION-STATES; MOLECULAR-DYNAMICS; NATIVE TOPOLOGY; GO MODELS; ELECTROSTATIC INTERACTIONS; HYDROPHOBIC INTERACTIONS; UNSTRUCTURED PROTEINS; KINETIC COOPERATIVITY	Proteins function by interacting with other molecules, where both native and nonnative interactions play important roles. Native interactions contribute to the stability and specificity of a complex, whereas nonnative interactions mainly perturb the binding kinetics. For intrinsically disordered proteins (IDPs), which do not adopt rigid structures when being free in solution, the role of nonnative interactions may be more prominent in binding processes due to their high flexibilities. In this work, we investigated the effect of nonnative hydrophobic interactions on the coupled folding and binding processes of IDPs and its interplay with chain flexibility by conducting molecular dynamics simulations. Our results showed that the free-energy profiles became rugged, and intermediate states occurred when nonnative hydrophobic interactions were introduced. The binding rate was initially accelerated and subsequently dramatically decreased as the strength of the nonnative hydrophobic interactions increased. Both thermodynamic and kinetic analysis showed that disordered systems were more readily affected by nonnative interactions than ordered systems. Furthermore, it was demonstrated that the kinetic advantage of IDPs ("fly-casting'' mechanism) was enhanced by nonnative hydrophobic interactions. The relationship between chain flexibility and protein aggregation is also discussed.	[Huang, Yongqi; Liu, Zhirong] Peking Univ, Coll Chem & Mol Engn, State Key Lab Struct Chem Unstable & Stable Speci, Beijing 100871, Peoples R China; [Huang, Yongqi; Liu, Zhirong] Peking Univ, Ctr Theoret Biol, Beijing 100871, Peoples R China; [Huang, Yongqi; Liu, Zhirong] Peking Univ, Beijing Natl Lab Mol Sci, Beijing 100871, Peoples R China	Chinese Academy of Sciences; Peking University; Peking University; Chinese Academy of Sciences; Peking University	Huang, YQ (corresponding author), Peking Univ, Coll Chem & Mol Engn, State Key Lab Struct Chem Unstable & Stable Speci, Beijing 100871, Peoples R China.	LiuZhiRong@pku.edu.cn	Liu, Zhirong/K-8703-2012		Ministry of Science and Technology of China [2009CB918500]; National Natural Science Foundation of China [20973016, 10721403]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Ministry of Science and Technology of China (No. 2009CB918500) (http://www.most.gov.cn/) and the National Natural Science Foundation of China (No. 20973016 and No. 10721403) (http://www.nsfc.gov.cn/Portal0/default124.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsallaq R, 2008, PROTEINS, V71, P320, DOI 10.1002/prot.21679; Azia A, 2009, J MOL BIOL, V393, P527, DOI 10.1016/j.jmb.2009.08.010; Badasyan A, 2008, J MOL BIOL, V384, P512, DOI 10.1016/j.jmb.2008.09.023; Blanco FJ, 1997, FOLD DES, V2, P123, DOI 10.1016/S1359-0278(97)00017-5; BOCZKO EM, 1993, J PHYS CHEM-US, V97, P4509, DOI 10.1021/j100119a043; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; Canet D, 2003, J MOL BIOL, V330, P397, DOI 10.1016/S0022-2836(03)00507-2; Capaldi AP, 2002, NAT STRUCT BIOL, V9, P209, DOI 10.1038/nsb757; CHAN HS, 1994, J CHEM PHYS, V100, P9238, DOI 10.1063/1.466677; Chen YT, 2010, PROTEINS, V78, P2090, DOI 10.1002/prot.22724; Cho JH, 2005, J MOL BIOL, V353, P174, DOI 10.1016/j.jmb.2005.08.019; Cho JH, 2004, J MOL BIOL, V338, P827, DOI 10.1016/j.jmb.2004.02.073; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Cieplak M, 2002, INT J MOD PHYS C, V13, P1231, DOI 10.1142/S012918310200408X; Clementi C, 2000, J MOL BIOL, V298, P937, DOI 10.1006/jmbi.2000.3693; Clementi C, 2004, PROTEIN SCI, V13, P1750, DOI 10.1110/ps.03580104; Curcio R, 2005, PROTEIN SCI, V14, P2499, DOI 10.1110/ps.041280705; Di Nardo AA, 2004, P NATL ACAD SCI USA, V101, P7954, DOI 10.1073/pnas.0400550101; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Fan K, 2002, EUR PHYS J B, V30, P381, DOI 10.1140/epjb/e2002-00393-4; Gao M, 2010, ACTA PHYS-CHIM SIN, V26, P1998, DOI 10.3866/PKU.WHXB20100733; Gardino AK, 2009, CELL, V139, P1109, DOI 10.1016/j.cell.2009.11.022; Gin BC, 2009, J MOL BIOL, V392, P1303, DOI 10.1016/j.jmb.2009.06.058; Givaty O, 2009, J MOL BIOL, V385, P1087, DOI 10.1016/j.jmb.2008.11.016; GO N, 1983, ANNU REV BIOPHYS BIO, V12, P183, DOI 10.1146/annurev.bb.12.060183.001151; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Huang YQ, 2010, ACTA PHYS-CHIM SIN, V26, P2061, DOI 10.3866/PKU.WHXB20100644; Huang YQ, 2010, PROTEINS, V78, P3251, DOI 10.1002/prot.22820; Huang YQ, 2009, J MOL BIOL, V393, P1143, DOI 10.1016/j.jmb.2009.09.010; Karanicolas J, 2003, J MOL BIOL, V334, P309, DOI 10.1016/j.jmb.2003.09.047; Kaya H, 2004, J MOL BIOL, V337, P1069, DOI 10.1016/j.jmb.2004.02.025; Kaya H, 2003, J MOL BIOL, V326, P911, DOI 10.1016/S0022-2836(02)01434-1; Kriwacki RW, 1996, P NATL ACAD SCI USA, V93, P11504, DOI 10.1073/pnas.93.21.11504; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Levy Y, 2005, J MOL BIOL, V346, P1121, DOI 10.1016/j.jmb.2004.12.021; Levy Y, 2007, J AM CHEM SOC, V129, P738, DOI 10.1021/ja065531n; Li L, 2000, NAT STRUCT BIOL, V7, P336; Liu ZR, 2005, PHYS BIOL, V2, pS75, DOI 10.1088/1478-3975/2/4/S01; Liu ZR, 2005, J MOL BIOL, V349, P872, DOI 10.1016/j.jmb.2005.03.084; Lu Q, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.128105; Meszaros B, 2007, J MOL BIOL, V372, P549, DOI 10.1016/j.jmb.2007.07.004; Micheletti C, 1999, PHYS REV LETT, V82, P3372, DOI 10.1103/PhysRevLett.82.3372; Midic U, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S12; Morton VL, 2007, J MOL BIOL, V371, P554, DOI 10.1016/j.jmb.2007.05.010; Neudecker P, 2006, J MOL BIOL, V363, P958, DOI 10.1016/j.jmb.2006.08.047; Oldfield CJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S1; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P1989, DOI 10.1021/bi047993o; Otzen D, 2005, PROTEIN ENG DES SEL, V18, P547, DOI 10.1093/protein/gzi063; Paci E, 2005, J PHYS-CONDENS MAT, V17, pS1617, DOI 10.1088/0953-8984/17/18/017; Paci E, 2002, BIOPHYS J, V83, P3032, DOI 10.1016/S0006-3495(02)75308-3; Pechmann S, 2009, P NATL ACAD SCI USA, V106, P10159, DOI 10.1073/pnas.0812414106; Plotkin SS, 2001, PROTEINS, V45, P337, DOI 10.1002/prot.1154; Qi YF, 2010, BIOPHYS J, V98, P321, DOI 10.1016/j.bpj.2009.10.018; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Rothwarf DM, 1996, BIOCHEMISTRY-US, V35, P13797, DOI 10.1021/bi9608119; Salvatella X, 2005, P NATL ACAD SCI USA, V102, P12389, DOI 10.1073/pnas.0408226102; Sanchez IE, 2010, P NATL ACAD SCI USA, V107, P7751, DOI 10.1073/pnas.0911734107; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Tang C, 2006, NATURE, V444, P383, DOI 10.1038/nature05201; Tsai CJ, 1999, PROTEIN SCI, V8, P1181, DOI 10.1110/ps.8.6.1181; Turjanski AG, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000060; Turoverov KK, 2010, PROG BIOPHYS MOL BIO, V102, P73, DOI 10.1016/j.pbiomolbio.2010.01.003; UEDA Y, 1978, BIOPOLYMERS, V17, P1531, DOI 10.1002/bip.1978.360170612; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Vavouri T, 2009, CELL, V138, P198, DOI 10.1016/j.cell.2009.04.029; Viguera AR, 2002, P NATL ACAD SCI USA, V99, P5349, DOI 10.1073/pnas.072387799; Wallin S, 2007, J MOL BIOL, V368, P884, DOI 10.1016/j.jmb.2007.02.035; Wang J, 2006, PLOS COMPUT BIOL, V2, P842, DOI 10.1371/journal.pcbi.0020078; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wrabl JO, 1996, PROTEIN SCI, V5, P2343, DOI 10.1002/pro.5560051121; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Zarrine-Afsar A, 2008, P NATL ACAD SCI USA, V105, P9999, DOI 10.1073/pnas.0801874105; Zhang ZQ, 2010, P NATL ACAD SCI USA, V107, P2920, DOI 10.1073/pnas.0911844107; Zhang ZQ, 2009, BIOPHYS J, V96, pL25, DOI 10.1016/j.bpj.2008.11.004; Zhou HX, 2005, PHYS BIOL, V2, pR1, DOI 10.1088/1478-3975/2/3/R01; Zhou HX, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.178101	79	33	33	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e15375	10.1371/journal.pone.0015375	http://dx.doi.org/10.1371/journal.pone.0015375			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079758	Green Published, Green Submitted, gold			2022-12-25	WOS:000283838600024
J	Tong, JS; Zhang, QH; Wang, ZB; Li, S; Yang, CR; Fu, XQ; Hou, Y; Wang, ZY; Sheng, J; Sun, QY				Tong, Jing-Shan; Zhang, Qing-Hua; Wang, Zhen-Bo; Li, Sen; Yang, Cai-Rong; Fu, Xue-Qi; Hou, Yi; Wang, Zhao-Yi; Sheng, Jun; Sun, Qing-Yuan			ER-alpha 36, a Novel Variant of ER-alpha, Mediates Estrogen-Stimulated Proliferation of Endometrial Carcinoma Cells via the PKC delta/ERK Pathway	PLOS ONE			English	Article							PROTEIN-KINASE-C; BREAST-CANCER CELLS; CYCLIN D1; RECEPTOR-ALPHA; SIGNALING PATHWAY; NUCLEAR RECEPTORS; MAPK ACTIVATION; TUMOR-CELLS; EXPRESSION; 17-BETA-ESTRADIOL	Background: Recently, a variant of ER-alpha, ER-alpha 36 was identified and cloned. ER-alpha 36 lacks intrinsic transcription activity and mainly mediates non-genomic estrogen signaling. The purpose of this study was to investigate the function and the underlying mechanisms of ER-alpha 36 in growth regulation of endometrial Ishikawa cancer cells. Methods: The cellular localization of ER-alpha 36 and ER-alpha 66 were determined by immunofluorescence in the Ishikawa cells. Ishikawa endometrial cancer control cells transfected with an empty expression vector, Ishikawa cells with shRNA knockdown of ER-alpha 36 (Ishikawa/RNAiER36) and Ishikawa cells with shRNA knockdown of ER-alpha 66 (Ishikawa/RNAiER66) were treated with E2 and E2-conjugated to bovine serum albumin (E2-BSA, membrane impermeable) in the absence and presence of different kinase inhibitors HBDDE, bisindolylmaleimide, rottlerin, H89 and U0126. The phosphorylation levels of signaling molecules and cyclin D1/cdk4 expression were examined with Western blot analysis and cell growth was monitored with the MTT assay. Results: Immunofluorescence staining of Ishikawa cells demonstrated that ER-alpha 36 was expressed mainly on the plasma membrane and in the cytoplasm, while ER-alpha 66 was predominantly localized in the cell nucleus. Both E2 and E2-BSA rapidly activated PKC delta not PKC alpha in Ishikawa cells, which could be abrogated by ER-alpha 36 shRNA expression. E2-and E2-BSA-induced ERK phosphorylation required ER-alpha 36 and PKCd. However, only E2 was able to induce Camp-dependent protein kinase A (PKA) phosphorylation. Furthermore, E2 enhances cyclin D1/cdk4 expression via ER-alpha 36. Conclusion: E2 activates the PKC delta/ERK pathway and enhances cyclin D1/cdk4 expression via the membrane-initiated signaling pathways mediated by ER-alpha 36, suggesting a possible involvement of ER-alpha 36 in E2-dependent growth-promoting effects in endometrial cancer cells.	[Tong, Jing-Shan; Fu, Xue-Qi; Sheng, Jun] Jilin Univ, Coll Life Sci, Changchun 130023, Peoples R China; [Tong, Jing-Shan; Zhang, Qing-Hua; Wang, Zhen-Bo; Li, Sen; Yang, Cai-Rong; Hou, Yi; Sun, Qing-Yuan] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Wang, Zhao-Yi] Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Omaha, NE USA; [Sheng, Jun] Yunnan Agr Univ, Kunming, Peoples R China	Jilin University; Chinese Academy of Sciences; Institute of Zoology, CAS; Creighton University; Yunnan Agricultural University	Tong, JS (corresponding author), Jilin Univ, Coll Life Sci, Changchun 130023, Peoples R China.	shengj63@126.com; sunqy@ioz.ac.cn	Yang, Cairong/AAB-1440-2021	Yang, Cairong/0000-0001-9594-0529; Tong, Jingshan/0000-0003-1640-5769	Major State Basic Research Program of China; National Institute of Health [DK84328]; Nebraska Tobacco Settlement Biomedical Research Program [LB595]	Major State Basic Research Program of China(National Basic Research Program of China); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nebraska Tobacco Settlement Biomedical Research Program	This work was supported by Major State Basic Research Program of China to QYS and also supported by National Institute of Health Grant, DK84328 and the Nebraska Tobacco Settlement Biomedical Research Program LB595 to ZYW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acconcia F, 2005, MOL BIOL CELL, V16, P231, DOI 10.1091/mbc.e04-07-0547; Boyan BD, 2003, ENDOCRINOLOGY, V144, P1812, DOI 10.1210/en.2002-221018; Brodie C, 2003, APOPTOSIS, V8, P19, DOI 10.1023/A:1021640817208; Caldon CE, 2009, MOL CELL BIOL, V29, P4623, DOI 10.1128/MCB.00269-09; Cao QJ, 2002, INT J GYNECOL PATHOL, V21, P147, DOI 10.1097/00004347-200204000-00007; Chaudhry P, 2009, ENDOCR-RELAT CANCER, V16, P363, DOI 10.1677/ERC-08-0266; Collins P, 1999, NAT MED, V5, P1130, DOI 10.1038/13453; Deucher A, 2002, J BIOL CHEM, V277, P17032, DOI 10.1074/jbc.M109076200; Grossoni VC, 2007, MOL CARCINOGEN, V46, P381, DOI 10.1002/mc.20287; Guo RX, 2006, J STEROID BIOCHEM, V99, P9, DOI 10.1016/j.jsbmb.2005.11.013; Henderson BE, 2000, CARCINOGENESIS, V21, P427, DOI 10.1093/carcin/21.3.427; Hsieh YC, 2007, AM J PATHOL, V170, P1210, DOI 10.2353/ajpath.2007.060883; Jiang XH, 2004, CANCER RES, V64, P5787, DOI 10.1158/0008-5472.CAN-03-1172; Kashima H, 2009, ENDOCR-RELAT CANCER, V16, P113, DOI 10.1677/ERC-08-0117; Knudsen KE, 1998, J BIOL CHEM, V273, P20213, DOI 10.1074/jbc.273.32.20213; Koivunen J, 2006, CANCER LETT, V235, P1, DOI 10.1016/j.canlet.2005.03.033; Koivunen J, 2004, CANCER RES, V64, P5693, DOI 10.1158/0008-5472.CAN-03-3511; Leirdal M, 1999, BRIT J CANCER, V80, P1558, DOI 10.1038/sj.bjc.6690560; Li WQ, 1998, MOL CELL BIOL, V18, P5888, DOI 10.1128/MCB.18.10.5888; Lin SL, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-102; LIN SL, PLOS ONE, V5, pE9013; Liu JF, 2002, BIOCHEM BIOPH RES CO, V293, P1174, DOI 10.1016/S0006-291X(02)00350-9; Marino M, 2006, CURR GENOMICS, V7, P497, DOI 10.2174/138920206779315737; Muchekehu RW, 2008, CELL CALCIUM, V44, P276, DOI 10.1016/j.ceca.2007.12.001; Muramatsu M, 2000, BIOCHEM BIOPH RES CO, V270, P1, DOI 10.1006/bbrc.2000.2214; Nakagawa S, 2003, MOL CARCINOGEN, V38, P106, DOI 10.1002/mc.10150; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; Ordonez-Moran P, 2009, CELL CYCLE, V8, P1675, DOI 10.4161/cc.8.11.8579; QIU ZH, 1994, J BIOL CHEM, V269, P19480; Quddus MR, 2002, ARCH PATHOL LAB MED, V126, P459; QUELLE DE, 1993, GENE DEV, V7, P1559, DOI 10.1101/gad.7.8.1559; Reyland ME, 2007, BIOCHEM SOC T, V35, P1001, DOI 10.1042/BST0351001; Rosenfeld MG, 2001, J BIOL CHEM, V276, P36865, DOI 10.1074/jbc.R100041200; Roy PG, 2006, BREAST, V15, P718, DOI 10.1016/j.breast.2006.02.005; SCHMITT JM, MOL CELL BIOCH, V335, P155; Shang YF, 2006, NAT REV CANCER, V6, P360, DOI 10.1038/nrc1879; Shiozawa T, 2004, ONCOGENE, V23, P8603, DOI 10.1038/sj.onc.1207849; Singleton DW, 2003, ENDOCRINOLOGY, V144, P121, DOI 10.1210/en.2002-220625; Sinha R, 1999, CANCER LETT, V146, P135, DOI 10.1016/S0304-3835(99)00250-5; Song RXD, 2002, MOL ENDOCRINOL, V16, P116, DOI 10.1210/me.16.1.116; Ueda Y, 1996, J BIOL CHEM, V271, P23512, DOI 10.1074/jbc.271.38.23512; Vivacqua A, 2006, MOL ENDOCRINOL, V20, P631, DOI 10.1210/me.2005-0280; Wang ZY, 2006, P NATL ACAD SCI USA, V103, P9063, DOI 10.1073/pnas.0603339103; Wang ZY, 2005, BIOCHEM BIOPH RES CO, V336, P1023, DOI 10.1016/j.bbrc.2005.08.226; Watson CS, 1999, EXP PHYSIOL, V84, P1013, DOI 10.1111/j.1469-445X.1999.01903.x; Way KJ, 2000, TRENDS PHARMACOL SCI, V21, P181, DOI 10.1016/S0165-6147(00)01468-1; Zhang LL, 2009, J CELL BIOCHEM, V106, P553, DOI 10.1002/jcb.22017; Zhang YJ, 2003, CHINESE MED J-PEKING, V116, P383; Zhang ZG, 2002, BIOCHEM BIOPH RES CO, V294, P926, DOI 10.1016/S0006-291X(02)00348-0; Zou Y, 2009, FEBS LETT, V583, P1368, DOI 10.1016/j.febslet.2009.03.047	53	59	71	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e15408	10.1371/journal.pone.0015408	http://dx.doi.org/10.1371/journal.pone.0015408			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079811	Green Published, gold, Green Submitted			2022-12-25	WOS:000283838600026
J	Ma, L; Li, W; Zhu, HP; Li, Z; Sun, ZJ; Liu, XP; Zhao, J; Zhang, JS; Zhang, YQ				Ma, Li; Li, Wei; Zhu, Hua-Ping; Li, Zhen; Sun, Zhi-Jian; Liu, Xin-Ping; Zhao, Jie; Zhang, Jin-Shan; Zhang, Yuan-Qiang			Localization and Androgen Regulation of Metastasis-Associated Protein 1 in Mouse Epididymis	PLOS ONE			English	Article							RAT EPIDIDYMIS; EFFERENT DUCTS; EPITHELIAL-CELLS; MALE-MICE; EXPRESSION; GENES; SPERM; SPERMATOGENESIS; IDENTIFICATION; RECEPTOR	Background: Metastasis-associated protein 1 (MTA1), the founding member of the MTA family of genes, can modulate transcription by influencing the status of chromatin remodeling. Despite its strong correlation with the metastatic potential of cancer cells, MTA1 can also regulate crucial cellular pathways by modifying the acetylation status. We have previously reported the presence of MTA1/MTA1 in human and mouse testes, providing the evidence for its involvement in the regulation of testicular function during murine spermatogenesis. The objective of present study was to further assess the localization of MTA1 in mouse epididymis on both transcriptional and translational level, and then to explore whether MTA1 expression is regulated by androgens and postnatal epididymal development. Methodology/Principal Findings: Mice were deprived of circulating androgen by bilaterally castration and were then supplemented with exogenous testosterone propionate for one week. MTA1 was immunolocalized in the epithelium of the entire epididymis with the maximal expression in the nuclei of principal cells and of clear cells in proximal region. Its expression decreased gradually after castration, whereas testosterone treatment could restore the expression, indicating that the expression of this gene is dependent on androgen. During postnatal development, the protein expression in the epididymis began to appear from day 7 to day 14, increased dramatically from postnatal day 28, and peaked at adulthood onwards, coinciding with both the well differentiated status of epididymis and the mature levels of circulating androgens. This region-and cell-specific pattern was also conservative in normal human epididymis. Conclusions: Our data suggest that the expression of MTA1 protein could be regulated by androgen pathway and its expression level is closely associated with the postnatal development of the epididymis, giving rise to the possibility that this gene plays a potential role in sperm maturation and fertility.	[Ma, Li; Li, Wei; Zhu, Hua-Ping; Li, Zhen; Sun, Zhi-Jian; Zhao, Jie; Zhang, Jin-Shan; Zhang, Yuan-Qiang] Fourth Mil Med Univ, Dept Human Anat & Histol & Embryol, Xian 710032, Peoples R China; [Liu, Xin-Ping] Fourth Mil Med Univ, Dept Biochem & Mol Biol, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Ma, L (corresponding author), Fourth Mil Med Univ, Dept Human Anat & Histol & Embryol, Xian 710032, Peoples R China.	zhangyq@fmmu.edu.cn			Natural Science Foundation of China (NSFC) [30800395, 30771138]; Military Medical Foundation [06MA216]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Military Medical Foundation	This work was supported by the Natural Science Foundation of China (NSFC) (30800395, 2008; 30771138, 2007) and by the Military Medical Foundation (06MA216) (http://www.nsfc.gov.cn/Portal0/default124.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUHAILA A, 1985, INT J ANDROL, V8, P441, DOI 10.1111/j.1365-2605.1985.tb00858.x; Aramaki Y, 2005, FEBS LETT, V579, P3731, DOI 10.1016/j.febslet.2005.05.069; Bagheri-Yarmand R, 2004, DEVELOPMENT, V131, P3469, DOI 10.1242/dev.01213; Baska KM, 2008, J CELL PHYSIOL, V215, P684, DOI 10.1002/jcp.21349; Belleannee C, 2009, BIOL REPROD, V80, P134, DOI 10.1095/biolreprod.108.070797; Beumer TL, 1998, CELL DEATH DIFFER, V5, P669, DOI 10.1038/sj.cdd.4400396; Bomgardner D, 2003, BIOL REPROD, V68, P644, DOI 10.1095/biolreprod.102.009324; CHAREST NJ, 1989, ENDOCRINOLOGY, V125, P942, DOI 10.1210/endo-125-2-942; Chauvin TR, 2004, BIOL REPROD, V71, P560, DOI 10.1095/biolreprod.103.026302; CORNWALL GA, 1995, J ANDROL, V16, P379; FAYE JC, 1980, BIOL REPROD, V23, P423, DOI 10.1095/biolreprod23.2.423; Fouchecourt S, 2003, ENDOCRINOLOGY, V144, P887, DOI 10.1210/en.2002-220932; GALLON C, 1989, J ANDROL, V10, P188; HERMO L, 1992, ANAT RECORD, V232, P202, DOI 10.1002/ar.1092320206; Hermo L, 2008, J HISTOCHEM CYTOCHEM, V56, P1121, DOI 10.1369/jhc.2008.951947; Hu YX, 2003, ENDOCRINOLOGY, V144, P1612, DOI 10.1210/en.2002-220915; KIMURA M, 1974, P NATL ACAD SCI USA, V71, P2848, DOI 10.1073/pnas.71.7.2848; Kirchhoff C, 2008, REPRODUCTION, V136, P235, DOI 10.1530/REP-08-0078; Kumar R, 2003, SEMIN ONCOL, V30, P30, DOI 10.1053/j.seminoncol.2003.08.005; Li DQ, 2009, J BIOL CHEM, V284, P34545, DOI 10.1074/jbc.M109.056499; Li W, 2008, FEBS LETT, V582, P869, DOI 10.1016/j.febslet.2008.02.013; Li W, 2007, CELL TISSUE RES, V329, P351, DOI 10.1007/s00441-007-0412-8; Li W, 2007, ASIAN J ANDROL, V9, P345, DOI 10.1111/j.1745-7262.2007.00245.x; Li W, 2009, TISSUE CELL, V41, P390, DOI 10.1016/j.tice.2009.04.002; Li Z, 2010, FERTIL STERIL, V93, P2661, DOI 10.1016/j.fertnstert.2010.01.053; Manavathi B, 2007, J BIOL CHEM, V282, P1529, DOI 10.1074/jbc.R600029200; Nicolson GL, 1998, IN VIVO, V12, P579; Oh J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-314; Pietrement C, 2006, BIOL REPROD, V74, P185, DOI 10.1095/biolreprod.105.043752; Prabagaran E, 2007, J ANDROL, V28, P755, DOI 10.2164/jandrol.106.002394; Raymond AS, 2009, J CELL SCI, V122, P849, DOI 10.1242/jcs.041731; Robaire B, 2007, ASIAN J ANDROL, V9, P545, DOI 10.1111/j.1745-7262.2007.00316.x; Schurmann A, 2002, MOL CELL BIOL, V22, P2761, DOI 10.1128/MCB.22.8.2761-2768.2002; Shum WWC, 2009, J EXP BIOL, V212, P1753, DOI 10.1242/jeb.027284; Suarez-Quian CA, 1999, J CLIN ENDOCR METAB, V84, P350, DOI 10.1210/jc.84.1.350; TOH Y, 1994, J BIOL CHEM, V269, P22958; Tomaszewski J, 2007, P NATL ACAD SCI USA, V104, P11322, DOI 10.1073/pnas.0703445104; VERI JP, 1993, J ANDROL, V14, P23; Wennemuth G, 2000, J BIOL CHEM, V275, P21210, DOI 10.1074/jbc.M002068200; Zhen W, 2009, BIOL REPROD, V80, P696, DOI 10.1095/biolreprod.108.071589; Zhou X, 2007, ACTA BIOCH BIOPH SIN, V39, P939, DOI 10.1111/j.1745-7270.2007.00359.x; Zhou YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004106; Zhu CF, 2007, BIOL REPROD, V76, P63, DOI 10.1095/biolreprod.106.054635	43	16	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e15439	10.1371/journal.pone.0015439	http://dx.doi.org/10.1371/journal.pone.0015439			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	800AR	21082030	Green Published, Green Submitted, gold			2022-12-25	WOS:000293329500007
J	Wang, Y; Yu, Y; Tsuyada, A; Ren, X; Wu, X; Stubblefield, K; Rankin-Gee, EK; Wang, SE				Wang, Y.; Yu, Y.; Tsuyada, A.; Ren, X.; Wu, X.; Stubblefield, K.; Rankin-Gee, E. K.; Wang, S. E.			Transforming growth factor-beta regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM	ONCOGENE			English	Article						TGF-beta; cancer stem cells; microRNA; ATM; CHK2	TGF-BETA; SOLID TUMORS; MICRORNA EXPRESSION; P53; HETEROGENEITY; PATHWAYS; LEUKEMIA; DELETION	Recent studies indicate that a subset of cancer cells possessing stem cell properties, referred to as cancer-initiating or cancer stem cells (CSCs), have crucial roles in tumor initiation, metastasis and resistance to anticancer therapies. Transforming growth factor (TGF)-beta and their family members have been implicated in both normal (embryonic and somatic) stem cells and CSCs. In this study, we observed that exposure to TGF-beta increased the population of breast cancer (BC) cells that can form mammospheres in suspension, a feature endowed by stem cells. This was mediated by the micro (mi) RNA family miR-181, which was upregulated by TGF-beta at the post-transcriptional level. Levels of the miR-181 family members were elevated in mammospheres grown in undifferentiating conditions, compared with cells grown in two-dimensional conditions. Ataxia telangiectasia mutated (ATM), a target gene of miR-181, exhibited reduced expression in mammospheres and upon TGF-b treatment. Overexpression of miR-181a/b, or depletion of ATM or its substrate CHK2, was sufficient to induce sphere formation in BC cells. Finally, knockdown of ATM enhanced in vivo tumorigenesis of the MDA361 BC cells. Our results elucidate a novel mechanism through which the TGF-b pathway regulates the CSC property by interfering with the tumor suppressor ATM, providing insights into the cellular and environmental factors regulating CSCs, which may guide future studies on therapeutic strategies targeting these cells. Oncogene (2011) 30, 1470-1480; doi:10.1038/onc.2010.531; published online 22 November 2010	[Wang, Y.; Yu, Y.; Tsuyada, A.; Stubblefield, K.; Rankin-Gee, E. K.; Wang, S. E.] Beckman Res Inst City Hope, Div Tumor Cell Biol, Duarte, CA 91010 USA; [Yu, Y.] Tianjin Med Univ, Tianjin Canc Inst & Hosp, Dept Head & Neck Tumor, Tianjin, Peoples R China; [Ren, X.] Tianjin Med Univ, Tianjin Canc Inst & Hosp, Dept Immunol & Biotherapy, Tianjin, Peoples R China; [Wu, X.] City Hope Comprehens Canc Ctr, Bioinformat Core Facil, Duarte, CA USA; [Wang, S. E.] City Hope Comprehens Canc Ctr, Canc Biol Program, Duarte, CA USA	City of Hope; Beckman Research Institute of City of Hope; Tianjin Medical University; Tianjin Medical University; City of Hope; City of Hope	Wang, SE (corresponding author), Beckman Res Inst City Hope, Div Tumor Cell Biol, 1500 E Duarte Rd,KCRB Room 2007, Duarte, CA 91010 USA.	ewang@coh.org	Rankin-Gee, Elyse/B-2776-2013	Rankin-Gee, Elyse/0000-0002-0675-6955; Wang, Shizhen Emily/0000-0002-5036-8175	NCI [R00 CA125892]; CBCRP [16IB-0081]; NATIONAL CANCER INSTITUTE [R00CA125892, K99CA125892] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CBCRP; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI R00 CA125892 (SEW) and CBCRP 16IB-0081 (SEW). We thank Dr John J Rossi for kindly providing reagents, Dr Shiuan Chen and Dr Susan Kane for valuable comments, the Bioinformatics Core for professional service and colleagues in the Division of Tumor Cell Biology for enthusiastic support and discussion. Financial Support: NCI R00 CA125892 (SEW); CBCRP 16IB-0081 (SEW).	Ailles LE, 2007, CURR OPIN BIOTECH, V18, P460, DOI 10.1016/j.copbio.2007.10.007; Austen B, 2007, J CLIN ONCOL, V25, P5448, DOI 10.1200/JCO.2007.11.2649; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Dontu G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2130; Dumont N, 2003, CANCER CELL, V3, P531, DOI 10.1016/S1535-6108(03)00135-1; Haidar MA, 2000, CANCER-AM CANCER SOC, V88, P1057, DOI 10.1002/(SICI)1097-0142(20000301)88:5<1057::AID-CNCR16>3.0.CO;2-6; Ji JF, 2009, HEPATOLOGY, V50, P472, DOI 10.1002/hep.22989; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Ren YS, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-111; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Topczewska JM, 2006, NAT MED, V12, P925, DOI 10.1038/nm1448; Tribius S, 2001, INT J RADIAT ONCOL, V50, P511, DOI 10.1016/S0360-3016(01)01489-4; Vallier L, 2009, STEM CELLS, V27, P2655, DOI 10.1002/stem.199; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang B, 2010, ONCOGENE, V29, P1787, DOI 10.1038/onc.2009.468; Wang SE, 2005, MOL CELL BIOL, V25, P4703, DOI 10.1128/MCB.25.11.4703-4715.2005; Wang SZE, 2007, J BIOL CHEM, V282, P5661, DOI 10.1074/jbc.M608499200; Wang SZE, 2006, CANCER CELL, V10, P25, DOI 10.1016/j.ccr.2006.05.023; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323	32	212	228	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR	2011	30	12					1470	1480		10.1038/onc.2010.531	http://dx.doi.org/10.1038/onc.2010.531			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	739UM	21102523	Green Accepted, Bronze, Green Published			2022-12-25	WOS:000288743800009
J	Pillai, SM; Meredith, D				Pillai, Samyuktha Muralidharan; Meredith, David			SLC36A4 (hPAT4) Is a High Affinity Amino Acid Transporter When Expressed in Xenopus laevis Oocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-SPECIFICITY; FUNCTIONAL-CHARACTERIZATION; SMALL-INTESTINE; L-TRYPTOPHAN; RAT PAT2; MEMBRANE; SYSTEM; ABSORPTION; NUTRIENT; CARRIER	The SLC36 family of transporters consists of four genes, two of which, SLC36A1 and SLC36A2, have been demonstrated to code for human proton-coupled amino acid transporters or hPATs. Here we report the characterization of the fourth member of the family, SLC36A4 or hPAT4, which when expressed in Xenopus laevis oocytes also encodes a plasma membrane amino acid transporter, but one that is not proton-coupled and has a very high substrate affinity for the amino acids proline and tryptophan. hPAT4 in Xenopus oocytes mediated sodium-independent, electroneutral uptake of [H-3] proline, with the highest rate of uptake when the uptake medium pH was 7.4 and an affinity of 3.13 mu M. Tryptophan was also an excellently transported substrate with a similarly high affinity (1.72 mu M). Other amino acids that inhibited [H-3] proline were isoleucine (K-i 0.23 mM), glutamine (0.43 mM), methionine (0.44 mM), and alanine (1.48 mM), and with lower affinity, glycine, threonine, and cysteine (K-i > 5mM for all). Of the amino acids directly tested for transport, only proline, tryptophan, and alanine showed significant uptake, whereas glycine and cysteine did not. Of the non-proteogenic amino acids and drugs tested, only sarcosine produced inhibition (K-i 1.09 mM), whereas gamma-aminobutyric acid (GABA), beta-alanine, L-Dopa, D-serine, and delta-aminolevulinic acid were without effect on [H-3] proline uptake. This characterization of hPAT4 as a very high affinity/low capacity non-proton-coupled amino acid transporter raises questions about its physiological role, especially as the transport characteristics of hPAT4 are very similar to the Drosophila orthologue PATH, an amino acid "transceptor" that plays a role in nutrient sensing.	[Pillai, Samyuktha Muralidharan; Meredith, David] Oxford Brookes Univ, Sch Life Sci, Oxford OX3 0BP, England	Oxford Brookes University	Meredith, D (corresponding author), Oxford Brookes Univ, Sch Life Sci, Oxford OX3 0BP, England.	dmeredith@brookes.ac.uk	Meredith, David/F-3664-2010		School of Life Sciences, Oxford Brookes University	School of Life Sciences, Oxford Brookes University	This work was supported by a scholarship from the School of Life Sciences, Oxford Brookes University (to S.M.P.).	Abbot EL, 2006, BRIT J PHARMACOL, V147, P298, DOI 10.1038/sj.bjp.0706557; Anderson CMH, 2010, J PHARMACOL EXP THER, V332, P220, DOI 10.1124/jpet.109.159822; Anderson CMH, 2004, GASTROENTEROLOGY, V127, P1410, DOI 10.1053/j.gastro.2004.08.017; Bermingham JR, 2004, MAMM GENOME, V15, P114, DOI 10.1007/s00335-003-2319-3; Bevington A, 2002, EUR J CLIN INVEST, V32, P590, DOI 10.1046/j.1365-2362.2002.01038.x; Boll M, 2004, PFLUG ARCH EUR J PHY, V447, P776, DOI 10.1007/s00424-003-1073-4; Boll M, 2003, MOL MEMBR BIOL, V20, P261, DOI 10.1080/0968768031000100759; Boll M, 2002, J BIOL CHEM, V277, P22966, DOI 10.1074/jbc.M200374200; Broer S, 2008, J CLIN INVEST, V118, P3881, DOI 10.1172/JCI36625; Broer A, 2006, PFLUG ARCH EUR J PHY, V451, P511, DOI 10.1007/s00424-005-1481-8; Chen Z, 2003, BIOCHEM BIOPH RES CO, V304, P747, DOI 10.1016/S0006-291X(03)00648-X; Christie GR, 2002, J BIOL CHEM, V277, P9952, DOI 10.1074/jbc.M107694200; DEVES R, 1989, PROC R SOC SER B-BIO, V237, P85, DOI 10.1098/rspb.1989.0038; DOMINGUEZ I, 1995, P NATL ACAD SCI USA, V92, P8498, DOI 10.1073/pnas.92.18.8498; Foltz M, 2004, EUR J BIOCHEM, V271, P3340, DOI 10.1111/j.1432-1033.2004.04268.x; Frolund S, 2010, BRIT J PHARMACOL, V159, P1339, DOI 10.1111/j.1476-5381.2009.00620.x; Goberdhan DCI, 2005, DEVELOPMENT, V132, P2365, DOI 10.1242/dev.01821; Hediger MA, 2004, PFLUG ARCH EUR J PHY, V447, P465, DOI 10.1007/s00424-003-1192-y; Heublein S, 2010, ONCOGENE, V29, P4068, DOI 10.1038/onc.2010.177; Javitt Daniel C, 2002, Curr Opin Investig Drugs, V3, P1067; Kennedy DJ, 2005, BRIT J PHARMACOL, V144, P28, DOI 10.1038/sj.bjp.0706029; Larsen M, 2009, BRIT J PHARMACOL, V157, P1380, DOI 10.1111/j.1476-5381.2009.00253.x; Meredith D, 2004, J BIOL CHEM, V279, P15795, DOI 10.1074/jbc.M313922200; Metzner L, 2006, AMINO ACIDS, V31, P111, DOI 10.1007/s00726-005-0314-6; Metzner L, 2005, FASEB J, V19, P1468, DOI 10.1096/fj.05-3683com; Metzner L, 2009, MOL PHARMACEUT, V6, P1006, DOI 10.1021/mp9000684; NEWEY H, 1964, J PHYSIOL-LONDON, V170, P328, DOI 10.1113/jphysiol.1964.sp007334; Reynolds B, 2007, BIOCHEM SOC T, V35, P1215, DOI 10.1042/BST0351215; Rubio-Aliaga I, 2004, J BIOL CHEM, V279, P2754, DOI 10.1074/jbc.M305556200; Sagne C, 2001, P NATL ACAD SCI USA, V98, P7206, DOI 10.1073/pnas.121183498; Thwaites DT, 2007, EXP PHYSIOL, V92, P603, DOI 10.1113/expphysiol.2005.029959; Thwaites DT, 2000, BRIT J PHARMACOL, V129, P457, DOI 10.1038/sj.bjp.0703069	32	32	35	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2455	2460		10.1074/jbc.M110.172403	http://dx.doi.org/10.1074/jbc.M110.172403			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21097500	Green Published, hybrid			2022-12-25	WOS:000286464300009
J	Goto, K; Kurashima, R; Gokan, H; Inoue, N; Ito, I; Watanabe, S				Goto, Kazuhiro; Kurashima, Ryo; Gokan, Hayato; Inoue, Naomi; Ito, Isao; Watanabe, Shigeru			Left-Right Asymmetry Defect in the Hippocampal Circuitry Impairs Spatial Learning and Working Memory in iv Mice	PLOS ONE			English	Article							PERFORMANCE; RECEPTORS; C57BL/6N; INVERSUS; LESIONS; POTENT; BRAIN; TASK; FLOW	Although left-right (L-R) asymmetry is a fundamental feature of higher-order brain function, little is known about how asymmetry defects of the brain affect animal behavior. Previously, we identified structural and functional asymmetries in the circuitry of the mouse hippocampus resulting from the asymmetrical distribution of NMDA receptor GluR epsilon 2 (NR2B) subunits. We further examined the epsilon 2 asymmetry in the inversus viscerum (iv) mouse, which has randomized laterality of internal organs, and found that the iv mouse hippocampus exhibits right isomerism (bilateral right-sidedness) in the synaptic distribution of the epsilon 2 subunit, irrespective of the laterality of visceral organs. To investigate the effects of hippocampal laterality defects on higher-order brain functions, we examined the capacity of reference and working memories of iv mice using a dry maze and a delayed nonmatching-to-position (DNMTP) task, respectively. The iv mice improved dry maze performance more slowly than control mice during acquisition, whereas the asymptotic level of performance was similar between the two groups. In the DNMTP task, the iv mice showed poorer accuracy than control mice as the retention interval became longer. These results suggest that the L-R asymmetry of hippocampal circuitry is critical for the acquisition of reference memory and the retention of working memory.	[Goto, Kazuhiro] Japan Soc Promot Sci, Tokyo, Japan; [Goto, Kazuhiro; Kurashima, Ryo; Gokan, Hayato; Inoue, Naomi; Watanabe, Shigeru] Keio Univ, Fac Letters, Dept Psychol, Tokyo, Japan; [Ito, Isao] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan	Japan Society for the Promotion of Science; Keio University; Kyushu University	Goto, K (corresponding author), Kyoto Univ, Human Brain Res Ctr, Kyoto, Japan.	kgoto@psy.flet.keio.ac.jp	Goto, Kazuhiro/E-6456-2011; Goto, Kazuhiro/ABB-3677-2020		Japan Science and Technology Corporation; Ministry of Education, Culture, Sports, Science and Technology of Japan [18/5950, 21300125]; Global Center of Excellence [D029]	Japan Science and Technology Corporation(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global Center of Excellence(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Solution Oriented Research or Science and Technology from the Japan Science and Technology Corporation to II, the Global Center of Excellence Program (D029) to Keio University, and Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant No. 18/5950 to KG and No. 21300125 to II). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa H, 2005, CURR BIOL, V15, P238, DOI 10.1016/j.cub.2005.01.014; Bailey KR, 2005, BEHAV NEUROSCI, V119, P410, DOI 10.1037/0735-7044.119.2.410; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; BURK JA, 1998, BEHAV NEUROSCI, V112, P2; Chen C, 1997, ANNU REV NEUROSCI, V20, P157, DOI 10.1146/annurev.neuro.20.1.157; Chizh BA, 2001, TRENDS PHARMACOL SCI, V22, P636, DOI 10.1016/S0165-6147(00)01863-0; DAVISON MC, 1978, J EXP ANAL BEHAV, V29, P331, DOI 10.1901/jeab.1978.29-331; Deadwyler SA, 1996, J NEUROSCI, V16, P354; Fischer G, 1997, J PHARMACOL EXP THER, V283, P1285; GESCHWIND N, 1987, CAREBRAL LATERALIZAT; Goto K, 2010, BEHAV PROCESS, V84, P591, DOI 10.1016/j.beproc.2010.02.022; Halpern ME, 2005, J NEUROSCI, V25, P10351, DOI 10.1523/JNEUROSCI.3439-05.2005; Hummel K. P., 1959, Journal of Heredity, V50, P9; JARRARD LE, 1993, BEHAV NEURAL BIOL, V60, P9, DOI 10.1016/0163-1047(93)90664-4; Kawakami R, 2003, SCIENCE, V300, P990, DOI 10.1126/science.1082609; Kawakami R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001945; Kolkman MJM, 2004, BEHAV BRAIN RES, V154, P171, DOI 10.1016/j.bbr.2004.02.006; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; Mutel V, 1998, J NEUROCHEM, V70, P2147; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Nonaka S, 2002, NATURE, V418, P96, DOI 10.1038/nature00849; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Okada Y, 1999, MOL CELL, V4, P459, DOI 10.1016/S1097-2765(00)80197-5; Sloan HL, 2006, BEHAV BRAIN RES, V171, P240, DOI 10.1016/j.bbr.2006.03.042; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Supp DM, 1999, DEVELOPMENT, V126, P5495; Supp DM, 1997, NATURE, V389, P963, DOI 10.1038/40140; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; Vallortigara G, 2000, BRAIN LANG, V73, P189, DOI 10.1006/brln.2000.2303; White KG, 2001, ANIM LEARN BEHAV, V29, P193, DOI 10.3758/BF03192887; Wu Y, 2005, J NEUROSCI, V25, P9213, DOI 10.1523/JNEUROSCI.2134-05.2005; Yoshida M, 2001, PHYSIOL BEHAV, V73, P37, DOI 10.1016/S0031-9384(01)00419-X	33	43	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2010	5	11							e15468	10.1371/journal.pone.0015468	http://dx.doi.org/10.1371/journal.pone.0015468			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681OY	21103351	Green Published, gold			2022-12-25	WOS:000284327800020
J	Xu, M; Bi, YF; Xu, Y; Yu, B; Huang, Y; Gu, LN; Wu, YH; Zhu, XL; Li, MA; Wang, TG; Song, AY; Hou, JN; Li, XY; Ning, GA				Xu, Min; Bi, Yufang; Xu, Yu; Yu, Bing; Huang, Yun; Gu, Lina; Wu, Yaohua; Zhu, Xiaolin; Li, Mian; Wang, Tiange; Song, Aiyun; Hou, Jianing; Li, Xiaoying; Ning, Guang			Combined Effects of 19 Common Variations on Type 2 Diabetes in Chinese: Results from Two Community-Based Studies	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; IMPAIRED GLUCOSE-TOLERANCE; SUSCEPTIBILITY LOCI; GENETIC-VARIANTS; FASTING GLUCOSE; PLASMA-GLUCOSE; RISK; HHEX; CDKN2A/B; IGF2BP2	Background: Many susceptible loci for type 2 diabetes mellitus (T2DM) have recently been identified from Caucasians through genome wide association studies (GWAS). We aimed to determine the association of 11 known loci with T2DM and impaired glucose regulation (IGR), individually and in combination, in Chinese. Methods/Principal Findings: Subjects were enrolled in: (1) a case-control study including 1825 subjects with T2DM, 1487 with IGR and 2200 with normal glucose regulation; and (2) a prospective cohort with 734 non-diabetic subjects at baseline. The latter was followed up for 3.5 years, in which 67 subjects developed T2DM. Nineteen single nucleotide polymorphisms (SNPs) were selected to replicate in both studies. We found that CDKAL1 (rs7756992), SLC30A8 (rs13266634, rs2466293), CDKN2A/2B (rs10811661) and KCNQ1 (rs2237892) were associated with T2DM with odds ratio from 1.21 to 1.35. In the prospective study, the fourth quartile of risk scores based on the combined effects of the risk alleles had 3.05 folds (95% CI, 1.31-7.12) higher risk for incident T2DM as compared with the first quartile, after adjustment for age, gender, body mass index and diabetes family history. This combined effect was confirmed in the case-control study after the same adjustments. The addition of the risk scores to the model of clinical risk factors modestly improved discrimination for T2DM by 1.6% in the case-control study and 2.9% in the prospective study. Conclusions/Significance: Our study provided further evidence for these GWAS derived SNPs as the genetic susceptible loci for T2DM in Chinese and extended this association to IGR.	[Xu, Min; Zhu, Xiaolin; Li, Xiaoying; Ning, Guang] Shanghai Jiao Tong Univ, State Key Lab Med Genom, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China; [Xu, Min; Bi, Yufang; Xu, Yu; Huang, Yun; Gu, Lina; Wu, Yaohua; Zhu, Xiaolin; Li, Mian; Wang, Tiange; Song, Aiyun; Hou, Jianing; Li, Xiaoying; Ning, Guang] Shanghai Jiao Tong Univ, Dept Endocrine & Metab Dis, Shanghai Clin Ctr Endocrine & Metab Dis, Ruijin Hosp, Shanghai 200030, Peoples R China; [Yu, Bing] Univ Sydney, Dept Mol & Clin Genet, Royal Prince Alfred Hosp, Sydney, NSW 2006, Australia; [Yu, Bing] Univ Sydney, Cent Clin Sch, Sydney, NSW 2006, Australia; [Li, Xiaoying; Ning, Guang] Shanghai Jiao Tong Univ, Lab Endocrinol & Metab, Shanghai Inst Biol Sci, Chinese Acad Sci, Shanghai 200030, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of Sydney; University of Sydney; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University	Xu, M (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Med Genom, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China.	gning@sibs.ac.cn	Li, Mian/HGE-6038-2022; Zhu, Xiaolin/GLV-1533-2022	Zhu, Xiaolin/0000-0002-3221-595X; Yu, Bing/0000-0001-6013-5220; Li, Xiaoying/0000-0002-9383-5757	State Key Laboratory of Medical Genomics; Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Chinese Public Health [1994DP131044]; National Key New Drug Creation and Manufacturing Program [2008ZX09312/019]; 863 Project [2006AA02A409]; Nature Science Foundation of China [30800536]; Shanghai Committee for Science and Technology [08DJ1400602, 08ZR141700]; E-Institute of Shanghai Universities, Shanghai Education Commission	State Key Laboratory of Medical Genomics; Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Chinese Public Health; National Key New Drug Creation and Manufacturing Program; 863 Project(National High Technology Research and Development Program of China); Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee for Science and Technology(Shanghai Science & Technology Committee); E-Institute of Shanghai Universities, Shanghai Education Commission	This study was supported by the grants from State Key Laboratory of Medical Genomics, Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Chinese Public Health (No. 1994DP131044), National Key New Drug Creation and Manufacturing Program (2008ZX09312/019), 863 Project (No. 2006AA02A409), Nature Science Foundation of China (No. 30800536), Shanghai Committee for Science and Technology (No. 08DJ1400602 and 08ZR141700) and E-Institute of Shanghai Universities, Shanghai Education Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; Chen JM, 2009, AM J HUM GENET, V85, P775, DOI 10.1016/j.ajhg.2009.10.016; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Gerstein HC, 2007, DIABETES RES CLIN PR, V78, P305, DOI 10.1016/j.diabres.2007.05.004; Grarup N, 2007, DIABETES, V56, P3105, DOI 10.2337/db07-0856; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Horikoshi M, 2007, DIABETOLOGIA, V50, P2461, DOI 10.1007/s00125-007-0827-5; Hu C, 2009, DIABETOLOGIA, V52, P1322, DOI 10.1007/s00125-009-1335-6; Kraft P, 2009, NEW ENGL J MED, V360, P1701, DOI 10.1056/NEJMp0810107; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Lango H, 2008, DIABETES, V57, P3129, DOI 10.2337/db08-0504; Li HX, 2008, DIABETES, V57, P264, DOI 10.2337/db07-1130; Li XY, 2009, CLIN ENDOCRINOL, V70, P691, DOI 10.1111/j.1365-2265.2008.03371.x; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Ng MCY, 2008, DIABETES, V57, P2226, DOI 10.2337/db07-1583; Nicolson TJ, 2009, DIABETES, V58, P2070, DOI 10.2337/db09-0551; Nordman S, 2005, EXP CLIN ENDOCR DIAB, V113, P282, DOI 10.1055/s-2005-865650; Omori S, 2008, DIABETES, V57, pA331; Palmer ND, 2008, DIABETES, V57, P1093, DOI 10.2337/db07-1169; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Qi QB, 2009, HUM MOL GENET, V18, P3508, DOI 10.1093/hmg/ddp294; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; SAAD MF, 1988, NEW ENGL J MED, V319, P1500, DOI 10.1056/NEJM198812083192302; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; SLAKED R, 2007, NATURE, V445, P828; Staiger H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000832; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; van Hoek M, 2008, DIABETES, V57, P3122, DOI 10.2337/db08-0425; Wang J, 2007, DIABETOLOGIA, V50, P1192, DOI 10.1007/s00125-007-0656-6; Weedon MN, 2006, PLOS MED, V3, P1877, DOI 10.1371/journal.pmed.0030374; Wijesekara N, 2010, DIABETOLOGIA, V53, P1656, DOI 10.1007/s00125-010-1733-9; Xiang J, 2008, J CLIN ENDOCR METAB, V93, P4107, DOI 10.1210/jc.2008-0161; Xu M, 2009, DIABETOLOGIA, V52, P1511, DOI 10.1007/s00125-009-1386-8; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	42	74	82	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2010	5	11							e14022	10.1371/journal.pone.0014022	http://dx.doi.org/10.1371/journal.pone.0014022			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681OY	21103332	Green Published, Green Submitted, gold			2022-12-25	WOS:000284327800009
J	Yang, F; Cheng, Y; An, JY; Kwon, YT; Eckardt, S; Leu, NA; McLaughlin, KJ; Wang, PJ				Yang, Fang; Cheng, Yong; An, Jee Young; Kwon, Yong Tae; Eckardt, Sigrid; Leu, N. Adrian; McLaughlin, K. John; Wang, Peijing Jeremy			The Ubiquitin Ligase Ubr2, a Recognition E3 Component of the N-End Rule Pathway, Stabilizes Tex19.1 during Spermatogenesis	PLOS ONE			English	Article							ROTHMUND-THOMSON; MICE LACKING; PROTEIN; MOUSE; DEGRADATION; EXPRESSION; MUTATIONS; APOPTOSIS; RECQL4; GENES	Ubiquitin E3 ligases target their substrates for ubiquitination, leading to proteasome-mediated degradation or altered biochemical properties. The ubiquitin ligase Ubr2, a recognition E3 component of the N-end rule proteolytic pathway, recognizes proteins with N-terminal destabilizing residues and plays an important role in spermatogenesis. Tex19.1 (also known as Tex19) has been previously identified as a germ cell-specific protein in mouse testis. Here we report that Tex19.1 forms a stable protein complex with Ubr2 in mouse testes. The binding of Tex19.1 to Ubr2 is independent of the second position cysteine of Tex19.1, a putative target for arginylation by the N-end rule pathway R-transferase. The Tex19.1-null mouse mutant phenocopies the Ubr2-deficient mutant in three aspects: heterogeneity of spermatogenic defects, meiotic chromosomal asynapsis, and embryonic lethality preferentially affecting females. In Ubr2-deficient germ cells, Tex19.1 is transcribed, but Tex19.1 protein is absent. Our results suggest that the binding of Ubr2 to Tex19.1 metabolically stabilizes Tex19.1 during spermatogenesis, revealing a new function for Ubr2 outside the conventional N-end rule pathway.	[Yang, Fang; Cheng, Yong; Leu, N. Adrian; Wang, Peijing Jeremy] Univ Penn, Sch Vet Med, Ctr Anim Transgenesis & Germ Cell Res, Dept Anim Biol, Philadelphia, PA 19104 USA; [An, Jee Young; Kwon, Yong Tae] Univ Pittsburgh, Ctr Pharmacogenet, Dept Pharmaceut Sci, Pittsburgh, PA USA; [Kwon, Yong Tae] Seoul Natl Univ, Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea; [Eckardt, Sigrid; McLaughlin, K. John] Nationwide Childrens Hosp, Res Inst, Columbus, OH USA	University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Seoul National University (SNU); University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital	Yang, F (corresponding author), Univ Penn, Sch Vet Med, Ctr Anim Transgenesis & Germ Cell Res, Dept Anim Biol, Philadelphia, PA 19104 USA.	pwang@vet.upenn.edu	McLaughlin, Kenneth/E-3648-2011		National Institutes of Health/National Institute of General Medical Sciences [GM089893, GM076327, GM074000, HL083365]; World Class University; NRF (National Research Foundation of Korea); MEST (Ministry of Education, Science and Technology) [R31-2008-000-10103-0]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD064628] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089893, R01GM074000, R01GM076327] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); World Class University; NRF (National Research Foundation of Korea)(National Research Foundation of Korea); MEST (Ministry of Education, Science and Technology)(Ministry of Education, Science & Technology (MEST), Republic of Korea); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health/National Institute of General Medical Sciences [Grant number GM089893 and GM076327 to P.J.W.; GM074000 and HL083365 to Y.T.K], and World Class University and World Class Institute programs of the NRF (National Research Foundation of Korea) and the MEST (Ministry of Education, Science and Technology) [grant number R31-2008-000-10103-0 to Y.T.K.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JY, 2010, P NATL ACAD SCI USA, V107, P1912, DOI 10.1073/pnas.0910267107; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Byrd C, 1998, EMBO J, V17, P269, DOI 10.1093/emboj/17.1.269; de Vries FAT, 2005, GENE DEV, V19, P1376, DOI 10.1101/gad.329705; Ditzel M, 2003, NAT CELL BIOL, V5, P467, DOI 10.1038/ncb984; HARLOW E, 1998, USING ANTIBODIES LAB; Hu RG, 2005, NATURE, V437, P981, DOI 10.1038/nature04027; Kitao S, 1999, NAT GENET, V22, P82, DOI 10.1038/8788; Kuntz S, 2008, STEM CELLS, V26, P734, DOI 10.1634/stemcells.2007-0772; Kwon YT, 2003, MOL CELL BIOL, V23, P8255, DOI 10.1128/MCB.23.22.8255-8271.2003; Kwon YT, 2002, SCIENCE, V297, P96, DOI 10.1126/science.1069531; Lee MJ, 2005, P NATL ACAD SCI USA, V102, P15030, DOI 10.1073/pnas.0507533102; Ollinger R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000199; Rao H, 2001, NATURE, V410, P955, DOI 10.1038/35073627; REDDI PP, 1995, BIOL REPROD, V53, P873, DOI 10.1095/biolreprod53.4.873; Sasaki T, 2006, MOL CELL, V24, P63, DOI 10.1016/j.molcel.2006.08.005; Schmekel K, 1996, EXP CELL RES, V226, P20, DOI 10.1006/excr.1996.0198; Siitonen HA, 2003, HUM MOL GENET, V12, P2837, DOI 10.1093/hmg/ddg306; Tasaki T, 2007, TRENDS BIOCHEM SCI, V32, P520, DOI 10.1016/j.tibs.2007.08.010; Tasaki T, 2009, J BIOL CHEM, V284, P1884, DOI 10.1074/jbc.M803641200; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Wang PJ, 2005, HUM MOL GENET, V14, P2911, DOI 10.1093/hmg/ddi322; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Yang F, 2008, GENE DEV, V22, P682, DOI 10.1101/gad.1613608; Yang F, 2006, J CELL BIOL, V173, P497, DOI 10.1083/jcb.200603063; Yin JH, 2004, HUM MOL GENET, V13, P2421, DOI 10.1093/hmg/ddh269; Zenker M, 2005, NAT GENET, V37, P1345, DOI 10.1038/ng1681	27	27	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e14017	10.1371/journal.pone.0014017	http://dx.doi.org/10.1371/journal.pone.0014017			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103378	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000284257400016
J	Stern, RF; Horak, A; Andrew, RL; Coffroth, MA; Andersen, RA; Kupper, FC; Jameson, I; Hoppenrath, M; Veron, B; Kasai, F; Brand, J; James, ER; Keeling, PJ				Stern, Rowena F.; Horak, Ales; Andrew, Rose L.; Coffroth, Mary-Alice; Andersen, Robert A.; Kuepper, Frithjof C.; Jameson, Ian; Hoppenrath, Mona; Veron, Benoit; Kasai, Fumai; Brand, Jerry; James, Erick R.; Keeling, Patrick J.			Environmental Barcoding Reveals Massive Dinoflagellate Diversity in Marine Environments	PLOS ONE			English	Article							SP-NOV DINOPHYCEAE; GENETIC DIVERSITY; FRESH-WATER; TOXIC DINOFLAGELLATE; MOLECULAR PHYLOGENY; NATURAL-ENVIRONMENT; COASTAL WATERS; GENUS; SYMBIODINIUM; MORPHOLOGY	Background: Dinoflagellates are an ecologically important group of protists with important functions as primary producers, coral symbionts and in toxic red tides. Although widely studied, the natural diversity of dinoflagellates is not well known. DNA barcoding has been utilized successfully for many protist groups. We used this approach to systematically sample known "species", as a reference to measure the natural diversity in three marine environments. Methodology/Principal Findings: In this study, we assembled a large cytochrome c oxidase 1 (COI) barcode database from 8 public algal culture collections plus 3 private collections worldwide resulting in 336 individual barcodes linked to specific cultures. We demonstrate that COI can identify to the species level in 15 dinoflagellate genera, generally in agreement with existing species names. Exceptions were found in species belonging to genera that were generally already known to be taxonomically challenging, such as Alexandrium or Symbiodinium. Using this barcode database as a baseline for cultured dinoflagellate diversity, we investigated the natural diversity in three diverse marine environments (Northeast Pacific, Northwest Atlantic, and Caribbean), including an evaluation of single-cell barcoding to identify uncultivated groups. From all three environments, the great majority of barcodes were not represented by any known cultured dinoflagellate, and we also observed an explosion in the diversity of genera that previously contained a modest number of known species, belonging to Kareniaceae. In total, 91.5% of non-identical environmental barcodes represent distinct species, but only 51 out of 603 unique environmental barcodes could be linked to cultured species using a conservative cut-off based on distances between cultured species. Conclusions/Significance: COI barcoding was successful in identifying species from 70% of cultured genera. When applied to environmental samples, it revealed a massive amount of natural diversity in dinoflagellates. This highlights the extent to which we underestimate microbial diversity in the environment.	[Stern, Rowena F.; Horak, Ales; Andrew, Rose L.; James, Erick R.; Keeling, Patrick J.] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Coffroth, Mary-Alice] SUNY Buffalo, Dept Geol, Buffalo, NY 14260 USA; [Andersen, Robert A.] Bigelow Lab Ocean Sci, Provasoli Guillard Natl Ctr Culture Marine Phytop, W Boothbay Harbor, ME USA; [Kuepper, Frithjof C.] Scottish Marine Inst, Scottish Assoc Marine Sci, Oban, Argyll, Scotland; [Jameson, Ian] CSIRO Marine & Atmospher Res, Australian Natl Algae Culture Collect, Hobart, Tas, Australia; [Hoppenrath, Mona] DZMB, Forschungsinst Senckenberg, Wilhelmshaven, Germany; [Veron, Benoit] Univ Caen Basse Normandie, Algobank Caen, Caen, France; [Veron, Benoit; Kasai, Fumai] Natl Inst Environm Studies, Tsukuba, Ibaraki, Japan; [Brand, Jerry] Univ Texas Austin, Sch Biol Sci, Austin, TX 78712 USA	University of British Columbia; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Bigelow Laboratory for Ocean Sciences; UHI Millennium Institute; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Senckenberg Gesellschaft fur Naturforschung (SGN); Universite de Caen Normandie; National Institute for Environmental Studies - Japan; University of Texas System; University of Texas Austin	Stern, RF (corresponding author), Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V5Z 1M9, Canada.	rstern71@yahoo.com	/AAY-2080-2020; James, Erick R/D-4725-2012; Perez, Pilar/B-4948-2010; Véron, Benoît/I-2942-2012; Brand, JJ/GQR-2139-2022; Horak, Ales/H-6723-2012; Andrew, Rose/B-5929-2008	/0000-0002-1365-9723; Perez, Pilar/0000-0003-3557-2247; Véron, Benoît/0000-0002-8434-8981; Horak, Ales/0000-0002-3364-7383; Andrew, Rose/0000-0003-0099-8336; Keeling, Patrick/0000-0002-7644-0745; Kuepper, Frithjof/0000-0003-1273-7109	Genome Canada; Canadian Barcode of Life Network; Natural Environment Research Council [dml010007, SAH01001] Funding Source: researchfish; NERC [dml010007, SAH01001] Funding Source: UKRI	Genome Canada(Genome Canada); Canadian Barcode of Life Network; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This project was funded by Genome Canada and the Canadian Barcode of Life Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato A, 2007, PROTIST, V158, P193, DOI 10.1016/j.protis.2006.10.001; ANDERSON DM, 1987, NATURE, V325, P616, DOI 10.1038/325616a0; Bergholtz T, 2006, J PHYCOL, V42, P170, DOI 10.1111/j.1529-8817.2006.00172.x; Biegala IC, 2003, APPL ENVIRON MICROB, V69, P5519, DOI 10.1128/AEM.69.9.5519-5529.2003; BRALEWSKA JM, 1995, MAR ECOL PROG SER, V117, P241, DOI 10.3354/meps117241; Carlos AA, 1999, J PHYCOL, V35, P1054, DOI 10.1046/j.1529-8817.1999.3551054.x; Cavalier-Smith T, 2008, PROTIST, V159, P591, DOI 10.1016/j.protis.2008.04.002; Chantangsi C, 2007, INT J SYST EVOL MICR, V57, P2412, DOI 10.1099/ijs.0.64865-0; Clarkston BE, 2010, BOTANY, V88, P119, DOI 10.1139/B09-101; Coffroth MA, 2005, PROTIST, V156, P19, DOI 10.1016/j.protis.2005.02.004; Daugbjerg N, 2000, PHYCOLOGIA, V39, P302, DOI 10.2216/i0031-8884-39-4-302.1; de Salas MF, 2008, J PHYCOL, V44, P241, DOI 10.1111/j.1529-8817.2007.00458.x; Delwiche Charles F., 2007, P191; Evans KM, 2007, PROTIST, V158, P349, DOI 10.1016/j.protis.2007.04.001; Fenchel T, 2005, AQUAT MICROB ECOL, V41, P49, DOI 10.3354/ame041049; Finlay BJ, 2004, PHILOS T R SOC B, V359, P599, DOI 10.1098/rstb.2003.1450; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Foissner W, 2008, BIODIVERS CONSERV, V17, P235, DOI 10.1007/s10531-007-9248-5; FULLER N, 2006, AQUAT MICROB ECOL, V43; Gast RJ, 2007, ENVIRON MICROBIOL, V9, P39, DOI 10.1111/j.1462-2920.2006.01109.x; Gast RJ, 2006, J PHYCOL, V42, P233, DOI 10.1111/j.1529-8817.2006.00183.x; Glasgow HB, 2001, PHYCOLOGIA, V40, P234, DOI 10.2216/i0031-8884-40-3-234.1; Gomez Fernando, 2005, Acta Botanica Croatica, V64, P129; Gottschling M, 2005, MOL PHYLOGENET EVOL, V36, P444, DOI 10.1016/j.ympev.2005.03.036; Guillou L, 2008, ENVIRON MICROBIOL, V10, P3349, DOI 10.1111/j.1462-2920.2008.01731.x; Guillou L, 2002, PROTIST, V153, P223, DOI 10.1078/1434-4610-00100; Gunderson JH, 2002, J EUKARYOT MICROBIOL, V49, P469, DOI 10.1111/j.1550-7408.2002.tb00230.x; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HALLEGRAEFF GM, 1993, PHYCOLOGIA, V32, P79, DOI 10.2216/i0031-8884-32-2-79.1; Harper JT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006577; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hoef-Emden K, 2002, J MOL EVOL, V55, P161, DOI 10.1007/s00239-002-2313-5; Hoef-Emden K, 2003, PROTIST, V154, P371, DOI 10.1078/143446103322454130; Hoef-Emden Kerstin, 2007, Protist, V158, P135, DOI 10.1016/j.protis.2007.02.001; Hoppenrath M, 2005, J PHYCOL, V41, P1284, DOI 10.1111/j.1529-8817.2005.00155.x; Hoppenrath M, 2004, J PHYCOL, V40, P946, DOI 10.1111/j.1529-8817.2004.03045.x; HOPPENRATH M, 2003, PHYCOL RES, V51, P61; Hoppenrath M, 2008, J PHYCOL, V44, P451, DOI 10.1111/j.1529-8817.2008.00483.x; Howe AT, 2009, PROTIST, V160, P159, DOI 10.1016/j.protis.2008.11.007; Jeong HJ, 2005, J EUKARYOT MICROBIOL, V52, P382, DOI 10.1111/j.1550-7408.2005.00051.x; Kooistra WHCF, 2008, PROTIST, V159, P177, DOI 10.1016/j.protis.2007.09.004; Kucera H, 2008, BOTANY, V86, P1065, DOI 10.1139/B08-056; LaJeunesse TC, 2005, J PHYCOL, V41, P880, DOI 10.1111/j.0022-3646.2005.04231.x; LaJeunesse TC, 2001, J PHYCOL, V37, P866, DOI 10.1046/j.1529-8817.2001.01031.x; LaJeunesse TC, 2000, BIOL BULL, V199, P126, DOI 10.2307/1542872; LaJeunesse TC, 2010, J BIOGEOGR, V37, P785, DOI 10.1111/j.1365-2699.2010.02273.x; Lane CE, 2007, MOL PHYLOGENET EVOL, V44, P634, DOI 10.1016/j.ympev.2007.03.016; Lefevre E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002324; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Lilly EL, 2007, J PHYCOL, V43, P1329, DOI 10.1111/j.1529-8817.2007.00420.x; Lin S, 2009, APPL ENVIRON MICROB, V75, P1279, DOI 10.1128/AEM.01578-08; Litaker RW, 2007, J PHYCOL, V43, P344, DOI 10.1111/j.1529-8817.2007.00320.x; LOGARES R, 2007, MICROBIAL EVOLUTION; Logares R, 2008, ENVIRON MICROBIOL, V10, P1231, DOI 10.1111/j.1462-2920.2007.01538.x; Lopez-Garcia P, 2001, NATURE, V409, P603, DOI 10.1038/35054537; Marshall HG, 2006, HARMFUL ALGAE, V5, P481, DOI 10.1016/j.hal.2006.05.001; Mason PL, 2007, J PHYCOL, V43, P799, DOI 10.1111/j.1529-8817.2007.00370.x; Masseret E, 2009, APPL ENVIRON MICROB, V75, P2037, DOI 10.1128/AEM.01686-08; MCGLONE ML, 2008, MAR POLLUT B, V57, P295; McLachlin J, 1997, PHYCOLOGIA, V36, P48; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Montresor M, 2003, PHYCOLOGIA, V42, P56, DOI 10.2216/i0031-8884-42-1-56.1; Moon-van der Staay SY, 2001, NATURE, V409, P607, DOI 10.1038/35054541; MOORE RB, 2006, MOL ECOLOGY PHYLOGEN; Murray S, 2005, PROTIST, V156, P269, DOI 10.1016/j.protis.2005.05.003; Murray S, 2007, PHYCOL RES, V55, P176, DOI 10.1111/j.1440-1835.2007.00460.x; Murray S, 2009, PROTIST, V160, P245, DOI 10.1016/j.protis.2008.12.004; Nash EA, 2007, MOL BIOL EVOL, V24, P1528, DOI 10.1093/molbev/msm074; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pochon X, 2006, MOL PHYLOGENET EVOL, V38, P20, DOI 10.1016/j.ympev.2005.04.028; Potter D, 1997, BIODIVERS CONSERV, V6, P99, DOI 10.1023/A:1018379716868; Richards TA, 2005, ENVIRON MICROBIOL, V7, P1413, DOI 10.1111/j.1462-2920.2005.00828.x; ROWAN R, 1992, P NATL ACAD SCI USA, V89, P3639, DOI 10.1073/pnas.89.8.3639; Saldarriaga JF, 2004, EUR J PROTISTOL, V40, P85, DOI 10.1016/j.ejop.2003.11.003; Sampayo EM, 2009, MOL ECOL, V18, P500, DOI 10.1111/j.1365-294X.2008.04037.x; SANTOS S, 2002, MOL PHYLOGENET EVOL, V23; Santos SR, 2004, J PHYCOL, V40, P395, DOI 10.1111/j.1529-8817.2004.03186.x; Santos SR, 2003, MAR BIOTECHNOL, V5, P130, DOI 10.1007/s10126-002-0076-9; Santos SR, 2001, J PHYCOL, V37, P900, DOI 10.1046/j.1529-8817.2001.00194.x; Saunders GW, 2005, PHILOS T R SOC B, V360, P1879, DOI 10.1098/rstb.2005.1719; Scheckenbach F, 2006, APPL ENVIRON MICROB, V72, P6638, DOI 10.1128/AEM.02547-05; SCHOLIN CA, 1994, J PHYCOL, V30, P999, DOI 10.1111/j.0022-3646.1994.00999.x; Sims PA, 2006, PHYCOLOGIA, V45, P361, DOI 10.2216/05-22.1; Smirnov AV, 2008, EUR J PROTISTOL, V44, P35, DOI 10.1016/j.ejop.2007.08.001; Smith VS, 2005, SYST BIOL, V54, P841, DOI 10.1080/10635150500354894; Steidinger KA, 1996, J PHYCOL, V32, P157, DOI 10.1111/j.0022-3646.1996.00157.x; Steidinger KA, 2006, J PHYCOL, V42, P951, DOI 10.1111/j.1529-8817.2006.00248.x; Sunamura M, 2004, APPL ENVIRON MICROB, V70, P1190, DOI 10.1128/AEM.70.2.1190-1198.2004; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Takabayashi M, 2004, J PHYCOL, V40, P160, DOI 10.1111/j.0022-3646.2003.03-097.x; TAKAHASHI M, 1978, J EXP MAR BIOL ECOL, V31, P283, DOI 10.1016/0022-0981(78)90064-3; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor FJR, 2008, BIODIVERS CONSERV, V17, P407, DOI 10.1007/s10531-007-9258-3; TAYLOR FJR, 1987, BIOL DINOFLAGELLATES, P1; Tengs T, 2000, MOL BIOL EVOL, V17, P718, DOI 10.1093/oxfordjournals.molbev.a026350; Thornhill DJ, 2007, MOL ECOL, V16, P5326, DOI 10.1111/j.1365-294X.2007.03576.x; Touzet N, 2007, APPL ENVIRON MICROB, V73, P3333, DOI 10.1128/AEM.02161-06; Vaulot D, 2008, FEMS MICROBIOL REV, V32, P795, DOI 10.1111/j.1574-6976.2008.00121.x; von der Heyden S, 2005, INT J SYST EVOL MICR, V55, P2605, DOI 10.1099/ijs.0.63606-0; Von der Heyden S, 2004, EUR J PHYCOL, V39, P343, DOI 10.1080/09670260400005567; Wilcox TP, 1998, MOL PHYLOGENET EVOL, V10, P436, DOI 10.1006/mpev.1998.0546; Zaikova E, 2010, ENVIRON MICROBIOL, V12, P172, DOI 10.1111/j.1462-2920.2009.02058.x; ZARDOYA R, 1995, J MOL EVOL, V41, P637; Zhang H, 2008, APPL ENVIRON MICROB, V74, P1546, DOI 10.1128/AEM.02103-07; Zhang H, 2007, J MOL EVOL, V65, P463, DOI 10.1007/s00239-007-9038-4; Zhang ZD, 2002, MOL BIOL EVOL, V19, P489, DOI 10.1093/oxfordjournals.molbev.a004104	107	93	99	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e13991	10.1371/journal.pone.0013991	http://dx.doi.org/10.1371/journal.pone.0013991			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085582	gold, Green Published, Green Submitted			2022-12-25	WOS:000284231800021
J	Wang, YH; Li, JN; Tang, LH; Wang, Y; Charnigo, R; de Villiers, W; Eckhardt, E				Wang, Yuehui; Li, Jianing; Tang, Lihua; Wang, Yu; Charnigo, Richard; de Villiers, Willem; Eckhardt, Erik			T-Lymphocyte Responses to Intestinally Absorbed Antigens Can Contribute to Adipose Tissue Inflammation and Glucose Intolerance during High Fat Feeding	PLOS ONE			English	Article							DIET-INDUCED OBESITY; INSULIN-RESISTANCE; METABOLIC SYNDROME; MICE; DISEASE; HUMANS; CELLS; ENDOTOXEMIA; ADIPOCYTES; MECHANISMS	Background: Obesity is associated with inflammation of visceral adipose tissues, which increases the risk for insulin resistance. Animal models suggest that T-lymphocyte infiltration is an important early step, although it is unclear why these cells are attracted. We have recently demonstrated that dietary triglycerides, major components of high fat diets, promote intestinal absorption of a protein antigen (ovalbumin, "OVA''). The antigen was partly transported on chylomicrons, which are prominently cleared in adipose tissues. We hypothesized that intestinally absorbed gut antigens may cause T-lymphocyte associated inflammation in adipose tissue. Methodology/Principal Findings: Triglyceride absorption promoted intestinal absorption of OVA into adipose tissue, in a chylomicron-dependent manner. Absorption tended to be higher in mesenteric than subcutaneous adipose tissue, and was lowest in gonadal tissue. OVA immunoreactivity was detected in stromal vascular cells, including endothelial cells. In OVA-sensitized mice, OVA feeding caused marked accumulation of CD3+ and osteopontin+ cells in mesenteric adipose tissue. The accumulating T-lymphocytes were mainly CD4+. As expected, high-fat (60% kCal) diets promoted mesenteric adipose tissue inflammation compared to low-fat diets (10% Kcal), as reflected by increased expression of osteopontin and interferon-gamma. Immune responses to dietary OVA further increased diet-induced osteopontin and interferon-gamma expression in mesenteric adipose. Inflammatory gene expression in subcutaneous tissue did not respond significantly to OVA or dietary fat content. Lastly, whereas OVA responses did not significantly affect bodyweight or adiposity, they significantly impaired glucose tolerance. Conclusions/Significance: Our results suggest that loss or lack of immunological tolerance to intestinally absorbed T-lymphocyte antigens can contribute to mesenteric adipose tissue inflammation and defective glucose metabolism during high-fat dieting.	[Wang, Yuehui; Li, Jianing; Tang, Lihua; Wang, Yu; de Villiers, Willem; Eckhardt, Erik] Univ Kentucky, Grad Ctr Nutrit Sci, Lexington, KY 40506 USA; [Wang, Yuehui; Li, Jianing; Tang, Lihua; Wang, Yu; de Villiers, Willem; Eckhardt, Erik] Univ Kentucky, Dept Internal Med, Lexington, KY USA; [Charnigo, Richard] Univ Kentucky, Dept Biostat, Lexington, KY USA	University of Kentucky; University of Kentucky; University of Kentucky	Wang, YH (corresponding author), Univ Kentucky, Grad Ctr Nutrit Sci, Lexington, KY 40506 USA.	erik.eckhardt@uky.edu	WANG, YUE/GWQ-9256-2022; Eckhardt, Erik/G-1567-2010; Gorvel, Jean-Pierre/O-1332-2018	Eckhardt, Erik/0000-0002-3015-5180; Gorvel, Jean-Pierre/0000-0002-2829-9804	NIH [1P20RR021954-01A2, 1R21AI088605-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088605] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by NIH grants 1P20RR021954-01A2 and 1R21AI088605-01. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Bickerton AST, 2007, DIABETES, V56, P168, DOI 10.2337/db06-0822; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Chehade M, 2005, J ALLERGY CLIN IMMUN, V115, P3, DOI 10.1016/j.jaci.2004.11.008; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Ding SZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009875; Erridge C, 2007, AM J CLIN NUTR, V86, P1286, DOI 10.1093/ajcn/86.5.1286; Fain JN, 2004, ENDOCRINOLOGY, V145, P2273, DOI 10.1210/en.2003-1336; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Fontana L, 2007, DIABETES, V56, P1010, DOI 10.2337/db06-1656; Ghoshal S, 2009, J LIPID RES, V50, P90, DOI 10.1194/jlr.M800156-JLR200; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Karpe F, 1997, J LIPID RES, V38, P2335; KINTSCHER U, 2008, ARTERIOSCLEROSI 0419; KVIETYS PR, 1991, AM J PHYSIOL, V261, pG384, DOI 10.1152/ajpgi.1991.261.3.G384; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Nomiyama T, 2007, J CLIN INVEST, V117, P2877, DOI 10.1172/JCI31986; Rabot S, 2010, FASEB J; Rocha VZ, 2008, CIRC RES, V103, P467, DOI 10.1161/CIRCRESAHA.108.177105; Schaffler A, 2005, NAT CLIN PRACT GASTR, V2, P103, DOI 10.1038/ncpgasthep0090; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; TSO P, 1981, AM J PHYSIOL, V241, pG487, DOI 10.1152/ajpgi.1981.241.6.G487; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004899; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yamamoto K, 2005, GUT, V54, P789, DOI 10.1136/gut.2004.046516	33	80	82	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e13951	10.1371/journal.pone.0013951	http://dx.doi.org/10.1371/journal.pone.0013951			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21085605	Green Published, Green Submitted, gold			2022-12-25	WOS:000284087800016
J	Loguercio, S; Overall, RW; Michaelson, JJ; Wiltshire, T; Pletcher, MT; Miller, BH; Walker, JR; Kempermann, G; Su, AI; Beyer, A				Loguercio, Salvatore; Overall, Rupert W.; Michaelson, Jacob J.; Wiltshire, Tim; Pletcher, Mathew T.; Miller, Brooke H.; Walker, John R.; Kempermann, Gerd; Su, Andrew I.; Beyer, Andreas			Integrative Analysis of Low- and High-Resolution eQTL	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; GENE-EXPRESSION; BIOINFORMATICS TOOLBOX; MICE; DISCOVERY; NETWORKS; STRAINS; LINKAGE; LISTS; BXD	The study of expression quantitative trait loci (eQTL) is a powerful way of detecting transcriptional regulators at a genomic scale and for elucidating how natural genetic variation impacts gene expression. Power and genetic resolution are heavily affected by the study population: whereas recombinant inbred (RI) strains yield greater statistical power with low genetic resolution, using diverse inbred or outbred strains improves genetic resolution at the cost of lower power. In order to overcome the limitations of both individual approaches, we combine data from RI strains with genetically more diverse strains and analyze hippocampus eQTL data obtained from mouse RI strains (BXD) and from a panel of diverse inbred strains (Mouse Diversity Panel, MDP). We perform a systematic analysis of the consistency of eQTL independently obtained from these two populations and demonstrate that a significant fraction of eQTL can be replicated. Based on existing knowledge from pathway databases we assess different approaches for using the high-resolution MDP data for fine mapping BXD eQTL. Finally, we apply this framework to an eQTL hotspot on chromosome 1 (Qrr1), which has been implicated in a range of neurological traits. Here we present the first systematic examination of the consistency between eQTL obtained independently from the BXD and MDP populations. Our analysis of fine-mapping approaches is based on 'real life' data as opposed to simulated data and it allows us to propose a strategy for using MDP data to fine map BXD eQTL. Application of this framework to Qrr1 reveals that this eQTL hotspot is not caused by just one (or few) 'master regulators', but actually by a set of polymorphic genes specific to the central nervous system.	[Loguercio, Salvatore; Michaelson, Jacob J.; Beyer, Andreas] Tech Univ Dresden, Ctr Biotechnol, Dresden, Germany; [Overall, Rupert W.; Kempermann, Gerd; Beyer, Andreas] Tech Univ Dresden, CRTD, Dresden, Germany; [Wiltshire, Tim] Univ N Carolina, Sch Pharm, Div Pharmacotherapy & Expt Therapeut, Chapel Hill, NC USA; [Pletcher, Mathew T.] Pfizer Global Res & Dev, Compound Safety Predict, Groton, CT USA; [Miller, Brooke H.] Scripps Florida, Scripps Res Inst, Dept Neurosci, Jupiter, FL USA; [Walker, John R.; Su, Andrew I.] Novartis Res Fdn, Genom Inst, San Diego, CA USA	Technische Universitat Dresden; Technische Universitat Dresden; University of North Carolina; University of North Carolina Chapel Hill; Pfizer; Scripps Research Institute; State University System of Florida; University of Florida; Novartis	Loguercio, S (corresponding author), Tech Univ Dresden, Ctr Biotechnol, Dresden, Germany.	andreas.beyer@biotec.tu-dresden.de	Overall, Rupert W/P-3102-2016; Beyer, Andreas/A-3352-2009; Kempermann, Gerd/F-5416-2010; Beyer, Andreas/AAQ-5519-2020	Overall, Rupert W/0000-0002-3882-6073; Beyer, Andreas/0000-0002-3891-2123; Kempermann, Gerd/0000-0002-5304-4061; Beyer, Andreas/0000-0002-3891-2123; Su, Andrew I./0000-0002-9859-4104; Michaelson, Jacob/0000-0001-9713-0992	Klaus Tschira Foundation; Helmholtz Alliance for Systems Biology; European Community [FP7-223539]	Klaus Tschira Foundation; Helmholtz Alliance for Systems Biology; European Community(European Commission)	This work was funded by the Klaus Tschira Foundation http://www.klaus-tschira-stiftung.de/english/index.html, the Helmholtz Alliance for Systems Biology http://www.helmholtz.de/en/joint_initiative_for_innovation_and_research/initiating_and_networking/helmholtz_alliances/systems_biology/helmholtz_alliance_on_systems_biology/ and the European Community's Seventh Framework Programme (grant no. FP7-223539) http://www.phenoxigen.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000622; Belmont PJ, 2008, J BIOL CHEM, V283, P14012, DOI 10.1074/jbc.M709776200; Bennett BJ, 2010, GENOME RES, V20, P281, DOI 10.1101/gr.099234.109; BOEHNKE M, 1994, AM J HUM GENET, V55, P379; Breitling R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000232; Brem RB, 2005, NATURE, V436, P701, DOI 10.1038/nature03865; Buck K, 1999, MAMM GENOME, V10, P431, DOI 10.1007/s003359901018; Burgess-Herbert SL, 2008, GENETICS, V180, P2227, DOI 10.1534/genetics.108.090175; Caldarone B, 1997, NAT GENET, V17, P335, DOI 10.1038/ng1197-335; Casley WL, 1999, DRUG METAB DISPOS, V27, P1375; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Crabbe JC, 1996, ADDICT BIOL, V1, P229, DOI 10.1080/1355621961000124846; DEFRIES JC, 1978, BEHAV GENET, V8, P3, DOI 10.1007/BF01067700; DiPetrillo K, 2005, TRENDS GENET, V21, P683, DOI 10.1016/j.tig.2005.09.008; Doss S, 2005, GENOME RES, V15, P681, DOI 10.1101/gr.3216905; Drenan RM, 2005, J CELL BIOL, V169, P623, DOI 10.1083/jcb.200502007; Ferraro TN, 2007, EPILEPSIA, V48, P1667, DOI 10.1111/j.1528-1167.2007.01126.x; FLINT J, 1995, SCIENCE, V269, P1432, DOI 10.1126/science.7660127; Gatti DM, 2009, MAMM GENOME, V20, P437, DOI 10.1007/s00335-009-9199-0; Gershenfeld HK, 1997, BEHAV GENET, V27, P201, DOI 10.1023/A:1025653812535; Ghazalpour A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000149; Gilad Y, 2008, TRENDS GENET, V24, P408, DOI 10.1016/j.tig.2008.06.001; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kang HM, 2008, GENETICS, V180, P1909, DOI 10.1534/genetics.108.094201; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Lee SI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000358; Malmanger B, 2006, MAMM GENOME, V17, P1193, DOI 10.1007/s00335-006-0070-2; Matthews DB, 2005, ALCOHOL CLIN EXP RES, V29, p195A; McClurg P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-61; McClurg P, 2007, GENETICS, V176, P675, DOI 10.1534/genetics.106.066241; Michaelson JJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-502; Michaelson JJ, 2009, METHODS, V48, P265, DOI 10.1016/j.ymeth.2009.03.004; Mozhui K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000260; Odom DT, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100059; OVERALL R, 2009, FRONTIERS NEUROGENOM, V1, P1; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Patel NV, 1999, BEHAV GENET, V29, P303, DOI 10.1023/A:1021653732147; Peirce JL, 2006, MAMM GENOME, V17, P643, DOI 10.1007/s00335-005-0187-8; Peirce JL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001036; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7; Plaisier CL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000642; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Suthram S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.4; Taylor BA, 1999, MAMM GENOME, V10, P335, DOI 10.1007/s003359900998; Turri MG, 1999, MAMM GENOME, V10, P1098, DOI 10.1007/s003359901169; Wu CL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000070; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222; Zhu J, 2008, NAT GENET, V40, P854, DOI 10.1038/ng.167	59	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e13920	10.1371/journal.pone.0013920	http://dx.doi.org/10.1371/journal.pone.0013920			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085707	Green Published, Green Submitted, gold			2022-12-25	WOS:000284036800013
J	Nguyen, LT; Yen, PH; Nie, J; Liadis, N; Ghazarian, D; Al-Habeeb, A; Easson, A; Leong, W; Lipa, J; McCready, D; Reedijk, M; Hogg, D; Joshua, AM; Quirt, I; Messner, H; Shaw, P; Crump, M; Sharon, E; Ohashi, PS				Nguyen, Linh T.; Yen, Pei Hua; Nie, Jessica; Liadis, Nicole; Ghazarian, Danny; Al-Habeeb, Ayman; Easson, Alexandra; Leong, Wey; Lipa, Joan; McCready, David; Reedijk, Michael; Hogg, David; Joshua, Anthony M.; Quirt, Ian; Messner, Hans; Shaw, Patricia; Crump, Michael; Sharon, Eran; Ohashi, Pamela S.			Expansion and Characterization of Human Melanoma Tumor-Infiltrating Lymphocytes (TILs)	PLOS ONE			English	Article							T-CELL RESPONSES; OVERCOMING IMMUNOLOGICAL-TOLERANCE; METASTATIC MELANOMA; ADOPTIVE TRANSFER; PHASE-I; RECOMBINANT INTERLEUKIN-2; MALIGNANT-MELANOMA; TARGETING CTLA-4; TRANSFER THERAPY; HLA-A	Background: Various immunotherapeutic strategies for cancer are aimed at augmenting the T cell response against tumor cells. Adoptive cell therapy (ACT), where T cells are manipulated ex vivo and subsequently re-infused in an autologous manner, has been performed using T cells from various sources. Some of the highest clinical response rates for metastatic melanoma have been reported in trials using tumor-infiltrating lymphocytes (TILs). These protocols still have room for improvement and furthermore are currently only performed at a limited number of institutions. The goal of this work was to develop TILs as a therapeutic product at our institution. Principal Findings: TILs from 40 melanoma tissue specimens were expanded and characterized. Under optimized culture conditions, 72% of specimens yielded rapidly proliferating TILs as defined as at least one culture reaching >= 3x10(7) TILs within 4 weeks. Flow cytometric analyses showed that cultures were predominantly CD3+ T cells, with highly variable CD4+:CD8+ T cell ratios. In total, 148 independent bulk TIL cultures were assayed for tumor reactivity. Thirty-four percent (50/148) exhibited tumor reactivity based on IFN-gamma production and/or cytotoxic activity. Thirteen percent (19/148) showed specific cytotoxic activity but not IFN-gamma production and only 1% (2/148) showed specific IFN-gamma production but not cytotoxic activity. Further expansion of TILs using a 14-day "rapid expansion protocol'' (REP) is required to induce a 500-to 2000-fold expansion of TILs in order to generate sufficient numbers of cells for current ACT protocols. Thirty-eight consecutive test REPs were performed with an average 1865-fold expansion (+/- 1034-fold) after 14 days. Conclusions: TILs generally expanded efficiently and tumor reactivity could be detected in vitro. These preclinical data from melanoma TILs lay the groundwork for clinical trials of ACT.	[Nguyen, Linh T.; Yen, Pei Hua; Nie, Jessica; Liadis, Nicole; Ohashi, Pamela S.] Univ Hlth Network, Ontario Canc Inst, Campbell Family Inst Breast Canc Res, Toronto, ON, Canada; [Ghazarian, Danny; Al-Habeeb, Ayman; Shaw, Patricia] Univ Hlth Network, Princess Margaret Hosp, Dept Pathol, Toronto, ON, Canada; [Easson, Alexandra; Leong, Wey; Lipa, Joan; McCready, David; Reedijk, Michael; Sharon, Eran] Univ Hlth Network, Princess Margaret Hosp, Dept Surg Oncol, Toronto, ON, Canada; [Hogg, David; Joshua, Anthony M.; Quirt, Ian; Messner, Hans; Crump, Michael] Univ Hlth Network, Princess Margaret Hosp, Dept Med Oncol Hematol, Toronto, ON, Canada; [Ohashi, Pamela S.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Ohashi, Pamela S.] Univ Toronto, Dept Immunol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto	Nguyen, LT (corresponding author), Univ Hlth Network, Ontario Canc Inst, Campbell Family Inst Breast Canc Res, Toronto, ON, Canada.	pohashi@uhnres.utoronto.ca	; Easson, Alexandra/U-9850-2017	Ghazarian, Danny/0000-0002-3531-1074; Easson, Alexandra/0000-0003-0998-3659; Ohashi, Pamela S./0000-0003-2915-9317; Joshua, Anthony/0000-0001-5159-4580	Campbell Institute for Breast Cancer Research; Canadian Breast Cancer Research Alliance [019361]; Government of Ontario	Campbell Institute for Breast Cancer Research; Canadian Breast Cancer Research Alliance; Government of Ontario	This work was supported by the Campbell Institute for Breast Cancer Research and the Canadian Breast Cancer Research Alliance (grant number 019361; http://www.breast.cancer.ca/). This study was also conducted with the support of the Ontario Institute for Cancer Research through funding provided by the Government of Ontario (ORBiT grant; http://www.oicr.on.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOKI Y, 1991, CANCER RES, V51, P1934; Atkins MB, 2000, CANCER J SCI AM, V6, pS8; BAARS JW, 1992, BIOTHERAPY, V4, P289, DOI 10.1007/BF02172659; Bachmann MF, 1996, EUR J IMMUNOL, V26, P2017, DOI 10.1002/eji.1830260908; Barrow C, 2006, CLIN CANCER RES, V12, P764, DOI 10.1158/1078-0432.CCR-05-1544; Bedikian AY, 2006, J CLIN ONCOL, V24, P4738, DOI 10.1200/JCO.2006.06.0483; BELLDEGRUN A, 1993, J UROLOGY, V150, P1384, DOI 10.1016/S0022-5347(17)35785-3; Berger R, 2008, CLIN CANCER RES, V14, P3044, DOI 10.1158/1078-0432.CCR-07-4079; Besser MJ, 2010, CLIN CANCER RES, V16, P2646, DOI 10.1158/1078-0432.CCR-10-0041; Besser MJ, 2009, J IMMUNOTHER, V32, P415, DOI 10.1097/CJI.0b013e31819c8bda; Blank C, 2005, CANCER IMMUNOL IMMUN, V54, P307, DOI 10.1007/s00262-004-0593-x; Boon T, 2006, ANNU REV IMMUNOL, V24, P175, DOI 10.1146/annurev.immunol.24.021605.090733; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Cao K, 2001, HUM IMMUNOL, V62, P1009, DOI 10.1016/S0198-8859(01)00298-1; CLARK WH, 1986, HUM PATHOL, V17, P443, DOI 10.1016/S0046-8177(86)80032-6; DILLMAN RO, 1993, CANCER, V71, P2358, DOI 10.1002/1097-0142(19930401)71:7<2358::AID-CNCR2820710730>3.0.CO;2-M; Dreno B, 2002, CANCER IMMUNOL IMMUN, V51, P539, DOI 10.1007/s00262-002-0315-1; Dudley ME, 2008, J CLIN ONCOL, V26, P5233, DOI 10.1200/JCO.2008.16.5449; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Dudley ME, 2003, J IMMUNOTHER, V26, P332, DOI 10.1097/00002371-200307000-00005; Dudley ME, 2001, J IMMUNOTHER, V24, P363, DOI 10.1097/00002371-200107000-00012; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Gardini A, 2004, J SURG ONCOL, V87, P46, DOI 10.1002/jso.20066; GOEDEGEBUURE PS, 1995, J CLIN ONCOL, V13, P1939, DOI 10.1200/JCO.1995.13.8.1939; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; Kawakami Y, 2000, J IMMUNOTHER, V23, P17, DOI 10.1097/00002371-200001000-00004; KRADIN RL, 1989, LANCET, V1, P577; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Ohlen C, 2002, J EXP MED, V195, P1407, DOI 10.1084/jem.20011063; Pittet MJ, 2000, J IMMUNOL, V164, P1148, DOI 10.4049/jimmunol.164.3.1148; Pittet MJ, 1999, J EXP MED, V190, P705, DOI 10.1084/jem.190.5.705; Queirolo P, 1999, ANN SURG ONCOL, V6, P272, DOI 10.1007/s10434-999-0272-4; RATTO GB, 1995, J THORAC CARDIOV SUR, V109, P1212, DOI 10.1016/S0022-5223(95)70205-9; RAVAUD A, 1995, BRIT J CANCER, V71, P331, DOI 10.1038/bjc.1995.66; Reali UM, 1998, MELANOMA RES, V8, P77; Ribas A, 2008, ONCOLOGIST, V13, P10, DOI 10.1634/theoncologist.13-S4-10; Romero P, 1998, J EXP MED, V188, P1641, DOI 10.1084/jem.188.9.1641; ROSENBERG SA, 1994, J NATL CANCER I, V86, P1159, DOI 10.1093/jnci/86.15.1159; ROSENBERG SA, 1988, NEW ENGL J MED, V319, P1676, DOI 10.1056/NEJM198812223192527; Schwartzentruber DJ, 2009, J CLIN ONCOL, V27, p18s; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Speiser DE, 2005, J CLIN INVEST, V115, P739, DOI 10.1172/JCI200523373; Tran KQ, 2008, J IMMUNOTHER, V31, P742, DOI 10.1097/CJI.0b013e31818403d5; Vignard V, 2005, J IMMUNOL, V175, P4797, DOI 10.4049/jimmunol.175.7.4797; Wallen H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004749; Weber J, 2008, ONCOLOGIST, V13, P16, DOI 10.1634/theoncologist.13-S4-16; Yee C, 2002, P NATL ACAD SCI USA, V99, P16168, DOI 10.1073/pnas.242600099	49	32	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e13940	10.1371/journal.pone.0013940	http://dx.doi.org/10.1371/journal.pone.0013940			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085676	gold, Green Submitted, Green Published			2022-12-25	WOS:000284036800025
J	Chiu, YW; Lo, MT; Tsai, MR; Chang, YC; Hsu, RB; Yu, HY; Sun, CK; Ho, YL				Chiu, Yu-Wei; Lo, Men Tzung; Tsai, Ming-Rung; Chang, Yi-Chung; Hsu, Rong-Bin; Yu, Hsu-Yu; Sun, Chi-Kuang; Ho, Yi-Lwun			Applying Harmonic Optical Microscopy for Spatial Alignment of Atrial Collagen Fibers	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; 2ND-HARMONIC GENERATION; FIBRILLATION; EXPRESSION; FIBROSIS; MECHANISMS; TISSUE	Background: Atrial fibrosis creates a vulnerable tissue for atrial fibrillation (AF), but the spatial disarray of collagen fibers underlying atrial fibrosis is not fully elucidated. Objective: This study hypothesizes that harmonics optical microscopy can illuminate the spatial mal-alignment of collagen fibers in AF via a layer-by-layer approach. Patients and Methods: Atrial tissues taken from patients who underwent open-heart surgery were examined by harmonics optical microscopy. Using the two-dimensional Fourier transformation method, a spectral-energy description of image texture was constituted and its entropy was used to quantify the mal-alignment of collagen fibers. The amount of collagen fiber was derived from its area ratio to total atrial tissue in each image. Serum C-terminal pro-collagen pro-peptide (CICP), pro-matrix metalloproteinase-1 (pro-MMP-1), and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) were also evaluated. Results: 46 patients were evaluated, including 20 with normal sinus rhythm and 26 with AF. The entropy of spectral-energy distribution of collagen alignment was significantly higher in AF than that in sinus rhythm (3.97 +/- 0.33 vs. 2.80 +/- 0.18, p<0.005). This difference was more significant in the permanent AF group. The amount of collagen was also significantly higher in AF patients (0.39 +/- 0.13 vs. 0.18 +/- 0.06, p<0.005) but serum markers of cardiac fibrosis were not significantly different between the two groups. Conclusions: Harmonics optical microscopy can quantify the spatial mal-alignment of collagen fibers in AF. The entropy of spectral-energy distribution of collagen alignment is a potential tool for research in atrial remodeling.	[Chiu, Yu-Wei] Far Eastern Mem Hosp, Div Cardiol, Dept Internal Med, Taipei, Taiwan; [Lo, Men Tzung] Natl Cent Univ, Res Ctr Adapt Data Anal, Tao Yuan, Taiwan; [Tsai, Ming-Rung; Sun, Chi-Kuang] Natl Taiwan Univ, Dept Elect Engn, Grad Inst Photon & Optoelect, Taipei 10764, Taiwan; [Chang, Yi-Chung] Natl Taiwan Univ, Grad Inst Commun Engn, Taipei 10764, Taiwan; [Hsu, Rong-Bin; Yu, Hsu-Yu] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Hsu, Rong-Bin; Yu, Hsu-Yu; Ho, Yi-Lwun] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Ho, Yi-Lwun] Natl Taiwan Univ Hosp, Grad Inst Clin Med, Taipei 100, Taiwan; [Ho, Yi-Lwun] Natl Taiwan Univ Hosp, Dept Internal Med, Div Cardiol, Taipei 100, Taiwan	Far Eastern Memorial Hospital; National Central University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Chiu, YW (corresponding author), Far Eastern Mem Hosp, Div Cardiol, Dept Internal Med, Taipei, Taiwan.	ylho@ntu.edu.tw	huang, yuting/T-4341-2019; Wang, Pa-Chun/AAD-4094-2019	HO, YI-LWUN/0000-0002-8936-9570; Sun, Chi-Kuang/0000-0002-4467-2509	National Science Council, Taipei, Taiwan [NSC 97-2314-B-002-139]; Department of Health, Executive Yuan, Taipei, Taiwan [DOH99-TD-B-111-001]; Far-Eastern Memorial Hospital, Taipei, Taiwan [FEMH-96-C-019]; NSC (Taiwan, ROC) [99-2627-B-008-003-]; foundation of CGH [99CGH-NCU-A4]; foundation of NCU [99CGH-NCU-A4]	National Science Council, Taipei, Taiwan(Ministry of Science and Technology, Taiwan); Department of Health, Executive Yuan, Taipei, Taiwan; Far-Eastern Memorial Hospital, Taipei, Taiwan; NSC (Taiwan, ROC)(Ministry of Science and Technology, Taiwan); foundation of CGH; foundation of NCU	This study was supported in part by the National Science Council, Taipei, Taiwan (grant NSC 97-2314-B-002-139), in part by the Department of Health, Executive Yuan, Taipei, Taiwan (grant DOH99-TD-B-111-001) and by Far-Eastern Memorial Hospital, Taipei, Taiwan (grant FEMH-96-C-019). M-T Lo was supported by NSC (Taiwan, ROC), Grant No 99-2627-B-008-003-, and joint foundation of CGH and NCU, 99CGH-NCU-A4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allessie M, 2002, CARDIOVASC RES, V54, P230, DOI 10.1016/S0008-6363(02)00258-4; Anne W, 2005, CARDIOVASC RES, V67, P655, DOI 10.1016/j.cardiores.2005.04.016; Ausma J, 1997, CIRCULATION, V96, P3157, DOI 10.1161/01.CIR.96.9.3157; Bayan C, 2009, J APPL PHYS, V105, DOI 10.1063/1.3116626; Boldt A, 2004, HEART, V90, P400, DOI 10.1136/hrt.2003.015347; BOYDEN PA, 1984, CIRCULATION, V69, P1036, DOI 10.1161/01.CIR.69.5.1036; BOYDEN PA, 1982, AM J CARDIOL, V49, P1896, DOI 10.1016/0002-9149(82)90208-9; Burstein B, 2008, J AM COLL CARDIOL, V51, P802, DOI 10.1016/j.jacc.2007.09.064; Campagnola PJ, 2003, NAT BIOTECHNOL, V21, P1356, DOI 10.1038/nbt894; CHAUDHURI S, 1987, IEEE T BIO-MED ENG, V34, P509, DOI 10.1109/TBME.1987.325980; Chiu YT, 2005, J CARDIOVASC ELECTR, V16, P753, DOI 10.1046/j.1540-8167.2005.40794.x; CHU SW, 2007, J MED BIOL ENG, V27, P177; Duffy HS, 2007, HEART RHYTHM, V4, P950, DOI 10.1016/j.hrthm.2007.03.039; Gonzalez R C, 1992, DIGITAL IMAGE PROCES; Gramley F, 2007, J CARDIOVASC ELECTR, V18, P1076, DOI 10.1111/j.1540-8167.2007.00906.x; Ho YL, 2009, CLIN BIOCHEM, V42, P1407, DOI 10.1016/j.clinbiochem.2009.06.013; Kallergis EM, 2008, J AM COLL CARDIOL, V52, P211, DOI 10.1016/j.jacc.2008.03.045; Lin CS, 2007, HEART RHYTHM, V4, P938, DOI 10.1016/j.hrthm.2007.03.034; Lo Li-Wei, 2007, J Chin Med Assoc, V70, P303, DOI 10.1016/S1726-4901(08)70010-8; Marquez JP, 2006, INT J SOLIDS STRUCT, V43, P6413, DOI 10.1016/j.ijsolstr.2005.11.003; Matteini P, 2009, OPT EXPRESS, V17, P4868, DOI 10.1364/OE.17.004868; Okumura K, 2007, J CARDIOVASC ELECTR, V18, P1083, DOI 10.1111/j.1540-8167.2007.00918.x; Oron D, 2004, J STRUCT BIOL, V147, P3, DOI 10.1016/S1047-8477(03)00125-4; PATT WK, 1991, DIGITAL IMAGE PROCES; Plotnikov S, 2006, BIOPHYS J, V90, P328, DOI 10.1529/biophysj.105.066944; Polyakova V, 2008, J CELL MOL MED, V12, P189, DOI 10.1111/j.1582-4934.2008.00219.x; Pope AJ, 2008, AM J PHYSIOL-HEART C, V295, pH1243, DOI 10.1152/ajpheart.00484.2008; Sakabe M, 2004, J AM COLL CARDIOL, V43, p110A, DOI 10.1016/S0735-1097(04)90456-1; Schenke-Layland K, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1896966; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Stoller P, 2002, BIOPHYS J, V82, P3330, DOI 10.1016/S0006-3495(02)75673-7; Sun CK, 2005, ADV BIOCHEM ENG BIOT, V95, P17, DOI 10.1007/b102209; Takemoto M, 2001, J CLIN INVEST, V108, P1429, DOI 10.1172/JCI200113350; Tsai MR, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3365943; Tziakas DN, 2007, EUROPACE, V9, P589, DOI 10.1093/europace/eum072; Williams RM, 2005, BIOPHYS J, V88, P1377, DOI 10.1529/biophysj.104.047308; Xia Y, 2001, J MICROSC-OXFORD, V204, P3, DOI 10.1046/j.1365-2818.2001.00925.x; Xu J, 2004, CIRCULATION, V109, P363, DOI 10.1161/01.CIR.0000109495.02213.52; Yelin D, 1999, OPT EXPRESS, V5, P169, DOI 10.1364/OE.5.000169	39	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e13917	10.1371/journal.pone.0013917	http://dx.doi.org/10.1371/journal.pone.0013917			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085489	Green Published, gold, Green Submitted			2022-12-25	WOS:000284035900022
J	Micol, R; Tajahmady, A; Lortholary, O; Balkan, S; Quillet, C; Dousset, JP; Chanroeun, H; Madec, Y; Fontanet, A; Yazdanpanah, Y				Micol, Romain; Tajahmady, Ayden; Lortholary, Olivier; Balkan, Suna; Quillet, Catherine; Dousset, Jean-Philippe; Chanroeun, Hak; Madec, Yoann; Fontanet, Arnaud; Yazdanpanah, Yazdan			Cost-Effectiveness of Primary Prophylaxis of AIDS Associated Cryptococcosis in Cambodia	PLOS ONE			English	Article							RECONSTITUTION INFLAMMATORY SYNDROME; SYSTEMIC FUNGAL-INFECTIONS; ANTIRETROVIRAL THERAPY; FLUCONAZOLE RESISTANCE; MENINGITIS; ANTIGENEMIA; PREVENTION; THAILAND; DISEASE; UTILITY	Background: Cryptococcal infection is a frequent cause of mortality in Cambodian HIV-infected patients with CD4+ count <= 100 cells/mu l. This study assessed the cost-effectiveness of three strategies for cryptococcosis prevention in HIV-infected patients. Methods: A Markov decision tree was used to compare the following strategies at the time of HIV diagnosis: no intervention, one time systematic serum cryptococcal antigen (CRAG) screening and treatment of positive patients, and systematic primary prophylaxis with fluconazole. The trajectory of a hypothetical cohort of HIV-infected patients with CD4+ count <= 100 cells/mu l initiating care was simulated over a 1-year period (cotrimoxazole initiation at enrollment; antiretroviral therapy within 3 months). Natural history and cost data (US$ 2009) were from Cambodia. Efficacy data were from international literature. Results: In a population in which 81% of patients had a CD4+ count <= 50 cells/mu l and 19% a CD4+ count between 51-100 cells/mu l, the proportion alive 1 year after enrolment was 61% (cost $ 472) with no intervention, 70% (cost $ 483) with screening, and 72% (cost $ 492) with prophylaxis. After one year of follow-up, the cost-effectiveness of screening vs. no intervention was US$ 180/life year gained (LYG). The cost-effectiveness of prophylaxis vs. screening was $ 511/LYG. The cost-effectiveness of prophylaxis vs. screening was estimated at $1538/LYG if the proportion of patients with CD4+ count <= 50 cells/mu l decreased by 75%. Conclusion: In a high endemic area of cryptococcosis and HIV infection, serum CRAG screening and prophylaxis are two cost effective strategies to prevent AIDS associated cryptococcosis in patients with CD4+ count <= 100 cells/mu l, at a short-term horizon, screening being more cost-effective but less effective than prophylaxis. Systematic primary prophylaxis may be preferred in patients with CD4+ below 50 cells/mu l while systematic serum CRAG screening for early targeted treatment may be preferred in patients with CD4+ between 51-100 cells/mu l.	[Micol, Romain; Madec, Yoann; Fontanet, Arnaud] Inst Pasteur, Unite Epidemiol Malad Emergentes, Paris, France; [Micol, Romain] Univ Paris Descartes EA 36 20, Hop Necker Enfants Malad, Virol Lab, Paris, France; [Tajahmady, Ayden] Mission Natl Expertise & Audit Hosp, Paris, France; [Lortholary, Olivier] CNRS, URA3012, Ctr Natl Reference Mycol & Antifong, Unite Mycol Mol,Inst Pasteur, Paris, France; [Lortholary, Olivier] Univ Paris 05, Serv Malad Infect & Trop, Ctr Infectiol Necker Pasteur, Hop Necker Enfants Malad, Paris, France; [Balkan, Suna; Quillet, Catherine] Med Sans Frontieres, Paris, France; [Dousset, Jean-Philippe] Hop Kosamak, Phnom Penh, Cambodia; [Chanroeun, Hak] Hop Calmette, Serv Malad Infect, Phnom Penh, Cambodia; [Yazdanpanah, Yazdan] INSERM, U995, Avenir ATIP Unit, Paris, France; [Yazdanpanah, Yazdan] Fac Med Lille, CH Tourcoing, Serv Univ Malad Infect & Voyageur, F-59045 Lille, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Doctors Without Borders; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille	Micol, R (corresponding author), Inst Merieux, Lyon, France.	romain.micol@gmail.com		Madec, Yoann/0000-0002-6201-1261; , arnaud/0000-0002-5239-6110	SIDACTION - Ensemble Contre le Sida; Bristol-Myers Squibb; Gilead; Glaxo-SmithKline; Merck; Pfizer; Roche; Tibotec	SIDACTION - Ensemble Contre le Sida; Bristol-Myers Squibb(Bristol-Myers Squibb); Gilead(Gilead Sciences); Glaxo-SmithKline(GlaxoSmithKline); Merck(Merck & Company); Pfizer(Pfizer); Roche(Roche Holding); Tibotec	This work was financed by SIDACTION - Ensemble Contre le Sida. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Y. Yazdanpanah has received travel grants, honoraria for presentation at workshops and consultancy honoraria from Bristol-Myers Squibb, Gilead, Glaxo-SmithKline, Merck, Pfizer, Roche and Tibotec. O. Lortholary is a member of the speaker's bureau of Pfizer, MSD, Astellas, Schering Plough and Gilead Sciences and consultant for Astellas. R. Micol has received travel grants from Pfizer. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Amornkul PN, 2003, AIDS RES HUM RETROV, V19, P85, DOI 10.1089/088922203762688586; Apisarnthanarak A, 2008, JAIDS-J ACQ IMM DEF, V47, P644, DOI 10.1097/QAI.0b013e31815bad0c; Bicanic T, 2006, CLIN INFECT DIS, V43, P1069, DOI 10.1086/507895; Chariyalertsak S, 2001, CLIN INFECT DIS, V32, P955, DOI 10.1086/319348; Chariyalertsak S, 2002, CLIN INFECT DIS, V34, P277, DOI 10.1086/338154; Chhin S, 2004, INT J STD AIDS, V15, P48, DOI 10.1258/095646204322637263; Freedberg KA, 1998, JAMA-J AM MED ASSOC, V279, P130, DOI 10.1001/jama.279.2.130; GADE W, 1991, J CLIN MICROBIOL, V29, P1616, DOI 10.1128/JCM.29.8.1616-1619.1991; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; Jarvis JN, 2009, AIDS, V23, P1182, DOI 10.1097/QAD.0b013e32832be0fc; Jarvis JN, 2009, CLIN INFECT DIS, V48, P856, DOI 10.1086/597262; John L, 2004, HIV MED, V5, P131, DOI 10.1111/j.1468-1293.2004.00199.x; Liechty CA, 2007, TROP MED INT HEALTH, V12, P929, DOI 10.1111/j.1365-3156.2007.01874.x; Lortholary O, 2005, AIDS, V19, P1043, DOI 10.1097/01.aids.0000174450.70874.30; Lortholary O, 2006, AIDS, V20, P2183, DOI 10.1097/01.aids.0000252060.80704.68; Madec Y, 2007, AIDS, V21, P351, DOI 10.1097/QAD.0b013e328012c54f; McCarthy KM, 2006, AIDS, V20, P2199, DOI 10.1097/QAD.0b013e3280106d6a; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Meya DB, 2010, CLIN INFECT DIS, V51, P448, DOI 10.1086/655143; Micol R, 2007, JAIDS-J ACQ IMM DEF, V45, P555, DOI 10.1097/QAI.0b013e31811ed32c; *MIN HLTH NCFHA DE, 2009, 2 Q COMPR REP; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; Pichith K, 2001, Sante, V11, P17; Pongsai P, 2010, J INFECTION, V60, P474, DOI 10.1016/j.jinf.2010.03.015; Scharfstein JA, 1997, MED DECIS MAKING, V17, P373, DOI 10.1177/0272989X9701700402; Shrestha RK, 2007, INT J TUBERC LUNG D, V11, P747; Sungkanuparph S, 2009, CLIN INFECT DIS, V49, P931, DOI 10.1086/605497; Walensky RP, 2009, ANN INTERN MED, V151, P157, DOI 10.7326/0003-4819-151-3-200908040-00138; WERTHEIMER AI, 2004, J INT ASS PHYS AIDS, V3, P84; Wertheimer Albert I, 2004, J Int Assoc Physicians AIDS Care (Chic), V3, P74, DOI 10.1177/154510970400300302; WHO Commission on Macroeconomics and Health, MACR HLTH INV HLTH E; Yazdanpanah Y, 2005, AIDS, V19, P1299, DOI 10.1097/01.aids.0000180101.80888.c6; Yazdanpanah Y, 2003, CLIN INFECT DIS, V36, P86, DOI 10.1086/344902	34	32	32	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e13856	10.1371/journal.pone.0013856	http://dx.doi.org/10.1371/journal.pone.0013856			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085478	gold, Green Published, Green Submitted			2022-12-25	WOS:000284035900003
J	de Morree, A; Hensbergen, PJ; van Haagen, HHHBM; Dragan, I; Deelder, AM; 't Hoen, PAC'; Frants, RR; van der Maarel, SM				de Morree, Antoine; Hensbergen, Paul J.; van Haagen, Herman H. H. B. M.; Dragan, Irina; Deelder, Andre M.; 't Hoen, Peter A. C.; Frants, Rune R.; van der Maarel, Silvere M.			Proteomic Analysis of the Dysferlin Protein Complex Unveils Its Importance for Sarcolemmal Maintenance and Integrity	PLOS ONE			English	Article							GIRDLE MUSCULAR-DYSTROPHY; NORMAL MYOBLAST FUSION; FOCAL ADHESION KINASE; SKELETAL-MUSCLE; MEMBRANE REPAIR; PLASMA-MEMBRANE; REGULATED EXOCYTOSIS; MIYOSHI MYOPATHY; GENE; ENDOCYTOSIS	Dysferlin is critical for repair of muscle membranes after damage. Mutations in dysferlin lead to a progressive muscular dystrophy. Recent studies suggest additional roles for dysferlin. We set out to study dysferlin's protein-protein interactions to obtain comprehensive knowledge of dysferlin functionalities in a myogenic context. We developed a robust and reproducible method to isolate dysferlin protein complexes from cells and tissue. We analyzed the composition of these complexes in cultured myoblasts, myotubes and skeletal muscle tissue by mass spectrometry and subsequently inferred potential protein functions through bioinformatics analyses. Our data confirm previously reported interactions and support a function for dysferlin as a vesicle trafficking protein. In addition novel potential functionalities were uncovered, including phagocytosis and focal adhesion. Our data reveal that the dysferlin protein complex has a dynamic composition as a function of myogenic differentiation. We provide additional experimental evidence and show dysferlin localization to, and interaction with the focal adhesion protein vinculin at the sarcolemma. Finally, our studies reveal evidence for cross-talk between dysferlin and its protein family member myoferlin. Together our analyses show that dysferlin is not only a membrane repair protein but also important for muscle membrane maintenance and integrity.	[de Morree, Antoine; van Haagen, Herman H. H. B. M.; 't Hoen, Peter A. C.; Frants, Rune R.; van der Maarel, Silvere M.] Leiden Univ, Ctr Human Genet, Med Ctr, Leiden, Netherlands; [Hensbergen, Paul J.; Dragan, Irina; Deelder, Andre M.] Leiden Univ, Biomol Mass Spectrometry Unit, Med Ctr, Dept Parasitol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	de Morree, A (corresponding author), Leiden Univ, Ctr Human Genet, Med Ctr, Leiden, Netherlands.	maarel@lumc.nl	't Hoen, Peter/A-4857-2012; Hoen, Peter A 't/D-3950-2018; van der Maarel, Silvere/X-3631-2018	Hoen, Peter A 't/0000-0003-4450-3112; van der Maarel, Silvere/0000-0001-8103-711X; de Morree, Antoine/0000-0002-8316-4531; Hensbergen, Paul/0000-0002-3193-5445	Dutch Prinses Beatrix Fonds [MAR05-0112]; Jain Foundation	Dutch Prinses Beatrix Fonds; Jain Foundation	Funding: This work was supported by grants from the Dutch Prinses Beatrix Fonds (MAR05-0112) and the Jain Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ampong Beryl N, 2005, Acta Myol, V24, P134; Anderson LVB, 1999, HUM MOL GENET, V8, P855, DOI 10.1093/hmg/8.5.855; Azakir BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010122; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Bashir R, 1998, NAT GENET, V20, P37, DOI 10.1038/1689; Beckmann JS, 2008, NEUROMUSCULAR DISORD, V18, P913, DOI 10.1016/j.nmd.2008.08.005; Borgonovo B, 2002, NAT CELL BIOL, V4, P955, DOI 10.1038/ncb888; Bushby Kate, 2009, Pract Neurol, V9, P314, DOI 10.1136/jnnp.2009.193938; Cai CX, 2009, J BIOL CHEM, V284, P15894, DOI 10.1074/jbc.M109.009589; Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; Chiu YH, 2009, HUM MOL GENET, V18, P1976, DOI 10.1093/hmg/ddp121; Cocucci E, 2007, TRAFFIC, V8, P742, DOI 10.1111/j.1600-0854.2007.00566.x; Collinet C, 2010, NATURE, V464, P243, DOI 10.1038/nature08779; Covian-Nares JF, 2010, J CELL SCI, V123, P1884, DOI 10.1242/jcs.066084; Davis DB, 2000, HUM MOL GENET, V9, P217, DOI 10.1093/hmg/9.2.217; De Luna N, 2007, NEUROMUSCULAR DISORD, V17, P69, DOI 10.1016/j.nmd.2006.09.006; De Luna N, 2010, J NEUROPATH EXP NEUR, V69, P643, DOI 10.1097/NEN.0b013e3181e0d01c; Disatnik MH, 1999, J BIOL CHEM, V274, P32486, DOI 10.1074/jbc.274.45.32486; Doherty KR, 2005, DEVELOPMENT, V132, P5565, DOI 10.1242/dev.02155; Foxton RM, 2004, EUR J HUM GENET, V12, P127, DOI 10.1038/sj.ejhg.5201092; Fujita E, 2007, HUM MOL GENET, V16, P618, DOI 10.1093/hmg/ddm002; Hayashi YK, 1998, NAT GENET, V19, P94, DOI 10.1038/ng0598-94; Hernandez-Deviez DJ, 2008, J BIOL CHEM, V283, P6476, DOI 10.1074/jbc.M708776200; Hernandez-Deviez DJ, 2006, HUM MOL GENET, V15, P129, DOI 10.1093/hmg/ddi434; Ho MF, 2002, ANN NEUROL, V51, P129, DOI 10.1002/ana.10080; Huang YC, 2008, HUM MOL GENET, V17, P1855, DOI 10.1093/hmg/ddn081; Huang YC, 2007, FASEB J, V21, P732, DOI 10.1096/fj.06-6628com; Huang YC, 2005, EUR J HUM GENET, V13, P721, DOI 10.1038/sj.ejhg.5201414; Illa I, 2001, ANN NEUROL, V49, P130, DOI 10.1002/1531-8249(200101)49:1<130::AID-ANA22>3.0.CO;2-0; Impagliazzo A, 2010, FEBS LETT, V584, P1558, DOI 10.1016/j.febslet.2010.03.010; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Izzedine H, 2006, AM J KIDNEY DIS, V48, P143, DOI 10.1053/j.ajkd.2006.04.074; Jelier R, 2008, INT J MED INFORM, V77, P354, DOI 10.1016/j.ijmedinf.2007.07.004; Klinge L, 2007, FASEB J, V21, P1768, DOI 10.1096/fj.06-7659com; Krajacic P, 2009, PHYSIOL GENOMICS, V40, P8, DOI 10.1152/physiolgenomics.00106.2009; Lennon NJ, 2003, J BIOL CHEM, V278, P50466, DOI 10.1074/jbc.M307247200; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; Lorusso A, 2006, EMBO J, V25, P5443, DOI 10.1038/sj.emboj.7601419; Luft FC, 2007, J MOL MED, V85, P1157, DOI 10.1007/s00109-007-0252-8; Martinez LO, 2003, NATURE, V421, P75, DOI 10.1038/nature01250; Matsuda C, 2005, J NEUROPATH EXP NEUR, V64, P334, DOI 10.1093/jnen/64.4.334; Matsuda C, 2001, HUM MOL GENET, V10, P1761, DOI 10.1093/hmg/10.17.1761; Matsuda C, 2008, FEBS LETT, V582, P1189, DOI 10.1016/j.febslet.2008.01.064; McNeil AK, 2006, J BIOL CHEM, V281, P35202, DOI 10.1074/jbc.M606406200; Mellgren RL, 2007, J BIOL CHEM, V282, P2567, DOI 10.1074/jbc.M604560200; Mellgren RL, 2009, BBA-MOL CELL RES, V1793, P1886, DOI 10.1016/j.bbamcr.2009.09.013; MORGAN JE, 1994, DEV BIOL, V162, P486, DOI 10.1006/dbio.1994.1103; MUNOZ P, 1995, BIOCHEM J, V307, P273, DOI 10.1042/bj3070273; Nagaraju K, 2008, AM J PATHOL, V172, P774, DOI 10.2353/ajpath.2008.070327; Olson TM, 2002, CIRCULATION, V105, P431, DOI 10.1161/hc0402.102930; Patel P, 2008, J MOL BIOL, V379, P981, DOI 10.1016/j.jmb.2008.04.046; Pramono ZAD, 2006, HUM GENET, V120, P410, DOI 10.1007/s00439-006-0230-1; Quach NL, 2009, MOL BIOL CELL, V20, P3422, DOI 10.1091/mbc.E09-02-0175; Quach NL, 2006, DEV BIOL, V293, P38, DOI 10.1016/j.ydbio.2005.12.040; Roche JA, 2008, NEUROREPORT, V19, P1579, DOI 10.1097/WNR.0b013e328311ca35; Roux I, 2006, CELL, V127, P277, DOI 10.1016/j.cell.2006.08.040; Rutgers KS, 2009, NEUROBIOL AGING; Therrien C, 2009, BIOCHEMISTRY-US, V48, P2377, DOI 10.1021/bi802242r; Washington NL, 2006, J CELL SCI, V119, P2552, DOI 10.1242/jcs.02980; Wein N, 2010, NEUROMUSCULAR DISORD, V20, P57, DOI 10.1016/j.nmd.2009.08.004; Wenzel Katrin, 2006, Hum Mutat, V27, P599, DOI 10.1002/humu.9424; Yamaji S, 2004, J CELL BIOL, V165, P539, DOI 10.1083/jcb.200308141; Yasunaga S, 2000, AM J HUM GENET, V67, P591, DOI 10.1086/303049; Yasunaga S, 1999, NAT GENET, V21, P363, DOI 10.1038/7693	64	51	52	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2010	5	11							e13854	10.1371/journal.pone.0013854	http://dx.doi.org/10.1371/journal.pone.0013854			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675OD	21079765	gold, Green Published, Green Submitted			2022-12-25	WOS:000283839100011
J	Algire, C; Amrein, L; Bazile, M; David, S; Zakikhani, M; Pollak, M				Algire, C.; Amrein, L.; Bazile, M.; David, S.; Zakikhani, M.; Pollak, M.			Diet and tumor LKB1 expression interact to determine sensitivity to anti-neoplastic effects of metformin in vivo	ONCOGENE			English	Article						metformin; insulin; cancer; LKB1	HIGH-ENERGY DIET; BREAST-CANCER; DIABETES-MELLITUS; LKB1-AMPK PATHWAY; GLUCOSE-UPTAKE; RISK; GROWTH; KINASE; ACTIVATION; INSULIN	Hypothesis-generating epidemiological research has suggested that cancer burden is reduced in diabetics treated with metformin and experimental work has raised questions regarding the role of direct adenosine monophosphate-activated protein kinase (AMPK)-mediated antineoplastic effects of metformin as compared with indirect effects attributable to reductions in circulating insulin levels in the host. We treated both tumor LKB1 expression and host diet as variables, and observed that metformin inhibited tumor growth and reduced insulin receptor activation in tumors of mice with diet-induced hyperinsulinemia, independent of tumor LKB1 expression. In the absence of hyperinsulinemia, metformin inhibited only the growth of tumors transfected with short hairpin RNA against LKB1, a finding attributable neither to an effect on host insulin level nor to activation of AMPK within the tumor. Further investigation in vitro showed that cells with reduced LKB1 expression are more sensitive to metformin-induced adenosine triphosphate depletion owing to impaired ability to activate LKB1-AMPK-dependent energy-conservation mechanisms. Thus, loss of function of LKB1 can accelerate proliferation in contexts where it functions as a tumor suppressor, but can also sensitize cells to metformin. These findings predict that any clinical utility of metformin or similar compounds in oncology will be restricted to subpopulations defined by host insulin levels and/or loss of function of LKB1. Oncogene (2011) 30, 1174-1182; doi:10.1038/onc.2010.483; published online 22 November 2010	[Algire, C.; Pollak, M.] McGill Univ, Segal Canc Ctr E423, Jewish Gen Hosp, Dept Expt Med, Montreal, PQ H3T 1E2, Canada; [Algire, C.; Pollak, M.] McGill Univ, Dept Oncol, Montreal, PQ H3T 1E2, Canada; [Amrein, L.; Bazile, M.; David, S.; Zakikhani, M.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada	McGill University; McGill University; Lady Davis Institute; McGill University	Pollak, M (corresponding author), McGill Univ, Segal Canc Ctr E423, Jewish Gen Hosp, Dept Expt Med, 3755 Cote Ste Catherine, Montreal, PQ H3T 1E2, Canada.	michael.pollak@mcgill.ca	Pollak, Michael/G-9094-2011	Pollak, Michael/0000-0003-3047-0604	Terry Fox Research Institute; Montreal Centre for Experimental Therapeutics in Cancer; Canadian Institute of Health Research Canada	Terry Fox Research Institute; Montreal Centre for Experimental Therapeutics in Cancer; Canadian Institute of Health Research Canada(Canadian Institutes of Health Research (CIHR))	We thank Dr Andre Veillette for his advice and technical expertise, Dr Pnina Brodt for the MC38 cells, Drs Lawrence Panasci and Ernesto Schiffrin for sharing laboratory resources, and Dr Nahum Sonenberg and Dr Russell Jones for reviewing the manuscript prior to submission. This work was supported by a grant from the Terry Fox Research Institute. Ms Algire is supported through the Montreal Centre for Experimental Therapeutics in Cancer student fellowship and the Canadian Institute of Health Research Canada Graduate Fellowship.	Algire C, 2008, ENDOCR-RELAT CANCER, V15, P833, DOI 10.1677/ERC-08-0038; Algire C, 2010, ENDOCR-RELAT CANCER, V17, P351, DOI 10.1677/ERC-09-0252; BLAKE DA, 1989, ANAL BIOCHEM, V177, P156, DOI 10.1016/0003-2697(89)90031-6; Bodmer M, 2010, DIABETES CARE, V33, P1304, DOI 10.2337/dc09-1791; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Currie CJ, 2009, DIABETOLOGIA, V52, P1766, DOI 10.1007/s00125-009-1440-6; DEFRONZO RA, 1995, NEW ENGL J MED, V333, P541, DOI 10.1056/NEJM199508313330902; Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310; Dykens JA, 2008, TOXICOL APPL PHARM, V233, P203, DOI 10.1016/j.taap.2008.08.013; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Engelman JA, 2010, CANCER PREV RES, V3, P1049, DOI 10.1158/1940-6207.CAPR-10-0178; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2006, GASTROENTEROLOGY, V131, P973, DOI 10.1053/j.gastro.2006.07.032; HOSONO K, 2007, CAN PREV RES, V3, P1077; Huang X, 2008, BIOCHEM J, V412, P211, DOI 10.1042/BJ20080557; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kalaany NY, 2009, NATURE, V458, P725, DOI 10.1038/nature07782; Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Landman GWD, 2010, DIABETES CARE, V33, P322, DOI 10.2337/dc09-1380; Larsson SC, 2005, JNCI-J NATL CANCER I, V97, P1679, DOI 10.1093/jnci/dji375; Larsson SC, 2007, INT J CANCER, V121, P856, DOI 10.1002/ijc.22717; Libby G, 2009, DIABETES CARE, V32, P1620, DOI 10.2337/dc08-2175; Liu BL, 2009, CELL CYCLE, V8, P2031, DOI 10.4161/cc.8.13.8814; Memmott RM, 2010, CANCER PREV RES, V3, P1066, DOI 10.1158/1940-6207.CAPR-10-0055; Novosyadlyy R, 2010, CANCER RES, V70, P741, DOI 10.1158/0008-5472.CAN-09-2141; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Pollak M, 2010, CANCER PREV RES, V3, P1060, DOI 10.1158/1940-6207.CAPR-10-0175; Pollak M, 2009, CELL METAB, V9, P401, DOI 10.1016/j.cmet.2009.04.006; Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Tomimoto A, 2008, CANCER SCI, V99, P2136, DOI 10.1111/j.1349-7006.2008.00933.x; van Lier MGF, 2010, AM J GASTROENTEROL, V105, P1258, DOI 10.1038/ajg.2009.725; Venkateswaran V, 2007, J NATL CANCER I, V99, P1793, DOI 10.1093/jnci/djm231; Vigneri P, 2009, ENDOCR-RELAT CANCER, V16, P1103, DOI 10.1677/ERC-09-0087; Wingo SN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005137; Zakikhani M, 2006, CANCER RES, V66, P10269, DOI 10.1158/0008-5472.CAN-06-1500; Zakikhani M, 2008, CANCER PREV RES, V1, P369, DOI 10.1158/1940-6207.CAPR-08-0081	48	150	158	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2011	30	10					1174	1182		10.1038/onc.2010.483	http://dx.doi.org/10.1038/onc.2010.483			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	732QD	21102522				2022-12-25	WOS:000288202400004
J	Huynh, C; Segura, MF; Gaziel-Sovran, A; Menendez, S; Darvishian, F; Chiriboga, L; Levin, B; Meruelo, D; Osman, I; Zavadil, J; Marcusson, EG; Hernando, E				Huynh, C.; Segura, M. F.; Gaziel-Sovran, A.; Menendez, S.; Darvishian, F.; Chiriboga, L.; Levin, B.; Meruelo, D.; Osman, I.; Zavadil, J.; Marcusson, E. G.; Hernando, E.			Efficient in vivo microRNA targeting of liver metastasis	ONCOGENE			English	Article						microRNA; melanoma; metastasis; liver; miR-182	ANTISENSE OLIGONUCLEOTIDES; LUNG-CANCER; MELANOMA; THERAPY; CELLS; EXPRESSION; MIR-182; SIRNA; PROGRESSION; PRIMATES	Targeting oncogenic microRNAs ( miRNAs) is emerging as a promising strategy for cancer therapy. In this study, we provide proof of principle for the safety and efficacy of miRNA targeting against metastatic tumors. We tested the impact of targeting miR-182, a pro-metastatic miRNA frequently overexpressed in melanoma, the in vitro silencing of which represses invasion and induces apoptosis. Specifically, we assessed the effect of anti-miR-182 oligo-nucleotides synthesized with 20 sugar modifications and a phosphorothioate backbone in a mouse model of melanoma liver metastasis. Luciferase imaging showed that mice treated with anti-miR-182 had a lower burden of liver metastases compared with control. We confirmed that miR-182 levels were effectively downregulated in the tumors of anti-miR-treated mice compared with tumors of control-treated mice, both in the liver and in the spleen. This effect was accompanied by an upregulation of multiple miR-182 direct targets. Transcriptional profiling of tumors treated with anti-miR-182 or with control oligo-nucleotides revealed an enrichment of genes controlling survival, adhesion and migration modulated in response to anti-miR-182 treatment. These data indicate that in vivo administration of anti-miRs allows for efficient miRNA targeting and concomitant upregulation of miRNA-controlled genes. Our results demonstrate that the use of anti-miR-182 is a promising therapeutic strategy for metastatic melanoma and provide a solid basis for testing similar strategies in human metastatic tumors. Oncogene (2011) 30, 1481-1488; doi:10.1038/onc.2010.523; published online 22 November 2010	[Huynh, C.; Segura, M. F.; Gaziel-Sovran, A.; Menendez, S.; Darvishian, F.; Chiriboga, L.; Levin, B.; Meruelo, D.; Zavadil, J.; Hernando, E.] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Huynh, C.] NYU, Sch Med, Dept Med, New York, NY 10016 USA; [Osman, I.] NYU, Sch Med, Dept Dermatol, New York, NY 10016 USA; [Zavadil, J.] NYU, Sch Med, NYU Ctr Hlth Informat & Bioinformat, New York, NY 10016 USA; [Huynh, C.; Segura, M. F.; Gaziel-Sovran, A.; Menendez, S.; Darvishian, F.; Chiriboga, L.; Osman, I.; Hernando, E.] NYU, Sch Med, Interdisciplinary Melanoma Cooperat Grp, New York, NY 10016 USA; [Marcusson, E. G.] Regulus Therapeut Inc, San Diego, CA USA	New York University; New York University; New York University; New York University; New York University; Isis Pharmaceuticals Inc	Hernando, E (corresponding author), NYU, Sch Med, Dept Pathol, 550 1st Ave,Smilow 305, New York, NY 10016 USA.	eva.hernando@med.nyu.edu	Segura, Miguel F/J-4749-2013; Zavadil, Jiri/ABG-1780-2020	Segura, Miguel F/0000-0003-0916-3618; Zavadil, Jiri/0000-0003-0640-5562; Marcusson, Eric/0000-0002-0504-8674; Hernando, Eva/0000-0003-1023-0312; Chiriboga, Luis/0000-0002-2028-6873	ConCerN foundation; Harry Lloyd Charitable Trust; NYU; National Cancer Center; NIH [T32 CA09454-19]; NATIONAL CANCER INSTITUTE [T32CA009454] Funding Source: NIH RePORTER	ConCerN foundation; Harry Lloyd Charitable Trust; NYU; National Cancer Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank members of the NYU Cancer Institute Genomics Facility for array profiling. We are grateful to Dr Cindy Loomis and members of the NYU Histopathology (Tim Macatee) and the Immunohistochemistry Core Laboratories for tissue processing and histological staining, and to Dr Elisa de Stanchina (MSKCC Antitumor Assessment core facility) for mouse blood work. This work was funded by the ConCerN foundation and the Harry Lloyd Charitable Trust. CH is supported by the NYU Physician Scientist Training Program, National Cancer Center Postdoctoral fellowship and the NIH T32 CA09454-19 fellowship training grant. MFS by a National Cancer Center Postdoctoral fellowship.	Bandres E, 2007, ONCOL REP, V17, P1089; Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; Camacho LH, 2009, J CLIN ONCOL, V27, P1075, DOI 10.1200/JCO.2008.19.2435; Chi KN, 2008, CLIN CANCER RES, V14, P833, DOI 10.1158/1078-0432.CCR-07-1310; Chijiwa Tsuyoshi, 2009, Int J Oncol, V34, P5; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956; Davis S, 2009, NUCLEIC ACIDS RES, V37, P70, DOI 10.1093/nar/gkn904; de Fougerolles A, 2007, NAT REV DRUG DISCOV, V6, P443, DOI 10.1038/nrd2310; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Devi GR, 2006, CANCER GENE THER, V13, P819, DOI 10.1038/sj.cgt.7700931; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Garbe C, 2009, CLIN DERMATOL, V27, P3, DOI 10.1016/j.clindermatol.2008.09.001; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Hau P, 2009, EXPERT REV ANTICANC, V9, P1663, DOI [10.1586/era.09.138, 10.1586/ERA.09.138]; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jansen B, 2000, LANCET, V356, P1728, DOI 10.1016/S0140-6736(00)03207-4; Jemal A, 2008, JNCI-J NATL CANCER I, V100, P1672, DOI 10.1093/jnci/djn389; Jiang LL, 2010, AM J PATHOL, V177, P29, DOI 10.2353/ajpath.2010.090812; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krumschnabel G, 2009, ONCOGENE, V28, P3093, DOI 10.1038/onc.2009.173; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Paschos KA, 2010, HEPATOL RES, V40, P83, DOI 10.1111/j.1872-034X.2009.00578.x; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Rubin Krista M, 2009, Oncology (Williston Park), V23, P13; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tolcher AW, 2002, CLIN CANCER RES, V8, P2530; Tong AW, 2008, CANCER GENE THER, V15, P341, DOI 10.1038/cgt.2008.8; Trang P, 2010, ONCOGENE, V29, P1580, DOI 10.1038/onc.2009.445; Treisman J, 2010, CLIN PLAST SURG, V37, P127, DOI 10.1016/j.cps.2009.07.008; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Valastyan S, 2009, RNA BIOL, V6, P541, DOI 10.4161/rna.6.5.10081; Valastyan S, 2009, CELL CYCLE, V8, P3506, DOI 10.4161/cc.8.21.9802; Wiggins JF, 2010, CANCER RES, V70, P5923, DOI 10.1158/0008-5472.CAN-10-0655; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Yang H, 2010, CANCER RES, V70, P5518, DOI 10.1158/0008-5472.CAN-10-0646	43	82	88	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR	2011	30	12					1481	1488		10.1038/onc.2010.523	http://dx.doi.org/10.1038/onc.2010.523			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	739UM	21102518				2022-12-25	WOS:000288743800010
J	Balendiran, GK; Sawaya, MR; Schwarz, FP; Ponniah, G; Cuckovich, R; Verma, M; Cascio, D				Balendiran, Ganesaratnam K.; Sawaya, Michael R.; Schwarz, Frederick P.; Ponniah, Gomathinayagam; Cuckovich, Richard; Verma, Malkhey; Cascio, Duilio			The Role of Cys-298 in Aldose Reductase Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIABETIC COMPLICATIONS; HUMAN-ERYTHROCYTE; BINDING-SITE; ACTIVATION; MECHANISM; INVOLVEMENT; INHIBITION; CONSTANTS; SORBITOL; PATHWAY	Diabetic tissues are enriched in an "activated" form of human aldose reductase (hAR), a NADPH-dependent oxidoreductase involved in sugar metabolism. Activated hAR has reduced sensitivity to potential anti-diabetes drugs. The C298S mutant of hAR reproduces many characteristics of activated hAR, although it differs from wild-type hAR only by the replacement of a single sulfur atom with oxygen. Isothermal titration calorimetry measurements revealed that the binding constant of NADPH to the C298S mutant is decreased by a factor of two, whereas that of NADP(+) remains the same. Similarly, the heat capacity change for the binding of NADPH to the C298S mutant is twice increased; however, there is almost no difference in the heat capacity change for binding of the NADP(+) to the C298S. X-ray crystal structures of wild-type and C298S hAR reveal that the side chain of residue 298 forms a gate to the nicotinamide pocket and is more flexible for cysteine compared with serine. Unlike Cys-298, Ser-298 forms a hydrogen bond with Tyr-209 across the nicotinamide ring, which inhibits movements of the nicotinamide. We hypothesize that the increased polarity of the oxidized nicotinamide weakens the hydrogen bond potentially formed by Ser-298, thus, accounting for the relatively smaller effect of the mutation on NADP(+) binding. The effects of the mutant on catalytic rate constants and binding constants for various substrates are the same as for activated hAR. It is, thus, further substantiated that activated hAR arises from oxidative modification of Cys-298, a residue near the nicotinamide binding pocket.	[Balendiran, Ganesaratnam K.; Cuckovich, Richard] Youngstown State Univ, Dept Chem, Youngstown, OH 44555 USA; [Sawaya, Michael R.; Cascio, Duilio] UCLA DOE, Los Angeles, CA 90095 USA; [Schwarz, Frederick P.] Natl Inst Stand & Technol, Ctr Adv Res Biotechnol, Rockville, MD 20850 USA; [Ponniah, Gomathinayagam] Merck & Co Inc, Lebanon, NH 03766 USA; [Verma, Malkhey] Univ Manchester, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England	University System of Ohio; Youngstown State University; United States Department of Energy (DOE); University of California System; University of California Los Angeles; National Institute of Standards & Technology (NIST) - USA; Merck & Company; University of Manchester	Balendiran, GK (corresponding author), Youngstown State Univ, Dept Chem, WBSH 6017,1 Univ Plaza, Youngstown, OH 44555 USA.	pl_note@yahoo.com			Office of Biological and Environmental Research, United States Department of Energy; National Institutes of Health, National Center for Research Resources, Biomedical; National Institute of General Medical Sciences; National Institute of Diabetes and Digestive and Kidney Diseases [DK085496]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R15DK085496] Funding Source: NIH RePORTER	Office of Biological and Environmental Research, United States Department of Energy(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources, Biomedical(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank David Eisenberg and Todd Yeates for use of their facilities, Peter Kasvinsky and the Youngstown State University Graduate School, for encouragement and support the staff at Synchrotron Radiation Laboratory beamline 9-1 and Advanced Light Source beamline 8.2.2 for expert assistance, and Dino Moras and Alberto Podjarny for the gift of the His-tag recombinant hAR overexpression cells. Data collection facilities at the Stanford Synchrotron Radiation Laboratory are funded by The Office of Biological and Environmental Research, United States Department of Energy, the National Institutes of Health, National Center for Research Resources, Biomedical, and the National Institute of General Medical Sciences.; This study was supported by Grant DK085496 from the National Institute of Diabetes and Digestive and Kidney Diseases.	Balendiran GK, 2005, BIOCHEM PHARMACOL, V70, P1653, DOI 10.1016/j.bcp.2005.06.029; BOHREN KM, 1993, ADV EXP MED BIOL, V328, P267; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cappiello M, 1996, J BIOL CHEM, V271, P33539, DOI 10.1074/jbc.271.52.33539; Caprio S, 1997, DIABETOLOGIA, V40, pB78, DOI 10.1007/s001250051411; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; DAS B, 1985, DIABETES, V34, P1145, DOI 10.2337/diabetes.34.11.1145; DELCORSO A, 1987, BIOCHEM BIOPH RES CO, V148, P369, DOI 10.1016/0006-291X(87)91120-X; Dixit BL, 2000, J BIOL CHEM, V275, P21587, DOI 10.1074/jbc.M909235199; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FLYNN TG, 1982, BIOCHEM PHARMACOL, V31, P2705, DOI 10.1016/0006-2952(82)90123-X; GABBAY KH, 1973, NEW ENGL J MED, V288, P831, DOI 10.1056/NEJM197304192881609; GREENE DA, 1987, NEW ENGL J MED, V316, P599; GRIMSHAW CE, 1995, BIOCHEMISTRY-US, V34, P14356, DOI 10.1021/bi00044a012; GRIMSHAW CE, 1990, BIOCHEMISTRY-US, V29, P9947, DOI 10.1021/bi00494a027; Grimshaw CE, 1996, ARCH BIOCHEM BIOPHYS, V327, P89, DOI 10.1006/abbi.1996.0096; GRIMSHAW CE, 1989, BIOCHEMISTRY-US, V28, P5343, DOI 10.1021/bi00439a006; IPPOLITO JA, 1990, J MOL BIOL, V215, P457, DOI 10.1016/S0022-2836(05)80364-X; JASPAN J, 1986, DRUGS, V32, P23, DOI 10.2165/00003495-198600322-00007; KINOSHITA JH, 1988, DIABETES METAB REV, V4, P323, DOI 10.1002/dmr.5610040403; Kissinger CR, 2001, ACTA CRYSTALLOGR D, V57, P1474, DOI 10.1107/S0907444901012458; KUBISESKI TJ, 1992, J BIOL CHEM, V267, P6510; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LIU SQ, 1992, BIOCHEM PHARMACOL, V44, P2427, DOI 10.1016/0006-2952(92)90693-D; Lorenzi M, 2007, EXP DIABETES RES, DOI 10.1155/2007/61038; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Newfield RS, 1997, DIABETOLOGIA, V40, pB62, DOI 10.1007/BF03168189; NISHIMURA C, 1991, BIOCHIM BIOPHYS ACTA, V1078, P171, DOI 10.1016/0167-4838(91)99006-E; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PETRASH JM, 1992, J BIOL CHEM, V267, P24833; PRIVALOV PL, 1992, J MOL BIOL, V224, P715, DOI 10.1016/0022-2836(92)90555-X; SPOLAR RS, 1992, BIOCHEMISTRY-US, V31, P3947, DOI 10.1021/bi00131a009; Srivastava S, 1998, BIOCHEM J, V329, P469, DOI 10.1042/bj3290469; SRIVASTAVA SK, 1986, METABOLISM, V35, P114, DOI 10.1016/0026-0495(86)90199-X; SRIVASTAVA SK, 1985, P NATL ACAD SCI USA, V82, P7222, DOI 10.1073/pnas.82.21.7222; WILSON DK, 1992, SCIENCE, V257, P81, DOI 10.1126/science.1621098; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3	39	17	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6336	6344		10.1074/jbc.M110.154195	http://dx.doi.org/10.1074/jbc.M110.154195			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21084309	hybrid, Green Published			2022-12-25	WOS:000287476400044
J	Tremp, AZ; Dessens, JT				Tremp, Annie Z.; Dessens, Johannes T.			Malaria IMC1 Membrane Skeleton Proteins Operate Autonomously and Participate in Motility Independently of Cell Shape	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARASITE TOXOPLASMA-GONDII; PLASMODIUM-BERGHEI; APICOMPLEXAN PARASITES; INTERMEDIATE-FILAMENTS; GLIDING MOTILITY; MOSQUITO MIDGUT; XIV MYOSIN; LIFE-CYCLE; INVASION; CYTOSKELETON	Plasmodium IMC1 (inner membrane complex 1) proteins comprise components of the subpellicular network, a lattice of intermediate filaments that form a structural part of the pellicle in the zoite stages of malaria parasites. Family members IMC1a and IMC1b are differentially expressed in sporozoites and ookinetes, respectively, but have functionally equivalent roles affecting cell morphology, strength, motility, and infectivity. Because of the coincident effects of previous imc1 gene disruptions on both zoite shape and locomotion, it has been impossible to ascribe a direct involvement in motility to these proteins. We show here that a third family member, IMC1h, has a distinct differential expression pattern and localizes to the pellicle of both ookinetes and sporozoites. Knock-out of IMC1h mimics the loss-of-function phenotypes of IMC1a and IMC1b in their respective life stages, indicating that IMC1 proteins could be operating co-dependently. By generating double null mutant parasites for IMC1h and IMC1b, we tested this hypothesis: double knock-out exacerbated the phenotypes of the single knock-outs in terms of ookinete strength, motility, and infectivity but did not further affect ookinete morphology. These findings provide the first genetic evidence that IMC1 proteins can function independently of each other and contribute to gliding motility independently of cell shape.	[Tremp, Annie Z.; Dessens, Johannes T.] Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Pathogen Mol Biol, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Dessens, JT (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Pathogen Mol Biol, Keppel St, London WC1E 7HT, England.	johannes.dessens@lshtm.ac.uk		Dessens, Johannes/0000-0002-2070-6073; Tremp, Annie/0000-0003-4042-9074	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust.	Anderson-White BR, 2011, CELL MICROBIOL, V13, P18, DOI 10.1111/j.1462-5822.2010.01514.x; Arai M, 2001, MOL BIOCHEM PARASIT, V116, P17, DOI 10.1016/S0166-6851(01)00299-7; Ausmees N, 2003, CELL, V115, P705, DOI 10.1016/S0092-8674(03)00935-8; Bannister LH, 2000, PARASITOL TODAY, V16, P427, DOI 10.1016/S0169-4758(00)01755-5; Baum J, 2006, NAT REV MICROBIOL, V4, P621, DOI 10.1038/nrmicro1465; Bullen HE, 2009, J BIOL CHEM, V284, P25353, DOI 10.1074/jbc.M109.036772; Carter V, 2008, MOL MICROBIOL, V68, P1560, DOI 10.1111/j.1365-2958.2008.06254.x; de Koning-Ward TF, 2000, MOL BIOCHEM PARASIT, V106, P199, DOI 10.1016/S0166-6851(99)00189-9; Dessens JT, 2001, INFECT IMMUN, V69, P4041, DOI 10.1128/IAI.69.6.4041-4047.2001; Dessens JT, 1999, EMBO J, V18, P6221, DOI 10.1093/emboj/18.22.6221; Dessens JT, 2003, MOL MICROBIOL, V49, P319, DOI 10.1046/j.1365-2958.2003.03566.x; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Gaskins E, 2004, J CELL BIOL, V165, P383, DOI 10.1083/jcb.200311137; Gould SB, 2008, MOL BIOL EVOL, V25, P1219, DOI 10.1093/molbev/msn070; Greenwood BM, 2005, LANCET, V365, P1487, DOI 10.1016/S0140-6736(05)66420-3; Gubbels MJ, 2004, MOL BIOCHEM PARASIT, V137, P99, DOI 10.1016/j.molbiopara.2004.05.007; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Han YS, 2000, EMBO J, V19, P6030, DOI 10.1093/emboj/19.22.6030; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Herrmann H, 2009, J CLIN INVEST, V119, P1772, DOI 10.1172/JCI38214; Hu K, 2002, MOL BIOL CELL, V13, P593, DOI 10.1091/mbc.01-06-0309; Johnson TM, 2007, MOL BIOL CELL, V18, P3039, DOI 10.1091/mbc.E07-01-0040; Kappe SHI, 2004, TRENDS PARASITOL, V20, P13, DOI 10.1016/j.pt.2003.10.011; Keeley A, 2004, TRENDS CELL BIOL, V14, P528, DOI 10.1016/j.tcb.2004.08.002; Khater EI, 2004, J CELL BIOL, V167, P425, DOI 10.1083/jcb.200406068; Kooij TWA, 2005, PLOS PATHOG, V1, P349, DOI 10.1371/journal.ppat.0010044; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; Le Chat L, 2007, MOL BIOCHEM PARASIT, V153, P41, DOI 10.1016/j.molbiopara.2007.01.016; Mann T, 2002, J BIOL CHEM, V277, P41240, DOI 10.1074/jbc.M205056200; Mann T, 2001, MOL BIOCHEM PARASIT, V115, P257, DOI 10.1016/S0166-6851(01)00289-4; Matuschewski Kai, 2008, V47, P110; MENKE A, 1991, NATURE, V349, P69, DOI 10.1038/349069a0; Morrissette NS, 2002, MICROBIOL MOL BIOL R, V66, P21, DOI 10.1128/MMBR.66.1.21-38.2002; Saeed S, 2010, MOL BIOCHEM PARASIT, V170, P49, DOI 10.1016/j.molbiopara.2009.11.008; Santos JM, 2009, INT J PARASITOL, V39, P153, DOI 10.1016/j.ijpara.2008.10.007; Sibley LD, 2004, SCIENCE, V304, P248, DOI 10.1126/science.1094717; SINDEN RE, 1985, PARASITOLOGY, V91, P227, DOI 10.1017/S0031182000057334; Soldati D, 2004, CURR OPIN CELL BIOL, V16, P32, DOI 10.1016/j.ceb.2003.11.013; Templeton TJ, 2000, MOL MICROBIOL, V36, P1, DOI 10.1046/j.1365-2958.2000.01821.x; Tremp AZ, 2008, J BIOL CHEM, V283, P27604, DOI 10.1074/jbc.M801302200; Vernick KD, 1999, EXP PARASITOL, V91, P362, DOI 10.1006/expr.1998.4388; Waters AP, 1997, METHODS, V13, P134, DOI 10.1006/meth.1997.0506; Yuda M, 1999, J EXP MED, V190, P1711, DOI 10.1084/jem.190.11.1711	43	34	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5383	5391		10.1074/jbc.M110.187195	http://dx.doi.org/10.1074/jbc.M110.187195			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21098480	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000287230600047
J	Bodnar, M; Wang, H; Riedel, T; Hintze, S; Kato, E; Fallah, G; Groger-Arndt, H; Giniatullin, R; Grohmann, M; Hausmann, R; Schmalzing, G; Illes, P; Rubini, P				Bodnar, Mandy; Wang, Haihong; Riedel, Thomas; Hintze, Stefan; Kato, Erzsebet; Fallah, Ghada; Groeger-Arndt, Helke; Giniatullin, Rashid; Grohmann, Marcus; Hausmann, Ralf; Schmalzing, Guenther; Illes, Peter; Rubini, Patrizia			Amino Acid Residues Constituting the Agonist Binding Site of the Human P2X3 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN P2X(1) RECEPTORS; C-TERMINAL DOMAIN; ATP-BINDING; ION-CHANNEL; PURINERGIC RECEPTORS; EXTRACELLULAR LOOP; CYSTEINE RESIDUES; CELL-SURFACE; KINASE-C; DESENSITIZATION	Homomeric P2X3 receptors are present in sensory ganglia and participate in pain perception. Amino acid (AA) residues were replaced in the four supposed nucleotide binding segments (NBSs) of the human (h) P2X3 receptor by alanine, and these mutants were expressed in HEK293 cells and Xenopus laevis oocytes. Patch clamp and two-electrode voltage clamp measurements as well as the Ca2+ imaging technique were used to compare the concentration-response curves of the selective P2X1,3 agonist alpha, beta-methylene ATP obtained at the wild-type P2X3 receptor and its NBS mutants. Within these NBSs, certain Gly (Gly-66), Lys (Lys-63, Lys-176, Lys-284, Lys-299), Asn (Asn-177, Asn-279), Arg (Arg-281, Arg-295), and Thr (Thr-172) residues were of great importance for a full agonist response. However, the replacement of further AAs in the NBSs by Ala also appeared to modify the amplitude of the current and/or [Ca2+] i responses, although sometimes to a minor degree. The agonist potency decrease was additive after the simultaneous replacement of two adjacent AAs by Ala (K65A/G66A, F171A/T172A, N279A/F280A, F280A/R281A) but was not altered after Ala substitution of two non-adjacent AAs within the same NBS (F171A/N177A). SDS-PAGE in the Cy5 cell surface-labeled form demonstrated that the mutants appeared at the cell surface in oocytes. Thus, groups of AAs organized in NBSs rather than individual amino acids appear to be responsible for agonist binding at the hP2X3 receptor. These NBSs are located at the interface of the three subunits forming a functional receptor.	[Groeger-Arndt, Helke; Grohmann, Marcus; Illes, Peter] Univ Leipzig, Rudolf Boehm Inst Pharmacol & Toxicol, D-04107 Leipzig, Germany; [Fallah, Ghada; Hausmann, Ralf; Schmalzing, Guenther] Rhein Westfal TH Aachen Univ, Dept Mol Pharmacol, Univ Hosp, D-52074 Aachen, Germany; [Giniatullin, Rashid] AI Virtanen Inst, Dept Neurobiol, Kuopio 70211, Finland	Leipzig University; RWTH Aachen University; RWTH Aachen University Hospital	Illes, P (corresponding author), Univ Leipzig, Rudolf Boehm Inst Pharmacol & Toxicol, Haertelstr 16-18, D-04107 Leipzig, Germany.	Peter.Illes@medizin.uni-leipzig.de	Giniatullin, Rashid/Y-9687-2018; Riedel, Thomas/A-5079-2012	Giniatullin, Rashid/0000-0002-1580-6280	Deutsche Forschungsgemeinschaft [IL 20/11-3, WI 1674/4-1, IL20/18-2]; Volkswagen Foundation [I/82 940]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Volkswagen Foundation(Volkswagen)	This work was supported by grants from the Deutsche Forschungsgemeinschaft (Grants IL 20/11-3; WI 1674/4-1; and IL20/18-2) and the Volkswagen Foundation (Grant I/82 940).	Aschrafi A, 2004, J MOL BIOL, V342, P333, DOI 10.1016/j.jmb.2004.06.092; Becker D, 2008, J BIOL CHEM, V283, P25725, DOI 10.1074/jbc.M803855200; Browne LE, 2010, TRENDS PHARMACOL SCI, V31, P229, DOI 10.1016/j.tips.2010.02.004; Chaumont S, 2004, J BIOL CHEM, V279, P29628, DOI 10.1074/jbc.M403940200; Chizh BA, 2001, PHARMACOL REV, V53, P553; Digby HR, 2005, J NEUROCHEM, V95, P1746, DOI 10.1111/j.1471-4159.2005.03494.x; Ding SH, 1999, J GEN PHYSIOL, V113, P695, DOI 10.1085/jgp.113.5.695; Donnelly-Roberts D, 2008, J PHARMACOL EXP THER, V324, P409, DOI 10.1124/jpet.106.105890; Egan TM, 2004, J NEUROSCI, V24, P3413, DOI 10.1523/JNEUROSCI.5429-03.2004; Ennion S, 2000, J BIOL CHEM, V275, P29361, DOI 10.1074/jbc.M003637200; Ennion SJ, 2002, MOL PHARMACOL, V61, P303, DOI 10.1124/mol.61.2.303; Evans RJ, 2009, EUR BIOPHYS J BIOPHY, V38, P319, DOI 10.1007/s00249-008-0275-2; Fischer W, 2007, EUR J PHARMACOL, V576, P7, DOI 10.1016/j.ejphar.2007.07.068; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Fountain SJ, 2006, J BIOL CHEM, V281, P15044, DOI 10.1074/jbc.M600442200; Freist W, 1998, FEBS LETT, V434, P61, DOI 10.1016/S0014-5793(98)00958-2; Gerevich Z, 2007, BRIT J PHARMACOL, V151, P226, DOI 10.1038/sj.bjp.0707217; Gerevich Z, 2007, J BIOL CHEM, V282, P33949, DOI 10.1074/jbc.M705840200; Hausmann R, 2006, MOL PHARMACOL, V69, P2058, DOI 10.1124/mol.106.022665; He ML, 2002, MOL PHARMACOL, V62, P1187, DOI 10.1124/mol.62.5.1187; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Illes P, 2004, EUR J PHARMACOL, V483, P5, DOI 10.1016/j.ejphar.2003.10.030; Jarvis MF, 2009, NEUROPHARMACOLOGY, V56, P208, DOI 10.1016/j.neuropharm.2008.06.067; Jiang LH, 2000, J BIOL CHEM, V275, P34190, DOI 10.1074/jbc.M005481200; Karoly R, 2008, MOL PHARMACOL, V73, P224, DOI 10.1124/mol.107.038901; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Koshimizu T, 1999, J BIOL CHEM, V274, P37651, DOI 10.1074/jbc.274.53.37651; Mager PP, 2006, EXPERT OPIN DRUG DIS, V1, P303, DOI 10.1517/17460441.1.4.303; Mager PP, 2004, CURR TOP MED CHEM, V4, P1657, DOI 10.2174/1568026043387197; Marquez-Klaka B, 2007, J NEUROSCI, V27, P1456, DOI 10.1523/JNEUROSCI.3105-06.2007; Milescu LS, 2005, BIOPHYS J, V88, P2494, DOI 10.1529/biophysj.104.053256; Murrell-Lagnado RD, 2008, MOL MEMBR BIOL, V25, P321, DOI 10.1080/09687680802050385; Nakazawa K, 2005, EUR J PHARMACOL, V518, P107, DOI 10.1016/j.ejphar.2005.06.018; Newbolt A, 1998, J BIOL CHEM, V273, P15177, DOI 10.1074/jbc.273.24.15177; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; North RA, 2000, ANNU REV PHARMACOL, V40, P563, DOI 10.1146/annurev.pharmtox.40.1.563; Ormond SJ, 2006, MOL PHARMACOL, V69, P1692, DOI 10.1124/mol.105.020404; Riedel T, 2007, BIOPHYS J, V92, P2377, DOI 10.1529/biophysj.106.091413; Roberts JA, 2004, J BIOL CHEM, V279, P9043, DOI 10.1074/jbc.M308964200; Roberts JA, 2008, J BIOL CHEM, V283, P20126, DOI 10.1074/jbc.M800294200; SCHMALZING G, 1991, BIOCHEM J, V279, P329, DOI 10.1042/bj2790329; Shinozaki Y, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000103; Sokolova E, 2004, BRIT J PHARMACOL, V141, P1048, DOI 10.1038/sj.bjp.0705701; Stanchev D, 2006, NEUROSCI LETT, V393, P78, DOI 10.1016/j.neulet.2005.09.045; Vial C, 2004, TRENDS PHARMACOL SCI, V25, P487, DOI 10.1016/j.tips.2004.07.008; Wilkinson WJ, 2006, MOL PHARMACOL, V70, P1159, DOI 10.1124/mol.106.026658; Wirkner K, 2005, J NEUROSCI, V25, P7734, DOI 10.1523/JNEUROSCI.2028-05.2005; Wirkner K, 2007, MOL NEUROBIOL, V36, P165, DOI 10.1007/s12035-007-0033-y; Yan ZH, 2005, MOL PHARMACOL, V67, P1078, DOI 10.1124/mol.104.010108; Young MT, 2010, TRENDS BIOCHEM SCI, V35, P83, DOI 10.1016/j.tibs.2009.09.006; Zemkova H, 2007, J NEUROCHEM, V102, P1139, DOI 10.1111/j.1471-4159.2007.04616.x; Zhou Z, 1998, BIOCHEM BIOPH RES CO, V252, P541, DOI 10.1006/bbrc.1998.9689	53	35	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2739	2749		10.1074/jbc.M110.167437	http://dx.doi.org/10.1074/jbc.M110.167437			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21098022	hybrid, Green Published			2022-12-25	WOS:000286464300040
J	Murakawa, T; Machida, Y; Hayashi, H				Murakawa, Takeshi; Machida, Yasuhiro; Hayashi, Hideyuki			Product-assisted Catalysis as the Basis of the Reaction Specificity of Threonine Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARABIDOPSIS-THALIANA; MECHANISM; ENZYMES; VINYLGLYCINE; SERINE; AMINOTRANSFERASE; CYSTATHIONINE; DEHYDRATASE; SYNTHETASE; INHIBITORS	Threonine synthase (TS), which is a pyridoxal 5 '-phosphate (PLP)-dependent enzyme, catalyzes the elimination of the gamma-phosphate group from O-phospho-L-homoserine (OPHS) and the subsequent addition of water at C beta to form L-threonine. The catalytic course of TS is the most complex among the PLP enzymes, and it is an intriguing problem how the elementary steps are controlled in TS to carry out selective reactions. When L-vinylglycine was added to Thermus thermophilus HB8 TS in the presence of phosphate, L-threonine was formed with k(cat) and reaction specificity comparable with those when OPHS was used as the substrate. However, in the absence of phosphate or when sulfate was used in place of phosphate, only the side reaction product-alpha-ketobutyrate, was formed. Global analysis of the spectral changes in the reaction of TS with L-threonine showed that compared with the more acidic sulfate ion, the phosphate ion decreased the energy levels of the transition states of the addition of water at the C beta of the PLP-alpha-aminocrotonate aldimine (AC) and the transaldimination to form L-threonine. The x-ray crystallographic analysis of TS complexed with an analog for AC gave a distinct electron density assigned to the phosphate ion derived from the solvent near the C beta of the analog. These results indicated that the phosphate ion released from OPHS by gamma-elimination acts as the base catalyst for the addition of water at C beta of AC, thereby providing the basis of the reaction specificity. The phosphate ion is also considered to accelerate the protonation/deprotonation at C gamma	[Murakawa, Takeshi; Machida, Yasuhiro; Hayashi, Hideyuki] Osaka Med Coll, Dept Biochem, Fac Med, Takatsuki, Osaka 5698686, Japan	Osaka Medical College	Hayashi, H (corresponding author), Osaka Med Coll, Dept Biochem, Fac Med, 2-7 Daigakumachi, Takatsuki, Osaka 5698686, Japan.	hayashi@art.osaka-med.ac.jp			Japan Society for the Promotion of Science [21570120, 91445990]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grants-in-aid for Scientific Research 21570120 (to H. H.) and 91445990 (to T. M.) from the Japan Society for the Promotion of Science.	ALEXANDER FW, 1994, EUR J BIOCHEM, V219, P953, DOI 10.1111/j.1432-1033.1994.tb18577.x; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Covarrubias AS, 2008, J MOL BIOL, V381, P622, DOI 10.1016/j.jmb.2008.05.086; DUNATHAN HC, 1966, P NATL ACAD SCI USA, V55, P712, DOI 10.1073/pnas.55.4.712; ESAKI N, 1977, FEBS LETT, V84, P309, DOI 10.1016/0014-5793(77)80713-8; Feng L, 2000, BIOCHEMISTRY-US, V39, P2436, DOI 10.1021/bi9922704; FLAVIN M, 1960, J BIOL CHEM, V235, P1112; Fromme JC, 2003, NAT STRUCT BIOL, V10, P204, DOI 10.1038/nsb902; Garrido-Franco M, 2002, J BIOL CHEM, V277, P12396, DOI 10.1074/jbc.M108734200; HAYASHI H, 1995, J BIOCHEM-TOKYO, V118, P463, DOI 10.1093/oxfordjournals.jbchem.a124931; Hur O, 2002, BIOCHEMISTRY-US, V41, P9991, DOI 10.1021/bi025568u; Ikushiro H, 2004, BIOCHEMISTRY-US, V43, P1082, DOI 10.1021/bi035706v; Jhee KH, 2001, BIOCHEMISTRY-US, V40, P10873, DOI 10.1021/bi011087j; JOHNSTON M, 1979, BIOCHEMISTRY-US, V18, P1729, DOI 10.1021/bi00576a015; Karsten WE, 2002, METHOD ENZYMOL, V354, P223; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P208, DOI 10.1016/S0076-6879(97)77013-7; Laber B, 1999, EUR J BIOCHEM, V263, P212, DOI 10.1046/j.1432-1327.1999.00487.x; LABER B, 1994, BIOCHEMISTRY-US, V33, P3413, DOI 10.1021/bi00177a035; MADSEN BC, 1981, ANAL CHEM, V53, P1924, DOI 10.1021/ac00235a046; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; MOCKEL B, 1992, J BACTERIOL, V174, P8065; Omi R, 2003, J BIOL CHEM, V278, P46035, DOI 10.1074/jbc.M308065200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; SCHNACKERZ KD, 1979, BIOCHEMISTRY-US, V18, P3557, DOI 10.1021/bi00583a019; Thomazeau K, 2001, PROTEIN SCI, V10, P638, DOI 10.1110/ps.44301; TONEY MD, 1993, BIOCHEMISTRY-US, V32, P1471, DOI 10.1021/bi00057a010	27	10	11	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2774	2784		10.1074/jbc.M110.186205	http://dx.doi.org/10.1074/jbc.M110.186205			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21084312	hybrid, Green Published			2022-12-25	WOS:000286464300043
J	Schmidt, DR; Schmidt, S; Holmstrom, SR; Makishima, M; Yu, RT; Cummins, CL; Mangelsdorf, DJ; Kliewer, SA				Schmidt, Daniel R.; Schmidt, Samuel; Holmstrom, Sam R.; Makishima, Makoto; Yu, Ruth T.; Cummins, Carolyn L.; Mangelsdorf, David J.; Kliewer, Steven A.			AKR1B7 Is Induced by the Farnesoid X Receptor and Metabolizes Bile Acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE VAS-DEFERENS; FEEDBACK-REGULATION; NUCLEAR RECEPTOR; URSODEOXYCHOLIC ACID; LIVER; MICE; FXR; CARCINOGENESIS; IDENTIFICATION; EXPRESSION	Although bile acids are crucial for the absorption of lipophilic nutrients in the intestine, they are cytotoxic at high concentrations and can cause liver damage and promote colorectal carcinogenesis. The farnesoid X receptor (FXR), which is activated by bile acids and abundantly expressed in enterohepatic tissues, plays a crucial role in maintaining bile acids at safe concentrations. Here, we show that FXR induces expression of Akr1b7 (aldo-keto reductase 1b7) in murine small intestine, colon, and liver by binding directly to a response element in the Akr1b7 promoter. We further show that AKR1B7 metabolizes 3-keto bile acids to 3 beta-hydroxy bile acids that are less toxic to cultured cells than their 3 alpha-hydroxy precursors. These findings reveal a feed-forward, protective pathway operative in murine enterohepatic tissues wherein FXR induces AKR1B7 to detoxify bile acids.	[Schmidt, Daniel R.; Schmidt, Samuel; Holmstrom, Sam R.; Makishima, Makoto; Cummins, Carolyn L.; Mangelsdorf, David J.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Kliewer, Steven A.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Schmidt, Daniel R.; Cummins, Carolyn L.; Mangelsdorf, David J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Yu, Ruth T.] Salk Inst Biol Sci, Gene Express Lab, La Jolla, CA 92037 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Salk Institute	Mangelsdorf, DJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	davo.mango@utsouthwestern.edu; steven.kliewer@utsouthwestern.edu		Yu, Ruth/0000-0002-9527-9627; Mangelsdorf, David/0000-0002-4355-0796; Cummins, Carolyn/0000-0001-7603-6577	Howard Hughes Medical Institute; Robert A. Welch Foundation [I-1275, I-588]; National Institutes of Health [CA114109, GM007062]; Nuclear Receptor Signaling Atlas (NURSA); NATIONAL CANCER INSTITUTE [R01CA114109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007062] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Robert A. Welch Foundation(The Welch Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nuclear Receptor Signaling Atlas (NURSA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Howard Hughes Medical Institute (to D.J.M.), the Robert A. Welch Foundation (I-1275 to D.J. M. and I-588 to S.A.K.), the National Institutes of Health (CA114109 to S.A.K.), Nuclear Receptor Signaling Atlas (NURSA), and National Institutes of Health Pharmacological Sciences Training Grant GM007062.	Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Cheng JB, 2003, FALK SYMP, V129, P1; EARNEST DL, 1994, CANCER RES, V54, P5071; Hamilton JP, 2007, AM J PHYSIOL-GASTR L, V293, pG256, DOI 10.1152/ajpgi.00027.2007; Hofmann AF, 1999, ARCH INTERN MED, V159, P2647, DOI 10.1001/archinte.159.22.2647; Hofmann AF, 2009, CLIN GASTROENTEROL H, V7, P1151, DOI 10.1016/j.cgh.2009.07.026; Inagaki T, 2006, P NATL ACAD SCI USA, V103, P3920, DOI 10.1073/pnas.0509592103; Kang DJ, 2008, BBA-MOL CELL BIOL L, V1781, P16, DOI 10.1016/j.bbalip.2007.10.008; Kuipers F, 2004, REV ENDOCR METAB DIS, V5, P319, DOI 10.1023/B:REMD.0000045103.00467.9a; Lee YK, 2008, MOL ENDOCRINOL, V22, P1345, DOI 10.1210/me.2007-0565; Lefrancois-Martinez AM, 1999, J BIOL CHEM, V274, P32875, DOI 10.1074/jbc.274.46.32875; Li-Hawkins J, 2002, J CLIN INVEST, V110, P1191, DOI 10.1172/JCI200216309; Liu MJ, 2009, MOL PHARMACOL, V76, P604, DOI 10.1124/mol.109.057455; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Maloney PR, 2000, J MED CHEM, V43, P2971, DOI 10.1021/jm0002127; Maran RRM, 2009, J PHARMACOL EXP THER, V328, P469, DOI 10.1124/jpet.108.145409; Martinez A, 2001, CHEM-BIOL INTERACT, V130, P903, DOI 10.1016/S0009-2797(00)00244-1; Modica S, 2008, CANCER RES, V68, P9589, DOI 10.1158/0008-5472.CAN-08-1791; Narisawa T, 1999, J EXP CLIN CANC RES, V18, P259; Perez MJ, 2009, WORLD J GASTROENTERO, V15, P1677, DOI 10.3748/wjg.15.1677; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; RODA A, 1983, J BIOL CHEM, V258, P6362; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Schmidt DR, 2008, NUTR REV, V66, pS88, DOI 10.1111/j.1753-4887.2008.00092.x; Schmidt DR, 2010, J BIOL CHEM, V285, P14486, DOI 10.1074/jbc.M110.116004; Scotti E, 2007, CELL MOL LIFE SCI, V64, P2477, DOI 10.1007/s00018-007-7280-y; Shea HC, 2007, P NATL ACAD SCI USA, V104, P11526, DOI 10.1073/pnas.0705089104; Val P, 2002, ENDOCRINOLOGY, V143, P3435, DOI 10.1210/en.2002-220293; Vergnes L, 2003, J LIPID RES, V44, P503, DOI 10.1194/jlr.M200399-JLR200; Volle DH, 2004, MOL ENDOCRINOL, V18, P888, DOI 10.1210/me.2003-0338; Yang F, 2007, CANCER RES, V67, P863, DOI 10.1158/0008-5472.CAN-06-1078	33	29	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2425	2432		10.1074/jbc.M110.181230	http://dx.doi.org/10.1074/jbc.M110.181230			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21081494	hybrid, Green Published			2022-12-25	WOS:000286464300006
J	Collinson, EJ; Wimmer-Kleikamp, S; Gerega, SK; Yang, YH; Parish, CR; Dawes, IW; Stocker, R				Collinson, Emma J.; Wimmer-Kleikamp, Sabine; Gerega, Sebastien K.; Yang, Yee Hwa; Parish, Christopher R.; Dawes, Ian W.; Stocker, Roland			The Yeast Homolog of Heme Oxygenase-1 Affords Cellular Antioxidant Protection via the Transcriptional Regulation of Known Antioxidant Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROBE LEVEL DATA; SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS; GLUTATHIONE-PEROXIDASE; SULFOXIDE REDUCTASE; HYDROGEN-PEROXIDE; IRON DEPRIVATION; CELLS; EXPRESSION; BILIRUBIN	Heme oxygenase-1 (HO-1) degrades heme and protects cells from oxidative challenge. This antioxidant activity is thought to result from the HO-1 enzymatic activity, manifested by a decrease in the concentration of the pro-oxidant substrate heme, and an increase in the antioxidant product bilirubin. Using a global transcriptional approach, and yeast as a model, we show that HO-1 affords cellular protection via up-regulation of transcripts encoding enzymes involved in cellular antioxidant defense, rather than via its oxygenase activity. Like mammalian cells, yeast responds to oxidative stress by expressing its HO-1 homolog and, compared with the wild type, heme oxygenase-null mutant cells have increased sensitivity toward oxidants that is rescued by overexpression of human HO-1 or its yeast homolog. Increased oxidant sensitivity of heme oxygenase-null mutant cells is explained by a decrease in the expression of the genes encoding gamma-glutamylcysteine synthetase, glutathione peroxidase, catalase, and methionine sulfoxide reductase, because overexpression of any of these genes affords partial, and overexpression of all four genes provides complete, protection to the null mutant. Genes encoding antioxidant enzymes represent only a small portion of the 480 differentially expressed transcripts in heme oxygenase-null mutants. Transcriptional regulation may be explained by the nuclear localization of heme oxygenase observed in oxidant-challenged cells. Our results challenge the notion that HO-1 functions simply as a catabolic and antioxidant enzyme. They indicate much broader functions for HO-1, the unraveling of which may help explain the multiple biological responses reported in animals as a result of altered HO-1 expression.	[Collinson, Emma J.; Wimmer-Kleikamp, Sabine; Stocker, Roland] Univ Sydney, Sch Med Sci Pathol, Ctr Vasc Res, Sydney, NSW 2006, Australia; [Collinson, Emma J.; Wimmer-Kleikamp, Sabine; Stocker, Roland] Univ Sydney, Sydney Med Sch, Bosch Inst, Sydney, NSW 2006, Australia; [Yang, Yee Hwa] Univ Sydney, Sch Math & Stat, Sydney, NSW 2006, Australia; [Parish, Christopher R.] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia; [Dawes, Ian W.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Ramaciotti Ctr Gene Funct Anal, Sydney, NSW 2052, Australia	University of Sydney; University of Sydney; University of Sydney; Australian National University; John Curtin School of Medical Research; University of New South Wales Sydney	Stocker, R (corresponding author), Univ Sydney, Sch Med Sci Pathol, Ctr Vasc Res, Sydney, NSW 2006, Australia.	roland.stocker@sydney.edu.au	Yang, Jean YH/D-2920-2015; Stocker, Roland/AAV-4489-2021	Yang, Jean YH/0000-0002-5271-2603; Parish, Christopher/0000-0001-7740-0430	Australian Research Council [DP0988470]; University of Sydney Medical Foundation; National Health & Medical Research Council of Australia (NHMRC) [455395]; Sydney Medical School; University of Sydney	Australian Research Council(Australian Research Council); University of Sydney Medical Foundation(University of Sydney); National Health & Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Sydney Medical School; University of Sydney(University of Sydney)	This work was supported by the Australian Research Council DP0988470, University of Sydney Medical Foundation, and the National Health & Medical Research Council of Australia (NHMRC) Program Grant 455395.; Supported by a NHMRC CJ Martin Fellowship and an Early Career Grant of the Sydney Medical School.; Supported by a NHMRC Senior Principal Research Fellowship and a University of Sydney Professorial Fellowship. To whom correspondence should be addressed: Centre for Vascular Research, School of Medical Sciences (Pathology) and Bosch Institute, Sydney Medical School, University of Sydney, Sydney, NSW 2006. Tel.: 61-2-9036-3207; Fax: 61-2-90363038; E-mail:roland.stocker@sydney.edu.au.	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; ASKWITH C, 1994, CELL, V76, P403, DOI 10.1016/0092-8674(94)90346-8; Avery AM, 2001, J BIOL CHEM, V276, P33730, DOI 10.1074/jbc.M105672200; CHANG SW, 1988, J APPL PHYSIOL, V65, P358, DOI 10.1152/jappl.1988.65.1.358; Clark JE, 2000, BIOCHEM J, V348, P615, DOI 10.1042/0264-6021:3480615; CRUSE I, 1988, J BIOL CHEM, V263, P3348; Deshane J, 2007, J EXP MED, V204, P605, DOI 10.1084/jem.20061609; Grant CM, 1998, BIOCHEM BIOPH RES CO, V253, P893, DOI 10.1006/bbrc.1998.9864; Hori R, 2002, J BIOL CHEM, V277, P10712, DOI 10.1074/jbc.M107749200; Inoue Y, 1999, J BIOL CHEM, V274, P27002, DOI 10.1074/jbc.274.38.27002; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kim DY, 2006, JPN J APPL PHYS 2, V45, pL74, DOI 10.1143/JJAP.45.L74; King MC, 2006, NATURE, V442, P1003, DOI 10.1038/nature05075; Kwast KE, 1998, J EXP BIOL, V201, P1177; LAUTIER D, 1992, CARCINOGENESIS, V13, P227, DOI 10.1093/carcin/13.2.227; Le DT, 2009, J BIOL CHEM, V284, P4354, DOI 10.1074/jbc.M805891200; Lin Q, 2007, J BIOL CHEM, V282, P20621, DOI 10.1074/jbc.M607954200; Lushchak V, 2005, ARCH BIOCHEM BIOPHYS, V441, P35, DOI 10.1016/j.abb.2005.06.010; MAINES MD, 1986, J BIOL CHEM, V261, P411; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Moskovitz J, 1997, P NATL ACAD SCI USA, V94, P9585, DOI 10.1073/pnas.94.18.9585; OHTAKE Y, 1991, YEAST, V7, P953, DOI 10.1002/yea.320070907; Philpott CC, 2008, EUKARYOT CELL, V7, P20, DOI 10.1128/EC.00354-07; Piantadosi CA, 2008, CIRC RES, V103, P1232, DOI 10.1161/01.RES.0000338597.71702.ad; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; Protchenko O, 2003, J BIOL CHEM, V278, P36582, DOI 10.1074/jbc.M306584200; Reeves WM, 2003, MOL CELL BIOL, V23, P349, DOI 10.1128/MCB.23.1.349-358.2003; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; SCHNEIDER BL, 1995, YEAST, V11, P1265, DOI 10.1002/yea.320111306; Shakoury-Elizeh M, 2004, MOL BIOL CELL, V15, P1233, DOI 10.1091/mbc.E03-09-0642; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sousa-Lopes A, 2004, FEBS LETT, V578, P152, DOI 10.1016/j.febslet.2004.10.090; Stearman R, 1996, SCIENCE, V271, P1552, DOI 10.1126/science.271.5255.1552; Stocker R, 2004, ANTIOXID REDOX SIGN, V6, P841, DOI 10.1089/1523086041797999; STOCKER R, 1990, FREE RADICAL RES COM, V9, P101, DOI 10.3109/10715769009148577; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Stocker R, 2006, CIRCULATION, V114, P2178, DOI 10.1161/CIRCULATIONAHA.105.598698; Tanaka T, 2005, J BIOL CHEM, V280, P42078, DOI 10.1074/jbc.M508622200; TENHUNEN R, 1969, J BIOL CHEM, V244, P6388; Williams SEJ, 2004, SCIENCE, V306, P2093, DOI 10.1126/science.1105010; Wu CY, 2009, J BIOL CHEM, V284, P27544, DOI 10.1074/jbc.M109.042036; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165; YAMAGUCHIIWAI Y, 1995, EMBO J, V14, P1231, DOI 10.1002/j.1460-2075.1995.tb07106.x; Yi L, 2007, J BIOL CHEM, V282, P21056, DOI 10.1074/jbc.M700664200	46	35	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2205	2214		10.1074/jbc.M110.187062	http://dx.doi.org/10.1074/jbc.M110.187062			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21081499	Green Published, hybrid			2022-12-25	WOS:000286191500061
J	Jin, ZN; Deval, J; Johnson, KA; Swinney, DC				Jin, Zhinan; Deval, Jerome; Johnson, Kenneth A.; Swinney, David C.			Characterization of the Elongation Complex of Dengue Virus RNA Polymerase ASSEMBLY, KINETICS OF NUCLEOTIDE INCORPORATION, AND FIDELITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DE-NOVO INITIATION; DNA-POLYMERASE; CRYSTAL-STRUCTURE; VIRAL-RNA; IN-VITRO; MECHANISM; REPLICATION; NS5B; DISCRIMINATION; TEMPERATURE	Dengue virus (DENV) infects 50-100 million people worldwide per year, causing severe public health problems. DENV RNA-dependent RNA polymerase, an attractive target for drug development, catalyzes de novo replication of the viral genome in three phases: initiation, transition, and elongation. The aim of this work was to characterize the mechanism of nucleotide addition catalyzed by the polymerase domain of DENV serotype 2 during elongation using transient kinetic methods. We measured the kinetics of formation of the elongation complex containing the polymerase and a double-stranded RNA by pre-incubation experiments. The elongation complex assembly is slow, following a one-step binding mechanism with an association rate of 0.0016 +/- 0.0001 mu M(-1)s(-1) and a dissociation rate of 0.00020 +/- 0.00005 s(-1) at 37 degrees C. The elongation complex assembly is 6 times slower at 30 degrees C and requires Mg2+ during preincubation. The assembled elongation complex incorporates a correct nucleotide, GTP, to the primer with a K-d of 275 +/- 52 mu M and k(pol) of 18 +/- 1 s(-1). The fidelity of the polymerase is 1/34,000, 1/59,000, 1/135,000 for misincorporation of UTP, ATP, and CTP opposite CMP in the template, respectively. The fidelity of DENV polymerase is comparable with HIV reverse transcriptase and the poliovirus polymerase. This work reports the first description of presteady-state kinetics and fidelity for an RNA-dependent RNA polymerase from the Flaviviridae family.	[Jin, Zhinan; Deval, Jerome; Swinney, David C.] Roche Palo Alto LLC, Virol DTA, Palo Alto, CA 94034 USA; [Johnson, Kenneth A.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA	Roche Holding; University of Texas System; University of Texas Austin	Swinney, DC (corresponding author), iRND3, Inst Rare & Neglected Dis Drug Discovery, 1514 Ridge Rd, Belmont, CA 94002 USA.	david.swinney@iRND3.org	jin, zhinan/D-4217-2013		Roche Postdoc fellowship	Roche Postdoc fellowship	Supported by a Roche Postdoc fellowship.	Ackermann M, 2001, J BIOL CHEM, V276, P39926, DOI 10.1074/jbc.M104248200; Ahn J, 1997, BIOCHEMISTRY-US, V36, P1100, DOI 10.1021/bi961653o; Arias A, 2008, J VIROL, V82, P12346, DOI 10.1128/JVI.01297-08; Arnold JJ, 2004, BIOCHEMISTRY-US, V43, P5126, DOI 10.1021/bi035212y; Beaulieu PL, 2009, EXPERT OPIN THER PAT, V19, P145, DOI 10.1517/13543770802672598; Benzaghou I, 2004, J BIOL CHEM, V279, P49755, DOI 10.1074/jbc.M409657200; Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009; Butcher SJ, 2001, NATURE, V410, P235, DOI 10.1038/35065653; Carroll SS, 2000, BIOCHEMISTRY-US, V39, P8243, DOI 10.1021/bi991992s; Castro C, 2005, VIRUS RES, V107, P141, DOI 10.1016/j.virusres.2004.11.004; Castro C, 2009, NAT STRUCT MOL BIOL, V16, P212, DOI 10.1038/nsmb.1540; Chinnaswamy S, 2008, J BIOL CHEM, V283, P20535, DOI 10.1074/jbc.M801490200; Choi KH, 2004, P NATL ACAD SCI USA, V101, P4425, DOI 10.1073/pnas.0400660101; Choi KH, 2009, CURR OPIN STRUC BIOL, V19, P746, DOI 10.1016/j.sbi.2009.10.015; Cramer J, 2006, BIOCHEMISTRY-US, V45, P3610, DOI 10.1021/bi051483s; Deval J, 2007, J BIOL CHEM, V282, P16907, DOI 10.1074/jbc.M701973200; Domingo E, 1996, FASEB J, V10, P859, DOI 10.1096/fasebj.10.8.8666162; DONLIN MJ, 1991, BIOCHEMISTRY-US, V30, P538, DOI 10.1021/bi00216a031; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Dutartre H, 2005, J BIOL CHEM, V280, P6359, DOI 10.1074/jbc.M410191200; Ferrer-Orta C, 2006, CURR OPIN STRUC BIOL, V16, P27, DOI 10.1016/j.sbi.2005.12.002; Fiala KA, 2004, BIOCHEMISTRY-US, V43, P2106, DOI 10.1021/bi0357457; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Hong Z, 2001, VIROLOGY, V285, P6, DOI 10.1006/viro.2001.0948; Johnson AA, 2001, J BIOL CHEM, V276, P38097; Johnson AA, 2001, J BIOL CHEM, V276, P38090; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100; KATI WM, 1992, J BIOL CHEM, V267, P25988; Kellinger MW, 2010, P NATL ACAD SCI USA, V107, P7734, DOI 10.1073/pnas.0913946107; Latour DR, 2010, ANTIVIR RES, V87, P213, DOI 10.1016/j.antiviral.2010.05.003; Lee HR, 2006, J BIOL CHEM, V281, P36236, DOI 10.1074/jbc.M607964200; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Maag D, 2001, J BIOL CHEM, V276, P46094, DOI 10.1074/jbc.C100349200; Malet H, 2008, ANTIVIR RES, V80, P23, DOI 10.1016/j.antiviral.2008.06.007; Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; Nomaguchi M, 2003, J VIROL, V77, P8831, DOI 10.1128/JVI.77.16.8831-8842.2003; Ranjith-Kumar CT, 2002, J VIROL, V76, P12513, DOI 10.1128/JVI.76.24.12513-12525.2002; Sampath A, 2009, ANTIVIR RES, V81, P6, DOI 10.1016/j.antiviral.2008.08.004; Selisko B, 2006, VIROLOGY, V351, P145, DOI 10.1016/j.virol.2006.03.026; TILTON RF, 1992, BIOCHEMISTRY-US, V31, P2469, DOI 10.1021/bi00124a006; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; Villordo SM, 2009, VIRUS RES, V139, P230, DOI 10.1016/j.virusres.2008.07.016; WONG I, 1991, BIOCHEMISTRY-US, V30, P526, DOI 10.1021/bi00216a030; Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06; You S, 1999, J BIOL CHEM, V274, P33714, DOI 10.1074/jbc.274.47.33714; Zhong WD, 2000, J VIROL, V74, P2017, DOI 10.1128/JVI.74.4.2017-2022.2000	49	40	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2067	2077		10.1074/jbc.M110.162685	http://dx.doi.org/10.1074/jbc.M110.162685			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21078673	hybrid, Green Published			2022-12-25	WOS:000286191500049
J	Murai, T; Maruyama, Y; Mio, K; Nishiyama, H; Suga, M; Sato, C				Murai, Toshiyuki; Maruyama, Yuusuke; Mio, Kazuhiro; Nishiyama, Hidetoshi; Suga, Mitsuo; Sato, Chikara			Low Cholesterol Triggers Membrane Microdomain-dependent CD44 Shedding and Suppresses Tumor Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; LIPID RAFTS; MATRIX-METALLOPROTEINASE; ADAM10; RECEPTOR; CLEAVAGE; BETA; GLYCOPROTEIN; ACTIVATION; DEPLETION	CD44 is a cell surface adhesion molecule for hyaluronan and is implicated in tumor invasion and metastasis. Proteolytic cleavage of CD44 plays a critical role in the migration of tumor cells and is regulated by factors present in the tumor microenvironment, such as hyaluronan oligosaccharides and epidermal growth factor. However, molecular mechanisms underlying the proteolytic cleavage on membranes remain poorly understood. In this study, we demonstrated that cholesterol depletion with methyl-beta-cyclodextrin, which disintegrates membrane lipid rafts, enhances CD44 shedding mediated by a disintegrin and metalloproteinase 10 (ADAM10) and that cholesterol depletion disorders CD44 localization to the lipid raft. We also evaluated the effect of long term cholesterol reduction using a statin agent and demonstrated that statin enhances CD44 shedding and suppresses tumor cell migration on a hyaluronan-coated substrate. Our results indicate that membrane lipid organization regulates CD44 shedding and propose a possible molecular mechanism by which cholesterol reduction might be effective for preventing and treating the progression of malignant tumors.	[Murai, Toshiyuki] Osaka Univ, Grad Sch Med, Div Prevent & Environm Med, Dept Immunol & Microbiol, Suita, Osaka 5650871, Japan; [Maruyama, Yuusuke; Mio, Kazuhiro; Sato, Chikara] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki 3058568, Japan; [Mio, Kazuhiro; Sato, Chikara] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Tokyo 1350064, Japan; [Nishiyama, Hidetoshi; Suga, Mitsuo] JEOL Ltd, Adv Technol Div, Tokyo 1968558, Japan	Osaka University; National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); Jeol Ltd; JEOL Japan	Murai, T (corresponding author), Osaka Univ, Grad Sch Med, Div Prevent & Environm Med, Dept Immunol & Microbiol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	murai@orgctl.med.osaka-u.ac.jp	Sato, Chikara/M-7183-2016; Mio, Kazuhiro/L-7488-2018	Sato, Chikara/0000-0001-5543-4496; Mio, Kazuhiro/0000-0002-1655-8231	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a research grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Alfandari D, 2009, SEMIN CELL DEV BIOL, V20, P153, DOI 10.1016/j.semcdb.2008.09.006; Anderegg U, 2009, J INVEST DERMATOL, V129, P1471, DOI 10.1038/jid.2008.323; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; BOURGUIGNON LYW, 1991, J BIOL CHEM, V266, P11761; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Cisse MA, 2005, J BIOL CHEM, V280, P40624, DOI 10.1074/jbc.M506069200; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Drappatz J, 2009, EXPERT REV NEUROTHER, V9, P519, DOI [10.1586/ern.09.10, 10.1586/ERN.09.10]; Gimpl G, 1997, BIOCHEMISTRY-US, V36, P10959, DOI 10.1021/bi963138w; Gliemroth J, 2003, NEUROSURG REV, V26, P117, DOI 10.1007/s10143-003-0258-9; Gomez-Mouton C, 2001, P NATL ACAD SCI USA, V98, P9642, DOI 10.1073/pnas.171160298; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; Hakulinen J, 2006, J BIOL CHEM, V281, P21369, DOI 10.1074/jbc.M602053200; Harris B, 2009, BRAIN RES, V1296, P203, DOI 10.1016/j.brainres.2009.07.105; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Ilangumaran S, 1998, BIOCHEM J, V335, P433, DOI 10.1042/bj3350433; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; KLEIN U, 1995, BIOCHEMISTRY-US, V34, P13784, DOI 10.1021/bi00042a009; Kojro E, 2001, P NATL ACAD SCI USA, V98, P5815, DOI 10.1073/pnas.081612998; LIBERMANN TA, 1985, NATURE, V313, P144, DOI 10.1038/313144a0; Lokeshwar VB, 1997, CANCER RES, V57, P773; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Matthews V, 2003, J BIOL CHEM, V278, P38829, DOI 10.1074/jbc.M210584200; MCGOOKEY DJ, 1983, J CELL BIOL, V96, P1273, DOI 10.1083/jcb.96.5.1273; Mechtersheimer S, 2001, J CELL BIOL, V155, P661, DOI 10.1083/jcb.200101099; Mio K, 2000, J BIOL CHEM, V275, P32413, DOI 10.1074/jbc.M005428200; Murai T, 2006, BIOCHEM J, V395, P65, DOI 10.1042/BJ20050582; Murai T, 2004, J BIOL CHEM, V279, P4541, DOI 10.1074/jbc.M307356200; Murphy G, 2009, SEMIN CELL DEV BIOL, V20, P138, DOI 10.1016/j.semcdb.2008.09.004; Nishiyama H, 2010, J STRUCT BIOL, V169, P438, DOI 10.1016/j.jsb.2010.01.005; Okamoto I, 1999, J BIOL CHEM, V274, P25525, DOI 10.1074/jbc.274.36.25525; Oliferenko S, 1999, J CELL BIOL, V146, P843, DOI 10.1083/jcb.146.4.843; Patra SK, 2008, BBA-REV CANCER, V1785, P182, DOI 10.1016/j.bbcan.2007.11.002; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; ROTHBERG KG, 1990, J CELL BIOL, V111, P2931, DOI 10.1083/jcb.111.6.2931; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Solomon KR, 2008, TRENDS ENDOCRIN MET, V19, P113, DOI 10.1016/j.tem.2007.12.004; Suenaga N, 2005, ONCOGENE, V24, P859, DOI 10.1038/sj.onc.1208258; Sugahara KN, 2006, J BIOL CHEM, V281, P5861, DOI 10.1074/jbc.M506740200; Sugahara KN, 2003, J BIOL CHEM, V278, P32259, DOI 10.1074/jbc.M300347200; TARONE G, 1984, J CELL BIOL, V99, P512, DOI 10.1083/jcb.99.2.512; Teodorczyk M, 2010, J CELL PHYSIOL, V222, P1, DOI 10.1002/jcp.21901; THOMAS L, 1992, J CELL BIOL, V118, P971, DOI 10.1083/jcb.118.4.971; Veit G, 2007, J BIOL CHEM, V282, P27424, DOI 10.1074/jbc.M703425200; von Tresckow B, 2004, J IMMUNOL, V172, P4324, DOI 10.4049/jimmunol.172.7.4324; Wolozin B, 2001, P NATL ACAD SCI USA, V98, P5371, DOI 10.1073/pnas.101123198; Wu HL, 2009, ACTA CRYSTALLOGR E, V65, pO1014, DOI 10.1107/S1600536809012781; Xu DS, 2009, FASEB J, V23, P3674, DOI 10.1096/fj.09-133462; Zimina EP, 2005, J BIOL CHEM, V280, P34019, DOI 10.1074/jbc.M503751200	51	120	125	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1999	2007		10.1074/jbc.M110.184010	http://dx.doi.org/10.1074/jbc.M110.184010			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21087933	Green Published, hybrid			2022-12-25	WOS:000286191500041
J	Wang, W; Zhu, JQ; Springer, TA; Luo, BH				Wang, Wei; Zhu, Jieqing; Springer, Timothy A.; Luo, Bing-Hao			Tests of Integrin Transmembrane Domain Homo-oligomerization during Integrin Ligand Binding and Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOPLASMIC DOMAINS; STRUCTURAL BASIS; EXTRACELLULAR SEGMENT; CRYSTAL-STRUCTURE; CELL-MEMBRANES; ALPHA-SUBUNIT; OUTSIDE-IN; ACTIVATION; ALPHA-IIB-BETA-3; ALPHA(IIB)BETA(3)	Integrin transmembrane (TM) and/or cytoplasmic domains play a critical role in integrin bidirectional signaling. Although it has been shown that TM and/or cytoplasmic alpha and beta domains associate in the resting state and separation of these domains is required for both inside-out and outside-in signaling, the role of TM homomeric association remains elusive. Formation of TM homo-oligomers was observed in micelles and bacterial membranes previously, and it has been proposed that homomeric association is important for integrin activation and clustering. This study addresses whether integrin TM domains form homo-oligomers in mammalian cell membranes using cysteine scanning mutagenesis. Our results show that TM homomeric interaction does not occur before or after soluble ligand binding or during inside-out activation. In addition, even though the cysteine mutants and the heterodimeric disulfide-bounded mutant could form clusters after adhering to immobilized ligand, the integrin TM domains do not form homo-oligomers, suggesting that integrin TM homomeric association is not critical for integrin clustering or outside-in signaling. Therefore, integrin TM homo-oligomerization is not required for integrin activation, ligand binding, or signaling.	[Luo, Bing-Hao] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Zhu, Jieqing; Springer, Timothy A.] Harvard Univ, Sch Med, Dept Pathol, Immune Dis Inst, Boston, MA 02115 USA; [Zhu, Jieqing; Springer, Timothy A.] Childrens Hosp, Boston, MA 02115 USA	Louisiana State University System; Louisiana State University; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Boston Children's Hospital	Luo, BH (corresponding author), Louisiana State Univ, Dept Biol Sci, 202 Life Sci Bldg, Baton Rouge, LA 70803 USA.	luo@lsu.edu			American Heart Association [10GRNT3960011]; Louisiana Board of Regents [LEQSF(2009-12)-RD-A07]	American Heart Association(American Heart Association); Louisiana Board of Regents	This work was supported by American Heart Association Grant 10GRNT3960011 and Louisiana Board of Regents Grant LEQSF(2009-12)-RD-A07.	Anthis NJ, 2009, J BIOL CHEM, V284, P36700, DOI 10.1074/jbc.M109.061275; Askari JA, 2010, J CELL BIOL, V188, P891, DOI 10.1083/jcb.200907174; Beglova N, 2002, NAT STRUCT BIOL, V9, P282, DOI 10.1038/nsb779; Buensuceso C, 2003, J BIOL CHEM, V278, P15217, DOI 10.1074/jbc.M213234200; DU XP, 1993, J BIOL CHEM, V268, P23087; Gottschalk KE, 2004, STRUCTURE, V12, P1109, DOI 10.1016/j.str.2004.02.039; Gottschalk KE, 2002, PROTEIN SCI, V11, P1800, DOI 10.1110/ps.4120102; Hantgan RR, 2004, BBA-PROTEINS PROTEOM, V1700, P19, DOI 10.1016/j.bbapap.2004.03.011; Hantgan RR, 1999, BIOCHEMISTRY-US, V38, P14461, DOI 10.1021/bi9907680; Hantgan RR, 2003, J BIOL CHEM, V278, P3417, DOI 10.1074/jbc.M208869200; Hato T, 1998, J CELL BIOL, V141, P1685, DOI 10.1083/jcb.141.7.1685; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Imai Y, 2008, BLOOD, V112, P5007, DOI 10.1182/blood-2008-03-144543; Kim C, 2009, BLOOD, V113, P4747, DOI 10.1182/blood-2008-10-186551; Kim M, 2004, J CELL BIOL, V167, P1241, DOI 10.1083/jcb.200404160; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; KORNBERG L, 1992, J BIOL CHEM, V267, P23439; KORNBERG LJ, 1991, P NATL ACAD SCI USA, V88, P8392, DOI 10.1073/pnas.88.19.8392; Lau TL, 2008, J BIOL CHEM, V283, P16162, DOI 10.1074/jbc.M801748200; Lau TL, 2008, BIOCHEMISTRY-US, V47, P4008, DOI 10.1021/bi800107a; Lau TL, 2009, EMBO J, V28, P1351, DOI 10.1038/emboj.2009.63; Li R, 2004, BIOCHEM SOC T, V32, P412, DOI 10.1042/BST0320412; Li RH, 2004, J BIOL CHEM, V279, P26666, DOI 10.1074/jbc.M314168200; Li RH, 2003, SCIENCE, V300, P795, DOI 10.1126/science.1079441; Li RH, 2001, P NATL ACAD SCI USA, V98, P12462, DOI 10.1073/pnas.221463098; Li W, 2005, P NATL ACAD SCI USA, V102, P1424, DOI 10.1073/pnas.0409334102; Lin X, 2006, PROTEINS, V63, P16, DOI 10.1002/prot.20882; Lu CF, 2001, J BIOL CHEM, V276, P14642, DOI 10.1074/jbc.M100600200; Luo BH, 2005, P NATL ACAD SCI USA, V102, P3679, DOI 10.1073/pnas.0409440102; Luo BH, 2004, PLOS BIOL, V2, P776, DOI 10.1371/journal.pbio.0020153; Luo BH, 2003, P NATL ACAD SCI USA, V100, P2403, DOI 10.1073/pnas.0438060100; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; MIYAMOTO S, 1995, SCIENCE, V267, P883, DOI 10.1126/science.7846531; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; Park EJ, 2007, J CLIN INVEST, V117, P2526, DOI 10.1172/JCI31570; Park EJ, 2010, BLOOD, V115, P1572, DOI 10.1182/blood-2009-08-237917; Parthasarathy K, 2008, PROTEIN SCI, V17, P930, DOI 10.1110/ps.073234208; Partridge AW, 2005, J BIOL CHEM, V280, P7294, DOI 10.1074/jbc.M412701200; SACHEZMADRID F, 1999, EMBO J, V18, P501; Schneider D, 2004, J BIOL CHEM, V279, P9840, DOI 10.1074/jbc.M312749200; Semmrich M, 2005, J EXP MED, V201, P1987, DOI 10.1084/jem.20041850; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Wang W, 2010, J CELL BIOCHEM, V109, P447, DOI 10.1002/jcb.22427; Wegener KL, 2008, MOL MEMBR BIOL, V25, P376, DOI 10.1080/09687680802269886; Whitlock BB, 2000, J CELL BIOL, V151, P1305, DOI 10.1083/jcb.151.6.1305; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yang J, 2009, P NATL ACAD SCI USA, V106, P17729, DOI 10.1073/pnas.0909589106; Ye F, 2010, J CELL BIOL, V188, P157, DOI 10.1083/jcb.200908045; Zhu H, 2010, J MOL BIOL, V401, P882, DOI 10.1016/j.jmb.2010.06.062; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018; Zhu JQ, 2007, BLOOD, V110, P2475, DOI 10.1182/blood-2007-03-080077; Zhu J, 2009, MOL CELL, V34, P234, DOI 10.1016/j.molcel.2009.02.022	58	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1860	1867		10.1074/jbc.M110.193797	http://dx.doi.org/10.1074/jbc.M110.193797			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21081497	Green Published, hybrid			2022-12-25	WOS:000286191500026
J	Llorente, B; Rodriguez, V; Alonso, GD; Torres, HN; Flawia, MM; Bravo-Almonacid, FF				Llorente, Briardo; Rodriguez, Vanina; Alonso, Guillermo D.; Torres, Hector N.; Flawia, Mirtha M.; Bravo-Almonacid, Fernando F.			Improvement of Aroma in Transgenic Potato As a Consequence of Impairing Tuber Browning	PLOS ONE			English	Article							NUTRITIONAL-VALUE; EXPRESSION; QUALITY; MOUSE; ENRICHMENT; HEALTH; FLAVOR; MICE	Sensory analysis studies are critical in the development of quality enhanced crops, and may be an important component in the public acceptance of genetically modified foods. It has recently been established that odor preferences are shared between humans and mice, suggesting that odor exploration behavior in mice may be used to predict the effect of odors in humans. We have previously found that mice fed diets supplemented with engineered nonbrowning potatoes (-PPO) consumed more potato than mice fed diets supplemented with wild-type potatoes (WT). This prompted us to explore a possible role of potato odor in mice preference for nonbrowning potatoes. Taking advantage of two well established neuroscience paradigms, the "open field test" and the "nose-poking preference test", we performed experiments where mice exploration behavior was monitored in preference assays on the basis of olfaction alone. No obvious preference was observed towards -PPO or WT lines when fresh potato samples were tested. However, when oxidized samples were tested, mice consistently investigated -PPO potatoes more times and for longer periods than WT potatoes. Congruently, humans discriminated WT from -PPO samples with a considerably better performance when oxidized samples were tested than when fresh samples were tested in blind olfactory experiments. Notably, even though participants ranked all samples with an intermediate level of pleasantness, there was a general consensus that the -PPO samples had a more intense odor and also evoked the sense-impression of a familiar vegetable more often than the WT samples. Taken together, these findings suggest that our previous observations might be influenced, at least in part, by differential odors that are accentuated among the lines once oxidative deterioration takes place. Additionally, our results suggest that nonbrowning potatoes, in addition to their extended shelf life, maintain their odor quality for longer periods of time than WT potatoes. To our knowledge this is the first report on the use of an animal model applied to the sensory analysis of a transgenic crop.	[Llorente, Briardo; Rodriguez, Vanina; Alonso, Guillermo D.; Torres, Hector N.; Flawia, Mirtha M.; Bravo-Almonacid, Fernando F.] Consejo Nacl Invest Cient & Tecn CONICET, Inst Invest Ingn Genet & Biol Mol INGEBI, Buenos Aires, DF, Argentina; [Alonso, Guillermo D.; Torres, Hector N.; Flawia, Mirtha M.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol Biol Mol & Celular, Buenos Aires, DF, Argentina; [Bravo-Almonacid, Fernando F.] Univ Nacl Quilmes, Dept Ciencia & Tecnol, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Llorente, B (corresponding author), Consejo Nacl Invest Cient & Tecn CONICET, Inst Invest Ingn Genet & Biol Mol INGEBI, Buenos Aires, DF, Argentina.	fbravo@dna.uba.ar	Llorente, Briardo/B-1341-2014; Torres, Héctor/GXG-1780-2022; Llorente, Briardo/AAX-2422-2020; Alonso, Guillermo Daniel/AAI-6674-2020	Llorente, Briardo/0000-0002-3727-1395; Llorente, Briardo/0000-0002-3727-1395; Alonso, Guillermo Daniel/0000-0001-9386-9431	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Facultad de Ciencias Exactas y Naturales (FCEyN); Universidad de Buenos Aires (UBA); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Facultad de Ciencias Exactas y Naturales (FCEyN); Universidad de Buenos Aires (UBA)(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), Argentina(ANPCyT)	This work was funded by Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Facultad de Ciencias Exactas y Naturales (FCEyN), Universidad de Buenos Aires (UBA), Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluru M, 2008, J EXP BOT, V59, P3551, DOI 10.1093/jxb/ern212; Amiri L, 1998, DEV PSYCHOBIOL, V33, P157, DOI 10.1002/(SICI)1098-2302(199809)33:2<157::AID-DEV6>3.0.CO;2-I; Arab A, 2007, J CHEM ECOL, V33, P1845, DOI 10.1007/s10886-007-9358-2; Baker JM, 2006, PLANT BIOTECHNOL J, V4, P381, DOI 10.1111/j.1467-7652.2006.00197.x; Butelli E, 2008, NAT BIOTECHNOL, V26, P1301, DOI 10.1038/nbt.1506; Senar JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010716; Davidovich-Rikanati R, 2007, NAT BIOTECHNOL, V25, P899, DOI 10.1038/nbt1312; Diretto G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000350; Dominguez T, 2010, PLANT PHYSIOL, V153, P655, DOI 10.1104/pp.110.154815; Dudareva N, 2008, CURR OPIN BIOTECH, V19, P181, DOI 10.1016/j.copbio.2008.02.011; Friedman M, 1996, J AGR FOOD CHEM, V44, P631, DOI 10.1021/jf950394r; Goff SA, 2006, SCIENCE, V311, P815, DOI 10.1126/science.1112614; Graff GD, 2009, NAT BIOTECHNOL, V27, P702, DOI 10.1038/nbt0809-702; Haddad R, 2008, CURR OPIN NEUROBIOL, V18, P438, DOI 10.1016/j.conb.2008.09.007; Khan RM, 2007, J NEUROSCI, V27, P10015, DOI 10.1523/JNEUROSCI.1158-07.2007; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Koob AO, 2006, J NEUROSCI METH, V157, P330, DOI 10.1016/j.jneumeth.2006.04.020; Larrinaga AR, 2010, ACTA OECOL, V36, P141, DOI 10.1016/j.actao.2009.11.003; LLORENTE B, 2010, PLANT BIOTE IN PRESS, DOI DOI 10.1111/J.1467-7652.2010.00534.X; Mandairon N, 2009, J NEUROSCI METH, V180, P296, DOI 10.1016/j.jneumeth.2009.04.008; Mandairon N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004209; Morris J, 2008, P NATL ACAD SCI USA, V105, P1431, DOI 10.1073/pnas.0709005105; Niu XL, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-100; Paine JA, 2005, NAT BIOTECHNOL, V23, P482, DOI 10.1038/nbt1082; PANHUBER H, 1982, PHYSIOL BEHAV, V28, P149, DOI 10.1016/0031-9384(82)90116-0; Park S, 2009, PLANT BIOTECHNOL J, V7, P106, DOI 10.1111/j.1467-7652.2008.00379.x; Peters HC, 2005, NAT NEUROSCI, V8, P51, DOI 10.1038/nn1375; ROESSLER EB, 1978, J FOOD SCI, V43, P940, DOI 10.1111/j.1365-2621.1978.tb02458.x; Schwab W, 2008, PLANT J, V54, P712, DOI 10.1111/j.1365-313X.2008.03446.x; Small DM, 2008, NEURON, V57, P786, DOI 10.1016/j.neuron.2008.01.021; Smallegange RC, 2009, J CHEM ECOL, V35, P933, DOI 10.1007/s10886-009-9668-7; Smith DR, 2009, BEHAV BRAIN RES, V201, P22, DOI 10.1016/j.bbr.2009.01.024; THYGESEN PW, 1995, PLANT PHYSIOL, V109, P525, DOI 10.1104/pp.109.2.525; Tomas-Barberan F, 2001, J SCI FOOD AGR, V81, P853, DOI 10.1002/jsfa.885; Underwood BA, 2005, PLANT PHYSIOL, V138, P255, DOI 10.1104/pp.104.051144; Veyrac A, 2007, LEARN MEMORY, V14, P847, DOI 10.1101/lm.708807	36	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2010	5	11							e14030	10.1371/journal.pone.0014030	http://dx.doi.org/10.1371/journal.pone.0014030			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681OY	21103333	Green Published, gold, Green Submitted			2022-12-25	WOS:000284327800015
J	Maminiaina, OF; Gil, P; Briand, FX; Albina, E; Keita, D; Andriamanivo, HR; Chevalier, V; Lancelot, R; Martinez, D; Rakotondravao, R; Rajaonarison, JJ; Koko, M; Andriantsimahavandy, AA; Jestin, V; de Almeida, RS				Maminiaina, Olivier F.; Gil, Patricia; Briand, Francois-Xavier; Albina, Emmanuel; Keita, Djeneba; Andriamanivo, Harentsoaniaina Rasamoelina; Chevalier, Veronique; Lancelot, Renaud; Martinez, Dominique; Rakotondravao, R.; Rajaonarison, Jean-Joseph; Koko, M.; Andriantsimahavandy, Abel A.; Jestin, Veronique; de Almeida, Renata Servan			Newcastle Disease Virus in Madagascar: Identification of an Original Genotype Possibly Deriving from a Died Out Ancestor of Genotype IV	PLOS ONE			English	Article							HEMAGGLUTININ-NEURAMINIDASE PROTEIN; ACID BINDING-SITE; PHYLOGENETIC ANALYSIS; FUSION GLYCOPROTEIN; NUCLEOTIDE-SEQUENCE; MONOCLONAL-ANTIBODIES; CLEAVAGE-ACTIVATION; VIRULENT-STRAINS; OUTBREAKS; HN	In Madagascar, Newcastle disease (ND) has become enzootic after the first documented epizootics in 1946, with recurrent annual outbreaks causing mortality up to 40%. Four ND viruses recently isolated in Madagascar were genotypically and pathotypically characterised. By phylogenetic inference based on the F and HN genes, and also full-genome sequence analyses, the NDV Malagasy isolates form a cluster distant enough to constitute a new genotype hereby proposed as genotype XI. This new genotype is presumably deriving from an ancestor close to genotype IV introduced in the island probably more than 50 years ago. Our data show also that all the previously described neutralising epitopes are conserved between Malagasy and vaccine strains. However, the potential implication in vaccination failures of specific amino acid substitutions predominantly found on surface-exposed epitopes of F and HN proteins is discussed.	[Maminiaina, Olivier F.; Andriamanivo, Harentsoaniaina Rasamoelina; Rakotondravao, R.] FOFIFA DRZV, Antananarivo, Madagascar; [Gil, Patricia; Albina, Emmanuel; Keita, Djeneba; Lancelot, Renaud; Martinez, Dominique; de Almeida, Renata Servan] CIRAD, BIOS Dept, UMR CMAEE, Montpellier, France; [Briand, Francois-Xavier; Jestin, Veronique] Anses Ploufragan Plouzane Lab, VIPAC Unit, Ploufragan, France; [Chevalier, Veronique] CIRAD, ES Dept, UPR AGIRS, Montpellier, France; [Rajaonarison, Jean-Joseph; Koko, M.; Andriantsimahavandy, Abel A.] Antananarivo Univ Madagascar, Antananarivo, Madagascar	CIRAD; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); CIRAD	Maminiaina, OF (corresponding author), FOFIFA DRZV, Antananarivo, Madagascar.	renata.almeida@cirad.fr	Lancelot, Renaud/HGE-1086-2022	Lancelot, Renaud/0000-0002-5826-5242; BRIAND, Francois-Xavier/0000-0002-8094-9368; Albina, Emmanuel/0000-0002-6613-3047	French Ministry of Foreign Affairs (MAE) [GRIPAVI 2006-26]; EU [016236, 01/06/2006-31/05/2011]	French Ministry of Foreign Affairs (MAE); EU(European Commission)	This study was mainly funded by the French Ministry of Foreign Affairs (MAE) via the FSP project [GRIPAVI 2006-26] and partly by the EU network of excellence project [EPIZONE (016236, 01/06/2006-31/05/2011, http://www.epizone-eu.net/default.aspx)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.l	Abolnik C, 2004, ARCH VIROL, V149, P603, DOI 10.1007/s00705-003-0218-2; Aldous EW, 2003, AVIAN PATHOL, V32, P239, DOI 10.1080/030794503100009783; Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; ALEXANDER DJ, 1985, AVIAN PATHOL, V14, P365, DOI 10.1080/03079458508436238; Alexander DJ, 1997, AVIAN PATHOL, V26, P399, DOI 10.1080/03079459708419222; Alexander DJ, 2003, DIS POULTRY, P63; Bogoyavlenskiy A, 2005, VIRUS GENES, V31, P13, DOI 10.1007/s11262-004-2195-2; Chen L, 2001, STRUCTURE, V9, P255, DOI 10.1016/S0969-2126(01)00581-0; Cho SH, 2007, VIRUS GENES, V35, P293, DOI 10.1007/s11262-007-0078-z; Connaris H, 2002, J VIROL, V76, P1816, DOI 10.1128/JVI.76.4.1816-1824.2002; Crennell S, 2000, NAT STRUCT BIOL, V7, P1068; Czegledi A, 2003, AVIAN PATHOL, V32, P271, DOI 10.1080/0307945031000097868; Czegledi A, 2002, EPIDEMIOL INFECT, V129, P679, DOI 10.1017/S0950268802007732; Czegledi A, 2006, VIRUS RES, V120, P36, DOI 10.1016/j.virusres.2005.11.009; de Almeida RS, 2009, VACCINE, V27, P3127, DOI 10.1016/j.vaccine.2009.03.076; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fields B. N, 1996, FIELDS VIROLOGY, V1, P1177; GOTOH B, 1992, J VIROL, V66, P6391, DOI 10.1128/JVI.66.11.6391-6397.1992; Gravel KA, 2003, J VIROL, V77, P11040, DOI 10.1128/JVI.77.20.11040-11049.2003; Han GZ, 2008, VIROLOGY, V371, P54, DOI 10.1016/j.virol.2007.09.038; Herczeg J, 1999, ARCH VIROL, V144, P2087, DOI 10.1007/s007050050624; Huang ZH, 2004, J VIROL, V78, P4176, DOI 10.1128/JVI.78.8.4176-4184.2004; Huovilainen A, 2001, ARCH VIROL, V146, P1775, DOI 10.1007/s007050170063; IORIO RM, 1989, VIRUS RES, V13, P245, DOI 10.1016/0168-1702(89)90019-1; IORIO RM, 1991, J VIROL, V65, P4999, DOI 10.1128/JVI.65.9.4999-5006.1991; JORGENSEN ED, 1987, VIROLOGY, V156, P12, DOI 10.1016/0042-6822(87)90431-4; Kapczynski DR, 2005, VACCINE, V23, P3424, DOI 10.1016/j.vaccine.2005.01.140; Kattenbelt JA, 2006, VET MICROBIOL, V114, P134, DOI 10.1016/j.vetmic.2005.10.041; Kim LM, 2007, J VIROL, V81, P12641, DOI 10.1128/JVI.00843-07; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KIMURA S, 2004, CHEMBIO INFORMATICS, V4, P1; Koko M., 2006, International Atomic Energy Agency Technical Documents (IAEA-TECDOCs), P157; Lee YJ, 2004, AVIAN PATHOL, V33, P482, DOI 10.1080/03079450400003700; Lien YY, 2007, VET MICROBIOL, V123, P194, DOI 10.1016/j.vetmic.2007.03.006; Liu HL, 2007, J VIROL METHODS, V140, P206, DOI 10.1016/j.jviromet.2006.10.012; Liu XF, 2003, ARCH VIROL, V148, P1387, DOI 10.1007/s00705-003-0014-z; Lomniczi B, 1998, ARCH VIROL, V143, P49, DOI 10.1007/s007050050267; Maminiaina OF, 2007, REV SCI TECH OIE, V26, P691, DOI 10.20506/rst.26.3.1776; Martin S, 2009, J GEN VIROL, V90, P1527, DOI 10.1099/vir.0.008193-0; Mayo M A, 2002, Arch Virol, V147, P1071, DOI 10.1007/s007050200036; Mayo MA, 2002, ARCH VIROL, V147, P1655, DOI 10.1007/s007050200039; Meulemans G, 2002, AVIAN PATHOL, V31, P515, DOI 10.1080/0307945021000005897; MILLAR NS, 1986, J GEN VIROL, V67, P1917, DOI 10.1099/0022-1317-67-9-1917; Miller PJ, 2007, VACCINE, V25, P7238, DOI 10.1016/j.vaccine.2007.07.017; Miller PJ, 2010, INFECT GENET EVOL, V10, P26, DOI 10.1016/j.meegid.2009.09.012; Miller PJ, 2009, VIROLOGY, V391, P64, DOI 10.1016/j.virol.2009.05.033; MILLER PJ, 2009, INFECT GENETICS EVOL; OIE, 2004, MAN DIAGN TESTS VACC, P270; OIE, 2009, MAN DIAGN TESTS VACC, P576; Panda A, 2004, J VIROL, V78, P4965, DOI 10.1128/JVI.78.10.4965-4975.2004; Peeters BPH, 2000, ARCH VIROL, V145, P1829, DOI 10.1007/s007050070059; Qin ZM, 2008, VIRUS RES, V131, P299, DOI 10.1016/j.virusres.2007.10.001; Qin Zhuoming, 2008, Weishengwu Xuebao, V48, P226; RAJAONARISON JJ, 1991, P WORKSH NEWC DIS VA, P135; Romer-Oberdorfer A, 2003, J GEN VIROL, V84, P3121, DOI 10.1099/vir.0.19416-0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Seal Bruce S., 2004, Functional & Integrative Genomics, V4, P246; Sinkovics JG, 2000, J CLIN VIROL, V16, P1, DOI 10.1016/S1386-6532(99)00072-4; Snoeck CJ, 2009, ARCH VIROL, V154, P47, DOI 10.1007/s00705-008-0269-5; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Terregino C, 2003, AVIAN PATHOL, V32, P63, DOI 10.1080/0307945021000070732; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TOYODA T, 1987, VIROLOGY, V158, P242, DOI 10.1016/0042-6822(87)90261-3; Tsai HJ, 2004, VET MICROBIOL, V104, P19, DOI 10.1016/j.vetmic.2004.09.005; Ujvari D, 2003, VIRUS RES, V96, P63, DOI 10.1016/S0168-1702(03)00173-4; Wang ZL, 2006, ANN NY ACAD SCI, V1081, P228, DOI 10.1196/annals.1373.027; Wehmann E, 2003, VET MICROBIOL, V94, P269, DOI 10.1016/S0378-1135(03)00133-0; Xu M, 2008, ARCH VIROL, V153, P1281, DOI 10.1007/s00705-008-0115-9; Yang CY, 1999, AVIAN DIS, V43, P125, DOI 10.2307/1592771; Yu L, 2001, J CLIN MICROBIOL, V39, P3512, DOI 10.1128/JCM.39.10.3512-3519.2001; YUSOFF K, 1988, VIRUS RES, V11, P319, DOI 10.1016/0168-1702(88)90005-6; YUSOFF K, 1989, J GEN VIROL, V70, P3105, DOI 10.1099/0022-1317-70-11-3105; Zaitsev V, 2004, J VIROL, V78, P3733, DOI 10.1128/JVI.78.7.3733-3741.2004; Zou J, 2005, VIRUS GENES, V30, P13, DOI 10.1007/s11262-004-4577-x	74	57	64	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e13987	10.1371/journal.pone.0013987	http://dx.doi.org/10.1371/journal.pone.0013987			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085573	Green Published, gold			2022-12-25	WOS:000284231800017
J	Perlot, T; Pawlitzky, I; Manis, JP; Zarrin, AA; Brodeur, PH; Alt, FW				Perlot, Thomas; Pawlitzky, Inka; Manis, John P.; Zarrin, Ali A.; Brodeur, Peter H.; Alt, Frederick W.			Analysis of Mice Lacking DNaseI Hypersensitive Sites at the 5 ' End of the IgH Locus	PLOS ONE			English	Article							HEAVY-CHAIN LOCUS; LYMPHOCYTE DEVELOPMENT; IMMUNOGLOBULIN LOCI; V(D)J RECOMBINATION; ENHANCER; REGION; GENE; COMPARTMENTALIZATION; REARRANGEMENTS; MECHANISM	The 5' end of the IgH locus contains a cluster of DNaseI hypersensitive sites, one of which (HS1) was shown to be pro-B cell specific and to contain binding sites for the transcription factors PU. 1, E2A, and Pax5. These data as well as the location of the hypersensitive sites at the 5' border of the IgH locus suggested a possible regulatory function for these elements with respect to the IgH locus. To test this notion, we generated mice carrying targeted deletions of either the pro-B cell specific site HS1 or the whole cluster of DNaseI hypersensitive sites. Lymphocytes carrying these deletions appear to undergo normal development, and mutant B cells do not exhibit any obvious defects in V(D)J recombination, allelic exclusion, or class switch recombination. We conclude that deletion of these DNaseI hypersensitive sites does not have an obvious impact on the IgH locus or B cell development.	[Perlot, Thomas; Zarrin, Ali A.; Alt, Frederick W.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Childrens Hosp,Immune Dis Inst, Boston, MA 02115 USA; [Perlot, Thomas; Zarrin, Ali A.; Alt, Frederick W.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Pawlitzky, Inka; Brodeur, Peter H.] Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Program Immunol, Boston, MA 02111 USA; [Manis, John P.] Harvard Univ, Sch Med, Childrens Hosp Boston, Boston, MA USA; [Manis, John P.] Harvard Univ, Sch Med, Joint Program Transfus Med, Boston, MA USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Tufts University; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Perlot, T (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, IMBA, A-1010 Vienna, Austria.	alt@enders.tch.harvard.edu			National Institutes of Health [R01 AI020047, GM36064]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036064] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health R01 AI020047 (to FWA) and GM36064 (to PHB). FWA is an Investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALT FW, 1984, EMBO J, V3, P1209, DOI 10.1002/j.1460-2075.1984.tb01955.x; Chaudhuri Jayanta, 2007, Adv Immunol, V94, P157, DOI 10.1016/S0065-2776(06)94006-1; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; Chowdhury D, 2001, EMBO J, V20, P6394, DOI 10.1093/emboj/20.22.6394; Dudley DD, 2003, J EXP MED, V198, P1439, DOI 10.1084/jem.20030627; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Hewitt SL, 2008, NAT IMMUNOL, V9, P396, DOI 10.1038/ni1567; Jolly CJ, 1997, NUCLEIC ACIDS RES, V25, P1913, DOI 10.1093/nar/25.10.1913; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Khamlichi AA, 2000, ADV IMMUNOL, V75, P317, DOI 10.1016/S0065-2776(00)75008-5; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Mostoslavsky R, 2004, CELL, V118, P539, DOI 10.1016/j.cell.2004.08.023; Pawlitzky I, 2006, J IMMUNOL, V176, P6839, DOI 10.4049/jimmunol.176.11.6839; Perlot T, 2005, P NATL ACAD SCI USA, V102, P14362, DOI 10.1073/pnas.0507090102; Perlot T, 2008, ADV IMMUNOL, V99, P1, DOI 10.1016/S0065-2776(08)00601-9; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Sakai E, 1999, P NATL ACAD SCI USA, V96, P1526, DOI 10.1073/pnas.96.4.1526; Sleckman BP, 1997, IMMUNITY, V7, P505, DOI 10.1016/S1074-7613(00)80372-6; Yang QX, 2005, MOL CELL BIOL, V25, P6021, DOI 10.1128/MCB.25.14.6021-6030.2005	20	10	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e13992	10.1371/journal.pone.0013992	http://dx.doi.org/10.1371/journal.pone.0013992			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085586	Green Published, Green Submitted, gold			2022-12-25	WOS:000284231800022
J	Flatz, R; Gerber, LR				Flatz, Ramona; Gerber, Leah R.			First Evidence for Adoption in California Sea Lions	PLOS ONE			English	Article							FOSTERING BEHAVIOR; EUMETOPIAS-JUBATUS; RELATEDNESS; CARE	Demographic parameters such as birth and death rates determine the persistence of populations. Understanding the mechanisms that influence these rates is essential to developing effective management strategies. Alloparental behavior, or the care of non-filial young, has been documented in many species and has been shown to influence offspring survival. However, the role of alloparental behavior in maintaining population viability has not been previously studied. Here, we provide the first evidence for adoption in California sea lions and show that adoption potentially works to maintain a high survival rate of young and may ultimately contribute to population persistence. Alloparental behavior should have a positive effect on the population growth rate when the sum of the effects on fitness for the alloparent and beneficiary is positive.	[Flatz, Ramona; Gerber, Leah R.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Flatz, R (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	Rflatz@Willamette.edu		Gerber, Leah/0000-0002-6763-6842	National Science Foundation [0347960]	National Science Foundation(National Science Foundation (NSF))	The research was supported by the National Science Foundation (grant no. 0347960 to LG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony LL, 2000, BIOL CONSERV, V95, P303, DOI 10.1016/S0006-3207(00)00037-9; BONESS DJ, 1990, BEHAV ECOL SOCIOBIOL, V27, P113, DOI 10.1007/BF00168454; Bowen W.D., 1991, P66; BRANDBURY RB, 2001, TRENDS ECOL EVOL, V16, P440; Childerhouse S, 2001, NEW ZEAL J ZOOL, V28, P189, DOI 10.1080/03014223.2001.9518263; Gerber LR, 2006, FRONT ECOL ENVIRON, V4, P419, DOI 10.1890/1540-9295(2006)4[419:IBDIDM]2.0.CO;2; Gonzalez-Suarez M, 2009, MOL ECOL, V18, P1088, DOI 10.1111/j.1365-294X.2009.04093.x; Hoberecht LK, 2006, MAR MAMMAL SCI, V22, P683, DOI 10.1111/j.1748-7692.2006.00046.x; HOFFMAN JI, 2005, P R SOC B, V272, P2063; Insley SJ, 2000, NATURE, V406, P404, DOI 10.1038/35019064; Insley Stephen J., 2003, Aquatic Mammals, V29, P181, DOI 10.1578/016754203101024149; Maniscalco JM, 2007, J ETHOL, V25, P125, DOI 10.1007/s10164-006-0001-4; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; McAndrew FT, 2002, CURR DIR PSYCHOL SCI, V11, P79, DOI 10.1111/1467-8721.00173; ONO KA, 1987, BEHAV ECOL SOCIOBIOL, V21, P109, DOI 10.1007/BF02395438; PACKER C, 1992, ANIM BEHAV, V43, P265, DOI 10.1016/S0003-3472(05)80222-2; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; RIEDMAN M, 1990, PINNIPEDS SEALS SEA; RIEDMAN ML, 1982, BEHAV ECOL SOCIOBIOL, V11, P203, DOI 10.1007/BF00300063; RIEDMAN ML, 1982, Q REV BIOL, V57, P405, DOI 10.1086/412936; Roulin A, 2002, ANIM BEHAV, V63, P201, DOI 10.1006/anbe.2001.1895; Schaeff CM, 1999, ANIM BEHAV, V57, P427, DOI 10.1006/anbe.1998.1001; Szteren D, 2006, LOW WAKE FI, P369; Valsecchi E, 2002, MOL ECOL, V11, P507, DOI 10.1046/j.0962-1083.2001.01459.x; Wilson AB, 2009, MOL ECOL, V18, P1307, DOI 10.1111/j.1365-294X.2009.04103.x	25	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e13873	10.1371/journal.pone.0013873	http://dx.doi.org/10.1371/journal.pone.0013873			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	676NU	21079727	Green Published, gold			2022-12-25	WOS:000283920000007
J	Mhawech-Fauceglia, P; Wang, D; Kesterson, J; Clark, K; Monhollen, L; Odunsi, K; Lele, S; Liu, S				Mhawech-Fauceglia, Paulette; Wang, Dan; Kesterson, Joshua; Clark, Kimberly; Monhollen, Laketa; Odunsi, Kunle; Lele, Shashikant; Liu, Song			Microarray Analysis Reveals Distinct Gene Expression Profiles Among Different Tumor Histology, Stage and Disease Outcomes in Endometrial Adenocarcinoma	PLOS ONE			English	Article							LYSOPHOSPHATIDIC ACID; TRANSCRIPTION FACTOR; TREFOIL FACTOR-3; OVARIAN-CANCER; RHO-GTPASES; CARCINOMA; GRADE; SUBFAMILY; INVASION; SUBTYPES	Background: Endometrial cancer is the most common gynecologic malignancy in developed countries and little is known about the underlying mechanism of stage and disease outcomes. The goal of this study was to identify differentially expressed genes (DEG) between late vs. early stage endometrioid adenocarcinoma (EAC) and uterine serous carcinoma (USC), as well as between disease outcomes in each of the two histological subtypes. Methodology/Principal Finding: Gene expression profiles of 20 cancer samples were analyzed (EAC = 10, USC = 10) using the human genome wide illumina bead microarrays. There was little overlap in the DEG sets between late vs. early stages in EAC and USC, and there was an insignificant overlap in DEG sets between good and poor prognosis in EAC and USC. Remarkably, there was no overlap between the stage-derived DEGs and the prognosis-derived DEGs for each of the two histological subtypes. Further functional annotation of differentially expressed genes showed that the composition of enriched function terms were different among different DEG sets. Gene expression differences for selected genes of various stages and outcomes were confirmed by qRT-PCR with a high validation rate. Conclusion: This data, although preliminary, suggests that there might be involvement of distinct groups of genes in tumor progression (late vs. early stage) in each of the EAC and USC. It also suggests that these genes are different from those involved in tumor outcome (good vs. poor prognosis). These involved genes, once clinically verified, may be important for predicting tumor progression and tumor outcome.	[Mhawech-Fauceglia, Paulette; Monhollen, Laketa] Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY 14263 USA; [Wang, Dan; Liu, Song] Roswell Pk Canc Inst, Dept Biostat, Buffalo, NY 14263 USA; [Kesterson, Joshua; Odunsi, Kunle; Lele, Shashikant] Roswell Pk Canc Inst, Dept Gynecol Oncol Surg, Buffalo, NY 14263 USA; [Clark, Kimberly] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute	Mhawech-Fauceglia, P (corresponding author), Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY 14263 USA.	pmhawech1@yahoo.com; song.liu@roswellaprk.org			NATIONAL CANCER INSTITUTE [T32CA108456] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA108456] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aznar S, 2004, CANCER LETT, V206, P181, DOI 10.1016/j.canlet.2003.08.035; Babyatsky M, 2009, CLIN EXP METASTAS, V26, P143, DOI 10.1007/s10585-008-9224-9; Benito V, 2009, INT J GYNECOL CANCER, V19, P1364, DOI 10.1111/IGC.0b013e3181b7a1d5; Berthold J, 2008, ACTA PHARMACOL SIN, V29, P285, DOI 10.1111/j.1745-7254.2008.00773.x; Bignotti E, 2008, BRIT J CANCER, V99, P768, DOI 10.1038/sj.bjc.6604546; Campbell TN, 2008, CURR ISSUES MOL BIOL, V10, P61; CHENG YY, BR J CANC, V99, P2083; Corson TW, 2006, INT J CANCER, V119, P1088, DOI 10.1002/ijc.21954; Corson TW, 2005, ONCOGENE, V24, P4741, DOI 10.1038/sj.onc.1208641; del Pulgar TG, 2005, BIOESSAYS, V27, P602, DOI 10.1002/bies.20238; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gallagher WM, 2005, TRENDS MOL MED, V11, P336, DOI 10.1016/j.molmed.2005.06.001; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Herath NI, 2009, BRIT J CANCER, V100, P1095, DOI 10.1038/sj.bjc.6604970; Herath NI, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-144; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Idaghdour Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000052; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kieback DG, 1996, ANTICANCER RES, V16, P3371; Kim TM, 2008, INT J CANCER, V123, P2808, DOI 10.1002/ijc.23901; Kitchener HC, 2009, INT J GYNECOL CANCER, V19, P134, DOI 10.1111/IGC.0b013e3181995f90; KOHLER MF, 1992, CANCER RES, V52, P1622; LUKES AS, 1994, CANCER, V73, P2380, DOI 10.1002/1097-0142(19940501)73:9<2380::AID-CNCR2820730922>3.0.CO;2-G; Maitra A, 2003, CLIN CANCER RES, V9, P5988; Markowski J, 2009, J PHYSIOL PHARMACOL, V60, P57; Maxwell GL, 2005, CLIN CANCER RES, V11, P4056, DOI 10.1158/1078-0432.CCR-04-2001; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Moreno-Bueno G, 2003, CANCER RES, V63, P5697; National Comprehensive Cancer Network (NCCN), 2011, NCCN CLIN PRACT GUID; Naumann RW, 2008, CURR ONCOL REP, V10, P505, DOI 10.1007/s11912-008-0076-x; Osborne J, 1998, J SOC GYNECOL INVEST, V5, P277, DOI 10.1016/S1071-5576(98)00020-3; Planaguma J, 2004, CANCER RES, V64, P8846, DOI 10.1158/0008-5472.CAN-04-2066; Richter AM, 2009, BBA-REV CANCER, V1796, P114, DOI 10.1016/j.bbcan.2009.03.004; Risinger JI, 2003, CANCER RES, V63, P6; RISINGER JI, 1993, CANCER RES, V53, P5100; Santin AD, 2005, BRIT J CANCER, V92, P1561, DOI 10.1038/sj.bjc.6602480; Schafer G, 2008, CANCER RES, V68, P457, DOI 10.1158/0008-5472.CAN-07-5136; Sherwood V, 2008, MOL BIOL CELL, V19, P1772, DOI 10.1091/mbc.E07-07-0652; Smid-Koopman E, 2004, GYNECOL ONCOL, V93, P292, DOI 10.1016/j.ygyno.2004.01.022; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Soslow RA, 2007, AM J SURG PATHOL, V31, P979, DOI 10.1097/PAS.0b013e31802ee494; Su JL, 2006, CANCER RES, V66, P2553, DOI 10.1158/0008-5472.CAN-05-2645; Sutton G, 2005, GYNECOL ONCOL, V97, P755, DOI 10.1016/j.ygyno.2005.03.011; Tashiro H, 1997, CANCER RES, V57, P3935; Taylor HS, 2000, SEMIN REPROD MED, V18, P81, DOI 10.1055/s-2000-13478; van der Weyden L, 2007, BBA-REV CANCER, V1776, P58, DOI 10.1016/j.bbcan.2007.06.003; Wlazlinski A, 2007, PROSTATE, V67, P1770, DOI 10.1002/pros.20667; Yu SX, 2008, JNCI-J NATL CANCER I, V100, P1630, DOI 10.1093/jnci/djn378; Zhou J, 1998, ONCOGENE, V17, P2719, DOI 10.1038/sj.onc.1202198; Zorn KK, 2005, CLIN CANCER RES, V11, P6422, DOI 10.1158/1078-0432.CCR-05-0508	51	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e15415	10.1371/journal.pone.0015415	http://dx.doi.org/10.1371/journal.pone.0015415			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	676NU	21079744	gold, Green Published			2022-12-25	WOS:000283920000022
J	Schollenberger, L; Gronemeyer, T; Huber, CM; Lay, D; Wiese, S; Meyer, HE; Warscheid, B; Saffrich, R; Peranen, J; Gorgas, K; Just, WW				Schollenberger, Lukas; Gronemeyer, Thomas; Huber, Christoph M.; Lay, Dorothee; Wiese, Sebastian; Meyer, Helmut E.; Warscheid, Bettina; Saffrich, Rainer; Peranen, Johan; Gorgas, Karin; Just, Wilhelm W.			RhoA Regulates Peroxisome Association to Microtubules and the Actin Cytoskeleton	PLOS ONE			English	Article							RAT-LIVER; LYSOPHOSPHATIDIC ACID; MASS-SPECTROMETRY; ADP-RIBOSYLATION; CELL MOTILITY; MYOSIN-VI; VISUALIZATION; BINDING; DIVISION; DYNAMICS	The current view of peroxisome inheritance provides for the formation of new peroxisomes by both budding from the endoplasmic reticulum and autonomous division. Here we investigate peroxisome-cytoskeleton interactions and show by proteomics, biochemical and immunofluorescence analyses that actin, non-muscle myosin IIA (NMM IIA), RhoA, Rho kinase II (ROCKII) and Rab8 associate with peroxisomes. Our data provide evidence that (i) RhoA in its inactive state, maintained for example by C. botulinum toxin exoenzyme C3, dissociates from peroxisomes enabling microtubule-based peroxisomal movements and (ii) dominant-active RhoA targets to peroxisomes, uncouples the organelles from microtubules and favors Rho kinase recruitment to peroxisomes. We suggest that ROCKII activates NMM IIA mediating local peroxisomal constrictions. Although our understanding of peroxisome-cytoskeleton interactions is still incomplete, a picture is emerging demonstrating alternate RhoA-dependent association of peroxisomes to the microtubular and actin cytoskeleton. Whereas association of peroxisomes to microtubules clearly serves bidirectional, long-range saltatory movements, peroxisome-actomyosin interactions may support biogenetic functions balancing peroxisome size, shape, number, and clustering.	[Schollenberger, Lukas; Huber, Christoph M.; Lay, Dorothee; Just, Wilhelm W.] Heidelberg Univ, Heidelberg Ctr Biochem, Heidelberg, Germany; [Gronemeyer, Thomas; Wiese, Sebastian; Meyer, Helmut E.; Warscheid, Bettina] Univ Bochum, Med Proteom Ctr, Bochum, Germany; [Gronemeyer, Thomas] Univ Ulm, Dept Mol Genet & Cell Biol, Ulm, Germany; [Saffrich, Rainer] Heidelberg Univ, Dept Internal Med 5, Heidelberg, Germany; [Peranen, Johan] Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland; [Gorgas, Karin] Heidelberg Univ, Dept Anat & Med Cell Biol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruhr University Bochum; Ulm University; Ruprecht Karls University Heidelberg; University of Helsinki; Ruprecht Karls University Heidelberg	Schollenberger, L (corresponding author), Heidelberg Univ, Heidelberg Ctr Biochem, Heidelberg, Germany.	wilhelm.just@bzh.uni-heidelberg.de		Warscheid, Bettina/0000-0001-5096-1975; Saffrich, Rainer/0000-0002-0547-4550	European Union [LSGH-CT-2004-512018]; Deutsche Forschungsgemeinschaft [SFB 642]	European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the FP6 European Union Project "Peroxisomes in health and disease'' (LSGH-CT-2004-512018) as well as by funds from the Deutsche Forschungsgemeinschaft (SFB 642). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSON P, 1992, J CELL BIOL, V119, P617, DOI 10.1083/jcb.119.3.617; Armstrong J, 1996, J CELL SCI, V109, P1265; Boukharov AA, 1998, BIOCHEM J, V330, P1391, DOI 10.1042/bj3301391; Buss F, 2002, TRAFFIC, V3, P851, DOI 10.1034/j.1600-0854.2002.31201.x; Chakraborty AK, 2003, CELL TISSUE RES, V314, P381, DOI 10.1007/s00441-003-0773-6; Chen JL, 2005, J CELL BIOL, V169, P383, DOI 10.1083/jcb.200501157; Chen S, 2001, J BIOL CHEM, V276, P13209, DOI 10.1074/jbc.M010798200; Chevrier V, 2002, J CELL BIOL, V157, P807, DOI 10.1083/jcb.200203034; Coudrier E, 2007, PIGM CELL RES, V20, P153, DOI 10.1111/j.1600-0749.2007.00376.x; De Vos KJ, 2005, CURR BIOL, V15, P678, DOI 10.1016/j.cub.2005.02.064; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Fagarasanu A, 2007, ANNU REV CELL DEV BI, V23, P321, DOI 10.1146/annurev.cellbio.23.090506.123456; Fransen M, 2008, BBA-MOL CELL RES, V1783, P864, DOI 10.1016/j.bbamcr.2008.02.013; FRITZ G, 1994, BIOCHEM J, V300, P133, DOI 10.1042/bj3000133; Fukata Y, 2001, TRENDS PHARMACOL SCI, V22, P32, DOI 10.1016/S0165-6147(00)01596-0; GARRETT MD, 1989, J BIOL CHEM, V264, P10; GORGAS K, 1989, J LIPID RES, V30, P1859; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Hales CM, 2002, J BIOL CHEM, V277, P50415, DOI 10.1074/jbc.M209270200; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Harada A, 1998, J CELL BIOL, V141, P51, DOI 10.1083/jcb.141.1.51; HARTL FU, 1985, ARCH BIOCHEM BIOPHYS, V237, P124, DOI 10.1016/0003-9861(85)90261-9; Hattula K, 2006, J CELL SCI, V119, P4866, DOI 10.1242/jcs.03275; Hering F, 1997, EXP FLUIDS, V23, P472, DOI 10.1007/s003480050137; Herr Stefan, 1993, Methods in Molecular and Cellular Biology, V4, P164; Hoepfner D, 2001, J CELL BIOL, V155, P979, DOI 10.1083/jcb.200107028; HUBER C, 1999, THESIS U HEIDELBERG; Huber CM, 2000, PROTOPLASMA, V213, P18, DOI 10.1007/BF01280501; Huber CM, 1997, J CELL SCI, V110, P2955; Huber CN, 1999, EMBO J, V18, P5476, DOI 10.1093/emboj/18.20.5476; Hume AN, 2001, J CELL BIOL, V152, P795, DOI 10.1083/jcb.152.4.795; Ikonen E, 1997, J CELL SCI, V110, P2155; Jeynov B, 2006, FEBS LETT, V580, P5917, DOI 10.1016/j.febslet.2006.09.058; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; Knodler A, 2010, P NATL ACAD SCI USA, V107, P6346, DOI 10.1073/pnas.1002401107; Koch A, 2003, J BIOL CHEM, V278, P8597, DOI 10.1074/jbc.M211761200; KOSTER A, 1986, BIOCHEM BIOPH RES CO, V137, P626, DOI 10.1016/0006-291X(86)91124-1; Kranenburg O, 1999, MOL BIOL CELL, V10, P1851, DOI 10.1091/mbc.10.6.1851; Lay D, 2005, J BIOL CHEM, V280, P34489, DOI 10.1074/jbc.M503497200; Lay D, 2006, BBA-MOL CELL RES, V1763, P1678, DOI 10.1016/j.bbamcr.2006.08.036; Li XL, 2003, J BIOL CHEM, V278, P17012, DOI 10.1074/jbc.M212031200; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Ma C, 2009, IUBMB LIFE, V61, P713, DOI 10.1002/iub.196; Marelli M, 2004, J CELL BIOL, V167, P1099, DOI 10.1083/jcb.200404119; Mathur J, 2002, PLANT PHYSIOL, V128, P1031, DOI 10.1104/pp.011018; McNiven MA, 2000, TRENDS BIOCHEM SCI, V25, P115, DOI 10.1016/S0968-0004(99)01538-8; Meinecke M, 2010, NAT CELL BIOL, V12, P273, DOI 10.1038/ncb2027; Mejillano MR, 2004, CELL, V118, P363, DOI 10.1016/j.cell.2004.07.019; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Nie ZZ, 2006, J CELL SCI, V119, P1203, DOI 10.1242/jcs.02924; Noma K, 2006, AM J PHYSIOL-CELL PH, V290, pC661, DOI 10.1152/ajpcell.00459.2005; Orth JD, 2002, P NATL ACAD SCI USA, V99, P167, DOI 10.1073/pnas.012607899; Passreiter M, 1998, J CELL BIOL, V141, P373, DOI 10.1083/jcb.141.2.373; Pinner S, 2008, NAT CELL BIOL, V10, P127, DOI 10.1038/ncb1675; Qualmann B, 2003, BIOCHEM J, V371, P233, DOI 10.1042/bj20030139; Ramalho JS, 2009, PIGM CELL MELANOMA R, V22, P461, DOI 10.1111/j.1755-148X.2009.00567.x; Rapp S, 1996, J CELL SCI, V109, P837; Rasure J., 1990, International Journal of Imaging Systems and Technology, V2, P183, DOI 10.1002/ima.1850020304; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Rottensteiner H, 2003, MOL BIOL CELL, V14, P4316, DOI 10.1091/mbc.E03-03-0153; Rumenapp U, 1999, FEBS LETT, V459, P313, DOI 10.1016/S0014-5793(99)01270-3; Sahlender DA, 2005, J CELL BIOL, V169, P285, DOI 10.1083/jcb.200501162; Sato T, 2007, NATURE, V448, P366, DOI 10.1038/nature05929; Seabra MC, 2004, TRAFFIC, V5, P393, DOI 10.1111/j.1398-9219.2004.00190.x; Soldati T, 2006, NAT REV MOL CELL BIO, V7, P897, DOI 10.1038/nrm2060; Sorkin A, 2004, CURR OPIN CELL BIOL, V16, P392, DOI 10.1016/j.ceb.2004.06.001; Southwick FS, 2003, CELL MOTIL CYTOSKEL, V54, P41, DOI 10.1002/cm.10083; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tam YYC, 2003, MOL BIOL CELL, V14, P4089, DOI 10.1091/mbc.E03-03-0150; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; Thoms S, 2005, FEBS J, V272, P5169, DOI 10.1111/j.1742-4658.2005.04939.x; Tvarusko W, 1999, P NATL ACAD SCI USA, V96, P7950, DOI 10.1073/pnas.96.14.7950; Wiemer EAC, 1997, J CELL BIOL, V136, P71, DOI 10.1083/jcb.136.1.71; Wiese S, 2007, MOL CELL PROTEOMICS, V6, P2045, DOI 10.1074/mcp.M700169-MCP200; Woodcroft BJ, 2009, CYTOM PART A, V75A, P941, DOI 10.1002/cyto.a.20786; Wu XF, 1998, J CELL BIOL, V143, P1899, DOI 10.1083/jcb.143.7.1899; Wu XF, 2001, J CELL SCI, V114, P1091; Yan MD, 2005, CURR OPIN CELL BIOL, V17, P376, DOI 10.1016/j.ceb.2005.06.003; Yumura S, 2001, J CELL BIOL, V154, P137, DOI 10.1083/jcb.200011013	80	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e13886	10.1371/journal.pone.0013886	http://dx.doi.org/10.1371/journal.pone.0013886			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	676NU	21079737	Green Published, gold, Green Submitted			2022-12-25	WOS:000283920000017
J	Viviani, R; Lo, HN; Sim, EJ; Beschoner, P; Stingl, JC; Horn, AB				Viviani, Roberto; Lo, Hanna; Sim, Eun-Jin; Beschoner, Petra; Stingl, Julia C.; Horn, Andrea B.			The Neural Substrate of Positive Bias in Spontaneous Emotional Processing	PLOS ONE			English	Article							CONSCIOUS RESTING STATE; WORKING-MEMORY CAPACITY; MENTAL CONTROL; INDIVIDUAL-DIFFERENCES; PREFRONTAL CORTEX; IRONIC PROCESSES; HUMAN BRAIN; BLOOD-FLOW; DEPRESSION; SUPPRESSION	Even in the presence of negative information, healthy human beings display an optimistic tendency when thinking of past success and future chances, giving a positive bias to everyday's cognition. The tendency to actively select positive thoughts suggests the existence of a mechanism to exclude negative content, raising the issue of its dependence on mechanisms like those of effortful control. Using perfusion imaging, we examined how brain activations differed according to whether participants were left to prefer positive thoughts spontaneously, or followed an explicit instruction to the same effect, finding a widespread dissociation of brain perfusion patterns. Under spontaneous processing of emotional material, recruitment of areas associated with effortful attention, such as the dorsolateral prefrontal cortex, was reduced relative to instructed avoidance of negative material (F-1,F-58 = 26.24, p = 0.047, corrected). Under spontaneous avoidance perfusion increments were observed in several areas that were deactivated by the task, including the perigenual medial prefrontal cortex. Furthermore, individual differences in executive capacity were not associated with positive bias. These findings suggest that spontaneous positive cognitive emotion regulation in health may result from processes that, while actively suppressing emotionally salient information, differ from those associated with effortful and directed control.	[Viviani, Roberto] Univ Cambridge, Dept Psychiat, Human Brain Mapping Unit, Cambridge, England; [Viviani, Roberto; Lo, Hanna; Sim, Eun-Jin; Beschoner, Petra] Univ Ulm, Dept Psychiat & Psychotherapy 3, Ulm, Germany; [Beschoner, Petra] Univ Ulm, Psychotherapy & Psychosomat Clin, Ulm, Germany; [Stingl, Julia C.] Univ Ulm, Dept Clin Pharmacol, Ulm, Germany; [Horn, Andrea B.] Univ Zurich, Dept Psychol, Div Psychopathol & Clin Intervent, Zurich, Switzerland	University of Cambridge; Ulm University; Ulm University; Ulm University; University of Zurich	Viviani, R (corresponding author), Univ Cambridge, Dept Psychiat, Human Brain Mapping Unit, Cambridge, England.	rv103@hermes.cam.ac.uk	Stingl, Julia/H-2410-2013; Viviani, Roberto/A-8787-2015; Stingl, Julia C./ABA-7201-2020	Stingl, Julia/0000-0002-1566-8156; Stingl, Julia C./0000-0002-1566-8156; Horn, Andrea B./0000-0003-2729-7062; Viviani, Roberto/0000-0002-7517-6006				Aguirre GK, 2002, NEUROIMAGE, V15, P488, DOI 10.1006/nimg.2001.0990; ANDREASEN NC, 1995, AM J PSYCHIAT, V152, P1576; [Anonymous], 1993, HDB MENTAL CONTROL; Baddeley A., WORKING MEMORY THOUG, DOI [10.1093/acprof:oso/9780198528012.001.0001, DOI 10.1093/ACPROF:OSO/9780198528012.001.0001]; Badre D, 2009, NAT REV NEUROSCI, V10, P659, DOI 10.1038/nrn2667; Bar M, 2007, TRENDS COGN SCI, V11, P280, DOI 10.1016/j.tics.2007.05.005; Bargh JA, 2000, PSYCHOL BULL, V126, P925, DOI 10.1037//0033-2909.126.6.925; Bargh John A., 2007, HDB EMOTION REGULATI, P429, DOI DOI 10.1037/A0017745; Barrett LF, 2004, PSYCHOL BULL, V130, P553, DOI 10.1037/0033-2909.130.4.553; Beck A., 1976, COGNITIVE THEORY EMO; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Binder JR, 1999, J COGNITIVE NEUROSCI, V11, P80, DOI 10.1162/089892999563265; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Brewin CR, 2002, BEHAV RES THER, V40, P923, DOI 10.1016/S0005-7967(01)00127-9; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Damasio A.R., 1994, DESCARTES ERROR EMOT; de Fockert JW, 2001, SCIENCE, V291, P1803, DOI 10.1126/science.1056496; De Martino B, 2006, SCIENCE, V313, P684, DOI 10.1126/science.1128356; De Neys W, 2006, Q J EXP PSYCHOL, V59, P1070, DOI 10.1080/02724980543000123; DeRubeis RJ, 2008, NAT REV NEUROSCI, V9, P788, DOI 10.1038/nrn2345; Detre JA, 2000, MED RAD DIA IMG, P47; Drevets WC, 2000, BIOL PSYCHIAT, V48, P813, DOI 10.1016/S0006-3223(00)01020-9; Drevets WC, 1998, COGNITION EMOTION, V12, P353, DOI 10.1080/026999398379646; Egner T, 2008, CEREB CORTEX, V18, P1475, DOI 10.1093/cercor/bhm179; FRISTON KJ, 1991, P ROY SOC B-BIOL SCI, V244, P101, DOI 10.1098/rspb.1991.0057; GRASBY PM, 1994, BRAIN, V117, P1271, DOI 10.1093/brain/117.6.1271; Hautzinger M., 1993, ALLGEMEINE DEPRESSIO; Holmes AP, 1996, J CEREBR BLOOD F MET, V16, P7, DOI 10.1097/00004647-199601000-00002; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kahneman D, 2011, THINKING FAST SLOW; Kalisch R, 2006, NEUROIMAGE, V30, P1458, DOI 10.1016/j.neuroimage.2005.11.011; Kincade JM, 2005, J NEUROSCI, V25, P4593, DOI 10.1523/JNEUROSCI.0236-05.2005; Mauss IB, 2007, SOC PERSONAL PSYCHOL, V1, P146, DOI 10.1111/j.1751-9004.2007.00005.x; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; Mazoyer B, 2001, BRAIN RES BULL, V54, P287, DOI 10.1016/S0361-9230(00)00437-8; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Paus T, 1996, NEUROPSYCHOLOGIA, V34, P475, DOI 10.1016/0028-3932(95)00134-4; Phan KL, 2005, BIOL PSYCHIAT, V57, P210, DOI 10.1016/j.biopsych.2004.10.030; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Phillips M, 2008, MOL PSYCHIATR, V13, P833, DOI 10.1038/mp.2008.65; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Phillips ML, 2003, BIOL PSYCHIAT, V54, P515, DOI 10.1016/S0006-3223(03)00171-9; Pinheiro J, 2001, MIXED EFFECTS MODELS; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; Rude SS, 2003, COGNITIVE THER RES, V27, P415, DOI 10.1023/A:1025472413805; Rude SS, 2002, COGNITION EMOTION, V16, P423, DOI 10.1080/02699930143000554; Rypma B, 1999, P NATL ACAD SCI USA, V96, P6558, DOI 10.1073/pnas.96.11.6558; Serences JT, 2005, PSYCHOL SCI, V16, P114, DOI 10.1111/j.0956-7976.2005.00791.x; Sharot T, 2007, NATURE, V450, P102, DOI 10.1038/nature06280; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Simpson JR, 2001, P NATL ACAD SCI USA, V98, P688, DOI 10.1073/pnas.98.2.688; Sloman SA, 1996, PSYCHOL BULL, V119, P3, DOI 10.1037/0033-2909.119.1.3; Slovic P, 2002, HEURISTICS BIASES PS, P397, DOI [DOI 10.1017/CBO9780511808098.025, 10.1017/CBO9780511808098.025]; Stanovich KE, 1998, J EXP PSYCHOL GEN, V127, P161, DOI 10.1037/0096-3445.127.2.161; TAYLOR SE, 1988, PSYCHOL BULL, V103, P193, DOI 10.1037/0033-2909.103.2.193; Thayer JF, 2000, J AFFECT DISORDERS, V61, P201, DOI 10.1016/S0165-0327(00)00338-4; TURNER ML, 1989, J MEM LANG, V28, P127, DOI 10.1016/0749-596X(89)90040-5; TVERSKY A, 1983, PSYCHOL REV, V90, P293, DOI 10.1037/0033-295X.90.4.293; Unsworth N., 2005, COGNITIVE LIMITATION, P19, DOI [10.1017/CBO9780511720413.003, DOI 10.1017/CBO9780511720413.003]; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Viviani R, 2009, NEUROIMAGE, V46, P12, DOI 10.1016/j.neuroimage.2009.01.041; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; Wang JJ, 2005, RADIOLOGY, V235, P218, DOI 10.1148/radiol.2351031663; WEGNER DM, 1993, J PERS SOC PSYCHOL, V65, P1093, DOI 10.1037/0022-3514.65.6.1093; WEGNER DM, 1994, PSYCHOL REV, V101, P34, DOI 10.1037/0033-295X.101.1.34; WENZLAFF RM, 1988, J PERS SOC PSYCHOL, V55, P882, DOI 10.1037/0022-3514.55.6.882; Wenzlaff RM, 1998, J PERS SOC PSYCHOL, V75, P1559, DOI 10.1037/0022-3514.75.6.1559; Zeintl M, 2007, PSYCHOL AGING, V22, P826, DOI 10.1037/0882-7974.22.4.826	78	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e15454	10.1371/journal.pone.0015454	http://dx.doi.org/10.1371/journal.pone.0015454			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	676NU	21079747	Green Submitted, Green Published, gold			2022-12-25	WOS:000283920000026
J	Bessadok, A; Garcia, E; Jacquet, H; Martin, S; Garrigues, A; Loiseau, N; Andre, F; Orlowski, S; Vivaudou, M				Bessadok, Anis; Garcia, Elisabeth; Jacquet, Helene; Martin, Solenne; Garrigues, Alexia; Loiseau, Nicolas; Andre, Francois; Orlowski, Stephane; Vivaudou, Michel			Recognition of Sulfonylurea Receptor (ABCC8/9) Ligands by the Multidrug Resistance Transporter P-glycoprotein (ABCB1) FUNCTIONAL SIMILARITIES BASED ON COMMON STRUCTURAL FEATURES BETWEEN TWO MULTISPECIFIC ABC PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-ATP CHANNEL; 3-DIMENSIONAL STRUCTURES; MAXIMUM-LIKELIHOOD; PROTEIN STRUCTURES; MOLECULAR-BASIS; DRUG-BINDING; OPENERS; MODEL; MODULATORS; PROGRAMS	ATP-sensitive K+ (K-ATP) channels are the target of a number of pharmacological agents, blockers like hypoglycemic sulfonylureas and openers like the hypotensive cromakalim and diazoxide. These agents act on the channel regulatory subunit, the sulfonylurea receptor (SUR), which is an ABC protein with homologies to P-glycoprotein (P-gp). P-gp is a multidrug transporter expressed in tumor cells and in some healthy tissues. Because these two ABC proteins both exhibit multispecific recognition properties, we have tested whether SUR ligands could be substrates of P-gp. Interaction with P-gp was assayed by monitoring ATPase activity of P-gp-enriched vesicles. The blockers glibenclamide, tolbutamide, and meglitinide increased ATPase activity, with a rank order of potencies that correlated with their capacity to block K-ATP channels. P-gp ATPase activity was also increased by the openers SR47063 (a cromakalim analog), P1075 (a pinacidil analog), and diazoxide. Thus, these molecules bind to P-gp (although with lower affinities than for SUR) and are possibly transported by P-gp. Competition experiments among these molecules as well as with typical P-gp substrates revealed a structural similarity between drug binding domains in the two proteins. To rationalize the observed data, we addressed the molecular features of these proteins and compared structural models, computerized by homology from the recently solved structures of murine P-gp and bacterial ABC transporters MsbA and Sav1866. Considering the various residues experimentally assigned to be involved in drug binding, we uncovered several hot spots, which organized spatially in two main binding domains, selective for SR47063 and for glibenclamide, in matching regions of both P-gp and SUR.	[Bessadok, Anis; Martin, Solenne; Garrigues, Alexia; Andre, Francois; Orlowski, Stephane] CEA Saclay, CNRS, URA 2096, Serv Bioenerget Biol Struct & Mecanismes,iBiTec S, F-91191 Gif Sur Yvette, France; [Garcia, Elisabeth; Jacquet, Helene; Vivaudou, Michel] Univ Grenoble 1, CNRS, CEA, Inst Biol Struct, F-38027 Grenoble, France; [Loiseau, Nicolas] INRA, UR66, Lab Pharmacol Toxicol, F-31027 Toulouse, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); INRAE	Orlowski, S (corresponding author), CEA Saclay, CNRS, URA 2096, Serv Bioenerget Biol Struct & Mecanismes,iBiTec S, F-91191 Gif Sur Yvette, France.	stephane.orlowski@cea.fr; michel.vivaudou@ibs.fr	LOISEAU, Nicolas/ADN-2394-2022; Le Discorde, Magali/A-5127-2009; Vivaudou, Michel/C-5338-2008; ANDRE, François/E-5555-2015	LOISEAU, Nicolas/0000-0003-3783-0879; Le Discorde, Magali/0000-0001-5126-0900; Vivaudou, Michel/0000-0002-9777-3127; 	Ligue Nationale de Recherche contre le Cancer; Les Amis des Sciences; SPI-Bio; ARC	Ligue Nationale de Recherche contre le Cancer; Les Amis des Sciences; SPI-Bio; ARC(Australian Research Council)	Supported by studentships from the "Ligue Nationale de Recherche contre le Cancer" and "Les Amis des Sciences." Present address: Commissariat a l'Energie Atomique/Cadarache, IBEB-LEMS, 13108 St. Paul Lez Durance, France.; Supported by studentships from SPI-Bio and ARC. Present address: Bio-predic, Parc d'Affaires de la Breteche, Batiment B1, 35760 Saint-Gregoire, France.	Al-Shawi MK, 2003, J BIOL CHEM, V278, P52629, DOI 10.1074/jbc.M308175200; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; Antcliff JF, 2005, EMBO J, V24, P229, DOI 10.1038/sj.emboj.7600487; Ashfield R, 1999, DIABETES, V48, P1341, DOI 10.2337/diabetes.48.6.1341; Avendano C, 2002, CURR MED CHEM, V9, P159, DOI 10.2174/0929867023371175; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Bienengraeber M, 2000, FASEB J, V14, P1943, DOI 10.1096/fj.00-0027com; Bryan J, 2005, CURR PHARM DESIGN, V11, P2699, DOI 10.2174/1381612054546879; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Coghlan MJ, 2001, J MED CHEM, V44, P1627, DOI 10.1021/jm000484+; D'hahan N, 1999, P NATL ACAD SCI USA, V96, P12162, DOI 10.1073/pnas.96.21.12162; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; de Wet H, 2007, FEBS J, V274, P3532, DOI 10.1111/j.1742-4658.2007.05879.x; de Wet H, 2010, FEBS J, V277, P2654, DOI [10.1111/j.1742-4658.2010.07675.x, 10.1111/j.1742-464X.2010.07675.x]; Dorschner H, 1999, MOL PHARMACOL, V55, P1060; Efron B., 1982, JACKKNIFE BOOTSTRAP; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Forestier C, 1996, J GEN PHYSIOL, V107, P489, DOI 10.1085/jgp.107.4.489; Fromm MF, 2004, TRENDS PHARMACOL SCI, V25, P423, DOI 10.1016/j.tips.2004.06.002; Garrigos M, 1997, EUR J BIOCHEM, V244, P664, DOI 10.1111/j.1432-1033.1997.00664.x; GARRIGOS M, 1993, BIOCHEM BIOPH RES CO, V196, P1034, DOI 10.1006/bbrc.1993.2355; Garrigues A, 2002, MOL PHARMACOL, V62, P1288, DOI 10.1124/mol.62.6.1288; Golstein PE, 1999, PFLUG ARCH EUR J PHY, V437, P652, DOI 10.1007/s004240050829; Gribble FM, 2002, BIOCHEM SOC T, V30, P333, DOI 10.1042/bst0300333; Gribble FM, 1998, DIABETES, V47, P1412, DOI 10.2337/diabetes.47.9.1412; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gutmann DAP, 2010, TRENDS BIOCHEM SCI, V35, P36, DOI 10.1016/j.tibs.2009.07.009; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Jahangir A, 2005, J MOL CELL CARDIOL, V39, P99, DOI 10.1016/j.yjmcc.2005.04.006; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Le T, 1999, MOL MEMBR BIOL, V16, P173, DOI 10.1080/096876899294634; Lee JY, 2008, J BIOL CHEM, V283, P5769, DOI 10.1074/jbc.M707028200; Litman T, 1997, BBA-MOL BASIS DIS, V1361, P169, DOI 10.1016/S0925-4439(97)00027-6; Loffler-Walz C, 1998, BRIT J PHARMACOL, V123, P1395, DOI 10.1038/sj.bjp.0701756; Loo TW, 2006, BIOCHEM J, V399, P351, DOI 10.1042/BJ20060715; Marchler-Bauer A, 2003, NUCLEIC ACIDS RES, V31, P383, DOI 10.1093/nar/gkg087; Megard I, 2002, BRAIN RES, V927, P153, DOI 10.1016/S0006-8993(01)03337-6; Moreau C, 2005, J MOL CELL CARDIOL, V38, P951, DOI 10.1016/j.yjmcc.2004.11.030; Moreau C, 2005, MOL PHARMACOL, V67, P1026, DOI 10.1124/mol.104.008698; Moreau C, 2000, EMBO J, V19, P6644, DOI 10.1093/emboj/19.24.6644; Morgenstern B, 1996, P NATL ACAD SCI USA, V93, P12098, DOI 10.1073/pnas.93.22.12098; Nagashima K, 2004, DIABETES RES CLIN PR, V66, pS75, DOI 10.1016/j.diabres.2003.12.011; O'Mara ML, 2007, FEBS LETT, V581, P4217, DOI 10.1016/j.febslet.2007.07.069; Orlowski S, 1996, BIOCHEM J, V317, P515, DOI 10.1042/bj3170515; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pascaud C, 1998, BIOCHEM J, V333, P351, DOI 10.1042/bj3330351; Payen L, 2001, BRIT J PHARMACOL, V132, P778, DOI 10.1038/sj.bjp.0703863; Polli JW, 2001, J PHARMACOL EXP THER, V299, P620; Ravna AW, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-33; Rosenberg MF, 2003, J BIOL CHEM, V278, P8294, DOI 10.1074/jbc.M211758200; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Schwanstecher M, 1998, EMBO J, V17, P5529, DOI 10.1093/emboj/17.19.5529; Sharom FJ, 1997, J MEMBRANE BIOL, V160, P161, DOI 10.1007/s002329900305; SHEPPARD DN, 1992, J GEN PHYSIOL, V100, P573, DOI 10.1085/jgp.100.4.573; Shi NQ, 2005, J MOL CELL CARDIOL, V39, P51, DOI 10.1016/j.yjmcc.2004.11.024; Shilling RA, 2006, TRENDS PHARMACOL SCI, V27, P195, DOI 10.1016/j.tips.2006.02.008; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Vasiliou Vasilis, 2009, Human Genomics, V3, P281; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104	68	25	27	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3552	3569		10.1074/jbc.M110.155200	http://dx.doi.org/10.1074/jbc.M110.155200			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21098040	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000286653200040
J	Holland, S; Coste, O; Zhang, DD; Pierre, SC; Geisslinger, G; Scholich, K				Holland, Sabrina; Coste, Ovidiu; Zhang, Dong Dong; Pierre, Sandra C.; Geisslinger, Gerd; Scholich, Klaus			The Ubiquitin Ligase MYCBP2 Regulates Transient Receptor Potential Vanilloid Receptor 1 (TRPV1) Internalization through Inhibition of p38 MAPK Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; LONG-TERM DEPRESSION; THERMAL NOCICEPTION; ADENYLYL CYCLASES; FORMATION REVEALS; SYNAPTIC GROWTH; MICE LACKING; MYOSIN-VI; PAM; ACTIVATION	The E3 ubiquitin ligase MYCBP2 negatively regulates neuronal growth, synaptogenesis, and synaptic strength. More recently it was shown that MYCBP2 is also involved in receptor and ion channel internalization. We found that mice with a MYCBP2-deficiency in peripheral sensory neurons show prolonged thermal hyperalgesia. Loss of MYCBP2 constitutively activated p38 MAPK and increased expression of several proteins involved in receptor trafficking. Surprisingly, loss of MYCBP2 inhibited internalization of transient receptor potential vanilloid receptor 1 (TRPV1) and prevented desensitization of capsaicin-induced calcium increases. Lack of desensitization, TRPV internalization and prolonged hyperalgesia were reversed by inhibition of p38 MAPK. The effects were TRPV-specific, since neither mustard oil-induced desensitization nor behavioral responses to mechanical stimuli were affected. In summary, we show here for the first time that p38 MAPK activation can inhibit activity-induced ion channel internalization and that MYCBP2 regulates internalization of TRPV1 in peripheral sensory neurons as well as duration of thermal hyperalgesia through p38 MAPK.	[Holland, Sabrina; Coste, Ovidiu; Zhang, Dong Dong; Pierre, Sandra C.; Geisslinger, Gerd; Scholich, Klaus] Klinikum Goethe Univ Frankfurt, Inst Klin Pharmakol, Pharmazentrum Frankfurt ZAFES, D-60590 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital	Scholich, K (corresponding author), Klinikum Goethe Univ Frankfurt, Inst Klin Pharmakol, Pharmazentrum Frankfurt ZAFES, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	Scholich@em.uni-frankfurt.de		Holland, Sabrina M/0000-0003-4805-1803	DFG [SCHO817-3]; LOEWE Lipid Signaling Forschungszentrum Frankfurt (LiFF)	DFG(German Research Foundation (DFG)); LOEWE Lipid Signaling Forschungszentrum Frankfurt (LiFF)	This work was supported by the DFG Grant SCHO817-3 and the LOEWE Lipid Signaling Forschungszentrum Frankfurt (LiFF).	Agarwal N, 2004, GENESIS, V38, P122, DOI 10.1002/gene.20010; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; BENNETT MR, 1974, J PHYSIOL-LONDON, V241, P515, DOI 10.1113/jphysiol.1974.sp010670; Bloom AJ, 2007, GENE DEV, V21, P2593, DOI 10.1101/gad.1592107; Bolcskei K, 2005, PAIN, V117, P368, DOI 10.1016/j.pain.2005.06.024; Brauchi S, 2007, P NATL ACAD SCI USA, V104, P10246, DOI 10.1073/pnas.0703420104; Bridgman PC, 1999, J CELL BIOL, V146, P1045, DOI 10.1083/jcb.146.5.1045; Burgess RW, 2004, MOL CELL BIOL, V24, P1096, DOI 10.1128/MCB.24.3.1096-1105.2004; Cavalli V, 2001, MOL CELL, V7, P421, DOI 10.1016/S1097-2765(01)00189-7; D'Souza J, 2005, DEVELOPMENT, V132, P247, DOI 10.1242/dev.01578; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; DENNIS MJ, 1981, DEV BIOL, V81, P266, DOI 10.1016/0012-1606(81)90290-6; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Ehnert C, 2004, J NEUROCHEM, V88, P948, DOI 10.1046/j.1471-4159.2003.02229.x; Frey MR, 2006, EMBO J, V25, P5683, DOI 10.1038/sj.emboj.7601457; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Guo QB, 1998, P NATL ACAD SCI USA, V95, P9172, DOI 10.1073/pnas.95.16.9172; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Huang CC, 2004, J BIOL CHEM, V279, P12286, DOI 10.1074/jbc.M312868200; Ji RR, 2002, NEURON, V36, P57, DOI 10.1016/S0896-6273(02)00908-X; Klein RM, 2008, J BIOL CHEM, V283, P26208, DOI 10.1074/jbc.M801912200; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Le Bars D, 2001, PHARMACOL REV, V53, P597; Lewcock JW, 2007, NEURON, V56, P604, DOI 10.1016/j.neuron.2007.09.009; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Liu BY, 2005, J NEUROSCI, V25, P4835, DOI 10.1523/JNEUROSCI.1296-05.2005; Mace T, 2005, EMBO J, V24, P3235, DOI 10.1038/sj.emboj.7600799; Maeurer C, 2009, CELL SIGNAL, V21, P293, DOI 10.1016/j.cellsig.2008.10.016; Mizushima T, 2005, PAIN, V113, P51, DOI 10.1016/j.pain.2004.09.038; Mohapatra DP, 2005, J BIOL CHEM, V280, P13424, DOI 10.1074/jbc.M410917200; Murthy V, 2004, J BIOL CHEM, V279, P1351, DOI 10.1074/jbc.M310208200; Naccache SN, 2006, P NATL ACAD SCI USA, V103, P12735, DOI 10.1073/pnas.0605317103; Nakata K, 2005, CELL, V120, P407, DOI 10.1016/j.cell.2004.12.017; NOAKES PG, 1993, DEV BIOL, V155, P275, DOI 10.1006/dbio.1993.1025; Numazaki M, 2003, P NATL ACAD SCI USA, V100, P8002, DOI 10.1073/pnas.1337252100; Park EC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004284; Patwardhan AM, 2006, P NATL ACAD SCI USA, V103, P11393, DOI 10.1073/pnas.0603861103; Pierre S, 2009, NAT REV DRUG DISCOV, V8, P321, DOI 10.1038/nrd2827; Pierre SC, 2004, EMBO J, V23, P3031, DOI 10.1038/sj.emboj.7600321; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Roder IV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003871; Roux I, 2009, HUM MOL GENET, V18, P4615, DOI 10.1093/hmg/ddp429; Sango K, 1996, NAT GENET, V14, P348, DOI 10.1038/ng1196-348; Sann S, 2009, TRENDS CELL BIOL, V19, P317, DOI 10.1016/j.tcb.2009.05.001; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; Scholich K, 2001, J BIOL CHEM, V276, P47583, DOI 10.1074/jbc.M107816200; SILVERMAN JD, 1990, J NEUROCYTOL, V19, P789, DOI 10.1007/BF01188046; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Tegeder I, 2004, P NATL ACAD SCI USA, V101, P3253, DOI 10.1073/pnas.0304076101; Tong JF, 2009, MOL CELL PROTEOMICS, V8, P2131, DOI 10.1074/mcp.M900148-MCP200; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Wu CL, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-16; Wu CL, 2005, J NEUROSCI, V25, P9557, DOI 10.1523/JNEUROSCI.2532-05.2005; Yang HT, 2002, DEV BRAIN RES, V136, P35, DOI 10.1016/S0165-3806(02)00311-5; Yin L, 2010, P NATL ACAD SCI USA, V107, P11614, DOI 10.1073/pnas.1000438107; Zhong P, 2008, J PHYSIOL-LONDON, V586, P4465, DOI 10.1113/jphysiol.2008.155143; Zwang Y, 2006, EMBO J, V25, P4195, DOI 10.1038/sj.emboj.7601297	58	32	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3671	3680		10.1074/jbc.M110.154765	http://dx.doi.org/10.1074/jbc.M110.154765			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21098484	Green Published, hybrid			2022-12-25	WOS:000286653200050
J	Ladiwala, ARA; Dordick, JS; Tessier, PM				Ladiwala, Ali Reza A.; Dordick, Jonathan S.; Tessier, Peter M.			Aromatic Small Molecules Remodel Toxic Soluble Oligomers of Amyloid beta through Three Independent Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-BETA; METHYLENE-BLUE; IN-VITRO; ALZHEIMERS-DISEASE; PROTEIN OLIGOMERS; FIBRIL FORMATION; SHEET STRUCTURES; ALPHA-SYNUCLEIN; TANNIC-ACID; AGGREGATION	In protein conformational disorders ranging from Alzheimer to Parkinson disease, proteins of unrelated sequence misfold into a similar array of aggregated conformers ranging from small oligomers to large amyloid fibrils. Substantial evidence suggests that small, prefibrillar oligomers are the most toxic species, yet to what extent they can be selectively targeted and remodeled into non-toxic conformers using small molecules is poorly understood. We have evaluated the conformational specificity and remodeling pathways of a diverse panel of aromatic small molecules against mature soluble oligomers of the A beta 42 peptide associated with Alzheimer disease. We find that small molecule antagonists can be grouped into three classes, which we herein define as Class I, II, and III molecules, based on the distinct pathways they utilize to remodel soluble oligomers into multiple conformers with reduced toxicity. Class I molecules remodel soluble oligomers into large, off-pathway aggregates that are non-toxic. Moreover, Class IA molecules also remodel amyloid fibrils into the same off-pathway structures, whereas Class IB molecules fail to remodel fibrils but accelerate aggregation of freshly disaggregated A beta. In contrast, a Class II molecule converts soluble A beta oligomers into fibrils, but is inactive against disaggregated and fibrillar A beta. Class III molecules disassemble soluble oligomers (as well as fibrils) into low molecular weight species that are non-toxic. Strikingly, A beta non-toxic oligomers (which are morphologically indistinguishable from toxic soluble oligomers) are significantly more resistant to being remodeled than A beta soluble oligomers or amyloid fibrils. Our findings reveal that relatively subtle differences in small molecule structure encipher surprisingly large differences in the pathways they employ to remodel A beta soluble oligomers and related aggregated conformers.	Rensselaer Polytech Inst, Dept Chem & Biol Engn, Troy, NY 12180 USA; [Dordick, Jonathan S.] Rensselaer Polytech Inst, Dept Biol, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Tessier, PM (corresponding author), 110 8th St, Troy, NY 12180 USA.	tessier@rpi.edu	Tessier, Peter/GPP-3396-2022; Tessier, Peter/I-5730-2013	Tessier, Peter/0000-0002-3220-007X	Alzheimer's Association [NIRG-08-90967]	Alzheimer's Association(Alzheimer's Association)	This work was supported by the Alzheimer's Association Grant NIRG-08-90967 (to P.M.T.).	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Amijee H, 2009, J ALZHEIMERS DIS, V17, P33, DOI 10.3233/JAD-2009-1044; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Boye-Harnasch M, 2006, J BIOTECHNOL, V125, P222, DOI 10.1016/j.jbiotec.2006.03.006; Bulic B, 2009, ANGEW CHEM INT EDIT, V48, P1741, DOI 10.1002/anie.200802621; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Cerf E, 2009, BIOCHEM J, V421, P415, DOI 10.1042/BJ20090379; Chien P, 2003, NATURE, V424, P948, DOI 10.1038/nature01894; Chien P, 2001, NATURE, V410, P223, DOI 10.1038/35065632; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; DISANTO AR, 1972, J PHARM SCI, V61, P1086, DOI 10.1002/jps.2600610710; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Feng BY, 2008, NAT CHEM BIOL, V4, P197, DOI 10.1038/nchembio.65; Frost B, 2009, J BIOL CHEM, V284, P3546, DOI 10.1074/jbc.M805627200; Gazit E, 2002, FASEB J, V16, P77, DOI 10.1096/fj.01-0442hyp; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Goldsbury C, 2005, J MOL BIOL, V352, P282, DOI 10.1016/j.jmb.2005.07.029; Gura T, 2008, NAT MED, V14, P894, DOI 10.1038/nm0908-894; Gursky O, 2000, BBA-PROTEIN STRUCT M, V1476, P93, DOI 10.1016/S0167-4838(99)00228-9; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2009, J BIOL CHEM, V284, P4230, DOI 10.1074/jbc.M808591200; Kocisko DA, 2003, J VIROL, V77, P10288, DOI 10.1128/JVI.77.19.10288-10294.2003; Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007; KUPFER A, 1994, LANCET, V343, P763, DOI 10.1016/S0140-6736(94)91839-2; Kvam E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005727; Ladiwala ARA, 2010, J BIOL CHEM, V285, P24228, DOI 10.1074/jbc.M110.133108; Lambert MP, 2001, J NEUROCHEM, V79, P595, DOI 10.1046/j.1471-4159.2001.00592.x; Lee S, 2007, PROTEIN SCI, V16, P723, DOI 10.1110/ps.062514807; MANAVALAN P, 1983, NATURE, V305, P831, DOI 10.1038/305831a0; Margittai M, 2008, Q REV BIOPHYS, V41, P265, DOI 10.1017/S0033583508004733; Meng XY, 2009, BIOCHEMISTRY-US, V48, P8206, DOI 10.1021/bi900506b; Necula M, 2007, BIOCHEMISTRY-US, V46, P8850, DOI 10.1021/bi700411k; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Nekooki-Machida Y, 2009, P NATL ACAD SCI USA, V106, P9679, DOI 10.1073/pnas.0812083106; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; Ono K, 2004, BBA-MOL BASIS DIS, V1690, P193, DOI 10.1016/j.bbadis.2004.06.008; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Peter C, 2000, EUR J CLIN PHARMACOL, V56, P247, DOI 10.1007/s002280000124; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Riviere C, 2009, NEUROCHEM RES, V34, P1120, DOI 10.1007/s11064-008-9883-6; Roberts BE, 2008, NAT STRUCT MOL BIOL, V15, P544, DOI 10.1038/nsmb0608-544; Roberts BE, 2009, NAT CHEM BIOL, V5, P936, DOI 10.1038/nchembio.246; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Stains CI, 2007, CHEMMEDCHEM, V2, P1674, DOI 10.1002/cmdc.200700140; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Taniguchi S, 2005, J BIOL CHEM, V280, P7614, DOI 10.1074/jbc.M408714200; Tessier PM, 2007, NATURE, V447, P556, DOI 10.1038/nature05848; Tycko R, 2009, BIOCHEMISTRY-US, V48, P6072, DOI 10.1021/bi9002666; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang H, 2008, P NATL ACAD SCI USA, V105, P7159, DOI 10.1073/pnas.0801934105; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Wu JW, 2010, J BIOL CHEM, V285, P6071, DOI 10.1074/jbc.M109.069542; Yamaguchi K, 2005, J MOL BIOL, V352, P952, DOI 10.1016/j.jmb.2005.07.061; Yu LP, 2009, BIOCHEMISTRY-US, V48, P1870, DOI 10.1021/bi802046n; Zameer A, 2008, J MOL BIOL, V384, P917, DOI 10.1016/j.jmb.2008.09.068; Zhang A, 2009, BIOPHYS J, V96, P1091, DOI 10.1016/j.bpj.2008.10.022; Zhu M, 2004, J BIOL CHEM, V279, P26846, DOI 10.1074/jbc.M403129200	61	147	150	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3209	3218		10.1074/jbc.M110.173856	http://dx.doi.org/10.1074/jbc.M110.173856			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21098486	Green Published, hybrid			2022-12-25	WOS:000286653200005
J	Hsu, CC; Chiang, CW; Cheng, HC; Chang, WT; Chou, CY; Tsai, HW; Lee, CT; Wu, ZH; Lee, TY; Chao, A; Chow, NH; Ho, CL				Hsu, C-C; Chiang, C-W; Cheng, H-C; Chang, W-T; Chou, C-Y; Tsai, H-W; Lee, C-T; Wu, Z-H; Lee, T-Y; Chao, A.; Chow, N-H; Ho, C-L			Identifying LRRC16B as an oncofetal gene with transforming enhancing capability using a combined bioinformatics and experimental approach	ONCOGENE			English	Article						oncofetal genes; expressed sequence tags; LRRC16B	LEUCINE-RICH REPEAT; ALPHA-FETOPROTEIN; TUMOR-MARKERS; FLIGHTLESS I; STEM-CELLS; PROTEIN; WNT; EXPRESSION; GROWTH; BETA	Oncofetal genes are expressed in embryos or fetuses, are downregulated or undetectable in adult tissues, and then re-expressed in tumors. Known oncofetal genes, such as AFP, GCB, FGF18, IMP-1 and SOX1, often have important clinical applications or pivotal biological functions. To find new oncofetal-like genes, we used the public information of expressed sequence tags to systematically analyze gene expression patterns and identified a novel oncofetal-like gene, LRRC16B. It increased the proliferation, anchorage-independent growth and tumorigenesis of transformed cells in xenografts, possibly through its effects on cyclin B1 protein levels. These findings exemplify the feasibility of using bioinformatics to find new oncofetal-like genes and suggest that more genes with important functional roles will be uncovered in the candidate gene list. Oncogene (2011) 30, 654-667; doi:10.1038/onc.2010.451; published online 22 November 2010	[Chou, C-Y; Tsai, H-W; Chow, N-H; Ho, C-L] Natl Cheng Kung Univ Hosp, Dept Pathol, Tainan 70428, Taiwan; [Hsu, C-C; Chiang, C-W; Cheng, H-C; Chang, W-T; Lee, T-Y; Chow, N-H; Ho, C-L] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan; [Chiang, C-W; Wu, Z-H; Chow, N-H; Ho, C-L] Natl Cheng Kung Univ, Coll Med, Inst Mol Med, Tainan 70101, Taiwan; [Chou, C-Y] Natl Cheng Kung Univ Hosp, Dept Obstet & Gynecol, Tainan 70428, Taiwan; [Chao, A.] Chang Gung Univ, Chang Gung Mem Hosp, Coll Med, Dept Ophthalmol, Tao Yuan, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; Chang Gung Memorial Hospital; Chang Gung University	Ho, CL (corresponding author), Natl Cheng Kung Univ Hosp, Dept Pathol, 138 Sheng Li Rd, Tainan 70428, Taiwan.	clh9@mail.ncku.edu.tw			National Science Council, Taiwan [NSC-95-2320-B-006-057-MY2]; Department of Health, Taiwan [DOH99-TD-C-111-003]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Department of Health, Taiwan	This was supported by Grant NSC-95-2320-B-006-057-MY2 from the National Science Council, Taiwan, and Grant DOH99-TD-C-111-003 from the Department of Health, Taiwan. There is no competing financial interest in relation to this work.	Adachi-Yamada T, 2005, MOL CELL BIOL, V25, P3140, DOI 10.1128/MCB.25.8.3140-3150.2005; ALEXANDER P, 1970, MEDICINA, V30, P176; Aouacheria A, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-94; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; BERGSTRAND CG, 1956, SCAND J CLIN LAB INV, V8, P174, DOI 10.3109/00365515609049266; BOGUSKI MS, 1995, NAT GENET, V10, P369, DOI 10.1038/ng0895-369; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Campagne F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-481; Chen CMA, 1996, CELL, V86, P731, DOI 10.1016/S0092-8674(00)80148-8; Cleynen I, 2007, MOL CANCER RES, V5, P363, DOI 10.1158/1541-7786.MCR-06-0331; Colantuoni C, 2000, J NEUROSCI RES, V59, P1, DOI 10.1002/(SICI)1097-4547(20000101)59:1<1::AID-JNR1>3.0.CO;2-2; Cowin AJ, 2007, J PATHOL, V211, P572, DOI 10.1002/path.2143; Dao DY, 2007, ANN NY ACAD SCI, V1116, P82, DOI 10.1196/annals.1402.082; Ding S, 2004, NAT BIOTECHNOL, V22, P833, DOI 10.1038/nbt987; Eisenmann KM, 2007, CURR BIOL, V17, P579, DOI 10.1016/j.cub.2007.03.024; Esteve P, 2006, CURR OPIN NEUROBIOL, V16, P13, DOI 10.1016/j.conb.2006.01.001; FARGHALY SA, 1992, GYNECOL OBSTET INVES, V34, P65, DOI 10.1159/000292728; Fukada M, 2000, J BIOL CHEM, V275, P37957, DOI 10.1074/jbc.M003277200; Gabory A, 2006, CYTOGENET GENOME RES, V113, P188, DOI 10.1159/000090831; Garcia-Barcelo MM, 2007, ANN HUM GENET, V71, P746, DOI 10.1111/j.1469-1809.2007.00384.x; Gilboa E, 1999, CANCER IMMUNOL IMMUN, V48, P382, DOI 10.1007/s002620050590; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Grozdanov PN, 2006, LAB INVEST, V86, P1272, DOI 10.1038/labinvest.3700479; Hishinuma M, 2006, HISTOPATHOLOGY, V49, P479, DOI 10.1111/j.1365-2559.2006.02522.x; Hossain MS, 2008, ONCOGENE, V27, P6075, DOI 10.1038/onc.2008.200; Imamura F, 2006, J COMP NEUROL, V495, P754, DOI 10.1002/cne.20896; Kato T, 2007, CLIN CANCER RES, V13, P434, DOI 10.1158/1078-0432.CCR-06-1297; Katoh M, 2007, STEM CELL REV, V3, P30, DOI 10.1007/s12015-007-0006-6; Katoh M, 2007, INT J MOL MED, V19, P197; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Kopecki Z, 2008, INT J BIOCHEM CELL B, V40, P1415, DOI 10.1016/j.biocel.2007.04.011; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; Liu CI, 2005, DEV BIOL, V285, P238, DOI 10.1016/j.ydbio.2005.05.045; Matouk IJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000845; MCNAMEE D, 1995, LANCET, V345, P1169, DOI 10.1016/S0140-6736(95)90998-2; Monk M, 2001, ONCOGENE, V20, P8085, DOI 10.1038/sj.onc.1205088; Morton JP, 2007, P NATL ACAD SCI USA, V104, P5103, DOI 10.1073/pnas.0701158104; Nielsen J, 1999, MOL CELL BIOL, V19, P1262; Niemann H, 2007, THERIOGENOLOGY, V68, pS165, DOI 10.1016/j.theriogenology.2007.05.041; Park TJ, 2009, EXP CELL RES, V315, P3152, DOI 10.1016/j.yexcr.2009.07.009; Qiao M, 2007, CANCER RES, V67, P5293, DOI 10.1158/0008-5472.CAN-07-0877; Sarandakou A, 2007, CRIT REV CL LAB SCI, V44, P151, DOI 10.1080/10408360601003143; Shimokawa T, 2003, CANCER RES, V63, P6116; Sugimori M, 2008, DEVELOPMENT, V135, P1271, DOI 10.1242/dev.015370; TROJAN J, 1995, MOL REPROD DEV, V42, P369, DOI 10.1002/mrd.1080420402; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang R, 2010, BIOL CELL, V102, P173, DOI 10.1042/BC20090091; Xu L, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-275	48	13	15	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2011	30	6					654	667		10.1038/onc.2010.451	http://dx.doi.org/10.1038/onc.2010.451			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	719GY	21102520	Bronze			2022-12-25	WOS:000287192000003
J	Sousa, IP; Carvalho, CAM; Ferreira, DF; Weissmuller, G; Rocha, GM; Silva, JL; Gomes, AMO				Sousa, Ivanildo P., Jr.; Carvalho, Carlos A. M.; Ferreira, Davis F.; Weissmueller, Gilberto; Rocha, Gustavo M.; Silva, Jerson L.; Gomes, Andre M. O.			Envelope Lipid-packing as a Critical Factor for the Biological Activity and Stability of Alphavirus Particles Isolated from Mammalian and Mosquito Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEMLIKI-FOREST-VIRUS; SINDBIS VIRUS; IMMUNODEFICIENCY-VIRUS; MEMBRANE CHOLESTEROL; INFLUENZA-VIRUS; LAURDAN FLUORESCENCE; PLASMA-MEMBRANE; LOW-PH; ENTRY; PROTEINS	Alphaviruses are enveloped arboviruses. The viral envelope is derived from the host cell and is positioned between two icosahedral protein shells (T = 4). Because the viral envelope contains glycoproteins involved in cell recognition and entry, the integrity of the envelope is critical for the success of the early events of infection. Differing levels of cholesterol in different hosts leads to the production of alphaviruses with distinct levels of this sterol loaded in the envelope. Using Mayaro virus, a New World alphavirus, we investigated the role of cholesterol on the envelope of alphavirus particles assembled in either mammalian or mosquito cells. Our results show that although quite different in their cholesterol content, Mayaro virus particles obtained from both cells share a similar high level of lateral organization in their envelopes. This organization, as well as viral stability and infectivity, is severely compromised when cholesterol is depleted from the envelope of virus particles isolated from mammalian cells, but virus particles isolated from mosquito cells are relatively unaffected by cholesterol depletion. We suggest that it is not cholesterol itself, but rather the organization of the viral envelope, that is critical for the biological activity of alphaviruses.	[Sousa, Ivanildo P., Jr.; Carvalho, Carlos A. M.; Silva, Jerson L.; Gomes, Andre M. O.] Univ Fed Rio de Janeiro, Inst Bioquim Med, BR-21341902 Rio De Janeiro, Brazil; [Sousa, Ivanildo P., Jr.; Carvalho, Carlos A. M.; Silva, Jerson L.; Gomes, Andre M. O.] Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, BR-21341902 Rio De Janeiro, Brazil; [Ferreira, Davis F.] Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo Goes, BR-21341902 Rio De Janeiro, Brazil; [Weissmueller, Gilberto; Rocha, Gustavo M.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21341902 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Gomes, AMO (corresponding author), Ave Carlos Chagas Filho,373 CCS Rm E1-008,Cidade, BR-21941902 Rio De Janeiro, Brazil.	amog@bioqmed.ufrj.br	Gomes, Andre M.O./C-4009-2014; Silva, Jerson/J-8984-2014; Sousa, Ivanildo/HCH-7825-2022; Sousa, ivanildo/ABC-1067-2020; SILVA, JERSON Lima/GRF-1442-2022; Ferreira, Davis/D-9356-2014	Gomes, Andre M.O./0000-0003-1052-8004; Silva, Jerson/0000-0001-9523-9441; Sousa, Ivanildo/0000-0003-1840-3302; SILVA, JERSON Lima/0000-0001-9523-9441; Carvalho, Carlos/0000-0001-6615-1387	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Fundacao Universitaria Jose Bonifacio (FUJB); Instituto Milenio de Biologia Estrutural em Biomedicina e Biotecnologia (IMBEBB); Instituto Nacional de Ciencia e Tecnologia em Biologia Estrutural e Bioimagem (INCTBEB); Programa de Apoio a Nucleos de Excelencia (PRONEX)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao Universitaria Jose Bonifacio (FUJB); Instituto Milenio de Biologia Estrutural em Biomedicina e Biotecnologia (IMBEBB); Instituto Nacional de Ciencia e Tecnologia em Biologia Estrutural e Bioimagem (INCTBEB); Programa de Apoio a Nucleos de Excelencia (PRONEX)	The work was supported by grants from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Fundacao Universitaria Jose Bonifacio (FUJB), Instituto Milenio de Biologia Estrutural em Biomedicina e Biotecnologia (IMBEBB), Instituto Nacional de Ciencia e Tecnologia em Biologia Estrutural e Bioimagem (INCTBEB), and Programa de Apoio a Nucleos de Excelencia (PRONEX).	Bagatolli LA, 2003, METHOD ENZYMOL, V360, P481; Barman S, 2007, J VIROL, V81, P12169, DOI 10.1128/JVI.00835-07; Bender FC, 2003, J VIROL, V77, P9542, DOI 10.1128/JVI.77.17.9542-9552.2003; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Campbell SM, 2002, AIDS, V16, P2253, DOI 10.1097/00002030-200211220-00004; Campbell SM, 2001, J CLIN VIROL, V22, P217, DOI 10.1016/S1386-6532(01)00193-7; Chung CS, 2005, J VIROL, V79, P1623, DOI 10.1128/JVI.79.3.1623-1634.2005; Clayton RB, 1964, J LIPID RES, V15, P3; Dhileepan K, 1996, J MED ENTOMOL, V33, P180, DOI 10.1093/jmedent/33.1.180; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; Gaus K, 2006, MOL MEMBR BIOL, V23, P41, DOI 10.1080/09687860500466857; Graham DRM, 2003, J VIROL, V77, P8237, DOI 10.1128/JVI.77.15.8237-8248.2003; Guyader M, 2002, J VIROL, V76, P10356, DOI 10.1128/JVI.76.20.10356-10364.2002; Hafer A, 2009, J VIROL, V83, P9113, DOI 10.1128/JVI.00755-09; Hambleton S, 2007, J VIROL, V81, P7548, DOI 10.1128/JVI.00486-07; Harris FM, 2002, BBA-BIOMEMBRANES, V1565, P123, DOI 10.1016/S0005-2736(02)00514-X; Hassing RJ, 2010, J INFECTION, V61, P343, DOI 10.1016/j.jinf.2010.06.009; He LL, 2010, J VIROL, V84, P5270, DOI 10.1128/JVI.00044-10; Huang HL, 2006, J GEN VIROL, V87, P277, DOI 10.1099/vir.0.81551-0; Huster D, 1998, BIOCHEMISTRY-US, V37, P17299, DOI 10.1021/bi980078g; IVANOVA L, 1993, J VIROL, V67, P2546, DOI 10.1128/JVI.67.5.2546-2551.1993; Jones LJ, 1998, ANAL BIOCHEM, V265, P368, DOI 10.1006/abio.1998.2914; Lorizate M, 2009, J BIOL CHEM, V284, P22238, DOI 10.1074/jbc.M109.029256; Lu YE, 2000, J VIROL, V74, P7708, DOI 10.1128/JVI.74.17.7708-7719.2000; Lu YPE, 1999, J VIROL, V73, P4272, DOI 10.1128/JVI.73.5.4272-4278.1999; LUUKKONEN A, 1976, BIOCHIM BIOPHYS ACTA, V450, P109, DOI 10.1016/0005-2760(76)90082-5; LUUKKONEN A, 1977, VIROLOGY, V78, P331, DOI 10.1016/0042-6822(77)90105-2; MARQUARDT MT, 1993, J CELL BIOL, V123, P57, DOI 10.1083/jcb.123.1.57; MEZENCIO JMS, 1993, MEM I OSWALDO CRUZ, V88, P299, DOI 10.1590/S0074-02761993000200020; MOORE NF, 1976, J VIROL, V19, P126, DOI 10.1128/JVI.19.1.126-135.1976; Niu SL, 2002, BIOPHYS J, V83, P3408, DOI 10.1016/S0006-3495(02)75340-X; PARASASSI T, 1990, BIOPHYS J, V57, P1179, DOI 10.1016/S0006-3495(90)82637-0; Paredes AM, 2004, VIROLOGY, V324, P373, DOI 10.1016/j.virol.2004.03.046; PHALEN T, 1991, J CELL BIOL, V112, P615, DOI 10.1083/jcb.112.4.615; Polozov IV, 2004, BIOPHYS J, V87, P1741, DOI 10.1529/biophysj.104.040725; Polozov IV, 2008, NAT CHEM BIOL, V4, P248, DOI 10.1038/nchembio.77; RECEVEUR MC, 2010, EUROSURVEILLANCE, V15, pP11; Scheiffele P, 1999, J BIOL CHEM, V274, P2038, DOI 10.1074/jbc.274.4.2038; SEFTON BM, 1974, J MOL BIOL, V90, P343, DOI 10.1016/0022-2836(74)90378-7; Silvius JR, 2003, BBA-BIOMEMBRANES, V1610, P174, DOI 10.1016/S0005-2736(03)00016-6; Smit JM, 1999, J VIROL, V73, P8476, DOI 10.1128/JVI.73.10.8476-8484.1999; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Sun XJ, 2003, J VIROL, V77, P12543, DOI 10.1128/JVI.77.23.12543-12551.2003; Takeda M, 2003, P NATL ACAD SCI USA, V100, P14610, DOI 10.1073/pnas.2235620100; Tesh RB, 1999, CLIN INFECT DIS, V28, P67, DOI 10.1086/515070; Vasconcelos P F, 2001, Cad Saude Publica, V17 Suppl, P155, DOI 10.1590/S0102-311X2001000700025; Viard M, 2002, J VIROL, V76, P11584, DOI 10.1128/JVI.76.22.11584-11595.2002; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	49	16	17	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1730	1736		10.1074/jbc.M110.198002	http://dx.doi.org/10.1074/jbc.M110.198002			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21075845	Green Published, hybrid			2022-12-25	WOS:000286191500012
J	Bocchino, M; Agnese, S; Fagone, E; Svegliati, S; Grieco, D; Vancheri, C; Gabrielli, A; Sanduzzi, A; Avvedimento, EV				Bocchino, Marialuisa; Agnese, Savina; Fagone, Evelina; Svegliati, Silvia; Grieco, Domenico; Vancheri, Carlo; Gabrielli, Armando; Sanduzzi, Alessandro; Avvedimento, Enrico V.			Reactive Oxygen Species Are Required for Maintenance and Differentiation of Primary Lung Fibroblasts in Idiopathic Pulmonary Fibrosis	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASES; SIGNAL-REGULATED KINASE; SYSTEMIC-SCLEROSIS; OXIDATIVE STRESS; INFLAMMATORY MECHANISMS; MINOR COMPONENT; NADPH OXIDASE; PDGF RECEPTOR; GROWTH-FACTOR; DISEASES	Background: Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal illness whose pathogenesis remains poorly understood. Recent evidence suggests oxidative stress as a key player in the establishment/progression of lung fibrosis in animal models and possibly in human IPF. The aim of the present study was to characterize the cellular phenotype of fibroblasts derived from IPF patients and identify underlying molecular mechanisms. Methodology/Principal Findings: We first analyzed the baseline differentiation features and growth ability of primary lung fibroblasts derived from 7 histology proven IPF patients and 4 control subjects at different culture passages. Then, we focused on the redox state and related molecular pathways of IPF fibroblasts and investigated the impact of oxidative stress in the establishment of the IPF phenotype. IPF fibroblasts were differentiated into alpha-smooth muscle actin (SMA)-positive myofibroblasts, displayed a pro-fibrotic phenotype as expressing type-I collagen, and proliferated lower than controls cells. The IPF phenotype was inducible upon oxidative stress in control cells and was sensitive to ROS scavenging. IPF fibroblasts also contained large excess of reactive oxygen species (ROS) due to the activation of an NADPH oxidase-like system, displayed higher levels of tyrosine phosphorylated proteins and were more resistant to oxidative-stress induced cell death. Interestingly, the IPF traits disappeared with time in culture, indicating a transient effect of the initial trigger. Conclusions/Significance: Robust expression of alpha-SMA and type-I collagen, high and uniformly-distributed ROS levels, resistance to oxidative-stress induced cell death and constitutive activation of tyrosine kinase(s) signalling are distinctive features of the IPF phenotype. We suggest that this phenotype can be used as a model to identify the initial trigger of IPF.	[Bocchino, Marialuisa; Sanduzzi, Alessandro] Univ Naples Federico II, Dipartimento Med Clin & Sperimentale, Sez Malattie Apparato Resp, Naples, Italy; [Bocchino, Marialuisa; Agnese, Savina; Grieco, Domenico; Avvedimento, Enrico V.] Univ Naples Federico II, Dipartimento Biol & Patol Cellulare & Mol L Calif, Naples, Italy; [Fagone, Evelina; Vancheri, Carlo] Univ Catania, Dipartimento Med Interna & Specialist, Sez Malattie Resp, Catania, Italy; [Svegliati, Silvia; Gabrielli, Armando] Univ Politecn Marche, Dipartimento Sci Med & Chirurg, Sez Clin Med, Ancona, Italy	University of Naples Federico II; University of Naples Federico II; University of Catania; Marche Polytechnic University	Bocchino, M (corresponding author), Univ Naples Federico II, Dipartimento Med Clin & Sperimentale, Sez Malattie Apparato Resp, Naples, Italy.	marialuisa.bocchino@unina.it	Svegliati, Silvia/L-2614-2016; Gabrielli, Armando/AAC-3173-2019; VANCHERI, Carlo/K-9417-2016	Svegliati, Silvia/0000-0001-6863-2600; GRIECO, Domenico/0000-0002-7131-5742; VANCHERI, Carlo/0000-0002-5120-9926; Fagone, Evelina/0000-0001-8413-7300	Associazione Italiana per la Lotta al Cancro (A.I.R.C.); Fondazione Cariverona	Associazione Italiana per la Lotta al Cancro (A.I.R.C.)(Fondazione AIRC per la ricerca sul cancro); Fondazione Cariverona(Fondazione Cariverona)	This work has been supported by Associazione Italiana per la Lotta al Cancro (A.I.R.C.) and by a generous grant from Fondazione Cariverona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Babior BM, 2004, CURR OPIN IMMUNOL, V16, P42, DOI 10.1016/j.coi.2003.12.001; Baroni SS, 2006, NEW ENGL J MED, V354, P2667; Beeh KM, 2002, EUR RESPIR J, V19, P1119, DOI 10.1183/09031936.02.00262402; CANTIN AM, 1987, J CLIN INVEST, V79, P1665, DOI 10.1172/JCI113005; Chan EC, 2009, PHARMACOL THERAPEUT, V122, P97, DOI 10.1016/j.pharmthera.2009.02.005; Chaudhary NI, 2007, EUR RESPIR J, V29, P976, DOI 10.1183/09031936.00152106; Cong YS, 2006, MECH AGEING DEV, V127, P332, DOI 10.1016/j.mad.2005.12.005; Cool CD, 2006, AM J RESP CRIT CARE, V174, P654, DOI 10.1164/rccm.200602-205OC; Das R, 2007, FREE RADICAL BIO MED, V42, P541, DOI 10.1016/j.freeradbiomed.2006.11.020; Escano CS, 2008, J PHARMACOL EXP THER, V324, P34, DOI 10.1124/jpet.107.126300; Flaherty KR, 2003, AM J RESP CRIT CARE, V167, P1410, DOI 10.1164/rccm.200204-373OC; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Gabrielli A, 2009, NEW ENGL J MED, V360, P1989, DOI 10.1056/NEJMra0806188; Gauldie J, 2002, AM J RESP CRIT CARE, V165, P1205, DOI 10.1164/rccm.2202054; Goodwin A, 2009, BIOCHEM SOC T, V37, P849, DOI 10.1042/BST0370849; Hardie WD, 2008, AM J PHYSIOL-LUNG C, V294, pL1217, DOI 10.1152/ajplung.00020.2008; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Ingram JL, 2006, CURR MOL MED, V6, P409, DOI 10.2174/156652406777435426; JORDANA M, 1988, AM REV RESPIR DIS, V137, P579, DOI 10.1164/ajrccm/137.3.579; King TE, 2001, AM J RESP CRIT CARE, V164, P1025, DOI 10.1164/ajrccm.164.6.2001056; Kinnula VL, 2003, AM J RESP CRIT CARE, V167, P1600, DOI 10.1164/rccm.200212-1479SO; Kinnula VL, 2005, AM J RESP CRIT CARE, V172, P417, DOI 10.1164/rccm.200501-017PP; Lenz AG, 1996, EUR RESPIR J, V9, P307, DOI 10.1183/09031936.96.09020307; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manoury B, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-11; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Nicholson AG, 2002, AM J RESP CRIT CARE, V166, P173, DOI 10.1164/rccm.2109039; Phan Sem H, 2008, Proc Am Thorac Soc, V5, P334, DOI 10.1513/pats.200708-146DR; Psathakis K, 2006, EUR J CLIN INVEST, V36, P362, DOI 10.1111/j.1365-2362.2006.01636.x; RAGHU G, 1988, AM REV RESPIR DIS, V138, P703, DOI 10.1164/ajrccm/138.3.703; Ramos C, 2001, AM J RESP CELL MOL, V24, P591, DOI 10.1165/ajrcmb.24.5.4333; Rottoli P, 2005, PROTEOMICS, V5, P2612, DOI 10.1002/pmic.200401206; Sambo P, 2001, ARTHRITIS RHEUM-US, V44, P2653, DOI 10.1002/1529-0131(200111)44:11<2653::AID-ART445>3.0.CO;2-1; Sauer H, 2001, CELL PHYSIOL BIOCHEM, V11, P173, DOI 10.1159/000047804; Selman M, 2001, RESP RES, V3, DOI 10.1186/rr175; Strieter RM, 2002, AM J RESP CRIT CARE, V165, P1206, DOI 10.1164/rccm.2202055; Sugiura H, 2009, PULM PHARMACOL THER, V22, P487, DOI 10.1016/j.pupt.2009.04.002; Svegliati S, 2005, J BIOL CHEM, V280, P36474, DOI 10.1074/jbc.M502851200; Waghray M, 2005, FASEB J, V19, P854, DOI 10.1096/fj.04-2882fje; Webber J, 2009, J BIOL CHEM, V284, P9083, DOI 10.1074/jbc.M806989200; Wu WS, 2006, MOL CANCER RES, V4, P747, DOI 10.1158/1541-7786.MCR-06-0096	42	102	104	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e14003	10.1371/journal.pone.0014003	http://dx.doi.org/10.1371/journal.pone.0014003			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103368	Green Published, gold, Green Submitted			2022-12-25	WOS:000284257400007
J	Sankey, C; Henry, S; Gorecka-Bruzda, A; Richard-Yris, MA; Hausberger, M				Sankey, Carol; Henry, Severine; Gorecka-Bruzda, Aleksandra; Richard-Yris, Marie-Annick; Hausberger, Martine			The Way to a Man's Heart Is through His Stomach: What about Horses?	PLOS ONE			English	Article							OXYTOCIN; STRESS	Background: How do we bond to one another? While in some species, like humans, physical contact plays a role in the process of attachment, it has been suggested that tactile contact's value may greatly differ according to the species considered. Nevertheless, grooming is often considered as a pleasurable experience for domestic animals, even though scientific data is lacking. On another hand, food seems to be involved in the creation of most relationships in a variety of species. Methodology/Principal Findings: In this study, we used the horse training context to test the effects of food versus grooming during repeated human-horse interactions. The results reveal that food certainly holds a key role in the attachment process, while tactile contact was here clearly insufficient for bonding to occur. Conclusion/Significance: This study raises important questions on the way tactile contact is perceived, and shows that large inter-species differences are to be expected.	[Sankey, Carol; Henry, Severine; Richard-Yris, Marie-Annick; Hausberger, Martine] Univ Rennes 1, UMR CNRS6552, Biol Stn, Paimpont, France; [Gorecka-Bruzda, Aleksandra] Polish Acad Sci, Inst Genet & Anim Breeding, Jastrzebiec, Wolka Kosowska, Poland	Universite de Rennes; Institute of Genetics & Animal Biotechnology, Polish Academy of Sciences; Polish Academy of Sciences	Sankey, C (corresponding author), Univ Rennes 1, UMR CNRS6552, Biol Stn, Paimpont, France.	carol.sankey@univ-rennes1.fr	Gorecka-Bruzda, Aleksandra/F-7399-2010	Gorecka-Bruzda, Aleksandra/0000-0002-2770-2278; Sankey, Carol/0000-0001-9890-9287	Comite d'Orientation Scientifique et Technique (COST, Les Haras Nationaux); Region Bretagne	Comite d'Orientation Scientifique et Technique (COST, Les Haras Nationaux); Region Bretagne(Region Bretagne)	Funding was provided by Comite d'Orientation Scientifique et Technique (COST, Les Haras Nationaux, http://www.haras-nationaux.fr/portail/) and Region Bretagne (http://www.bretagne.fr/internet/jcms/j_6/accueil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnard K., 1990, TOUCH FDN EXPERIENCE; Beck AM, 2003, AM BEHAV SCI, V47, P79, DOI 10.1177/0002764203255214; BOWLBY J, 2005, MAKING BREAKING AFFE, pCH4; BOYD LE, 1988, APPL ANIM BEHAV SCI, V21, P5, DOI 10.1016/0168-1591(88)90098-6; Cloutier S, 2008, APPL ANIM BEHAV SCI, V112, P158, DOI 10.1016/j.applanim.2007.07.003; De Kort SR, 2006, ANIM BEHAV, V72, P297, DOI 10.1016/j.anbehav.2005.10.016; Ditzen B, 2007, PSYCHONEUROENDOCRINO, V32, P565, DOI 10.1016/j.psyneuen.2007.03.011; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Emery NJ, 2007, PHILOS T R SOC B, V362, P489, DOI 10.1098/rstb.2006.1991; FEH C, 1993, ANIM BEHAV, V46, P1191, DOI 10.1006/anbe.1993.1309; FEH C, 2005, DOMESTIC HORSE; Hausberger M, 2007, J COMP PSYCHOL, V121, P109, DOI 10.1037/0735-7036.121.1.109; Hausberger M, 2008, APPL ANIM BEHAV SCI, V109, P1, DOI 10.1016/j.applanim.2007.04.015; Henry S, 2007, DEV PSYCHOBIOL, V49, P514, DOI 10.1002/dev.20225; Henry S, 2006, DEV PSYCHOBIOL, V48, P712, DOI 10.1002/dev.20189; Holden M. D., 2006, International Zoo Yearbook, V40, P144, DOI 10.1111/j.1748-1090.2006.00144.x; Jansen J, 2008, DEV REV, V28, P503, DOI 10.1016/j.dr.2008.07.001; Jezierski T, 1999, APPL ANIM BEHAV SCI, V62, P1, DOI 10.1016/S0168-1591(98)00209-3; KELLEHER ROGER T., 1962, JOUR EXPTL ANALYSIS BEHAVIOR, V5, P543, DOI 10.1901/jeab.1962.5-s543; Laule Gail E., 2003, Journal of Applied Animal Welfare Science, V6, P163, DOI 10.1207/S15327604JAWS0603_02; Lower SE, 2001, ANIM BEHAV, V61, P231, DOI 10.1006/anbe.2000.1545; McKinley Jean, 2003, Journal of Applied Animal Welfare Science, V6, P209, DOI 10.1207/S15327604JAWS0603_06; Normando S, 2003, VET RES COMMUN, V27, P615, DOI 10.1023/B:VERC.0000014230.52006.df; Prescott Mark J., 2003, Journal of Applied Animal Welfare Science, V6, P157, DOI 10.1207/S15327604JAWS0603_01; Price EO, 1999, APPL ANIM BEHAV SCI, V65, P245, DOI 10.1016/S0168-1591(99)00087-8; Reinhardt V., 1991, Animal Technology, V42, P11; Sankey C, 2010, ANIM COGN, V13, P753, DOI 10.1007/s10071-010-0326-9; Sankey C, 2010, ANIM BEHAV, V79, P869, DOI 10.1016/j.anbehav.2009.12.037; Skinner B. F., 1938, BEHAV ORGAN EXP ANAL; SKINNER BF, 1981, SCIENCE, V213, P501, DOI 10.1126/science.7244649; Tallet C, 2005, APPL ANIM BEHAV SCI, V94, P59, DOI 10.1016/j.applanim.2005.02.007; Uvnas-Moberg K, 1998, PSYCHONEUROENDOCRINO, V23, P819, DOI 10.1016/S0306-4530(98)00056-0; Wauters AM, 2003, CR BIOL, V326, P677, DOI 10.1016/S1631-0691(03)00128-8; Yin S, 2008, APPL ANIM BEHAV SCI, V113, P123, DOI 10.1016/j.applanim.2007.11.001	34	21	21	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e15446	10.1371/journal.pone.0015446	http://dx.doi.org/10.1371/journal.pone.0015446			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085576	Green Published, gold, Green Submitted			2022-12-25	WOS:000284231800032
J	Yu, WF; Liu, JA; Shi, MA; Wang, JA; Xiang, MX; Kitamoto, S; Wang, B; Sukhova, GK; Murphy, GF; Orasanu, G; Grubb, A; Shi, GP				Yu, Weifang; Liu, Jian; Shi, Michael A.; Wang, Jianan; Xiang, Meixiang; Kitamoto, Shiro; Wang, Bing; Sukhova, Galina K.; Murphy, George F.; Orasanu, Gabriela; Grubb, Anders; Shi, Guo-Ping			Cystatin C Deficiency Promotes Epidermal Dysplasia in K14-HPV16 Transgenic Mice	PLOS ONE			English	Article							HUMAN GLIOBLASTOMA CELLS; CHAIN VARIABLE FRAGMENT; MMP-9 GENE-EXPRESSION; HUMAN-MELANOMA CELLS; CATHEPSIN-B; TUMOR-GROWTH; MULTISTAGE TUMORIGENESIS; CYSTEINE PROTEASES; CANCER-CELLS; LUNG-CANCER	Background: Cysteine protease cathepsins are important in extracellular matrix protein degradation, cell apoptosis, and angiogenesis. Mice lacking cathepsins are protected from tumor progression in several animal models, suggesting that the regulation of cathepsin activities controls the growth of various malignant tumors. Methods and Results: We tested the role of cathepsins using a mouse model of multistage epithelial carcinogenesis, in which the human keratin-14 promoter/enhancer drove the expression of human papillomavirus type 16 (HPV16) early region E6/E7 transgenes. During the progression of premalignant dysplasia, we observed increased expression of cysteine protease cathepsin S, but concomitantly reduced expression of cathepsin endogenous inhibitor cystatin C in the skin tissue extract. Absence of cystatin C in these transgenic mice resulted in more progression of dysplasia to carcinoma in situ on the face, ear, chest, and tail. Chest and ear skin extract real time PCR and immunoblot analysis, mouse serum sample ELISA, tissue immunohistological analysis, and tissue extract-mediated in vitro elastinolysis and collagenolysis assays demonstrated that cystatin C deficiency significantly increased cathepsin expression and activity. In skin from both the chest and ear, we found that the absence of cystatin C reduced epithelial cell apoptosis but increased proliferation. From the same tissue preparations, we detected significantly higher levels of pro-angiogenic laminin 5-derived c2 peptides and concurrently increased neovascularization in cystatin C-deficient mice, compared to those from wild-type control mice. Conclusion: Enhanced cathepsin expression and activity in cystatin C-deficient mice contributed to the progression of dysplasia by altering premalignant tissue epithelial proliferation, apoptosis, and neovascularization.	[Yu, Weifang; Liu, Jian; Shi, Michael A.; Kitamoto, Shiro; Wang, Bing; Sukhova, Galina K.; Orasanu, Gabriela; Shi, Guo-Ping] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Yu, Weifang; Liu, Jian; Shi, Michael A.; Kitamoto, Shiro; Wang, Bing; Sukhova, Galina K.; Murphy, George F.; Orasanu, Gabriela; Shi, Guo-Ping] Harvard Univ, Sch Med, Boston, MA USA; [Yu, Weifang; Wang, Jianan; Xiang, Meixiang] Zhejiang Univ, Coll Med, Affiliated Hosp 2, Dept Cardiol, Hangzhou 310003, Zhejiang, Peoples R China; [Liu, Jian] Hefei Univ Technol, Sch Biotechnol & Food Engn, Dept Life Sci, Hefei, Peoples R China; [Murphy, George F.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Grubb, Anders] Univ Lund Hosp, Dept Clin Chem, S-22185 Lund, Sweden	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Zhejiang University; Hefei University of Technology; Harvard University; Brigham & Women's Hospital; Lund University; Skane University Hospital	Yu, WF (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.	gshi@rics.bwh.harvard.edu		Grubb, Anders/0000-0002-0125-3662; Shi, Michael/0000-0003-3243-4439	National Institutes of Health [HL60942, HL81090, HL88547, HL56985]; American Heart Association [0840118N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081090, R01HL088547, R01HL060942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study is supported by National Institutes of Health grants HL60942, HL81090, HL88547 (GPS); HL56985 (PL); and Established Investigator Award (0840118N) from the American Heart Association (GPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burden RE, 2009, CLIN CANCER RES, V15, P6042, DOI 10.1158/1078-0432.CCR-09-1262; Coussens LM, 1996, AM J PATHOL, V149, P1899; Daniel D, 2003, J EXP MED, V197, P1017, DOI 10.1084/jem.20021047; ERDEL M, 1990, J HISTOCHEM CYTOCHEM, V38, P1313, DOI 10.1177/38.9.2201737; Ervin H, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-14; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Frade R, 2008, CANCER GENE THER, V15, P591, DOI 10.1038/cgt.2008.51; Gocheva V, 2006, GENE DEV, V20, P543, DOI 10.1101/gad.1407406; GUINEC N, 1993, BIOL CHEM H-S, V374, P1135, DOI 10.1515/bchm3.1993.374.7-12.1135; Hirai K, 1999, HUM PATHOL, V30, P680, DOI 10.1016/S0046-8177(99)90094-1; Huh CG, 1999, J CLIN PATHOL-MOL PA, V52, P332, DOI 10.1136/mp.52.6.332; Jiborn T, 2006, BJU INT, V98, P189, DOI 10.1111/j.1464-410X.2006.06345.x; Joyce JA, 2004, CANCER CELL, V5, P443, DOI 10.1016/S1535-6108(04)00111-4; Kaznelson DW, 2004, VIROLOGY, V320, P301, DOI 10.1016/j.virol.2003.12.018; Kenig S, 2010, CANCER LETT, V289, P53, DOI 10.1016/j.canlet.2009.07.014; Kitamoto S, 2007, CIRCULATION, V115, P2065, DOI 10.1161/CIRCULATIONAHA.107.688523; Klein S, 2005, NAT REV CANCER, V5, P573, DOI 10.1038/nrc1651; Konduri SD, 2002, ONCOGENE, V21, P8705, DOI 10.1038/sj.onc.1205949; Kopitz C, 2005, CANCER RES, V65, P8608, DOI 10.1158/0008-5472.CAN-05-1572; Krepela E, 1998, NEOPLASMA, V45, P318; Kruszewski WJ, 2004, NEOPLASMA, V51, P38; Lakka SS, 2004, ONCOGENE, V23, P4681, DOI 10.1038/sj.onc.1207616; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Moin K, 1998, BIOL CHEM, V379, P1093, DOI 10.1515/bchm.1998.379.8-9.1093; Mundel TM, 2007, MICROVASC RES, V74, P85, DOI 10.1016/j.mvr.2007.05.005; Nakabayashi H, 2005, HUM PATHOL, V36, P1008, DOI 10.1016/j.humpath.2005.06.021; NEUCHRIST C, 1990, BRIT J CANCER, V62, P748, DOI 10.1038/bjc.1990.371; Nishikawa H, 2004, GYNECOL ONCOL, V92, P881, DOI 10.1016/j.ygyno.2003.11.017; Ortegel JW, 2000, CANCER IMMUNOL IMMUN, V48, P627, DOI 10.1007/s002620050011; Pennacchio LA, 1998, NAT GENET, V20, P251, DOI 10.1038/3059; Premzl A, 2003, EXP CELL RES, V283, P206, DOI 10.1016/S0014-4827(02)00055-1; Rousselet N, 2004, CANCER RES, V64, P146, DOI 10.1158/0008-5472.CAN-03-1717; Sasaki T, 2001, J MOL BIOL, V314, P751, DOI 10.1006/jmbi.2001.5176; Shi GP, 2000, J EXP MED, V191, P1177, DOI 10.1084/jem.191.7.1177; SHI GP, 1994, J BIOL CHEM, V269, P11530; Sokol JP, 2004, MOL CANCER RES, V2, P183; Stoka V, 2001, J BIOL CHEM, V276, P3149, DOI 10.1074/jbc.M008944200; Strojan P, 2004, CLIN CHIM ACTA, V344, P155, DOI 10.1016/j.cccn.2004.02.011; Sukhova GK, 2005, CIRC RES, V96, P368, DOI 10.1161/01.RES.0000155964.34150.F7; Sukhova GK, 1998, J CLIN INVEST, V102, P576, DOI 10.1172/JCI181; Sun JS, 2009, CIRCULATION, V120, P973, DOI 10.1161/CIRCULATIONAHA.109.849679; Szpaderska AM, 2001, CANCER RES, V61, P3493; Tummalapalli P, 2007, INT J ONCOL, V31, P1039; Urbich C, 2005, NAT MED, V11, P206, DOI 10.1038/nm1182; Wang B, 2006, J BIOL CHEM, V281, P6020, DOI 10.1074/jbc.M509134200; Yanamandra N, 2004, ONCOGENE, V23, P2224, DOI 10.1038/sj.onc.1207338; Yasuda Y, 2005, ADV DRUG DELIVER REV, V57, P973, DOI 10.1016/j.addr.2004.12.013; YOSHII A, 1995, ARCH DERMATOL RES, V287, P209, DOI 10.1007/BF01262334	48	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e13973	10.1371/journal.pone.0013973	http://dx.doi.org/10.1371/journal.pone.0013973			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085595	Green Submitted, Green Published, gold			2022-12-25	WOS:000284231800008
J	Zhang, ZF; Shively, JE				Zhang, Zhifang; Shively, John E.			Generation of Novel Bone Forming Cells (Monoosteophils) from the Cathelicidin-Derived Peptide LL-37 Treated Monocytes	PLOS ONE			English	Article							HUMAN DENDRITIC CELLS; HUMAN ANTIBACTERIAL CATHELICIDIN; ENDOTHELIAL PROGENITOR CELLS; PERIPHERAL-BLOOD; GROWTH-FACTORS; ANTIMICROBIAL PEPTIDES; DIFFERENTIATION; OSTEOCLASTS; RECEPTOR; HCAP-18	Background: Bone generation and maintenance involve osteoblasts, osteoclasts, and osteocytes which originate from unique precursors and rely on key growth factors for differentiation. However, an incomplete understanding of bone forming cells during wound healing has led to an unfilled clinical need such as nonunion of bone fractures. Since circulating monocytes are often recruited to sites of injury and may differentiate into various cell types including osteoclasts, we investigated the possibility that circulating monocytes in the context of tissue injury may also contribute to bone repair. In particular, we hypothesized that LL-37 (produced from hCAP-18, cathelicidin), which recruits circulating monocytes during injury, may play a role in bone repair. Methods and Findings: Treatment of monocytes from blood with LL-37 for 6 days resulted in their differentiation to large adherent cells. Growth of LL-37-differentiated monocytes on osteologic discs reveals bone-like nodule formation by scanning electron microscopy (SEM). In vivo transplantation studies in NOD/SCID mice show that LL-37-differentiated monocytes form bone-like structures similar to endochondral bone formation. Importantly, LL-37-differentiated monocytes are distinct from conventional monocyte-derived osteoclasts, macrophages, and dendritic cells and do not express markers of the mesenchymal stem cells (MSC) lineage, distinguishing them from the conventional precursors of osteoblasts. Furthermore, LL-37 differentiated monocytes express intracellular proteins of both the osteoblast and osteoclast lineage including osteocalcin (OC), osteonectin (ON), bone sialoprotein II (BSP II), osteopontin (OP), RANK, RANKL, MMP-9, tartrate resistant acid phosphatase (TRAP), and cathepsin K (CK). Conclusion: Blood derived monocytes treated with LL-37 can be differentiated into a novel bone forming cell that functions both in vitro and in vivo. We propose the name monoosteophil to indicate their monocyte derived lineage and their bone forming phenotype. These cells may have wide ranging implications in the clinic including repair of broken bones and treatment of osteoporosis.	[Zhang, Zhifang; Shively, John E.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Immunol, Duarte, CA USA	City of Hope; Beckman Research Institute of City of Hope	Zhang, ZF (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Immunol, Duarte, CA USA.	jshively@coh.org			National Institutes of Health (NIH) [CA84202]; NATIONAL CANCER INSTITUTE [R01CA084202] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (NIH), CA84202. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerberth B, 2000, BLOOD, V96, P3086, DOI 10.1182/blood.V96.9.3086.h8003086_3086_3093; Bandholtz L, 2006, SCAND J IMMUNOL, V63, P410, DOI 10.1111/j.1365-3083.2006.001752.x; Davidson DJ, 2004, J IMMUNOL, V172, P1146, DOI 10.4049/jimmunol.172.2.1146; Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501; FALZONI S, 1995, J CLIN INVEST, V95, P1207, DOI 10.1172/JCI117770; Franc NC, 1996, IMMUNITY, V4, P431, DOI 10.1016/S1074-7613(00)80410-0; Frohm M, 1996, EUR J BIOCHEM, V237, P86, DOI 10.1111/j.1432-1033.1996.0086n.x; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; GORDON S, 1995, BIOESSAYS, V17, P977, DOI 10.1002/bies.950171111; Hayman AR, 2000, J HISTOCHEM CYTOCHEM, V48, P219, DOI 10.1177/002215540004800207; Heilborn JD, 2003, J INVEST DERMATOL, V120, P379, DOI 10.1046/j.1523-1747.2003.12069.x; Isenmann S, 2009, STEM CELLS, V27, P2457, DOI 10.1002/stem.181; Jilka RL, 1998, J BONE MINER RES, V13, P793, DOI 10.1359/jbmr.1998.13.5.793; Johansson J, 1998, J BIOL CHEM, V273, P3718, DOI 10.1074/jbc.273.6.3718; Kake T, 2009, AM J PHYSIOL-ENDOC M, V297, pE1339, DOI 10.1152/ajpendo.00272.2009; Kandler K, 2006, INT IMMUNOL, V18, P1729, DOI 10.1093/intimm/dxl107; Khosla S, 2008, J CLIN INVEST, V118, P421, DOI 10.1172/JCI33612; Koczulla R, 2003, J CLIN INVEST, V111, P1665, DOI 10.1172/JCI200317545; Kuwana M, 2003, J LEUKOCYTE BIOL, V74, P833, DOI 10.1189/jlb.0403170; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Malm J, 2000, INFECT IMMUN, V68, P4297, DOI 10.1128/IAI.68.7.4297-4302.2000; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Miyamoto T, 2001, BLOOD, V98, P2544, DOI 10.1182/blood.V98.8.2544; Naito M, 1997, MICROSC RES TECHNIQ, V39, P350, DOI 10.1002/(SICI)1097-0029(19971115)39:4<350::AID-JEMT5>3.0.CO;2-L; Niyonsaba F, 2002, IMMUNOLOGY, V106, P20, DOI 10.1046/j.1365-2567.2002.01398.x; Nuttall ME, 2004, CURR OPIN PHARMACOL, V4, P290, DOI 10.1016/j.coph.2004.03.002; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; Palucka KA, 1999, J LEUKOCYTE BIOL, V65, P232, DOI 10.1002/jlb.65.2.232; Puig-Kroger A, 2000, J IMMUNOL, V165, P4338, DOI 10.4049/jimmunol.165.8.4338; Pujol BF, 2000, DIFFERENTIATION, V65, P287, DOI 10.1046/j.1432-0436.2000.6550287.x; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Romani N, 1996, J IMMUNOL METHODS, V196, P137, DOI 10.1016/0022-1759(96)00078-6; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schaller-Bals S, 2002, AM J RESP CRIT CARE, V165, P992, DOI 10.1164/ajrccm.165.7.200110-020; Schmeisser A, 2001, CARDIOVASC RES, V49, P671, DOI 10.1016/S0008-6363(00)00270-4; Scott MG, 2002, J IMMUNOL, V169, P3883, DOI 10.4049/jimmunol.169.7.3883; Servet-Delprat Christine, 2002, BMC Immunol, V3, P15, DOI 10.1186/1471-2172-3-15; Shapiro F, 2008, EUR CELLS MATER, V15, P53, DOI 10.22203/eCM.v015a05; Sorensen MG, 2007, J BONE MINER METAB, V25, P36, DOI 10.1007/s00774-006-0725-9; Sorensen O, 1997, BLOOD, V90, P2796; Sorensen O, 1999, J BIOL CHEM, V274, P22445, DOI 10.1074/jbc.274.32.22445; Sorensen OE, 2003, J IMMUNOL, V170, P5583, DOI 10.4049/jimmunol.170.11.5583; Sorensen OE, 2001, BLOOD, V97, P3951, DOI 10.1182/blood.V97.12.3951; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Tjabringa GS, 2003, J IMMUNOL, V171, P6690, DOI 10.4049/jimmunol.171.12.6690; Tosello V, 2009, EUR J IMMUNOL, V39, P56, DOI 10.1002/eji.200738098; Urbich C, 2003, CIRCULATION, V108, P2511, DOI 10.1161/01.CIR.0000096483.29777.50; van der Does AM, 2010, J IMMUNOL, V185, P1442, DOI 10.4049/jimmunol.1000376; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Yuasa K, 2007, BIOCHEM BIOPH RES CO, V356, P354, DOI 10.1016/j.bbrc.2007.02.118; Zhang ZF, 2008, EXP BIOL MED, V233, P1171, DOI 10.3181/0712-RM-328; Zhang ZF, 2008, J LEUKOCYTE BIOL, V84, P780, DOI 10.1189/jlb.0208086; Zhang ZF, 2009, EUR J IMMUNOL, V39, P3181, DOI 10.1002/eji.200939496; Zhao Y, 2003, P NATL ACAD SCI USA, V100, P2426, DOI 10.1073/pnas.0536882100; Zhou LJ, 1996, P NATL ACAD SCI USA, V93, P2588, DOI 10.1073/pnas.93.6.2588	59	39	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e13985	10.1371/journal.pone.0013985	http://dx.doi.org/10.1371/journal.pone.0013985			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085494	Green Submitted, Green Published, gold			2022-12-25	WOS:000284231800015
J	Lan, L; Lin, SY; Zhang, S; Cohen, RS				Lan, Lan; Lin, Shengyin; Zhang, Sui; Cohen, Robert S.			Evidence for a Transport-Trap Mode of Drosophila melanogaster gurken mRNA Localization	PLOS ONE			English	Article							ALPHA-LIKE PROTEIN; TRANSLATIONAL CONTROL; GENE-EXPRESSION; OOGENESIS; OOCYTE; OSKAR; DYNEIN; POLARITY; REVEALS; PATTERN	The Drosophila melanogaster gurken gene encodes a TGF alpha-like signaling molecule that is secreted from the oocyte during two distinct stages of oogenesis to define the coordinate axes of the follicle cell epithelium that surrounds the oocyte and its 15 anterior nurse cells. Because the gurken receptor is expressed throughout the epithelium, axial patterning requires region-specific secretion of Gurken protein, which in turn requires subcellular localization of gurken transcripts. The first stage of Gurken signaling induces anteroposterior pattern in the epithelium and requires the transport of gurken transcripts from nurse cells into the oocyte. The second stage of Gurken signaling induces dorsovental polarity in the epithelium and requires localization of gurken transcripts to the oocyte's anterodorsal corner. Previous studies, relying predominantly on real-time imaging of injected transcripts, indicated that anterodorsal localization involves transport of gurken transcripts to the oocyte's anterior cortex followed by transport to the anterodorsal corner, and anchoring. Such studies further indicated that a single RNA sequence element, the GLS, mediates both transport steps by facilitating association of gurken transcripts with a cytoplasmic dynein motor complex. Finally, it was proposed that the GLS somehow steers the motor complex toward that subset of microtubules that are nucleated around the oocyte nucleus, permitting directed transport to the anterodorsal corner. Here, we re-investigate the role of the GLS using a transgenic fly assay system that includes use of the endogenous gurken promoter and biological rescue as well as RNA localization assays. In contrast to previous reports, our studies indicate that the GLS is sufficient for anterior localization only. Our data support a model in which anterodorsal localization is brought about by repeated rounds of anterior transport, accompanied by specific trapping at the anterodorsal cortex. Our data further indicate that trapping at the anterodorsal corner requires at least one as-yet-unidentified gurken RLE.	[Lan, Lan; Lin, Shengyin; Zhang, Sui; Cohen, Robert S.] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA	University of Kansas	Lan, L (corresponding author), Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA.	rcohen@ku.edu	LAN, LAN/N-8872-2018		National Institutes of Health [R01GM068022]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068022] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by National Institutes of Health grant R01GM068022 awarded to RSC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M., 1989, DROSOPHILA; Bashirullah A, 1998, ANNU REV BIOCHEM, V67, P335, DOI 10.1146/annurev.biochem.67.1.335; Bastock R, 2008, CURR BIOL, V18, pR1082, DOI 10.1016/j.cub.2008.09.011; Becalska AN, 2009, DEVELOPMENT, V136, P2493, DOI 10.1242/dev.032391; BERLETH T, 1988, EMBO J, V7, P1749, DOI 10.1002/j.1460-2075.1988.tb03004.x; BRENNER HR, 1990, NATURE, V344, P544, DOI 10.1038/344544a0; Chekulaeva M, 2006, CELL, V124, P521, DOI 10.1016/j.cell.2006.01.031; CHEUNG HK, 1992, DEVELOPMENT, V114, P653; Clark IE, 1997, DEVELOPMENT, V124, P461; Clouse KN, 2008, DEV BIOL, V313, P713, DOI 10.1016/j.ydbio.2007.11.008; Cohen RS, 2005, RNA, V11, P1017, DOI 10.1261/rna.7218905; Delanoue R, 2007, DEV CELL, V13, P523, DOI 10.1016/j.devcel.2007.08.022; Dollar G, 2002, DEVELOPMENT, V129, P517; Duncan JE, 2002, CURR BIOL, V12, P1982, DOI 10.1016/S0960-9822(02)01303-9; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Filardo P, 2003, MECH DEVELOP, V120, P289, DOI 10.1016/S0925-4773(02)00454-9; Forrest KM, 2003, CURR BIOL, V13, P1159, DOI 10.1016/S0960-9822(03)00451-2; GONZALEZREYES A, 1995, NATURE, V375, P654, DOI 10.1038/375654a0; Grunert S, 1996, CURR OPIN GENET DEV, V6, P395, DOI 10.1016/S0959-437X(96)80059-1; Heger A, 2007, GENETICS, V177, P1337, DOI 10.1534/genetics.107.070466; Januschke J, 2002, CURR BIOL, V12, P1971, DOI 10.1016/S0960-9822(02)01302-7; Jaramillo AM, 2008, J CELL SCI, V121, P887, DOI 10.1242/jcs.019091; Kugler JM, 2009, FLY, V3, P15, DOI 10.4161/fly.3.1.7751; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; LEHMANN R, 1986, CELL, V47, P141, DOI 10.1016/0092-8674(86)90375-2; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Meignin C, 2010, CURR OPIN CELL BIOL, V22, P112, DOI 10.1016/j.ceb.2009.11.011; NeumanSilberberg FS, 1996, MECH DEVELOP, V59, P105, DOI 10.1016/0925-4773(96)00567-9; NEUMANSILBERBERG FS, 1993, CELL, V75, P165, DOI 10.1016/S0092-8674(05)80093-5; Nielsen CB, 2010, NAT METHODS, V7, pS5, DOI [10.1038/NMETH.1422, 10.1038/nmeth.1422]; Nilson LA, 1999, CURR TOP DEV BIOL, V44, P203; Norvell A, 1999, GENE DEV, V13, P864, DOI 10.1101/gad.13.7.864; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Pirrotta V, 1988, Biotechnology, V10, P437; Queenan AM, 1999, MECH DEVELOP, V89, P35, DOI 10.1016/S0925-4773(99)00196-3; Rom I, 2007, BBA-MOL CELL RES, V1773, P1526, DOI 10.1016/j.bbamcr.2007.05.005; Roth S, 2003, PHILOS T ROY SOC B, V358, P1317, DOI 10.1098/rstb.2003.1325; ROTH S, 1995, CELL, V81, P967, DOI 10.1016/0092-8674(95)90016-0; Saunders C, 1999, MOL CELL, V3, P43, DOI 10.1016/S1097-2765(00)80173-2; SCHUPBACH T, 1987, CELL, V49, P699, DOI 10.1016/0092-8674(87)90546-0; SERANO T, 1995, DEVELOPMENT, V121, P3809; SERANO TL, 1995, MECH DEVELOP, V51, P183, DOI 10.1016/0925-4773(95)00363-0; SIMON AM, 1992, DEVELOPMENT, V114, P545; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; THEURKAUF WE, 1992, DEVELOPMENT, V115, P923; Van De Bor V, 2005, DEV CELL, V9, P51, DOI 10.1016/j.devcel.2005.04.012; Yan N, 2004, GENETICS, V168, P1433, DOI 10.1534/genetics.104.033985	49	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e15448	10.1371/journal.pone.0015448	http://dx.doi.org/10.1371/journal.pone.0015448			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103393	Green Published, gold, Green Submitted			2022-12-25	WOS:000284147700027
J	Barz, M; Beimgraben, C; Staller, T; Germer, F; Opitz, F; Marquardt, C; Schwarz, C; Gutekunst, K; Vanselow, KH; Schmitz, R; LaRoche, J; Schulz, R; Appel, J				Barz, Martin; Beimgraben, Christian; Staller, Torsten; Germer, Frauke; Opitz, Friederike; Marquardt, Claudia; Schwarz, Christoph; Gutekunst, Kirstin; Vanselow, Klaus Heinrich; Schmitz, Ruth; LaRoche, Julie; Schulz, Ruediger; Appel, Jens			Distribution Analysis of Hydrogenases in Surface Waters of Marine and Freshwater Environments	PLOS ONE			English	Article							OCEAN SAMPLING EXPEDITION; SP PCC 6803; MOLECULAR-HYDROGEN; ALCALIGENES-EUTROPHUS; NITROGEN-FIXATION; NIFE-HYDROGENASE; BIDIRECTIONAL HYDROGENASE; DISSOLVED HYDROGEN; RALSTONIA-EUTROPHA; ESCHERICHIA-COLI	Background: Surface waters of aquatic environments have been shown to both evolve and consume hydrogen and the ocean is estimated to be the principal natural source. In some marine habitats, H-2 evolution and uptake are clearly due to biological activity, while contributions of abiotic sources must be considered in others. Until now the only known biological process involved in H-2 metabolism in marine environments is nitrogen fixation. Principal Findings: We analyzed marine and freshwater environments for the presence and distribution of genes of all known hydrogenases, the enzymes involved in biological hydrogen turnover. The total genomes and the available marine metagenome datasets were searched for hydrogenase sequences. Furthermore, we isolated DNA from samples from the North Atlantic, Mediterranean Sea, North Sea, Baltic Sea, and two fresh water lakes and amplified and sequenced part of the gene encoding the bidirectional NAD(P)-linked hydrogenase. In 21% of all marine heterotrophic bacterial genomes from surface waters, one or several hydrogenase genes were found, with the membrane-bound H-2 uptake hydrogenase being the most widespread. A clear bias of hydrogenases to environments with terrestrial influence was found. This is exemplified by the cyanobacterial bidirectional NAD(P)-linked hydrogenase that was found in freshwater and coastal areas but not in the open ocean. Significance: This study shows that hydrogenases are surprisingly abundant in marine environments. Due to its ecological distribution the primary function of the bidirectional NAD(P)-linked hydrogenase seems to be fermentative hydrogen evolution. Moreover, our data suggests that marine surface waters could be an interesting source of oxygen-resistant uptake hydrogenases. The respective genes occur in coastal as well as open ocean habitats and we presume that they are used as additional energy scavenging devices in otherwise nutrient limited environments. The membrane-bound H-2-evolving hydrogenases might be useful as marker for bacteria living inside of marine snow particles.	[Barz, Martin; Beimgraben, Christian; Germer, Frauke; Opitz, Friederike; Marquardt, Claudia; Schulz, Ruediger] Univ Kiel, Inst Bot, D-2300 Kiel, Germany; [Staller, Torsten; Vanselow, Klaus Heinrich] Univ Kiel, Forsch & Technol Zentrum Westkuste FTZ, Busum, Germany; [Schwarz, Christoph; Gutekunst, Kirstin; Appel, Jens] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Schmitz, Ruth] Univ Kiel, Inst Allgemeine Mikrobiol, D-2300 Kiel, Germany; [LaRoche, Julie] IFM GEOMAR, Leibniz Inst Marine Sci, Kiel, Germany	University of Kiel; University of Kiel; Arizona State University; Arizona State University-Tempe; University of Kiel; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel	Barz, M (corresponding author), Univ Kiel, Inst Bot, Olshausenstr 40, D-2300 Kiel, Germany.	jens.appel@asu.edu	LaRoche, Julie/A-1109-2010	Gutekunst, Kirstin/0000-0003-4366-423X; Appel, Jens/0000-0002-0658-7899; LaRoche, Julie/0000-0003-4809-6411	Innovationsfond Schleswig-Holstein, Linde AG; cluster of excellence "Future Ocean"	Innovationsfond Schleswig-Holstein, Linde AG; cluster of excellence "Future Ocean"	Funding: Financial support was from the Innovationsfond Schleswig-Holstein, Linde AG and from the cluster of excellence "Future Ocean". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Appel J, 2000, ARCH MICROBIOL, V173, P333, DOI 10.1007/s002030000139; Appel J, 1996, BBA-PROTEIN STRUCT M, V1298, P141, DOI 10.1016/S0167-4838(96)00176-8; Appel J, 1998, J PHOTOCH PHOTOBIO B, V47, P1, DOI 10.1016/S1011-1344(98)00179-1; Arahal DR, 2007, INT J SYST EVOL MICR, V57, P1000, DOI 10.1099/ijs.0.64524-0; BALLANTINE SP, 1986, EUR J BIOCHEM, V156, P277, DOI 10.1111/j.1432-1033.1986.tb09578.x; Bernhard M, 1996, J BACTERIOL, V178, P4522, DOI 10.1128/jb.178.15.4522-4529.1996; Boyd ES, 2009, APPL ENVIRON MICROB, V75, P4620, DOI 10.1128/AEM.00582-09; BOYD ES, 2010, ISME J          0610; Buhrke T, 2004, MOL MICROBIOL, V51, P1677, DOI 10.1111/j.1365-2958.2003.03933.x; Buhrke T, 1998, ARCH MICROBIOL, V170, P460, DOI 10.1007/s002030050667; Burgdorf T, 2005, J MOL MICROB BIOTECH, V10, P181, DOI 10.1159/000091564; CONRAD R, 1980, J GEOPHYS RES-OCEANS, V85, P5493, DOI 10.1029/JC085iC10p05493; Conrad R, 1996, MICROBIOL REV, V60, P609, DOI 10.1128/MMBR.60.4.609-640.1996; CONRAD R, 1988, DEEP-SEA RES, V35, P1903, DOI 10.1016/0198-0149(88)90116-1; CONRAD R, 1983, APPL ENVIRON MICROB, V45, P502, DOI 10.1128/AEM.45.2.502-510.1983; Constant P, 2010, ENVIRON MICROBIOL, V12, P821, DOI 10.1111/j.1462-2920.2009.02130.x; Cournac L, 2004, J BACTERIOL, V186, P1737, DOI 10.1128/JB.186.6.1737-1746.2003; Cournac L, 2002, INT J HYDROGEN ENERG, V27, P1229, DOI 10.1016/S0360-3199(02)00105-2; Cracknell JA, 2008, J AM CHEM SOC, V130, P424, DOI 10.1021/ja078299+; Cummings L, 2002, FEMS MICROBIOL LETT, V216, P133, DOI 10.1016/S0378-1097(02)00955-2; DeLong EE, 2005, NAT REV MICROBIOL, V3, P459, DOI 10.1038/nrmicro1158; Ehhalt DH, 2009, TELLUS B, V61, P500, DOI 10.1111/j.1600-0889.2009.00416.x; Elsen S, 2003, J BACTERIOL, V185, P7111, DOI 10.1128/JB.185.24.7111-7119.2003; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FITCH WM, 1967, SCIENCE, V155, P279, DOI 10.1126/science.155.3760.279; Fong AA, 2008, ISME J, V2, P663, DOI 10.1038/ismej.2008.22; Fontecilla-Camps JC, 2007, CHEM REV, V107, P4273, DOI 10.1021/cr050195z; Giovannoni SJ, 2005, NATURE, V437, P343, DOI 10.1038/nature04158; Gonzalez JM, 1997, APPL ENVIRON MICROB, V63, P4237; Gutekunst K, 2006, INT J HYDROGEN ENERG, V31, P1452, DOI 10.1016/j.ijhydene.2006.06.010; Gutthann F, 2007, BBA-BIOENERGETICS, V1767, P161, DOI 10.1016/j.bbabio.2006.12.003; Hedderich R, 2005, J MOL MICROB BIOTECH, V10, P92, DOI 10.1159/000091557; HERR FL, 1984, DEEP-SEA RES, V31, P13, DOI 10.1016/0198-0149(84)90069-4; HERR FL, 1981, DEEP-SEA RES, V28, P1001, DOI 10.1016/0198-0149(81)90014-5; Hoehler TM, 2001, NATURE, V412, P324, DOI 10.1038/35085554; IARSMARTINEZ E, 2008, ISME J, V2, P1194; King GM, 2007, NAT REV MICROBIOL, V5, P107, DOI 10.1038/nrmicro1595; King GM, 2003, APPL ENVIRON MICROB, V69, P7266, DOI 10.1128/AEM.69.12.7266-7272.2003; Langlois RJ, 2008, APPL ENVIRON MICROB, V74, P1922, DOI 10.1128/AEM.01720-07; Lechner S, 1997, FEMS MICROBIOL ECOL, V22, P193, DOI 10.1016/S0168-6496(96)00090-6; Lenz O, 1998, P NATL ACAD SCI USA, V95, P12474, DOI 10.1073/pnas.95.21.12474; Lindberg P, 2004, APPL ENVIRON MICROB, V70, P2137, DOI 10.1128/AEM.70.4.2137-2145.2004; Ludwig M, 2006, J MOL EVOL, V63, P758, DOI 10.1007/s00239-006-0001-6; Ludwig M, 2009, J BIOL CHEM, V284, P2159, DOI 10.1074/jbc.M808488200; Lukey MJ, 2010, J BIOL CHEM, V285, P3928, DOI 10.1074/jbc.M109.067751; Maroti G, 2009, APPL ENVIRON MICROB, V75, P5821, DOI 10.1128/AEM.00580-09; MITSUI A, 1995, CURR MICROBIOL, V30, P1, DOI 10.1007/BF00294515; Montoya JP, 2004, NATURE, V430, P1027, DOI 10.1038/nature02824; Moran MA, 2007, NAT REV MICROBIOL, V5, P792, DOI 10.1038/nrmicro1746; Morita RY, 1999, MICROB ECOL, V38, P307, DOI 10.1007/s002489901002; Ng G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004695; Novelli PC, 1999, J GEOPHYS RES-ATMOS, V104, P30427, DOI 10.1029/1999JD900788; ORTEGA-CALVO JJ, 1991, J GEN MICROBIOL, V137, P1789; Paulmier A, 2009, PROG OCEANOGR, V80, P113, DOI 10.1016/j.pocean.2008.08.001; Pedros-Alio C, 2006, TRENDS MICROBIOL, V14, P257, DOI 10.1016/j.tim.2006.04.007; Ploug H, 1997, AQUAT MICROB ECOL, V13, P285, DOI 10.3354/ame013285; Poretsky RS, 2009, ENVIRON MICROBIOL, V11, P1358, DOI 10.1111/j.1462-2920.2008.01863.x; Price H, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008152; Punshon S, 2008, MAR CHEM, V108, P215, DOI 10.1016/j.marchem.2007.11.010; Punshon S, 2007, MAR CHEM, V105, P129, DOI 10.1016/j.marchem.2007.01.009; Redwood MD, 2008, FEMS MICROBIOL LETT, V278, P48, DOI 10.1111/j.1574-6968.2007.00966.x; RHAN T, 2003, NATURE, V424, P918; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sawers RG, 2005, BIOCHEM SOC T, V33, P42, DOI 10.1042/BST0330042; SCHMIDT U, 1993, LIMNOL OCEANOGR, V38, P1214, DOI 10.4319/lo.1993.38.6.1214; Schmitz O, 1996, NATURWISSENSCHAFTEN, V83, P525; SCHUTZ H, 1988, BIOGEOCHEMISTRY, V5, P295, DOI 10.1007/BF02180069; SCHWARTZ E, 2005, HDB BIOL BACTERIA EC, V2, P496; SCRANTON MI, 1982, J MAR RES, V40, P873; SCRANTON MI, 1987, LIMNOL OCEANOGR, V32, P998, DOI 10.4319/lo.1987.32.4.0998; Sorokin YI., 2002, BIO INL WAT; Tamagnini P, 2007, FEMS MICROBIOL REV, V31, P692, DOI 10.1111/j.1574-6976.2007.00085.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tripp HJ, 2010, NATURE, V464, P90, DOI 10.1038/nature08786; Troshina O, 2002, INT J HYDROGEN ENERG, V27, P1283, DOI 10.1016/S0360-3199(02)00103-9; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Vignais PM, 2005, BIOCHEM SOC T, V33, P28, DOI 10.1042/BST0330028; Vignais PM, 2001, FEMS MICROBIOL REV, V25, P455, DOI 10.1111/j.1574-6976.2001.tb00587.x; Vincent KA, 2006, CHEM COMMUN, P5033, DOI 10.1039/b614272a; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016; Yutin N, 2007, ENVIRON MICROBIOL, V9, P1464, DOI 10.1111/j.1462-2920.2007.01265.x; Zehr JP, 2008, SCIENCE, V322, P1110, DOI 10.1126/science.1165340; Zehr JP, 2001, NATURE, V412, P635, DOI 10.1038/35088063	86	39	41	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2010	5	11							e13846	10.1371/journal.pone.0013846	http://dx.doi.org/10.1371/journal.pone.0013846			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675OD	21079771	Green Published, gold, Green Accepted			2022-12-25	WOS:000283839100007
J	Nordstrand, LM; Svard, J; Larsen, E; Nilsen, A; Ougland, R; Furu, K; Lien, GF; Rognes, T; Namekawa, SH; Lee, JT; Klungland, A				Nordstrand, Line M.; Svard, Jessica; Larsen, Elisabeth; Nilsen, Anja; Ougland, Rune; Furu, Kari; Lien, Guro F.; Rognes, Torbjorn; Namekawa, Satoshi H.; Lee, Jeannie T.; Klungland, Arne			Mice Lacking Alkbh1 Display Sex-Ratio Distortion and Unilateral Eye Defects	PLOS ONE			English	Article							GERM-CELL APOPTOSIS; ALKYLATION DAMAGE; OXIDATIVE DEMETHYLATION; MOUSE DEVELOPMENT; ESCHERICHIA-COLI; GENE ENCODES; DNA-DAMAGE; PROTEIN; RNA; EXPRESSION	Background: Eschericia coli AlkB is a 2-oxoglutarate- and iron-dependent dioxygenase that reverses alkylated DNA damage by oxidative demethylation. Mouse AlkB homolog 1 (Alkbh1) is one of eight members of the newly discovered family of mammalian dioxygenases. Methods and Findings: In the present study we show non-Mendelian inheritance of the Alkbh1 targeted allele in mice. Both Alkbh1(-/-) and heterozygous Alkbh1(+/-) offspring are born at a greatly reduced frequency. Additionally, the sex-ratio is considerably skewed against female offspring, with one female born for every three to four males. Most mechanisms that cause segregation distortion, act in the male gametes and affect male fertility. The skewing of the sexes appears to be of paternal origin, and might be set in the pachythene stage of meiosis during spermatogenesis, in which Alkbh1 is upregulated more than 10-fold. In testes, apoptotic spermatids were revealed in 5-10% of the tubules in Alkbh1(-/-) adults. The deficiency of Alkbh1 also causes misexpression of Bmp2, 4 and 7 at E11.5 during embryonic development. This is consistent with the incompletely penetrant phenotypes observed, particularly recurrent unilateral eye defects and craniofacial malformations. Conclusions: Genetic and phenotypic assessment suggests that Alkbh1 mediates gene regulation in spermatogenesis, and that Alkbh1 is essential for normal sex-ratio distribution and embryonic development in mice.	[Nordstrand, Line M.; Svard, Jessica; Larsen, Elisabeth; Nilsen, Anja; Ougland, Rune; Furu, Kari; Lien, Guro F.; Rognes, Torbjorn; Klungland, Arne] Oslo Univ Hosp, Inst Med Microbiol, Ctr Mol Biol & Neurosci, Oslo, Norway; [Rognes, Torbjorn] Univ Oslo, Dept Informat, N-0316 Oslo, Norway; [Larsen, Elisabeth; Ougland, Rune; Namekawa, Satoshi H.; Lee, Jeannie T.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Klungland, Arne] Univ Oslo, Inst Basic Med Sci, Oslo, Norway; [Lee, Jeannie T.] Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA	University of Oslo; University of Oslo; Harvard University; Massachusetts General Hospital; University of Oslo; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute	Nordstrand, LM (corresponding author), Oslo Univ Hosp, Inst Med Microbiol, Ctr Mol Biol & Neurosci, Oslo, Norway.	arne.klungland@rr-research.no	Rognes, Torbjørn/A-9692-2008; Klungland, Arne/X-1233-2019	Rognes, Torbjørn/0000-0002-9329-9974; Klungland, Arne/0000-0001-7274-3661	Norwegian Research Council; Norwegian Cancer Society; European Union	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society); European Union(European Commission)	This work was supported by the National Program in Functional Genomics (FUGE) sponsored by the Norwegian Research Council, the Norwegian Cancer Society and the European Union program 'DNA repair'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; Avraham S, 1997, GENE, V204, P5, DOI 10.1016/S0378-1119(97)00420-4; Baldridge D, 2010, ANNU REV GENOM HUM G, V11, P189, DOI 10.1146/annurev-genom-082908-150158; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; BELLVE AR, 1993, METHOD ENZYMOL, V225, P84; Beltran PJ, 2003, J COMP NEUROL, V456, P384, DOI 10.1002/cne.10532; Boissel S, 2009, AM J HUM GENET, V85, P106, DOI 10.1016/j.ajhg.2009.06.002; BOSE J, 2004, J BIOL LONDON, V3, pNIL5; Castranio T, 2009, DEV DYNAM, V238, P110, DOI 10.1002/dvdy.21829; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Copp AJ, 2003, NAT REV GENET, V4, P784, DOI 10.1038/nrg1181; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Dix DJ, 1996, P NATL ACAD SCI USA, V93, P3264, DOI 10.1073/pnas.93.8.3264; Ducy P, 2000, KIDNEY INT, V57, P2207, DOI 10.1046/j.1523-1755.2000.00081.x; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; Dunn NR, 1997, DEV BIOL, V188, P235, DOI 10.1006/dbio.1997.8664; Falnes PO, 2007, NEUROSCIENCE, V145, P1222, DOI 10.1016/j.neuroscience.2006.11.018; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Fu D, 2010, MOL CELL BIOL, V30, P2449, DOI 10.1128/MCB.01604-09; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Glazier AM, 2002, SCIENCE, V298, P2345, DOI 10.1126/science.1076641; Graw J, 2003, NAT REV GENET, V4, P876, DOI 10.1038/nrg1202; Hall BK, 2000, BIOESSAYS, V22, P138, DOI 10.1002/(SICI)1521-1878(200002)22:2<138::AID-BIES5>3.3.CO;2-W; Han ZF, 2010, NATURE, V464, P1205, DOI 10.1038/nature08921; KATAOKA H, 1983, J BACTERIOL, V153, P1301, DOI 10.1128/JB.153.3.1301-1307.1983; Kawakatsu T, 2005, J BIOL CHEM, V280, P4940, DOI 10.1074/jbc.M408710200; Kurowski MA, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-48; Lee DH, 2005, J BIOL CHEM, V280, P39448, DOI 10.1074/jbc.M509881200; Li MO, 2003, SCIENCE, V302, P1560, DOI 10.1126/science.1087621; Liu D, 1998, NAT GENET, V20, P377, DOI 10.1038/3855; Liu Y, 2004, BIOCHEM BIOPH RES CO, V322, P497, DOI 10.1016/j.bbrc.2004.07.161; LIU Z, 2009, J BIOL CHEM; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Martianov I, 2001, MOL CELL, V7, P509, DOI 10.1016/S1097-2765(01)00198-8; Monsen VT, 2010, NUCLEIC ACIDS RES, V38, P6447, DOI 10.1093/nar/gkq518; Ohkubo Y, 2002, NEUROSCIENCE, V111, P1, DOI 10.1016/S0306-4522(01)00616-9; Pan ZS, 2008, DEV DYNAM, V237, P316, DOI 10.1002/dvdy.21418; Raya A, 2004, NATURE, V427, P121, DOI 10.1038/nature02190; Ringvoll J, 2006, EMBO J, V25, P2189, DOI 10.1038/sj.emboj.7601109; Rizzoti K, 2007, DEVELOPMENT, V134, P3437, DOI 10.1242/dev.007906; Robert B, 2007, DEV GROWTH DIFFER, V49, P455, DOI 10.1111/j.1440-169x.2007.00946.x; Ruggiu M, 1997, NATURE, V389, P73, DOI 10.1038/37987; Sedgwick B, 2004, NAT REV MOL CELL BIO, V5, P148, DOI 10.1038/nrm1312; Sedgwick B, 2006, METHOD ENZYMOL, V408, P108, DOI 10.1016/S0076-6879(06)08008-6; Shimada K, 2009, CANCER RES, V69, P3157, DOI 10.1158/0008-5472.CAN-08-3530; Sinha KM, 2010, EMBO J, V29, P68, DOI 10.1038/emboj.2009.332; SOLARI AJ, 1974, INT REV CYTOL, V38, P273, DOI 10.1016/S0074-7696(08)60928-6; Songe-Moller L, 2010, MOL CELL BIOL, V30, P1814, DOI 10.1128/MCB.01602-09; Tachibana M, 2007, EMBO J, V26, P3346, DOI 10.1038/sj.emboj.7601767; Tanaka SS, 2000, GENE DEV, V14, P841; Taylor DR, 2003, GENETICA, V117, P27, DOI 10.1023/A:1022308414864; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Tsujikawa K, 2007, J CELL MOL MED, V11, P1105, DOI 10.1111/j.1582-4934.2007.00094.x; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Uchimura T, 2009, GENESIS, V47, P374, DOI 10.1002/dvg.20511; van Heyningen V, 2004, HUM MOL GENET, V13, pR225, DOI 10.1093/hmg/ddh254; Wang SS, 2004, DEVELOPMENT, V131, P4381, DOI 10.1242/dev.01269; Westbye MP, 2008, J BIOL CHEM, V283, P25046, DOI 10.1074/jbc.M803776200; Wordinger RJ, 2007, EXP BIOL MED, V232, P979, DOI 10.3181/0510-MR-345; Wyatt AW, 2010, HUM MUTAT, V31, P781, DOI 10.1002/humu.21280; Zhang D, 2001, SCIENCE, V292, P1153, DOI 10.1126/science.1059188; Zhu DH, 1997, DEVELOPMENT, V124, P3007	62	51	53	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e13827	10.1371/journal.pone.0013827	http://dx.doi.org/10.1371/journal.pone.0013827			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21072209	Green Published, Green Submitted, gold			2022-12-25	WOS:000283780800024
J	Schroeder, M; Shbiro, L; Moran, TH; Weller, A				Schroeder, Mariana; Shbiro, Liat; Moran, Timothy H.; Weller, Aron			Maternal Environmental Contribution to Adult Sensitivity and Resistance to Obesity in Long Evans Rats	PLOS ONE			English	Article							DIET-INDUCED OBESITY; OLETF RATS; FAT; EXPRESSION; SUSCEPTIBILITY; BEHAVIOR; IMPROVES; ONSET	Background: The OLETF rat is an animal model of early onset hyperphagia induced obesity, presenting multiple pre-obese characteristics during the suckling period. In the present study, we used a cross-fostering strategy to assess whether interactions with obese dams in the postnatal environment contributed to the development of obesity. Methodology: On postnatal Day (PND)-1 OLETF and control LETO pups were cross-fostered to same or opposite strain dams. An independent ingestion test was performed on PND11 and a nursing test on PND18. Rats were sacrificed at weaning or on PND90, and plasma leptin, insulin, cholesterol, triglycerides and alanine aminotransferase (ALT) were assayed. Fat pads were collected and weighed and adipocyte size and number were estimated. Body weight and intake, as well as the estrous cycle of the female offspring were monitored. Principal Findings: During the suckling period, the pups' phenotype was almost completely determined by the strain of the mother. However, pups independently ingested food according to their genotype, regardless of their actual phenotype. At adulthood, cross fostered males of both strains and LETO females were affected in regard of their adiposity levels in the direction of the foster dam. On the other hand, OLETF females showed almost no alterations in adiposity but were affected by the strain of the dams in parameters related to the metabolic syndrome. Thus, OLETF females showed reduced liver adiposity and circulating levels of ALT, while LETO females presented a disrupted estrous cycle and increased cholesterol and triglycerides in the long term. Conclusions: The present study provides further support for the early postnatal environment playing a sex-divergent role in programming later life phenotype. In addition, it plays a more central role in determining the functioning of mechanisms involved in energy balance that may provide protection from or sensitivity to later life obesity and pathologies related to the metabolic syndrome.	[Schroeder, Mariana; Shbiro, Liat; Weller, Aron] Bar Ilan Univ, Dept Psychol, Ramat Gan, Israel; [Schroeder, Mariana; Shbiro, Liat; Weller, Aron] Bar Ilan Univ, Gonda Goldschmied Brain Res Ctr, Ramat Gan, Israel; [Moran, Timothy H.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA	Bar Ilan University; Bar Ilan University; Johns Hopkins University	Schroeder, M (corresponding author), Bar Ilan Univ, Dept Psychol, Ramat Gan, Israel.	schatzyo@gmail.com	Schroeder, Mariana/AAA-9216-2020; Weller, Aron/AAU-3074-2020	Schroeder, Mariana/0000-0002-9517-4243; Weller, Aron/0000-0002-0663-4384	NIH/NIDDK [RO1 DK57609]; Bar-Ilan University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057609, P30DK079637] Funding Source: NIH RePORTER	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Bar-Ilan University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH/NIDDK - RO1 DK57609. The first two authors (MS and LS) were supported by President's Fellowships, Bar-Ilan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHWELL M, 1976, J LIPID RES, V17, P190; Attig L, 2008, INT J OBESITY, V32, P1153, DOI 10.1038/ijo.2008.39; Bergman RN, 2006, OBESITY, V14, p16S, DOI 10.1038/oby.2006.277; Blumberg S, 2006, AM J PHYSIOL-REG I, V290, pR208, DOI 10.1152/ajpregu.00379.2005; GIBBS J, 1973, NATURE, V245, P323, DOI 10.1038/245323a0; Gorski JN, 2006, AM J PHYSIOL-REG I, V291, pR768, DOI 10.1152/ajpregu.00138.2006; Gorski JN, 2007, AM J PHYSIOL-REG I, V292, pR1782, DOI 10.1152/ajpregu.00749.2006; KAWANO K, 1994, DIABETES RES CLIN PR, V24, pS317, DOI 10.1016/0168-8227(94)90269-0; KAWANO K, 1992, DIABETES, V41, P1422, DOI 10.2337/diabetes.41.11.1422; Lavi-Avnon Y, 2007, DEV PSYCHOBIOL, V49, P685, DOI 10.1002/dev.20235; Levin BE, 1998, AM J PHYSIOL-REG I, V275, pR1374, DOI 10.1152/ajpregu.1998.275.4.R1374; MacLean PS, 2006, AM J PHYSIOL-REG I, V290, pR1577, DOI 10.1152/ajpregu.00810.2005; Moran TH, 2006, DEV PSYCHOBIOL, V48, P360, DOI 10.1002/dev.20149; Morris RT, 2008, J APPL PHYSIOL, V104, P708, DOI 10.1152/japplphysiol.01034.2007; Nakamura H, 1998, J GASTROENTEROL, V33, P702, DOI 10.1007/s005350050158; Park SY, 2005, ARCH BIOCHEM BIOPHYS, V436, P276, DOI 10.1016/j.abb.2005.01.010; Plagemann A, 2006, HORM RES, V65, P83, DOI 10.1159/000091511; Reifsnyder PC, 2000, GENOME RES, V10, P1568, DOI 10.1101/gr.147000; Schroeder M, 2007, DEV PSYCHOBIOL, V49, P323, DOI 10.1002/dev.20206; Schroeder M, 2006, PHYSIOL BEHAV, V89, P402, DOI 10.1016/j.physbeh.2006.07.008; Schroeder M, 2009, AM J PHYSIOL-REG I, V297, pR1749, DOI 10.1152/ajpregu.00461.2009; Schroeder M, 2009, AM J PHYSIOL-REG I, V296, pR224, DOI 10.1152/ajpregu.90697.2008; Schroeder M, 2009, DEV PSYCHOBIOL, V51, P358, DOI 10.1002/dev.20374; Srinivasan M, 2006, AM J PHYSIOL-ENDOC M, V291, pE792, DOI 10.1152/ajpendo.00078.2006; Tamashiro KLK, 2009, DIABETES, V58, P1116, DOI 10.2337/db08-1129; Taylor PD, 2007, EXP PHYSIOL, V92, P287, DOI 10.1113/expphysiol.2005.032854; Trottier G, 1998, ENDOCRINOLOGY, V139, P3704, DOI 10.1210/en.139.9.3704; Watanobe H, 2001, NEUROPEPTIDES, V35, P45, DOI 10.1054/npep.2000.0842; Weller A, 2006, DEV PSYCHOBIOL, V48, P368, DOI 10.1002/dev.20148; Yura S, 2005, CELL METAB, V1, P371, DOI 10.1016/j.cmet.2005.05.005; Yura S, 2008, OBESITY, V16, P1289, DOI 10.1038/oby.2008.57	31	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e13825	10.1371/journal.pone.0013825	http://dx.doi.org/10.1371/journal.pone.0013825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21072207	gold, Green Published, Green Submitted			2022-12-25	WOS:000283780800022
J	Bairwa, NK; Mohanty, BK; Stamenova, R; Curcio, MJ; Bastia, D				Bairwa, Narendra K.; Mohanty, Bidyut K.; Stamenova, Radostina; Curcio, M. Joan; Bastia, Deepak			The Intra-S Phase Checkpoint Protein Tof1 Collaborates with the Helicase Rrm3 and the F-box Protein Dia2 to Maintain Genome Stability in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SISTER-CHROMATID COHESION; REGULATES DNA-REPLICATION; TRANSFER-RNA GENES; MRC1; DAMAGE; YEAST; FORK; COMPLEXES; REPAIR; TY1	The intra-S phase checkpoint protein complex Tof1/Csm3 of Saccharomyces cerevisiae antagonizes Rrm3 helicase to modulate replication fork arrest not only at the replication termini of rDNA but also at strong nonhistone protein binding sites throughout the genome. We investigated whether these checkpoint proteins acted either antagonistically or synergistically with Rrm3 in mediating other important functions such as maintenance of genome stability. High retromobility of a normally quiescent retrovirus-like transposable element Ty1 of S. cerevisiae is a form of genome instability, because the transposition events induce mutations. We measured the transposition of Ty1 in various genetic backgrounds and discovered that Tof1 suppressed excessive retromobility in collaboration with either Rrm3 or the F-box protein Dia2. Although both Rrm3 and Dia2 are believed to facilitate fork movement, fork stalling at DNA-protein complexes did not appear to be a major contributor to enhancement of retromobility. Absence of the aforementioned proteins either individually or in pair-wise combinations caused karyotype changes as revealed by the altered migrations of the individual chromosomes in pulsed field gels. The mobility changes were RNase H-resistant and therefore, unlikely to have been caused by extensive R loop formation. These mutations also resulted in alterations of telomere lengths. However, the latter changes could not fully account for the magnitude of the observed karyotypic alterations. We conclude that unlike other checkpoint proteins that are known to be required for elevated retromobility, Tof1 suppressed high frequency retrotransposition and maintained karyotype stability in collaboration with the aforementioned proteins.	[Bairwa, Narendra K.; Mohanty, Bidyut K.; Bastia, Deepak] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Curcio, M. Joan] Wadsworth Ctr, Mol Genet Lab, Albany, NY 12208 USA; [Stamenova, Radostina] SUNY Albany, Dept Biomed Sci, New York, NY 12208 USA	Medical University of South Carolina; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Bastia, D (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.	bastia@musc.edu		Curcio, M. Joan/0000-0001-5361-3909	National Institutes of Health [GM049264, GM049264-17S1, GM52072]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049264, R01GM052072, R29GM052072] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM049264 and GM049264-17S1 (to D.B.) and by GM52072 (to M.J.C.).	Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; Bachman N, 2004, GENOME RES, V14, P1232, DOI 10.1101/gr.2052904; Bashir A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000051; Beauregard A, 2008, ANNU REV GENET, V42, P587, DOI 10.1146/annurev.genet.42.110807.091549; Bessler JB, 2004, GENETICS, V168, P1205, DOI 10.1534/genetics.104.028035; BOEKE JD, 1985, CELL, V40, P491, DOI 10.1016/0092-8674(85)90197-7; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; Calzada A, 2005, GENE DEV, V19, P1905, DOI 10.1101/gad.337205; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chan RC, 2003, NATURE, V423, P1002, DOI 10.1038/nature01697; CHRISTMAN MF, 1993, P NATL ACAD SCI USA, V90, P7637, DOI 10.1073/pnas.90.16.7637; Curcio MJ, 2007, MOL CELL BIOL, V27, P8874, DOI 10.1128/MCB.01095-07; CURCIO MJ, 1991, P NATL ACAD SCI USA, V88, P936, DOI 10.1073/pnas.88.3.936; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Foss EJ, 2001, GENETICS, V157, P567; GARFINKEL DJ, 1985, CELL, V42, P507, DOI 10.1016/0092-8674(85)90108-4; Gotter AL, 2003, J MOL BIOL, V331, P167, DOI 10.1016/S0022-2836(03)00633-8; Gotter AL, 2000, NAT NEUROSCI, V3, P755, DOI 10.1038/77653; Ivessa AS, 2003, MOL CELL, V12, P1525, DOI 10.1016/S1097-2765(03)00456-8; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Kemp MG, 2010, J BIOL CHEM, V285, P16562, DOI 10.1074/jbc.M110.110304; Koepp DM, 2006, MOL BIOL CELL, V17, P1540, DOI 10.1091/mbc.E05-09-0884; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Mayer ML, 2004, MOL BIOL CELL, V15, P1736, DOI 10.1091/mbc.E03-08-0619; Mimura S, 2009, EMBO J, V28, P3693, DOI 10.1038/emboj.2009.320; Mohanty BK, 2009, EUKARYOT CELL, V8, P487, DOI 10.1128/EC.00382-08; Mohanty BK, 2006, P NATL ACAD SCI USA, V103, P897, DOI 10.1073/pnas.0506540103; Morohashi H, 2009, CURR BIOL, V19, P1943, DOI 10.1016/j.cub.2009.09.062; Morrison AJ, 2007, CELL, V130, P499, DOI 10.1016/j.cell.2007.06.010; Mou ZM, 2006, GENETICS, V172, P2157, DOI 10.1534/genetics.105.054072; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Razidlo DF, 2008, DNA REPAIR, V7, P633, DOI 10.1016/j.dnarep.2008.01.009; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Schmidt KH, 2004, MOL CELL BIOL, V24, P3213, DOI 10.1128/MCB.24.8.3213-3226.2004; Scholes DT, 2003, P NATL ACAD SCI USA, V100, P15736, DOI 10.1073/pnas.2136609100; Scholes DT, 2001, GENETICS, V159, P1449; SHAMPAY J, 1984, NATURE, V310, P154, DOI 10.1038/310154a0; Stamenova R, 2009, GENETICS, V182, P711, DOI 10.1534/genetics.109.104208; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Torres JZ, 2004, MOL CELL BIOL, V24, P3198, DOI 10.1128/MCB.24.8.3198-3212.2004; Tourriere H, 2005, MOL CELL, V19, P699, DOI 10.1016/j.molcel.2005.07.028; Unsal-Kacmaz K, 2004, MOL CELL BIOL, V24, P1292, DOI 10.1128/MCB.24.3.1292-1300.2003; Warren CD, 2004, MOL BIOL CELL, V15, P1724, DOI 10.1091/mbc.E03-09-0637; Xu H, 2004, MOL CELL BIOL, V24, P7082, DOI 10.1128/MCB.24.16.7082-7090.2004	44	10	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2445	2454		10.1074/jbc.M110.189456	http://dx.doi.org/10.1074/jbc.M110.189456			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21087929	hybrid, Green Published			2022-12-25	WOS:000286464300008
J	Mattera, R; Boehm, M; Chaudhuri, R; Prabhu, Y; Bonifacino, JS				Mattera, Rafael; Boehm, Markus; Chaudhuri, Rittik; Prabhu, Yogikala; Bonifacino, Juan S.			Conservation and Diversification of Dileucine Signal Recognition by Adaptor Protein (AP) Complex Variants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLARIZED EPITHELIAL-CELLS; LINKED MENTAL-RETARDATION; VIRUS TYPE-1 NEF; CD4 DOWN-REGULATION; CLATHRIN ADAPTER; SORTING SIGNALS; GAMMA-ADAPTIN; HIV-1 NEF; STRUCTURAL EXPLANATION; APPENDAGE DOMAIN	The clathrin-associated, heterotetrameric adaptor protein (AP) complexes, AP-1, AP-2, and AP-3, recognize signals in the cytosolic domains of transmembrane proteins, leading to their sorting to endosomes, lysosomes, lysosome-related organelles, and/or the basolateral membrane of polarized epithelial cells. One type of signal, referred to as "dileucine-based," fits the consensus motif (D/E)XXXL(L/I). Previous biochemical analyses showed that (D/E)XXXL(L/I) signals bind to a combination of two subunits of each AP complex, namely the AP-1 gamma-sigma 1, AP-2 alpha-sigma 2, and AP-3 delta-sigma 3 hemicomplexes, and structural studies revealed that an imperfect variant of this motif lacking the (D/E) residue binds to a site straddling the interface of alpha and sigma 2. Herein, we report mutational and binding analyses showing that canonical (D/E)XXXL(L/I) signals bind to this same site on AP-2, and to similar sites on AP-1 and AP-3. The strength and amino acid requirements of different interactions depend on the specific signals and AP complexes involved. We also demonstrate the occurrence of diverse AP-1 heterotetramers by combinatorial assembly of various gamma and sigma 1 subunit isoforms encoded by different genes. These AP-1 variants bind (D/E)XXXL(L/I) signals with marked preferences for certain sequences, implying that they are not functionally equivalent. Our results thus demonstrate that different AP complexes share a conserved binding site for (D/E)XXXL(L/I) signals. However, the characteristics of the binding site on each complex vary, providing for the specific recognition of a diverse repertoire of (D/E)XXXL(L/I) signals.	[Mattera, Rafael; Boehm, Markus; Chaudhuri, Rittik; Prabhu, Yogikala; Bonifacino, Juan S.] NICHD, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Bonifacino, JS (corresponding author), NICHD, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA.	juan@helix.nih.gov		Bonifacino, Juan S./0000-0002-5673-6370	Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001607] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Intramural Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health.	Boehm M, 2001, EMBO J, V20, P6265, DOI 10.1093/emboj/20.22.6265; Boehm M, 2001, MOL BIOL CELL, V12, P2907, DOI 10.1091/mbc.12.10.2907; Boll W, 1996, EMBO J, V15, P5789, DOI 10.1002/j.1460-2075.1996.tb00965.x; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; BONIFACINO JS, 2001, CURR PROTOC CELL BIO, V1; Borck G, 2008, HUM MUTAT, V29, P966, DOI 10.1002/humu.20531; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; Bresnahan PA, 1998, CURR BIOL, V8, P1235, DOI 10.1016/S0960-9822(07)00517-9; Chaudhuri R, 2007, J VIROL, V81, P3877, DOI 10.1128/JVI.02725-06; Chaudhuri R, 2009, J VIROL, V83, P2518, DOI 10.1128/JVI.02227-08; Chuang E, 1997, J IMMUNOL, V159, P144; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Craig HM, 1998, P NATL ACAD SCI USA, V95, P11229, DOI 10.1073/pnas.95.19.11229; Delevoye C, 2009, J CELL BIOL, V187, P247, DOI 10.1083/jcb.200907122; DellAngelica EC, 1997, J BIOL CHEM, V272, P15078, DOI 10.1074/jbc.272.24.15078; DellAngelica EC, 1997, EMBO J, V16, P917, DOI 10.1093/emboj/16.5.917; Doray B, 2007, MOL BIOL CELL, V18, P1887, DOI 10.1091/mbc.E07-01-0012; Folsch H, 1999, CELL, V99, P189, DOI 10.1016/S0092-8674(00)81650-5; Folsch H, 2001, J CELL BIOL, V152, P595, DOI 10.1083/jcb.152.3.595; Glyvuk N, 2010, EMBO J, V29, P1318, DOI 10.1038/emboj.2010.15; Greenberg M, 1998, CURR BIOL, V8, P1239, DOI 10.1016/S0960-9822(07)00518-0; Heldwein EE, 2004, P NATL ACAD SCI USA, V101, P14108, DOI 10.1073/pnas.0406102101; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; Honing S, 1998, EMBO J, V17, P1304, DOI 10.1093/emboj/17.5.1304; Jackson LP, 2010, CELL, V141, P1220, DOI 10.1016/j.cell.2010.05.006; Janvier K, 2003, J CELL BIOL, V163, P1281, DOI 10.1083/jcb.200307157; Kelly BT, 2008, NATURE, V456, P976, DOI 10.1038/nature07422; Kent HM, 2002, STRUCTURE, V10, P1139, DOI 10.1016/S0969-2126(02)00801-8; Keyel PA, 2008, MOL BIOL CELL, V19, P5309, DOI 10.1091/mbc.E08-07-0712; Lewin DA, 1998, FEBS LETT, V435, P263, DOI 10.1016/S0014-5793(98)01083-7; Li W, 2010, CLEFT PALATE-CRAN J, V47, P566, DOI 10.1597/09-145; Lindwasser OW, 2008, J VIROL, V82, P1166, DOI 10.1128/JVI.01874-07; Meyer C, 2000, EMBO J, V19, P2193, DOI 10.1093/emboj/19.10.2193; Montpetit A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000296; Nogi T, 2002, NAT STRUCT BIOL, V9, P527, DOI 10.1038/nsb808; Ohno H, 1999, FEBS LETT, V449, P215, DOI 10.1016/S0014-5793(99)00432-9; Ohno H, 1996, J BIOL CHEM, V271, P29009, DOI 10.1074/jbc.271.46.29009; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Owen DJ, 2000, EMBO J, V19, P4216, DOI 10.1093/emboj/19.16.4216; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Owen DJ, 1999, CELL, V97, P805, DOI 10.1016/S0092-8674(00)80791-6; Owen DJ, 2001, TRAFFIC, V2, P105, DOI 10.1034/j.1600-0854.2001.020205.x; Rapoport I, 1997, EMBO J, V16, P2240, DOI 10.1093/emboj/16.9.2240; Ricotta D, 2002, J CELL BIOL, V156, P791, DOI 10.1083/jcb.200111068; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Saillour Y, 2007, J MED GENET, V44, P739, DOI 10.1136/jmg.2007.051334; Simmen T, 1999, J CELL SCI, V112, P45; Stephens DJ, 1997, J BIOL CHEM, V272, P14104, DOI 10.1074/jbc.272.22.14104; Takatsu H, 1998, J BIOL CHEM, V273, P24693, DOI 10.1074/jbc.273.38.24693; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; Tarpey PS, 2006, AM J HUM GENET, V79, P1119, DOI 10.1086/510137; Theos AC, 2005, MOL BIOL CELL, V16, P5356, DOI 10.1091/mbc.E05-07-0626; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Traub LM, 1999, P NATL ACAD SCI USA, V96, P8907, DOI 10.1073/pnas.96.16.8907; Zhang Y, 1997, P NATL ACAD SCI USA, V94, P9273, DOI 10.1073/pnas.94.17.9273; Zizioli D, 1999, J BIOL CHEM, V274, P5385, DOI 10.1074/jbc.274.9.5385	56	78	80	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2022	2030		10.1074/jbc.M110.197178	http://dx.doi.org/10.1074/jbc.M110.197178			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21097499	hybrid, Green Published			2022-12-25	WOS:000286191500044
J	Renigunta, A; Renigunta, V; Saritas, T; Decher, N; Mutig, K; Waldegger, S				Renigunta, Aparna; Renigunta, Vijay; Saritas, Turgay; Decher, Niels; Mutig, Kerim; Waldegger, Siegfried			Tamm-Horsfall Glycoprotein Interacts with Renal Outer Medullary Potassium Channel ROMK2 and Regulates Its Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIMBRIATED ESCHERICHIA-COLI; UROMODULIN STORAGE DISEASES; THICK ASCENDING LIMB; PROTEIN; EXPRESSION; MICE; GENE; TRANSPORT; MUTATIONS; ER	Tamm-Horsfall glycoprotein (THGP) or Uromodulin is a membrane protein exclusively expressed along the thick ascending limb (TAL) and early distal convoluted tubule (DCT) of the nephron. Mutations in the THGP encoding gene result in Familial Juvenile Hyperuricemic Nephropathy (FJHN), Medullary Cystic Kidney Disease type 2 (MCKD-2), and Glomerulocystic Kidney Disease (GCKD). The physicochemical and biological properties of THGP have been studied extensively, but its physiological function in the TAL remains obscure. We performed yeast two-hybrid screening employing a human kidney cDNA library and identified THGP as a potential interaction partner of the renal outer medullary potassium channel (ROMK2), a key player in the process of salt reabsorption along the TAL. Functional analysis by electrophysiological techniques in Xenopus oocytes showed a strong increase in ROMK current amplitudes when co-expressed with THGP. The effect of THGP was specific for ROMK2 and did not influence current amplitudes upon co-expression with Kir2.x, inward rectifier potassium channels related to ROMK. Single channel conductance and open probability of ROMK2 were not altered by co-expression of THGP, which instead increased surface expression of ROMK2 as determined by patch clamp analysis and luminometric surface quantification, respectively. Despite preserved interaction with ROMK2, disease-causing THGP mutants failed to increase its current amplitude and surface expression. THGP(-/-) mice exhibited increased ROMK accumulation in intracellular vesicular compartments when compared with WT animals. Therefore, THGP modulation of ROMK function confers a new role of THGP on renal ion transport and may contribute to salt wasting observed in FJHN/MCKD-2/GCKD patients.	[Renigunta, Aparna; Waldegger, Siegfried] Univ Marburg, Childrens Hosp, Dept Pediat Nephrol, D-35043 Marburg, Germany; [Renigunta, Vijay; Decher, Niels] Univ Marburg, Inst Physiol, D-35037 Marburg, Germany; [Saritas, Turgay; Mutig, Kerim] Charite, Inst Anat, D-13353 Berlin, Germany	Philipps University Marburg; Philipps University Marburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Renigunta, A (corresponding author), Univ Marburg, Childrens Hosp, Dept Pediat Nephrol, Baldingerstr, D-35043 Marburg, Germany.	renigunt@med.uni-marburg.de; siegfried.waldegger@med.uni-marburg.de	Turgay, Saritas/AAH-5127-2020; Mutig, Kerim/L-9010-2017; Decher, Niels/AAF-5002-2020	Turgay, Saritas/0000-0002-6691-9218; Mutig, Kerim/0000-0001-9006-5112; 	Deutsche Forschungsgemeinschaft (DFG) [SFB-593]; P. E. Kempkes Foundation [15/06, 10/08]; Rhoen AG	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); P. E. Kempkes Foundation; Rhoen AG	This study was supported by the Deutsche Forschungsgemeinschaft (DFG, SFB-593), Rhoen AG, and P. E. Kempkes Foundation (Grants 15/06 and 10/08, to A. R.).	Bachmann S, 2005, AM J PHYSIOL-RENAL, V288, pF559, DOI 10.1152/ajprenal.00143.2004; Bates JM, 2004, KIDNEY INT, V65, P791, DOI 10.1111/j.1523-1755.2004.00452.x; Bernascone I, 2006, TRAFFIC, V7, P1567, DOI 10.1111/j.1600-0854.2006.00481.x; Caldwell SR, 2001, J BIOL CHEM, V276, P23296, DOI 10.1074/jbc.M102962200; Carvalho M, 2002, BRAZ J MED BIOL RES, V35, P1165, DOI 10.1590/S0100-879X2002001000009; Cavallone D, 2001, BIOCHEM BIOPH RES CO, V280, P110, DOI 10.1006/bbrc.2000.4090; Chatterjee S, 2001, CELL MOL LIFE SCI, V58, P1969, DOI 10.1007/PL00000831; Cukras CA, 2002, J GEN PHYSIOL, V119, P581, DOI 10.1085/jgp.20028562; Devuyst O, 2005, NEPHROL DIAL TRANSPL, V20, P1290, DOI 10.1093/ndt/gfh851; DULAWA J, 1988, EUR J CLIN INVEST, V18, P87, DOI 10.1111/j.1365-2362.1988.tb01171.x; Gersch M, 2006, NEPHROL DIAL TRANSPL, V21, P2028, DOI 10.1093/ndt/gfk081; Haass FA, 2007, P NATL ACAD SCI USA, V104, P18079, DOI 10.1073/pnas.0708765104; Hart TC, 2002, J MED GENET, V39, P882, DOI 10.1136/jmg.39.12.882; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jennings P, 2007, J AM SOC NEPHROL, V18, P264, DOI 10.1681/ASN.2006020158; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; Koh K, 2008, SCIENCE, V321, P372, DOI 10.1126/science.1155942; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; Lu M, 2004, AM J PHYSIOL-RENAL, V286, pF490, DOI 10.1152/ajprenal.00305.2003; Malagolini N, 1997, KIDNEY INT, V52, P1340, DOI 10.1038/ki.1997.459; Mo L, 2004, AM J PHYSIOL-RENAL, V286, pF795, DOI 10.1152/ajprenal.00357.2003; Mo L, 2007, AM J PHYSIOL-RENAL, V293, pF1935, DOI 10.1152/ajprenal.00383.2007; MORISHIGE K, 1993, FEBS LETT, V336, P375, DOI 10.1016/0014-5793(93)80840-Q; Nakanishi H, 2007, J CELL SCI, V120, P908, DOI 10.1242/jcs.03405; Okamoto M, 2006, J BIOL CHEM, V281, P4013, DOI 10.1074/jbc.M504684200; ORSKOV I, 1980, LANCET, V1, P887; Pak J, 2001, J BIOL CHEM, V276, P9924, DOI 10.1074/jbc.M008610200; Powers J, 1998, J CELL BIOL, V142, P1209, DOI 10.1083/jcb.142.5.1209; Rampoldi L, 2003, HUM MOL GENET, V12, P3369, DOI 10.1093/hmg/ddg353; RINDLER MJ, 1990, J BIOL CHEM, V265, P20784; Romanenko VG, 2004, BIOPHYS J, V87, P3850, DOI 10.1529/biophysj.104.043273; Sachs AN, 2008, AM J PHYSIOL-RENAL, V295, pF1799, DOI 10.1152/ajprenal.90510.2008; Schmitt R, 2004, HISTOCHEM CELL BIOL, V121, P319, DOI 10.1007/s00418-004-0638-4; Scolari F, 2004, AM J KIDNEY DIS, V44, P987, DOI 10.1053/j.ajkd.2004.08.021; Simon DB, 1996, NAT GENET, V14, P152, DOI 10.1038/ng1096-152; Takiue Y, 2008, BIOL PHARM BULL, V31, P405, DOI 10.1248/bpb.31.405; TAMM I, 1950, P SOC EXP BIOL MED, V74, P108, DOI 10.3181/00379727-74-17825; Wang WH, 2006, AM J PHYSIOL-RENAL, V290, pF14, DOI 10.1152/ajprenal.00093.2005; Welker P, 2008, AM J PHYSIOL-RENAL, V295, pF789, DOI 10.1152/ajprenal.90227.2008; Wolf MTF, 2003, KIDNEY INT, V64, P1580, DOI 10.1046/j.1523-1755.2003.00269.x; Zuzarte M, 2007, TRAFFIC, V8, P1093, DOI 10.1111/j.1600-0854.2007.00593.x	41	79	85	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2224	2235		10.1074/jbc.M110.149880	http://dx.doi.org/10.1074/jbc.M110.149880			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21081491	Green Published, hybrid			2022-12-25	WOS:000286191500063
J	Sheikh, SZ; Kobayashi, T; Matsuoka, K; Onyiah, JC; Plevy, SE				Sheikh, Shehzad Z.; Kobayashi, Taku; Matsuoka, Katsuyoshi; Onyiah, Joseph C.; Plevy, Scott E.			Characterization of an Interferon-stimulated Response Element (ISRE) in the Il23a Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLAGEN-INDUCED ARTHRITIS; IFN-GAMMA; IL-23 P19; T-CELLS; MURINE MACROPHAGES; ULCERATIVE-COLITIS; GENE-EXPRESSION; DENDRITIC CELLS; C-REL; INTERLEUKIN-12	We have demonstrated previously that IFN-gamma plays a protective role in the initiation of chronic intestinal inflammation through attenuation of Toll-like receptor-mediated IL-23 induction in macrophages. Here, an interferon-stimulated response element (ISRE) is identified in a region of conserved nucleotide sequences in the Il23a promoter. This ISRE mediated, in part, Il23a promoter induction by LPS and inhibition of LPS-induced activity by IFN-gamma. LPS and IFN-gamma recruit interferon regulatory factors (IRFs) to the Il23a ISRE in murine bone marrow-derived macrophages (BMMs). Functionally, IRF-1 is a negative regulator of Il23a in LPS-stimulated BMMs. IRF-1(-/-) BMMs demonstrated enhanced LPS-induced Il23a expression compared with WT BMMs. Moreover, IRF-1 deficiency resulted in prolonged occupancy of RelA on the Il23a promoter. Consequently, IRF-1(-/-) mice were more susceptible to colonic injury by trinitrobenzenesulfonic acid, and IL-10/IRF-1 double-deficient (IL-10/IRF-1(-/-)) mice demonstrated more severe colonic inflammation compared with IL-10(-/-) mice. The severity of colitis in both models correlated with increased colonic IL-23. CD11b(+) lamina propria mononuclear cells, comprising predominantly macrophages, were identified as the major source of IL-23 in colitis-prone mice. Basal and heat-killed Escherichia coli-stimulated levels of Il23a were increased in IL-10/IRF-1(-/-) compared with WT and IL-10(-/-) colonic CD11b(+) lamina propria mononuclear cells. In conclusion, these experiments characterize IRF-ISRE interactions on the Il23a promoter, which have in vivo relevance as a homeostatic checkpoint in chronic intestinal inflammation.	Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Plevy, SE (corresponding author), CB 7032,7341C MBRB,103 Mason Farm Rd, Chapel Hill, NC 27599 USA.	scott_plevy@med.unc.edu	Matsuoka, Katsuyoshi/AAB-1580-2022; Kobayashi, Taku/AAO-6437-2020	Matsuoka, Katsuyoshi/0000-0002-2950-7660; Kobayashi, Taku/0000-0002-2073-4234	National Institutes of Health [RO1 DK54452]; Gastroenterology Research Training Grant [T32 DK007737, P30 DK034987]; National Research Service [F32 DK083186]; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987, F32DK083186, T32DK007737, R01DK054452] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gastroenterology Research Training Grant; National Research Service; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by, in whole or in part, by National Institutes of Health Grant RO1 DK54452 (to S. E. P.), Gastroenterology Research Training Grant T32 DK007737 (to S. Z. S. and J. C. O.), and Grant P30 DK034987 (to the Center for Gastrointestinal Biology and Disease, Immunotechnologies, Gnotobiotic, and Histology Cores). This work was also supported by National Research Service Award F32 DK083186 (to S. Z. S.) and a Crohn's and Colitis Foundation of America Research fellowship award (to K. M.).	Al-Salleeh F, 2008, J IMMUNOL, V181, P4523, DOI 10.4049/jimmunol.181.7.4523; Brereton CF, 2009, J IMMUNOL, V183, P1715, DOI 10.4049/jimmunol.0803851; Carmody RJ, 2007, SCIENCE, V317, P675, DOI 10.1126/science.1142953; Carmody RJ, 2007, J IMMUNOL, V178, P186, DOI 10.4049/jimmunol.178.1.186; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hegazi RAF, 2005, J EXP MED, V202, P1703, DOI 10.1084/jem.20051047; Kano SI, 2008, NAT IMMUNOL, V9, P34, DOI 10.1038/ni1538; Kelchtermans H, 2007, J LEUKOCYTE BIOL, V81, P1044, DOI 10.1189/jlb.0806486; Kobayashi T, 2008, GUT, V57, P1682, DOI 10.1136/gut.2007.135053; Liu JG, 2003, J EXP MED, V198, P1265, DOI 10.1084/jem.20030026; Liu WC, 2009, J BIOL CHEM, V284, P24006, DOI 10.1074/jbc.M109.025528; Mahler M, 2002, INFLAMM BOWEL DIS, V8, P347; Mise-Omata S, 2007, J IMMUNOL, V179, P6596, DOI 10.4049/jimmunol.179.10.6596; Neurath M, 2000, Int Rev Immunol, V19, P51, DOI 10.3109/08830180009048389; Ozato K, 2007, J BIOL CHEM, V282, P20065, DOI 10.1074/jbc.R700003200; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Reinhard C, 2006, INFLAMM BOWEL DIS, V12, P227, DOI 10.1097/01.MIB.0000202413.16360.a1; Sheikh SZ, 2010, J IMMUNOL, V184, P4069, DOI 10.4049/jimmunol.0903600; Silverberg MS, 2009, NAT GENET, V41, P216, DOI 10.1038/ng.275; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Vermeire K, 1997, J IMMUNOL, V158, P5507; Xiong HB, 2004, J BIOL CHEM, V279, P10776, DOI 10.1074/jbc.M313416200; Zhao J, 2006, J BIOL CHEM, V281, P10073, DOI 10.1074/jbc.M507788200; Zhou L, 2007, MOL CELL BIOL, V27, P2698, DOI 10.1128/MCB.00788-06; Zhu C, 2003, J BIOL CHEM, V278, P39372, DOI 10.1074/jbc.M306441200	26	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1174	1180		10.1074/jbc.M110.147884	http://dx.doi.org/10.1074/jbc.M110.147884			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21097874	hybrid, Green Published			2022-12-25	WOS:000286005000028
J	Waning, DL; Lehman, JA; Batuello, CN; Mayo, LD				Waning, David L.; Lehman, Jason A.; Batuello, Christopher N.; Mayo, Lindsey D.			c-Abl Phosphorylation of Mdm2 Facilitates Mdm2-Mdmx Complex Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; TYROSINE KINASE; P53 ACTIVATION; DEGRADATION; ATM; PROTEIN; UBIQUITINATION; STABILIZATION; APOPTOSIS; HDMX	Mdm2 and Mdmx are oncoproteins that have essential yet nonredundant roles in development and function as part of a multicomponent ubiquitinating complex that targets p53 for proteasomal degradation. However, in response to DNA damage, Mdm2 and Mdmx are phosphorylated and protect p53 through various mechanisms. It has been predicted that Mdm2-Mdmx complex formation modulates Mdm2 ligase activity, yet the mechanism that promotes formation of Mdm2-Mdmx complexes is unknown. Here, we show that optimal Mdm2-Mdmx complex formation requires c-Abl phosphorylation of Mdm2 both in vitro and in vivo. In addition, Abl phosphorylation of Mdm2 is required for efficient ubiquitination of Mdmx in vitro, and eliminating c-Abl signaling, using c-Abl(-/-) knock-out murine embryonic fibroblasts, led to a decrease in Mdmx ubiquitination. Further, p53 levels are not induced as efficiently in c-Abl(-/-) murine embryonic fibroblasts following DNA damage. Overall, these results define a direct link between genotoxic stress-activated c-Abl kinase signaling and Mdm2-Mdmx complex formation. Our results add an important regulatory mechanism for the activation of p53 in response to DNA damage.	[Waning, David L.; Lehman, Jason A.; Mayo, Lindsey D.] Indiana Univ, Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Batuello, Christopher N.; Mayo, Lindsey D.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Mayo, LD (corresponding author), 980 W Walnut,Bldg R3,Rm C548, Indianapolis, IN 46202 USA.	ldmayo@iupui.edu			National Institutes of Health [CA109262]; NATIONAL CANCER INSTITUTE [R21CA205437, R01CA109262] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA109262 (to L. D. M.).	Baskaran R, 1997, NATURE, V387, P516, DOI 10.1038/387516a0; Buchdunger E, 1996, CANCER RES, V56, P100; Chen LH, 2005, EMBO J, V24, P3411, DOI 10.1038/sj.emboj.7600812; Cheng Q, 2009, EMBO J, V28, P3857, DOI 10.1038/emboj.2009.294; Dias SS, 2006, ONCOGENE, V25, P6666, DOI 10.1038/sj.onc.1209671; Goldberg Z, 2002, EMBO J, V21, P3715, DOI 10.1093/emboj/cdf384; Gu JJ, 2002, J BIOL CHEM, V277, P19251, DOI 10.1074/jbc.C200150200; Jackson MW, 2000, MOL CELL BIOL, V20, P1001, DOI 10.1128/MCB.20.3.1001-1007.2000; Kentsis A, 2002, P NATL ACAD SCI USA, V99, P15404, DOI 10.1073/pnas.202608799; LeBron C, 2006, EMBO J, V25, P1196, DOI 10.1038/sj.emboj.7601032; Levav-Cohen Y, 2005, BIOCHEM BIOPH RES CO, V331, P737, DOI 10.1016/j.bbrc.2005.03.152; Levy D, 2008, MOL CELL, V29, P350, DOI 10.1016/j.molcel.2007.12.022; Linares LK, 2003, P NATL ACAD SCI USA, V100, P12009, DOI 10.1073/pnas.2030930100; Linke K, 2008, CELL DEATH DIFFER, V15, P841, DOI 10.1038/sj.cdd.4402309; Lu XB, 2007, CANCER CELL, V12, P342, DOI 10.1016/j.ccr.2007.08.033; Ma Yongxian, 2000, Molecular Cell Biology Research Communications, V3, P122, DOI 10.1006/mcbr.2000.0201; Mancini F, 2004, J BIOL CHEM, V279, P8169, DOI 10.1074/jbc.M311793200; Maya R, 2001, GENE DEV, V15, P1067, DOI 10.1101/gad.886901; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Momand J, 1996, ONCOGENE, V12, P2279; Okamoto K, 2005, MOL CELL BIOL, V25, P9608, DOI 10.1128/MCB.25.21.9608-9620.2005; PENDERGAST AM, 1991, P NATL ACAD SCI USA, V88, P5927, DOI 10.1073/pnas.88.13.5927; Pereg Y, 2006, MOL CELL BIOL, V26, P6819, DOI 10.1128/MCB.00562-06; Poyurovsky MV, 2007, EMBO J, V26, P90, DOI 10.1038/sj.emboj.7601465; Rinaldo C, 2007, MOL CELL, V25, P739, DOI 10.1016/j.molcel.2007.02.008; Shafman T, 1997, NATURE, V387, P520, DOI 10.1038/387520a0; Sharp DA, 1999, J BIOL CHEM, V274, P38189, DOI 10.1074/jbc.274.53.38189; Stad R, 2001, EMBO REP, V2, P1029, DOI 10.1093/embo-reports/kve227; Stommel JM, 2004, EMBO J, V23, P1547, DOI 10.1038/sj.emboj.7600145; Tang X, 2007, CELL, V129, P1165, DOI 10.1016/j.cell.2007.04.042; Toledo F, 2007, INT J BIOCHEM CELL B, V39, P1476, DOI 10.1016/j.biocel.2007.03.022; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Waning DL, 2010, PHARMACEUTICALS, V3, P1576, DOI 10.3390/ph3051576; Zhang XN, 2009, CANCER RES, V69, P7960, DOI 10.1158/0008-5472.CAN-09-0634; Zuckerman V, 2009, J BIOL CHEM, V284, P4031, DOI 10.1074/jbc.M809211200	35	24	27	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					216	222		10.1074/jbc.M110.183012	http://dx.doi.org/10.1074/jbc.M110.183012			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21081495	Green Published, hybrid			2022-12-25	WOS:000285782800024
J	Netherton, SJ; Bonni, S				Netherton, Stuart J.; Bonni, Shirin			Suppression of TGF beta-Induced Epithelial-Mesenchymal Transition Like Phenotype by a PIAS1 Regulated Sumoylation Pathway in NMuMG Epithelial Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; E-CADHERIN; COLORECTAL-CANCER; TUMOR PROGRESSION; GENE-ACTIVATION; SNON; RECEPTOR; CARCINOMA; SNAIL; PHOSPHORYLATION	Epithelial-mesenchymal-transition (EMT) is a fundamental cellular process that is critical for normal development and tumor metastasis. The transforming growth factor beta (TGF beta) is a potent inducer of EMT like effects, but the mechanisms that regulate TGF beta-induced EMT remain incompletely understood. Using the widely employed NMuMG mammary epithelial cells as a model to study TGF beta-induced EMT, we report that TGF beta downregulates the levels of the SUMO E3 ligase PIAS1 in cells undergoing EMT. Gain and loss of function analyses indicate that PIAS1 acts in a SUMO ligase dependent manner to suppress the ability of TGF beta to induce EMT in these cells. We also find that TGF beta inhibits sumoylation of the PIAS1 substrate SnoN, a transcriptional regulator that antagonizes TGF beta-induced EMT. Accordingly, loss of function mutations of SnoN sumoylation impair the ability of SnoN to inhibit TGF beta-induced EMT in NMuMG cells. Collectively, our findings suggest that PIAS1 is a novel negative regulator of EMT and reveal that inhibition of the PIAS1-SnoN sumoylation pathway represents a key mechanism by which TGF beta induces EMT, with important implications in normal development and tumor metastasis.	[Netherton, Stuart J.; Bonni, Shirin] Univ Calgary, Dept Biochem & Mol Biol, So Alberta Canc Res Inst, Calgary, AB, Canada	University of Calgary	Netherton, SJ (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, So Alberta Canc Res Inst, Calgary, AB, Canada.	sbonni@ucalgary.ca			Alberta Cancer Board (ACB); Canadian Institutes of Health Research	Alberta Cancer Board (ACB); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work is supported by grants from the Alberta Cancer Board (ACB), and the Canadian Institutes of Health Research to SB. SJN is an ACB Postdoctoral Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; ATTISANO L, 1994, BBA-MOL CELL RES, V1222, P71, DOI 10.1016/0167-4889(94)90026-4; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Bates RC, 2005, CANCER BIOL THER, V4, P365; Bates RC, 2007, CELLS TISSUES ORGANS, V185, P29, DOI 10.1159/000101300; Callahan JF, 2002, J MED CHEM, V45, P999, DOI 10.1021/jm010493y; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Deckers M, 2006, CANCER RES, V66, P2202, DOI 10.1158/0008-5472.CAN-05-3560; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Greenhalgh CJ, 2001, J LEUKOCYTE BIOL, V70, P348; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Heiz M, 2004, J BIOL CHEM, V279, P31149, DOI 10.1074/jbc.M403587200; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; Hsu YHR, 2006, J BIOL CHEM, V281, P33008, DOI 10.1074/jbc.M604380200; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Jakowlew SB, 2006, CANCER METAST REV, V25, P435, DOI 10.1007/s10555-006-9006-2; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kadare G, 2003, J BIOL CHEM, V278, P47434, DOI 10.1074/jbc.M308562200; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Kondo M, 2004, CELL DEATH DIFFER, V11, P1092, DOI 10.1038/sj.cdd.4401467; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Liu B, 1998, P NATL ACAD SCI USA, V95, P10626, DOI 10.1073/pnas.95.18.10626; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; Madhavan M, 2001, MODERN PATHOL, V14, P423, DOI 10.1038/modpathol.3880329; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; Massague Joan, 1994, Trends in Cell Biology, V4, P172, DOI 10.1016/0962-8924(94)90202-X; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Miyazono K, 2009, P JPN ACAD B-PHYS, V85, P314, DOI 10.2183/pjab.85.314; OKA H, 1993, CANCER RES, V53, P1696; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Peng SB, 2005, BIOCHEMISTRY-US, V44, P2293, DOI 10.1021/bi048851x; Pot I, 2008, CURR MOL MED, V8, P319, DOI 10.2174/156652408784533797; ROBERTS AB, 1990, PEPTIDE GROWTH FACTO, P419; Rytinki MM, 2009, CELL MOL LIFE SCI, V66, P3029, DOI 10.1007/s00018-009-0061-z; Sarker KP, 2005, J BIOL CHEM, V280, P13037, DOI 10.1074/jbc.M409367200; Sarker KP, 2008, J BIOL CHEM, V283, P13269, DOI 10.1074/jbc.M708834200; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shuai K, 2005, NAT REV IMMUNOL, V5, P593, DOI 10.1038/nri1667; Suzuki T, 1999, J BIOL CHEM, V274, P31131, DOI 10.1074/jbc.274.44.31131; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tomaskovic-Crook E, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2416; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; von Both I, 2004, DEV CELL, V7, P331, DOI 10.1016/j.devcel.2004.07.023; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; WRANA JL, 1992, COLD SPRING HARB SYM, V57, P81, DOI 10.1101/SQB.1992.057.01.011; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Wrighton KH, 2007, J BIOL CHEM, V282, P6517, DOI 10.1074/jbc.M610206200; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhou YN, 2002, WORLD J GASTROENTERO, V8, P987, DOI 10.3748/wjg.v8.i6.987; Zhu QW, 2007, MOL CELL BIOL, V27, P324, DOI 10.1128/MCB.01394-06	59	40	43	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e13971	10.1371/journal.pone.0013971	http://dx.doi.org/10.1371/journal.pone.0013971			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103059	Green Submitted, Green Published, gold			2022-12-25	WOS:000284147700018
J	Kruh, NA; Troudt, J; Izzo, A; Prenni, J; Dobos, KM				Kruh, Nicole A.; Troudt, Jolynn; Izzo, Angelo; Prenni, Jessica; Dobos, Karen M.			Portrait of a Pathogen: The Mycobacterium tuberculosis Proteome In Vivo	PLOS ONE			English	Article							GENE-EXPRESSION; DIFFERENTIAL EXPRESSION; STATISTICAL-MODEL; MASS-SPECTROMETRY; HYPOXIC RESPONSE; GUINEA-PIGS; GROWTH; MACROPHAGES; VIRULENCE; PROTEINS	Background: Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB), is a facultative intracellular pathogen that can persist within the host. The bacteria are thought to be in a state of reduced replication and metabolism as part of the chronic lung infection. Many in vitro studies have dissected the hypothesized environment within the infected lung, defining the bacterial response to pH, starvation and hypoxia. While these experiments have afforded great insight, the picture remains incomplete. The only way to study the combined effects of these environmental factors and the mycobacterial response is to study the bacterial response in vivo. Methodology/Principal Findings: We used the guinea pig model of tuberculosis to examine the bacterial proteome during the early and chronic stages of disease. Lungs were harvested thirty and ninety days after aerosol challenge with Mtb, and analyzed by liquid chromatography-mass spectrometry. To date, in vivo proteomics of the tubercle bacillus has not been described and this work has generated the first large-scale shotgun proteomic data set, comprising over 500 unique protein identifications. Cell wall and cell wall processes, and intermediary metabolism and respiration were the two major functional classes of proteins represented in the infected lung. These classes of proteins displayed the greatest heterogeneity indicating important biological processes for establishment of a productive bacterial infection and its persistence. Proteins necessary for adaptation throughout infection, such as nitrate/nitrite reduction were found at both time points. The PE-PPE protein class, while not well characterized, represented the third most abundant category and showed the most consistent expression during the infection. Conclusions/Significance: Cumulatively, the results of this work may provide the basis for rational drug design - identifying numerous Mtb proteins, from essential kinases to products involved in metal regulation and cell wall remodeling, all present throughout the course of infection.	[Kruh, Nicole A.; Troudt, Jolynn; Izzo, Angelo; Dobos, Karen M.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Prenni, Jessica] Colorado State Univ, Prote & Metab Facil, Ft Collins, CO 80523 USA; [Prenni, Jessica] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University; Colorado State University	Kruh, NA (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	Karen.Dobos@Colostate.edu	Kruh-Garcia, Nicole/D-5853-2017; Dobos, Karen/D-1170-2017; Izzo, Angelo A/F-1229-2017	Kruh-Garcia, Nicole/0000-0002-9896-8380; Dobos, Karen/0000-0001-7115-8524; Izzo, Angelo A/0000-0003-3208-2330; Prenni, Jessica/0000-0002-0337-8450	Bill and Melinda Gates Foundation [42775]; NIH-NIAID [HHSN266200400091c]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were performed with funding from the Bill and Melinda Gates Foundation (Grant # 42775, Mycobacterium tuberculosis in vivo) to KMD and AAI (J. Belisle, PI) and funding from the NIH-NIAID (Contract # HHSN266200400091c, Tuberculosis Vaccine Testing and Research Materials) to KMD and AAI (KMD, PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Av-Gay Y, 1999, INFECT IMMUN, V67, P5676, DOI 10.1128/IAI.67.11.5676-5682.1999; Bentley-Hibbert SI, 1999, INFECT IMMUN, V67, P581, DOI 10.1128/IAI.67.2.581-588.1999; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Bhatnagar S, 2007, J BIOL CHEM, V282, P25779, DOI 10.1074/jbc.M702277200; Braunstein M, 2003, MOL MICROBIOL, V48, P453, DOI 10.1046/j.1365-2958.2003.03438.x; Chauhan A, 2006, J BACTERIOL, V188, P1856, DOI 10.1128/JB.188.5.1856-1865.2006; Cho SH, 2006, TUBERCULOSIS, V86, P445, DOI 10.1016/j.tube.2005.10.002; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Converse SE, 2003, P NATL ACAD SCI USA, V100, P6121, DOI 10.1073/pnas.1030024100; Cowley S, 2004, MOL MICROBIOL, V52, P1691, DOI 10.1111/j.1365-2958.2004.04085.x; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; Crick DC, 2001, GLYCOBIOLOGY, V11, p107R, DOI 10.1093/glycob/11.9.107R; De Voss JJ, 2000, P NATL ACAD SCI USA, V97, P1252, DOI 10.1073/pnas.97.3.1252; Deb C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006077; Domenech P, 2005, INFECT IMMUN, V73, P3492, DOI 10.1128/IAI.73.6.3492-3501.2005; Dubnau E, 2005, INFECT IMMUN, V73, P3754, DOI 10.1128/IAI.73.6.3754-3757.2005; Fenhalls G, 2002, INFECT IMMUN, V70, P6330, DOI 10.1128/IAI.70.11.6330-6338.2002; Fisher MA, 2002, J BACTERIOL, V184, P4025, DOI 10.1128/JB.184.14.4025-4032.2002; Grover A, 2009, INFECT IMMUN, V77, P4837, DOI 10.1128/IAI.00704-09; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hegymegi-Barakonyi B, 2008, CURR MED CHEM, V15, P2760, DOI 10.2174/092986708786242886; Hutter B, 2000, FEMS MICROBIOL LETT, V188, P141, DOI 10.1016/S0378-1097(00)00227-5; Izzo A, 2005, TUBERCULOSIS, V85, P25, DOI 10.1016/j.tube.2004.09.008; Jain SK, 2007, J INFECT DIS, V195, P1634, DOI 10.1086/517526; Kaplan G, 2003, INFECT IMMUN, V71, P7099, DOI 10.1128/IAI.71.12.7099-7108.2003; Kashyap RS, 2005, CLIN DIAGN LAB IMMUN, V12, P752, DOI 10.1128/CDLI.12.6.752-758.2005; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kumar P, 2007, P NATL ACAD SCI USA, V104, P11221, DOI 10.1073/pnas.0611649104; Lamichhane G, 2005, INFECT IMMUN, V73, P2533, DOI 10.1128/IAI.73.4.2533-2540.2005; Mattow J, 2006, PROTEOMICS, V6, P2485, DOI 10.1002/pmic.200500547; McMurray DN, 2003, TUBERCULOSIS, V83, P131, DOI 10.1016/S1472-9792(02)00079-3; MEHAFFY C, PROTEOMICS; Mohammadi T, 2007, MOL MICROBIOL, V65, P1106, DOI 10.1111/j.1365-2958.2007.05851.x; Monahan IM, 2001, MICROBIOL-SGM, V147, P459, DOI 10.1099/00221287-147-2-459; Murphy DJ, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-84; Muttucumaru DGN, 2004, TUBERCULOSIS, V84, P239, DOI 10.1016/j.tube.2003.12.006; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Ojha AK, 2008, MOL MICROBIOL, V69, P164, DOI 10.1111/j.1365-2958.2008.06274.x; Papavinasasundaram KG, 2005, J BACTERIOL, V187, P5751, DOI 10.1128/JB.187.16.5751-5760.2005; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Rachman H, 2006, INFECT IMMUN, V74, P1233, DOI 10.1128/IAI.74.2.1233-1242.2006; RAGHU B, 1993, BIOCHEM MOL BIOL INT, V31, P341; Raynaud C, 2002, MOL MICROBIOL, V45, P203, DOI 10.1046/j.1365-2958.2002.03009.x; Rifat D, 2009, J INFECT DIS, V200, P1126, DOI 10.1086/605700; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; Rosenkrands I, 2002, J BACTERIOL, V184, P3485, DOI 10.1128/JB.184.13.3485-3491.2002; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schwab U, 2009, MICROB PATHOGENESIS, V46, P185, DOI 10.1016/j.micpath.2008.12.006; Searle BC, 2010, PROTEOMICS, V10, P1265, DOI 10.1002/pmic.200900437; SEGAL W, 1956, J BACTERIOL, V72, P132, DOI 10.1128/JB.72.2.132-141.1956; Seiler P, 2003, J INFECT DIS, V188, P1326, DOI 10.1086/378563; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; SMITH DW, 1991, TUBERCLE, V72, P223, DOI 10.1016/0041-3879(91)90013-I; SMITH DW, 1989, REV INFECT DIS, V11, pS385; Sohaskey CD, 2003, J BACTERIOL, V185, P7247, DOI 10.1128/JB.185.24.7247-7256.2003; Talaat AM, 2004, P NATL ACAD SCI USA, V101, P4602, DOI 10.1073/pnas.0306023101; Timm J, 2003, P NATL ACAD SCI USA, V100, P14321, DOI 10.1073/pnas.2436197100; Tundup S, 2006, FEBS LETT, V580, P1285, DOI 10.1016/j.febslet.2006.01.042; Turner OC, 2003, INFECT IMMUN, V71, P864, DOI 10.1128/IAI.71.2.864-871.2003; van Veen HW, 1997, ANTON LEEUW INT J G, V72, P299, DOI 10.1023/A:1000530927928; Voskuil MI, 2004, TUBERCULOSIS, V84, P256, DOI 10.1016/j.tube.2003.12.014; Voskuil MI, 2004, TUBERCULOSIS, V84, P218, DOI 10.1016/j.tube.2004.02.003; Ward SK, 2008, J BACTERIOL, V190, P2939, DOI 10.1128/JB.01847-07; WARD SK, MOL MICROBIOL; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; Wehenkel A, 2008, BBA-PROTEINS PROTEOM, V1784, P193, DOI 10.1016/j.bbapap.2007.08.006; WHEELER PR, 1990, J GEN MICROBIOL, V136, P211, DOI 10.1099/00221287-136-1-211; Zvi A, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-18	68	152	157	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e13938	10.1371/journal.pone.0013938	http://dx.doi.org/10.1371/journal.pone.0013938			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21085642	gold, Green Published, Green Submitted			2022-12-25	WOS:000284087800008
J	Tsuruyama, T; Nakai, T; Hiratsuka, T; Jin, GA; Nakamura, T; Yoshikawa, K				Tsuruyama, Tatsuaki; Nakai, Tonau; Hiratsuka, Takuya; Jin, Guang; Nakamura, Takuro; Yoshikawa, Kenichi			In Vitro HIV-1 Selective Integration into the Target Sequence and Decoy-Effect of the Modified Sequence	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN GENOME; PREFERENCES; MOLECULE; SITES	Although there have been a few reports that the HIV-1 genome can be selectively integrated into the genomic DNA of cultured host cell, the biochemistry of integration selectivity has not been fully understood. We modified the in vitro integration reaction protocol and developed a reaction system with higher efficiency. We used a substrate repeat, 59(GTCCCTTCCCAGT)(n)(ACTGGGAAGGGAC)(n)-3', and a modified sequence DNA ligated into a circular plasmid. CAGT and ACTG (shown in italics in the above sequence) in the repeat units originated from the HIV-1 proviral genome ends. Following the incubation of the HIV-1 genome end cDNA and recombinant integrase for the formation of the pre-integration (PI) complex, substrate DNA was reacted with this complex. It was confirmed that the integration selectively occurred in the middle segment of the repeat sequence. In addition, integration frequency and selectivity were positively correlated with repeat number n. On the other hand, both frequency and selectivity decreased markedly when using sequences with deletion of CAGT in the middle position of the original target sequence. Moreover, on incubation with the deleted DNAs and original sequence, the integration efficiency and selectivity for the original target sequence were significantly reduced, which indicated interference effects by the deleted sequence DNAs. Efficiency and selectivity were also found to vary discontinuously with changes in manganese dichloride concentration in the reaction buffer, probably due to its influence on the secondary structure of substrate DNA. Finally, integrase was found to form oligomers on the binding site and substrate DNA formed a loop-like structure. In conclusion, there is a considerable selectivity in HIV-integration into the specified sequence; however, similar DNA sequences can interfere with the integration process, and it is therefore difficult for in vivo integration to occur selectively in the actual host genome DNA.	[Tsuruyama, Tatsuaki] Kyoto Univ, Grad Sch Med, Dept Forens Med & Mol Pathol, Kyoto, Japan; [Nakai, Tonau; Yoshikawa, Kenichi] Kyoto Univ, Dept Phys, Grad Sch Sci, Kyoto 606, Japan; [Hiratsuka, Takuya] Noe Saiseikai Hosp, Pathol Lab, Osaka, Japan; [Jin, Guang; Nakamura, Takuro] Japanese Fdn Canc Res, Inst Canc, Div Carcinogenesis, Koto Ku, Tokyo 170, Japan	Kyoto University; Kyoto University; Japanese Foundation for Cancer Research	Tsuruyama, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Forens Med & Mol Pathol, Kyoto, Japan.	tsuruyam@fp.med.kyoto-u.ac.jp	Yoshikawa, Kenichi/N-1867-2019	Yoshikawa, Kenichi/0000-0002-2751-7136	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Ministry of Health, Labor, and Welfare, Japan [17013086]	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant-in-Aid for Cancer Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, and a Grant for Strategic Research on Cancer from the Ministry of Health, Labor, and Welfare, Japan. Grant number is 17013086. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARMAGEN T, 2010, J VIROL; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; FARNET CM, 1990, P NATL ACAD SCI USA, V87, P4164, DOI 10.1073/pnas.87.11.4164; Grinsztejn B, 2007, LANCET, V369, P1261, DOI 10.1016/S0140-6736(07)60597-2; Holman AG, 2005, P NATL ACAD SCI USA, V102, P6103, DOI 10.1073/pnas.0501646102; Iwaki T, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2967860; KITAMURA Y, 1992, P NATL ACAD SCI USA, V89, P5532, DOI 10.1073/pnas.89.12.5532; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Ueda M, 1996, PHYS REV LETT, V77, P2133, DOI 10.1103/PhysRevLett.77.2133; VERDIN E, 1991, J VIROL, V65, P6790, DOI 10.1128/JVI.65.12.6790-6799.1991; VINK C, 1991, NUCLEIC ACIDS RES, V19, P6691, DOI 10.1093/nar/19.24.6691; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; YOSHINAGA T, 1995, J VIROL, V69, P3233, DOI 10.1128/JVI.69.5.3233-3236.1995	14	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e13841	10.1371/journal.pone.0013841	http://dx.doi.org/10.1371/journal.pone.0013841			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079805	gold, Green Published			2022-12-25	WOS:000283838600015
J	Strebovsky, J; Walker, P; Lang, R; Dalpke, AH				Strebovsky, Julia; Walker, Patrick; Lang, Roland; Dalpke, Alexander H.			Suppressor of cytokine signaling 1 (SOCS1) limits NF kappa B signaling by decreasing p65 stability within the cell nucleus	FASEB JOURNAL			English	Article						cell activation; inflammation; signal transduction; nuclear factor kappa B; ubiquitination	UBIQUITIN-LIGASE; LOCALIZATION SIGNAL; NEGATIVE REGULATION; EXPORT SIGNAL; DEGRADATION; PROTEIN; RECEPTOR; ACTIVATION; TERMINATION; DOMAIN	Suppressor of cytokine signaling (SOCS) proteins are inhibitors of cytoplasmic Janus kinases (Jak) and signal transducer and activator of transcription (STAT) signaling pathways. Previously the authors surprisingly observed that SOCS1 translocated into the nucleus, which was because of the presence of a nuclear localization sequence. This report now hypothesizes that SOCS1 mediates specific functions within the nuclear compartment because it is instantly transported into the nucleus, as shown by photoactivation and live cell imaging in human HEK293 cells. The NF kappa B component p65 is identified as an interaction partner for SOCS1 but not for other members of the SOCS family. SOCS1 bound to p65 only within the nucleus. By means of its SOCS box domain, SOCS1 operated as a ubiquitin ligase, leading to polyubiquitination and proteasomal degradation of nuclear p65. Thus, SOCS1 limited prolonged p65 signaling and terminated expression of NF kappa B inducible genes. Using mutants that lack either nuclear translocation or a functional SOCS box, this report identifies genes that are regulated in a manner dependent on the nuclear availability of SOCS1. Data show that beyond its receptor-proximal function in Jak/STAT signaling, SOCS1 also regulates the duration of NF kappa B signaling within the cell nucleus, thus exerting a heretofore unrecognized function.-Strebovsky, J., Walker, P., Lang, R., Dalpke, A. H. Suppressor of cytokine signaling 1 (SOCS1) limits NF kappa B signaling by decreasing p65 stability within the cell nucleus. FASEB J. 25, 863-874 (2011). www.fasebj.org	[Strebovsky, Julia; Walker, Patrick; Dalpke, Alexander H.] Heidelberg Univ, Dept Infect Dis Med Microbiol & Hyg, D-69120 Heidelberg, Germany; [Lang, Roland] Univ Hosp Erlangen, Inst Clin Microbiol Immunol & Hyg, Erlangen, Germany	Ruprecht Karls University Heidelberg; University of Erlangen Nuremberg	Dalpke, AH (corresponding author), Heidelberg Univ, Dept Infect Dis Med Microbiol & Hyg, Neuenheimer Feld 324, D-69120 Heidelberg, Germany.	alexander.dalpke@med.uni-heidelberg.de	Lang, Roland/C-3287-2011		Deutsche Forschungsgemeinschaft [Da592/4]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors thank M. L. Schmitz and T. Wittwer for help with NiNTA assays and for fruitful discussions, as well as K. Bode for auxiliary advice. The authors appreciate excellent technical support by A. Elfner. This work was supported by a grant from Deutsche Forschungsgemeinschaft to A.D. (Da592/4). The authors report no conflicting financial interests.	Baens M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000054; Baetz A, 2004, J BIOL CHEM, V279, P54708, DOI 10.1074/jbc.M410992200; Baetz A, 2008, FASEB J, V22, P4296, DOI 10.1096/fj.08-116079; Bartz H, 2006, BLOOD, V108, P4102, DOI 10.1182/blood-2006-03-008946; Bayle J, 2006, FEBS LETT, V580, P2609, DOI 10.1016/j.febslet.2006.03.093; Bode KA, 2009, J IMMUNOL, V182, P2176, DOI 10.4049/jimmunol.0802560; Calabrese V, 2009, MOL CELL, V36, P754, DOI 10.1016/j.molcel.2009.09.044; Chen XP, 2002, P NATL ACAD SCI USA, V99, P2175, DOI 10.1073/pnas.042035699; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; De Sepulveda P, 2000, J BIOL CHEM, V275, P14005, DOI 10.1074/jbc.C000106200; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Geng H, 2009, EMBO REP, V10, P381, DOI 10.1038/embor.2009.10; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Gingras S, 2004, J BIOL CHEM, V279, P54702, DOI 10.1074/jbc.M411043200; Haffner MC, 2008, J BIOL CHEM, V283, P22089, DOI 10.1074/jbc.M801041200; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; Huang TT, 2000, P NATL ACAD SCI USA, V97, P1014, DOI 10.1073/pnas.97.3.1014; Hwang MN, 2007, BIOCHEM BIOPH RES CO, V360, P333, DOI 10.1016/j.bbrc.2007.06.062; Johnson C, 1999, EMBO J, V18, P6682, DOI 10.1093/emboj/18.23.6682; Kamio M, 2004, ONCOGENE, V23, P3107, DOI 10.1038/sj.onc.1207453; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Kile BT, 2002, TRENDS BIOCHEM SCI, V27, P235, DOI 10.1016/S0968-0004(02)02085-6; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Koelsche C, 2009, MOL IMMUNOL, V46, P2474, DOI 10.1016/j.molimm.2009.05.020; Lee KH, 2008, FEBS LETT, V582, P2319, DOI 10.1016/j.febslet.2008.05.039; Madonna S, 2010, J IMMUNOL, V185, P2467, DOI 10.4049/jimmunol.1001426; Maine GN, 2007, EMBO J, V26, P436, DOI 10.1038/sj.emboj.7601489; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Natoli G, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.11pe1; Nicholson SE, 1999, EMBO J, V18, P375, DOI 10.1093/emboj/18.2.375; Nihira K, 2010, CELL DEATH DIFFER, V17, P689, DOI 10.1038/cdd.2009.174; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Prele CM, 2008, J IMMUNOL, V181, P8018, DOI 10.4049/jimmunol.181.11.8018; Rodrigues L, 2009, EMBO J, V28, P1283, DOI 10.1038/emboj.2009.74; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Saccani S, 2004, J EXP MED, V200, P107, DOI 10.1084/jem.20040196; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; Shirangi TR, 2002, FASEB J, V16, P420, DOI 10.1096/fj.01-0617fje; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Sui SG, 2007, J CELL BIOL, V178, P231, DOI 10.1083/jcb.200611081; Tanaka T, 2007, NAT IMMUNOL, V8, P584, DOI 10.1038/ni1464; Toniato E, 2002, J BIOL CHEM, V277, P37315, DOI 10.1074/jbc.M205900200; Yang XD, 2009, EMBO J, V28, P1055, DOI 10.1038/emboj.2009.55; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309	45	120	123	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2011	25	3					863	874		10.1096/fj.10-170597	http://dx.doi.org/10.1096/fj.10-170597			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	727MZ	21084693				2022-12-25	WOS:000287806200007
J	Lin, WY; Wu, GY; Li, SY; Weinberg, EM; Kumthip, K; Peng, LF; Mendez-Navarro, J; Chen, WC; Jilg, N; Zhao, H; Goto, K; Zhang, LL; Brockman, MA; Schuppan, D; Chung, RT				Lin, Wenyu; Wu, Guoyang; Li, Shaoyong; Weinberg, Ethan M.; Kumthip, Kattareeya; Peng, Lee F.; Mendez-Navarro, Jorge; Chen, Wen-Chi; Jilg, Nikolaus; Zhao, Hong; Goto, Kaku; Zhang, Leiliang; Brockman, Mark A.; Schuppan, Detlef; Chung, Raymond T.			HIV and HCV Cooperatively Promote Hepatic Fibrogenesis via Induction of Reactive Oxygen Species and NF kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS CORE PROTEIN; INDUCED LIVER FIBROSIS; C VIRUS; STELLATE CELLS; MITOCHONDRIAL INJURY; OXIDATIVE STRESS; GENE-EXPRESSION; RAT-LIVER; ACTIVATION; REPLICATION	HIV/HCV coinfection leads to accelerated hepatic fibrosis progression, with higher rates of cirrhosis, liver failure, and liver death than does HCV mono-infection. However, the pro-fibrogenic role of HIV on hepatocytes and hepatic stellate cells (HSC) has not been fully clarified. We hypothesized that HIV, HCV induce liver fibrosis through altered regulation of the production of extracellular matrix and matrix metalloproteinases. We examined the fibrogenesis- and fibrolysis-related gene activity in LX2 HSC and Huh7.5.1 cells in the presence of inactivated CXCR4 and CCR5 HIV, as well as HCV JFH1 virus. The role of reactive oxygen species (ROS) upon fibrosis gene expression was assessed using the ROS inhibitor. Fibrosis-related transcripts including procollagen alpha 1(I) (CoL1A), TIMP1, and MMP3 mRNA were measured by qPCR. TIMP1 and MMP3 protein expression were assessed by ELISA. We found that inactivated CXCR4 HIV and CCR5 HIV increased CoL1A, and TIMP1 expression in both HSC and Huh7.5.1 cells; the addition of JFH1 HCV further increased CoL1A and TIMP1 expression. CXCR4 HIV and CCR5 HIV induced ROS production in HSC and Huh7.5.1 cells which was further enhanced by JFH1 HCV. The ROS inhibitor DPI abrogated HIV -and HCV-induced CoL1A and TIMP1 expression. HIV and HCV-induced CoL1A and TIMP1 expression were also blocked by NF kappa B siRNA. Our data provide further evidence that HIV and HCV independently regulate hepatic fibrosis progression through the generation of ROS; this regulation occurs in an NF kappa B-dependent fashion. Strategies to limit the viral induction of oxidative stress are warranted to inhibit fibrogenesis.	[Mendez-Navarro, Jorge; Chen, Wen-Chi; Jilg, Nikolaus; Zhao, Hong; Goto, Kaku; Zhang, Leiliang] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit,Dept Med, Boston, MA 02114 USA; [Wu, Guoyang] Xiamen Univ, Hepatobiliary Surg Dept, Zhongshan Hosp, Xiamen, Fujian, Peoples R China; [Li, Shaoyong; Schuppan, Detlef] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA; [Brockman, Mark A.] Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada	Harvard University; Harvard Medical School; Massachusetts General Hospital; Xiamen University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Simon Fraser University	Chung, RT (corresponding author), MA Gen Hosp, Gastrointestinal Unit, Warren 1007, Boston, MA 02114 USA.	rtchung@partners.org	LI, Shaoyong/D-1052-2013; Jilg, Nikolaus/GON-5240-2022; Weinberg, Ethan Michael/AAH-8009-2019; Brockman, Mark/D-1669-2016	Weinberg, Ethan Michael/0000-0002-5605-8995; Kumthip, Kattareeya/0000-0001-7028-7607; Brockman, Mark/0000-0001-6432-1426	National Institutes of Health-MGH Center For Human Immunology Pilot/Feasibility Study; National Institutes of Health [AI069939, AI082630, AI066313U19]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI066313, U19AI082630, R01AI069939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK078772] Funding Source: NIH RePORTER	National Institutes of Health-MGH Center For Human Immunology Pilot/Feasibility Study; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health-MGH Center For Human Immunology Pilot/Feasibility Study Grant (to W. L.), and National Institutes of Health Grants AI069939 (to R. T. C.), AI082630 (to R. T. C.), and AI066313U19 (to D. S.).	Benali-Furet NL, 2005, ONCOGENE, V24, P4921, DOI 10.1038/sj.onc.1208673; Blackard JT, 2006, J INTERF CYTOK RES, V26, P834, DOI 10.1089/jir.2006.26.834; Boudreau HE, 2009, J VIROL, V83, P12934, DOI 10.1128/JVI.01059-09; Bruno R, 2010, GUT, V59, P513, DOI 10.1136/gut.2008.163287; CASINI A, 1994, LIFE SCI, V55, P1311, DOI 10.1016/0024-3205(94)00763-2; Choi J, 2006, AM J PHYSIOL-GASTR L, V290, pG847, DOI 10.1152/ajpgi.00522.2005; Choi JN, 2004, HEPATOLOGY, V39, P81, DOI 10.1002/hep.20001; Choi SH, 2006, J BIOL CHEM, V281, P7468, DOI 10.1074/jbc.M512438200; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Gressner AM, 2002, FRONT BIOSCI-LANDMRK, V7, pD793, DOI 10.2741/gressner; Hiscott J, 2001, J CLIN INVEST, V107, P143, DOI 10.1172/JCI11918; Hong F, 2009, HEPATOLOGY, V49, P2055, DOI 10.1002/hep.22890; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Kim AY, 2009, GASTROENTEROLOGY, V137, P795, DOI 10.1053/j.gastro.2009.06.040; Kim SM, 2007, AM J PHYSIOL-RENAL, V292, pF415, DOI 10.1152/ajprenal.00317.2006; Koziel MJ, 2007, NEW ENGL J MED, V356, P1445, DOI 10.1056/NEJMra065142; Lin W, 2008, GASTROENTEROLOGY, V134, P803, DOI 10.1053/j.gastro.2008.01.005; Lin WY, 2006, J VIROL, V80, P9226, DOI 10.1128/JVI.00459-06; Lin WY, 2010, GASTROENTEROLOGY, V138, P2509, DOI 10.1053/j.gastro.2010.03.008; Lin WY, 2005, GASTROENTEROLOGY, V128, P1034, DOI 10.1053/j.gastro.2005.02.006; Liu RM, 2010, J BIOL CHEM, V285, P16239, DOI 10.1074/jbc.M110.111732; Machida K, 2006, J VIROL, V80, P7199, DOI 10.1128/JVI.00321-06; Macias J, 2009, HEPATOLOGY, V50, P1056, DOI 10.1002/hep.23136; Mazzocca A, 2005, J BIOL CHEM, V280, P11329, DOI 10.1074/jbc.M410161200; MILANI S, 1990, GASTROENTEROLOGY, V98, P175, DOI 10.1016/0016-5085(90)91307-R; MILANI S, 1989, HEPATOLOGY, V10, P84, DOI 10.1002/hep.1840100117; Miura K, 2008, HEPATOLOGY, V48, p789A; Okuda M, 2002, GASTROENTEROLOGY, V122, P366, DOI 10.1053/gast.2002.30983; Otani K, 2005, GASTROENTEROLOGY, V128, P96, DOI 10.1053/j.gastro.2004.10.045; Pascual-Pareja JF, 2009, AIDS, V23, P971, DOI 10.1097/QAD.0b013e328329f994; Popov Y, 2006, J BIOL CHEM, V281, P15090, DOI 10.1074/jbc.M600030200; Rotman Y, 2009, J VIROL, V83, P7366, DOI 10.1128/JVI.00191-09; Schulze-Krebs A, 2005, GASTROENTEROLOGY, V129, P246, DOI 10.1053/j.gastro.2005.03.089; SCHUPPAN D, 1990, J BIOL CHEM, V265, P8823; Schuppan D, 2003, CELL DEATH DIFFER, V10, pS59, DOI 10.1038/sj.cdd.4401163; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Sherman KE, 2007, HEPATOLOGY, V45, P1566, DOI 10.1002/hep.21722; Taura K, 2010, HEPATOLOGY, V51, P1027, DOI 10.1002/hep.23368; Tuyama AC, 2010, HEPATOLOGY, V52, P612, DOI 10.1002/hep.23679; Urtasun R, 2009, GASTROENTEROLOGY, V136, P1410, DOI 10.1053/j.gastro.2008.12.065; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wang JH, 2009, GASTROENTEROLOGY, V137, P713, DOI 10.1053/j.gastro.2009.04.011; Wang L, 2004, J BIOL CHEM, V279, P33213, DOI 10.1074/jbc.M403758200; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zhu ZW, 2008, HEPATOLOGY, V48, P1430, DOI 10.1002/hep.22491	46	80	83	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2665	2674		10.1074/jbc.M110.168286	http://dx.doi.org/10.1074/jbc.M110.168286			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21098019	Green Published, hybrid			2022-12-25	WOS:000286464300032
J	Wan, XP; Dennis, AT; Obejero-Paz, C; Overholt, JL; Heredia-Moya, J; Kirk, KL; Ficker, E				Wan, Xiaoping; Dennis, Adrienne T.; Obejero-Paz, Carlos; Overholt, Jeffrey L.; Heredia-Moya, Jorge; Kirk, Kenneth L.; Ficker, Eckhard			Oxidative Inactivation of the Lipid Phosphatase Phosphatase and Tensin Homolog on Chromosome Ten (PTEN) as a Novel Mechanism of Acquired Long QT Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; PROTEIN-TYROSINE PHOSPHATASES; TUMOR-SUPPRESSOR PTEN; GROWTH-FACTOR-I; ARSENIC TRIOXIDE; PHOSPHATIDYLINOSITOL 3-KINASE; CARDIAC REPOLARIZATION; CA2+ CHANNEL; KINASE-C; CELLS	The most common cause of cardiac side effects of pharmaco-therapy is acquired long QT syndrome, which is characterized by abnormal cardiac repolarization and most often caused by direct blockade of the cardiac potassium channel human ether a-go-go-related gene (hERG). However, little is known about therapeutic compounds that target ion channels other than hERG. We have discovered that arsenic trioxide (As2O3), a very potent antineoplastic compound for the treatment of acute promyelocytic leukemia, is proarrhythmic via two separate mechanisms: a well characterized inhibition of hERG/I-Kr trafficking and a poorly understood increase of cardiac calcium currents. We have analyzed the latter mechanism in the present study using biochemical and electrophysiological methods. We find that oxidative inactivation of the lipid phosphatase PTEN by As2O3 enhances cardiac calcium currents in the therapeutic concentration range via a PI3K alpha-dependent increase in phosphatidylinositol 3,4,5-triphosphate (PIP3) production. In guinea pig ventricular myocytes, even a modest reduction in PTEN activity is sufficient to increase cellular PIP3 levels. Under control conditions, PIP3 levels are kept low by PTEN and do not affect calcium current amplitudes. Based on pharmacological experiments and intracellular infusion of PIP3, we propose that in guinea pig ventricular myocytes, PIP3 regulates calcium currents independently of the protein kinase Akt along a pathway that includes a secondary oxidation-sensitive target. Overall, our report describes a novel form of acquired long QT syndrome where the target modified by As2O3 is an intracellular signaling cascade.	[Wan, Xiaoping; Dennis, Adrienne T.; Ficker, Eckhard] Case Western Reserve Univ, Rammelkamp Ctr Educ & Res, Cleveland, OH 44109 USA; [Obejero-Paz, Carlos] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Overholt, Jeffrey L.] Winston Salem State Univ, Dept Life Sci, Winston Salem, NC 27110 USA; [Heredia-Moya, Jorge; Kirk, Kenneth L.] NIDDK, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA	Case Western Reserve University; MetroHealth System; Case Western Reserve University; Winston-Salem State University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Ficker, E (corresponding author), Metrohlth Med Ctr, Rammelkamp Ctr, 2500 Metrohlth Dr, Cleveland, OH 44109 USA.	eficker@metrohealth.org		Heredia-Moya, Jorge/0000-0001-7620-9140	National Institutes of Health [HL71789]; NIDDK, National Institutes of Health; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071789] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL71789 (to E. F.) and intramural funds of NIDDK, National Institutes of Health (to J. H.-M. and K. L. K.). This work was also supported by a grant from the American Heart Association (to J. L. O.).	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Blair LAC, 1997, NEURON, V19, P421, DOI 10.1016/S0896-6273(00)80950-2; Callaghan B, 2004, CIRC RES, V94, P626, DOI 10.1161/01.RES.0000118248.17466.B7; Catalucci D, 2009, J CELL BIOL, V184, P923, DOI 10.1083/jcb.200805063; Chiang CE, 2002, BLOOD, V100, P2249, DOI 10.1182/blood-2002-02-0598; Chou WC, 2004, P NATL ACAD SCI USA, V101, P4578, DOI 10.1073/pnas.0306687101; Delbono O, 1997, J NEUROSCI, V17, P6918; Ficker E, 2004, MOL PHARMACOL, V66, P33, DOI 10.1124/mol.66.1.33; Ficker E, 2003, CIRC RES, V92, pE87, DOI 10.1161/01.RES.0000079028.31393.15; GARCIAMORALES P, 1990, P NATL ACAD SCI USA, V87, P9255, DOI 10.1073/pnas.87.23.9255; HECHT D, 1992, BIOCHEM BIOPH RES CO, V188, P773, DOI 10.1016/0006-291X(92)91123-8; Holleran JL, 2003, ANAL BIOCHEM, V323, P19, DOI 10.1016/j.ab.2003.08.030; Kim YK, 2003, J BIOL CHEM, V278, P47622, DOI 10.1074/jbc.M305909200; Kumagai Y, 2007, ANNU REV PHARMACOL, V47, P243, DOI 10.1146/annurev.pharmtox.47.120505.105144; Kuryshev YA, 2006, MOL PHARMACOL, V69, P1216, DOI 10.1124/mol.105.019281; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Kwon Y, 2007, MOL CELL, V25, P491, DOI 10.1016/j.molcel.2007.01.021; Laurent A, 2005, CANCER RES, V65, P948; Le Blanc C, 2004, CIRC RES, V95, P300, DOI 10.1161/01.RES.0000138017.76125.8b; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Leslie NR, 2003, EMBO J, V22, P5501, DOI 10.1093/emboj/cdg513; Liu SX, 2001, P NATL ACAD SCI USA, V98, P1643, DOI 10.1073/pnas.031482998; Lu ZJ, 2007, DIABETES, V56, P2780, DOI 10.2337/db06-1629; Nasr R, 2008, NAT MED, V14, P1333, DOI 10.1038/nm.1891; Ohnishi K, 2000, ANN INTERN MED, V133, P881, DOI 10.7326/0003-4819-133-11-200012050-00012; Oudit GY, 2009, CARDIOVASC RES, V82, P250, DOI 10.1093/cvr/cvp014; Pathak MK, 2001, J IMMUNOL, V167, P3391, DOI 10.4049/jimmunol.167.6.3391; Platanias LC, 2009, J BIOL CHEM, V284, P18583, DOI 10.1074/jbc.R900003200; Pochynyuk O, 2007, J PHYSIOL-LONDON, V580, P365, DOI 10.1113/jphysiol.2006.127449; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Schmid AC, 2004, FEBS LETT, V566, P35, DOI 10.1016/j.febslet.2004.03.102; Seo JH, 2005, MOL BIOL CELL, V16, P348, DOI 10.1091/mbc.E04-05-0369; Shen ZX, 2004, P NATL ACAD SCI USA, V101, P5328, DOI 10.1073/pnas.0400053101; Siu CW, 2006, BLOOD, V108, P103, DOI 10.1182/blood-2006-01-0054; Splawski I, 2005, P NATL ACAD SCI USA, V102, P8089, DOI 10.1073/pnas.0502506102; Sulis ML, 2003, TRENDS CELL BIOL, V13, P478, DOI 10.1016/S0962-8924(03)00175-2; Sun H, 2006, CIRC RES, V98, P1390, DOI 10.1161/01.RES.0000223321.34482.8c; Sun Y, 2008, CANCER RES, V68, P8269, DOI 10.1158/0008-5472.CAN-08-2010; Takeishi Y, 1999, CIRC RES, V85, P264, DOI 10.1161/01.RES.85.3.264; Unnikrishnan D, 2001, BLOOD, V97, P1514, DOI 10.1182/blood.V97.5.1514; Vasudevan KM, 2009, CANCER CELL, V16, P21, DOI 10.1016/j.ccr.2009.04.012; Viard P, 2004, NAT NEUROSCI, V7, P939, DOI 10.1038/nn1300; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; Xie LH, 2009, CIRC RES, V104, P79, DOI 10.1161/CIRCRESAHA.108.183475	45	22	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2843	2852		10.1074/jbc.M110.125526	http://dx.doi.org/10.1074/jbc.M110.125526			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21097842	hybrid, Green Published			2022-12-25	WOS:000286464300050
J	Weiss, MS; Bernabe, BP; Bellis, AD; Broadbelt, LJ; Jeruss, JS; Shea, LD				Weiss, Michael S.; Bernabe, Beatriz Penalver; Bellis, Abigail D.; Broadbelt, Linda J.; Jeruss, Jacqueline S.; Shea, Lonnie D.			Dynamic, Large-Scale Profiling of Transcription Factor Activity from Live Cells in 3D Culture	PLOS ONE			English	Article							BREAST-CANCER CELLS; NF-KAPPA-B; TUMOR-SUPPRESSOR GENE; SIGNALING PATHWAY; EXTRACELLULAR-MATRIX; AP-1 TRANSCRIPTION; GROWTH-INHIBITION; ESTROGEN-RECEPTOR; EPITHELIAL-CELLS; MICROARRAY DATA	Background: Extracellular activation of signal transduction pathways and their downstream target transcription factors (TFs) are critical regulators of cellular processes and tissue development. The intracellular signaling network is complex, and techniques that quantify the activities of numerous pathways and connect their activities to the resulting phenotype would identify the signals and mechanisms regulating tissue development. The ability to investigate tissue development should capture the dynamic pathway activity and requires an environment that supports cellular organization into structures that mimic in vivo phenotypes. Taken together, our objective was to develop cellular arrays for dynamic, large-scale quantification of TF activity as cells organized into spherical structures within 3D culture. Methodology/Principal Findings: TF-specific and normalization reporter constructs were delivered in parallel to a cellular array containing a well-established breast cancer cell line cultured in Matrigel. Bioluminescence imaging provided a rapid, non-invasive, and sensitive method to quantify luciferase levels, and was applied repeatedly on each sample to monitor dynamic activity. Arrays measuring 28 TFs identified up to 19 active, with 13 factors changing significantly over time. Stimulation of cells with beta-estradiol or activin A resulted in differential TF activity profiles evolving from initial stimulation of the ligand. Many TFs changed as expected based on previous reports, yet arrays were able to replicate these results in a single experiment. Additionally, arrays identified TFs that had not previously been linked with activin A. Conclusions/Significance: This system provides a method for large-scale, non-invasive, and dynamic quantification of signaling pathway activity as cells organize into structures. The arrays may find utility for investigating mechanisms regulating normal and abnormal tissue growth, biomaterial design, or as a platform for screening therapeutics.	[Weiss, Michael S.; Bernabe, Beatriz Penalver; Bellis, Abigail D.; Broadbelt, Linda J.; Shea, Lonnie D.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA; [Jeruss, Jacqueline S.] Northwestern Univ, Dept Surg, Feinberg Sch Med, Evanston, IL USA; [Jeruss, Jacqueline S.; Shea, Lonnie D.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL USA; [Shea, Lonnie D.] Northwestern Univ, Inst Bionanotechnol Med IBNAM, Evanston, IL USA	Northwestern University; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University	Weiss, MS (corresponding author), Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.	j-jeruss@md.northwestern.edu; l-shea@northwestern.edu	Broadbelt, Linda/B-7640-2009; Shea, Lonnie D/B-7615-2009		National Institutes of Health [R21CA125285, UL1DE019587, T32GM008449]; Chicago Biomedical Consortium; NATIONAL CANCER INSTITUTE [R21CA125285, K22CA138776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [UL1DE019587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008449] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chicago Biomedical Consortium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health - R21CA125285, UL1DE019587, T32GM008449 (www.nih.gov). Chicago Biomedical Consortium (http://www.chicagobiomedicalconsortium.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Benitah SA, 2004, BBA-REV CANCER, V1705, P121, DOI 10.1016/j.bbcan.2004.10.002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Burdette JE, 2005, CANCER RES, V65, P7968, DOI 10.1158/0008-5472.CAN-04-3553; Chang JH, 1998, MOL CELL BIOL, V18, P4986, DOI 10.1128/MCB.18.9.4986; Cheng C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-116; Cocolakis E, 2001, J BIOL CHEM, V276, P18430, DOI 10.1074/jbc.M010768200; Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; de la Iglesia N, 2008, J NEUROSCI, V28, P5870, DOI 10.1523/JNEUROSCI.5385-07.2008; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Dedieu S, 2006, CELL SIGNAL, V18, P889, DOI 10.1016/j.cellsig.2005.08.001; Denhardt DT, 1996, BIOCHEM J, V318, P729, DOI 10.1042/bj3180729; Deniaud E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007035; Dimri M, 2007, CANCER RES, V67, P4164, DOI 10.1158/0008-5472.CAN-06-2580; Dreesen O, 2007, STEM CELL REV, V3, P7, DOI 10.1007/s12015-007-0004-8; Duan RQ, 2002, BIOCHEM BIOPH RES CO, V294, P384, DOI 10.1016/S0006-291X(02)00499-0; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harris CC, 1996, CARCINOGENESIS, V17, P1187, DOI 10.1093/carcin/17.6.1187; Ho J, 2004, CELL SIGNAL, V16, P693, DOI 10.1016/j.cellsig.2003.11.002; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601; Ignowski JM, 2004, BIOTECHNOL BIOENG, V86, P827, DOI 10.1002/bit.20059; Ikeda K, 2004, ARCH HISTOL CYTOL, V67, P435, DOI 10.1679/aohc.67.435; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; JIANG SY, 1992, MOL CELL ENDOCRINOL, V90, P77, DOI 10.1016/0303-7207(92)90104-E; Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; King KR, 2007, LAB CHIP, V7, P77, DOI 10.1039/b612516f; Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004; Lewis-Wambi JS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2255; Liu JW, 1999, CELL GROWTH DIFFER, V10, P677; Lonnstedt I, 2002, STAT SINICA, V12, P31; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Miller-Jensen K, 2007, NATURE, V448, P604, DOI 10.1038/nature06001; Molchadsky A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003707; Molinari AM, 2000, CANCER RES, V60, P2594; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Pannier AK, 2007, BIOTECHNOL BIOENG, V98, P486, DOI 10.1002/bit.21477; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; Peyton SR, 2008, BIOMATERIALS, V29, P2597, DOI 10.1016/j.biomaterials.2008.02.005; PHILIPS A, 1993, J BIOL CHEM, V268, P14103; R. T. eam, 2008, R LANG ENV STAT COMP; Reuter JA, 2009, CANCER CELL, V15, P477, DOI 10.1016/j.ccr.2009.04.002; Romanov S, 2008, NAT METHODS, V5, P253, DOI 10.1038/NMETH.1186; Sabbah M, 1999, P NATL ACAD SCI USA, V96, P11217, DOI 10.1073/pnas.96.20.11217; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shen Q, 2008, ONCOGENE, V27, P366, DOI 10.1038/sj.onc.1210643; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Souchelnytskyi S, 2002, J MAMMARY GLAND BIOL, V7, P359, DOI 10.1023/A:1024029930563; Streuli CH, 1999, J MAMMARY GLAND BIOL, V4, P183, DOI 10.1023/A:1018729308878; Varga CM, 2001, MOL THER, V4, P438, DOI 10.1006/mthe.2001.0475; Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3; Wieland JA, 2007, J CONTROL RELEASE, V120, P233, DOI 10.1016/j.jconrel.2007.04.015; Woodward TL, 2000, ENDOCRINOLOGY, V141, P2814, DOI 10.1210/en.141.8.2814; Wozniak MA, 2003, J CELL BIOL, V163, P583, DOI 10.1083/jcb.200305010; Yun CH, 2007, DEVELOPMENT, V134, P769, DOI 10.1242/dev.02778; Zaykin DV, 2002, GENET EPIDEMIOL, V22, P170, DOI 10.1002/gepi.0042; Zhang YY, 2009, MOL CANCER RES, V7, P498, DOI 10.1158/1541-7786.MCR-08-0415	66	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2010	5	11							e14026	10.1371/journal.pone.0014026	http://dx.doi.org/10.1371/journal.pone.0014026			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681OY	21103341	Green Published, Green Submitted, gold			2022-12-25	WOS:000284327800012
J	Brown-Steinke, K; deRonde, K; Yemen, S; Palmer, LA				Brown-Steinke, Kathleen; deRonde, Kimberly; Yemen, Sean; Palmer, Lisa A.			Gender Differences in S-Nitrosoglutathione Reductase Activity in the Lung	PLOS ONE			English	Article							PULMONARY-HYPERTENSION; NATURAL-HISTORY; NITROSOTHIOLS; REGULATOR; ESTROGEN; ANDROGEN; HYPOXIA; ASTHMA; SEX; NITROSOHEMOGLOBIN	S-nitrosothiols have been implicated in the etiology of various pulmonary diseases. Many of these diseases display gender preferences in presentation or altered severity that occurs with puberty, the mechanism by which is unknown. Estrogen has been shown to influence the expression and activity of endothelial nitric oxide synthase (eNOS) which is associated with increased S-nitrosothiol production. The effects of gender hormones on the expression and activity of the de-nitrosylating enzyme S-nitrosoglutathione reductase (GSNO-R) are undefined. This report evaluates the effects of gender hormones on the activity and expression of GSNO-R and its relationship to N-acetyl cysteine (NAC)-induced pulmonary hypertension (PH). GSNO-R activity was elevated in lung homogenates from female compared to male mice. Increased activity was not due to changes in GSNO-R expression, but correlated with GSNO-R S-nitrosylation: females were greater than males. The ability of GSNO-R to be activated by S-nitrosylation was confirmed by: 1) the ability of S-nitrosoglutathione (GSNO) to increase the activity of GSNO-R in murine pulmonary endothelial cells and 2) reduced activity of GSNO-R in lung homogenates from eNOS(-/-) mice. Gender differences in GSNO-R activity appear to explain the difference in the ability of NAC to induce PH: female and castrated male animals are protected from NAC-induced PH. Castration results in elevated GSNO-R activity that is similar to that seen in female animals. The data suggest that GSNO-R activity is modulated by both estrogens and androgens in conjunction with hormonal regulation of eNOS to maintain S-nitrosothiol homeostasis. Moreover, disruption of this eNOS-GSNO-R axis contributes to the development of PH.	[Brown-Steinke, Kathleen; deRonde, Kimberly; Yemen, Sean; Palmer, Lisa A.] Univ Virginia Hlth Syst, Dept Pediat, Charlottesville, VA USA	University of Virginia	Brown-Steinke, K (corresponding author), Univ Virginia Hlth Syst, Dept Pediat, Charlottesville, VA USA.	lap5w@virginia.edu			Department of Defense [W81XWH-07-1-0134]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL101871] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Work for this project has been supported by the Peer Reviewed Medical Research Program through the Department of Defense, Award Number W81XWH-07-1-0134 to LAP. The funders had no role in study design, data colletion and analysis, decision to publish or preparation of the manuscript.	Angelo M, 2006, P NATL ACAD SCI USA, V103, P8366, DOI 10.1073/pnas.0600942103; Bai CX, 2005, CIRCULATION, V112, P1701, DOI 10.1161/CIRCULATIONAHA.104.523217; Baraona E, 2001, ALCOHOL CLIN EXP RES, V25, P502, DOI 10.1097/00000374-200104000-00004; Baron S, 2004, J BIOL CHEM, V279, P14579, DOI 10.1074/jbc.M306143200; Beall CM, 2004, P NATL ACAD SCI USA, V101, P14300, DOI 10.1073/pnas.0405949101; Beall CM, 2002, P NATL ACAD SCI USA, V99, P17215, DOI 10.1073/pnas.252649199; Benhar M, 2009, NAT REV MOL CELL BIO, V10, P721, DOI 10.1038/nrm2764; BONNER JR, 1984, CLIN CHEST MED, V5, P557; Carey MA, 2007, TRENDS ENDOCRIN MET, V18, P308, DOI 10.1016/j.tem.2007.08.003; Chambliss KL, 2002, ENDOCR REV, V23, P665, DOI 10.1210/er.2001-0045; Chen Z, 1999, J CLIN INVEST, V103, P401, DOI 10.1172/JCI5347; Foster MW, 2009, TRENDS MOL MED, V15, P391, DOI 10.1016/j.molmed.2009.06.007; Funai EF, 1997, BIOCHEM BIOPH RES CO, V239, P875, DOI 10.1006/bbrc.1997.7565; Gaston B, 1998, BIOCHEM BIOPH RES CO, V253, P899, DOI 10.1006/bbrc.1998.9865; Gaston B, 2006, AM J RESP CRIT CARE, V173, P1186, DOI 10.1164/rccm.200510-1584PP; Goetz RM, 1999, P NATL ACAD SCI USA, V96, P2788, DOI 10.1073/pnas.96.6.2788; Haqqani AS, 2003, NITRIC OXIDE-BIOL CH, V9, P172, DOI 10.1016/j.niox.2003.11.003; Ikeda Y, 2009, ENDOCRINOLOGY, V150, P2857, DOI 10.1210/en.2008-1254; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Liu L, 2004, CELL, V116, P617, DOI 10.1016/S0092-8674(04)00131-X; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; MARTIN AJ, 1980, BRIT MED J, V280, P1397, DOI 10.1136/bmj.280.6229.1397; McMahon TJ, 2005, P NATL ACAD SCI USA, V102, P14801, DOI 10.1073/pnas.0506957102; MCMURTRY IF, 1973, J APPL PHYSIOL, V35, P459, DOI 10.1152/jappl.1973.35.4.459; MORISHIGE WK, 1978, ENDOCRINOLOGY, V102, P1827, DOI 10.1210/endo-102-6-1827; Palmer LA, 2007, J CLIN INVEST, V117, P2592, DOI 10.1172/JCI29444; Que LG, 2005, SCIENCE, V308, P1618, DOI 10.1126/science.1108228; Que LG, 2009, AM J RESP CRIT CARE, V180, P226, DOI 10.1164/rccm.200901-0158OC; RABINOVITCH M, 1981, AM J PHYSIOL, V240, pH62, DOI 10.1152/ajpheart.1981.240.1.H62; Resta TC, 2001, AM J PHYSIOL-LUNG C, V280, pL88, DOI 10.1152/ajplung.2001.280.1.L88; SKOBELOFF EM, 1992, JAMA-J AM MED ASSOC, V268, P3437, DOI 10.1001/jama.268.24.3437; Smith A. M., 2006, Current Vascular Pharmacology, V4, P9, DOI 10.2174/157016106775203090; Wei W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000328; Wu H, 2007, J ALLERGY CLIN IMMUN, V120, P322, DOI 10.1016/j.jaci.2007.04.022; Zaman K, 2001, BIOCHEM BIOPH RES CO, V284, P65, DOI 10.1006/bbrc.2001.4935; Zaman K, 2006, MOL PHARMACOL, V70, P1435, DOI 10.1124/mol.106.023242	36	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e14007	10.1371/journal.pone.0014007	http://dx.doi.org/10.1371/journal.pone.0014007			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103380	gold, Green Submitted, Green Published			2022-12-25	WOS:000284257400011
J	Fogarty, AW; Lewis, SA; McKeever, TM; Lowe, GDO; Clark, L; Britton, J				Fogarty, Andrew W.; Lewis, Sarah A.; McKeever, Tricia M.; Lowe, Gordon D. O.; Clark, Lorna; Britton, John			The Association Between Blood Coagulation Activity and Lung Function: A Population-Based Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; FIBRIN D-DIMER; PULMONARY-FUNCTION; PLASMA-FIBRINOGEN; HEART-DISEASE; AIR-POLLUTION; DECLINE; RISK	Background: Increased in susceptibility to thrombotic disease may be associated with lower lung function. If causal, this association may suggest an area for development of new interventions for lung disease. The aim of this study was to investigate the association between blood coagulation activation as measured by plasma d-dimers and lung function. Methodology/Principal Findings: We conducted a cross-sectional study on 2463 randomly selected adults in 1991 and followed up 1252 of these individuals in 2000. Plasma D-dimer levels, a marker of activity of blood coagulation pathways, were analysed in the baseline 1991 samples. There was an inverse cross-sectional association between plasma D-dimer and Forced Expiratory Volume in one second, with a decrease of 71 ml per mg FEU/ml increment in plasma D-dimer (95% confidence intervals CI: -135 to -6), and a decrease in Forced Vital Capacity (97 ml per mg FEU/ml increase in D-dimer, 95% CI: -170 to -24). These associations were attenuated after adjustment for serum highly sensitive CRP. No association was observed between plasma D-dimer and the decline in lung function between 1991 and 2000. Conclusions/Significance: The cross-sectional findings are consistent with the hypothesis that activation of blood coagulation pathways is associated with decreased lung function, and that systemic inflammation may contribute to this relation. However, the lack of an association with decline in lung function suggests that clotting pathways that involve d-dimers may not be a promising therapeutic target for new interventions for respiratory disease.	[Fogarty, Andrew W.; Lewis, Sarah A.; McKeever, Tricia M.; Britton, John] Univ Nottingham, Resp Biomed Res Unit, Div Epidemiol & Publ Hlth, City Hosp, Nottingham NG7 2RD, England; [Lowe, Gordon D. O.] Univ Glasgow, Div Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Clark, Lorna] City Hosp Nottingham, Dept Clin Chem, Nottingham, England	Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham; University of Glasgow; Nottingham University Hospital NHS Trust; Nottingham City Hospital	Fogarty, AW (corresponding author), Univ Nottingham, Resp Biomed Res Unit, Div Epidemiol & Publ Hlth, City Hosp, Clin Sci Bldg, Nottingham NG7 2RD, England.	andrew.fogarty@nottingham.ac.uk		McKeever, Tricia/0000-0003-0914-0416	Asthma UK; British Lung Foundation [07/03]	Asthma UK; British Lung Foundation	This work was supported by Asthma UK (http://www.asthma.org.uk/) and the British Lung Foundation (Grant 07/03) (http://www.lunguk.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson D, 2006, AM J RESP CRIT CARE, V174, P626, DOI 10.1164/rccm.200602-243OC; Barnes PJ, 2000, NEW ENGL J MED, V343, P269, DOI 10.1056/NEJM200007273430407; Begbie ME, 2003, POSTGRAD MED J, V79, P18, DOI 10.1136/pmj.79.927.18; BRITTON J, 1994, LANCET, V344, P357, DOI 10.1016/S0140-6736(94)91399-4; Calderon-Garciduenas L, 2001, TOXICOL SCI, V61, P342, DOI 10.1093/toxsci/61.2.342; Dahl M, 2001, AM J RESP CRIT CARE, V164, P1008, DOI 10.1164/ajrccm.164.6.2010067; Danesh J, 2001, CIRCULATION, V103, P2323; Danesh J, 2005, JAMA-J AM MED ASSOC, V294, P1799, DOI 10.1001/jama.294.14.1799; Fletcher C, 1976, NATURAL HIST CHRONIC, P70; Fogarty AW, 2007, THORAX, V62, P515, DOI 10.1136/thx.2006.066969; Gauderman WJ, 2004, NEW ENGL J MED, V351, P1057, DOI 10.1056/NEJMoa040610; Jiang R, 2008, AM J EPIDEMIOL, V168, P602, DOI 10.1093/aje/kwn174; Juul K, 2005, ARCH INTERN MED, V165, P2032, DOI 10.1001/archinte.165.17.2032; Kony S, 2004, THORAX, V59, P892, DOI 10.1136/thx.2003.015768; Lowe GDO, 2004, ARTERIOSCL THROM VAS, V24, P1957, DOI 10.1161/01.ATV.0000141842.27810.a9; McKeever TM, 2002, AM J RESP CRIT CARE, V165, P1299, DOI 10.1164/rccm.2109030; SEATON A, 1995, LANCET, V345, P176, DOI 10.1016/S0140-6736(95)90173-6; Sin DD, 2005, CHEST, V127, P1952, DOI 10.1378/chest.127.6.1952; Thyagarajan B, 2006, INT J EPIDEMIOL, V35, P1001, DOI 10.1093/ije/dyl049; Torres-Duque Carlos, 2008, Proc Am Thorac Soc, V5, P577, DOI 10.1513/pats.200707-100RP; Tuder RM, 2007, AM J RESP CELL MOL, V37, P130, DOI 10.1165/rcmb.2007-0163TR; WELLS PS, 1995, CIRCULATION, V91, P2184, DOI 10.1161/01.CIR.91.8.2184	22	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e15014	10.1371/journal.pone.0015014	http://dx.doi.org/10.1371/journal.pone.0015014			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103357	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000284257400021
J	Ledevin, R; Quere, JP; Renaud, S				Ledevin, Ronan; Quere, Jean-Pierre; Renaud, Sabrina			Morphometrics as an Insight Into Processes Beyond Tooth Shape Variation in a Bank Vole Population	PLOS ONE			English	Article							DEVELOPMENTAL CONSTRAINTS; MAMMALIAN TEETH; BODY-SIZE; EVOLUTION; PATTERNS; PHYLOGENY; RADIATION; RODENTIA; HABITAT; HISTORY	Phenotype variation is a key feature in evolution, being produced by development and the target of the screening by selection. We focus here on a variable morphological feature: the third upper molar (UM3) of the bank vole, aiming at identifying the sources of this variation. Size and shape of the UM3 occlusal surface was quantified in successive samples of a bank vole population. The first source of variation was the season of trapping, due to differences in the age structure of the population in turn affecting the wear of the teeth. The second direction of variation corresponded to the occurrence, or not, of an additional triangle on the tooth. This intra-specific variation was attributed to the space available at the posterior end of the UM3, allowing or not the addition of a further triangle. This size variation triggering the shape polymorphism is not controlled by the developmental cascade along the molar row. This suggests that other sources of size variation, possibly epigenetic, might be involved. They would trigger an important shape variation as side-effect by affecting the termination of the sequential addition of triangles on the tooth.	[Ledevin, Ronan; Renaud, Sabrina] Univ Lyon 1, CNRS, UMR 5125, F-69622 Villeurbanne, France; [Quere, Jean-Pierre] INRA, UMR CBGP 1064, Montferrier Sur Lez, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; INRAE; Institut de Recherche pour le Developpement (IRD)	Ledevin, R (corresponding author), Univ Lyon 1, CNRS, UMR 5125, F-69622 Villeurbanne, France.	ronan.ledevin@pepsmail.univ-lyon1.fr	Renaud, Sabrina/AAV-3141-2020; Renaud, Sabrina/D-4247-2009	Renaud, Sabrina/0000-0002-8730-3113; Renaud, Sabrina/0000-0002-8730-3113	ANR; Rhone-Alpes Emergence	ANR(French National Research Agency (ANR)); Rhone-Alpes Emergence(Region Auvergne-Rhone-Alpes)	This study has been supported by the ANR "Quenottes" and the program Rhone-Alpes Emergence. Altai samples were collected in the framework of the French-Chinese Programme of Advanced Research: Pra E95-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUCHAU V, 1987, MAMMALIA, V51, P588; Beldade P, 2002, NATURE, V416, P844, DOI 10.1038/416844a; Chaline J, 1999, ANN ZOOL FENN, V36, P239; Contoli Longino, 1993, Hystrix, V4, P1; COWLEY DE, 1989, GENETICS, V122, P193; CRAMPTON JS, 1995, LETHAIA, V28, P179, DOI 10.1111/j.1502-3931.1995.tb01611.x; Deffontaine V, 2005, MOL ECOL, V14, P1727, DOI 10.1111/j.1365-294X.2005.02506.x; Dempsey PJ, 2001, HEREDITY, V86, P685, DOI 10.1046/j.1365-2540.2001.00878.x; FERSON S, 1985, SYST ZOOL, V34, P59, DOI 10.2307/2413345; GARN SM, 1979, AM J PHYS ANTHROPOL, V51, P665, DOI 10.1002/ajpa.1330510416; GIRAUDOUX P, 1994, ACTA OECOL, V15, P385; Giraudoux P, 2008, MAMMALIA, V72, P309, DOI 10.1515/MAMM.2008.048; Guerecheau A, 2010, MAMM BIOL, V75, P311, DOI 10.1016/j.mambio.2009.03.013; GUTHRIE R D, 1971, Zeitschrift fuer Saeugetierkunde, V36, P37; JEANNET M, 1978, B MENS SOC LINN LYON, V5, P206; Jernvall J, 2000, P NATL ACAD SCI USA, V97, P2641, DOI 10.1073/pnas.050586297; Jernvall J, 2000, P NATL ACAD SCI USA, V97, P14444, DOI 10.1073/pnas.97.26.14444; Kaneko Y, 1998, RES POPUL ECOL, V40, P21, DOI 10.1007/BF02765219; Kassai Y, 2005, SCIENCE, V309, P2067, DOI 10.1126/science.1116848; Kavanagh KD, 2007, NATURE, V449, P427, DOI 10.1038/nature06153; Koskela E, 1998, OECOLOGIA, V115, P379, DOI 10.1007/s004420050531; KOZAKIEWICZ M, 1976, Acta Theriologica, V21, P314; KUHL FP, 1982, COMPUT VISION GRAPH, V18, P236, DOI 10.1016/0146-664X(82)90034-X; Laffont R, 2009, EVOL DEV, V11, P302, DOI 10.1111/j.1525-142X.2009.00332.x; Ledevin R, 2010, BIOL J LINN SOC, V100, P681, DOI 10.1111/j.1095-8312.2010.01445.x; LIENARD E, 2003, CONTRIBUTION ETUDE C, P1; Markova E, 2010, J MAMM EVOL, V17, P121, DOI 10.1007/s10914-009-9128-8; MATSON CW, 2001, MOL BIOL EVOL, V18, P23; Natsume A, 2008, ARCH ORAL BIOL, V53, P95, DOI 10.1016/j.archoralbio.2007.07.013; Navarro N, 2004, BIOL J LINN SOC, V83, P243, DOI 10.1111/j.1095-8312.2004.00385.x; Oksanen TA, 2007, EVOLUTION, V61, P2822, DOI 10.1111/j.1558-5646.2007.00245.x; Pantalacci S, 2009, EVOL DEV, V11, P422, DOI 10.1111/j.1525-142X.2009.00348.x; Polly PD, 2007, NATURE, V449, P413, DOI 10.1038/449413a; Renaud S, 2005, MAMM BIOL, V70, P157, DOI 10.1016/j.mambio.2004.10.004; Renaud S, 1996, PALEOBIOLOGY, V22, P255, DOI 10.1017/S0094837300016201; Renaud S, 2007, ZOOL SCR, V36, P525, DOI 10.1111/j.1463-6409.2007.00297.x; Renaud S, 2009, EVOL DEV, V11, P590, DOI 10.1111/j.1525-142X.2009.00365.x; Renvoise E, 2009, EVOLUTION, V63, P1327, DOI 10.1111/j.1558-5646.2009.00639.x; ROHLF FJ, 1984, SYST ZOOL, V33, P302, DOI 10.2307/2413076; Rohlf FJ., 1990, P MICH MORPH WORKSH, P169; Salazar-Ciudad I, 2004, EVOL DEV, V6, P6, DOI 10.1111/j.1525-142X.2004.04002.x; Salazar-Ciudad I, 2002, P NATL ACAD SCI USA, V99, P8116, DOI 10.1073/pnas.132069499; Schluter D, 1996, EVOLUTION, V50, P1766, DOI 10.1111/j.1558-5646.1996.tb03563.x; Steppan SJ, 2005, MOL PHYLOGENET EVOL, V37, P370, DOI 10.1016/j.ympev.2005.04.016; Tkadlec E, 1998, EVOL ECOL, V12, P191, DOI 10.1023/A:1006583713042	45	20	21	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e15470	10.1371/journal.pone.0015470	http://dx.doi.org/10.1371/journal.pone.0015470			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085584	Green Published, gold, Green Submitted			2022-12-25	WOS:000284231800034
J	Weber, KP; De, S; Kozarewa, I; Turner, DJ; Babu, MM; de Bono, M				Weber, Katherine P.; De, Subhajyoti; Kozarewa, Iwanka; Turner, Daniel J.; Babu, M. Madan; de Bono, Mario			Whole Genome Sequencing Highlights Genetic Changes Associated with Laboratory Domestication of C. elegans	PLOS ONE			English	Article							MUS-MUSCULUS-MUSCULUS; CAENORHABDITIS-ELEGANS; NATURAL VARIATION; HOUSE MICE; WILD; EVOLUTION; BEHAVIOR; OXYGEN; POLYMORPHISM; EXPLORATION	Defining the mutational landscape when individuals of a species grow separately and diverge over many generations can provide insights into trait evolution. A specific example of this involves studying changes associated with domestication where different lines of the same wild stock have been cultivated independently in different standard environments. Whole genome sequence comparison of such lines permits estimation of mutation rates, inference of genes' ancestral states and ancestry of existing strains, and correction of sequencing errors in genome databases. Here we study domestication of the C. elegans Bristol strain as a model, and report the genome sequence of LSJ1 (Bristol), a sibling of the standard C. elegans reference wild type N2 (Bristol). The LSJ1 and N2 lines were cultivated separately from shortly after the Bristol strain was isolated until methods to freeze C. elegans were developed. We find that during this time the two strains have accumulated 1208 genetic differences. We describe phenotypic variation between N2 and LSJ1 in the rate at which embryos develop, the rate of production of eggs, the maturity of eggs at laying, and feeding behavior, all the result of post-isolation changes. We infer the ancestral alleles in the original Bristol isolate and highlight 2038 likely sequencing errors in the original N2 reference genome sequence. Many of these changes modify genome annotation. Our study provides a starting point to further investigate genotype-phenotype association and offers insights into the process of selection as a result of laboratory domestication.	[Weber, Katherine P.; De, Subhajyoti; Babu, M. Madan; de Bono, Mario] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Kozarewa, Iwanka; Turner, Daniel J.] Wellcome Trust Sanger Inst, Hinxton, England	MRC Laboratory Molecular Biology; Wellcome Trust Sanger Institute	Weber, KP (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	debono@mrc-lmb.cam.ac.uk	Mohan, Babu P./I-7362-2019	de Bono, Mario/0000-0001-8347-0443	Medical Research Council; Wellcome Trust; Marshall Scholarship; National Science Foundation [2008068356]; MRC [MC_U105185859, MC_U105178786] Funding Source: UKRI; Medical Research Council [MC_U105178786, MC_U105185859] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Marshall Scholarship; National Science Foundation(National Science Foundation (NSF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council (http://www.mrc.ac.uk/index.htm) and the Wellcome Trust (http://www.wellcome.ac.uk/). K. Weber was supported by a Marshall Scholarship (http://www.marshallscholarship.org/) and a National Science Foundation Graduate Fellowship (Fellow ID: 2008068356; http://www.nsf.gov/funding/pgm_summ.jsp?pims_id = 6201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustsson H, 2004, PHYSIOL BEHAV, V81, P685, DOI 10.1016/j.physbeh.2004.03.014; Bridges CB., 1944, MUTANTS DROSOPHILA M; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Cheung BHH, 2005, CURR BIOL, V15, P905, DOI 10.1016/j.cub.2005.04.017; Cutter AD, 2006, GENETICS, V172, P171, DOI 10.1534/genetics.105.048207; Darwin Charles R, 1875, VARIATION ANIMALS PL, Vsecond; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; Denver DR, 2009, P NATL ACAD SCI USA, V106, P16310, DOI 10.1073/pnas.0904895106; Denver DR, 2003, MOL BIOL EVOL, V20, P393, DOI 10.1093/molbev/msg044; Devlin RH, 2009, P NATL ACAD SCI USA, V106, P3047, DOI 10.1073/pnas.0809798106; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; DOHM MR, 1994, AM J PHYSIOL-REG I, V267, pR1098, DOI 10.1152/ajpregu.1994.267.4.R1098; Fernandes C, 2004, BEHAV GENET, V34, P621, DOI 10.1007/s10519-004-5589-y; Flint J, 2003, J NEUROBIOL, V54, P46, DOI 10.1002/neu.10161; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Gutteling EW, 2007, HEREDITY, V98, P28, DOI 10.1038/sj.hdy.6800894; HANSEN LE, 1960, NEMATOLOGICA, V5, P27; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; Koch R, 2000, GENOME RES, V10, P1690, DOI 10.1101/gr.GR-1471R; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lindsley D.L., 1968, GENETIC VARIATIONS D; Mackay TFC, 2010, PHILOS T R SOC B, V365, P1229, DOI 10.1098/rstb.2009.0315; McGrath PT, 2009, NEURON, V61, P692, DOI 10.1016/j.neuron.2009.02.012; Milloz J, 2008, GENE DEV, V22, P3064, DOI 10.1101/gad.495308; NICHOLAS WL, 1959, ANN NY ACAD SCI, V77, P218, DOI 10.1111/j.1749-6632.1959.tb36902.x; Persson A, 2009, NATURE, V458, P1030, DOI 10.1038/nature07820; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Rockman MV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000419; Rogers C, 2006, CURR BIOL, V16, P649, DOI 10.1016/j.cub.2006.03.023; Rogers C, 2003, NAT NEUROSCI, V6, P1178, DOI 10.1038/nn1140; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Ruebenbauer A, 2008, CURR BIOL, V18, P1438, DOI 10.1016/j.cub.2008.08.062; Sarin S, 2008, NAT METHODS, V5, P865, DOI 10.1038/NMETH.1249; Seidel HS, 2008, SCIENCE, V319, P589, DOI 10.1126/science.1151107; Silver L.M., 1995, MOUSE GENETICS CONCE; Sulston JHJ, 1988, NEMATODE CAENORHABDI; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Witherspoon DJ, 2003, J MOL EVOL, V56, P751, DOI 10.1007/s00239-002-2450-x; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394	41	59	59	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e13922	10.1371/journal.pone.0013922	http://dx.doi.org/10.1371/journal.pone.0013922			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21085631	gold, Green Published			2022-12-25	WOS:000284087800005
J	Bostrom, BL; Jones, TT; Hastings, M; Jones, DR				Bostrom, Brian L.; Jones, T. Todd; Hastings, Mervin; Jones, David R.			Behaviour and Physiology: The Thermal Strategy of Leatherback Turtles	PLOS ONE			English	Article							SEA-TURTLES; TEMPERATURES; ENDOTHERMY; EVOLUTION; ECOLOGY; NICHE	Background: Adult leatherback turtles (Dermochelys coriacea) exhibit thermal gradients between their bodies and the environment of >= 8 degrees C in sub-polar waters and <= 4 degrees C in the tropics. There has been no direct evidence for thermoregulation in leatherbacks although modelling and morphological studies have given an indication of how thermoregulation may be achieved. Methodology/Principal Findings: We show for the first time that leatherbacks are indeed capable of thermoregulation from studies on juvenile leatherbacks of 16 and 37 kg. In cold water (< 25 degrees C), flipper stroke frequency increased, heat loss through the plastron, carapace and flippers was minimized, and a positive thermal gradient of up to 2.3 degrees C was maintained between body and environment. In warm water (25 - 31 degrees C), turtles were inactive and heat loss through their plastron, carapace and flippers increased. The thermal gradient was minimized (0.5 degrees C). Using a scaling model, we estimate that a 300 kg adult leatherback is able to maintain a maximum thermal gradient of 18.2 degrees C in cold sub-polar waters. Conclusions/Significance: In juvenile leatherbacks, heat gain is controlled behaviourally by increasing activity while heat flux is regulated physiologically, presumably by regulation of blood flow distribution. Hence, harnessing physiology and behaviour allows leatherbacks to keep warm while foraging in cold sub-polar waters and to prevent overheating in a tropical environment.	[Bostrom, Brian L.; Jones, T. Todd; Jones, David R.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Jones, T. Todd] Univ Hawaii Manoa, Joint Inst Marine & Atmospher Res, Natl Ocean & Atmospher Adm, Kewalo Res Facil, Honolulu, HI 96822 USA	University of British Columbia; National Oceanic Atmospheric Admin (NOAA) - USA; University of Hawaii System; University of Hawaii Manoa	Bostrom, BL (corresponding author), Univ British Columbia, Dept Zool, Vancouver, BC, Canada.	bbostrom@interchange.ubc.ca			NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a NSERC Discovery Grant to David R. Jones (http://www.nserc-crsng.gc.ca/). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angilletta MJ, 2002, J THERM BIOL, V27, P249, DOI 10.1016/S0306-4565(01)00094-8; Bernal D, 2001, COMP BIOCHEM PHYS A, V129, P695, DOI 10.1016/S1095-6433(01)00333-6; BLOCK BA, 1993, SCIENCE, V260, P210, DOI 10.1126/science.8469974; Bostrom BL, 2007, COMP BIOCHEM PHYS A, V147, P323, DOI 10.1016/j.cbpa.2006.10.032; BRETT JR, 1971, AM ZOOL, V11, P99; Davenport J, 2009, J EXP BIOL, V212, P2753, DOI 10.1242/jeb.026500; Eckert SA, 2002, J EXP BIOL, V205, P3689; GOFF PG, 1988, COPEIA, V4, P1071; GREER AE, 1973, NATURE, V244, P181, DOI 10.1038/244181a0; Hawkes LA, 2007, DIVERS DISTRIB, V13, P447, DOI 10.1111/j.1472-4642.2007.00354.x; HEATH ME, 1980, COPEIA, P767; Hochscheid S, 2002, PHYSIOL BIOCHEM ZOOL, V75, P66, DOI 10.1086/339050; HUEY RB, 1979, AM ZOOL, V19, P357; HUTCHISON VH, 1979, AM ZOOL, V19, P367; James MC, 2004, CAN J ZOOL, V82, P1302, DOI 10.1139/z04-110; James MC, 2005, ECOL LETT, V8, P195, DOI 10.1111/j.1461-0248.2004.00710.x; James MC, 2006, J EXP MAR BIOL ECOL, V335, P221, DOI 10.1016/j.jembe.2006.03.013; Kvadsheim PH, 1996, J THERM BIOL, V21, P123, DOI 10.1016/0306-4565(95)00034-8; Moon DY, 1997, J EXP ZOOL, V278, P372; PALADINO FV, 1990, NATURE, V344, P858, DOI 10.1038/344858a0; SATO K, 1994, MAR BIOL, V118, P343, DOI 10.1007/BF00349802; Southwood AL, 2005, PHYSIOL BIOCHEM ZOOL, V78, P285, DOI 10.1086/427048; STANDORA EA, 1982, J THERM BIOL, V7, P159, DOI 10.1016/0306-4565(82)90006-7; Wallace BP, 2008, J EXP MAR BIOL ECOL, V356, P8, DOI 10.1016/j.jembe.2007.12.023	24	41	41	2	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e13925	10.1371/journal.pone.0013925	http://dx.doi.org/10.1371/journal.pone.0013925			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085716	Green Published, gold			2022-12-25	WOS:000284036800016
J	Okello, JBA; Rodriguez, L; Poinar, D; Bos, K; Okwi, AL; Bimenya, GS; Sewankambo, NK; Henry, KR; Kuch, M; Poinar, HN				Okello, John B. A.; Rodriguez, Linda; Poinar, Debi; Bos, Kirsten; Okwi, Andrew L.; Bimenya, Gabriel S.; Sewankambo, Nelson K.; Henry, Kenneth R.; Kuch, Melanie; Poinar, Hendrik N.			Quantitative Assessment of the Sensitivity of Various Commercial Reverse Transcriptases Based on Armored HIV RNA	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; VIRUS TYPE-1 RNA; RT-PCR; GENE-EXPRESSION; MESSENGER-RNA; VIRAL-RNA; INHIBITION; ASSAY; CDNA; DNA	Background: The in-vitro reverse transcription of RNA to its complementary DNA, catalyzed by the enzyme reverse transcriptase, is the most fundamental step in the quantitative RNA detection in genomic studies. As such, this step should be as analytically sensitive, efficient and reproducible as possible, especially when dealing with degraded or low copy RNA samples. While there are many reverse transcriptases in the market, all claiming to be highly sensitive, there is need for a systematic independent comparison of their applicability in quantification of rare RNA transcripts or low copy RNA, such as those obtained from archival tissues. Methodology/Principal Findings: We performed RT-qPCR to assess the sensitivity and reproducibility of 11 commercially available reverse transcriptases in cDNA synthesis from low copy number RNA levels. As target RNA, we used a serially known number of Armored HIV-RNA molecules, and observed that 9 enzymes we tested were consistently sensitive to similar to 1000 copies, seven of which were sensitive to similar to 100 copies, while only 5 were sensitive to similar to 10 RNA template copies across all replicates tested. Despite their demonstrated sensitivity, these five best performing enzymes (Accuscript, HIV-RT, M-MLV, Superscript III and Thermoscript) showed considerable variation in their reproducibility as well as their overall amplification efficiency. Accuscript and Superscript III were the most sensitive and consistent within runs, with Accuscript and Superscript II ranking as the most reproducible enzymes between assays. Conclusions/Significance: We therefore recommend the use of Accuscript or Superscript III when dealing with low copy number RNA levels, and suggest purification of the RT reactions prior to downstream applications (eg-qPCR) to augment detection. Although the results presented in this study were based on a viral RNA surrogate, and applied to nucleic acid lysates derived from archival formalin-fixed paraffin embedded tissue, their relative performance on RNA obtained from other tissue types may vary, and needs future evaluation.	[Okello, John B. A.; Rodriguez, Linda; Poinar, Debi; Bos, Kirsten; Kuch, Melanie; Poinar, Hendrik N.] McMaster Univ, Dept Anthropol, McMaster Ancient DNA Ctr, Hamilton, ON, Canada; [Okwi, Andrew L.; Bimenya, Gabriel S.] Makerere Univ, Coll Hlth Sci, Sch Biomed Sci, Dept Pathol, Kampala, Uganda; [Sewankambo, Nelson K.] Makerere Univ, Coll Hlth Sci, Off Principal, Kampala, Uganda; [Henry, Kenneth R.] Case Western Reserve Univ, Div Infect Dis, Cleveland, OH 44106 USA; [Poinar, Hendrik N.] McMaster Univ, Michael DeGroote Inst Infect Dis Res, Hamilton, ON, Canada; [Poinar, Hendrik N.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada	McMaster University; Makerere University; Makerere University; Case Western Reserve University; McMaster University; McMaster University	Okello, JBA (corresponding author), McMaster Univ, Dept Anthropol, McMaster Ancient DNA Ctr, Hamilton, ON, Canada.	jokello@mcmaster.ca; poinarh@mcmaster.ca	Okello, John B A/B-5157-2018	Okello, John B A/0000-0002-5889-1905; Sewankambo, Nelson/0000-0001-9362-053X	Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This study was funded by the Canadian Institutes of Health Research (CIHR, to HNP). The funders, however, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AREZI B, 2006, STRATEGIES STRATAGEN, V19, P52; Arezi B, 2010, ANAL BIOCHEM, V400, P301, DOI 10.1016/j.ab.2010.01.024; BarraganGonzalez E, 1997, CLIN CHIM ACTA, V260, P73, DOI 10.1016/S0009-8981(96)06509-6; BUSTIN S, 2004, J BIOMOL TECH, V153, P155; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chandler DP, 1998, APPL ENVIRON MICROB, V64, P669; CHUMAKOV KM, 1994, PCR METH APPL, V4, P62; Cikos S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-113; Cottam EM, 2009, VIRUS RES, V140, P199, DOI 10.1016/j.virusres.2008.10.012; Deprez RHL, 2002, ANAL BIOCHEM, V307, P63, DOI 10.1016/S0003-2697(02)00021-0; FEHLMANN C, 1993, CLIN CHEM, V39, P368; Gal AB, 2006, REPROD FERT DEVELOP, V18, P365, DOI 10.1071/RD05012; Henning TR, 2009, J CLIN VIROL, V46, P309, DOI 10.1016/j.jcv.2009.08.015; Hietala SK, 2006, J CLIN MICROBIOL, V44, P67, DOI 10.1128/JCM.44.1.67-70.2006; Jefferies D, 2002, ANAL BIOCHEM, V308, P192, DOI 10.1016/S0003-2697(02)00204-X; Karlen Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-131; KARRER EE, 1995, P NATL ACAD SCI USA, V92, P3814, DOI 10.1073/pnas.92.9.3814; Kawasaki ES, 1990, PCR PROTOCOLS GUIDE; Kermekchiev MB, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1055; King CE, 2009, BIOTECHNIQUES, V47, P941, DOI 10.2144/000113244; Levesque-Sergerie JP, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-93; McKinney MD, 2009, J CLIN VIROL, V44, P39, DOI 10.1016/j.jcv.2008.09.003; MULDER J, 1994, J CLIN MICROBIOL, V32, P292, DOI 10.1128/JCM.32.2.292-300.1994; Okello JBA, 2010, ANAL BIOCHEM, V400, P110, DOI 10.1016/j.ab.2010.01.014; Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003; Pasloske BL, 1998, J CLIN MICROBIOL, V36, P3590, DOI 10.1128/JCM.36.12.3590-3594.1998; Pfaffl M. W., 2004, QUANTIFICATION STRAT; R Development Core Team, 2010, R VERS 2 11 1 LANG E; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Schwarz C, 2009, NUCLEIC ACIDS RES, V37, P3215, DOI 10.1093/nar/gkp159; SELLNER LN, 1992, NUCLEIC ACIDS RES, V20, P1487, DOI 10.1093/nar/20.7.1487; Sieber MW, 2010, ANAL BIOCHEM, V401, P303, DOI 10.1016/j.ab.2010.03.007; Stahlberg A, 2004, CLIN CHEM, V50, P1678, DOI 10.1373/clinchem.2004.035469; Stahlberg A, 2003, CLIN CHEM, V49, P51, DOI 10.1373/49.1.51; Stangegaard M, 2006, BIOTECHNIQUES, V40, P649, DOI 10.2144/000112153; Suslov O, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni176; Taniguchi K, 2009, NAT METHODS, V6, P503, DOI 10.1038/nmeth.1338; VERMA IM, 1977, BIOCHIM BIOPHYS ACTA, V473, P1, DOI 10.1016/0304-419X(77)90005-1; WalkerPeach CR, 1999, CLIN CHEM, V45, P2079; Wilson IG, 1997, APPL ENVIRON MICROB, V63, P3741, DOI 10.1128/AEM.63.10.3741-3751.1997; Wittwer CT., 2004, MOL MICROBIOLOGY DIA, P71; Wong L, 1998, BIOTECHNOL TECH, V12, P485, DOI 10.1023/A:1008871608947	45	23	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e13931	10.1371/journal.pone.0013931	http://dx.doi.org/10.1371/journal.pone.0013931			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085668	Green Published, gold			2022-12-25	WOS:000284036800022
J	Amin, AD; Chaix, ABH; Mason, RP; Badge, RM; Borts, RH				Amin, Amit Dipak; Chaix, Alexandre B. H.; Mason, Robert P.; Badge, Richard M.; Borts, Rhona H.			The Roles of the Saccharomyces cerevisiae RecQ Helicase SGS1 in Meiotic Genome Surveillance	PLOS ONE			English	Article							MISMATCH REPAIR PROTEINS; DNA TOPOISOMERASE-III; DOUBLE-STRAND BREAKS; WERNERS-SYNDROME GENES; HOMEOLOGOUS RECOMBINATION; CROSSING-OVER; HOMOLOGOUS RECOMBINATION; HETERODUPLEX REJECTION; SALMONELLA-TYPHIMURIUM; MULTIPLE PATHWAYS	Background: The Saccharomyces cerevisiae RecQ helicase Sgs1 is essential for mitotic and meiotic genome stability. The stage at which Sgs1 acts during meiosis is subject to debate. Cytological experiments showed that a deletion of SGS1 leads to an increase in synapsis initiation complexes and axial associations leading to the proposal that it has an early role in unwinding surplus strand invasion events. Physical studies of recombination intermediates implicate it in the dissolution of double Holliday junctions between sister chromatids. Methodology/Principal Findings: In this work, we observed an increase in meiotic recombination between diverged sequences (homeologous recombination) and an increase in unequal sister chromatid events when SGS1 is deleted. The first of these observations is most consistent with an early role of Sgs1 in unwinding inappropriate strand invasion events while the second is consistent with unwinding or dissolution of recombination intermediates in an Mlh1- and Top3-dependent manner. We also provide data that suggest that Sgs1 is involved in the rejection of 'second strand capture' when sequence divergence is present. Finally, we have identified a novel class of tetrads where non-sister spores (pairs of spores where each contains a centromere marker from a different parent) are inviable. We propose a model for this unusual pattern of viability based on the inability of sgs1 mutants to untangle intertwined chromosomes. Our data suggest that this role of Sgs1 is not dependent on its interaction with Top3. We propose that in the absence of SGS1 chromosomes may sometimes remain entangled at the end of pre-meiotic replication. This, combined with reciprocal crossing over, could lead to physical destruction of the recombined and entangled chromosomes. We hypothesise that Sgs1, acting in concert with the topoisomerase Top2, resolves these structures. Conclusions: This work provides evidence that Sgs1 interacts with various partner proteins to maintain genome stability throughout meiosis.	[Amin, Amit Dipak; Chaix, Alexandre B. H.; Mason, Robert P.; Badge, Richard M.; Borts, Rhona H.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England	University of Leicester	Amin, AD (corresponding author), Univ Leicester, Dept Genet, Univ Rd, Leicester LE1 7RH, Leics, England.	rhb7@le.ac.uk		Amin, Amit Dipak/0000-0002-2613-2082; Badge, Richard/0000-0003-3201-336X	Royal Society; Cancer Research UK	Royal Society(Royal Society of London); Cancer Research UK(Cancer Research UK)	This work was supported by the Royal Society http://royalsociety.org/ and Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah MFF, 2001, P NATL ACAD SCI USA, V98, P14524, DOI 10.1073/pnas.201529598; Bachrati CZ, 2008, CHROMOSOMA, V117, P219, DOI 10.1007/s00412-007-0142-4; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett RJ, 2000, J BIOL CHEM, V275, P26898; Bennett RJ, 1998, J BIOL CHEM, V273, P9644, DOI 10.1074/jbc.273.16.9644; Bennett RJ, 2001, P NATL ACAD SCI USA, V98, P11108, DOI 10.1073/pnas.201387098; Bernstein KA, 2009, EMBO J, V28, P915, DOI 10.1038/emboj.2009.28; Bishop DK, 2004, CELL, V117, P9, DOI 10.1016/S0092-8674(04)00297-1; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; BRITTEN RJ, 1988, P NATL ACAD SCI USA, V85, P4770, DOI 10.1073/pnas.85.13.4770; Cejka Petr, 2010, J Biol Chem, V285, P8290, DOI 10.1074/jbc.M109.083196; Chakraverty RK, 2001, MOL CELL BIOL, V21, P7150, DOI 10.1128/MCB.21.21.7150-7162.2001; Chambers SR, 1996, MOL CELL BIOL, V16, P6110; CHAMBERS SR, 1999, THESIS U OXFORD; Chang M, 2005, EMBO J, V24, P2024, DOI 10.1038/sj.emboj.7600684; Chen WL, 1999, GENETICS, V151, P1299; Chen WL, 1998, MOL CELL BIOL, V18, P6525, DOI 10.1128/MCB.18.11.6525; Coghlan A, 2005, TRENDS GENET, V21, P673, DOI 10.1016/j.tig.2005.09.009; Cotton VE, 2009, METHODS MOL BIOL, V557, P3, DOI 10.1007/978-1-59745-527-5_1; Dherin C, 2009, MOL CELL BIOL, V29, P907, DOI 10.1128/MCB.00945-08; Duno M, 2000, MOL GEN GENET, V264, P89, DOI 10.1007/s004380000286; EGEL R, 1978, HEREDITY, V41, P233, DOI 10.1038/hdy.1978.92; Frei C, 2000, GENE DEV, V14, P81; Fricke WM, 2001, J BIOL CHEM, V276, P8848, DOI 10.1074/jbc.M009719200; Gangloff S, 2000, NAT GENET, V25, P192, DOI 10.1038/76055; GANGLOFF S, 1994, MOL CELL BIOL, V14, P8391, DOI 10.1128/MCB.14.12.8391; Gellon L, 2002, J BIOL CHEM, V277, P29963, DOI 10.1074/jbc.M202963200; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Goldfarb T, 2005, GENETICS, V169, P563, DOI 10.1534/genetics.104.035204; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; HOLM C, 1994, CELL, V77, P955, DOI 10.1016/0092-8674(94)90433-2; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Hunter N, 1996, EMBO J, V15, P1726, DOI 10.1002/j.1460-2075.1996.tb00518.x; Hunter N, 1997, GENE DEV, V11, P1573, DOI 10.1101/gad.11.12.1573; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Jessop L, 2008, MOL CELL, V31, P313, DOI 10.1016/j.molcel.2008.05.021; Jessop L, 2006, PLOS GENET, V2, P1402, DOI 10.1371/journal.pgen.0020155; Karow JK, 2000, P NATL ACAD SCI USA, V97, P6504, DOI 10.1073/pnas.100448097; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; LOUIS EJ, 1990, GENETICS, V124, P533; Lu JA, 1996, NATURE, V383, P678, DOI 10.1038/383678a0; Mankouri HW, 2006, MOL BIOL CELL, V17, P4473, DOI 10.1091/mbc.E06-06-0516; Miyajima A, 2000, MOL CELL BIOL, V20, P6399, DOI 10.1128/MCB.20.17.6399-6409.2000; Miyajima A, 2000, GENES GENET SYST, V75, P319, DOI 10.1266/ggs.75.319; Mullen JR, 2005, MOL CELL BIOL, V25, P4476, DOI 10.1128/MCB.25.11.4476-4487.2005; Mullen JR, 2000, GENETICS, V154, P1101; Myung K, 2001, NATURE, V411, P1073, DOI 10.1038/35082608; Myung K, 2001, NAT GENET, V27, P113, DOI 10.1038/83673; Nicholson A, 2000, GENETICS, V154, P133; Oh SD, 2008, MOL CELL, V31, P324, DOI 10.1016/j.molcel.2008.07.006; Oh SD, 2007, CELL, V130, P259, DOI 10.1016/j.cell.2007.05.035; Onoda F, 2000, MUTAT RES-DNA REPAIR, V459, P203, DOI 10.1016/S0921-8777(99)00071-3; Onoda F, 2001, MOL GEN GENET, V264, P702, DOI 10.1007/s004380000358; Ouyang KJ, 2008, MECH AGEING DEV, V129, P425, DOI 10.1016/j.mad.2008.03.003; Page SL, 2003, SCIENCE, V301, P785, DOI 10.1126/science.1086605; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Pedrazzi G, 2003, BIOL CHEM, V384, P1155, DOI 10.1515/BC.2003.128; PERKINS DD, 1949, GENETICS, V34, P607; Putnam CD, 2009, NATURE, V460, P984, DOI 10.1038/nature08217; RADMAN M, 1989, GENOME, V31, P68, DOI 10.1139/g89-014; RAYSSIGUIER C, 1989, NATURE, V342, P396, DOI 10.1038/342396a0; Rieseberg LH, 2003, SCIENCE, V301, P1211, DOI 10.1126/science.1086949; Rockmill B, 2003, CURR BIOL, V13, P1954, DOI 10.1016/j.cub.2003.10.059; Rockmill B, 2006, GENETICS, V174, P1745, DOI 10.1534/genetics.106.058933; Rossetti Liliana C, 2004, Hum Mutat, V24, P440, DOI 10.1002/humu.9288; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; Seki M, 2006, MOL CELL BIOL, V26, P6299, DOI 10.1128/MCB.00702-06; Selva EM, 1997, MOL GEN GENET, V257, P71; SELVA EM, 1995, GENETICS, V139, P1175; Shinohara A, 2004, CYTOGENET GENOME RES, V107, P201, DOI 10.1159/000080598; SINGH DK, 2008, BIOGERONTOLOGY; Spell RM, 2004, GENETICS, V168, P1855, DOI 10.1534/genetics.104.032771; Sugawara N, 2004, P NATL ACAD SCI USA, V101, P9315, DOI 10.1073/pnas.0305749101; SUN H, 1991, CELL, V64, P1155, DOI 10.1016/0092-8674(91)90270-9; Tay Y, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1089; Ui A, 2001, MOL GENET GENOMICS, V265, P837, DOI 10.1007/s004380100479; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wang TF, 2002, BIOCHEM BIOPH RES CO, V296, P949, DOI 10.1016/S0006-291X(02)02034-X; Watt PM, 1996, GENETICS, V144, P935; WATT PM, 1995, CELL, V81, P253, DOI 10.1016/0092-8674(95)90335-6; Weinstein J, 2008, DNA REPAIR, V7, P558, DOI 10.1016/j.dnarep.2007.12.010; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Yamagata K, 1998, P NATL ACAD SCI USA, V95, P8733, DOI 10.1073/pnas.95.15.8733; Zahrt TC, 1997, P NATL ACAD SCI USA, V94, P9786, DOI 10.1073/pnas.94.18.9786	89	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e15380	10.1371/journal.pone.0015380	http://dx.doi.org/10.1371/journal.pone.0015380			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085703	Green Submitted, gold, Green Published			2022-12-25	WOS:000284035900025
J	Murshid, A; Chou, SD; Prince, T; Zhang, Y; Bharti, A; Calderwood, SK				Murshid, Ayesha; Chou, Shiuh-Dih; Prince, Thomas; Zhang, Yue; Bharti, Ajit; Calderwood, Stuart K.			Protein Kinase A Binds and Activates Heat Shock Factor 1	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-I; DNA-BINDING; GENE-TRANSCRIPTION; CYCLIC-AMP; PHOSPHORYLATION; STRESS; CELLS; HSF1; GRANULES; DOMAIN	Background: Many inducible transcription factors are regulated through batteries of posttranslational modifications that couple their activity to inducing stimuli. We have studied such regulation of Heat Shock Factor 1 (HSF1), a key protein in control of the heat shock response, and a participant in carcinogenisis, neurological health and aging. As the mechanisms involved in the intracellular regulation of HSF1 in good health and its dysregulation in disease are still incomplete we are investigating the role of posttranslational modifications in such regulation. Methodology/Principal Findings: In a proteomic study of HSF1 binding partners, we have discovered its association with the pleiotropic protein kinase A (PKA). HSF1 binds avidly to the catalytic subunit of PKA, (PKAc alpha) and becomes phosphorylated on a novel serine phosphorylation site within its central regulatory domain (serine 320 or S320), both in vitro and in vivo. Intracellular PKAc alpha levels and phosphorylation of HSF1 at S320 were both required for HSF1 to be localized to the nucleus, bind to response elements in the promoter of an HSF1 target gene (hsp70.1) and activate hsp70.1 after stress. Reduction in PKAc alpha levels by small hairpin RNA led to HSF1 exclusion from the nucleus, its exodus from the hsp70.1 promoter and decreased hsp70.1 transcription. Likewise, null mutation of HSF1 at S320 by alanine substitution for serine led to an HSF1 species excluded from the nucleus and deficient in hsp70.1 activation. Conclusions: These findings of PKA regulation of HSF1 through S320 phosphorylation add to our knowledge of the signaling networks converging on this factor and may contribute to elucidating its complex roles in the stress response and understanding HSF1 dysregulation in disease.	[Murshid, Ayesha; Chou, Shiuh-Dih; Prince, Thomas; Zhang, Yue; Calderwood, Stuart K.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA; [Bharti, Ajit] Boston Univ, Med Ctr, Stress Response Ctr, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Boston University	Murshid, A (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA.	scalderw@bidmc.harvard.edu		Bharti, Ajit/0000-0001-7972-6688	NIH [2RO1CA047407, RO1CA077465]; Department of Radiation Oncology; Beth Israel Medical Center; NATIONAL CANCER INSTITUTE [R01CA077465, R01CA047407] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Radiation Oncology; Beth Israel Medical Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Studies were supported by NIH research grants 2RO1CA047407 and RO1CA077465. These are peer-reviewed National Institutes of Health RO-1 grants intended to investigate the role of cell signaling in the heat shock/stress response. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.; We thank Fabrice Soncin, Md Abdul Khaleque and Christine Mieck for contributions to developing this project. We thank the Department of Radiation Oncology, Beth Israel Medical Center for support and encouragement.	Anckar J, 2007, BIOCHEM SOC T, V35, P1409, DOI 10.1042/BST0351409; BRUCE JL, 1993, CANCER RES, V53, P12; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; CALDERWOOD SK, 1985, BIOCHEM BIOPH RES CO, V126, P911, DOI 10.1016/0006-291X(85)90272-4; CALDERWOOD SK, 2010, SIGNAL TRANSDUCTION, V3, P13; CALDERWOOD SK, 2009, GERONTOLOGY; Chen CM, 1997, J BIOL CHEM, V272, P26803, DOI 10.1074/jbc.272.43.26803; CHOI HS, 1991, J BIOL CHEM, V266, P11858; Chu BY, 1998, J BIOL CHEM, V273, P18640, DOI 10.1074/jbc.273.29.18640; Chu BY, 1996, J BIOL CHEM, V271, P30847, DOI 10.1074/jbc.271.48.30847; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Dessauer CW, 2009, MOL PHARMACOL, V76, P935, DOI 10.1124/mol.109.059345; GREEN M, 1995, MOL CELL BIOL, V15, P3354; Guettouche Toumy, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-4; He B, 1998, MOL CELL BIOL, V18, P6624, DOI 10.1128/MCB.18.11.6624; HENSOLD JO, 1990, MOL CELL BIOL, V10, P1600, DOI 10.1128/MCB.10.4.1600; Hietakangas V, 2003, MOL CELL BIOL, V23, P2953, DOI 10.1128/MCB.23.8.2953-2968.2003; Holmberg CI, 2000, CELL STRESS CHAPERON, V5, P219, DOI 10.1379/1466-1268(2000)005<0219:FONHGV>2.0.CO;2; Holmberg CI, 2001, EMBO J, V20, P3800, DOI 10.1093/emboj/20.14.3800; KEMP BE, 1975, P NATL ACAD SCI USA, V72, P3448, DOI 10.1073/pnas.72.9.3448; Khaleque M, 2008, ONCOGENE, V27, P1886, DOI 10.1038/sj.onc.1210834; Khaleque MA, 2005, ONCOGENE, V24, P6564, DOI 10.1038/sj.onc.1208798; Kline MP, 1997, MOL CELL BIOL, V17, P2107, DOI 10.1128/MCB.17.4.2107; Knauf U, 1996, GENE DEV, V10, P2782, DOI 10.1101/gad.10.21.2782; Metz A, 2004, J CELL SCI, V117, P4551, DOI 10.1242/jcs.01329; MEZGER V, 1987, DEV BIOL, V124, P544, DOI 10.1016/0012-1606(87)90507-0; Min JN, 2007, ONCOGENE, V26, P5086, DOI 10.1038/sj.onc.1210317; MIVECHI NF, 1995, CANCER RES, V55, P5512; Mosser DD, 2004, ONCOGENE, V23, P2907, DOI 10.1038/sj.onc.1207529; Newton EM, 1996, MOL CELL BIOL, V16, P839; PEARSON RB, 1991, METHOD ENZYMOL A, V200, P62; PRICE BD, 1991, MOL CELL BIOL, V11, P3365, DOI 10.1128/MCB.11.6.3365; RABINDRAN SK, 1991, P NATL ACAD SCI USA, V88, P6906, DOI 10.1073/pnas.88.16.6906; RABINDRAN SK, 1993, SCIENCE, V259, P230, DOI 10.1126/science.8421783; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; SARGE KD, 1991, GENE DEV, V5, P1902, DOI 10.1101/gad.5.10.1902; SHELDON LA, 1993, GENE DEV, V7, P1549, DOI 10.1101/gad.7.8.1549; SORGER PK, 1989, CELL, V59, P807, DOI 10.1016/0092-8674(89)90604-1; SORGER PK, 1988, CELL, V54, P855, DOI 10.1016/S0092-8674(88)91219-6; Takacs-Vellai K, 2007, DEV BIOL, V302, P661, DOI 10.1016/j.ydbio.2006.09.049; Tang D, 2005, CELL STRESS CHAPERON, V10, P46, DOI 10.1379/CSC-44R.1; Tonkiss J, 2005, INT J HYPERTHER, V21, P433, DOI 10.1080/02656730500165514; Vujanac M, 2005, TRAFFIC, V6, P214, DOI 10.1111/j.1600-0854.2005.00266.x; Wang XZ, 2006, J BIOL CHEM, V281, P782, DOI 10.1074/jbc.M505822200; Wang XZ, 2004, J BIOL CHEM, V279, P49460, DOI 10.1074/jbc.M406059200; Wang XZ, 2003, MOL CELL BIOL, V23, P6013, DOI 10.1128/MCB.23.17.6013-6026.2003; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; WESTWOOD T, 1993, MOL CELL BIOL, V13, P3481; WIEDERRECHT G, 1988, CELL, V54, P841, DOI 10.1016/S0092-8674(88)91197-X; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Xavier IJ, 2000, J BIOL CHEM, V275, P29147, DOI 10.1074/jbc.M002169200; Xia WL, 1997, J BIOL CHEM, V272, P4094, DOI 10.1074/jbc.272.7.4094; Xu W, 2007, EMBO J, V26, P2890, DOI 10.1038/sj.emboj.7601734; Yoon C, 2008, J NEUROSCI, V28, P3738, DOI 10.1523/JNEUROSCI.4439-07.2008; ZUO JR, 1994, MOL CELL BIOL, V14, P7557, DOI 10.1128/MCB.14.11.7557; ZUO JR, 1995, MOL CELL BIOL, V15, P4319	56	55	56	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e13830	10.1371/journal.pone.0013830	http://dx.doi.org/10.1371/journal.pone.0013830			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085490	Green Submitted, Green Published, gold			2022-12-25	WOS:000284035900002
J	Borst, JW; Willemse, M; Slijkhuis, R; van der Krogt, G; Laptenok, SP; Jalink, K; Wieringa, B; Fransen, JAM				Borst, Jan Willem; Willemse, Marieke; Slijkhuis, Rik; van der Krogt, Gerard; Laptenok, Sergey P.; Jalink, Kees; Wieringa, Be; Fransen, Jack A. M.			ATP Changes the Fluorescence Lifetime of Cyan Fluorescent Protein via an Interaction with His148	PLOS ONE			English	Article							ENERGY-TRANSFER; VARIANT; FRET; CELL; SPECTROSCOPY; CHROMOPHORE; BINDING; DECAYS	Recently, we described that ATP induces changes in YFP/CFP fluorescence intensities of Fluorescence Resonance Energy Transfer (FRET) sensors based on CFP-YFP. To get insight into this phenomenon, we employed fluorescence lifetime spectroscopy to analyze the influence of ATP on these fluorescent proteins in more detail. Using different donor and acceptor pairs we found that ATP only affected the CFP-YFP based versions. Subsequent analysis of purified monomers of the used proteins showed that ATP has a direct effect on the fluorescence lifetime properties of CFP. Since the fluorescence lifetime analysis of CFP is rather complicated by the existence of different lifetimes, we tested a variant of CFP, i.e. Cerulean, as a monomer and in our FRET constructs. Surprisingly, this CFP variant shows no ATP concentration dependent changes in the fluorescence lifetime. The most important difference between CFP and Cerulean is a histidine residue at position 148. Indeed, changing this histidine in CFP into an aspartic acid results in identical fluorescence properties as observed for the Cerulean fluorescent based FRET sensor. We therefore conclude that the changes in fluorescence lifetime of CFP are affected specifically by possible electrostatic interactions of the negative charge of ATP with the positively charged histidine at position 148. Clearly, further physicochemical characterization is needed to explain the sensitivity of CFP fluorescence properties to changes in environmental (i.e. ATP concentrations) conditions.	[Borst, Jan Willem; Slijkhuis, Rik; Laptenok, Sergey P.] Wageningen Univ, Microspect Ctr, Biochem Lab, Wageningen, Netherlands; [Willemse, Marieke; Wieringa, Be; Fransen, Jack A. M.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Cell Biol, NL-6525 ED Nijmegen, Netherlands; [van der Krogt, Gerard; Jalink, Kees] Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands	Wageningen University & Research; Radboud University Nijmegen; Netherlands Cancer Institute	Borst, JW (corresponding author), Wageningen Univ, Microspect Ctr, Biochem Lab, Wageningen, Netherlands.	j.fransen@ncmls.ru.nl	Borst, Jan Willem/B-1259-2011; Fransen, Jack/E-8924-2010; Wieringa, Berend/A-5346-2011	Fransen, Jack/0000-0002-0571-7639; Wieringa, Berend/0000-0001-9192-8020; Jalink, Kees/0000-0001-7019-3440; Laptenok, Sergey/0000-0002-6468-3010	ZonMw HORIZON [050-71-019]; NKB-KWF [KUN-2004-3125, KUN-2005-3333]	ZonMw HORIZON; NKB-KWF	Funding: This work was supported by ZonMw HORIZON Breakthrough Grant 050-71-019 and NKB-KWF grants KUN-2004-3125 and KUN-2005-3333. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae JH, 2003, J MOL BIOL, V328, P1071, DOI 10.1016/S0022-2836(03)00364-4; Berg J, 2009, NAT METHODS, V6, P161, DOI [10.1038/NMETH.1288, 10.1038/nmeth.1288]; Berg JM, 2002, BIOCHEMISTRY-US, V5th; BOENS N, 1990, PHOTOCHEM PHOTOBIOL, V52, P911, DOI 10.1111/j.1751-1097.1990.tb08702.x; Borst JW, 2008, BIOPHYS J, V95, P5399, DOI 10.1529/biophysj.107.114587; Borst JW, 2005, J FLUORESC, V15, P153, DOI 10.1007/s10895-005-2523-5; Digris AV, 1999, EUR BIOPHYS J BIOPHY, V28, P526, DOI 10.1007/s002490050235; Evers TH, 2006, BIOCHEMISTRY-US, V45, P13183, DOI 10.1021/bi061288t; Goedhart J, 2010, NAT METHODS, V7, P137, DOI [10.1038/nmeth.1415, 10.1038/NMETH.1415]; Grailhe R, 2006, CHEMPHYSCHEM, V7, P1442, DOI 10.1002/cphc.200600057; HO CJ, 1989, CHEM PHYS LETT, V158, P51, DOI 10.1016/0009-2614(89)87292-6; Hoffman J F, 1997, Curr Opin Hematol, V4, P112; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Kim J, 2009, MOL BIOSYST, V5, P151, DOI 10.1039/b815445g; Kneen M, 1998, BIOPHYS J, V74, P1591, DOI 10.1016/S0006-3495(98)77870-1; Kuiper JWP, 2008, PLOS BIOL, V6, P568, DOI 10.1371/journal.pbio.0060051; Malo GD, 2007, BIOCHEMISTRY-US, V46, P9865, DOI 10.1021/bi602664c; Mao LS, 2004, J MOL BIOL, V336, P787, DOI 10.1016/j.jmb.2003.12.056; Pyrkov TV, 2007, PROTEINS, V66, P388, DOI 10.1002/prot.21122; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Seifert MH, 2002, J AM CHEM SOC, V124, P7932, DOI 10.1021/ja0257725; Suhling K, 2005, PHOTOCH PHOTOBIO SCI, V4, P13, DOI 10.1039/b412924p; UEDA T, 1987, EXP CELL RES, V169, P191, DOI 10.1016/0014-4827(87)90237-0; van der Krogt GNM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001916; van Horssen R, 2009, J BIOL CHEM, V284, P1620, DOI 10.1074/jbc.M806974200; Villoing A, 2008, BIOCHEMISTRY-US, V47, P12483, DOI 10.1021/bi801400d; WEISS JN, 1989, J GEN PHYSIOL, V94, P911, DOI 10.1085/jgp.94.5.911; Willemse M, 2007, NAT BIOTECHNOL, V25, P170, DOI 10.1038/nbt0207-170	28	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2010	5	11							e13862	10.1371/journal.pone.0013862	http://dx.doi.org/10.1371/journal.pone.0013862			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675OD	21079777	Green Published, gold			2022-12-25	WOS:000283839100015
J	Hartsperger, ML; Strache, R; Stumpflen, V				Hartsperger, Mara L.; Strache, Robert; Stuempflen, Volker			HiNO: An Approach for Inferring Hierarchical Organization from Regulatory Networks	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATION; ESCHERICHIA-COLI; MOTIFS; CELLS; P53	Background: Gene expression as governed by the interplay of the components of regulatory networks is indeed one of the most complex fundamental processes in biological systems. Although several methods have been published to unravel the hierarchical structure of regulatory networks, weaknesses such as the incorrect or inconsistent assignment of elements to their hierarchical levels, the incapability to cope with cyclic dependencies within the networks or the need for a manual curation to retrieve non-overlapping levels remain unsolved. Methodology/Results: We developed HiNO as a significant improvement of the so-called breadth-first-search (BFS) method. While BFS is capable of determining the overall hierarchical structures from gene regulatory networks, it especially has problems solving feed-forward type of loops leading to conflicts within the level assignments. We resolved these problems by adding a recursive correction approach consisting of two steps. First each vertex is placed on the lowest level that this vertex and its regulating vertices are assigned to (downgrade procedure). Second, vertices are assigned to the next higher level (upgrade procedure) if they have successors with the same level assignment and have themselves no regulators. We evaluated HiNO by comparing it with the BFS method by applying them to the regulatory networks from Saccharomyces cerevisiae and Escherichia coli, respectively. The comparison shows clearly how conflicts in level assignment are resolved in HiNO in order to produce correct hierarchical structures even on the local levels in an automated fashion. Conclusions: We showed that the resolution of conflicting assignments clearly improves the BFS-method. While we restricted our analysis to gene regulatory networks, our approach is suitable to deal with any directed hierarchical networks structure such as the interaction of microRNAs or the action of non-coding RNAs in general. Furthermore we provide a user-friendly web-interface for HiNO that enables the extraction of the hierarchical structure of any directed regulatory network.	[Hartsperger, Mara L.; Strache, Robert; Stuempflen, Volker] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol MIPS, Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Hartsperger, ML (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol MIPS, Neuherberg, Germany.	mara.hartsperger@helmholtz-muenchen.de			Helmholtz Alliance on Systems Biology; Federal Ministry of Education and Research [FKZ: 0315494A]; Graduate School for Information Science in Health (GSISH)	Helmholtz Alliance on Systems Biology; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Graduate School for Information Science in Health (GSISH)	This work was supported by the Helmholtz Alliance on Systems Biology (project 'CoReNe'), the Federal Ministry of Education and Research (project SysMBo, FKZ: 0315494A) and the Graduate School for Information Science in Health (GSISH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Balazsi G, 2005, P NATL ACAD SCI USA, V102, P7841, DOI 10.1073/pnas.0500365102; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Cormen T. H., 2009, INTRO ALGORITHMS, P1312; Hasler J, 2006, NUCLEIC ACIDS RES, V34, P5491, DOI 10.1093/nar/gkl706; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Jothi R, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.52; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Ma HW, 2004, NUCLEIC ACIDS RES, V32, P6643, DOI 10.1093/nar/gkh1009; Ma HW, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-199; Magnusson M, 2007, BLOOD, V109, P3687, DOI 10.1182/blood-2006-10-054676; Oltvai ZN, 2002, SCIENCE, V298, P763, DOI 10.1126/science.1078563; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Ravasz E, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026112; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Yu HY, 2006, P NATL ACAD SCI USA, V103, P14724, DOI 10.1073/pnas.0508637103	19	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e13698	10.1371/journal.pone.0013698	http://dx.doi.org/10.1371/journal.pone.0013698			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079808	Green Submitted, Green Published, gold			2022-12-25	WOS:000283838600004
J	Hagner, PR; Mazan-Mamczarz, K; Dai, B; Balzer, EM; Corl, S; Martin, SS; Zhao, XF; Gartenhaus, RB				Hagner, P. R.; Mazan-Mamczarz, K.; Dai, B.; Balzer, E. M.; Corl, S.; Martin, S. S.; Zhao, X. F.; Gartenhaus, R. B.			Ribosomal protein S6 is highly expressed in non-Hodgkin lymphoma and associates with mRNA containing a 5 ' terminal oligopyrimidine tract	ONCOGENE			English	Article						RPS6; diffuse large B-cell lymphoma; 5 ' terminal oligopyrimidine; p53	TRANSLATIONAL CONTROL; P53 EXPRESSION; PHOSPHORYLATION; GENE; PATHWAY; CANCER; TRANSDUCTION; ACTIVATION; INDUCTION; CARCINOMA	The molecular mechanism(s) linking tumorigenesis and morphological alterations in the nucleolus are presently coming into focus. The nucleolus is the cellular organelle in which the formation of ribosomal subunits occurs. Ribosomal biogenesis occurs through the transcription of ribosomal RNA (rRNA), rRNA processing and production of ribosomal proteins. An error in any of these processes may lead to deregulated cellular translation, evident in multiple cancers and 'ribosomopathies'. Deregulated protein synthesis may be achieved through the overexpression of ribosomal proteins as seen in primary leukemic blasts with elevated levels of ribosomal proteins S11 and S14. In this study, we demonstrate that ribosomal protein S6 (RPS6) is highly expressed in primary diffuse large B-cell lymphoma (DLBCL) samples. Genetic modulation of RPS6 protein levels with specifically targeted short hairpin RNA (shRNA) lentiviruses led to a decrease in the actively proliferating population of cells compared with control shRNA. Low-dose rapamycin treatments have been shown to affect the translation of 5' terminal oligopyrimidine (5' TOP) tract mRNA, which encodes the translational machinery, implicating RPS6 in 5' TOP translation. Recently, it was shown that disruption of 40S ribosomal biogenesis through specific small inhibitory RNA knockdown of RPS6 defined RPS6 as a critical regulator of 5' TOP translation. For the first time, we show that RPS6 associates with multiple mRNAs containing a 5' TOP tract. These findings expand our understanding of the mechanism(s) involved in ribosomal biogenesis and deregulated protein synthesis in DLBCL. Oncogene (2011) 30, 1531-1541; doi: 10.1038/onc.2010.533; published online 22 November 2010	[Hagner, P. R.; Mazan-Mamczarz, K.; Dai, B.; Balzer, E. M.; Corl, S.; Martin, S. S.; Zhao, X. F.; Gartenhaus, R. B.] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Dept Med, Baltimore, MD 21201 USA; [Hagner, P. R.] Harvard Univ, Sch Med, Dept Biochem & Mol Pharmacol, Boston, MA USA; [Gartenhaus, R. B.] Vet Adm Med Ctr, Baltimore, MD 21218 USA	University System of Maryland; University of Maryland Baltimore; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Gartenhaus, RB (corresponding author), Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Dept Med, 9-011 BRB,655 W Baltimore St,22 S Greene St, Baltimore, MD 21201 USA.	rgartenhaus@som.umaryland.edu			Department of Veterans Affairs; National Institutes of Health [R01AA017972]; NATIONAL CANCER INSTITUTE [P30CA134274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017972] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The WT-RPS16-hGH and Cm5-RPS16-hGH constructs that contain the coding region of hGH fused to the first 29 nucleotides of the RPS16 5' untranslated region (WT-RPS16-hGH) or to the mutant in which five of the eight pyrimidines within the 5' TOP have been mutated to purines (Cm5) were kindly provided by the laboratories of Dr Oded Meyuhas and Dr George Thomas, This work was funded in part by a Merit Review Award from the Department of Veterans Affairs (RBG) and R01AA017972 from the National Institutes of Health (RBG).	Avni D, 1997, NUCLEIC ACIDS RES, V25, P995, DOI 10.1093/nar/25.5.995; Badis G, 2004, MOL CELL, V15, P5, DOI 10.1016/j.molcel.2004.06.028; Dai BJ, 2006, CANCER RES, V66, P8058, DOI 10.1158/0008-5472.CAN-06-1364; Draptchinskaia N, 1999, NAT GENET, V21, P169, DOI 10.1038/5951; Espinosa L, 1997, BBA-GENE STRUCT EXPR, V1354, P58, DOI 10.1016/S0167-4781(97)00124-3; Fatica A, 2002, CURR OPIN CELL BIOL, V14, P313, DOI 10.1016/S0955-0674(02)00336-8; FERRARI S, 1990, CANCER RES, V50, P5825; Fewell SW, 1999, MOL CELL BIOL, V19, P826; FRANCO R, 1990, J BIOL CHEM, V265, P4321; FRIGERIO JM, 1995, BBA-GENE STRUCT EXPR, V1262, P64, DOI 10.1016/0167-4781(95)00045-I; Fumagalli S, 2000, COLD SPRING HARBOR M, V39, P695; Fumagalli S, 2009, NAT CELL BIOL, V11, P501, DOI 10.1038/ncb1858; Galban S, 2003, MOL CELL BIOL, V23, P7083, DOI 10.1128/MCB.23.20.7083-7095.2003; Ganapathi KA, 2008, BRIT J HAEMATOL, V141, P376, DOI 10.1111/j.1365-2141.2008.07095.x; GROSS T, 1988, CURR GENET, V13, P57, DOI 10.1007/BF00365757; Iadevaia V, 2008, RNA, V14, P1730, DOI 10.1261/rna.1037108; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; JEFFERIES HBJ, 1994, P NATL ACAD SCI USA, V91, P4441, DOI 10.1073/pnas.91.10.4441; Kapasi P, 2007, MOL CELL, V25, P113, DOI 10.1016/j.molcel.2006.11.028; Koduru PRK, 1997, BLOOD, V90, P4078, DOI 10.1182/blood.V90.10.4078; Kondoh N, 2001, ANTICANCER RES, V21, P2429; Law PTW, 1996, BBA-GENE STRUCT EXPR, V1305, P105, DOI 10.1016/0167-4781(95)00224-3; Lee-Fruman KK, 1999, ONCOGENE, V18, P5108, DOI 10.1038/sj.onc.1202894; Lerner RS, 2003, RNA, V9, P1123, DOI 10.1261/rna.5610403; LEVY S, 1991, P NATL ACAD SCI USA, V88, P3319, DOI 10.1073/pnas.88.8.3319; Mazan-Mamczarz K, 2008, ONCOGENE, V27, P6151, DOI 10.1038/onc.2008.215; Meyuhas O, 2000, EUR J BIOCHEM, V267, P6321, DOI 10.1046/j.1432-1327.2000.01719.x; Mitrovich QM, 2000, GENE DEV, V14, P2173, DOI 10.1101/gad.819900; Nakamura JL, 2008, CANCER RES, V68, P6516, DOI 10.1158/0008-5472.CAN-07-6188; NYGARD O, 1990, EUR J BIOCHEM, V191, P1, DOI 10.1111/j.1432-1033.1990.tb19087.x; Ofir-Rosenfeld Y, 2008, MOL CELL, V32, P180, DOI 10.1016/j.molcel.2008.08.031; Patursky-Polischuk I, 2009, MOL CELL BIOL, V29, P640, DOI 10.1128/MCB.00980-08; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Perry RP, 2007, GENE, V401, P1, DOI 10.1016/j.gene.2007.07.007; Pianese G., 1896, BEITR PATHOL ANAT AL, V142, P1; Reinert LS, 2006, CANCER RES, V66, P8994, DOI 10.1158/0008-5472.CAN-06-1999; ROMMENS JM, 1995, GENOMICS, V28, P530, DOI 10.1006/geno.1995.1185; Ruggero D, 2003, SCIENCE, V299, P259, DOI 10.1126/science.1079447; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; Ruvinsky I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005618; Sanchez-Beato M, 2003, BLOOD, V101, P1220, DOI 10.1182/blood-2002-07-2009; Stolovich M, 2002, MOL CELL BIOL, V22, P8101, DOI 10.1128/MCB.22.23.8101-8113.2002; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Vladimirov SN, 1996, EUR J BIOCHEM, V239, P144, DOI 10.1111/j.1432-1033.1996.0144u.x; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; WATSON KL, 1992, P NATL ACAD SCI USA, V89, P11302, DOI 10.1073/pnas.89.23.11302	47	37	38	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR	2011	30	13					1531	1541		10.1038/onc.2010.533	http://dx.doi.org/10.1038/onc.2010.533			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	743DU	21102526	Green Accepted			2022-12-25	WOS:000288998300004
J	Delarasse, C; Auger, R; Gonnord, P; Fontaine, B; Kanellopoulos, JM				Delarasse, Cecile; Auger, Rodolphe; Gonnord, Pauline; Fontaine, Bertrand; Kanellopoulos, Jean M.			The Purinergic Receptor P2X7 Triggers alpha-Secretase-dependent Processing of the Amyloid Precursor Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; P2X(7) RECEPTOR; ALZHEIMER-DISEASE; EXTRACELLULAR ATP; MICE LACKING; LIPID RAFTS; MOUSE MODEL; CELL-DEATH; L-SELECTIN; RELEASE	The amyloid precursor protein (APP) is cleaved by beta- and gamma-secretases to generate the beta-amyloid (A beta) peptides, which are present in large amounts in the amyloid plaques of Alzheimer disease (AD) patient brains. Non-amyloidogenic processing of APP by alpha-secretases leads to proteolytic cleavage within the A beta peptide sequence and shedding of the soluble APP ectodomain (sAPP alpha), which has been reported to be endowed with neuroprotective properties. In this work, we have shown that activation of the purinergic receptor P2X7 (P2X7R) stimulates sAPP alpha release from mouse neuroblastoma cells expressing human APP, from human neuroblastoma cells and from mouse primary astrocytes or neural progenitor cells. sAPP alpha shedding is inhibited by P2X7R antagonists or knockdown of P2X7R with specific small interfering RNA (siRNA) and is not observed in neural cells from P2X7R-deficient mice. P2X7R-dependent APP-cleavage is independent of extracellular calcium and strongly inhibited by hydroxamate-based metalloprotease inhibitors, TAPI-2 and GM6001. However, knockdown of a disintegrin and metalloproteinase-9 (ADAM9), ADAM10 and ADAM17 by specific siRNA, known to have alpha-secretase activity, does not block the P2X7R-dependent non-amyloidogenic pathway. Using several specific pharmacological inhibitors, we demonstrate that the mitogen-activated protein kinase modules Erk1/2 and JNK are involved in P2X7R-dependent alpha-secretase activity. Our study suggests that P2X7R, which is expressed in hippocampal neurons and glial cells, is a potential therapeutic target in AD.	[Kanellopoulos, Jean M.] Univ Paris 11, CNRS, Inst Biochim & Biophys Mol & Cellulaire,UMR 8619, Lab Activat Cellulaire & Transduct Signaux, F-91405 Orsay, France; [Delarasse, Cecile; Fontaine, Bertrand] INSERM, CRICM, UMR S975, F-75013 Paris, France; [Delarasse, Cecile; Fontaine, Bertrand] Univ Paris 06, F-75013 Paris, France; [Delarasse, Cecile; Fontaine, Bertrand] CNRS, UMR7225, F-75013 Paris, France; [Delarasse, Cecile; Auger, Rodolphe; Gonnord, Pauline; Kanellopoulos, Jean M.] Univ Paris 11, F-91405 Orsay, France; [Fontaine, Bertrand] Grp Hosp Pitie Salpetriere, AP HP, F-75013 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Kanellopoulos, JM (corresponding author), Univ Paris 11, CNRS, Inst Biochim & Biophys Mol & Cellulaire,UMR 8619, Lab Activat Cellulaire & Transduct Signaux, Batiment 430, F-91405 Orsay, France.	jean.kanellopoulos@u-psud.fr	Delarasse, Cecile/K-8234-2017	Delarasse, Cecile/0000-0001-9739-4306	Centre National de la Recherche Scientifique (CNRS); Agence Nationale pour la Recherche [ANR-07-BLAN-0089-02]; Association France Alzheimer; Neuropole de Recherche francilien (NeRF); ANR	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Association France Alzheimer; Neuropole de Recherche francilien (NeRF); ANR(French National Research Agency (ANR))	This work was supported by the Centre National de la Recherche Scientifique (CNRS), Agence Nationale pour la Recherche (ANR-07-BLAN-0089-02), Association France Alzheimer, and Neuropole de Recherche francilien (NeRF).; Supported by ANR.	Allinson TMJ, 2003, J NEUROSCI RES, V74, P342, DOI 10.1002/jnr.10737; Armstrong S, 2009, J CELL SCI, V122, P136, DOI 10.1242/jcs.031534; Auger R, 2005, J BIOL CHEM, V280, P28142, DOI 10.1074/jbc.M501290200; Bandyopadhyay S, 2007, CURR MED CHEM, V14, P2848, DOI 10.2174/092986707782360060; Barth K, 2007, FEBS J, V274, P3021, DOI 10.1111/j.1742-4658.2007.05830.x; BUXBAUM JD, 1992, P NATL ACAD SCI USA, V89, P10075, DOI 10.1073/pnas.89.21.10075; Caccamo A, 2006, NEURON, V49, P671, DOI 10.1016/j.neuron.2006.01.020; Caille I, 2004, DEVELOPMENT, V131, P2173, DOI 10.1242/dev.01103; Camden JM, 2005, J BIOL CHEM, V280, P18696, DOI 10.1074/jbc.M500219200; Carroll WA, 2009, PURINERG SIGNAL, V5, P63, DOI 10.1007/s11302-008-9110-6; Delarasse C, 2009, J NEUROCHEM, V109, P846, DOI 10.1111/j.1471-4159.2009.06008.x; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; Duan SM, 2003, J NEUROSCI, V23, P1320, DOI 10.1523/JNEUROSCI.23-04-01320.2003; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Fuller S, 2009, EXPERT REV NEUROTHER, V9, P1585, DOI 10.1586/ERN.09.111; Gandy S, 2005, J CLIN INVEST, V115, P1121, DOI 10.1172/JCI200525100; Garcia-Marcos M, 2006, J LIPID RES, V47, P705, DOI 10.1194/jlr.M500408-JLR200; Gendron FP, 2003, AM J PHYSIOL-CELL PH, V284, pC571, DOI 10.1152/ajpcell.00286.2002; Gonnord P, 2009, FASEB J, V23, P795, DOI 10.1096/fj.08-114637; Gu B, 1998, BLOOD, V92, P946; Gu BJ, 2006, BLOOD, V107, P4946, DOI 10.1182/blood-2005-07-2994; Gudipaty L, 2003, AM J PHYSIOL-CELL PH, V285, pC286, DOI 10.1152/ajpcell.00070.2003; Haring R, 1998, J NEUROCHEM, V71, P2094; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hoey SE, 2009, J NEUROSCI, V29, P4442, DOI 10.1523/JNEUROSCI.6017-08.2009; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Jarvis MF, 2009, NEUROPHARMACOLOGY, V56, P208, DOI 10.1016/j.neuropharm.2008.06.067; Kojro E, 2006, FASEB J, V20, P512, DOI 10.1096/fj.05-4812fje; Labasi JM, 2002, J IMMUNOL, V168, P6436, DOI 10.4049/jimmunol.168.12.6436; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Le Stunff H, 2004, J BIOL CHEM, V279, P16918, DOI 10.1074/jbc.M313064200; Lee MS, 2003, J CELL BIOL, V163, P83, DOI 10.1083/jcb.200301115; LEE RKK, 1995, P NATL ACAD SCI USA, V92, P8083, DOI 10.1073/pnas.92.17.8083; Ma GZ, 2005, J NEUROSCI RES, V80, P683, DOI 10.1002/jnr.20515; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; McLarnon JG, 2006, J NEUROPATH EXP NEUR, V65, P1090, DOI 10.1097/01.jnen.0000240470.97295.d3; Moon H, 2006, IMMUNOL LETT, V102, P98, DOI 10.1016/j.imlet.2005.08.004; Muresan Z, 2005, J NEUROSCI, V25, P3741, DOI 10.1523/JNEUROSCI.0152-05.2005; NITSCH RM, 1992, SCIENCE, V258, P304, DOI 10.1126/science.1411529; Nitsch RM, 1996, J BIOL CHEM, V271, P4188; Ohsawa I, 1999, EUR J NEUROSCI, V11, P1907, DOI 10.1046/j.1460-9568.1999.00601.x; Panenka W, 2001, J NEUROSCI, V21, P7135, DOI 10.1523/JNEUROSCI.21-18-07135.2001; Papp L, 2007, BIOCHEM BIOPH RES CO, V355, P568, DOI 10.1016/j.bbrc.2007.02.014; Parkin E, 2009, J NEUROCHEM, V108, P1464, DOI 10.1111/j.1471-4159.2009.05907.x; Parvathenani LK, 2003, J BIOL CHEM, V278, P13309, DOI 10.1074/jbc.M209478200; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Robert SJ, 2001, J BIOL CHEM, V276, P44881, DOI 10.1074/jbc.M109008200; Schobel S, 2008, J BIOL CHEM, V283, P14257, DOI 10.1074/jbc.M801531200; Shemon AN, 2006, J BIOL CHEM, V281, P2079, DOI 10.1074/jbc.M507816200; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Sperlagh B, 2006, PROG NEUROBIOL, V78, P327, DOI 10.1016/j.pneurobio.2006.03.007; Suadicani SO, 2006, J NEUROSCI, V26, P1378, DOI 10.1523/JNEUROSCI.3902-05.2006; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Suzuki T, 2004, J NEUROSCI, V24, P1, DOI 10.1523/JNEUROSCI.3792-03.2004; Suzuki T, 2008, J BIOL CHEM, V283, P29633, DOI 10.1074/jbc.R800003200; Thathiah A, 2009, SCIENCE, V323, P946, DOI 10.1126/science.1160649; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Tousseyn T, 2009, J BIOL CHEM, V284, P11738, DOI 10.1074/jbc.M805894200; Walter L, 2004, J NEUROSCI, V24, P8068, DOI 10.1523/JNEUROSCI.2419-04.2004; Weskamp G, 2002, MOL CELL BIOL, V22, P1537, DOI 10.1128/MCB.22.5.1537-1544.2002; Wiley JS, 2002, LANCET, V359, P1114, DOI 10.1016/S0140-6736(02)08156-4; Wilquet V, 2004, CURR OPIN NEUROBIOL, V14, P582, DOI 10.1016/j.conb.2004.08.001	66	77	93	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2596	2606		10.1074/jbc.M110.200618	http://dx.doi.org/10.1074/jbc.M110.200618			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21081501	hybrid, Green Published			2022-12-25	WOS:000286464300025
J	Ruffieux-Daidie, D; Staub, O				Ruffieux-Daidie, Dorothee; Staub, Olivier			Intracellular Ubiquitylation of the Epithelial Na+ Channel Controls Extracellular Proteolytic Channel Activation via Conformational Change	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE EXPRESSION; SODIUM-CHANNEL; GAMMA-SUBUNIT; LIDDLES-SYNDROME; ESSENTIAL-HYPERTENSION; UBIQUITIN LIGASE; SERINE PROTEASES; XENOPUS-OOCYTES; RAT-KIDNEY; ENAC	The epithelial Na+ channel ENaC is a key player in the maintenance of whole body Na+ balance, and consequently of blood pressure. It is tightly regulated by numerous signaling pathways including ubiquitylation via the ubiquitin-protein ligase Nedd4-2. This mechanism is itself under the control of several kinases, which phosphorylate Nedd4-2, thereby interfering with ENaC/Nedd4-2 interaction, or by Usp2-45, which binds to and deubiquitylates ENaC. Another, different regulatory mechanism concerns the proteolytic activation of ENaC, during which the channel is cleaved on its luminal side by intracellular convertases such as furin, and further activated by extracellular proteases such as CAP-1. This process is regulated as well but the underlying mechanisms are not understood. Previously, evidence was provided that the ubiquitylation status of ENaC may affect the cleavage of the channel. When ubiquitylation of ENaC was reduced, either by co-expressing Usp2-45, or mutating either the ENaC PY-motifs (i.e. the binding sites for Nedd4-2) or intracellular lysines (i.e. ubiquitylation sites), the level of channel cleavage was increased. Here we demonstrate that lysine-mutated ENaC channels are not ubiquitylated at the cell surface, are preferentially cleaved, and Usp2-45 does not affect their cleavage efficiency. We further show by limited proteolysis that the intracellular ubiquitylation status of ENaC affects the extracellular conformation of alpha ENaC, by demonstrating that non-ubiquitylated channels are more efficiently cleaved when treated with extracellularly added trypsin or chymotrypsin. These results present a new paradigm in which an intracellular, post-translational modification (e.g. ubiquitylation) of a transmembrane protein can affect its extracellular conformation.	[Ruffieux-Daidie, Dorothee; Staub, Olivier] Univ Lausanne, Dept Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland	University of Lausanne	Staub, O (corresponding author), Univ Lausanne, Dept Pharmacol & Toxicol, Rue Bugnon 27, CH-1005 Lausanne, Switzerland.	Olivier.Staub@unil.ch			Swiss National Science Foundation [31003A_125422/1]; Leducq Foundation (Transatlantic Network on Hypertension); Swiss Kidney Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Leducq Foundation (Transatlantic Network on Hypertension)(Leducq Foundation); Swiss Kidney Foundation	This work was supported by the Swiss National Science Foundation (31003A_125422/1), by the Leducq Foundation (Transatlantic Network on Hypertension), and by the Swiss Kidney Foundation.	Chraibi A, 1998, J GEN PHYSIOL, V111, P127, DOI 10.1085/jgp.111.1.127; Dahlberg J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000432; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Diakov A, 2008, J PHYSIOL-LONDON, V586, P4587, DOI 10.1113/jphysiol.2008.154435; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; DUC C, 1994, J CELL BIOL, V127, P1907, DOI 10.1083/jcb.127.6.1907; Ergonul Z, 2006, AM J PHYSIOL-RENAL, V291, pF683, DOI 10.1152/ajprenal.00422.2005; Fakitsas P, 2007, J AM SOC NEPHROL, V18, P1084, DOI 10.1681/ASN.2006080902; Fava C, 2006, KIDNEY INT, V70, P562, DOI 10.1038/sj.ki.5001590; Fejes-Toth G, 2008, AM J PHYSIOL-RENAL, V294, pF1298, DOI 10.1152/ajprenal.00579.2007; Firsov D, 1996, P NATL ACAD SCI USA, V93, P15370, DOI 10.1073/pnas.93.26.15370; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; HANSSON JH, 1995, NAT GENET, V11, P76, DOI 10.1038/ng0995-76; Harris M, 2007, J BIOL CHEM, V282, P58, DOI 10.1074/jbc.M605125200; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kamynina E, 2001, FASEB J, V15, P204, DOI 10.1096/fj.00-0191com; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Knight KK, 2006, P NATL ACAD SCI USA, V103, P2805, DOI 10.1073/pnas.0511184103; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; Passero CJ, 2008, J BIOL CHEM, V283, P36586, DOI 10.1074/jbc.M805676200; Rossier BC, 2009, ANNU REV PHYSIOL, V71, P361, DOI 10.1146/annurev.physiol.010908.163108; Ruffieux-Daidie D, 2008, J AM SOC NEPHROL, V19, P2170, DOI 10.1681/ASN.2007101130; Russo CJ, 2005, HYPERTENSION, V46, P488, DOI 10.1161/01.HYP.0000178594.63193.c0; Shi PP, 2008, AM J PHYSIOL-RENAL, V295, pF462, DOI 10.1152/ajprenal.90300.2008; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; Soundararajan R, 2009, P NATL ACAD SCI USA, V106, P7804, DOI 10.1073/pnas.0809892106; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Svenningsen P, 2009, J AM SOC NEPHROL, V20, P299, DOI 10.1681/ASN.2008040364; Tanswell AK, 1998, AM J PHYSIOL-LUNG C, V275, pL452, DOI 10.1152/ajplung.1998.275.3.L452; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; Vuagniaux G, 2002, J GEN PHYSIOL, V120, P191, DOI 10.1085/jgp.20028598; Wakida N, 2006, KIDNEY INT, V70, P1432, DOI 10.1038/sj.ki.5001787; Wen H, 2008, CLIN EXP HYPERTENS, V30, P87, DOI 10.1080/10641960801949909; Woelk T, 2006, NAT CELL BIOL, V8, P1246, DOI 10.1038/ncb1484	36	26	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2416	2424		10.1074/jbc.M110.176156	http://dx.doi.org/10.1074/jbc.M110.176156			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21084303	Green Published, hybrid			2022-12-25	WOS:000286464300005
J	Gorski, JP; Huffman, NT; Chittur, S; Midura, RJ; Black, C; Oxford, J; Seidah, NG				Gorski, Jeff P.; Huffman, Nichole T.; Chittur, Sridar; Midura, Ronald J.; Black, Claudine; Oxford, Julie; Seidah, Nabil G.			Inhibition of Proprotein Convertase SKI-1 Blocks Transcription of Key Extracellular Matrix Genes Regulating Osteoblastic Mineralization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEINS; ENDOPLASMIC-RETICULUM STRESS; BONE ACIDIC GLYCOPROTEIN-75; UBIQUITIN-PROTEASOME PATHWAY; COENZYME-A SYNTHASE; IN-VITRO; SQUALENE SYNTHASE; CYSTEINE PROTEASE; SITE-1 PROTEASE; COLLAGEN GENE	Mineralization, a characteristic phenotypic property of osteoblastic lineage cells, was blocked by 4-(2-aminoethyl) benzenesulfonyl fluoride hydrochloride (AEBSF) and decanoyl-Arg-Arg-Leu-Leu-chloromethyl ketone (dec-RRLL-cmk), inhibitors of SKI-1 (site 1; subtilisin kexin like-1) protease. Because SKI-1 is required for activation of SREBP and CREB (cAMP-response element-binding protein)/ATF family transcription factors, we tested the effect of these inhibitors on gene expression. AEBSF decreased expression of 140 genes by 1.5-3.0-fold including Phex, Dmp1, COL1A1, COL11A1, and fibronectin. Direct comparison of AEBSF and dec-RRLL-cmk, a more specific SKI-1 inhibitor, demonstrated that expression of Phex, Dmp1, COL11A1, and fibronectin was reduced by both, whereas COL1A2 and HMGCS1 were reduced only by AEBSF. AEBSF and decRRLL-cmk decreased the nuclear content of SKI-1-activated forms of transcription factors SREBP-1, SREBP-2, and OASIS. In contrast to AEBSF, the actions of dec-RRLL-cmk represent the sum of its direct actions on SKI-1 and indirect actions on caspase-3. Specifically, dec-RRLL-cmk reduced intracellular caspase-3 activity by blocking the formation of activated 19-kDa caspase-3. Conversely, overexpression of SKI-1-activated SREBP-1a and CREB-H in UMR106-01 osteoblastic cells increased the number of mineralized foci and altered their morphology to yield mineralization nodules, respectively. In summary, SKI-1 regulates the activation of transmembrane transcription factor precursors required for expression of key genes required for mineralization of osteoblastic cultures in vitro and bone formation in vivo. Our results indicate that the differentiated phenotype of osteoblastic cells and possibly osteocytes depends upon the non-apoptotic actions of SKI-1.	[Gorski, Jeff P.] Univ Missouri, Sch Dent, Ctr Excellence Study Musculoskeletal & Dent Tissu, Bone Biol Program,Dept Oral Biol, Kansas City, MO 64108 USA; [Chittur, Sridar] SUNY Albany, Ctr Funct Genom, Rensselaer, NY 12144 USA; [Midura, Ronald J.] Cleveland Clin, Lerner Inst, Dept Biomed Engn, Cleveland, OH 44195 USA; [Oxford, Julie] Boise State Univ, Dept Biol, Boise, ID 83725 USA; [Seidah, Nabil G.] Inst Rech Clin Montreal, Montreal, PQ H2W 1R, Canada	University of Missouri System; University of Missouri Kansas City; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Cleveland Clinic Foundation; Idaho; Boise State University; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Gorski, JP (corresponding author), Univ Missouri, Sch Dent, Ctr Excellence Study Musculoskeletal & Dent Tissu, Bone Biol Program,Dept Oral Biol, 650 E 25th St, Kansas City, MO 64108 USA.	gorskij@umkc.edu	/W-2676-2019; Oxford, Julia Thom/AAH-2842-2019; Seidah, Nabil/I-3596-2013	Oxford, Julia Thom/0000-0002-4850-3569; Seidah, Nabil/0000-0001-6503-9342	National Institutes of Health (NIAMS) [R01-052775]; University of Missouri-Kansas City Center of Excellence for Mineralized Tissues; University of Missouri Research Board	National Institutes of Health (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); University of Missouri-Kansas City Center of Excellence for Mineralized Tissues; University of Missouri Research Board	This work was supported, in whole or in part, by National Institutes of Health Grant R01-052775 (NIAMS; to J.P.G.). This work was also supported by University of Missouri-Kansas City Center of Excellence for Mineralized Tissues and the University of Missouri Research Board (to J.P.G.).	Amemiya-Kudo M, 2005, J BIOL CHEM, V280, P34577, DOI 10.1074/jbc.M506718200; Bengoechea-Alonso MT, 2009, J BIOL CHEM, V284, P5885, DOI 10.1074/jbc.M807906200; Castoreno AB, 2005, P NATL ACAD SCI USA, V102, P13129, DOI 10.1073/pnas.0506716102; Chandhoke TK, 2008, BONE, V43, P101, DOI 10.1016/j.bone.2008.03.012; Chandler JM, 1998, J BIOL CHEM, V273, P10815, DOI 10.1074/jbc.273.18.10815; Costes S, 2009, DIABETES, V58, P1105, DOI 10.2337/db08-0926; Dixon PH, 1998, J CLIN ENDOCR METAB, V83, P3615, DOI 10.1210/jc.83.10.3615; Dooley KA, 1999, J BIOL CHEM, V274, P5285, DOI 10.1074/jbc.274.9.5285; Elagoz A, 2002, J BIOL CHEM, V277, P11265, DOI 10.1074/jbc.M109011200; Farr GH, 2000, J CELL BIOL, V148, P691, DOI 10.1083/jcb.148.4.691; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; FRANCIS F, 1995, NAT GENET, V11, P130, DOI 10.1038/ng1095-130; Gondret F, 2001, J LIPID RES, V42, P106; Gorski JP, 2009, CELLS TISSUES ORGANS, V189, P25, DOI 10.1159/000151723; Gorski JP, 2004, J BIOL CHEM, V279, P25455, DOI 10.1074/jbc.M312408200; Guan GM, 1997, J BIOL CHEM, V272, P10295; Gupta S, 2004, ONCOGENE, V23, P2507, DOI 10.1038/sj.onc.1207353; Hansen U, 2003, J BIOL CHEM, V278, P37352, DOI 10.1074/jbc.M304325200; Henrich S, 2003, NAT STRUCT BIOL, V10, P520, DOI 10.1038/nsb941; Higgins ME, 2001, J LIPID RES, V42, P1939; Hirano Y, 2001, J BIOL CHEM, V276, P36431, DOI 10.1074/jbc.M105200200; Huffman NT, 2007, J BIOL CHEM, V282, P26002, DOI 10.1074/jbc.M701332200; Hunter I, 2001, J BONE MINER RES, V16, P466, DOI 10.1359/jbmr.2001.16.3.466; Inoue J, 1998, J BIOCHEM-TOKYO, V123, P1191; Kalajzic I, 2005, J BIOL CHEM, V280, P24618, DOI 10.1074/jbc.M413834200; Kalajzic I, 2002, J BONE MINER RES, V17, P15, DOI 10.1359/jbmr.2002.17.1.15; Kalajzic I, 2004, BONE, V35, P74, DOI 10.1016/j.bone.2004.03.006; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI Y, 1995, CELL, V80, P423, DOI 10.1016/0092-8674(95)90492-1; LIAN JB, 1992, CRIT REV ORAL BIOL M, V3, P269, DOI 10.1177/10454411920030030501; Liu XS, 1996, J BIOL CHEM, V271, P13371, DOI 10.1074/jbc.271.23.13371; Liu Y, 2002, ARTERIOSCL THROM VAS, V22, P76, DOI 10.1161/hq0102.101822; Lorenz-Depiereux B, 2006, NAT GENET, V38, P1248, DOI 10.1038/ng1868; Meares GP, 2007, J BIOL CHEM, V282, P16989, DOI 10.1074/jbc.M700610200; Michaelson JE, 2002, AM J PHYSIOL-LUNG C, V282, pL291, DOI 10.1152/ajplung.00445.2000; Midura RJ, 2004, J BIOL CHEM, V279, P25464, DOI 10.1074/jbc.M312409200; Miura M, 2004, J CLIN INVEST, V114, P1704, DOI 10.1172/JCI200420427; Mogi M, 2003, J BIOL CHEM, V278, P47477, DOI 10.1074/jbc.M307055200; Moursi AM, 1997, J CELL SCI, V110, P2187; Moursi AM, 1996, J CELL SCI, V109, P1369; Murakami T, 2006, J NEUROCHEM, V96, P1090, DOI 10.1111/j.1471-4159.2005.03596.x; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Nohturfft A, 2000, CELL, V102, P315, DOI 10.1016/S0092-8674(00)00037-4; Omori Y, 2002, BIOCHEM BIOPH RES CO, V293, P470, DOI 10.1016/S0006-291X(02)00253-X; Park IC, 2000, INT J ONCOL, V16, P1243; Pasquato A, 2006, J BIOL CHEM, V281, P23471, DOI 10.1074/jbc.M513675200; Patra D, 2007, J CELL BIOL, V179, P687, DOI 10.1083/jcb.200708092; PIHLAJANIEMI T, 1984, J BIOL CHEM, V259, P2941; Pullikotil P, 2004, J BIOL CHEM, V279, P17338, DOI 10.1074/jbc.M313764200; Pullikotil P, 2007, J BIOL CHEM, V282, P27402, DOI 10.1074/jbc.M703200200; Punga T, 2006, J BIOL CHEM, V281, P25278, DOI 10.1074/jbc.M604983200; Richards AJ, 1996, HUM MOL GENET, V5, P1339, DOI 10.1093/hmg/5.9.1339; Ruchon AF, 2000, J BONE MINER RES, V15, P1440, DOI 10.1359/jbmr.2000.15.8.1440; Schlombs K, 2003, P NATL ACAD SCI USA, V100, P14024, DOI 10.1073/pnas.2331794100; Schneider GB, 2001, J DENT RES, V80, P1540, DOI 10.1177/00220345010800061201; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seidah NG, 1999, P NATL ACAD SCI USA, V96, P1321, DOI 10.1073/pnas.96.4.1321; Singh LP, 2001, DIABETES, V50, P2355, DOI 10.2337/diabetes.50.10.2355; STANFORD CM, 1995, J BIOL CHEM, V270, P9420, DOI 10.1074/jbc.270.16.9420; Wang AM, 2000, J BIOL CHEM, V275, P11082, DOI 10.1074/jbc.275.15.11082; Wang CY, 2009, J BIOL CHEM, V284, P7100, DOI 10.1074/jbc.M805898200; Wang XD, 1996, EMBO J, V15, P1012, DOI 10.1002/j.1460-2075.1996.tb00438.x; WANG XD, 1995, J BIOL CHEM, V270, P18044, DOI 10.1074/jbc.270.30.18044; Webb SJ, 1999, FASEB J, V13, P339, DOI 10.1096/fasebj.13.2.339; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040	66	29	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1836	1849		10.1074/jbc.M110.151647	http://dx.doi.org/10.1074/jbc.M110.151647			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21075843	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000286191500024
J	Kalwa, H; Michel, T				Kalwa, Hermann; Michel, Thomas			The MARCKS Protein Plays a Critical Role in Phosphatidylinositol 4,5-Bisphosphate Metabolism and Directed Cell Movement in Vascular Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FILAMENT CROSS-LINKING; SIGNALING PATHWAYS; KINASE-C; N-WASP; SUBCELLULAR-LOCALIZATION; ACTIN CYTOSKELETON; PLASMA-MEMBRANE; CARCINOMA-CELLS; LIPID DOMAINS; NITRIC-OXIDE	The MARCKS protein (myristoylated alanine-rich C kinase substrate) is an actin-and calmodulin-binding protein that is expressed in many mammalian tissues. The role of MARCKS in endothelial signaling responses is incompletely understood. We found that siRNA-mediated knockdown of MARCKS in cultured endothelial cells abrogated directed cell movement in a wound healing assay. We used biochemical and cell imaging approaches to explore the role of MARCKS in endothelial signal transduction pathways activated by insulin. Insulin treatment of vascular endothelial cells promoted the dose-and time-dependent phosphorylation of MARCKS. Cell imaging and hydrodynamic approaches revealed that MARCKS is targeted to plasmalemmal caveolae and undergoes subcellular translocation in response to insulin. Insulin treatment promoted an increase in levels of the signaling phospholipid phosphatidylinositol 4,5-bisphosphate (PIP2) in plasmalemmal caveolae. The insulin-stimulated increase in caveolar PIP2 was blocked by siRNA-mediated knockdown of MARCKS, as determined using both biochemical assays and imaging studies using FRET-based PIP2 biosensors. The critical role of PIP2 in MARCKS responses was explored by examining the PIP2- and actin-binding proteins Arp2/3 and N-WASP. Insulin promoted the rapid and robust phosphorylation of both N-WASP and Arp2/3, but these phosphorylation responses were markedly attenuated by siRNA-mediated MARCKS knockdown. Moreover, MARCKS knockdown effectively abrogated N-WASP activation in response to insulin, as determined using a FRET-based N-WASP activity biosensor. Taken together, these studies show that MARCKS plays a key role in insulin-dependent endothelial signaling to PIP2 and is a critical determinant of actin assembly and directed cell movement in the vascular endothelium.	[Kalwa, Hermann; Michel, Thomas] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc Med,Dept Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Michel, T (corresponding author), 75 Francis St,Thorn Bldg 1210A, Boston, MA 02115 USA.	thomas_michel@harvard.edu	Kalwa, Hermann/ABG-2323-2021		National Institutes of Health [GM36259, HL48743, HL46457]; Fonds National de la Recherche (Luxembourg) [PDR-09-002]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL046457, R01HL046457, P01HL048743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036259, R37GM036259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonds National de la Recherche (Luxembourg)(Luxembourg National Research Fund); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM36259, HL48743, and HL46457 (to T. M.). This work was also supported by Postdoctoral Fellowship PDR-09-002 from the Fonds National de la Recherche (Luxembourg) (to H. K.).	Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Arbuzova A, 2002, BIOCHEM J, V362, P1, DOI 10.1042/0264-6021:3620001; ARNOLD TP, 1993, BIOCHEM J, V295, P155, DOI 10.1042/bj2950155; Baba Y, 1999, BLOOD, V93, P2003, DOI 10.1182/blood.V93.6.2003.406k13_2003_2012; Baron AD, 2002, J DIABETES COMPLICAT, V16, P92, DOI 10.1016/S1056-8727(01)00209-4; Cai L, 2007, CELL, V128, P915, DOI 10.1016/j.cell.2007.01.031; Calabrese B, 2005, NEURON, V48, P77, DOI 10.1016/j.neuron.2005.08.027; Cho SJ, 2001, BIOCHEM BIOPH RES CO, V283, P273, DOI 10.1006/bbrc.2001.4773; Dykxhoorn DM, 2003, NAT REV MOL CELL BIO, V4, P457, DOI 10.1038/nrm1129; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fujita A, 2009, P NATL ACAD SCI USA, V106, P9256, DOI 10.1073/pnas.0900216106; Gamper N, 2007, J PHYSIOL-LONDON, V582, P967, DOI 10.1113/jphysiol.2007.132787; Gonzalez E, 2006, J BIOL CHEM, V281, P3210, DOI 10.1074/jbc.M510434200; Gonzalez E, 2004, J BIOL CHEM, V279, P40659, DOI 10.1074/jbc.M407051200; HARTWIG JH, 1992, NATURE, V356, P618, DOI 10.1038/356618a0; Jiang ZY, 2003, J BIOL CHEM, V278, P31964, DOI 10.1074/jbc.M303314200; Lajoie P, 2009, J CELL BIOL, V185, P381, DOI 10.1083/jcb.200811059; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lorenz M, 2004, CURR BIOL, V14, P697, DOI 10.1016/j.cub.2004.04.008; MICHEL T, 1993, P NATL ACAD SCI USA, V90, P6252, DOI 10.1073/pnas.90.13.6252; Papayannopoulos V, 2005, MOL CELL, V17, P181, DOI 10.1016/j.molcel.2004.11.054; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; ROBINSON PJ, 1993, ANAL BIOCHEM, V210, P172, DOI 10.1006/abio.1993.1169; Saltiel AR, 2003, TRAFFIC, V4, P711, DOI 10.1034/j.1600-0854.2003.00119.x; Sarmiento C, 2008, J CELL BIOL, V180, P1245, DOI 10.1083/jcb.200708123; Schwencke C, 2006, CARDIOVASC RES, V70, P42, DOI 10.1016/j.cardiores.2005.11.029; Sheetz MP, 2006, ANNU REV BIOPH BIOM, V35, P417, DOI 10.1146/annurev.biophys.35.040405.102017; Soderholm J, 2005, CHEM BIOL, V12, P263, DOI 10.1016/j.chembiol.2005.03.001; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Stahlhut M, 2000, MOL BIOL CELL, V11, P325, DOI 10.1091/mbc.11.1.325; STUMPO DJ, 1995, P NATL ACAD SCI USA, V92, P944, DOI 10.1073/pnas.92.4.944; van Rheenen J, 2005, EMBO J, V24, P1664, DOI 10.1038/sj.emboj.7600655; Watt SA, 2002, BIOCHEM J, V363, P657, DOI 10.1042/0264-6021:3630657; Weisswange I, 2009, NATURE, V458, P87, DOI 10.1038/nature07773; Wu XY, 2004, J BIOL CHEM, V279, P43392, DOI 10.1074/jbc.M408959200; Yamagishi SI, 2001, J BIOL CHEM, V276, P25096, DOI 10.1074/jbc.M007383200; Yamaguchi H, 2009, J CELL PHYSIOL, V220, P748, DOI 10.1002/jcp.21822; Yarmola EG, 2001, J BIOL CHEM, V276, P22351, DOI 10.1074/jbc.M101457200; Yarrow JC, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-21; Zeng GY, 2000, CIRCULATION, V101, P1539, DOI 10.1161/01.CIR.101.13.1539	41	43	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2320	2330		10.1074/jbc.M110.196022	http://dx.doi.org/10.1074/jbc.M110.196022			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21097841	Green Published, hybrid			2022-12-25	WOS:000286191500071
J	Yokogawa, M; Osawa, M; Takeuchi, K; Mase, Y; Shimada, I				Yokogawa, Mariko; Osawa, Masanori; Takeuchi, Koh; Mase, Yoko; Shimada, Ichio			NMR Analyses of the G beta gamma Binding and Conformational Rearrangements of the Cytoplasmic Pore of G Protein-activated Inwardly Rectifying Potassium Channel 1 (GIRK1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECTIFIER K+ CHANNELS; CRYSTAL-STRUCTURE; CROSS-SATURATION; SUBUNITS; IDENTIFICATION; COMPLEXES; DOMAIN; SITES; RECTIFICATION; RESIDUES	G protein-activated inwardly rectifying potassium channel (GIRK) plays crucial roles in regulating heart rate and neuronal excitability in eukaryotic cells. GIRK is activated by the direct binding of heterotrimeric G protein beta gamma subunits (G beta gamma) upon stimulation of G protein-coupled receptors, such as M2 acetylcholine receptor. The binding of G beta gamma to the cytoplasmic pore (CP) region of GIRK causes structural rearrangements, which are assumed to open the transmembrane ion gate. However, the crucial residues involved in the G beta gamma binding and the structural mechanism of GIRK gating have not been fully elucidated. Here, we have characterized the interaction between the CP region of GIRK and G beta gamma, by ITC and NMR. The ITC analyses indicated that four G beta gamma molecules bind to a tetramer of the CP region of GIRK with a dissociation constant of 250 mu M. The NMR analyses revealed that the G beta gamma binding site spans two neighboring subunits of the GIRK tetramer, which causes conformational rearrangements between subunits. A possible binding mode and mechanism of GIRK gating are proposed.	[Yokogawa, Mariko; Osawa, Masanori; Takeuchi, Koh; Mase, Yoko; Shimada, Ichio] Univ Tokyo, Grad Sch Pharmaceut Sci, Div Phys Chem, Tokyo 1130033, Japan; [Yokogawa, Mariko] Japan Biol Informat Consortium JBiC, Tokyo 1350064, Japan; [Shimada, Ichio] Natl Inst Adv Ind Sci & Technol, BIRC, Tokyo 1350064, Japan	University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST)	Shimada, I (corresponding author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1130033, Japan.	shimada@iw-nmr.f.u-tokyo.ac.jp	Takeuchi, Koh/B-4971-2010; Osawa, Masanori/GRS-5726-2022	Takeuchi, Koh/0000-0002-6227-4627; Osawa, Masanori/0000-0002-1285-4316	Japan New Energy and Industrial Technology Development Organization (NEDO); Ministry of Economy, Trade, and Industry (METI); Japanese Ministry of Education, Culture, Sports, and Technology; Takeda Science Foundation	Japan New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Ministry of Economy, Trade, and Industry (METI); Japanese Ministry of Education, Culture, Sports, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by grants from the Japan New Energy and Industrial Technology Development Organization (NEDO) and the Ministry of Economy, Trade, and Industry (METI) (to I. S.), a Grant-in-aid for Scientific Research on Priority Areas from the Japanese Ministry of Education, Culture, Sports, and Technology (to M. O. and I. S.), and a grant from Takeda Science Foundation (to M. O.).	Albsoul-Younes AM, 2001, J BIOL CHEM, V276, P12712, DOI 10.1074/jbc.M011231200; Bichet D, 2003, NAT REV NEUROSCI, V4, P957, DOI 10.1038/nrn1244; Clarke OB, 2010, CELL, V141, P1018, DOI 10.1016/j.cell.2010.05.003; Corey S, 2001, J BIOL CHEM, V276, P11409, DOI 10.1074/jbc.M100058200; Davis TL, 2005, BIOCHEMISTRY-US, V44, P10593, DOI 10.1021/bi050655i; Finley M, 2004, J PHYSIOL-LONDON, V555, P643, DOI 10.1113/jphysiol.2003.056101; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; GRASBERGER B, 1986, P NATL ACAD SCI USA, V83, P6258, DOI 10.1073/pnas.83.17.6258; He C, 1999, J BIOL CHEM, V274, P12517, DOI 10.1074/jbc.274.18.12517; He C, 2002, J BIOL CHEM, V277, P6088, DOI 10.1074/jbc.M104851200; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Inanobe A, 2007, CHANNELS, V1, P40, DOI 10.4161/chan.3842; Ivanina T, 2003, J BIOL CHEM, V278, P29174, DOI 10.1074/jbc.M304518200; Ivanova-Nikolova TT, 1998, J GEN PHYSIOL, V112, P199, DOI 10.1085/jgp.112.2.199; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Matsumoto M, 2010, J MAGN RESON, V205, P114, DOI 10.1016/j.jmr.2010.04.011; Matsuo H, 1999, J AM CHEM SOC, V121, P9903, DOI 10.1021/ja991881g; Nakanishi T, 2002, J MOL BIOL, V318, P245, DOI 10.1016/S0022-2836(02)00018-9; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Osawa M, 2009, J BIOL CHEM, V284, P26117, DOI 10.1074/jbc.M109.029355; Ozcan F, 2006, P NATL ACAD SCI USA, V103, P5735, DOI 10.1073/pnas.0601469103; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; Riven I, 2003, NEURON, V38, P225, DOI 10.1016/S0896-6273(03)00193-4; Sarvazyan NA, 1998, J BIOL CHEM, V273, P7934, DOI 10.1074/jbc.273.14.7934; Shimada I, 2009, PROG NUCL MAG RES SP, V54, P123, DOI 10.1016/j.pnmrs.2008.07.001; Stratikos E, 2002, J EXP MED, V196, P173, DOI 10.1084/jem.20020117; Takahashi H, 2006, J BIOMOL NMR, V34, P167, DOI 10.1007/s10858-006-0008-8; WICKMAN KD, 1994, NATURE, V368, P255, DOI 10.1038/368255a0; Yokogawa M, 2009, BIOMOL NMR ASSIGN, V3, P125, DOI 10.1007/s12104-009-9156-6	31	41	42	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2215	2223		10.1074/jbc.M110.160754	http://dx.doi.org/10.1074/jbc.M110.160754			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21075842	Green Published, hybrid			2022-12-25	WOS:000286191500062
J	Steffen, R; Menzies, D; Oxlade, O; Pinto, M; de Castro, AZ; Monteiro, P; Trajman, A				Steffen, Ricardo; Menzies, Dick; Oxlade, Olivia; Pinto, Marcia; de Castro, Analia Zuleika; Monteiro, Paula; Trajman, Anete			Patients' Costs and Cost-Effectiveness of Tuberculosis Treatment in DOTS and Non-DOTS Facilities in Rio de Janeiro, Brazil	PLOS ONE			English	Article							DIRECTLY OBSERVED THERAPY; COMMUNITY; FAMILY; DIAGNOSIS; ZAMBIA; IMPACT	Background: Costs of tuberculosis diagnosis and treatment may represent a significant burden for the poor and for the health system in resource-poor countries. Objectives: The aim of this study was to analyze patients' costs of tuberculosis care and to estimate the incremental cost-effectiveness ratio (ICER) of the directly observed treatment (DOT) strategy per completed treatment in Rio de Janeiro, Brazil. Methods: We interviewed 218 adult patients with bacteriologically confirmed pulmonary tuberculosis. Information on direct (out-of-pocket expenses) and indirect (hours lost) costs, loss in income and costs with extra help were gathered through a questionnaire. Healthcare system additional costs due to supervision of pill-intake were calculated considering staff salaries. Effectiveness was measured by treatment completion rate. The ICER of DOT compared to self-administered therapy (SAT) was calculated. Principal Findings: DOT increased costs during the treatment phase, while SAT increased costs in the pre-diagnostic phase, for both the patient and the health system. Treatment completion rates were 71% in SAT facilities and 79% in DOT facilities. Costs per completed treatment were US$ 194 for patients and U$ 189 for the health system in SAT facilities, compared to US$ 336 and US$ 726 in DOT facilities. The ICER was US$ 6,616 per completed DOT treatment compared to SAT. Conclusions: Costs incurred by TB patients are high in Rio de Janeiro, especially for those under DOT. The DOT strategy doubles patients' costs and increases by fourfold the health system costs per completed treatment. The additional costs for DOT may be one of the contributing factors to the completion rates below the targeted 85% recommended by WHO.	[Steffen, Ricardo] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil; [Steffen, Ricardo; de Castro, Analia Zuleika; Monteiro, Paula; Trajman, Anete] Rio de Janeiro TB Sci League, Rio De Janeiro, Brazil; [Menzies, Dick; Oxlade, Olivia] McGill Univ, Montreal Chest Inst, Montreal, PQ, Canada; [Pinto, Marcia] Fundacao Oswaldo Cruz, Inst Fernandes Figueira, Rio De Janeiro, Brazil; [Monteiro, Paula; Trajman, Anete] Univ Gama Filho, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; McGill University; Fundacao Oswaldo Cruz; Universidade Gama Filho	Steffen, R (corresponding author), Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.	atrajman@gmail.com	Trajman, Anete/C-7679-2016	Trajman, Anete/0000-0002-4000-4984	Canadian Institutes of Health Research (CIHR) [PHI-77906]; Fundacao Carlos Chagas de Amparo a Pesquisa do Rio de Janeiro (FAPERJ) [E-26/170.420/2007]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [551497/2007-6]; International Clinical, Operational, and Health Services Research and Training Award (ICOHRTA) [5 U2R TW006883-02]; FOGARTY INTERNATIONAL CENTER [U2RTW006883] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fundacao Carlos Chagas de Amparo a Pesquisa do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); International Clinical, Operational, and Health Services Research and Training Award (ICOHRTA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported by the Canadian Institutes of Health Research (CIHR, PHI-77906), Fundacao Carlos Chagas de Amparo a Pesquisa do Rio de Janeiro (FAPERJ, grant E-26/170.420/2007) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, grant # 551497/2007-6). RS had a Scientific Initiation scholarship from FAPERJ. AT has financial support from the International Clinical, Operational, and Health Services Research and Training Award (ICOHRTA, Grant # 5 U2R TW006883-02). CIHR, FAPERJ, CNPq and ICOHRTA are not responsible for the statements in this article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkslip S, 1999, INT J TUBERC LUNG D, V3, P1061; Aspler A, 2008, INT J TUBERC LUNG D, V12, P928; Baltussen R, 2005, BMJ-BRIT MED J, V331, P1364, DOI 10.1136/bmj.38645.660093.68; Burman WJ, 1997, CHEST, V112, P63, DOI 10.1378/chest.112.1.63; Cavalcante SC, 2007, INT J TUBERC LUNG D, V11, P544; Floyd K, 2003, INT J TUBERC LUNG D, V7, pS29; Hill AR, 2002, MEDICINE, V81, P179, DOI 10.1097/00005792-200205000-00002; Jacquet V, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-209; LONNROTH K, 2009, SOC SCI MED; Mohan CI, 2007, INT J TUBERC LUNG D, V11, P27; Muniyandi M, 2006, J Commun Dis, V38, P204; Needham DM, 1998, INT J TUBERC LUNG D, V2, P811; Newell JN, 2006, LANCET, V367, P903, DOI 10.1016/S0140-6736(06)68380-3; Rajeswari R, 1999, INT J TUBERC LUNG D, V3, P869; SOUZA FB, 2007, J BRAS PNEUMOL, V33, P318; *WHO, 2009, TB2009411 WHOHTM	16	55	61	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2010	5	11							e14014	10.1371/journal.pone.0014014	http://dx.doi.org/10.1371/journal.pone.0014014			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	681OY	21103344	Green Submitted, Green Published, gold			2022-12-25	WOS:000284327800006
J	Cox, HS; McDermid, C; Azevedo, V; Muller, O; Coetzee, D; Simpson, J; Barnard, M; Coetzee, G; van Cutsem, G; Goemaere, E				Cox, Helen S.; McDermid, Cheryl; Azevedo, Virginia; Muller, Odelia; Coetzee, David; Simpson, John; Barnard, Marinus; Coetzee, Gerrit; van Cutsem, Gilles; Goemaere, Eric			Epidemic Levels of Drug Resistant Tuberculosis (MDR and XDR-TB) in a High HIV Prevalence Setting in Khayelitsha, South Africa	PLOS ONE			English	Article							MULTIDRUG-RESISTANT; MYCOBACTERIUM-TUBERCULOSIS; RISK-FACTORS	Background: Although multidrug-resistant tuberculosis (MDR-TB) is emerging as a significant threat to tuberculosis control in high HIV prevalence countries such as South Africa, limited data is available on the burden of drug resistant tuberculosis and any association with HIV in such settings. We conducted a community-based representative survey to assess the MDR-TB burden in Khayelitsha, an urban township in South Africa with high HIV and TB prevalence. Methodology/Principal Findings: A cross-sectional survey was conducted among adult clinic attendees suspected for pulmonary tuberculosis in two large primary care clinics, together constituting 50% of the tuberculosis burden in Khayelitsha. Drug susceptibility testing (DST) for isoniazid and rifampicin was conducted using a line probe assay on positive sputum cultures, and with culture-based DST for first and second-line drugs. Between May and November 2008, culture positive pulmonary tuberculosis was diagnosed in 271 new and 264 previously treated tuberculosis suspects (sample enriched with previously treated cases). Among those with known HIV status, 55% and 71% were HIV infected respectively. MDR-TB was diagnosed in 3.3% and 7.7% of new and previously treated cases. These figures equate to an estimated case notification rate for MDR-TB of 51/100,000/year, with new cases constituting 55% of the estimated MDR-TB burden. HIV infection was not significantly associated with rifampicin resistance in multivariate analyses. Conclusions/Significance: There is an extremely high burden of MDR-TB in this setting, most likely representing ongoing transmission. These data highlight the need to diagnose drug resistance among all TB cases, and for innovative models of case detection and treatment for MDR-TB, in order to interrupt transmission and control this emerging epidemic.	[Cox, Helen S.] Burnet Inst, Melbourne, Vic, Australia; [Cox, Helen S.; McDermid, Cheryl; Muller, Odelia; van Cutsem, Gilles; Goemaere, Eric] Med Sans Frontieres, Cape Town, South Africa; [Cox, Helen S.] Monash Univ, Melbourne, Vic 3004, Australia; [Azevedo, Virginia] City Cape Town Hlth, Cape Town, South Africa; [Coetzee, David; van Cutsem, Gilles; Goemaere, Eric] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Simpson, John; Barnard, Marinus] Natl Hlth Lab Serv, Cape Town, South Africa; [Coetzee, Gerrit] Natl Hlth Lab Serv, Johannesburg, South Africa	Burnet Institute; Monash University; University of Cape Town; National Health Laboratory Service	Cox, HS (corresponding author), Burnet Inst, Melbourne, Vic, Australia.	hcox@burnet.edu.au	Van Cutsem, Gilles/ABB-1171-2021	Van Cutsem, Gilles/0000-0002-8972-4480; Cox, Helen/0000-0002-6538-7192	Medecins Sans Frontieres, Belgium	Medecins Sans Frontieres, Belgium	This study was funded by Medecins Sans Frontieres, Belgium. The funders were involved in study design, data collection and analysis. However, final preparation of the manuscript and the decision to publish rests with the first author.	ALLEN BW, 1984, MED LAB SCI, V41, P400; Andrews JR, 2008, J INFECT DIS, V198, P1582, DOI 10.1086/592991; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; [Anonymous], 2008, 4 WHO; Barnard M, 2008, AM J RESP CRIT CARE, V177, P787, DOI 10.1164/rccm.200709-1436OC; *CIT CAP TOWN HLTH, 2009, HLTH STAT; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; *DEP HLTH, 2007, W CAP HIV ANT SER SU; Enarson D.A., 2000, MANAGEMENT TUBERCULO; Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC; HOSMER DW, 1980, COMMUN STAT A-THEOR, V9, P1043, DOI 10.1080/03610928008827941; Jenny-Avital Elizabeth R, 2002, AIDS Clin Care, V14, P72; Lawn SD, 2005, AIDS, V19, P2109, DOI 10.1097/01.aids.0000194808.20035.c1; March F, 1997, CLIN INFECT DIS, V25, P1044, DOI 10.1086/516065; Medecins Sans Frontieres, 2009, PAT CTR APPR DRUG RE; Mitchison DA, 1998, INT J TUBERC LUNG D, V2, P10; Panjabi R, 2007, INT J TUBERC LUNG D, V11, P828; PELOQUIN CA, 1993, NEW ENGL J MED, V329, P1122, DOI 10.1056/NEJM199310073291513; Sahai J, 1997, ANN INTERN MED, V127, P289, DOI 10.7326/0003-4819-127-4-199708150-00006; Scarparo C, 2004, J CLIN MICROBIOL, V42, P1109, DOI 10.1128/JCM.42.3.1109-1114.2004; Vernon A, 1999, LANCET, V353, P1843, DOI 10.1016/S0140-6736(98)11467-8; Weyer K, 2007, SAMJ S AFR MED J, V97, P1120; Zager EM, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-10	23	60	61	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e13901	10.1371/journal.pone.0013901	http://dx.doi.org/10.1371/journal.pone.0013901			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085569	Green Published, gold			2022-12-25	WOS:000284231800002
J	Berg, M; Danielsen, SA; Ahlquist, T; Merok, MA; Agesen, TH; Vatn, MH; Mala, T; Sjo, OH; Bakka, A; Moberg, I; Fetveit, T; Mathisen, O; Husby, A; Sandvik, O; Nesbakken, A; Thiis-Evensen, E; Lothe, RA				Berg, Marianne; Danielsen, Stine A.; Ahlquist, Terje; Merok, Marianne A.; Agesen, Trude H.; Vatn, Morten H.; Mala, Tom; Sjo, Ole H.; Bakka, Arne; Moberg, Ingvild; Fetveit, Torunn; Mathisen, Oystein; Husby, Anders; Sandvik, Oddvar; Nesbakken, Arild; Thiis-Evensen, Espen; Lothe, Ragnhild A.			DNA Sequence Profiles of the Colorectal Cancer Critical Gene Set KRAS-BRAF-PIK3CA-PTEN-TP53 Related to Age at Disease Onset	PLOS ONE			English	Article							MICROSATELLITE INSTABILITY; PTEN/MMAC1 GENE; MUTATIONS; PTEN; TP53; CETUXIMAB; P53; PANITUMUMAB; CARCINOMAS; IMPACT	The incidence of colorectal cancer (CRC) increases with age and early onset indicates an increased likelihood for genetic predisposition for this disease. The somatic genetics of tumor development in relation to patient age remains mostly unknown. We have examined the mutation status of five known cancer critical genes in relation to age at diagnosis, and compared the genomic complexity of tumors from young patients without known CRC syndromes with those from elderly patients. Among 181 CRC patients, stratified by microsatellite instability status, DNA sequence changes were identified in KRAS (32%), BRAF (16%), PIK3CA (4%), PTEN (14%) and TP53 (51%). In patients younger than 50 years (n = 45), PIK3CA mutations were not observed and TP53 mutations were more frequent than in the older age groups. The total gene mutation index was lowest in tumors from the youngest patients. In contrast, the genome complexity, assessed as copy number aberrations, was highest in tumors from the youngest patients. A comparable number of tumors from young (<50 years) and old patients (>70 years) was quadruple negative for the four predictive gene markers (KRAS-BRAF-PIK3CA-PTEN); however, 16% of young versus only 1% of the old patients had tumor mutations in PTEN/PIK3CA exclusively. This implies that mutation testing for prediction of EGFR treatment response may be restricted to KRAS and BRAF in elderly (>70 years) patients. Distinct genetic differences found in tumors from young and elderly patients, whom are comparable for known clinical and pathological variables, indicate that young patients have a different genetic risk profile for CRC development than older patients.	[Berg, Marianne; Danielsen, Stine A.; Ahlquist, Terje; Merok, Marianne A.; Agesen, Trude H.; Lothe, Ragnhild A.] Norwegian Radium Hosp, Inst Canc Res, Dept Canc Prevent, Oslo Univ Hosp, Oslo, Norway; [Berg, Marianne; Danielsen, Stine A.; Ahlquist, Terje; Merok, Marianne A.; Agesen, Trude H.; Nesbakken, Arild; Lothe, Ragnhild A.] Univ Oslo, Ctr Canc Biomed, Oslo, Norway; [Merok, Marianne A.; Mala, Tom; Sjo, Ole H.; Nesbakken, Arild] Oslo Univ Hosp, Dept Gastrointestinal Surg, Oslo, Norway; [Vatn, Morten H.; Thiis-Evensen, Espen] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Organ Transplantat Gastroenterol & Nephrol, N-0027 Oslo, Norway; [Bakka, Arne; Moberg, Ingvild] Akershus Univ Hosp, Dept Digest Surg, Lorenskog, Norway; [Bakka, Arne; Nesbakken, Arild; Lothe, Ragnhild A.] Univ Oslo, Fac Med, Oslo, Norway; [Fetveit, Torunn] Sorlandet Hosp, Dept Surg, Arendal, Norway; [Mathisen, Oystein] Univ Oslo, Rikshosp, Dept Liver Gastrointestinal & Pediat Surg, N-0027 Oslo, Norway; [Husby, Anders] Diakonhjemmet Hosp, Dept Surg, Oslo, Norway; [Sandvik, Oddvar] Sorlandet Hosp, Dept Gastrointestinal Surg, Kristiansand, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; Diakonhjemmet Hospital	Berg, M (corresponding author), Norwegian Radium Hosp, Inst Canc Res, Dept Canc Prevent, Oslo Univ Hosp, Oslo, Norway.	ragnhild.a.lothe@rr-research.no	Mala, Tom/J-5418-2019	Mala, Tom/0000-0003-3058-4775; Lothe, Ragnhild A./0000-0002-1693-1032	Norwegian Cancer Society [95068/RAL]; Norwegian Foundation for Health and Rehabilitation [HF-52015/002]	Norwegian Cancer Society(Norwegian Cancer Society); Norwegian Foundation for Health and Rehabilitation	This study was funded by grants from the Norwegian Cancer Society (http://www.kreftforeningen.no/english) to R. A. L. (grant number 95068/RAL, including PhD grants to S. A. D., M. B. and T. H. A., and Post doc grant to T. A.), and grants from the Norwegian Foundation for Health and Rehabilitation (http://www.helseogrehab.no/) through the EXTRA funds (grant number HF-52015/002) to E. T. E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlquist T, 2008, NEOPLASIA, V10, P680, DOI 10.1593/neo.08312; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Andreyev HJN, 1998, J NATL CANCER I, V90, P675, DOI 10.1093/jnci/90.9.675; Bardelli A, 2010, J CLIN ONCOL, V28, P1254, DOI 10.1200/JCO.2009.24.6116; Berg M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-100; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Boland CR, 1998, CANCER RES, V58, P5248; BOS JL, 1989, CANCER RES, V49, P4682; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Cancer Registry of Norway, 2009, CANC NORW 2008 CANC; Chan TL, 2003, CANCER RES, V63, P4878; Chang JG, 1999, EUR J CANCER, V35, P647, DOI 10.1016/S0959-8049(98)00411-0; Danielsen SA, 2008, HUM MUTAT, V29, pE252, DOI 10.1002/humu.20860; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; DEJONG UW, 1972, INT J CANCER, V10, P463, DOI 10.1002/ijc.2910100305; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Dicuonzo G, 2001, CLIN CANCER RES, V7, P4049; Diep CB, 2003, J CLIN ONCOL, V21, P820, DOI 10.1200/JCO.2003.05.190; Engstrom PF, 2008, PHARMACOTHERAPY, V28, p18S, DOI 10.1592/phco.28.11-supp.18S; Ericson K, 2010, P NATL ACAD SCI USA, V107, P2598, DOI 10.1073/pnas.0914018107; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Frizis H, 2004, Tech Coloproctol, V8 Suppl 1, ps147, DOI 10.1007/s10151-004-0139-4; Garnett MJ, 2004, CANCER CELL, V6, P313, DOI 10.1016/j.ccr.2004.09.022; Gonzalez EC, 2001, DIS COLON RECTUM, V44, P251, DOI 10.1007/BF02234301; Gryfe R, 2000, NEW ENGL J MED, V342, P69, DOI 10.1056/NEJM200001133420201; Haglund Kaisa, 2007, Critical Reviews in Oncogenesis, V13, P39; HERREROSVILLANU.M, 2010, MOL BIOL REP; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; Karoui M, 2004, BRIT J CANCER, V90, P1230, DOI 10.1038/sj.bjc.6601687; Khan SA, 2008, J SURG ONCOL, V97, P621, DOI 10.1002/jso.20996; LAND H, 1983, SCIENCE, V222, P771, DOI 10.1126/science.6356358; Liang JT, 2003, BRIT J SURG, V90, P205, DOI 10.1002/bjs.4015; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; LOTHE RA, 1993, CANCER RES, V53, P5849; Lothe RA, 1997, MOL MED TODAY, V3, P61, DOI 10.1016/S1357-4310(96)10055-1; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; McGivern A, 2004, Fam Cancer, V3, P101; Nassif NT, 2004, ONCOGENE, V23, P617, DOI 10.1038/sj.onc.1207059; O'Connell JB, 2004, AM J SURG, V187, P343, DOI 10.1016/j.amjsurg.2003.12.020; Ogino S, 2009, J CLIN ONCOL, V27, P1477, DOI 10.1200/JCO.2008.18.6544; Oikonomou E, 2009, NEOPLASIA, V11, P1116, DOI 10.1593/neo.09514; Perrone F, 2009, ANN ONCOL, V20, P84, DOI 10.1093/annonc/mdn541; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; Russo A, 2005, J CLIN ONCOL, V23, P7518, DOI 10.1200/JCO.2005.00.471; Samowitz WS, 2009, CANCER CAUSE CONTROL, V20, P1763, DOI 10.1007/s10552-009-9410-3; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Samuels Y, 2006, CURR OPIN ONCOL, V18, P77, DOI 10.1097/01.cco.0000198021.99347.b9; Sengupta S, 2005, NAT REV MOL CELL BIO, V6, P44, DOI 10.1038/nrm1546; Shin KH, 2001, CANCER LETT, V174, P189, DOI 10.1016/S0304-3835(01)00691-7; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; TOL J, 2010, EUR J CANC; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wang ZJ, 1998, AM J PATHOL, V153, P363, DOI 10.1016/S0002-9440(10)65579-4; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu Q, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-45; Yantiss RK, 2009, AM J SURG PATHOL, V33, P572, DOI 10.1097/PAS.0b013e31818afd6b; Zbuk K, 2009, SEMIN ONCOL, V36, P439, DOI 10.1053/j.seminoncol.2009.07.008; Zhou XP, 2002, AM J PATHOL, V161, P439, DOI 10.1016/S0002-9440(10)64200-9	61	91	95	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e13978	10.1371/journal.pone.0013978	http://dx.doi.org/10.1371/journal.pone.0013978			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103049	Green Published, Green Submitted, gold			2022-12-25	WOS:000284147700023
J	de Kroon, MLA; Renders, CM; van Wouwe, JP; van Buuren, S; Hirasing, RA				de Kroon, Marlou L. A.; Renders, Carry M.; van Wouwe, Jacobus P.; van Buuren, Stef; Hirasing, Remy A.			The Terneuzen Birth Cohort: BMI Change between 2 and 6 Years Is Most Predictive of Adult Cardiometabolic Risk	PLOS ONE			English	Article							BODY-MASS INDEX; IMPAIRED GLUCOSE-TOLERANCE; C-REACTIVE PROTEIN; METABOLIC SYNDROME; ADIPOSE-TISSUE; CHILDHOOD GROWTH; YOUNG ADULTHOOD; WEIGHT-GAIN; ADOLESCENCE; OBESITY	Background: We recently reported the age interval 2-6y being the earliest and most critical for adult overweight. We now aim to determine which age intervals are predictive of cardiometabolic risk at young adulthood. Methods and Findings: We analyzed data from 642 18-28 years olds from the Terneuzen Birth Cohort. Individual BMI SDS trajectories were fitted by a piecewise linear model. By multiple regression analyses relationships were assessed between subsequent conditional BMI SDS changes and components of the metabolic syndrome (MetS), skinfold thickness and hsCRP at young adulthood. Results were adjusted for gender and age, and other confounders. Gender was studied as an effect modifier. All BMI SDS changes throughout childhood were related to waist circumference and skinfold thickness. No other significant relationship was found before the age of 2 years, except between the BMI SDS change 0-1y and hsCRP. Fasting blood glucose was not predicted by any BMI SDS change. BMI SDS change 2-6y was strongly related to most outcome variables, especially to waist circumference (beta 0.47, SE 0.02), systolic and diastolic blood pressure (beta 0.20 SE 0.04 and beta 0.19 SE 0.03), and hsCRP (beta 0.16 SE 0.04). The BMI SDS change 10-18y was most strongly related to HDL cholesterol (beta -0.10, SE 0.03), and triglycerides (beta 0.21, SE 0.03). To a lesser degree, the BMI SDS change 6-10y was related to most outcome variables. BMI SDS changes 2-6y and 10-18y were significantly related to MetS: the OR was respectively 3.39 (95% CI 2.33-4.94) and 2.84 (95% CI 1.94-4.15). Conclusion: BMI SDS changes from 2y onwards were related to cardiometabolic risk at young adulthood, the age interval 2-6y being the most predictive. Monitoring and stabilizing the BMI SDS of children as young as 2-6y may not only reverse the progression towards adult overweight, but it may also safeguard cardiometabolic status.	[de Kroon, Marlou L. A.; Hirasing, Remy A.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth, Amsterdam, Netherlands; [Renders, Carry M.] Vrije Univ Amsterdam, Dept Hlth Sci, Amsterdam, Netherlands; [van Wouwe, Jacobus P.] TNO Qual Life Prevent & Hlth Care, Netherlands Org Appl Sci Res, Leiden, Netherlands; [van Buuren, Stef] Univ Utrecht, Dept Methodol & Stat, FSS, Utrecht, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Netherlands Organization Applied Science Research; Utrecht University	de Kroon, MLA (corresponding author), Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth, Amsterdam, Netherlands.	top@fms.demon.nl	Van Wouwe, Jacobus P/D-5549-2018; de Kroon, Marlou MLA/M-4040-2014	Van Wouwe, Jacobus P/0000-0001-9273-6258; van Buuren, Stef/0000-0003-1098-2119; Renders, Carry/0000-0001-6688-1312; de Kroon, Marlou/0000-0003-1730-4994	Health Research and Development Council of The Netherlands (ZONMw) [2100.0092]; Community Hospital laboratory in the city of Terneuzen; Municipal Health Service of Terneuzen (GGD Zeeland)	Health Research and Development Council of The Netherlands (ZONMw)(Netherlands Organization for Health Research and Development); Community Hospital laboratory in the city of Terneuzen; Municipal Health Service of Terneuzen (GGD Zeeland)	The study was funded by the Health Research and Development Council of The Netherlands (ZONMw Grants no. 2100.0092). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully thank all the participants for their time and efforts, the assistants for their contribution to the research work, the Community Hospital laboratory in the city of Terneuzen and especially Ruud Muusze PhD, Municipal Health Service of Terneuzen (GGD Zeeland) for their support and cooperation, especially Dr Victor Slenter, director, and Guus A. de Jonge, PhD, Professor Emeritus, for laying the foundations of this study between 1977-1986. We would like to thank Professor Dr Willem van Mechelen and Dr Mai JM Chin A Paw for their useful comments on an earlier version of this manuscript.	Addo OY, 2010, AM J CLIN NUTR, V91, P635, DOI 10.3945/ajcn.2009.28385; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Baadenhuijsen H, 2005, CLIN CHEM LAB MED, V43, P304, DOI 10.1515/CCLM.2005.052; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; Boulat O, 1998, CLIN CHIM ACTA, V272, P127, DOI 10.1016/S0009-8981(98)00017-5; Cole T J, 2004, BMC Pediatr, V4, P6; De Kroon MLA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009155; DEKROON ML, 2008, EUR J PUBLIC HEALTH, V6, P656; Eriksson JG, 2003, DIABETOLOGIA, V46, P190, DOI 10.1007/s00125-002-1012-5; Fall CHD, 2008, DIABETES CARE, V31, P2349, DOI 10.2337/dc08-0911; Fredriks AM, 2000, ARCH DIS CHILD, V82, P107, DOI 10.1136/adc.82.2.107; Gonzalez DA, 2010, INT J OBESITY, V34, P195, DOI 10.1038/ijo.2009.201; HAGER A, 1977, METABOLISM, V26, P607, DOI 10.1016/0026-0495(77)90082-8; Keijzer-Veen MG, 2005, J CLIN EPIDEMIOL, V58, P1320, DOI 10.1016/j.jclinepi.2005.04.004; Khera A, 2005, J AM COLL CARDIOL, V46, P464, DOI 10.1016/j.jacc.2005.04.051; Kindblom JM, 2009, DIABETES, V58, P867, DOI 10.2337/db08-0606; Kvaavik E, 2003, ARCH PEDIAT ADOL MED, V157, P1212, DOI 10.1001/archpedi.157.12.1212; Law CM, 2002, CIRCULATION, V105, P1088, DOI 10.1161/hc0902.104677; Leunissen RWJ, 2009, JAMA-J AM MED ASSOC, V301, P2234, DOI 10.1001/jama.2009.761; Monteiro POA, 2003, INT J OBESITY, V27, P1274, DOI 10.1038/sj.ijo.0802409; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Oren A, 2003, INT J OBESITY, V27, P1383, DOI 10.1038/sj.ijo.0802404; PARKER LN, 1991, ENDOCRIN METAB CLIN, V20, P71, DOI 10.1016/S0889-8529(18)30282-2; Porter SA, 2009, DIABETES CARE, V32, P1068, DOI 10.2337/dc08-2280; Ridker PM, 2008, CIRCULATION, V118, P2243, DOI 10.1161/CIRCULATIONAHA.108.814251; Ruppert D, 2003, SEMIPARAMETRIC REGRE; Scholtens S, 2007, AM J EPIDEMIOL, V165, P919, DOI 10.1093/aje/kwk083; Singhal A, 2007, CIRCULATION, V115, P213, DOI 10.1161/CIRCULATIONAHA.106.617811; Snijders T, 1999, MULTILEVEL ANAL; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Srinivasan SR, 2002, DIABETES, V51, P204, DOI 10.2337/diabetes.51.1.204; St-Onge MP, 2004, DIABETES CARE, V27, P2222, DOI 10.2337/diacare.27.9.2222; Thomas L., 1998, LABOR DIAGNOSE; WIINBERG N, 1995, AM J HYPERTENS, V8, P978, DOI 10.1016/0895-7061(95)00216-2	35	29	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e13966	10.1371/journal.pone.0013966	http://dx.doi.org/10.1371/journal.pone.0013966			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103047	Green Published, gold			2022-12-25	WOS:000284147700015
J	Wohlkonig, A; Huet, J; Looze, Y; Wintjens, R				Wohlkonig, Alexandre; Huet, Joelle; Looze, Yvan; Wintjens, Rene			Structural Relationships in the Lysozyme Superfamily: Significant Evidence for Glycoside Hydrolase Signature Motifs	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; N-ACETYLMURAMIC ACID; PROTEIN FUNCTION; SUBSTRATE-BINDING; CONFORMATIONAL STABILITY; HEVEA-BRASILIENSIS; FUNCTIONAL SITES; CHITINASE; SEQUENCE; IDENTIFICATION	Background: Chitin is a polysaccharide that forms the hard, outer shell of arthropods and the cell walls of fungi and some algae. Peptidoglycan is a polymer of sugars and amino acids constituting the cell walls of most bacteria. Enzymes that are able to hydrolyze these cell membrane polymers generally play important roles for protecting plants and animals against infection with insects and pathogens. A particular group of such glycoside hydrolase enzymes share some common features in their three-dimensional structure and in their molecular mechanism, forming the lysozyme superfamily. Results: Besides having a similar fold, all known catalytic domains of glycoside hydrolase proteins of lysozyme superfamily (families and subfamilies GH19, GH22, GH23, GH24 and GH46) share in common two structural elements: the central helix of the all-alpha domain, which invariably contains the catalytic glutamate residue acting as general-acid catalyst, and a beta-hairpin pointed towards the substrate binding cleft. The invariant beta-hairpin structure is interestingly found to display the highest amino acid conservation in aligned sequences of a given family, thereby allowing to define signature motifs for each GH family. Most of such signature motifs are found to have promising performances for searching sequence databases. Our structural analysis further indicates that the GH motifs participate in enzymatic catalysis essentially by containing the catalytic water positioning residue of inverting mechanism. Conclusions: The seven families and subfamilies of the lysozyme superfamily all have in common a beta-hairpin structure which displays a family-specific sequence motif. These GH beta-hairpin motifs contain potentially important residues for the catalytic activity, thereby suggesting the participation of the GH motif to catalysis and also revealing a common catalytic scheme utilized by enzymes of the lysozyme superfamily.	[Wohlkonig, Alexandre] VIB, Brussels, Belgium; [Huet, Joelle; Looze, Yvan; Wintjens, Rene] Univ Libre Bruxelles, Inst Pharm, Lab Chim Gen, Brussels, Belgium; [Wintjens, Rene] USR 3078 CNRS, Interdisciplinary Res Inst, Villeneuve Dascq, France	Flanders Institute for Biotechnology (VIB); Universite Libre de Bruxelles; Universite de Lille - ISITE; Universite de Lille	Wohlkonig, A (corresponding author), VIB, Brussels, Belgium.	Rene.Wintjens@ulb.ac.be		Wohlkonig, Alexandre/0000-0003-3103-5022	Belgian Fund for Scientific Research (FNRS-FRS)	Belgian Fund for Scientific Research (FNRS-FRS)(Fonds de la Recherche Scientifique - FNRS)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by the Belgian Fund for Scientific Research (FNRS-FRS) (FRFC project). RW is Research Associate at the FNRS-FRC.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersen MD, 1997, BIOCHEM J, V322, P815, DOI 10.1042/bj3220815; ATTWOOD TK, 1994, NUCLEIC ACIDS RES, V22, P3590; Ausiello G, 2005, NUCLEIC ACIDS RES, V33, pW133, DOI 10.1093/nar/gki499; Ausiello G, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S2; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Berman Helen M, 2004, Am J Pharmacogenomics, V4, P247, DOI 10.2165/00129785-200404040-00004; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BLAKE CCF, 1965, NATURE, V206, P757, DOI 10.1038/206757a0; Bokma E, 1997, FEBS LETT, V411, P161, DOI 10.1016/S0014-5793(97)00682-0; BOLLER T, 1983, PLANTA, V157, P22, DOI 10.1007/BF00394536; Bourne PE, 2004, NUCLEIC ACIDS RES, V32, pD223, DOI 10.1093/nar/gkh096; BOUTONNET NS, 1995, PROTEIN ENG, V8, P647, DOI 10.1093/protein/8.7.647; CANFIELD RE, 1963, J BIOL CHEM, V238, P2698; CHIPMAN DM, 1967, J BIOL CHEM, V242, P4388; COLLINGE DB, 1993, PLANT J, V3, P31, DOI 10.1046/j.1365-313X.1993.t01-1-00999.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Di Gennaro JA, 2001, J STRUCT BIOL, V134, P232, DOI 10.1006/jsbi.2001.4391; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Espadaler J, 2006, BIOINFORMATICS, V22, P2237, DOI 10.1093/bioinformatics/btl382; FELSENSTEIN J, 1995, PHYLIP PHYLOGENY INF; FUKAMIZO T, 1995, BIOCHEM J, V311, P377, DOI 10.1042/bj3110377; Fukamizo T, 2000, CURR PROTEIN PEPT SC, V1, P105, DOI 10.2174/1389203003381450; Funahashi J, 1999, PROTEIN ENG, V12, P841, DOI 10.1093/protein/12.10.841; Garcia-Casado G, 1998, GLYCOBIOLOGY, V8, P1021, DOI 10.1093/glycob/8.10.1021; Golovin A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-312; Hahn M, 2000, ACTA CRYSTALLOGR D, V56, P1096, DOI 10.1107/S090744490000857X; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hashimoto Y, 1996, J BIOCHEM-TOKYO, V119, P145; Helland R, 2009, CELL MOL LIFE SCI, V66, P2585, DOI 10.1007/s00018-009-0063-x; Henikoff JG, 2000, NUCLEIC ACIDS RES, V28, P228, DOI 10.1093/nar/28.1.228; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; HOLM L, 1994, FEBS LETT, V340, P129, DOI 10.1016/0014-5793(94)80187-8; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Huet J, 2008, BIOCHEMISTRY-US, V47, P8283, DOI 10.1021/bi800655u; Hulo N, 2008, NUCLEIC ACIDS RES, V36, pD245, DOI 10.1093/nar/gkm977; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Iseli B, 1996, FEBS LETT, V382, P186, DOI 10.1016/0014-5793(96)00174-3; JEKEL PA, 1991, EUR J BIOCHEM, V200, P123, DOI 10.1111/j.1432-1033.1991.tb21057.x; JOLLES P, 1984, MOL CELL BIOCHEM, V63, P165; Jones S, 2004, CURR OPIN CHEM BIOL, V8, P3, DOI 10.1016/j.cbpa.2003.11.001; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kinoshita K, 2003, CURR OPIN STRUC BIOL, V13, P396, DOI 10.1016/S0959-440X(03)00074-5; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kuroki R, 1999, P NATL ACAD SCI USA, V96, P8949, DOI 10.1073/pnas.96.16.8949; Lacombe-Harvey ME, 2009, FEBS J, V276, P857, DOI 10.1111/j.1742-4658.2008.06830.x; LANYON SM, 1985, SYST ZOOL, V34, P397, DOI 10.2307/2413204; Laskowski RA, 2005, J MOL BIOL, V351, P614, DOI 10.1016/j.jmb.2005.05.067; Leung AKW, 2001, BIOCHEMISTRY-US, V40, P5665, DOI 10.1021/bi0028035; Loon L. C. van, 1994, Plant Molecular Biology Reporter, V12, P245, DOI 10.1007/BF02668748; Lupyan D, 2005, BIOINFORMATICS, V21, P3255, DOI 10.1093/bioinformatics/bti527; Maenaka K, 1998, BIOCHEM J, V333, P71, DOI 10.1042/bj3330071; MAENAKA K, 1994, J BIOL CHEM, V269, P7070; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Monzingo AF, 1996, NAT STRUCT BIOL, V3, P133, DOI 10.1038/nsb0296-133; MURAKI M, 1992, BIOCHEMISTRY-US, V31, P9212, DOI 10.1021/bi00153a014; Pal D, 2005, STRUCTURE, V13, P121, DOI 10.1016/j.str.2004.10.015; Pazos F, 2004, P NATL ACAD SCI USA, V101, P14754, DOI 10.1073/pnas.0404569101; Pei JM, 2001, BIOINFORMATICS, V17, P700, DOI 10.1093/bioinformatics/17.8.700; RAMBAUT A, 2006, FIGTREE VERSION 1 0; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Stark A, 2003, NUCLEIC ACIDS RES, V31, P3341, DOI 10.1093/nar/gkg506; Takano K, 2001, PROTEINS, V44, P233, DOI 10.1002/prot.1088; Tang CM, 2004, PLANT MOL BIOL, V56, P285, DOI 10.1007/s11103-004-3382-1; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; VANSCHELTINGA ACT, 1994, STRUCTURE, V2, P1181, DOI 10.1016/S0969-2126(94)00120-0; VERBURG JG, 1993, ARCH BIOCHEM BIOPHYS, V300, P223, DOI 10.1006/abbi.1993.1031; VERBURG JG, 1992, J BIOL CHEM, V267, P3886; Wallace AC, 1997, PROTEIN SCI, V6, P2308; WANG QP, 1994, J AM CHEM SOC, V116, P11594, DOI 10.1021/ja00104a060; Watson JD, 2005, CURR OPIN STRUC BIOL, V15, P275, DOI 10.1016/j.sbi.2005.04.003; WEAVER LH, 1995, J MOL BIOL, V245, P54, DOI 10.1016/S0022-2836(95)80038-7; Whisstock JC, 2003, Q REV BIOPHYS, V36, P307, DOI 10.1017/S0033583503003901	75	64	69	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e15388	10.1371/journal.pone.0015388	http://dx.doi.org/10.1371/journal.pone.0015388			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085702	Green Published, Green Submitted, gold			2022-12-25	WOS:000284035900026
J	Lalonde, MS; Arts, EJ				Lalonde, Matthew S.; Arts, Eric J.			DNA Suspension Arrays: Silencing Discrete Artifacts for High-Sensitivity Applications	PLOS ONE			English	Article							OLIGONUCLEOTIDE LIGATION ASSAY; NEVIRAPINE RESISTANCE MUTATIONS; REVERSE-TRANSCRIPTASE; DRUG-RESISTANCE; HIV-1; INFECTION; VARIANTS	Detection of low frequency single nucleotide polymorphisms (SNPs) has important implications in early screening for tumorgenesis, genetic disorders and pathogen drug resistance. Nucleic acid arrays are a powerful tool for genome-scale SNP analysis, but detection of low-frequency SNPs in a mixed population on an array is problematic. We demonstrate a model assay for HIV-1 drug resistance mutations, wherein ligase discrimination products are collected on a suspension array. In developing this system, we discovered that signal from multiple polymorphisms was obscured by two discrete hybridization artifacts. Specifically: 1) tethering of unligated probes on the template DNA elicited false signal and 2) unpredictable probe secondary structures impaired probe capture and suppressed legitimate signal from the array. Two sets of oligonucleotides were used to disrupt these structures; one to displace unligated reporter labels from the bead-bound species and another to occupy sequences which interfered with array hybridization. This artifact silencing system resulted in a mean 21-fold increased sensitivity for 29 minority variants of 17 codons in our model assay for mutations most commonly associated with HIV-1 drug resistance. Furthermore, since the artifacts we characterized are not unique to our system, their specific inhibition might improve the quality of data from solid-state microarrays as well as from the growing number of multiple analyte suspension arrays relying on sequence-specific nucleic acid target capture.	[Lalonde, Matthew S.; Arts, Eric J.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Arts, Eric J.] Case Western Reserve Univ, Div Infect Dis, Dept Med, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Lalonde, MS (corresponding author), Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA.	eja3@case.edu	Lalonde, Matthew/I-1134-2012	Arts, Eric/0000-0002-4880-7968	National Institutes of Health [AI49170, AI36219]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI049170, R01AI049170, R21AI049170, P30AI036219] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant number AI49170. Core facilities were provided by the Case Western Reserve/University Hospitals Center for AIDS Research, supported by National Institutes of Health grant number AI36219. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai FP, 2007, NAT METHODS, V4, P123, DOI 10.1038/nmeth995; Carnevale EP, 2007, J CLIN MICROBIOL, V45, P752, DOI 10.1128/JCM.01683-06; Carson RT, 1999, J IMMUNOL METHODS, V227, P41, DOI 10.1016/S0022-1759(99)00069-1; CHEN HB, 1990, NUCLEIC ACIDS RES, V18, P871, DOI 10.1093/nar/18.4.871; Cooper DA, 2008, NEW ENGL J MED, V359, P355, DOI 10.1056/NEJMoa0708978; Dare JT, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-57; Dent AE, 2007, AM J TROP MED HYG, V77, P250, DOI 10.4269/ajtmh.2007.77.250; Descamps D, 2009, HIV CLIN TRIALS, V10, P385, DOI 10.1310/hct1006-385; Einstein MH, 2009, CLIN CANCER RES, V15, P1019, DOI 10.1158/1078-0432.CCR-08-1207; Lalonde MS, 2007, J CLIN MICROBIOL, V45, P2604, DOI 10.1128/JCM.00431-07; Li J, 2008, NAT MED, V14, P579, DOI 10.1038/nm1708; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; McNamara DT, 2006, AM J TROP MED HYG, V74, P413, DOI 10.4269/ajtmh.2006.74.413; Palmer S, 2006, P NATL ACAD SCI USA, V103, P7094, DOI 10.1073/pnas.0602033103; Pozhitkov Alex E., 2007, Briefings in Functional Genomics & Proteomics, V6, P141, DOI 10.1093/bfgp/elm014; Rahimian M, 2008, J PHYS CHEM B, V112, P8770, DOI 10.1021/jp801997v; Taylor JD, 2001, BIOTECHNIQUES, V30, P661, DOI 10.2144/01303dd04; Troyer RM, 2008, AIDS RES HUM RETROV, V24, P235, DOI 10.1089/aid.2007.0138; Varghese V, 2009, JAIDS-J ACQ IMM DEF, V52, P309, DOI 10.1097/QAI.0b013e3181bca669; Villahermosa ML, 2001, J HUMAN VIROL, V4, P238	20	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e15476	10.1371/journal.pone.0015476	http://dx.doi.org/10.1371/journal.pone.0015476			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	676NU	21079742	Green Published, Green Submitted, gold			2022-12-25	WOS:000283920000027
J	Yang, JS; Kim, JT; Jeon, J; Park, HS; Kang, GH; Park, KS; Lee, HK; Kim, S; Cho, YM				Yang, Jae-Seong; Kim, Jin Taek; Jeon, Jouhyun; Park, Ho Sun; Kang, Gyeong Hoon; Park, Kyong Soo; Lee, Hong Kyu; Kim, Sanguk; Cho, Young Min			Changes in Hepatic Gene Expression upon Oral Administration of Taurine-Conjugated Ursodeoxycholic Acid in ob/ob Mice	PLOS ONE			English	Article							NONALCOHOLIC FATTY LIVER; TAUROURSODEOXYCHOLIC ACID; INSULIN-RESISTANCE; OXIDATIVE STRESS; STEATOHEPATITIS; DISEASE; METABOLISM; STEATOSIS; MODEL; RATS	Nonalcoholic fatty liver disease (NAFLD) is highly prevalent and associated with considerable morbidities. Unfortunately, there is no currently available drug established to treat NAFLD. It was recently reported that intraperitoneal administration of taurine-conjugated ursodeoxycholic acid (TUDCA) improved hepatic steatosis in ob/ob mice. We hereby examined the effect of oral TUDCA treatment on hepatic steatosis and associated changes in hepatic gene expression in ob/ob mice. We administered TUDCA to ob/ob mice at a dose of 500 mg/kg twice a day by gastric gavage for 3 weeks. Body weight, glucose homeostasis, endoplasmic reticulum (ER) stress, and hepatic gene expression were examined in comparison with control ob/ob mice and normal littermate C57BL/6J mice. Compared to the control ob/ob mice, TUDCA treated ob/ob mice revealed markedly reduced liver fat stained by oil red O (44.2 +/- 5.8% vs. 21.1 +/- 10.4%, P<0.05), whereas there was no difference in body weight, oral glucose tolerance, insulin sensitivity, and ER stress. Microarray analysis of hepatic gene expression demonstrated that oral TUDCA treatment mainly decreased the expression of genes involved in de novo lipogenesis among the components of lipid homeostasis. At pathway levels, oral TUDCA altered the genes regulating amino acid, carbohydrate, and drug metabolism in addition to lipid metabolism. In summary, oral TUDCA treatment decreased hepatic steatosis in ob/ob mice by cooperative regulation of multiple metabolic pathways, particularly by reducing the expression of genes known to regulate de novo lipogenesis.	[Yang, Jae-Seong; Kim, Sanguk] Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang, South Korea; [Kim, Jin Taek; Park, Ho Sun; Park, Kyong Soo; Lee, Hong Kyu; Cho, Young Min] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Jeon, Jouhyun; Kim, Sanguk] Pohang Univ Sci & Technol, Dept Life Sci, Pohang, South Korea; [Kang, Gyeong Hoon] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea	Pohang University of Science & Technology (POSTECH); Seoul National University (SNU); Pohang University of Science & Technology (POSTECH); Seoul National University (SNU)	Yang, JS (corresponding author), Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang, South Korea.	sukim@postech.ac.kr; ymchomd@snu.ac.kr	Kang, Gyeong Hoon/F-1051-2010; Park, Kyong Soo/C-2265-2008; Cho, Young Min/J-5669-2012; Yang, Jae-Seong/AAH-6965-2019	Kang, Gyeong Hoon/0000-0003-2380-6675; Park, Kyong Soo/0000-0003-3597-342X; Yang, Jae-Seong/0000-0001-9910-3170; Park, Ho Seon/0000-0003-1200-4626; Kim, Sanguk/0000-0002-3449-3814	Ministry of Education, Science and Technology [20090084155, M10753020006-07N5302-00500, R31-2008-000-10100-0]; Daewoong Co. LTD., Seoul, South Korea	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Daewoong Co. LTD., Seoul, South Korea	Funding: This work was supported by grants from the National Research Foundation Grant (MEST) (No. 20090084155, M10753020006-07N5302-00500), and the World Class University (No. R31-2008-000-10100-0), which is funded by the Ministry of Education, Science and Technology, and Daewoong Co. LTD., Seoul, South Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmalek MF, 2007, MED CLIN N AM, V91, P1125, DOI 10.1016/j.mcna.2007.06.001; Adams LA, 2007, ANN EPIDEMIOL, V17, P863, DOI 10.1016/j.annepidem.2007.05.013; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Aragno M, 2009, FREE RADICAL BIO MED, V47, P1067, DOI 10.1016/j.freeradbiomed.2009.07.016; Bellentani S, 1996, BIOCHEM BIOPH RES CO, V220, P479, DOI 10.1006/bbrc.1996.0430; Bellentani S, 2008, HEPATOLOGY, V47, P746, DOI 10.1002/hep.22009; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Caldwell SH, 1999, HEPATOLOGY, V29, P664, DOI 10.1002/hep.510290347; Charlton M, 2004, CLIN GASTROENTEROL H, V2, P1048, DOI 10.1016/S1542-3565(04)00440-9; Diraison F, 2003, DIABETES METAB, V29, P478, DOI 10.1016/S1262-3636(07)70061-7; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; Edmison John, 2007, Clin Liver Dis, V11, P75, DOI 10.1016/j.cld.2007.02.011; Ellis EM, 2007, PHARMACOL THERAPEUT, V115, P13, DOI 10.1016/j.pharmthera.2007.03.015; Greenfield V, 2008, CURR OPIN GASTROEN, V24, P320, DOI 10.1097/MOG.0b013e3282fbccf2; Hussein O, 2007, DIGEST DIS SCI, V52, P2512, DOI 10.1007/s10620-006-9631-1; KARS M, DIABETES; KITANI K, 1985, AM J PHYSIOL, V248, pG407, DOI 10.1152/ajpgi.1985.248.4.G407; Kotronen A, 2008, ARTERIOSCL THROM VAS, V28, P27, DOI 10.1161/ATVBAHA.107.147538; Laurin J, 1996, HEPATOLOGY, V23, P1464; Lazaridis KN, 2001, J HEPATOL, V35, P134, DOI 10.1016/S0168-8278(01)00092-7; Li TG, 2009, PPAR RES, V2009, DOI 10.1155/2009/501739; Lindor KD, 2004, HEPATOLOGY, V39, P770, DOI 10.1002/hep.20092; Lukivskaya O, 2007, LIFE SCI, V80, P2397, DOI 10.1016/j.lfs.2007.02.042; Lundasen T, 2003, J BIOL CHEM, V278, P43224, DOI 10.1074/jbc.M302645200; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223; NAKAI T, 1992, BIOCHEM J, V288, P613, DOI 10.1042/bj2880613; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Parks EJ, 2006, J LIPID RES, V47, P1651, DOI 10.1194/jlr.R600018-JLR200; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Reigner BG, 2002, EUR J CLIN PHARMACOL, V57, P835, DOI 10.1007/s00228-001-0405-6; Rizos CV, 2009, EXPERT OPIN DRUG SAF, V8, P15, DOI [10.1517/14740330802597821 , 10.1517/14740330802597821]; Rodrigues CMP, 1998, MOL MED, V4, P165, DOI 10.1007/BF03401914; Rodrigues CMP, 2001, BIOCHEM BIOPH RES CO, V281, P468, DOI 10.1006/bbrc.2001.4370; Rudolph G, 2002, EUR J CLIN INVEST, V32, P575, DOI 10.1046/j.1365-2362.2002.01030.x; Sabuncu Tevfik, 2003, Rom J Gastroenterol, V12, P189; Sanyal AJ, N ENGL J MED, V362, P1675; Schreuder TCMA, 2008, WORLD J GASTROENTERO, V14, P2474, DOI 10.3748/wjg.14.2474; Sekiya M, 2008, BIOCHEM BIOPH RES CO, V375, P602, DOI 10.1016/j.bbrc.2008.08.068; Setchell KDR, 1996, GUT, V38, P439, DOI 10.1136/gut.38.3.439; Stefan N, 2008, ENDOCR REV, V29, P939, DOI 10.1210/er.2008-0009; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Svegliati-Baroni G, 2006, AM J PATHOL, V169, P846, DOI 10.2353/ajpath.2006.050953; Targher G, 2007, DIABETES CARE, V30, P2119, DOI 10.2337/dc07-0349; Tilg H, 2005, NAT CLIN PRACT GASTR, V2, P148, DOI 10.1038/ncpgasthep0116; TSUKAHARA K, 1993, LIVER, V13, P262; Yu W, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-528	49	37	39	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2010	5	11							e13858	10.1371/journal.pone.0013858	http://dx.doi.org/10.1371/journal.pone.0013858			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675OD	21079772	Green Published, Green Submitted, gold			2022-12-25	WOS:000283839100012
J	Gupta, L; Noh, JY; Jo, YH; Oh, SH; Kumar, S; Noh, MY; Lee, YS; Cha, SJ; Seo, SJ; Kim, I; Han, YS; Barillas-Mury, C				Gupta, Lalita; Noh, Ju Young; Jo, Yong Hun; Oh, Seung Han; Kumar, Sanjeev; Noh, Mi Young; Lee, Yong Seok; Cha, Sung-Jae; Seo, Sook Jae; Kim, Iksoo; Han, Yeon Soo; Barillas-Mury, Carolina			Apolipophorin-III Mediates Antiplasmodial Epithelial Responses in Anopheles gambiae (G3) Mosquitoes	PLOS ONE			English	Article							INSECT IMMUNE ACTIVATION; LIPID-BINDING PROPERTIES; PLASMODIUM-BERGHEI; HELIX-BUNDLE; EXCHANGEABLE APOLIPOPROTEIN; MIDGUT CELLS; HEMOLYMPH; LIPOPHORIN; CDNA	Background: Apolipophorin-III (ApoLp-III) is known to play an important role in lipid transport and innate immunity in lepidopteran insects. However, there is no evidence of involvement of ApoLp-IIIs in the immune responses of dipteran insects such as Drosophila and mosquitoes. Methodology/Principal Findings: We report the molecular and functional characterization of An. gambiae apolipophorin-III (AgApoLp-III). Mosquito ApoLp-IIIs have diverged extensively from those of lepidopteran insects; however, the predicted tertiary structure of AgApoLp-III is similar to that of Manduca sexta (tobacco hornworm). We found that AgApoLp-III mRNA expression is strongly induced in the midgut of An. gambiae (G3 strain) mosquitoes in response to Plasmodium berghei infection. Furthermore, immunofluorescence stainings revealed that high levels of AgApoLp-III protein accumulate in the cytoplasm of Plasmodium-invaded cells and AgApoLp-III silencing increases the intensity of P. berghei infection by five fold. Conclusion: There are broad differences in the midgut epithelial responses to Plasmodium invasion between An. gambiae strains. In the G3 strain of An. gambiae AgApoLp-III participates in midgut epithelial defense responses that limit Plasmodium infection.	[Gupta, Lalita; Kumar, Sanjeev; Barillas-Mury, Carolina] NIAID, Mosquito Immun & Vector Competence Unit, Lab Malaria & Vector Res, NIH, Rockville, MD USA; [Noh, Ju Young; Jo, Yong Hun; Oh, Seung Han; Noh, Mi Young; Kim, Iksoo; Han, Yeon Soo] Chonnam Natl Univ, Coll Agr & Life Sci, Dept Agr Biol, Kwangju, South Korea; [Lee, Yong Seok] Inje Univ, Coll Med & Frontier Inje Res Sci & Technol, Dept Parasitol, Pusan, South Korea; [Cha, Sung-Jae] Johns Hopkins Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Cha, Sung-Jae] Johns Hopkins Sch Publ Hlth, Malaria Res Inst, Baltimore, MD USA; [Seo, Sook Jae] Gyeongsang Natl Univ, Div Appl Life Sci, Jinju, South Korea	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Chonnam National University; Inje University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Gyeongsang National University	Gupta, L (corresponding author), Birla Inst Technol & Sci, Biol Sci Grp, Pilani, Rajasthan, India.	hanys@chonnam.ac.kr; cbarillas@niaid.nih.gov	Gupta, Lalita/R-1111-2019	GUPTA, LALITA/0000-0002-0712-8512; Lee, Yongseok/0000-0002-8687-589X; Kumar, Sanjeev/0000-0003-3866-4593	Korean Government [KRF 2008 531 C00064]; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000947] Funding Source: NIH RePORTER	Korean Government(Korean Government); Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health and by the National Research Foundation of Korea Grant funded by the Korean Government (KRF 2008 531 C00064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atella GC, 2006, INSECT BIOCHEM MOLEC, V36, P375, DOI 10.1016/j.ibmb.2006.01.019; Billker O, 1997, PARASITOLOGY, V115, P1, DOI 10.1017/S0031182097008895; Canavoso LE, 2001, ANNU REV NUTR, V21, P23, DOI 10.1146/annurev.nutr.21.1.23; Chung KT, 2002, COMP BIOCHEM PHYS B, V132, P505, DOI 10.1016/S1096-4959(02)00064-7; Colton CA, 2001, BBA-MOL BASIS DIS, V1535, P134, DOI 10.1016/S0925-4439(00)00092-2; Dettloff M, 2001, J INSECT PHYSIOL, V47, P789, DOI 10.1016/S0022-1910(01)00069-5; Dettloff M, 2001, BIOCHEMISTRY-US, V40, P3150, DOI 10.1021/bi0013804; Fan DP, 2003, J BIOL CHEM, V278, P21212, DOI 10.1074/jbc.M208486200; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Halwani AE, 2000, J INVERTEBR PATHOL, V76, P233, DOI 10.1006/jipa.2000.4978; Halwani AE, 1999, DEV COMP IMMUNOL, V23, P563, DOI 10.1016/S0145-305X(99)00037-3; Han YS, 2000, EMBO J, V19, P6030, DOI 10.1093/emboj/19.22.6030; Iimura Y, 1998, ARCH INSECT BIOCHEM, V38, P119, DOI 10.1002/(SICI)1520-6327(1998)38:3&lt;119::AID-ARCH2&gt;3.0.CO;2-N; Jaramillo-Gutierrez G, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-154; Kim HJ, 2004, INSECT BIOCHEM MOLEC, V34, P1011, DOI 10.1016/j.ibmb.2004.05.005; Kumar S, 2004, J BIOL CHEM, V279, P53475, DOI 10.1074/jbc.M409905200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Marinotti O, 2006, COMP BIOCHEM PHYS B, V144, P101, DOI 10.1016/j.cbpb.2006.01.012; Mendes AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000069; Mullen LM, 2004, J INSECT PHYSIOL, V50, P409, DOI 10.1016/j.jinsphys.2004.02.008; Narayanaswami V, 1999, P NATL ACAD SCI USA, V96, P4366, DOI 10.1073/pnas.96.8.4366; Niere M, 1999, BBA-PROTEIN STRUCT M, V1433, P16, DOI 10.1016/S0167-4838(99)00148-X; Niere M, 2001, BIOCHEMISTRY-US, V40, P11502, DOI 10.1021/bi010117f; Park SY, 2005, DEV COMP IMMUNOL, V29, P43, DOI 10.1016/j.dci.2004.06.001; Pratt CC, 2004, BIOL CHEM, V385, P1113, DOI 10.1515/BC.2004.145; Sahoo D, 2002, J MOL BIOL, V321, P201, DOI 10.1016/S0022-2836(02)00618-6; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SALAZAR CE, 1993, NUCLEIC ACIDS RES, V21, P4147, DOI 10.1093/nar/21.17.4147; Seo SJ, 2008, COMP BIOCHEM PHYS B, V151, P433, DOI 10.1016/j.cbpb.2008.09.081; SUN DH, 1995, J NEUROBIOL, V26, P119, DOI 10.1002/neu.480260110; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wang JJ, 2002, P NATL ACAD SCI USA, V99, P1188, DOI 10.1073/pnas.032565999; WEERS PMM, 1993, J BIOL CHEM, V268, P4300; Weers PMM, 2006, INSECT BIOCHEM MOLEC, V36, P231, DOI 10.1016/j.ibmb.2006.01.001; Whitten MMA, 2004, J IMMUNOL, V172, P2177, DOI 10.4049/jimmunol.172.4.2177; Wiesner A, 1997, J INSECT PHYSIOL, V43, P383, DOI 10.1016/S0022-1910(96)00113-8; Yamauchi Y, 2000, ARCH INSECT BIOCHEM, V43, P16, DOI 10.1002/(SICI)1520-6327(200001)43:1&lt;16::AID-ARCH3&gt;3.0.CO;2-W	37	44	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2010	5	11							e15410	10.1371/journal.pone.0015410	http://dx.doi.org/10.1371/journal.pone.0015410			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674VY	21072214	Green Published, gold, Green Submitted			2022-12-25	WOS:000283779700018
J	Nakahira, M; Macedo, JNA; Seraphim, TV; Cavalcante, N; Souza, TACB; Damalio, JCP; Reyes, LF; Assmann, EM; Alborghetti, MR; Garratt, RC; Araujo, APU; Zanchin, NIT; Barbosa, JARG; Kobarg, J				Nakahira, Marcel; Alves Macedo, Joci Neuby; Seraphim, Thiago Vargas; Cavalcante, Nayara; Souza, Tatiana A. C. B.; Pissuti Damalio, Julio Cesar; Reyes, Luis Fernando; Assmann, Eliana M.; Alborghetti, Marcos R.; Garratt, Richard C.; Araujo, Ana Paula U.; Zanchin, Nilson I. T.; Barbosa, Joao A. R. G.; Kobarg, Joerg			A Draft of the Human Septin Interactome	PLOS ONE			English	Article							PROTEIN-KINASE; GTP-BINDING; CENP-F; INTERACTION PARTNER; IDENTIFICATION; FAMILY; SUMO; ORGANIZATION; EXPRESSION; PHOSPHORYLATION	Background: Septins belong to the GTPase superclass of proteins and have been functionally implicated in cytokinesis and the maintenance of cellular morphology. They are found in all eukaryotes, except in plants. In mammals, 14 septins have been described that can be divided into four groups. It has been shown that mammalian septins can engage in homo- and heterooligomeric assemblies, in the form of filaments, which have as a basic unit a hetero-trimeric core. In addition, it has been speculated that the septin filaments may serve as scaffolds for the recruitment of additional proteins. Methodology/Principal Findings: Here, we performed yeast two-hybrid screens with human septins 1-10, which include representatives of all four septin groups. Among the interactors detected, we found predominantly other septins, confirming the tendency of septins to engage in the formation of homo- and heteropolymeric filaments. Conclusions/Significance: If we take as reference the reported arrangement of the septins 2, 6 and 7 within the heterofilament, (7-6-2-2-6-7), we note that the majority of the observed interactions respect the "group rule", i.e. members of the same group (e. g. 6, 8, 10 and 11) can replace each other in the specific position along the heterofilament. Septins of the SEPT6 group preferentially interacted with septins of the SEPT2 group (p<0.001), SEPT3 group (p<0.001) and SEPT7 group (p<0.001). SEPT2 type septins preferentially interacted with septins of the SEPT6 group (p<0.001) aside from being the only septin group which interacted with members of its own group. Finally, septins of the SEPT3 group interacted preferentially with septins of the SEPT7 group (p<0.001). Furthermore, we found non-septin interactors which can be functionally attributed to a variety of different cellular activities, including: ubiquitin/sumoylation cycles, microtubular transport and motor activities, cell division and the cell cycle, cell motility, protein phosphorylation/signaling, endocytosis, and apoptosis.	[Nakahira, Marcel; Souza, Tatiana A. C. B.; Assmann, Eliana M.; Alborghetti, Marcos R.; Kobarg, Joerg] Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias, Campinas, SP, Brazil; [Nakahira, Marcel; Seraphim, Thiago Vargas; Alborghetti, Marcos R.; Kobarg, Joerg] Univ Estadual Campinas, Dept Bioquim, Programa Posgrad Biol Func & Mol, Campinas, SP, Brazil; [Alves Macedo, Joci Neuby; Cavalcante, Nayara; Pissuti Damalio, Julio Cesar; Reyes, Luis Fernando; Garratt, Richard C.; Araujo, Ana Paula U.] Univ Sao Paulo, Ctr Biotecnol Mol Estrutural, Sao Carlos, SP, Brazil; [Zanchin, Nilson I. T.] Univ Estadual Campinas, Ctr Biol Mol & Engn Genet, Campinas, SP, Brazil; [Zanchin, Nilson I. T.] Univ Estadual Campinas, Fac Ciencias Aplicadas, Campinas, SP, Brazil; [Barbosa, Joao A. R. G.] Univ Catolica Brasilia, Brasilia, DF, Brazil	Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Catolica de Brasilia	Nakahira, M (corresponding author), Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias, Campinas, SP, Brazil.	jorg.kobarg@lnbio.org.br	Araujo, Ana Paula U/I-6664-2012; Macedo, Joci/I-7230-2013; Kobarg, Jörg/T-4736-2019; 4, INCT/H-4499-2013; Barbosa, João Alexandre/E-2261-2012; Seraphim, Thiago V/J-9949-2013; garratt, richard c/F-6921-2011; Barbosa, João/GVT-7916-2022; Zanchin, Nilson Ivo Tonin/AAB-4907-2019; Inbeqmedi, Inct/I-1929-2013; Alborghetti, Marcos Rodrigo/K-7547-2012	Araujo, Ana Paula U/0000-0001-5455-084X; Kobarg, Jörg/0000-0002-9419-0145; Barbosa, João Alexandre/0000-0002-0534-481X; Zanchin, Nilson Ivo Tonin/0000-0002-1153-0694; Vargas Seraphim, Thiago/0000-0002-8682-8962; Alborghetti, Marcos Rodrigo/0000-0003-4517-5579; garratt, richard/0000-0002-2016-3179	Fundao de Amparo a Pesquisa do Estado Sao Paulo (Fapesp); CAPES: Coordenao de Aperfeioamento de Pessoal de Navel Superior; Conselho Nacional de Pesquisa e Desenvolvimento (CNPq); Laboratorio Nacional de Biociencias-Centro Nacional de Pesquisa em Energia e Materais (LNBio-CNPEM)	Fundao de Amparo a Pesquisa do Estado Sao Paulo (Fapesp)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES: Coordenao de Aperfeioamento de Pessoal de Navel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Pesquisa e Desenvolvimento (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Laboratorio Nacional de Biociencias-Centro Nacional de Pesquisa em Energia e Materais (LNBio-CNPEM)	Financially supported by: Fundao de Amparo a Pesquisa do Estado Sao Paulo (Fapesp), CAPES: Coordenao de Aperfeioamento de Pessoal de Navel Superior, Conselho Nacional de Pesquisa e Desenvolvimento (CNPq) and the Laboratorio Nacional de Biociencias-Centro Nacional de Pesquisa em Energia e Materais (LNBio-CNPEM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Assmann EM, 2006, J BIOL CHEM, V281, P9869, DOI 10.1074/jbc.M513280200; Barral Y, 1999, GENE DEV, V13, P176, DOI 10.1101/gad.13.2.176; BARTEL PL, 1995, METHOD ENZYMOL, V254, P241; Bertin A, 2008, P NATL ACAD SCI USA, V105, P8274, DOI 10.1073/pnas.0803330105; Blaser S, 2006, J PATHOL, V210, P103, DOI 10.1002/path.2013; Blaser S, 2004, THROMB HAEMOSTASIS, V91, P959, DOI 10.1160/TH03-09-0578; Cao LH, 2007, FEBS LETT, V581, P5526, DOI 10.1016/j.febslet.2007.10.032; Cao LH, 2009, CELL MOL LIFE SCI, V66, P3309, DOI 10.1007/s00018-009-0087-2; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; Ding XM, 2008, MOL CELLS, V25, P385; Dobbelaere J, 2004, SCIENCE, V305, P393, DOI 10.1126/science.1099892; Douglas LM, 2005, EUKARYOT CELL, V4, P1503, DOI 10.1128/EC.4.9.1503-1512.2005; Fujishima K, 2007, J NEUROCHEM, V102, P77, DOI 10.1111/j.1471-4159.2007.04478.x; Gonzalez ME, 2007, CANCER RES, V67, P8554, DOI 10.1158/0008-5472.CAN-07-1474; Gonzalez-Novo A, 2006, MICROBIOL IMMUNOL, V50, P499, DOI 10.1111/j.1348-0421.2006.tb03820.x; Gout I, 2000, EMBO J, V19, P4015, DOI 10.1093/emboj/19.15.4015; Grigoryan G, 2008, CURR OPIN STRUC BIOL, V18, P477, DOI 10.1016/j.sbi.2008.04.008; Hall PA, 2005, J PATHOL, V206, P269, DOI 10.1002/path.1789; Havrylov S, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-21; Hickson GRX, 2008, BIOCHEM SOC T, V36, P439, DOI 10.1042/BST0360439; Huang YW, 2008, MOL BIOL CELL, V19, P1717, DOI 10.1091/mbc.E07-07-0641; Ihara M, 2003, J BIOL CHEM, V278, P24095, DOI 10.1074/jbc.M301352200; Jackson PK, 2001, GENE DEV, V15, P3053, DOI 10.1101/gad.955501; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Joo E, 2005, TRAFFIC, V6, P626, DOI 10.1111/j.1600-0854.2005.00305.x; Kinoshita A, 1998, AM J PATHOL, V153, P1551, DOI 10.1016/S0002-9440(10)65743-4; Kinoshita M, 2006, CURR OPIN CELL BIOL, V18, P54, DOI 10.1016/j.ceb.2005.12.005; Kinoshita M, 2003, J BIOCHEM, V134, P491, DOI 10.1093/jb/mvg182; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Kishi K, 2009, MOL CELL BIOL, V29, P3134, DOI 10.1128/MCB.01663-08; Kozubowski L, 2010, MOL MICROBIOL, V75, P658, DOI 10.1111/j.1365-2958.2009.06983.x; Kuhlenbaumer G, 2005, NAT GENET, V37, P1044, DOI 10.1038/ng1649; LIAO H, 1995, J CELL BIOL, V130, P507, DOI 10.1083/jcb.130.3.507; Longtine MS, 1998, J CELL BIOL, V143, P719, DOI 10.1083/jcb.143.3.719; Macara IG, 2002, MOL BIOL CELL, V13, p2A; Martin SW, 2004, J BIOL CHEM, V279, P40861, DOI 10.1074/jbc.M406422200; Martinez C, 2004, BIOCHEM J, V382, P783, DOI 10.1042/BJ20040372; McIlhatton MA, 2001, ONCOGENE, V20, P5930, DOI 10.1038/sj.onc.1204752; Moraes KCM, 2003, BIOL CHEM, V384, P25, DOI 10.1515/BC.2003.004; Mostowy S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004196; Nagata K, 2004, J BIOL CHEM, V279, P55895, DOI 10.1074/jbc.M406153200; Nagata KI, 2005, ONCOGENE, V24, P65, DOI 10.1038/sj.onc.1208101; Nery FC, 2004, J BIOL CHEM, V279, P11444, DOI 10.1074/jbc.M306672200; Ogawa Y, 2009, J NEUROSCI RES, V87, P3502, DOI 10.1002/jnr.21984; Pan FF, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-103; Parks WT, 2001, J BIOL CHEM, V276, P19332, DOI 10.1074/jbc.M100606200; Peterson EA, 2007, MAMM GENOME, V18, P796, DOI 10.1007/s00335-007-9065-x; Qin HM, 2007, CURR BIOL, V17, P193, DOI 10.1016/j.cub.2006.12.040; RATTNER JB, 1993, CELL MOTIL CYTOSKEL, V26, P214, DOI 10.1002/cm.970260305; Rochat-Steiner V, 2000, J EXP MED, V192, P1165, DOI 10.1084/jem.192.8.1165; Rose A, 2004, CELL MOL LIFE SCI, V61, P1996, DOI 10.1007/s00018-004-4039-6; Schmidt D, 2003, CELL MOL LIFE SCI, V60, P2561, DOI 10.1007/s00018-003-3129-1; Schmidt MHH, 2003, J CELL SCI, V116, P2845, DOI 10.1242/jcs.00522; Sirajuddin M, 2007, NATURE, V449, P311, DOI 10.1038/nature06052; Sirajuddin M, 2009, P NATL ACAD SCI USA, V106, P16592, DOI 10.1073/pnas.0902858106; Spiliotis ET, 2005, SCIENCE, V307, P1781, DOI 10.1126/science.1106823; Surka MC, 2002, MOL BIOL CELL, V13, P3532, DOI 10.1091/mbc.E02-01-0042; Surpili MJ, 2003, BIOCHEMISTRY-US, V42, P15369, DOI 10.1021/bi034575v; Take H, 2000, BIOCHEM BIOPH RES CO, V268, P321, DOI 10.1006/bbrc.2000.2147; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; Varis A, 2006, CHROMOSOMA, V115, P288, DOI 10.1007/s00412-005-0046-0; Wassmer T, 2007, J CELL SCI, V120, P45, DOI 10.1242/jcs.03302; Weirich CS, 2008, NAT REV MOL CELL BIO, V9, P478, DOI 10.1038/nrm2407; Xie YL, 2007, CURR BIOL, V17, P1746, DOI 10.1016/j.cub.2007.08.042; Zhang J, 2009, CELL RES, V19, P733, DOI 10.1038/cr.2009.51; Zhang JS, 1999, CURR BIOL, V9, P1458, DOI 10.1016/S0960-9822(00)80115-3; Zhu M, 2008, J BIOL CHEM, V283, P18916, DOI 10.1074/jbc.M710591200; [No title captured]; [No title captured]; [No title captured]	73	64	66	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2010	5	11							e13799	10.1371/journal.pone.0013799	http://dx.doi.org/10.1371/journal.pone.0013799			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674VY	21082023	Green Published, Green Submitted, gold			2022-12-25	WOS:000283779700011
J	Alvarez, MN; Peluffo, G; Piacenza, L; Radi, R				Noel Alvarez, Mara; Peluffo, Gonzalo; Piacenza, Luca; Radi, Rafael			Intraphagosomal Peroxynitrite as a Macrophage-derived Cytotoxin against Internalized Trypanosoma cruzi CONSEQUENCES FOR OXIDATIVE KILLING AND ROLE OF MICROBIAL PEROXIREDOXINS IN INFECTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; PROTEIN-TYROSINE NITRATION; NADPH-OXIDASE; MURINE MACROPHAGES; REACTIVE OXYGEN; IFN-GAMMA; POLYMORPHONUCLEAR LEUKOCYTES; LUMINOL CHEMILUMINESCENCE; PERITONEAL-MACROPHAGES; MEDIATED CYTOTOXICITY	Macrophage-derived radicals generated by the NADPH oxidase complex and inducible nitric-oxide synthase (iNOS) participate in cytotoxic mechanisms against microorganisms. Nitric oxide ((NO)-N-center dot) plays a central role in the control of acute infection by Trypanosoma cruzi, the causative agent of Chagas disease, and we have proposed that much of its action relies on macrophage-derived peroxynitrite (ONOO- + ONOOH) formation, a strong oxidant arising from the reaction of (NO)-N-center dot with superoxide radical (O-2(radical anion)). Herein, we have shown that internalization of T. cruzi trypomastigotes by macrophages triggers the assembly of the NADPH oxidase complex to yield O-2(radical anion) during a 60-90-min period. This does not interfere with IFN-gamma-dependent iNOS induction and a sustained (NO)-N-center dot production (similar to 24 h). The major mechanism for infection control via reactive species formation occurred when (NO)-N-center dot and O-2(radical anion) were produced simultaneously, generating intraphagosomal peroxynitrite levels compatible with microbial killing. Moreover, biochemical and ultrastructural analysis confirmed cellular oxidative damage and morphological disruption in internalized parasites. Overexpression of cytosolic tryparedoxin peroxidase in T. cruzi neutralized macrophage-derived peroxynitrite-dependent cytotoxicity to parasites and favored the infection in an animal model. Collectively, the data provide, for the first time, direct support for the action of peroxynitrite as an intraphagosomal cytotoxin against pathogens and the premise that microbial peroxiredoxins facilitate infectivity via decomposition of macrophage-derived peroxynitrite.	[Radi, Rafael] Univ Republica, Dpto Bioquim, Fac Med, Montevideo 11800, Uruguay; Univ Republica, Ctr Free Rad & Biomed Res, Fac Med, Montevideo 11800, Uruguay	Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay	Radi, R (corresponding author), Univ Republica, Dpto Bioquim, Fac Med, Avda Gen Flores 2125, Montevideo 11800, Uruguay.	rradi@fmed.edu.uy			Howard Hughes Medical Institute; International Centre for Genetic Engineering and Biotechnology; Fondo Clemente Estable (Programa de Desarrollo Tecnologico); Comision Sectorial de Investigacion Cientifica, Universidad de la Republica	Howard Hughes Medical Institute(Howard Hughes Medical Institute); International Centre for Genetic Engineering and Biotechnology; Fondo Clemente Estable (Programa de Desarrollo Tecnologico); Comision Sectorial de Investigacion Cientifica, Universidad de la Republica	This work was supported by grants from the Howard Hughes Medical Institute and the International Centre for Genetic Engineering and Biotechnology (to R. R.), the Fondo Clemente Estable (Programa de Desarrollo Tecnologico) (to L. P.), and the Comision Sectorial de Investigacion Cientifica, Universidad de la Republica (to M. N. A.).	Aliberti JCS, 1996, INFECT IMMUN, V64, P1961, DOI 10.1128/IAI.64.6.1961-1967.1996; Alvarez MN, 2004, ARCH BIOCHEM BIOPHYS, V432, P222, DOI 10.1016/j.abb.2004.09.015; Alvarez MN, 2002, METHOD ENZYMOL, V359, P353; Atwood JA, 2005, SCIENCE, V309, P473, DOI 10.1126/science.1110289; BABIOR BM, 1984, J CLIN INVEST, V73, P599, DOI 10.1172/JCI111249; BAEHNER RL, 1976, BLOOD, V48, P309; Barr SD, 2003, J BIOL CHEM, V278, P10816, DOI 10.1074/jbc.M212990200; BAXTER MA, 1983, IMMUNOLOGY, V48, P657; Bergeron M, 2006, J IMMUNOL, V177, P6271, DOI 10.4049/jimmunol.177.9.6271; BONALDO MC, 1988, J CELL BIOL, V106, P1349, DOI 10.1083/jcb.106.4.1349; Brennan ML, 2002, J BIOL CHEM, V277, P17415, DOI 10.1074/jbc.M112400200; Brito C, 1999, J IMMUNOL, V162, P3356; Bryk R, 2000, NATURE, V407, P211, DOI 10.1038/35025109; Campos MA, 2001, J IMMUNOL, V167, P416, DOI 10.4049/jimmunol.167.1.416; Cape JL, 2009, ARCH BIOCHEM BIOPHYS, V484, P190, DOI 10.1016/j.abb.2009.01.010; Cardillo F, 1996, INFECT IMMUN, V64, P128, DOI 10.1128/IAI.64.1.128-134.1996; CARDONI RL, 1984, CELL IMMUNOL, V86, P518, DOI 10.1016/0008-8749(84)90407-6; Cardoni RL, 1997, AM J TROP MED HYG, V56, P329, DOI 10.4269/ajtmh.1997.56.329; Cassina P, 2008, J NEUROSCI, V28, P4115, DOI 10.1523/JNEUROSCI.5308-07.2008; Castro L, 1996, ARCH BIOCHEM BIOPHYS, V333, P179, DOI 10.1006/abbi.1996.0379; Chakravortty D, 2002, J EXP MED, V195, P1155, DOI 10.1084/jem.20011547; Chen L, 1998, MOL CELL, V1, P795, DOI 10.1016/S1097-2765(00)80079-9; CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V16, P315, DOI 10.1016/0166-6851(85)90073-8; DaMatta RA, 2007, FEMS MICROBIOL LETT, V266, P29, DOI 10.1111/j.1574-6968.2006.00495.x; DeGroote MA, 1997, P NATL ACAD SCI USA, V94, P13997, DOI 10.1073/pnas.94.25.13997; DENICOLA A, 1993, ARCH BIOCHEM BIOPHYS, V304, P279, DOI 10.1006/abbi.1993.1350; Detweiler CD, 2002, FREE RADICAL BIO MED, V33, P364, DOI 10.1016/S0891-5849(02)00895-X; Pineyro MD, 2011, ARCH BIOCHEM BIOPHYS, V507, P287, DOI 10.1016/j.abb.2010.12.014; Eiserich JP, 1998, NATURE, V391, P393, DOI 10.1038/34923; Eu JP, 2000, BIOCHEMISTRY-US, V39, P1040, DOI 10.1021/bi992046e; Evans TJ, 1996, P NATL ACAD SCI USA, V93, P9553, DOI 10.1073/pnas.93.18.9553; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Ferrer-Sueta G, 2009, ACS CHEM BIOL, V4, P161, DOI 10.1021/cb800279q; Fridovich I, 1997, J BIOL CHEM, V272, P18515, DOI 10.1074/jbc.272.30.18515; Gazzinelli RT, 2006, NAT REV IMMUNOL, V6, P895, DOI 10.1038/nri1978; Gomez-Mejiba SE, 2010, J BIOL CHEM, V285, P20062, DOI 10.1074/jbc.M109.086579; Gookin JL, 2005, INFECT IMMUN, V73, P3929, DOI 10.1128/IAI.73.7.3929-3936.2005; Granger DL, 1996, METHOD ENZYMOL, V268, P142; Groemping Y, 2005, BIOCHEM J, V386, P401, DOI 10.1042/BJ20041835; Guinazu N, 2007, INT J PARASITOL, V37, P1243, DOI 10.1016/j.ijpara.2007.03.010; Gutierrez FRS, 2009, MEM I OSWALDO CRUZ, V104, P236, DOI 10.1590/S0074-02762009000900030; HANCOCK JT, 1987, BIOCHEM J, V242, P103, DOI 10.1042/bj2420103; Hickman-Davis J, 1999, P NATL ACAD SCI USA, V96, P4953, DOI 10.1073/pnas.96.9.4953; Hurst JK, 1997, CHEM RES TOXICOL, V10, P802, DOI 10.1021/tx970008v; Irigoin F, 2008, FREE RADICAL BIO MED, V45, P733, DOI 10.1016/j.freeradbiomed.2008.05.028; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P446, DOI 10.1016/0003-9861(92)90433-W; James PE, 1998, J LEUKOCYTE BIOL, V64, P78, DOI 10.1002/jlb.64.1.78; KIERSZENBAUM F, 1974, J IMMUNOL, V112, P1839; Krauth-Siegel RL, 2008, BBA-GEN SUBJECTS, V1780, P1236, DOI 10.1016/j.bbagen.2008.03.006; Lodge R, 2006, CELL MICROBIOL, V8, P1922, DOI 10.1111/j.1462-5822.2006.00758.x; Luo Yi, 2001, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0320s22; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; MARTIN E, 1994, J EXP MED, V180, P977, DOI 10.1084/jem.180.3.977; Master SS, 2002, MICROBIOL-SGM, V148, P3139, DOI 10.1099/00221287-148-10-3139; MCCABE RE, 1990, J IMMUNOL, V144, P2384; Mohapatra NP, 2010, J IMMUNOL, V184, P5141, DOI 10.4049/jimmunol.0903413; MUNOZFERNANDEZ MA, 1992, IMMUNOL LETT, V33, P35, DOI 10.1016/0165-2478(92)90090-B; MUNOZFERNANDEZ MA, 1992, EUR J IMMUNOL, V22, P301, DOI 10.1002/eji.1830220203; Nakatsubo N, 1998, FEBS LETT, V427, P263, DOI 10.1016/S0014-5793(98)00440-2; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Nauser T, 2002, J PHYS CHEM A, V106, P4084, DOI 10.1021/jp025518z; Oliveira MAP, 2000, EXP PARASITOL, V95, P96, DOI 10.1006/expr.2000.4523; Palazzolo-Ballance AM, 2007, BIOCHEMISTRY-US, V46, P7536, DOI 10.1021/bi700123s; Pfeiffer S, 2001, J BIOL CHEM, V276, P34051, DOI 10.1074/jbc.M100585200; Piacenza L, 2009, INT J PARASITOL, V39, P1455, DOI 10.1016/j.ijpara.2009.05.010; Piacenza L, 2001, P NATL ACAD SCI USA, V98, P7301, DOI 10.1073/pnas.121520398; Piacenza L, 2008, BIOCHEM J, V410, P359, DOI 10.1042/BJ20071138; Piacenza L, 2009, CURR OPIN MICROBIOL, V12, P415, DOI 10.1016/j.mib.2009.06.011; Quijano C, 1997, BIOCHEM J, V322, P167, DOI 10.1042/bj3220167; Quijano C, 2005, FREE RADICAL BIO MED, V39, P728, DOI 10.1016/j.freeradbiomed.2005.04.014; Radi R, 2001, FREE RADICAL BIO MED, V30, P463, DOI 10.1016/S0891-5849(00)00373-7; RADI R, 1993, BIOCHEM J, V290, P51, DOI 10.1042/bj2900051; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; REED SG, 1987, J EXP MED, V166, P1734, DOI 10.1084/jem.166.6.1734; RIMOLDI MT, 1981, IMMUNOLOGY, V42, P521; Roman-Campos D, 2009, BASIC RES CARDIOL, V104, P238, DOI 10.1007/s00395-009-0776-x; Romero N, 2003, J BIOL CHEM, V278, P44049, DOI 10.1074/jbc.M305895200; Roychowdhury S, 2002, GLIA, V38, P103, DOI 10.1002/glia.10024; RUBBO H, 1994, J BIOL CHEM, V269, P26066; RUBBO H, 1994, ARCH BIOCHEM BIOPHYS, V308, P96, DOI 10.1006/abbi.1994.1014; Stempin C, 2002, J LEUKOCYTE BIOL, V72, P727; Stempin CC, 2008, ACTA TROP, V106, P119, DOI 10.1016/j.actatropica.2008.02.004; STUEHR DJ, 1989, J EXP MED, V169, P1543, DOI 10.1084/jem.169.5.1543; Szabo C, 1996, FREE RADICAL BIO MED, V21, P855, DOI 10.1016/0891-5849(96)00170-0; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; TANAKA Y, 1983, INFECT IMMUN, V41, P1322, DOI 10.1128/IAI.41.3.1322-1331.1983; Thomson L, 2003, ARCH BIOCHEM BIOPHYS, V412, P55, DOI 10.1016/S0003-9861(02)00745-2; TORRICO F, 1991, J IMMUNOL, V146, P3626; Trujillo M, 2004, J BIOL CHEM, V279, P34175, DOI 10.1074/jbc.M404317200; Vazquez-Torres A, 2000, J EXP MED, V192, P227, DOI 10.1084/jem.192.2.227; VazquezTorres A, 1996, INFECT IMMUN, V64, P3127, DOI 10.1128/IAI.64.8.3127-3133.1996; VILLALTA F, 1983, J IMMUNOL, V131, P1504; VODOVOTZ Y, 1995, J IMMUNOL, V154, P2914; Wilkinson SR, 2000, J BIOL CHEM, V275, P8220, DOI 10.1074/jbc.275.11.8220; WIRTH JJ, 1982, J IMMUNOL, V129, P2759; Wrona M, 2005, FREE RADICAL BIO MED, V38, P262, DOI 10.1016/j.freeradbiomed.2004.10.022; XIE QW, 1993, J EXP MED, V177, P1779, DOI 10.1084/jem.177.6.1779; Zago MP, 2008, INFECT IMMUN, V76, P443, DOI 10.1128/IAI.00400-07; Zhang SY, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000648	100	168	171	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6627	6640		10.1074/jbc.M110.167247	http://dx.doi.org/10.1074/jbc.M110.167247			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21098483	Green Published, hybrid			2022-12-25	WOS:000287476400071
J	Liu, ZH; Shan, M; Li, L; Lu, L; Meng, S; Chen, C; He, YX; Jiang, SB; Zhang, LQ				Liu, Zhonghua; Shan, Mei; Li, Li; Lu, Lu; Meng, Shu; Chen, Cheng; He, Yuxian; Jiang, Shibo; Zhang, Linqi			In Vitro Selection and Characterization of HIV-1 Variants with Increased Resistance to Sifuvirtide, a Novel HIV-1 Fusion Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CCR5 MONOCLONAL-ANTIBODY; ENVELOPE GLYCOPROTEIN; SYNTHETIC PEPTIDES; POTENT INHIBITORS; CRYSTAL-STRUCTURE; ENTRY INHIBITORS; ATOMIC-STRUCTURE; CORE STRUCTURE; SPIKE PROTEIN	Sifuvirtide, a novel fusion inhibitor against human immunodeficiency virus type I (HIV-1), which is more potent than enfuvirtide (T20) in cell culture, is currently under clinical investigation for the treatment of HIV-1 infection. We now report that in vitro selection of HIV-1 variants resistant to sifuvirtide in the presence of increasing concentrations of sifuvirtide has led to several specific mutations in the gp41 region that had not been previously reported. Many of these substitutions were confined to the N-terminal heptad repeat region at positions 37, 38, 41, and 43, either singly or in combination. A downstream substitution at position 126 (N126K) in the C-terminal heptad repeat region was also found. Site-directed mutagenesis studies have further identified the critical amino acid substitutions and combinations thereof in conferring the resistant genotypes. Furthermore, the mutant viruses demonstrated variable degrees of cross-resistance to enfuvirtide, some of which are preferentially more resistant to sifuvirtide. Impaired infectivity was also found for many of the mutant viruses. Biophysical and structural analyses of the key substitutions have revealed several potential novel mechanisms against sifuvirtide. Our results may help to predict potential resistant patterns in vivo and facilitate the further clinical development and therapeutic utility of sifuvirtide.	[Liu, Zhonghua; Shan, Mei; Li, Li; Meng, Shu; He, Yuxian; Zhang, Linqi] Chinese Acad Med Sci, Inst Pathogen Biol, AIDS Res Ctr, Beijing 100730, Peoples R China; [Liu, Zhonghua; Shan, Mei; Li, Li; Meng, Shu; He, Yuxian; Zhang, Linqi] Peking Union Med Coll, Beijing 100730, Peoples R China; [Lu, Lu; Jiang, Shibo] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA; [Chen, Cheng; Zhang, Linqi] Tsinghua Univ, Sch Med, Comprehens AIDS Res Ctr, Beijing 100084, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; New York Blood Center; Tsinghua University	Zhang, LQ (corresponding author), Tsinghua Univ, Sch Med, Comprehens AIDS Res Ctr, Beijing 100084, Peoples R China.	zhanglinqi@tsinghua.edu.cn	lu, lu/HGA-0894-2022; Jiang, Shibo/L-4500-2014; lu, lu/HII-7530-2022; ZHANG, LIN/GYD-9123-2022; Lu, Lu/K-7070-2014	Jiang, Shibo/0000-0001-8283-7135; Lu, Lu/0000-0002-2255-0391	National Institutes of Health [AI046221]; Chinese Ministry of Science and Technology [2006CB504200]; Chinese Natural Science Foundation [30825035]; Tsinghua University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046221, R21AI046221] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Tsinghua University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI046221 (to S. J.). This work was also supported by National Basic Research Program (also called the 973 Program) of the Chinese Ministry of Science and Technology Grant 2006CB504200 (to L. Z.), National Outstanding Youth Award of the Chinese Natural Science Foundation 30825035 (to L. Z.), and a grant from the Tsinghua University Initiative Scientific Research Program and Tsinghua Yue-Yuen Medical Sciences Fund (to L. Z.).	Baldwin CE, 2004, J VIROL, V78, P12428, DOI 10.1128/JVI.78.22.12428-12437.2004; Baldwin C, 2008, J VIROL, V82, P7735, DOI 10.1128/JVI.02524-07; Bewley CA, 2002, J BIOL CHEM, V277, P14238, DOI 10.1074/jbc.M201453200; BLACKLOW SC, 1995, BIOCHEMISTRY-US, V34, P14955, DOI 10.1021/bi00046a001; Buzon V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000880; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chen X, 2010, J BIOL CHEM, V285, P25506, DOI 10.1074/jbc.M110.101170; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Dwyer JJ, 2007, P NATL ACAD SCI USA, V104, P12772, DOI 10.1073/pnas.0701478104; Eggink D, 2008, J VIROL, V82, P6678, DOI 10.1128/JVI.00352-08; Eggink D, 2009, J BIOL CHEM, V284, P26941, DOI 10.1074/jbc.M109.004416; Fatkenheuer G, 2005, NAT MED, V11, P1170, DOI 10.1038/nm1319; He YX, 2008, J BIOL CHEM, V283, P11126, DOI 10.1074/jbc.M800200200; Izumi K, 2009, J BIOL CHEM, V284, P4914, DOI 10.1074/jbc.M807169200; Jacobson JM, 2008, J INFECT DIS, V198, P1345, DOI 10.1086/592169; Jiang S, 1998, J VIROL, V72, P10213, DOI 10.1128/JVI.72.12.10213-10217.1998; Jiang SB, 2004, ANTIMICROB AGENTS CH, V48, P4349, DOI 10.1128/AAC.48.11.4349-4359.2004; Jiang SB, 1999, J VIROL METHODS, V80, P85, DOI 10.1016/S0166-0934(99)00041-5; Jiang SB, 2000, BIOCHEM BIOPH RES CO, V269, P641, DOI 10.1006/bbrc.1999.1972; Katritzky AR, 2009, J MED CHEM, V52, P7631, DOI 10.1021/jm900450n; Kromdijk W, 2010, EXPERT OPIN PHARMACO, V11, P1215, DOI 10.1517/14656561003801081; Kuritzkes DR, 2004, J INFECT DIS, V189, P286, DOI 10.1086/380802; Lambert DM, 1996, P NATL ACAD SCI USA, V93, P2186, DOI 10.1073/pnas.93.5.2186; Liu K, 2008, J MED CHEM, V51, P7843, DOI 10.1021/jm800869t; Liu SW, 2007, J BIOL CHEM, V282, P9612, DOI 10.1074/jbc.M609148200; Liu SW, 2004, LANCET, V363, P938, DOI 10.1016/S0140-6736(04)15788-7; Liu SW, 2005, J BIOL CHEM, V280, P11259, DOI 10.1074/jbc.M411141200; Liu SW, 2003, PEPTIDES, V24, P1303, DOI 10.1016/j.peptides.2003.07.013; Lombardi S, 1996, VIROLOGY, V220, P274, DOI 10.1006/viro.1996.0315; Lu J, 2004, J VIROL, V78, P4628, DOI 10.1128/JVI.78.9.4628-4637.2004; Melikyan GB, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-111; Pan CG, 2009, J VIROL, V83, P7862, DOI 10.1128/JVI.00168-09; Peitsch MC, 1996, BIOCHEM SOC T, V24, P274, DOI 10.1042/bst0240274; RAPAPORT D, 1995, EMBO J, V14, P5524, DOI 10.1002/j.1460-2075.1995.tb00239.x; Rimsky LT, 1998, J VIROL, V72, P986, DOI 10.1128/JVI.72.2.986-993.1998; Root MJ, 2001, SCIENCE, V291, P884, DOI 10.1126/science.1057453; Shimura K, 2010, J BIOL CHEM, V285, P39471, DOI 10.1074/jbc.M110.145789; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; Tripet B, 2004, J BIOL CHEM, V279, P20836, DOI 10.1074/jbc.M400759200; Trkola A, 2001, J VIROL, V75, P579, DOI 10.1128/JVI.75.2.579-588.2001; Wang EX, 2003, BIOCHEM BIOPH RES CO, V302, P469, DOI 10.1016/S0006-291X(03)00197-9; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Weissenhorn W, 1998, MOL CELL, V2, P605, DOI 10.1016/S1097-2765(00)80159-8; Xu YH, 2004, J BIOL CHEM, V279, P49414, DOI 10.1074/jbc.M408782200; Xu YH, 2004, BIOCHEM BIOPH RES CO, V315, P664, DOI 10.1016/j.bbrc.2004.01.115; Zhu Y, 2010, J VIROL, V84, P9359, DOI 10.1128/JVI.00644-10	48	48	51	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3277	3287		10.1074/jbc.M110.199323	http://dx.doi.org/10.1074/jbc.M110.199323			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21098485	hybrid, Green Published			2022-12-25	WOS:000286653200013
J	Chakravarty, AK; Shuman, S				Chakravarty, Anupam K.; Shuman, Stewart			RNA 3 '-Phosphate Cyclase (RtcA) Catalyzes Ligase-like Adenylylation of DNA and RNA 5 '-Monophosphate Ends	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3'-TERMINAL PHOSPHATE CYCLASE; HELA-CELL EXTRACT; ESCHERICHIA-COLI; MUTATIONAL ANALYSIS; NICK RECOGNITION; LIGATION; ENZYME; INTERMEDIATE; SPECIFICITY; ADENYLATE	RNA 3'-phosphate cyclase (Rtc) enzymes are a widely distributed family that catalyze the synthesis of RNA 2',3'-cyclic phosphate ends via an ATP-dependent pathway comprising three nucleotidyl transfer steps: reaction of Rtc with ATP to form a covalent Rtc-(histidinyl-N)-AMP intermediate and release PPi; transfer of AMP from Rtc to an RNA 3'-phosphate to form an RNA(3')pp(5')A intermediate; and attack by the terminal nucleoside O2' on the 3'-phosphate to form an RNA 2',3'-cyclic phosphate product and release AMP. The chemical transformations of the cyclase pathway resemble those of RNA and DNA ligases, with the key distinction being that ligases covalently adenylylate 5'-phosphate ends en route to phosphodiester synthesis. Here we show that the catalytic repertoire of RNA cyclase overlaps that of ligases. We report that Escherichia coli RtcA catalyzes adenylylation of 5'-phosphate ends of DNA or RNA strands to form AppDNA and AppRNA products. The polynucleotide 5' modification reaction requires the His(309) nucleophile, signifying that it proceeds through a covalent RtcA-AMP intermediate. We established this point directly by demonstrating transfer of [P-32] AMP from RtcA to a pDNA strand. RtcA readily adenylylated the 5'-phosphate at a 5'-PO4/3'-OH nick in duplex DNA but was unable to covert the nicked DNA-adenylate to a sealed phosphodiester. Our findings raise the prospect that cyclization of RNA 3'-ends might not be the only biochemical pathway in which Rtc enzymes participate; we discuss scenarios in which the 5'-adenylyltransferase of RtcA might play a role.	[Chakravarty, Anupam K.; Shuman, Stewart] Sloan Kettering Inst, Program Mol Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Shuman, S (corresponding author), Sloan Kettering Inst, Program Mol Biol, New York, NY 10065 USA.	s-shuman@ski.mskcc.org			National Institutes of Health [GM46330]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046330, R37GM046330] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM46330.	Billy E, 2000, EMBO J, V19, P2115, DOI 10.1093/emboj/19.9.2115; Billy E, 1999, J BIOL CHEM, V274, P34955, DOI 10.1074/jbc.274.49.34955; FILIPOWICZ W, 1985, P NATL ACAD SCI USA, V82, P1316, DOI 10.1073/pnas.82.5.1316; FILIPOWICZ W, 1990, METHOD ENZYMOL, V181, P499; FILIPOWICZ W, 1983, CELL, V32, P547, DOI 10.1016/0092-8674(83)90474-9; FILIPOWICZ W, 1983, NUCLEIC ACIDS RES, V11, P1405, DOI 10.1093/nar/11.5.1405; Genschik P, 1998, J BIOL CHEM, V273, P25516, DOI 10.1074/jbc.273.39.25516; Genschik P, 1997, EMBO J, V16, P2955, DOI 10.1093/emboj/16.10.2955; GREER CL, 1983, CELL, V32, P537, DOI 10.1016/0092-8674(83)90473-7; KONARSKA M, 1982, P NATL ACAD SCI-BIOL, V79, P1474, DOI 10.1073/pnas.79.5.1474; LASKI FA, 1983, J BIOL CHEM, V258, P1974; Nair PA, 2007, NAT STRUCT MOL BIOL, V14, P770, DOI 10.1038/nsmb1266; Nandakumar J, 2007, MOL CELL, V26, P257, DOI 10.1016/j.molcel.2007.02.026; Nandakumar J, 2006, CELL, V127, P71, DOI 10.1016/j.cell.2006.08.038; Palm GJ, 2000, STRUCTURE, V8, P13, DOI 10.1016/S0969-2126(00)00076-9; Pascal JM, 2004, NATURE, V432, P473, DOI 10.1038/nature03082; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; REINBERG D, 1985, J BIOL CHEM, V260, P6088; SHUMAN S, 1995, VIROLOGY, V211, P73, DOI 10.1006/viro.1995.1380; Shuman S, 2004, CURR OPIN STRUC BIOL, V14, P757, DOI 10.1016/j.sbi.2004.10.006; Shuman S, 2009, J BIOL CHEM, V284, P17365, DOI 10.1074/jbc.R900017200; Sriskanda V, 1998, NUCLEIC ACIDS RES, V26, P525, DOI 10.1093/nar/26.2.525; Tanaka N, 2010, STRUCTURE, V18, P449, DOI 10.1016/j.str.2010.01.016; Tanaka N, 2009, RNA, V15, P1865, DOI 10.1261/rna.1771509; VICENTE O, 1988, EUR J BIOCHEM, V176, P431, DOI 10.1111/j.1432-1033.1988.tb14300.x	25	27	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4117	4122		10.1074/jbc.M110.196766	http://dx.doi.org/10.1074/jbc.M110.196766			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21098490	hybrid, Green Published			2022-12-25	WOS:000286975700010
J	Severin, S; Pollitt, AY; Navarro-Nunez, L; Nash, CA; Mourao-Sa, D; Eble, JA; Senis, YA; Watson, SP				Severin, Sonia; Pollitt, Alice Y.; Navarro-Nunez, Leyre; Nash, Craig A.; Mourao-Sa, Diego; Eble, Johannes A.; Senis, Yotis A.; Watson, Steve P.			Syk-dependent Phosphorylation of CLEC-2 A NOVEL MECHANISM OF HEM-IMMUNORECEPTOR TYROSINE-BASED ACTIVATION MOTIF SIGNALING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-GAMMA-CHAIN; SRC FAMILY KINASES; GLYCOPROTEIN-VI; PLATELET ACTIVATION; PHOSPHATASE CD148; CRYSTAL-STRUCTURE; B-CELL; LYN; ASSOCIATION; PODOPLANIN	The C-type lectin-like receptor CLEC-2 signals via phosphorylation of a single cytoplasmic YXXL sequence known as a hem-immunoreceptor tyrosine-based activation motif (hemITAM). In this study, we show that phosphorylation of CLEC-2 by the snake toxin rhodocytin is abolished in the absence of the tyrosine kinase Syk but is not altered in the absence of the major platelet Src family kinases, Fyn, Lyn, and Src, or the tyrosine phosphatase CD148, which regulates the basal activity of Src family kinases. Further, phosphorylation of CLEC-2 by rhodocytin is not altered in the presence of the Src family kinase inhibitor PP2, even though PLC gamma 2 phosphorylation and platelet activation are abolished. A similar dependence of phosphorylation of CLEC-2 on Syk is also seen in response to stimulation by an IgG mAb to CLEC-2, although interestingly CLEC-2 phosphorylation is also reduced in the absence of Lyn. These results provide the first definitive evidence that Syk mediates phosphorylation of the CLEC-2 hemITAM receptor with Src family kinases playing a critical role further downstream through the regulation of Syk and other effector proteins, providing a new paradigm in signaling by YXXL-containing receptors.	[Severin, Sonia; Pollitt, Alice Y.; Navarro-Nunez, Leyre; Nash, Craig A.; Senis, Yotis A.; Watson, Steve P.] Univ Birmingham, Coll Med & Dent Sci, Inst Biomed Res, Ctr Cardiovasc Sci, Birmingham B15 2TT, W Midlands, England; [Mourao-Sa, Diego] Lincolns Inn Fields Labs, Immunobiol Lab, Canc Res UK, London Res Inst, London WC2A 3PX, England; [Eble, Johannes A.] Frankfurt Univ Hosp, Ctr Mol Med, D-60590 Frankfurt, Germany	University of Birmingham; Cancer Research UK; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Severin, S (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Inst Biomed Res, Ctr Cardiovasc Sci, Birmingham B15 2TT, W Midlands, England.	s.severin@bham.ac.uk	Severin, Sonia/M-5276-2014; Navarro Nuñez, Leyre/C-7093-2013; Watson, Stephen P/Q-6292-2016; Senis, Yotis/AAD-7183-2021	Navarro Nuñez, Leyre/0000-0001-7115-8065; Watson, Stephen P/0000-0002-7846-7423; Mourao, Diego/0000-0001-6618-6969; Pollitt, Alice/0000-0001-8706-5154; SEVERIN, Sonia/0000-0002-1566-2619; Senis, Yotis/0000-0002-0947-9957	British Heart Foundation [PG/06/129/21681]; Wellcome Trust [088410]; Spanish Ministry of Education [EX2009_0242]; Deutsche Forschungsgemeinschaft [SFB/TR23, A8]; British Heart Foundation [FS/08/034/25085] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Spanish Ministry of Education(Spanish Government); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); British Heart Foundation(British Heart Foundation)	Supported by British Heart Foundation Grant PG/06/129/21681.; Supported by Wellcome Trust Grant 088410.; Supported by the Spanish Ministry of Education (EX2009_0242).; Supported by Deutsche Forschungsgemeinschaft Grant SFB/TR23 Project A8.	Bertozzi CC, 2010, BLOOD, V116, P661, DOI 10.1182/blood-2010-02-270876; Bori-Sanz T, 2003, J BIOL CHEM, V278, P35914, DOI 10.1074/jbc.M301826200; Christou CM, 2008, BIOCHEM J, V411, P133, DOI 10.1042/BJ20071216; CLARK EA, 1994, J BIOL CHEM, V269, P28859; Colonna M, 2000, EUR J IMMUNOL, V30, P697; Cooper JA, 2008, BIOCHEMISTRY-US, V47, P5681, DOI 10.1021/bi8003044; Ezumi Y, 1998, J EXP MED, V188, P267, DOI 10.1084/jem.188.2.267; Falet H, 2010, J EXP MED, V207, P1967, DOI 10.1084/jem.20100222; Fuller GLJ, 2007, J BIOL CHEM, V282, P12397, DOI 10.1074/jbc.M609558200; Hooley E, 2008, BIOCHEMISTRY-US, V47, P7831, DOI 10.1021/bi800528t; Hughes CE, 2010, J THROMB HAEMOST, V8, P2328, DOI 10.1111/j.1538-7836.2010.04006.x; Hughes CE, 2010, BLOOD, V115, P2947, DOI 10.1182/blood-2009-08-237834; Kerrigan AM, 2009, J IMMUNOL, V182, P4150, DOI 10.4049/jimmunol.0802808; Kunita A, 2007, AM J PATHOL, V170, P1337, DOI 10.2353/ajpath.2007.060790; Lannutti BJ, 2003, EXP HEMATOL, V31, P1268, DOI 10.1016/j.exphem.2003.09.009; Lin J, 2004, J IMMUNOL, V173, P2324, DOI 10.4049/jimmunol.173.4.2324; May F, 2009, BLOOD, V114, P3464, DOI 10.1182/blood-2009-05-222273; McCarty OJT, 2005, J BIOL CHEM, V280, P39474, DOI 10.1074/jbc.M504672200; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Mori J, 2008, J BIOL CHEM, V283, P35419, DOI 10.1074/jbc.M806895200; Pearce AC, 2004, J BIOL CHEM, V279, P53955, DOI 10.1074/jbc.M410355200; Pestina TI, 1997, ARTERIOSCL THROM VAS, V17, P3278, DOI 10.1161/01.ATV.17.11.3278; Pollitt AY, 2010, BLOOD, V115, P2938, DOI 10.1182/blood-2009-12-257212; Poole A, 1997, EMBO J, V16, P2333, DOI 10.1093/emboj/16.9.2333; Quek LS, 2000, BLOOD, V96, P4246; Schacht V, 2003, EMBO J, V22, P3546, DOI 10.1093/emboj/cdg342; Schmaier AA, 2009, P NATL ACAD SCI USA, V106, P21167, DOI 10.1073/pnas.0906436106; Senis YA, 2007, MOL CELL PROTEOMICS, V6, P548, DOI 10.1074/mcp.D600007-MCP200; Senis YA, 2009, BLOOD, V113, P4942, DOI 10.1182/blood-2008-08-174318; Sobanov Y, 2001, EUR J IMMUNOL, V31, P3493, DOI 10.1002/1521-4141(200112)31:12<3493::AID-IMMU3493>3.0.CO;2-9; Spalton JC, 2009, J THROMB HAEMOST, V7, P1192, DOI 10.1111/j.1538-7836.2009.03451.x; Suzuki-Inoue K, 2006, BLOOD, V107, P542, DOI 10.1182/blood-2005-05-1994; Suzuki-Inoue K, 2003, BLOOD, V102, P1367, DOI 10.1182/blood-2003-01-0029; Suzuki-Inoue K, 2002, J BIOL CHEM, V277, P21561, DOI 10.1074/jbc.M201012200; Suzuki-Inoue K, 2007, J BIOL CHEM, V282, P25993, DOI 10.1074/jbc.M702327200; Suzuki-Inoue K, 2010, J BIOL CHEM, V285, P24494, DOI 10.1074/jbc.M110.130575; Uhrin P, 2010, BLOOD, V115, P3997, DOI 10.1182/blood-2009-04-216069; Watanabe D, 2001, J BIOL CHEM, V276, P38595, DOI 10.1074/jbc.M103675200; Watson AA, 2008, PROTEIN SCI, V17, P1611, DOI 10.1110/ps.035568.108; Watson AA, 2009, BIOCHEMISTRY-US, V48, P10988, DOI 10.1021/bi901427d; Zhu JW, 2008, IMMUNITY, V28, P183, DOI 10.1016/j.immuni.2007.11.024	41	80	82	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4107	4116		10.1074/jbc.M110.167502	http://dx.doi.org/10.1074/jbc.M110.167502			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21098033	Green Published, hybrid			2022-12-25	WOS:000286975700009
J	Andreotti, G; Vitale, RM; Avidan-Shpalter, C; Amodeo, P; Gazit, E; Motta, A				Andreotti, Giuseppina; Vitale, Rosa Maria; Avidan-Shpalter, Carmit; Amodeo, Pietro; Gazit, Ehud; Motta, Andrea			Converting the Highly Amyloidogenic Human Calcitonin into a Powerful Fibril Inhibitor by Three-dimensional Structure Homology with a Non-amyloidogenic Analogue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SALMON-CALCITONIN; SECONDARY STRUCTURE; ALPHA-HELIX; PROTEIN AGGREGATION; DYNAMIC PROPERTIES; NMR-SPECTROSCOPY; BETA PEPTIDE; FIBRILLOGENESIS; OLIGOMERIZATION; DETERMINANTS	Irreversible aggregation limits bioavailability and therapeutic activity of protein-based drugs. Here we show that an aggregation-resistant mutant can be engineered by structural homology with a non-amyloidogenic analogue and that the aggregation-resistant variant may act as an inhibitor. This strategy has successfully been applied to the amyloidogenic human calcitonin (hCT). Including only five residues from the non-amyloidogenic salmon calcitonin (sCT), we obtained a variant, polar human calcitonin (phCT), whose solution structure was shown by CD, NMR, and calculations to be practically identical to that of sCT. phCT was also observed to be a potent amyloidogenesis inhibitor of hCT when mixed with it in a 1:1 ratio. Fibrillation studies of phCT and the phCT-hCT mixture mimicked the sCT behavior in the kinetics and shapes of the fibrils with a dramatic reduction with respect to hCT. Finally, the effect of phCT alone and of the mixture on the intracellular cAMP level in T47D cells confirmed for the mutant and the mixture their calcitonin-like activity, exhibiting stimulation effects identical to those of sCT, the current therapeutic form. The strategy followed appears to be suitable to develop new forms of hCT with a striking reduction of aggregation and improved activity. Finally, the inhibitory properties of the aggregation-resistant analogue, if confirmed for other amyloidogenic peptides, may favor a new strategy for controlling fibril formation in a variety of human diseases.	[Andreotti, Giuseppina; Vitale, Rosa Maria; Amodeo, Pietro; Motta, Andrea] CNR, Ist Chim Biomol, Comprensorio Olivetti, I-80078 Pozzuoli, Naples, Italy; [Avidan-Shpalter, Carmit; Gazit, Ehud] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, George S Wise Fac Life Sci, IL-69978 Tel Aviv, Israel	Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica Biomolecolare (ICB-CNR); Tel Aviv University	Motta, A (corresponding author), CNR, Ist Chim Biomol, Comprensorio Olivetti, Edificio A,Via Campi Flegrei 34, I-80078 Pozzuoli, Naples, Italy.	andrea.motta@icb.cnr.it	Vitale, Rosa Maria/AAY-1522-2020; ANDREOTTI, GIUSEPPINA/AAX-8952-2020; Gazit, Ehud/C-3715-2011; Amodeo, Pietro/P-1800-2015; Gazit, Ehud/AHE-9332-2022; Gazit, Ehud/M-8026-2019	Vitale, Rosa Maria/0000-0001-9243-1307; ANDREOTTI, GIUSEPPINA/0000-0002-1594-0156; Gazit, Ehud/0000-0001-5764-1720; Amodeo, Pietro/0000-0002-6439-7575; Gazit, Ehud/0000-0001-5764-1720; Motta, Andrea/0000-0002-8643-658X	DIP, German-Israeli Project Cooperation	DIP, German-Israeli Project Cooperation	This research was partly funded by DIP, German-Israeli Project Cooperation.	Abedini A, 2007, J AM CHEM SOC, V129, P11300, DOI 10.1021/ja072157y; Abedini A, 2009, PROTEIN ENG DES SEL, V22, P453, DOI 10.1093/protein/gzp036; Abedini A, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/1/015005; Amodeo P, 1999, J BIOMOL NMR, V13, P161, DOI 10.1023/A:1008365322148; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Andreotti G, 2004, J BIOL CHEM, V279, P6364, DOI 10.1074/jbc.M310882200; ANDREOTTI G, Patent No. 2007000481; Andreotti G, 2006, J BIOL CHEM, V281, P24193, DOI 10.1074/jbc.M603528200; ARVINTE T, 1993, J BIOL CHEM, V268, P6415; ARVINTE T, 1993, J BIOL CHEM, V268, P6408; ARVINTE T, 1996, CIBA F SYMP, V199, P90; BAUER HH, 1995, J STRUCT BIOL, V115, P1, DOI 10.1006/jsbi.1995.1024; Beaudreuil J, 2000, BONE, V27, P161, DOI 10.1016/S8756-3282(00)00305-7; Case D, 2006, AMBER 9; Chi EY, 2003, PHARM RES-DORDR, V20, P1325, DOI 10.1023/A:1025771421906; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; CUDD A, 1995, J PHARM SCI, V84, P717, DOI 10.1002/jps.2600840610; Estrada LD, 2007, CURR TOP MED CHEM, V7, P115, DOI 10.2174/156802607779318262; FELETTI C, 1979, NEPHRON, V24, P85, DOI 10.1159/000181689; Fezoui Y, 2002, J BIOL CHEM, V277, P36948, DOI 10.1074/jbc.M204168200; Fowler SB, 2005, P NATL ACAD SCI USA, V102, P10105, DOI 10.1073/pnas.0501215102; Gazit E, 2002, FASEB J, V16, P77, DOI 10.1096/fj.01-0442hyp; GRAUER A, 1993, HORM METAB RES, V25, P486, DOI 10.1055/s-2007-1002156; GRIESINGER C, 1988, J AM CHEM SOC, V110, P7870, DOI 10.1021/ja00231a044; Hermeling S, 2004, PHARM RES-DORDR, V21, P897, DOI 10.1023/B:PHAM.0000029275.41323.a6; Hwang TL, 1998, J MAGN RESON, V135, P280, DOI 10.1006/jmre.1998.1598; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; Kallberg Y, 2001, J BIOL CHEM, V276, P12945, DOI 10.1074/jbc.M010402200; Kammerer RA, 1998, P NATL ACAD SCI USA, V95, P13419, DOI 10.1073/pnas.95.23.13419; KANAORI K, 1995, BIOCHEMISTRY-US, V34, P12138, DOI 10.1021/bi00038a006; Kazantzis A, 2002, EUR J BIOCHEM, V269, P780, DOI 10.1046/j.0014-2956.2001.02689.x; Kim J, 2007, J NEUROSCI, V27, P627, DOI 10.1523/JNEUROSCI.4849-06.2007; Kim W, 2008, J MOL BIOL, V377, P565, DOI 10.1016/j.jmb.2007.12.079; Kirkitadze MD, 2001, J MOL BIOL, V312, P1103, DOI 10.1006/jmbi.2001.4970; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LAMP SJ, 1981, J BIOL CHEM, V256, P2269; LeVine H, 1999, METHOD ENZYMOL, V309, P274; LEVITT M, 1988, J MOL BIOL, V201, P751, DOI 10.1016/0022-2836(88)90471-8; Maji SK, 2009, J BIOL CHEM, V284, P23580, DOI 10.1074/jbc.M109.038133; Manicourt D.-H., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P285; Marek P, 2007, BIOCHEMISTRY-US, V46, P3255, DOI 10.1021/bi0621967; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; MORAN J, 1978, P NATL ACAD SCI USA, V75, P3984, DOI 10.1073/pnas.75.8.3984; MORELLI MAC, 1992, J BIOMOL NMR, V2, P335, DOI 10.1007/BF01874812; Moriarty DF, 1998, BIOCHEM BIOPH RES CO, V245, P344, DOI 10.1006/bbrc.1998.8425; Motta A, 1998, PROTEINS, V32, P314, DOI 10.1002/(SICI)1097-0134(19980815)32:3<314::AID-PROT7>3.3.CO;2-J; Murray MM, 2009, J AM CHEM SOC, V131, P6316, DOI 10.1021/ja8092604; Nerelius C, 2009, P NATL ACAD SCI USA, V106, P9191, DOI 10.1073/pnas.0810364106; Reches M, 2002, J BIOL CHEM, V277, P35475, DOI 10.1074/jbc.M206039200; Rodan G. A., 2002, PRINCIPLES BONE BIOL, P1423; Routledge KE, 2009, J MOL BIOL, V389, P776, DOI 10.1016/j.jmb.2009.04.042; Rymer DL, 2001, J BIOL CHEM, V276, P2523, DOI 10.1074/jbc.M005800200; Schellekens H, 2002, NAT REV DRUG DISCOV, V1, P457, DOI 10.1038/nrd818; Schmidt MC, 1998, BIOCHEMISTRY-US, V37, P16582, DOI 10.1021/bi981219h; Sciarretta KL, 2006, METHOD ENZYMOL, V413, P273, DOI 10.1016/S0076-6879(06)13015-3; Sexton PM, 1999, CURR MED CHEM, V6, P1067; Shtainfeld A, 2010, BIOCHEMISTRY-US, V49, P5299, DOI 10.1021/bi1002713; SIMMERLING CL, 1999, AMBER 6; SINGER FR, 1972, J CLIN INVEST, V51, P2331, DOI 10.1172/JCI107044; SLETTEN K, 1976, J EXP MED, V143, P993, DOI 10.1084/jem.143.4.993; Stipani V, 2001, BIOPHYS J, V81, P3332, DOI 10.1016/S0006-3495(01)75966-8; Stroop SD, 1996, ENDOCRINOLOGY, V137, P4752, DOI 10.1210/en.137.11.4752; Tartaglia GG, 2004, PROTEIN SCI, V13, P1939, DOI 10.1110/ps.04663504; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; Tjernberg L, 2002, J BIOL CHEM, V277, P43243, DOI 10.1074/jbc.M205570200; Tsui V, 2001, BIOPOLYMERS, V56, P275, DOI 10.1002/1097-0282(2000)56:4<275::AID-BIP10024>3.0.CO;2-E; WADA S, 1995, ENDOCRINOLOGY, V136, P2611, DOI 10.1210/en.136.6.2611; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; YAMAMOTO Y, 1982, JPN J PHARMACOL, V32, P1013, DOI 10.1254/jjp.32.1013; Yan LM, 2006, P NATL ACAD SCI USA, V103, P2046, DOI 10.1073/pnas.0507471103; Yan YL, 2007, J MOL BIOL, V369, P909, DOI 10.1016/j.jmb.2007.04.014; Yang MF, 2008, J MOL BIOL, V384, P450, DOI 10.1016/j.jmb.2008.09.039; Zaidi M, 2002, BONE, V30, P655, DOI 10.1016/S8756-3282(02)00688-9; ZHONG LX, 1992, P NATL ACAD SCI USA, V89, P4462, DOI 10.1073/pnas.89.10.4462	74	23	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2707	2718		10.1074/jbc.M110.182014	http://dx.doi.org/10.1074/jbc.M110.182014			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21078667	Green Published, hybrid			2022-12-25	WOS:000286464300037
J	Brenneis, C; Coste, O; Altenrath, K; Angioni, C; Schmidt, H; Schuh, CD; Zhang, DD; Henke, M; Weigert, A; Brune, B; Rubin, B; Nusing, R; Scholich, K; Geisslinger, G				Brenneis, Christian; Coste, Ovidiu; Altenrath, Kai; Angioni, Carlo; Schmidt, Helmut; Schuh, Claus-Dieter; Zhang, Dong Dong; Henke, Marina; Weigert, Andreas; Bruene, Bernhard; Rubin, Barry; Nusing, Rolf; Scholich, Klaus; Geisslinger, Gerd			Anti-inflammatory Role of Microsomal Prostaglandin E Synthase-1 in a Model of Neuroinflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; E RECEPTOR SUBTYPES; RAT SPINAL-CORD; INNATE IMMUNITY; PAIN HYPERSENSITIVITY; ISCHEMIC TOLERANCE; LIGAND-BINDING; MESSENGER-RNA; NEONATAL-RAT; LIPOPOLYSACCHARIDE	A major immunological response during neuroinflammation is the activation of microglia, which subsequently release proinflammatory mediators such as prostaglandin E-2 (PGE(2)). Besides its proinflammatory properties, cyclooxygenase-2 (COX-2)-derived PGE(2) has been shown to exhibit anti-inflammatory effects on innate immune responses. Here, we investigated the role of microsomal PGE(2) synthase-1 (mPGES-1), which is functionally coupled to COX-2, in immune responses using a model of lipopolysaccharide (LPS)-induced spinal neuroinflammation. Interestingly, we found that activation of E-prostanoid (EP)2 and EP4 receptors, but not EP1, EP3, PGI(2) receptor (IP), thromboxane A(2) receptor (TP), PGD(2) receptor (DP), and PGF(2) receptor (FP), efficiently blocked LPS-induced tumor necrosis factor alpha (TNF alpha) synthesis and COX-2 and mPGES-1 induction as well as prostaglandin synthesis in spinal cultures. In vivo, spinal EP2 receptors were up-regulated in microglia in response to intrathecally injected LPS. Accordingly, LPS priming reduced spinal synthesis of TNF alpha, interleukin 1 beta (IL-1 beta), and prostaglandins in response to a second intrathecal LPS injection. Importantly, this reduction was only seen in wild-type but not in mPGES-1-deficient mice. Furthermore, intrathecal application of EP2 and EP4 agonists as well as genetic deletion of EP2 significantly reduced spinal TNF alpha and IL-1 beta synthesis in mPGES-1 knock-out mice after LPS priming. These data suggest that initial inflammation prepares the spinal cord for a negative feedback regulation by mPGES-1- derived PGE(2) followed by EP2 activation, which limits the synthesis of inflammatory mediators during chronic inflammation. Thus, our data suggest a role of mPGES-1-derived PGE(2) in resolution of neuroinflammation.	[Zhang, Dong Dong; Henke, Marina; Nusing, Rolf; Geisslinger, Gerd] Klinikum Goethe Univ Frankfurt, Inst Clin Pharmacol, ZAFES, Pharmazentrum Frankfurt, D-60590 Frankfurt, Germany; [Weigert, Andreas; Bruene, Bernhard] Klinikum Goethe Univ Frankfurt, ZAFES, Inst Biochem 1, D-60590 Frankfurt, Germany; [Rubin, Barry] Univ Toronto, Div Vasc Surg, Toronto, ON M5S 1A1, Canada	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Toronto	Geisslinger, G (corresponding author), Klinikum Goethe Univ Frankfurt, Inst Clin Pharmacol, ZAFES, Pharmazentrum Frankfurt, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	geisslinger@em.uni-frankfurt.de	Schuh, Claus D/G-9032-2013; Weigert, Andreas/E-6540-2010	Weigert, Andreas/0000-0002-7529-1952	Deutsche Forschungsgemeinschaft [GE695]; LOEWE Lipid Signaling Forschungszentrum Frankfurt	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); LOEWE Lipid Signaling Forschungszentrum Frankfurt	This work was supported by Deutsche Forschungsgemeinschaft Grant GE695 and the LOEWE Lipid Signaling Forschungszentrum Frankfurt.	ARMSTRONG RA, 1989, BRIT J PHARMACOL, V97, P657, DOI 10.1111/j.1476-5381.1989.tb12001.x; Baba H, 2001, J NEUROSCI, V21, P1750, DOI 10.1523/JNEUROSCI.21-05-01750.2001; Brenneis C, 2008, J CELL MOL MED, V12, P639, DOI 10.1111/j.1582-4934.2007.00110.x; Brenneis C, 2006, FASEB J, V20, P1352, DOI 10.1096/fj.05-5346com; Buenafe AC, 2007, J NEUROIMMUNOL, V182, P32, DOI 10.1016/j.jneuroim.2006.09.004; Caggiano AO, 1999, J NEUROCHEM, V72, P565, DOI 10.1046/j.1471-4159.1999.0720565.x; Choi JS, 2006, CELL TISSUE RES, V324, P203, DOI 10.1007/s00441-005-0121-0; Cimino PJ, 2008, CURR MED CHEM, V15, P1863, DOI 10.2174/092986708785132915; Coste O, 2008, J BIOL CHEM, V283, P32442, DOI 10.1074/jbc.M806410200; Coste O, 2008, J CELL MOL MED, V12, P995, DOI 10.1111/j.1582-4934.2008.00160.x; Engblom D, 2003, NAT NEUROSCI, V6, P1137, DOI 10.1038/nn1137; FitzGerald GA, 2001, NEW ENGL J MED, V345, P433, DOI 10.1056/NEJM200108093450607; FitzGerald GA, 2004, NEW ENGL J MED, V351, P1709, DOI 10.1056/NEJMp048288; Griffin RS, 2007, J NEUROSCI, V27, P8699, DOI 10.1523/JNEUROSCI.2018-07.2007; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; Herber DL, 2006, GLIA, V53, P382, DOI 10.1002/glia.20272; Hizaki H, 1999, P NATL ACAD SCI USA, V96, P10501, DOI 10.1073/pnas.96.18.10501; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; Ikeda-Matsuo Y, 2005, J NEUROCHEM, V94, P1546, DOI 10.1111/j.1471-4159.2005.03302.x; Ji KA, 2007, GLIA, V55, P1577, DOI 10.1002/glia.20571; Kawamura T, 1997, LIFE SCI, V61, P2111, DOI 10.1016/S0024-3205(97)00884-9; Kim E, 2007, NEUROSCIENCE, V145, P931, DOI 10.1016/j.neuroscience.2006.12.063; Lambertsen KL, 2009, J NEUROSCI, V29, P1319, DOI 10.1523/JNEUROSCI.5505-08.2009; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Liang XB, 2008, ANN NEUROL, V64, P304, DOI 10.1002/ana.21437; Lin HY, 2010, STROKE, V41, P1543, DOI 10.1161/STROKEAHA.109.574004; Lin HY, 2009, PEDIATR RES, V66, P254, DOI 10.1203/PDR.0b013e3181b0d336; Linke B, 2009, J PROTEOME RES, V8, P4851, DOI 10.1021/pr900106v; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; Montine TJ, 2002, J NEUROCHEM, V83, P463, DOI 10.1046/j.1471-4159.2002.01157.x; Morath R, 1999, J AM SOC NEPHROL, V10, P1851; Narita M, 2008, NEUROSCIENCE, V152, P477, DOI 10.1016/j.neuroscience.2007.10.039; Noda M, 2007, J NEUROCHEM, V101, P397, DOI 10.1111/j.1471-4159.2006.04339.x; Pierre S, 2009, NAT REV DRUG DISCOV, V8, P321, DOI 10.1038/nrd2827; Pierre S, 2008, MOL CELL PROTEOMICS, V7, P2475, DOI 10.1074/mcp.M800201-MCP200; Pierre SC, 2004, EMBO J, V23, P3031, DOI 10.1038/sj.emboj.7600321; Reinold H, 2005, J CLIN INVEST, V115, P673; Sacco S, 1998, J NEUROCHEM, V71, P2063; Samad TA, 2001, NATURE, V410, P471, DOI 10.1038/35068566; Scholich K, 2006, TRENDS PHARMACOL SCI, V27, P399, DOI 10.1016/j.tips.2006.06.001; Schubert W, 2006, NAT BIOTECHNOL, V24, P1270, DOI 10.1038/nbt1250; SELDON PM, 1995, MOL PHARMACOL, V48, P747; Shen AG, 2009, NEUROCHEM RES, V34, P333, DOI 10.1007/s11064-008-9780-z; Shie FS, 2005, GLIA, V52, P70, DOI 10.1002/glia.20220; Skaper SD, 2007, ANN NY ACAD SCI, V1122, P23, DOI 10.1196/annals.1403.002; Strauss KI, 2008, BRAIN BEHAV IMMUN, V22, P285, DOI 10.1016/j.bbi.2007.09.011; SUGIMOTO Y, 1993, J BIOL CHEM, V268, P2712; Suzawa T, 2000, ENDOCRINOLOGY, V141, P1554, DOI 10.1210/en.141.4.1554; TAFFET SM, 1989, CELL IMMUNOL, V120, P291, DOI 10.1016/0008-8749(89)90198-6; Trebino CE, 2005, J BIOL CHEM, V280, P16579, DOI 10.1074/jbc.M412075200; Zeilhofer HU, 2005, CELL MOL LIFE SCI, V62, P2027, DOI 10.1007/s00018-005-5107-2; Zhao P, 2007, J NEUROSCI, V27, P2357, DOI 10.1523/JNEUROSCI.0138-07.2007	52	56	56	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2331	2342		10.1074/jbc.M110.157362	http://dx.doi.org/10.1074/jbc.M110.157362			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21075851	Green Published, hybrid			2022-12-25	WOS:000286191500072
J	Stogios, PJ; Shakya, T; Evdokimova, E; Savchenko, A; Wright, GD				Stogios, Peter J.; Shakya, Tushar; Evdokimova, Elena; Savchenko, Alexei; Wright, Gerard D.			Structure and Function of APH(4)-Ia, a Hygromycin B Resistance Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; KINETIC MECHANISM; PHOSPHOTRANSFERASE; PURIFICATION; SUBSTRATE; TRANSLOCATION; ENTEROCOCCUS; SELECTIVITY; SEQUENCE; GENE	The aminoglycoside phosphotransferase (APH) APH(4)-Ia is one of two enzymes responsible for bacterial resistance to the atypical aminoglycoside antibiotic hygromycin B (hygB). The crystal structure of APH(4)-Ia enzyme was solved in complex with hygB at 1.95A resolution. The APH(4)-Ia structure adapts a general two-lobe architecture shared by other APH enzymes and eukaryotic kinases, with the active site located at the interdomain cavity. The enzyme forms an extended hydrogen bond network with hygB primarily through polar and acidic side chain groups. Individual alanine substitutions of seven residues involved in hygB binding did not have significant effect on APH(4)-Ia enzymatic activity, indicating that the binding affinity is spread across a distributed network. hygB appeared as the only substrate recognized by APH(4)-Ia among the panel of 14 aminoglycoside compounds. Analysis of the active site architecture and the interaction with the hygB molecule demonstrated several unique features supporting such restricted substrate specificity. Primarily the APH(4)-Ia substrate-binding site contains a cluster of hydrophobic residues that provides a complementary surface to the twisted structure of the substrate. Similar to APH(2 '') enzymes, the APH(4)-Ia is able to utilize either ATP or GTP for phosphoryl transfer. The defined structural features of APH(4)-Ia interactions with hygB and the promiscuity in regard to ATP or GTP binding could be exploited for the design of novel aminoglycoside antibiotics or inhibitors of this enzyme.	[Wright, Gerard D.] McMaster Univ, MDCL 2301, Dept Biochem & Biomed Sci, MG DeGroote Inst Infect Dis Res, Hamilton, ON L8N 3Z5, Canada; Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada	McMaster University; University of Toronto	Wright, GD (corresponding author), McMaster Univ, MDCL 2301, Dept Biochem & Biomed Sci, MG DeGroote Inst Infect Dis Res, 1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	wrightge@mcmaster.ca	Wright, G/ABB-7666-2021	Stogios, Peter/0000-0001-8663-1425; Wright, Gerard/0000-0002-9129-7131	National Institutes of Health [HHSN272200700058C]; Canadian Institutes of Health Research [MT-13536]; Canada Research Chairs program	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs program(Canada Research Chairs)	This work was supported, in whole or in part, by National Institutes of Health Contract HHSN272200700058C (to A. S.). This work was also supported by Canadian Institutes of Health Research Grant MT-13536 (to G. D. W.) and the Canada Research Chairs program (to G. D. W.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Borovinskaya MA, 2008, RNA, V14, P1590, DOI 10.1261/rna.1076908; BRENNER S, 1987, NATURE, V329, P21, DOI 10.1038/329021a0; Burk DL, 2001, BIOCHEMISTRY-US, V40, P8756, DOI 10.1021/bi010504p; CABANAS MJ, 1978, EUR J BIOCHEM, V87, P21, DOI 10.1111/j.1432-1033.1978.tb12347.x; Daigle DM, 1999, CHEM BIOL, V6, P99, DOI 10.1016/S1074-5521(99)80006-4; Eisenstein BI, 2010, CLIN INFECT DIS, V50, pS10, DOI 10.1086/647938; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fong DH, 2010, J BIOL CHEM, V285, P9545, DOI 10.1074/jbc.M109.038364; GONZALEZ A, 1978, BIOCHIM BIOPHYS ACTA, V521, P459, DOI 10.1016/0005-2787(78)90287-3; GRITZ L, 1983, GENE, V25, P179, DOI 10.1016/0378-1119(83)90223-8; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hon WC, 1997, CELL, V89, P887, DOI 10.1016/S0092-8674(00)80274-3; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MCKAY GA, 1994, BIOCHEMISTRY-US, V33, P6936, DOI 10.1021/bi00188a024; MCKAY GA, 1994, BIOCHEMISTRY-US, V33, P14115, DOI 10.1021/bi00251a021; McKay GA, 1996, BIOCHEMISTRY-US, V35, P8680, DOI 10.1021/bi9603884; Nurizzo D, 2003, J MOL BIOL, V327, P491, DOI 10.1016/S0022-2836(03)00121-9; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARDO JM, 1985, J GEN MICROBIOL, V131, P1289; Petrey D, 2003, METHOD ENZYMOL, V374, P492, DOI 10.1016/S0076-6879(03)74021-X; PITTENGER RC, 1953, ANTIBIOT CHEMOTHER, V3, P1268; PON NG, 1967, ANAL BIOCHEM, V19, P272, DOI 10.1016/0003-2697(67)90163-7; RAO RN, 1983, ANTIMICROB AGENTS CH, V24, P689, DOI 10.1128/AAC.24.5.689; Scheeff ED, 2005, PLOS COMPUT BIOL, V1, P359, DOI 10.1371/journal.pcbi.0010049; Shakya T, 2010, ANTIMICROB AGENTS CH, V54, P1909, DOI 10.1128/AAC.01570-09; SIREGAR JJ, 1995, BIOCHEMISTRY-US, V34, P12681, DOI 10.1021/bi00039a026; Thompson PR, 2002, BIOCHEMISTRY-US, V41, P7001, DOI 10.1021/bi0256680; Toth M, 2007, BIOCHEMISTRY-US, V46, P5570, DOI 10.1021/bi6024512; Toth M, 2010, PROTEIN SCI, V19, P1565, DOI 10.1002/pro.437; Toth M, 2009, J BIOL CHEM, V284, P6690, DOI 10.1074/jbc.M808148200; Tsai SF, 1998, ANTIMICROB AGENTS CH, V42, P1229, DOI 10.1128/AAC.42.5.1229; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wright Gerard D., 1999, Frontiers in Bioscience, V4, pD9, DOI 10.2741/Wright; Young PG, 2009, J BACTERIOL, V191, P4133, DOI 10.1128/JB.00149-09; ZALACAIN M, 1987, EUR J BIOCHEM, V162, P419, DOI 10.1111/j.1432-1033.1987.tb10618.x; ZHENG JH, 1993, ACTA CRYSTALLOGR D, V49, P362, DOI 10.1107/S0907444993000423	39	22	22	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1966	1975		10.1074/jbc.M110.194266	http://dx.doi.org/10.1074/jbc.M110.194266			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21084294	hybrid, Green Published			2022-12-25	WOS:000286191500038
J	Szmola, R; Bence, M; Carpentieri, A; Szabo, A; Costello, CE; Samuelson, J; Sahin-Toth, M				Szmola, Richard; Bence, Melinda; Carpentieri, Andrea; Szabo, Andras; Costello, Catherine E.; Samuelson, John; Sahin-Toth, Miklos			Chymotrypsin C Is a Co-activator of Human Pancreatic Procarboxypeptidases A1 and A2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CATIONIC TRYPSINOGEN; SERINE PROTEINASE-INHIBITOR; SITE-DIRECTED MUTAGENESIS; HEREDITARY PANCREATITIS; BOVINE PROCARBOXYPEPTIDASE; ACTIVATION PATHWAY; 3-DIMENSIONAL STRUCTURE; ENZYMATIC SPECIFICITY; TRYPTIC ACTIVATION; CARBOXYPEPTIDASE-A	Human digestive carboxypeptidases CPA1, CPA2, and CPB1 are secreted by the pancreas as inactive proenzymes containing a 94-96-amino acid-long propeptide. Activation of procarboxypeptidases is initiated by proteolytic cleavage at the C-terminal end of the propeptide by trypsin. Here, we demonstrate that subsequent cleavage of the propeptide by chymotrypsin C (CTRC) induces a nearly 10-fold increase in the activity of trypsin-activated CPA1 and CPA2, whereas CPB1 activity is unaffected. Other human pancreatic proteases such as chymotrypsin B1, chymotrypsin B2, chymotrypsin-like enzyme-1, elastase 2A, elastase 3A, or elastase 3B are inactive or markedly less effective at promoting procarboxypeptidase activation. On the basis of these observations, we propose that CTRC is a physiological co-activator of proCPA1 and proCPA2. Furthermore, the results confirm and extend the notion that CTRC is a key regulator of digestive zymogen activation.	[Sahin-Toth, Miklos] Boston Univ, Henry M Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02118 USA; [Costello, Catherine E.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University; Boston University	Sahin-Toth, M (corresponding author), 72 E Concord St,Evans 433, Boston, MA 02118 USA.	miklos@bu.edu		Sahin-Toth, Miklos/0000-0003-4513-9922; Costello, Catherine/0000-0003-1594-5122; Samuelson, John/0000-0001-9533-3040; Carpentieri, Andrea/0000-0002-1944-5355	National Institutes of Health [R01 DK082412, R01 DK082412-S2, R01 DK058088, R01 AI44070, P41 RR010888, S10 RR020946]; Rosztoczy Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR010888, S10RR020946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082412, R01DK058088] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rosztoczy Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK082412, R01 DK082412-S2 (American Recovery and Reinvestment Act), R01 DK058088 (to M.S.-T.), R01 AI44070 (to J.S.), P41 RR010888 (to C.E.C.), S10 RR020946 (to J. Zaia). This work was also supported by a scholarship from the Rosztoczy Foundation (to M.B.).	AVILES FX, 1993, EUR J BIOCHEM, V211, P381, DOI 10.1111/j.1432-1033.1993.tb17561.x; BROWN JR, 1961, P NATL ACAD SCI USA, V47, P1554, DOI 10.1073/pnas.47.10.1554; CATASUS L, 1992, BIOCHEM J, V287, P299, DOI 10.1042/bj2870299; CATASUS L, 1995, J BIOL CHEM, V270, P6651, DOI 10.1074/jbc.270.12.6651; CHAPUS C, 1987, EUR J BIOCHEM, V166, P379, DOI 10.1111/j.1432-1033.1987.tb13526.x; FOLK JE, 1965, J BIOL CHEM, V240, P193; FOLK JE, 1965, J BIOL CHEM, V240, P181; GOMISRUTH FX, 1995, EMBO J, V14, P4387, DOI 10.1002/j.1460-2075.1995.tb00117.x; GUASCH A, 1992, J MOL BIOL, V224, P141, DOI 10.1016/0022-2836(92)90581-4; IIOAKAMA K, 1985, BIOCHIM BIOPHYS ACTA, V831, P249, DOI 10.1016/0167-4838(85)90042-1; KEILDLOUHA V, 1972, BIOCHIM BIOPHYS ACTA, V276, P531, DOI 10.1016/0005-2744(72)91013-3; KELLER PJ, 1958, J BIOL CHEM, V230, P905; KERFELEC B, 1985, EUR J BIOCHEM, V151, P515, DOI 10.1111/j.1432-1033.1985.tb09132.x; Kiraly O, 2007, HUM MUTAT, V28, P469, DOI 10.1002/humu.20471; LACKO AG, 1970, BIOCHEMISTRY-US, V9, P4680; Laethem RM, 1996, ARCH BIOCHEM BIOPHYS, V332, P8, DOI 10.1006/abbi.1996.0310; Lengyel Z, 1998, PROTEIN EXPRES PURIF, V12, P291, DOI 10.1006/prep.1997.0837; Masson E, 2008, HUM GENET, V123, P83, DOI 10.1007/s00439-007-0459-3; Mock WL, 1996, ANAL BIOCHEM, V239, P218, DOI 10.1006/abio.1996.0318; Mock WL, 2002, BIOORG MED CHEM LETT, V12, P1193, DOI 10.1016/S0960-894X(02)00128-2; Nemoda Z, 2006, J BIOL CHEM, V281, P11879, DOI 10.1074/jbc.M600124200; OPPEZZO O, 1994, EUR J BIOCHEM, V222, P55, DOI 10.1111/j.1432-1033.1994.tb18841.x; Pal G, 1996, FEBS LETT, V385, P165, DOI 10.1016/0014-5793(96)00376-6; PAL G, 1994, FEBS LETT, V342, P57, DOI 10.1016/0014-5793(94)80584-9; PASCUAL R, 1989, EUR J BIOCHEM, V179, P609, DOI 10.1111/j.1432-1033.1989.tb14590.x; PETERSON LM, 1976, BIOCHEMISTRY-US, V15, P2501, DOI 10.1021/bi00657a001; PHILLIPS MA, 1990, J BIOL CHEM, V265, P20692; PHILLIPS MA, 1992, PROTEIN SCI, V1, P517; Reverter D, 1997, FEBS LETT, V420, P7, DOI 10.1016/S0014-5793(97)01476-2; Reverter D, 1998, J BIOL CHEM, V273, P3535, DOI 10.1074/jbc.273.6.3535; Rosendahl J, 2008, NAT GENET, V40, P78, DOI 10.1038/ng.2007.44; Sahin-Toth M, 2000, BIOCHEM BIOPH RES CO, V278, P286, DOI 10.1006/bbrc.2000.3797; Sahin-Toth M, 2000, J BIOL CHEM, V275, P22750, DOI 10.1074/jbc.M002943200; Szepessy E, 2006, PANCREATOLOGY, V6, P117, DOI 10.1159/000090031; Szmola R, 2007, P NATL ACAD SCI USA, V104, P11227, DOI 10.1073/pnas.0703714104; UREN JR, 1972, BIOCHEMISTRY-US, V11, P4483, DOI 10.1021/bi00774a010; Vendrell J, 2000, BBA-PROTEIN STRUCT M, V1477, P284, DOI 10.1016/S0167-4838(99)00280-0; VENDRELL J, 1992, BIOL CHEM H-S, V373, P387, DOI 10.1515/bchm3.1992.373.2.387; VENDRELL J, 1990, J BIOL CHEM, V265, P6949; VILLEGAS V, 1995, PROTEIN SCI, V4, P1792, DOI 10.1002/pro.5560040914; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141	41	26	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1819	1827		10.1074/jbc.M110.187369	http://dx.doi.org/10.1074/jbc.M110.187369			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21098023	hybrid, Green Published			2022-12-25	WOS:000286191500022
J	Tsukada, T; Kotlyanskaya, L; Huynh, R; Desai, B; Novak, SM; Kajava, AV; Gregorio, CC; Kostyukova, AS				Tsukada, Takehiro; Kotlyanskaya, Lucy; Huynh, Robert; Desai, Brinda; Novak, Stefanie M.; Kajava, Andrey V.; Gregorio, Carol C.; Kostyukova, Alla S.			Identification of Residues within Tropomodulin-1 Responsible for Its Localization at the Pointed Ends of the Actin Filaments in Cardiac Myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TROPOMYOSIN BINDING; CAPPING PROTEIN; STRIATED-MUSCLE; DOMAINS; LENGTH; HEART; DYNAMICS; LEADS; MICE	Tropomodulin is a tropomyosin-dependent actin filament capping protein involved in the structural formation of thin filaments and in the regulation of their lengths through its localization at the pointed ends of actin filaments. The disordered N-terminal domain of tropomodulin contains three functional sites: two tropomyosin-binding and one tropomyosin-dependent actin-capping sites. The C-terminal half of tropomodulin consists of one compact domain containing a tropomyosin-independent actin-capping site. Here we determined the structural properties of tropomodulin-1 that affect its roles in cardiomyocytes. To explore the significance of individual tropomyosin-binding sites, GFP-tropomodulin-1 with single mutations that destroy each tropomyosin-binding site was expressed in cardiomyocytes. We demonstrated that both sites are necessary for the optimal localization of tropomodulin-1 at thin filament pointed ends, with site 2 acting as the major determinant. To investigate the functional properties of the tropomodulin C-terminal domain, truncated versions of GFP-tropomodulin-1 were expressed in cardiomyocytes. We discovered that the leucine-rich repeat (LRR) fold and the C-terminal helix are required for its proper targeting to the pointed ends. To investigate the structural significance of the LRR fold, we generated three mutations within the C-terminal domain (V232D, F263D, and L313D). Our results show that these mutations affect both tropomyosin-independent actin-capping activity and pointed end localization, most likely by changing local conformations of either loops or side chains of the surfaces involved in the interactions of the LRR domain. Studying the influence of these mutations individually, we concluded that, in addition to the tropomyosin-independent actin-capping site, there appears to be another regulatory site within the tropomodulin C-terminal domain.	[Tsukada, Takehiro; Novak, Stefanie M.; Gregorio, Carol C.] Univ Arizona, Dept Cell Biol & Anat, Tucson, AZ 85724 USA; [Tsukada, Takehiro; Novak, Stefanie M.; Gregorio, Carol C.] Univ Arizona, Mol Cardiovasc Res Program, Tucson, AZ 85724 USA; [Kotlyanskaya, Lucy; Huynh, Robert; Desai, Brinda; Kostyukova, Alla S.] Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA; [Kajava, Andrey V.] Univ Montpellier 1 & 2, CNRS, Ctr Rech Biochim Macromol, F-34293 Montpellier, France	University of Arizona; University of Arizona; Rutgers State University New Brunswick; Rutgers State University Medical Center; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Gregorio, CC (corresponding author), Univ Arizona, Dept Cell Biol & Anat, 1656 E Mabel St, Tucson, AZ 85724 USA.	gregorio@arizona.edu; kostyuas@umdnj.edu	Kajava, Andrey V/E-1107-2014	Kajava, Andrey V/0000-0002-2342-6886; Huynh, Robert/0000-0003-3056-5830	National Institutes of Health [HL083146, 5R25GM62584, GM081688]; American Heart Association [0825870G]; University of Medicine; Dentistry of New Jersey Foundation; Schering Plough Corp.; Dentistry of New Jersey Neuroscience Summer Undergraduate Research Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083146] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081688, R25GM062584] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); University of Medicine; Dentistry of New Jersey Foundation; Schering Plough Corp.(Merck & CompanySchering Plough Corporation); Dentistry of New Jersey Neuroscience Summer Undergraduate Research Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant HL083146 (to C. C. G.), National Institutes of Health IMSD Fellowship 5R25GM62584 (to S. M. N.), and National Institutes of Health Grant GM081688 (to A. S. K.). This work was also supported by American Heart Association Grant 0825870G to (T. T.) and University of Medicine and Dentistry of New Jersey Foundation grants (to A. S. K.).; Supported by the University of Medicine and Dentistry of New Jersey Neuroscience Summer Undergraduate Research Program, supported in part by Schering Plough Corp.	Chu X, 2003, AM J PHYSIOL-HEART C, V284, pH1827, DOI 10.1152/ajpheart.00947.2002; Conley CA, 2001, GENOMICS, V73, P127, DOI 10.1006/geno.2000.6501; DAYRINGER HE, 1986, J MOL GRAPHICS, V4, P82; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; FASMAN GD, 1989, PRACTICAL HDB BIOCH, P84; Fowler VM, 2003, J BIOL CHEM, V278, P40000, DOI 10.1074/jbc.M306895200; Fritz-Six KL, 2003, J CELL BIOL, V163, P1033, DOI 10.1083/jcb.200308164; Fujisawa T, 2001, FEBS LETT, V498, P67, DOI 10.1016/S0014-5793(01)02498-X; Greenfield NJ, 2005, BIOPHYS J, V88, P372, DOI 10.1529/biophysj.104.051128; Greenfield NJ, 2002, BIOPHYS J, V82, P2580, DOI 10.1016/S0006-3495(02)75600-2; GREGORIO CC, 1995, NATURE, V377, P83, DOI 10.1038/377083a0; GUSTAFSON TA, 1987, J BIOL CHEM, V262, P13316; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Kong KY, 2004, J BIOL CHEM, V279, P30856, DOI 10.1074/jbc.M302845200; Kostyukova A, 2000, EUR J BIOCHEM, V267, P6470, DOI 10.1046/j.1432-1327.2000.01738.x; Kostyukova AS, 2008, CELL MOL LIFE SCI, V65, P563, DOI 10.1007/s00018-007-7347-9; Kostyukova AS, 2007, J MOL BIOL, V372, P608, DOI 10.1016/j.jmb.2007.05.084; Kostyukova AS, 2006, BIOCHEMISTRY-US, V45, P12068, DOI 10.1021/bi060899i; Kostyukova AS, 2005, BIOCHEMISTRY-US, V44, P4905, DOI 10.1021/bi047468p; Kostyukova AS, 2004, J BIOL CHEM, V279, P5066, DOI 10.1074/jbc.M311186200; Kostyukova AS, 2001, BIOPHYS J, V81, P345, DOI 10.1016/S0006-3495(01)75704-9; Krieger I, 2002, BIOPHYS J, V83, P2716, DOI 10.1016/S0006-3495(02)75281-8; Littlefield R, 2001, NAT CELL BIOL, V3, P544, DOI 10.1038/35078517; Littlefield RS, 2008, SEMIN CELL DEV BIOL, V19, P511, DOI 10.1016/j.semcdb.2008.08.009; McKeown CR, 2008, CIRC RES, V103, P1241, DOI 10.1161/CIRCRESAHA.108.178749; Mudry RE, 2003, J CELL BIOL, V162, P1057, DOI 10.1083/jcb.200305031; Ono Y, 2005, DEV BIOL, V282, P336, DOI 10.1016/j.ydbio.2005.03.015; Pappas CT, 2008, MOL BIOL CELL, V19, P1837, DOI 10.1091/mbc.E07-07-0690; Pappas CT, 2010, J CELL BIOL, V189, P859, DOI 10.1083/jcb.201001043; Sussman MA, 1998, J CLIN INVEST, V101, P51, DOI 10.1172/JCI1167	30	30	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2194	2204		10.1074/jbc.M110.186924	http://dx.doi.org/10.1074/jbc.M110.186924			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21078668	Green Published, hybrid			2022-12-25	WOS:000286191500060
J	Walker, MF; Tian, J; Shan, XY; Tamargo, RJ; Ying, H; Zee, DS				Walker, Mark F.; Tian, Jing; Shan, Xiaoyan; Tamargo, Rafael J.; Ying, Howard; Zee, David S.			The Cerebellar Nodulus/Uvula Integrates Otolith Signals for the Translational Vestibulo-Ocular Reflex	PLOS ONE			English	Article							EYE-MOVEMENTS; SQUIRREL-MONKEY; OCULAR REFLEX; SPATIAL ORIENTATION; NEURAL INTEGRATOR; VIEWING DISTANCE; RHESUS-MONKEYS; HEAD MOTION; BRAIN-STEM; UVULA	Background: The otolith-driven translational vestibulo-ocular reflex (tVOR) generates compensatory eye movements to linear head accelerations. Studies in humans indicate that the cerebellum plays a critical role in the neural control of the tVOR, but little is known about mechanisms of this control or the functions of specific cerebellar structures. Here, we chose to investigate the contribution of the nodulus and uvula, which have been shown by prior studies to be involved in the processing of otolith signals in other contexts. Methodology/Principal Findings: We recorded eye movements in two rhesus monkeys during steps of linear motion along the interaural axis before and after surgical lesions of the cerebellar uvula and nodulus. The lesions strikingly reduced eye velocity during constant-velocity motion but had only a small effect on the response to initial head acceleration. We fit eye velocity to a linear combination of head acceleration and velocity and to a dynamic mathematical model of the tVOR that incorporated a specific integrator of head acceleration. Based on parameter optimization, the lesion decreased the gain of the pathway containing this new integrator by 62%. The component of eye velocity that depended directly on head acceleration changed little (gain decrease of 13%). In a final set of simulations, we compared our data to the predictions of previous models of the tVOR, none of which could account for our experimental findings. Conclusions/Significance: Our results provide new and important information regarding the neural control of the tVOR. Specifically, they point to a key role for the cerebellar nodulus and uvula in the mathematical integration of afferent linear head acceleration signals. This function is likely to be critical not only for the tVOR but also for the otolith-mediated reflexes that control posture and balance.	[Walker, Mark F.; Tian, Jing; Shan, Xiaoyan; Zee, David S.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Walker, Mark F.; Ying, Howard; Zee, David S.] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Tamargo, Rafael J.] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA; [Tamargo, Rafael J.; Zee, David S.] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Zee, David S.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Walker, Mark F.] Case Western Reserve Univ, Dept Neurol, Cleveland, OH 44106 USA; [Walker, Mark F.] Vet Affairs Med Ctr, Cleveland, OH USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Walker, MF (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.	mark.walker@case.edu			National Institutes of Health [RO1-EY01849]; Arnold Chiari Foundation; Albert Pennington Fund; NATIONAL EYE INSTITUTE [R01EY001849] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arnold Chiari Foundation; Albert Pennington Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by the National Institutes of Health (RO1-EY01849), by the Arnold Chiari Foundation, and by the Albert Pennington Fund. Dr. Walker was a Pollin Scholar. Dr. Tian was a Betty and Paul Cinquegrana Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	ANGELAKI DE, 1995, J NEUROPHYSIOL, V73, P1729; Angelaki DE, 1999, J NEUROPHYSIOL, V82, P1651, DOI 10.1152/jn.1999.82.3.1651; Angelaki DE, 2004, J NEUROPHYSIOL, V92, P20, DOI 10.1152/jn.00047.2004; Angelaki DE, 2002, ARCH ITAL BIOL, V140, P315; Angelaki DE, 1998, J NEUROPHYSIOL, V80, P680, DOI 10.1152/jn.1998.80.2.680; Angelaki DE, 2001, J NEUROSCI, V21, P3968, DOI 10.1523/JNEUROSCI.21-11-03968.2001; ANGELAKI DE, 1994, J NEUROPHYSIOL, V72, P1443, DOI 10.1152/jn.1994.72.3.1443; BARMACK NH, 1993, J COMP NEUROL, V327, P521, DOI 10.1002/cne.903270405; Buttner-Ennever JA, 1999, ANN NY ACAD SCI, V871, P51, DOI 10.1111/j.1749-6632.1999.tb09175.x; CANNON SC, 1987, J NEUROPHYSIOL, V57, P1383, DOI 10.1152/jn.1987.57.5.1383; COHEN H, 1992, EXP BRAIN RES, V90, P526; Crane BT, 2003, EXP BRAIN RES, V148, P247, DOI 10.1007/s00221-002-1301-8; Crane BT, 2000, EXP BRAIN RES, V130, P486, DOI 10.1007/s002219900266; FUCHS AF, 1988, J NEUROPHYSIOL, V60, P1874, DOI 10.1152/jn.1988.60.6.1874; Gordon CR, 2003, J NEUROL NEUROSUR PS, V74, P1403, DOI 10.1136/jnnp.74.10.1403; Green AM, 1998, J NEUROPHYSIOL, V80, P2222, DOI 10.1152/jn.1998.80.4.2222; Green AM, 2003, J NEUROSCI, V23, P9265; GREEN AM, 2004, J NEUROPHYSIOL; Green AM, 2007, J NEUROSCI, V27, P1346, DOI 10.1523/JNEUROSCI.3822-06.2007; HAIN TC, 1988, ACTA OTO-LARYNGOL, V105, P13, DOI 10.3109/00016488809119440; Lewis RF, 2003, CEREBELLUM, V2, P123, DOI 10.1080/14734220309407; Liao K, 2008, ANN NEUROL, V64, P224, DOI 10.1002/ana.21407; LUEBKE AE, 1988, VISION RES, V28, P941, DOI 10.1016/0042-6989(88)90103-4; Maklad A, 2003, DEV BRAIN RES, V140, P223, DOI 10.1016/S0165-3806(02)00609-0; Migliaccio AA, 2004, BRAIN, V127, P280, DOI 10.1093/brain/awh030; Miles FA, 1999, ANN NY ACAD SCI, V871, P260, DOI 10.1111/j.1749-6632.1999.tb09190.x; Minor LB, 1999, J NEUROPHYSIOL, V82, P1254, DOI 10.1152/jn.1999.82.3.1254; Musallam S, 2002, J NEUROPHYSIOL, V88, P2104, DOI 10.1152/jn.2002.88.4.2104; Musallam WS, 1999, J NEUROPHYSIOL, V82, P2010, DOI 10.1152/jn.1999.82.4.2010; Newlands SD, 2003, J COMP NEUROL, V466, P31, DOI 10.1002/cne.10876; PAIGE GD, 1991, J NEUROPHYSIOL, V65, P1183, DOI 10.1152/jn.1991.65.5.1183; Ramat S, 2003, J NEUROPHYSIOL, V90, P887, DOI 10.1152/jn.01121.2002; RAPHAN T, 1979, EXP BRAIN RES, V35, P229; SCHWARZ U, 1991, J NEUROPHYSIOL, V66, P851, DOI 10.1152/jn.1991.66.3.851; Shan XY, 2007, INVEST OPHTH VIS SCI, V48, P2602, DOI 10.1167/iovs.06-1316; Sheliga BM, 1999, ANN NY ACAD SCI, V871, P94, DOI 10.1111/j.1749-6632.1999.tb09178.x; Telford L, 1997, J NEUROPHYSIOL, V78, P1775, DOI 10.1152/jn.1997.78.4.1775; THURSTON SE, 1987, NEUROLOGY, V37, P53, DOI 10.1212/WNL.37.1.53; Tian J, 2007, VISION RES, V47, P1003, DOI 10.1016/j.visres.2006.12.011; WAESPE W, 1985, SCIENCE, V228, P199, DOI 10.1126/science.3871968; Walker MF, 2008, J NEUROPHYSIOL, V100, P1813, DOI 10.1152/jn.01193.2007; Walker MF, 2008, PROG BRAIN RES, V171, P167, DOI 10.1016/S0079-6123(08)00622-5; Walker MF, 2005, J NEUROPHYSIOL, V94, P3417, DOI 10.1152/jn.00375.2005; Walker MF, 2004, VISION RES, V44, P613, DOI 10.1016/j.visres.2003.10.009; WALKER MF, 2008, ADV UNDERSTANDING ME; Wearne S, 1997, PROG BRAIN RES, V114, P321; Wearne S, 1998, J NEUROPHYSIOL, V79, P2690, DOI 10.1152/jn.1998.79.5.2690; Wiest G, 2001, BRAIN, V124, P2407, DOI 10.1093/brain/124.12.2407; Wyatt HJ, 1998, VISION RES, V38, P2147, DOI 10.1016/S0042-6989(97)00410-0; Yakusheva T, 2008, J NEUROSCI, V28, P9997, DOI 10.1523/JNEUROSCI.2232-08.2008; ZEE DS, 1976, BRAIN, V99, P207, DOI 10.1093/brain/99.2.207; ZEE DS, 1981, J NEUROPHYSIOL, V46, P878, DOI 10.1152/jn.1981.46.4.878; Zee DS, 2002, ANN NY ACAD SCI, V956, P178, DOI 10.1111/j.1749-6632.2002.tb02818.x; Zhou W, 2003, J NEUROSCI, V23, P4288	54	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e13981	10.1371/journal.pone.0013981	http://dx.doi.org/10.1371/journal.pone.0013981			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085587	Green Published, Green Submitted, gold			2022-12-25	WOS:000284231800011
J	Bisanzio, D; Bertolotti, L; Tomassone, L; Amore, G; Ragagli, C; Mannelli, A; Giacobini, M; Provero, P				Bisanzio, Donal; Bertolotti, Luigi; Tomassone, Laura; Amore, Giusi; Ragagli, Charlotte; Mannelli, Alessandro; Giacobini, Mario; Provero, Paolo			Modeling the Spread of Vector-Borne Diseases on Bipartite Networks	PLOS ONE			English	Article							IXODES-RICINUS ACARI; BORRELIA-LUSITANIAE; TRANSMISSION; IXODIDAE; TUSCANY; PATTERNS; LIZARDS; LARVAE; TICKS; HOSTS	Background: Vector-borne diseases for which transmission occurs exclusively between vectors and hosts can be modeled as spreading on a bipartite network. Methodology/Principal Findings: In such models the spreading of the disease strongly depends on the degree distribution of the two classes of nodes. It is sufficient for one of the classes to have a scale-free degree distribution with a slow enough decay for the network to have asymptotically vanishing epidemic threshold. Data on the distribution of Ixodes ricinus ticks on mice and lizards from two independent studies are well described by a scale-free distribution compatible with an asymptotically vanishing epidemic threshold. The commonly used negative binomial, instead, cannot describe the right tail of the empirical distribution. Conclusions/Significance: The extreme aggregation of vectors on hosts, described by the power-law decay of the degree distribution, makes the epidemic threshold decrease with the size of the network and vanish asymptotically.	[Bisanzio, Donal; Bertolotti, Luigi; Tomassone, Laura; Amore, Giusi; Mannelli, Alessandro; Giacobini, Mario] Univ Turin, Dept Anim Prod Epidemiol & Ecol, Turin, Italy; [Bisanzio, Donal; Bertolotti, Luigi; Giacobini, Mario; Provero, Paolo] Univ Turin, Ctr Mol Biotechnol, Turin, Italy; [Ragagli, Charlotte] Minist Forestry & Agr Polit, State Forestry Dept, Terr Unit Biodivers, Lucca, Italy; [Provero, Paolo] Univ Torino, Dept Genet Biol & Biochem, Turin, Italy	University of Turin; University of Turin; University of Turin	Bisanzio, D (corresponding author), Univ Turin, Dept Anim Prod Epidemiol & Ecol, Turin, Italy.	mario.giacobini@unito.it; paolo.provero@unito.it	Bertolotti, Luigi/F-9236-2013; Tomassone, Laura/J-4524-2012; Provero, Paolo/AAC-1930-2019	Bertolotti, Luigi/0000-0001-7931-4528; Tomassone, Laura/0000-0003-2201-8802; Giacobini, Mario/0000-0002-7647-5649; Bisanzio, Donal/0000-0002-7832-2291; Mannelli, Alessandro/0000-0003-1623-8761	ISI Foundation of Torino, Italy; Ministero dell'Universita e della Ricerca Scientifica e Tecnologica, Italy; Associazione Italiana per la Ricerca sul Cancro (AIRC)	ISI Foundation of Torino, Italy; Ministero dell'Universita e della Ricerca Scientifica e Tecnologica, Italy(Ministry of Education, Universities and Research (MIUR)); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	The work of D. B. is supported by a Lagrange Fellowship of the ISI Foundation of Torino, Italy. M. G. acknowledges funding by the Ministero dell'Universita e della Ricerca Scientifica e Tecnologica, Italy. P. P. acknowledges funding by the Associazione Italiana per la Ricerca sul Cancro (AIRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amore G, 2007, J MED ENTOMOL, V44, P303, DOI 10.1603/0022-2585(2007)44[303:BLIIIR]2.0.CO;2; ANDERSON RM, 1978, J ANIM ECOL, V47, P219, DOI 10.2307/3933; Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; BAUWENS D, 1983, HOLARCTIC ECOL, V6, P32; Bertolotti L, 2006, J MED ENTOMOL, V43, P159, DOI 10.1603/0022-2585(2006)043[0159:BLASFG]2.0.CO;2; Bisanzio D, 2008, J MED ENTOMOL, V45, P547, DOI 10.1603/0022-2585(2008)45[547:TVITUO]2.0.CO;2; Clauset A, 2007, J CONFLICT RESOLUT, V51, P58, DOI 10.1177/0022002706296157; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Dorogovtsev SN, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.062101; Gern L, 1996, J MED ENTOMOL, V33, P189, DOI 10.1093/jmedent/33.1.189; Gomez-Gardenes J, 2008, P NATL ACAD SCI USA, V105, P1399, DOI 10.1073/pnas.0707332105; Gray J, 2002, LYME BORRELIOSIS BIO; Lindquist L, 2008, LANCET, V371, P1861, DOI 10.1016/S0140-6736(08)60800-4; Matuschka FR, 1998, APPL ENVIRON MICROB, V64, P3089; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; NILSSON A, 1978, OIKOS, V31, P313, DOI 10.2307/3543656; Ostfeld RS, 2006, PLOS BIOL, V4, P1058, DOI 10.1371/journal.pbio.0040145; Pastor-Satorras R, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.035108; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Patrican LA, 1997, J MED ENTOMOL, V34, P52, DOI 10.1093/jmedent/34.1.52; Perkins SE, 2003, INT J PARASITOL, V33, P909, DOI 10.1016/S0020-7519(03)00128-0; Ragagli C, 2011, VECTOR-BORNE ZOONOT, V11, P21, DOI 10.1089/vbz.2008.0195; RANDOLPH SE, 1995, J MED ENTOMOL, V32, P765, DOI 10.1093/jmedent/32.6.765; Randolph SE, 1999, PARASITOLOGY, V118, P177, DOI 10.1017/S0031182098003643; Shaw DJ, 1998, PARASITOLOGY, V117, P597, DOI 10.1017/S0031182098003448; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; Zhou T, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046115	27	23	24	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e13796	10.1371/journal.pone.0013796	http://dx.doi.org/10.1371/journal.pone.0013796			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103064	Green Published, gold, Green Submitted			2022-12-25	WOS:000284147700002
J	Hartholt, KA; van der Velde, N; Looman, CWN; Panneman, MJM; Van Beeck, EF; Patka, P; van der Cammen, TJM				Hartholt, Klaas A.; van der Velde, Nathalie; Looman, Caspar W. N.; Panneman, Martien J. M.; Van Beeck, Ed F.; Patka, Peter; van der Cammen, Tischa J. M.			Adverse Drug Reactions Related Hospital Admissions in Persons Aged 60 Years and over, The Netherlands, 1981-2007: Less Rapid Increase, Different Drugs	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT VISITS; ELDERLY-PEOPLE; THERAPY; EVENTS	Background: Epidemiologic information on time trends of Adverse Drug Reactions (ADR) and ADR-related hospitalizations is scarce. Over time, pharmacotherapy has become increasingly complex. Because of raised awareness of ADR, a decrease in ADR might be expected. The aim of this study was to determine trends in ADR-related hospitalizations in the older Dutch population. Methodology and Principal Findings: Secular trend analysis of ADR-related hospital admissions in patients >= 60 years between 1981 and 2007, using the National Hospital Discharge Registry of the Netherlands. Numbers, age-specific and age-adjusted incidence rates (per 10,000 persons) of ADR-related hospital admissions were used as outcome measures in each year of the study. Between 1981 and 2007, ADR-related hospital admissions in persons >= 60 years increased by 143%. The overall standardized incidence rate increased from 23.3 to 38.3 per 10,000 older persons. The increase was larger in males than in females. Since 1997, the increase in incidence rates of ADR-related hospitalizations flattened (percentage annual change 0.65%), compared to the period 1981-1996 (percentage annual change 2.56%). Conclusion/Significance: ADR-related hospital admissions in older persons have shown a rapidly increasing trend in the Netherlands over the last three decades with a temporization since 1997. Although an encouraging flattening in the increasing trend of ADR-related admissions was found around 1997, the incidence is still rising, which warrants sustained attention to this problem.	[Hartholt, Klaas A.; van der Velde, Nathalie; van der Cammen, Tischa J. M.] Univ Med Ctr, Erasmus MC, Dept Internal Med, Geriatr Med Sect, Rotterdam, Netherlands; [Hartholt, Klaas A.; Patka, Peter] Univ Med Ctr, Erasmus MC, Dept Surg Traumatol, Rotterdam, Netherlands; [Looman, Caspar W. N.; Van Beeck, Ed F.] Univ Med Ctr, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Panneman, Martien J. M.] Consumer & Safety Inst, Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Hartholt, KA (corresponding author), Univ Med Ctr, Erasmus MC, Dept Internal Med, Geriatr Med Sect, Rotterdam, Netherlands.	t.vandercammen@erasmusmc.nl	Hartholt, Klaas A/Q-1782-2016	Hartholt, Klaas A/0000-0001-5019-9239; van der Velde, Nathalie/0000-0002-6477-6209	Netherlands Organization for Health Research and Development (ZonMw) [170.885.607]	Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	Klaas Hartholt is a research fellow at the Erasmus MC, appointed on a research grant from The Netherlands Organization for Health Research and Development (ZonMw), project number 170.885.607. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou A, 2008, EUR J INTERN MED, V19, P505, DOI 10.1016/j.ejim.2007.06.030; Barat I, 2001, BRIT J CLIN PHARMACO, V51, P615, DOI 10.1046/j.0306-5251.2001.01401.x; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Brvar Miran, 2009, BMC Clin Pharmacol, V9, P8, DOI 10.1186/1472-6904-9-8; Budnitz DS, 2006, JAMA-J AM MED ASSOC, V296, P1858, DOI 10.1001/jama.296.15.1858; Budnitz DS, 2007, ANN INTERN MED, V147, P755, DOI 10.7326/0003-4819-147-11-200712040-00006; Burgess CL, 2005, MED J AUSTRALIA, V182, P267, DOI 10.5694/j.1326-5377.2005.tb06698.x; CASPERS PWJ, 2004, MEDICATION SAFETY SO, P1; Eguale T, 2008, DRUG SAFETY, V31, P1005, DOI 10.2165/00002018-200831110-00005; *FDN PHARM STAT SF, 2009, PHARMACEUTISCH WEEKB, V144; Fialova D, 2005, JAMA-J AM MED ASSOC, V293, P1348, DOI 10.1001/jama.293.11.1348; Hartholt KA, 2010, ARCH INTERN MED, V170, P905, DOI 10.1001/archinternmed.2010.106; HURWITZ N, 1969, BRIT MED J, V1, P536, DOI 10.1136/bmj.1.5643.536; Khong Teck K, 2002, Expert Opin Pharmacother, V3, P1289; Kohn LT, 2000, ERR IS HUMAN BUILDIN; Langley J, 2006, INJURY PREV, V12, P58, DOI 10.1136/ip.2005.010173; Langley J, 2002, INJ PREV, V8, P332, DOI 10.1136/ip.8.4.332; Leendertse AJ, 2008, ARCH INTERN MED, V168, P1890, DOI 10.1001/archinternmed.2008.3; Mallet L, 2007, LANCET, V370, P185, DOI 10.1016/S0140-6736(07)61092-7; Mannesse CK, 2000, AGE AGEING, V29, P35, DOI 10.1093/ageing/29.1.35; McLean AJ, 2004, PHARMACOL REV, V56, P163, DOI 10.1124/pr.56.2.4; MCNEIL DR, 1977, DEMOGRAPHY, V14, P245, DOI 10.2307/2060581; Meerding Willem Jan, 2006, Eur J Public Health, V16, P272, DOI 10.1093/eurpub/ckl006; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; Noble RE, 2003, METABOLISM, V52, P27, DOI 10.1053/S0026-0495(03)00298-1; Onder G, 2010, ARCH INTERN MED, V170, P1142, DOI 10.1001/archinternmed.2010.153; PAAS G, 2002, RELIABLITY LMR DATAB; Patel Hitesh, 2007, BMC Clin Pharmacol, V7, P9, DOI 10.1186/1472-6904-7-9; PERENBOOM R, HLTH LIFE EXPECTANCY, P3; Somers A, 2003, EUR J CLIN PHARMACOL, V58, P707, DOI 10.1007/s00228-002-0535-5; Spinewine A, 2007, LANCET, V370, P173, DOI 10.1016/S0140-6736(07)61091-5; *STAT NETH CBS, 2009, HEALTHC US HOSP ADM; *STAT NETH CBS, 2010, US HEALTHC SERV NETH; Swoboda WJ, 1999, PHARMACOEPIDEM DR S, V8, pS47, DOI 10.1002/(SICI)1099-1557(199904)8:1+<S47::AID-PDS408>3.3.CO;2-C; United Nations, 2007, WORLD POP PROSP 2006; *US GAO, 2000, ADV DRUG EV MAGN HLT; van der Hooft CS, 2008, PHARMACOEPIDEM DR S, V17, P365, DOI 10.1002/pds.1565; van der Hooft CS, 2006, DRUG SAFETY, V29, P161, DOI 10.2165/00002018-200629020-00006; VANSIJL M, 2005, CORRECTING MISSING D; Zhang Min, 2009, BMJ, V338, pa2752, DOI 10.1136/bmj.a2752	40	43	43	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e13977	10.1371/journal.pone.0013977	http://dx.doi.org/10.1371/journal.pone.0013977			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103046	Green Published, gold, Green Submitted			2022-12-25	WOS:000284147700022
J	Mukhopadhyay, A; Bandyopadhyay, S; Maulik, U				Mukhopadhyay, Anirban; Bandyopadhyay, Sanghamitra; Maulik, Ujjwal			Multi-Class Clustering of Cancer Subtypes through SVM Based Ensemble of Pareto-Optimal Solutions for Gene Marker Identification	PLOS ONE			English	Article							EXPRESSION; CLASSIFICATION; ALGORITHM; DIFFERENTIATION; PREDICTION; PATTERNS; TUMOR	With the advancement of microarray technology, it is now possible to study the expression profiles of thousands of genes across different experimental conditions or tissue samples simultaneously. Microarray cancer datasets, organized as samples versus genes fashion, are being used for classification of tissue samples into benign and malignant or their subtypes. They are also useful for identifying potential gene markers for each cancer subtype, which helps in successful diagnosis of particular cancer types. In this article, we have presented an unsupervised cancer classification technique based on multiobjective genetic clustering of the tissue samples. In this regard, a real-coded encoding of the cluster centers is used and cluster compactness and separation are simultaneously optimized. The resultant set of near-Pareto-optimal solutions contains a number of non-dominated solutions. A novel approach to combine the clustering information possessed by the non-dominated solutions through Support Vector Machine (SVM) classifier has been proposed. Final clustering is obtained by consensus among the clusterings yielded by different kernel functions. The performance of the proposed multiobjective clustering method has been compared with that of several other microarray clustering algorithms for three publicly available benchmark cancer datasets. Moreover, statistical significance tests have been conducted to establish the statistical superiority of the proposed clustering method. Furthermore, relevant gene markers have been identified using the clustering result produced by the proposed clustering method and demonstrated visually. Biological relationships among the gene markers are also studied based on gene ontology. The results obtained are found to be promising and can possibly have important impact in the area of unsupervised cancer classification as well as gene marker identification for multiple cancer subtypes.	[Mukhopadhyay, Anirban] Univ Kalyani, Dept Comp Sci & Engn, Kalyani 741235, W Bengal, India; [Bandyopadhyay, Sanghamitra] Indian Stat Inst, Machine Intelligence Unit, Kolkata, W Bengal, India; [Maulik, Ujjwal] Jadavpur Univ, Dept Comp Sci & Engn, Kolkata, W Bengal, India	Kalyani University; Indian Statistical Institute; Indian Statistical Institute Kolkata; Jadavpur University	Mukhopadhyay, A (corresponding author), Univ Kalyani, Dept Comp Sci & Engn, Kalyani 741235, W Bengal, India.	anirban@klyuniv.ac.in	Mukhopadhyay, Anirban/ABB-5739-2021; Bandyopadhyay, Sanghamitra/AAO-7010-2020; Bandyopadhyay, Sanghamitra/AAP-4578-2020; Maulik, Ujjwal/AAO-8754-2020; Bandyopadhyay, Sanghamitra/A-6597-2010; Mukhopadhyay, Anirban/H-3220-2012	Mukhopadhyay, Anirban/0000-0001-8128-3521; Bandyopadhyay, Sanghamitra/0000-0001-6370-2083; Maulik, Ujjwal/0000-0003-1167-0774	Department of Science and Technology, India [DST/INT/MEX/RPO-04/2008(ii)]	Department of Science and Technology, India(Department of Science & Technology (India))	SB and UM acknowledge Department of Science and Technology, India (Grant No. DST/INT/MEX/RPO-04/2008(ii)) for partially supporting this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Bandyopadhyay S, 2007, BIOINFORMATICS, V23, P2859, DOI 10.1093/bioinformatics/btm418; Bandyopadhyay S, 2007, IEEE T GEOSCI REMOTE, V45, P1506, DOI 10.1109/TGRS.2007.892604; Chlenski A, 2002, CANCER RES, V62, P7357; Coello CAC, 2006, IEEE COMPUT INTELL M, V1, P28, DOI 10.1109/MCI.2006.1597059; Crammer K., 2001, J MACHINE LEARNING R, V2, P265; de Souto MCP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-497; Deb K, 2003, BIOSYSTEMS, V72, P111, DOI 10.1016/S0303-2647(03)00138-2; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Deb K., 2001, MULTIOBJECTIVE OPTIM; Goldberg D. E., 1989, GENETIC ALGORITHMS S; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Handl J, 2007, IEEE T EVOLUT COMPUT, V11, P56, DOI 10.1109/TEVC.2006.877146; HEDBORG F, 1995, AM J PATHOL, V146, P833; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Jain AK., 1988, TECHNOMETRICS; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; KUMAR KP, 2007, P 15 INT C ADV COMP, P75; Kwon S, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-23; Luo Fei, 2008, 2008 2nd International Conference on Bioinformatics and Biomedical Engineering (ICBBE '08), P1912, DOI 10.1109/ICBBE.2008.807; Maulik U, 2003, IEEE T GEOSCI REMOTE, V41, P1075, DOI 10.1109/TGRS.2003.810924; Maulik U, 2002, IEEE T PATTERN ANAL, V24, P1650, DOI 10.1109/TPAMI.2002.1114856; Maulik U, 2000, PATTERN RECOGN, V33, P1455, DOI 10.1016/S0031-3203(99)00137-5; MELINO G, 1993, NEUROSCI LETT, V151, P187, DOI 10.1016/0304-3940(93)90017-F; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Schaefer KL, 2004, CANCER RES, V64, P3395, DOI 10.1158/0008-5472.CAN-03-0809; Strehl A., 2003, Journal of Machine Learning Research, V3, P583, DOI 10.1162/153244303321897735; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Vapnik V., 1998, STAT LEARNING THEORY; Ward T, 1998, J VIROL, V72, P5360, DOI 10.1128/JVI.72.7.5360-5365.1998; Yeung KY, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-5-r34; Yeung KY, 2001, BIOINFORMATICS, V17, P763, DOI 10.1093/bioinformatics/17.9.763; Zitzler E., 1998, 43 TIK, P43; Zitzler E, 2001, EVOLUTIONARY METHODS	37	36	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e13803	10.1371/journal.pone.0013803	http://dx.doi.org/10.1371/journal.pone.0013803			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103052	Green Published, gold			2022-12-25	WOS:000284147700003
J	Maloberti, PM; Duarte, AB; Orlando, UD; Pasqualini, ME; Solano, AR; Lopez-Otin, C; Podesta, EJ				Maloberti, Paula M.; Duarte, Alejandra B.; Orlando, Ulises D.; Pasqualini, Maria E.; Solano, Angela R.; Lopez-Otin, Carlos; Podesta, Ernesto J.			Functional Interaction between Acyl-CoA Synthetase 4, Lipooxygenases and Cyclooxygenase-2 in the Aggressive Phenotype of Breast Cancer Cells	PLOS ONE			English	Article							ARACHIDONIC-ACID RELEASE; HUMAN HEPATOCELLULAR-CARCINOMA; BENZODIAZEPINE-RECEPTOR PBR; EPIDERMAL-GROWTH-FACTOR; RAT-LIVER; TUMOR PROGRESSION; CYCLIC-AMP; CHOLESTEROL TRANSPORT; STEROIDOGENIC CELLS; LEYDIG-CELLS	The acyl-CoA synthetase 4 (ACSL4) is increased in breast cancer, colon and hepatocellular carcinoma. ACSL4 mainly esterifies arachidonic acid (AA) into arachidonoyl-CoA, reducing free AA intracellular levels, which is in contradiction with the need for AA metabolites in tumorigenesis. Therefore, the causal role of ACSL4 is still not established. This study was undertaken to determine the role of ACSL4 in AA metabolic pathway in breast cancer cells. The first novel finding is that ACSL4 regulates the expression of cyclooxygenase-2 (COX-2) and the production of prostaglandin in MDA-MB-231 cells. We also found that ACSL4 is significantly up-regulated in the highly aggressive MDA-MB-231 breast cancer cells. In terms of its overexpression and inhibition, ACSL4 plays a causal role in the control of the aggressive phenotype. These results were confirmed by the increase in the aggressive behaviour of MCF-7 cells stably transfected with a Tet-off ACSL4 vector. Concomitantly, another significant finding was that intramitochondrial AA levels are significantly higher in the aggressive cells. Thus, the esterification of AA by ACSL4 compartmentalizes the release of AA in mitochondria, a mechanism that serves to drive the specific lipooxygenase metabolization of the fatty acid. To our knowledge, this is the first report that ACSL4 expression controls both lipooxygenase and cyclooxygenase metabolism of AA. Thus, this functional interaction represents an integrated system that regulates the proliferating and metastatic potential of cancer cells. Therefore, the development of combinatory therapies that profit from the ACSL4, lipooxygenase and COX-2 synergistic action may allow for lower medication doses and avoidance of side effects.	[Maloberti, Paula M.; Duarte, Alejandra B.; Orlando, Ulises D.; Solano, Angela R.; Podesta, Ernesto J.] Univ Buenos Aires, Inst Invest Mol Enfermedades Hormonales Neurodege, Dept Human Biochem, Sch Med, Buenos Aires, DF, Argentina; [Pasqualini, Maria E.] Natl Univ Cordoba, Sch Med, Inst Biol Celular, Cordoba, Argentina; [Lopez-Otin, Carlos] Univ Oviedo, Inst Univ Oncol, Dept Biochem & Mol Biol, Oviedo, Spain	University of Buenos Aires; National University of Cordoba; University of Oviedo; Instituto Universitario de Oncologia de Asturias	Maloberti, PM (corresponding author), Univ Buenos Aires, Inst Invest Mol Enfermedades Hormonales Neurodege, Dept Human Biochem, Sch Med, Buenos Aires, DF, Argentina.	ernestopodesta@yahoo.com.ar	Maloberti, Paula/AAU-5216-2020; López-Otín, Carlos/AAB-2106-2020	López-Otín, Carlos/0000-0001-6964-1904	CONICET [112-200801-01976]; FONCyT [200600819, 25368, 32527]	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); FONCyT(FONCyT)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by CONICET (112-200801-01976) http://www.conicet.gov.ar/, Podesta; UBA (M059, M810) Podesta, Maloberti, http://www.uba.ar/homepage.php; FONCyT (200600819, 25368, 32527) Podesta, Podesta, Maloberti; http://www.agencia.mincyt.gov.ar/, Bunge & Born Foundation, Podesta, Solano, http://www.fundacionbyb.org/ing_investigacion_cientifica.asp; and Ministerio de Ciencia e Innovacion-Spain, http://www.micinn.es/portal/site/MICINN/, Fundacion "M. Botin", http://www. fundacionmbotin.org/, and European Union (FP7 MicroEnviMet) http://ec.europa.eu/research/health/medical-research/cancer/fp7-projects/microenvimet_en.html, Lopez Otin.	Alonso M, 2004, J NEUROCHEM, V89, P248, DOI 10.1111/j.1471-4159.2004.02323.x; Alvarez-Diaz S, 2010, CELL CYCLE, V9, P32, DOI 10.4161/cc.9.1.10266; Avis I, 2001, FASEB J, V15, P2007, DOI 10.1096/fj.00-0866fje; Basu GD, 2004, MOL CANCER RES, V2, P632; BLUMBERG PM, 1975, CELL, V6, P137, DOI 10.1016/0092-8674(75)90004-5; Cao Y, 2000, FEBS LETT, V467, P263, DOI 10.1016/S0014-5793(00)01159-5; Cao Y, 2000, P NATL ACAD SCI USA, V97, P11280, DOI 10.1073/pnas.200367597; Cao Y, 2001, CANCER RES, V61, P8429; CARNEY DH, 1977, NATURE, V268, P602, DOI 10.1038/268602a0; Castilla R, 2008, ENDOCRINOLOGY, V149, P3743, DOI 10.1210/en.2007-1580; Castillo AF, 2006, FEBS J, V273, P5011, DOI 10.1111/j.1742-4658.2006.05496.x; Castillo F, 2004, ENDOCR RES, V30, P623, DOI 10.1081/ERC-200043795; Darmoul D, 2001, BRIT J CANCER, V85, P772, DOI 10.1054/bjoc.2001.1976; Distler AM, 2007, BBA-PROTEINS PROTEOM, V1774, P628, DOI 10.1016/j.bbapap.2007.03.012; Duarte A, 2007, FEBS LETT, V581, P4023, DOI 10.1016/j.febslet.2007.07.040; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Gonzalez-Periz A, 2007, CURR TOP MED CHEM, V7, P297, DOI 10.2174/156802607779941378; Gupta S, 2001, CANCER-AM CANCER SOC, V91, P737, DOI 10.1002/1097-0142(20010215)91:4<737::AID-CNCR1059>3.0.CO;2-F; Gutierrez-Fernandez A, 2008, CANCER RES, V68, P2755, DOI 10.1158/0008-5472.CAN-07-5154; Half E, 2002, CANCER RES, V62, P1676; Han ZQ, 2003, J RECEPT SIG TRANSD, V23, P225, DOI 10.1081/RRS-120025210; Hardwick M, 1999, CANCER RES, V59, P831; Hayashi T, 2006, INT J UROL, V13, P1086, DOI 10.1111/j.1442-2042.2006.01485.x; Hennig R, 2002, AM J PATHOL, V161, P421, DOI 10.1016/S0002-9440(10)64198-3; Hong SH, 1999, CANCER RES, V59, P2223; Hyde CAC, 2009, INT IMMUNOPHARMACOL, V9, P701, DOI 10.1016/j.intimp.2009.02.003; Ihara A, 2007, J PHARMACOL SCI, V103, P24, DOI 10.1254/jphs.FP0060651; Jiang WG, 2003, PROSTAG LEUKOTR ESS, V69, P275, DOI 10.1016/S0952-3278(03)00110-8; Kang MJ, 1997, P NATL ACAD SCI USA, V94, P2880, DOI 10.1073/pnas.94.7.2880; Larkins TL, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-181; Lewin TM, 2002, ARCH BIOCHEM BIOPHYS, V404, P263, DOI 10.1016/S0003-9861(02)00247-3; Lewin TM, 2001, J BIOL CHEM, V276, P24674, DOI 10.1074/jbc.M102036200; Li W, 2007, BIOCHEM PHARMACOL, V73, P491, DOI 10.1016/j.bcp.2006.10.025; Liang YC, 2005, WORLD J GASTROENTERO, V11, P2557, DOI 10.3748/wjg.v11.i17.2557; Maloberti P, 2007, MOL CELL ENDOCRINOL, V265, P113, DOI 10.1016/j.mce.2006.12.026; Maloberti P, 2005, FEBS J, V272, P1804, DOI 10.1111/j.1742-4658.2005.04616.x; Maloberti P, 2002, EUR J BIOCHEM, V269, P5599, DOI 10.1046/j.1432-1033.2002.03267.x; Monaco ME, 2010, TRANSL ONCOL, V3, P91, DOI 10.1593/tlo.09202; Natarajan R, 1997, J CLIN ENDOCR METAB, V82, P1790, DOI 10.1210/jc.82.6.1790; Panguluri RCK, 2004, CARCINOGENESIS, V25, P961, DOI 10.1093/carcin/bgh100; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Pasqualini ME, 2003, PROSTAG LEUKOTR ESS, V68, P9, DOI 10.1016/S0952-3278(02)00230-2; Pidgeon GP, 2007, CANCER METAST REV, V26, P503, DOI 10.1007/s10555-007-9098-3; Poderoso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001443; Romano M, 2003, FASEB J, V17, P1986, DOI 10.1096/fj.03-0053rev; Singh-Ranger G, 2008, BREAST CANCER RES TR, V109, P189, DOI 10.1007/s10549-007-9641-5; SOLANO AR, 1988, J MOL ENDOCRINOL, V1, P147, DOI 10.1677/jme.0.0010147; Soslow RA, 2000, CANCER, V89, P2637, DOI 10.1002/1097-0142(20001215)89:12<2637::AID-CNCR17>3.0.CO;2-B; Soupene E, 2008, EXP BIOL MED, V233, P507, DOI 10.3181/0710-MR-287; STOCCO DM, 1983, ANAL BIOCHEM, V131, P453, DOI 10.1016/0003-2697(83)90198-7; Sung YK, 2003, CANCER SCI, V94, P421, DOI 10.1111/j.1349-7006.2003.tb01458.x; Sung YK, 2007, EXP MOL MED, V39, P477, DOI 10.1038/emm.2007.52; Wang MT, 2007, CANCER METAST REV, V26, P525, DOI 10.1007/s10555-007-9096-5; Wang XJ, 2003, J STEROID BIOCHEM, V85, P159, DOI 10.1016/S0960-0760(03)00189-4; Wikstrom K, 2003, BIOCHEM BIOPH RES CO, V302, P330, DOI 10.1016/S0006-291X(03)00187-6; YOSHIMOTO T, 1982, BIOCHIM BIOPHYS ACTA, V713, P470	56	67	68	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e15540	10.1371/journal.pone.0015540	http://dx.doi.org/10.1371/journal.pone.0015540			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21085606	Green Published, gold, Green Submitted			2022-12-25	WOS:000284087800029
J	Chen, JP; Rossiter, SJ; Flanders, JR; Sun, YH; Hua, PY; Miller-Butterworth, C; Liu, XS; Rajan, KE; Zhang, SY				Chen, Jinping; Rossiter, Stephen J.; Flanders, Jonathan R.; Sun, Yanhong; Hua, Panyu; Miller-Butterworth, Cassandra; Liu, Xusheng; Rajan, Koilmani E.; Zhang, Shuyi			Contrasting Genetic Structure in Two Co-Distributed Species of Old World Fruit Bat	PLOS ONE			English	Article							GREATER HORSESHOE BAT; CYNOPTERUS-SPHINX; COMPARATIVE PHYLOGEOGRAPHY; SOCIAL-STRUCTURE; ROUSETTUS-LESCHENAULTI; COMPUTER-PROGRAM; POPULATION; CONSEQUENCES; MITOCHONDRIAL; DISTANCES	The fulvous fruit bat (Rousettus leschenaulti) and the greater short-nosed fruit bat (Cynopterus sphinx) are two abundant and widely co-distributed Old World fruit bats in Southeast and East Asia. The former species forms large colonies in caves while the latter roots in small groups in trees. To test whether these differences in social organization and roosting ecology are associated with contrasting patterns of gene flow, we used mtDNA and nuclear loci to characterize population genetic subdivision and phylogeographic histories in both species sampled from China, Vietnam and India. Our analyses from R. leschenaulti using both types of marker revealed little evidence of genetic structure across the study region. On the other hand, C. sphinx showed significant genetic mtDNA differentiation between the samples from India compared with China and Vietnam, as well as greater structuring of microsatellite genotypes within China. Demographic analyses indicated signatures of past rapid population expansion in both taxa, with more recent demographic growth in C. sphinx. Therefore, the relative genetic homogeneity in R. leschenaulti is unlikely to reflect past events. Instead we suggest that the absence of substructure in R. leschenaulti is a consequence of higher levels of gene flow among colonies, and that greater vagility in this species is an adaptation associated with cave roosting.	[Chen, Jinping; Sun, Yanhong] Guangdong Entomol Inst, Guangzhou, Guangdong, Peoples R China; [Rossiter, Stephen J.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [Flanders, Jonathan R.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Sun, Yanhong; Liu, Xusheng] Huazhong Normal Univ, Wuhan, Peoples R China; [Hua, Panyu; Zhang, Shuyi] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China; [Miller-Butterworth, Cassandra] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA USA; [Rajan, Koilmani E.] Bharathidasan Univ, Sch Life Sci, Dept Anim Sci, Tiruchirappalli, Tamil Nadu, India	Guangdong Academy of Sciences; Institute of Zoology, Guangdong Academy of Sciences; University of London; Queen Mary University London; University of Bristol; Central China Normal University; East China Normal University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Bharathidasan University	Chen, JP (corresponding author), Guangdong Entomol Inst, Guangzhou, Guangdong, Peoples R China.	s.j.rossiter@qmul.ac.uk; syzhang@bio.ecnu.edu.cn	Miller-Butterworth, Cassandra/H-5994-2013; Zhang, Shuyi/B-5117-2011; Rossiter, Stephen J/E-2111-2011; Rajan, Koilman Emmanuvel/GSM-7214-2022	Flanders, Jon/0000-0001-7296-9601; Rossiter, Stephen/0000-0002-3881-4515	National "985" Project; National Science Foundation [31071905]; Guangdong Province Academy of Science [CX2007]; Royal Society (UK)	National "985" Project; National Science Foundation(National Science Foundation (NSF)); Guangdong Province Academy of Science; Royal Society (UK)(Royal Society of London)	This work was supported by the Key Construction Program of the National "985" Project to SY Zhang and a National Science Foundation grant (31071905) and innovation project grant (CX2007) of Guangdong Province Academy of Science to JP Chen. S Rossiter is supported by a Royal Society Research Fellowship (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADVANI R, 1982, Saeugetierkundliche Mitteilungen, V30, P49; Aeshita M, 2006, ACTA CHIROPTEROL, V8, P417, DOI 10.3161/1733-5329(2006)8[417:OAMVIT]2.0.CO;2; Anderson B, 2004, EVOLUTION, V58, P1730, DOI 10.1111/j.0014-3820.2004.tb00457.x; Arbogast BS, 2001, J BIOGEOGR, V28, P819, DOI 10.1046/j.1365-2699.2001.00594.x; Arbogast BS, 1998, SCIENCE, V282, P1955; Bailey NW, 2007, MOL ECOL, V16, P2079, DOI 10.1111/j.1365-294X.2007.03265.x; BELKHIR K, 2004, GENETIX 4 05 WINDOWS; Campbell P, 2004, MOL PHYLOGENET EVOL, V33, P764, DOI 10.1016/j.ympev.2004.06.019; Castella V, 2000, MOL ECOL, V9, P1761, DOI 10.1046/j.1365-294x.2000.01069.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Coulon A, 2006, MOL ECOL, V15, P1669, DOI 10.1111/j.1365-294X.2006.02861.x; EXCOFFIER L, 2009, ARLEQUIN VERSION 3 0, P47; Flanders J, 2009, MOL ECOL, V18, P306, DOI 10.1111/j.1365-294X.2008.04021.x; FLANDERS JR, 2010, J BIOGEOGRA IN PRESS; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hardy OJ, 2003, GENETICS, V163, P1467; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kraaijeveld-Smit FJL, 2007, OIKOS, V116, P1819, DOI 10.1111/j.0030-1299.2007.16087.x; Li G, 2006, J MAMMAL, V87, P1234, DOI 10.1644/05-MAMM-A-395R2.1; Michalakis Y, 1996, GENETICS, V142, P1061; Mickleburgh S.P., 1992, OLD WORLD FRUIT BATS; Miller-Butterworth CM, 2003, NATURE, V424, P187, DOI 10.1038/nature01742; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; Proctor MF, 2004, CAN J ZOOL, V82, P1108, DOI 10.1139/z04-077; Qu JY, 2009, MOL PHYLOGENET EVOL, V52, P125, DOI 10.1016/j.ympev.2009.03.015; Qu Y, 2010, MOL ECOL, V19, P338, DOI 10.1111/j.1365-294X.2009.04445.x; Racey P.A., 1982, P57; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rossiter SJ, 2007, MOL ECOL, V16, P4699, DOI 10.1111/j.1365-294X.2007.03546.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Shilton LA, 1999, P ROY SOC B-BIOL SCI, V266, P219, DOI 10.1098/rspb.1999.0625; Simmons N.B., 2005, MAMMAL SPECIES WORLD; Storz JF, 2001, EVOLUTION, V55, P1224; Storz JF, 2001, EVOLUTION, V55, P1215; Storz JF, 2000, J ZOOL, V251, P151; Struebig MJ, 2009, BIOL CONSERV, V142, P2089, DOI 10.1016/j.biocon.2009.04.005; Vanlalnghaka C, 2005, BIOL RHYTHM RES, V36, P453, DOI 10.1080/09291010500287568; Wang Y. X., 2003, COMPLETE CHECKLIST M; Zink RM, 1996, EVOLUTION, V50, P308, DOI 10.1111/j.1558-5646.1996.tb04494.x	45	24	26	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e13903	10.1371/journal.pone.0013903	http://dx.doi.org/10.1371/journal.pone.0013903			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085717	gold, Green Published, Green Accepted			2022-12-25	WOS:000284036800010
J	Sune, G; Sarro, E; Puigmule, M; Lopez-Hellin, J; Zufferey, M; Pertel, T; Luban, J; Meseguer, A				Sune, Guillermo; Sarro, Eduard; Puigmule, Marta; Lopez-Hellin, Joan; Zufferey, Madeleine; Pertel, Thomas; Luban, Jeremy; Meseguer, Anna			Cyclophilin B Interacts with Sodium-Potassium ATPase and Is Required for Pump Activity in Proximal Tubule Cells of the Kidney	PLOS ONE			English	Article							CYCLOSPORINE-INDUCED NEPHROTOXICITY; PROTEIN-KINASE-C; NA+-K+-ATPASE; BETA-SUBUNIT; NA,K-ATPASE; INHIBITION; TRAFFICKING; MECHANISMS; COMPLEXES; APOPTOSIS	Cyclophilins (Cyps), the intracellular receptors for Cyclosporine A (CsA), are responsible for peptidyl-prolyl cis-trans isomerisation and for chaperoning several membrane proteins. Those functions are inhibited upon CsA binding. Albeit its great benefits as immunosuppressant, the use of CsA has been limited by undesirable nephrotoxic effects, including sodium retention, hypertension, hyperkalemia, interstial fibrosis and progressive renal failure in transplant recipients. In this report, we focused on the identification of novel CypB-interacting proteins to understand the role of CypB in kidney function and, in turn, to gain further insight into the molecular mechanisms of CsA-induced toxicity. By means of yeast two-hybrid screens with human kidney cDNA, we discovered a novel interaction between CypB and the membrane Na/K-ATPase beta 1 subunit protein (Na/K-beta 1) that was confirmed by pull-down, co-immunoprecipitation and confocal microscopy, in proximal tubule-derived HK-2 cells. The Na/K-ATPase pump, a key plasma membrane transporter, is responsible for maintenance of electrical Na+ and K+ gradients across the membrane. We showed that CypB silencing produced similar effects on Na/K-ATPase activity than CsA treatment in HK-2 cells. It was also observed an enrichment of both alpha and beta subunits in the ER, what suggested a possible failure on the maturation and routing of the pump from this compartment towards the plasma membrane. These data indicate that CypB through its interaction with Na/K-beta 1 might regulate maturation and trafficking of the pump through the secretory pathway, offering new insights into the relationship between cyclophilins and the nephrotoxic effects of CsA.	[Sune, Guillermo; Sarro, Eduard; Puigmule, Marta; Lopez-Hellin, Joan; Meseguer, Anna] Hosp Univ Vall dHebron, Inst Recerca Vall dHebron VHIR, CIBBIM, Barcelona, Spain; [Meseguer, Anna] Univ Autonoma Barcelona, Fac Med, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain; [Zufferey, Madeleine; Pertel, Thomas; Luban, Jeremy] Univ Geneva, Dept Microbiol & Mol Med, Geneva, Switzerland	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; University of Barcelona; University of Geneva	Sune, G (corresponding author), Hosp Univ Vall dHebron, Inst Recerca Vall dHebron VHIR, CIBBIM, Barcelona, Spain.	ameseguer@ir.vhebron.net	Sarró Tauler, Eduard/M-1660-2014; Navarro, Anna Meseguer/M-2222-2014; Lopez-Hellin, Joan/M-2234-2014	Sarró Tauler, Eduard/0000-0001-7723-2916; Navarro, Anna Meseguer/0000-0003-3833-2249; Lopez-Hellin, Joan/0000-0001-7286-3882; Puigmule, Marta/0000-0001-7881-8839; Luban, Jeremy/0000-0001-5650-4054; Pertel, Thomas/0000-0002-2286-6011	Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion [FIS PI081351]; Ministerio de Educacion y Ciencia (MEC) [SAF2005-05167]; Fundacio La Marato de TV3 [002230]; Fundacion Renal Inigo Alvarez de Toledo (FRIAT), Fundacion SENEFRO y Fundacion Mutua Madrilena; Swiss National Science Foundation; National Institute of Allergy and Infectious Diseases (USA)	Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); Ministerio de Educacion y Ciencia (MEC)(Spanish Government); Fundacio La Marato de TV3; Fundacion Renal Inigo Alvarez de Toledo (FRIAT), Fundacion SENEFRO y Fundacion Mutua Madrilena; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institute of Allergy and Infectious Diseases (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants FIS PI081351 (Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion) SAF2005-05167 from Ministerio de Educacion y Ciencia (MEC), grant 002230 from Fundacio La Marato de TV3, from Fundacion Renal Inigo Alvarez de Toledo (FRIAT), Fundacion SENEFRO y Fundacion Mutua Madrilena to Dr. Anna Meseguer (AM). Funding was also provided by grants from the Swiss National Science Foundation and the National Institute of Allergy and Infectious Diseases (USA) to Dr. Jeremy Luban. Guillermo Sune was a predoctoral recipient fellow (FPI) from the CIRIT (Consell Interdepartamental de Recerca i Innovacio Tecnologica). Anna Meseguer's research group holds the Quality Mention from the Generalitat de Catalunya (2009SGR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baer PC, 1999, EXP NEPHROL, V7, P306; Baldridge D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010560; BATLLE DC, 1986, CLIN NEPHROL, V25, pS62; BLAIR JT, 1982, J PATHOL, V138, P163, DOI 10.1002/path.1711380206; Bobadilla NA, 2007, AM J PHYSIOL-RENAL, V293, pF2, DOI 10.1152/ajprenal.00072.2007; BOREL JF, 1990, PHARMACOL REV, V41, P259; Braaten D, 2001, EMBO J, V20, P1300, DOI 10.1093/emboj/20.6.1300; CAPASSO G, 1990, AM J HYPERTENS, V3, P204, DOI 10.1093/ajh/3.3.204; Chen YL, 2009, J BIOL CHEM, V284, P14881, DOI 10.1074/jbc.M109.003574; Chibalin AV, 1997, AM J PHYSIOL-CELL PH, V273, pC1458, DOI 10.1152/ajpcell.1997.273.5.C1458; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Espineda CE, 2004, MOL BIOL CELL, V15, P1364, DOI 10.1091/mbc.E03-09-0646; Fang F, 2009, AM J PATHOL, V174, P297, DOI 10.2353/ajpath.2009.080753; GEERING K, 1989, AM J PHYSIOL, V257, pC851, DOI 10.1152/ajpcell.1989.257.5.C851; Geering K, 1996, J CELL BIOL, V133, P1193, DOI 10.1083/jcb.133.6.1193; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; Hanoulle X, 2007, J BIOL CHEM, V282, P34148, DOI 10.1074/jbc.M706353200; Healy E, 1998, KIDNEY INT, V54, P1955, DOI 10.1046/j.1523-1755.1998.00202.x; KAMEL KS, 1992, J AM SOC NEPHROL, V2, P1279; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Kim J, 2008, J CELL SCI, V121, P3636, DOI 10.1242/jcs.028654; LEA JP, 1994, KIDNEY INT, V46, P647, DOI 10.1038/ki.1994.317; LINGREL JB, 1994, J BIOL CHEM, V269, P19659; Marks AR, 1996, PHYSIOL REV, V76, P631, DOI 10.1152/physrev.1996.76.3.631; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; MORELLO R, 2007, NAT GENET, V39, P359; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Ominato M, 1996, J MEMBRANE BIOL, V152, P235, DOI 10.1007/s002329900101; Oriji GK, 1999, AM J HYPERTENS, V12, P1091, DOI 10.1016/S0895-7061(99)00089-8; PRICE ER, 1994, P NATL ACAD SCI USA, V91, P3931, DOI 10.1073/pnas.91.9.3931; PRICE ER, 1991, P NATL ACAD SCI USA, V88, P1903, DOI 10.1073/pnas.88.5.1903; Puigmule M, 2009, NEPHROL DIAL TRANSPL, V24, P2672, DOI 10.1093/ndt/gfp149; Rajasekaran AK, 2003, ANN NY ACAD SCI, V986, P649, DOI 10.1111/j.1749-6632.2003.tb07276.x; Rajasekaran SA, 2009, FRONT BIOSCI-LANDMRK, V14, P2130, DOI 10.2741/3367; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; Sarro E, 2008, KIDNEY INT, V73, P77, DOI 10.1038/sj.ki.5002638; Seki T, 2005, J PHARMACOL SCI, V97, P132, DOI 10.1254/jphs.FP0040574; SKOU JC, 1990, FEBS LETT, V268, P314, DOI 10.1016/0014-5793(90)81278-V; Stabach PR, 2008, AM J PHYSIOL-CELL PH, V295, pC1202, DOI 10.1152/ajpcell.00273.2008; Streblow DN, 1998, VIROLOGY, V245, P197, DOI 10.1006/viro.1998.9155; SUTHERLAND DER, 1984, AM J KIDNEY DIS, V3, P456, DOI 10.1016/S0272-6386(84)80010-4; SUZUKI S, 1987, TRANSPLANTATION, V44, P363, DOI 10.1097/00007890-198709000-00008; Taylor P, 1997, PROG BIOPHYS MOL BIO, V67, P155, DOI 10.1016/S0079-6107(97)00014-X; TUMLIN JA, 1993, KIDNEY INT, V43, P246, DOI 10.1038/ki.1993.38; Ueno S, 1997, BIOSCIENCE REP, V17, P173, DOI 10.1023/A:1027333529412; Waldmeier PC, 2003, CURR MED CHEM, V10, P1485, DOI 10.2174/0929867033457160; Yurchenko V, 2010, CLIN EXP IMMUNOL, V160, P305, DOI 10.1111/j.1365-2249.2010.04115.x	47	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e13930	10.1371/journal.pone.0013930	http://dx.doi.org/10.1371/journal.pone.0013930			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085665	Green Published, Green Submitted, gold			2022-12-25	WOS:000284036800021
J	Van Dyck, S; Flammang, P; Meriaux, C; Bonnel, D; Salzet, M; Fournier, I; Wisztorski, M				Van Dyck, Severine; Flammang, Patrick; Meriaux, Celine; Bonnel, David; Salzet, Michel; Fournier, Isabelle; Wisztorski, Maxence			Localization of Secondary Metabolites in Marine Invertebrates: Contribution of MALDI MSI for the Study of Saponins in Cuvierian Tubules of H. forskali	PLOS ONE			English	Article							IMAGING MASS-SPECTROMETRY; DIRECT TISSUE-ANALYSIS; SEA-CUCUMBERS; TRITERPENE GLYCOSIDES; TROPICAL HOLOTHURIANS; NATURAL-PRODUCTS; ECHINODERMATA; HOLOTHUROIDEA; DEFENSE; MIXTURE	Background: Several species of sea cucumbers of the family Holothuriidae possess a particular mechanical defense system called the Cuvierian tubules (Ct). It is also a chemical defense system as triterpene glycosides (saponins) appear to be particularly concentrated in Ct. In the present study, the precise localization of saponins in the Ct of Holothuria forskali is investigated. Classical histochemical labeling using lectin was firstly performed but did not generate any conclusive results. Thus, MALDI mass spectrometry Imaging (MALDI-MSI) was directly applied and completed by statistical multivariate tests. A comparison between the tubules of relaxed and stressed animals was realized. Results: These analyses allowed the detection of three groups of ions, corresponding to the isomeric saponins of the tubules. Saponins detected at m/z 1287 and 1303 were the most abundant and were apparently localized in the connective tissue of the tubules of both relaxed and stressed individuals. Saponins at m/z 1125 and 1141 were detected in lower amount and were present in tissues of relaxed animals. Finally, saponin ions at 1433, 1449, 1463 and 1479 were observed in some Ct of stressed holothuroids in the outer part of the connective tissue. The saponin group m/z 14xx seems therefore to be stress-specific and could originate from modifications of the saponins with m/z of 11xx. Conclusions: All the results taken together indicate a complex chemical defense mechanism with, for a single organ, different sets of saponins originating from different cell populations and presenting different responses to stress. The present study also reflects that MALDI-MSI is a valuable tool for chemical ecology studies in which specific chemical signalling molecules like allelochemicals or pheromones have to be tracked. This report represents one of the very first studies using these tools to provide a functional and ecological understanding of the role of natural products from marine invertebrates.	[Van Dyck, Severine; Flammang, Patrick] Univ Mons UMONS, Marine Biol Lab, Mons, Belgium; [Meriaux, Celine; Bonnel, David; Salzet, Michel; Fournier, Isabelle; Wisztorski, Maxence] Univ Lille Nord France USTL, Lab Neuroimmunol & Neurochim Evolut, Villeneuve Dascq, France	University of Mons; Universite de Lille - ISITE; Universite de Lille	Van Dyck, S (corresponding author), Univ Mons UMONS, Marine Biol Lab, Mons, Belgium.	maxence.wisztorski@univ-lille1.fr	Flammang, Patrick/H-9465-2019; FOURNIER, Isabelle/H-9195-2015; Wisztorski, Maxence/F-4380-2010; Salzet, Michel/A-7675-2011	Flammang, Patrick/0000-0001-9938-1154; FOURNIER, Isabelle/0000-0003-1096-5044; Wisztorski, Maxence/0000-0003-1320-075X; Salzet, Michel/0000-0003-4318-0817; Meriaux, Celine/0000-0002-2413-2599	Centre National de la Recherche Scientifique (CNRS), Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche, Agence Nationale de la Recherche; Conseil Regional Nord-Pas de Calais; FRIA (Belgium); Fund for Scientific Research of Belgium; FRFC [2.4535.10]; Institut du Cancer	Centre National de la Recherche Scientifique (CNRS), Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche, Agence Nationale de la Recherche(Centre National de la Recherche Scientifique (CNRS)); Conseil Regional Nord-Pas de Calais(Region Hauts-de-France); FRIA (Belgium)(Fonds de la Recherche Scientifique - FNRS); Fund for Scientific Research of Belgium; FRFC(Fonds de la Recherche Scientifique - FNRS); Institut du Cancer(Institut National du Cancer (INCA) France)	The MALDI Imaging Team was supported by the Centre National de la Recherche Scientifique (CNRS), Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche, Agence Nationale de la Recherche, the Institut du Cancer, the Conseil Regional Nord-Pas de Calais. SVD benefited from a FRIA doctoral grant (Belgium). PF is Senior Research Associate of the Fund for Scientific Research of Belgium (F.R.S.-FNRS). Work was supported by a FRFC Grant no 2.4535.10. This study is a contribution of the "Centre Interuniversitaire de Biologie Marine" (CIBIM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKUS GJ, 1968, MAR BIOL, V2, P23, DOI 10.1007/BF00351634; Becker PT, 2010, BIOLOGICAL ADHESIVE SYSTEMS: FROM NATURE TO TECHNICAL AND MEDICAL APPLICATION, P87, DOI 10.1007/978-3-7091-0286-2_6; BINGHAM BL, 1986, J EXP MAR BIOL ECOL, V98, P311, DOI 10.1016/0022-0981(86)90220-0; DASILVA J, 1986, MAR BEHAV PHYSIOL, V12, P133, DOI 10.1080/10236248609378640; ELYAKOV GB, 1973, COMP BIOCHEM PHYSIOL, V44, P325, DOI 10.1016/0305-0491(73)90005-9; Esquenazi E, 2009, P NATL ACAD SCI USA, V106, P7269, DOI 10.1073/pnas.0902840106; Fang SP, 1998, RAPID COMMUN MASS SP, V12, P589, DOI 10.1002/(SICI)1097-0231(19980529)12:10<589::AID-RCM200>3.0.CO;2-Q; Flammang P, 2002, INTEGR COMP BIOL, V42, P1107, DOI 10.1093/icb/42.6.1107; Francese S, 2009, COMB CHEM HIGH T SCR, V12, P156, DOI 10.2174/138620709787315454; Franck J, 2009, MOL CELL PROTEOMICS, V8, P2023, DOI 10.1074/mcp.R800016-MCP200; Francour P, 1997, INVERTEBR BIOL, V116, P52, DOI 10.2307/3226924; GOLDSTEIN U, 1986, LECTINS; Guo MQ, 2006, ANAL CHIM ACTA, V557, P198, DOI 10.1016/j.aca.2005.10.056; Hamel JF, 2000, MAR FRESHW BEHAV PHY, V33, P115, DOI 10.1080/10236240009387085; Hayat MA, 1993, STAINS CYTOCHEMICAL; Hsieh Yunsheng, 2007, Journal of Pharmacological and Toxicological Methods, V55, P193, DOI 10.1016/j.vascn.2006.06.004; Kalinin V.I., 1996, Echinoderm Studies, V5, P139; Kalinin VI, 2000, J THEOR BIOL, V206, P151, DOI 10.1006/jtbi.2000.2110; Kalinin VI, 1996, TOXICON, V34, P475, DOI 10.1016/0041-0101(95)00142-5; KALYANI G A, 1988, Indian Journal of Natural Products, V4, P3; KOBAYASHI M, 1991, CHEM PHARM BULL, V39, P2282; Lemaire R, 2006, ANAL CHEM, V78, P7145, DOI 10.1021/ac060565z; Lemaire R, 2006, ANAL CHEM, V78, P809, DOI 10.1021/ac0514669; Madl T, 2006, J AM SOC MASS SPECTR, V17, P795, DOI 10.1016/j.jasms.2006.02.013; MASSIN C, 1976, CAH BIOL MAR, V17, P45; POPOV AM, 2002, IZV AKAD NAUK BIOL+, V2, P155; Seeley EH, 2008, J AM SOC MASS SPECTR, V19, P1069, DOI 10.1016/j.jasms.2008.03.016; Simmons TL, 2008, P NATL ACAD SCI USA, V105, P4587, DOI 10.1073/pnas.0709851105; SMITH DF, 1983, BIOCHEM BIOPH RES CO, V115, P360, DOI 10.1016/0006-291X(83)91012-4; Van de Plas R, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P458; Van Dyck S, 2010, MAR DRUGS, V8, P173, DOI 10.3390/md8010173; Van Dyck S, 2009, COMP BIOCHEM PHYS B, V152, P124, DOI 10.1016/j.cbpb.2008.10.011; VANDENSPIEGEL D, 1987, MAR BIOL, V96, P263, DOI 10.1007/BF00427026; Vandenspiegel D, 2000, BIOL BULL-US, V198, P34, DOI 10.2307/1542802; VANDYCK S, 2010, J EXP BIOL UNPUB; Verbist J.F., 1993, Echinoderm Studies, V4, P111; Wisztorski M, 2008, DEV NEUROBIOL, V68, P845, DOI 10.1002/dneu.20623	37	35	35	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e13923	10.1371/journal.pone.0013923	http://dx.doi.org/10.1371/journal.pone.0013923			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085713	Green Published, gold, Green Submitted			2022-12-25	WOS:000284036800014
J	Parapuram, SK; Cojocaru, RI; Chang, JR; Khanna, R; Brooks, M; Othman, M; Zareparsi, S; Khan, NW; Gotoh, N; Cogliati, T; Swaroop, A				Parapuram, Sunil K.; Cojocaru, Radu I.; Chang, Jessica R.; Khanna, Ritu; Brooks, Matthew; Othman, Mohammad; Zareparsi, Sepideh; Khan, Naheed W.; Gotoh, Norimoto; Cogliati, Tiziana; Swaroop, Anand			Distinct Signature of Altered Homeostasis in Aging Rod Photoreceptors: Implications for Retinal Diseases	PLOS ONE			English	Article							GENE-EXPRESSION PROFILE; FATTY-ACIDS; RECEPTOR-ALPHA; LIFE-SPAN; IN-VITRO; MECHANISMS; MICE; IDENTIFICATION; INFLAMMATION; ACTIVATION	Background: Advanced age contributes to clinical manifestations of many retinopathies and represents a major risk factor for age-related macular degeneration, a leading cause of visual impairment and blindness in the elderly. Rod photoreceptors are especially vulnerable to genetic defects and changes in microenvironment, and are among the first neurons to die in normal aging and in many retinal degenerative diseases. The molecular mechanisms underlying rod photoreceptor vulnerability and potential biomarkers of the aging process in this highly specialized cell type are unknown. Methodology/Principal Findings: To discover aging-associated adaptations that may influence rod function, we have generated gene expression profiles of purified rod photoreceptors from mouse retina at young adult to early stages of aging (1.5, 5, and 12 month old mice). We identified 375 genes that showed differential expression in rods from 5 and 12 month old mouse retina compared to that of 1.5 month old retina. Quantitative RT-PCR experiments validated expression change for a majority of the 25 genes that were examined. Macroanalysis of differentially expressed genes using gene class testing and protein interaction networks revealed overrepresentation of cellular pathways that are potentially photoreceptor-specific (angiogenesis and lipid/retinoid metabolism), in addition to age-related pathways previously described in several tissue types (oxidative phosphorylation, stress and immune response). Conclusions/Significance: Our study suggests a progressive shift in cellular homeostasis that may underlie aging-associated functional decline in rod photoreceptors and contribute to a more permissive state for pathological processes involved in retinal diseases.	[Parapuram, Sunil K.; Cojocaru, Radu I.; Khanna, Ritu; Brooks, Matthew; Othman, Mohammad; Zareparsi, Sepideh; Khan, Naheed W.; Swaroop, Anand] Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA; [Cojocaru, Radu I.; Chang, Jessica R.; Brooks, Matthew; Gotoh, Norimoto; Cogliati, Tiziana; Swaroop, Anand] NEI, Neurobiol Neurodegenerat & Repair Lab, NIH, Bethesda, MD 20892 USA; [Chang, Jessica R.] Natl Inst Hlth Res Scholars Program, Howard Hughes Med Inst, Bethesda, MD USA	University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA	Parapuram, SK (corresponding author), Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA.	swaroopa@nei.nih.gov		Swaroop, Anand/0000-0002-1975-1141; Chang, Jessica/0000-0001-6663-2519	National Eye Institute; National Institutes of Health [EY11115, EY07003, DK20572]; Foundation Fighting Blindness; Elmer and Sylvia Sramek Foundation; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY011115, ZIAEY000451, P30EY007003, ZIAEY000475, F31EY007003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572, P30DK020572] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); Elmer and Sylvia Sramek Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by intramural funds of the National Eye Institute and by grants (EY11115, EY07003, DK20572) from the National Institutes of Health, http://grants.nih.gov/grants/oer.htm, the Foundation Fighting Blindness, http://www.blindness.org/, the Elmer and Sylvia Sramek Foundation, and Research to Prevent Blindness, http://www.rpbusa.org/rpb/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto M, 2006, P NATL ACAD SCI USA, V103, P3890, DOI 10.1073/pnas.0508214103; Akiyama H, 2005, AM J PHYSIOL-CELL PH, V288, pC913, DOI 10.1152/ajpcell.00116.2004; Antonetti DA, 2006, DIABETES, V55, P2401, DOI 10.2337/db05-1635; Atherton HJ, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.18; Baba T, 2010, AM J PATHOL, V176, P3085, DOI 10.2353/ajpath.2010.090989; Barbieri M, 2003, AM J PHYSIOL-ENDOC M, V285, pE1064, DOI 10.1152/ajpendo.00296.2003; Bauer ME, 2009, ANN NY ACAD SCI, V1153, P139, DOI 10.1111/j.1749-6632.2008.03966.x; Birch DG, 1999, OPHTHALMOLOGY, V106, P258, DOI 10.1016/S0161-6420(99)90064-7; Bishop NA, 2007, NAT REV GENET, V8, P835, DOI 10.1038/nrg2188; Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983; Bonnel S, 2003, EXP GERONTOL, V38, P825, DOI 10.1016/S0531-5565(03)00093-7; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Cao JN, 2010, AGING CELL, V9, P19, DOI 10.1111/j.1474-9726.2009.00534.x; Carter TA, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r48; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; Chen H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001602; Chowers I, 2003, HUM MOL GENET, V12, P2881, DOI 10.1093/hmg/ddg326; Chung JH, 2008, AGEING RES REV, V7, P126, DOI 10.1016/j.arr.2008.01.001; Curcio CA, 2001, EYE, V15, P376, DOI 10.1038/eye.2001.140; CURCIO CA, 1993, INVEST OPHTH VIS SCI, V34, P3278; Curcio CA, 1996, INVEST OPHTH VIS SCI, V37, P1236; DOBRZYN P, 2010, BIOCH BIOPHYS ACTA; Duncan T, 1999, MOL VIS, V5, pU1; Ethen CM, 2005, INVEST OPHTH VIS SCI, V46, P769, DOI 10.1167/iovs.04-0810; Flurkey K, 2007, FACULTY RES, P637, DOI DOI 10.1016/B978-012369454-6/50074-1; GAO H, 1992, INVEST OPHTH VIS SCI, V33, P1; Gehrs K. M., ARCH OPHTHALMOL, V128, P349; Gresh J, 2003, VISUAL NEUROSCI, V20, P211, DOI 10.1017/S0952523803202108; Hicks D, 1999, INVEST OPHTH VIS SCI, V40, pS583; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Hulbert AJ, 2006, MECH AGEING DEV, V127, P653, DOI 10.1016/j.mad.2006.03.002; HUSSONG SA, 2010, J NEUROCHEM; Ida H, 2003, PHYSIOL GENOMICS, V15, P258, DOI 10.1152/physiolgenomics.00126.2003; *ING SYST, 2010, DAT WER AN US ING PA; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; KELLER H, 1993, P NATL ACAD SCI USA, V90, P2160, DOI 10.1073/pnas.90.6.2160; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kolesnikov AV, 2010, J NEUROSCI, V30, P11222, DOI 10.1523/JNEUROSCI.4239-09.2010; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; Lee SA, 2008, BBA-MOL BASIS DIS, V1782, P421, DOI 10.1016/j.bbadis.2008.03.004; Leveillard T, 2004, NAT GENET, V36, P755, DOI 10.1038/ng1386; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Marchette LD, 2010, FREE RADICAL BIO MED, V48, P16, DOI 10.1016/j.freeradbiomed.2009.08.005; *METACORE, 2010, NETW REC WAS MAD MET; Michaud K, 2009, BRAIN COGNITION, V71, P1, DOI 10.1016/j.bandc.2009.02.013; Milton RC, 2005, OPHTHALMOLOGY, V112, P533, DOI 10.1016/j.ophtha.2004.10.047; Murgatroyd C, 2010, AGING-US, V2, P107; Navarro A, 2007, AM J PHYSIOL-CELL PH, V292, pC670, DOI 10.1152/ajpcell.00213.2006; Neschen S, 2007, DIABETES, V56, P1034, DOI 10.2337/db06-1206; Oberdoerffer P, 2007, NAT REV MOL CELL BIO, V8, P692, DOI 10.1038/nrm2238; Oh ECT, 2008, BRAIN RES, V1236, P16, DOI 10.1016/j.brainres.2008.01.028; Park SK, 2009, AGING CELL, V8, P484, DOI 10.1111/j.1474-9726.2009.00496.x; Preston CC, 2008, MECH AGEING DEV, V129, P304, DOI 10.1016/j.mad.2008.02.010; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Rothman SM, 2010, NEUROMOL MED, V12, P56, DOI 10.1007/s12017-009-8107-9; SanGiovanni JP, 2005, PROG RETIN EYE RES, V24, P87, DOI 10.1016/j.preteyeres.2004.06.002; Sheehan B, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-468; Shen SM, 2008, NEUROBIOL AGING, V29, P452, DOI 10.1016/j.neurobiolaging.2006.10.026; Spaide RF, 1999, RETINA-J RET VIT DIS, V19, P141, DOI 10.1097/00006982-199902000-00010; Streichert LC, 1999, J NEUROBIOL, V39, P475, DOI 10.1002/(SICI)1097-4695(19990615)39:4<475::AID-NEU2>3.0.CO;2-#; STRUNNIKOVA NV, 2010, HUM MOL GENET; Swaroop A, 2009, ANNU REV GENOM HUM G, V10, P19, DOI 10.1146/annurev.genom.9.081307.164350; Tamai K, 2002, EXP EYE RES, V74, P301, DOI 10.1006/exer.2001.1121; Trifunovic A, 2008, J INTERN MED, V263, P167, DOI 10.1111/j.1365-2796.2007.01905.x; Wang L, 2009, INVEST OPHTH VIS SCI, V50, P870, DOI 10.1167/iovs.08-2376; Winkler BS, 1999, MOL VIS, V5; Xu HP, 2009, PROG RETIN EYE RES, V28, P348, DOI 10.1016/j.preteyeres.2009.06.001; Yan DG, 2007, ARTERIOSCL THROM VAS, V27, P1108, DOI 10.1161/ATVBAHA.106.138545; Yan JB, 2006, J EXP MED, V203, P647, DOI 10.1084/jem.20052271; Yang P, 2009, INVEST OPHTH VIS SCI, V50, P3473, DOI 10.1167/iovs.08-3202; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044; Yoshida S, 2002, INVEST OPHTH VIS SCI, V43, P2554; Zahn JM, 2007, PLOS GENET, V3, P2326, DOI 10.1371/journal.pgen.0030201	76	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e13885	10.1371/journal.pone.0013885	http://dx.doi.org/10.1371/journal.pone.0013885			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	676NU	21079736	Green Published, gold			2022-12-25	WOS:000283920000016
J	Lessi, F; Beggs, A; de Palo, M; Anti, M; Palmieri, RM; Francesconi, S; Gomes, V; Bevilacqua, G; Tomlinson, I; Segditsas, S				Lessi, Francesca; Beggs, Andrew; de Palo, Mariagrazia; Anti, Marcello; Palmieri, Raffaele Macarone; Francesconi, Simona; Gomes, Vito; Bevilacqua, Generoso; Tomlinson, Ian; Segditsas, Stefania			Down-Regulation of Serum/Glucocorticoid Regulated Kinase 1 in Colorectal Tumours Is Largely Independent of Promoter Hypermethylation	PLOS ONE			English	Article							THREONINE PROTEIN-KINASE; INDUCIBLE KINASE; GENE-EXPRESSION; DNA METHYLATION; MESSENGER-RNA; COLON-CANCER; CYCLIC-AMP; SERUM; SGK; CELLS	Background: We have previously shown that serum/glucocorticoid regulated kinase 1 (SGK1) is down-regulated in colorectal cancers (CRC) with respect to normal tissue. As hyper-methylation of promoter regions is a well-known mechanism of gene silencing in cancer, we tested whether the SGK1 promoter region was methylated in colonic tumour samples. Methodology/Principal Findings: We investigated the methylation profile of the two CpG islands present in the promoter region of SGK1 in a panel of 5 colorectal cancer cell lines by sequencing clones of bisulphite-treated DNA samples. We further confirmed our findings in a panel of 10 normal and 10 tumour colonic tissue samples of human origin. We observed CpG methylation only in the smaller and more distal CpG island in the promoter region of SGK1 in both normal and tumour samples of colonic origin. We further identified a single nucleotide polymorphism (SNP, rs1743963) which affects methylation of the corresponding CpG. Conclusions/Significance: Our results show that even though partial methylation of the promoter region of SGK1 is present, this does not account for the different expression levels seen between normal and tumour tissue.	[Lessi, Francesca; Beggs, Andrew; Tomlinson, Ian; Segditsas, Stefania] Univ Oxford, Wellcome Trust Ctr Human Genet, Mol & Populat Genet Lab, Oxford, England; [de Palo, Mariagrazia; Anti, Marcello; Palmieri, Raffaele Macarone; Francesconi, Simona; Gomes, Vito] Presidio Osped Belcolle Viterbo, Viterbo, Italy; [Lessi, Francesca; Bevilacqua, Generoso] Univ Pisa, Dept Oncol, Div Surg Mol & Ultrastructural Pathol, Pisa, Italy; [Lessi, Francesca; Bevilacqua, Generoso] Univ Hosp, Pisa, Italy	University of Oxford; Wellcome Centre for Human Genetics; University of Pisa; University of Pisa; Azienda Ospedaliero Universitaria Pisana	Lessi, F (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Mol & Populat Genet Lab, Oxford, England.	stefania.segditsas@well.ox.ac.uk	Lessi, Francesca/AAE-6812-2022; Beggs, Andrew D/A-6912-2013; Beggs, Andrew/F-5902-2010	Lessi, Francesca/0000-0002-3346-4296; Beggs, Andrew D/0000-0003-0784-2967; Beggs, Andrew/0000-0003-0784-2967; BEVILACQUA, GENEROSO/0000-0001-8857-2609	Nuffield Department for Clinical Medicine [H55160]; Wellcome Trust [075491/Z/04]	Nuffield Department for Clinical Medicine; Wellcome Trust(Wellcome TrustEuropean Commission)	Funding: This work was supported by the Nuffield Department for Clinical Medicine [H55160] and the Wellcome Trust [075491/Z/04]. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Allan LA, 2000, MOL CELL BIOL, V20, P1291, DOI 10.1128/MCB.20.4.1291-1298.2000; Alliston TN, 1997, MOL ENDOCRINOL, V11, P1934, DOI 10.1210/me.11.13.1934; Baylin SB, 1998, ADV CANCER RES, V72, P141; Bhargava A, 2001, ENDOCRINOLOGY, V142, P1587, DOI 10.1210/en.142.4.1587; BLAY J, 1984, CELL BIOL INT REP, V8, P551, DOI 10.1016/0309-1651(84)90054-7; Brennan FE, 2000, MOL CELL ENDOCRINOL, V166, P129, DOI 10.1016/S0303-7207(00)00274-4; Chen SY, 1999, P NATL ACAD SCI USA, V96, P2514, DOI 10.1073/pnas.96.5.2514; Chu S, 2002, MOL HUM REPROD, V8, P426, DOI 10.1093/molehr/8.5.426; Cowling RT, 2000, J LEUKOCYTE BIOL, V67, P240, DOI 10.1002/jlb.67.2.240; Cunningham JM, 1998, CANCER RES, V58, P3455; David S, 2005, FEBS LETT, V579, P1534, DOI 10.1016/j.febslet.2005.01.040; de la Rosa DA, 2003, J PHYSIOL-LONDON, V551, P455, DOI 10.1113/jphysiol.2003.042903; Failor KL, 2007, MOL ENDOCRINOL, V21, P2403, DOI 10.1210/me.2007-0143; Firestone GL, 2003, CELL PHYSIOL BIOCHEM, V13, P1, DOI 10.1159/000070244; Grady WM, 2004, CANCER METAST REV, V23, P11, DOI 10.1023/A:1025861527711; HERMAN JG, 1995, CANCER RES, V55, P4525; Hertweck M, 2004, DEV CELL, V6, P577, DOI 10.1016/S1534-5807(04)00095-4; Hong F, 2008, MOL CELL, V30, P701, DOI 10.1016/j.molcel.2008.04.027; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Lang F, 2009, CURR OPIN NEPHROL HY, V18, P439, DOI 10.1097/MNH.0b013e32832f125e; Leong MLL, 2003, J BIOL CHEM, V278, P5871, DOI 10.1074/jbc.M211649200; Mikosz CA, 2001, J BIOL CHEM, V276, P16649, DOI 10.1074/jbc.M010842200; Perrotti N, 2001, J BIOL CHEM, V276, P9406, DOI 10.1074/jbc.M007052200; Rauhala HE, 2005, INT J CANCER, V117, P738, DOI 10.1002/ijc.21270; SAKAI T, 1991, AM J HUM GENET, V48, P880; Segditsas S, 2009, ONCOGENE, V28, P146, DOI 10.1038/onc.2008.361; Segditsas S, 2008, HUM MOL GENET, V17, P3864, DOI 10.1093/hmg/ddn286; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Waldegger S, 1999, GASTROENTEROLOGY, V116, P1081, DOI 10.1016/S0016-5085(99)70011-9; Waldegger S, 1997, P NATL ACAD SCI USA, V94, P4440, DOI 10.1073/pnas.94.9.4440; WEBSTER MK, 1993, MOL CELL BIOL, V13, P2031, DOI 10.1128/MCB.13.4.2031; WEBSTER MK, 1993, J BIOL CHEM, V268, P11482; You H, 2004, P NATL ACAD SCI USA, V101, P14057, DOI 10.1073/pnas.0406286101; Zhang BH, 2001, J BIOL CHEM, V276, P31620, DOI 10.1074/jbc.M102808200	34	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2010	5	11							e13840	10.1371/journal.pone.0013840	http://dx.doi.org/10.1371/journal.pone.0013840			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675OD	21079778	Green Published, Green Submitted, gold			2022-12-25	WOS:000283839100005
J	Liu, FW; Liu, J; Weng, D; Chen, Y; Song, LY; He, QC; Chen, J				Liu, Fangwei; Liu, Jie; Weng, Dong; Chen, Ying; Song, Laiyu; He, Qincheng; Chen, Jie			CD4+CD25+Foxp3+Regulatory T Cells Depletion May Attenuate the Development of Silica-Induced Lung Fibrosis in Mice	PLOS ONE			English	Article							AIRWAY INFLAMMATION; NALP3 INFLAMMASOME; CYTOKINE PRODUCTION; IN-VIVO; RESPONSES; ACTIVATION; DISEASE; POLARIZATION; SUPPRESSION; PHENOTYPE	Background: Silicosis is an occupational lung disease caused by inhalation of silica dust characterized by lung inflammation and fibrosis. Previous study showed that Th1 and Th2 cytokines are involved in silicosis, but Th1/Th2 polarization during the development of silicosis is still a matter of debate. Regulatory T cells (Treg cells) represent a crucial role in modulation of immune homeostasis by regulating Th1/Th2 polarization, but their possible implication in silicosis remains to be explored. Methodology/Principal Findings: To evaluate the implication of Treg cells in the development of silicosis, we generated the Treg-depleted mice model by administration of anti-CD25 mAbs and mice were exposed to silica by intratracheal instillation to establish experimental model of silica-induced lung fibrosis. The pathologic examinations show that the Treg-depleted mice are susceptive to severer inflammation in the early stage, with enhanced infiltration of inflammatory cells. Also, depletion of Treg cells causes a delay of the progress of silica-induced lung fibrosis in mice model. Further study of mRNA expression of cytokines reveals that depletion of Tregs leads to the increased production of Th1-cytokines and decreased production of Th2-cytokine. The Flow Cytometry and realtime PCR study show that Treg cells exert the modulation function both directly by expressing CTLA-4 at the inflammatory stage, and indirectly by secreting increasing amount of IL-10 and TGF-beta during the fibrotic stage in silica-induced lung fibrosis. Conclusion/Significance: Our study suggests that depletion of Tregs may attenuate the progress of silica-induced lung fibrosis and enhance Th1 response and decelerate Th1/Th2 balance toward a Th2 phenotype in silica-induced lung fibrosis. The regulatory function of Treg cells may depend on direct mechanism and indirect mechanism during the inflammatory stage of silicosis.	[Liu, Fangwei; Liu, Jie; Weng, Dong; Chen, Ying; Song, Laiyu; He, Qincheng; Chen, Jie] China Med Univ, Sch Publ Hlth, Div Pneumoconiosis, Shenyang, Peoples R China	China Medical University	Liu, FW (corresponding author), China Med Univ, Sch Publ Hlth, Div Pneumoconiosis, Shenyang, Peoples R China.	chenjie@mail.cmu.edu.cn	Liu, FW/GQZ-5182-2022	Song, Laiyu/0000-0001-7979-8294	National Natural Science Foundation of China [30800924, 30771791]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The funding for this study is supported by grants from the National Natural Science Foundation of China (No. 30800924 and No. 30771791). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arras M, 2001, AM J RESP CELL MOL, V24, P368, DOI 10.1165/ajrcmb.24.4.4249; Barbarin V, 2005, AM J PHYSIOL-LUNG C, V288, pL841, DOI 10.1152/ajplung.00329.2004; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Bellinghausen I, 2003, J ALLERGY CLIN IMMUN, V111, P862, DOI 10.1067/mai.2003.1412; Brown JM, 2007, AM J RESP CELL MOL, V36, P43, DOI 10.1165/rcmb.2006-0197OC; Brown JM, 2004, INHAL TOXICOL, V16, P133, DOI 10.1080/08958370490270936; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Chen Y, 2005, TOXICOL LETT, V155, P353, DOI 10.1016/j.toxlet.2004.10.011; Dai ZH, 2004, J CLIN INVEST, V113, P310, DOI 10.1172/JCI200419727; Davis Gerald S., 2001, Journal of Environmental Pathology Toxicology and Oncology, V20, P53; Doganci A, 2005, J CLIN INVEST, V115, P313, DOI 10.1172/JCI200522433; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Edinger M, 2003, NAT MED, V9, P1144, DOI 10.1038/nm915; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Grindebacke H, 2004, CLIN EXP ALLERGY, V34, P1364, DOI 10.1111/j.1365-2222.2004.02067.x; Gutcher I, 2007, J CLIN INVEST, V117, P1119, DOI 10.1172/JCI31720; Haeryfar SMM, 2005, J IMMUNOL, V174, P3344, DOI 10.4049/jimmunol.174.6.3344; Hawrylowicz CM, 2005, NAT REV IMMUNOL, V5, P271, DOI 10.1038/nri1589; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Huaux F, 2007, CURR OPIN ALLERGY CL, V7, P168, DOI 10.1097/ACI.0b013e32802bf8a5; Jaffar Z, 2004, J IMMUNOL, V172, P3842, DOI 10.4049/jimmunol.172.6.3842; Kearley J, 2005, J EXP MED, V202, P1539, DOI 10.1084/jem.20051166; Knutson KL, 2005, CANCER IMMUNOL IMMUN, V54, P721, DOI 10.1007/s00262-004-0653-2; Kuhlmann UC, 2009, LIFE SCI, V84, P1, DOI 10.1016/j.lfs.2008.10.001; Lewkowich IP, 2005, J EXP MED, V202, P1549, DOI 10.1084/jem.20051506; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Ling EM, 2004, LANCET, V363, P608, DOI 10.1016/S0140-6736(04)15592-X; Misson P, 2007, AM J PHYSIOL-LUNG C, V292, pL107, DOI 10.1152/ajplung.00503.2005; O'Garra A, 2008, IMMUNOL REV, V223, P114, DOI 10.1111/j.1600-065X.2008.00635.x; ROM WN, 1992, CHEST, V101, P779, DOI 10.1378/chest.101.3.779; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Saito K, 2008, J IMMUNOL, V181, P6889, DOI 10.4049/jimmunol.181.10.6889; Suto A, 2001, AM J RESP CRIT CARE, V164, P680, DOI 10.1164/ajrccm.164.4.2010170; Suvas S, 2003, J EXP MED, V198, P889, DOI 10.1084/jem.20030171; Suzuki NL, 1996, THORAX, V51, P1036, DOI 10.1136/thx.51.10.1036; UEKI A, 1994, IMMUNOLOGY, V82, P332; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Wu P, 2006, INT J IMMUNOPATH PH, V19, P357, DOI 10.1177/039463200601900212	39	89	97	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2010	5	11							e15404	10.1371/journal.pone.0015404	http://dx.doi.org/10.1371/journal.pone.0015404			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674WJ	21072213	Green Published, Green Submitted, gold			2022-12-25	WOS:000283780800027
J	Coudriet, GM; He, J; Trucco, M; Mars, WM; Piganelli, JD				Coudriet, Gina M.; He, Jing; Trucco, Massimo; Mars, Wendy M.; Piganelli, Jon D.			Hepatocyte Growth Factor Modulates Interleukin-6 Production in Bone Marrow Derived Macrophages: Implications for Inflammatory Mediated Diseases	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; ACUTE-PHASE PROTEINS; FACTOR-KAPPA-B; ANTIINFLAMMATORY ACTION; IL-10 PRODUCTION; EXPRESSION; RECEPTOR; KIDNEY; CELLS; GSK3	The generation of the pro-inflammatory cytokines IL-6, TNF-alpha, and IL-1 beta fuel the acute phase response (APR). To maintain body homeostasis, the increase of inflammatory proteins is resolved by acute phase proteins via presently unknown mechanisms. Hepatocyte growth factor (HGF) is transcribed in response to IL-6. Since IL-6 production promotes the generation of HGF and induces the APR, we posited that accumulating HGF might be a likely candidate for quelling excess inflammation under non-pathological conditions. We sought to assess the role of HGF and how it influences the regulation of inflammation utilizing a well-defined model of inflammatory activation, lipopolysaccharide (LPS)-stimulation of bone marrow derived macrophages (BMM). BMM were isolated from C57BL6 mice and were stimulated with LPS in the presence or absence of HGF. When HGF was present, there was a decrease in production of the pro-inflammatory cytokine IL-6, along with an increase in the anti-inflammatory cytokine IL-10. Altered cytokine production correlated with an increase in phosphorylated GSK3 beta, increased retention of the phosphorylated NF kappa B p65 subunit in the cytoplasm, and an enhanced interaction between CBP and phospho-CREB. These changes were a direct result of signaling through the HGF receptor, MET, as effects were reversed in the presence of a selective inhibitor of MET (SU11274) or when using BMM from macrophage-specific conditional MET knockout mice. Combined, these data provide compelling evidence that under normal circumstances, HGF acts to suppress the inflammatory response.	[Coudriet, Gina M.; Mars, Wendy M.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA; [He, Jing; Trucco, Massimo; Piganelli, Jon D.] UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Coudriet, GM (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA.	jdp51@pitt.edu			American Heart Association; Children's Hospital of Pittsburgh of University of Pittsburgh Medical Center; Juvenile Diabetes Research Foundation [76-01]; American Diabetes Association [CDA 7.07 CD16]	American Heart Association(American Heart Association); Children's Hospital of Pittsburgh of University of Pittsburgh Medical Center; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); American Diabetes Association(American Diabetes Association)	This work was supported by an American Heart Association pre-doctoral award (GMC), a Research Advisory Council pre-doctoral award by Children's Hospital of Pittsburgh of University of Pittsburgh Medical Center (GMC), a Juvenile Diabetes Research Foundation (76-01) (JDP), and the American Diabetes Association (CDA 7.07 CD16) (JDP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Berthou S, 2004, ONCOGENE, V23, P5387, DOI 10.1038/sj.onc.1207691; Beurel E, 2010, TRENDS IMMUNOL, V31, P24, DOI 10.1016/j.it.2009.09.007; Demarchi F, 2003, J BIOL CHEM, V278, P39583, DOI 10.1074/jbc.M305676200; Eldar-Finkelman H, 1999, DIABETES, V48, P1662, DOI 10.2337/diabetes.48.8.1662; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Gabay C, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1917; Giannopoulou M, 2008, AM J PATHOL, V173, P30, DOI 10.2353/ajpath.2008.070583; Goetschel F, 2008, EXP CELL RES, V314, P1351, DOI 10.1016/j.yexcr.2007.12.015; Gong RJ, 2004, J AM SOC NEPHROL, V15, P2868, DOI 10.1097/01.ASN.0000141962.44300.3A; Gong RJ, 2008, CURR OPIN INVEST DR, V9, P1163; Gong RJ, 2008, J BIOL CHEM, V283, P7401, DOI 10.1074/jbc.M710396200; Gong RJ, 2006, J AM SOC NEPHROL, V17, P2464, DOI 10.1681/ASN.2006020185; Homsi E, 2009, AM J NEPHROL, V29, P283, DOI 10.1159/000159275; Hu XY, 2006, IMMUNITY, V24, P563, DOI 10.1016/j.immuni.2006.02.014; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Ito W, 2008, INT ARCH ALLERGY IMM, V146, P82, DOI 10.1159/000126067; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kamimoto M, 2009, INT J MOL MED, V24, P161, DOI 10.3892/ijmm_00000219; Li W, 2001, HEPATOLOGY, V33, P1377, DOI 10.1053/jhep.2001.24431; LIU YH, 1994, J BIOL CHEM, V269, P4152; MARS WM, 1995, HEPATOLOGY, V21, P1695, DOI 10.1016/0270-9139(95)90477-8; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Nikoulina SE, 2000, DIABETES, V49, P263, DOI 10.2337/diabetes.49.2.263; Rutella S, 2006, BLOOD, V108, P218, DOI 10.1182/blood-2005-08-3141; Sander LE, 2010, J EXP MED, V207, P1453, DOI 10.1084/jem.20091474; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Sattler M, 2003, CANCER RES, V63, P5462; Tjin EPM, 2006, BLOOD, V107, P760, DOI 10.1182/blood-2005-05-1929; To Y, 2002, AM J RESP CELL MOL, V27, P220, DOI 10.1165/ajrcmb.27.2.4804; Tse HM, 2004, FREE RADICAL BIO MED, V36, P233, DOI 10.1016/j.freeradbiomed.2003.10.029; Vines A, 2006, J BIOL CHEM, V281, P16985, DOI 10.1074/jbc.M602446200; Woodgett JR, 2005, NAT IMMUNOL, V6, P751, DOI 10.1038/ni0805-751; Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368; ZARNEGAR R, 1995, J CELL BIOL, V129, P1177, DOI 10.1083/jcb.129.5.1177; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	39	104	108	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2010	5	11							e15384	10.1371/journal.pone.0015384	http://dx.doi.org/10.1371/journal.pone.0015384			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674VY	21072211	Green Published, Green Accepted, gold			2022-12-25	WOS:000283779700017
J	Yagi, R; Tanaka, M; Sasaki, K; Kamata, R; Nakanishi, Y; Kanai, Y; Sakai, R				Yagi, R.; Tanaka, M.; Sasaki, K.; Kamata, R.; Nakanishi, Y.; Kanai, Y.; Sakai, R.			ARAP3 inhibits peritoneal dissemination of scirrhous gastric carcinoma cells by regulating cell adhesion and invasion	ONCOGENE			English	Article						ARAP3; scirrhous gastric carcinoma; Rho-GAP; cell-ECM adhesion; invasion	DEPENDENT MANNER; SRC; CANCER; RHO; TRAFFICKING; PROTEINS; KINASES	During the analysis of phosphotyrosine-containing proteins in scirrhous gastric carcinoma cell lines, we observed an unusual expression of Arf-GAP with Rho-GAP domain, ankyrin repeat and PH domain 3 (ARAP3), a multimodular signaling protein that is a substrate of Src family kinases. Unlike other phosphotyrosine proteins, such as CUB domain-containing protein 1 (CDCP1) and Homo sapiens chromosome 9 open reading frame 10/oxidative stress-associated Src activator (C9orf10/Ossa), which are overexpressed and hyperphosphorylated in scirrhous gastric carcinoma cell lines, ARAP3 was underexpressed in cancerous human gastric tissues. In this study, we found that overexpression of ARAP3 in the scirrhous gastric carcinoma cell lines significantly reduced peritoneal dissemination. In vitro studies also showed that ARAP3 regulated cell attachment to the extracellular matrix, as well as invasive activities. These effects were suppressed by mutations in the Rho-GTPase-activating protein (GAP) domain or in the C-terminal two tyrosine residues that are phosphorylated by Src. Thus, the expression and phosphorylation state of ARAP3 may affect the invasiveness of cancer by modulating cell adhesion and motility. Our results suggest that ARAP3 is a unique Src substrate that suppresses peritoneal dissemination of scirrhous gastric carcinoma cells. Oncogene (2011) 30, 1413-1421; doi:10.1038/onc.2010.522; published online 15 November 2010	[Sakai, R.] Natl Canc Ctr, Res Inst, Div Growth Factor, Chuo Ku, Tokyo 1040045, Japan; [Tanaka, M.] Akita Univ, Sch Med, Dept Mol Med & Biochem, Akita 010, Japan; [Sasaki, K.] Natl Cerebral & Cardiovasc Ctr, Dept Pharmacol, Res Inst, Suita, Osaka, Japan; [Nakanishi, Y.; Kanai, Y.] Natl Canc Ctr, Res Inst, Div Pathol, Tokyo 104, Japan	National Cancer Center - Japan; Akita University; National Cerebral & Cardiovascular Center - Japan; National Cancer Center - Japan	Sakai, R (corresponding author), Natl Canc Ctr, Res Inst, Div Growth Factor, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	rsakai@ncc.go.jp	Kanai, Yae/AAE-6987-2019	Sakai, Ryuichi/0000-0001-6833-1103	Ministry of Education, Culture, Science and Technology of Japan; Grants-in-Aid for Scientific Research [23650590] Funding Source: KAKEN	Ministry of Education, Culture, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The pEGFP-ARAP3 plasmid was a kind gift from Krugmann S (Cambridge, UK). This work was supported by a Grant-in-Aid for Cancer Research and by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Science and Technology of Japan for the Third Term Comprehensive 10-Year Strategy for Cancer Control.	Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; Carragher NO, 2004, TRENDS CELL BIOL, V14, P241, DOI 10.1016/j.tcb.2004.03.011; Carramusa L, 2007, J CELL SCI, V120, P3870, DOI 10.1242/jcs.014365; Chen TJ, 2006, J NEUROBIOL, V66, P103, DOI 10.1002/neu.20204; Daniele T, 2008, TRAFFIC, V9, P2221, DOI 10.1111/j.1600-0854.2008.00823.x; Faix J, 2006, DEV CELL, V10, P693, DOI 10.1016/j.devcel.2006.05.001; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Itoh K, 1999, NAT MED, V5, P221, DOI 10.1038/5587; Kim HS, 2010, J NEUROCHEM, V113, P1565, DOI 10.1111/j.1471-4159.2010.06713.x; Kowanetz K, 2004, MOL BIOL CELL, V15, P3155, DOI 10.1091/mbc.E03-09-0683; Krugmann S, 2006, J CELL SCI, V119, P425, DOI 10.1242/jcs.02755; Krugmann S, 2004, CURR BIOL, V14, P1380, DOI 10.1016/j.cub.2004.07.058; Krugmann S, 2002, MOL CELL, V9, P95, DOI 10.1016/S1097-2765(02)00434-3; Matsuoka T, 1998, CLIN EXP METASTAS, V16, P381; Nishimura S, 1996, BRIT J CANCER, V74, P1406, DOI 10.1038/bjc.1996.556; Raaijmakers JH, 2007, CELL SIGNAL, V19, P1249, DOI 10.1016/j.cellsig.2006.12.015; Sarmiento C, 2008, J CELL BIOL, V180, P1245, DOI 10.1083/jcb.200708123; Tanaka M, 2009, MOL CELL BIOL, V29, P402, DOI 10.1128/MCB.01035-08; Uekita T, 2008, AM J PATHOL, V172, P1729, DOI 10.2353/ajpath.2008.070981; Yanagihara K, 2005, CANCER SCI, V96, P323, DOI 10.1111/j.1349-7006.2005.00054.x; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Yoon HY, 2008, TRAFFIC, V9, P2236, DOI 10.1111/j.1600-0854.2008.00839.x; 2004, J CELL SCI, V117, P6071	24	19	19	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR	2011	30	12					1413	1421		10.1038/onc.2010.522	http://dx.doi.org/10.1038/onc.2010.522			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	739UM	21076469				2022-12-25	WOS:000288743800004
J	Farrow, MA; Kim, EY; Wolinsky, SM; Sheehy, AM				Farrow, Melissa A.; Kim, Eun-Young; Wolinsky, Steven M.; Sheehy, Ann M.			NFAT and IRF Proteins Regulate Transcription of the Anti-HIV Gene, APOBEC3G	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CYTIDINE DEAMINASE; DENDRITIC CELLS; VIF PROTEIN; ENZYME APOBEC3G; EDITING ENZYME; B-CELLS; EXPRESSION; ACTIVATION; HYPERMUTATION	The human cytidine deaminase APOBEC3G (A3G) is an innate restriction factor that inhibits human immunodeficiency virus, type 1 (HIV-1) replication. Regulation of A3G gene expression plays an important role in this suppression. Currently, an understanding of the mechanism of this gene regulation is largely unknown. Here, we have identified and characterized a TATA-less core promoter with an NFAT/IRF-4 composite binding site that confers cell type-specific transcriptional regulation. We found that A3G expression is critically dependent on NFATc1/NFATc2 and IRF-4. When either NFATc1 or NFATc2 and IRF-4 were co-expressed, A3G promoter activity was observed in cells that normally lack A3G expression and expression was not detected in the presence of the individual factors. This induced A3G expression allowed normally permissive CEMss cells to adopt a nonpermissive state, able to resist an HIV-1 Delta vif challenge. This represents the first reporting of manipulating the restrictive state of a cell type via gene regulation. Identification of NFAT and IRF family members as critical regulators of A3G expression offers important insight into the transcriptional control mechanisms that regulate innate immune responses and identifies specific targets for therapeutic intervention aimed at effectively boosting our natural immunity, in the form of a host defensive factor, against HIV-1.	[Farrow, Melissa A.; Sheehy, Ann M.] Coll Holy Cross, Dept Biol, Worcester, MA 01610 USA; [Kim, Eun-Young; Wolinsky, Steven M.] Northwestern Univ, Feinberg Sch Med, Div Infect Dis, Chicago, IL 60611 USA	College of the Holy Cross; Northwestern University; Feinberg School of Medicine	Sheehy, AM (corresponding author), Coll Holy Cross, Dept Biol, 1 Coll St, Worcester, MA 01610 USA.	asheehy@holycross.edu	Wolinsky, Steven/B-2893-2012	Wolinsky, Steven/0000-0002-9625-6697; Kim, Eunyoung/0000-0002-7436-7396	Richard and Susan Smith Family Foundation; Center for AIDS Research at the University of Massachusetts [P30AI42845]; National Institutes of Health [AI071766-01, AI-3070072]; Elizabeth Glaser Pediatric AIDS Foundation [PF-77521]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042845, F32AI071766, S15AI030700] Funding Source: NIH RePORTER	Richard and Susan Smith Family Foundation; Center for AIDS Research at the University of Massachusetts; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Elizabeth Glaser Pediatric AIDS Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the Richard and Susan Smith Family Foundation (to A.M.S.), by Grant P30AI42845 from the Center for AIDS Research at the University of Massachusetts, by National Institutes of Health Grants AI071766-01 (to A.M.S.) and AI-3070072 (to S.M.W.), and by Elizabeth Glaser Pediatric AIDS Foundation Grant PF-77521 (to M.A.F.).	Ahyi ANN, 2009, J IMMUNOL, V183, P1598, DOI 10.4049/jimmunol.0803302; An P, 2004, J VIROL, V78, P11070, DOI 10.1128/JVI.78.20.11070-11076.2004; Badran BM, 2002, J BIOL CHEM, V277, P47136, DOI 10.1074/jbc.M206330200; Biasin M, 2007, J INFECT DIS, V195, P960, DOI 10.1086/511988; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bishop KN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000231; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Farrow MA, 2008, FUTURE MICROBIOL, V3, P145, DOI 10.2217/17460913.3.2.145; Guo F, 2006, J VIROL, V80, P11710, DOI 10.1128/JVI.01038-06; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Hu CM, 2002, J BIOL CHEM, V277, P49238, DOI 10.1074/jbc.M205895200; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Jin X, 2005, J VIROL, V79, P11513, DOI 10.1128/JVI.79.17.11513-11516.2005; Land AM, 2008, J VIROL, V82, P8172, DOI 10.1128/JVI.01115-08; Lazorchak AS, 2006, MOL CELL BIOL, V26, P810, DOI 10.1128/MCB.26.3.810-821.2006; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Lee CG, 2009, MOL IMMUNOL, V46, P613, DOI 10.1016/j.molimm.2008.07.037; Luo H, 2010, MOL IMMUNOL, V47, P1383, DOI 10.1016/j.molimm.2010.02.016; Mamane Y, 1999, GENE, V237, P1, DOI 10.1016/S0378-1119(99)00262-0; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Muckenfuss H, 2007, NUCLEIC ACIDS RES, V35, P3784, DOI 10.1093/nar/gkm340; Nagulapalli S, 2002, MOL CELL BIOL, V22, P7337, DOI 10.1128/MCB.22.20.7337-7350.2002; Ozato K, 2007, J BIOL CHEM, V282, P20065, DOI 10.1074/jbc.R700003200; Pace C, 2006, J VIROL, V80, P9259, DOI 10.1128/JVI.00888-06; Peng G, 2006, J EXP MED, V203, P41, DOI 10.1084/jem.20051512; Peng G, 2007, BLOOD, V110, P393, DOI 10.1182/blood-2006-10-051763; Pido-Lopez J, 2007, J IMMUNOL, V178, P1671, DOI 10.4049/jimmunol.178.3.1671; Pion M, 2006, J EXP MED, V203, P2887, DOI 10.1084/jem.20061519; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rengarajan J, 2002, J EXP MED, V195, P1003, DOI 10.1084/jem.20011128; Rose KM, 2004, J BIOL CHEM, V279, P41744, DOI 10.1074/jbc.M406760200; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Stopak KS, 2007, J BIOL CHEM, V282, P3539, DOI 10.1074/jbc.M610138200; Tanaka Y, 2006, BIOCHEM BIOPH RES CO, V341, P314, DOI 10.1016/j.bbrc.2005.12.192; van der Stoep N, 2004, BLOOD, V104, P2849, DOI 10.1182/blood-2004-03-0790; Vazquez-Perez JA, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-23; Vetter ML, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000292; Wang YJ, 2009, J NEUROIMMUNOL, V206, P14, DOI 10.1016/j.jneuroim.2008.10.003; Ying SC, 2007, ACTA BIOCH BIOPH SIN, V39, P297, DOI 10.1111/j.1745-7270.2007.00275.x; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhu C, 2003, J BIOL CHEM, V278, P39372, DOI 10.1074/jbc.M306441200	47	21	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2567	2577		10.1074/jbc.M110.154377	http://dx.doi.org/10.1074/jbc.M110.154377			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21078663	Green Published, hybrid			2022-12-25	WOS:000286464300022
J	Sumitomo, T; Nakata, M; Higashino, M; Jin, YJ; Terao, Y; Fujinaga, Y; Kawabata, S				Sumitomo, Tomoko; Nakata, Masanobu; Higashino, Miharu; Jin, Yingji; Terao, Yutaka; Fujinaga, Yukako; Kawabata, Shigetada			Streptolysin S Contributes to Group A Streptococcal Translocation across an Epithelial Barrier	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRONECTIN-BINDING PROTEIN; TIGHT JUNCTION; HYALURONIC-ACID; REGULATORY SYSTEM; VIRULENCE FACTORS; GENE-EXPRESSION; E-CADHERIN; TNF-ALPHA; PYOGENES; INVASION	Group A Streptococcus pyogenes (GAS) is a human pathogen that causes local suppurative infections and severe invasive diseases. Systemic dissemination of GAS is initiated by bacterial penetration of the epithelial barrier of the pharynx or damaged skin. To gain insight into the mechanism by which GAS penetrates the epithelial barrier, we sought to identify both bacterial and host factors involved in the process. Screening of a transposon mutant library of a clinical GAS isolate recovered from an invasive episode allowed identification of streptolysin S (SLS) as a novel factor that facilitates the translocation of GAS. Of note, the wild type strain efficiently translocated across the epithelial monolayer, accompanied by a decrease in transepithelial electrical resistance and cleavage of transmembrane junctional proteins, including occludin and E-cadherin. Loss of integrity of intercellular junctions was inhibited after infection with a deletion mutant of the sagA gene encoding SLS, as compared with those infected with the wild type strain. Interestingly, following GAS infection, calpain was recruited to the plasma membrane along with E-cadherin. Moreover, bacterial translocation and destabilization of the junctions were partially inhibited by a pharmacological calpain inhibitor or genetic interference with calpain. Our data indicate a potential function of SLS that facilitates GAS invasion into deeper tissues via degradation of epithelial intercellular junctions in concert with the host cysteine protease calpain.	[Kawabata, Shigetada] Osaka Univ, Dept Oral & Mol Microbiol, Grad Sch Dent, Suita, Osaka 5650871, Japan; [Jin, Yingji; Fujinaga, Yukako] Osaka Univ, Lab Infect Cell Biol, Int Res Ctr Infect Dis, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Kawabata, S (corresponding author), Osaka Univ, Dept Oral & Mol Microbiol, Grad Sch Dent, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	kawabata@dent.osaka-u.ac.jp		Terao, Yutaka/0000-0002-4450-5583; Nakata, Masanobu/0000-0003-1686-5415	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [20791336]; MEXT [18073011, 2189048, 19791343]; Japan Society for the Promotion of Science (JSPS) [20390465]	Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-Aid for Scientific Research for Young Scientists (B) 20791336 from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) (to T. S.); Grant-in-Aid for Scientific Research on Priority Areas 18073011 from MEXT (to S. K.); Grant-in-Aid for Scientific Research (B) 20390465 from the Japan Society for the Promotion of Science (JSPS) (to S. K.); Grant-in-Aid for Scientific Research for Young Scientists (A) 2189048 from MEXT (to Y. T.); and Grant-in-Aid for Scientific Research for Young Scientists (B) 19791343 from MEXT (to M. N.).	Al-Sadi RM, 2007, J IMMUNOL, V178, P4641, DOI 10.4049/jimmunol.178.7.4641; Balkovetz DF, 2003, MICROBES INFECT, V5, P613, DOI 10.1016/S1286-4579(03)00089-3; Bentley CC, 2005, CELL MICROBIOL, V7, P945, DOI 10.1111/j.1462-5822.2005.00525.x; Bernish B, 1999, J BIOL CHEM, V274, P4786, DOI 10.1074/jbc.274.8.4786; Betschel SD, 1998, INFECT IMMUN, V66, P1671, DOI 10.1128/IAI.66.4.1671-1679.1998; Bisno AL, 2003, LANCET INFECT DIS, V3, P191, DOI 10.1016/S1473-3099(03)00576-0; Biswas I, 2001, INFECT IMMUN, V69, P7029, DOI 10.1128/IAI.69.11.7029-7038.2001; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Carapetis JR, 2005, LANCET, V366, P155, DOI 10.1016/S0140-6736(05)66874-2; Carr A, 2001, J BIOL CHEM, V276, P41790, DOI 10.1074/jbc.M107401200; Chun J, 2009, CELL HOST MICROBE, V5, P47, DOI 10.1016/j.chom.2008.11.009; Cleary P P, 2000, Subcell Biochem, V33, P137; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Cywes C, 2001, NATURE, V414, P648, DOI 10.1038/414648a; Dale JB, 2002, INFECT IMMUN, V70, P2166, DOI 10.1128/IAI.70.4.2166-2170.2002; Datta V, 2005, MOL MICROBIOL, V56, P681, DOI 10.1111/j.1365-2958.2005.04583.x; Engleberg NC, 2004, INFECT IMMUN, V72, P623, DOI 10.1128/IAI.72.2.623-628.2004; Engleberg NC, 2001, J INFECT DIS, V183, P1043, DOI 10.1086/319291; Federle MJ, 1999, J BACTERIOL, V181, P3649, DOI 10.1128/JB.181.12.3649-3657.1999; Fuller JD, 2002, INFECT IMMUN, V70, P5730, DOI 10.1128/IAI.70.10.5730-5739.2002; Gonzalez-Mariscal L, 2003, PROG BIOPHYS MOL BIO, V81, P1, DOI 10.1016/S0079-6107(02)00037-8; Graham MR, 2002, P NATL ACAD SCI USA, V99, P13855, DOI 10.1073/pnas.202353699; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Humar D, 2002, LANCET, V359, P124, DOI 10.1016/S0140-6736(02)07371-3; Joh D, 1999, MATRIX BIOL, V18, P211, DOI 10.1016/S0945-053X(99)00025-6; Kawabata S, 1999, MICROB PATHOGENESIS, V27, P71, DOI 10.1006/mpat.1999.0283; Klenk M, 2005, CELL MICROBIOL, V7, P1237, DOI 10.1111/j.1462-5822.2005.00548.x; Klenk M, 2007, ISME J, V1, P678, DOI 10.1038/ismej.2007.54; Kreikemeyer B, 2003, TRENDS MICROBIOL, V11, P224, DOI 10.1016/S0966-842X(03)00098-2; Lee SW, 2008, P NATL ACAD SCI USA, V105, P5879, DOI 10.1073/pnas.0801338105; Levin JC, 1998, MOL MICROBIOL, V30, P209, DOI 10.1046/j.1365-2958.1998.01057.x; Li ZQ, 1999, J BACTERIOL, V181, P6019, DOI 10.1128/JB.181.19.6019-6027.1999; Lin A, 2009, INFECT IMMUN, V77, P5190, DOI 10.1128/IAI.00420-09; Ma TY, 2005, AM J PHYSIOL-GASTR L, V288, pG422, DOI 10.1152/ajpgi.00412.2004; MADARA JL, 1989, J CLIN INVEST, V83, P724, DOI 10.1172/JCI113938; Mangold M, 2004, MOL MICROBIOL, V53, P1515, DOI 10.1111/j.1365-2958.2004.04222.x; Mariadason JM, 2002, CANCER RES, V62, P4791; Matsumura T, 2008, CELL MICROBIOL, V10, P355, DOI 10.1111/j.1462-5822.2007.01048.x; McKay DM, 1997, J IMMUNOL, V159, P2382; Nakagawa I, 2001, CELL MICROBIOL, V3, P395, DOI 10.1046/j.1462-5822.2001.00122.x; NIDA K, 1983, J BACTERIOL, V155, P1156, DOI 10.1128/JB.155.3.1156-1161.1983; Nizet V, 2002, TRENDS MICROBIOL, V10, P575, DOI 10.1016/S0966-842X(02)02473-3; Nizet V, 2000, INFECT IMMUN, V68, P4245, DOI 10.1128/IAI.68.7.4245-4254.2000; OFEK I, 1990, INFECT IMMUN, V58, P3737, DOI 10.1128/IAI.58.11.3737-3742.1990; Pezzicoli A, 2008, J INFECT DIS, V198, P890, DOI 10.1086/591182; Podbielski A, 2003, INT J MED MICROBIOL, V293, P179, DOI 10.1078/1438-4221-00253; Rios-Doria J, 2005, PROSTATE, V63, P259, DOI 10.1002/pros.20179; Rios-Doria J, 2003, J BIOL CHEM, V278, P1372, DOI 10.1074/jbc.M208772200; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Shao HS, 2006, MOL CELL BIOL, V26, P5481, DOI 10.1128/MCB.02243-05; Sousa S, 2005, CURR OPIN CELL BIOL, V17, P489, DOI 10.1016/j.ceb.2005.08.013; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Takamatsu D, 2001, PLASMID, V46, P140, DOI 10.1006/plas.2001.1532; Terao Y, 2002, J BIOL CHEM, V277, P47428, DOI 10.1074/jbc.M209133200; Terao Y, 2001, MOL MICROBIOL, V42, P75, DOI 10.1046/j.1365-2958.2001.02579.x; TRIEUCUOT P, 1991, GENE, V102, P99, DOI 10.1016/0378-1119(91)90546-N; Tsai PJ, 1998, INFECT IMMUN, V66, P1460, DOI 10.1128/IAI.66.4.1460-1466.1998; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612; Wessels MR, 2005, J INFECT DIS, V192, P13, DOI 10.1086/430625	59	55	58	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2750	2761		10.1074/jbc.M110.171504	http://dx.doi.org/10.1074/jbc.M110.171504			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21084306	Green Published, hybrid			2022-12-25	WOS:000286464300041
J	Tikhonov, DB; Zhorov, BS				Tikhonov, Denis B.; Zhorov, Boris S.			Possible Roles of Exceptionally Conserved Residues around the Selectivity Filters of Sodium and Calcium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SLOW INACTIVATION; MOLECULAR LOCALIZATION; AROMATIC RESIDUE; HOMOLOGY MODEL; NUCLEIC-ACIDS; CA2+ CHANNEL; BINDING-SITE; MU-CONOTOXIN; NA+ CHANNEL; FORCE-FIELD	In the absence of x-ray structures of sodium and calcium channels their homology models are used to rationalize experimental data and design new experiments. A challenge is to model the outer-pore region that folds differently from potassium channels. Here we report a new model of the outer-pore region of the NaV1.4 channel, which suggests roles of highly conserved residues around the selectivity filter. The model takes from our previous study (Tikhonov, D. B., and Zhorov, B. S. (2005) Biophys. J. 88, 184-197) the general disposition of the P-helices, selectivity filter residues, and the outer carboxylates, but proposes new intra-and inter-domain contacts that support structural stability of the outer pore. Glycine residues downstream from the selectivity filter are proposed to participate in knob-into-hole contacts with the P-helices and S6s. These contacts explain the adapted tetrodotoxin resistance of snakes that feed on toxic prey through valine substitution of isoleucine in the P-helix of repeat IV. Polar residues five positions upstream from the selectivity filter residues form H-bonds with the ascending-limb backbones. Exceptionally conserved tryptophans are engaged in inter-repeat H-bonds to form a ring whose pi-electrons would facilitate passage of ions from the outer carboxylates to the selectivity filter. The outer-pore model of CaV1.2 derived from the NaV1.4 model is also stabilized by the ring of exceptionally conservative tryptophans and H-bonds between the P-helices and ascending limbs. In this model, the exceptionally conserved aspartate downstream from the selectivity-filter glutamate in repeat II facilitates passage of calcium ions to the selectivity-filter ring through the tryptophan ring. Available experimental data are discussed in view of the models.	[Tikhonov, Denis B.; Zhorov, Boris S.] Russian Acad Sci, Sechenov Inst Evolutionary Physiol & Biochem, St Petersburg 194223, Russia; McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 325, Canada	Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry; McMaster University	Zhorov, BS (corresponding author), Russian Acad Sci, Sechenov Inst Evolutionary Physiol & Biochem, St Petersburg 194223, Russia.	zhorov@mcmaster.ca	Zhorov, Boris/T-9892-2019; Zhorov, Boris S./V-8072-2019; Tikhonov, Denis/AAK-9148-2020	Zhorov, Boris/0000-0002-3630-7114; Tikhonov, Denis/0000-0001-8523-4305	Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research [MOP-53229]; RAS	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); RAS(Russian Academy of SciencesRegione Sardegna)	This study was supported by grants from Natural Sciences and Engineering Research Council of Canada, the Canadian Institutes of Health Research (MOP-53229) (to B. S. Z.), and by a grant from the RAS Program Molecular and Cell Biology (to D. B. T.).	BACKX PH, 1992, SCIENCE, V257, P248, DOI 10.1126/science.1321496; Bruhova I, 2008, MOL PHARMACOL, V74, P1033, DOI 10.1124/mol.108.049759; Bruhova I, 2010, J GEN PHYSIOL, V135, P261, DOI 10.1085/jgp.200910288; Carbonneau E, 2002, PFLUG ARCH EUR J PHY, V445, P18, DOI 10.1007/s00424-002-0887-9; CHAHINE M, 1992, BIOPHYS J, V62, P37, DOI 10.1016/S0006-3495(92)81771-X; CHEN LQ, 1992, FEBS LETT, V309, P253, DOI 10.1016/0014-5793(92)80783-D; Cheng RCK, 2010, EUR BIOPHYS J BIOPHY, V39, P825, DOI 10.1007/s00249-009-0561-7; Cheng RCK, 2010, EUR BIOPHYS J BIOPHY, V39, P839, DOI 10.1007/s00249-009-0574-2; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024; Dudley SC, 2000, J GEN PHYSIOL, V116, P679, DOI 10.1085/jgp.116.5.679; Durell SR, 2001, BIOCHEM BIOPH RES CO, V281, P741, DOI 10.1006/bbrc.2001.4408; Garden DP, 2010, J COMPUT AID MOL DES, V24, P91, DOI 10.1007/s10822-009-9317-9; Geffeney SL, 2005, NATURE, V434, P759, DOI 10.1038/nature03444; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Ikeda T, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2768063; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; LI ZQ, 1987, P NATL ACAD SCI USA, V84, P6611, DOI 10.1073/pnas.84.19.6611; LIPKIND GM, 1994, BIOPHYS J, V66, P1, DOI 10.1016/S0006-3495(94)80746-5; MCPHALEN CA, 1991, ADV PROTEIN CHEM, V42, P77; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; Santarelli VP, 2007, BIOPHYS J, V93, P2341, DOI 10.1529/biophysj.107.106856; Santarelli VP, 2007, J BIOL CHEM, V282, P8044, DOI 10.1074/jbc.M611334200; SATIN J, 1992, SCIENCE, V256, P1202, DOI 10.1126/science.256.5060.1202; Struyk AF, 2002, J GEN PHYSIOL, V120, P509, DOI 10.1085/jgp.20028672; TANG SQ, 1993, J BIOL CHEM, V268, P13026; Tikhonov DB, 2005, BIOPHYS J, V88, P184, DOI 10.1529/biophysj.104.048173; Tikhonov DB, 2007, BIOPHYS J, V93, P1557, DOI 10.1529/biophysj.106.100248; Tsang SY, 2005, MOL PHARMACOL, V67, P424, DOI 10.1124/mol.67.2.424; Tsushima RG, 1997, J GEN PHYSIOL, V109, P463, DOI 10.1085/jgp.109.4.463; WEINER SJ, 1986, J COMPUT CHEM, V7, P230, DOI 10.1002/jcc.540070216; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; Xiong W, 2003, J GEN PHYSIOL, V122, P323, DOI 10.1085/jgp.200308881; Yamagishi T, 2001, J GEN PHYSIOL, V118, P171, DOI 10.1085/jgp.118.2.171; Yue LX, 2002, J GEN PHYSIOL, V120, P845, DOI 10.1085/jgp.20028699; Zhang MM, 2009, CHANNELS, V3, P32, DOI 10.4161/chan.3.1.7500; Zhorov BS, 2004, J NEUROCHEM, V88, P782, DOI 10.1111/j.1471-4159.2004.02261.x; Zhorov BS, 2001, ARCH BIOCHEM BIOPHYS, V393, P22, DOI 10.1006/abbi.2001.2484	38	29	29	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2998	3006		10.1074/jbc.M110.175406	http://dx.doi.org/10.1074/jbc.M110.175406			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21081490	hybrid, Green Published			2022-12-25	WOS:000286464300063
J	Mironova, E; Peti-Peterdi, J; Bugaj, V; Stockand, JD				Mironova, Elena; Peti-Peterdi, Janos; Bugaj, Vladislav; Stockand, James D.			Diminished Paracrine Regulation of the Epithelial Na+ Channel by Purinergic Signaling in Mice Lacking Connexin 30	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLECTING DUCT; SODIUM-CHANNEL; APICAL MONOCILIA; TRANSPORT; MECHANISMS; MEMBRANE; NEPHRON; KIDNEY; CELLS; ALDOSTERONE	We tested whether ATP release through Connexin 30 (Cx30) is part of a local purinergic regulatory system intrinsic to the aldosterone-sensitive distal nephron (ASDN) important for proper control of sodium excretion; if changes in sodium intake influence ATP release via Cx30; and if this allows a normal ENaC response to changes in systemic sodium levels. In addition, we define the consequences of disrupting ATP regulation of ENaC in Cx30(-/-) mice. Urinary ATP levels in wildtype mice increase with sodium intake, being lower and less dependent on sodium intake in Cx30(-/-) mice. Loss of inhibitory ATP regulation causes ENaC activity to be greater in Cx30(-/-) versus wild-type mice, particularly with high sodium intake. This results from compromised ATP release rather than end-organ resistance: ENaC in Cx30(-/-) mice responds to exogenous ATP. Thus, loss of paracrine ATP feedback regulation of ENaC in Cx30(-/-) mice disrupts normal responses to changes in sodium intake. Consequently, ENaC is hyperactive in Cx30(-/-) mice lowering sodium excretion particularly during increases in sodium intake. Clamping mineralocorticoids high in Cx30(-/-) mice fed a high sodium diet causes a marked decline in renal sodium excretion. This is not the case in wildtype mice, which are capable of undergoing aldosterone-escape. This loss of the ability of ENaC to respond to changes in sodium levels contributes to salt-sensitive hypertension in Cx30(-/-) mice.	[Mironova, Elena; Bugaj, Vladislav; Stockand, James D.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Peti-Peterdi, Janos] Univ So Calif, Dept Physiol & Biophys, Los Angeles, CA 90089 USA	University of Texas System; University of Texas Health San Antonio; University of Southern California	Stockand, JD (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, 7756 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	stockand@uthscsa.edu		Stockand, James/0000-0002-3817-4319	National Institutes of Health [R01DK59594]; American Heart Association (AHA) [0640054N, 0640056N]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059594, R01DK064324] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK59594 (to J. D. S.) and the American Heart Association (AHA) Established Investigator Awards 0640054N (to J. D. S.) and 0640056N (to J. P. P.).	AUGUST JT, 1958, J CLIN INVEST, V37, P1549, DOI 10.1172/JCI103747; Bonny O, 2000, KIDNEY INT, V57, P1313, DOI 10.1046/j.1523-1755.2000.00968.x; Burnstock G, 2007, CELL MOL LIFE SCI, V64, P1471, DOI 10.1007/s00018-007-6497-0; Corriden R, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3104re1; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Geyti CS, 2008, PFLUG ARCH EUR J PHY, V455, P1105, DOI 10.1007/s00424-007-0366-4; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hovater MB, 2008, PURINERG SIGNAL, V4, P109, DOI 10.1007/s11302-008-9102-6; Hovater MB, 2008, PURINERG SIGNAL, V4, P155, DOI 10.1007/s11302-007-9072-0; Hummler E, 1999, AM J PHYSIOL-GASTR L, V276, pG567, DOI 10.1152/ajpgi.1999.276.3.G567; Jensen MEJ, 2007, J AM SOC NEPHROL, V18, P2062, DOI 10.1681/ASN.2006070700; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Lehrmann H, 2002, J AM SOC NEPHROL, V13, P10, DOI 10.1681/ASN.V13110; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; MATSUZAKI T, 1992, Heart and Vessels, V7, P1, DOI 10.1007/BF01745861; McCulloch F, 2005, AM J PHYSIOL-RENAL, V289, pF1304, DOI 10.1152/ajprenal.00203.2005; Olteanu D, 2006, AM J PHYSIOL-CELL PH, V290, pC952, DOI 10.1152/ajpcell.00339.2005; Pochynyuk O, 2010, FASEB J, V24, P2056, DOI 10.1096/fj.09-151506; Pochynyuk O, 2008, J BIOL CHEM, V283, P36599, DOI 10.1074/jbc.M807129200; RELMAN AS, 1952, YALE J BIOL MED, V24, P540; Rieg T, 2009, AM J PHYSIOL-REG I, V296, pR419, DOI 10.1152/ajpregu.90784.2008; Rieg TM, 2007, FASEB J, V21, pA437; Rossier BC, 2002, ANNU REV PHYSIOL, V64, P877, DOI 10.1146/annurev.physiol.64.082101.143243; SAKMANN B, 1983, SINGLE CHANNEL RECOR; Schwiebert EM, 2001, AM J PHYSIOL-RENAL, V280, pF945, DOI 10.1152/ajprenal.2001.280.6.F945; Sipos A, 2009, J AM SOC NEPHROL, V20, P1724, DOI 10.1681/ASN.2008101099; Unwin RJ, 2003, NEWS PHYSIOL SCI, V18, P237, DOI 10.1152/nips.01436.2003; Vallon V, 2008, AM J PHYSIOL-RENAL, V294, pF10, DOI 10.1152/ajprenal.00432.2007; Vallon V, 2009, J AM SOC NEPHROL, V20, P721, DOI 10.1681/ASN.2008040415; Verrey F, 2000, KIDNEY INT, V57, P1277, DOI 10.1046/j.1523-1755.2000.00962.x	30	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1054	1060		10.1074/jbc.M110.176552	http://dx.doi.org/10.1074/jbc.M110.176552			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21075848	Green Published, hybrid			2022-12-25	WOS:000286005000016
J	Stephens, GJ; Johnson-Kerner, B; Bialek, W; Ryu, WS				Stephens, Greg J.; Johnson-Kerner, Bethany; Bialek, William; Ryu, William S.			From Modes to Movement in the Behavior of Caenorhabditis elegans	PLOS ONE			English	Article							SELF-PROPULSION; THERMOTAXIS; MECHANISM; DOPAMINE; GENETICS	Organisms move through the world by changing their shape, and here we explore the mapping from shape space to movements in the nematode Caenorhabditis elegans as it crawls on an agar plate. We characterize the statistics of the trajectories through the correlation functions of the orientation angular velocity, orientation angle and the mean-squared displacement, and we find that the loss of orientational memory has significant contributions from both abrupt, large amplitude turning events and the continuous dynamics between these events. Further, we discover long-time persistence of orientational memory in the intervals between abrupt turns. Building on recent work demonstrating that C. elegans movements are restricted to a low-dimensional shape space, we construct a map from the dynamics in this shape space to the trajectory of the worm along the agar. We use this connection to illustrate that changes in the continuous dynamics reveal subtle differences in movement strategy that occur among mutants defective in two classes of dopamine receptors.	[Stephens, Greg J.; Johnson-Kerner, Bethany; Bialek, William] Princeton Univ, Joseph Henry Labs Phys, Princeton, NJ 08544 USA; [Stephens, Greg J.; Johnson-Kerner, Bethany; Bialek, William] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Ryu, William S.] Univ Toronto, Banting & Best Dept Med Res, Dept Phys, Toronto, ON, Canada	Princeton University; Princeton University; University of Toronto	Stephens, GJ (corresponding author), Princeton Univ, Joseph Henry Labs Phys, Princeton, NJ 08544 USA.	gstephen@Princeton.EDU; wryu@physics.utoronto.ca		Stephens, Greg/0000-0003-3135-3514	National Institutes of Health [P50 GM071508, R01 EY017210]; National Science Foundation [PHY-0650617]; Swartz Foundation; NATIONAL EYE INSTITUTE [R01EY017210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Swartz Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health grants P50 GM071508 and R01 EY017210, by National Science Foundation grant PHY-0650617, and by the Swartz Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartumeus F, 2003, P NATL ACAD SCI USA, V100, P12771, DOI 10.1073/pnas.2137243100; BELL WJ, 1991, SEARCH BEHAV BEHAV E; Berg, 2018, RANDOM WALKS BIOL; BERG HC, 2004, BIOL MED PHYS BIOMED, P1; Biron D, 2008, P NATL ACAD SCI USA, V105, P11002, DOI 10.1073/pnas.0805004105; BRENNER S, 1974, GENETICS, V77, P71; BRENNER S, 1973, BRIT MED BULL, V29, P269, DOI 10.1093/oxfordjournals.bmb.a071019; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Chase DL, 2004, NAT NEUROSCI, V7, P1096, DOI 10.1038/nn1316; Childress S., 1981, MECH SWIMMING FLYING; d'Avella A, 1998, P NATL ACAD SCI USA, V95, P7711, DOI 10.1073/pnas.95.13.7711; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Faumont S, 2006, J NEUROPHYSIOL, V95, P1976, DOI 10.1152/jn.01050.2005; Geng W, 2003, GENETICS, V165, P1117; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Hills T, 2004, J NEUROSCI, V24, P1217, DOI 10.1523/JNEUROSCI.1569-03.2004; Huang KM, 2006, J NEUROSCI METH, V158, P323, DOI 10.1016/j.jneumeth.2006.06.007; Iino Y, 2009, J NEUROSCI, V29, P5370, DOI 10.1523/JNEUROSCI.3633-08.2009; LIGHTHILL J, 2006, MATH BIOFLUIDDYNAMIC; Osborne LC, 2005, NATURE, V437, P412, DOI 10.1038/nature03961; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Ramot D, 2008, J NEUROSCI, V28, P12546, DOI 10.1523/JNEUROSCI.2857-08.2008; Ryu WS, 2002, J NEUROSCI, V22, P5727; Sanger TD, 2000, J NEUROSCI, V20, P1066, DOI 10.1523/JNEUROSCI.20-03-01066.2000; Santello M, 1998, J NEUROSCI, V18, P10105; SHAPERE A, 1989, J FLUID MECH, V198, P557, DOI 10.1017/S002211208900025X; SHAPERE A, 1987, PHYS REV LETT, V58, P2051, DOI 10.1103/PhysRevLett.58.2051; SHAPERE A, 1989, J FLUID MECH, V198, P587, DOI 10.1017/S0022112089000261; Srivastava N, 2009, J NEUROPHYSIOL, V102, P1172, DOI 10.1152/jn.90952.2008; Stephens GJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000028	30	34	34	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e13914	10.1371/journal.pone.0013914	http://dx.doi.org/10.1371/journal.pone.0013914			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103370	Green Published, Green Submitted, gold			2022-12-25	WOS:000284257400003
J	Yokoyama, T; Masujin, K; Schmerr, MJ; Shu, YJ; Okada, H; Iwamaru, Y; Imamura, M; Matsuura, Y; Murayama, Y; Mohri, S				Yokoyama, Takashi; Masujin, Kentaro; Schmerr, Mary Jo; Shu, Yujing; Okada, Hiroyuki; Iwamaru, Yoshifumi; Imamura, Morikazu; Matsuura, Yuichi; Murayama, Yuichi; Mohri, Shirou			Intraspecies Prion Transmission Results in Selection of Sheep Scrapie Strains	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; MOLECULAR ANALYSIS; INTERSPECIES TRANSMISSION; ABNORMAL ISOFORM; PROTEIN; BSE; PRPSC; SIMILARITIES; ISOLATE; CH1641	Background: Sheep scrapie is caused by multiple prion strains, which have been classified on the basis of their biological characteristics in inbred mice. The heterogeneity of natural scrapie prions in individual sheep and in sheep flocks has not been clearly defined. Methodology/Principal Findings: In this study, we intravenously injected 2 sheep (Suffolk and Corriedale) with material from a natural case of sheep scrapie (Suffolk breed). These 3 sheep had identical prion protein (PrP) genotypes. The protease-resistant core of PrP (PrPres) in the experimental Suffolk sheep was similar to that in the original Suffolk sheep. In contrast, PrPres in the Corriedale sheep differed from the original PrPres but resembled the unusual scrapie isolate, CH1641. This unusual PrPres was not detected in the original sheep. The PrPres distributions in the brain and peripheral tissues differed between the 2 breeds of challenged sheep. A transmission study in wild-type and TgBoPrP mice, which overexpressing bovine PrP, led to the selection of different prion strains. The pathological features of prion diseases are thought to depend on the dominantly propagated strain. Conclusions/Significance: Our results indicate that prion strain selection occurs after both inter-and intraspecies transmission. The unusual scrapie prion was a hidden or an unexpressed component in typical sheep scrapie.	[Yokoyama, Takashi; Masujin, Kentaro; Shu, Yujing; Okada, Hiroyuki; Iwamaru, Yoshifumi; Imamura, Morikazu; Matsuura, Yuichi; Murayama, Yuichi; Mohri, Shirou] Natl Inst Anim Hlth, Pr Dis Res Ctr, Tsukuba, Ibaraki 305, Japan; [Schmerr, Mary Jo] Iowa State Univ, Ames Lab, Ames, IA USA	National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Iowa State University; United States Department of Energy (DOE); Ames National Laboratory	Yokoyama, T (corresponding author), Natl Inst Anim Hlth, Pr Dis Res Ctr, Tsukuba, Ibaraki 305, Japan.	tyoko@affrc.go.jp	Mohri, Shirou/AAK-1281-2020; Matsuura, Yuichi/AAF-3170-2021	Matsuura, Yuichi/0000-0003-3383-7918	Ministry of Agriculture, Forestry, and Fisheries of Japan; Ministry of Health, Labour and Welfare of Japan; Bio-oriented Technology Research Advancement Institution ( Tokyo, Japan)	Ministry of Agriculture, Forestry, and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Bio-oriented Technology Research Advancement Institution ( Tokyo, Japan)	This work was supported by grants from the BSE control project of the Ministry of Agriculture, Forestry, and Fisheries of Japan, and in part by grants from the Ministry of Health, Labour and Welfare of Japan and in part by grants from Bio-oriented Technology Research Advancement Institution ( Tokyo, Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apetri AC, 2004, J BIOL CHEM, V279, P18008, DOI 10.1074/jbc.M313581200; Arsac JN, 2007, EMERG INFECT DIS, V13, P58, DOI 10.3201/eid1301.060393; Baron T, 2004, J VIROL, V78, P6243, DOI 10.1128/JVI.78.12.6243-6251.2004; Baron T, 2007, J VIROL, V81, P7230, DOI 10.1128/JVI.02475-06; Baron T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010310; Baron T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000137; Bencsik AA, 2005, J HISTOCHEM CYTOCHEM, V53, P1199, DOI 10.1369/jhc.5C6703.2005; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; BRUCE ME, 1996, PRION DIS, P223; Casalone C, 2004, P NATL ACAD SCI USA, V101, P3065, DOI 10.1073/pnas.0305777101; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; Eloit M, 2005, VET REC, V156, P523, DOI 10.1136/vr.156.16.523-b; FOSTER JD, 1988, VET REC, V123, P5, DOI 10.1136/vr.123.1.5; FRASER H, 1968, J COMP PATHOL, V78, P301, DOI 10.1016/0021-9975(68)90006-6; Furuoka H, 2007, J COMP PATHOL, V136, P9, DOI 10.1016/j.jcpa.2006.09.002; Hayashi H, 2004, J VET MED SCI, V66, P515, DOI 10.1292/jvms.66.515; Hayashi HK, 2005, BIOCHEM BIOPH RES CO, V328, P1024, DOI 10.1016/j.bbrc.2005.01.065; Hope J, 1999, J GEN VIROL, V80, P1, DOI 10.1099/0022-1317-80-1-1; Jeffrey M, 2006, J COMP PATHOL, V134, P17, DOI 10.1016/j.jcpa.2005.06.005; Kim CL, 2004, VIROLOGY, V320, P40, DOI 10.1016/j.virol.2003.10.026; KIMBERLIN RH, 1978, J GEN VIROL, V39, P487, DOI 10.1099/0022-1317-39-3-487; Konold Timm, 2006, BMC Vet Res, V2, P31, DOI 10.1186/1746-6148-2-31; Lee HS, 2001, J INFECT DIS, V183, P192, DOI 10.1086/317935; Legname G, 2005, P NATL ACAD SCI USA, V102, P2168, DOI 10.1073/pnas.0409079102; Lezmi S, 2004, J VIROL, V78, P3654, DOI 10.1128/JVI.78.7.3654-3662.2004; Mabbott NA, 2001, J GEN VIROL, V82, P2307, DOI 10.1099/0022-1317-82-10-2307; Masujin K, 2009, ARCH VIROL, V154, P1929, DOI 10.1007/s00705-009-0534-2; Masujin K, 2008, PRION, V2, P123, DOI 10.4161/pri.2.3.7437; Owen JP, 2007, J VIROL, V81, P10532, DOI 10.1128/JVI.00640-07; Polymenidou M, 2005, LANCET NEUROL, V4, P805, DOI 10.1016/S1474-4422(05)70225-8; Prinz M, 2003, NATURE, V425, P957, DOI 10.1038/nature02072; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; Scott MR, 1997, P NATL ACAD SCI USA, V94, P14279, DOI 10.1073/pnas.94.26.14279; Scott MR, 1999, P NATL ACAD SCI USA, V96, P15137, DOI 10.1073/pnas.96.26.15137; Shimada K, 2005, MICROBIOL IMMUNOL, V49, P801, DOI 10.1111/j.1348-0421.2005.tb03660.x; SHINAGAWA M, 1985, MICROBIOL IMMUNOL, V29, P543, DOI 10.1111/j.1348-0421.1985.tb00856.x; Siso S, 2010, J COMP PATHOL, V142, P27, DOI 10.1016/j.jcpa.2009.06.002; Stack M, 2006, J GEN VIROL, V87, P2099, DOI 10.1099/vir.0.81254-0; Stack MJ, 2002, ACTA NEUROPATHOL, V104, P279, DOI 10.1007/s00401-002-0556-2; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Ushiki-Kaku Y, 2010, J BIOL CHEM, V285, P11931, DOI 10.1074/jbc.M109.058859; WESTAWAY D, 1987, CELL, V51, P651, DOI 10.1016/0092-8674(87)90134-6; WESTAWAY D, 1994, GENE DEV, V8, P959, DOI 10.1101/gad.8.8.959; WILESMITH JW, 1991, VET REC, V128, P199, DOI 10.1136/vr.128.9.199; Yokoyama T, 2001, J BIOL CHEM, V276, P11265, DOI 10.1074/jbc.M008734200; Yokoyama T, 2009, J GEN VIROL, V90, P261, DOI 10.1099/vir.0.004754-0; Yull HM, 2006, AM J PATHOL, V168, P151, DOI 10.2353/ajpath.2006.050766	50	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e15450	10.1371/journal.pone.0015450	http://dx.doi.org/10.1371/journal.pone.0015450			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103326	Green Submitted, Green Published, gold			2022-12-25	WOS:000284257400024
J	Odegaard, AO; Pereira, MA; Koh, WP; Gross, MD; Duval, S; Yu, MC; Yuan, JM				Odegaard, Andrew O.; Pereira, Mark A.; Koh, Woon-Puay; Gross, Myron D.; Duval, Sue; Yu, Mimi C.; Yuan, Jian-Min			BMI, All-Cause and Cause-Specific Mortality in Chinese Singaporean Men and Women: The Singapore Chinese Health Study	PLOS ONE			English	Article							BODY-MASS INDEX; POPULATION-BASED SAMPLE; OLDER CHINESE; OBESITY; WEIGHT; CANCER; RISK; OVERWEIGHT; FREQUENCY; COHORT	Background: The optimal range of relative weight for morbidity and mortality in Asian populations is an important question in need of more thorough investigation, especially as obesity rates increase. We aimed to examine the association between body mass index (BMI), all cause and cause-specific mortality to determine the optimal range of BMI in relation to mortality in Chinese men and women in Singapore. Methodology/Principal Findings: We analyzed data from a prospective cohort study of 51,251 middle-aged or older (4574) Chinese men and women in the Singapore Chinese Health Study. Participants were enrolled and data on body weight and covariates were collected in 1993-1998 and participants were followed through 2008. The analysis accounted for potential methodological issues through stratification on smoking and age, thorough adjustment of demographic and lifestyle confounders and exclusion of deaths early in the follow-up. Conclusions/Significance: Increased risk of mortality was apparent in underweight (<18.5) and obese BMI categories (>= 27.5) independent of age and smoking. Regardless of age or BMI, smoking considerably increased the rate of mortality and modified the association between BMI and mortality. The most favorable range of BMI for mortality rates and risk in non-smoking persons below age 65 was 18.5-21.4 kg/m(2), and for non-smoking persons aged 65 and above was 21.5-24.4 kg/m(2).	[Odegaard, Andrew O.; Pereira, Mark A.; Gross, Myron D.; Duval, Sue; Yu, Mimi C.; Yuan, Jian-Min] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA; [Koh, Woon-Puay] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Epidemiol & Publ Hlth, Singapore 117595, Singapore	University of Minnesota System; University of Minnesota Twin Cities; National University of Singapore	Odegaard, AO (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA.	odeg0025@umn.edu	Duval, Susan/AAI-1874-2020	Pereira, Mark/0000-0002-6704-5276; Yuan, Jian-Min/0000-0002-4620-3108; Duval, Sue/0000-0003-1025-8665	National Institutes of Health (NCI) [R01 CA55069, R35 CA53890, R01 CA80205]; National Institutes of Health (NIDDK) [R01 DK80720-01A1]; NATIONAL CANCER INSTITUTE [R01CA080205, R01CA055069, R35CA053890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080720] Funding Source: NIH RePORTER	National Institutes of Health (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by the National Institutes of Health (NCI R01 CA55069, R35 CA53890 and R01 CA80205 NIDDK R01 DK80720-01A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butler LM, 2008, BRIT J CANCER, V99, P1511, DOI 10.1038/sj.bjc.6604678; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Ceschi M, 2007, SWISS MED WKLY, V137, P50; Cooper RS, 2008, INT J OBESITY, V32, pS47, DOI 10.1038/ijo.2008.85; Deurenberg P, 1998, INT J OBESITY, V22, P1164, DOI 10.1038/sj/ijo/0800741; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; Durazo-Arvizu RA, 2008, INT J OBESITY, V32, pS52, DOI 10.1038/ijo.2008.86; Flanders WD, 2008, INT J OBESITY, V32, pS42, DOI 10.1038/ijo.2008.84; Fontaine K. R., 2004, HDB OBESITY ETIOLOGY, P767; Gu DF, 2006, JAMA-J AM MED ASSOC, V295, P776, DOI 10.1001/jama.295.7.776; Hankin JH, 2001, NUTR CANCER, V39, P187, DOI 10.1207/S15327914nc392_5; Hu FB, 2008, OBESITY EPIDEMIOLOGY, V1; Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017; KALMIJN S, 1998, INT J OBESITY, V23, P395; Koh WP, 2010, BRIT J CANCER, V102, P610, DOI 10.1038/sj.bjc.6605496; Koh WP, 2005, J NUTR, V135, P2473, DOI 10.1093/jn/135.10.2473; Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068; Manson JE, 2007, J WOMENS HEALTH, V16, P168, DOI 10.1089/jwh.2006.0080; Miller SL, 2008, J NUTR HEALTH AGING, V12, P487, DOI 10.1007/BF02982710; Mizoue T, 2007, CANCER SCI, V98, P1254, DOI 10.1111/j.1349-7006.2007.00511.x; Odegaard AO, 2009, DIABETES CARE, V32, P1104, DOI 10.2337/dc08-1674; Rothman KJ, 2008, INT J OBESITY, V32, pS56, DOI 10.1038/ijo.2008.87; Seow A, 1998, CANCER EPIDEM BIOMAR, V7, P135; Seow A, 1998, CANCER EPIDEM BIOMAR, V7, P775; Song YM, 2007, ANN EPIDEMIOL, V17, P556, DOI 10.1016/j.annepidem.2007.01.028; Stevens J, 2008, INT J OBESITY, V32, pS60, DOI 10.1038/ijo.2008.88; Tsugane S, 2002, INT J OBESITY, V26, P529, DOI 10.1038/sj.ijo.0801961; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Wada K, 2005, INT J OBESITY, V29, P1093, DOI 10.1038/sj.ijo.0803012; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; WHO, 2004, LANCET, V363, P902; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1; Yuan JM, 1998, INT J EPIDEMIOL, V27, P824, DOI 10.1093/ije/27.5.824; Zhang X, 2008, INT J OBESITY, V32, P1130, DOI 10.1038/ijo.2008.63	34	21	22	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e14000	10.1371/journal.pone.0014000	http://dx.doi.org/10.1371/journal.pone.0014000			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21085577	Green Submitted, Green Published, gold			2022-12-25	WOS:000284231800027
J	Chapman, J; Miles, PD; Ofrecio, JM; Neels, JG; Yu, JG; Resnik, JL; Wilkes, J; Talukdar, S; Thapar, D; Johnson, K; Sears, DD				Chapman, Justin; Miles, Philip D.; Ofrecio, Jachelle M.; Neels, Jaap G.; Yu, Joseph G.; Resnik, Jamie L.; Wilkes, Jason; Talukdar, Saswata; Thapar, Divya; Johnson, Kristen; Sears, Dorothy D.			Osteopontin Is Required for the Early Onset of High Fat Diet-Induced Insulin Resistance in Mice	PLOS ONE			English	Article							ADIPOSE-TISSUE; PPAR-GAMMA; ADIPOGENIC DIFFERENTIATION; SIGNALING PATHWAYS; ADIPOCYTE DEATH; GENE-EXPRESSION; DEFICIENT MICE; UP-REGULATION; BONE-MARROW; STEM-CELLS	Background: Insulin resistance is manifested in muscle, adipose tissue, and liver and is associated with adipose tissue inflammation. The cellular components and mechanisms that regulate the onset of diet-induced insulin resistance are not clearly defined. Methodology and Principal Findings: We initially observed osteopontin (OPN) mRNA over-expression in adipose tissue of obese, insulin resistant humans and rats which was normalized by thiazolidinedione (TZD) treatment in both species. OPN regulates inflammation and is implicated in pathogenic maladies resulting from chronic obesity. Thus, we tested the hypothesis that OPN is involved in the early development of insulin resistance using a 2-4 week high fat diet (HFD) model. OPN KO mice fed HFD for 2 weeks were completely protected from the severe skeletal muscle, liver and adipose tissue insulin resistance that developed in wild type (WT) controls, as determined by hyperinsulinemic euglycemic clamp and acute insulin-stimulation studies. Although two-week HFD did not alter body weight or plasma free fatty acids and cytokines in either strain, HFD-induced hyperleptinemia, increased adipose tissue inflammation (macrophages and cytokines), and adipocyte hypertrophy were significant in WT mice and blunted or absent in OPN KO mice. Adipose tissue OPN protein isoform expression was significantly altered in 2- and 4-week HFD-fed WT mice but total OPN protein was unchanged. OPN KO bone marrow stromal cells were more osteogenic and less adipogenic than WT cells in vitro. Interestingly, the two differentiation pathways were inversely affected by HFD in WT cells in vitro. Conclusions: The OPN KO phenotypes we report reflect protection from insulin resistance that is associated with changes in adipocyte biology and adipose tissue inflammatory status. OPN is a key component in the development of HFD-induced insulin resistance.	[Chapman, Justin] Pfizer Inc, San Diego, CA USA; [Miles, Philip D.; Ofrecio, Jachelle M.; Yu, Joseph G.; Wilkes, Jason; Talukdar, Saswata; Thapar, Divya; Johnson, Kristen; Sears, Dorothy D.] Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA; [Neels, Jaap G.] Univ Nice Sophia Antipolis, Inserm U907, Nice, France; [Resnik, Jamie L.] Univ Calif San Diego, Dept Reprod Med, La Jolla, CA 92093 USA	Pfizer; University of California System; University of California San Diego; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; University of California System; University of California San Diego	Chapman, J (corresponding author), Pfizer Inc, San Diego, CA USA.	dsears@ucsd.edu	Neels, Jaap G/F-5534-2010; Sears, Dorothy D/AHE-5524-2022	Neels, Jaap G/0000-0002-5900-8395; Sears, Dorothy D/0000-0002-9260-3540; Talukdar, Saswata/0000-0003-3042-0025; Johnson, Kristen/0000-0003-0788-7217	National Institutes of Health (NIH) [K01-DK62025, P30 DK063491]; American Heart Association [0635408N]; University of California [bio03-10383]; Pfizer Inc; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK062025, P30DK063491] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); University of California(University of California System); Pfizer Inc(Pfizer); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Support for this research was provided by National Institutes of Health (NIH) grants K01-DK62025 (DDS) and P30 DK063491 (DDS), an American Heart Association Scientist Development Grant, 0635408N (JGN), and the University of California Discovery Program Project #bio03-10383 with matching grant funds provided by Pfizer Inc (JMO, DDS). JC, a Pfizer employee, participated as a collaborator on the project as described. No other person or entity of Pfizer Inc. had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERESFORD JN, 1992, J CELL SCI, V102, P341; Berger JP, 2005, TRENDS PHARMACOL SCI, V26, P244, DOI 10.1016/j.tips.2005.03.003; Bertola A, 2009, DIABETES, V58, P125, DOI 10.2337/db08-0400; Bruemmer D, 2003, J CLIN INVEST, V112, P1318, DOI 10.1172/JCI200318141; Chae S, 2009, INT J ONCOL, V35, P1409, DOI 10.3892/ijo_00000458; Christensen B, 2005, BIOCHEM J, V390, P285, DOI 10.1042/BJ20050341; Chun TH, 2006, CELL, V125, P577, DOI 10.1016/j.cell.2006.02.050; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; Denhardt DT, 2001, ANNU REV PHARMACOL, V41, P723, DOI 10.1146/annurev.pharmtox.41.1.723; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; FREDERICH RC, 1995, J CLIN INVEST, V96, P1658, DOI 10.1172/JCI118206; Fruhbeck G, 2006, BIOCHEM J, V393, P7, DOI 10.1042/BJ20051578; Gimble JM, 2006, J CELL BIOCHEM, V98, P251, DOI 10.1002/jcb.20777; Gregoire FM, 2001, EXP BIOL MED, V226, P997, DOI 10.1177/153537020122601106; Harmey D, 2006, J BONE MINER RES, V21, P1377, DOI 10.1359/JBMR.060619; Hennige AM, 2006, FASEB J, V20, P1206, DOI 10.1096/fj.05-4635fje; Hevener AL, 2001, DIABETES, V50, P2316, DOI 10.2337/diabetes.50.10.2316; Hong EG, 2009, DIABETES, V58, P2525, DOI 10.2337/db08-1261; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HSIAO G, 2010, MULTITISSUE SE UNPUB; Ishijima M, 2006, EXP CELL RES, V312, P3075, DOI 10.1016/j.yexcr.2006.06.003; Keen HL, 2004, FASEB J, V18, pA1219; Kiefer F. W, 2010, DIABETES; Kiefer FW, 2008, ENDOCRINOLOGY, V149, P1350, DOI 10.1210/en.2007-1312; Kim JK, 2004, J CLIN INVEST, V113, P756, DOI 10.1172/JCI200418917; KRAEGEN EW, 1991, DIABETES, V40, P1397, DOI 10.2337/diabetes.40.11.1397; Kveiborg M, 2004, MOL CELL BIOL, V24, P2820, DOI 10.1128/MCB.24.7.2820-2830.2004; Lee RH, 2004, CELL PHYSIOL BIOCHEM, V14, P311, DOI 10.1159/000080341; Lofgren P, 2005, J CLIN ENDOCR METAB, V90, P6207, DOI 10.1210/jc.2005-0596; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Matsuzawa Y, 2006, FEBS LETT, V580, P2917, DOI 10.1016/j.febslet.2006.04.028; Nakajima I, 1998, DIFFERENTIATION, V63, P193, DOI 10.1111/j.1432-0436.1998.00193.x; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Nomiyama T, 2007, J CLIN INVEST, V117, P2877, DOI 10.1172/JCI31986; Ogawa D, 2005, CIRC RES, V96, P59, DOI 10.1161/01.RES.0000163630.86796.17; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Olefsky JM, 2000, J CLIN INVEST, V106, P467, DOI 10.1172/JCI10843; Oyama Y, 2000, J Atheroscler Thromb, V7, P77; Oyama Y, 2002, CIRC RES, V90, P348, DOI 10.1161/hh0302.105098; Parhami F, 1999, J BONE MINER RES, V14, P2067, DOI 10.1359/jbmr.1999.14.12.2067; Park SY, 2005, DIABETES, V54, P3530, DOI 10.2337/diabetes.54.12.3530; Patani N, 2008, ANTICANCER RES, V28, P4105; Pausova Z, 2006, CURR OPIN NEPHROL HY, V15, P173, DOI 10.1097/01.mnh.0000214775.42103.a5; REVERS RR, 1984, J CLIN INVEST, V73, P664, DOI 10.1172/JCI111258; Rieusset J, 2002, MOL ENDOCRINOL, V16, P2628, DOI 10.1210/me.2002-0036; Rosen CJ, 2006, NAT CLIN PRACT RHEUM, V2, P35, DOI 10.1038/ncprheum0070; Ross SE, 2002, MOL CELL BIOL, V22, P5989, DOI 10.1128/MCB.22.16.5989-5999.2002; Sahai A, 2004, AM J PHYSIOL-GASTR L, V287, pG264, DOI 10.1152/ajpgi.00002.2004; Sanchez-Margalet V, 2003, CLIN EXP IMMUNOL, V133, P11, DOI 10.1046/j.1365-2249.2003.02190.x; Sciaudone M, 2003, ENDOCRINOLOGY, V144, P5631, DOI 10.1210/en.2003-0463; Sears DD, 2009, P NATL ACAD SCI USA, V106, P18745, DOI 10.1073/pnas.0903032106; Sears DD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007250; Sekiya I, 2004, J BONE MINER RES, V19, P256, DOI 10.1359/JBMR.0301220; SHAUL ME, 2010, DIABETES IN PRESS; Shinohara ML, 2008, P NATL ACAD SCI USA, V105, P7235, DOI 10.1073/pnas.0802301105; STEELE R, 1959, ANN NY ACAD SCI, V82, P420, DOI 10.1111/j.1749-6632.1959.tb44923.x; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Wai PY, 2004, J SURG RES, V121, P228, DOI 10.1016/j.jss.2004.03.028; Weber GF, 2002, J LEUKOCYTE BIOL, V72, P752; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yamauchi T, 2001, J BIOL CHEM, V276, P41245, DOI 10.1074/jbc.M103241200; Yoshitake H, 1999, P NATL ACAD SCI USA, V96, P8156, DOI 10.1073/pnas.96.14.8156	63	59	63	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e13959	10.1371/journal.pone.0013959	http://dx.doi.org/10.1371/journal.pone.0013959			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103061	Green Published, Green Submitted, gold			2022-12-25	WOS:000284147700010
J	Youngleson, MS; Nkurunziza, P; Jennings, K; Arendse, J; Mate, KS; Barker, P				Youngleson, Michele S.; Nkurunziza, Paul; Jennings, Karen; Arendse, Juanita; Mate, Kedar S.; Barker, Pierre			Improving a Mother to Child HIV Transmission Programme through Health System Redesign: Quality Improvement, Protocol Adjustment and Resource Addition	PLOS ONE			English	Article							STATISTICAL PROCESS-CONTROL; WIDE PROGRAM; PREVENTION; LESSONS	Background: Health systems that deliver prevention of mother to child transmission (PMTCT) services in low and middle income countries continue to underperform, resulting in thousands of unnecessary HIV infections of newborns each year. We used a combination of approaches to health systems strengthening to reduce transmission of HIV from mother to infant in a multi-facility public health system in South Africa. Methodology/Principal Findings: All primary care sites and specialized birthing centers in a resource constrained subdistrict of Cape Metro District, South Africa, were enrolled in a quality improvement (QI) programme. All pregnant women receiving antenatal, intrapartum and postnatal infant care in the sub-district between January 2006 and March 2009 were included in the intervention that had a prototype-innovation phase and a rapid spread phase. System changes were introduced to help frontline healthcare workers to identify and improve performance gaps at each step of the PMTCT pathway. Improvement was facilitated and spread through the use of a Breakthrough Series Collaborative that accelerated learning and the spread of successful changes. Protocol changes and additional resources were introduced by provincial and municipal government. The proportion of HIV-exposed infants testing positive declined from 7.6% to 5%. Key intermediate PMTCT processes improved (antenatal AZT increased from 74% to 86%, PMTCT clients on HAART at the time of labour increased from 10% to 25%, intrapartum AZT increased from 43% to 84%, and postnatal HIV testing from 79% to 95%) compared to baseline. Conclusions/Significance: System improvement methods, protocol changes and addition/reallocation of resources contributed to improved PMTCT processes and outcomes in a resource constrained setting. The intervention requires a clear design, leadership buy-in, building local capacity to use systems improvement methods, and a reliable data system. A systems improvement approach offers a much needed approach to rapidly improve under-performing PMTCT implementation programmes at scale in sub-Saharan Africa.	[Youngleson, Michele S.; Mate, Kedar S.; Barker, Pierre] Inst Healthcare Improvement, Cambridge, MA USA; [Nkurunziza, Paul; Jennings, Karen] City Hlth Dept, Cape Town, South Africa; [Mate, Kedar S.] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Barker, Pierre] Univ N Carolina, Dept Pediat, Chapel Hill, NC USA	Institute for Healthcare Improvement; Cornell University; University of North Carolina; University of North Carolina Chapel Hill	Youngleson, MS (corresponding author), Inst Healthcare Improvement, Cambridge, MA USA.	pbarker@med.unc.edu		Mate, Kedar/0000-0001-7579-6697	Institute for Health Care Improvement	Institute for Health Care Improvement	No external funding was obtained for the execution of this project. Part of the salaries of SMY, KM and PB were supported by the Institute for Health Care Improvement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], REPORT UNICEF SCALIN; [Anonymous], 2003, BREAKTHR SER IHIS CO; Balas E A, 2000, Yearb Med Inform, P65; Benneyan JC, 2003, QUAL SAF HEALTH CARE, V12, P458, DOI 10.1136/qhc.12.6.458; Berwick DM, 2006, JAMA-J AM MED ASSOC, V295, P324, DOI 10.1001/jama.295.3.324; Berwick DM, 2004, BRIT MED J, V328, P1124, DOI 10.1136/bmj.328.7448.1124; Berwick DM, 2008, JAMA-J AM MED ASSOC, V299, P1182, DOI 10.1001/jama.299.10.1182; Catsambas TT, 2008, EVALUATING HLTH CARE; *CDC, 2007, CAS HIV INF AIDS US, V17; *CDC, 2007, CAS HIV INF AIDS US, V19; Chopra M, 2009, LANCET, V374, P835, DOI 10.1016/S0140-6736(09)61123-5; Coetzee D, 2005, B WORLD HEALTH ORGAN, V83, P489; Day C, 2010, DISTRICT HLTH BAROME; DRAPER B, 2005, 3 IAS C HIV PATH TRE; *ENG HLTH, 2003, EM OBST CAR LEAD MAN; Finison L J, 1996, J Healthc Qual, V18, P32; Fisher ES, 2009, NEW ENGL J MED, V360, P849, DOI 10.1056/NEJMp0809794; HORWOOD C, 2009, KZN IMPACTS RESULTS; *I HEALTHC IMPR 20, 2009, IHI FAC IMPR GUID; Kayongo M, 2006, INT J GYNECOL OBSTET, V92, P308, DOI 10.1016/j.ijgo.2005.12.003; Lallemant M, 2004, NEW ENGL J MED, V351, P217, DOI 10.1056/NEJMoa033500; Langley GL., 2009, IMPROVEMENT GUIDE PR, V2nd; McKenna MT, 2007, AM J OBSTET GYNECOL, V197, pS10, DOI 10.1016/j.ajog.2007.02.032; Mills Peter D, 2004, Jt Comm J Qual Saf, V30, P152; Paintsil E, 2009, CURR OPIN PEDIATR, V21, P94, DOI 10.1097/MOP.0b013e32831ec353; Rollins N, 2007, AIDS, V21, P1341, DOI 10.1097/QAD.0b013e32814db7d4; *S AFR DEP HLTH, 2008, 2008 NAT ANT SENT HI; *S AFR DEP OF HLTH, 2007, NAT STRAT PLAN HIV A; Schouten LMT, 2008, BMJ-BRIT MED J, V336, P1491, DOI 10.1136/bmj.39570.749884.BE; Stringer EM, 2008, B WORLD HEALTH ORGAN, V86, P57, DOI 10.2471/BLT.07.043117; Stringer JSA, 2005, AIDS, V19, P1309, DOI 10.1097/01.aids.0000180102.88511.7d; Teasdale CA, 2008, S AFR J HIV MED, P60; Thor J, 2007, QUAL SAF HEALTH CARE, V16, P387, DOI 10.1136/qshc.2006.022194; UNAIDS, 2009, AIDS EP UPD NOV 2009; *W CAP DEP HLTH HA, 2006, STAT REP PREV MOTH C; WHO, 2012, WHO GUID HIV INF FEE; Wilson Tim, 2003, Jt Comm J Qual Saf, V29, P85; WOODALL WH, 2006, J QUALITY TECHNOLOGY	38	75	77	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e13891	10.1371/journal.pone.0013891	http://dx.doi.org/10.1371/journal.pone.0013891			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085479	gold, Green Published, Green Submitted			2022-12-25	WOS:000284035900008
J	Sheridan, P; Kamimura, T; Shimodaira, H				Sheridan, Paul; Kamimura, Takeshi; Shimodaira, Hidetoshi			A Scale-Free Structure Prior for Graphical Models with Applications in Functional Genomics	PLOS ONE			English	Article							BAYESIAN PHYLOGENETIC INFERENCE; REGULATORY NETWORKS; ESTROGEN-RECEPTOR; BREAST-CANCER; GENE; EXPRESSION; LIKELIHOOD; TARGET; GROWTH	The problem of reconstructing large-scale, gene regulatory networks from gene expression data has garnered considerable attention in bioinformatics over the past decade with the graphical modeling paradigm having emerged as a popular framework for inference. Analysis in a full Bayesian setting is contingent upon the assignment of a so-called structure prior-a probability distribution on networks, encoding a priori biological knowledge either in the form of supplemental data or high-level topological features. A key topological consideration is that a wide range of cellular networks are approximately scale-free, meaning that the fraction, P(k), of nodes in a network with degree k is roughly described by a power-law P(k) proportional to k(-gamma) with exponent gamma between 2 and 3. The standard practice, however, is to utilize a random structure prior, which favors networks with binomially distributed degree distributions. In this paper, we introduce a scale-free structure prior for graphical models based on the formula for the probability of a network under a simple scale-free network model. Unlike the random structure prior, its scale-free counterpart requires a node labeling as a parameter. In order to use this prior for large-scale network inference, we design a novel Metropolis-Hastings sampler for graphical models that includes a node labeling as a state space variable. In a simulation study, we demonstrate that the scale-free structure prior outperforms the random structure prior at recovering scale-free networks while at the same time retains the ability to recover random networks. We then estimate a gene association network from gene expression data taken from a breast cancer tumor study, showing that scale-free structure prior recovers hubs, including the previously unknown hub SLC39A6, which is a zinc transporter that has been implicated with the spread of breast cancer to the lymph nodes. Our analysis of the breast cancer expression data underscores the value of the scale-free structure prior as an instrument to aid in the identification of candidate hub genes with the potential to direct the hypotheses of molecular biologists, and thus drive future experiments.	[Sheridan, Paul; Kamimura, Takeshi; Shimodaira, Hidetoshi] Tokyo Inst Technol, Dept Math & Comp Sci, Tokyo 152, Japan	Tokyo Institute of Technology	Sheridan, P (corresponding author), Tokyo Inst Technol, Dept Math & Comp Sci, Tokyo 152, Japan.	sherida6@is.titech.ac.jp	Shimodaira, Hidetoshi/B-9127-2008	Shimodaira, Hidetoshi/0000-0002-3371-7724	Japan Society for the Promotion of Science (JSPS) Global Centers for Excellence (COE)	Japan Society for the Promotion of Science (JSPS) Global Centers for Excellence (COE)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Funding: This research was supported in part by Computationism as a Foundation for the Sciences, a program of the Japan Society for the Promotion of Science (JSPS) Global Centers for Excellence (COE) (http://compview.titech.ac.jp/front-page-en/view?set_language=en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic L.A., 2002, GLOTTOMETRICS, V3, P143; Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; ALBERT R, 2002, REV MODERN PHYS, V74; Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BARNARD A, 2005, PSB 05, P459; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Beck S, 1999, DNA CELL BIOL, V18, P157, DOI 10.1089/104454999315547; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Burda Z, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.046118; Butte AJ, 2000, P NATL ACAD SCI USA, V97, P12182, DOI 10.1073/pnas.220392197; Carroll JS, 2006, MOL ENDOCRINOL, V20, P1707, DOI 10.1210/me.2005-0334; Carvalho LE, 2008, P NATL ACAD SCI USA, V105, P3209, DOI 10.1073/pnas.0712329105; CASTELO R, 2006, J MACHINE LEARNING R, V7; DEMPSTER AP, 1972, BIOMETRICS, V28, P157, DOI 10.2307/2528966; Dobra A, 2004, J MULTIVARIATE ANAL, V90, P196, DOI 10.1016/j.jmva.2004.02.009; Dorogovtsev SN, 2002, ADV PHYS, V51, P1079, DOI 10.1080/00018730110112519; Edwards D., 2000, INTRO GRAPHICAL MODE; ERDOS P, 1960, B INT STATIST INST, V38, P343; Erdos P, 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Farkas I, 2003, PHYSICA A, V318, P601, DOI 10.1016/S0378-4371(02)01731-4; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; FRYDENBERG M, 1989, BIOMETRIKA, V76, P539, DOI 10.1093/biomet/76.3.539; Giangrande PH, 2003, MOL CELL BIOL, V23, P3707, DOI 10.1128/MCB.23.11.3707-3720.2003; Giudici P, 1999, BIOMETRIKA, V86, P785, DOI 10.1093/biomet/86.4.785; Goh KI, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.278701; Grzegorczyk M, 2008, ANALYSIS OF MICROARRAY DATA: A NETWORK-BASED APPROACH, P101, DOI 10.1002/9783527622818.ch5; Hartemink AJ, 2005, NAT BIOTECHNOL, V23, P554, DOI 10.1038/nbt0505-554; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Husmeier D, 2003, BIOINFORMATICS, V19, P2271, DOI 10.1093/bioinformatics/btg313; Imoto S, 2003, PROCEEDINGS OF THE 2003 IEEE BIOINFORMATICS CONFERENCE, P104, DOI 10.1109/CSB.2003.1227309; Jones B, 2005, STAT SCI, V20, P388, DOI 10.1214/088342305000000304; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; Lauritzen S.L, 1996, GRAPHICAL MODELS; Lee DS, 2005, PRAMANA-J PHYS, V64, P1149, DOI 10.1007/BF02704176; Magwene PM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r100; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Markowetz F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S5; Matsuoka S, 2008, CH CRC COMP SCI SER, P289; Meinshausen N, 2006, ANN STAT, V34, P1436, DOI 10.1214/009053606000000281; Nakshatri H, 2007, EXPERT OPIN THER TAR, V11, P507, DOI 10.1517/14728222.11.4.507; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Ohno S., 1970, P1; Pastor-Satorras R, 2003, J THEOR BIOL, V222, P199, DOI 10.1016/S0022-5193(03)00028-6; Pe'er Dana, 2002, Bioinformatics, V18 Suppl 1, pS258; Rannala B, 1996, J MOL EVOL, V43, P304, DOI 10.1007/BF02338839; Ratmann O, 2007, PLOS COMPUT BIOL, V3, P2266, DOI 10.1371/journal.pcbi.0030230; SAHLIN L, 1994, J STEROID BIOCHEM, V51, P57, DOI 10.1016/0960-0760(94)90115-5; Schafer J, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1175; Schafer J, 2005, BIOINFORMATICS, V21, P754, DOI 10.1093/bioinformatics/bti062; Schlitt T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S9; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Sheridan P, 2008, ANN I STAT MATH, V60, P747, DOI 10.1007/s10463-008-0181-5; Smith E D, 2002, ADV COMPLEX SYST, V5, P43, DOI DOI 10.1142/S021952590200047X; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tamada Y, 2003, BIOINFORMATICS, V19, pII227, DOI 10.1093/bioinformatics/btg1082; Taylor KM, 2008, BIOCHEM SOC T, V36, P1247, DOI 10.1042/BST0361247; Werhli AV, 2007, STAT APPL GENET MOL, V6; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998; West M, 2003, BAYESIAN STATISTICS 7, P733; Whittaker J., 1990, GRAPHICAL MODELS APP; Wille A, 2006, STAT APPL GENET MOL, V5; Wiuf C, 2006, P NATL ACAD SCI USA, V103, P7566, DOI 10.1073/pnas.0600061103; Wong F, 2003, BIOMETRIKA, V90, P809, DOI 10.1093/biomet/90.4.809; Yang ZH, 1997, MOL BIOL EVOL, V14, P717, DOI 10.1093/oxfordjournals.molbev.a025811; Yu J, 2004, BIOINFORMATICS, V20, P3594, DOI 10.1093/bioinformatics/bth448	66	22	22	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2010	5	11							e13580	10.1371/journal.pone.0013580	http://dx.doi.org/10.1371/journal.pone.0013580			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675OD	21079769	Green Published, Green Submitted, gold			2022-12-25	WOS:000283839100001
J	Heider, B; Nathanson, JL; Isacoff, EY; Callaway, EM; Siegel, RM				Heider, Barbara; Nathanson, Jason L.; Isacoff, Ehud Y.; Callaway, Edward M.; Siegel, Ralph M.			Two-Photon Imaging of Calcium in Virally Transfected Striate Cortical Neurons of Behaving Monkey	PLOS ONE			English	Article							ADENOASSOCIATED VIRUS VECTORS; VISUAL ASSOCIATION CORTEX; CENTRAL-NERVOUS-SYSTEM; IN-VIVO; NEURAL ACTIVITY; FUNCTIONAL ARCHITECTURE; RECEPTIVE-FIELDS; DIRECTION SELECTIVITY; CELLULAR RESOLUTION; GENE DELIVERY	Two-photon scanning microscopy has advanced our understanding of neural signaling in non-mammalian species and mammals. Various developments are needed to perform two-photon scanning microscopy over prolonged periods in non-human primates performing a behavioral task. In striate cortex in two macaque monkeys, cortical neurons were transfected with a genetically encoded fluorescent calcium sensor, memTNXL, using AAV1 as a viral vector. By constructing an extremely rigid and stable apparatus holding both the two-photon scanning microscope and the monkey's head, single neurons were imaged at high magnification for prolonged periods with minimal motion artifacts for up to ten months. Structural images of single neurons were obtained at high magnification. Changes in calcium during visual stimulation were measured as the monkeys performed a fixation task. Overall, functional responses and orientation tuning curves were obtained in 18.8% of the 234 labeled and imaged neurons. This demonstrated that the two-photon scanning microscopy can be successfully obtained in behaving primates.	[Heider, Barbara; Siegel, Ralph M.] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA; [Nathanson, Jason L.; Callaway, Edward M.] Salk Inst Biol Studies, Syst Neurobiol Labs, La Jolla, CA 92037 USA; [Isacoff, Ehud Y.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Salk Institute; University of California System; University of California Berkeley	Heider, B (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA.	axon@cortex.rutgers.edu	isacoff, ehud/AAP-1459-2020; Callaway, Edward/D-4336-2011	Callaway, Edward/0000-0002-6366-5267; Isacoff, Ehud Y./0000-0003-4775-9359	NIH Whitehall Foundation; NIH [EY010742, NS050833]; NATIONAL EYE INSTITUTE [R01EY010742, PN2EY018241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050833] Funding Source: NIH RePORTER	NIH Whitehall Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH Whitehall Foundation (RMS); NIH EY010742 (EMC); NIH NS050833 (EYI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright TD, 2002, ANNU REV NEUROSCI, V25, P339, DOI 10.1146/annurev.neuro.25.112701.142900; Arieli A, 2002, J NEUROSCI METH, V114, P119, DOI 10.1016/S0165-0270(01)00507-6; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; Blab GA, 2001, CHEM PHYS LETT, V350, P71, DOI 10.1016/S0009-2614(01)01282-9; Broekman MLD, 2006, NEUROSCIENCE, V138, P501, DOI 10.1016/j.neuroscience.2005.11.057; Burger C, 2004, MOL THER, V10, P302, DOI 10.1016/j.ymthe.2004.05.024; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Cearley CN, 2008, MOL THER, V16, P1710, DOI 10.1038/mt.2008.166; Chanda B, 2005, NAT NEUROSCI, V8, P1619, DOI 10.1038/nn1558; Chen Y, 2008, NAT NEUROSCI, V11, P974, DOI 10.1038/nn.2147; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; CRICK FHC, 1979, SCI AM, V241, P219, DOI 10.1038/scientificamerican0979-219; Davidson BL, 2003, NAT REV NEUROSCI, V4, P353, DOI 10.1038/nrn1104; Deisseroth K, 2006, J NEUROSCI, V26, P10380, DOI 10.1523/JNEUROSCI.3863-06.2006; DENK W, 1994, J NEUROSCI METH, V54, P151, DOI 10.1016/0165-0270(94)90189-9; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; EVARTS EV, 1964, J NEUROPHYSIOL, V27, P152, DOI 10.1152/jn.1964.27.2.152; Gallant JL, 1998, NEUROREPORT, V9, P2153, DOI 10.1097/00001756-199806220-00045; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; GRINVALD A, 1991, P NATL ACAD SCI USA, V88, P11559, DOI 10.1073/pnas.88.24.11559; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; Guerrero G, 2005, NAT NEUROSCI, V8, P1188, DOI 10.1038/nn1526; Gur M, 2005, CEREB CORTEX, V15, P1207, DOI 10.1093/cercor/bhi003; Hasan MT, 2004, PLOS BIOL, V2, P763, DOI 10.1371/journal.pbio.0020163; Heider B, 2005, CEREB CORTEX, V15, P460, DOI 10.1093/cercor/bhh148; Heider B, 2000, EUR J NEUROSCI, V12, P4117, DOI 10.1046/j.1460-9568.2000.00293.x; Heim N, 2007, NAT METHODS, V4, P127, DOI 10.1038/nmeth1009; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Helmchen F, 2001, NEURON, V31, P903, DOI 10.1016/S0896-6273(01)00421-4; Hendel T, 2008, J NEUROSCI, V28, P7399, DOI 10.1523/JNEUROSCI.1038-08.2008; Hires SA, 2008, BRAIN CELL BIOL, V36, P69, DOI 10.1007/s11068-008-9029-4; Hollis ER, 2008, MOL THER, V16, P296, DOI 10.1038/sj.mt.6300367; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; Johnson I, 1998, HISTOCHEM J, V30, P123, DOI 10.1023/A:1003287101868; Jung JC, 2004, J NEUROPHYSIOL, V92, P3121, DOI 10.1152/jn.00234.2004; Kagan I, 2002, J NEUROPHYSIOL, V88, P2557, DOI 10.1152/jn.00858.2001; KURTZ R, 2007, MODERN RES ED TOPICS; LEVENTHAL AG, 1995, J NEUROSCI, V15, P1808, DOI 10.1523/JNEUROSCI.15-03-01808.1995; Likhtik E, 2006, J NEUROPHYSIOL, V96, P3257, DOI 10.1152/jn.00577.2006; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Mainen ZF, 1999, METHODS, V18, P231, DOI 10.1006/meth.1999.0776; Majewska AK, 2006, J NEUROSCI, V26, P3021, DOI 10.1523/JNEUROSCI.4454-05.2006; Mank M, 2006, BIOPHYS J, V90, P1790, DOI 10.1529/biophysj.105.073536; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; Mank M, 2008, CHEM REV, V108, P1550, DOI 10.1021/cr078213v; Mao T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001796; McCown TJ, 1996, BRAIN RES, V713, P99, DOI 10.1016/0006-8993(95)01488-8; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; MOUNTCAS.VB, 1967, SCIENCE, V155, P597, DOI 10.1126/science.155.3762.597; MOUNTCASTLE VB, 1987, J NEUROSCI, V7, P2239; Nathanson JL, 2009, NEUROSCIENCE, V161, P441, DOI 10.1016/j.neuroscience.2009.03.032; Nowak LG, 2008, CEREB CORTEX, V18, P1058, DOI 10.1093/cercor/bhm137; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Ohki K, 2006, NATURE, V442, P925, DOI 10.1038/nature05019; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Quraishi S, 2007, CEREB CORTEX, V17, P1841, DOI 10.1093/cercor/bhl093; Raffi M, 2005, J NEUROSCI, V25, P5171, DOI 10.1523/JNEUROSCI.5201-04.2005; Raffi M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000200; Reiff DF, 2005, J NEUROSCI, V25, P4766, DOI 10.1523/JNEUROSCI.4900-04.2005; Ringach DL, 2002, J NEUROSCI, V22, P5639; Royo NC, 2008, BRAIN RES, V1190, P15, DOI 10.1016/j.brainres.2007.11.015; SAS Institute Inc, 1989, SAS STAT US GUID VER; SCHILLER PH, 1976, J NEUROPHYSIOL, V39, P1288, DOI 10.1152/jn.1976.39.6.1288; Sekar RB, 2003, J CELL BIOL, V160, P629, DOI 10.1083/jcb.200210140; Shtoyerman E, 2000, J NEUROSCI, V20, P8111; Siegel RM, 2003, J NEUROPHYSIOL, V90, P1279, DOI 10.1152/jn.01179.2002; Souslova EA, 2007, BIOCHEMISTRY-MOSCOW+, V72, P683, DOI 10.1134/S0006297907070012; Takao K, 2005, J NEUROSCI, V25, P3107, DOI 10.1523/JNEUROSCI.0085-05.2005; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Tan EM, 2006, NEURON, V51, P157, DOI 10.1016/j.neuron.2006.06.018; TIAN L, 2009, NATURE METHODS; Truong K, 2001, NAT STRUCT BIOL, V8, P1069, DOI 10.1038/nsb728; Tsai PS, 2002, METH NE FRO NEUROSCI, P113; VONDERHEYDT R, 1992, J NEUROSCI, V12, P1416; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Xiao X, 1997, EXP NEUROL, V144, P113, DOI 10.1006/exnr.1996.6396	79	41	41	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e13829	10.1371/journal.pone.0013829	http://dx.doi.org/10.1371/journal.pone.0013829			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079806	Green Published, gold, Green Submitted			2022-12-25	WOS:000283838600007
J	Wang, HR; Wu, M; Zhu, WG; Shen, J; Shi, XM; Yang, J; Zhao, QH; Ni, CA; Xu, YC; Shen, HB; Shen, C; Gu, HF				Wang, Hairu; Wu, Ming; Zhu, Weiguang; Shen, Jin; Shi, Xiaoming; Yang, Jie; Zhao, Qihui; Ni, Chuan; Xu, Yaochu; Shen, Hongbing; Shen, Chong; Gu, Harvest F.			Evaluation of the Association between the AC3 Genetic Polymorphisms and Obesity in a Chinese Han Population	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; PROMOTER REGION; LINKAGE PHASE; ADIPONECTIN; GLUCOSE; RISK; HAPLOTYPES; TESTS	Background: AC3 is one of adenylyl cyclase isoforms involved in cAMP and insulin signaling pathway. Recent reports have demonstrated that the AC3 genetic polymorphisms are associated with obesity in a Swedish population. AC3 knock out mice exhibit obese when they age. These findings suggest that AC3 plays an important role in the regulation of body weight. Methodology/Principal Findings: In the present study, we evaluated the association between the AC3 genetic polymorphisms and obesity in a Han Chinese population. A total of 2580 adults, including 1490 lean (BMI = 18.5-23.9), 677 overweight (BMI 24.0-27.9) and 413 obese (BMI >= 28.0) subjects were genotyped for 5 TagSNPs in the AC3 gene. Single maker association analyses indicated that SNP rs753529 was significantly associated with BMI in obese subjects (P = 0.022, OR = 0.775 95% CI = 0.623-0.963), but not in overweight subjects (P = 0.818). Multiple maker association analyses showed that the haplotype (G-G-G) constructed with SNPs rs1127568, rs7604576 and rs753529 was significantly associated with obesity (P = 0.029). Further genotyping of SNP rs753529 in 816 children, including 361 overweight subjects (BMI > P-80) and 455 controls (BMI = P20-50) were performed, and no significant association with BMI was found. All tests were adjusted for age, sex, physical activity index, household income and/or diet expenses. Conclusions: The present study provides replication evidence that the AC3 genetic polymorphisms are associated with decreased risk of obesity among adults but not in children in a Chinese Han population. The data also suggest that the AC3 genetic effects on BMI may have interaction with the factors related to ageing and environment.	[Wang, Hairu; Xu, Yaochu; Shen, Hongbing; Shen, Chong] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Peoples R China; [Wu, Ming; Yang, Jie] Ctr Dis Control Jiangsu Prov, Nanjing, Peoples R China; [Zhu, Weiguang; Shen, Jin; Zhao, Qihui; Ni, Chuan] Ctr Dis Control Suqian City, Suqian, Peoples R China; [Shi, Xiaoming] Chinese Ctr Dis Control & Prevent, Div Chron Dis Control & Community Hlth, Beijing, Peoples R China; [Gu, Harvest F.] Karolinska Univ Hosp Solna, Karolinska Inst, Rolf Luft Ctr Diabet Res, Dept Mol Med & Surg, Stockholm, Sweden	Nanjing Medical University; Chinese Center for Disease Control & Prevention; Karolinska Institutet; Karolinska University Hospital	Wang, HR (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Peoples R China.	sc@njmu.edu.cn; harvest.gu@ki.se	Shi, Xiaoming/V-2119-2018	Shi, Xiaoming/0000-0002-7071-571X	National Basic Research Program of China [30800947]; Nanjing Medical University [06NMU2010]; Program of Preventive Medicine of Jiangsu [Y200707]	National Basic Research Program of China(National Basic Research Program of China); Nanjing Medical University; Program of Preventive Medicine of Jiangsu	This work was supported by the National Basic Research Program of China (Grant No. 30800947), Development Fund of Nanjing Medical University (Grant No. 06NMU2010) and Program of Preventive Medicine of Jiangsu (Grant No. Y200707). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Batty GD, 2009, CANCER EPIDEMIOL, V33, P469, DOI 10.1016/j.canep.2009.09.010; Du SF, 2004, SOC SCI MED, V59, P1505, DOI 10.1016/j.socscimed.2004.01.021; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; FAN Y, 2010, BMC PUBLIC HEALTH, DOI DOI 10.1186/1471-2350-10-118; Gu HF, 2009, BIOMARK INSIGHTS, V4, P123; Gu HF, 2004, DIABETES, V53, pS31, DOI 10.2337/diabetes.53.2007.S31; GU HF, 2010, OPEN DIABETES J, V3, P11; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; Hara K, 2002, DIABETES, V51, P536, DOI 10.2337/diabetes.51.2.536; Jakicic JM, 2009, OBESITY, V17, pS34, DOI 10.1038/oby.2009.386; Ji CY, 2008, OBES REV, V9, P78, DOI 10.1111/j.1467-789X.2007.00443.x; Ji CY, 2010, BIOMED ENVIRON SCI, V23, P12, DOI 10.1016/S0895-3988(10)60026-8; Jia WP, 2010, BIOMED ENVIRON SCI, V23, P4, DOI 10.1016/S0895-3988(10)60025-6; Joseph S, 2001, MOL CLONING LAB MANU; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Lake SL, 2003, HUM HERED, V55, P56, DOI 10.1159/000071811; Lee YY, 2005, DIABETIC MED, V22, P569, DOI 10.1111/j.1464-5491.2005.01460.x; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Mitri J, 2009, EXPERT OPIN DRUG SAF, V8, P573, DOI 10.1517/14740330903081725; Miyake K, 2009, J HUM GENET, V54, P236, DOI 10.1038/jhg.2009.17; Nicolucci A, 2010, ACTA DIABETOL, V47, P87, DOI 10.1007/s00592-010-0187-3; Nordman S, 2008, INT J OBESITY, V32, P407, DOI 10.1038/sj.ijo.0803742; O'Rahilly S, 2009, NATURE, V462, P307, DOI 10.1038/nature08532; Qu Ning-ning, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P265; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Schwarz PEH, 2006, HORM METAB RES, V38, P447, DOI 10.1055/s-2006-947842; Vasseur F, 2002, HUM MOL GENET, V11, P2607, DOI 10.1093/hmg/11.21.2607; Wang Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004246; Zacharova J, 2005, DIABETES, V54, P893, DOI 10.2337/diabetes.54.3.893	32	23	24	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e13851	10.1371/journal.pone.0013851	http://dx.doi.org/10.1371/journal.pone.0013851			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079816	gold, Green Published, Green Submitted			2022-12-25	WOS:000283838600021
J	Xu, X; Wang, KB; Zhao, XJ; Sullivan, C; Chen, SQ				Xu, Xing; Wang, Kebai; Zhao, Xijin; Sullivan, Corwin; Chen, Shuqing			A New Leptoceratopsid (Ornithischia: Ceratopsia) from the Upper Cretaceous of Shandong, China and Its Implications for Neoceratopsian Evolution	PLOS ONE			English	Article							DINOSAUR; MONGOLIA; ALBERTA; EUROPE; GEN.	Background: The ceratopsians represent one of the last dinosaurian radiations. Traditionally the only universally accepted speciose clade within the group was the Ceratopsidae. However, recent discoveries and phylogenetic analyses have led to the recognition of a new speciose clade, the Leptoceratopsidae, which is predominantly known from the Upper Cretaceous of North America. Methodology/Principal Findings: Here we report a new leptoceratopsid taxon, Zhuchengceratops inexpectus gen. et sp. nov., based on a partial, articulated skeleton recovered from the Upper Cretaceous Wangshi Group of Zhucheng, Shandong Province, China. Although Zhuchengceratops is significantly different from other known leptoceratopsids, it is recovered as a derived member of the group by our phylogenetic analysis. Furthermore, Zhuchengceratops exhibits several features previously unknown in leptoceratopsids but seen in ceratopsids and their close relatives, suggesting that the distribution of morphological features within ceratopsians is more complex than previously realized. Conclusion/Significance: The discovery of Zhuchengceratops increases both the taxonomic diversity and the morphological disparity of the Leptoceratopsidae, providing further support for the hypothesis that this clade represents a successful radiation of horned dinosaurs in parallel with the Ceratopsidae in the Late Cretaceous. This documents a surprising case of the coexistence and radiation of two closely-related lineages with contrasting suites of jaw and dental features that reflect adaptation to different food resources.	[Xu, Xing; Zhao, Xijin; Sullivan, Corwin] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Evolutionary Systemat Vertebrates, Beijing, Peoples R China; [Wang, Kebai; Chen, Shuqing] Bur Tourism, Zhucheng Dinosaur Museum, Zhucheng, Shandong, Peoples R China	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Xu, X (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Evolutionary Systemat Vertebrates, Beijing, Peoples R China.	xingxu@vip.sina.com		Sullivan, Corwin/0000-0002-5488-6797	Chinese Academy of Sciences; Zhucheng City Government	Chinese Academy of Sciences(Chinese Academy of Sciences); Zhucheng City Government	Grants from the Chinese Academy of Sciences and Zhucheng City Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alifanov V, 2008, PALEONTOL J+, V42, P621, DOI 10.1134/S0031030108060087; Alifanov VR, 2003, PALEONTOL J+, V37, P524; Brown B, 1914, B AM MUS NAT HIST, V33, P567; BROWN BARNUM, 1940, ANN NEW YORK ACAD SCI, V40, P133; Brown Barnum, 1942, AMER MUS NOVITATES, V1169, P1; Chinnery B, 2004, J VERTEBR PALEONTOL, V24, P572, DOI 10.1671/0272-4634(2004)024[0572:DOPPGE]2.0.CO;2; Chinnery BJ, 1998, J VERTEBR PALEONTOL, V18, P569, DOI 10.1080/02724634.1998.10011085; Chinnery BJ, 2007, J VERTEBR PALEONTOL, V27, P625, DOI 10.1671/0272-4634(2007)27[625:ANNDLN]2.0.CO;2; DODSON P, 1996, HORNED DINOAURS; Dodson P, 2004, DINOSAURIA, 2ND EDITION, P494; Fang, 2001, SHANTUNGOSAURUS GIGA; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; HATCHER JB, 1907, MONOGR US GEOL SURV, V49, P1; Hu C.Z., 1973, ACTA GEOL SINICA, V2, P179; KURZANOV S, 1990, PALEONTOL J, V4, P85; KURZANOV SM, 1992, PALEONTOL ZH, P81; Lindgren J, 2007, PALAEONTOLOGY, V50, P929, DOI 10.1111/j.1475-4983.2007.00690.x; Makovicky Peter J., 2010, P68; Makovicky PJ, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3530[1:YDANPC]2.0.CO;2; Makovicky Peter J., 2001, P243; MAKOVICKY PJ, 2002, TAXONOMIC REVISION P; Marsh O.C., 1890, AM J SCI, V39, P418, DOI DOI 10.2475/AJS.S3-39.233.418; MARYANSKA T, 1975, Palaeontologia Polonica, V33, P133; NESSOV LA, 1989, THEORETICAL APPL ASP, P144; Nopcsa, 1923, FORTSCHRITTE GEOLOGI, V2, P1; Osi A, 2010, NATURE, V465, P466, DOI 10.1038/nature09019; RICH R, 2003, RECORDS QUEEN VICTOR, V113, P1; RUSSELL DA, 1993, CAN J EARTH SCI, V30, P2002, DOI 10.1139/e93-176; SEELEY HG, 1888, 1887 BRIT ASS ADV SC, P698; SERENO PC, 1986, NATL GEOGR RES, V2, P234; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; SERENO PC, 2002, AGE DINOSAURS RUSSIA, P480; Sternberg CM, 1951, NATIONAL MUSEUM CANA, V123, P225; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P639, DOI 10.1080/02724634.1999.10011178; Wu XC, 2007, CAN J EARTH SCI, V44, P1243, DOI 10.1139/e07-011; Xu X, 2010, CHINESE SCI BULL, V55, P1631, DOI 10.1007/s11434-009-3614-5; You Hailu, 2004, P478; You HL, 2003, ACTA GEOL SIN-ENGL, V77, P299	38	33	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2010	5	11							e13835	10.1371/journal.pone.0013835	http://dx.doi.org/10.1371/journal.pone.0013835			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675NY	21079798	Green Published, Green Submitted, gold			2022-12-25	WOS:000283838600010
J	Merrell, KW; Crofts, JD; Smith, RL; Sin, JH; Kmetzsch, KE; Merrell, A; Miguel, RO; Candelaria, NR; Lin, CY				Merrell, K. W.; Crofts, J. D.; Smith, R. L.; Sin, J. H.; Kmetzsch, K. E.; Merrell, A.; Miguel, R. O.; Candelaria, N. R.; Lin, C-Y			Differential recruitment of nuclear receptor coregulators in ligand-dependent transcriptional repression by estrogen receptor-alpha	ONCOGENE			English	Article						estrogen receptor; transcriptional regulation; hormonal carcinogenesis; coregulators	HUMAN BREAST-CANCER; SURGICAL ADJUVANT BREAST; BOWEL PROJECT P-1; TARGET GENES; HORMONE-RECEPTORS; BINDING-SITES; EXPRESSION; ACTIVATION; MECHANISMS; TAMOXIFEN	Estrogen receptors (ERs) are normally expressed in breast tissues and mediate hormonal functions during development and in female reproductive physiology. In the majority of breast cancers, ERs are involved in regulating tumor cell proliferation and serve as prognostic markers and therapeutic targets in the management of hormone-dependent tumors. At the molecular level, ERs function as ligand-dependent transcription factors and activate target-gene expression following hormone stimulation. Recent transcriptomic and whole-genome-binding studies suggest, however, that ligand-activated ERs can also repress the expression of a significant subset of target genes. To characterize the molecular mechanisms of transcriptional repression by ERs, we examined recruitment of nuclear receptor coregulators, histone modifications and RNA polymerase II docking at ER-binding sites and cis-regulatory regions adjacent to repressed target genes. Moreover, we utilized gene expression data from patient samples to determine potential roles of repressed target genes in breast cancer biology. Results from these studies indicate that nuclear receptor corepressor recruitment is a key feature of ligand-dependent transcriptional repression by ERs, and some repressed target genes are associated with disease progression and response to endocrine therapy. These findings provide preliminary insights into a novel aspect of the molecular mechanisms of ER functions and their potential roles in hormonal carcinogenesis and breast cancer biology. Oncogene (2011) 30, 1608-1614; doi: 10.1038/onc.2010.528; published online 22 November 2010	[Merrell, K. W.; Crofts, J. D.; Smith, R. L.; Sin, J. H.; Kmetzsch, K. E.; Merrell, A.; Miguel, R. O.; Candelaria, N. R.; Lin, C-Y] Brigham Young Univ, Dept Microbiol & Mol Biol, Provo, UT 84602 USA	Brigham Young University	Lin, CY (corresponding author), Brigham Young Univ, Dept Microbiol & Mol Biol, 753 WIDB, Provo, UT 84602 USA.	clin23@central.uh.edu		Lin, Chin-Yo/0000-0002-4461-6216	Brigham Young University; Women's Research Institute; NIH [R03CA143981]; BYU Cancer Research Center; NATIONAL CANCER INSTITUTE [R03CA143981] Funding Source: NIH RePORTER	Brigham Young University; Women's Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BYU Cancer Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Mentoring Environment Grant (CYL) from Brigham Young University, a research grant (CYL) from the Women's Research Institute, NIH award number R03CA143981 (CYL) and summer research fellowships (KWM, JDC, RLS, KEK and NRC) from the BYU Cancer Research Center.	Ali S, 2000, J MAMMARY GLAND BIOL, V5, P271, DOI 10.1023/A:1009594727358; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Bookman MA, 2005, INT J GYNECOL CANCER, V15, P291, DOI 10.1111/j.1525-1438.2005.00442.x; Cappelletti V, 2004, ENDOCR-RELAT CANCER, V11, P761, DOI 10.1677/erc.1.00822; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; CAVAILLES V, 1995, EMBO J, V14, P3741, DOI 10.1002/j.1460-2075.1995.tb00044.x; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Fernandes I, 2003, MOL CELL, V11, P139, DOI 10.1016/S1097-2765(03)00014-5; Finlin BS, 2001, J BIOL CHEM, V276, P42259, DOI 10.1074/jbc.M105888200; Fisher B, 2005, JNCI-J NATL CANCER I, V97, P1652, DOI 10.1093/jnci/dji372; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Gruber CJ, 2002, NEW ENGL J MED, V346, P340, DOI 10.1056/NEJMra000471; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; HALACHMI S, 1994, SCIENCE, V264, P1455, DOI 10.1126/science.8197458; HEBBES TR, 1988, EMBO J, V7, P1395, DOI 10.1002/j.1460-2075.1988.tb02956.x; Hu X, 1999, NATURE, V402, P93, DOI 10.1038/47069; Lin CY, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1667; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Lin CY, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r66; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; Lindberg MK, 2003, MOL ENDOCRINOL, V17, P203, DOI 10.1210/me.2002-0206; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Montano MM, 1999, P NATL ACAD SCI USA, V96, P6947, DOI 10.1073/pnas.96.12.6947; Nilsson S, 2002, CRIT REV EUKAR GENE, V12, P237, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i4.10; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; ONATE SA, 1995, SCIENCE, V270, P1354; Phelan ML, 1999, MOL CELL, V3, P247, DOI 10.1016/S1097-2765(00)80315-9; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Sjogren S, 1996, J NATL CANCER I, V88, P173, DOI 10.1093/jnci/88.3-4.173; Soulez M, 2001, J MOL ENDOCRINOL, V27, P259, DOI 10.1677/jme.0.0270259; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Stossi F, 2006, J BIOL CHEM, V281, P16272, DOI 10.1074/jbc.M513405200; Stossi F, 2009, MOL CELL BIOL, V29, P1749, DOI 10.1128/MCB.01476-08; Treuter E, 1998, MOL ENDOCRINOL, V12, P864, DOI 10.1210/me.12.6.864; Vogel VG, 2006, JAMA-J AM MED ASSOC, V295, P2727, DOI 10.1001/jama.295.23.joc60074; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Webb P, 2000, MOL ENDOCRINOL, V14, P1976, DOI 10.1210/me.14.12.1976; Wei LN, 2000, J BIOL CHEM, V275, P40782, DOI 10.1074/jbc.M004821200; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776	44	19	20	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR	2011	30	13					1608	1614		10.1038/onc.2010.528	http://dx.doi.org/10.1038/onc.2010.528			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	743DU	21102521				2022-12-25	WOS:000288998300011
J	Chetrit, D; Barzilay, L; Horn, G; Bielik, T; Smorodinsky, NI; Ehrlich, M				Chetrit, David; Barzilay, Lior; Horn, Galit; Bielik, Tom; Smorodinsky, Nechama I.; Ehrlich, Marcelo			Negative Regulation of the Endocytic Adaptor Disabled-2 (Dab2) in Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; MYOSIN-VI; COATED PITS; MITOTIC PHOSPHORYLATION; MICROTUBULE DYNAMICS; PROTEIN; BINDING; MEMBRANE; CELLS; CARGO	Mitotic cells undergo extensive changes in shape and size through the altered regulation and function of their membrane trafficking machinery. Disabled 2 (Dab2), a multidomain cargo-specific endocytic adaptor and a mediator of signal transduction, is a potential integrator of trafficking and signaling. Dab2 binds effectors of signaling and trafficking that localize to different intracellular compartments. Thus, differential localization is a putative regulatory mechanism of Dab2 function. Furthermore, Dab2 is phosphorylated in mitosis and is thus regulated in the cell cycle. However, a detailed description of the intracellular localization of Dab2 in the different phases of mitosis and an understanding of the functional consequences of its phosphorylation are lacking. Here, we show that Dab2 is progressively displaced from the membrane in mitosis. This phenomenon is paralleled by a loss of co-localization with clathrin. Both phenomena culminate in metaphase/anaphase and undergo partial recovery in cytokinesis. Treatment with 2-methoxyestradiol, which arrests cells at the spindle assembly checkpoint, induces the same effects observed in metaphase cells. Moreover, 2-methoxyestradiol also induced Dab2 phosphorylation and reduced Dab2/clathrin interactions, endocytic vesicle motility, clathrin exchange dynamics, and the internalization of a receptor endowed with an NPXY endocytic signal. Serine/threonine to alanine mutations, of residues localized to the central region of Dab2, attenuated its phosphorylation, reduced its membrane displacement, and maintained its endocytic abilities in mitosis. We propose that the negative regulation of Dab2 is part of an accommodation of the cell to the altered physicochemical conditions prevalent in mitosis, aimed at allowing endocytic activity throughout the cell cycle.	[Ehrlich, Marcelo] Tel Aviv Univ, Dept Cell Res & Immunol, George S Wise Fac Life Sci, IL-69978 Tel Aviv, Israel; [Horn, Galit; Bielik, Tom; Smorodinsky, Nechama I.] Tel Aviv Univ, Alec & Myra Marmot Hybridoma Unit, George S Wise Fac Life Sci, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University	Ehrlich, M (corresponding author), Tel Aviv Univ, Dept Cell Res & Immunol, George S Wise Fac Life Sci, IL-69978 Tel Aviv, Israel.	marceloe@tauex.tau.ac.il		Ehrlich, Marcelo/0000-0002-2352-1808	Israel Science Foundation [1122/06]	Israel Science Foundation(Israel Science Foundation)	This work was supported in part by Israel Science Foundation Grant 1122/06.	ACTON SL, 1990, J CELL BIOL, V111, P1419, DOI 10.1083/jcb.111.4.1419; Albertson R, 2005, TRENDS CELL BIOL, V15, P92, DOI 10.1016/j.tcb.2004.12.008; Arden SD, 2007, MOL BIOL CELL, V18, P4750, DOI 10.1091/mbc.E07-02-0127; Attalla H, 1996, BIOCHEM BIOPH RES CO, V228, P467, DOI 10.1006/bbrc.1996.1683; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Borlido J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003115; Boucrot E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001477; Boucrot E, 2007, P NATL ACAD SCI USA, V104, P7939, DOI 10.1073/pnas.0702511104; Calderwood DA, 2003, P NATL ACAD SCI USA, V100, P2272, DOI 10.1073/pnas.262791999; Chao WT, 2009, FEBS LETT, V583, P1337, DOI 10.1016/j.febslet.2009.03.037; Chen H, 1999, J BIOL CHEM, V274, P3257, DOI 10.1074/jbc.274.6.3257; Chetrit D, 2009, BIOCHEM J, V418, P701, DOI 10.1042/BJ20081288; Cho SY, 2000, BIOCHEM J, V352, P645, DOI 10.1042/0264-6021:3520645; Cuitino L, 2005, TRAFFIC, V6, P820, DOI 10.1111/j.1600-0854.2005.00320.x; Dance AL, 2004, TRAFFIC, V5, P798, DOI 10.1111/j.1600-0854.2004.00224.x; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Habela CW, 2007, CELL CYCLE, V6, P1613, DOI 10.4161/cc.6.13.4357; Hasson T, 2003, J CELL SCI, V116, P3453, DOI 10.1242/jcs.00669; He JQ, 2003, ONCOGENE, V22, P4524, DOI 10.1038/sj.onc.1206767; Henne WM, 2010, SCIENCE, V328, P1281, DOI 10.1126/science.1188462; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Hocevar BA, 2005, J BIOL CHEM, V280, P25920, DOI 10.1074/jbc.M501150200; Hocevar BA, 2003, EMBO J, V22, P3084, DOI 10.1093/emboj/cdg286; Hocevar BA, 2001, EMBO J, V20, P2789, DOI 10.1093/emboj/20.11.2789; Huang CL, 2006, J CELL SCI, V119, P4420, DOI 10.1242/jcs.03195; Huang CH, 2007, CELL SIGNAL, V19, P1339, DOI 10.1016/j.cellsig.2007.01.019; Jiang Y, 2008, ONCOGENE, V27, P1865, DOI 10.1038/sj.onc.1210829; JORDAN MA, 1992, J CELL SCI, V102, P401; Kamath K, 2006, MOL CANCER THER, V5, P2225, DOI 10.1158/1535-7163.MCT-06-0113; Karam JA, 2007, CLIN CANCER RES, V13, P4400, DOI 10.1158/1078-0432.CCR-07-0287; Kariya K, 2000, J BIOL CHEM, V275, P18399, DOI 10.1074/jbc.M000521200; KEYDAR I, 1989, P NATL ACAD SCI USA, V86, P1362, DOI 10.1073/pnas.86.4.1362; Keyel PA, 2006, MOL BIOL CELL, V17, P4300, DOI 10.1091/mbc.E06-05-0421; Kowanetz K, 2003, FEBS LETT, V554, P81, DOI 10.1016/S0014-5793(03)01111-6; Kunda P, 2009, TRENDS CELL BIOL, V19, P174, DOI 10.1016/j.tcb.2009.01.006; Lehtonen S, 2008, MOL BIOL CELL, V19, P2949, DOI 10.1091/mbc.E07-05-0521; Liu ZH, 2009, J CELL BIOL, V186, P473, DOI 10.1083/jcb.200902071; Maurer ME, 2005, J CELL SCI, V118, P5345, DOI 10.1242/jcs.02650; Maurer ME, 2006, J CELL SCI, V119, P4235, DOI 10.1242/jcs.03217; Mettlen M, 2010, J CELL BIOL, V188, P919, DOI 10.1083/jcb.200908078; Mishra SK, 2002, EMBO J, V21, P4915, DOI 10.1093/emboj/cdf487; Morris SM, 2002, TRAFFIC, V3, P331, DOI 10.1034/j.1600-0854.2002.30503.x; Morris SM, 2002, EMBO J, V21, P1555, DOI 10.1093/emboj/21.7.1555; Morris SM, 2001, TRAFFIC, V2, P111, DOI 10.1034/j.1600-0854.2001.020206.x; Moskowitz HS, 2005, MOL BIOL CELL, V16, P1769, DOI 10.1091/mbc.E04-08-0739; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nagai J, 2005, AM J PHYSIOL-RENAL, V289, pF569, DOI 10.1152/ajprenal.00292.2004; Okamoto CT, 2000, AM J PHYSIOL-CELL PH, V279, pC369, DOI 10.1152/ajpcell.2000.279.2.C369; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Phichith D, 2009, P NATL ACAD SCI USA, V106, P17320, DOI 10.1073/pnas.0909748106; Pribluda VS, 2000, CANCER METAST REV, V19, P173, DOI 10.1023/A:1026543018478; Prunier C, 2005, J BIOL CHEM, V280, P17540, DOI 10.1074/jbc.M500974200; PYPAERT M, 1987, EUR J CELL BIOL, V45, P23; PYPAERT M, 1991, J CELL BIOL, V114, P1159, DOI 10.1083/jcb.114.6.1159; Raucher D, 1999, J CELL BIOL, V144, P497, DOI 10.1083/jcb.144.3.497; Rosse C, 2003, J BIOL CHEM, V278, P30597, DOI 10.1074/jbc.M302191200; Royle SJ, 2005, NATURE, V434, P1152, DOI 10.1038/nature03502; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Schweitzer JK, 2005, J BIOL CHEM, V280, P41628, DOI 10.1074/jbc.M504497200; Spudich G, 2007, NAT CELL BIOL, V9, P176, DOI 10.1038/ncb1531; Teckchandani A, 2009, J CELL BIOL, V186, P98, DOI 10.1083/jcb.200812160; Wang Z, 2002, J BIOL CHEM, V277, P12622, DOI 10.1074/jbc.M110568200; WARREN G, 1984, EMBO J, V3, P2217, DOI 10.1002/j.1460-2075.1984.tb02119.x; XU XX, 1995, J BIOL CHEM, V270, P14184, DOI 10.1074/jbc.270.23.14184; Xu XX, 1998, ONCOGENE, V16, P1561, DOI 10.1038/sj.onc.1201678; Yamauchi T, 2008, EMBO J, V27, P1852, DOI 10.1038/emboj.2008.118; Yang DH, 2002, DEV BIOL, V251, P27, DOI 10.1006/dbio.2002.0810; Yu C, 2009, CELL, V138, P537, DOI 10.1016/j.cell.2009.05.030; Zhou J, 2003, J BIOL CHEM, V278, P6936, DOI 10.1074/jbc.M210628200; Zhou J, 2001, J BIOL CHEM, V276, P27793, DOI 10.1074/jbc.M102803200	73	23	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5392	5403		10.1074/jbc.M110.161851	http://dx.doi.org/10.1074/jbc.M110.161851			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21097498	Green Published, hybrid			2022-12-25	WOS:000287230600048
J	Van Itallie, CM; Mitic, LL; Anderson, JM				Van Itallie, Christina M.; Mitic, Laura L.; Anderson, James M.			Claudin-2 Forms Homodimers and Is a Component of a High Molecular Weight Protein Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLUE NATIVE ELECTROPHORESIS; TIGHT-JUNCTION LOCALIZATION; BIOCHEMICAL-CHARACTERIZATION; PLASMA-MEMBRANE; OCCLUDIN; BARRIER; PALMITOYLATION; SOLUBILIZATION; PERMEABILITY; TRICELLULIN	Tight junctions are multiprotein complexes that form the fundamental physiologic and anatomic barrier between epithelial and endothelial cells, yet little information is available about their molecular organization. To begin to understand how the transmembrane proteins of the tight junction are organized into multiprotein complexes, we used blue native-PAGE (BN-PAGE) and cross-linking techniques to identify complexes extracted from MDCK II cells and mouse liver. In nonionic detergent extracts from MDCK II cells, the tight junction integral membrane protein claudin-2 was preferentially isolated as a homodimer, whereas claudin-4 was monomeric. Analysis of the interactions between chimeras of claudin-2 and -4 are consistent with the transmembrane domains of claudin-2 being responsible for dimerization, and mutational analysis followed by cross-linking indicated that the second transmembrane domains were arranged in close proximity in homodimers. BN-PAGE of mouse liver membrane identified a relatively discrete high molecular weight complex containing at least claudin-1, claudin-2, and occludin; the difference in the protein complex sizes between cultured cells and tissues may reflect differences in tight junction protein or lipid composition or post-translational modifications. Our results suggest that BN-PAGE may be a useful tool in understanding tight junction structure.	Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Mitic, Laura L.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Anderson, James M.] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Francisco; University of North Carolina; University of North Carolina Chapel Hill	Van Itallie, CM (corresponding author), NHLBI, NIH, Bldg 50,Rm 4530, Bethesda, MD 20892 USA.	Christina.VanItallie@nih.gov		Anderson, James/0000-0003-2765-7996	National Institutes of Health [RO1 DK45134]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045134] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 DK45134.	Anderson JM, 2001, NEWS PHYSIOL SCI, V16, P126; Azem A, 2010, BBA-PROTEINS PROTEOM, V1804, P768, DOI 10.1016/j.bbapap.2009.11.024; Babusiak M, 2007, PROTEOMICS, V7, P121, DOI 10.1002/pmic.200600382; Blasig IE, 2006, CELL MOL LIFE SCI, V63, P505, DOI 10.1007/s00018-005-5472-x; BOONE CW, 1969, J CELL BIOL, V41, P378, DOI 10.1083/jcb.41.2.378; Colegio OR, 2003, AM J PHYSIOL-CELL PH, V284, pC1346, DOI 10.1152/ajpcell.00547.2002; Coyne CB, 2003, AM J PHYSIOL-LUNG C, V285, pL1166, DOI 10.1152/ajplung.00182.2003; Crane JM, 2009, J BIOL CHEM, V284, P35850, DOI 10.1074/jbc.M109.071670; Cukierman L, 2009, J VIROL, V83, P5477, DOI 10.1128/JVI.02262-08; Daugherty BL, 2007, J BIOL CHEM, V282, P30005, DOI 10.1074/jbc.M703547200; Furuse M, 1998, J CELL BIOL, V143, P391, DOI 10.1083/jcb.143.2.391; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Furuse M, 1999, J CELL BIOL, V147, P891, DOI 10.1083/jcb.147.4.891; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Galka JJ, 2008, BIOCHEMISTRY-US, V47, P3513, DOI 10.1021/bi7021409; Heuberger EHML, 2002, J MOL BIOL, V317, P591, DOI 10.1006/jmbi.2002.5416; Hou JH, 2008, J CLIN INVEST, V118, P619, DOI 10.1172/JCI33970; Hou JH, 2010, P NATL ACAD SCI USA, V107, P18010, DOI 10.1073/pnas.1009399107; Ikenouchi J, 2005, J CELL BIOL, V171, P939, DOI 10.1083/jcb.200510043; Jiang JS, 2006, J BIOL CHEM, V281, P454, DOI 10.1074/jbc.M508926200; Kiss A, 2008, MOL BIOL CELL, V19, P4042, DOI 10.1091/mbc.E08-04-0394; Kovalenko OV, 2004, BIOCHEM J, V377, P407, DOI 10.1042/BJ20031037; Li XW, 2009, J PROTEOME RES, V8, P3475, DOI 10.1021/pr900101d; Martin-Padura I, 1998, J CELL BIOL, V142, P117, DOI 10.1083/jcb.142.1.117; Mitic LL, 2003, PROTEIN SCI, V12, P218, DOI 10.1110/ps.0233903; Mrsny RJ, 2008, AM J PATHOL, V172, P905, DOI 10.2353/ajpath.2008.070698; PAYNE JW, 1973, BIOCHEM J, V135, P867, DOI 10.1042/bj1350867; Piontek J, 2008, FASEB J, V22, P146, DOI 10.1096/fj.07-8319com; Raleigh DR, 2010, MOL BIOL CELL, V21, P1200, DOI 10.1091/mbc.E09-08-0734; Reifschneider NH, 2006, J PROTEOME RES, V5, P1117, DOI 10.1021/pr0504440; Reisinger Veronika, 2007, Proteomics, V7 Suppl 1, P6, DOI 10.1002/pmic.200700205; Reisinger V, 2008, J PROTEOMICS, V71, P277, DOI 10.1016/j.jprot.2008.05.004; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Sorbo JG, 2008, BIOCHEMISTRY-US, V47, P2631, DOI 10.1021/bi702146k; Steed E, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-95; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; STEVENSON BR, 1984, J CELL BIOL, V98, P1209, DOI 10.1083/jcb.98.4.1209; Van Itallie C, 2001, J CLIN INVEST, V107, P1319, DOI 10.1172/JCI12464; Van Itallie CM, 2009, MOL BIOL CELL, V20, P3930, DOI 10.1091/mbc.E09-04-0320; Van Itallie CM, 2005, J CELL SCI, V118, P1427, DOI 10.1242/jcs.01735; Van Itallie CM, 2004, J MEMBRANE BIOL, V199, P29, DOI 10.1007/s00232-004-0673-z; Wittig I, 2010, MOL CELL PROTEOMICS, V9, P2149, DOI 10.1074/mcp.M900526-MCP200; Wittig I, 2009, PROTEOMICS, V9, P5214, DOI 10.1002/pmic.200900151; Yang XW, 2002, MOL BIOL CELL, V13, P767, DOI 10.1091/mbc.01-05-0275	44	61	62	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3442	3450		10.1074/jbc.M110.195578	http://dx.doi.org/10.1074/jbc.M110.195578			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21098027	Green Published, hybrid			2022-12-25	WOS:000286653200030
J	Bot, N; Schweizer, C; Ben Halima, S; Fraering, PC				Bot, Nathalie; Schweizer, Claude; Ben Halima, Saoussen; Fraering, Patrick C.			Processing of the Synaptic Cell Adhesion Molecule Neurexin-3 beta by Alzheimer Disease alpha- and gamma-Secretases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; NECROSIS-FACTOR-ALPHA; PRESENILIN/GAMMA-SECRETASE; NEURITE OUTGROWTH; MEDIATED CLEAVAGE; NEUROLIGIN; BACE1; MUTATIONS; RECEPTOR; SYNAPSES	Neurexins (NRXNs) are synaptic cell adhesion molecules having essential roles in the assembly and maturation of synapses into fully functional units. Immunocytochemical and electrophysiological studies have shown that specific binding across the synaptic cleft of the ectodomains of presynaptic NRXNs and postsynaptic neuroligins have the potential to bi-directionally coordinate and trigger synapse formation. Moreover, in vivo studies as well as genome-wide association studies pointed out implication of NRXNs in the pathogenesis of cognitive disorders including autism spectrum disorders and different types of addictions including opioid and alcohol dependences, suggesting an important role in synaptic function. Despite extensive investigations, the mechanisms by which NRXNs modulate the properties of synapses remain largely unknown. We report here that alpha- and gamma-secretases can sequentially process NRXN3 beta, leading to the formation of two final products, an similar to 80-kDa N-terminal extracellular domain of Neurexin-3 beta (sNRXN3 beta) and an similar to 12-kDa C-terminal intracellular NRXN3 beta domain (NRXN3 beta-ICD), both of them being potentially implicated in the regulation of NRXNs and neuroligins functions at the synapses or in yet unidentified signal transduction pathways. We further report that this processing is altered by several PS1 mutations in the catalytic subunit of the gamma-secretase that cause early-onset familial Alzheimer disease.	[Fraering, Patrick C.] Swiss Fed Inst Technol EPFL, Stn 15, Lab Mol & Cellular Biol Alzheimer Dis, Brain Mind Inst,Sch Life Sci, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Fraering, PC (corresponding author), Swiss Fed Inst Technol EPFL, Stn 15, Lab Mol & Cellular Biol Alzheimer Dis, Brain Mind Inst,Sch Life Sci, CH-1015 Lausanne, Switzerland.	patrick.fraering@epfl.ch		Fraering, Patrick/0000-0002-5841-5327	Swiss National Foundation [310000-116652/1]; National Center for Competence in Research; Strauss foundation	Swiss National Foundation(Swiss National Science Foundation (SNSF)); National Center for Competence in Research; Strauss foundation	This work was supported by Swiss National Foundation Grant 310000-116652/1 (to P. C. F. and L. Aeschbach) and the National Center for Competence in Research ("Neuronal Plasticity and Repair" (to P. C. F.)) and the Strauss foundation (to P. C. F. and C. S.).	Beel AJ, 2008, BIOCHEMISTRY-US, V47, P9428, DOI 10.1021/bi800993c; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Biederer T, 2000, J BIOL CHEM, V275, P39803, DOI 10.1074/jbc.C000656200; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Blobel CP, 2000, CURR OPIN CELL BIOL, V12, P606, DOI 10.1016/S0955-0674(00)00139-3; Bourgeron T, 2009, CURR OPIN NEUROBIOL, V19, P231, DOI 10.1016/j.conb.2009.06.003; Cacquevel M, 2008, J NEUROCHEM, V104, P210, DOI 10.1111/j.1471-4159.2007.05041.x; Cheng SB, 2009, J BIOL CHEM, V284, P23251, DOI 10.1074/jbc.M109.017384; Cho RW, 2008, NEURON, V57, P858, DOI 10.1016/j.neuron.2008.01.010; Cupers P, 2001, J NEUROCHEM, V78, P1168, DOI 10.1046/j.1471-4159.2001.00516.x; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dean C, 2006, TRENDS NEUROSCI, V29, P21, DOI 10.1016/j.tins.2005.11.003; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Fortini ME, 2002, NAT REV MOL CELL BIO, V3, P673, DOI 10.1038/nrm910; Fraering PC, 2007, CURR GENOMICS, V8, P531, DOI 10.2174/138920207783769521; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Harrison SM, 2003, MOL CELL NEUROSCI, V24, P646, DOI 10.1016/S1044-7431(03)00227-6; Hata Y, 1996, J NEUROSCI, V16, P2488; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Hinkle CL, 2006, J NEUROBIOL, V66, P1378, DOI 10.1002/neu.20257; Hishimoto A, 2007, HUM MOL GENET, V16, P2880, DOI 10.1093/hmg/ddm247; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kaimori JY, 2007, HUM MOL GENET, V16, P942, DOI 10.1093/hmg/ddm039; Kalus I, 2006, J NEUROCHEM, V98, P78, DOI 10.1111/j.1471-4159.2006.03847.x; Kenchappa RS, 2006, NEURON, V50, P219, DOI 10.1016/j.neuron.2006.03.011; Kim DY, 2007, NAT CELL BIOL, V9, P755, DOI 10.1038/ncb1602; Kim DY, 2005, J BIOL CHEM, V280, P23251, DOI 10.1074/jbc.M412938200; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Ko J, 2009, NEURON, V64, P791, DOI 10.1016/j.neuron.2009.12.012; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; Levinson JN, 2005, NEURON, V48, P171, DOI 10.1016/j.neuron.2005.09.017; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; Liao YF, 2004, J BIOL CHEM, V279, P49523, DOI 10.1074/jbc.M402034200; Lise MF, 2006, CELL MOL LIFE SCI, V63, P1833, DOI 10.1007/s00018-006-6061-3; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Maretzky T, 2005, MOL CELL BIOL, V25, P9040, DOI 10.1128/MCB.25.20.9040-9053.2005; Miller RK, 2009, MOL BIOL CELL, V20, P3608, DOI 10.1091/mbc.E09-03-0208; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Missler M, 1998, J NEUROCHEM, V71, P1339; Missler M, 1998, TRENDS GENET, V14, P20, DOI 10.1016/S0168-9525(97)01324-3; Moehlmann T, 2002, P NATL ACAD SCI USA, V99, P8025, DOI 10.1073/pnas.112686799; Moss ML, 1997, J NEUROIMMUNOL, V72, P127, DOI 10.1016/S0165-5728(96)00180-4; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; Rockenstein E, 2005, J BIOL CHEM, V280, P32957, DOI 10.1074/jbc.M507016200; Rowen L, 2002, GENOMICS, V79, P587, DOI 10.1006/geno.2002.6734; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Savonenko AV, 2008, P NATL ACAD SCI USA, V105, P5585, DOI 10.1073/pnas.0710373105; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Selkoe DJ, 2007, CELL, V131, P215, DOI 10.1016/j.cell.2007.10.012; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tanabe Y, 2008, NEUROSCI LETT, V444, P16, DOI 10.1016/j.neulet.2008.08.023; Uemura T, 2010, CELL, V141, P1068, DOI 10.1016/j.cell.2010.04.035; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; USHKARYOV YA, 1994, J BIOL CHEM, V269, P11987; USHKARYOV YA, 1993, P NATL ACAD SCI USA, V90, P6410, DOI 10.1073/pnas.90.14.6410; Wang H, 2008, J NEUROSCI, V28, P8677, DOI 10.1523/JNEUROSCI.2440-08.2008; Zhang C, 2009, NATURE, V460, P632, DOI 10.1038/nature08177; Zhang CB, 2010, ACTA CRYSTALLOGR E, V66, pO1047, DOI 10.1107/S1600536810012535	65	64	65	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2762	2773		10.1074/jbc.M110.142521	http://dx.doi.org/10.1074/jbc.M110.142521			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21084300	hybrid, Green Accepted, Green Published			2022-12-25	WOS:000286464300042
J	Hoshino, D; Koshikawa, N; Seiki, M				Hoshino, Daisuke; Koshikawa, Naohiko; Seiki, Motoharu			A p27(kip1)-binding Protein, p27RF-Rho, Promotes Cancer Metastasis via Activation of RhoA and RhoC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR FUNCTIONS; CELL-MIGRATION; BREAST-CANCER; INVASION; INHIBITION; PHOSPHORYLATION; MOTILITY; GTPASES; IDENTIFICATION; TRANSFORMATION	Rho family proteins regulate multiple cellular functions including motility and invasion through regulation of the actin cytoskeleton and gene expression. Activation of Rho proteins is controlled precisely by multiple regulators in a spatiotemporal manner. RhoA and/or RhoC are key players that regulate the metastatic activity of malignant tumor cells, and it is therefore of particular interest to understand how activation of these Rho proteins is controlled. We recently identified an upstream regulator of RhoA activation, p27RF-Rho (p27(kip1) releasing factor from RhoA) that acts by freeing RhoA from inhibition by p27(kip1). p27(kip1) is a cell cycle regulator when it is localized to the nucleus, but it binds RhoA and inhibits activation of the latter when it is localized to the cytoplasm. Here, we show that a metastatic variant of mouse melanoma B16 cells (F10) exhibits greater expression of p27RF-Rho, RhoA, and RhoC than the nonmetastatic parental cells (F0). Injection of F10 cells into mouse tail vein resulted in the formation of metastatic lung colonies, whereas prior knockdown of expression of either one of the three proteins using specific shRNA sequences decreased metastasis markedly. p27RF-Rho regulated the activation of RhoA and RhoC and thereby modulated cellular adhesion and motility, in addition to pericellullar proteolysis. The Rho activities enhanced by p27RF-Rho had a marked effect upon efficiency of lodging of F10 cells in the lung, which represents an early step of metastasis. p27RF-Rho also regulated metastasis of human melanoma and fibrosarcoma cells. Thus, p27RF-Rho is a key upstream regulator of RhoA and RhoC that controls spreading of tumor cells.	[Hoshino, Daisuke; Koshikawa, Naohiko; Seiki, Motoharu] Univ Tokyo, Inst Med Sci, Minato Ku, Div Canc Cell Res, Tokyo 1088639, Japan	University of Tokyo	Seiki, M (corresponding author), Univ Tokyo, Inst Med Sci, Minato Ku, Div Canc Cell Res, Tokyo 1088639, Japan.	mseiki@ims.u-tokyo.ac.jp	Seiki, Motoharu/K-9443-2015; Koshikawa, Naohiko/S-7306-2017	Koshikawa, Naohiko/0000-0002-4539-888X	Specific Coordination Fund for Promoting Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Specific Coordination Fund for Promoting Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the Specific Coordination Fund for Promoting Science (to D. H.) and by a Grant-in-Aid for Scientific Research on Priority Areas, "Integrative Research toward the Conquest of Cancer," from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to M. S.).	Bellovin DI, 2006, ONCOGENE, V25, P6959, DOI 10.1038/sj.onc.1209682; Berger JC, 2005, CANCER BIOL THER, V4, P805, DOI 10.4161/cbt.4.8.1865; Berton S, 2009, MOL CELL BIOL, V29, P5031, DOI 10.1128/MCB.00144-09; Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bryan B, 2005, FEBS LETT, V579, P1015, DOI 10.1016/j.febslet.2004.12.074; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Denicourt C, 2007, CANCER RES, V67, P9238, DOI 10.1158/0008-5472.CAN-07-1375; Friedl P, 2008, CANCER RES, V68, P7247, DOI 10.1158/0008-5472.CAN-08-0784; Fritz G, 2002, BRIT J CANCER, V87, P635, DOI 10.1038/sj.bjc.6600510; Guillaumot P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010977; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hall A, 2009, CANCER METAST REV, V28, P5, DOI 10.1007/s10555-008-9166-3; Hoshino D, 2009, J BIOL CHEM, V284, P27315, DOI 10.1074/jbc.M109.041400; Itoh K, 1999, NAT MED, V5, P221, DOI 10.1038/5587; Jiang K, 2004, MOL CELL BIOL, V24, P5565, DOI 10.1128/MCB.24.12.5565-5576.2004; Larreaa MD, 2009, P NATL ACAD SCI USA, V106, P9268, DOI 10.1073/pnas.0805057106; McAllister SS, 2003, MOL CELL BIOL, V23, P216, DOI 10.1128/MCB.23.1.216-228.2003; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Nada S, 2009, EMBO J, V28, P477, DOI 10.1038/emboj.2008.308; Narumiya S, 2009, CANCER METAST REV, V28, P65, DOI 10.1007/s10555-008-9170-7; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Olson MF, 2009, CLIN EXP METASTAS, V26, P273, DOI 10.1007/s10585-008-9174-2; Pinner S, 2008, NAT CELL BIOL, V10, P127, DOI 10.1038/ncb1675; Ridley AJ, 2004, BREAST CANCER RES TR, V84, P13, DOI 10.1023/B:BREA.0000018423.47497.c6; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; Sahai E, 2005, CURR OPIN GENET DEV, V15, P87, DOI 10.1016/j.gde.2004.12.002; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sahai E, 2007, J CELL BIOL, V176, P35, DOI 10.1083/jcb.200605135; Salsmann A, 2006, EUR J CELL BIOL, V85, P249, DOI 10.1016/j.ejcb.2005.08.003; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Shin I, 2002, NAT MED, V8, P1145, DOI 10.1038/nm759; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Viglietto G, 2002, NAT MED, V8, P1136, DOI 10.1038/nm762; Wang WG, 2007, NAT REV CANCER, V7, P429, DOI 10.1038/nrc2148; Wang WG, 2004, CANCER RES, V64, P8585, DOI 10.1158/0008-5472.CAN-04-1136; Wu SD, 2009, MOL CELL, V35, P735, DOI 10.1016/j.molcel.2009.09.012; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001	40	23	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					3139	3148		10.1074/jbc.M110.159715	http://dx.doi.org/10.1074/jbc.M110.159715			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21087931	Green Published, hybrid			2022-12-25	WOS:000286464300075
J	Muralidhar, SA; Ramakrishnan, V; Kalra, IS; Li, W; Pace, BS				Muralidhar, Shalini A.; Ramakrishnan, Valya; Kalra, Inderdeep S.; Li, Wei; Pace, Betty S.			Histone Deacetylase 9 Activates gamma-Globin Gene Expression in Primary Erythroid Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FETAL-HEMOGLOBIN INDUCTION; TRANSCRIPTION FACTOR; TRICHOSTATIN-A; DIFFERENTIATION; INHIBITORS; HDACS; ACETYLATION; REPRESSOR; THERAPY; DISEASE	Strategies to induce fetal hemoglobin (HbF) synthesis for the treatment of beta-hemoglobinopathies probably involve protein modifications by histone deacetylases (HDACs) that mediate gamma-globin gene regulation. However, the role of individual HDACs in globin gene expression is not very well understood; thus, the focus of our study was to identify HDACs involved in gamma-globin activation. K562 erythroleukemia cells treated with the HbF inducers hemin, trichostatin A, and sodium butyrate had significantly reduced mRNA levels of HDAC9 and its splice variant histone deacetylase-related protein. Subsequently, HDAC9 gene knockdown produced dose-dependent gamma-globin gene silencing over an 80-320 nM range. Enforced expression with the pTarget-HDAC9 vector produced a dose-dependent 2.5-fold increase in gamma-globin mRNA (p < 0.05). Furthermore, ChIP assays showed HDAC9 binding in vivo in the upstream G gamma-globin gene promoter region. To determine the physiological relevance of these findings, human primary erythroid progenitors were treated with HDAC9 siRNA; we observed 40 and 60% gamma-globin gene silencing in day 11 (early) and day 28 (late) progenitors. Moreover, enforced HDAC9 expression increased gamma-globin mRNA levels by 2.5-fold with a simultaneous 7-fold increase in HbF. Collectively, these data support a positive role for HDAC9 in gamma-globin gene regulation.	Univ Texas Dallas, Dept Mol & Cell Biol, Richardson, TX 75080 USA; [Li, Wei] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Pace, BS (corresponding author), 800 W Campbell Rd, Richardson, TX 75080 USA.	bpace@utdallas.edu	RAMAKRISHNAN, VALYA/L-6415-2016	Pace, Betty/0000-0002-1275-4112	National Institutes of Health, NHLBI [HL69234]; Center for Applied Biology at the University of Texas at Dallas; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069234] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Center for Applied Biology at the University of Texas at Dallas; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health, NHLBI, Grant HL69234. This work was also supported by funding through the Center for Applied Biology at the University of Texas at Dallas.	Asano H, 1999, MOL CELL BIOL, V19, P3571; Asano H, 2000, BLOOD, V95, P3578, DOI 10.1182/blood.V95.11.3578.011k48_3578_3584; Atweh GF, 2001, CURR OPIN HEMATOL, V8, P123, DOI 10.1097/00062752-200103000-00010; Avram D, 2000, J BIOL CHEM, V275, P10315, DOI 10.1074/jbc.275.14.10315; Bertos NR, 2001, BIOCHEM CELL BIOL, V79, P243, DOI 10.1139/bcb-79-3-243; Boosalis MS, 2001, BLOOD, V97, P3259, DOI 10.1182/blood.V97.10.3259; Bottardi S, 2009, MOL CELL BIOL, V29, P1526, DOI 10.1128/MCB.01523-08; Bradner JE, 2010, P NATL ACAD SCI USA, V107, P12617, DOI 10.1073/pnas.1006774107; Cao H, 2004, BLOOD, V103, P701, DOI 10.1182/blood-2003-02-0478; CHARACHE S, 1987, BLOOD, V69, P109; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; FIBACH E, 1993, STEM CELLS, V11, P36, DOI 10.1002/stem.5530110608; Ficner R, 2009, CURR TOP MED CHEM, V9, P235, DOI 10.2174/156802609788085304; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hassig CA, 1997, CURR OPIN CHEM BIOL, V1, P300, DOI 10.1016/S1367-5931(97)80066-X; Hazzalin CA, 2005, PLOS BIOL, V3, P2111, DOI 10.1371/journal.pbio.0030393; Hsiao CH, 2006, EXP HEMATOL, V34, P264, DOI 10.1016/j.exphem.2005.12.009; Joseph J, 2004, ONCOGENE, V23, P6304, DOI 10.1038/sj.onc.1207852; Kramer OH, 2001, TRENDS ENDOCRIN MET, V12, P294, DOI 10.1016/S1043-2760(01)00438-6; Li QL, 2002, BLOOD, V100, P3077, DOI 10.1182/blood-2002-04-1104; Lou TF, 2009, EXP BIOL MED, V234, P1374, DOI 10.3181/0811-RM-339; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Mai A, 2005, MED RES REV, V25, P261, DOI 10.1002/med.20024; Mankidy R, 2006, BLOOD, V108, P3179, DOI 10.1182/blood-2005-12-010934; Martin M, 2009, INT J DEV BIOL, V53, P291, DOI 10.1387/ijdb.082698mm; McElveen RL, 2005, CELL MOL BIOL, V51, P215, DOI 10.1170/T621; Mejat A, 2005, NAT NEUROSCI, V8, P313, DOI 10.1038/nn1408; Moreira JMA, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-30; Morrison BE, 2006, MOL CELL BIOL, V26, P3550, DOI 10.1128/MCB.26.9.3550-3564.2006; Nusinzon Inna, 2005, Sci STKE, V2005, pre11, DOI 10.1126/stke.2962005re11; Pace BS, 2003, EXP HEMATOL, V31, P1089, DOI 10.1016/S0301-472X(03)00235-2; Pace BS, 2004, CELL MOL BIOL, V50, P43; Perrine SP, 2005, ANN NY ACAD SCI, V1054, P257, DOI 10.1196/annals.1345.033; PERRINE SP, 1994, AM J PEDIAT HEMATOL, V16, P67; Reid G, 2005, ONCOGENE, V24, P4894, DOI 10.1038/sj.onc.1208662; Sangerman J, 2006, BLOOD, V108, P3590, DOI 10.1182/blood-2006-01-023713; Sankaran VG, 2009, NATURE, V460, P1093, DOI 10.1038/nature08243; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Smith CL, 2008, BIOESSAYS, V30, P15, DOI 10.1002/bies.20687; Sparrow DB, 1999, EMBO J, V18, P5085, DOI 10.1093/emboj/18.18.5085; Stamatoyannopoulos G, 2005, EXP HEMATOL, V33, P259, DOI 10.1016/j.exphem.2004.11.007; Stamatoyannopoulos G., 2001, MOL BASIS BLOOD DIS, Vthird, P135; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Witt O, 2000, BLOOD, V95, P2391, DOI 10.1182/blood.V95.7.2391.007k21_2391_2396; Wittich S, 2005, ANTI-CANCER DRUG, V16, P635, DOI 10.1097/00001813-200507000-00008; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Yao X, 2009, EXP HEMATOL, V37, P889, DOI 10.1016/j.exphem.2009.05.004; Zhao Q, 2004, J BIOL CHEM, V279, P41477, DOI 10.1074/jbc.M405129200; Zhou XB, 2001, P NATL ACAD SCI USA, V98, P10572, DOI 10.1073/pnas.191375098	50	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2343	2353		10.1074/jbc.M110.115725	http://dx.doi.org/10.1074/jbc.M110.115725			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21078662	hybrid, Green Published			2022-12-25	WOS:000286191500073
J	Qian, XS; Zhang, JD; Liu, JG				Qian, Xuesong; Zhang, Jidong; Liu, Jianguo			Tumor-secreted PGE(2) Inhibits CCL5 Production in Activated Macrophages through cAMP/PKA Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERFERON REGULATORY FACTOR-1; MOUSE MAMMARY-CARCINOMA; NECROSIS-FACTOR-ALPHA; FACTOR-KAPPA-B; BREAST-CANCER; GENE-EXPRESSION; ANTITUMOR IMMUNITY; CHEMOKINE RANTES; MURINE MODEL; IFN-GAMMA	One of the major characteristics of tumors is their ability to evade immunosurveillance through altering the properties and functions of host stromal and/or immune cells. CCL5 has been shown to play important roles in T cell proliferation, IFN-gamma, and IL-2 production, which promotes the differentiation and proliferation of Th1 cells important for immune defense against intracellular infection. In this study we found that tumor-bearing mice were more susceptible to bacterial infection and showed reduced CCL5 levels in serum during endotoxic shock. Our data further demonstrated that the soluble factors secreted by mammary gland tumor cells but not normal mammary gland epithelial cells inhibited CCL5 expression in macrophages in response to LPS, but not to TNF-alpha stimulation. The inhibitory effect of tumor-secreted molecules on LPS-induced CCL5 expression was regulated at the post-transcriptional level. Blocking PGE(2) synthesis by NS398 or through the use of PGE(2) receptor antagonists AH-6809 (EP2 antagonist) and AH-23848 ( EP4 antagonist) completely reversed the inhibitory effect of tumor-conditioned medium (TCM) on LPS-induced CCL5 expression. Moreover, PGE(2) and the cAMP analog forskolin could mimic tumor-mediated CCL5 inhibition, and the inhibitory effects of TCM, PGE(2), and cAMP analog on LPS-induced CCL5 expression could be completely reversed by the PKA inhibitor H89. Furthermore, blocking PGE(2) synthesis in vivo led to partial recovery of CCL5 production during endotoxic shock. Taken together, our data indicate that PGE(2) secreted from breast cancer cells suppresses CCL5 secretion in LPS-activated macrophages through a cAMP/PKA signaling pathway, which may result in suppression of host immune responses against subsequent bacterial infection.	[Qian, Xuesong; Zhang, Jidong; Liu, Jianguo] St Louis Univ, Sch Med, Dept Internal Med, Div Immunobiol, St Louis, MO 63104 USA	Saint Louis University	Liu, JG (corresponding author), St Louis Univ, Sch Med, Dept Internal Med, Div Immunobiol, 1100 S Grand Blvd,DRC Rm 811, St Louis, MO 63104 USA.	jliu9@slu.edu			NCI of the National Institutes of Health [K22CA137126]; NATIONAL CANCER INSTITUTE [K22CA137126] Funding Source: NIH RePORTER	NCI of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by Grant Number K22CA137126 from the NCI of the National Institutes of Health.	Appay V, 2001, TRENDS IMMUNOL, V22, P83, DOI 10.1016/S1471-4906(00)01812-3; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Azenshtein E, 2002, CANCER RES, V62, P1093; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Bieche I, 2004, CLIN CANCER RES, V10, P6789, DOI 10.1158/1078-0432.CCR-04-0306; Brault MS, 2003, INT REV IMMUNOL, V22, P199, DOI 10.1080/08830180305224; Cavaillon JM, 2003, SCAND J INFECT DIS, V35, P535, DOI 10.1080/00365540310015935; Christensen CRL, 1998, CANCER RES, V58, P1238; Dorner BG, 2002, P NATL ACAD SCI USA, V99, P6181, DOI 10.1073/pnas.092141999; Erickson L, 2004, TRANSPL IMMUNOL, V13, P169, DOI 10.1016/j.trim.2004.06.003; Half E, 2002, CANCER RES, V62, P1676; Hollmann CA, 2001, ONCOGENE, V20, P7645, DOI 10.1038/sj.onc.1204980; Howe LR, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1678; Jayasinghe MM, 2008, BREAST CANCER RES TR, V111, P511, DOI 10.1007/s10549-007-9802-6; Lee AH, 2000, BIOCHEM J, V350, P131, DOI 10.1042/0264-6021:3500131; Levy JA, 2009, J IMMUNOL, V182, P3945, DOI 10.4049/jimmunol.0990015; Lin PN, 1998, P NATL ACAD SCI USA, V95, P8829, DOI 10.1073/pnas.95.15.8829; Liu JG, 2005, J BIOL CHEM, V280, P24347, DOI 10.1074/jbc.M500973200; Liu JG, 2004, J BIOL CHEM, V279, P55609, DOI 10.1074/jbc.M406565200; Liu JG, 2006, J BIOL CHEM, V281, P19188, DOI 10.1074/jbc.M602059200; Luboshits G, 1999, CANCER RES, V59, P4681; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Makino Y, 2002, CLIN IMMUNOL, V102, P302, DOI 10.1006/clim.2001.5178; Mi ZY, 2004, J BIOL CHEM, V279, P46659, DOI 10.1074/jbc.M407952200; MILLER FR, 1983, INVAS METAST, V3, P22; Mitsuhashi M, 2004, J LEUKOCYTE BIOL, V76, P322, DOI 10.1189/jlb.1203641; Morecki S, 1998, INT J CANCER, V75, P894, DOI 10.1002/(SICI)1097-0215(19980316)75:6<894::AID-IJC12>3.0.CO;2-3; Morecki S, 2000, CANCER IMMUNOL IMMUN, V48, P613; Nicolini A, 2009, MED RES REV, V29, P436, DOI 10.1002/med.20143; Niwa Y, 2001, CLIN CANCER RES, V7, P285; Ohmori Y, 1997, J BIOL CHEM, V272, P14899, DOI 10.1074/jbc.272.23.14899; Pulaski BA, 1998, CANCER RES, V58, P1486; Pulaski BA, 2000, CANCER IMMUNOL IMMUN, V49, P34, DOI 10.1007/s002620050024; Rakhmilevich AL, 2000, CANCER GENE THER, V7, P826, DOI 10.1038/sj.cgt.7700176; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Robinson SC, 2003, CANCER RES, V63, P8360; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; SCHALL TJ, 1988, J IMMUNOL, V141, P1018; Schrum S, 1996, J IMMUNOL, V157, P3598; Shi XY, 2004, J IMMUNOL, V172, P4111, DOI 10.4049/jimmunol.172.7.4111; Shi XY, 2004, INT J CANCER, V110, P570, DOI 10.1002/ijc.20145; Siveke JT, 1998, J IMMUNOL, V160, P550; Taccone FS, 2009, CRIT CARE, V13, DOI 10.1186/cc7713; VANOTTEREN GM, 1995, J IMMUNOL, V154, P1900; Villalta F, 1998, INFECT IMMUN, V66, P4690, DOI 10.1128/IAI.66.10.4690-4695.1998; Wang H, 1998, INT J MOL MED, V1, P915; Werts C, 2007, EUR J IMMUNOL, V37, P2499, DOI 10.1002/eji.200737069; Wigler N, 2002, ISRAEL MED ASSOC J, V4, P940; Williams MD, 2004, CRIT CARE, V8, pR291, DOI 10.1186/cc2893; Xu XJ, 2008, J IMMUNOL, V180, P2125, DOI 10.4049/jimmunol.180.4.2125; Yaal-Hahoshen N, 2006, CLIN CANCER RES, V12, P4474, DOI 10.1158/1078-0432.CCR-06-0074	51	44	44	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2111	2120		10.1074/jbc.M110.154971	http://dx.doi.org/10.1074/jbc.M110.154971			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21097507	Green Published, hybrid			2022-12-25	WOS:000286191500053
J	Yildirim, S; Yeoman, CJ; Sipos, M; Torralba, M; Wilson, BA; Goldberg, TL; Stumpf, RM; Leigh, SR; White, BA; Nelson, KE				Yildirim, Suleyman; Yeoman, Carl J.; Sipos, Maksim; Torralba, Manolito; Wilson, Brenda A.; Goldberg, Tony L.; Stumpf, Rebecca M.; Leigh, Steven R.; White, Bryan A.; Nelson, Karen E.			Characterization of the Fecal Microbiome from Non-Human Wild Primates Reveals Species Specific Microbial Communities	PLOS ONE			English	Article							GUT MICROBIOTA; BACTERIAL DIVERSITY; EVOLUTION; CHIMPANZEES; MICROORGANISMS; SYMBIONTS; SYSTEM; HEALTH; ENERGY; TWINS	Background: Host-associated microbes comprise an integral part of animal digestive systems and these interactions have a long evolutionary history. It has been hypothesized that the gastrointestinal microbiome of humans and other non-human primates may have played significant roles in host evolution by facilitating a range of dietary adaptations. We have undertaken a comparative sequencing survey of the gastrointestinal microbiomes of several non-human primate species, with the goal of better understanding how these microbiomes relate to the evolution of non-human primate diversity. Here we present a comparative analysis of gastrointestinal microbial communities from three different species of Old World wild monkeys. Methodology/Principal Findings: We analyzed fecal samples from three different wild non-human primate species (black-and-white colobus [Colubus guereza], red colobus [Piliocolobus tephrosceles], and red-tailed guenon [Cercopithecus ascanius]). Three samples from each species were subjected to small subunit rRNA tag pyrosequencing. Firmicutes comprised the vast majority of the phyla in each sample. Other phyla represented were Bacterioidetes, Proteobacteria, Spirochaetes, Actinobacteria, Verrucomicrobia, Lentisphaerae, Tenericutes, Planctomycetes, Fibrobacateres, and TM7. Bray-Curtis similarity analysis of these microbiomes indicated that microbial community composition within the same primate species are more similar to each other than to those of different primate species. Comparison of fecal microbiota from non-human primates with microbiota of human stool samples obtained in previous studies revealed that the gut microbiota of these primates are distinct and reflect host phylogeny. Conclusion/Significance: Our analysis provides evidence that the fecal microbiomes of wild primates co-vary with their hosts, and that this is manifested in higher intraspecies similarity among wild primate species, perhaps reflecting species specificity of the microbiome in addition to dietary influences. These results contribute to the limited body of primate microbiome studies and provide a framework for comparative microbiome analysis between human and non-human primates as well as a comparative evolutionary understanding of the human microbiome.	[Yildirim, Suleyman; Yeoman, Carl J.; Wilson, Brenda A.; Stumpf, Rebecca M.; Leigh, Steven R.; White, Bryan A.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Sipos, Maksim] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Torralba, Manolito; Nelson, Karen E.] J Craig Venter Inst, Rockville, MD USA; [Wilson, Brenda A.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Goldberg, Tony L.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA; [Stumpf, Rebecca M.; Leigh, Steven R.] Univ Illinois, Dept Anthropol, Urbana, IL 61801 USA; [White, Bryan A.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; J. Craig Venter Institute; University of Illinois System; University of Illinois Urbana-Champaign; University of Wisconsin System; University of Wisconsin Madison; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Yildirim, S (corresponding author), Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.	bwhite44@illinois.edu	Yeoman, Carl/ABA-1906-2021	Yeoman, Carl/0000-0002-8775-7879; Yildirim, Suleyman/0000-0002-2752-1223; LEIGH, STEVEN/0000-0001-6844-7122	National Science Foundation [0935347]	National Science Foundation(National Science Foundation (NSF))	This project is funded by the National Science Foundation (grant no. 0935347). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; BOTTA GA, 1994, CLIN INFECT DIS, V18, pS260, DOI 10.1093/clinids/18.Supplement_4.S260; Brownlie JC, 2009, TRENDS MICROBIOL, V17, P348, DOI 10.1016/j.tim.2009.05.005; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Dale C, 2006, CELL, V126, P453, DOI 10.1016/j.cell.2006.07.014; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Engelbrektson A, 2009, J MED MICROBIOL, V58, P663, DOI 10.1099/jmm.0.47615-0; Fish JL, 2003, AM J PHYS ANTHROPOL, V120, P171, DOI 10.1002/ajpa.10136; FLEAGLE JG, 1999, PRIMATE ADAPTATION E; Flint HJ, 2008, ANN NY ACAD SCI, V1125, P280, DOI 10.1196/annals.1419.022; Frey JC, 2006, APPL ENVIRON MICROB, V72, P3788, DOI 10.1128/AEM.72.5.3788-3792.2006; Goldberg TL, 2008, EMERG INFECT DIS, V14, P1375, DOI [10.3201/eid14.9.071196, 10.3201/eid1409.071196]; Griswold KE, 1999, CURR MICROBIOL, V39, P187, DOI 10.1007/s002849900443; Hickman C. S., 2005, INFLUENCE COOPERATIV, P3; Holmstrom K, 2004, ANAEROBE, V10, P197, DOI 10.1016/j.anaerobe.2004.01.004; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; JAFFE KE, 2007, PRIMATES PERSPECTIVE, P203; Kisidayova S, 2009, AM J PRIMATOL, V71, P548, DOI 10.1002/ajp.20687; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lambert JE, 2002, GUENONS DIVERSITY AD, P303; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; McFall-Ngai MJ, 2002, DEV BIOL, V242, P1, DOI 10.1006/dbio.2001.0522; Moran NA, 2006, CURR BIOL, V16, pR866, DOI 10.1016/j.cub.2006.09.019; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Nicholson JK, 2005, NAT REV MICROBIOL, V3, P431, DOI 10.1038/nrmicro1152; Oh PL, 2010, ISME J, V4, P377, DOI 10.1038/ismej.2009.123; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Schloss PD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008230; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schultze M, 1998, ANNU REV GENET, V32, P33, DOI 10.1146/annurev.genet.32.1.33; Szekely BA, 2010, AM J PRIMATOL, V72, P566, DOI 10.1002/ajp.20809; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Uenishi G, 2007, AM J PRIMATOL, V69, P367, DOI 10.1002/ajp.20351; Ungar PS, 2006, ANNU REV ANTHROPOL, V35, P209, DOI 10.1146/annurev.anthro.35.081705.123153; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wasserman MD, 2003, J ANIM ECOL, V72, P650, DOI 10.1046/j.1365-2656.2003.00736.x; Wood B, 1999, NATURE, V400, P219, DOI 10.1038/22227; Xu B, 2010, AM J PRIMATOL, V72, P699, DOI 10.1002/ajp.20826; Youssef N, 2009, APPL ENVIRON MICROB, V75, P5227, DOI 10.1128/AEM.00592-09	49	154	160	1	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e13963	10.1371/journal.pone.0013963	http://dx.doi.org/10.1371/journal.pone.0013963			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103066	gold, Green Published			2022-12-25	WOS:000284147700013
J	Gutfraind, A				Gutfraind, Alexander			Optimizing Topological Cascade Resilience Based on the Structure of Terrorist Networks	PLOS ONE			English	Article								Complex socioeconomic networks such as information, finance and even terrorist networks need resilience to cascades - to prevent the failure of a single node from causing a far-reaching domino effect. We show that terrorist and guerrilla networks are uniquely cascade-resilient while maintaining high efficiency, but they become more vulnerable beyond a certain threshold. We also introduce an optimization method for constructing networks with high passive cascade resilience. The optimal networks are found to be based on cells, where each cell has a star topology. Counterintuitively, we find that there are conditions where networks should not be modified to stop cascades because doing so would come at a disproportionate loss of efficiency. Implementation of these findings can lead to more cascade-resilient networks in many diverse areas.	Los Alamos Natl Lab, Ctr Nonlinear Studies & T5 D6, Los Alamos, NM USA	United States Department of Energy (DOE); Los Alamos National Laboratory	Gutfraind, A (corresponding author), Los Alamos Natl Lab, Ctr Nonlinear Studies & T5 D6, Los Alamos, NM USA.	agutfraind.research@gmail.com	Gutfraind, Alexander/E-9641-2011	GUTFRAIND, ALEXANDER/0000-0002-3324-2220	Department of Energy at the Los Alamos National Laboratory [LA-UR 10-01563, DE-AC52-06NA25396]; Defense Threat Reduction Agency	Department of Energy at the Los Alamos National Laboratory; Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	This work was supported by the Department of Energy at the Los Alamos National Laboratory (LA-UR 10-01563) under contract DE-AC52-06NA25396 through the Laboratory Directed Research and Development program, and by the Defense Threat Reduction Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, CONNECTIONS; BAKER WE, 1993, AM SOCIOL REV, V58, P837, DOI 10.2307/2095954; Battiston S, 2007, J ECON DYN CONTROL, V31, P2061, DOI 10.1016/j.jedc.2007.01.004; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Centola D, 2007, AM J SOCIOL, V113, P702, DOI 10.1086/521848; Crepey P, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.046131; Dobson I, 2007, CHAOS, V17, DOI 10.1063/1.2737822; Draief M, 2008, ANN APPL PROBAB, V18, P359, DOI 10.1214/07-AAP470; Guimera R, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.065103; Gunther G., 1978, P ENGL MAN C NUM MAT, P285; Huang W, 2007, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2007/01/P01014; Iori G, 2008, J ECON DYN CONTROL, V32, P259, DOI 10.1016/j.jedc.2007.01.032; JOHNSON JK, 2010, 49 IEEE C DEC UNPUB; Kempe David, 2003, P 9 INT C KNOWL DISC, P137, DOI DOI 10.1145/956750.956769; Klau GW, 2005, LECT NOTES COMPUT SC, V3418, P417; Lai YC, 2004, LECT NOTES PHYS, V650, P299; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Leskovec J., 2005, P 11 ACM SIGKDD INT, P177, DOI DOI 10.1145/1081870.1081893; Leskovec J, 2007, ACM T WEB, V1, DOI 10.1145/1232722.1232727; Lindelauf R.H., 2008, HETEROGENEOUS COVERT; Lindelauf R, 2009, SOC NETWORKS, V31, P126, DOI 10.1016/j.socnet.2008.12.003; Miksche F.O., 1950, SECRET FORCES; Morselli C, 2007, SOC NETWORKS, V29, P143, DOI 10.1016/j.socnet.2006.05.001; Motter AE, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.098701; Motter AE, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.065103; Motter AE, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.065102; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Raab J, 2003, J PUBL ADM RES THEOR, V13, P413, DOI 10.1093/jopart/mug029; Ripeanu M, 2002, IEEE INTERNET COMPUT, V6, P50, DOI 10.1109/4236.978369; Rodriguez J., 2004, WORKING PAPERS EPP L; Sageman M, 2008, LEADERLESS JIHAD: TERROR NETWORKS IN THE TWENTY-FIRST CENTURY, P1; Sharp G., 2003, DICTATORSHIP DEMOCRA; U.S. Government, 2007, 9 11 COMM REP; Watts DJ, 2002, P NATL ACAD SCI USA, V99, P5766, DOI 10.1073/pnas.082090499; Woo G, 2009, MATHEMATICAL METHODS IN COUNTERTERRORISM, P205, DOI 10.1007/978-3-211-09442-6_12; ZAWODNY JK, 1978, TERRORISM, V1, P277	39	28	28	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e13448	10.1371/journal.pone.0013448	http://dx.doi.org/10.1371/journal.pone.0013448			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	677ZN	21085710	Green Submitted, Green Published, gold			2022-12-25	WOS:000284036800003
J	Kresse, SH; Ohnstad, HO; Bjerkehagen, B; Myklebost, O; Meza-Zepeda, LA				Kresse, Stine H.; Ohnstad, Hege O.; Bjerkehagen, Bodil; Myklebost, Ola; Meza-Zepeda, Leonardo A.			DNA Copy Number Changes in Human Malignant Fibrous Histiocytomas by Array Comparative Genomic Hybridisation	PLOS ONE			English	Article							SOFT-TISSUE TUMORS; IMBALANCES; GENE; REVEALS; LEIOMYOSARCOMA; CHROMOSOME-13; OSTEOSARCOMAS; DELETIONS; TARGET; CGH	Background: Malignant fibrous histiocytomas (MFHs), or undifferentiated pleomorphic sarcomas, are in general high-grade tumours with extensive chromosomal aberrations. In order to identify recurrent chromosomal regions of gain and loss, as well as novel gene targets of potential importance for MFH development and/or progression, we have analysed DNA copy number changes in 33 MFHs using microarray-based comparative genomic hybridisation (array CGH). Principal findings: In general, the tumours showed numerous gains and losses of large chromosomal regions. The most frequent minimal recurrent regions of gain were 1p33-p32.3, 1p31.3-p31.2 and 1p21.3 (all gained in 58% of the samples), as well as 1q21.2-q21.3 and 20q13.2 (both 55%). The most frequent minimal recurrent regions of loss were 10q25.3-q26.11, 13q13.3-q14.2 and 13q14.3-q21.1 (all lost in 64% of the samples), as well as 2q36.3-q37.2 (61%), 1q41 (55%) and 16q12.1-q12.2 (52%). Statistical analyses revealed that gain of 1p33-p32.3 and 1p21.3 was significantly associated with better patient survival (P = 0.021 and 0.046, respectively). Comparison with similar array CGH data from 44 leiomyosarcomas identified seven chromosomal regions; 1p36.32-p35.2, 1p21.3-p21.1, 1q32.1-q42.13, 2q14.1-q22.2, 4q33-q34.3, 6p25.1-p21.32 and 7p22.3-p13, which were significantly different in copy number between the MFHs and leiomyosarcomas. Conclusions: A number of recurrent regions of gain and loss have been identified, some of which were associated with better patient survival. Several specific chromosomal regions with significant differences in copy number between MFHs and leiomyosarcomas were identified, and these aberrations may be used as additional tools for the differential diagnosis of MFHs and leiomyosarcomas.	[Kresse, Stine H.; Ohnstad, Hege O.; Myklebost, Ola; Meza-Zepeda, Leonardo A.] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Tumour Biol, Oslo, Norway; [Bjerkehagen, Bodil] Oslo Univ Hosp, Norwegian Radium Hosp, Pathol Clin, Oslo, Norway; [Myklebost, Ola; Meza-Zepeda, Leonardo A.] Univ Oslo, Dept Mol Biosci, Norwegian Microarray Consortium, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Kresse, SH (corresponding author), Oslo Univ Hosp, Norwegian Radium Hosp, Dept Tumour Biol, Oslo, Norway.	leonardm@rr-research.no	Meza-Zepeda, Leonardo Andres/CAG-5229-2022; Myklebost, Ola/E-9335-2010	Meza-Zepeda, Leonardo Andres/0000-0003-3056-212X; Myklebost, Ola/0000-0002-2866-3223	Norwegian Research Council; Norwegian Cancer Society	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society)	Microarray analyses were supported by the FUnctional GEnomic (FUGE) Platform for Microarray Technology (Norwegian Microarray Consortium, www.microarray.no), funded by the Norwegian Research Council (www.forskningsradet.no). The present study was supported by The Norwegian Cancer Society (www.kreftforeningen.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carneiro A, 2009, LAB INVEST, V89, P668, DOI 10.1038/labinvest.2009.18; Chibon F, 2004, GENE CHROMOSOME CANC, V40, P32, DOI 10.1002/gcc.20012; Chibon F, 2002, CANCER GENET CYTOGEN, V139, P24, DOI 10.1016/S0165-4608(02)00614-3; Chibon F, 2000, CANCER RES, V60, P6339; Dysvik B, 2001, BIOINFORMATICS, V17, P369, DOI 10.1093/bioinformatics/17.4.369; Fletcher CDM, 2006, HISTOPATHOLOGY, V48, P3, DOI 10.1111/j.1365-2559.2005.02284.x; Fletcher CDM, 2002, WHO CLASSIFICATION T; Guillou L, 2010, VIRCHOWS ARCH, V456, P201, DOI 10.1007/s00428-009-0853-4; Hinze R, 1999, INT J MOL MED, V3, P75; Idbaih A, 2005, LAB INVEST, V85, P176, DOI 10.1038/labinvest.3700202; Kresse SH, 2009, GENE CHROMOSOME CANC, V48, P679, DOI 10.1002/gcc.20675; Larramendy ML, 2008, CANCER GENET CYTOGEN, V187, P1, DOI 10.1016/j.cancergencyto.2008.06.005; Larramendy ML, 1997, AM J PATHOL, V151, P1153; Lau CC, 2004, GENE CHROMOSOME CANC, V39, P11, DOI 10.1002/gcc.10291; Lingjaerde OC, 2005, BIOINFORMATICS, V21, P821, DOI 10.1093/bioinformatics/bti113; Mairal A, 1999, CANCER GENET CYTOGEN, V111, P134, DOI 10.1016/S0165-4608(98)00227-1; Meza-Zepeda LA, 2006, CANCER RES, V66, P8984, DOI 10.1158/0008-5472.CAN-06-1972; Ozaki T, 2002, INT J CANCER, V102, P355, DOI 10.1002/ijc.10709; Parente F, 1999, CANCER GENET CYTOGEN, V115, P89, DOI 10.1016/S0165-4608(99)00082-5; Sakabe T, 1999, CANCER RES, V59, P511; Simons A, 2000, CANCER GENET CYTOGEN, V118, P89, DOI 10.1016/S0165-4608(99)00178-8; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang JB, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-74; Weiss SW, 2008, ENZINGER WEISSS SOFT, P303; Weng WH, 2003, BRIT J CANCER, V89, P720, DOI 10.1038/sj.bjc.6601069	25	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e15378	10.1371/journal.pone.0015378	http://dx.doi.org/10.1371/journal.pone.0015378			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085701	Green Published, gold, Green Submitted			2022-12-25	WOS:000284035900024
J	Kintzer, AF; Sterling, HJ; Tang, II; Williams, ER; Krantz, BA				Kintzer, Alexander F.; Sterling, Harry J.; Tang, Iok I.; Williams, Evan R.; Krantz, Bryan A.			Anthrax Toxin Receptor Drives Protective Antigen Oligomerization and Stabilizes the Heptameric and Octameric Oligomer by a Similar Mechanism	PLOS ONE			English	Article							BACILLUS-ANTHRACIS; LETHAL FACTOR; CRYSTAL-STRUCTURE; EDEMA FACTOR; PROTEOLYTIC INACTIVATION; ADENYLATE-CYCLASE; DEPENDENT PROCESS; EUKARYOTIC CELLS; PORE FORMATION; KINASE-KINASE	Background: Anthrax toxin is comprised of protective antigen (PA), lethal factor (LF), and edema factor (EF). These proteins are individually nontoxic; however, when PA assembles with LF and EF, it produces lethal toxin and edema toxin, respectively. Assembly occurs either on cell surfaces or in plasma. In each milieu, PA assembles into a mixture of heptameric and octameric complexes that bind LF and EF. While octameric PA is the predominant form identified in plasma under physiological conditions (pH 7.4, 37 degrees C), heptameric PA is more prevalent on cell surfaces. The difference between these two environments is that the anthrax toxin receptor (ANTXR) binds to PA on cell surfaces. It is known that the extracellular ANTXR domain serves to stabilize toxin complexes containing the PA heptamer by preventing premature PA channel formation-a process that inactivates the toxin. The role of ANTXR in PA oligomerization and in the stabilization of toxin complexes containing octameric PA are not understood. Methodology: Using a fluorescence assembly assay, we show that the extracellular ANTXR domain drives PA oligomerization. Moreover, a dimeric ANTXR construct increases the extent of and accelerates the rate of PA assembly relative to a monomeric ANTXR construct. Mass spectrometry analysis shows that heptameric and octameric PA oligomers bind a full stoichiometric complement of ANTXR domains. Electron microscopy and circular dichroism studies reveal that the two different PA oligomers are equally stabilized by ANTXR interactions. Conclusions: We propose that PA oligomerization is driven by dimeric ANTXR complexes on cell surfaces. Through their interaction with the ANTXR, toxin complexes containing heptameric and octameric PA oligomers are similarly stabilized. Considering both the relative instability of the PA heptamer and extracellular assembly pathway identified in plasma, we propose a means to regulate the development of toxin gradients around sites of infection during anthrax pathogenesis.	[Kintzer, Alexander F.; Sterling, Harry J.; Tang, Iok I.; Williams, Evan R.; Krantz, Bryan A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Williams, Evan R.; Krantz, Bryan A.] Univ Calif Berkeley, Calif Inst Quantitat Biomed Res QB3, Berkeley, CA 94720 USA; [Krantz, Bryan A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Kintzer, AF (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	bakrantz@berkeley.edu	Williams, Evan/I-3924-2013	Kintzer, Alexander/0000-0001-9630-7258; Krantz, Bryan/0000-0002-4911-5824	University of California; National Institutes of Health [R01-AI077703, R01-GM064712]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064712] Funding Source: NIH RePORTER	University of California(University of California System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by University of California start-up funds and the following National Institutes of Health research grants: R01-AI077703 (to B.A.K.) and R01-GM064712 (to E.R.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; BEALL FA, 1962, J BACTERIOL, V83, P1274, DOI 10.1128/JB.83.6.1274-1280.1962; Beauregard KE, 2000, CELL MICROBIOL, V2, P251, DOI 10.1046/j.1462-5822.2000.00052.x; BLAUSTEIN RO, 1989, P NATL ACAD SCI USA, V86, P2209, DOI 10.1073/pnas.86.7.2209; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Christensen KA, 2006, BIOCHEMISTRY-US, V45, P2380, DOI 10.1021/bi051830y; Cunningham K, 2002, P NATL ACAD SCI USA, V99, P7049, DOI 10.1073/pnas.062160399; Drum CL, 2002, NATURE, V415, P396, DOI 10.1038/415396a; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Duesbery NS, 1999, J APPL MICROBIOL, V87, P289, DOI 10.1046/j.1365-2672.1999.00892.x; Elliott JL, 2000, BIOCHEMISTRY-US, V39, P6706, DOI 10.1021/bi000310u; Ezzell JW, 2009, INFECT IMMUN, V77, P749, DOI 10.1128/IAI.00764-08; EZZELL JW, 1992, J GEN MICROBIOLOGY, V138; Fabrini R, 2009, BIOCHEMISTRY-US, V48, P10473, DOI 10.1021/bi901238t; FISH DC, 1968, J BACTERIOL, V95, P919, DOI 10.1128/JB.95.3.919-924.1968; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; FRIEDLANDER AM, 1986, J BIOL CHEM, V261, P7123; Go MY, 2006, J MOL BIOL, V360, P145, DOI 10.1016/j.jmb.2006.04.072; JI X, 1993, BIOCHEMISTRY-US, V32, P12949, DOI 10.1021/bi00211a001; Katayama H, 2008, NAT STRUCT MOL BIOL, V15, P754, DOI 10.1038/nsmb.1442; Kintzer AF, 2010, J MOL BIOL, V399, P741, DOI 10.1016/j.jmb.2010.04.041; Kintzer AF, 2009, J MOL BIOL, V392, P614, DOI 10.1016/j.jmb.2009.07.037; Lacy DB, 2004, P NATL ACAD SCI USA, V101, P6367, DOI 10.1073/pnas.0401506101; Lacy DB, 2004, P NATL ACAD SCI USA, V101, P13147, DOI 10.1073/pnas.0405405101; Lacy DB, 2002, J BIOL CHEM, V277, P3006, DOI 10.1074/jbc.M109997200; LEPPLA SH, 1984, ADV CYCLIC NUCL PROT, V17, P189; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Liu SH, 2003, J BIOL CHEM, V278, P5227, DOI 10.1074/jbc.M210321200; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mabry R, 2006, CLIN VACCINE IMMUNOL, V13, P671, DOI 10.1128/CVI.00023-06; Miller CJ, 1999, BIOCHEMISTRY-US, V38, P10432, DOI 10.1021/bi990792d; MILNE JC, 1994, J BIOL CHEM, V269, P20607; MMITH H, 1954, NATURE, V173, P689; Pannifer AD, 2001, NATURE, V414, P229, DOI 10.1038/n35101998; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; PEZARD C, 1991, INFECT IMMUN, V59, P3472, DOI 10.1128/IAI.59.10.3472-3477.1991; Santelli E, 2004, NATURE, V430, P905, DOI 10.1038/nature02763; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; STANLEY JL, 1961, J GEN MICROBIOL, V26, P49, DOI 10.1099/00221287-26-1-49; STARK H, 1995, STRUCTURE, V3, P815, DOI 10.1016/S0969-2126(01)00216-7; Sun JJ, 2007, J BIOL CHEM, V282, P1059, DOI 10.1074/jbc.M609869200; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Vernier G, 2009, PROTEIN SCI, V18, P1882, DOI 10.1002/pro.199; Wigelsworth DJ, 2004, J BIOL CHEM, V279, P23349, DOI 10.1074/jbc.M401292200; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728	45	37	37	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e13888	10.1371/journal.pone.0013888	http://dx.doi.org/10.1371/journal.pone.0013888			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	676NU	21079738	Green Submitted, Green Published, gold			2022-12-25	WOS:000283920000018
J	Hu, CX; Hoene, M; Zhao, XJ; Haring, HU; Schleicher, E; Lehmann, R; Han, XL; Xu, GW; Weigert, C				Hu, Chunxiu; Hoene, Miriam; Zhao, Xinjie; Haering, Hans U.; Schleicher, Erwin; Lehmann, Rainer; Han, Xianlin; Xu, Guowang; Weigert, Cora			Lipidomics Analysis Reveals Efficient Storage of Hepatic Triacylglycerides Enriched in Unsaturated Fatty Acids after One Bout of Exercise in Mice	PLOS ONE			English	Article							LIFE-STYLE INTERVENTION; POSTPRANDIAL LIPEMIA; ENDURANCE EXERCISE; PROLONGED EXERCISE; SKELETAL-MUSCLE; ADIPOSE-TISSUE; SINGLE BOUT; TRIGLYCERIDE SECRETION; INSULIN SENSITIVITY; VLDL-TRIGLYCERIDE	Background: Endurance exercise induces lipolysis, increases circulating concentrations of free fatty acids (FFA) and the uptake and oxidation of fatty acids in the working muscle. Less is known about the regulation of lipid metabolism in the liver during and post-exercise. Methodology/Principal Findings: We performed an ultra fast liquid chromatography-mass spectrometry (UFLC-MS) based lipidomics analysis of liver tissue samples obtained from C57Bl/6J mice immediately after a 60 min treadmill run of moderate intensity, and after 3 h of recovery. The PLS-DA scores plot for 115 quantified lipid molecular species revealed a clear separation of the hepatic lipid profile of sedentary from recovering mice, but not from mice immediately after running. 21 lipid species were considered to be most responsible for the difference in the hepatic lipid profiles, including 17 triacylglycerides (TG), one lysophosphatidylcholine (LPC) and three phosphatidylcholines (PC). TG species were found to be more abundant in the recovery phase, while PC species were decreased. The degree of accumulation of individual TG species correlated well with the amount of theoretical energy stored whereas no increase was found for TG species containing only saturated or one monounsaturated fatty acid. Total liver TG content as assayed by an enzymatic method was increased to 163% in the recovery phase, while it was significantly decreased in skeletal muscle by the exercise bout and remained less in the recovery phase. Results from fasted and refed mice indicate that fasting-induced lipolysis was associated with a pronounced accumulation of hepatic TG, which is reversed by refeeding for 5 h. Thus food intake per se did not elevate hepatic TG. Conclusion: These data indicate that high availability of FFA induced by endurance exercise or fasting resulted in a transient hepatic TG accumulation, while muscle TG content was decreased during exercise presumably due to increased muscle fatty acid oxidation.	[Hu, Chunxiu; Zhao, Xinjie; Xu, Guowang] Chinese Acad Sci, Dalian Inst Chem Phys, CAS Key Lab Separat Sci Analyt Chem, Dalian, Peoples R China; [Hoene, Miriam; Haering, Hans U.; Schleicher, Erwin; Lehmann, Rainer; Weigert, Cora] Univ Hosp Tuebingen, Div Endocrinol, Dept Internal Med, Tubingen, Germany; [Han, Xianlin] Washington Univ, Sch Med, Dept Med, Div Bioorgan Chem & Mol Pharmacol, St Louis, MO 63110 USA; [Hoene, Miriam; Haering, Hans U.; Schleicher, Erwin; Lehmann, Rainer; Weigert, Cora] Paul Langerhans Inst Tuebingen, Tubingen, Germany	Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Washington University (WUSTL)	Hu, CX (corresponding author), Chinese Acad Sci, Dalian Inst Chem Phys, CAS Key Lab Separat Sci Analyt Chem, Dalian, Peoples R China.	xugw@dicp.ac.cn; Cora.Weigert@med.uni-tuebingen.de	Lehmann, Rainer/AAF-4281-2019; Xu, Guowang/L-6910-2014; Wang, Congrong/HDM-0959-2022	Lehmann, Rainer/0000-0003-1218-6810; Xu, Guowang/0000-0003-4298-3554; Hu, Cheng/0000-0003-4314-2386; Wang, Congrong/0000-0002-8645-1114	Deutsche Forschungsgemeinschaft [WE 4176, GRK 1302/1]; Federal Ministry of Education and Research [FKZ 01GI0803-04]; German Federal Ministry of Education and Research (BMBF); Sino-German Center for Research Promotion [GZ 364]; State Ministry of Science and Technology of China [2006CB503902]; National Natural Science Foundation of China [20835006]; Chinese Academy of Sciences [KSCX1-YW-02]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Sino-German Center for Research Promotion; State Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was supported by grants from the Deutsche Forschungsgemeinschaft to C. W. (WE 4176) and to E. S. (GRK 1302/1), by the Kompetenznetz Diabetes mellitus (Competence Network for Diabetes mellitus) funded by the Federal Ministry of Education and Research to R. L. and H. U. H. (FKZ 01GI0803-04), by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.), the Sino-German Center for Research Promotion to R. L. and G. X. (DFG and NSFC, GZ 364), the 973 Project of the State Ministry of Science and Technology of China to G. X. (No. 2006CB503902), the National Natural Science Foundation of China to G. X. (No. 20835006), and the Knowledge Innovation Program of the Chinese Academy of Sciences to G. X. (KSCX1-YW-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLBORG G, 1974, J CLIN INVEST, V53, P1080, DOI 10.1172/JCI107645; ALDRED HE, 1994, METABOLISM, V43, P836, DOI 10.1016/0026-0495(94)90263-1; Andersson A, 1998, AM J PHYSIOL-ENDOC M, V274, pE432, DOI 10.1152/ajpendo.1998.274.3.E432; ANNUZZI G, 1987, METABOLISM, V36, P438, DOI 10.1016/0026-0495(87)90040-0; Bijlsma S, 2006, ANAL CHEM, V78, P567, DOI 10.1021/ac051495j; Borsheim E, 1999, MED SCI SPORT EXER, V31, P522; Burguera B, 2000, AM J PHYSIOL-ENDOC M, V278, pE113, DOI 10.1152/ajpendo.2000.278.1.E113; CHEN ZY, 1992, AM J PHYSIOL, V263, pR233, DOI 10.1152/ajpregu.1992.263.2.R233; CULLINANE E, 1982, METABOLISM, V31, P844, DOI 10.1016/0026-0495(82)90085-3; Eriksson L, 2001, MULTI AND MEGAVARIAT; Fernandez C, 2008, AM J PHYSIOL-ENDOC M, V295, pE179, DOI 10.1152/ajpendo.00282.2007; Gauthier MS, 2004, INT J OBESITY, V28, P1064, DOI 10.1038/sj.ijo.0802628; Gill JMR, 2001, EUR J CLIN INVEST, V31, P201, DOI 10.1046/j.1365-2362.2001.00799.x; GORSKI J, 1988, EUR J APPL PHYSIOL, V57, P554, DOI 10.1007/BF00418461; Han XL, 2004, BIOCHEMISTRY-US, V43, P15584, DOI 10.1021/bi048307o; Herd SL, 1998, BRIT J NUTR, V80, P57, DOI 10.1017/S0007114598001779; Hoene M, 2009, J PHYSIOL-LONDON, V587, P241, DOI 10.1113/jphysiol.2008.160275; HOLLOSZY JO, 1964, AM J CARDIOL, V14, P753, DOI 10.1016/0002-9149(64)90004-9; Hu CX, 2008, J PROTEOME RES, V7, P4982, DOI 10.1021/pr800373m; Jensen MD, 2003, ACTA PHYSIOL SCAND, V178, P385, DOI 10.1046/j.1365-201X.2003.01167.x; Johnson NA, 2009, HEPATOLOGY, V50, P1105, DOI 10.1002/hep.23129; Larson-Meyer DE, 2006, DIABETES CARE, V29, P1337, DOI 10.2337/dc05-2565; Leon AS, 2001, MED SCI SPORT EXER, V33, pS502, DOI 10.1097/00005768-200106001-00021; Li ZZ, 2009, J BIOL CHEM, V284, P5637, DOI 10.1074/jbc.M807616200; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Magkos F, 2006, AM J PHYSIOL-ENDOC M, V290, pE355, DOI 10.1152/ajpendo.00259.2005; Magkos F, 2008, J APPL PHYSIOL, V105, P1228, DOI 10.1152/japplphysiol.90761.2008; Magkos F, 2007, AM J PHYSIOL-ENDOC M, V292, pE1568, DOI 10.1152/ajpendo.00636.2006; Mitchell TW, 2004, J APPL PHYSIOL, V97, P1823, DOI 10.1152/japplphysiol.00344.2004; MONDON CE, 1984, J APPL PHYSIOL, V57, P1466, DOI 10.1152/jappl.1984.57.5.1466; Nielsen HB, 2007, J APPL PHYSIOL, V103, P1227, DOI 10.1152/japplphysiol.00027.2007; Peter A, 2008, AM J PHYSIOL-ENDOC M, V295, pE339, DOI 10.1152/ajpendo.00022.2008; Petridou A, 2005, EUR J APPL PHYSIOL, V94, P84, DOI 10.1007/s00421-004-1294-z; Rector RS, 2008, AM J PHYSIOL-GASTR L, V294, pG619, DOI 10.1152/ajpgi.00428.2007; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; SADY SP, 1988, METABOLISM, V37, P568, DOI 10.1016/0026-0495(88)90173-4; Schafer S, 2007, EUR J CLIN INVEST, V37, P535, DOI 10.1111/j.1365-2362.2007.01820.x; Schoiswohl G, 2010, J LIPID RES, V51, P490, DOI 10.1194/jlr.M001073; SIMONELLI C, 1978, AM J PHYSIOL, V234, pE221, DOI 10.1152/ajpendo.1978.234.3.E221; Tamura Y, 2005, J CLIN ENDOCR METAB, V90, P3191, DOI 10.1210/jc.2004-1959; Thamer C, 2007, OBESITY, V15, P531, DOI 10.1038/oby.2007.568; TRISCARI J, 1980, METABOLISM, V29, P377, DOI 10.1016/0026-0495(80)90013-X; Tsekouras YE, 2008, AM J PHYSIOL-ENDOC M, V295, pE851, DOI 10.1152/ajpendo.90545.2008; Tsekouras YE, 2009, CLIN SCI, V116, P147, DOI 10.1042/CS20080078; van Ginneken V, 2007, BBA-MOL CELL BIOL L, V1771, P1263, DOI 10.1016/j.bbalip.2007.07.007; Vance DE, 2008, CURR OPIN LIPIDOL, V19, P229, DOI 10.1097/MOL.0b013e3282fee935; Vieira VJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE1164, DOI 10.1152/ajpendo.00054.2009; Wiklund S, 2008, ANAL CHEM, V80, P115, DOI 10.1021/ac0713510; Ziogas GG, 1997, MED SCI SPORT EXER, V29, P986, DOI 10.1097/00005768-199708000-00002	49	71	72	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13318	10.1371/journal.pone.0013318	http://dx.doi.org/10.1371/journal.pone.0013318			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967198	Green Published, gold			2022-12-25	WOS:000282869800021
